Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
DRUG
PRODUCTS
WITH
THERAPEUTIC
EQUIVALENCE
EVALUATIONS
32nd EDITION
THE PRODUCTS IN THIS LIST HAVE BEEN APPROVED UNDER SECTION 505 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
2012
with
THERAPEUTIC EQUIVALENCE EVALUATIONS
The products in this list have been approved under section 505 of the Federal Food, Drug, and Cosmetic Act. This volume is current through December 31, 2011.
32nd EDITION
2012
FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH APPROVED DRUG PRODUCTS with Therapeutic Equivalence Evaluations
CONTENTS
PAGE
..................iv
HOW TO USE THE DRUG PRODUCTS LISTS ..............................................................2-1
Key Sections for Using the Drug Product Lists ........2-1
Drug Product Illustration ......2-3
Therapeutic Equivalence Evaluations Illustration ....2-4
iii
iv
on October 31, 1980 (45 FR 72582). The first publication, October 1980, of the final version of the List incorporated appropriate corrections and additions. Each subsequent edition has included the new approvals and made appropriate changes in data. On September 24, 1984, the President signed into law the Drug Price Competition and Patent Term Restoration Act (1984 Amendments). The 1984 Amendments require that FDA, among other things, make publicly available a list of approved drug products with monthly supplements. The Approved Drug Products with Therapeutic Equivalence Evaluations publication and its monthly Cumulative Supplements satisfy this requirement. The Addendum to this publication identifies drugs that qualify under the 1984 Amendments for periods of exclusivity (during which ANDAs or applications described in Section 505(b)(2) of the Act for those drugs may not be submitted for a specified period of time and, if allowed to be submitted, would be tentatively approved) and provides patent information concerning the listed drugs which also may delay the approval of ANDAs or Section 505(b)(2) applications. The Addendum also provides additional information that may be helpful to those submitting a new drug application to the Agency. The Agency intends to use this publication to further its objective of obtaining input and comment on the publication itself and related Agency procedures. Therefore, if you have comments on how the publication can be improved, please send them to the Director, Division of Labeling and Program Support, HFD-610, Office of Generic Drugs, Center for Drug and Evaluation and Research, 7620 Standish Place, Rockville, MD 20855. Comments received are publicly available to the extent allowable under the Freedom of Information regulations.
1. INTRODUCTION
1.1 Content and Exclusion The List is composed of four parts: (1) approved prescription drug products with therapeutic equivalence evaluations; (2) approved over-the-counter (OTC) drug products for those drugs that may not be marketed without NDAs or ANDAs because they are not covered under existing OTC monographs; (3) drug products with approval under Section 505 of the Act administered by the Center for Biologics Evaluation and Research; and (4) a cumulative list of approved products that have never been marketed, are for exportation, are for military use, have been discontinued from marketing, or have had their approvals withdrawn for other than safety or efficacy reasons subsequent to being discontinued from marketing. 1 This publication also includes indices of prescription and OTC drug products by trade or established name (if no trade name exists) and by applicant name (holder of the approved application). All established names for active ingredients generally conform to official compendial names or United States Adopted Names (USAN) as prescribed in (21 CFR 299.4(e)). The latter list includes applicants names as abbreviated in this publication; in addition, a list of uniform terms is provided. An Addendum contains drug patent and exclusivity information for the Prescription, OTC, Discontinued Drug Product Lists, and for the Drug Products with Approval under Section 505 of the Act Administered by the Center for Biologics Evaluation and Research. The publication may include additional information that the Agency deems appropriate to disseminate. Prior to the 6th Edition, the publication had excluded OTC drug products and drug products with approval under Section 505 of the Act administered by the Center for Biologics Evaluation and Research because the main purpose of the publication was to provide information to states regarding FDA's recommendation as to which generic prescription drug products were acceptable candidates for drug product selection. The 1984 Amendments required the Agency to begin publishing an up-to-date list of all marketed drug products, OTC as well as prescription, that have been approved for safety and efficacy and for which new drug applications are required. Under the 1984 Amendments, some drug products are given tentative approvals. The Agency will not include drug products with tentative approval in the List. Tentative approval lists are available at ANDA (Generic) Drug Approvals. When the tentative approval becomes a full approval through a subsequent action letter to the application holder, the Agency will list the drug product and the final approval date in the appropriate approved drug product list. Distributors or repackagers of products on the List are not identified. Because distributors or repackagers are not required to notify FDA when they shift their sources of supply from one approved manufacturer to another, it is not possible to maintain complete information linking product approval with the distributor or repackager handling the products. 1.2 Therapeutic Equivalence-Related Terms Pharmaceutical Equivalents. Drug products are considered pharmaceutical equivalents if they contain the same active ingredient(s), are of the same
1 Newly approved products are added to parts 1, 2, or 3, of the List, depending on the dispensing requirements (prescription or OTC) or approval authority, unless the Orange Book staff is otherwise notified before publication.
vi
dosage form, route of administration and are identical in strength or concentration (e.g., chlordiazepoxide hydrochloride, 5mg capsules). Pharmaceutically equivalent drug products are formulated to contain the same amount of active ingredient in the same dosage form and to meet the same or compendial or other applicable standards (i.e., strength, quality, purity, and identity), but they may differ in characteristics such as shape, scoring configuration, release mechanisms, packaging, excipients (including colors, flavors, preservatives), expiration time, and, within certain limits, labeling. Pharmaceutical Alternatives. Drug products are considered pharmaceutical alternatives if they contain the same therapeutic moiety, but are different salts, esters, or complexes of that moiety, or are different dosage forms or strengths (e.g., tetracycline hydrochloride, 250mg capsules vs. tetracycline phosphate complex, 250mg capsules; quinidine sulfate, 200mg tablets vs. quinidine sulfate, 200mg capsules). Data are generally not available for FDA to make the determination of tablet to capsule bioequivalence. Different dosage forms and strengths within a product line by a single manufacturer are thus pharmaceutical alternatives, as are extended-release products when compared with immediate-release or standard-release formulations of the same active ingredient. Therapeutic Equivalents. Drug products are considered to be therapeutic equivalents only if they are pharmaceutical equivalents and if they can be expected to have the same clinical effect and safety profile when administered to patients under the conditions specified in the labeling. FDA classifies as therapeutically equivalent those products that meet the following general criteria: (1) they are approved as safe and effective; (2) they are pharmaceutical equivalents in that they (a) contain identical amounts of the same active drug ingredient in the same dosage form and route of administration, and (b) meet compendial or other applicable standards of strength, quality, purity, and identity; (3) they are bioequivalent in that (a) they do not present a known or potential bioequivalence problem, and they meet an acceptable in vitro standard, or (b) if they do present such a known or potential problem, they are shown to meet an appropriate bioequivalence standard; (4) they are adequately labeled; (5) they are manufactured in compliance with Current Good Manufacturing Practice regulations. The concept of therapeutic equivalence, as used to develop the List, applies only to drug products containing the same active ingredient(s) and does not encompass a comparison of different therapeutic agents used for the same condition (e.g., propoxyphene hydrochloride vs. pentazocine hydrochloride for the treatment of pain). Any drug product in the List repackaged and/or distributed by other than the application holder is considered to be therapeutically equivalent to the application holder's drug product even if the application holder's drug product is single source or coded as non-equivalent (e.g., BN). Also, distributors or repackagers of an application holder's drug product are considered to have the same code as the application holder. Therapeutic equivalence determinations are not made for unapproved, off-label indications. FDA considers drug products to be therapeutically equivalent if they meet the criteria outlined above, even though they may differ in certain other characteristics such as shape, scoring configuration, release mechanisms, packaging, excipients (including colors, flavors, preservatives), expiration date/time and minor aspects of labeling (e.g., the presence of specific pharmacokinetic information) and storage conditions. When such differences are important in the care of a particular patient, it may be appropriate for the prescribing physician to require that a particular brand be dispensed as a medical necessity. With this limitation, however, FDA believes that products classified as therapeutically equivalent can be substituted with the full expectation that the substituted product will produce the same clinical effect and safety profile as the prescribed product. Bioavailability. This term means the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes
vii
available at the site of action. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action. Bioequivalent Drug Products. This term describes pharmaceutical equivalent or pharmaceutical alternative products that display comparable bioavailability when studied under similar experimental conditions. Section 505 (j)(8)(B) of the Act describes one set of conditions under which a test and reference listed drug (see Section 1.4) shall be considered bioequivalent: the rate and extent of absorption of the test drug do not show a significant difference from the rate and extent of absorption of the reference drug when administered at the same molar dose of the therapeutic ingredient under similar experimental conditions in either a single dose or multiple doses; or the extent of absorption of the test drug does not show a significant difference from the extent of absorption of the reference drug when administered at the same molar dose of the therapeutic ingredient under similar experimental conditions in either a single dose or multiple doses and the difference from the reference drug in the rate of absorption of the drug is intentional, is reflected in its proposed labeling, is not essential to the attainment of effective body drug concentrations on chronic use, and is considered medically insignificant for the drug. Where these above methods are not applicable (e.g., for drug products that are not intended to be absorbed into the bloodstream), other in vivo or in vitro test methods to demonstrate bioequivalence may be appropriate. Bioequivalence may sometimes be demonstrated using an in vitro bioequivalence standard, especially when such an in vitro test has been correlated with human in vivo bioavailability data. In other situations, bioequivalence may sometimes be demonstrated through comparative clinical trials or pharmacodynamic studies. 1.3 Statistical Criteria for Bioequivalence Under the Drug Price Competition and Patent Term Restoration Act of 1984, manufacturers seeking approval to market a generic drug product must submit data demonstrating that the drug product is bioequivalent to the pioneer (innovator) drug product. A major premise underlying the 1984 law is that bioequivalent drug products are therapeutically equivalent, and therefore, interchangeable. Bioavailability refers to the rate and extent to which the active ingredient or therapeutic ingredient is absorbed from a drug product and becomes available at the site of drug action (Federal Food, Drug and Cosmetic Act, section 505(j)(8)). Bioequivalence refers to equivalent release of the same drug substance from two or more drug products or formulations. This leads to an equivalent rate and extent of absorption from these formulations. Underlying the concept of bioequivalence is the thesis that, if a drug product contains a drug substance that is chemically identical and is delivered to the site of action at the same rate and extent as another drug product, then it is equivalent and can be substituted for that drug product. Methods used to define bioequivalence can be found in 21 CFR 320.24, and include (1) pharmacokinetic (PK) studies, (2) pharmacodynamic (PD) studies, (3) comparative clinical trials, and (4) in-vitro studies. The choice of study used is based on the site of action of the drug and the ability of the study design to compare drug delivered to that site by the two products. The standard bioequivalence (PK) study is conducted using a two-treatment crossover study design in a limited number of volunteers, usually 24 to 36
viii
adults. Alternately, a four-period, replicate design crossover study may also be used. Single doses of the test and reference drug products are administered and blood or plasma levels of the drug are measured over time. Pharmacokinetic parameters characterizing rate and extent of drug absorption are evaluated statistically. The PK parameters of interest are the resulting area under the plasma concentration-time curve (AUC), calculated to the last measured concentration (AUC(0-t)) and extrapolated to infinity (AUC(0-inf)), for extent of absorption; and the maximum or peak drug concentrations (Cmax), for rate of absorption. Crossover studies may not be practical in drugs with a long half-life in the body, and a parallel study design may be used instead. Alternate study methods, such as in-vitro studies or equivalence studies with clinical or pharmacodynamic endpoints, are used for drug products where plasma concentrations are not useful to determine delivery of the drug substance to the site of activity (such as inhalers, nasal sprays and topical products applied to the skin). The statistical methodology for analyzing these bioequivalence studies is called the two one-sided test procedure. Two situations are tested with this statistical methodology. The first of the two one-sided tests determines whether a generic product (test), when substituted for a brand-name product (reference) is significantly less bioavailable. The second of the two onesided tests determines whether a brand-name product when substituted for a generic product is significantly less bioavailable. Based on the opinions of FDA medical experts, a difference of greater than 20% for each of the above tests was determined to be significant, and therefore, undesirable for all drug products. Numerically, this is expressed as a limit of test-product average/reference-product average of 80% for the first statistical test and a limit of reference-product average/test-product average of 80% for the second statistical test. By convention, all data is expressed as a ratio of the average response (AUC and Cmax) for test/reference, so the limit expressed in the second statistical test is 125% (reciprocal of 80%). For statistical reasons, all data is log-transformed prior to conducting statistical testing. In practice, these statistical tests are carried out using an analysis of variance procedure (ANOVA) and calculating a 90% confidence interval for each pharmacokinetic parameter (Cmax and AUC). The confidence interval for both pharmacokinetic parameters, AUC and Cmax, must be entirely within the 80% to 125% boundaries cited above. Because the mean of the study data lies in the center of the 90% confidence interval, the mean of the data is usually close to 100% (a test/reference ratio of 1). Different statistical criteria are sometimes used when bioequivalence is demonstrated through comparative clinical trials pharmacodynamic studies, or comparative in-vitro methodology. The bioequivalence methodology and criteria described above simultaneously control for both differences in the average response between test and reference, as well as the precision with which the average response in the population is estimated. This precision depends on the within-subject (normal volunteer or patient) variability in the pharmacokinetic parameters (AUC and Cmax) of the two products and on the number of subjects in the study. The width of the 90% confidence interval is a reflection in part of the withinsubject variability of the test and reference products in the bioequivalence study. A test product with no differences in the average response when compared to the reference might still fail to pass the bioequivalence criteria if the variability of one or both products is high and the bioequivalence study has insufficient statistical power (i.e., insufficient number of subjects). Likewise, a test product with low variability may pass the bioequivalence criteria, when there are somewhat larger differences in the average response. This system of assessing bioequivalence of generic products assures that these substitutable products do not deviate substantially in in-vivo performance from the reference product. The Office of Generic Drugs has conducted two surveys to quantify the differences between generic and brand name products. The first survey included 224 bioequivalence studies submitted
ix
in approved applications during 1985 and 1986. The observed average differences between reference and generic products for AUC was 3.5% (JAMA, Sept. 4, 1987, Vol. 258, No. 9). The second survey included 127 bioequivalence studies submitted to the agency in 273 ANDAs approved in 1997. The three measures reviewed include AUC(0-t), AUC(0-inf), and Cmax. The observed average differences between the reference and generic products were + 3.47% (SD 2.84) for AUC(0-t), + 3.25% (SD 2.97) for AUC(0-inf), and + 4.29% (SD 3.72) for Cmax (JAMA, Dec. 1, 1999, Vol. 282, No. 21). The primary concern from the regulatory point of view is the protection of the patient against approval of products that are not bioequivalent. The current practice of carrying out two one-sided tests at the 0.05 level of significance ensures that there is no more than a 5% chance that a generic product that is not truly equivalent to the reference will be approved. 1.4 Reference Listed Drug A reference listed drug (21 CFR 314.94(a)(3)) means the listed drug identified by FDA as the drug product upon which an applicant relies in seeking approval of its ANDA. FDA has identified in the Prescription Drug Product and OTC Drug Product Lists those reference listed drugs to which the in vivo bioequivalence (reference standard) and, in some instances, the in vitro bioequivalence of the applicant's product is compared. By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. Such variations could result if generic drugs were compared to different reference listed drugs. However, in some instances when listed drugs are approved for a single drug product, a product not designated as the reference listed drug and not shown to be bioequivalent to the reference listed drug may be shielded from generic competition. A firm wishing to market a generic version of a listed drug that is not designated as the reference listed drug may petition the Agency through the Citizen Petition procedure (see 21 CFR 10.25(a) and CFR 10.30). When the Citizen Petition is approved, the second listed drug will be designated as an additional reference listed drug and the petitioner may submit an Abbreviated New Drug Application citing the designated reference listed drug. Section 1.7, Therapeutic Equivalence Evaluations Codes products meeting necessary bioequivalence requirements explains the (AB, AB1, AB2, AB3... coding system for multisource drug products listed under the same heading with two reference listed drugs. In addition, there are two situations in which two listed drugs that have been shown to be bioequivalent to each other may both be designated as reference listed drugs. The first situation occurs when the in vivo determination of bioequivalence is self-evident and a waiver of the in vivo bioequivalence may be granted. The second situation occurs when the bioequivalence of two listed products may be determined through in vitro methodology. The reference listed drug is identified by the symbol "+" in the Prescription and Over-the-Counter (OTC) Drug Product Lists. These identified reference listed drugs represent the best judgment of the Division of Bioequivalence at this time. The Prescription and OTC Drug Product Lists identify reference drugs for oral dosage forms, Injectables, ophthalmics, otics, and topical products. It is recommended that a firm planning to conduct an in vivo bioequivalence study, or planning to manufacture a batch of a drug product for which an in vivo waiver of bioequivalence will be requested, contact the Division of Bioequivalence, Office of Generic Drugs, to confirm the appropriate reference listed drug.
1.5 General Policies and Legal Status The List contains public information and advice. It does not mandate the drug products which is purchased, prescribed, dispensed, or substituted for one another, nor does it, conversely, mandate the products that should be avoided. To the extent that the List sets forth FDA's evaluations of the therapeutic equivalence of drug products that have been approved, it contains FDA's advice to the public, to practitioners and to the states regarding drug product selection. These evaluations do not constitute determinations that any product is in violation of the Act or that any product is preferable to any other. Therapeutic equivalence evaluations are a scientific judgment based upon evidence, while generic substitution may involve social and economic policy administered by the states, intended to reduce the cost of drugs to consumers. To the extent that the List identifies drug products approved under Section 505 of the Act, it sets forth information that the Agency is required to publish and that the public is entitled to under the Freedom of Information Act. Exclusion of a drug product from the List does not necessarily mean that the drug product is either in violation of Section 505 of the Act, or that such a product is not safe or effective, or that such a product is not therapeutically equivalent to other drug products. Rather, the exclusion is based on the fact that FDA has not evaluated the safety, effectiveness, and quality of the drug product. 1.6 Practitioner/User Responsibilities
Professional care and judgment should be exercised in using the List. Evaluations of therapeutic equivalence for prescription drugs are based on scientific and medical evaluations by FDA. Products evaluated as therapeutically equivalent can be expected, in the judgment of FDA, to have equivalent clinical effect and no difference in their potential for adverse effects when used under the conditions of their labeling. However, these products may differ in other characteristics such as shape, scoring configuration, release mechanisms, packaging, excipients (including colors, flavors, preservatives), expiration date/time, and, in some instances, labeling. If products with such differences are substituted for each other, there is a potential for patient confusion due to differences in color or shape of tablets, inability to provide a given dose using a partial tablet if the proper scoring configuration is not available, or decreased patient acceptance of certain products because of flavor. There may also be better stability of one product over another under adverse storage conditions, or allergic reactions in rare cases due to a coloring or a preservative ingredient, as well as differences in cost to the patient. FDA evaluation of therapeutic equivalence in no way relieves practitioners of their professional responsibilities in prescribing and dispensing such products with due care and with appropriate information to individual patients. In those circumstances where the characteristics of a specific product, other than its active ingredient, are important in the therapy of a particular patient, the physician's specification of that product is appropriate. Pharmacists must also be familiar with the expiration dates/times and labeling directions for storage of the different products, particularly for reconstituted products, to assure that patients are properly advised when one product is substituted for another. Multisource and single-source drug products. FDA has evaluated for therapeutic equivalence only multisource prescription drug products approved under Section 505 of the Act, which in most instances means those pharmaceutical equivalents available from more than one manufacturer. For such products, a therapeutic equivalence code is included and, in addition, product information is highlighted in bold face and underlined. Those products with approved applications that are single-source (i.e., there is only one approved product available for that active ingredient, dosage form, route of administration, and strength) are also included on the List, but no therapeutic equivalence code is included with such products. Any drug product
xi
in the List repackaged and/or distributed by other than the application holder is considered to be therapeutically equivalent to the application holder's drug product even if the application holder's drug product is single source or coded as non-equivalent (e.g., BN). Also, although not identified in the List, distributors or repackagers of an application holder's drug product are considered to have the same code as the application holder. The details of these codes and the policies underlying them are discussed in Section 1.7, Therapeutic Equivalence Evaluations Codes. Products on the List are identified by the names of the holders of approved applications (applicants) who may not necessarily be the manufacturer of the product. The applicant may have had its product manufactured by a contract manufacturer and may simply be distributing the product for which it has obtained approval. In most instances, however, the manufacturer of the product is also the applicant. The name of the manufacturer is permitted by regulation to appear on the label, even when the manufacturer is not the marketer. Although the products on the List are identified by the names of the applicants, circumstances, such as changing corporate ownership, have sometimes made identification of the applicant difficult. The Agency believes, based on continuing document review and communication with firms, that the applicant designations on the List are, in most cases, correct. To relate firm name information on a product label to that on the List, the following should be noted: the applicant's name always appears on the List. This applies whether the applicant (firm name on the Form FDA 356h in the application) is the marketer (firm name in largest letters on the label) or not. However, the applicant's name may not always appear on the label of the product. If the applicant is the marketer, its name appears on the List and on the label; if the applicant is not the marketer, and the Agency is aware of a corporate relationship (e.g., parent and subsidiary) between the applicant and the marketer, the name of the applicant appears on the List and both firm names may appear on the label. Firms with known corporate relationships are displayed in Appendix B. If there is no known corporate relationship between the applicant and the marketer, the applicant's name appears on the List; however, unless the applicant is the manufacturer, packager, or distributor, the applicant's name may not appear on the label. In this case, the practitioner, from labeling alone, will not be able to relate the marketed product to an applicant cited in the List, and hence to a specific approved drug product. In such cases, to assure that the product in question is the subject of an approved application, the firm named on the label should be contacted. To relate trade name (proprietary name) information on a product label to that on the List, the following should be noted: if the applicant is the marketer, its name appears on the List and on the label; if the Agency is aware of a corporate relationship between the applicant and the marketer, the trade name (proprietary name) of the drug product (established drug name if no trade name exists) appears on the List. If a corporate relationship exists between an application holder and a marketer and both firms are distributing the drug product, the FDA reserves the right to select the trade name of either the marketer or the application holder to appear on the List. If there is no known corporate relationship between the applicant and the marketer, the established drug name appears on the List. Every product on the List is subject at all times to regulatory action. From time to time, approved products may be found in violation of one or more provisions of the Act. In such circumstances, the Agency will commence appropriate enforcement action to correct the violation, if necessary, by securing removal of the product from the market by voluntary recall, seizure, or other enforcement actions. Such regulatory actions are, however, independent of the inclusion of a product on the List. The main criterion for
xii
inclusion of a product is that it has an application with an effective approval that has not been withdrawn for safety or efficacy reasons. FDA believes that retention of a violative product on the List will not have any significant adverse health consequences, because other legal mechanisms are available to the Agency to prevent the product's actual marketing. FDA may however, change a product's therapeutic equivalence rating if the circumstances giving rise to the violation change or otherwise call into question the data upon which the Agency's assessment of whether a product meets the criteria for therapeutic equivalence was made.
1.7 Therapeutic Equivalence Evaluations Codes The coding system for therapeutic equivalence evaluations is constructed to allow users to determine quickly whether the Agency has evaluated a particular approved product as therapeutically equivalent to other pharmaceutically equivalent products (first letter) and to provide additional information on the basis of FDA's evaluations (second letter). With few exceptions, the therapeutic equivalence evaluation date is the same as the approval date. The two basic categories into which multisource drugs have been placed are indicated by the first letter as follows: A Drug products that FDA considers to be therapeutically equivalent to other pharmaceutically equivalent products, i.e., drug products for which: (1) there are no known or suspected bioequivalence problems. These are designated AA, AN, AO, AP, or AT, depending on the dosage form; or (2) actual or potential bioequivalence problems have been resolved with adequate in vivo and/or in vitro evidence supporting bioequivalence. These are designated AB. B Drug products that FDA at this time, considers not to be therapeutically equivalent to other pharmaceutically equivalent products, i.e., drug products for which actual or potential bioequivalence problems have not been resolved by adequate evidence of bioequivalence. Often the problem is with specific dosage forms rather than with the active ingredients. These are designated BC, BD, BE, BN, BP, BR, BS, BT, BX, or B*. Individual drug products have been evaluated as therapeutically equivalent to the reference product in accordance with the definitions and policies outlined below: "A" CODES Drug products that are considered to be therapeutically equivalent to other pharmaceutically equivalent products. "A" products are those for which actual or potential bioequivalence problems have been resolved with adequate in vivo and/or in vitro evidence supporting bio-equivalence. Drug products designated with an "A" code fall under one of two main policies: (1) for those active ingredients or dosage forms for which no in vivo bioequivalence issue is known or suspected, the information necessary to show bioequivalence between pharmaceutically equivalent products is presumed and considered self-evident based on other data in the application for some dosage forms (e.g., solutions) or satisfied for
xiii
solid oral dosage forms by a showing that an acceptable in vitro dissolution standard is met. A therapeutically equivalent rating is assigned such products so long as they are manufactured in accordance with Current Good Manufacturing Practice regulations and meet the other requirements of their approved applications (these are designated AA, AN, AO, AP, or AT, depending on the dosage form, as described below); or (2) for those DESI drug products containing active ingredients or dosage
forms that have been identified by FDA as having actual or potential
bioequivalence problems, and for post-1962 drug products in a dosage
form presenting a potential bioequivalence problem, an evaluation of
therapeutic equivalence is assigned to pharmaceutical equivalents only
if the approved application contains adequate scientific evidence
establishing through in vivo and/or in vitro studies the bioequivalence
of the product to a selected reference product (these products are
designated as AB).
There are some general principles that may affect the substitution of pharmaceutically equivalent products in specific cases. Prescribers and dispensers of drugs should be alert to these principles so as to deal appropriately with situations that require professional judgment and discretion. There may be labeling differences among pharmaceutically equivalent products that require attention on the part of the health professional. For example, pharmaceutically equivalent powders to be reconstituted for administration as oral or injectable liquids may vary with respect to their expiration time or storage conditions after reconstitution. An FDA evaluation that such products are therapeutically equivalent is applicable only when each product is reconstituted, stored, and used under the conditions specified in the labeling of that product. The Agency will use notes in this publication to point out special situations such as potential differences between two drug products that have been evaluated as bioequivalent and otherwise therapeutically equivalent, when they should be brought to the attention of health professionals. These notes are contained in Section 1.8, Description of Special Situations. For example, in rare instances, there may be variations among therapeutically equivalent products in their use or in conditions of administration. Such differences may be due to patent or exclusivity rights associated with such use. When such variations may, in the Agency's opinion, affect prescribing or substitution decisions by health professionals, a note will be added to Section 1.8. Also, occasionally a situation may arise in which changes in a listed drug product after its approval (for example, a change in dosing interval) may have an impact on the substitutability of already approved generic versions of that product that were rated by the Agency as therapeutically equivalent to the listed product. When such changes in the listed drug product are considered by the Agency to have a significant impact on therapeutic equivalence, the Agency will change the therapeutic equivalence ratings for other versions of the drug product unless the manufacturers of those other versions of the product provide additional information to assure equivalence under the changed conditions. Pending receipt of the additional data, the Agency may add a note to Section 1.8, or, in rare cases, may even change the therapeutic equivalence rating. In some cases (e.g., Isolyte S w/ Dextrose 5% in Plastic Container and Plasma-Lyte 148 and Dextrose 5% in Plastic Container), closely related products are listed as containing the same active ingredients, but in somewhat different amounts. In determining which of these products are pharmaceutically equivalent, the Agency has considered products to be pharmaceutically equivalent with labeled strengths of an ingredient that do not vary by more than 1%.
xiv
Different salts and esters of the same therapeutic moiety are regarded as pharmaceutical alternatives. For the purpose of this publication, such products are not considered to be therapeutically equivalent. There are no instances in this List where pharmaceutical alternatives are evaluated or coded with regard to therapeutic equivalence. Anhydrous and hydrated entities, as well as different polymorphs, are considered pharmaceutical equivalents and must meet the same standards and, where necessary, as in the case of ampicillin/ampicillin trihydrate, their equivalence is supported by appropriate bioavailability/bioequivalence studies. The codes in this book are not intended to preclude health care professionals from converting pharmaceutically different concentrations into pharmaceutical equivalents using accepted professional practice. Where package size variations have therapeutic implications, products so packaged have not been considered pharmaceutically equivalent. For example, some oral contraceptives are supplied in 21-tablet and 28-tablet packets; the 28-tablet packets contain 7 placebo or iron tablets. These two packaging configurations are not regarded as pharmaceutically equivalent; thus, they are not designated as therapeutically equivalent. Preservatives may differ among some therapeutically equivalent drug products. Differences in preservatives and other inactive ingredients do not affect FDA's evaluation of therapeutic equivalence except in cases where these components may influence bioequivalence or routes of administration. The specific sub-codes for those drugs evaluated as therapeutically equivalent and the policies underlying these sub-codes follow: AA Products in conventional dosage forms not presenting bioequivalence problems Products coded as AA contain active ingredients and dosage forms that are not regarded as presenting either actual or potential bioequivalence problems or drug quality or standards issues. However, all oral dosage forms must, nonetheless, meet an appropriate in vitro bioequivalence standard that is acceptable to the Agency in order to be approved. AB, AB1, AB2, AB3... Products meeting necessary bioequivalence requirements Multisource drug products listed under the same heading (i.e., identical active ingredients(s), dosage form, and route(s) of administration) and having the same strength (see Section 1.2, Therapeutic Equivalence-Related Terms, Pharmaceutical Equivalents) generally will be coded AB if a study is submitted demonstrating bioequivalence. In certain instances, a number is added to the end of the AB code to make a three character code (i.e., AB1, AB2, AB3, etc.). Three-character codes are assigned only in situations when more than one reference listed drug of the same strength has been designated under the same heading. Two or more reference listed drugs are generally selected only when there are at least two potential reference drug products which are not bioequivalent to each other. If a study is submitted that demonstrates bioequivalence to a specific listed drug product, the generic product will be given the same three-character code as the reference listed drug it was compared against. For example, Adalat CC (Miles) and Procardia XL (Pfizer), extendedrelease tablets, are listed under the active ingredient nifedipine. These drug products, listed under the same heading, are not bioequivalent to each other. Generic drug products deemed by FDA to be bioequivalent to Adalat CC and Procardia XL have been approved, Adalat CC and Procardia XL have been assigned ratings of AB1 and AB2, respectively. The generic drug products bioequivalent to Adalat CC would be assigned a rating of AB1 and those bioequivalent to Procardia XL would be assigned a rating of
xv
AB2. (The assignment of an AB1 or AB2 rating to a specific product does not imply product preference.) Even though drug products of distributors and/or repackagers are not included in the List, they are considered therapeutically equivalent to the application holder's drug product if the application holder's drug product is rated either with an AB or threecharacter code or is single source in the List. Drugs coded as AB under a heading are considered therapeutically equivalent only to other drugs coded as AB under that heading. Drugs coded with a three-character code under a heading are considered therapeutically equivalent only to other drugs coded with the same three-character code under that heading. AN Solutions and powders for aerosolization Uncertainty regarding the therapeutic equivalence of aerosolized products arises primarily because of differences in the drug delivery system. Solutions and powders intended for aerosolization that are marketed for use in any of several delivery systems are considered to be pharmaceutically and therapeutically equivalent and are coded AN. Those products that are compatible only with a specific delivery system or those products that are packaged in and with a specific delivery system are coded BN, unless they have met an appropriate bioequivalence standard. Solutions or suspensions in a specific delivery system will be coded AN if the bioequivalence standard is based upon in vitro methodology, if bioequivalence needs to be demonstrated by in vivo methodology then the drug products will be coded AB.
AO Injectable oil solutions The absorption of drugs in injectable (parenteral) oil solutions may vary substantially with the type of oil employed as a vehicle and the concentration of the active ingredient. Injectable oil solutions are therefore considered to be pharmaceutically and therapeutically equivalent only when the active ingredient, its concentration, and the type of oil used as a vehicle are all identical.
AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions It should be noted that even though injectable (parenteral) products under a specific listing may be evaluated as therapeutically equivalent, there may be important differences among the products in the general category, Injectable; Injection. For example, some injectable products that are rated therapeutically equivalent are labeled for different routes of administration. In addition, some products evaluated as therapeutically equivalent may have different preservatives or no preservatives at all. Injectable products available as dry powders for reconstitution, concentrated sterile solutions for dilution, or sterile solutions ready for injection are pharmaceutical alternative drug products. They are not rated as therapeutically equivalent (AP) to each other even if these pharmaceutical alternative drug products are designed to produce the same concentration prior to injection and are similarly labeled. Consistent with accepted professional practice, it is the responsibility of the prescriber, dispenser, or individual administering the product to be familiar with a product's labeling to assure that it is given only by the route(s) of administration stated in the labeling. Certain commonly used large volume intravenous products containers are not included on the List (e.g., dextrose dextrose injection 10%, sodium chloride injection 0.9%) products are on the market without FDA approval and the in glass injection 5%, since these FDA has not
xvi
published conditions for marketing such parenteral products under approved NDAs. When packaged in plastic containers, however, FDA regulations require approved applications prior to marketing. Approval then depends on, among other things, the extent of the available safety data involving the specific plastic component of the product. All large volume parenteral products are manufactured under similar standards, regardless of whether they are packaged in glass or plastic. Thus, FDA has no reason to believe that the packaging container of large volume parenteral drug products that are pharmaceutically equivalent would have any effect on their therapeutic equivalence. The strength of parenteral drugs products is defined as the total drug content of the container. Until recently the strength of liquid parenteral drug products in the Orange Book have not been displayed. The concentration of the liquid parenteral drug product in the Orange Book has been shown as xmg/ml. The amount of dry powder or freeze dried powder in a container has always been identified as the strength. With the finalization of the Waxman-Hatch amendments that characterized each strength of a drug product as a listed drug, it became evident that the format of the Orange Book should be changed to reflect each strength of a parenteral solution. To this end the OGD has started to display the strength of all new approvals of parenteral solutions. Previously we would have displayed only the concentration of an approved parenteral solution, e.g. 50mg/ml. If this drug product had a 20 ml and 60 ml container approved the two products would be shown as 1Gm / 20ml (50mg/ml) and 3Gm / 60ml (50mg/ml).
AT Topical products There are a variety of topical dosage forms available for dermatologic, ophthalmic, otic, rectal, and vaginal administration, including creams, gels, lotions, oils, ointments, pastes, solutions, sprays and suppositories. Even though different topical dosage forms may contain the same active ingredient and potency, these dosage forms are not considered pharmaceutically equivalent. Therefore, they are not considered therapeutically equivalent. All solutions and DESI drug products containing the same active ingredient in the same topical dosage form for which a waiver of in vivo bioequivalence has been granted and for which chemistry and manufacturing processes are adequate to demonstrate bioequivalence, are considered therapeutically equivalent and coded AT. Pharmaceutically equivalent topical products that raise questions of bioequivalence, including all post-1962 non-solution topical drug products, are coded AB when supported by adequate bioequivalence data, and BT in the absence of such data.
"B" CODES Drug products that FDA, at this time, considers not to be therapeutically equivalent to other pharmaceutically equivalent products. "B" products, for which actual or potential bioequivalence problems have not been resolved by adequate evidence of bioequivalence, often have a problem with specific dosage forms rather than with the active ingredients. Drug products designated with a "B" code fall under one of three main policies: (1) the drug products contain active ingredients or are manufactured in dosage forms that have been identified by the Agency as having documented bio-equivalence problems or a significant potential for such problems and for which no adequate studies demonstrating bioequivalence have been submitted to FDA; or
xvii
(2) (3)
the quality standards are inadequate or FDA has an insufficient basis to determine therapeutic equivalence; or the drug products are under regulatory review.
The specific coding definitions and policies for the "B" sub-codes are as follows:
B* Drug products requiring further FDA investigation and review to determine therapeutic equivalence The code B* is assigned to products previously assigned an A or B code when FDA receives new information that raises a significant question regarding therapeutic equivalence that can be resolved only through further Agency investigation and/or review of data and information submitted by the applicant. The B* code signifies that the Agency will take no position regarding the therapeutic equivalence of the product until the Agency completes its investigation and review. BC Extended-release dosage forms (capsules, injectables and tablets) Extended-release tablets are formulated in such a manner as to make the contained medicament available over an extended period of time following ingestion. Although bioavailability studies have been conducted on these dosage forms, they may be subject to bioavailability differences, primarily because firms developing extended-release products for the same active ingredient rarely employ the same formulation approach. FDA, therefore, does not consider different extended-release dosage forms containing the same active ingredient in equal strength to be therapeutically equivalent unless equivalence between individual products in both rate and extent has been specifically demonstrated through appropriate bioequivalence studies. Extended-release products for which such bioequivalence data have not been submitted are coded BC, while those for which such data are available have been coded AB.
BD Active ingredients and dosage forms with documented bioequivalence problems The BD code denotes products containing active ingredients with known bioequivalence problems and for which adequate studies have not been submitted to FDA demonstrating bioequivalence. Where studies showing bioequivalence have been submitted, the product has been coded AB.
BE Delayed-release oral dosage forms Where the drug may be destroyed or inactivated by the gastric juice or where it may irritate the gastric mucosa, the use of enteric coatings is indicated. Such coatings are intended to delay the release of the medication until the tablet has passed through the stomach. Drug products in delayed-release dosage forms containing the same active ingredients are subject to significant differences in absorption. Unless otherwise specifically noted, the Agency considers different delayed-release products containing the same active ingredients as presenting a potential bioequivalence problem and codes these products BE in the absence of in vivo studies showing bioequivalence. If adequate in vivo studies have demonstrated the bioequivalence of specific delayed-release products, such products are coded AB.
xviii
BN Products in aerosol-nebulizer drug delivery systems This code applies to drug solutions or powders that are marketed only as a component of, or as compatible with, a specific drug delivery system. There may, for example, be significant differences in the dose of drug and particle size delivered by different products of this type. Therefore, the Agency does not consider different metered aerosol dosage forms containing the same active ingredient(s) in equal strengths to be therapeutically equivalent unless the drug products meet an appropriate bioequivalence standard, such products are coded AB.
BP Active ingredients and dosage forms with potential bioequivalence problems FDA's bioequivalence regulations (21 CFR 320.33) contain criteria and procedures for determining whether a specific active ingredient in a specific dosage form has a potential for causing a bioequivalence problem. It is FDA's policy to consider an ingredient meeting these criteria as having a potential bioequivalence problem even in the absence of positive data demonstrating inequivalence. Pharmaceutically equivalent products containing these ingredients in oral dosage forms are coded BP until adequate in vivo bioequivalence data are submitted, such products are coded AB. Injectable suspensions containing an active ingredient suspended in an aqueous or oleaginous vehicle have also been coded BP. Injectable suspensions are subject to bioequivalence problems because differences in particle size, polymorphic structure of the suspended active ingredient, or the suspension formulation can significantly affect the rate of release and absorption. FDA does not consider pharmaceutical equivalents of these products bioequivalent without adequate evidence of bioequivalence, such products would be coded AB.
BR Suppositories or enemas that deliver drugs for systemic absorption The absorption of active ingredients from suppositories or enemas that are intended to have a systemic effect (as distinct from suppositories administered for local effect) can vary significantly from product to product. Therefore, FDA considers pharmaceutically equivalent systemic suppositories or enemas bio-equivalent only if in vivo evidence of bioequivalence is available. In those cases where in vivo evidence is available, the product is coded AB. If such evidence is not available, the products are coded BR.
BS Products having drug standard deficiencies If the drug standards for an active ingredient in a particular dosage form are found by FDA to be deficient so as to prevent an FDA evaluation of either pharmaceutical or therapeutic equivalence, all drug products containing that active ingredient in that dosage form are coded BS. For example, if the standards permit a wide variation in pharmacologically active components of the active ingredient such that pharmaceutical equivalence is in question, all products containing that active ingredient in that dosage form are coded BS.
xix
BT Topical products with bioequivalence issues This code applies mainly to post-1962 dermatologic, ophthalmic, otic, rectal, and vaginal products for topical administration, including creams, ointments, gels, lotions, pastes, and sprays, as well as suppositories not intended for systemic drug absorption. Topical products evaluated as having acceptable clinical performance, but that are not bioequivalent to other pharmaceutically equivalent products or that lack sufficient evidence of bioequivalence, will be coded BT.
BX Drug products for which the data are insufficient to determine therapeutic equivalence The code BX is assigned to specific drug products for which the data that have been reviewed by the Agency are insufficient to determine therapeutic equivalence under the policies stated in this document. In these situations, the drug products are presumed to be therapeutically inequivalent until the Agency has determined that there is adequate information to make a full evaluation of therapeutic equivalence.
1.8 Description of Special Situations Certain drugs listed in the Orange Book present special situations that merit further discussion. Following is a description of those special situations: Amino Acid and Protein Hydrolysate Injections. These products differ in the amount and kinds of amino acids they contain and, therefore, are not considered pharmaceutical equivalents. For this reason, these products are not considered therapeutically equivalent. At the same time, the Agency believes that it is appropriate to point out that where nitrogen balance is the sole therapeutic objective and individual amino acid content is not a consideration, pharmaceutical alternatives with the same total amount of nitrogen content may be considered therapeutically equivalent. Follitropin Alfa and Beta. Based on available data derived from physico chemical tests and bioassay, follitropin alfa and follitropin beta are indistinguishable. Gaviscon. Gaviscon is an OTC product which has been marketed since September 1970. The active ingredients in this product, aluminum hydroxide and magnesium trisilicate, were reviewed by the Agency's OTC Antacid Panel and were considered to be safe and effective ingredients (Category I) by that Panel. However, the tablet failed to pass the antacid test which is required of all antacid products. The Agency, therefore, placed the tablet in Category III for lack of effectiveness. A full NDA with clinical studies was submitted by Marion Laboratories, Inc., and approved by FDA on December 9, 1983. Gaviscons activity in treating reflux acidity is made possible by the physical-chemical properties of the inactive ingredients, sodium bicarbonate and alginic acid. Therefore, all ANDAs which cite Gaviscon tablets as the listed drug must contain the inactive ingredients sodium bicarbonate and alginic acid. A full NDA will be required to support the effectiveness of the drug product if different inactive ingredients are to be substituted for sodium bicarbonate or alginic acid or if different proportions of these ingredients are to be used. Levothyroxine Sodium. Because there are multiple reference listed drugs of levothyroxine sodium tablets and some reference listed drugs' sponsors have conducted studies to establish their drugs' therapeutic equivalence to other reference listed drugs, FDA has determined that its usual practice of assigning two or three character TE codes may be potentially confusing and inadequate for these drug products. Accordingly, FDA provides the following explanation and chart of therapeutic equivalence evaluations for levothyroxine
xx
sodium drug products. Levothyroxine Sodium (Mylan ANDA 76187) tablets have been determined to be therapeutically equivalent to corresponding strengths of Unithroid (Jerome Stevens NDA 021210) tablets. Levo-T (Alara NDA 021342), Levothyroxine Sodium (Mylan ANDA 76187), Unithroid (Jerome Stevens NDA 021210), and Levothyroxine Sodium (Merck KGAA ANDA 76752)tablets have been determined to be therapeutically equivalent to corresponding strengths of Synthroid (Abbott NDA 021402) tablets. Levo-T (Alara NDA 021342), Unithroid (Jerome Stevens NDA 021210), Levothyroxine Sodium (Mylan ANDA 076187), and Levothyroxine Sodium (Merck KGAA ANDA 76752) tablets have been determined to be therapeutically equivalent to corresponding strengths of Levoxyl (King Pharms NDA 021301) tablets. Levothyroxine Sodium (Mylan ANDA 76187) tablets have been determined to be therapeutically equivalent to corresponding strengths of Levothroid (Lloyd NDA 021116) tablets. The chart outlines TE codes for all 0.025mg products. Other product strengths may be similar. Therapeutic equivalence has been established between products that have the same AB+number TE code. More than one TE code may apply to some products. One common TE code indicates therapeutic equivalence between products. Trade Name
UNITHROID LEVOTHYROXINE SODIUM LEVOXYL SYNTHROID LEVO-T
Applicant
STEVENS J MYLAN KING PHARMS ABBOTT ALARA PHARM
Potency
0.025MG 0.025MG 0.025MG 0.025MG 0.025MG
TE Code
AB1 AB1 AB1 AB1 AB1
Appl No
021210 076187 021301 021402 021342
Product No
001 001 001 001 001
LLOYD MYLAN
0.025MG 0.025MG
AB4 AB4
021116 076187
001 001
Patent Certification(s) Reference Listed Drug based upon a suitability petition. An abbreviated new drug application that refers to a Reference Listed Drug (RLD) approved pursuant to a suitability petition must demonstrate that the proposed product is bioequivalent to the RLD, and it must include appropriate patent certification(s) and an exclusivity statement with respect to the listed drug which served as the basis for the approved suitability petition. This concept also applies to an ANDA applicant that cites a RLD that was based upon an NDA that is still covered by patent (s) and/or
xxi
exclusivity, e.g. a second RLD that was selected when the in vivo determination of bioequivalence of the original RLD is self evident and the waiver of the in vivo determination of bioequivalence may be granted. Waived exclusivity. If a new drug application (NDA) submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (Act) qualifies for exclusivity under sections 505(c)(3)(D) and 505(j)(5)(D), the exclusivity is listed in the Patent and Exclusivity Section of the Orange Book. If a drug product has received this exclusivity, the FDA will delay the approval of a 505(b)(2) application or an abbreviated new drug application (ANDA) under section 505(j) of the Act until the expiration of the exclusivity. If the listed drug is also protected by one or more patents, the approval date for the 505(b)(2) application or ANDA will be determined by the latest expiring patent or exclusivity listed in the Orange Book. However, the holder of the NDA may waiver its exclusivity as to any or all 505(b)(2) and ANDA applications referencing the protected drug product. If an NDA sponsor waivers its right to the exclusivity protection, qualified 505(b)(2) or ANDA applications may be approved without regard to the NDA holder's exclusivity. An NDA for which the holder has waived its exclusivity as to all 505(b)(2) and ANDA applications will be coded with a W in the Patent and Exclusivity Section of the Orange Book and be referred to this section. The applicant referencing this listed drug should indicate in the exclusivity statement that the holder of the listed drug has waived its exclusivity.
1.9 Therapeutic Equivalence Code Change for a Drug Entity The Agency will use the following procedures when, in response to a petition or on its own initiative, it is considering a change in the therapeutic equivalence code for approved multi-source drug products. Such changes will generally occur when the Agency becomes aware of new scientific information affecting the therapeutic equivalence of an entire category of drug products in the List (e.g., information concerning the active ingredient or the dosage form), rather than information concerning a single drug product within the category. These procedures will be used when a change in therapeutic equivalence code is under consideration for all drug products found in the Prescription Drug Product List under a specific drug entity and dosage form. The change may be from the code signifying that the drug does not present a bioequivalence problem (e.g., AA) to a code signifying a bioequivalence problem (e.g., BP), or vice versa. This procedure does not apply to a change of a particular product code (e.g., a change from BP to AB or from AB to BX). Before making a change in a therapeutic equivalence code for an entire category of drugs, the Agency will announce in the Introduction to the Cumulative Supplement that it is considering the change and will invite comment. Comments, along with scientific data, may be sent to the Director, Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, HFD-650, 7620 Standish Place, Rockville, MD 20855. The comment period will generally be 60 days in length, and the closing date for comments will be listed in the description of the proposed change for each drug entity. The most useful type of scientific data submission is an in vivo bioavailability/bioequivalence study conducted on batches of the subject drug products. These submissions should present a full description of the analytical procedures and equipment used, a validation of the analytical methodology, including the standard curve, a description of the method of calculating results, and a description of the pharmacokinetic and statistical models used in analyzing the data. Anecdotal or testimonial information is the least useful to the Agency, and such submissions are discouraged. Copies
xxii
of supporting reports published in the scientific literature or unpublished material, however, are welcome.
1.10 Change of the Therapeutic Equivalence Evaluation for a Single Product The aforementioned procedure does not apply to a change in a single drug product code. For example, a change in a single drug product's code from BP to AB as a result of the submission of an acceptable bioequivalence study ordinarily will not be the subject of notice and comment. Likewise, a change in a single drug product's code from AB to BX (e.g., as a result of new information raising a significant question as to bioequivalence) does not require notice and comment. The Agency's responsibility to provide the public with the Agency's most current information related to therapeutic equivalence may require a change in a drug product's code prior to any formal notice and opportunity for the applicant to be heard. The publication in the Federal Register of a proposal to withdraw approval of a drug product will ordinarily result in a change in a product's code from AB to BX if this action has not already been taken. 1.11 Discontinued Section Those drug products in the Discontinued Section of the Orange Book in which a determination has already been made that the products were not withdrawn for safety or efficacy reasons have **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** following the product strength. Those drug products are only reflective of citizen petitions determinations made since 1995. The identification of these drug products in the Discontinued Section of the Orange Book should avoid the submission of multiple citizen petitions for the same drug product. FR notices no longer applicable are removed from the Annual Edition (i.e., there is a currently marketed Reference Listed Drug and no applicable patent or exclusivity). FR Safety or Effectiveness Determinations List lists products that have current and removed notices. The list is updated quarterly. Notices issued during the year are added to the Electronic Orange Book Query in the month they become effective. Generally, approved products are added to the Discontinued Section of the Orange Book when the applicant holder notifies the Orange Book staff of the products not marketed status. Products may also be added if annual reports indicate the product is no longer marketed or other Agency administrative action (e.g., Withdrawal of an Application). Changes to the Orange Book are not affected by the drug registration and listing requirements of Section 510 of the Act.
xxiii
1.12 Changes to the Orange Book Every effort is made to ensure the Annual Edition is current and accurate. Applicant holders are requested to inform the FDA Orange Book Staff (OBS) of any changes or corrections. Please inform the OBS when products are no longer marketed. Notification of the Orange Book staff to include the newly approved product in the Discontinued Drug Product List rather than parts 1, 2 or 3 of the List (as discussed in Section 1.1) must occur by the end of the month in which the product is approved to ensure that the product is not included in the active portions of the next published Orange Book update We can be contacted by email at drugproducts@fda.hhs.gov. FAX: 240-276-8974; mail to: FDA/CDER Orange Book Staff Office of Generic Drugs, HFD-610 7620 Standish Place Rockville, MD 20855 Send Changes by
1.13 Availability of the Edition Commencing with the 25th edition, the Annual Edition and current monthly Cumulative Supplement are available in a Portable Document Format (PDF) at the EOB home page, Electronic Orange Book Query, by clicking on Publications. The PDF annual format duplicates previous paper versions except for the Orphan Products Designations and Approvals List. An annual subscription of the PDF format may be obtained from the U.S. Government Printing Office, 866-512-1800.
xxiv
This publication contains illustrations, along with Drug Product Lists, indices, and lists of abbreviations and terms which facilitate their use. Illustrations. The annotated Drug Product Illustration, see Section 2.2, and the Therapeutic Equivalence Evaluations Illustration, see Section 2.3, are offered to provide further clarification. These depict the format found in the Prescription Drug Product List (the only list in which therapeutic equivalence evaluation codes are displayed). Drug Product Lists. The Prescription and OTC Drug Product Lists, arranged alphabetically by active ingredient(s), contain product identification information (active ingredients, dosage forms, routes of administration, product names, application holders, strengths) for single and multiple ingredient drug products. Also shown are the application number and drug product number (FDA internal computer data use only) and approval dates for those drug products approved on or after January 1, 1982. The application number preceded by N is a New Drug Application (NDA or commonly the innovator). The application number preceded by an A is an Abbreviated New Drug Application (ANDA or commonly the generic). The Discontinued Product List, arranged alphabetically by active ingredient(s), contains product identification information (dosage form, product name, strength, and application number). If a prescription drug product is available from more than one source (multisource), a therapeutic equivalence code will appear in front of the applicant's name. If a product is therapeutically equivalent to one or more products or to an appropriate reference, it will be designated with a code beginning with "A" and the entry will be underlined and printed in bold font for emphasis. Active ingredient headings for multiple ingredient (combination) drug products are arranged alphabetically. For purposes of this publication, this alphabetical sort takes precedence over United States Pharmacopeia official monograph order (i.e., Reserpine, Hydralazine Hydrochloride, Hydrochlorothiazide). For example, product information labeled as Reserpine, Hydrochlorothiazide and Hydralazine Hydrochloride appears under the active ingredient heading Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine. A cross-reference to the product information (for prescription and OTC products) appears for each additional active ingredient in the product. For combination drug products, the ingredient strengths are separated by semicolons and appear in the same relative sequence as the ingredients in the heading. Available strengths of the dosage form from an applicant appear on separate lines. To use the Drug Product Lists, determine by alphabetical order the ingredient under which the product information is listed, using the Product Name Index, if necessary. Then, find the ingredient in the applicable Drug Product List. Proceed to the dosage form and route of administration and compare products within that ingredient heading only. Therapeutic equivalence or inequivalence for prescription products is determined on the basis of the therapeutic equivalence codes provided within that specific dosage form and route heading. The OTC Drug Product List, Discontinued Drug Product List, and
2-1
Drug Products with Approval under Section 505 of the Act Administered by the Center for Biologics Evaluation and Research List have their data arranged similarly. The Discontinued Drug Product List contains approved products that have never been marketed, have been discontinued from marketing, are for military use, or have had their approvals withdrawn for other than safety or efficacy reasons subsequent to being discontinued from marketing. All products having a "@" in the 12th Cumulative Supplement of the 31st Edition List have been added to the Discontinued Drug Product List appearing in the 32nd Edition. In addition, approved drug products that are not in the commercial distribution channel e.g., approved drug products in applications for export only are also listed in the Discontinued Section of the Orange Book. Product Name Index (Prescription and OTC Drug Product Lists). This is an index of drug products by established or trade name. The second term of each entry indicates the active ingredient name under which product information can be found in the appropriate Drug Product List. For those drug products with multiple active ingredients, only the first active ingredient (in alphabetical order) will appear. OTC products are so designated. Product Name Index Listed by Applicant (Prescription and OTC Drug Product Lists). This is an index that cross-references applicants to drug products. The bolded and underlined entry represents the applicant name abbreviation used in this publication. Each complete applicant name that is represented by the abbreviated name is marked with an asterisk (*). Listed under each complete applicant name is the first alphabetically arranged ingredient under which product information can be found in the appropriate Drug Product List. OTC products are so designated. To use the Drug Product Lists, determine by alphabetical order the ingredient under which the product information is listed, using the Product Name Index, if appropriate. Uniform Terms. To improve readability, uniform terms are used to designate dosage forms, routes of administration, and abbreviations used to express strengths. These terms are listed in Appendix C. In some cases, the terms used may differ from those used in product labels and other labeling.
2-2
2.2
THERAPEUTIC EQUIVALENCE (TE) CODE FOR MULTISOURCE PRODUCT FINAL APPROVAL DATE
SINGLE SOURCE PRODUCT (NO TE CODE)
AP AP AP AP
AP
HOLOVAC LLC
RHONDA PHARM
APPLICANT AVAILABLE STRENGTH(S) OF A PRODUCT APPLICATION NUMBER AND PRODUCT NUMBER PRODUCT NUMBER IS FOR FDA INTERNAL COMPUTER DATA USE ONLY
JOHNSON MED
100MG/ML
MULTIPLE INGREDIENTS WITH PRODUCT INFORMATION ALPHABETICALLY SORTED BY ACTIVE INGREDIENT PRODUCT INFORMATION
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE TABLET; ORAL HYDROCHLOROTHIAZIDE, RESERPINE AND HYDRALAZINE HCL MADISON 25MG;15MG;0.1MG A69808 001 AUG 27, 1987 JAN 18, 1982
IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE PRESCRIPTION DRUG PRODUCT LIST.
2.3
DRUG PRODUCTS CODED AB (OR ANY CODE BEGINNING WITH AN "A") UNDER AN INGREDIENT AND DOSAGE FORM HEADING ARE CONSIDERED THERAPEUTICALLY EQUIVALENT ONLY TO OTHER PRODUCTS CODED AB (OR ANY CODE BEGINNING WITH AN A") AND NOT TO THOSE CODED BP (OR ANY CODE BEGINNING WITH "B") AND ANY PRODUCTS NOT LISTED. DRUG PRODUCTS CODED BP (OR ANY CODE BEGINNING WITH A "B") ARE NOT CONSIDERED THERAPEUTICALLY EQUIVALENT TO ANY OTHER PRODUCT. FOR A COMPLETE EXPLANATION OF THE TE CODES REFER TO SECTION 1.7 OF THE INTRODUCTION.
SULFASALAZINE TABLET; ORAL FAZINE AB PRODUCTS CONSIDERED THERAPEUTICALLY AB EQUIVALENT TO EACH OTHER SULFASALAZINE PRODUCTS CONSIDERED NOT THERAPEUTICALLY BP BROWN 500MG A41297 001 PARKLAND SULAZINE URSA 500MG A42222 001 500MG A42999 001
EQUIVALENT TO ANY OTHER PRODUCTS LISTED SULFASALAZINE TABLET; ORAL FAZINE AB PRODUCTS CONSIDERED NOT THERAPEUTICALLY BP EQUIVALENT TO EACH OTHER SOUTH 500MG A67627 001 PARKLAND SULFASALAZINE BROWN 500MG A41297 001 500MG A42999 001
NOTE: BOLD FONT AND UNDERLINING DENOTES MULTISOURCE PRODUCTS WHICH ARE CONSIDERED THERAPEUTICALLY EQUIVALENT. THIS EXAMPLE IS FOR PURPOSES OF ILLUSTRATION ONLY. IT DOES NOT REPRESENT ACTUAL PRODUCTS FROM THE PRESCRIPTION DRUG PRODUCT LIST.
3 - 1 (of 424)
EQ 20MG BASE/ML
N020978 001
EQ 300MG BASE
N020977 001
TABLET; ORAL
EPZICOM
XX + VIIV HLTHCARE
EQ 600MG BASE;300MG
N021652 001
EQ 300MG BASE;150MG;300MG
N021205 001
ABIRATERONE ACETATE
TABLET; ORAL
ZYTIGA
XX + JANSSEN BIOTECH
250MG
N202379 001
ACAMPROSATE CALCIUM
TABLET, DELAYED RELEASE; ORAL
CAMPRAL
333MG XX + FOREST LABS
N021431 001
ACARBOSE
TABLET; ORAL ACARBOSE IMPAX LABS AB AB AB MYLAN AB AB AB ROXANE AB AB AB STRIDES ARCOLAB LTD AB AB AB WATSON LABS AB AB AB PRECOSE AB + BAYER HLTHCARE AB AB
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG
A078441 A078441 A078441 A091053 A091053 A091053 A078470 A078470 A078470 A090912 A090912 A090912 A077532 A077532 A077532
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
May May May Jan Jan Jan May May May Jul Jul Jul May May May
14, 14, 14, 06, 06, 06, 07, 07, 07, 27, 27, 27, 07, 07, 07,
2009 2009 2009 2011 2011 2011 2008 2008 2008 2011 2011 2011 2008 2008 2008
ACEBUTOLOL HYDROCHLORIDE
CAPSULE; ORAL ACEBUTOLOL HYDROCHLORIDE AMNEAL PHARM EQ EQ MYLAN EQ EQ WATSON LABS EQ
AB AB AB AB AB
3 - 2 (of 424)
ACETAMINOPHEN
SOLUTION; IV (INFUSION)
OFIRMEV
XX + CADENCE PHARMS
1000MG/100ML (10MG/ML)
N022450 001
ACETAMINOPHEN; BUTALBITAL
CAPSULE; ORAL
PHRENILIN FORTE
XX + VALEANT
650MG;50MG
A088831 001
AA AA XX XX
TABLET; ORAL BUTAPAP MIKART 325MG;50MG PHRENILIN + VALEANT 325MG;50MG BUTALBITAL AND ACETAMINOPHEN NEXGEN PHARMA 300MG;50MG BUTAPAP + MIKART 650MG;50MG
AA AA XX XX
SOLUTION; ORAL
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
325MG/15ML;50MG/15ML;40MG/15ML XX + MIKART TABLET; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE MALLINCKRODT 325MG;50MG;40MG MIKART 325MG;50MG;40MG MIRROR PHARMS 325MG;50MG;40MG 500MG;50MG;40MG VINTAGE PHARMS 325MG;50MG;40MG 500MG;50MG;40MG WATSON LABS 500MG;50MG;40MG WEST WARD 325MG;50MG;40MG 500MG;50MG;40MG ESGIC-PLUS 500MG;50MG;40MG + MIKART FIORICET + WATSON PHARMS 325MG;50MG;40MG BUTALBITAL, ACETAMINOPHEN AND CAFFEINE + MIKART 750MG;50MG;40MG
A040387 001
AA AA AA AA AA AA AA AA AA AA AA XX
3 - 3 (of 424)
AB AB AB AB AB
A076560 001 A075929 001 A075618 001 N020232 001 A074911 001
Jun 10, 2004 Apr 22, 2002 Mar 23, 2001 Jul 30, 1992 Aug 22, 2001
AA AA AA AA AA
120MG/5ML;12MG/5ML
A086024 001
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA XX XX
TABLET; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE AMNEAL PHARMS NY 300MG;30MG + MALLINCKRODT INC 300MG;15MG 300MG;30MG 300MG;60MG MIKART 300MG;30MG RANBAXY 300MG;30MG 300MG;60MG TEVA 300MG;15MG 300MG;30MG + 300MG;60MG VINTAGE 300MG;15MG 300MG;30MG VINTAGE PHARMS 300MG;60MG TYLENOL W/ CODEINE NO. 3 + JANSSEN PHARMS 300MG;30MG TYLENOL W/ CODEINE NO. 4 JANSSEN PHARMS 300MG;60MG ACETAMINOPHEN AND CODEINE PHOSPHATE + MIKART 650MG;30MG + 650MG;60MG
A040779 A040419 A040419 A040419 A089238 A085868 A087083 A088627 A088628 A088629 A089990 A089805 A089828
001 001 002 003 001 001 001 001 001 001 001 001 001
A085055 003 A085055 004 A089231 001 A089363 001 Mar 03, 1986 Sep 09, 1991
A081067 001
3 - 4 (of 424)
A089008 001
AA AA AA AA AA AA AA XX XX
TABLET; ORAL ANEXSIA MALLINCKRODT AA 500MG;5MG AA 750MG;10MG ANEXSIA 5/325 MALLINCKRODT AA 325MG;5MG ANEXSIA 7.5/325 MALLINCKRODT AA 325MG;7.5MG ANEXSIA 7.5/650 MALLINCKRODT AA 650MG;7.5MG CO-GESIC UCB INC AA 500MG;5MG HYDROCODONE BITARTRATE AND ACETAMINOPHEN AMNEAL PHARMS NY AA 325MG;5MG AA 325MG;10MG AA 500MG;5MG AA 500MG;7.5MG AA 500MG;10MG AA 650MG;7.5MG AA 650MG;10MG AA 750MG;7.5MG BOCA PHARMA AA 300MG;5MG AA 300MG;7.5MG AA 300MG;10MG MALLINCKRODT AA 325MG;10MG AA 500MG;5MG AA 500MG;7.5MG AA 500MG;10MG AA 650MG;10MG AA + 660MG;10MG AA 750MG;7.5MG AA + MIKART 300MG;5MG AA + 300MG;7.5MG AA + 300MG;10MG AA 325MG;7.5MG AA + 500MG;2.5MG AA + 500MG;7.5MG AA + 650MG;7.5MG AA + 650MG;10MG SUN PHARM INDS INC AA 325MG;5MG AA 325MG;7.5MG AA 325MG;10MG AA 500MG;5MG AA 500MG;7.5MG
A089160 001 A040468 001 A040409 001 A040405 001 A089725 001 A087757 001 A040736 A040746 A040729 A040748 A040813 A040754 A040757 A040769 A090415 A090415 A090415 A040400 A040084 A040201 A040201 A040084 A040084 A040084 A040658 A040556 A040556 A040432 A089698 A089699 A089689 A081223 A090118 A090118 A090118 A090265 A090265 001 001 001 001 001 001 001 001 001 002 003 001 002 001 002 004 003 001 001 002 001 001 001 001 001 001 001 002 003 001 002
Apr 23, 1987 Oct 31, 2002 Oct 20, 2000 Sep 08, 2000 Sep 30, 1987 May 03, 1982 Aug Aug Aug Aug Feb Aug Aug Aug Jan Jan Jan Jul Jun Feb Feb Oct Jul Jun Jan Mar Jun Jan Aug Aug Jun May Dec Dec Dec Dec Dec 25, 25, 25, 25, 23, 25, 25, 28, 24, 24, 24, 26, 01, 27, 27, 16, 29, 01, 19, 24, 23, 22, 25, 25, 29, 29, 23, 23, 23, 23, 23, 2006 2006 2006 2006 2007 2006 2006 2006 2011 2011 2011 2000 1995 1998 1998 1996 1996 1995 2006 2006 2004 2003 1989 1989 1988 1992 2008 2008 2008 2008 2008
3 - 5 (of 424)
A090265 A090380 A090380 A090380 A090380 A040655 A040656 A040355 A040144 A089971 A040144 A040356 A040155 A040143 A040358 A040157 A081079 A089883 A081080 A040148 A040094 A040094 A040094 A081083 A040094 A040495
003 001 002 003 004 001 001 001 002 001 001 001 001 001 001 001 001 001 001 002 001 002 003 001 004 001
Dec Dec Dec Dec Dec Jan Jan May Apr Dec Feb May Apr Feb May Apr Aug Dec Aug Feb Sep Sep Aug Aug Mar May
23, 23, 23, 23, 23, 19, 19, 31, 25, 02, 22, 31, 14, 22, 31, 12, 30, 01, 30, 14, 29, 29, 08, 30, 22, 28,
2008 2008 2008 2008 2008 2006 2006 2000 1997 1988 1996 2000 1997 1996 2000 1996 1991 1988 1991 1997 1995 1995 2000 1991 1999 2003
A087722 001 A040100 001 A040099 001 A040148 003 A040148 001 A088058 001 A089736 001 A040117 001 A040846 001 A040849 001 A040288 001 A040288 002 A040288 003
Jul 09, 1982 Jan 26, 1996 Jun 25, 1997 Sep 12, 2000 Feb 14, 1997 Jan 07, 1983 Dec 09, 1988 Sep 23, 1996 Jun 09, 2010 Jun 09, 2010 Nov 27, 1998 Nov 27, 1998 Nov 27, 1998
AA AA AA AA AA
A040061 001
3 - 6 (of 424)
500MG;5MG
A088790 001
325MG/5ML;5MG/5ML
A089351 001
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA XX XX XX XX XX XX XX XX XX XX
TABLET; ORAL OXYCET MALLINCKRODT 325MG;5MG OXYCODONE AND ACETAMINOPHEN AMNEAL PHARMS NY 325MG;5MG 325MG;10MG 500MG;7.5MG 650MG;10MG COASTAL PHARMS 325MG;2.5MG 325MG;5MG 325MG;7.5MG 325MG;10MG 500MG;7.5MG 650MG;10MG MALLINCKRODT 325MG;7.5MG 325MG;10MG 500MG;7.5MG 650MG;10MG VINTAGE PHARMS 325MG;5MG WATSON LABS 325MG;5MG 325MG;7.5MG 325MG;10MG 500MG;7.5MG 650MG;10MG PERCOCET + ENDO PHARMS 325MG;2.5MG + 325MG;5MG + 325MG;7.5MG + 325MG;10MG + 500MG;7.5MG + 650MG;10MG ROXICET ROXANE 325MG;5MG OXYCODONE AND ACETAMINOPHEN + MIKART 300MG;2.5MG + 300MG;5MG + 300MG;7.5MG + 300MG;10MG + 400MG;2.5MG + 400MG;5MG + 400MG;7.5MG + 400MG;10MG 500MG;10MG ROXICET 5/500 + ROXANE 500MG;5MG
A087463 001 A040777 A040778 A040789 A040789 A090177 A090177 A090177 A090177 A090177 A090177 A040545 A040545 A040550 A040550 A040105 A040171 A040535 A040535 A040371 A040371 A040330 A040330 A040434 A040434 A040341 A040341 001 001 001 002 001 002 003 004 005 006 001 002 001 002 001 001 001 002 001 002 001 002 001 002 001 002
Dec 07, 1983 Nov Nov Nov Nov Oct Oct Oct Oct Oct Oct Jun Jun Jun Jun Jul Oct Sep Sep Dec Dec Jun Jun Nov Nov Jul Jul 27, 27, 27, 27, 20, 20, 20, 20, 20, 20, 30, 30, 30, 30, 30, 30, 05, 05, 29, 29, 25, 25, 23, 23, 26, 26, 2007 2007 2007 2007 2008 2008 2008 2008 2008 2008 2004 2004 2004 2004 1996 1997 2003 2003 2000 2000 1999 1999 2001 2001 1999 1999
A087003 001 A040608 A040608 A040608 A040608 A040679 A040687 A040698 A040692 A040676 001 002 003 004 001 001 001 001 001 Dec Dec Dec Dec May Apr Apr Apr Apr 30, 30, 30, 30, 16, 27, 27, 27, 19, 2005 2005 2005 2005 2006 2006 2006 2006 2006
A089775 001
3 - 7 (of 424)
AB AB AB AB AB AB
N021123 001
ACETAZOLAMIDE
CAPSULE, EXTENDED RELEASE; ORAL ACETAZOLAMIDE HERITAGE PHARMS INC AB 500MG ZYDUS PHARMS USA INC 500MG AB DIAMOX AB + DURAMED PHARMS BARR 500MG TABLET; ORAL ACETAZOLAMIDE LANNETT MUTUAL PHARM TARO + WATSON LABS
AB AB AB AB AB
ACETAZOLAMIDE SODIUM
INJECTABLE; INJECTION ACETAZOLAMIDE SODIUM BEDFORD AP X GEN PHARMS AP DIAMOX AP + DURAMED PHARMS BARR
AT AT AT AT
2% 2% 2% 2%
A040063 001
3 - 8 (of 424)
ACETOHEXAMIDE
TABLET; ORAL ACETOHEXAMIDE WATSON LABS XX XX +
250MG 500MG
ACETOHYDROXAMIC ACID
TABLET; ORAL
LITHOSTAT
XX + MISSION PHARMA
250MG
N018749 001
ACETYLCHOLINE CHLORIDE
FOR SOLUTION; OPHTHALMIC
MIOCHOL-E
XX + BAUSCH AND LOMB
20MG/VIAL
N020213 001
ACETYLCYSTEINE
INJECTABLE; INTRAVENOUS
ACETADOTE
XX + CUMBERLAND PHARMS
6GM/30ML (200MG/ML)
N021539 001
SOLUTION; INHALATION, ORAL ACETYLCYSTEINE BEDFORD AN 10% AN 20% HOSPIRA AN 10% AN 20% AN + LUITPOLD 10% AN + 20%
ACITRETIN
CAPSULE; ORAL
SORIATANE
STIEFEL LABS INC XX XX XX XX +
8MG;60MG
N019806 001
ACYCLOVIR
CAPSULE; ORAL ACYCLOVIR APOTEX INC AB DAVA PHARMS INC AB MYLAN AB AB RANBAXY AB STASON AB TEVA AB
3 - 9 (of 424)
200MG 200MG
5%
N021478 001
5%
N018604 001
400MG 800MG 400MG 800MG 400MG 800MG 400MG 400MG 800MG 800MG 400MG 800MG 400MG 800MG 400MG 800MG
A077309 A077309 A075382 A075382 A074946 A074946 A074976 A075211 A074976 A075211 A074980 A074980 A074556 A074556
001 002 001 002 001 002 001 001 002 002 001 002 002 003
Sep Sep Apr Apr Nov Nov Apr Sep Apr Sep Sep Sep Apr Apr
29, 29, 30, 30, 19, 19, 13, 28, 13, 28, 30, 30, 22, 22,
2005 2005 1999 1999 1997 1997 1998 1998 1998 1998 1998 1998 1997 1997
ACYCLOVIR SODIUM
INJECTABLE; INJECTION ACYCLOVIR SODIUM AP + APP PHARMS EQ 50MG BASE/ML AP + EQ 500MG BASE/VIAL BAXTER HLTHCARE AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL BEDFORD AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE EQ 500MG BASE/VIAL XX + BAXTER HLTHCARE EQ 1GM BASE/VIAL XX
ACYCLOVIR; HYDROCORTISONE
CREAM; TOPICAL
XERESE
XX + VALEANT INTL
5%;1%
N022436 001
3 - 10 (of 424)
0.1% 0.1%
AB AB AB XX
Jul 01, 2010 Jun 02, 2010 May 31, 1996 Jun 19, 2007
LOTION; TOPICAL
DIFFERIN
XX + GALDERMA R AND D
0.1%
N022502 001
GEL; TOPICAL
EPIDUO
XX + GALDERMA LABS
0.1%;2.5%
N022320 001
ADEFOVIR DIPIVOXIL
TABLET; ORAL
HEPSERA
XX + GILEAD
10MG
N021449 001
ADENOSINE
INJECTABLE; INJECTION ADENOCARD + ASTELLAS ADENOSINE AKORN APP PHARMS BAXTER HLTHCARE BEDFORD GLAND PHARMA LTD LUITPOLD STRIDES ARCOLAB LTD TEVA PARENTERAL WOCKHARDT ADENOSCAN + ASTELLAS
AP AP AP AP AP AP AP AP AP AP AP XX
3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML 3MG/ML
N019937 002 A078076 A077133 A076500 A076404 A077283 A090010 A078686 A076564 A078676 A090220 001 001 001 001 001 001 001 001 001 001
Oct 30, 1989 Oct Apr Jun Jun Jun Apr May Jun Jul Jul 31, 27, 16, 16, 14, 28, 13, 16, 31, 20, 2008 2005 2004 2004 2007 2009 2009 2004 2008 2009
N020059 001
ALBENDAZOLE
TABLET; ORAL
ALBENZA
XX + COREPHARMA
200MG
N020666 001
ALBUMIN HUMAN
INJECTABLE; INJECTION
OPTISON
XX + GE HEALTHCARE
10MG/ML
N020899 001
3 - 11 (of 424)
0.5mCi/VIAL 1mCi/VIAL
ALBUTEROL SULFATE
AEROSOL, METERED; INHALATION PROAIR HFA BX + TEVA GLOBAL EQ 0.09MG BASE/INH PROVENTIL-HFA BX + 3M EQ 0.09MG BASE/INH VENTOLIN HFA BX + GLAXOSMITHKLINE EQ 0.09MG BASE/INH SOLUTION; INHALATION ACCUNEB AN + DEY AN + ALBUTEROL SULFATE APOTEX INC AN AN AN AN + BAUSCH AND LOMB AN + DEY HI TECH PHARMA AN AN LANDELA PHARM AN NEPHRON AN AN AN AN NOVEX AN RITEDOSE CORP AN TEVA PARENTERAL AN WATSON LABS AN AN WATSON LABS INC AN WOCKHARDT AN SYRUP; ORAL ALBUTEROL SULFATE ACTAVIS MID ATLANTIC AMNEAL PHARMS HI TECH PHARMA + TEVA VINTAGE VISTAPHARM
EQ 0.021% BASE EQ 0.042% BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 0.021% BASE 0.042% BASE 0.083% BASE 0.5% BASE 0.083% BASE 0.083% BASE 0.5% BASE 0.083% BASE 0.021% BASE 0.042% BASE 0.083% BASE 0.5% BASE 0.5% BASE 0.083% BASE 0.083% BASE 0.021% BASE 0.042% BASE 0.083% BASE 0.083% BASE
N020949 002 N020949 001 A078623 A078623 A075717 A075050 A072652 A075063 A074543 A077569 A076355 A076355 A074880 A075664 A076391 A077839 A075343 A077772 A077772 A076370 A075394 001 002 001 001 001 001 001 001 002 001 001 001 001 001 001 001 002 001 001
Apr 30, 2001 Apr 30, 2001 Apr Apr Feb Jun Feb Feb Jan Apr Mar Jun Sep Jun Apr Dec Nov Sep Sep Nov Nov 05, 05, 02, 18, 21, 09, 15, 04, 31, 28, 17, 26, 01, 16, 09, 25, 25, 24, 22, 2010 2010 2007 1998 1992 1999 1998 2006 2010 2004 1997 2001 2003 2008 1999 2007 2007 2003 1999
AA AA AA AA AA AA
EQ EQ EQ EQ EQ EQ
EQ EQ EQ EQ
3 - 12 (of 424)
EQ 2MG BASE
A072764 001
TABLET, EXTENDED RELEASE; ORAL ALBUTEROL SULFATE MYLAN AB EQ 4MG AB EQ 8MG VOSPIRE ER DAVA PHARMS INC AB EQ 4MG AB + EQ 8MG
N020291 001
AN AN AN AN AN AN AN
N020950 001
N021747 001
ALCAFTADINE
SOLUTION/DROPS; OPHTHALMIC
LASTACAFT
XX + ALLERGAN 0.25%
N022134 001
ALCLOMETASONE DIPROPIONATE
CREAM; TOPICAL ACLOVATE + FOUGERA PHARMS 0.05% ALCLOMETASONE DIPROPIONATE ALTANA 0.05% GLENMARK GENERICS 0.05% TARO 0.05% OINTMENT; TOPICAL ACLOVATE + FOUGERA PHARMS 0.05% ALCLOMETASONE DIPROPIONATE ALTANA 0.05% GLENMARK GENERICS 0.05% TARO 0.05%
AB AB AB AB
Dec 14, 1982 Jul 12, 2005 Jun 23, 2009 Sep 15, 2005
AB AB AB AB
Dec 14, 1982 Jul 18, 2005 Jul 30, 2009 Jul 29, 2004
ALCOHOL; DEXTROSE
INJECTABLE; INJECTION ALCOHOL 5% AND DEXTROSE 5% AP + B BRAUN 5ML/100ML;5GM/100ML ALCOHOL 10% AND DEXTROSE 5% 10ML/100ML;5GM/100ML XX + B BRAUN
3 - 13 (of 424)
EQ 70MG BASE/75ML
N021575 001
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 35MG BASE 70MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 35MG BASE 70MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 40MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 35MG BASE 40MG BASE 40MG BASE 70MG BASE 70MG BASE 5MG BASE 10MG BASE 35MG BASE 40MG BASE 70MG BASE
A077982 A077982 A077982 A077982 A090124 A090124 A090124 A090258 A090258 A090258 A090258 A090557 A090557 A090557 A090557 A079109 A079109 A079049 A079049 A076584 A076584 A076584 A078638 A076584 A078638 A090022 A090022 A090022 A090022 A075710 A075710 A075710 A075710 A075710 A076768 A076768 A076768 A076984 A076768 A076984 A076768 A076984 N020560 N020560 N020560 N020560 N020560
001 002 003 004 001 002 003 001 002 003 004 001 002 003 004 001 002 001 002 001 002 003 001 004 002 001 002 003 004 001 002 003 004 005 001 002 003 001 004 002 005 003 003 001 004 002 005
Aug Aug Aug Aug Aug Aug Aug Sep Sep Sep Sep Feb Feb Feb Feb Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Sep Sep Sep Sep Feb Feb Feb Feb Feb Aug Aug Aug Aug Aug Aug Aug Aug Apr Sep Oct Sep Oct
04, 04, 04, 04, 04, 04, 04, 24, 24, 24, 24, 18, 18, 18, 18, 04, 04, 04, 04, 04, 04, 04, 04, 04, 04, 10, 10, 10, 10, 06, 06, 06, 06, 06, 04, 04, 04, 04, 04, 04, 04, 04, 25, 29, 20, 29, 20,
2008 2008 2008 2008 2008 2008 2008 2009 2009 2009 2009 2010 2010 2010 2010 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 1997 1995 2000 1995 2000
3 - 14 (of 424)
ALFUZOSIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ALFUZOSIN HYDROCHLORIDE APOTEX INC MYLAN SUN PHARMA GLOBAL TEVA PHARMS TORRENT PHARMS UROXATRAL + SANOFI AVENTIS US ORAL 10MG 10MG 10MG 10MG 10MG 10MG A079013 A079014 A079057 A079056 A079054 001 001 001 001 001 Jul Jul Jul Jul Jul 18, 18, 18, 18, 18, 2011 2011 2011 2011 2011
AB AB AB AB AB AB
N021287 001
ALGLUCERASE
INJECTABLE; INJECTION
CEREDASE
XX + GENZYME
80 UNITS/ML
N020057 003
ALISKIREN HEMIFUMARATE
TABLET; ORAL
TEKTURNA
XX NOVARTIS
XX +
EQ EQ EQ EQ
EQ EQ EQ EQ EQ
5MG BASE;12.5MG 5MG BASE;12.5MG 5MG BASE;25MG 10MG BASE;12.5MG 10MG BASE;25MG
EQ EQ EQ EQ
BASE;12.5MG
BASE;25MG
BASE;12.5MG BASE;25MG
EQ 150MG BASE;160MG
EQ 300MG BASE;320MG
3 - 15 (of 424)
EQ 0.1% BASE
N020886 001
ALLOPURINOL
TABLET; ORAL ALLOPURINOL APOTEX INC AB AB CARACO AB AB IPCA LABS LTD AB AB MUTUAL PHARM AB AB MYLAN AB AB NORTHSTAR HLTHCARE AB AB VINTAGE PHARMS AB AB WATSON LABS AB AB LOPURIN DR REDDYS LA AB AB ZYLOPRIM PROMETHEUS LABS AB AB +
100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG
A077353 A077353 A078390 A078390 A090637 A090637 A071449 A071450 N018659 N018659 A078253 A078253 A075798 A075798 N018832 N018877
001 002 001 002 001 002 001 001 001 002 001 002 001 002 002 001
Sep Sep Aug Aug Mar Mar Jan Jan Oct Oct Sep Sep Jun Jun Sep Sep
08, 08, 30, 30, 16, 16, 09, 09, 24, 24, 11, 11, 27, 27, 28, 28,
2005 2005 2007 2007 2011 2011 1987 1987 1986 1986 2007 2007 2003 2003 1984 1984
ALLOPURINOL SODIUM
INJECTABLE; INJECTION ALLOPURINOL SODIUM BEDFORD LABS AP ALOPRIM AP + MYLAN INSTITUTIONAL
ALMOTRIPTAN MALATE
TABLET; ORAL AXERT JANSSEN PHARMS XX XX +
ALOSETRON HYDROCHLORIDE
TABLET; ORAL LOTRONEX PROMETHEUS LABS XX XX +
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
INJECTABLE; INJECTION
INFUVITE ADULT
XX + SANDOZ
N021163 001
3 - 16 (of 424)
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
INJECTABLE; IV (INFUSION)
INFUVITE ADULT
XX + SANDOZ 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1 .2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
N021559 001
ALPRAZOLAM
CONCENTRATE; ORAL
ALPRAZOLAM
XX + ROXANE TABLET; ORAL ALPRAZOLAM ACTAVIS ELIZABETH AB AB AB AB ALPHAPHARM AB AB AB AB APOTEX INC AB AB AB AB BOCA PHARMA AB AB AB AB DAVA INTL INC AB AB AB AB MYLAN AB AB AB AB SANDOZ AB AB AB AB SUN PHARMA GLOBAL AB AB AB AB VINTAGE AB AB AB AB XANAX PHARMACIA AND UPJOHN AB AB AB + AB
1MG/ML
A074312 001
0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.5MG 1MG 2MG
A074342 A074342 A074342 A074342 A074046 A074046 A074046 A074046 A077741 A077741 A077741 A077741 A090248 A090248 A090248 A090248 A074174 A074174 A074174 A074174 A074215 A074215 A074215 A074215 A074112 A074112 A074112 A074909 A090082 A090082 A090082 A090082 A078491 A078491 A078491 A078491 N018276 N018276 N018276 N018276
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 001 002 003 004 001 002 003 004 001 002 003 004
Oct Oct Oct Oct Oct Oct Oct May Jan Jan Jan Jan Sep Sep Sep Sep Oct Oct Oct Oct Jan Jan Jan Jan Dec Dec Dec Mar Jun Jun Jun Jun Sep Sep Sep Dec
31, 31, 31, 31, 19, 19, 19, 07, 19, 19, 19, 19, 17, 17, 17, 17, 19, 19, 19, 19, 27, 27, 27, 27, 29, 29, 29, 25, 17, 17, 17, 17, 25, 25, 25, 12,
1993 1993 1993 1993 1993 1993 1993 1997 2007 2007 2007 2007 2010 2010 2010 2010 1993 1993 1993 1993 1994 1994 1994 1994 1995 1995 1995 1998 2010 2010 2010 2010 2008 2008 2008 2008
3 - 17 (of 424)
A078056 A078056 A078387 A078387 A078387 A078387 A078469 A078469 A078469 A078469 A078449 A078449 A078449 A090871 A090871 A090871 A090871 A077725 A077725 A077725 A077725 A077996 A077996 A077996 A077996 A077968 A077968 A077968 A077968 A077391 A077391 A077391 A077391 A077777 A077777 A077777 A077777 A077979 A077979 A077979 A077979 A078442 A078442 A078442 A078442 A077198 A077198 A077198 A077198 A078489 A078489 A078489 A078489
003 004 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 004 003 001 002 003 004 004 003 002 001 002 003 004 001 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Feb Feb May May May May Sep Sep Sep Sep Nov Nov Nov Jun Jun Jun Jun Jul Jul Jul Jul Jan Jan Jan Jan May May May May Jan Jan Jan Jan Jun Jun Jun Jun Feb Feb Feb Feb Oct Oct Oct Oct May May May May Oct Oct Oct Oct
13, 13, 30, 30, 30, 30, 29, 29, 29, 29, 12, 12, 12, 07, 07, 07, 07, 31, 31, 31, 31, 31, 31, 31, 31, 24, 24, 24, 24, 26, 26, 26, 26, 30, 30, 30, 30, 28, 28, 28, 28, 15, 15, 15, 15, 13, 13, 13, 13, 17, 17, 17, 17,
2007 2007 2008 2008 2008 2008 2011 2011 2011 2011 2008 2008 2008 2011 2011 2011 2011 2006 2006 2006 2006 2007 2007 2007 2007 2007 2007 2007 2007 2006 2006 2006 2006 2006 2006 2006 2006 2007 2007 2007 2007 2007 2007 2007 2007 2010 2010 2010 2010 2008 2008 2008 2008
3 - 18 (of 424)
N021434 004
AB AB AB AB AB AB AB AB AB AB AB AB
A078561 A078561 A078561 A078561 A078088 A078088 A078088 A078088 N021726 N021726 N021726 N021726
001 002 003 004 001 002 003 004 001 002 003 004
Mar Mar Mar Mar Jan Jan Jan Jan Jan Jan Jan Jan
16, 16, 16, 16, 09, 09, 09, 09, 19, 19, 19, 19,
2010 2010 2010 2010 2009 2009 2009 2009 2005 2005 2005 2005
ALPROSTADIL
INJECTABLE; INJECTION ALPROSTADIL BEDFORD TEVA PARENTERAL CAVERJECT PHARMACIA AND UPJOHN + + EDEX SCHWARZ PHARMA + PROSTIN VR PEDIATRIC + PHARMACIA AND UPJOHN CAVERJECT PHARMACIA AND UPJOHN CAVERJECT IMPULSE PHARMACIA AND UPJOHN EDEX + SCHWARZ PHARMA + +
AP AP AP AP AP AP AP AP AP XX XX XX XX XX XX
0.5MG/ML 0.5MG/ML 0.01MG/VIAL 0.02MG/VIAL 0.04MG/VIAL 0.01MG/VIAL 0.02MG/VIAL 0.04MG/VIAL 0.5MG/ML 0.005MG/VIAL 0.01MG/VIAL 0.02MG/VIAL 0.01MG/VIAL 0.02MG/VIAL 0.04MG/VIAL
A074815 001 A075196 001 N020379 001 N020379 002 N020379 004 N020649 002 N020649 003 N020649 004 N018484 001 N020379 003 N021212 001 N021212 002 N020649 005 N020649 006 N020649 007
Jan 20, 1998 Apr 30, 1999 Jul 06, 1995 Jul 06, 1995 May 19, 1997 Jun 12, 1997 Jun 12, 1997 Jun 12, 1997
Jun 27, 1996 Jun 11, 2002 Jun 11, 2002 Jul 30, 1998 Jul 30, 1998 Jul 30, 1998
ALTRETAMINE
CAPSULE; ORAL
HEXALEN
XX + EISAI INC
50MG
N019926 001
ALVIMOPAN
CAPSULE; ORAL
ENTEREG
XX + ADOLOR
12MG
N021775 001
3 - 19 (of 424)
AA AA AA AA AA AA AA
TABLET; ORAL
AMANTADINE HYDROCHLORIDE
100MG XX + USL PHARMA
A076186 001
AMBENONIUM CHLORIDE
TABLET; ORAL
MYTELASE
XX + SANOFI AVENTIS US
10MG
N010155 002
AMBRISENTAN
TABLET; ORAL LETAIRIS GILEAD XX XX +
5MG 10MG
AMCINONIDE
CREAM; TOPICAL AMCINONIDE AB + ALTANA TARO PHARM INDS AB LOTION; TOPICAL
AMCINONIDE
XX + ALTANA OINTMENT; TOPICAL AMCINONIDE AB + ALTANA TARO PHARM INDS AB
0.1% 0.1%
0.1%
A076329 001
0.1% 0.1%
AMIFOSTINE
INJECTABLE; INJECTION AMIFOSTINE SUN PHARMA GLOBAL AP ETHYOL AP + MEDIMMUNE
500MG/VIAL 500MG/VIAL
AMIKACIN SULFATE
INJECTABLE; INJECTION AMIKACIN SULFATE AP + BEDFORD AP + HOSPIRA AP AP TEVA PARENTERAL AP
EQ EQ EQ EQ EQ
50MG BASE/ML 250MG BASE/ML 50MG BASE/ML 250MG BASE/ML 250MG BASE/ML
3 - 20 (of 424)
A071111 001
A073209 001
AMINO ACIDS
INJECTABLE; INJECTION AMINOSYN 10% HOSPIRA 10% (10GM/100ML) AMINOSYN 10% (PH6) HOSPIRA 10% (10GM/100ML) AMINOSYN 3.5% HOSPIRA 3.5% (3.5GM/100ML) AMINOSYN 5% HOSPIRA 5% (5GM/100ML) AMINOSYN 7% HOSPIRA 7% (7GM/100ML) AMINOSYN 7% (PH6) HOSPIRA 7% (7GM/100ML) AMINOSYN 8.5% HOSPIRA 8.5% (8.5GM/100ML) AMINOSYN 8.5% (PH6) HOSPIRA 8.5% (8.5GM/100ML) AMINOSYN II 10% HOSPIRA 10% (10GM/100ML) AMINOSYN II 10% IN PLASTIC CONTAINER HOSPIRA 10% (10GM/100ML) AMINOSYN II 15% IN PLASTIC CONTAINER HOSPIRA 15% (15GM/100ML) AMINOSYN II 7% HOSPIRA 7% (7GM/100ML) AMINOSYN II 8.5% HOSPIRA 8.5% (8.5GM/100ML) AMINOSYN-HBC 7% HOSPIRA 7% (7GM/100ML) AMINOSYN-HF 8% HOSPIRA 8% (8GM/100ML) AMINOSYN-PF 10% HOSPIRA 10% (10GM/100ML) AMINOSYN-PF 7% HOSPIRA 7% (7GM/100ML) AMINOSYN-RF 5.2% HOSPIRA 5.2% (5.2GM/100ML) BRANCHAMIN 4% IN PLASTIC CONTAINER BAXTER HLTHCARE 4% (4GM/100ML) CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER CLINTEC NUTR 15% (15GM/100ML) FREAMINE HBC 6.9% B BRAUN 6.9% (6.9GM/100ML) FREAMINE III 10% B BRAUN 10% (10GM/100ML)
XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX
N017673 003 N017673 008 N017789 004 N017673 001 N017673 002 N017673 006 N017673 004 N017673 007 N019438 005 N020015 001 N020041 001 N019438 003 N019438 004 N019374 001 N020345 001 N019492 002 N019398 001 N018429 001 N018684 001 A020512 001 N016822 006 N016822 005 Sep 28, 1984 Aug 30, 1996 May 17, 1983 Nov 18, 1985 Apr 03, 1986 Dec 19, 1991 Dec 19, 1991 Apr 03, 1986 Apr 03, 1986 Jul 12, 1985 Apr 04, 1996 Oct 17, 1986 Sep 06, 1985 Nov 18, 1985 Nov 18, 1985
3 - 21 (of 424)
XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX
N016822 004 N018676 001 A020360 001 N017766 001 A075880 002 A075880 001 N020849 001 N017493 007 N018931 003 N017493 006 N018931 001 N017493 004 N018931 002 N017493 005
N019018 001 N019018 003 Jul 20, 1984 Sep 07, 1988 Aug 23, 1984 Aug 23, 1984 Jun 19, 2003 Jun 19, 2003 Aug 26, 1998 Oct 15, 1982 Aug 23, 1984 Aug 03, 1982 Apr 04, 1996
AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
PROCALAMINE
B BRAUN XX
N018582 001
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.75%;33MG/100ML;10GM/100ML;51MG/100ML; N020678 002 Mar 26, 1997 261MG/100ML;217MG/100ML;112MG/100ML CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.75%;33MG/100ML;25GM/100ML;51MG/100ML; N020678 005 Mar 26, 1997 261MG/100ML;217MG/100ML;112MG/100ML CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.75%;33MG/100ML;5GM/100ML;51MG/100ML;2 N020678 001 Mar 26, 1997 61MG/100ML;217MG/100ML;112MG/100ML CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 4.25%;33MG/100ML;10GM/100ML;51MG/100ML; N020678 009 Mar 26, 1997 261MG/100ML;297MG/100ML;77MG/100ML CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 4.25%;33MG/100ML;20GM/100ML;51MG/100ML; N020678 011 Mar 26, 1997 261MG/100ML;297MG/100ML;77MG/100ML
XX
XX
XX
XX
XX
3 - 22 (of 424)
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 4.25%;33MG/100ML;25GM/100ML;51MG/100ML; N020678 012 Mar 26, 1997 261MG/100ML;297MG/100ML;77MG/100ML CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 4.25%;33MG/100ML;5GM/100ML;51MG/100ML;2 N020678 008 Mar 26, 1997 61MG/100ML;297MG/100ML;77MG/100ML CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;10GM/100ML;51MG/100ML;261 N020678 016 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;15GM/100ML;51MG/100ML;261 N020678 017 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;20GM/100ML;51MG/100ML;261 N020678 018 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;25GM/100ML;51MG/100ML;261 N020678 019 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER + BAXTER HLTHCARE 5%;33MG/100ML;35GM/100ML;51MG/100ML;261 N020678 021 Mar 26, 1997 MG/100ML;340MG/100ML;59MG/100ML
XX
XX
XX
XX
XX
XX
XX
XX XX XX XX XX XX XX XX XX XX XX XX
002 005 001 008 010 011 007 014 015 016 017 018
Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997 Sep 29, 1997
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
INJECTABLE; INJECTION FREAMINE III 8.5% W/ ELECTROLYTES B BRAUN 8.5%;110MG/100ML;230MG/100ML;10MG/100ML XX ;440MG/100ML;690MG/100ML
N016822 007
3 - 23 (of 424)
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
AMINOSYN 3.5% M
HOSPIRA XX
3.5%;21MG/100ML;40MG/100ML;128MG/100ML; 234MG/100ML
N017789 003
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
FREAMINE III 3% W/ ELECTROLYTES
B BRAUN 3%;54MG/100ML;40MG/100ML;150MG/100ML;20 XX 0MG/100ML;120MG/100ML
N016822 003
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 10% W/ ELECTROLYTES HOSPIRA 10%;102MG/100ML;45MG/100ML;522MG/100ML; XX 410MG/100ML AMINOSYN II 8.5% W/ ELECTROLYTES HOSPIRA 8.5%;102MG/100ML;45MG/100ML;522MG/100ML XX ;410MG/100ML
N019437 004
N019437 005
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER BAXTER HLTHCARE 3.5%;51MG/100ML;131MG/100ML;218MG/100ML XX ;35MG/100ML TRAVASOL 3.5% W/ ELECTROLYTES BAXTER HLTHCARE 3.5%;51MG/100ML;131MG/100ML;218MG/100ML XX ;35MG/100ML TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER BAXTER HLTHCARE 5.5%;102MG/100ML;522MG/100ML;431MG/100M XX L;224MG/100ML TRAVASOL 5.5% W/ ELECTROLYTES BAXTER HLTHCARE 5.5%;102MG/100ML;522MG/100ML;431MG/100M XX L;224MG/100ML TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER XX BAXTER HLTHCARE 8.5%;102MG/100ML;522MG/100ML;594MG/100M L;154MG/100ML TRAVASOL 8.5% W/ ELECTROLYTES XX BAXTER HLTHCARE 8.5%;102MG/100ML;522MG/100ML;594MG/100M L;154MG/100ML
N020177 001
N017493 003
N020173 001
N017493 001
N020173 002
N017493 002
N017789 002
N017673 005
AMINOCAPROIC ACID
INJECTABLE; INJECTION AMINOCAPROIC ACID LUITPOLD AP 250MG/ML AMINOCAPROIC ACID IN PLASTIC CONTAINER AP + HOSPIRA 250MG/ML SYRUP; ORAL AMICAR AA + XANODYNE PHARM
1.25GM/5ML
N015230 002
3 - 24 (of 424)
1.25GM/5ML
A074759 001
N015197 001 A075602 001 N015197 002 May 24, 2001 Jun 24, 2004
AMINOHIPPURATE SODIUM
INJECTABLE; INJECTION
AMINOHIPPURATE SODIUM
XX + MERCK
20%
N005619 001
SOLUTION; TOPICAL
LEVULAN
XX + DUSA
20%
N020965 001
AMINOPHYLLINE
INJECTABLE; INJECTION AMINOPHYLLINE + HOSPIRA INTL MEDICATION LUITPOLD PHARMA SERVE NY
AP AP AP AP
TABLET; ORAL
AMINOPHYLLINE
XX + WEST WARD XX +
100MG 200MG
AMINOSALICYLIC ACID
GRANULE, DELAYED RELEASE; ORAL
PASER
4GM/PACKET XX + JACOBUS
A074346 001
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION AMIODARONE HYDROCHLORIDE + AKORN 50MG/ML + APP PHARMS 50MG/ML + BEDFORD 50MG/ML + BEDFORD LABS 50MG/ML + BIONICHE PHARMA 50MG/ML + CLARIS LIFESCIENCES 50MG/ML + GLAND PHARMA LTD 50MG/ML HIKMA FARMACEUTICA 50MG/ML + HOSPIRA 50MG/ML + TEVA PARENTERAL 50MG/ML WOCKHARDT 50MG/ML 50MG/ML NEXTERONE BAXTER HLTHCARE 50MG/ML NEXTERONE + BAXTER HLTHCARE 150MG/100ML (1.5MG/ML) + 360MG/200ML (1.8MG/ML)
AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX
A076232 A075761 A076018 A076299 A076217 A076394 A077161 A077234 A075955 A076163 A077610 A077834
001 001 001 001 001 001 001 001 001 001 001 001
Jul Oct Oct Oct Oct Apr Apr Feb Oct Sep Oct Oct
05, 15, 15, 24, 15, 25, 20, 25, 18, 05, 30, 30,
2006 2002 2002 2002 2002 2003 2005 2008 2002 2003 2008 2008
3 - 25 (of 424)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB XX
A078578 A077069 A077069 A075389 A075188 A075315 A075315 A075424 A075424 A076362 A074739 A079029
001 001 002 001 001 001 002 002 001 001 001 001
Nov Apr Apr Jan Feb Dec Jun Dec Mar Nov Nov Sep
06, 08, 08, 25, 24, 23, 30, 18, 30, 29, 30, 16,
2008 2005 2005 2001 1999 1998 2000 2002 2001 2002 1998 2008
Dec 24, 1985 Apr 12, 2005 Apr 30, 1998 Dec 02, 2003
AMITRIPTYLINE HYDROCHLORIDE
TABLET; ORAL AMITRIPTYLINE HYDROCHLORIDE CARACO AB 10MG AB 25MG AB 50MG AB 75MG AB 100MG AB 150MG MUTUAL PHARM AB 10MG AB 25MG AB 50MG AB 75MG AB 100MG AB 150MG MYLAN AB 10MG AB 25MG AB 50MG AB 75MG AB 100MG AB 150MG SANDOZ AB 10MG AB + 25MG AB 50MG AB 75MG AB 100MG AB 150MG VINTAGE PHARMS AB 10MG AB 25MG AB 50MG AB 75MG AB 100MG AB 150MG
A040815 A040816 A040817 A040818 A040819 A040820 A089398 A089399 A089400 A089401 A089402 A089403 A086009 A086009 A086009 A086009 A086009 A086009 A085969 A085966 A085968 A085971 A085967 A085970 A040218 A040218 A040218 A040218 A040218 A040218
001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 004 005 006 001 001 001 001 001 001 001 002 003 004 005 006
Jun Jun Jun Jun Jun Jun Jul Jul Jul Jul Jul Jul
27, 27, 27, 27, 27, 27, 14, 14, 14, 14, 14, 14,
2008 2008 2008 2008 2008 2008 1987 1987 1987 1987 1987 1987
3 - 26 (of 424)
AMLEXANOX
PASTE; DENTAL
APHTHASOL
XX + ULURU
5%
N020511 001
AMLODIPINE BESYLATE
TABLET; ORAL AMLODIPINE BESYLATE ALKEM AB AB AB AMNEAL PHARMS NY AB AB AB APOTEX AB AB AB AUROBINDO PHARMA AB AB AB CARACO AB AB AB DR REDDYS LABS LTD AB AB AB EPIC PHARMA LLC AB AB AB HIKMA PHARMS AB AB AB INVAGEN PHARMS AB AB AB LEK PHARMS DD AB AB AB LUPIN AB AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE
A078925 A078925 A078925 A078477 A078477 A078477 A076719 A076719 A076719 A078021 A078021 A078021 A078231 A078231 A078231 A076692 A076692 A076692 A078552 A078552 A078552 A077771 A077771 A077771 A077955 A077955 A077955 A076859 A076859 A076859 A078043 A078043 A078043
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
May May May Jan Jan Jan May May May Jul Jul Jul Nov Nov Nov Jul Jul Jul Apr Apr Apr Apr Apr Apr Aug Aug Aug Sep Sep Sep Jul Jul Jul
04, 04, 04, 16, 16, 16, 23, 23, 23, 17, 17, 17, 30, 30, 30, 20, 20, 20, 08, 08, 08, 12, 12, 12, 28, 28, 28, 10, 10, 10, 12, 12, 12,
2009 2009 2009 2008 2008 2008 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2009 2009 2009 2011 2011 2011 2007 2007 2007 2007 2007 2007 2007 2007 2007
3 - 27 (of 424)
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 2.5MG BASE 5MG BASE 5MG BASE 10MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE 2.5MG BASE 5MG BASE 10MG BASE
A078224 A078224 A078224 A076418 A076418 A076418 A078453 A078453 A078453 A078131 A078131 A078131 A077974 A077974 A077974 A077262 A077262 A077262 A090752 A090752 A076846 A076846 A076846 A078573 A078573 A078573 A077759 A077759 A077759 A078414 A078414 A078414 A077073 A077671 A077073 A077671 A077073 A077671 A078500 A078500 A078500 A077516 A077516 A077516 A078226 A078226 A078226
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 002 003
Feb Feb Feb Oct Oct Oct Jul Jul Jul Sep Sep Sep Jul Jul Jul Jul Jul Jul Apr Apr Jun Jun Jun Sep Sep Sep Jul Jul Jul Apr Apr Apr Sep Jul Sep Jul Sep Jul Sep Sep Sep Jul Jul Jul Jul Jul Jul
27, 27, 27, 03, 03, 03, 02, 02, 02, 04, 04, 04, 09, 09, 09, 09, 09, 09, 15, 15, 28, 28, 28, 22, 22, 22, 09, 09, 09, 07, 07, 07, 26, 19, 26, 19, 26, 19, 06, 06, 06, 11, 11, 11, 09, 09, 09,
2008 2008 2008 2005 2005 2005 2009 2009 2009 2007 2007 2007 2007 2007 2007 2007 2007 2007 2011 2011 2007 2007 2007 2008 2008 2008 2007 2007 2007 2010 2010 2010 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007
3 - 28 (of 424)
EQ EQ EQ EQ EQ EQ EQ EQ EQ
2.5MG BASE;EQ 40MG BASE 5MG BASE;EQ 10MG BASE 5MG BASE;EQ 20MG BASE 5MG BASE;EQ 40MG BASE 5MG BASE;EQ 80MG BASE 10MG BASE;EQ 10MG BASE 10MG BASE;EQ 20MG BASE 10MG BASE;EQ 40MG BASE 10MG BASE;EQ 80MG BASE
A077183 A077183 A077183 A090149 A077183 A090149 A078466 A078466 A078466 A078466 A078466 A078466 A077375 A077375 A077375 A079047 A077375 A079047 A078381 A078381 A078381 A078381 A078381 A078381 A077179 A077179 A077179 A077179 A077179 A077179 A077890 A077890 A077890 A077890 A090364 A090364 N020364 N020364 N020364 N020364 N020364 N020364
001 002 003 001 004 002 001 002 003 005 004 006 001 002 003 001 004 002 001 002 003 005 004 006 001 002 003 005 004 006 001 002 003 004 001 002 002 003 004 007 005 006
Apr Apr Apr Jul Apr Jul Feb Feb Feb Jul Feb Jul May May May Jul May Jul Jul Jul Jul Jul Jul Jul May May May Jul May Jul Oct Oct Oct Oct Jul Jul Mar Mar Mar Apr Jun Apr
15, 15, 15, 05, 15, 05, 05, 05, 05, 05, 05, 05, 21, 21, 21, 05, 21, 05, 29, 29, 29, 29, 29, 29, 18, 18, 18, 05, 18, 05, 14, 14, 14, 14, 05, 05, 03, 03, 03, 11, 20, 11,
2010 2010 2010 2011 2010 2011 2010 2010 2010 2011 2010 2011 2010 2010 2010 2011 2010 2011 2010 2010 2010 2010 2010 2010 2007 2007 2007 2011 2007 2011 2010 2010 2010 2010 2011 2011 1995 1995 1995 2006 2002 2006
3 - 29 (of 424)
EQ EQ EQ EQ EQ
5MG BASE;12.5MG;20MG
5MG BASE;12.5MG;40MG
5MG BASE;25MG;40MG
10MG BASE;12.5MG;40MG
10MG BASE;25MG;40MG
5MG;12.5MG;160MG
5MG;25MG;160MG
10MG;12.5MG;160MG
10MG;25MG;160MG
10MG;25MG;320MG
EQ EQ EQ EQ
5MG BASE;20MG
5MG BASE;40MG
10MG BASE;20MG
10MG BASE;40MG
EQ EQ EQ EQ
5MG BASE;40MG
5MG BASE;80MG
10MG BASE;40MG
10MG BASE;80MG
EQ EQ EQ EQ
AMMONIA, N-13
INJECTABLE; INTRAVENOUS
AMMONIA N 13
XX + FEINSTEIN
30MCI-300MCI/8ML (3.75-37.5MCI/ML)
N022119 001
AMMONIUM CHLORIDE
INJECTABLE; INJECTION
AMMONIUM CHLORIDE IN PLASTIC CONTAINER
5MEQ/ML XX + HOSPIRA
A088366 001
AMMONIUM LACTATE
CREAM; TOPICAL AMMONIUM LACTATE PADDOCK LLC AB PERRIGO NEW YORK AB TARO AB
3 - 30 (of 424)
EQ 12% BASE
N020508 001
AB AB AB AB
Jun 11, 2002 Jun 23, 2004 May 28, 2004 Apr 24, 1985
AMOXAPINE
TABLET; ORAL AMOXAPINE WATSON LABS XX XX XX XX +
AMOXICILLIN
CAPSULE; ORAL AMOXICILLIN AM ANTIBIOTICS AB AB AUROBINDO AB AB DAVA PHARMS INC AB AB HIKMA PHARMS AB AB RANBAXY AB AB SANDOZ AB AB TEVA AB AB + AMOXIL DR REDDYS LABS INC AB AB FOR SUSPENSION; ORAL AMOXICILLIN AUROBINDO AB AB DAVA PHARMS INC AB AB HIKMA AB AB AB AB RANBAXY AB AB SANDOZ AB AB AB AB TEVA AB AB AB + AB +
250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG
A062058 A062058 A065271 A065271 A062884 A062881 A065291 A065291 A065016 A065016 A064076 A064076 A061926 A061926
001 002 001 002 001 001 001 002 001 002 001 002 001 003
Nov Nov Feb Feb Feb Feb Apr Apr Sep Sep
09, 09, 25, 25, 05, 05, 08, 08, 30, 30,
2005 2005 1988 1988 2007 2007 1999 1999 1994 1994
200MG/5ML 400MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 200MG/5ML 250MG/5ML 400MG/5ML 200MG/5ML 400MG/5ML 125MG/5ML 200MG/5ML 250MG/5ML 400MG/5ML 125MG/5ML 200MG/5ML 250MG/5ML 400MG/5ML
A065334 A065334 A062927 A062927 A065322 A065325 A065322 A065325 A065113 A065113 A065387 A065378 A065387 A065378 A061931 A065119 A061931 A065119
001 002 001 002 002 002 001 001 001 002 001 001 002 002 001 001 002 002
Dec Dec Nov Nov Jun Jun Jun Jun Nov Nov Mar Mar Mar Mar
28, 28, 25, 25, 19, 19, 19, 19, 29, 29, 26, 26, 26, 26,
2006 2006 1988 1988 2006 2006 2006 2006 2002 2002 2007 2007 2007 2007
3 - 31 (of 424)
A065319 002 A061931 003 A062226 A062226 N050760 A062226 N050760 005 001 001 002 002
500MG 875MG 875MG 875MG 500MG 875MG 500MG 875MG 500MG 875MG 500MG 875MG
A065256 A065256 A065344 A065255 A065059 A065059 A065228 A065228 A065056 A065056
001 002 001 001 001 002 001 002 001 002
Nov Nov Jan Mar Nov Nov Jul Jul Sep Sep
09, 09, 15, 29, 24, 24, 13, 13, 18, 18,
2005 2005 2009 2006 2000 2000 2005 2005 2000 2000
125MG 250MG 125MG 250MG 125MG 250MG 125MG 200MG 250MG 400MG 200MG 400MG
A064139 A064139 A065021 A065021 A064013 A064013 N050542 N050761 N050542 N050761
001 002 001 002 002 001 002 001 001 002
Apr 15, 1999 Apr 15, 1999 Nov 29, 2000 Nov 29, 2000
N050813 001
3 - 32 (of 424)
N050757 001
N050824 001
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A065191 A065191 A065373 A065098 A065098 A065358 A065132 A065132 A065207 A065066 A065066 A065089 A065089 A065162 A065431
002 001 001 001 002 001 001 002 002 001 002 001 002 001 001
Jan Jan Nov Dec Dec Aug Mar Mar Jan Jun Jun May May Mar Nov
25, 25, 09, 16, 16, 13, 19, 19, 30, 05, 05, 25, 25, 12, 25,
2005 2005 2007 2002 2002 2007 2003 2003 2007 2002 2002 2004 2004 2004 2008
N050575 001 N050725 001 N050575 002 N050725 002 N050755 001
Aug 06, 1984 May 31, 1996 Aug 06, 1984 May 31, 1996 Jun 22, 2001
SUSPENSION; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM AUROBINDO PHARMA LTD 200MG/5ML;EQ 28.5MG BASE/5ML AB AB 400MG/5ML;EQ 57MG BASE/5ML AB 600MG/5ML;EQ 42.9MG BASE/5ML TABLET; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM APOTEX AB 250MG;EQ 125MG AB 500MG;EQ 125MG APOTEX INC AB 875MG;EQ 125MG LEK PHARMS AB 500MG;EQ 125MG AB 875MG;EQ 125MG RANBAXY AB 500MG;EQ 125MG AB 875MG;EQ 125MG SANDOZ AB 250MG;EQ 125MG AB 500MG;EQ 125MG AB 875MG;EQ 125MG TEVA AB 500MG;EQ 125MG AB + 875MG;EQ 125MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A065333 A065333 A065317 A065117 A065093 A065109 A065102 A065189 A065064 A065063 A065101 A065096
001 002 003 001 001 001 001 001 001 001 001 001
Feb Feb Oct Nov Nov Nov Sep Aug Mar Mar Oct Oct
24, 24, 20, 27, 21, 04, 17, 23, 15, 14, 30, 29,
2009 2009 2008 2002 2002 2002 2002 2005 2002 2002 2002 2002
3 - 33 (of 424)
TABLET, CHEWABLE; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM RANBAXY AB 200MG;EQ 28.5MG BASE AB 400MG;EQ 57MG BASE SANDOZ AB 200MG;EQ 28.5MG BASE AB 400MG;EQ 57MG BASE TEVA AB 200MG;EQ 28.5MG BASE AB + 400MG;EQ 57MG BASE AUGMENTIN '125' DR REDDYS LABS INC AB 125MG;EQ 31.25MG BASE AUGMENTIN '200' DR REDDYS LABS INC AB 200MG;EQ 28.5MG BASE AUGMENTIN '250' DR REDDYS LABS INC AB 250MG;EQ 62.5MG BASE AUGMENTIN '400' DR REDDYS LABS INC AB 400MG;EQ 57MG BASE TABLET, EXTENDED RELEASE; ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM SANDOZ AB 1GM;EQ 62.5MG BASE AUGMENTIN XR AB + DR REDDYS LABS INC 1GM;EQ 62.5MG BASE
Jul 22, 1985 May 31, 1996 Jul 22, 1985 May 31, 1996
XX XX XX XX XX XX
N021303 001 N021303 006 N021303 002 N021303 004 N021303 003 N021303 005
Oct 11, 2001 May 22, 2002 Oct 11, 2001 May 22, 2002 Oct 11, 2001 May 22, 2002
TABLET; ORAL DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE BARR AB 1.25MG;1.25MG;1.25MG;1.25MG A040422 AB 1.875MG;1.875MG;1.875MG;1.875MG A040422 AB 2.5MG;2.5MG;2.5MG;2.5MG A040422 AB 3.125MG;3.125MG;3.125MG;3.125MG A040422 AB 3.75MG;3.75MG;3.75MG;3.75MG A040422 AB 5MG;5MG;5MG;5MG A040422 AB + 7.5MG;7.5MG;7.5MG;7.5MG A040422 COREPHARMA AB 1.25MG;1.25MG;1.25MG;1.25MG A040444 AB 2.5MG;2.5MG;2.5MG;2.5MG A040444 AB 5MG;5MG;5MG;5MG A040444 AB 7.5MG;7.5MG;7.5MG;7.5MG A040444 SANDOZ AB 1.25MG;1.25MG;1.25MG;1.25MG A040439 AB 2.5MG;2.5MG;2.5MG;2.5MG A040439
001 005 002 006 007 003 004 001 002 003 004 004 001
Feb Mar Feb Mar Mar Feb Feb Jun Jun Jun Jun Sep Jun
11, 19, 11, 19, 19, 11, 11, 19, 19, 19, 19, 27, 14,
2002 2003 2002 2003 2003 2002 2002 2002 2002 2002 2002 2002 2002
3 - 34 (of 424)
AMPHOTERICIN B
INJECTABLE; INJECTION AMPHOTERICIN B AP + X GEN PHARMS
50MG/VIAL
A063206 001
N050740 001
AMPICILLIN SODIUM
INJECTABLE; INJECTION AMPICILLIN SODIUM ACIC FINE CHEMS AP AP AP AP AUROBINDO PHARMA AP AP AP AP AP AP HANFORD GC AP AP AP AP AP IBI AP AP AP INSTITUTO BIOCHEMICO AP AP AP + SANDOZ AP + AP + AP + AP AP + AP AP +
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 125MG BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
A090354 A090354 A090354 A090354 A065499 A065499 A065499 A065499 A065499 A065493 A063145 A063146 A062772 A063140 A063142 A062719 A062719 A062719 A062797 A062797 A061395 A061395 A061395 A061395 A062738 A061395 A062738 A061395
001 002 003 004 001 002 003 004 005 001 001 001 001 001 001 001 003 002 001 002 001 002 003 004 001 005 002 006
Dec Dec Dec Dec Aug Aug Aug Aug Aug Aug Apr Apr Apr Apr Apr May May May Jul Jul
28, 28, 28, 28, 17, 17, 17, 17, 17, 17, 15, 15, 15, 15, 15, 12, 12, 12, 12, 12,
2009 2009 2009 2009 2010 2010 2010 2010 2010 2010 1993 1993 1993 1993 1993 1987 1987 1987 1993 1993
3 - 35 (of 424)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 1GM BASE/VIAL;EQ 500MG BASE/VIAL 2GM BASE/VIAL;EQ 1GM BASE/VIAL 10GM BASE/VIAL;EQ 5GM BASE/VIAL
A065406 A065406 A065403 A090340 A090349 A090340 A090349 A090339 A065074 A065074 A065076 A065316 A065316 A065176 A065176 A065188 A090375 A090653 A090375 A090653 A090646 A065222 A065222 A065314 A065241 A065310 A065241 A065310 A065240 A062901 N050608 N050608 N050608
001 002 001 001 001 002 002 001 001 002 001 001 002 001 002 001 001 001 002 002 001 001 002 001 001 001 002 002 001 001 002 001 005
Dec Dec Dec Sep Sep Sep Sep Sep Mar Mar Mar Jun Jun Nov Nov Nov Dec Dec Dec Dec Dec Nov Nov Nov Jul Jul Jul Jul Jul Nov Dec Dec Dec
22, 22, 23, 20, 20, 20, 20, 20, 19, 19, 19, 29, 29, 30, 30, 25, 21, 21, 21, 21, 21, 29, 29, 27, 25, 25, 25, 25, 25, 23, 31, 31, 10,
2009 2009 2009 2010 2010 2010 2010 2010 2002 2002 2002 2007 2007 2005 2005 2005 2011 2011 2011 2011 2011 2005 2005 2006 2006 2006 2006 2006 2006 1988 1986 1986 1993
AMPICILLIN/AMPICILLIN TRIHYDRATE
CAPSULE; ORAL AMPICILLIN TRIHYDRATE DAVA PHARMS INC AB AB + SANDOZ AB AB FOR SUSPENSION; ORAL AMPICILLIN TRIHYDRATE DAVA PHARMS INC XX XX +
EQ EQ EQ EQ
ANAGRELIDE HYDROCHLORIDE
CAPSULE; ORAL AGRYLIN SHIRE EQ ANAGRELIDE HYDROCHLORIDE ALPHAPHARM EQ EQ BARR EQ EQ IMPAX LABS EQ
AB AB AB AB AB AB
0.5MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE
N020333 001 A077613 A077613 A076530 A076530 A076910 001 002 001 002 001
Mar 14, 1997 Jun Jun Apr Apr Apr 27, 27, 18, 18, 18, 2006 2006 2005 2005 2005
3 - 36 (of 424)
AB AB AB AB AB AB AB AB AB
1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE 0.5MG BASE 1MG BASE
ANASTROZOLE
TABLET; ORAL ANASTROZOLE ACCORD HLTHCARE INC DR REDDYS LABS LTD FRESENIUS KABI ONCOL KUDCO IRELAND MYLAN NATCO PHARMA LTD ROXANE SANDOZ SANTOS BIOTECH SUN PHARM INDS LTD TEVA PHARMS THREE RIVERS PHARMS WATSON LABS ZYDUS PHARMS USA INC ARIMIDEX + ASTRAZENECA
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG
A090568 A090732 A090088 A091331 A091051 A079220 A078485 A079007 A078944 A091177 A078058 A091164 A078984 A078921
001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jun Jun Jun Jan Jun Jun Jun Jun Jun Jul Jun Jun Jun Jun
28, 28, 28, 05, 28, 28, 28, 28, 28, 15, 28, 28, 28, 28,
2010 2010 2010 2011 2010 2010 2010 2010 2010 2011 2010 2010 2010 2010
N020541 001
ANIDULAFUNGIN
INJECTABLE; IV (INFUSION)
ERAXIS
XX + VICURON 50MG/VIAL XX + 100MG/VIAL
APOMORPHINE HYDROCHLORIDE
INJECTABLE; SUBCUTANEOUS
APOKYN
XX + US WORLDMEDS
30MG/3ML (10MG/ML)
N021264 002
APRACLONIDINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC APRACLONIDINE HYDROCHLORIDE AKORN INC AT EQ 0.5% BASE IOPIDINE AT + ALCON EQ 0.5% BASE IOPIDINE EQ 1% BASE XX + ALCON
APREPITANT
CAPSULE; ORAL EMEND MERCK XX XX XX +
3 - 37 (of 424)
10,000KIU/ML
N020304 001
ARFORMOTEROL TARTRATE
SOLUTION; INHALATION
BROVANA
XX + SUNOVION
EQ 0.015MG BASE/2ML
N021912 001
ARGATROBAN
INJECTABLE; INJECTION
ARGATROBAN
XX + PFIZER
100MG/ML
N020883 001
INJECTABLE; IV (INFUSION)
ARGATROBAN IN SODIUM CHLORIDE
XX + EAGLE PHARMS 50MG/50ML (1MG/ML) XX + SANDOZ 125MG/125ML (1MG/ML)
ARGININE HYDROCHLORIDE
INJECTABLE; INJECTION
R-GENE 10
XX + PHARMACIA AND UPJOHN 10GM/100ML
N016931 001
ARIPIPRAZOLE
INJECTABLE; INTRAMUSCULAR
ABILIFY
XX + OTSUKA 9.75MG/1.3ML (7.5MG/ML) SOLUTION; ORAL
ABILIFY
XX + OTSUKA TABLET; ORAL
ABILIFY
OTSUKA
XX XX +
XX +
XX XX XX
N021866 001
1MG/ML
N021713 001
ARMODAFINIL
TABLET; ORAL
NUVIGIL
CEPHALON
XX XX XX +
ARSENIC TRIOXIDE
INJECTABLE; INJECTION
TRISENOX
XX + CEPHALON
1MG/ML
N021248 001
TABLET; ORAL
COARTEM
XX + NOVARTIS
3 - 38 (of 424)
20MG;120MG
N022268 001
A079138 001
N020971 001
N022010 001
ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K
INJECTABLE; IV (INFUSION)
INFUVITE PEDIATRIC
80MG/VIAL;0.02MG/VIAL;400 XX + SANDOZ IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VI AL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/ VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL XX INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) + SANDOZ 80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VI AL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/ VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL
N021265 001
N021646 001
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
FOR SOLUTION; IV (INFUSION) M.V.I. PEDIATRIC XX + HOSPIRA 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/ VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL; 0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
N018920 001
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
INJECTABLE; INJECTION
M.V.I.-12 (WITHOUT VITAMIN K)
XX + HOSPIRA 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML; 0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0 .36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML
N008809 006
3 - 39 (of 424)
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K
INJECTABLE; IV (INFUSION) M.V.I. ADULT XX + HOSPIRA 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15M G/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIA L;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL ;10MG/VIAL;0.15MG/VIAL XX M.V.I. ADULT (PHARMACY BULK PACKAGE) + HOSPIRA 200MG/5ML;0.06MG/5ML;0.005MG/5ML;15MG/5 ML;0.005MG/5ML;0.6MG/5ML;40MG/5ML;6MG/5 ML;3.6MG/5ML;6MG/5ML;1MG/5ML;10MG/5ML;0 .15MG/5ML
N021625 001
N021643 001
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM
N021881 001
ASENAPINE MALEATE
TABLET; SUBLINGUAL SAPHRIS XX ORGANON USA INC XX +
325MG;50MG;40MG 325MG;50MG;40MG
A086162 002
AB AB AB AB
Nov 30, 2001 Aug 31, 1998 Aug 31, 1995 Oct 26, 1990
356.4MG;30MG;16MG
N011483 004
AB AB AB AB
Nov 27, 1996 Nov 27, 1996 Oct 27, 1982 Oct 27, 1982
3 - 40 (of 424)
ASPIRIN; CARISOPRODOL
TABLET; ORAL CARISOPRODOL AND ASPIRIN HERITAGE PHARMS INC 325MG;200MG MIRROR PHARMS 325MG;200MG PROSAM LABS 325MG;200MG SANDOZ 325MG;200MG SOMA COMPOUND + MEDA PHARMS 325MG;200MG
AB AB AB AB AB
N012365 005
AB AB AB AB
Jan 07, 2010 Dec 29, 1998 Apr 16, 1996 Jul 11, 1983
ASPIRIN; DIPYRIDAMOLE
CAPSULE, EXTENDED RELEASE; ORAL AGGRENOX AB + BOEHRINGER INGELHEIM 25MG;200MG ASPIRIN AND DIPYRIDAMOLE BARR AB 25MG;200MG
ASPIRIN; METHOCARBAMOL
TABLET; ORAL
METHOCARBAMOL AND ASPIRIN
325MG;400MG XX + STEVENS J
A081145 001
325MG;4.5MG;0.38MG
A040255 001
ATAZANAVIR SULFATE
CAPSULE; ORAL REYATAZ BRISTOL MYERS SQUIBB XX XX XX XX +
EQ EQ EQ EQ
3 - 41 (of 424)
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 25MG 50MG 50MG 100MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG
A078512 A078512 A078512 A078210 A078210 A078210 A074099 A073542 A073543 A077877 A077877 A077877 A073646 A072303 A072304 A074499 A073475 A073476 A073457 A074126 A073456 A074126 A073457 A074126 A078254 A078254 A078254 A074052 A073025 A073026 A074056 A074056 A074056 A077443 A077443 A077443 A073352 A073353 A076900 A076900 A076900
001 002 003 001 002 003 001 001 001 001 002 003 001 001 001 001 001 001 002 003 001 001 001 002 001 002 003 001 001 001 003 001 002 001 002 003 001 001 001 002 003
Oct Oct Oct Jul Jul Jul Apr Dec Dec Dec Dec Dec Jul Jul Jul Jul Mar Mar Apr Aug Jan Mar Jan Mar Sep Sep Sep May Sep Sep Jul Jan Jan Sep Sep Sep Dec Dec Jan Jan Jan
31, 31, 31, 10, 10, 10, 28, 19, 19, 27, 27, 27, 31, 15, 15, 30, 30, 30, 26, 26, 24, 23, 24, 23, 25, 25, 25, 01, 17, 17, 19, 18, 18, 13, 13, 13, 27, 27, 28, 28, 28,
2007 2007 2007 2007 2007 2007 1992 1991 1991 2006 2006 2006 1992 1988 1988 1997 1993 1993 1999 1998 1992 1994 1992 1994 2009 2009 2009 1992 1991 1991 2004 1995 1995 2006 2006 2006 1991 1991 2005 2005 2005
ATENOLOL; CHLORTHALIDONE
TABLET; ORAL ATENOLOL AND CHLORTHALIDONE IPR AB 50MG;25MG AB 100MG;25MG MUTUAL PHARM AB 50MG;25MG AB 100MG;25MG MYLAN AB 50MG;25MG 100MG;25MG AB WATSON LABS AB 50MG;25MG AB 100MG;25MG
3 - 42 (of 424)
100MG;25MG 50MG;25MG
ATOMOXETINE HYDROCHLORIDE
CAPSULE; ORAL ATOMOXETINE HYDROCHLORIDE AUROBINDO PHARM AB 10MG AB 18MG AB 25MG AB 40MG AB 60MG AB 80MG AB 100MG MYLAN AB 10MG AB 18MG AB 25MG AB 40MG AB 60MG AB 80MG AB 100MG SANDOZ AB 10MG AB 18MG AB 25MG AB 40MG AB 60MG AB 80MG AB 100MG SUN PHARMA GLOBAL AB 10MG AB 18MG AB 25MG AB 40MG AB 60MG AB 80MG AB 100MG TEVA PHARMS AB 10MG AB 18MG AB 25MG AB 40MG AB 60MG AB 80MG AB 100MG ZYDUS PHARMS USA INC 18MG AB AB 25MG AB 40MG AB 60MG AB 80MG AB 100MG STRATTERA LILLY AB 10MG AB 18MG AB 25MG AB 40MG AB + 60MG AB 80MG AB 100MG
A079016 A079016 A079016 A079016 A079016 A079016 A079016 A079021 A079021 A079021 A079021 A079021 A079021 A079021 A079018 A079018 A079018 A079018 A079018 A079018 A079018 A079020 A079020 A079020 A079020 A079020 A079020 A079020 A079022 A079022 A079022 A079022 A079022 A079022 A079022 A079017 A079017 A079017 A079017 A079017 A079017 N021411 N021411 N021411 N021411 N021411 N021411 N021411
001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 002 003 004 005 006 007 008
Sep Sep Sep Sep Sep Sep Sep Aug Aug Aug Aug Aug Aug Aug Sep Sep Sep Sep Sep Sep Sep Aug Aug Aug Aug Aug Aug Aug Oct Oct Oct Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Nov Nov Nov Nov Nov Feb Feb
13, 13, 13, 13, 13, 13, 13, 30, 30, 30, 30, 30, 30, 30, 13, 13, 13, 13, 13, 13, 13, 30, 30, 30, 30, 30, 30, 30, 01, 01, 01, 01, 01, 01, 01, 17, 17, 17, 17, 17, 17, 26, 26, 26, 26, 26, 14, 14,
2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2002 2002 2002 2002 2002 2005 2005
3 - 43 (of 424)
EQ EQ EQ EQ EQ EQ EQ EQ
ATOVAQUONE
SUSPENSION; ORAL
MEPRON
XX + GLAXOSMITHKLINE LLC
750MG/5ML
N020500 001
ATRACURIUM BESYLATE
INJECTABLE; INJECTION
ATRACURIUM BESYLATE
10MG/ML XX + BEDFORD ATRACURIUM BESYLATE PRESERVATIVE FREE 10MG/ML XX + BEDFORD
ATROPINE
INJECTABLE; INJECTION
ATROPEN
+ MERIDIAN MEDCL TECHN + + +
XX XX XX XX
EQ EQ EQ EQ
ATROPINE SULFATE
INJECTABLE; IM-IV-SC ATROPINE SULFATE ANSYR PLASTIC SYRINGE XX HOSPIRA 0.05MG/ML XX + 0.1MG/ML
TABLET; ORAL
MOTOFEN
XX + VALEANT
0.025MG;1MG
N017744 002
3 - 44 (of 424)
AA AA AA AA AA
A085372 001 A085762 001 A040357 001 N012462 001 A085311 002
0.14MG/ML;10MG/ML
N019678 001
N021983 001
AURANOFIN
CAPSULE; ORAL
RIDAURA
XX + PROMETHEUS LABS
3MG
N018689 001
AZACITIDINE
INJECTABLE; IV-SC
VIDAZA
XX + CELGENE
100MG/VIAL
N050794 001
AZATHIOPRINE
TABLET; ORAL AZASAN AAIPHARMA LLC AB AB AB AB AZATHIOPRINE MYLAN AB ROXANE AB ZYDUS PHARMS USA AB AB AB AB IMURAN AB + PROMETHEUS LABS
25MG 50MG 75MG 100MG 50MG 50MG 25MG 50MG 75MG 100MG 50MG
A075252 A075252 A075252 A075252 A075568 A074069 A077621 A077621 A077621 A077621
002 001 003 004 001 001 002 001 003 004
Feb Jun Feb Feb Dec Feb Sep Mar Sep Sep
03, 07, 03, 03, 13, 16, 05, 15, 05, 05,
2003 1999 2003 2003 1999 1996 2008 2007 2008 2008
N016324 001
AZATHIOPRINE SODIUM
INJECTABLE; INJECTION
AZATHIOPRINE SODIUM
XX + BEDFORD
EQ 100MG BASE/VIAL
A074419 001
AZELAIC ACID
CREAM; TOPICAL
AZELEX
XX + ALLERGAN
20%
N020428 001
3 - 45 (of 424)
15%
N021470 001
AZELASTINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AZELASTINE HYDROCHLORIDE APOTEX INC AT 0.05% SUN PHARMA GLOBAL AT 0.05% OPTIVAR AT + MEDA PHARMS 0.05% SPRAY, METERED; NASAL ASTELIN AB + MEDA PHARMS EQ 0.125MG BASE/SPRAY AZELASTINE HYDROCHLORIDE APOTEX INC AB EQ 0.125MG BASE/SPRAY ASTEPRO EQ 0.1876MG BASE/SPRAY XX + MEDA PHARMS
AZILSARTAN KAMEDOXOMIL
TABLET; ORAL EDARBI XX TAKEDA PHARMS XX +
AZITHROMYCIN
FOR SUSPENSION; ORAL AZITHROMYCIN PLIVA AB AB SANDOZ AB AB TEVA PHARMS AB AB ZITHROMAX PFIZER AB AB + ZITHROMAX XX + PFIZER
EQ EQ EQ EQ EQ EQ
N050797 001
EQ EQ EQ EQ EQ EQ EQ
3 - 46 (of 424)
SOLUTION/DROPS; OPHTHALMIC
AZASITE
XX + INSPIRE 1% TABLET; ORAL AZITHROMYCIN APOTEX CORP AB AB AB MYLAN AB AB AB PLIVA AB AB AB SANDOZ AB AB AB TEVA AB AB AB WOCKHARDT AB AB AB ZITHROMAX PFIZER AB AB AB +
N050810 001
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG 500MG 600MG 250MG 500MG 600MG 250MG 500MG 600MG 250MG 500MG 600MG 250MG 500MG 600MG 250MG 500MG 600MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A065507 A065509 A065508 A065365 A065366 A065360 A065225 A065223 A065218 A065211 A065212 A065209 A065153 A065193 A065150 A065404 A065405 A065302
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 003
Jul Jul Jul May May Jan Nov Nov Nov Nov Nov Nov Nov Nov Nov Feb Feb Feb
13, 13, 13, 30, 30, 08, 14, 14, 14, 14, 14, 14, 14, 14, 14, 11, 11, 11,
2011 2011 2011 2007 2007 2007 2005 2005 2005 2005 2005 2005 2005 2005 2005 2008 2008 2008
AZTREONAM
75MG/VIAL
N050814 001
INJECTABLE; INJECTION AZACTAM AP + BRISTOL MYERS SQUIBB 1GM/VIAL AP + 2GM/VIAL AZTREONAM APP PHARMS AP 1GM/VIAL AP 2GM/VIAL BEDFORD AP 1GM/VIAL AP 2GM/VIAL AZACTAM IN PLASTIC CONTAINER XX + BRISTOL MYERS SQUIBB 20MG/ML 40MG/ML XX + AZTREONAM APP PHARMS 500MG/VIAL XX
N050580 002 N050580 003 A065439 A065439 A065286 A065286 002 003 001 002
Dec 31, 1986 Dec 31, 1986 Jun Jun Mar Mar 18, 18, 23, 23, 2010 2010 2011 2011
BACITRACIN
INJECTABLE; INJECTION BACIIM X GEN PHARMS AP BACITRACIN APP PHARMS AP
3 - 47 (of 424)
500 UNITS/GM
A061212 001
A061580 001
N050168 002
A062166 002
BACLOFEN
INJECTABLE; INTRATHECAL GABLOFEN CNS THERAPS INC AP AP AP LIORESAL AP + MEDTRONIC AP + AP + TABLET; ORAL BACLOFEN CARACO AB
N022462 001 N022462 002 N022462 003 N020075 003 N020075 001 N020075 002
Nov 19, 2010 Nov 19, 2010 Nov 19, 2010 Nov 07, 1996 Jun 17, 1992 Jun 17, 1992
10MG
A077984 001
3 - 48 (of 424)
20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG
A077862 A078146 A077971 A072234 A072235 A078220 A077241 A090334 A090334 A077181 A077121 A078504 A078401 A077089 A077088 A074584 A074584 A077156 A077068 A072824 A072825
002 001 002 001 001 001 001 001 002 001 002 001 001 001 001 001 002 001 001 001 001
Aug Oct Oct Jul Jul Jul Dec Feb Feb Jul Jul Sep Sep Oct Oct Aug Aug Aug Aug Sep Sep
14, 26, 26, 21, 21, 06, 20, 18, 18, 29, 29, 18, 18, 31, 31, 19, 19, 30, 30, 18, 18,
2006 2007 2007 1988 1988 2007 2005 2010 2010 2005 2005 2009 2009 2007 2007 1996 1996 2005 2005 1991 1991
BALSALAZIDE DISODIUM
CAPSULE; ORAL BALSALAZIDE DISODIUM APOTEX INC MYLAN ROXANE COLAZAL + SALIX PHARMS
AB AB AB AB
Dec 28, 2007 Dec 28, 2007 Dec 28, 2007 Jul 18, 2000
BECLOMETHASONE DIPROPIONATE
AEROSOL, METERED; INHALATION
QVAR 40
0.04MG/INH XX + TEVA BRANDED PHARM QVAR 80
0.08MG/INH XX + TEVA BRANDED PHARM
EQ 0.042MG DIPROP/SPRAY
N019389 001
BENAZEPRIL HYDROCHLORIDE
TABLET; ORAL BENAZEPRIL HYDROCHLORIDE APOTEX INC 5MG 10MG 20MG 40MG AUROBINDO PHARMA 10MG 20MG 40MG BIOKEY 5MG 10MG 20MG 40MG
AB AB AB AB AB AB AB AB AB AB AB
A077128 A077128 A077128 A077128 A078212 A078212 A078212 A076820 A076820 A076820 A076820
001 002 003 004 001 002 003 001 002 003 004
Mar Mar Mar Mar May May May Feb Feb Feb Feb
08, 08, 08, 08, 22, 22, 22, 03, 03, 03, 03,
2006 2006 2006 2006 2008 2008 2008 2006 2006 2006 2006
3 - 49 (of 424)
A076333 A076333 A076333 A076333 A076430 A076430 A076430 A076430 A076118 A076118 A076118 A076118 A076344 A076344 A076344 A076344 A076402 A076402 A076402 A076402 A076211 A076211 A076211 A076211 A076267 A076267 A076267 A076267 A078848 A078848 A078848 A078848 N019851 N019851 N019851 N019851
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb May May May May Jun Jun Jun Jun
11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 23, 23, 23, 23, 25, 25, 25, 25,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2008 2008 2008 2008 1991 1991 1991 1991
A076348 A076348 A076348 A076348 A076612 A076688 A076612 A076688 A076612 A076688 A076612 A076688 A077483 A077483 A077483 A077483
001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004
Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Sep Sep Sep Sep
11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 08, 08, 08, 08,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2005 2005 2005 2005
3 - 50 (of 424)
A076631 A076631 A076631 A076631 A076342 A076342 A076342 A076342 N020033 N020033 N020033 N020033
001 002 003 004 001 002 003 004 001 002 004 003
Feb Feb Feb Feb Feb Feb Feb Feb May May May May
11, 11, 11, 11, 11, 11, 11, 11, 19, 19, 19, 19,
2004 2004 2004 2004 2004 2004 2004 2004 1992 1992 1992 1992
BENDAMUSTINE HYDROCHLORIDE
POWDER; IV (INFUSION)
TREANDA
XX + CEPHALON XX +
25MG/VIAL 100MG/VIAL
BENDROFLUMETHIAZIDE; NADOLOL
TABLET; ORAL CORZIDE KING PHARMS 5MG;40MG + 5MG;80MG NADOLOL AND BENDROFLUMETHAZIDE MYLAN 5MG;40MG 5MG;80MG NADOLOL AND BENDROFLUMETHIAZIDE IMPAX LABS 5MG;40MG 5MG;80MG
AB AB AB AB AB AB
N018647 001 N018647 002 A078688 001 A078688 002 A077833 001 A077833 002
May 25, 1983 May 25, 1983 Feb 15, 2008 Feb 15, 2008 Mar 30, 2007 Mar 30, 2007
BENZONATATE
CAPSULE; ORAL BENZONATATE BANNER PHARMACAPS AA AA MIKART AA AA NESHER PHARMS AA AA ORIT LABS LLC AA AA SUN PHARM INDS INC AA AA THE PHARMA NETWORK AA AA ZYDUS PHARMS USA AA AA TESSALON AA + FOREST LABS AA + BENZONATATE MIKART XX
100MG 200MG 100MG 200MG 100MG 200MG 100MG 200MG 100MG 200MG 100MG 200MG 100MG 200MG 100MG 200MG 150MG
A081297 A081297 A040851 A040851 A040795 A040795 A040682 A040682 A040587 A040587 A040627 A040749 A040597 A040597
001 002 001 003 001 002 001 002 001 002 001 001 001 002
Jan Oct Nov Nov Oct Oct Jul Jul Mar Mar Mar Jul Jun Jun
29, 30, 09, 09, 31, 31, 30, 30, 19, 19, 30, 25, 08, 08,
1993 2007 2009 2009 2007 2007 2007 2007 2008 2008 2007 2007 2007 2007
3 - 51 (of 424)
AB AB BT BT XX
N050756 001 A065443 001 N050756 002 N050741 001 N050819 001
Dec 21, 2000 Aug 11, 2009 Apr 20, 2007 Aug 26, 2002 Oct 23, 2008
BENZPHETAMINE HYDROCHLORIDE
TABLET; ORAL BENZPHETAMINE HYDROCHLORIDE COREPHARMA 50MG IMPAX LABS 50MG KVK TECH 50MG MALLINCKRODT INC 50MG MIKART 25MG 50MG PADDOCK 50MG TEDOR PHARM 50MG DIDREX + PHARMACIA AND UPJOHN 50MG
AA AA AA AA AA AA AA AA AA
N012427 002
BENZTROPINE MESYLATE
INJECTABLE; INJECTION BENZTROPINE MESYLATE HIKMA FARMACEUTICA LUITPOLD NEXUS PHARMS COGENTIN + LUNDBECK INC
AP AP AP AP
TABLET; ORAL BENZTROPINE MESYLATE COREPHARMA AA AA AA INVAGEN PHARMS AA AA AA AA + LANNETT AA + AA + PLIVA AA AA AA USL PHARMA AA AA
0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG
A072264 A072265 A072266 A090294 A090294 A090294 A088877 A088894 A088895 A089058 A089059 A089060 A040103 A040103
001 001 001 001 002 003 001 001 001 001 001 001 001 002
Feb Feb Feb Mar Mar Mar Apr Apr Apr Aug Aug Aug Dec Dec
27, 27, 27, 29, 29, 29, 11, 11, 11, 10, 10, 10, 12, 12,
1989 1989 1989 2010 2010 2010 1985 1985 1985 1988 1988 1988 1996 1996
3 - 52 (of 424)
BENZYL ALCOHOL
LOTION; TOPICAL
ULESFIA
XX + SHIONOGI INC
5%
N022129 001
BENZYLPENICILLOYL POLYLYSINE
INJECTABLE; INJECTION
PRE-PEN
XX + ALLERQUEST
60UMOLAR
N050114 001
BEPOTASTINE BESILATE
SOLUTION/DROPS; OPHTHALMIC
BEPREVE
1.5% XX + ISTA PHARMS
N022288 001
BERACTANT
SUSPENSION; INTRATRACHEAL
SURVANTA
25MG/ML XX + ROSS LABS
N020032 001
BESIFLOXACIN HYDROCHLORIDE
SUSPENSION/DROPS; OPHTHALMIC
BESIVANCE
EQ 0.6% BASE XX + BAUSCH AND LOMB
N022308 001
BETAINE HYDROCHLORIDE
FOR SOLUTION; ORAL
CYSTADANE
XX + RARE DIS THERAP
1GM/SCOOPFUL
N020576 001
BETAMETHASONE
SYRUP; ORAL
CELESTONE
XX + SCHERING
0.6MG/5ML
N014215 002
BETAMETHASONE DIPROPIONATE
CREAM; TOPICAL BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ 0.05% BASE AB AB + FOUGERA EQ 0.05% BASE TARO AB EQ 0.05% BASE
3 - 53 (of 424)
AB AB AB AB AB AB
0.05% BASE
N019555 001
GEL, AUGMENTED; TOPICAL BETAMETHASONE DIPROPIONATE AB + ALTANA EQ 0.05% BASE TARO AB EQ 0.05% BASE LOTION; TOPICAL BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ 0.05% BASE + FOUGERA EQ 0.05% BASE PERRIGO NEW YORK EQ 0.05% BASE TEVA EQ 0.05% BASE
AB AB AB AB
LOTION, AUGMENTED; TOPICAL BETAMETHASONE DIPROPIONATE ALTANA AB EQ 0.05% BASE TARO AB EQ 0.05% BASE DIPROLENE AB + SCHERING EQ 0.05% BASE OINTMENT; TOPICAL BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ 0.05% BASE AB AB + FOUGERA EQ 0.05% BASE TARO AB EQ 0.05% BASE OINTMENT, AUGMENTED; TOPICAL BETAMETHASONE DIPROPIONATE ACTAVIS MID ATLANTIC EQ ALTANA EQ TARO EQ DIPROLENE + SCHERING EQ
AB AB AB AB
Aug 31, 1995 Jun 22, 1999 Oct 12, 2004 Jul 27, 1983
0.064%;0.005%
N021852 001
0.064%;0.005%
N022185 001
AB AB AB AB
Aug 02, 2002 Jun 05, 2001 May 29, 2001 Jul 10, 1984
LOTION; TOPICAL CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE ALTANA PHARMA AB EQ 0.05% BASE;1%
A076516 001
3 - 54 (of 424)
BETAMETHASONE VALERATE
AEROSOL, FOAM; TOPICAL
LUXIQ
XX + CONNECTICS CREAM; TOPICAL BETAMETHASONE VALERATE + FOUGERA BETA-VAL TEVA DERMABET TARO VALNAC ACTAVIS MID ATLANTIC
EQ 0.12% BASE
N020934 001
AB AB AB AB
Aug 31, 1983 Mar 24, 1983 Jan 06, 1988 Oct 10, 1984
LOTION; TOPICAL BETAMETHASONE VALERATE AB + FOUGERA STI PHARMA LLC AB BETA-VAL TEVA AB OINTMENT; TOPICAL BETAMETHASONE VALERATE ACTAVIS MID ATLANTIC AB AB + FOUGERA
BETAXOLOL HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC BETAXOLOL HYDROCHLORIDE AKORN EQ BAUSCH AND LOMB EQ NOVEX EQ WOCKHARDT EQ BETOPTIC + ALCON EQ
AT AT AT AT AT
0.5% BASE
N019270 001
SUSPENSION/DROPS; OPHTHALMIC
BETOPTIC S
EQ 0.25% BASE XX + ALCON TABLET; ORAL BETAXOLOL HYDROCHLORIDE EPIC PHARMA AB 10MG AB + 20MG KVK TECH AB 10MG AB 20MG
N019845 001
BETHANECHOL CHLORIDE
TABLET; ORAL BETHANECHOL CHLORIDE AMNEAL PHARM AA AA AA AA EMCURE USA AA AA
3 - 55 (of 424)
25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG
A091256 A091256 A040739 A040741 A040740 A040721 A040703 A040704 A040678 A040677 A040725 A040726 A040727 A040728 A040897 A040897 A040897 A040897 A040633 A040634 A040635 A040636 A040532 A040533 A040534 A040518
003 004 001 001 001 004 001 001 003 001 001 001 001 001 001 002 003 004 001 001 001 001 001 001 001 001
May May Nov Nov Nov Nov Mar Mar Mar Mar Oct Oct Oct Oct Apr Apr Apr Apr Jun Jun Jun Jun Sep Sep Sep Sep
04, 04, 01, 01, 01, 01, 27, 27, 27, 27, 26, 26, 26, 26, 22, 22, 22, 22, 01, 01, 01, 01, 29, 29, 29, 29,
2010 2010 2006 2006 2006 2006 2008 2008 2008 2008 2007 2007 2007 2007 2009 2009 2009 2009 2005 2005 2005 2005 2003 2003 2003 2003
A086262 001 A086263 001 A085882 003 A089095 A088440 A088441 A089096 001 001 001 001 Dec May May Dec 19, 29, 29, 19, 1985 1984 1984 1985
BEXAROTENE
CAPSULE; ORAL
TARGRETIN
XX + EISAI INC GEL; TOPICAL
TARGRETIN
XX + EISAI INC
75MG
N021055 001
1%
N021056 001
BICALUTAMIDE
TABLET; ORAL BICALUTAMIDE ACCORD HLTHCARE INC ACTAVIS TOTOWA FRESENIUS KABI ONCOL KUDCO IRELAND MYLAN ROXANE SANDOZ SUN PHARMA GLOBAL SYNTHON PHARMS TEVA
AB AB AB AB AB AB AB AB AB AB
50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG
A078917 A078634 A079045 A077995 A079185 A078285 A078575 A079110 A077973 A076932
001 001 001 001 001 001 001 001 001 001
Jul Aug May Jul Jul Mar Jul Jul Jul Jul
06, 28, 13, 06, 06, 24, 06, 06, 06, 06,
2009 2009 2010 2009 2009 2011 2009 2009 2009 2009
3 - 56 (of 424)
50MG 50MG
BIMATOPROST
SOLUTION/DROPS; OPHTHALMIC
LUMIGAN
0.01% XX + ALLERGAN 0.03% XX + SOLUTION/DROPS; TOPICAL
LATISSE
XX + ALLERGAN
0.03%
N022369 001
BIPERIDEN HYDROCHLORIDE
TABLET; ORAL
AKINETON
XX + ABBOTT
2MG
N012003 001
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
N021551 003
CAPSULE; ORAL
PYLERA
XX + APTALIS PHARMA US
140MG;125MG;125MG
N050786 001
N050719 001
BISOPROLOL FUMARATE
TABLET; ORAL BISOPROLOL FUMARATE AUROBINDO PHARMA AB AB MYLAN AB AB SANDOZ AB AB TEVA PHARMS AB AB UNICHEM PHARMS (USA) AB AB ZEBETA DURAMED PHARMS BARR AB AB +
5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG
A077910 A077910 A075831 A075831 A075643 A075643 A075644 A075644 A078635 A078635
001 002 001 002 001 002 001 002 001 002
Dec Dec Dec Dec Nov Nov Jun Jun Aug Aug
27, 27, 14, 14, 16, 16, 26, 26, 18, 18,
2006 2006 2005 2005 2000 2000 2001 2001 2009 2009
3 - 57 (of 424)
A075768 A075768 A075768 A075579 A075579 A075579 A079106 A079106 A079106 A075469 A075469 A075469
001 002 003 001 002 003 001 002 003 001 002 003
Sep Sep Sep Sep Sep Sep Jul Jul Jul Sep Sep Sep
25, 25, 25, 25, 25, 25, 28, 28, 28, 25, 25, 25,
2000 2000 2000 2000 2000 2000 2010 2010 2010 2000 2000 2000
BIVALIRUDIN
INJECTABLE; INTRAVENOUS
ANGIOMAX
XX + MEDICINES CO
250MG/VIAL
N020873 001
BLEOMYCIN SULFATE
INJECTABLE; INJECTION BLEOMYCIN SULFATE AP + APP PHARMS AP + BEDFORD AP AP HOSPIRA AP AP PHARMACHEMIE BV AP TEVA PARENTERAL AP AP
EQ EQ EQ EQ EQ EQ EQ EQ EQ
15 30 15 30 15 30 15 15 30
BOCEPREVIR
CAPSULE; ORAL
VICTRELIS
XX + SCHERING
200MG
N202258 001
BORTEZOMIB
INJECTABLE; INTRAVENOUS
VELCADE
XX + MILLENNIUM PHARMS
3.5MG/VIAL
N021602 001
BOSENTAN
TABLET; ORAL TRACLEER ACTELION XX XX +
62.5MG 125MG
BRETYLIUM TOSYLATE
INJECTABLE; INJECTION
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
100MG/100ML XX + B BRAUN 200MG/100ML XX +
3 - 58 (of 424)
N019121 003
BRIMONIDINE TARTRATE
SOLUTION/DROPS; OPHTHALMIC ALPHAGAN P + ALLERGAN 0.15% BRIMONIDINE TARTRATE AKORN 0.2% ALCON PHARMS LTD 0.15% 0.2% + BAUSCH AND LOMB 0.2% SANDOZ 0.2% ALPHAGAN P + ALLERGAN 0.1%
AT AT AT AT AT AT XX
N021262 001 A076439 N021764 A076254 A076260 A078075 001 001 001 001 001
Mar 16, 2001 Mar May Sep May Jan 14, 22, 16, 28, 30, 2006 2006 2003 2003 2008
N021770 001
N021398 001
BRINZOLAMIDE
SUSPENSION/DROPS; OPHTHALMIC
AZOPT
XX + ALCON PHARMS LTD 1%
N020816 001
BROMFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC
BROMDAY
0.09% XX + ISTA PHARMS INC BROMFENAC SODIUM COASTAL PHARMS 0.09% XX
BROMOCRIPTINE MESYLATE
CAPSULE; ORAL BROMOCRIPTINE MESYLATE MYLAN AB ZYDUS PHARMS USA INC AB PARLODEL AB + NOVARTIS TABLET; ORAL BROMOCRIPTINE MESYLATE LEK PHARMS MYLAN PADDOCK LLC PARLODEL + NOVARTIS CYCLOSET + VEROSCIENCE
AB AB AB AB XX
EQ 2.5MG BASE EQ 2.5MG BASE EQ 2.5MG BASE EQ 2.5MG BASE EQ 0.8MG BASE
A074631 001 A076962 001 A077646 001 N017962 001 N020866 001
2MG/5ML;10MG/5ML;30MG/5ML
A088811 001
3 - 59 (of 424)
3MG 3MG
0.032MG/INH
N020746 001
BUMETANIDE
INJECTABLE; INJECTION BUMETANIDE BAXTER HLTHCARE AP AP + BEDFORD HOSPIRA AP TABLET; ORAL BUMETANIDE IVAX SUB TEVA PHARMS AB AB AB SANDOZ AB AB AB +
BUPIVACAINE
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION BUPIVACAINE HYDROCHLORIDE HOSPIRA AP 0.25% AP 0.25%
3 - 60 (of 424)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A070590 N018053 A070584 A070597 A070609 N018053 A070585 A070587 N018053 A091503 A091503 A076012 A076012 A076012 A091487 A091487 A091487
001 002 001 001 001 001 001 001 003 001 002 001 002 003 002 001 003
Feb 17, 1987 Feb 17, 1986 Mar 03, 1987 Mar 03, 1987 Mar 03, 1987 Mar 03, 1987 Oct 18, 2011 Oct 18, 2011 Jan Jan Jan Oct Oct Oct 09, 09, 09, 18, 18, 18, 2002 2002 2002 2011 2011 2011
N016964 001 N016964 006 N016964 012 N016964 005 N016964 009 A070552 N018304 A070553 N018304 A070554 N018304 001 001 001 002 001 003 May 21, 1986 May 21, 1986 May 21, 1986
INJECTABLE; SPINAL BUPIVACAINE HYDROCHLORIDE HOSPIRA 0.75% AP MARCAINE AP + HOSPIRA 0.75% SENSORCAINE APP PHARMS AP 0.75%
AP AP XX XX
Jun 16, 1988 Jun 16, 1988 Jun 16, 1988 Jun 16, 1988
3 - 61 (of 424)
AP AP AP AP AP AP AP AP AP
N016964 008 N016964 013 N016964 007 N016964 010 A070966 A070967 A070968 N018304 N018304 001 001 001 004 005 Oct Oct Oct Sep Sep 13, 13, 13, 02, 02, 1987 1987 1987 1983 1983
BUPRENORPHINE
FILM, EXTENDED RELEASE; TRANSDERMAL
BUTRANS
PURDUE PHARMA LP 5MCG/HR
XX 10MCG/HR
XX 20MCG/HR XX +
BUPRENORPHINE HYDROCHLORIDE
INJECTABLE; INJECTION BUPRENEX + RECKITT BENCKISER EQ 0.3MG BUPRENORPHINE HYDROCHLORIDE BEDFORD EQ 0.3MG HOSPIRA EQ 0.3MG LUITPOLD EQ 0.3MG TABLET; SUBLINGUAL BUPRENORPHINE HYDROCHLORIDE BARR EQ 2MG EQ 8MG ETHYPHARM EQ 2MG EQ 8MG ROXANE EQ 2MG EQ 8MG SUBUTEX RECKITT BENCKISER EQ 2MG + EQ 8MG
AP AP AP AP
N018401 001 A076931 001 A074137 001 A078331 001 Mar 02, 2005 Jun 03, 1996 Mar 27, 2007
AB AB AB AB AB AB AB AB
2MG;0.5MG 8MG;2MG
BUPRENORPHINE; NALOXONE
FILM; SUBLINGUAL SUBOXONE RECKITT BENCKISER XX XX +
2MG;0.5MG 8MG;2MG
BUPROPION HYDROBROMIDE
TABLET, EXTENDED RELEASE; ORAL APLENZIN VALEANT INTL 174MG XX 348MG XX +
3 - 62 (of 424)
N022108 003
BUPROPION HYDROCHLORIDE
TABLET; ORAL BUPROPION HYDROCHLORIDE APOTEX INC AB 75MG AB 100MG MYLAN AB 75MG AB 100MG SANDOZ AB 75MG AB 100MG TEVA AB 75MG AB 100MG WELLBUTRIN GLAXOSMITHKLINE AB 75MG AB + 100MG TABLET, EXTENDED RELEASE; BUPROPION HYDROCHLORIDE ACTAVIS AB1 AB1 AB1 ANCHEN PHARMS AB1 AB1 AB1 IMPAX LABS AB1 AB1 AB1 MYLAN AB1 AB1 AB1 SANDOZ AB1 AB1 AB1 SUN PHARMA GLOBAL AB1 AB1 AB1 WATSON LABS FLORIDA AB1 AB1 AB1 WELLBUTRIN SR GLAXOSMITHKLINE AB1 AB1 + AB1 BUPROPION HYDROCHLORIDE ACTAVIS AB2 ANCHEN PHARMS AB2 IMPAX LABS AB2 MYLAN AB2 WATSON LABS FLORIDA AB2 ZYBAN AB2 + GLAXOSMITHKLINE BUPROPION HYDROCHLORIDE ACTAVIS AB3 AB3 ANCHEN PHARMS AB3 AB3 IMPAX LABS AB3 ORAL 100MG 150MG 200MG 100MG 150MG 200MG 100MG 150MG 200MG 100MG 150MG 200MG 100MG 150MG 200MG 100MG 150MG 200MG 100MG 150MG 200MG 100MG 150MG 200MG 150MG 150MG 150MG 150MG 150MG 150MG 150MG 300MG 150MG 300MG 150MG A077455 A077455 A077455 A091459 A091459 A091459 A075913 A075913 A076711 A090325 A090325 A090325 A075932 A075932 A075932 A078866 A078866 A078866 A079095 A079095 A079095 001 002 003 001 002 003 001 002 001 001 002 003 001 002 003 001 002 003 001 002 003 Jul Mar Jul Jun Jun Jun Jan Mar Dec Apr Apr Apr Nov Mar Jun Apr Apr Apr Mar Mar Mar 19, 12, 19, 09, 09, 09, 28, 22, 03, 08, 08, 08, 25, 22, 22, 06, 06, 06, 24, 24, 24, 2010 2008 2010 2011 2011 2011 2004 2004 2004 2010 2010 2010 2003 2004 2005 2010 2010 2010 2009 2009 2009
N020358 002 N020358 003 N020358 004 A077475 A091520 A075914 A090941 A079094 001 001 001 001 001
Oct 04, 1996 Oct 04, 1996 Jun 14, 2002 Mar Jun May May Mar 12, 09, 27, 03, 24, 2008 2011 2004 2010 2009
N020711 003 A077285 A077285 A077284 A077284 A077415 001 002 001 002 001
May 14, 1997 Nov Aug Dec Dec Nov 26, 15, 14, 14, 26, 2008 2008 2006 2006 2008
3 - 63 (of 424)
BUSPIRONE HYDROCHLORIDE
TABLET; ORAL BUSPIRONE HYDROCHLORIDE APOTEX AB 5MG AB 10MG AB 15MG DR REDDYS LABS LTD AB 5MG AB 10MG AB 15MG AB 30MG EGIS AB 5MG AB 10MG AB 15MG MYLAN AB 5MG AB 5MG AB 7.5MG AB 10MG AB 10MG AB 15MG AB 15MG AB 30MG NESHER PHARMS AB 5MG AB 10MG AB 15MG TEVA AB 5MG AB 10MG AB + 15MG AB 30MG WATSON LABS AB 5MG AB 10MG AB 15MG
A075521 A075521 A075521 A078246 A078246 A078246 A078246 A075119 A075119 A075119 A075272 A075467 A075467 A075272 A075467 A075272 A075467 A076008 A075572 A075572 A075572 A075022 A075022 A075022 A075022 A074253 A074253 A074253
001 002 003 001 002 003 004 001 002 003 001 001 002 002 003 003 004 001 001 002 003 001 002 003 004 001 002 003
Apr Apr Apr Feb Feb Feb Feb Mar Mar Jan Mar Feb Mar Mar Feb Mar Feb Jun Feb Feb Feb Feb Feb Feb Mar Mar Mar Mar
05, 05, 05, 27, 27, 27, 27, 14, 14, 23, 01, 28, 28, 01, 28, 28, 28, 28, 27, 27, 27, 28, 28, 28, 25, 28, 28, 13,
2002 2002 2002 2009 2009 2009 2009 2002 2002 2003 2002 2002 2001 2002 2002 2001 2002 2001 2002 2002 2002 2002 2002 2002 2004 2001 2001 2002
BUSULFAN
INJECTABLE; INJECTION
BUSULFEX
XX + OTSUKA PHARM
TABLET; ORAL
MYLERAN
XX + ASPEN GLOBAL
6MG/ML
N020954 001
2MG
N009386 001
BUTABARBITAL SODIUM
ELIXIR; ORAL
BUTISOL SODIUM
XX + MEDA PHARMS
30MG/5ML
A085380 001
3 - 64 (of 424)
30MG 50MG
BUTENAFINE HYDROCHLORIDE
CREAM; TOPICAL
MENTAX
XX + MYLAN MENTAX-TC XX + MYLAN
1% 1%
BUTOCONAZOLE NITRATE
CREAM; VAGINAL
GYNAZOLE-1
XX + KV PHARM
2%
N019881 001
BUTORPHANOL TARTRATE
INJECTABLE; INJECTION BUTORPHANOL TARTRATE BEDFORD AP 2MG/ML CLARIS LIFESCIENCES AP 2MG/ML HIKMA FARMACEUTICA AP 1MG/ML AP 2MG/ML AP 2MG/ML BUTORPHANOL TARTRATE PRESERVATIVE FREE BEDFORD AP 1MG/ML AP 2MG/ML CLARIS LIFESCIENCES AP 1MG/ML AP 2MG/ML HOSPIRA AP 1MG/ML AP 2MG/ML STADOL AP + APOTHECON 2MG/ML STADOL PRESERVATIVE FREE AP + APOTHECON 1MG/ML AP + 2MG/ML SPRAY, METERED; NASAL BUTORPHANOL TARTRATE AB + MYLAN NOVEX AB ROXANE AB
A075046 A075697 A078400 A078247 A078400 A075045 A075045 A075695 A075695 A074626 A074626
001 001 001 001 002 001 002 001 002 001 002
Aug Oct May Apr May Aug Aug Oct Oct Jan Jan
12, 23, 01, 29, 01, 12, 12, 23, 23, 23, 23,
1998 2001 2009 2009 2009 1998 1998 2001 2001 1997 1997
CABAZITAXEL
SOLUTION; IV (INFUSION)
JEVTANA KIT
XX + SANOFI AVENTIS US
60MG/1.5ML (40MG/ML)
N201023 001
CABERGOLINE
TABLET; ORAL CABERGOLINE IMPAX LABS INC IVAX SUB TEVA PHARMS + PAR PHARM WATSON LABS
AB AB AB AB
3 - 65 (of 424)
AP AP AP AP AP
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) EQ EQ EQ EQ 30MG 30MG 30MG 30MG BASE/3ML BASE/3ML BASE/3ML BASE/3ML (EQ (EQ (EQ (EQ 10MG 10MG 10MG 10MG BASE/ML) BASE/ML) BASE/ML) BASE/ML)
N020793 001 A077997 A077906 A077233 A090077 001 001 001 001
Sep 21, 1999 Jul May Sep Sep 20, 15, 21, 30, 2007 2007 2006 2009
AA AA AA AA AA
EQ 30MG BASE/3ML (EQ 10MG BASE/ML) EQ EQ EQ EQ 30MG 30MG 30MG 30MG BASE/3ML BASE/3ML BASE/3ML BASE/3ML (EQ (EQ (EQ (EQ 10MG 10MG 10MG 10MG BASE/ML) BASE/ML) BASE/ML) BASE/ML)
N020793 002 A078002 A090064 A077304 A090357 001 001 001 001
Apr 12, 2000 Jan Nov Sep Sep 31, 20, 21, 30, 2008 2009 2006 2009
100MG;2MG
A086557 001
TABLET; ORAL CAFERGOT AA + SANDOZ 100MG;1MG ERGOTAMINE TARTRATE AND CAFFEINE MIKART AA 100MG;1MG WEST WARD AA 100MG;1MG
A084294 001 A040590 001 A040510 001 Sep 16, 2005 Sep 17, 2004
CALCIPOTRIENE
0.005%
N022563 001
0.005%
N020554 001
0.005%
A090633 001
AT AT AT AT AT
N020611 001
CALCITONIN SALMON
INJECTABLE; INJECTION
MIACALCIN
XX + NOVARTIS SPRAY, METERED; NASAL CALCITONIN-SALMON APOTEX INC AB PAR PHARM AB MIACALCIN AB + NOVARTIS
200 IU/ML
N017808 002
3 - 66 (of 424)
200 IU/SPRAY
N021406 001
CALCITRIOL
CAPSULE; ORAL CALCITRIOL ROXANE AB TEVA AB AB ROCALTROL VALIDUS PHARMS AB AB + INJECTABLE; INJECTION CALCIJEX AP + ABBOTT AP + CALCITRIOL AKORN AP AP APP PHARMS AP AP FRESENIUS MEDCL AP AP LUITPOLD AP AP ROCKWELL MEDCL AP SAGENT PHARMS AP TEVA PARENTERAL AP OINTMENT; TOPICAL
VECTICAL
XX + GALDERMA LABS LP SOLUTION; ORAL CALCITRIOL ROXANE AA ROCALTROL AA + VALIDUS PHARMS
A076917 001 A075765 001 A075765 002 N018044 001 N018044 002
0.001MG/ML 0.002MG/ML 0.001MG/ML 0.002MG/ML 0.001MG/ML 0.002MG/ML 0.001MG/ML 0.002MG/ML 0.001MG/ML 0.002MG/ML 0.001MG/ML 0.001MG/ML 0.002MG/ML
N018874 001 N018874 002 A078066 A078066 A075836 A075836 A075766 A075766 A075746 A075746 A076206 A077102 A075823 001 002 001 002 001 002 001 002 001 001 002
Sep 25, 1986 Sep 25, 1986 Jan Jan Dec Dec Feb Feb Sep Sep Sep Feb Mar 29, 29, 31, 31, 20, 20, 26, 26, 17, 08, 31, 2008 2008 2002 2002 2003 2003 2003 2003 2003 2006 2003
3MCG/GM
N022087 001
1MCG/ML 1MCG/ML
CALCIUM ACETATE
CAPSULE; ORAL CALCIUM ACETATE ROXANE AB PHOSLO GELCAPS AB + FRESENIUS MEDCL SOLUTION; ORAL
PHOSLYRA
XX + FRESENIUS MEDCL TABLET; ORAL CALCIUM ACETATE PADDOCK LLC AB ELIPHOS AB + CYPRESS PHARM
EQ 169MG CALCIUM/5ML
N022581 001
CALCIUM CHLORIDE
INJECTABLE; INJECTION
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
100MG/ML XX + HOSPIRA
N021117 001
3 - 67 (of 424)
CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION; IRRIGATION BSS PLUS AT + ALCON
N018469 001
AT
N020079 001
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 XX + GAMBRO RENAL PRODS 5GM/1000ML;0.157GM/1000ML;2.21GM/1000ML ;7.07GM/1000ML PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 XX + GAMBRO RENAL PRODS 5GM/1000ML;0.314GM/1000ML;2.21GM/1000ML ;7.07GM/1000ML PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; XX + GAMBRO RENAL PRODS 3.05GM/1000ML;0.314GM/1000ML;2.21GM/100 0ML;7.07GM/1000ML PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; XX + GAMBRO RENAL PRODS 3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML; 6.46GM/1000ML PRISMASOL BGK 2/0 IN PLASTIC CONTAINER N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.0 XX + GAMBRO RENAL PRODS 3GM/1000ML;0.157GM/1000ML;3.09GM/1000ML ;6.46GM/1000ML PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML; XX + GAMBRO RENAL PRODS 2.03GM/1000ML;0.157GM/1000ML;3.09GM/100 0ML;6.46GM/1000ML PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.4 XX + GAMBRO RENAL PRODS 4GM/1000ML;0.314GM/1000ML;3.09GM/1000ML ;6.46GM/1000ML PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; XX + GAMBRO RENAL PRODS 3.05GM/1000ML;0.314GM/1000ML;3.09GM/100 0ML;6.46GM/1000ML PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44 XX + GAMBRO RENAL PRODS GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46 GM/1000ML PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2 XX + GAMBRO RENAL PRODS .03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6 .46GM/1000ML
N021703 010
N021703 011
N021703 013
N021703 006
N021703 002
N021703 003
N021703 015
N021703 004
N021703 014
N021703 001
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION; IRRIGATION
NAVSTEL
XX + ALCON PHARMS LTD
0.154MG/ML;0.92MG/ML;0.2MG/ML;0.184MG/M L;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/M L
N022193 001
3 - 68 (of 424)
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER
37MG/100ML;5GM/100ML;31MG/100ML;120MG/1 XX + B BRAUN 00ML;330MG/100ML;88MG/100ML
N019864 001
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
INJECTABLE; INJECTION
ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER
XX + B BRAUN 35MG/100ML;5GM/100ML;30MG/100ML;74MG/10 0ML;640MG/100ML;500MG/100ML;74MG/100ML
N019867 001
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION
PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER
37MG/100ML;5GM/100ML;30MG/100ML;119MG/1 XX + BAXTER HLTHCARE 00ML;161MG/100ML;94MG/100ML;138MG/100ML
N017390 001
XX XX
XX XX
AT AT
AT
004
AT
001
AT AT
AT
005
AT
002
AT
007
3 - 69 (of 424)
AT AT
AT
006
AT
003
AT
004
AT
005
AT
008
AT
006
AT
001
AT
003
AT
002
AT
001
AT
007
AT
008
AT
010
AT
009
AT AT
AT AT
AT
011
AT
006
3 - 70 (of 424)
AT
N020163 003
AT
N020374 001
AT
N020374 002
AT
N020374 004
XX
N018460 007
XX
N018460 005
XX
N018460 009
XX
N020183 002
XX
N020183 003
XX
N020183 004
XX
N020374 003
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INTRATHECAL
ELLIOTTS B SOLUTION
XX + QOL MEDCL
0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9 MG/ML;7.3MG/ML;0.2MG/ML
N020577 001
INJECTABLE; INJECTION
DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER
20MG/100ML;5GM/100ML;30MG/100ML;380MG/1 XX + B BRAUN
00ML;600MG/100ML
N018258 001
N018254 001
3 - 71 (of 424)
AP
AP
24, 1988
AP
AP
05, 1985
AP AP AP AP
AP
05, 1985
AP AP
XX
24, 1988
XX XX
XX
05, 1985
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
TPN ELECTROLYTES IN PLASTIC CONTAINER
16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML; XX + HOSPIRA 16.1MG/ML
N018895 001
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
INJECTABLE; INJECTION
ISOLYTE E IN PLASTIC CONTAINER
35MG/100ML;30MG/100ML;74MG/100ML;640MG/ XX + B BRAUN 100ML;500MG/100ML;74MG/100ML SOLUTION; IRRIGATION BALANCED SALT AKORN AT AT B BRAUN
N019718 001
3 - 72 (of 424)
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
SOLUTION; IRRIGATION BSS AT + ALCON
0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6 .4MG/ML;1.7MG/ML
N020742 001
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION
PLASMA-LYTE R IN PLASTIC CONTAINER
XX + BAXTER HLTHCARE 36.8MG/100ML;30.5MG/100ML;74.6MG/100ML;
640MG/100ML;496MG/100ML;89.6MG/100ML
N017438 001
A075323 001
N018608 001
N018681 001 N018494 001 N018921 001 N019933 001 N019416 001
Dec 27, 1982 Feb 19, 1982 Apr 03, 1984 Aug 29, 1989 Jan 17, 1986
CALFACTANT
SUSPENSION; INTRATRACHEAL
INFASURF PRESERVATIVE FREE
35MG/ML XX + ONY
N020521 001
3 - 73 (of 424)
CAPECITABINE
TABLET; ORAL XELODA HOFFMANN LA ROCHE XX XX +
150MG 500MG
CAPREOMYCIN SULFATE
INJECTABLE; INJECTION
CAPASTAT SULFATE
XX + AKORN
EQ 1GM BASE/VIAL
N050095 001
CAPSAICIN
PATCH; TOPICAL
QUTENZA
XX + NEUROGESX
8%
N022395 001
CAPTOPRIL
TABLET; ORAL CAPOTEN PAR PHARM AB AB AB AB + CAPTOPRIL APOTEX AB AB AB AB MYLAN AB AB AB AB PRINSTON INC AB AB AB AB SANDOZ AB AB AB AB STASON AB AB AB AB
12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG
N018343 N018343 N018343 N018343 A074737 A074737 A074737 A074737 A074434 A074434 A074434 A074434 A074477 A074477 A074477 A074477 A074363 A074363 A074363 A074363 A074677 A074677 A074677 A074677
005 002 001 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 004 002 001 003
Oct Oct Oct Oct Feb Feb Feb Feb Feb Feb Feb Feb Nov Nov Nov Nov May May May May
28, 28, 28, 28, 13, 13, 13, 13, 13, 13, 13, 13, 09, 09, 09, 09, 30, 30, 30, 30,
1998 1998 1998 1998 1996 1996 1996 1996 1996 1996 1996 1996 1995 1995 1995 1995 1997 1997 1997 1997
3 - 74 (of 424)
12.5MG 12.5MG 25MG 25MG 50MG 50MG 100MG 100MG 12.5MG 12.5MG 25MG 25MG 50MG 50MG 100MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG
A074322 A074483 A074322 A074483 A074322 A074483 A074322 A074483 A074386 A074451 A074386 A074451 A074386 A074451 A074386 A074451 A074505 A074505 A074505 A074505 A074532 A074532 A074532 A074532
001 001 002 002 003 003 004 004 001 001 002 002 003 003 004 004 001 002 003 004 001 002 003 004
Feb Feb Feb Feb Feb Feb Feb Feb May Feb May Feb May Feb May Feb Feb Feb Feb Feb Mar Mar Mar Mar
13, 13, 13, 13, 13, 13, 13, 13, 23, 13, 23, 13, 23, 13, 23, 13, 13, 13, 13, 13, 28, 28, 28, 28,
1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1997 1997 1997 1997
CAPTOPRIL; HYDROCHLOROTHIAZIDE
TABLET; ORAL CAPOZIDE 25/15 APOTHECON 25MG;15MG CAPOZIDE 25/25 + APOTHECON 25MG;25MG CAPOZIDE 50/15 + APOTHECON 50MG;15MG CAPOZIDE 50/25 APOTHECON 50MG;25MG CAPTOPRIL AND HYDROCHLOROTHIAZIDE MYLAN 25MG;15MG 25MG;25MG 50MG;15MG 50MG;25MG TEVA 25MG;15MG 25MG;25MG 50MG;15MG 50MG;25MG
AB AB AB AB AB AB AB AB AB AB AB AB
N018709 001 N018709 002 N018709 004 N018709 003 A074896 A074896 A074896 A074896 A074827 A074827 A074827 A074827 001 002 004 003 001 002 004 003
Oct 12, 1984 Oct 12, 1984 Oct 12, 1984 Oct 12, 1984 Dec Dec Dec Dec Dec Dec Dec Dec 29, 29, 29, 29, 29, 29, 29, 29, 1997 1997 1997 1997 1997 1997 1997 1997
CARBACHOL
SOLUTION; INTRAOCULAR
MIOSTAT
XX + ALCON
0.01%
N016968 001
CARBAMAZEPINE
CAPSULE, EXTENDED RELEASE; ORAL CARBAMAZEPINE APOTEX INC AB 100MG AB 200MG AB 300MG NOSTRUM AB 100MG
3 - 75 (of 424)
A076697 002 A076697 003 N020712 003 N020712 001 N020712 002 N021710 001 N021710 002 N021710 003
May 20, 2011 May 20, 2011 Sep 30, 1997 Sep 30, 1997 Sep 30, 1997 Dec 10, 2004 Dec 10, 2004 Dec 10, 2004
AB AB AB AB AB XX XX XX
A075948 001 A074649 001 A077272 002 A070541 001 N016608 001 A077272 001 A077272 003 A077272 004
Feb 27, 2002 Oct 03, 1996 Dec 07, 2005 Sep 17, 1986
AB AB AB AB XX
TABLET, CHEWABLE; ORAL CARBAMAZEPINE TARO PHARM INDS TORRENT PHARMS EPITOL TEVA TEGRETOL + NOVARTIS CARBAMAZEPINE + TARO PHARM INDS
A075687 001 A075712 001 A073524 001 N018281 001 A075687 002
TABLET, EXTENDED RELEASE; ORAL CARBAMAZEPINE TARO 100MG AB 200MG AB 400MG AB TEGRETOL-XR NOVARTIS AB 100MG AB 200MG AB + 400MG
A078115 001 A078115 002 A078115 003 N020234 001 N020234 002 N020234 003
Mar 31, 2009 Mar 31, 2009 Mar 31, 2009 Mar 25, 1996 Mar 25, 1996 Mar 25, 1996
CARBIDOPA
TABLET; ORAL
LODOSYN
XX + ATON
25MG
N017830 001
3 - 76 (of 424)
XX XX XX XX XX XX
N021485 002 N021485 006 N021485 003 N021485 004 N021485 001 N021485 005
CARBIDOPA; LEVODOPA
TABLET; ORAL CARBIDOPA AND LEVODOPA ACTAVIS ELIZABETH AB AB AB APOTEX INC AB AB AB MYLAN AB AB AB SUN PHARM INDS AB AB AB TEVA AB AB AB SINEMET MERCK SHARP DOHME AB AB AB +
10MG;100MG 25MG;100MG 25MG;250MG 10MG;100MG 25MG;100MG 25MG;250MG 10MG;100MG 25MG;100MG 25MG;250MG 10MG;100MG 25MG;100MG 25MG;250MG 10MG;100MG 25MG;100MG 25MG;250MG 10MG;100MG 25MG;100MG 25MG;250MG
A074260 A074260 A074260 A077120 A077120 A077120 A090324 A090324 A090324 A078536 A078536 A078536 A073618 A073589 A073607
001 002 003 001 002 003 001 002 003 001 002 003 001 001 001
Sep Sep Sep Jun Jun Jun Sep Sep Sep Oct Oct Oct Aug Aug Aug
03, 03, 03, 02, 02, 02, 28, 28, 28, 28, 28, 28, 28, 28, 28,
1993 1993 1993 2008 2008 2008 2009 2009 2009 2008 2008 2008 1992 1992 1992
TABLET, EXTENDED RELEASE; ORAL CARBIDOPA AND LEVODOPA APOTEX AB 25MG;100MG AB 50MG;200MG IMPAX LABS AB 25MG;100MG AB 50MG;200MG MYLAN AB 25MG;100MG AB 50MG;200MG SUN PHARM INDS AB 25MG;100MG AB 50MG;200MG SINEMET CR MERCK SHARP DOHME AB 25MG;100MG AB + 50MG;200MG TABLET, ORALLY DISINTEGRATING; ORAL CARBIDOPA AND LEVODOPA IMPAX LABS 10MG;100MG 25MG;100MG 25MG;250MG MYLAN 10MG;100MG 25MG;100MG 25MG;250MG SUN PHARM INDS 10MG;100MG 25MG;100MG
AB AB AB AB AB AB AB AB
3 - 77 (of 424)
AB AB AB AB
Jul 31, 2009 Aug 27, 2004 Aug 27, 2004 Aug 27, 2004
CARBINOXAMINE MALEATE
SOLUTION; ORAL CARBINOXAMINE MALEATE BOCA PHARMA AA CYPRESS PHARM AA AA + MIKART TABLET; ORAL CARBINOXAMINE MALEATE BOCA PHARMA CYPRESS PHARM INVAGEN PHARMS LYNROSE LABS + MIKART
AA AA AA AA AA
CARBOPLATIN
INJECTABLE; INJECTION CARBOPLATIN APP PHARMS AP AP AP BEDFORD AP AP AP PLIVA AP AP AP SANDOZ AP AP AP AP + WATSON LABS AP AP + AP AP + AP
50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 150MG/VIAL 450MG/VIAL 50MG/VIAL 50MG/VIAL 150MG/VIAL 150MG/VIAL 450MG/VIAL 450MG/VIAL
A076235 A076235 A076235 A076099 A076099 A076099 A076602 A076602 A076602 A076959 A076959 A076959 A076162 A077383 A076162 A077383 A076162 A077383
001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003
Oct Oct Oct Oct Oct Oct Nov Nov Nov Mar Mar Mar Oct Jan Oct Jan Oct Jan
14, 14, 14, 14, 14, 14, 16, 16, 16, 18, 18, 18, 14, 27, 14, 27, 14, 27,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2005 2005 2005 2004 2006 2004 2006 2004 2006
INJECTABLE; IV (INFUSION) CARBOPLATIN AKORN AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 600MG/60ML (10MG/ML) APP PHARMS AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 600MG/60ML (10MG/ML) BEDFORD LABS AP 50MG/5ML (10MG/ML) AP 150MG/15ML (10MG/ML) AP 450MG/45ML (10MG/ML) AP 600MG/60ML (10MG/ML) BIONICHE PHARMA USA AP 50MG/5ML (10MG/ML)
A090475 A090475 A090475 A091268 A077266 A077266 A077247 A077266 A077266 A077244 A077244 A077244 A077244 A077998
001 002 003 002 001 002 003 003 004 001 002 003 004 001
Jul Jul Jul Jul Feb Feb Oct Feb Feb Oct Oct Oct Jan Apr
29, 29, 29, 28, 15, 15, 21, 15, 15, 15, 15, 15, 20, 24,
2009 2009 2009 2010 2006 2006 2004 2006 2006 2004 2004 2004 2006 2007
3 - 78 (of 424)
A077998 A077998 A078280 A078280 A078280 A077432 A077432 A077432 A076517 A076517 A076517 A077059 A091063 A091063 A091063 A091063 A077269 A077269 A077269 A077269 A077679 A077679 A077679 A078631 A078631 A078631 A078631 A077926 A077926 A077926 A077139 A077139 A077139 A077139 A077861 A077861 A077861 A077861
002 003 001 002 003 003 001 002 001 002 003 001 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 003 001 002 003 004 001 002 003 004
Apr Apr May May May Sep Sep Sep Oct Oct Oct Nov Nov Nov Nov Nov Oct Oct Oct Dec Feb Feb Feb Dec Dec Dec Dec Sep Sep Sep Sep Sep Sep Sep Jan Jan Jan Jan
24, 24, 08, 08, 08, 29, 29, 29, 14, 14, 14, 23, 09, 09, 09, 09, 14, 14, 14, 28, 25, 25, 25, 02, 02, 02, 02, 19, 19, 19, 21, 21, 21, 21, 18, 18, 18, 18,
2007 2007 2008 2008 2008 2006 2006 2006 2004 2004 2004 2004 2011 2011 2011 2011 2004 2004 2004 2007 2009 2009 2009 2008 2008 2008 2008 2008 2008 2008 2005 2005 2005 2005 2007 2007 2007 2007
A091478 001
CARBOPROST TROMETHAMINE
INJECTABLE; INJECTION
HEMABATE
XX + PHARMACIA AND UPJOHN
EQ 0.25MG BASE/ML
N017989 001
CARGLUMIC ACID
TABLET; ORAL
CARBAGLU
XX + ORPHAN EUROPE
200MG
N022562 001
CARISOPRODOL
TABLET; ORAL CARISOPRODOL ADVENT PHARMS AA AUROBINDO PHARMA AA COREPHARMA AA
3 - 79 (of 424)
AA AA AA AA AA AA AA AA XX
CARMUSTINE
IMPLANT; INTRACRANIAL
GLIADEL
XX + EISAI INC INJECTABLE; INJECTION
BICNU
XX + BRISTOL
7.7MG
N020637 001
100MG/VIAL
N017422 001
CARTEOLOL HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC CARTEOLOL HYDROCHLORIDE ALCON 1% BAUSCH AND LOMB 1% NOVEX 1% OCUPRESS + NOVARTIS 1%
AT AT AT AT
Jan 03, 2000 Jan 20, 2000 Feb 06, 2002 May 23, 1990
CARVEDILOL
TABLET; ORAL CARVEDILOL APOTEX INC AB AB AB AB AUROBINDO PHARMA AB AB AB AB BEXIMCO USA AB AB AB AB CARACO AB AB AB AB DR REDDYS LABS LTD AB AB AB AB GLENMARK GENERICS AB AB AB AB HIKMA AB
3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG
A078165 A078165 A078165 A078165 A078332 A078332 A078332 A078332 A078384 A078384 A078384 A078384 A077346 A077346 A077346 A077346 A076649 A076649 A076649 A076649 A078251 A078251 A078251 A078251 A077887
001 002 003 004 001 002 003 004 001 002 003 004 004 001 002 003 001 002 003 004 001 002 003 004 001
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 07,
2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007
3 - 80 (of 424)
6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG 3.125MG 6.25MG 12.5MG 25MG
A077887 A077887 A077887 A078217 A078217 A078217 A078217 A077316 A077316 A077316 A077316 A078240 A078240 A078240 A078240 A076989 A076989 A076989 A076989 A078227 A078227 A078227 A078227 A077780 A077780 A077780 A077780 A076373 A076373 A076373 A076373 A077474 A077474 A077474 A077474 A078786 A078786 A078786 A078786 A077614 A077614 A077614 A077614 N020297 N020297 N020297 N020297
002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 004 001 002 003 004 003 002 001
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Dec Dec Dec Dec Sep Sep Sep Sep May Sep Sep Sep
07, 07, 07, 05, 05, 05, 05, 05, 05, 05, 05, 30, 30, 30, 30, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 05, 22, 22, 22, 22, 05, 05, 05, 05, 29, 14, 14, 14,
2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2009 2009 2009 2009 2007 2007 2007 2007 1997 1995 1995 1995
CARVEDILOL PHOSPHATE
CAPSULE, EXTENDED RELEASE; ORAL COREG CR SB PHARMCO 10MG XX 20MG XX 40MG XX + 80MG XX
3 - 81 (of 424)
CEFACLOR
CAPSULE; ORAL CEFACLOR HIKMA AB AB + RANBAXY AB AB YUNG SHIN PHARM AB AB
FOR SUSPENSION; ORAL
CEFACLOR
+ RANBAXY + + +
EQ EQ EQ EQ EQ EQ
XX XX XX XX
EQ EQ EQ EQ
EQ EQ EQ EQ
TABLET, EXTENDED RELEASE; ORAL CEFACLOR TEVA EQ 375MG BASE XX EQ 500MG BASE XX +
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL CEFADROXIL AUROBINDO PHARMA HIKMA LUPIN ORCHID HLTHCARE RANBAXY SANDOZ + TEVA PHARMS
AB AB AB AB AB AB AB
EQ EQ EQ EQ EQ EQ EQ
FOR SUSPENSION; ORAL CEFADROXIL LUPIN AB AB + ORCHID HLTHCARE AB AB RANBAXY AB AB TEVA PHARMS AB AB CEFADROXIL RANBAXY XX TABLET; ORAL CEFADROXIL HIKMA AB ORCHID HLTHCARE AB RANBAXY AB
EQ EQ EQ EQ EQ EQ EQ EQ
EQ 125MG BASE/5ML
A065115 001
3 - 82 (of 424)
EQ 1GM BASE
A062774 001
CEFAZOLIN SODIUM
INJECTABLE; INJECTION CEFAZOLIN SODIUM ACS DOBFAR AP EQ AP EQ AP EQ AP + APP PHARMS EQ AP + EQ AP + EQ AP + EQ AUROBINDO PHARMA AP EQ AP EQ CEPHAZONE PHARMA AP EQ AP EQ AP EQ AP EQ HIKMA FARMACEUTICA AP EQ AP EQ AP EQ HOSPIRA INC AP EQ AP EQ AP EQ AP EQ SANDOZ AP EQ AP EQ AP EQ AP EQ STERI PHARMA AP EQ AP EQ AP EQ AP EQ AP EQ AP EQ KEFZOL ACS DOBFAR AP EQ AP EQ AP EQ ANCEF IN PLASTIC CONTAINER EQ XX + BAXTER HLTHCARE EQ XX + CEFAZOLIN AND DEXTROSE EQ XX + B BRAUN CEFAZOLIN SODIUM EQ XX + SAMSON MEDCL EQ XX +
500MG BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 10MG BASE/ML 20MG BASE/ML 1GM BASE/VIAL 100GM BASE/VIAL 300GM BASE/VIAL
A065303 A065303 A065306 A064169 A064169 A064170 A064170 A065395 A065395 A065280 A065280 A065295 A065296 A065047 A065047 A065143 A065226 A065226 A065244 A065247 A062831 A062831 A065345 A062831 A063214 A063216 A063207 A063208 A063209 A063209
001 002 001 001 002 001 002 001 002 001 002 001 001 001 002 001 001 002 001 001 001 002 001 003 001 001 001 001 001 002
Oct Oct Oct Aug Aug Mar Mar Aug Aug Mar Mar Mar Mar Sep Sep Oct Apr Apr Aug Aug Dec Dec May Sep Dec Dec Dec Dec Dec Apr
22, 22, 22, 14, 14, 18, 18, 08, 08, 18, 18, 18, 18, 18, 18, 18, 21, 21, 12, 12, 09, 09, 09, 25, 27, 27, 27, 27, 27, 30,
2008 2008 2008 1998 1998 1998 1998 2008 2008 2009 2009 2009 2009 2001 2001 2004 2005 2005 2005 2005 1988 1988 2007 1992 1991 1991 1991 1991 1991 1999
A061773 002 A061773 003 A061773 004 A063002 001 A063002 002 N050779 002 A065141 001 A065141 002 Mar 28, 1991 Mar 28, 1991 Jul 27, 2000 Nov 29, 2006 Nov 29, 2006
CEFDINIR
CAPSULE; ORAL CEFDINIR AUROBINDO PHARMA LUPIN ORCHID HLTHCARE + SANDOZ TEVA PHARMS
AB AB AB AB AB
3 - 83 (of 424)
125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML
A065473 A065473 A065259 A065259 A065429 A065429 A065337 A065337 A065332 A065332
001 002 001 002 001 002 001 002 001 002
Dec Dec May May Jul Jul Apr Apr May May
14, 14, 31, 07, 18, 18, 06, 06, 04, 04,
2007 2007 2006 2007 2007 2007 2007 2007 2007 2007
CEFDITOREN PIVOXIL
TABLET; ORAL SPECTRACEF CORNERSTONE THERAP XX XX +
200MG 400MG
CEFEPIME HYDROCHLORIDE
INJECTABLE; INJECTION CEFEPIME HYDROCHLORIDE ACS DOBFAR AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL HOSPIRA INC AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL SANDOZ AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL MAXIPIME AP + HOSPIRA INC EQ 500MG BASE/VIAL AP + EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER B BRAUN EQ 1GM BASE/VIAL XX EQ 2GM BASE/VIAL XX CEFEPIME IN PLASTIC CONTAINER EQ 1GM BASE/50ML (EQ 20MG BASE/ML) XX + BAXTER HLTHCARE EQ 2GM BASE/100ML (EQ 20MG BASE/ML) XX +
N050679 001 N050679 002 N050679 003 N050821 001 N050821 002 N050817 001 N050817 002
Jan 18, 1996 Jan 18, 1996 Jan 18, 1996 May 06, 2010 May 06, 2010 Aug 05, 2008 Aug 05, 2008
CEFIXIME
SUSPENSION; ORAL SUPRAX LUPIN PHARMS XX XX +
TABLET; ORAL
SUPRAX
XX + LUPIN PHARMS TABLET, CHEWABLE; ORAL SUPRAX LUPIN LTD XX XX XX +
100MG/5ML 200MG/5ML
400MG
A065130 001
3 - 84 (of 424)
A064200 A064200 A064200 A064201 A065072 A065072 A065072 A065071 A065197 A065517 A065517 A065517 A065516 A065348 A065290 A065290 A065293 A065290 A065293 A065292 A065124 A065124 A065124 A065197 A065197 N050547 A062659 N050547 A062659 N050547 N050547
001 002 003 001 001 002 003 001 001 001 002 003 001 001 001 002 001 003 002 001 001 002 003 002 003 001 001 002 002 003 004
Mar Mar Mar Mar Nov Nov Nov Nov Aug Nov Nov Nov Nov Jan Aug Aug Aug Aug Aug Aug Sep Sep Sep Jun Jun
24, 24, 24, 24, 20, 20, 20, 20, 29, 06, 06, 06, 06, 25, 11, 11, 10, 11, 10, 10, 24, 24, 24, 20, 20,
2000 2000 2000 2000 2002 2002 2002 2002 2006 2009 2009 2009 2009 2010 2006 2006 2006 2006 2006 2006 2003 2003 2003 2008 2008
Jan 13, 1987 Jan 13, 1987 Dec 29, 1983 Mar 24, 2000 May 20, 1985 May 20, 1985
CEFOTETAN DISODIUM
INJECTABLE; INJECTION CEFOTETAN + APP PHARMS + + WEST-WARD PHARM CORP
AP AP AP AP AP AP XX XX
EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER + B BRAUN EQ 1GM BASE/VIAL + EQ 2GM BASE/VIAL
CEFOXITIN
INJECTABLE; INJECTION CEFOXITIN ANTIBIOTICOS BRASIL AP AP
3 - 85 (of 424)
EQ 10GM BASE/VIAL
A065464 001
CEFOXITIN SODIUM
INJECTABLE; INJECTION CEFOXITIN ACS DOBFAR AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL AP + APP PHARMS EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL AP + EQ 10GM BASE/VIAL BAXTER HLTHCARE AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL HIKMA FARMACEUTICA AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL HOSPIRA INC AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER B BRAUN AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL MEFOXIN IN PLASTIC CONTAINER EQ 20MG BASE/ML XX + BIONICHE PHARMA EQ 40MG BASE/ML XX +
A065414 A065414 A065415 A065012 A065012 A065011 A065051 A065051 A065050 A065238 A065238 A065239 A065313 A065313 A065312
001 002 001 001 002 001 001 002 001 001 002 001 001 002 001
Jun Jun May Jul Jul Jul Sep Sep Sep Mar Mar Mar Jan Jan Feb
12, 12, 19, 03, 03, 03, 11, 11, 11, 12, 12, 02, 23, 23, 13,
2009 2009 2010 2000 2000 2000 2000 2000 2000 2010 2010 2010 2006 2006 2006
Mar 10, 2006 Mar 10, 2006 Jan 25, 1993 Jan 25, 1993
CEFPODOXIME PROXETIL
FOR SUSPENSION; ORAL CEFPODOXIME PROXETIL AUROBINDO PHARMA AB AB + RANBAXY AB AB SANDOZ AB AB TABLET; ORAL CEFPODOXIME PROXETIL AUROBINDO PHARMA AB AB ORCHID HLTHCARE AB AB RANBAXY AB AB SANDOZ AB AB +
EQ EQ EQ EQ EQ EQ
50MG BASE/5ML 100MG BASE/5ML 50MG BASE/5ML 100MG BASE/5ML 50MG BASE/5ML 100MG BASE/5ML
EQ EQ EQ EQ EQ EQ EQ EQ
CEFPROZIL
FOR SUSPENSION; ORAL CEFPROZIL AUROBINDO PHARMA AB AB LUPIN AB AB + ORCHID HLTHCARE AB AB RANBAXY AB
3 - 86 (of 424)
250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG
A065327 A065327 A065340 A065340 A065276 A065276 A065267 A065267 A065198 A065198 A065235 A065235 A065208 A065208 A065428 A065428
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Mar Mar May May Dec Dec Dec Dec Dec Dec Nov Nov Dec Dec Jun Jun
26, 26, 24, 24, 08, 08, 19, 19, 13, 13, 14, 14, 06, 06, 14, 14,
2008 2008 2007 2007 2005 2005 2005 2005 2006 2006 2005 2005 2005 2005 2007 2007
CEFTAROLINE FOSAMIL
POWDER; IV (INFUSION) TEFLARO CEREXA XX XX +
400MG/VIAL 600MG/VIAL
CEFTAZIDIME
INJECTABLE; INJECTION CEFTAZIDIME ACS DOBFAR AP AP AP AP AUROBINDO PHARMA AP AP AP AP WOCKHARDT AP FORTAZ AP + GLAXOSMITHKLINE AP + AP + AP + TAZICEF HOSPIRA AP AP AP AP AP AP CEFTAZIDIME IN DEXTROSE B BRAUN XX XX +
500MG/VIAL 1GM/VIAL 2GM/VIAL 6GM/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL 6GM/VIAL 1GM/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL 6GM/VIAL 500MG/VIAL 1GM/VIAL 1GM/VIAL 2GM/VIAL 2GM/VIAL 6GM/VIAL CONTAINER EQ 1GM BASE EQ 2GM BASE
A062640 A062640 A062640 A062640 A065481 A065481 A065481 A065482 A065196 N050578 N050578 N050578 N050578 A062662 A062662 A064032 A062662 A064032 A062662
001 002 003 004 001 002 003 001 001 001 002 003 004 001 002 001 003 002 004
Nov Nov Nov Feb May May May May Oct Jul Jul Jul Jul Mar Mar Oct Mar Oct Mar
20, 20, 20, 03, 28, 28, 28, 28, 15, 19, 19, 19, 19, 06, 06, 31, 06, 31, 06,
1985 1985 1985 1992 2010 2010 2010 2010 2008 1985 1985 1985 1985 1986 1986 1993 1986 1993 1986
3 - 87 (of 424)
CEFTIBUTEN DIHYDRATE
CAPSULE; ORAL
CEDAX
XX + PERNIX THERAP
FOR SUSPENSION; ORAL
CEDAX
XX + PERNIX THERAP
EQ 400MG BASE
N050685 002
EQ 90MG BASE/5ML
N050686 001
CEFTRIAXONE SODIUM
INJECTABLE; IM-IV CEFTRIAXONE APP PHARMS AP AP AP AP AUROBINDO PHARMA AP AP AP AP BEDFORD AP AP AP AP CEPHAZONE PHARMA AP AP AP AP HIKMA FARMACEUTICA AP AP AP AP HOSPIRA INC AP AP AP AP LUITPOLD AP AP AP AP LUPIN AP AP AP AP AP + SANDOZ AP + AP + AP + STERI PHARMA AP AP TEVA AP AP TEVA PARENTERAL AP AP AP
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
A065245 A065245 A065245 A065245 A065505 A065505 A065505 A065505 A065465 A065465 A065465 A065465 A065294 A065294 A065294 A065294 A065342 A065342 A065342 A065342 A065230 A065230 A065230 A065230 A065305 A065305 A065305 A065305 A065125 A065125 A065125 A065125 A065169 A065169 A065169 A065169 A065268 A065268 A065262 A065262 A065227 A065227 A065227
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 001 002 001 002 003
Feb Feb Feb Feb Jul Jul Jul Jul Aug Aug Aug Aug Mar Mar Mar Mar Jan Jan Jan Jan Aug Aug Aug Aug Jan Jan Jan Jan Sep Sep Sep Sep May May May May Feb Feb Jun Jun Mar Mar Mar
15, 15, 15, 15, 31, 31, 31, 31, 18, 18, 18, 18, 26, 26, 26, 26, 10, 10, 10, 10, 02, 02, 02, 02, 11, 11, 11, 11, 30, 30, 30, 30, 09, 09, 09, 09, 28, 28, 29, 29, 15, 15, 15,
2006 2006 2006 2006 2008 2008 2008 2008 2008 2008 2008 2008 2007 2007 2007 2007 2008 2008 2008 2008 2005 2005 2005 2005 2008 2008 2008 2008 2003 2003 2003 2003 2005 2005 2005 2005 2007 2007 2006 2006 2007 2007 2007
3 - 88 (of 424)
EQ EQ EQ EQ
INJECTABLE; INJECTION CEFTRIAXONE ACS DOBFAR AP EQ 500MG BASE/VIAL AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL APP PHARMS AP EQ 10GM BASE/VIAL AUROBINDO PHARMA AP EQ 10GM BASE/VIAL BEDFORD AP EQ 10GM BASE/VIAL HOSPIRA INC AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP EQ 10GM BASE/VIAL LUPIN AP EQ 10GM BASE/VIAL SANDOZ AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL AP + EQ 10GM BASE/VIAL STERI PHARMA AP EQ 10GM BASE/VIAL TEVA AP EQ 10GM BASE/VIAL WOCKHARDT AP EQ 1GM BASE/VIAL CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER AP + B BRAUN EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL ROCEPHIN AP + HOFFMANN LA ROCHE EQ 500MG BASE/VIAL AP + EQ 1GM BASE/VIAL CEFTRIAXONE IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 20MG BASE/ML XX EQ 40MG BASE/ML XX
A065329 A065329 A065329 A065328 A065252 A065504 A065475 A065231 A065231 A065232 A065263 A065204 A065204 A065168 A065269 A065274 A065180
001 002 003 001 001 001 001 001 002 001 001 001 002 001 001 001 001
Jul Jul Jul Jul Feb Jul Aug Aug Aug Aug Sep May May May Feb May May
24, 24, 24, 24, 15, 31, 18, 02, 02, 02, 12, 03, 03, 17, 28, 01, 12,
2008 2008 2008 2008 2006 2008 2008 2005 2005 2005 2006 2005 2005 2005 2007 2006 2006
N050796 001 N050796 002 A063239 002 A063239 003 A065224 001 A065224 002
Apr 20, 2005 Apr 20, 2005 Aug 13, 1993 Aug 13, 1993 Aug 23, 2005 Aug 23, 2005
CEFUROXIME AXETIL
FOR SUSPENSION; ORAL CEFTIN GLAXOSMITHKLINE AB AB + CEFUROXIME AXETIL RANBAXY AB AB TABLET; ORAL CEFTIN GLAXOSMITHKLINE AB AB AB + CEFUROXIME AXETIL ALKEM LABS LTD AB AB APOTEX AB AB AUROBINDO PHARMA LTD AB AB AB LUPIN AB AB ORCHID HLTHCARE AB
Jun 30, 1994 Apr 29, 1997 Feb 05, 2008 Feb 05, 2008
EQ 125MG BASE EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 125MG 250MG 500MG 250MG 500MG 125MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N050605 001 N050605 002 N050605 003 A065496 A065496 A065069 A065069 A065308 A065308 A065308 A065135 A065135 A065359 001 002 001 002 001 002 003 001 002 001
Dec 28, 1987 Dec 28, 1987 Dec 28, 1987 Jun Jun Oct Oct Mar Mar Mar Jul Jul Feb 07, 07, 02, 02, 29, 29, 29, 25, 25, 15, 2010 2010 2002 2002 2006 2006 2006 2003 2003 2008
3 - 89 (of 424)
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG 500MG 125MG 125MG 250MG 250MG 500MG 500MG 250MG 500MG 125MG 250MG 500MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A065359 A065359 A065043 A065118 A065043 A065118 A065043 A065118 A065190 A065190 A065166 A065166 A065166
002 003 003 001 002 002 001 003 001 002 001 002 003
Feb Feb Feb Apr Feb Apr Feb Apr Oct Oct Jul Jul Jul
15, 15, 15, 25, 15, 25, 15, 25, 18, 18, 29, 29, 29,
2008 2008 2002 2003 2002 2003 2002 2003 2004 2004 2005 2005 2005
CEFUROXIME SODIUM
INJECTABLE; IM-IV CEFUROXIME SODIUM APP PHARMS HIKMA FARMACEUTICA STERI PHARMA TEVA ZINACEF + GLAXOSMITHKLINE CEFUROXIME SODIUM HOSPIRA INC
AB AB AB AB AB AP
EQ EQ EQ EQ
INJECTABLE; INJECTION CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER AP + B BRAUN EQ 750MG BASE/VIAL AP + EQ 1.5GM BASE/VIAL CEFUROXIME SODIUM APP PHARMS AP EQ 1.5GM BASE/VIAL AP EQ 7.5GM BASE/VIAL HIKMA FARMACEUTICA AP EQ 1.5GM BASE/VIAL AP EQ 7.5GM BASE/VIAL HOSPIRA INC AP EQ 1.5GM BASE/VIAL AP EQ 1.5GM BASE/VIAL AP EQ 7.5GM BASE/VIAL STERI PHARMA AP EQ 1.5GM BASE/VIAL AP EQ 7.5GM BASE/VIAL TEVA AP EQ 1.5GM BASE/VIAL AP EQ 7.5GM BASE/VIAL ZINACEF AP + GLAXOSMITHKLINE EQ 1.5GM BASE/VIAL AP + EQ 7.5GM BASE/VIAL CEFUROXIME SODIUM IN PLASTIC CONTAINER EQ 75GM BASE/VIAL XX + SAMSON MEDCL EQ 225GM BASE/VIAL XX + ZINACEF IN PLASTIC CONTAINER EQ 15MG BASE/ML XX + GLAXOSMITHKLINE EQ 30MG BASE/ML XX +
N050780 001 N050780 002 A065001 A065002 A065048 A065046 A065483 A065503 A065484 A064125 A064124 A064192 A064191 002 001 002 001 002 001 001 002 001 001 001
Feb 21, 2001 Feb 21, 2001 May Sep Jan Jan Oct Oct Oct May May Apr Apr 30, 28, 09, 09, 15, 15, 15, 30, 30, 16, 16, 2001 1998 2004 2004 2008 2008 2008 1997 1997 1998 1998
N050558 003 N050558 004 A065251 001 A065251 002 N050643 001 N050643 002
Oct 19, 1983 Oct 23, 1986 Dec 30, 2009 Dec 30, 2009 Apr 28, 1989 Apr 28, 1989
CELECOXIB
CAPSULE; ORAL CELEBREX GD SEARLE XX XX XX
3 - 90 (of 424)
400MG
N020998 003
CEPHALEXIN
CAPSULE; ORAL CEPHALEXIN ALKEM AB AB AUROBINDO PHARMA LTD AB AB BELCHER PHARMS AB AB FACTA FARMA AB AB HIKMA AB AB LUPIN AB AB ORCHID HLTHCARE AB AB RANBAXY AB AB STEVENS J AB SUN PHARM INDS (IN) AB AB TEVA AB AB YUNG SHIN PHARM AB AB KEFLEX SHIONOGI INC AB AB KEFLEX XX + SHIONOGI INC FOR SUSPENSION; ORAL CEPHALEXIN FACTA FARMA AB AB + HIKMA PHARMS AB AB LUPIN AB AB ORCHID HLTHCARE AB AB RANBAXY AB AB TEVA AB AB YUNG SHIN PHARM AB AB TABLET; ORAL
CEPHALEXIN
TEVA
XX XX +
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 250MG 500MG 250MG 500MG 250MG 500MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A090836 A090836 A065253 A065253 A062713 A062713 A062118 A062118 A065215 A065215 A065229 A065229 A065248 A065248 A065007 A065007 A062870 A062791 A062791 A062702 A062702 A065152 A065152
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 001 002 001 002 001 002
Jan Jan Nov Nov Jun Jun Sep Sep Mar Jun Jun Feb Feb Feb Feb
24, 24, 25, 25, 28, 28, 16, 16, 17, 11, 11, 13, 13, 24, 24,
2006 2006 2005 2005 2005 2005 1999 1999 1988 1987 1987 1987 1987 2005 2005
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
125MG 250MG 125MG 250MG 125MG 250MG 125MG 250MG 125MG 250MG 125MG 250MG 125MG 250MG
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062117 A062117 A065444 A065444 A065234 A065234 A065326 A065326 A065081 A065081 A062703 A062703 A065336 A065336
002 003 001 002 001 002 001 002 001 002 001 002 001 002
Aug Aug Aug Aug Jul Jul Jul Jul Feb Feb Jul Jul
28, 28, 17, 17, 10, 10, 27, 27, 13, 13, 25, 25,
2009 2009 2005 2005 2006 2006 2001 2001 1987 1987 2007 2007
3 - 91 (of 424)
AA AA AA AA AA AA AA AA AA AA AA AA AA
A090766 A078412 A090751 A078488 A078870 A078398 A077472 A090191 A076601 A077279 A078496 A078757
001 001 001 001 001 001 001 001 001 001 001 001
Oct Jun Dec Oct Apr Jun Jun Nov Jun May Sep Aug
07, 18, 16, 06, 27, 17, 18, 12, 20, 27, 25, 28,
2009 2008 2009 2008 2009 2008 2008 2009 2008 2008 2009 2009
N020346 001
CETRORELIX
INJECTABLE; INJECTION
CETROTIDE
XX + EMD SERONO XX +
CEVIMELINE HYDROCHLORIDE
CAPSULE; ORAL CEVIMELINE APOTEX INC AB EVOXAC AB + DAIICHI SANKYO CO
30MG 30MG
CHENODIOL
TABLET; ORAL
CHENODIOL
XX + NEXGEN PHARMA
250MG
A091019 001
CHLORAMBUCIL
TABLET; ORAL
LEUKERAN
XX + PBS
2MG
N010669 002
INJECTABLE; INJECTION
CHLORAMPHENICOL SODIUM SUCCINATE
EQ 1GM BASE/VIAL XX + APP PHARMS
A062365 001
CHLORDIAZEPOXIDE HYDROCHLORIDE
CAPSULE; ORAL CHLORDIAZEPOXIDE HYDROCHLORIDE BARR AB 5MG AB 10MG AB 25MG USL PHARMA AB 10MG WATSON LABS AB 5MG AB 10MG AB 25MG LIBRIUM VALEANT PHARM INTL AB 5MG AB 10MG
3 - 92 (of 424)
25MG
A085475 001
CHLORHEXIDINE GLUCONATE
SOLUTION; DENTAL CHLORHEXIDINE GLUCONATE HI TECH PHARMA JOHN O BUTLER CO LYNE NOVEX TEVA WOCKHARDT XTTRIUM PERIDEX + 3M PERIOGARD COLGATE
AT AT AT AT AT AT AT AT AT
TABLET; DENTAL
PERIOCHIP
XX + DEXCEL PHARMA
2.5MG
N020774 001
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION CHLOROPROCAINE HYDROCHLORIDE BEDFORD 2% 3% HOSPIRA 2% 3% NESACAINE APP PHARMS 2% NESACAINE-MPF + APP PHARMS 2% + 3% NESACAINE + APP PHARMS 1%
AP AP AP AP AP AP AP XX
N009435 002 N009435 006 N009435 007 N009435 001 May 02, 1996 May 02, 1996
CHLOROQUINE PHOSPHATE
TABLET; ORAL ARALEN AA + SANOFI AVENTIS US CHLOROQUINE PHOSPHATE IMPAX LABS AA AA IPCA LABS LTD AA AA NATCO PHARMA LTD AA AA AA + WEST WARD AA
EQ 300MG BASE EQ EQ EQ EQ EQ EQ EQ EQ 150MG 300MG 150MG 300MG 150MG 300MG 150MG 300MG BASE BASE BASE BASE BASE BASE BASE BASE
N006002 001 A080880 A040516 A090610 A090249 A091621 A090612 A083082 A083082 001 001 001 001 001 001 001 002
CHLOROTHIAZIDE
SUSPENSION; ORAL
DIURIL
XX + SALIX PHARMS TABLET; ORAL CHLOROTHIAZIDE AB + MYLAN
250MG/5ML
N011870 001
250MG
A084388 001
TABLET; ORAL
CHLOROTHIAZIDE MYLAN AB WEST WARD AB AB
3 - 93 (of 424)
CHLOROTHIAZIDE SODIUM
INJECTABLE; INJECTION CHLOROTHIAZIDE SODIUM APP PHARMS AP SUN PHARMA GLOBAL AP DIURIL AP + LUNDBECK INC
4MG/5ML;5MG/5ML;60MG/5ML
N022439 001
A091632 001
N019111 001
CHLORPROMAZINE HYDROCHLORIDE
INJECTABLE; INJECTION
CHLORPROMAZINE HYDROCHLORIDE
25MG/ML XX + BAXTER HLTHCARE TABLET; ORAL CHLORPROMAZINE HYDROCHLORIDE BP SANDOZ 10MG BP 25MG BP 50MG BP + 100MG BP 200MG BP USL PHARMA 10MG BP 25MG BP 50MG BP 100MG BP 200MG
A083329 001
A080439 A080439 A080439 A080439 A080439 A083386 A084112 A084113 A084114 A084115
001 002 003 004 005 001 001 001 001 001
CHLORPROPAMIDE
TABLET; ORAL CHLORPROPAMIDE MYLAN AB AB PLIVA AB AB WATSON LABS AB AB
3 - 94 (of 424)
100MG 250MG
CHLORTHALIDONE
TABLET; ORAL CHLORTHALIDONE MYLAN AB AB + PLIVA AB AB THALITONE XX + MONARCH PHARMS
N019574 001
CHLORZOXAZONE
TABLET; ORAL CHLORZOXAZONE BARR AA WATSON LABS AA AA AA PARAFON FORTE DSC AA + JANSSEN R AND D CHLORZOXAZONE MIKART XX XX
CHOLESTYRAMINE
POWDER; ORAL CHOLESTYRAMINE PAR PHARM AB AB AB + SANDOZ AB CHOLESTYRAMINE LIGHT PAR PHARM AB AB SANDOZ AB AB + LOCHOLEST SANDOZ AB AB LOCHOLEST LIGHT SANDOZ AB AB PREVALITE UPSHER SMITH AB AB
EQ EQ EQ EQ EQ EQ EQ EQ
EQ 4GM RESIN/SCOOPFUL EQ 4GM RESIN/PACKET EQ 4GM RESIN/PACKET EQ 4GM RESIN/SCOOPFUL EQ 4GM RESIN/PACKET EQ 4GM RESIN/SCOOPFUL
A074561 002 A074561 001 A074562 001 A074562 002 A073263 001 A073263 002
Aug 15, 1996 Aug 15, 1996 Aug 15, 1996 Aug 15, 1996 Feb 22, 1996 Oct 30, 1997
3 - 95 (of 424)
CHORIOGONADOTROPIN ALFA
INJECTABLE; SUBCUTANEOUS
OVIDREL
XX + EMD SERONO
EQ 0.25MG /0.5ML
N021149 002
CHROMIC CHLORIDE
INJECTABLE; INJECTION
CHROMIC CHLORIDE IN PLASTIC CONTAINER
XX + HOSPIRA EQ 0.004MG CHROMIUM/ML
N018961 001
CICLESONIDE
AEROSOL, METERED; INHALATION ALVESCO NYCOMED US 0.08MG/INH XX 0.16MG/INH XX + SPRAY, METERED; NASAL
OMNARIS
XX + NYCOMED US
0.05MG/INH
N022004 001
CICLOPIROX
CREAM; TOPICAL CICLOPIROX ALTANA G AND W LABS INC GLENMARK PHARMS PERRIGO TARO LOPROX + MEDICIS
AB AB AB AB AB AB
N018748 001
GEL; TOPICAL CICLOPIROX NYCOMED US AB PADDOCK LLC AB LOPROX AB + MEDICIS SHAMPOO; TOPICAL CICLOPIROX NYCOMED US PADDOCK LLC PERRIGO TARO LOPROX + MEDICIS SOLUTION; TOPICAL CICLOPIROX ACTAVIS MID ATLANTIC APOTEX CORP G AND W LABS HI TECH PHARMA PERRIGO NEW YORK SYNERX PHARMA TARO PHARM INDS TEVA PHARMS
AT AT AT AT AT
1% 1% 1% 1% 1%
N021159 001
AT AT AT AT AT AT AT AT
8% 8% 8% 8% 8% 8% 8% 8%
3 - 96 (of 424)
AT AT AT AT
8% 8% 8% 8%
Sep 18, 2007 Feb 17, 2010 Sep 18, 2007 Dec 17, 1999
AB AB AB AB
Aug 06, 2004 Dec 15, 2006 Aug 10, 2005 Dec 30, 1988
CIDOFOVIR
INJECTABLE; INJECTION
VISTIDE
XX + GILEAD
EQ 75MG BASE/ML
N020638 001
250MG 500MG 250MG 500MG 500MG 250MG 250MG 500MG 500MG 500MG
BASE/VIAL;250MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;250MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;250MG/VIAL BASE/VIAL;250MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;500MG/VIAL BASE/VIAL;500MG/VIAL
A090577 A090577 A090825 A090825 A091007 A062756 N050587 A062756 N050587 N050630
001 002 001 002 001 001 001 002 002 001
Dec Dec Nov Nov Nov Jan Nov Jan Nov Dec
21, 21, 16, 16, 16, 08, 26, 08, 26, 14,
2011 2011 2011 2011 2011 1987 1985 1987 1985 1990
CILOSTAZOL
TABLET; ORAL CILOSTAZOL ALPHAPHARM AB AB APOTEX INC AB AB BRECKENRIDGE PHARM AB AB COREPHARMA AB AB MYLAN AB AB PLIVA HRVATSKA DOO AB AB ROXANE AB AB SANDOZ AB AB TEVA AB AB PLETAL AB + OTSUKA AB +
50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG
A077019 A077019 A077030 A077030 A077708 A077708 A077150 A077022 A077323 A077323 A077898 A077898 A077024 A077024 A077310 A077021 A077027 A077027
001 002 001 002 001 002 001 001 002 001 001 002 001 002 001 001 001 002
Nov Nov Dec Dec Sep Sep Mar Nov Apr Apr Oct Oct May May Nov Nov Nov Nov
23, 23, 10, 10, 28, 28, 11, 23, 20, 20, 29, 29, 17, 17, 08, 23, 24, 24,
2004 2004 2004 2004 2009 2009 2005 2004 2006 2006 2007 2007 2005 2005 2005 2004 2004 2004
3 - 97 (of 424)
200MG 300MG 400MG 800MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG
A074890 A074890 A074890 A074890 A074340 A074340 A074339 A074424 A074424 A074424 A074424 A074246 A074246 A074246 A074246 A074568 A074568 A074568 A074566 A074506 A074506 A074506 A074506 A074151 A074151 A074151 A074463 A074349 A074349 A074349 A074316 N017920 N017920 N017920 N017920
001 002 003 004 001 002 001 001 002 003 004 001 002 003 004 001 002 003 001 001 002 003 004 001 002 003 001 001 002 003 001 002 003 004 005
Dec Dec Dec Dec Jun Jun Jun Jul Jul Jul Jul May May May May Feb Feb Feb Feb Jan Jan Jan Jan May May May May Aug Aug Aug Feb
18, 18, 18, 18, 23, 23, 23, 28, 28, 28, 28, 17, 17, 17, 17, 27, 27, 27, 27, 24, 24, 24, 24, 17, 17, 17, 17, 30, 30, 30, 28,
1998 1998 1998 1998 1995 1995 1995 1995 1995 1995 1995 1994 1994 1994 1994 1997 1997 1997 1997 1996 1996 1996 1996 1994 1994 1994 1994 1996 1996 1996 1996
CIMETIDINE HYDROCHLORIDE
INJECTABLE; INJECTION CIMETIDINE HYDROCHLORIDE DAVA PHARMS INC AP EQ 300MG BASE/2ML HOSPIRA AP EQ 300MG BASE/2ML AP EQ 300MG BASE/2ML SOLUTION; ORAL CIMETIDINE HYDROCHLORIDE + HI TECH PHARMA EQ NOVEX EQ PHARM ASSOC EQ TEVA EQ WOCKHARDT EQ
AA AA AA AA AA
CINACALCET HYDROCHLORIDE
TABLET; ORAL SENSIPAR AMGEN XX XX XX +
3 - 98 (of 424)
250MG/5ML 500MG/5ML
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N019847 001 N019847 002 N019857 001 N019857 002 A078062 A078062 A076717 A076717 A077245 A077245 A077782 A077782 A078252 A078252 A077888 A077888 A078024 A078024 A078431 A077753 A077753 001 002 001 002 002 001 002 001 001 002 001 002 001 002 001 001 002
Dec 26, 1990 Dec 26, 1990 Dec 26, 1990 Dec 26, 1990 Apr Apr Dec Dec Aug Aug Aug Aug Mar Mar Mar Mar Mar Mar Nov Mar Mar 29, 29, 22, 22, 28, 28, 28, 28, 18, 18, 18, 18, 18, 18, 18, 18, 18, 2008 2008 2009 2009 2006 2006 2006 2006 2008 2008 2008 2008 2008 2008 2009 2008 2008
200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) HIKMA FARMACEUTICA 200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) HOSPIRA 400MG/40ML (10MG/ML) 200MG/20ML (10MG/ML) TEVA PARENTERAL 400MG/40ML (10MG/ML) 200MG/20ML (10MG/ML) CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ACS DOBFAR INFO SA 200MG/100ML 400MG/200ML BAXTER HLTHCARE 200MG/100ML 400MG/200ML CLARIS LIFESCIENCES 200MG/100ML 400MG/200ML HIKMA FARMACEUTICA 400MG/200ML HOSPIRA 200MG/100ML 400MG/200ML
CIPROFLOXACIN HYDROCHLORIDE
OINTMENT; OPHTHALMIC
CILOXAN
XX + ALCON PHARMS LTD
EQ 0.3% BASE
N020369 001
AT AT AT AT AT AT AT AT
SOLUTION/DROPS; OPHTHALMIC CILOXAN + ALCON PHARMS LTD EQ 0.3% CIPROFLOXACIN HYDROCHLORIDE AKORN INC EQ 0.3% APOTEX EQ 0.3% BAUSCH AND LOMB EQ 0.3% FDC LTD EQ 0.3% HITECH PHARMA EQ 0.3% NEXUS PHARMS EQ 0.3% PHARMAFORCE EQ 0.3%
N019992 001 A076555 A075928 A076754 A077568 A076673 A077689 A078598 001 001 001 001 001 001 001
Dec 31, 1990 Dec Jun Jun Jun Jan Dec Jan 11, 09, 09, 30, 21, 13, 16, 2008 2004 2004 2008 2005 2006 2008
SOLUTION/DROPS; OTIC
CETRAXAL
XX + WRASER PHARMS
EQ 0.2% BASE
N021918 001
TABLET; ORAL CIPRO BAYER HLTHCARE AB EQ 100MG AB EQ 250MG AB + EQ 500MG AB EQ 750MG CIPROFLOXACIN HYDROCHLORIDE APOTEX AB EQ 250MG AB EQ 500MG
3 - 99 (of 424)
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB BX BX BX BX
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A076896 A077859 A077859 A077859 A076126 A076126 A076126 A075593 A075593 A075593 A075593 A076558 A076558 A076558 A076089 A076089 A076089 A075817 A075685 A075817 A075685 A075817 A075685 A075817 A075747 A075747 A075747 A076912 A076912 A076912 A076912 A076639 A076639 A076639 A076794 A076794 A076794 A076794 A076426 A076426 A076426 A076426
003 001 002 003 002 003 004 002 003 004 001 002 003 004 002 003 004 001 002 002 003 003 001 004 001 002 003 001 002 003 004 001 002 003 001 002 003 004 001 002 003 004
Nov Apr Apr Apr Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Feb Oct Oct Oct Sep Sep Sep Feb Jun Jun Jun Jun Jun Jun Jun
04, 26, 26, 26, 09, 09, 09, 09, 09, 09, 09, 09, 09, 09, 09, 09, 09, 25, 09, 09, 09, 09, 09, 09, 09, 09, 09, 18, 06, 06, 06, 10, 10, 10, 10, 09, 09, 09, 15, 15, 15, 15,
2004 2007 2007 2007 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2007 2004 2004 2004 2004 2004 2004 2004 2004 2004 2005 2004 2004 2004 2004 2004 2004 2005 2004 2004 2004 2005 2005 2005 2005
EQ 0.2% BASE;1%
N020805 001
AB AB AB AB
Dec 13, 2002 Aug 28, 2003 Nov 27, 2007 Nov 27, 2007
AB AB AB AB AB AB
CIPROFLOXACIN; DEXAMETHASONE
SUSPENSION/DROPS; OTIC
CIPRODEX
XX + ALCON PHARMS LTD
0.3%;0.1%
N021537 001
CISATRACURIUM BESYLATE
INJECTABLE; INJECTION
NIMBEX
EQ 2MG BASE/ML XX + ABBOTT NIMBEX PRESERVATIVE FREE EQ 2MG BASE/ML XX + ABBOTT EQ 10MG BASE/ML XX +
CISPLATIN
INJECTABLE; INJECTION CISPLATIN + APP PHARMS BEDFORD PHARMACHEMIE TEVA PARENTERAL
AP AP AP AP
CITALOPRAM HYDROBROMIDE
CAPSULE; ORAL CITALOPRAM HYDROBROMIDE ALPHAPHARM EQ 10MG BASE XX EQ 20MG BASE XX EQ 40MG BASE XX + SOLUTION; ORAL CELEXA + FOREST LABS CITALOPRAM HYDROBROMIDE AUROBINDO PHARMA LTD ROXANE SILARX
AA AA AA AA
Dec 22, 1999 Aug 28, 2006 Dec 13, 2004 Jun 15, 2006
TABLET; ORAL CELEXA FOREST LABS AB AB AB + CITALOPRAM HYDROBROMIDE ALPHAPHARM AB AB AB AMNEAL PHARMS NY AB AB AB APOTEX INC AB AB AB
EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG BASE BASE BASE BASE BASE BASE BASE BASE BASE
N020822 001 N020822 002 N020822 003 A077037 A077037 A077037 A077289 A077289 A077289 A077046 A077046 A077046 001 002 003 001 002 003 001 002 003
Apr 27, 2000 Jul 17, 1998 Jul 17, 1998 Nov Nov Nov Nov Nov Nov Nov Nov Nov 05, 05, 05, 30, 30, 30, 24, 24, 24, 2004 2004 2004 2006 2006 2006 2004 2004 2004
10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 10MG 20MG 20MG 40MG 40MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 10MG 20MG 20MG 40MG 40MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A077031 A077031 A077031 A077032 A077032 A077032 A077036 A077036 A077036 A077038 A077038 A077038 A077045 A077045 A077045 A077654 A077654 A077654 A077534 A077534 A077534 A077048 A077048 A077048 A077039 A077042 A077039 A077042 A077039 A077042 A077141 A077141 A077232 A077232 A077232 A077035 A077035 A077035 A078216 A078216 A078216 A077034 A077044 A077034 A077044 A077034 A077044
001 002 003 001 002 003 001 002 003 001 002 003 003 002 001 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 002 001 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003
Oct Oct Oct Nov Nov Nov Oct Oct Oct Oct Oct Oct Apr Apr Apr Feb Feb Feb Oct Oct Oct Nov Nov Nov Feb Nov Feb Nov Feb Nov Apr Apr Oct Oct Oct Oct Oct Oct Mar Mar Mar Jun Nov Jun Nov Jun Nov
28, 28, 28, 12, 12, 12, 28, 28, 28, 28, 28, 28, 29, 29, 29, 27, 27, 27, 03, 03, 03, 16, 16, 16, 03, 05, 03, 05, 03, 05, 10, 10, 31, 31, 31, 28, 28, 28, 27, 27, 27, 30, 05, 30, 05, 30, 05,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2005 2005 2005 2009 2009 2009 2006 2006 2006 2004 2004 2004 2005 2004 2005 2004 2005 2004 2008 2008 2005 2005 2005 2004 2004 2004 2007 2007 2007 2005 2004 2005 2004 2005 2004
6.602GM/100ML;198MG/100ML;3.177GM/100ML
N019481 001
N021314 001
AP AP AP AP
Apr 22, 2004 Feb 28, 2000 Oct 06, 2011 Feb 26, 1993
CLARITHROMYCIN
FOR SUSPENSION; ORAL BIAXIN ABBOTT AB AB + CLARITHROMYCIN RANBAXY AB AB SANDOZ AB AB TABLET; ORAL BIAXIN AB + ABBOTT AB + CLARITHROMYCIN APOTEX CORP AB AB MYLAN AB AB RANBAXY AB AB ROXANE AB AB SANDOZ AB AB TEVA AB AB WOCKHARDT AB AB TABLET, EXTENDED RELEASE; BIAXIN XL + ABBOTT CLARITHROMYCIN SANDOZ TEVA WATSON LABS FLORIDA
N050698 001 N050698 002 A065382 A065382 A065283 A065283 001 002 002 003
Dec 23, 1993 Dec 23, 1993 Aug Aug Sep Sep 30, 30, 04, 04, 2007 2007 2007 2007
250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG ORAL 500MG 500MG 500MG 500MG
N050662 001 N050662 002 A065384 A065384 A065195 A065195 A065174 A065174 A065178 A065178 A065144 A065136 A065155 A065155 A065266 A065266 001 002 001 002 001 002 002 001 001 001 001 002 001 002
Oct 31, 1991 Oct 31, 1991 Aug Aug Mar Mar Sep Sep May May Oct Aug May May May May 20, 20, 11, 11, 24, 24, 25, 25, 18, 25, 31, 31, 31, 31, 2007 2007 2005 2005 2004 2004 2004 2004 2005 2005 2005 2005 2006 2006
AB AB AB AB
Mar 03, 2000 Aug 25, 2005 May 18, 2005 Jun 24, 2004
INJECTABLE; INJECTION
TIMENTIN
EQ 1GM BASE/VIAL;EQ 30GM BASE/VIAL XX + GLAXOSMITHKLINE EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL XX EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL XX + EQ 200MG BASE/VIAL;EQ 3GM BASE/VIAL XX + TIMENTIN IN PLASTIC CONTAINER EQ 100MG BASE/100ML;EQ 3GM BASE/100ML XX + GLAXOSMITHKLINE
N050658 001
AA AA AA AA
EQ EQ EQ EQ
2.68MG 2.68MG
CLEVIDIPINE BUTYRATE
EMULSION; INTRAVENOUS
CLEVIPREX
XX + MEDICINES CO XX +
CLINDAMYCIN HYDROCHLORIDE
CAPSULE; ORAL CLEOCIN HYDROCHLORIDE PHARMACIA AND UPJOHN EQ AB AB EQ AB + EQ CLINDAMYCIN HYDROCHLORIDE AUROBINDO PHARMA AB EQ AB EQ COREPHARMA AB EQ AB EQ LANNETT AB EQ AB EQ AB EQ MATRIX LABS LTD AB EQ AB EQ AB EQ RANBAXY AB EQ AB EQ TEVA AB EQ AB EQ WATSON LABS AB EQ AB EQ ZYDUS PHARMS USA AB EQ AB EQ AB EQ
75MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 75MG BASE 150MG BASE 300MG BASE 75MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 150MG BASE 300MG BASE 75MG BASE 150MG BASE 300MG BASE
N050162 001 N050162 002 N050162 003 A065442 A065442 A065194 A065194 A065242 A065242 A065243 A091225 A091225 A091225 A065061 A065061 A063029 A063029 A063083 A063083 A065217 A065217 A065217 001 002 001 002 001 002 001 001 002 003 001 002 001 002 001 002 001 002 003
Apr 14, 1988 Aug Aug Mar Mar Aug Aug Aug May May May Feb Feb Sep Aug Jul Mar Jan Jan Jan 26, 26, 22, 22, 12, 12, 12, 31, 31, 31, 02, 02, 20, 05, 31, 18, 31, 31, 31, 2009 2009 2004 2004 2005 2005 2005 2011 2011 2011 2001 2001 1989 2005 1991 2003 2005 2005 2005
CLINDAMYCIN PHOSPHATE
AEROSOL, FOAM; TOPICAL CLINDAMYCIN PHOSPHATE PERRIGO UK FINCO AT EVOCLIN AT + STIEFEL LABS INC
1% 1%
INJECTABLE; INJECTION CLEOCIN PHOSPHATE PHARMACIA AND UPJOHN EQ 150MG BASE/ML AP AP + EQ 150MG BASE/ML CLINDAMYCIN PHOSPHATE APP PHARMS AP EQ 150MG BASE/ML AP EQ 150MG BASE/ML BAXTER HLTHCARE AP EQ 150MG BASE/ML BEDFORD AP EQ 150MG BASE/ML HOSPIRA AP EQ 150MG BASE/ML AP EQ 150MG BASE/ML AP EQ 150MG BASE/ML SAGENT STRIDES AP EQ 150MG BASE/ML AP EQ 150MG BASE/ML CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER XX + PHARMACIA AND UPJOHN EQ 6MG BASE/ML EQ 12MG BASE/ML XX + EQ 18MG BASE/ML XX + CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% EQ 900MG BASE/100ML XX + ABRAXIS PHARM LOTION; TOPICAL CLEOCIN T AB + PHARMACIA AND UPJOHN CLINDAMYCIN PHOSPHATE ALTANA AB SOLUTION; TOPICAL CLEOCIN T + PHARMACIA AND UPJOHN CLINDA-DERM PADDOCK LLC CLINDAMYCIN PHOSPHATE ALTANA FOUGERA PERRIGO NEW YORK TARO PHARM INDS WOCKHARDT
A062803 001 N050441 001 A065346 A065347 A062889 A065206 A062800 A062801 A062943 A090108 A090109 001 001 001 001 001 001 001 001 001
Aug 30, 1989 Aug 30, 1989 Apr 10, 1991 Dec 22, 1989
EQ 1% BASE EQ 1% BASE
AT AT AT AT AT AT AT
N050537 001 A063329 001 A065254 A064159 A064050 A065184 A063304 001 001 001 001 001 Sep 30, 1992 Feb Jun Nov Mar Jul 14, 05, 30, 31, 15, 2006 1997 1995 2004 1997
SUPPOSITORY; VAGINAL
CLEOCIN
XX + PHARMACIA AND UPJOHN SWAB; TOPICAL CLEOCIN PHARMACIA AND UPJOHN AT CLINDAMYCIN PHOSPHATE PERRIGO NEW YORK AT
100MG
N050767 001
EQ 1% BASE EQ 1% BASE
EQ 1% BASE EQ 1% BASE
1.2%;0.025% 1.2%;0.025%
CLOBAZAM
TABLET; ORAL ONFI XX LUNDBECK INC XX XX +
CLOBETASOL PROPIONATE
AEROSOL, FOAM; TOPICAL CLOBETASOL PROPIONATE PERRIGO ISRAEL AB OLUX AB + STIEFEL LABS INC OLUX E XX + STIEFEL LABS INC
CREAM; TOPICAL CLOBETASOL PROPIONATE FOUGERA AB1 0.05% TARO AB1 0.05% TEVA PHARMS AB1 0.05% CORMAX HI TECH PHARMA AB1 0.05% TEMOVATE AB1 + NYCOMED US 0.05% CLOBETASOL PROPIONATE (EMOLLIENT) ALTANA AB2 0.05% TARO AB2 0.05% EMBELINE E HI TECH PHARMA AB2 0.05% TEMOVATE E AB2 + FOUGERA PHARMS 0.05% GEL; TOPICAL CLOBETASOL PROPIONATE ALTANA PERRIGO TARO EMBELINE HI TECH PHARMA TEMOVATE + NYCOMED US
A074392 001 A074249 001 A074087 001 A074220 001 N019322 001 A075430 001 A075633 001 A075325 001 N020340 001
Sep 30, 1996 Jul 08, 1996 Feb 16, 1994 May 16, 1997 Dec 27, 1985 May 26, 1999 May 17, 2000 Dec 24, 1998 Jun 17, 1994
AB AB AB AB AB
A075368 001 A075027 001 A075279 001 A076141 001 N020337 001
Feb 15, 2000 Oct 31, 1997 May 28, 1999 Apr 12, 2002 Apr 29, 1994
LOTION; TOPICAL CLOBETASOL PROPIONATE ACTAVIS MID ATLANTIC AB CLOBEX AB + GALDERMA LABS LP
0.05% 0.05%
AB AB AB AB AB
A074407 001 A074248 001 A074089 001 A074221 001 N019323 001
Feb 23, 1996 Jul 12, 1996 Feb 16, 1994 Mar 31, 1995 Dec 27, 1985
SHAMPOO; TOPICAL CLOBETASOL PROPIONATE ACTAVIS MID ATLANTIC AB CLOBEX AB + GALDERMA LABS SOLUTION; TOPICAL CLOBETASOL PROPIONATE NYCOMED US AT TARO AT AT TOLMAR AT WOCKHARDT AT EMBELINE HI TECH PHARMA AT TEMOVATE AT + NYCOMED US SPRAY; TOPICAL CLOBETASOL PROPIONATE PADDOCK LLC AT CLOBEX AT + GALDERMA LABS LP
0.05% 0.05%
0.05% 0.05%
CLOCORTOLONE PIVALATE
CREAM; TOPICAL
CLODERM
XX + PROMIUS PHARMA LLC
0.1%
N017765 001
CLOFARABINE
INJECTABLE; IV (INFUSION)
CLOLAR
20MG/20ML (1MG/ML) XX + GENZYME
N021673 001
CLOFAZIMINE
CAPSULE; ORAL
LAMPRENE
XX + NOVARTIS
50MG
N019500 002
CLOMIPHENE CITRATE
TABLET; ORAL CLOMID AB + SANOFI AVENTIS US CLOMIPHENE CITRATE PAR PHARM AB SEROPHENE EMD SERONO AB
N016131 002 A075528 001 N018361 001 Aug 30, 1999 Mar 22, 1982
N019906 001 N019906 002 N019906 003 A074947 A074947 A074947 A074364 A074364 A074364 A074694 A074694 A074694 A074958 A074958 A074958 001 002 003 001 002 003 001 002 003 001 002 003
Dec 29, 1989 Dec 29, 1989 Dec 29, 1989 Apr Apr Apr Mar Mar Mar Dec Dec Dec Aug Aug Aug 30, 30, 30, 29, 29, 29, 31, 31, 31, 26, 26, 26, 1998 1998 1998 1996 1996 1996 1996 1996 1996 1997 1997 1997
CLONAZEPAM
TABLET; ORAL CLONAZEPAM ACCORD HLTHCARE INC AB AB AB ACTAVIS ELIZABETH AB AB AB ALPHAPHARM AB AB AB APOTEX AB AB AB CARACO AB AB AB MYLAN AB AB AB SANDOZ AB AB AB TEVA AB AB AB VINTAGE PHARMS AB AB AB WATSON LABS AB AB AB KLONOPIN ROCHE AB AB + AB
0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG
A077147 A077147 A077147 A074869 A074869 A074869 A074940 A074940 A074940 A075468 A075468 A075468 A075423 A075423 A075423 A075150 A075150 A075150 A074979 A074979 A074979 A074569 A074569 A074569 A077856 A077856 A077856 A074964 A074964 A074964
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
May May May Oct Oct Oct Oct Oct Oct Oct Oct Oct Apr Apr Apr Oct Oct Oct Aug Aug Aug Sep Sep Sep Jun Jun Jun Dec Dec Dec
02, 02, 02, 31, 31, 31, 30, 30, 30, 06, 06, 06, 27, 27, 27, 05, 05, 05, 29, 29, 29, 10, 10, 10, 28, 28, 28, 30, 30, 30,
2005 2005 2005 1996 1996 1996 1997 1997 1997 2000 2000 2000 2001 2001 2001 1998 1998 1998 1997 1997 1997 1996 1996 1996 2006 2006 2006 1997 1997 1997
A077194 001
CLONIDINE
FILM, EXTENDED RELEASE; TRANSDERMAL CATAPRES-TTS-1 BOEHRINGER INGELHEIM 0.1MG/24HR CATAPRES-TTS-2 BOEHRINGER INGELHEIM 0.2MG/24HR CATAPRES-TTS-3 + BOEHRINGER INGELHEIM 0.3MG/24HR CLONIDINE AVEVA 0.1MG/24HR 0.2MG/24HR 0.3MG/24HR BARR 0.1MG/24HR 0.2MG/24HR 0.3MG/24HR MYLAN TECHNOLOGIES 0.1MG/24HR 0.2MG/24HR 0.3MG/24HR
AB AB AB AB AB AB AB AB AB AB AB AB
N018891 001 N018891 002 N018891 003 A076157 A076157 A076157 A079090 A079090 A079090 A076166 A076166 A076166 001 002 003 001 002 003 001 002 003
Oct 10, 1984 Oct 10, 1984 Oct 10, 1984 Aug Aug Aug Aug Aug Aug Jul Jul Jul 18, 18, 18, 20, 20, 20, 16, 16, 16, 2009 2009 2009 2010 2010 2010 2010 2010 2010
CLONIDINE HYDROCHLORIDE
INJECTABLE; INJECTION CLONIDINE HYDROCHLORIDE APP PHARMS AP 1MG/10ML (0.1MG/ML) AP 5MG/10ML (0.5MG/ML) HIKMA FARMACEUTICA AP 1MG/10ML (0.1MG/ML) AP 5MG/10ML (0.5MG/ML) LUITPOLD AP 1 MG/10 ML (0.1 MG/ML) AP 5 MG/10 ML (0.5 MG/ML) DURACLON BIONICHE PHARMA USA AP 1 MG/10 ML (0.1 MG/ML) AP + 5 MG/10 ML (0.5 MG/ML) TABLET; ORAL CATAPRES BOEHRINGER INGELHEIM AB AB AB + CLONIDINE HYDROCHLORIDE ACTAVIS ELIZABETH AB AB AB ALEMBIC PHARMS LTD AB AB AB DAVA PHARMS INC AB AB AB IMPAX LABS AB
0.1MG 0.2MG 0.3MG 0.1MG 0.2MG 0.3MG 0.1MG 0.2MG 0.3MG 0.1MG 0.2MG 0.3MG 0.1MG
N017407 001 N017407 002 N017407 003 A070974 A070975 A070976 A091368 A091368 A091368 A071783 A071784 A071785 A078099 001 001 001 001 002 003 001 001 001 001 Dec Dec Dec Dec Dec Dec Apr Apr Apr Aug 16, 16, 16, 06, 06, 06, 05, 05, 05, 27, 1986 1986 1986 2011 2011 2011 1988 1988 1988 2009
A078099 A078099 A070925 A070924 A070923 A070317 A070317 A070317 A078895 A078895 A078895 A077901 A077901 A077901 A070963
002 003 001 001 001 002 003 001 001 002 003 001 002 003 001
Aug Aug Sep Sep Sep Jul Jun Jun Aug Aug Aug Mar Mar Mar Jul
27, 27, 04, 04, 04, 09, 09, 09, 26, 26, 26, 09, 09, 09, 08,
2009 2009 1987 1987 1987 1987 1987 1987 2009 2009 2009 2007 2007 2007 1986
N022331 003
CLOPIDOGREL BISULFATE
TABLET; ORAL PLAVIX SANOFI AVENTIS US XX XX +
CLORAZEPATE DIPOTASSIUM
TABLET; ORAL CLORAZEPATE DIPOTASSIUM MYLAN AB 3.75MG AB 7.5MG AB 15MG RANBAXY AB 3.75MG AB 7.5MG AB 15MG TARO AB 3.75MG AB 7.5MG AB 15MG WATSON LABS AB 3.75MG AB 7.5MG AB 15MG GEN-XENE ALRA AB 3.75MG AB 7.5MG AB 15MG TRANXENE LUNDBECK INC AB 3.75MG AB 7.5MG AB + 15MG
A071858 A071858 A071858 A076911 A076911 A076911 A075731 A075731 A075731 A071852 A071853 A071854
002 003 001 001 002 003 003 002 001 001 001 001
Jul Jul Jul Sep Sep Sep Apr Apr Apr Feb Feb Feb
17, 17, 17, 29, 29, 29, 27, 27, 27, 09, 09, 09,
1987 1987 1987 2004 2004 2004 2000 2000 2000 1988 1988 1988
A071787 001 A071788 001 A071789 001 N017105 006 N017105 007 N017105 008
CLOTRIMAZOLE
CREAM; TOPICAL CLOTRIMAZOLE GLENMARK PHARMS AB NYCOMED US AB AB + TARO
1% 1% 1%
1% 1% 1%
CLOZAPINE
TABLET; ORAL CLOZAPINE CARACO AB AB AB IVAX SUB TEVA PHARMS AB AB AB AB AB MYLAN AB AB CLOZARIL NOVARTIS AB AB + CLOZAPINE IVAX SUB TEVA PHARMS XX XX
25MG 50MG 100MG 25MG 50MG 50MG 100MG 100MG 25MG 100MG 25MG 100MG 12.5MG 200MG
A075713 A075713 A075713 A074949 A074949 A076809 A074949 A076809 A075417 A075417
001 003 002 001 004 003 002 002 001 002
Nov Aug Nov Nov Apr Dec Nov Dec May May
15, 19, 15, 26, 25, 16, 26, 16, 27, 27,
2002 2005 2002 1997 2005 2005 1997 2005 1999 1999
Sep 26, 1989 Sep 26, 1989 Jul 31, 2003 Dec 16, 2005
XX XX XX XX XX
TABLET, ORALLY DISINTEGRATING; ORAL FAZACLO ODT AZUR PHARMA INTL 12.5MG 25MG + 100MG 150MG 200MG
AA AA AA AA AA AA
A040650 001
10MG/5ML;30MG/5ML;1.25MG/5ML
A088704 001
CODEINE SULFATE
SOLUTION; ORAL
CODEINE SULFATE
XX + ROXANE TABLET; ORAL CODEINE SULFATE ROXANE XX XX XX +
30MG/5ML
N202245 001
COLCHICINE
TABLET; ORAL
COLCRYS
XX + AR HOLDING CO INC
0.6MG
N022352 001
COLCHICINE; PROBENECID
TABLET; ORAL COL-PROBENECID AB + WATSON LABS 0.5MG;500MG PROBENECID AND COLCHICINE MIRROR PHARMS 0.5MG;500MG AB
COLESEVELAM HYDROCHLORIDE
FOR SUSPENSION; ORAL
WELCHOL
DAIICHI SANKYO
XX XX +
TABLET; ORAL
WELCHOL
XX + DAIICHI SANKYO
1.875GM/PACKET 3.75GM/PACKET
625MG
N021176 001
COLESTIPOL HYDROCHLORIDE
GRANULE; ORAL COLESTID PHARMACIA AND UPJOHN 5GM/SCOOPFUL 5GM/PACKET + COLESTIPOL HYDROCHLORIDE IMPAX LABS 5GM/PACKET 5GM/SCOOPFUL FLAVORED COLESTID
PHARMACIA AND UPJOHN 5GM/PACKET 5GM/SCOOPFUL
AB AB AB AB XX XX
N017563 003 N017563 004 A077277 002 A077277 001 N017563 001
N017563 002
Sep 22, 1995 Sep 22, 1995 May 02, 2006 May 02, 2006
TABLET; ORAL COLESTID AB + PHARMACIA AND UPJOHN 1GM COLESTIPOL HYDROCHLORIDE IMPAX LABS 1GM AB
COLISTIMETHATE SODIUM
INJECTABLE; INJECTION COLISTIMETHATE SODIUM APP PHARMS AP PADDOCK LLC AP X GEN PHARMS AP
EQ 150MG BASE/VIAL
N050108 002
N050356 001
CONIVAPTAN HYDROCHLORIDE
INJECTABLE; IV (INFUSION) VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER XX + ASTELLAS 20MG/100ML (0.2MG/ML)
N021697 002
COPPER
INTRAUTERINE DEVICE; INTRAUTERINE
PARAGARD T 380A
309MG/COPPER XX + DURAMED RES
N018680 001
EQ 0.1MG BASE/VIAL
N020162 001
CORTICOTROPIN
INJECTABLE; INJECTION H.P. ACTHAR GEL XX + QUESTCOR PHARMS
80 UNITS/ML
N008372 008
CORTISONE ACETATE
TABLET; ORAL
CORTISONE ACETATE
XX + WEST WARD
25MG
A080776 002
COSYNTROPIN
INJECTABLE; INJECTION CORTROSYN AP + AMPHASTAR PHARMS INC COSYNTROPIN BIONICHE PHARMA AP SOLUTION; INTRAVENOUS COSYNTROPIN SANDOZ XX
0.25MG/VIAL 0.25MG/VIAL
0.25MG/ML (0.25MG/ML)
N022028 001
CRIZOTINIB
CAPSULE; ORAL XALKORI PFIZER XX XX +
200MG 250MG
CROMOLYN SODIUM
AEROSOL, METERED; INHALATION INTAL XX + KING PHARMS 0.8MG/INH
N018887 001
100MG/5ML 100MG/5ML
AN AN AN AN AN AN
AT AT AT AT AT
SOLUTION/DROPS; OPHTHALMIC CROLOM BAUSCH AND LOMB 4% CROMOLYN SODIUM AKORN 4% ALCON 4% NOVEX 4% OPTICROM + ALLERGAN 4%
A074443 001 A074706 001 A075282 001 A075615 001 N018155 001
Jan 30, 1995 Apr 29, 1998 Jun 16, 1999 Jan 26, 2001 Oct 03, 1984
CROTAMITON
CREAM; TOPICAL
EURAX
XX + RANBAXY LOTION; TOPICAL CROTAN SUMMERS AT EURAX AT + RANBAXY
10%
N006927 001
10% 10%
CUPRIC CHLORIDE
INJECTABLE; INJECTION
CUPRIC CHLORIDE IN PLASTIC CONTAINER
EQ 0.4MG COPPER/ML XX + HOSPIRA
N018960 001
CYANOCOBALAMIN
INJECTABLE; INJECTION CYANOCOBALAMIN AP + LUITPOLD VIBISONE AP + APP PHARMS SPRAY, METERED; NASAL
NASCOBAL
XX + PAR PHARM
1MG/ML 1MG/ML
0.5MG/SPRAY
N021642 001
CYCLOBENZAPRINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL AMRIX ANESTA AG AB 15MG AB + 30MG CYCLOBENZAPRINE HYDROCHLORIDE MYLAN AB 15MG AB 30MG
Feb 01, 2007 Feb 01, 2007 Apr 18, 2011 Apr 18, 2011
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A078643 A078643 A090478 A090478 A077563 A077563 A078048 A078048 A073541 A073541 A073144 A073144 A078218 A074421 A077291 A077209 A078722 A078722 A078722 A072854 A072854 A077797 A077797 A071611 A071611 A071611
001 002 001 002 001 002 001 002 002 001 002 001 001 001 001 001 001 002 003 002 001 001 002 002 003 001
Sep Sep Jul Jul Apr Apr Feb Feb Apr May Feb May Apr Sep Feb Oct May May May Feb Nov Feb Feb Feb Feb May
26, 26, 23, 23, 19, 19, 28, 28, 06, 23, 03, 30, 18, 29, 03, 04, 12, 12, 12, 03, 19, 28, 28, 03, 03, 03,
2008 2008 2010 2010 2006 2006 2011 2011 2006 1995 2006 1991 2008 1995 2006 2005 2008 2008 2008 2006 1991 2007 2007 2006 2006 1989
CYCLOPENTOLATE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AKPENTOLATE AKORN AT 1% AT 2% CYCLOGYL AT + ALCON 1% AT + 2% PENTOLAIR BAUSCH AND LOMB 1% AT CYCLOGYL 0.5% XX + ALCON
A040164 001 A040165 001 A084110 001 A084108 001 A040075 001 A084109 001
A084300 001
CYCLOPHOSPHAMIDE
INJECTABLE; INJECTION CYCLOPHOSPHAMIDE + BAXTER HLTHCARE + + CYTOXAN BAXTER HLTHCARE
AP AP AP AP AP
A040745 001 A040745 002 A040745 003 N012142 003 N012142 004
2GM/VIAL
N012142 005
25MG 50MG
CYCLOSERINE
CAPSULE; ORAL
SEROMYCIN
XX + PURDUE GMP
250MG
A060593 001
CYCLOSPORINE
CAPSULE; ORAL CYCLOSPORINE IVAX SUB TEVA PHARMS AB1 AB1 AB1 PLIVA AB1 AB1 SANDOZ AB1 AB1 GENGRAF ABBOTT AB1 AB1 AB1 NEORAL NOVARTIS AB1 AB1 + CYCLOSPORINE APOTEX AB2 AB2 SANDIMMUNE NOVARTIS AB2 AB2 + SANDIMMUNE BX NOVARTIS EMULSION; OPHTHALMIC
RESTASIS
XX + ALLERGAN INJECTABLE; INJECTION CYCLOSPORINE BEDFORD AP LUITPOLD AP SANDIMMUNE AP + NOVARTIS SOLUTION; ORAL CYCLOSPORINE ABBOTT AB1 IVAX SUB TEVA PHARMS AB1 NOVEX AB1 WATSON LABS AB1 NEORAL AB1 + NOVARTIS CYCLOSPORINE WOCKHARDT AB2
25MG 50MG 100MG 25MG 100MG 25MG 100MG 25MG 50MG 100MG 25MG 100MG 25MG 100MG 25MG 100MG 50MG
A065003 001 A065003 002 A065003 003 N050715 001 N050715 002 A065040 001 A065040 002 N050625 001 N050625 002 N050625 003
May 12, 2000 May 12, 2000 May 12, 2000 Jul 14, 1995 Jul 14, 1995 May 09, 2002 May 09, 2002 Mar 02, 1990 Mar 02, 1990 Nov 23, 1992
0.05%
N050790 001
100MG/ML
N050574 001
CYPROHEPTADINE HYDROCHLORIDE
SYRUP; ORAL CYPROHEPTADINE HYDROCHLORIDE AA + LYNE 2MG/5ML TABLET; ORAL CYPROHEPTADINE HYDROCHLORIDE COREPHARMA 4MG + IVAX SUB TEVA PHARMS 4MG PAR PHARM 4MG STASON PHARMS 4MG
A040668 001
AA AA AA AA
CYSTEAMINE BITARTRATE
CAPSULE; ORAL CYSTAGON MYLAN XX XX +
CYTARABINE
INJECTABLE; INJECTION CYTARABINE AP + APP PHARMS BEDFORD AP AP AP AP AP + HOSPIRA AP + AP + AP ONCO THERAPIES LTD AP AP AP CYTOSAR-U TEVA PARENTERAL AP AP + AP + AP +
100MG/ML 100MG/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL 20MG/ML 20MG/ML 20MG/ML 100MG/ML 20MG/ML 20MG/ML 20MG/ML 100MG/VIAL 500MG/VIAL 1GM/VIAL 2GM/VIAL
A076512 A071471 A071472 A074245 A074245 A071868 A072168 A072945 A075383 A200914 A200915 A200916 A075206 A075206 A075206 A075206
001 001 001 001 002 001 001 001 001 001 001 001 001 002 004 003
Jan Aug Aug Aug Aug Jun Aug Feb Nov Dec Dec Dec Dec Dec Dec Dec
15, 02, 02, 31, 31, 04, 31, 28, 22, 13, 13, 13, 30, 30, 30, 30,
2004 1989 1989 1994 1994 1990 1990 1994 1999 2011 2011 2011 1998 1998 1998 1998
N021041 001
75MG 150MG
DACARBAZINE
INJECTABLE; INJECTION DACARBAZINE APP PHARMS AP AP BEDFORD AP AP
AP AP AP AP AP
A075940 001 A075259 002 A075259 001 N017575 001 N017575 002
DACTINOMYCIN
INJECTABLE; INJECTION COSMEGEN AP + LUNDBECK INC DACTINOMYCIN BEDFORD AP
0.5MG/VIAL 0.5MG/VIAL
DALFAMPRIDINE
TABLET, EXTENDED RELEASE; ORAL
AMPYRA
XX + ACORDA 10MG
N022250 001
DALFOPRISTIN; QUINUPRISTIN
INJECTABLE; IV (INFUSION)
SYNERCID
350MG/VIAL;150MG/VIAL XX + KING PHARMS
N050748 001
DALTEPARIN SODIUM
INJECTABLE; SUBCUTANEOUS FRAGMIN EISAI INC XX XX XX XX XX XX XX XX XX + XX
2,500IU/0.2ML (12,500IU/ML) 5,000IU/0.2ML (25,000IU/ML) 7,500IU/0.3ML (25,000IU/ML) 10,000IU/ML (10,000IU/ML) 10,000IU/0.4ML (25,000IU/ML) 12,500IU/0.5ML (25,000IU/ML) 15,000IU/0.6ML (25,000IU/ML) 18,000IU/0.72ML (25,000IU/ML) 95,000IU/3.8ML (25,000IU/ML) 95,000IU/9.5ML (10,000IU/ML)
N020287 N020287 N020287 N020287 N020287 N020287 N020287 N020287 N020287 N020287
001 003 005 004 002 009 010 011 006 007
Dec Mar Apr Jan May May May May Apr Apr
22, 18, 04, 30, 01, 01, 01, 01, 04, 04,
1994 1996 2002 1998 2007 2007 2007 2007 2002 2002
DANAZOL
CAPSULE; ORAL DANAZOL BARR AB AB AB + LANNETT AB AB AB
DANTROLENE SODIUM
CAPSULE; ORAL DANTRIUM JHP PHARMS AB AB AB + DANTROLENE SODIUM IMPAX LABS AB
N017443 001 N017443 003 N017443 002 A076856 001 Mar 01, 2005
50MG 100MG
20MG/VIAL 20MG/VIAL
DAPSONE
GEL; TOPICAL
ACZONE
XX + ALLERGAN
TABLET; ORAL
DAPSONE
JACOBUS XX XX +
5%
N021794 001
25MG
100MG
A086841 001
A086842 001
DAPTOMYCIN
INJECTABLE; IV (INFUSION)
CUBICIN
XX + CUBIST 500MG/VIAL
N021572 002
DARIFENACIN HYDROBROMIDE
TABLET, EXTENDED RELEASE; ORAL ENABLEX XX WARNER CHILCOTT LLC EQ 7.5MG BASE XX + EQ 15MG BASE
DARUNAVIR ETHANOLATE
SUSPENSION; ORAL
PREZISTA
XX + TIBOTEC TABLET; ORAL PREZISTA TIBOTEC XX XX XX XX +
EQ 100MG BASE/ML
N202895 001
EQ EQ EQ EQ
DASATINIB
TABLET; ORAL
SPRYCEL
BRISTOL MYERS SQUIBB XX XX XX XX XX XX +
20MG
50MG
70MG
80MG
100MG
140MG
DAUNORUBICIN CITRATE
N050704 002
AP AP AP AP XX
20MG BASE/VIAL 20MG BASE/VIAL 5MG BASE/ML 5MG BASE/ML 5MG BASE/VIAL
A064103 001 A065000 001 N050731 001 A065035 001 A065034 001
Feb 03, 1995 May 25, 1999 Jan 30, 1998 Jan 24, 2000 Nov 20, 2001
DECITABINE
INJECTABLE; INTRAVENOUS
DACOGEN
XX + EISAI INC
50MG/VIAL
N021790 001
DEFERASIROX
TABLET, FOR SUSPENSION; ORAL EXJADE NOVARTIS 125MG XX 250MG XX 500MG XX +
DEFERIPRONE
TABLET; ORAL
FERRIPROX
XX + APOPHARMA INC
500MG
N021825 001
DEFEROXAMINE MESYLATE
INJECTABLE; INJECTION DEFEROXAMINE MESYLATE APP PHARMS AP AP BEDFORD AP AP HOSPIRA AP AP WATSON LABS AP AP DESFERAL AP + NOVARTIS AP +
500MG/VIAL 2GM/VIAL 500MG/VIAL 2GM/VIAL 500MG/VIAL 2GM/VIAL 500MG/VIAL 2GM/VIAL 500MG/VIAL 2GM/VIAL
DEGARELIX ACETATE
POWDER; SUBCUTANEOUS FIRMAGON FERRING XX XX +
DELAVIRDINE MESYLATE
TABLET; ORAL RESCRIPTOR VIIV HLTHCARE XX XX +
100MG 200MG
DEMECLOCYCLINE HYDROCHLORIDE
TABLET; ORAL DECLOMYCIN COREPHARMA AB
150MG
N050261 002
N050261 003 A065425 A065425 A065171 A065171 A065094 A065094 A065389 A065389 001 002 001 002 001 002 001 002 Feb Feb Dec Dec Mar Mar Dec Dec 27, 27, 13, 13, 22, 22, 01, 01, 2008 2008 2004 2004 2004 2004 2008 2008
DESFLURANE
LIQUID; INHALATION
SUPRANE
XX + BAXTER HLTHCARE CORP
99.9%
N020118 001
DESIPRAMINE HYDROCHLORIDE
TABLET; ORAL DESIPRAMINE HYDROCHLORIDE ACTAVIS TOTOWA 10MG 25MG 50MG 75MG 100MG 150MG SANDOZ 10MG 25MG 50MG 75MG 100MG 150MG NORPRAMIN SANOFI AVENTIS US 10MG 25MG + 50MG 75MG + 100MG 150MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A074430 A071601 A071588 A071602 A071766 A074430 A072099 A072100 A072101 A072102 A072103 A072104 N014399 N014399 N014399 N014399 N014399 N014399
001 001 001 001 001 002 001 001 001 001 001 001 007 001 003 004 005 006
Feb Jun Jun Oct Oct Feb May May May Jun Jun Jun
09, 05, 05, 05, 05, 09, 24, 24, 24, 20, 20, 20,
1996 1987 1987 1987 1987 1996 1988 1988 1988 1988 1988 1988
DESIRUDIN RECOMBINANT
INJECTABLE; SUBCUTANEOUS
IPRIVASK
XX + CANYON
15MG/VIAL
N021271 001
DESLORATADINE
SYRUP; ORAL
CLARINEX
XX + SCHERING TABLET; ORAL CLARINEX + SCHERING PLOUGH DESLORATADINE DR REDDYS LABS LTD LUPIN PHARMS ORCHID HLTHCARE PERRIGO R AND D
0.5MG/ML
N021300 001
AB AB AB AB AB
N021165 001 A078365 A078352 A078357 A078361 001 001 001 001
Dec 21, 2001 Mar Oct Feb Dec 08, 25, 19, 22, 2011 2010 2010 2011
5MG 5MG
AB AB AB AB
TABLET, ORALLY DISINTEGRATING; ORAL CLARINEX SCHERING 2.5MG + 5MG DESLORATADINE REDDYS 2.5MG 5MG
Jul 14, 2005 Jun 26, 2002 Jul 12, 2010 Jul 12, 2010
DESMOPRESSIN ACETATE
INJECTABLE; INJECTION DDAVP AP + SANOFI AVENTIS US DESMOPRESSIN ACETATE HOSPIRA AP TEVA PARENTERAL AP SOLUTION; NASAL
DDAVP
XX + SANOFI AVENTIS US
0.01%
N017922 001
AB AB AB AB XX
SPRAY, METERED; NASAL DDAVP (NEEDS NO REFRIGERATION) + SANOFI AVENTIS US 0.01MG/SPRAY DESMOPRESSIN ACETATE + BAUSCH AND LOMB 0.01MG/SPRAY DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) APOTEX INC 0.01MG/SPRAY MINIRIN + FERRING 0.01MG/SPRAY STIMATE (NEEDS NO REFRIGERATION) + CSL BEHRING 1.5MG/SPRAY
N017922 003 A074830 001 A076703 001 N021333 001 N020355 002
Aug 07, 1996 Jan 25, 1999 Jan 27, 2005 Sep 16, 2002 Oct 24, 2007
TABLET; ORAL DDAVP SANOFI AVENTIS US AB AB + DESMOPRESSIN ACETATE APOTEX INC AB AB TEVA PHARMS AB AB WATSON LABS AB AB DESMOPRESSIN ACETATE FERRING XX XX +
0.1MG 0.2MG 0.1MG 0.2MG 0.1MG 0.2MG 0.1MG 0.2MG 0.1MG 0.2MG
N019955 001 N019955 002 A077414 A077414 A077122 A077122 A076470 A076470 001 002 001 002 001 002
Sep 06, 1995 Sep 06, 1995 Mar Mar Jan Jan Jul Jul 07, 07, 25, 25, 01, 01, 2006 2006 2006 2006 2005 2005
0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0. 025MG 0.15MG;0.03MG ESTRADIOL 0.15MG;0.03MG 0.15MG,N/A;0.02MG,0.01MG 0.15MG;0.03MG 0.15MG;0.03MG 0.15MG,N/A;0.02MG,0.01MG 0.15MG,N/A;0.02MG,0.01MG 0.15MG;0.03MG 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0. 025MG
N021090 001
AB AB AB AB AB AB AB AB AB
N020071 002 A075256 002 A076916 001 A076915 001 A076675 001 A075863 001 N020713 001 N020301 002 A076455 001
Dec 10, 1992 Aug 12, 1999 Dec 29, 2008 Jul 29, 2005 Feb 25, 2011 Apr 05, 2002 Apr 22, 1998 Dec 14, 1992 Feb 24, 2004
DESONIDE
AEROSOL, FOAM; TOPICAL
VERDESO
XX + STIEFEL LABS INC CREAM; TOPICAL DESONIDE AB + PERRIGO NEW YORK TARO AB DESOWEN GALDERMA LABS LP AB GEL; TOPICAL
DESONATE
XX + INTENDIS LOTION; TOPICAL DESONIDE ALTANA AB DESOWEN AB + GALDERMA LABS LP OINTMENT; TOPICAL DESONIDE ALTANA + PERRIGO NEW YORK TARO DESOWEN GALDERMA LABS LP
0.05%
N021978 001
0.05%
N021844 001
0.05% 0.05%
AB AB AB AB
DESOXIMETASONE
CREAM; TOPICAL DESOXIMETASONE NYCOMED US AB PERRIGO NEW YORK AB AB + TARO AB TOPICORT AB + TARO PHARMS NORTH TOPICORT LP TARO PHARMS NORTH AB
AB AB AB AB
Jan 09, 2006 Jul 14, 1998 Mar 10, 2011 Mar 29, 1982
OINTMENT; TOPICAL DESOXIMETASONE TARO AB TOPICORT AB + TARO PHARMS NORTH TOPICORT XX + TARO PHARMS NORTH
DESVENLAFAXINE SUCCINATE
TABLET, EXTENDED RELEASE; ORAL
PRISTIQ
EQ 50MG BASE XX + WYETH PHARMS INC EQ 100MG BASE XX +
DEXAMETHASONE
CONCENTRATE; ORAL
DEXAMETHASONE INTENSOL
1MG/ML XX + ROXANE ELIXIR; ORAL DEXAMETHASONE LYNE + STI PHARMA LLC VINTAGE PHARMS + WOCKHARDT
A088252 001
AA AA AA AA
IMPLANT; INTRAVITREAL
OZURDEX
XX + ALLERGAN SOLUTION; ORAL
DEXAMETHASONE
XX + ROXANE
0.7MG
N022315 001
0.5MG/5ML
A088248 001
SUSPENSION/DROPS; OPHTHALMIC
MAXIDEX
XX + ALCON 0.1% TABLET; ORAL DEXAMETHASONE ECR AB ROXANE AB DEXAMETHASONE BP PAR PHARM BP BP BP BP + BP ROXANE BP BP BP BP BP +
N013422 001
1.5MG 1.5MG 0.5MG 0.75MG 1.5MG 4MG 6MG 0.5MG 0.75MG 1MG 2MG 4MG 6MG
A040700 001 A084610 001 A088148 A088160 A088237 A088238 A088481 A084611 A084613 A088306 A087916 A084612 A088316 001 001 001 001 001 001 001 001 001 001 001
N050065 002 A064063 001 A062938 001 Jul 25, 1994 Jul 31, 1989
AT AT AT AT
DEXAMETHASONE; TOBRAMYCIN
OINTMENT; OPHTHALMIC
TOBRADEX
XX + ALCON
0.1%;0.3%
N050616 001
SUSPENSION/DROPS; OPHTHALMIC TOBRADEX AB + ALCON 0.1%;0.3% TOBRAMYCIN AND DEXAMETHASONE BAUSCH AND LOMB AB 0.1%;0.3% TOBRADEX ST 0.05%;0.3% XX + ALCON PHARMS LTD
DEXCHLORPHENIRAMINE MALEATE
SYRUP; ORAL
DEXCHLORPHENIRAMINE MALEATE
2MG/5ML XX + WOCKHARDT
A088251 001
DEXLANSOPRAZOLE
CAPSULE, DELAYED RELEASE; ORAL DEXILANT XX TAKEDA PHARMS 30MG XX + 60MG
DEXMEDETOMIDINE HYDROCHLORIDE
INJECTABLE; INJECTION
PRECEDEX
XX + HOSPIRA
N021038 001
A077107 003 A077107 001 A077107 002 N021278 001 N021278 002 N021278 003
Jan 29, 2007 Jan 29, 2007 Jan 29, 2007 Nov 13, 2001 Nov 13, 2001 Nov 13, 2001
DEXRAZOXANE HYDROCHLORIDE
INJECTABLE; INJECTION DEXRAZOXANE HYDROCHLORIDE BEDFORD EQ EQ MYLAN INSTITUTIONAL EQ EQ ZINECARD + PHARMACIA AND UPJOHN EQ + EQ TOTECT + TOPOTARGET EQ
AP AP AP AP AP AP XX
DEXTROAMPHETAMINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL DEXEDRINE COREPHARMA AB 5MG AB 10MG AB + 15MG DEXTROAMPHETAMINE SULFATE BARR 5MG AB 10MG AB 15MG AB MALLINCKRODT 5MG AB 10MG AB 15MG AB SOLUTION; ORAL
DEXTROAMPHETAMINE SULFATE
5MG/5ML XX + OUTLOOK PHARMS TABLET; ORAL DEXTROAMPHETAMINE SULFATE BARR 5MG AA 10MG AA + MALLINCKRODT 5MG AA 10MG AA MIKART 5MG AA 10MG AA NESHER PHARMS 5MG AA
N017078 001 N017078 002 N017078 003 A076137 A076137 A076137 A076353 A076353 A076353 001 002 003 001 002 003 Jan Jan Jan May May May 18, 18, 18, 06, 06, 06, 2002 2002 2002 2003 2003 2003
A040776 001
A040367 001 A090533 A090533 A090533 A090533 A090533 001 003 005 006 007
Oct 31, 2002 Oct Oct Oct Oct Oct 25, 25, 25, 25, 25, 2011 2011 2011 2011 2011
AA AA AA AA AA
A088762 001 A040649 001 A090575 001 A040027 001 A088864 001
Oct 31, 1984 Feb 14, 2006 Feb 08, 2011 Jul 31, 1996 Jan 04, 1985
20MG;10MG
N021879 001
DEXTROSE
INJECTABLE; INJECTION DEXTROSE 10% IN PLASTIC CONTAINER + B BRAUN 10GM/100ML + BAXTER HLTHCARE 10GM/100ML + HOSPIRA 10GM/100ML DEXTROSE 20% IN PLASTIC CONTAINER + BAXTER HLTHCARE 20GM/100ML + HOSPIRA 20GM/100ML DEXTROSE 30% IN PLASTIC CONTAINER + BAXTER HLTHCARE 30GM/100ML + HOSPIRA 30GM/100ML DEXTROSE 40% IN PLASTIC CONTAINER + BAXTER HLTHCARE 40GM/100ML + HOSPIRA 40GM/100ML DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 50MG/ML + 5GM/100ML + 5GM/100ML + BAXTER HLTHCARE 50MG/ML + 50MG/ML + 5GM/100ML + 5GM/100ML + HOSPIRA 50MG/ML + 50MG/ML + 5GM/100ML + 5GM/100ML DEXTROSE 50% IN PLASTIC CONTAINER + BAXTER HLTHCARE 50GM/100ML + 50GM/100ML HOSPIRA 500MG/ML + 50GM/100ML
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N019626 004 N016694 001 N018080 001 N017521 004 N018564 001 N017521 003 N019345 001 N017521 002 N018562 001 N016730 N016730 N019626 N016673 N020179 N016673 N020179 N016367 N019222 N019466 N019479 N017521 N020047 N019445 N018563 002 001 002 003 002 001 001 002 001 001 001 001 001 001 001
Feb 02, 1988 Oct 30, 1985 Dec 07, 1992 Dec 07, 1992 Jul 13, 1984 Jul 15, 1985 Sep 17, 1985
AP AP AP AP AP AP XX
N019894 001 N017521 005 N017521 N020047 N018561 N019893 006 003 001 001
Dec 26, 1989 Mar 26, 1982 Mar Jul Mar Dec 26, 02, 23, 26, 1982 1991 1982 1989
N019445 002
INJECTABLE; INJECTION
PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;32MG/100ML;128MG/100ML;234MG/ XX
100ML
N017385 001
INJECTABLE; INJECTION
NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 5GM/100ML;21MG/100ML;128MG/100ML;234MG/ XX
100ML
N017610 001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
INJECTABLE; INJECTION ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;31MG/100ML;130MG/100ML;26MG/1 XX 00ML;320MG/100ML
N019873 001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
INJECTABLE; INJECTION
IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER
HOSPIRA 5GM/100ML;53MG/100ML;100MG/100ML;100MG/ XX 100ML;180MG/100ML;280MG/100ML;16MG/100M L
N019515 001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION
DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER
BAXTER HLTHCARE 5GM/100ML;31MG/100ML;141MG/100ML;20MG/1 XX
00ML;12MG/100ML;260MG/100ML
N017484 001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
INJECTABLE; INJECTION IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;30MG/100ML;141MG/100ML;15MG/1 XX 00ML;260MG/100ML;25MG/100ML
N019513 001
N019844 001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE; INJECTION ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;30MG/100ML;37MG/100ML;370MG/1 XX 00ML;530MG/100ML;500MG/100ML NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;30MG/100ML;37MG/100ML;222MG/1 XX 00ML;526MG/100ML;502MG/100ML PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;30MG/100ML;37MG/100ML;368MG/1 XX 00ML;526MG/100ML;502MG/100ML
N019843 001
N017609 001
N017451 001
AP AP AP AP AP AP AP AP AP AP XX XX XX
N017634 004 N017634 001 N017634 003 N017634 002 N018744 001 N018744 002 N019699 004 N018744 004 N019699 006 N018371 003 N018744 003 N018371 001 N018371 002 Nov 09, 1982 Nov 09, 1982 Nov 09, 1982 Sep 29, 1989 Nov 09, 1982 Sep 29, 1989
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;150MG/100ML;130MG/100ML;280MG XX /100ML;91MG/100ML
N019870 001
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;205MG/100ML;100MG/100ML;120MG XX /100ML;220MG/100ML
N018840 001
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ Apr 13, 1982 5GM/100ML;150MG/100ML;200MG/100ML N018037 008 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K) 5GM/100ML;300MG/100ML;200MG/100ML N018037 001 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ Apr 13, 1982 5GM/100ML;224MG/100ML;200MG/100ML N018037 005 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ Apr 13, 1982 5GM/100ML;300MG/100ML;200MG/100ML N018037 009 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ 5GM/100ML;75MG/100ML;200MG/100ML N018037 002 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K) 5GM/100ML;150MG/100ML;200MG/100ML N018037 003 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER Mar 23, 1982 5GM/100ML;75MG/100ML;330MG/100ML N018629 005 Mar 23, 1982 5GM/100ML;150MG/100ML;330MG/100ML N018629 002 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 5GM/100ML;224MG/100ML;330MG/100ML N018629 003 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 5GM/100ML;150MG/100ML;330MG/100ML N018629 004 Mar 23, 1982 5GM/100ML;300MG/100ML;330MG/100ML N018629 006 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 5GM/100ML;224MG/100ML;330MG/100ML N018629 007 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 5GM/100ML;300MG/100ML;330MG/100ML N018629 008 DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER BAXTER HLTHCARE Mar 23, 1982 5GM/100ML;75MG/100ML;330MG/100ML N018629 001 DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;300MG/100ML;450MG/100ML N018008 010 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;75MG/100ML;200MG/100ML N019630 008 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;75MG/100ML;330MG/100ML N019630 014 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;75MG/100ML;450MG/100ML N019630 020 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;75MG/100ML;900MG/100ML N019630 026 POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;150MG/100ML;200MG/100ML N019630 010 POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;150MG/100ML;330MG/100ML N019630 016 POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;150MG/100ML;450MG/100ML N019630 022 POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;150MG/100ML;900MG/100ML N019630 028 POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;300MG/100ML;200MG/100ML N019630 012 POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;300MG/100ML;330MG/100ML N019630 018 POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;300MG/100ML;450MG/100ML N019630 024 POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN Feb 17, 1988 5GM/100ML;300MG/100ML;900MG/100ML N019630 030 POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 28, 1982 5GM/100ML;75MG/100ML;450MG/100ML N018008 005 Apr 28, 1982 5GM/100ML;150MG/100ML;450MG/100ML N018008 006 HOSPIRA Mar 28, 1988 5GM/100ML;74.5MG/100ML;450MG/100ML N018362 005 Jul 05, 1983 5GM/100ML;74.5MG/100ML;450MG/100ML N018362 009 POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 1985 5GM/100ML;75MG/100ML;900MG/100ML N019308 004
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX XX XX XX XX XX XX XX XX XX
INJECTABLE; INJECTION POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 1985 5GM/100ML;150MG/100ML;900MG/100ML N019308 002 HOSPIRA Mar 24, 1988 5GM/100ML;74.5MG/100ML;900MG/100ML N019691 002 Mar 24, 1988 5GM/100ML;149MG/100ML;900MG/100ML N019691 004 POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER HOSPIRA Mar 28, 1988 5GM/100ML;224MG/100ML;450MG/100ML N018362 006 POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA Mar 24, 1988 5GM/100ML;224MG/100ML;900MG/100ML N019691 006 POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 28, 1982 5GM/100ML;150MG/100ML;450MG/100ML N018008 007 HOSPIRA Jul 05, 1983 5GM/100ML;149MG/100ML;450MG/100ML N018362 010 Mar 28, 1988 5GM/100ML;298MG/100ML;450MG/100ML N018362 007 POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 1985 5GM/100ML;150MG/100ML;900MG/100ML N019308 005 Apr 05, 1985 5GM/100ML;300MG/100ML;900MG/100ML N019308 003 HOSPIRA Mar 24, 1988 5GM/100ML;149MG/100ML;900MG/100ML N019691 005 Mar 24, 1988 5GM/100ML;298MG/100ML;900MG/100ML N019691 008 POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 28, 1982 5GM/100ML;224MG/100ML;450MG/100ML N018008 008 HOSPIRA 5GM/100ML;224MG/100ML;450MG/100ML N018362 002 POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 1985 5GM/100ML;224MG/100ML;900MG/100ML N019308 006 HOSPIRA Mar 24, 1988 5GM/100ML;224MG/100ML;900MG/100ML N019691 007 POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 28, 1982 5GM/100ML;300MG/100ML;450MG/100ML N018008 009 HOSPIRA 5GM/100ML;298MG/100ML;450MG/100ML N018362 003 POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 1985 5GM/100ML;300MG/100ML;900MG/100ML N019308 007 HOSPIRA Mar 24, 1988 5GM/100ML;298MG/100ML;900MG/100ML N019691 009 POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE 5GM/100ML;150MG/100ML;450MG/100ML N018008 004 HOSPIRA Mar 28, 1988 5GM/100ML;74.5MG/100ML;450MG/100ML N018362 008 Mar 28, 1988 5GM/100ML;149MG/100ML;450MG/100ML N018362 004 POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE Apr 05, 1985 5GM/100ML;150MG/100ML;900MG/100ML N019308 001 HOSPIRA Mar 24, 1988 5GM/100ML;74.5MG/100ML;900MG/100ML N019691 001 Mar 24, 1988 5GM/100ML;149MG/100ML;900MG/100ML N019691 003 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;37MG/100ML;200MG/100ML N019630 031 Feb 17, 1988 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;37MG/100ML;450MG/100ML N019630 037 Feb 17, 1988 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;37MG/100ML;900MG/100ML N019630 043 Feb 17, 1988 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;110MG/100ML N019630 001 Feb 17, 1988 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;200MG/100ML N019630 007 Feb 17, 1988 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;330MG/100ML N019630 013 Feb 17, 1988 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;450MG/100ML N019630 019 Feb 17, 1988 POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;37MG/100ML;900MG/100ML N019630 025 Feb 17, 1988 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;75MG/100ML;200MG/100ML N019630 032 Feb 17, 1988 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;75MG/100ML;450MG/100ML N019630 038 Feb 17, 1988 POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 10GM/100ML;75MG/100ML;900MG/100ML N019630 044 Feb 17, 1988
XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX
INJECTION CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 3.3GM/100ML;75MG/100ML;300MG/100ML N019630 049 May 07, 1992 CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER 5GM/100ML;75MG/100ML;110MG/100ML N019630 002 Feb 17, 1988 CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER 10GM/100ML;110MG/100ML;200MG/100ML N019630 033 Feb 17, 1988 CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 10GM/100ML;110MG/100ML;450MG/100ML N019630 039 Feb 17, 1988 CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 10GM/100ML;110MG/100ML;900MG/100ML N019630 045 Feb 17, 1988 CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 3.3GM/100ML;110MG/100ML;300MG/100ML N019630 050 May 07, 1992 CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER 5GM/100ML;110MG/100ML;110MG/100ML N019630 003 Feb 17, 1988 CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER 5GM/100ML;110MG/100ML;200MG/100ML N019630 009 Feb 17, 1988 CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER 5GM/100ML;110MG/100ML;330MG/100ML N019630 015 Feb 17, 1988 CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 5GM/100ML;110MG/100ML;450MG/100ML N019630 021 Feb 17, 1988 CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 5GM/100ML;110MG/100ML;900MG/100ML N019630 027 Feb 17, 1988 CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER 10GM/100ML;150MG/100ML;200MG/100ML N019630 034 Feb 17, 1988 CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 10GM/100ML;150MG/100ML;450MG/100ML N019630 040 Feb 17, 1988 CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 10GM/100ML;150MG/100ML;900MG/100ML N019630 046 Feb 17, 1988 CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 3.3GM/100ML;150MG/100ML;300MG/100ML N019630 051 May 07, 1992 CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER 5GM/100ML;150MG/100ML;110MG/100ML N019630 004 Feb 17, 1988 CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER 10GM/100ML;220MG/100ML;200MG/100ML N019630 035 Feb 17, 1988 CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 10GM/100ML;220MG/100ML;450MG/100ML N019630 041 Feb 17, 1988 CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 10GM/100ML;220MG/100ML;900MG/100ML N019630 047 Feb 17, 1988 CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 3.3GM/100ML;220MG/100ML;300MG/100ML N019630 052 May 07, 1992 CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;110MG/100ML N019630 005 Feb 17, 1988 CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;200MG/100ML N019630 011 Feb 17, 1988 CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;330MG/100ML N019630 017 Feb 17, 1988 CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;450MG/100ML N019630 023 Feb 17, 1988 CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;900MG/100ML N019630 029 Feb 17, 1988 CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER 10GM/100ML;300MG/100ML;200MG/100ML N019630 036 Feb 17, 1988 CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER 10GM/100ML;300MG/100ML;450MG/100ML N019630 042 Feb 17, 1988 CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 10GM/100ML;300MG/100ML;900MG/100ML N019630 048 Feb 17, 1988 CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 3.3GM/100ML;300MG/100ML;300MG/100ML N019630 053 May 07, 1992 CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;110MG/100ML N019630 006 Feb 17, 1988
INJECTABLE; INJECTION POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;74.5MG/100ML;225MG/100ML N018365 002 Jul 05, XX 5GM/100ML;149MG/100ML;225MG/100ML N018365 006 Mar 28, XX POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;74.5MG/100ML;300MG/100ML N018876 001 Jan 17, XX 5GM/100ML;149MG/100ML;300MG/100ML N018876 006 Mar 28, XX POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;224MG/100ML;225MG/100ML N018365 008 Mar 28, XX POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;224MG/100ML;300MG/100ML N018876 007 Mar 28, XX POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;149MG/100ML;225MG/100ML N018365 001 XX 5GM/100ML;298MG/100ML;225MG/100ML N018365 009 Mar 28, XX POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;298MG/100ML;300MG/100ML N018876 008 Mar 28, XX POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;149MG/100ML;300MG/100ML N018876 002 Jan 17, XX POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;224MG/100ML;225MG/100ML N018365 003 Jul 05, XX POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;224MG/100ML;300MG/100ML N018876 003 Jan 17, XX POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;298MG/100ML;225MG/100ML N018365 004 Jul 05, XX POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;298MG/100ML;300MG/100ML N018876 004 Mar 28, XX POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;74.5MG/100ML;225MG/100ML N018365 005 Mar 28, XX 5GM/100ML;149MG/100ML;225MG/100ML N018365 007 Mar 28, XX POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;74.5MG/100ML;300MG/100ML N018876 005 Mar 28, XX 5GM/100ML;149MG/100ML;300MG/100ML N018876 009 Mar 28, XX
1988 1988 1986 1983 1986 1983 1988 1988 1988 1988 1988
AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N019631 015 N016696 001 N019631 004 N016697 001 N019631 007 N019631 008 N019631 009 N017607 001 N019631 010 N017585 001 N016689 001 N016687 001 N016683 001 N016678 001
XX XX XX XX XX XX XX XX XX XX XX XX
N019631 011 N019631 012 N019631 013 N019631 014 N019631 001 N019631 002 N019631 003 N019631 005 N019631 016 N019631 006 N017606 001 N017799 001
Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Feb 24, 1988 Jan 19, 1990 Feb 24, 1988
DIATRIZOATE MEGLUMINE
SOLUTION; URETHRAL CYSTOGRAFIN XX BRACCO CYSTOGRAFIN DILUTE XX BRACCO
30% 18%
66%;10% 66%;10%
66%;10% 66%;10%
52.7%;26.8%
N011324 002
DIAZEPAM
CONCENTRATE; ORAL DIAZEPAM INTENSOL XX + ROXANE GEL; RECTAL DIASTAT VALEANT XX DIASTAT ACUDIAL VALEANT XX
5MG/ML
A071415 001
20MG/4ML (5MG/ML)
N020648 006
5MG/5ML
A070928 001
2MG 10MG 2MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG
A070152 A070154 A070226 A071307 A071321 A071322 A070325 A070325 A070325 A077749 A077749 A077749 A071134 A071135 A071136
001 001 001 001 001 001 002 003 001 001 002 003 001 001 001
Nov Nov Sep Dec Dec Dec Sep Sep Sep Mar Mar Mar Feb Feb Feb
01, 01, 26, 10, 10, 10, 04, 04, 04, 31, 31, 31, 03, 03, 03,
1985 1985 1985 1986 1986 1986 1985 1985 1985 2006 2006 2006 1987 1987 1987
DIAZOXIDE
SUSPENSION; ORAL
PROGLYCEM
XX + TEVA GLOBAL
50MG/ML
N017453 001
DICLOFENAC EPOLAMINE
PATCH; TOPICAL
FLECTOR
XX + INST BIOCHEM
1.3%
N021234 001
DICLOFENAC POTASSIUM
CAPSULE; ORAL
ZIPSOR
XX + XANODYNE PHARM
FOR SOLUTION; ORAL
CAMBIA
XX + NAUTILUS NEUROSCIENC TABLET; ORAL CATAFLAM + NOVARTIS DICLOFENAC POTASSIUM APOTEX MYLAN SANDOZ
25MG
N022202 001
50MG
N022165 001
AB AB AB AB
Nov 24, 1993 Mar 18, 2004 Jul 26, 1999 Nov 20, 1998
50MG
A075219 001
DICLOFENAC SODIUM
GEL; TOPICAL
SOLARAZE
XX + FOUGERA PHARMS VOLTAREN XX + NOVARTIS SOLUTION; TOPICAL
PENNSAID
XX + MALLINCKRODT
3% 1%
1.5%
N020947 001
AT AT AT AT AT AT
SOLUTION/DROPS; OPHTHALMIC DICLOFENAC SODIUM AKORN 0.1% ALCON PHARMS LTD 0.1% APOTEX INC 0.1% BAUSCH AND LOMB 0.1% NEXUS PHARMS 0.1% VOLTAREN + NOVARTIS 0.1%
N020037 001
TABLET, DELAYED RELEASE; ORAL DICLOFENAC SODIUM ACTAVIS ELIZABETH AB 50MG AB 75MG ALPHAPHARM AB 50MG AB 75MG CARLSBAD AB 25MG AB 50MG AB 75MG AB + SANDOZ 25MG AB + 50MG AB + 75MG UNIQUE PHARM LABS AB 25MG AB 50MG AB 75MG TABLET, EXTENDED RELEASE; DICLOFENAC SODIUM ACTAVIS ELIZABETH DEXCEL LTD MYLAN VALEANT INTL VOLTAREN-XR + NOVARTIS ORAL 100MG 100MG 100MG 100MG 100MG
A074514 A074514 A075281 A075281 A075185 A075185 A075185 A074376 A074376 A074394 A090066 A090066 A077863
001 002 002 003 002 003 001 001 002 001 001 002 003
Mar Mar Feb Feb Nov Nov Nov Sep Sep Nov Dec Dec Jun
26, 26, 12, 12, 13, 13, 13, 28, 28, 30, 01, 01, 08,
1996 1996 2002 2002 1998 1998 1998 1995 1995 1995 2010 2010 2007
AB AB AB AB AB
N020254 001
DICLOXACILLIN SODIUM
CAPSULE; ORAL DICLOXACILLIN SODIUM SANDOZ AB AB + TEVA AB
DICYCLOMINE HYDROCHLORIDE
CAPSULE; ORAL BENTYL + APTALIS PHARMA US 10MG DICYCLOMINE HYDROCHLORIDE LANNETT 10MG MYLAN 10MG WATSON LABS 10MG WEST WARD 10MG
AB AB AB AB AB
N007409 003 A084285 A040319 A085082 A040204 001 001 001 001
INJECTABLE; INJECTION BENTYL AP + APTALIS PHARMA US 10MG/ML BENTYL PRESERVATIVE FREE AP + APTALIS PHARMA US 10MG/ML DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE) BEDFORD AP 10MG/ML SYRUP; ORAL BENTYL AA + APTALIS PHARMA US 10MG/5ML DICYCLOMINE HYDROCHLORIDE MIKART AA 10MG/5ML TABLET; ORAL BENTYL + APTALIS PHARMA US 20MG DICYCLOMINE HYDROCHLORIDE LANNETT 20MG MYLAN 20MG WATSON LABS 20MG WEST WARD 20MG
AB AB AB AB AB
N007409 001 A040230 A040317 A085223 A040161 001 001 001 001
Oct 15, 1984 Feb Sep Jul Oct 26, 07, 30, 01, 1999 1999 1986 1996
DIDANOSINE
CAPSULE, DELAYED REL PELLETS; ORAL DIDANOSINE AUROBINDO PHARMA 125MG AB 200MG AB 250MG AB 400MG AB BARR 200MG AB 250MG AB 400MG AB MATRIX LABS LTD 125MG AB 200MG AB 250MG AB 400MG AB VIDEX EC BRISTOL MYERS SQUIBB 125MG AB 200MG AB 250MG AB 400MG AB + FOR SOLUTION; ORAL DIDANOSINE AUROBINDO PHARMA AA
A090094 A090094 A090094 A090094 A077167 A077167 A077167 A090788 A090788 A090788 A090788 N021183 N021183 N021183 N021183
001 002 003 004 001 002 003 001 002 003 004 001 002 003 004
Sep Sep Sep Sep Dec Dec Dec Apr Apr Apr Apr Oct Oct Oct Oct
24, 24, 24, 24, 03, 03, 03, 08, 08, 08, 08, 31, 31, 31, 31,
2008 2008 2008 2008 2004 2004 2004 2010 2010 2010 2010 2000 2000 2000 2000
10MG/ML
A078112 001
10MG/ML
N020156 001
N/A,2MG,3MG,N/A,N/A;3MG,2MG,2MG,1MG,N/A
N022252 001
DIETHYLPROPION HYDROCHLORIDE
TABLET; ORAL DIETHYLPROPION HYDROCHLORIDE AVANTHI INC 25MG COREPHARMA 25MG LANNETT HOLDINGS INC 25MG TENUATE + WATSON PHARMS 25MG
AA AA AA AA
TABLET, EXTENDED RELEASE; ORAL DIETHYLPROPION HYDROCHLORIDE LANNETT HOLDINGS INC 75MG AB TENUATE DOSPAN AB + WATSON PHARMS 75MG
DIFLORASONE DIACETATE
CREAM; TOPICAL DIFLORASONE DIACETATE AB1 + ALTANA TARO AB1 DIFLORASONE DIACETATE BX + ALTANA OINTMENT; TOPICAL DIFLORASONE DIACETATE ALTANA AB AB + TARO
0.05% 0.05%
DIFLUNISAL
TABLET; ORAL
DIFLUNISAL
XX + TEVA
500MG
A073673 001
DIFLUPREDNATE
EMULSION; OPHTHALMIC
DUREZOL
XX + ALCON PHARMS LTD
0.05%
N022212 001
DIGOXIN
ELIXIR; ORAL
DIGOXIN
XX + ROXANE INJECTABLE; INJECTION DIGOXIN BAXTER HLTHCARE HOSPIRA SANDOZ LANOXIN + COVIS PHARMA LANOXIN PEDIATRIC + COVIS PHARMA
0.05MG/ML
N021648 001
AP AP AP AP XX
A083391 001 A040093 001 A040481 001 N009330 002 N009330 004
0.125MG 0.25MG 0.125MG 0.25MG 0.125MG 0.25MG 0.125MG 0.25MG 0.125MG 0.25MG
DIHYDROERGOTAMINE MESYLATE
INJECTABLE; INJECTION D.H.E. 45 AP + VALEANT 1MG/ML DIHYDROERGOTAMINE MESYLATE BEDFORD LABS AP 1MG/ML PADDOCK LLC AP 1MG/ML
SPRAY, METERED; NASAL
MIGRANAL
XX + VALEANT
N005929 001 A040453 001 A040475 001 Jun 09, 2003 Apr 28, 2003
0.5MG/INH
N020148 001
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL DILACOR XR WATSON LABS AB2 120MG AB2 180MG AB2 + 240MG DILTIAZEM HYDROCHLORIDE APOTEX AB2 120MG AB2 180MG AB2 240MG MYLAN AB2 120MG AB2 180MG AB2 240MG WATSON LABS FLORIDA AB2 120MG AB2 180MG AB2 240MG CARDIZEM CD VALEANT INTL AB3 120MG AB3 180MG AB3 240MG AB3 300MG AB3 + 360MG CARTIA XT WATSON LABS FLORIDA AB3 120MG AB3 180MG AB3 240MG AB3 300MG DILT-CD APOTEX AB3 120MG AB3 180MG AB3 240MG AB3 300MG DILTIAZEM HYDROCHLORIDE ACTAVIS ELIZABETH AB3 120MG
N020092 001 N020092 002 N020092 003 A074943 A074943 A074943 A075124 A075124 A075124 A074852 A074852 A074852 N020062 N020062 N020062 N020062 N020062 A074752 A074752 A074752 A074752 A076151 A076151 A076151 A076151 003 002 001 002 003 001 001 002 003 001 002 003 004 005 002 001 003 004 001 002 003 004
May 29, 1992 May 29, 1992 May 29, 1992 Dec Dec Aug Mar Mar Mar Oct Oct Oct Aug Dec Dec Dec Aug Jul Jul Jul Jul May May May May 19, 19, 06, 18, 18, 18, 10, 10, 10, 10, 27, 27, 27, 24, 09, 09, 09, 09, 20, 20, 20, 20, 2000 2000 1998 1998 1998 1998 1997 1997 1997 1992 1991 1991 1991 1999 1998 1998 1998 1998 2004 2004 2004 2004
A074984 001
A074984 A074984 A074984 A090492 A090492 A090492 A090492 A090492 A075116 A075116 A075116 A075116 A076563 A076563 A076563 A076563 A076563 A076563 A090421 A090421 A090421 A090421 A090421 A076395 A076395 A076395 A076395 A076395 A075401 A075401 A075401 A075401 A075401 N020401 N020401 N020401 N020401 N020401 N020401
002 003 004 001 002 003 004 005 001 002 003 004 002 003 004 005 006 001 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 006
Dec Dec Dec Oct Oct Oct Oct Oct Dec Dec Dec Dec Sep Sep Sep Sep Sep Sep Nov Nov Nov Nov Nov Feb Feb Feb Feb Feb Apr Apr Apr Apr Apr Sep Sep Sep Sep Sep Oct
20, 20, 20, 28, 28, 28, 28, 28, 23, 23, 23, 23, 12, 12, 12, 12, 12, 12, 15, 15, 15, 15, 15, 01, 01, 01, 01, 01, 10, 10, 10, 10, 10, 11, 11, 11, 11, 11, 16,
1999 1999 1999 2011 2011 2011 2011 2011 1999 1999 1999 1999 2006 2006 2006 2006 2006 2006 2010 2010 2010 2010 2010 2006 2006 2006 2006 2006 2003 2003 2003 2003 2003 1995 1995 1995 1995 1995 1998
AP AP AP AP AP AP AP
30MG 60MG 90MG 120MG 30MG 60MG 90MG 120MG 30MG 60MG 90MG 120MG 30MG 60MG 90MG 120MG
N018602 N018602 N018602 N018602 A074093 A074093 A074093 A074093 A072838 A072838 A072838 A072838 A074185 A074185 A074185 A074185
001 002 003 004 001 002 003 004 004 003 002 001 001 002 003 004
Nov Nov Dec Dec Nov Nov Nov Nov Nov Nov Nov Nov May May May May
05, 05, 08, 08, 05, 05, 05, 05, 05, 05, 05, 05, 31, 31, 31, 31,
1982 1982 1986 1986 1992 1992 1992 1992 1992 1992 1992 1992 1995 1995 1995 1995
TABLET, EXTENDED RELEASE; ORAL CARDIZEM LA VALEANT INTL AB 120MG AB 180MG AB 240MG AB 300MG AB 360MG AB + 420MG DILTIAZEM HYDROCHLORIDE WATSON LABS FLORIDA AB 120MG AB 180MG AB 240MG AB 300MG AB 360MG AB 420MG
N021392 N021392 N021392 N021392 N021392 N021392 A077686 A077686 A077686 A077686 A077686 A077686
001 002 003 004 005 006 006 005 004 003 002 001
Feb Feb Feb Feb Feb Feb Mar Mar Mar Mar Mar Mar
06, 06, 06, 06, 06, 06, 15, 15, 15, 15, 15, 15,
2003 2003 2003 2003 2003 2003 2010 2010 2010 2010 2010 2010
DIMENHYDRINATE
INJECTABLE; INJECTION DIMENHYDRINATE APP PHARMS AP AP + WATSON LABS
50MG/ML 50MG/ML
DIMERCAPROL
INJECTABLE; INJECTION
BAL
XX + AKORN
10%
N005939 001
DIMETHYL SULFOXIDE
SOLUTION; INTRAVESICAL DIMETHYL SULFOXIDE BIONICHE PHARMA AT RIMSO-50 AT + BIONICHE PHARMA
50% 50%
0.5MG/3GM
N019617 001
N020411 001
20MG
N017810 001
DIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE; ORAL
DIPHENHYDRAMINE HYDROCHLORIDE
50MG XX + BARR ELIXIR; ORAL
DIPHENHYDRAMINE HYDROCHLORIDE
12.5MG/5ML XX + PHARM ASSOC INJECTABLE; INJECTION BENADRYL + MCNEIL CONS 50MG/ML BENADRYL PRESERVATIVE FREE + MCNEIL CONS 50MG/ML DIPHENHYDRAMINE HYDROCHLORIDE APP PHARMS 50MG/ML BAXTER HLTHCARE 50MG/ML BIONICHE PHARMA 50MG/ML HOSPIRA 50MG/ML WATSON LABS 50MG/ML DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE INTL MEDICATION 50MG/ML WATSON LABS 50MG/ML DIPHENHYDRAMINE HYDROCHLORIDE + WATSON LABS 10MG/ML
A080738 001
A087513 001
AP AP AP AP AP AP AP AP AP XX
N006146 002 N009486 001 A040466 A080817 A040498 A040140 A080873 001 002 001 001 002 May 28, 2002 Jul 12, 2005 Nov 20, 1998
DIPIVEFRIN HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AKPRO AKORN AT 0.1% DIPIVEFRIN HYDROCHLORIDE FALCON PHARMS AT 0.1% PROPINE AT + ALLERGAN 0.1%
DIPYRIDAMOLE
INJECTABLE; INJECTION DIPYRIDAMOLE APP PHARMS BAXTER HLTHCARE + BEDFORD CLARIS LIFESCIENCES TEVA PARENTERAL
AP AP AP AP AP
75MG 25MG 50MG 75MG 25MG 50MG 75MG 25MG 50MG 75MG 25MG 50MG 75MG 25MG 50MG 25MG 50MG 75MG 25MG 50MG 75MG
A089001 A040782 A040782 A040782 A040898 A040898 A040898 A040733 A040733 A040733 A040542 A040542 A040542 A089425 A087160 A040874 A040874 A040874
001 001 002 003 001 002 003 001 002 003 001 002 003 001 001 001 002 003
Feb Jul Jul Jul Apr Apr Apr Feb Feb Feb Apr Apr Apr Jul Jun Jan Jan Jan
05, 18, 18, 18, 23, 23, 23, 13, 13, 13, 21, 21, 21, 12, 07, 28, 28, 28,
1991 2007 2007 2007 2008 2008 2008 2007 2007 2007 2006 2006 2006 1990 1996 2008 2008 2008
DISOPYRAMIDE PHOSPHATE
CAPSULE; ORAL DISOPYRAMIDE PHOSPHATE TEVA AB AB WATSON LABS AB AB NORPACE GD SEARLE LLC AB AB +
EQ EQ EQ EQ
CAPSULE, EXTENDED RELEASE; ORAL DISOPYRAMIDE PHOSPHATE NESHER PHARMS AB EQ 150MG BASE NORPACE CR AB + GD SEARLE LLC EQ 150MG BASE NORPACE CR GD SEARLE LLC EQ 100MG BASE XX
DISULFIRAM
TABLET; ORAL ANTABUSE ODYSSEY PHARMS AB AB + DISULFIRAM SIGMAPHARM LABS LLC AB AB
Dec 08, 1983 Dec 08, 1983 Mar 28, 2011 Mar 28, 2011
DIVALPROEX SODIUM
CAPSULE, DELAYED REL PELLETS; ORAL DEPAKOTE AB + ABBOTT EQ 125MG VALPROIC ACID DIVALPROEX SODIUM DR REDDYS LABS LTD AB EQ 125MG VALPROIC ACID MYLAN AB EQ 125MG VALPROIC ACID
A078919 001
N018723 003 N018723 001 N018723 002 A078411 A090554 A090554 A090554 A078755 A078755 A078755 A078790 A078790 A078790 A077254 A090062 A077254 A090062 A077254 A090062 A077615 A077615 A077615 A078853 A078853 A078853 A078290 A078290 A078290 A078597 A078597 A078597 A076941 A076941 A076941 A079163 A079163 A079163 A078182 A078182 A078182 A090210 A090210 A090210 A079080 A077296 A077296 A077296 A077100 A077100 A077100 001 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 003 002 001 001 002 003 003 002 001 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 003 001 002 003
Oct 26, 1984 Mar 10, 1983 Mar 10, 1983 Nov Apr Apr Apr Jul Jul Jul Jul Jul Jul Jul Mar Jul Mar Jul Mar Jul Jul Jul Nov Nov Nov Jul Jul Jul Jul Jul Jul Jul Jul Jul Apr Apr Apr Jul Jul Jul Nov Nov Nov Feb Jul Jul Jul Mar Mar Mar 03, 21, 21, 21, 29, 29, 29, 29, 29, 29, 29, 17, 29, 17, 29, 17, 29, 29, 29, 25, 25, 25, 29, 29, 29, 29, 29, 29, 29, 29, 29, 05, 05, 05, 29, 29, 29, 30, 30, 30, 25, 31, 31, 31, 05, 05, 05, 2008 2011 2011 2011 2008 2008 2008 2008 2008 2008 2008 2009 2008 2009 2008 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2011 2011 2011 2008 2008 2008 2009 2009 2009 2011 2008 2008 2008 2009 2009 2009
N021168 002
VALPROIC ACID VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC VALPROIC ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID ACID
N021168 001 A078445 A078445 A078791 A078791 A077567 A077567 A078700 A078705 A078705 A078239 A078239 001 002 001 002 001 002 001 002 001 001 002
Aug 04, 2000 Feb Aug May Aug Jan Jan Aug Feb Aug Feb Aug 26, 04, 06, 04, 29, 29, 03, 10, 04, 27, 04, 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
DOBUTAMINE HYDROCHLORIDE
INJECTABLE; INJECTION DOBUTAMINE HYDROCHLORIDE BEDFORD EQ 12.5MG BASE/ML HOSPIRA EQ 12.5MG BASE/ML + EQ 12.5MG BASE/ML WATSON LABS EQ 12.5MG BASE/ML DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% + HOSPIRA EQ 50MG BASE/100ML + EQ 100MG BASE/100ML + EQ 200MG BASE/100ML DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER + BAXTER HLTHCARE EQ 50MG BASE/100ML + EQ 100MG BASE/100ML + EQ 200MG BASE/100ML + EQ 400MG BASE/100ML + HOSPIRA EQ 50MG BASE/100ML + EQ 100MG BASE/100ML + EQ 200MG BASE/100ML + EQ 400MG BASE/100ML
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N020269 001 N020269 002 N020269 003 N020255 N020255 N020255 N020255 N020201 N020201 N020201 N020201 001 003 004 005 003 002 001 006
Oct 19, 1993 Oct 19, 1993 Oct 19, 1993 Oct Oct Oct Oct Oct Oct Oct Jul 19, 19, 19, 19, 19, 19, 19, 07, 1993 1993 1993 1993 1993 1993 1993 1994
DOCETAXEL
INJECTABLE; INJECTION DOCETAXEL + HOSPIRA INC + + SANDOZ SANDOZ INC DOCEFREZ + SUN PHARMA GLOBAL + DOCETAXEL ACCORD HLTHCARE TAXOTERE + SANOFI AVENTIS US +
AP AP AP AP AP AP XX XX XX XX XX XX
20MG/2ML (10MG/ML) 80MG/8ML (10MG/ML) 160MG/16ML (10MG/ML) 20MG/2ML (10MG/ML) 160MG/16ML (10MG/ML) 80MG/8ML (10MG/ML) 20MG/VIAL 80MG/VIAL 20MG/0.5ML (40MG/ML) 80MG/2ML (40MG/ML) 20MG/ML (20MG/ML) 80MG/4ML (20MG/ML)
N022534 001 N022534 002 N201195 001 N201195 002 N020449 003 N020449 004
May 03, 2011 May 03, 2011 Jun 08, 2011 Jun 08, 2011 Aug 03, 2010 Aug 02, 2010
DOLASETRON MESYLATE
INJECTABLE; INJECTION
ANZEMET
XX + SANOFI AVENTIS US XX + XX + TABLET; ORAL ANZEMET SANOFI AVENTIS US XX XX +
50MG 100MG
DONEPEZIL HYDROCHLORIDE
TABLET; ORAL ARICEPT EISAI INC AB 5MG AB + 10MG DONEPEZIL HYDROCHLORIDE ACCORD HLTHCARE AB 5MG AB 10MG ACTAVIS PHARMA AB 5MG AB 10MG APOTEX AB 5MG AB 10MG AUROBINDO AB 5MG AB 10MG CIPLA LTD AB 5MG AB 10MG DR REDDYS LABS LTD AB 5MG AB 10MG HIKMA PHARMS AB 5MG AB 10MG HUAHAI US INC AB 5MG AB 10MG JUBILANT LIFE AB 5MG AB 10MG MATRIX LABS LTD AB 5MG AB 10MG PLIVA HRVATSKA DOO AB 5MG AB 10MG RANBAXY AB 5MG AB 10MG ROXANE AB 5MG AB 10MG SANDOZ AB 5MG AB 10MG SUN PHARM INDS AB 5MG AB 10MG TEVA AB 5MG AB 10MG TORRENT PHARMS AB 5MG AB 10MG WOCKHARDT AB 5MG AB 10MG
N020690 002 N020690 001 A201335 A201335 A090551 A090551 A078841 A078841 A090056 A090056 A077518 A077518 A201001 A201001 A090247 A090247 A200292 A200292 A090768 A090768 A090521 A090521 A090425 A090425 A076786 A076786 A078662 A078662 A090290 A090290 A090493 A090493 A077344 A077344 A090686 A090686 A091267 A091267 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Nov 25, 1996 Nov 25, 1996 Aug Aug May May Jun Jun May May May May May May May May May May May May May May May May Nov Nov May May May May May May May May May May May May 29, 29, 31, 31, 02, 02, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 26, 26, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2010 2010 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011
23MG
N022568 001
AB AB AB AB AB AB AB AB
TABLET, ORALLY DISINTEGRATING; ORAL ARICEPT ODT EISAI INC 5MG + 10MG DONEPEZIL HYDROCHLORIDE BARR 5MG 10MG SANDOZ 5MG 10MG ZYDUS PHARMS USA INC 5MG 10MG
N021720 001 N021720 002 A078388 A078388 A091198 A091198 A090175 A090175 002 001 001 002 001 002
Oct 18, 2004 Oct 18, 2004 Nov Nov May May May May 26, 26, 10, 10, 10, 10, 2010 2010 2011 2011 2011 2011
DOPAMINE HYDROCHLORIDE
INJECTABLE; INJECTION DOPAMINE HYDROCHLORIDE + HOSPIRA + + + + LUITPOLD + + DOPAMINE HYDROCHLORIDE + B BRAUN + DOPAMINE HYDROCHLORIDE + B BRAUN DOPAMINE HYDROCHLORIDE + BAXTER HLTHCARE + + + HOSPIRA + + DOPAMINE HYDROCHLORIDE + B BRAUN DOPAMINE HYDROCHLORIDE + BAXTER HLTHCARE
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX
40MG/ML 80MG/100ML 80MG/ML 160MG/100ML 40MG/ML 80MG/ML 160MG/ML AND DEXTROSE 5% 80MG/100ML 320MG/100ML AND DEXTROSE 5% IN PLASTIC CONTAINER 160MG/100ML IN DEXTROSE 5% IN PLASTIC CONTAINER 80MG/100ML 160MG/100ML 320MG/100ML 80MG/100ML 160MG/100ML 320MG/100ML AND DEXTROSE 5% IN PLASTIC CONTAINER 40MG/100ML IN DEXTROSE 5% IN PLASTIC CONTAINER 640MG/100ML
N019099 002 N019099 004 N019099 003 N019615 N019615 N019615 N018826 N018826 N018826 001 002 003 001 002 003
Oct 15, 1986 Oct 15, 1986 Oct 15, 1986 Mar Mar Mar Sep Sep Sep 27, 27, 27, 30, 30, 30, 1987 1987 1987 1983 1983 1983
DORIPENEM
INJECTABLE; IV (INFUSION) DORIBAX JANSSEN PHARMS 250MG/VIAL XX XX + 500MG/VIAL
DORZOLAMIDE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE ALCON PHARMS LTD EQ APOTEX INC EQ BAUSCH AND LOMB EQ HI TECH PHARMA EQ LUITPOLD EQ SANDOZ EQ TEVA PHARMS EQ
AT AT AT AT AT AT AT
2% 2% 2% 2% 2% 2% 2%
N020408 001
AT AT AT AT AT AT AT
0.5% BASE MALEATE 0.5% BASE 0.5% BASE 0.5% BASE 0.5% BASE 0.5% BASE 0.5% BASE
N020869 001 A090604 A078201 A090037 A077847 A078749 A078704 001 001 001 001 001 001
Apr 07, 1998 Nov Oct Jul Oct Nov Sep 18, 28, 14, 28, 06, 28, 2009 2008 2009 2008 2008 2009
DOXAPRAM HYDROCHLORIDE
INJECTABLE; INJECTION DOPRAM AP + BAXTER HLTHCARE DOXAPRAM HYDROCHLORIDE BEDFORD AP WATSON LABS AP
N014879 001 A076266 001 A073529 001 Jan 10, 2003 Jan 30, 1992
DOXAZOSIN MESYLATE
TABLET; ORAL CARDURA AB + PFIZER AB AB AB DOXAZOSIN MESYLATE APOTEX AB AB AB AB DAVA PHARMS INC AB AB AB AB MYLAN AB AB AB AB NESHER PHARMS AB AB AB AB PLIVA AB AB AB AB TEVA AB AB AB AB WATSON LABS AB AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
1MG 2MG 4MG 8MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N019668 N019668 N019668 N019668 A075580 A075580 A075580 A075580 A076161 A076161 A076161 A076161 A075509 A075509 A075509 A075509 A075609 A075609 A075609 A075609 A075750 A075750 A075750 A075750 A075536 A075536 A075536 A075536 A075426 A075426 A075426
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003
Nov Nov Nov Nov Oct Oct Oct Oct Jun Jun Jun Jun Oct Oct Oct Oct Oct Oct Oct Oct Jun Jun Jun Jun Oct Oct Oct Oct Oct Oct Oct
02, 02, 02, 02, 18, 18, 18, 18, 10, 10, 10, 10, 19, 19, 19, 19, 18, 18, 18, 18, 08, 08, 08, 08, 18, 18, 18, 18, 18, 18, 18,
1990 1990 1990 1990 2000 2000 2000 2000 2004 2004 2004 2004 2000 2000 2000 2000 2000 2000 2000 2000 2001 2001 2001 2001 2000 2000 2000 2000 2000 2000 2000
EQ 8MG BASE
A075426 004
TABLET, EXTENDED RELEASE; ORAL CARDURA XL PFIZER EQ 4MG BASE XX EQ 8MG BASE XX +
DOXEPIN HYDROCHLORIDE
CAPSULE; ORAL DOXEPIN HYDROCHLORIDE MYLAN AB AB AB AB AB PAR PHARM AB AB + AB AB AB + WATSON LABS AB AB AB AB AB DOXEPIN HYDROCHLORIDE PAR PHARM XX CONCENTRATE; ORAL DOXEPIN HYDROCHLORIDE PHARM ASSOC SILARX + TEVA PHARMS WOCKHARDT
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE
A070791 A070791 A070791 A070791 A070791 A071697 A071437 A071595 A071608 A071422 A071485 A071486 A071238 A071326 A071239
002 003 001 004 005 001 001 001 001 001 001 001 001 001 001
May May May May May Nov Nov Nov Nov Nov Apr Apr Apr Apr Apr
13, 13, 13, 13, 13, 09, 09, 09, 09, 09, 30, 30, 30, 30, 30,
1986 1986 1986 1986 1986 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987
EQ 150MG BASE
A071669 001
AA AA AA AA
EQ EQ EQ EQ
CREAM; TOPICAL
ZONALON
XX + NYCOMED US TABLET; ORAL SILENOR SOMAXON XX XX +
5%
N020126 001
DOXERCALCIFEROL
CAPSULE; ORAL DOXERCALCIFEROL ROXANE HECTOROL GENZYME CORP HECTOROL GENZYME CORP +
AB AB XX XX
Sep 23, 2011 Apr 23, 2004 Jul 13, 2009 Jun 09, 1999
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A063277 A062975 A062921 A062921 A062921 A064097 A200170 A200170 A063336 A063097 A063097 A063097 A063336 A064140 A064140
001 001 001 002 003 001 001 002 001 001 002 003 004 001 002
Oct Mar Mar Mar Mar Sep Oct Oct Feb May May May Feb Jul Jul
26, 17, 17, 17, 17, 13, 28, 28, 28, 21, 21, 21, 28, 28, 28,
1995 1989 1989 1989 1989 1994 2011 2011 1995 1990 1990 1990 1995 1995 1995
DOXYCYCLINE
CAPSULE; ORAL DOXYCYCLINE IMPAX LABS INC AB MYLAN AB PAR PHARM AB AB AB + RANBAXY AB AB AB SANDOZ AB AB WATSON LABS AB AB MONODOX WATSON PHARMS AB AB AB + ORACEA AB + GALDERMA LABS LP FOR SUSPENSION; ORAL DOXYCYCLINE IVAX SUB TEVA PHARMS AB VIBRAMYCIN AB + PFIZER TABLET; ORAL DOXYCYCLINE HERITAGE PHARMS INC AB AB AB AB LANNETT AB AB AB AB MYLAN AB
EQ 150MG BASE 40MG EQ 50MG BASE EQ 100MG BASE EQ 150MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE EQ 50MG BASE EQ 100MG BASE EQ 50MG BASE EQ 100MG BASE EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE 40MG
A200065 A090855 A065055 A065055 A065055 A065053 A065053 A065053 A065032 A065032 A065041 A065041
001 001 001 002 003 001 003 002 001 002 001 002
Feb Jul Dec Dec Jul Nov Sep Nov Jun Jun Apr Apr
17, 01, 01, 01, 15, 22, 10, 22, 30, 30, 28, 28,
2011 2010 2000 2000 2005 2000 2003 2000 2000 2000 2000 2000
Feb 10, 1992 Oct 18, 2006 Dec 29, 1989 May 26, 2006
EQ EQ EQ EQ EQ EQ EQ EQ EQ
50MG BASE 75MG BASE 100MG BASE 150MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 50MG BASE
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
75MG BASE 100MG BASE 150MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 50MG BASE 75MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE
A065377 A065377 A065427 A065070 A065070 A065070 A065070 A065356 A065356 A065356 A065353 A065353 A065353
002 003 001 001 003 002 004 001 002 003 001 002 003
Nov Nov Jun Dec Dec Dec Jul May May May Nov Nov Nov
07, 07, 07, 15, 30, 15, 14, 31, 31, 31, 27, 27, 27,
2006 2006 2007 2000 2002 2000 2005 2006 2006 2006 2006 2006 2006
DOXYCYCLINE CALCIUM
SUSPENSION; ORAL
VIBRAMYCIN
XX + PFIZER
EQ 50MG BASE/5ML
N050480 001
DOXYCYCLINE HYCLATE
CAPSULE; ORAL DOXYCYCLINE HYCLATE IVAX SUB TEVA PHARMS AB AB MUTUAL PHARM AB AB WATSON LABS FLORIDA AB AB WEST WARD AB AB VIBRAMYCIN PFIZER AB AB + DOXYCYCLINE HYCLATE XX + WEST WARD
EQ EQ EQ EQ EQ EQ EQ EQ
50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE
CAPSULE, DELAYED RELEASE; ORAL DOXYCYCLINE HYCLATE MEDICIS EQ 75MG BASE XX EQ 100MG BASE XX + INJECTABLE; INJECTION DOXY 100 AP + APP PHARMS DOXYCYCLINE AP + BEDFORD DOXY 200 XX + APP PHARMS
N050751 001
EQ EQ EQ EQ EQ
20MG BASE 20MG BASE 100MG BASE 20MG BASE 100MG BASE
AB AB AB AB AB
EQ EQ EQ EQ
EQ 20MG BASE
N050783 001
TABLET, DELAYED RELEASE; ORAL DORYX MAYNE PHARMA AB EQ 75MG BASE AB EQ 100MG BASE DOXYCYCLINE HYCLATE ACTAVIS ELIZABETH AB EQ 75MG BASE AB EQ 100MG BASE IMPAX LABS INC AB EQ 75MG BASE AB EQ 100MG BASE MYLAN AB EQ 75MG BASE AB EQ 100MG BASE DORYX EQ 150MG BASE XX + MAYNE PHARMA
N050795 001 N050795 002 A090134 A090134 A090505 A090505 A090431 A090431 001 002 001 002 001 002
May 06, 2005 May 06, 2005 Dec Dec Dec Dec Dec Dec 14, 14, 28, 28, 28, 28, 2011 2011 2010 2010 2010 2010
N050795 003
DRONABINOL
CAPSULE; ORAL DRONABINOL INSYS THERAP AB AB AB SVC PHARMA AB AB AB MARINOL ABBOTT PRODS AB AB + AB
DRONEDARONE HYDROCHLORIDE
TABLET; ORAL
MULTAQ
XX + SANOFI AVENTIS US
EQ 400MG BASE
N022425 001
DROPERIDOL
INJECTABLE; INJECTION DROPERIDOL HOSPIRA AP LUITPOLD AP INAPSINE AP + AKORN INC
DROSPIRENONE; ESTRADIOL
TABLET; ORAL
ANGELIQ
XX + BAYER HLTHCARE
0.5MG;1MG
N021355 002
A078515 001
AB AB AB AB
May 09, 2008 Sep 07, 2010 Mar 28, 2011 May 11, 2001
3MG,N/A;0.02MG,N/A;0.451MG,0.451MG 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG
DULOXETINE HYDROCHLORIDE
CAPSULE, DELAYED REL PELLETS; ORAL CYMBALTA LILLY EQ 20MG BASE XX EQ 30MG BASE XX EQ 60MG BASE XX +
DUTASTERIDE
CAPSULE; ORAL AVODART AB + GLAXOSMITHKLINE DUTASTERIDE BARR AB
0.5MG 0.5MG
0.5MG;0.4MG
N022460 001
DYPHYLLINE
TABLET; ORAL
LUFYLLIN
MEDA PHARMS XX XX +
200MG 400MG
A084566 001
A084566 002
ECHOTHIOPHATE IODIDE
FOR SOLUTION; OPHTHALMIC
PHOSPHOLINE IODIDE
XX + WYETH PHARMS INC
0.125%
N011963 001
ECONAZOLE NITRATE
CREAM; TOPICAL ECONAZOLE NITRATE AB + ALTANA PERRIGO NEW YORK AB
1% 1%
1% 1%
N008922 001
EDROPHONIUM CHLORIDE
INJECTABLE; INJECTION ENLON BIONICHE PHARMA AP 10MG/ML TENSILON AP + VALEANT PHARM INTL 10MG/ML
TENSILON PRESERVATIVE FREE
AP + VALEANT PHARM INTL 10MG/ML
EFAVIRENZ
CAPSULE; ORAL
SUSTIVA
BRISTOL MYERS SQUIBB XX XX +
50MG
200MG
TABLET; ORAL
SUSTIVA
XX + BRISTOL MYERS SQUIBB 600MG
N021360 002
600MG;200MG;300MG
N021937 001
EFLORNITHINE HYDROCHLORIDE
CREAM; TOPICAL
VANIQA
XX + SKINMEDICA
13.9%
N021145 001
ELETRIPTAN HYDROBROMIDE
TABLET; ORAL
RELPAX
PFIZER IRELAND XX XX +
EQ 20MG BASE
EQ 40MG BASE
ELTROMBOPAG OLAMINE
TABLET; ORAL
PROMACTA
GLAXOSMITHKLINE XX XX XX + XX
EQ EQ EQ EQ
12.5MG ACID
25MG ACID
50MG ACID
75MG ACID
EMEDASTINE DIFUMARATE
SOLUTION/DROPS; OPHTHALMIC
EMADINE
XX + ALCON 0.05%
N020706 001
200MG
N021500 001
10MG/ML
N021896 001
TABLET; ORAL
COMPLERA
XX + GILEAD SCIENCES INC
200MG;25MG;300MG
N202123 001
200MG;300MG
N021752 001
ENALAPRIL MALEATE
TABLET; ORAL ENALAPRIL MALEATE APOTEX AB AB AB AB LEK PHARMS AB AB AB AB MYLAN AB AB AB AB AB AB AB AB SANDOZ AB AB AB AB TARO AB AB AB AB TEVA AB AB AB AB WATSON LABS AB AB AB AB WOCKHARDT USA AB AB AB AB VASOTEC VALEANT INTL AB AB
2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 2.5MG 5MG 5MG 10MG 10MG 20MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG
A075178 A075178 A075178 A075178 A075496 A075496 A075459 A075459 A075472 A075480 A075472 A075480 A075472 A075480 A075472 A075480 A075621 A075621 A075621 A075621 A075657 A075657 A075657 A075657 A075479 A075479 A075479 A075479 A075501 A075501 A075501 A075501 A075483 A075483 A075483 A075483
002 001 003 004 001 002 001 002 001 001 002 002 003 003 004 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Mar Mar Mar Mar Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Jan Jan Jan Jan Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug
23, 23, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 23, 23, 23, 23, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22,
2001 2001 2001 2001 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2001 2001 2001 2001 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000
10MG 20MG
A076486 A076486 A075909 A075909 A075624 A075624 A076116 A076116 A075788 A075788 A075727 A075727
001 002 001 002 001 002 001 002 001 002 001 002
Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 15, 15, 18, 18, 19, 19, 18, 18, 18, 18,
2004 2004 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001
ENALAPRILAT
INJECTABLE; INJECTION ENALAPRILAT + BEDFORD HIKMA FARMACEUTICA + HOSPIRA TEVA PARENTERAL
AP AP AP AP
ENFLURANE
LIQUID; INHALATION ENFLURANE PIRAMAL CRITICAL AN ETHRANE AN + BAXTER HLTHCARE CORP
99.9% 99.9%
ENFUVIRTIDE
INJECTABLE; SUBCUTANEOUS
FUZEON
XX + ROCHE
90MG/VIAL
N021481 001
ENOXAPARIN SODIUM
INJECTABLE; INTRAVENOUS, SUBCUTANEOUS ENOXAPARIN SODIUM SANDOZ INC AB 300MG/3ML (100MG/ML) LOVENOX SANOFI AVENTIS US AB 300MG/3ML (100MG/ML) INJECTABLE; SUBCUTANEOUS ENOXAPARIN SODIUM (PRESERVATIVE FREE) AMPHASTAR PHARM 30MG/0.3ML (100MG/ML) 40MG/0.4ML (100MG/ML) 60MG/0.6ML (100MG/ML) 80MG/0.8ML (100MG/ML) 100MG/ML (100MG/ML) 120MG/0.8ML (150MG/ML)
AP AP AP AP AP AP
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A076684 A077857 A077857 A077857 A077857 A077857 A077857 A077857 N020164 N020164 N020164 N020164 N020164 N020164 N020164
007 002 003 004 005 001 006 007 001 002 003 004 005 007 008
Sep Jul Jul Jul Jul Jul Jul Jul Mar Jan Mar Mar Mar Jun Jun
19, 23, 23, 23, 23, 23, 23, 23, 29, 30, 27, 27, 27, 02, 02,
2011 2010 2010 2010 2010 2010 2010 2010 1993 1998 1998 1998 1998 2000 2000
ENTACAPONE
TABLET; ORAL
COMTAN
XX + ORION
200MG
N020796 001
ENTECAVIR
SOLUTION; ORAL
BARACLUDE
XX + BRISTOL MYERS SQUIBB TABLET; ORAL BARACLUDE BRISTOL MYERS SQUIBB XX XX +
0.05MG/ML
N021798 001
0.5MG 1MG
EPINASTINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC ELESTAT + ALLERGAN 0.05% EPINASTINE HYDROCHLORIDE APOTEX 0.05% CYPRESS PHARM 0.05% PHARMAFORCE 0.05% SUN PHARM INDS 0.05%
AT AT AT AT AT
N021565 001 A090919 A090870 A090951 A091626 001 001 001 001
Oct 16, 2003 Oct Mar Oct Oct 31, 14, 31, 31, 2011 2011 2011 2011
EPINEPHRINE
INJECTABLE; IM-SC ADRENACLICK + SHIONOGI INC + TWINJECT 0.15 + SHIONOGI INC TWINJECT 0.3 + SHIONOGI INC
BX BX BX BX
Nov 25, 2009 Nov 25, 2009 May 28, 2004 May 30, 2003
INJECTABLE; INTRAMUSCULAR EPIPEN BX + MERIDIAN MEDCL TECHN 0.3MG/DELIVERY EPIPEN JR. BX + MERIDIAN MEDCL TECHN 0.15MG/DELIVERY
A040057 A040057 A089635 A088571 A089645 A089651 A089644 A078772 A089646 A078772
002 001 001 001 001 001 001 001 001 002
Feb Feb Jun Sep Jun Jun Jun May Jun May
26, 26, 21, 13, 21, 21, 21, 12, 21, 12,
1993 1993 1988 1985 1988 1988 1988 2008 1988 2008
A084048 001 A084048 002 N021381 001 N021381 002 N006488 N006488 N006488 N006488 N006488 N006488 012 018 017 019 004 005
EPIRUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION ELLENCE AP + PFIZER INC 200MG/100ML (2MG/ML) AP 50MG/25ML (2MG/ML) EPIRUBICIN HYDROCHLORIDE ACTAVIS TOTOWA 10MG/5ML (2MG/ML) AP 50MG/25ML (2MG/ML) AP 200MG/100ML (2MG/ML) AP AKORN INC 50MG/25ML (2MG/ML) AP APP PHARMS 10MG/5ML (2MG/ML) AP 150MG/75ML (2MG/ML) AP 200MG/100ML (2MG/ML) AP 50MG/25ML (2MG/ML) AP BEDFORD 200MG/100ML (2MG/ML) AP 50MG/25ML (2MG/ML) AP BIONICHE PHARMA USA 50MG/25ML (2MG/ML) AP 200MG/100ML (2MG/ML) AP EBEWE PHARMA 50MG/25ML (2MG/ML) AP
N050778 001 N050778 002 A065445 A065445 A065445 A090163 A065408 A065408 A065408 A065408 A065289 A065289 A065371 A065371 A065339 001 002 003 001 001 003 004 002 002 001 001 002 001
Sep 15, 1999 Sep 15, 1999 Sep Sep Sep Jun Oct Oct Oct Oct Jun Jun Nov Nov Dec 18, 18, 18, 24, 15, 15, 15, 15, 27, 27, 28, 28, 22, 2008 2008 2008 2009 2007 2007 2007 2007 2007 2007 2007 2007 2009
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A065339 A065411 A065411 A065343 A065343 A065343 A065343 A090266 A090266 A065331 A065331 A065361 A065361 A090075 A090075
002 001 002 004 002 001 003 002 001 001 002 002 001 001 002
Dec Aug Aug Apr Apr Apr Apr Apr Apr Aug Aug Oct Oct Mar Mar
22, 20, 20, 19, 19, 19, 19, 15, 15, 09, 09, 22, 22, 25, 25,
2009 2007 2007 2007 2007 2007 2007 2011 2011 2007 2007 2007 2007 2010 2010
INJECTABLE; IV (INFUSION)
EPIRUBICIN HYDROCHLORIDE
50MG/VIAL XX + HOSPIRA
N050807 001
EPLERENONE
TABLET; ORAL EPLERENONE APOTEX AB AB SANDOZ AB AB INSPRA GD SEARLE LLC AB AB +
EPOPROSTENOL SODIUM
INJECTABLE; INJECTION EPOPROSTENOL SODIUM TEVA PARENTERAL AP AP FLOLAN AP + GLAXOSMITHKLINE LLC AP + VELETRI XX + ACTELION
EQ 0.5MG BASE/VIAL EQ 1.5MG BASE/VIAL EQ 0.5MG BASE/VIAL EQ 1.5MG BASE/VIAL EQ 1.5MG BASE/VIAL
A078396 001 A078396 002 N020444 001 N020444 002 N022260 001
Apr 23, 2008 Apr 23, 2008 Sep 20, 1995 Sep 20, 1995 Jun 27, 2008
EPROSARTAN MESYLATE
TABLET; ORAL EPROSARTAN MESYLATE MYLAN PHARMS INC AB AB TEVETEN ABBOTT AB AB +
Nov 16, 2011 Nov 16, 2011 Dec 22, 1997 May 27, 1999
600MG;12.5MG 600MG;25MG
2MG/ML 75MG/100ML
ERGOCALCIFEROL
CAPSULE; ORAL DRISDOL + SANOFI AVENTIS US ERGOCALCIFEROL ORIT LABS LLC SIGMAPHARM LABS LLC STRIDES ARCOLAB LTD SUN PHARM INDS INC VITAMIN D BANNER PHARMACAPS
AA AA AA AA AA AA
N003444 001 A040833 A091004 A090455 A040865 001 001 001 001 May Jul Aug Dec 20, 14, 03, 29, 2009 2010 2010 2009
50,000 IU
A080704 001
ERGOLOID MESYLATES
TABLET; ORAL ERGOLOID MESYLATES MUTUAL PHARM AB HYDERGINE AB + NOVARTIS
TABLET; SUBLINGUAL
ERGOLOID MESYLATES
WATSON LABS XX
1MG 1MG
0.5MG
A087233 001
ERGOTAMINE TARTRATE
TABLET; SUBLINGUAL
ERGOMAR
XX + ROSEDALE THERAPEUTIC
2MG
A087693 001
ERIBULIN MESYLATE
SOLUTION; INTRAVENOUS
HALAVEN
XX + EISAI INC
1MG/2ML (0.5MG/ML)
N201532 001
ERLOTINIB HYDROCHLORIDE
TABLET; ORAL TARCEVA OSI PHARMS XX XX XX +
ERTAPENEM SODIUM
INJECTABLE; INTRAMUSCULAR, IV (INFUSION)
INVANZ
XX + MERCK EQ 1GM BASE/VIAL
N021337 001
ERYTHROMYCIN
CAPSULE, DELAYED REL PELLETS; ORAL ERYC AB + HOSPIRA 250MG WARNER CHILCOTT AB 250MG ERYTHROMYCIN ARBOR PHARMS INC AB 250MG
AT AT AT AT
2% 2% 2% 2%
Mar 18, 2002 Oct 21, 1987 Sep 30, 1997 Jan 29, 1993
2%
N050584 001
AT AT AT AT AT
2% 2% 2% 2% 2%
A062687 001 A064187 001 A063038 001 A062825 001 A064101 001
Feb 05, 1988 Sep 30, 1997 Jan 11, 1991 Oct 23, 1987 Oct 22, 1996
2% 2% 2%
250MG 500MG
A061621 001
A061621 002
TABLET, COATED PARTICLES; ORAL PCE ARBOR PHARMS INC 333MG XX 500MG XX +
TABLET, DELAYED RELEASE; ORAL
ERY-TAB
250MG XX + ARBOR PHARMS INC 333MG XX + 500MG XX +
ERYTHROMYCIN ETHYLSUCCINATE
GRANULE; ORAL E.E.S. ARBOR PHARMS INC AB ERYPED ARBOR PHARMS INC AB ERYPED XX + ARBOR PHARMS INC SUSPENSION; ORAL E.E.S. 200 ARBOR PHARMS INC AB E.E.S. 400 AB + ARBOR PHARMS INC
TABLET; ORAL E.E.S. 400 BX + ARBOR PHARMS INC EQ 400MG BASE ERYTHROMYCIN ETHYLSUCCINATE BX + ARBOR PHARMS INC EQ 400MG BASE
A062759 001
ERYTHROMYCIN LACTOBIONATE
INJECTABLE; INJECTION ERYTHROCIN HOSPIRA AP AP + AP +
ERYTHROMYCIN STEARATE
TABLET; ORAL
ERYTHROCIN STEARATE
XX + ARBOR PHARMS INC
EQ 250MG BASE
A060359 001
ESCITALOPRAM OXALATE
SOLUTION; ORAL
LEXAPRO
XX + FOREST LABS TABLET; ORAL LEXAPRO FOREST LABS XX XX XX +
EQ 5MG BASE/5ML
N021365 001
ESMOLOL HYDROCHLORIDE
INJECTABLE; INJECTION BREVIBLOC + BAXTER HLTHCARE CORP 10MG/ML ESMOLOL HYDROCHLORIDE APP PHARMS 10MG/ML BEDFORD LABS 10MG/ML BIONICHE PHARMA 10MG/ML BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER + BAXTER HLTHCARE CORP 2GM/100ML BREVIBLOC IN PLASTIC CONTAINER + BAXTER HLTHCARE CORP 1GM/100ML
AP AP AP AP XX XX
N019386 006 A076573 001 A076323 001 A076474 001 N019386 005 N019386 004
Feb 25, 2003 May 02, 2005 Aug 10, 2004 May 02, 2005 Jan 27, 2003 Feb 16, 2001
ESOMEPRAZOLE MAGNESIUM
CAPSULE, DELAYED REL PELLETS; ORAL NEXIUM ASTRAZENECA EQ 20MG BASE XX EQ 40MG BASE XX +
ESOMEPRAZOLE SODIUM
INJECTABLE; INTRAVENOUS
NEXIUM IV
XX + ASTRAZENECA XX +
ESTAZOLAM
TABLET; ORAL ESTAZOLAM PAR PHARM AB AB TEVA AB AB + WATSON LABS AB AB
ESTRADIOL
CREAM; VAGINAL
ESTRACE
XX + WARNER CHILCOTT
0.01%
A086069 001
FILM, EXTENDED RELEASE; TRANSDERMAL CLIMARA BAYER HLTHCARE AB 0.0375MG/24HR AB 0.06MG/24HR ESTRADIOL MYLAN TECHNOLOGIES AB 0.0375MG/24HR AB 0.06MG/24HR VIVELLE NOVARTIS AB1 0.05MG/24HR AB1 0.1MG/24HR VIVELLE-DOT NOVARTIS AB1 0.05MG/24HR AB1 + 0.1MG/24HR CLIMARA BAYER HLTHCARE AB2 0.025MG/24HR AB2 0.05MG/24HR AB2 0.075MG/24HR AB2 + 0.1MG/24HR ESTRADIOL MYLAN TECHNOLOGIES AB2 0.025MG/24HR AB2 0.05MG/24HR AB2 0.075MG/24HR AB2 0.1MG/24HR ALORA BX WATSON LABS 0.025MG/24HR BX 0.05MG/24HR BX 0.075MG/24HR
N020375 005 N020375 006 A075182 004 A075182 005 N020323 002 N020323 004 N020538 006 N020538 008 N020375 N020375 N020375 N020375 A075182 A075182 A075182 A075182 004 001 003 002 003 006 002 001
May 27, 2003 May 27, 2003 Jul 20, 2006 Jul 20, 2006 Oct 28, 1994 Oct 28, 1994 Jan 08, 1999 Jan 08, 1999 Mar Dec Mar Dec Jan Feb Jan Feb 05, 22, 23, 22, 26, 24, 26, 24, 1999 1994 1998 1994 2005 2000 2005 2000
BX BX BX BX BX BX XX
N020655 003 N019081 002 N019081 003 N020538 009 N020538 005 N020538 007 N021674 001
Dec 20, 1996 Sep 10, 1986 Sep 10, 1986 May 03, 2002 Jan 08, 1999 Jan 08, 1999 Jun 08, 2004
N020472 001
1.53MG/SPRAY
N022014 001
1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG
A084499 001 A084500 001 A040197 A040197 A040197 A040326 A040326 A040326 A040297 A040297 A040297 A040114 A040114 A040114 001 002 003 001 002 003 001 002 003 003 001 002 Oct Oct Oct Apr Apr Apr Apr Apr Apr Mar Mar Mar 22, 22, 22, 21, 21, 21, 17, 17, 17, 14, 14, 14, 1997 1997 1997 1999 1999 1999 2002 2002 2002 1996 1996 1996
10MCG
N020908 002
ESTRADIOL ACETATE
INSERT, EXTENDED RELEASE; VAGINAL FEMRING GALEN LTD EQ 0.05MG BASE/24HR XX EQ 0.1MG BASE/24HR XX + TABLET; ORAL FEMTRACE WARNER CHILCOTT XX XX
0.45MG 0.9MG
1.8MG
N021633 003
ESTRADIOL CYPIONATE
INJECTABLE; INJECTION DEPO-ESTRADIOL AO + PHARMACIA AND UPJOHN ESTRADIOL CYPIONATE WATSON LABS AO
5MG/ML 5MG/ML
ESTRADIOL HEMIHYDRATE
EMULSION; TOPICAL
ESTRASORB
XX + MEDICIS
0.25%
N021371 001
ESTRADIOL VALERATE
INJECTABLE; INJECTION DELESTROGEN + JHP PHARMS + + ESTRADIOL VALERATE LUITPOLD SANDOZ
AO AO AO AO AO AO AO AO AO AO
10MG/ML 20MG/ML 40MG/ML 20MG/ML 40MG/ML 10MG/ML 20MG/ML 40MG/ML 20MG/ML 40MG/ML
N009402 002 N009402 004 N009402 003 A090920 A090920 A040628 A040628 A040628 A083547 A083714 001 002 001 002 003 001 001 Jan Jan Oct Oct Oct 19, 19, 04, 04, 04, 2010 2010 2007 2007 2007
WATSON LABS
ESTRADIOL; LEVONORGESTREL
FILM, EXTENDED RELEASE; TRANSDERMAL
CLIMARA PRO
0.045MG/24HR;0.015MG/24HR XX + BAYER HLTHCARE
N021258 001
AB AB AB AB AB
N020907 002 N020907 001 A079193 001 A078324 002 A078324 001
Dec 28, 2006 Nov 18, 1998 May 11, 2010 Jun 09, 2011 Apr 17, 2008
ESTRADIOL; NORGESTIMATE
TABLET; ORAL ESTRADIOL AND NORGESTIMATE BARR AB 1MG,1MG;N/A,0.09MG PREFEST AB + TEVA WOMENS 1MG,1MG;N/A,0.09MG
CAPSULE; ORAL
EMCYT
XX + PHARMACIA AND UPJOHN
EQ 140MG PHOSPHATE
N018045 001
ESTROGENS, CONJUGATED
0.625MG/GM
N020216 001
25MG/VIAL
N010402 001
CREAM; VAGINAL
SYNTHETIC CONJUGATED ESTROGENS A
XX + TEVA WOMENS 0.625MG/GM TABLET; ORAL CENESTIN XX TEVA WOMENS XX XX XX XX +
N021788 001
XX XX XX XX XX
N020527 002 N020527 N020527 N020527 N020527 005 004 001 003
Nov 17, 1995 Jun Mar Nov Jan 04, 12, 17, 09, 2003 2003 1995 1998
ESTROGENS, ESTERIFIED
TABLET; ORAL
MENEST
MONARCH PHARMS XX XX XX XX +
001
001
001
001
5MG/ML
A085239 001
ESTROPIPATE
TABLET; ORAL ESTROPIPATE BARR AB AB AB MYLAN AB AB WATSON LABS AB AB AB AB OGEN .625 PHARMACIA AND UPJOHN AB OGEN 1.25 PHARMACIA AND UPJOHN AB OGEN 2.5 AB + PHARMACIA AND UPJOHN OGEN 5 PHARMACIA AND UPJOHN AB ORTHO-EST SUN PHARM INDS (IN) AB AB
0.75MG 1.5MG 3MG 0.75MG 1.5MG 0.75MG 1.5MG 3MG 6MG 0.75MG 1.5MG 3MG 6MG 0.75MG 1.5MG
A083220 001 A083220 002 A083220 003 A083220 004 A089567 001 A089582 001 Feb 27, 1991 Jul 17, 1991
ESZOPICLONE
TABLET; ORAL LUNESTA SUNOVION PHARMS INC XX XX XX +
ETHACRYNATE SODIUM
INJECTABLE; INJECTION
EDECRIN
XX + ATON
EQ 50MG BASE/VIAL
N016093 001
ETHACRYNIC ACID
TABLET; ORAL
EDECRIN
XX + ATON
25MG
N016092 001
ETHAMBUTOL HYDROCHLORIDE
TABLET; ORAL ETHAMBUTOL HYDROCHLORIDE BARR AB 400MG LUPIN AB 100MG AB 400MG WEST WARD AB 100MG AB + 400MG MYAMBUTOL STI PHARMA LLC AB 100MG AB 400MG
50MG/ML
N019357 001
0.015MG;0.12MG
N021187 001
A079064 001 A091674 001 A077502 001 A079218 001 A200407 001 A078834 001 N022262 001 N021864 001 A077101 001 N021544 001 N021840 001
Sep 27, 2010 Oct 26, 2011 Nov 23, 2011 Jun 06, 2011 Oct 25, 2011 May 31, 2011 Oct 24, 2008 May 22, 2007 Sep 06, 2006 Sep 05, 2003 May 25, 2006
0.03MG;0.15MG 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 25MG 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 25MG 0.03MG;0.15MG 0.03MG;0.15MG 0.03MG;0.15MG 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 25MG 0.02MG;0.1MG
AB
A090719 001
AB AB AB AB
Dec 13, 1993 Jul 21, 1982 May 23, 2002 Dec 18, 1997
AB1
A075796 001
Nov 18, 2004 May 11, 2011 Mar 20, 2002 May 31, 2006
N021180 001
AB AB AB AB XX XX XX XX
A071480 001 A070685 001 N017565 001 A072693 001 A078379 001 A071043 001 A071041 001 A075478 001
Feb 28, 1992 Feb 23, 2010 Apr 01, 1988 Sep 24, 1991 Aug 30, 2002
AB AB AB AB AB AB
A076783 001 A076238 001 N017743 001 A090538 001 A076337 001 A076338 001
AB AB
AB AB AB AB
MODICON 28 + JANSSEN PHARMS 0.035MG;0.5MG NORETHIN 1/35E-28 WATSON LABS 0.035MG;1MG NORETHINDRONE AND ETHINYL ESTRADIOL WATSON LABS
0.035MG;0.4MG
0.035MG;0.5MG
N017735 001 A071481 001 A078323 001 A070686 001 Apr 12, 1988 Feb 04, 2010 Jan 29, 1987
A076393 001 A070687 001 N017565 002 A072695 001 A072696 001 A075478 002
N017716 001 A090947 001 N018977 002 A071044 001 A071042 001 N017576 001 Dec 22, 2011 Apr 13, 1984 Apr 01, 1988 Sep 24, 1991
AB AB AB XX
Nov 14, 2003 Aug 05, 2010 Sep 26, 2011 Dec 22, 2010
AB AB AB AB XX XX
Oct 15, 1999 Feb 17, 2006 Nov 06, 2009 Sep 01, 2009 Jan 14, 2005 Oct 21, 2010
0.03MG;1.5MG 0.02MG;1MG
AB AB AB AB XX
N017875 001 N017876 001 A075548 002 A075647 002 A076405 001 Jul 30, 2003 Jul 30, 2003 Oct 26, 2007
AB AB AB AB AB AB AB AB AB AB AB
TABLET; ORAL-28 ESTROSTEP FE + WARNER CHILCOTT 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG GILDESS FE 1.5/30 VINTAGE 0.03MG;1.5MG GILDESS FE 1/20 VINTAGE 0.02MG;1MG JUNEL FE 1.5/30 BARR 0.03MG;1.5MG JUNEL FE 1/20 BARR 0.02MG;1MG LOESTRIN FE 1.5/30 + WARNER CHILCOTT 0.03MG;1.5MG LOESTRIN FE 1/20 WARNER CHILCOTT 0.02MG;1MG MICROGESTIN FE 1.5/30 WATSON LABS 0.03MG;1.5MG MICROGESTIN FE 1/20 WATSON LABS 0.02MG;1MG NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL WATSON LABS 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG TRI-LEGEST FE BARR 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG
N020130 002 A077075 001 A077077 001 A076064 001 A076081 001 N017355 001 N017354 001 A075548 001 A075647 001 A076629 001 A076105 001
Oct 09, 1996 Apr 28, 2005 May 20, 2005 Sep 18, 2003 Sep 18, 2003
Feb 05, 2001 Feb 05, 2001 Mar 18, 2010 Oct 26, 2007
A200494 001
A090479 001 A076626 001 A076627 001 N019653 002 N019697 001
Mar 09, 2011 Aug 17, 2006 Aug 17, 2006 Dec 29, 1989 Jul 03, 1992
N021241 001
A076784 001
AB
A076335 001
AB
A075808 001
0.03MG;0.3MG 0.03MG;0.3MG
AB AB AB XX
ETHIONAMIDE
TABLET; ORAL
TRECATOR
XX + WYETH PHARMS INC
250MG
N013026 002
ETHOSUXIMIDE
CAPSULE; ORAL ETHOSUXIMIDE BANNER PHARMACAPS AB VERSAPHARM AB ZARONTIN AB + PARKE DAVIS SYRUP; ORAL ETHOSUXIMIDE MIKART PHARM ASSOC TEVA PHARMS ZARONTIN + PARKE DAVIS
AA AA AA AA
ETHOTOIN
TABLET; ORAL
PEGANONE
XX + LUNDBECK INC
250MG
N010841 001
ETIDRONATE DISODIUM
TABLET; ORAL DIDRONEL PROCTER AND GAMBLE AB AB + ETIDRONATE DISODIUM MYLAN AB
400MG
A075800 002
ETODOLAC
CAPSULE; ORAL ETODOLAC APOTEX AB AB TARO AB AB + TEVA AB TABLET; ORAL ETODOLAC APOTEX INC AB AB MYLAN AB AB SANDOZ AB AB TARO PHARM INDS AB AB + TEVA AB AB
400MG 500MG 400MG 500MG 400MG 500MG 400MG 500MG 400MG 500MG
A076004 A076004 A075104 A075104 A074903 A074903 A075074 A075074 A075009 A075009
001 002 001 002 001 002 001 002 001 002
Dec Dec Feb Nov Apr Apr Mar Apr Nov Dec
03, 03, 06, 20, 11, 19, 11, 25, 26, 28,
2002 2002 1998 1998 1997 1999 1998 2000 1997 1999
TABLET, EXTENDED RELEASE; ORAL ETODOLAC TARO AB 400MG AB 500MG AB 600MG TEVA AB 400MG AB 500MG AB + 600MG
ETOMIDATE
INJECTABLE; INJECTION AMIDATE + HOSPIRA ETOMIDATE BEDFORD LUITPOLD STRIDES ARCOLAB LTD
AP AP AP AP
Sep 07, 1982 Nov 04, 1996 Dec 22, 2009 Jan 02, 2009
ETONOGESTREL
IMPLANT; IMPLANTATION
IMPLANON
XX + ORGANON USA INC NEXPLANON XX + ORGANON USA INC
68MG/IMPLANT 68MG/IMPLANT
ETOPOSIDE
CAPSULE; ORAL
ETOPOSIDE
XX + MYLAN INJECTABLE; INJECTION ETOPOSIDE ACCORD HLTHCARE INC AP APP PHARMS AP AP + BEDFORD
50MG
A075635 001
ETOPOSIDE PHOSPHATE
INJECTABLE; INJECTION
ETOPOPHOS PRESERVATIVE FREE
XX + BRISTOL MYERS SQUIBB EQ 100MG BASE/VIAL
N020457 001
ETRAVIRINE
TABLET; ORAL
INTELENCE
TIBOTEC
XX XX +
100MG 200MG
EVEROLIMUS
TABLET; ORAL
AFINITOR
NOVARTIS
XX XX XX +
ZORTRESS
NOVARTIS
XX XX XX +
N022334 003 N022334 001 N022334 002 N021560 001 N021560 002 N021560 003
Jul 09, 2010 Mar 30, 2009 Mar 30, 2009 Apr 20, 2010 Apr 20, 2010 Apr 20, 2010
EXEMESTANE
TABLET; ORAL AROMASIN AB + PHARMACIA AND UPJOHN EXEMESTANE ROXANE AB
25MG 25MG
EXENATIDE SYNTHETIC
INJECTABLE; SUBCUTANEOUS
BYETTA
XX + AMYLIN
XX +
EZETIMIBE
TABLET; ORAL
ZETIA
XX + MSP SINGAPORE
10MG
N021445 001
EZETIMIBE; SIMVASTATIN
TABLET; ORAL
VYTORIN
MSD INTL
XX XX XX XX +
EZOGABINE
TABLET; ORAL
POTIGA
VALEANT PHARMS
XX
50MG
N022345 001
FAMCICLOVIR
TABLET; ORAL FAMCICLOVIR APOTEX AB AB AB AUROBINDO PHARMA LTD AB AB AB MYLAN AB AB AB ROXANE AB AB AB TEVA PHARMS AB AB AB WATSON LABS AB AB AB FAMVIR NOVARTIS AB AB AB +
125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG
A091480 A091480 A091480 A091114 A091114 A091114 A201333 A201333 A201333 A090128 A090128 A090128 A077487 A077487 A077487 A078278 A078278 A078278
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jul Jul Jul Mar Mar Mar Mar Mar Mar Mar Mar Mar Aug Aug Aug Mar Mar Mar
22, 22, 22, 21, 21, 21, 24, 24, 24, 21, 21, 21, 24, 24, 24, 21, 21, 21,
2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2007 2007 2007 2011 2011 2011
FAMOTIDINE
FOR SUSPENSION; ORAL FAMOTIDINE LUPIN LTD AB NAVINTA LLC AB PEPCID AB + SALIX PHARMS INJECTABLE; INJECTION FAMOTIDINE APP PHARMS + BAXTER HLTHCARE + BEDFORD
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML PFIZER 10MG/ML FAMOTIDINE PRESERVATIVE FREE APP PHARMS 10MG/ML + BAXTER HLTHCARE 10MG/ML + 10MG/ML BEDFORD 10MG/ML BEN VENUE 10MG/ML CLARIS LIFESCIENCES 10MG/ML PFIZER 10MG/ML FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK) CLARIS LIFESCIENCES 10MG/ML FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER + BAXTER HLTHCARE 0.4MG/ML
A075709 A075488 A075799 A075651 A075684 A078641 A075813 A075486 A075789 A075622 A075825 A076324 A078642
001 001 001 001 001 001 001 001 001 001 001 001 001
Apr Apr Apr Apr Apr Jun Apr Apr Apr Apr Apr Nov Jun
16, 16, 30, 16, 16, 25, 16, 16, 30, 16, 17, 27, 25,
2001 2001 2002 2001 2001 2008 2001 2001 2002 2001 2001 2002 2008
20MG 40MG 20MG 40MG 20MG 40MG 20MG 40MG 20MG 40MG 20MG 20MG 40MG 40MG 20MG 40MG 20MG 40MG 20MG 40MG 20MG 40MG 20MG 40MG 20MG 40MG
A078916 A078916 A075611 A075611 A075805 A075805 A075718 A075718 A075511 A075511 A075457 A075704 A075457 A075704 A077352 A077352 A075607 A075607 A075311 A075311 A075062 A075062 A075786 A075786
001 002 001 002 001 002 001 002 001 002 001 001 002 002 002 001 001 002 001 002 002 001 001 002
May May Jul Jul Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Jul Jul May May Apr Apr Apr Apr Apr Apr
22, 22, 23, 23, 16, 16, 16, 16, 16, 16, 18, 16, 18, 16, 27, 27, 10, 10, 16, 16, 16, 16, 16, 16,
2009 2009 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2005 2005 2001 2001 2001 2001 2001 2001 2001 2001
FAMOTIDINE; IBUPROFEN
TABLET; ORAL
DUEXIS
XX + HORIZON PHARMA
26.6MG;800MG
N022519 001
FEBUXOSTAT
TABLET; ORAL ULORIC TAKEDA PHARMS XX XX +
40MG 80MG
FELBAMATE
SUSPENSION; ORAL FELBAMATE AMNEAL PHARMS AB FELBATOL AB + MEDA PHARMS TABLET; ORAL FELBAMATE AMNEAL PHARMS AB AB FELBATOL MEDA PHARMS AB AB +
600MG/5ML 600MG/5ML
Sep 13, 2011 Sep 13, 2011 Jul 29, 1993 Jul 29, 1993
A200815 A200815 A200815 A090365 A090365 A090365 A075896 A075896 A075896 A078855 A078855 A078855 A202170 A202170 A202170
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Oct Oct Oct Dec Dec Dec Nov Nov Nov Apr Apr Apr Nov Nov Nov
28, 28, 28, 17, 17, 17, 02, 02, 02, 17, 17, 17, 28, 28, 28,
2011 2011 2011 2010 2010 2010 2004 2004 2004 2008 2008 2008 2011 2011 2011
FENOFIBRATE
CAPSULE; ORAL FENOFIBRATE (MICRONIZED) IMPAX LABS 67MG 134MG 200MG TEVA 67MG 134MG + 200MG ANTARA (MICRONIZED) LUPIN ATLANTIS 43MG + 130MG LIPOFEN CIPHER PHARMS INC 50MG + 150MG
AB AB AB AB AB AB XX XX XX XX
Nov 30, 2004 Nov 30, 2004 Jan 11, 2006 Jan 11, 2006
TABLET; ORAL FENOFIBRATE IMPAX LABS AB AB LUPIN LTD AB AB MYLAN AB AB RANBAXY AB AB TEVA AB AB + TRICOR ABBOTT LABS PHARM AB AB + TRIGLIDE BX + SKYEPHARMA AG FENOFIBRATE RANBAXY XX FENOGLIDE SANTARUS XX XX +
54MG 160MG 48MG 145MG 54MG 160MG 54MG 160MG 54MG 160MG 48MG 145MG 160MG 107MG 40MG 120MG
A076509 A076509 A090856 A090856 A076520 A076520 A076635 A076635 A076433 A076433
001 002 001 002 001 003 001 003 001 002
Mar Mar Dec Dec Oct Oct Oct Oct May May
26, 26, 23, 23, 25, 25, 31, 31, 13, 13,
2008 2008 2011 2011 2007 2007 2005 2005 2005 2005
N021656 001 N021656 002 N021350 002 A076635 002 N022118 001 N022118 002
Nov 05, 2004 Nov 05, 2004 May 07, 2005 Oct 31, 2005 Aug 10, 2007 Aug 10, 2007
50MG
N021350 001
FENOFIBRIC ACID
TABLET; ORAL FIBRICOR AR HOLDING CO INC XX XX +
35MG 105MG
FENOLDOPAM MESYLATE
INJECTABLE; INJECTION CORLOPAM AP + HOSPIRA FENOLDOPAM MESYLATE BEDFORD LABS AP SANDOZ AP
FENOPROFEN CALCIUM
CAPSULE; ORAL
NALFON
XX + PEDINOL XX TABLET; ORAL FENOPROFEN CALCIUM IVAX SUB TEVA PHARMS AB AB + MYLAN
FENTANYL
FILM, EXTENDED RELEASE; TRANSDERMAL DURAGESIC-100 JANSSEN PHARMS 100MCG/HR DURAGESIC-12 JANSSEN PHARMS 12.5MCG/HR DURAGESIC-25 + JANSSEN PHARMS 25MCG/HR DURAGESIC-50 JANSSEN PHARMS 50MCG/HR DURAGESIC-75 JANSSEN PHARMS 75MCG/HR FENTANYL-100 ACTAVIS 100MCG/HR LAVIPHARM LABS 100MCG/HR MALLINCKRODT INC 100MCG/HR MYLAN TECHNOLOGIES 100MCG/HR NOVEN 100MCG/HR TEVA PHARMS 100MCG/HR WATSON LABS 100MCG/HR FENTANYL-12 MYLAN TECHNOLOGIES 12.5MCG/HR FENTANYL-25 ACTAVIS 25MCG/HR LAVIPHARM LABS 25MCG/HR MALLINCKRODT INC 25MCG/HR MYLAN TECHNOLOGIES 25MCG/HR NOVEN 25MCG/HR TEVA PHARMS 25MCG/HR WATSON LABS 25MCG/HR
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
N019813 001 N019813 005 N019813 004 N019813 003 N019813 002 A077062 A077051 A077154 A076258 A077775 A077449 A076709 004 004 004 004 004 004 004
Aug 07, 1990 Feb 04, 2005 Aug 07, 1990 Aug 07, 1990 Aug 07, 1990 Aug Aug Feb Jan Oct Oct Aug 20, 04, 09, 28, 16, 20, 20, 2007 2006 2011 2005 2009 2008 2007
A076258 005 A077062 A077051 A077154 A076258 A077775 A077449 A076709 001 001 001 001 001 001 001
Jan 23, 2007 Aug Aug Feb Jan Oct Oct Aug 20, 04, 09, 28, 16, 20, 20, 2007 2006 2011 2005 2009 2008 2007
AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A077062 A077051 A077154 A076258 A077775 A077449 A076709 A077062 A077051 A077154 A076258 A077775 A077449 A076709
002 002 002 002 002 002 002 003 003 003 003 003 003 003
Aug Aug Feb Jan Oct Oct Aug Aug Aug Feb Jan Oct Oct Aug
20, 04, 09, 28, 16, 20, 20, 20, 04, 09, 28, 16, 20, 20,
2007 2006 2011 2005 2009 2008 2007 2007 2006 2011 2005 2009 2008 2007
FENTANYL CITRATE
FILM; BUCCAL ONSOLIS MEDA PHARMS XX XX + XX XX XX
EQ EQ EQ EQ EQ
AP AP AP AP
INJECTABLE; INJECTION FENTANYL CITRATE HOSPIRA EQ 0.05MG BASE/ML FENTANYL CITRATE PRESERVATIVE FREE + BAXTER HLTHCARE EQ 0.05MG BASE/ML HOSPIRA EQ 0.05MG BASE/ML SUBLIMAZE PRESERVATIVE FREE + AKORN EQ 0.05MG BASE/ML
SPRAY, METERED; NASAL LAZANDA ARCHIMEDES XX XX + TABLET; BUCCAL FENTANYL CITRATE WATSON LABS AB AB AB AB AB FENTORA CEPHALON AB AB AB + AB AB TABLET; SUBLINGUAL ABSTRAL PROSTRAKAN INC XX XX XX XX + XX
100MCG 400MCG
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
0.1MG 0.2MG 0.4MG 0.6MG 0.8MG 0.1MG 0.2MG 0.4MG 0.6MG 0.8MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A079075 A079075 A079075 A079075 A079075 N021947 N021947 N021947 N021947 N021947
001 002 003 004 005 001 002 003 004 005
Jan Jan Jan Jan Jan Sep Sep Sep Sep Sep
07, 07, 07, 07, 07, 25, 25, 25, 25, 25,
2011 2011 2011 2011 2011 2006 2006 2006 2006 2006
EQ EQ EQ EQ EQ
EQ 0.8MG BASE
N022510 006
TROCHE/LOZENGE; TRANSMUCOSAL ACTIQ CEPHALON AB EQ 0.2MG BASE AB + EQ 0.4MG BASE AB EQ 0.6MG BASE AB EQ 0.8MG BASE AB EQ 1.2MG BASE AB EQ 1.6MG BASE FENTANYL CITRATE BARR AB EQ 0.2MG BASE AB EQ 0.4MG BASE AB EQ 0.6MG BASE AB EQ 0.8MG BASE AB EQ 1.2MG BASE AB EQ 1.6MG BASE MALLINCKRODT AB EQ 0.2MG BASE AB EQ 0.4MG BASE AB EQ 0.6MG BASE AB EQ 0.8MG BASE AB EQ 1.2MG BASE AB EQ 1.6MG BASE
N020747 N020747 N020747 N020747 N020747 N020747 A077312 A077312 A077312 A077312 A077312 A077312 A078907 A078907 A078907 A078907 A078907 A078907
001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006
Nov Nov Nov Nov Nov Nov Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct
04, 04, 04, 04, 04, 04, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30,
1998 1998 1998 1998 1998 1998 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
FERRIC HEXACYANOFERRATE(II)
CAPSULE; ORAL
RADIOGARDASE (PRUSSIAN BLUE)
500MG XX + HEYL CHEMISCH
N021626 001
FERUMOXIDES
INJECTABLE; INJECTION
FERIDEX I.V.
XX + AMAG PHARMS INC
EQ 11.2MG IRON/ML
N020416 001
FERUMOXSIL
SUSPENSION; ORAL
GASTROMARK
XX + AMAG PHARMS INC
EQ 0.175MG IRON/ML
N020410 001
FERUMOXYTOL
SOLUTION; INTRAVENOUS
FERAHEME
XX + AMAG PHARMS INC
N022180 001
FESOTERODINE FUMARATE
TABLET, EXTENDED RELEASE; ORAL TOVIAZ PFIZER 4MG XX 8MG XX +
FEXOFENADINE HYDROCHLORIDE
SUSPENSION; ORAL
ALLEGRA
XX + SANOFI AVENTIS US
30MG/5ML
N021963 001
A076191 001
A076191 A076191 A076502 A076502 A076502 A077081 A077081 A077081 A076447 A076447 A076447
002 003 001 002 003 002 003 001 001 002 003
Aug Aug Apr Apr Apr Apr Apr Apr Sep Sep Sep
31, 31, 11, 11, 11, 11, 11, 16, 01, 01, 01,
2005 2005 2006 2006 2006 2008 2008 2007 2005 2005 2005
FIDAXOMICIN
TABLET; ORAL DIFICID XX + OPTIMER PHARMS
200MG
N201699 001
FINASTERIDE
TABLET; ORAL FINASTERIDE ACCORD HLTHCARE INC ACTAVIS TOTOWA AUROBINDO PHARMA DR REDDYS LABS INC DR REDDYS LABS LTD GEDEON RICHTER USA HETERO DRUGS LTD MYLAN SUN PHARMA GLOBAL TEVA ZYDUS PHARMS USA INC PROPECIA + MERCK PROSCAR + MERCK
AB AB AB AB AB AB AB AB AB AB AB AB AB
5MG 5MG 5MG 1MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 1MG 5MG
A090121 A077914 A078341 A076436 A076437 A077251 A090061 A077578 A090507 A076511 A078900
001 001 001 001 001 001 001 001 001 001 001
Feb Mar Oct Jul Feb Dec Jun Dec Aug Dec Dec
23, 28, 30, 28, 28, 22, 07, 18, 16, 15, 28,
2010 2007 2007 2006 2007 2006 2010 2006 2011 2006 2009
FINGOLIMOD
CAPSULE; ORAL
GILENYA
XX + NOVARTIS
0.5MG
N022527 001
FLAVOXATE HYDROCHLORIDE
TABLET; ORAL FLAVOXATE HYDROCHLORIDE EPIC PHARMA 100MG AB IMPAX PHARMS 100MG AB 100MG AB + PADDOCK LLC
50MG 100MG 150MG 50MG 100MG 150MG 50MG 100MG 150MG 50MG 100MG 150MG 50MG 100MG 150MG 50MG 100MG 150MG
A075442 A075442 A075442 A079164 A079164 A079164 A075882 A075882 A075882 A076421 A076421 A076421 A076278 A076278 A076278
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jul Jul Jul Jul Jul Jul Oct Oct Oct Mar Mar Mar Jan Jan Jan
31, 31, 31, 09, 09, 09, 28, 28, 28, 28, 28, 28, 14, 14, 14,
2001 2001 2001 2009 2009 2009 2002 2002 2002 2003 2003 2003 2003 2003 2003
FLOXURIDINE
INJECTABLE; INJECTION FLOXURIDINE APP PHARMS AP AP + BEDFORD
500MG/VIAL 500MG/VIAL
FLUCONAZOLE
FOR SUSPENSION; ORAL DIFLUCAN PFIZER AB AB + FLUCONAZOLE AUROBINDO PHARM AB AB IVAX SUB TEVA PHARMS AB AB RANBAXY AB AB ROXANE AB AB TARO PHARM INDS AB AB
50MG/5ML 200MG/5ML 50MG/5ML 200MG/5ML 50MG/5ML 200MG/5ML 50MG/5ML 200MG/5ML 50MG/5ML 200MG/5ML 50MG/5ML 200MG/5ML
N020090 001 N020090 002 A079150 A079150 A077523 A077523 A076332 A076332 A076246 A076246 A076918 A076918 001 002 001 002 001 002 001 002 001 002
Dec 23, 1993 Dec 23, 1993 Sep Sep Sep Sep Jul Jul Jul Jul Dec Dec 18, 18, 12, 12, 29, 29, 29, 29, 18, 18, 2009 2009 2007 2007 2004 2004 2004 2004 2006 2006
AP AP AP AP AP AP AP AP AP
INJECTABLE; INJECTION DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER + PFIZER 200MG/100ML (2MG/ML) + 400MG/200ML (2MG/ML) DIFLUCAN IN SODIUM CHLORIDE 0.9% + PFIZER 200MG/100ML (2MG/ML) + 400MG/200ML (2MG/ML) DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER + PFIZER 200MG/100ML (2MG/ML) + 400MG/200ML (2MG/ML) FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ACS DOBFAR INFO SA 200MG/100ML (2MG/ML) 400MG/200ML (2MG/ML) FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER APOTEX INC 200MG/100ML (2MG/ML)
N019950 003 N019950 005 N019950 001 N019950 006 N019950 002 N019950 004 A079104 001 A079104 002 A076888 001
Sep 29, 1992 Jul 08, 1994 Jan 29, 1990 Jan 29, 1990 Jan 29, 1990 Jan 29, 1990 Jul 30, 2009 Jul 30, 2009 Mar 25, 2005
A076888 002 A076304 001 A076304 002 A076145 A076145 A076087 A076087 A077947 A077947 A076736 A076653 A076653 A076766 A076766 A078107 A078107 A077909 A077909 A076303 A076303 A076837 A076837 001 002 001 003 001 002 001 001 002 001 002 001 002 001 002 001 002 001 002
Mar 25, 2005 Jul 29, 2004 Jul 29, 2004 Jul Jul Jul Jul May May Aug Jul Jul Jul Jul Jul Jul May May Jul Jul Jan Jan 29, 29, 29, 29, 26, 26, 23, 29, 29, 29, 29, 30, 30, 26, 26, 29, 29, 13, 13, 2004 2004 2004 2004 2010 2010 2005 2004 2004 2004 2004 2008 2008 2010 2010 2004 2004 2005 2005
50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG
N019949 N019949 N019949 N019949 A078423 A078423 A078423 A078423 A076665 A076665 A076665 A076665 A077731 A077731 A077731 A077731 A077253 A077253 A077253 A077253 A076077 A076077 A076077 A076077 A076042
001 002 004 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001
Jan Jan Jun Jan Mar Mar Mar Mar Jul Jul Jul Jul Oct Oct Oct Oct Jan Jan Jan Jan Jul Jul Jul Jul Jul
29, 29, 30, 29, 07, 07, 07, 07, 29, 29, 29, 29, 07, 07, 07, 07, 25, 25, 25, 25, 29, 29, 29, 29, 29,
1990 1990 1994 1990 2011 2011 2011 2011 2004 2004 2004 2004 2008 2008 2008 2008 2006 2006 2006 2006 2004 2004 2004 2004 2004
50MG 100MG 100MG 150MG 150MG 200MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 200MG 50MG 100MG 150MG 200MG 50MG 100MG 150MG 200MG
A076351 A076042 A076351 A076042 A076351 A076042 A076351 A076386 A076386 A076386 A076386 A076507 A076507 A076507 A076507 A074681 A074681 A074681 A074681 A076957 A076957 A076957 A076658 A076658 A076658 A076658 A076424 A076424 A076424 A076424
001 002 002 003 003 004 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 003 004
Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Sep Sep Sep Jul Jul Jul Jul Jul Jul Jul Jul
29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 28, 28, 28, 29, 29, 29, 29, 29, 29, 29, 29,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2005 2005 2005 2004 2004 2004 2004 2004 2004 2004 2004
FLUCYTOSINE
CAPSULE; ORAL ANCOBON VALEANT AB AB + FLUCYTOSINE SIGMAPHARM LABS LLC AB AB
N017001 001 N017001 002 A201566 001 A201566 002 Jun 28, 2011 Jun 28, 2011
FLUDARABINE PHOSPHATE
INJECTABLE; INJECTION FLUDARA AP + GENZYME FLUDARABINE PHOSPHATE ACTAVIS TOTOWA AP APP PHARMS AP AP BIONICHE PHARMA USA AP HOSPIRA AP ONCO THERAPIES LTD AP AP + SANDOZ TEVA PARENTERAL AP AP +
50MG/VIAL 50MG/VIAL 50MG/2ML (25MG/ML) 50MG/VIAL 50MG/2ML (25MG/ML) 50MG/VIAL 50MG/2ML (25MG/ML) 50MG/2ML (25MG/ML) 50MG/VIAL 50MG/2ML (25MG/ML)
N020038 001 A078610 A078393 A078544 A090724 A077790 A200647 N022137 A076349 A076661 001 001 001 001 001 001 001 001 001
Apr 18, 1991 Feb Oct Oct Sep Apr Dec Sep Aug Apr 11, 15, 15, 27, 06, 21, 21, 28, 28, 2009 2007 2007 2010 2007 2011 2007 2003 2004
TABLET; ORAL
OFORTA
XX + SANOFI AVENTIS US
10MG
N022273 001
FLUDEOXYGLUCOSE F-18
INJECTABLE; INTRAVENOUS FLUDEOXYGLUCOSE F18 + FEINSTEIN PETNET FLUDEOXYGLUCOSE F 18 + WEILL MEDCL COLL FLUDEOXYGLUCOSE F18 + FEINSTEIN
AP AP XX XX
Aug 19, 2005 Feb 25, 2011 Aug 05, 2004 Nov 21, 2008
FLUDROCORTISONE ACETATE
TABLET; ORAL FLUDROCORTISONE ACETATE BARR AB 0.1MG AB + IMPAX LABS 0.1MG WEST-WARD PHARM CORP 0.1MG AB
FLUMAZENIL
INJECTABLE; INJECTION FLUMAZENIL APP PHARMS AP AP BAXTER HLTHCARE AP AP BEDFORD LABS AP AP CLARIS LIFESCIENCES AP AP HIKMA FARMACEUTICA AP AP PFIZER AP AP SANDOZ AP AP TEVA PARENTERAL AP AP ROMAZICON AP + HOFFMANN LA ROCHE AP
0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 1MG/10ML (0.1MG/ML) 0.5MG/5ML (0.1MG/ML)
A076955 A076955 A076787 A076787 A076256 A076256 A076755 A076755 A078527 A078527 A078595 A078595 A077071 A077071 A076589 A076589
002 001 002 001 002 001 002 001 001 002 001 002 002 001 002 001
Oct Oct Oct Oct Oct Oct Oct Oct Mar Mar May May May May Oct Oct
12, 12, 12, 12, 12, 12, 12, 12, 23, 23, 13, 13, 03, 03, 12, 12,
2004 2004 2004 2004 2004 2004 2004 2004 2009 2009 2008 2008 2005 2005 2004 2004
FLUNISOLIDE
0.59MG
N021737 001
Feb 03, 1988 Nov 09, 2005 Oct 17, 2011 Oct 17, 2011
0.01% 0.1%
AT AT AT AT
SHAMPOO; TOPICAL
CAPEX
XX + GALDERMA LABS LP SOLUTION; TOPICAL FLUOCINOLONE ACETONIDE FOUGERA AT TARO AT SYNALAR AT + MEDIMETRIKS PHARMS
0.01%
N020001 001
0.01%;4%;0.05%
N021112 001
FLUOCINONIDE
CREAM; TOPICAL FLUOCINONIDE ACTAVIS MID ATLANTIC AB1 FOUGERA AB1 TARO AB1 TEVA AB1 LIDEX AB1 + MEDICIS
N016908 002
A076586 001 A072494 001 A072490 001 N016908 003 N021758 001
AB AB AB AB
AB AB AB AB
AT AT AT AT AT
N018849 001
FLUORESCEIN SODIUM
INJECTABLE; INTRAVENOUS AK-FLUOR 10% AKORN AP FLUORESCITE AP + ALCON PHARMS LTD
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
FLUOROMETHOLONE
OINTMENT; OPHTHALMIC
FML
XX + ALLERGAN
0.1%
N017760 001
SUSPENSION/DROPS; OPHTHALMIC
FML
0.1% XX + ALLERGAN FML FORTE ALLERGAN 0.25% XX
FLUOROMETHOLONE ACETATE
SUSPENSION/DROPS; OPHTHALMIC
FLAREX
XX + ALCON 0.1%
N019079 001
FLUOROURACIL
CREAM; TOPICAL
EFUDEX
AB + VALEANT PHARM INTL
5%
N016831 003
AB AB XX XX
5% 5% 0.5% 1%
AP AP AP AP AP AP AP AP AP AP AP AP AP AP
500MG/10ML (50MG/ML) 1GM/20ML (50MG/ML) 2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML) 500MG/10ML (50MG/ML) 1GM/20ML (50MG/ML) 2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML) 500MG/10ML (50MG/ML) 2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML) 500MG/10ML (50MG/ML) 2.5GM/50ML (50MG/ML) 5GM/100ML (50MG/ML)
A040279 A040279 A040278 A040278 A040743 A040743 A040798 A040798 A040772 A091299 A091299 A040333 A040334 A040334
002 001 001 002 002 001 002 001 001 001 002 001 001 002
Sep Sep Sep Sep Apr Apr Apr Apr Aug May May Jan Feb Feb
30, 30, 30, 30, 26, 26, 26, 26, 11, 02, 02, 27, 25, 25,
1998 1998 1998 1998 2007 2007 2007 2007 2008 2011 2011 2000 2000 2000
2% 5% 2% 5%
N016831 001 N016831 002 A076526 001 A076526 002 Nov 05, 2003 Nov 05, 2003
FLUOXETINE HYDROCHLORIDE
CAPSULE; ORAL FLUOXETINE HYDROCHLORIDE ALEMBIC PHARMS LTD AB EQ AUROBINDO PHARMA AB EQ DR REDDYS LABS INC AB EQ IVAX SUB TEVA PHARMS EQ AB MYLAN AB EQ RANBAXY AB EQ SANDOZ AB EQ TEVA AB EQ WOCKHARDT AB EQ PROZAC AB + LILLY EQ FLUOXETINE HYDROCHLORIDE ALEMBIC PHARMS LTD AB1 EQ AB1 EQ ALPHAPHARM AB1 EQ AB1 EQ AUROBINDO PHARMA AB1 EQ AB1 EQ BARR AB1 EQ AB1 EQ BEIJING DOUBLE CRANE EQ AB1 AB1 EQ CARLSBAD AB1 EQ AB1 EQ
40MG BASE 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N018936 003 A090223 A090223 A075577 A075577 A078619 A078619 A074803 A074803 A076165 A076165 A076022 A076022 001 002 001 002 001 002 002 001 001 002 001 002
Jun 15, 1999 Mar Mar Jan Jan Jan Jan Jan Aug Feb Feb Jan Jan 19, 19, 29, 29, 31, 31, 30, 02, 01, 01, 30, 30, 2009 2009 2002 2002 2008 2008 2002 2001 2002 2002 2002 2002
10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A075465 A075465 A075245 A075245 A075464 A075464 A075658 A075658 A075207 A075207 A076001 A076001 A075049 A075049 A075452 A075452 A078143 A078143
001 002 002 001 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Aug Jan Jan Jan Jan Jan
29, 29, 31, 31, 30, 30, 29, 29, 30, 30, 29, 29, 02, 29, 29, 29, 16, 16,
2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2001 2002 2002 2002 2008 2008
10MG BASE 20MG BASE 10MG 20MG 10MG 20MG 10MG 20MG BASE BASE BASE BASE BASE BASE
N018936 006 N018936 001 A078045 A078045 A077469 A077469 A076287 A076287 001 002 001 002 001 002
Dec 23, 1992 Dec 29, 1987 Nov Nov Nov Nov May May 17, 17, 17, 17, 20, 20, 2008 2008 2008 2008 2008 2008
CAPSULE, DELAYED REL PELLETS; ORAL FLUOXETINE HYDROCHLORIDE BARR EQ 90MG BASE AB DR REDDYS LABS LTD EQ 90MG BASE AB PROZAC WEEKLY AB + LILLY EQ 90MG BASE SOLUTION; ORAL FLUOXETINE HYDROCHLORIDE AUROBINDO PHARM EQ LANNETT EQ MALLINCKRODT EQ NOVEX EQ + PHARM ASSOC EQ SILARX EQ TEVA EQ WOCKHARDT EQ TABLET; ORAL FLUOXETINE HYDROCHLORIDE DR REDDYS LABS INC EQ MYLAN EQ TEVA EQ FLUOXETINE HYDROCHLORIDE EDGEMONT PHARMS LLC EQ + MYLAN EQ SARAFEM WARNER CHILCOTT EQ
AA AA AA AA AA AA AA AA
AB AB AB XX XX XX
10MG BASE 10MG BASE 10MG BASE 60MG BASE 20MG BASE 10MG BASE
A076006 001 A075755 001 A075872 001 N202133 001 A075755 002 N021860 001
Jan 30, 2002 Aug 02, 2001 Jan 29, 2002 Oct 06, 2011 Aug 02, 2001 May 19, 2006
EQ EQ EQ EQ EQ
3MG BASE 6MG BASE 12MG BASE 6MG BASE 12MG BASE
FLUOXYMESTERONE
TABLET; ORAL
FLUOXYMESTERONE
XX + USL PHARMA
10MG
A088342 001
FLUPHENAZINE DECANOATE
INJECTABLE; INJECTION FLUPHENAZINE DECANOATE AO + APP PHARMS BEDFORD AO CLARIS LIFESCIENCES AO
FLUPHENAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
FLUPHENAZINE HYDROCHLORIDE
5MG/ML XX + PHARM ASSOC
ELIXIR; ORAL
FLUPHENAZINE HYDROCHLORIDE
2.5MG/5ML XX + PHARM ASSOC
INJECTABLE; INJECTION
FLUPHENAZINE HYDROCHLORIDE
2.5MG/ML XX + APP PHARMS TABLET; ORAL FLUPHENAZINE HYDROCHLORIDE LANNETT AB 1MG AB 2.5MG AB 5MG AB 10MG MYLAN AB 1MG AB 2.5MG AB 5MG AB + 10MG SANDOZ AB 1MG AB 2.5MG AB 5MG AB 10MG
A074725 001
A040146 001
A089556 001
A089740 A089741 A089742 A089743 A089804 A089804 A089804 A089804 A089583 A089584 A089585 A089586
001 001 001 001 002 003 004 001 001 001 001 001
Aug Aug Aug Aug Aug Aug Aug Aug Oct Oct Oct Oct
25, 25, 25, 25, 12, 12, 12, 12, 16, 16, 16, 16,
1988 1988 1988 1988 1988 1988 1988 1988 1987 1987 1987 1987
FLURANDRENOLIDE
CREAM; TOPICAL CORDRAN SP WATSON PHARMS XX
0.025%
N012806 003
LOTION; TOPICAL
CORDRAN
XX + WATSON LABS
TAPE; TOPICAL
CORDRAN
XX + WATSON PHARMS
0.05%
N013790 001
0.004MG/SQ CM
N016455 001
FLURAZEPAM HYDROCHLORIDE
CAPSULE; ORAL FLURAZEPAM HYDROCHLORIDE MYLAN PHARMS INC 15MG + 30MG WATSON LABS 15MG 30MG 30MG WEST WARD 15MG 30MG
AB AB AB AB AB AB AB
FLURBIPROFEN
TABLET; ORAL ANSAID PHARMACIA AND UPJOHN AB AB + FLURBIPROFEN CARACO AB AB MYLAN AB AB TEVA AB
N018766 002 N018766 003 A075058 A075058 A074358 A074358 A074431 001 002 001 002 001
Oct 31, 1988 Oct 31, 1988 Apr Apr Jun Jun May 27, 27, 20, 20, 31, 2001 2001 1994 1994 1995
FLURBIPROFEN SODIUM
SOLUTION/DROPS; OPHTHALMIC FLURBIPROFEN SODIUM BAUSCH AND LOMB AT 0.03% OCUFEN AT + ALLERGAN 0.03%
FLUTAMIDE
CAPSULE; ORAL FLUTAMIDE IVAX SUB TEVA PHARMS MYLAN PAR PHARM + SANDOZ WATSON LABS
AB AB AB AB AB
FLUTICASONE FUROATE
0.0275MG/INH
N022051 001
FLUTICASONE PROPIONATE
AEROSOL, METERED; INHALATION FLOVENT HFA 0.044MG/INH XX + GLAXO GRP LTD 0.11MG/INH XX + 0.22MG/INH XX +
AB AB AB AB AB AB
N019958 001 A076451 A077055 A076865 A076793 A076633 001 001 001 001 001
Dec 18, 1990 May Jun Sep May May 14, 30, 10, 14, 14, 2004 2006 2004 2004 2004
LOTION; TOPICAL CUTIVATE AB + FOUGERA PHARMS FLUTICASONE PROPIONATE GLENMARK GENERICS AB OINTMENT; TOPICAL CUTIVATE + FOUGERA PHARMS FLUTICASONE PROPIONATE ALTANA G AND W LABS PERRIGO NEW YORK
0.05% 0.05%
AB AB AB AB
Dec 14, 1990 May 14, 2004 Mar 03, 2006 May 14, 2004
POWDER; INHALATION
FLOVENT DISKUS 100
XX + GLAXOSMITHKLINE FLOVENT DISKUS 250 XX + GLAXOSMITHKLINE FLOVENT DISKUS 50 XX + GLAXOSMITHKLINE SPRAY, METERED; NASAL FLONASE + GLAXOSMITHKLINE FLUTICASONE PROPIONATE APOTEX INC HI TECH PHARMA ROXANE WOCKHARDT
AB AB AB AB AB
N020121 001 A077538 A077570 A076504 A078492 001 001 001 001
Oct 19, 1994 Sep Jan Feb Jan 12, 16, 22, 09, 2007 2008 2006 2012
FLUVASTATIN SODIUM
CAPSULE; ORAL
LESCOL
NOVARTIS
XX XX +
N021192 001
FLUVOXAMINE MALEATE
CAPSULE, EXTENDED RELEASE; ORAL LUVOX CR JAZZ 100MG XX 150MG XX + TABLET; ORAL FLUVOXAMINE MALEATE APOTEX AB AB AB BARR AB AB AB CARACO AB AB AB MYLAN AB AB AB SANDOZ AB AB AB + TEVA AB AB AB LUVOX ANI PHARMS AB AB AB
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG
A075902 A075902 A075902 A075897 A075897 A075897 A075900 A075900 A075900 A075889 A075889 A075889 A075888 A075888 A075888 A075893 A075893 A075893
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
May May May Jan Jan Jan Feb Feb Feb Nov Nov Nov Nov Nov Nov Sep Sep Sep
07, 07, 07, 25, 25, 25, 23, 23, 23, 29, 29, 29, 29, 29, 29, 10, 10, 10,
2001 2001 2001 2001 2001 2001 2006 2006 2006 2000 2000 2000 2000 2000 2000 2002 2002 2002
FOLIC ACID
INJECTABLE; INJECTION
FOLIC ACID
XX + APP PHARMS TABLET; ORAL FOLIC ACID + AMNEAL PHARM CONTRACT PHARMACAL EXCELLIUM INVAGEN PHARMS JUBILANT CADISTA VINTAGE + WATSON LABS WEST WARD
5MG/ML
A089202 001
AA AA AA AA AA AA AA AA
Jul 21, 2005 Jan Jun Jun Jun 12, 09, 14, 04, 2009 2009 2005 2010
FOLLITROPIN ALFA/BETA
INJECTABLE; SUBCUTANEOUS FOLLISTIM AQ + ORGANON USA INC + + + +
XX XX XX XX XX
INJECTABLE; SUBCUTANEOUS
GONAL-F
XX + EMD SERONO XX GONAL-F RFF XX + EMD SERONO GONAL-F RFF PEN XX + EMD SERONO XX + XX +
450 IU/VIAL 1,050 IU/VIAL 75 IU/VIAL 300 IU/0.5ML 450 IU/0.75ML 900 IU/1.5ML
N020378 005 N020378 004 N021765 002 N021684 001 N021684 002 N021684 003
Mar 26, 2004 Feb 28, 2001 Mar 25, 2004 May 25, 2004 May 25, 2004 May 25, 2004
FOMEPIZOLE
INJECTABLE; INJECTION ANTIZOL + PALADIN LABS FOMEPIZOLE BIONICHE PHARMA USA LUITPOLD NAVINTA LLC SYNERX PHARMA
AP AP AP AP AP
1.5GM/1.5ML (1GM/ML) 1.5GM/1.5ML 1.5GM/1.5ML 1.5GM/1.5ML 1.5GM/1.5ML (1GM/ML) (1GM/ML) (1GM/ML) (1GM/ML)
N020696 001 A079033 A078368 A078537 A078639 001 001 001 001
Dec 04, 1997 Apr Dec Mar Mar 07, 14, 06, 03, 2009 2007 2008 2008
FONDAPARINUX SODIUM
INJECTABLE; SUBCUTANEOUS ARIXTRA + GLAXOSMITHKLINE + + + FONDAPARINUX SODIUM DR REDDYS LABS LTD
AP AP AP AP AP AP AP AP
FORMOTEROL FUMARATE
POWDER; INHALATION
FORADIL
XX + NOVARTIS
SOLUTION; INHALATION
PERFOROMIST
XX + DEY PHARMA
0.012MG/INH
N020831 001
0.02MG/2ML
N022007 001
FOSAMPRENAVIR CALCIUM
SUSPENSION; ORAL
LEXIVA
XX + VIIV HLTHCARE
TABLET; ORAL
LEXIVA
XX + VIIV HLTHCARE
EQ 50MG BASE/ML
N022116 001
EQ 700MG BASE
N021548 001
FOSCARNET SODIUM
INJECTABLE; INJECTION FOSCARNET SODIUM HOSPIRA AP FOSCAVIR AP + CLINIGEN HLTHCARE
2.4GM/100ML 2.4GM/100ML
FOSFOMYCIN TROMETHAMINE
EQ 3GM BASE/PACKET
N050717 001
FOSINOPRIL SODIUM
TABLET; ORAL FOSINOPRIL SODIUM APOTEX INC AB AB AB AUROBINDO PHARMA LTD AB AB AB INVAGEN PHARMS AB AB AB RANBAXY AB AB AB SANDOZ AB AB AB TEVA AB AB AB + WATSON LABS AB AB AB AB AB AB WATSON LABS FLORIDA AB AB AB MONOPRIL BRISTOL MYERS SQUIBB AB AB AB +
10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 10MG 20MG 20MG 40MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG
A076906 A076906 A076906 A091163 A091163 A091163 A077222 A077222 A077222 A076580 A076580 A076580 A076483 A076483 A076483 A076139 A076139 A076139 A076987 A077531 A076987 A077531 A076987 A077531 A076620 A076620 A076620
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003
May May May Mar Mar Mar Apr Apr Apr Apr Apr Apr Apr Apr Apr Nov Nov Nov Dec Aug Dec Aug Dec Aug Oct Oct Oct
17, 17, 17, 30, 30, 30, 20, 20, 20, 23, 23, 23, 23, 23, 23, 25, 25, 25, 23, 31, 23, 31, 23, 31, 15, 15, 15,
2005 2005 2005 2011 2011 2011 2005 2005 2005 2004 2004 2004 2004 2004 2004 2003 2003 2003 2004 2006 2004 2006 2004 2006 2004 2004 2004
FOSINOPRIL; HYDROCHLOROTHIAZIDE
TABLET; ORAL FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE EMCURE PHARMS USA AB 10MG;12.5MG AB 20MG;12.5MG
FOSPHENYTOIN SODIUM
INJECTABLE; INJECTION FOSPHENYTOIN SODIUM APOTEX INC + APP PHARMS BAXTER HLTHCARE BEDFORD HIKMA FARMACEUTICA HOSPIRA LUITPOLD PFIZER STRIDES ARCOLAB SUN PHARMA GLOBAL TEVA PARENTERAL WOCKHARDT
AP AP AP AP AP AP AP AP AP AP AP AP AP
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG
PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PNENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN PHENYTOIN
NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML NA/ML
A078126 A078052 A077989 A077481 A078765 A078158 A078277 A090099 A078476 A078736 A078417 A076886 A078137
001 001 001 001 001 001 001 001 001 001 001 001 001
Aug Aug Aug Aug Dec Aug Aug May Mar Jun Mar Aug Aug
06, 06, 06, 06, 02, 06, 06, 13, 18, 08, 18, 06, 06,
2007 2007 2007 2007 2009 2007 2007 2010 2008 2010 2008 2007 2007
FOSPROPOFOL DISODIUM
SOLUTION; INTRAVENOUS
LUSEDRA
XX + EISAI INC
1050MG/30ML (35MG/ML)
N022244 001
FROVATRIPTAN SUCCINATE
TABLET; ORAL
FROVA
XX + ENDO PHARMS
EQ 2.5MG BASE
N021006 001
FULVESTRANT
INJECTABLE; INTRAMUSCULAR
FASLODEX
50MG/ML XX + ASTRAZENECA
N021344 001
FUROSEMIDE
INJECTABLE; INJECTION FUROSEMIDE APP PHARMS AP HOSPIRA AP AP AP INTL MEDICATION AP AP + LUITPOLD
10MG/ML
A077941 001
20MG 40MG 80MG 20MG 40MG 80MG 20MG 40MG 80MG 20MG 40MG 20MG 40MG 80MG 20MG 40MG 80MG 20MG 40MG 80MG 20MG 40MG 80MG 20MG 20MG 20MG 40MG 80MG 80MG 20MG 40MG 80MG
N018415 N018415 N018415 A077293 A077293 A077293 A078010 A078010 A078010 N018413 N018413 N018487 N018487 A070082 N018823 N018823 A070086 N018569 N018569 N018569 A076796 A076796 A076796 A070412 A070449 A071379 A070450 A070528 A071594
001 002 003 001 002 003 001 002 003 001 002 001 002 001 001 002 001 002 001 005 001 002 003 001 001 001 001 001 001
Jul Jul Nov Nov Nov Nov Sep Sep Sep Nov Nov
27, 27, 26, 09, 09, 09, 18, 18, 18, 30, 30,
1982 1982 1984 2005 2005 2005 2006 2006 2006 1983 1983
Aug Mar Mar Mar Feb Nov Jan Nov Jan Feb
14, 26, 26, 26, 26, 22, 02, 22, 07, 09,
1984 2004 2004 2004 1986 1985 1987 1985 1986 1988
GABAPENTIN
CAPSULE; ORAL GABAPENTIN ACTAVIS ELIZABETH AB AB AB ALKEM AB AB AB AMNEAL PHARMS NY AB AB AB APOTEX INC AB AB
100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG
A075350 A075350 A075350 A090858 A090858 A090858 A078428 A078428 A078428 A075360 A075360
001 002 003 001 002 003 001 002 003 001 002
Sep Sep Sep Dec Dec Dec Jul Jul Jul Apr Apr
12, 12, 12, 17, 17, 17, 25, 25, 25, 06, 06,
2003 2003 2003 2010 2010 2010 2007 2007 2007 2005 2005
400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG 100MG 300MG 400MG
A075360 A078787 A078787 A078787 A078150 A078150 A078150 A090705 A090705 A090705 A090007 A090007 A090007 A090158 A090158 A090158 A076606 A076606 A076606 A077242 A077242 A077242 A075435 A075435 A075435 A075485 A075485 A075485
003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 003 002 001
Apr Jan Jan Jan Sep Sep Sep Dec Dec Dec Jul Jul Jul Feb Feb Feb Oct Oct Oct Aug Aug Aug Oct Oct Oct May May May
06, 31, 31, 31, 25, 25, 25, 30, 30, 30, 21, 21, 21, 14, 14, 14, 07, 07, 07, 24, 24, 24, 08, 08, 08, 11, 11, 11,
2005 2008 2008 2008 2007 2007 2007 2009 2009 2009 2011 2011 2011 2011 2011 2011 2005 2005 2005 2006 2006 2006 2004 2004 2004 2007 2007 2007
250MG/5ML 250MG/5ML
600MG 800MG 100MG 300MG 400MG 600MG 800MG 600MG 800MG 600MG 800MG 600MG 800MG 100MG 300MG 400MG 600MG 800MG
A075694 A075694 A077894 A077894 A077894 A077661 A077661 A200651 A200651 A077662 A077662 A078782 A078782 A076017 A076017 A076017 A076017 A076017
001 002 001 002 003 004 005 001 002 001 002 001 002 001 002 003 004 005
Oct Oct Oct Oct Oct Sep Sep Oct Oct Aug Aug Jul Jul Apr Apr Apr Apr Apr
21, 21, 10, 10, 10, 13, 13, 06, 06, 18, 18, 21, 21, 28, 28, 28, 29, 29,
2004 2004 2006 2006 2006 2006 2006 2011 2011 2006 2006 2011 2011 2004 2004 2004 2005 2005
600MG 800MG 600MG 800MG 600MG 800MG 600MG 800MG 300MG 600MG
Oct 09, 1998 Oct 09, 1998 Jan 28, 2011 Jan 28, 2011
GABAPENTIN ENACARBIL
TABLET, EXTENDED RELEASE; ORAL
HORIZANT
XX GLAXO GRP LTD 300MG
XX + 600MG
GADOBENATE DIMEGLUMINE
INJECTABLE; INTRAVENOUS
MULTIHANCE
+ BRACCO + + + MULTIHANCE MULTIPACK + BRACCO +
XX XX XX XX XX XX
2.645GM/5ML (529MG/ML) 5.29GM/10ML (529MG/ML) 7.935GM/15ML (529MG/ML) 10.58GM/20ML (529MG/ML) 26.45GM/50ML (529MG/ML) 52.9GM/100ML (529MG/ML)
GADOBUTROL
SOLUTION; INTRAVENOUS
GADAVIST
+ BAYER HLTHCARE + + + +
XX XX XX XX XX
4.5354GM/7.5ML (604.72MG/ML) 6.0472GM/10ML (604.72MG/ML) 9.0708GM/15ML (604.72MG/ML) 18.1416GM/30ML (604.72MG/ML) 39.3068GM/65ML (604.72MG/ML)
GADODIAMIDE
INJECTABLE; INJECTION
OMNISCAN
XX + GE HEALTHCARE XX +
GADOFOSVESET TRISODIUM
SOLUTION; INTRAVENOUS
ABLAVAR
LANTHEUS MEDCL XX XX +
2440MG/10ML (244MG/ML)
3660MG/15ML (244MG/ML)
GADOPENTETATE DIMEGLUMINE
INJECTABLE; INJECTION
MAGNEVIST
XX + BAYER HLTHCARE XX +
469.01MG/ML 469.01MG/ML
279.3MG/ML 279.3MG/ML
GADOVERSETAMIDE
INJECTABLE; INJECTION
OPTIMARK
+ MALLINCKRODT 1654.5MG/5ML (330.9MG/ML) + 3309MG/10ML (330.9MG/ML) + 4963.5MG/15ML (330.9MG/ML) + 6618MG/20ML (330.9MG/ML) + 16.545GM/50ML (330.9MG/ML) OPTIMARK IN PLASTIC CONTAINER + MALLINCKRODT 3309MG/10ML (330.9MG/ML) + 4963.5MG/15ML (330.9MG/ML) + 6618MG/20ML (330.9MG/ML) + 9927MG/30ML (330.9MG/ML)
XX XX XX XX XX XX XX XX XX
GADOXETATE DISODIUM
SOLUTION; INTRAVENOUS
EOVIST
XX + BAYER HLTHCARE
1.8143GM/10ML (181.43MG/ML)
N022090 001
GALANTAMINE HYDROBROMIDE
CAPSULE, EXTENDED RELEASE; ORAL GALANTAMINE HYDROBROMIDE BARR EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE IMPAX LABS EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE MYLAN EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE SUN PHARMA GLOBAL EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE WATSON LABS EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE RAZADYNE ER + JANSSEN PHARMS EQ 8MG BASE EQ 16MG BASE EQ 24MG BASE
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A078189 A078189 A078189 A078484 A078484 A078484 A090900 A090900 A090900 A090178 A090178 A090178 A079028 A079028 A079028
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Sep Sep Sep May May May Jan Jan Jan Feb Feb Feb Dec Dec Dec
15, 15, 15, 27, 27, 27, 24, 24, 24, 02, 02, 02, 15, 15, 15,
2008 2008 2008 2009 2009 2009 2011 2011 2011 2011 2011 2011 2008 2008 2008
SOLUTION; ORAL GALANTAMINE HYDROBROMIDE ROXANE AA 4MG/ML RAZADYNE AA + JANSSEN PHARMS 4MG/ML TABLET; ORAL GALANTAMINE HYDROBROMIDE APOTEX INC EQ EQ EQ AUROBINDO PHARMA LTD EQ
AB AB AB AB
8MG BASE 12MG BASE 4MG BASE 8MG BASE 12MG BASE 4MG BASE 8MG BASE 12MG BASE 4MG BASE 4MG BASE 8MG BASE 8MG BASE 12MG BASE 12MG BASE 4MG BASE 8MG BASE 12MG BASE 4MG BASE 8MG BASE 12MG BASE 4MG BASE 8MG BASE 12MG BASE 4MG BASE 8MG BASE 12MG BASE 4MG BASE 8MG BASE 12MG BASE
A090957 A090957 A077605 A077605 A077605 A077593 A077593 A077593 A077590 A077603 A077590 A077603 A077590 A077603 A077608 A077608 A077608 A077589 A077589 A077589 A077587 A077587 A077587 A078898 A078898 A078898
002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 002 003 001 002 003
Mar Mar Aug Aug Aug Sep Sep Sep May Aug May Aug May Aug Feb Feb Feb Jun Jun Jun Jul Jul Jul Feb Feb Feb
29, 29, 28, 28, 28, 11, 11, 11, 29, 28, 29, 28, 29, 28, 11, 11, 11, 22, 22, 22, 09, 09, 09, 17, 17, 17,
2011 2011 2008 2008 2008 2008 2008 2008 2009 2008 2009 2008 2009 2008 2009 2009 2009 2009 2009 2009 2009 2009 2009 2011 2011 2011
2mCi/ML 2mCi/ML
GALLIUM NITRATE
INJECTABLE; INJECTION
GANITE
XX + GENTA
25MG/ML
N019961 002
GANCICLOVIR
CAPSULE; ORAL GANCICLOVIR RANBAXY XX XX + GEL; OPHTHALMIC
ZIRGAN
XX + BAUSCH AND LOMB IMPLANT; IMPLANTATION
VITRASERT
XX + BAUSCH AND LOMB
250MG 500MG
0.15%
N022211 001
4.5MG
N020569 001
GANIRELIX ACETATE
INJECTABLE; INJECTION
GANIRELIX ACETATE INJECTION
EQ 250MCG BASE/0.5ML XX + ORGANON USA INC
N021057 001
GATIFLOXACIN
SOLUTION/DROPS; OPHTHALMIC GATIFLOXACIN APOTEX CORP AT 0.3% ZYMAR AT + ALLERGAN 0.3% ZYMAXID 0.5% XX + ALLERGAN
GEMCITABINE HYDROCHLORIDE
INJECTABLE; INJECTION GEMCITABINE HYDROCHLORIDE ACCORD HLTHCARE EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL ACTAVIS TOTOWA EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL APP PHARMS EQ 2GM BASE/VIAL DR REDDYS LABS LTD EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL FRESENIUS KABI ONCOL EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL HOSPIRA EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL + HOSPIRA INC EQ 2GM BASE/VIAL ONCO THERAPIES LTD EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL SUN PHARMA GLOBAL EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL TEVA PARENTERAL EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL WATSON LABS EQ 200MG BASE/VIAL EQ 1GM BASE/VIAL GEMZAR + LILLY EQ 200MG BASE/VIAL + EQ 1GM BASE/VIAL GEMCITABINE + HOSPIRA INC 200MG/5.26ML (38MG/ML) + 1GM/26.3ML (38MG/ML) + 2GM/52.6ML (38MG/ML)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX XX
A091594 A091594 A091594 A079160 A079160 A090242 A091365 A091365 A090799 A090799 A090799 A078339 A078339 A079183 A200145 A200145 A200145 A078433 A078433 A077983 A077983 A078759 A078759
001 002 003 001 002 003 001 002 001 002 003 001 002 001 001 002 003 001 002 002 001 001 002
Jul Jul Jul Jul Jul May Jul Jul Jul Jul May Jul Jul Nov Jul Jul Jul Jul Jul Jan Jan Jul Jul
25, 25, 25, 25, 25, 16, 25, 25, 25, 25, 16, 25, 25, 15, 25, 25, 25, 25, 25, 25, 25, 25, 25,
2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2010 2011 2011 2011 2011 2011 2011 2011 2011 2011
N020509 001 N020509 002 N200795 001 N200795 002 N200795 003
May 15, 1996 May 15, 1996 Aug 04, 2011 Aug 04, 2011 Aug 04, 2011
GEMFIBROZIL
TABLET; ORAL GEMFIBROZIL APOTEX AB BLU CARIBE AB
600MG 600MG
AB AB AB AB AB AB AB AB AB
N018422 003
GEMIFLOXACIN MESYLATE
TABLET; ORAL
FACTIVE
XX + CORNERSTONE THERAP
EQ 320MG BASE
N021158 001
GENTAMICIN SULFATE
CREAM; TOPICAL GENTAMICIN SULFATE AT + FOUGERA PERRIGO NEW YORK AT TARO AT
INJECTABLE; INJECTION GENTAMICIN SULFATE AP + APP PHARMS EQ 10MG BASE/ML AP + EQ 40MG BASE/ML AP EQ 40MG BASE/ML HOSPIRA AP EQ 10MG BASE/ML AP EQ 10MG BASE/ML AP EQ 40MG BASE/ML GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER AP + B BRAUN EQ 0.8MG BASE/ML AP + EQ 1.2MG BASE/ML AP + EQ 1.4MG BASE/ML AP + EQ 1.6MG BASE/ML AP + EQ 1.8MG BASE/ML AP + EQ 2MG BASE/ML AP + EQ 2.4MG BASE/ML AP + EQ 40MG BASE/100ML AP + EQ 60MG BASE/100ML AP + EQ 70MG BASE/100ML AP + EQ 80MG BASE/100ML AP + EQ 90MG BASE/100ML AP + EQ 100MG BASE/100ML AP + EQ 120MG BASE/100ML HOSPIRA AP EQ 1.2MG BASE/ML AP EQ 1.4MG BASE/ML AP EQ 1.6MG BASE/ML AP EQ 1.8MG BASE/ML AP EQ 2MG BASE/ML AP EQ 60MG BASE/100ML AP EQ 70MG BASE/100ML AP EQ 80MG BASE/100ML AP EQ 90MG BASE/100ML AP EQ 100MG BASE/100ML ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER BAXTER HLTHCARE AP EQ 0.8MG BASE/ML
A062356 A062356 A062366 A062420 A062612 A062420 A062814 A062814 A062814 A062814 A062814 A062814 A062814 A062814 A062814 A062814 A062814 A062814 A062814 A062814 A062414 A062414 A062414 A062414 A062414 A062414 A062414 A062414 A062414 A062414
001 002 001 001 004 002 001 002 003 004 005 006 007 008 009 010 011 012 013 014 001 002 003 004 005 006 007 008 009 010
Mar Mar Aug Aug Feb Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug
04, 04, 04, 15, 20, 15, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 28, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15,
1982 1982 1983 1983 1986 1983 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983
A062373 001
AT AT AT AT AT AT
SOLUTION/DROPS; OPHTHALMIC GENOPTIC ALLERGAN EQ GENTAK AKORN EQ GENTAMICIN SULFATE AKORN EQ + BAUSCH AND LOMB EQ FALCON PHARMS EQ FERA PHARMS EQ
0.3% BASE 0.3% BASE 0.3% 0.3% 0.3% 0.3% BASE BASE BASE BASE
A062452 001 A064163 001 A062635 A064048 A062196 A065121 001 001 001 001
Oct 10, 1984 Oct 12, 2001 Jan 08, 1987 May 11, 1994 Jan 30, 2004
EQ 0.3% BASE;0.6%
N050612 001
SUSPENSION/DROPS; OPHTHALMIC
PRED-G
XX + ALLERGAN EQ 0.3% BASE;1%
N050586 001
GLATIRAMER ACETATE
INJECTABLE; SUBCUTANEOUS
COPAXONE
XX + TEVA
20MG/ML
N020622 002
GLIMEPIRIDE
TABLET; ORAL AMARYL AB + SANOFI AVENTIS US AB AB GLIMEPIRIDE ACCORD HLTHCARE AB AB AB CARLSBAD AB AB AB COREPHARMA AB
1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG
N020496 001 N020496 002 N020496 003 A078181 A078181 A078181 A077911 A077911 A077911 A077274 001 002 003 001 002 003 001
Nov 30, 1995 Nov 30, 1995 Nov 30, 1995 Aug Aug Aug Sep Sep Sep Oct 23, 23, 23, 22, 22, 22, 06, 2007 2007 2007 2009 2009 2009 2005
2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 1MG 2MG 2MG 4MG 4MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 1MG 2MG 4MG
A077274 A077274 A077091 A077091 A077091 A077295 A077295 A077295 A077486 A077624 A077486 A077624 A077486 A077624 A076875 A076875 A076875 A076875 A076802 A076802 A076802 A077370 A077370 A077370 A077370 A077280 A077280 A077280 A076995 A076995 A076995
002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 004 001 002 003 001 002 003 004 001 002 003 001 002 003
Oct Oct Oct Oct Oct Oct Oct Oct Feb Nov Feb Nov Feb Nov Oct Oct Oct Oct Oct Oct Oct Dec Dec Dec Dec Feb Feb Feb Apr Apr Apr
06, 06, 06, 06, 06, 06, 06, 06, 10, 28, 10, 28, 10, 28, 06, 06, 06, 06, 06, 06, 06, 23, 23, 23, 23, 03, 03, 03, 27, 27, 27,
2005 2005 2005 2005 2005 2005 2005 2005 2006 2005 2006 2005 2006 2005 2005 2005 2005 2005 2005 2005 2005 2005 2005 2005 2005 2006 2006 2006 2010 2010 2010
2MG;30MG 4MG;30MG
GLIPIZIDE
TABLET; ORAL GLIPIZIDE ACCORD HLTHCARE INC AB AB APOTEX AB AB CARACO AB AB IVAX SUB TEVA PHARMS AB
10MG 5MG 5MG 10MG 10MG 5MG 10MG 5MG 5MG 10MG 10MG 5MG 10MG
A074497 A074226 A074438 A074226 A074438 A074305 A074305 A074223 A074370 A074223 A074370
002 001 001 002 002 001 002 001 001 002 002
Aug May Jun May Jun Apr Apr Feb Nov Feb Nov
31, 10, 20, 10, 20, 07, 07, 27, 22, 27, 22,
1995 1994 1995 1994 1995 1995 1995 1995 1994 1995 1994
TABLET, EXTENDED RELEASE; ORAL GLIPIZIDE WATSON LABS AB 2.5MG AB 5MG AB 10MG GLUCOTROL XL PFIZER AB 2.5MG AB 5MG AB + 10MG
A076467 003 A076467 001 A076467 002 N020329 003 N020329 001 N020329 002
Mar 27, 2006 Sep 08, 2003 Nov 07, 2003 Aug 10, 1999 Apr 26, 1994 Apr 26, 1994
A077620 A077620 A077620 A077507 A077507 A077507 A078728 A078728 A078728 A078083 A078083 A078083 A077270 A077270 A077270 A078905 A078905 A078905
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jan Jan Jan Oct Oct Oct Jun Jun Jun Apr Apr Apr Oct Oct Oct Jan Jan Jan
11, 11, 11, 27, 27, 27, 23, 23, 23, 12, 12, 12, 28, 28, 28, 31, 31, 31,
2008 2008 2008 2005 2005 2005 2010 2010 2010 2007 2007 2007 2005 2005 2005 2011 2011 2011
EQ 1MG BASE/VIAL
N020918 001
GLUCAGON RECOMBINANT
INJECTABLE; INJECTION
GLUCAGON
XX + LILLY
1MG/VIAL
N020928 001
5GM/PACKET
N021667 001
GLYBURIDE
TABLET; ORAL GLYBURIDE AUROBINDO PHARMA AB AB AB COREPHARMA AB AB AB HERITAGE PHARMS INC AB AB AB TEVA AB AB AB + GLYBURIDE (MICRONIZED) DAVA PHARMS INC AB AB AB AB HIKMA AB AB AB MYLAN AB AB AB TEVA AB AB AB AB GLYNASE PHARMACIA AND UPJOHN AB AB AB + DIABETA BX SANOFI AVENTIS US BX BX +
1.25MG 2.5MG 5MG 1.25MG 2.5MG 5MG 1.25MG 2.5MG 5MG 1.25MG 2.5MG 5MG 1.5MG 3MG 4.5MG 6MG 1.5MG 3MG 6MG 1.5MG 3MG 6MG 1.5MG 3MG 4.5MG 6MG 1.5MG 3MG 6MG 1.25MG 2.5MG 5MG
A077537 A077537 A077537 A076257 A076257 A076257 A090937 A090937 A090937 A074388 A074388 A074388 A074591 A074591 A074591 A074591 A075890 A075890 A075890 A074792 A074792 A074792 A074686 A074686 A074686 A074686
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 004 001 002 003 001 002 003 001 002 003 004
Oct Oct Oct Jun Jun Jun Feb Feb Feb Aug Aug Aug Dec Dec Dec Dec Jul Jul Jul Jun Jun Aug Apr Apr Apr Apr
18, 18, 18, 27, 27, 27, 28, 28, 28, 29, 29, 29, 22, 22, 22, 22, 31, 31, 31, 26, 26, 17, 20, 20, 20, 20,
2007 2007 2007 2002 2002 2002 2011 2011 2011 1995 1995 1995 1997 1997 1997 1997 2003 2003 2003 1998 1998 1999 1999 1999 1999 1999
N020051 001 N020051 002 N020051 004 N017532 001 N017532 002 N017532 003
Mar 04, 1992 Mar 04, 1992 Sep 24, 1993 May 01, 1984 May 01, 1984 May 01, 1984
1.25MG;250MG 2.5MG;500MG 5MG;500MG HYDROCHLORIDE 1.25MG;250MG 2.5MG;500MG 5MG;500MG 1.25MG;250MG 2.5MG;500MG 5MG;500MG 1.25MG;250MG 2.5MG;500MG 5MG;500MG
N021178 001 N021178 002 N021178 003 A076716 A076716 A076716 A077870 A077870 A077870 A076731 A076731 A076731 001 002 003 001 002 003 001 002 003
Jul 31, 2000 Jul 31, 2000 Jul 31, 2000 Jun Jun Jun Nov Nov Nov Nov Nov Nov 28, 28, 28, 14, 14, 14, 19, 19, 19, 2005 2005 2005 2007 2007 2007 2004 2004 2004
GLYCINE
SOLUTION; IRRIGATION AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER BAXTER HLTHCARE AT 1.5GM/100ML GLYCINE 1.5% IN PLASTIC CONTAINER B BRAUN AT 1.5GM/100ML HOSPIRA AT 1.5GM/100ML
GLYCOPYRROLATE
INJECTABLE; INJECTION GLYCOPYRROLATE HIKMA FARMACEUTICA AP LUITPOLD AP ROBINUL AP + BAXTER HLTHCARE SOLUTION; ORAL
CUVPOSA
XX + SHIONOGI INC TABLET; ORAL GLYCOPYRROLATE BOCA PHARMA AA AA COREPHARMA AA AA DR REDDYS LABS LTD AA AA PAR PHARM AA AA RANBAXY AA AA VINTAGE AA AA WEST WARD AA AA ROBINUL AA + SHIONOGI INC ROBINUL FORTE AA + SHIONOGI INC
1MG/5ML
N022571 001
1MG 2MG 1MG 2MG 1MG 2MG 1MG 2MG 1MG 2MG 1MG 2MG 1MG 2MG 1MG 2MG
A090020 A090020 A040568 A040568 A040847 A040847 A040653 A040653 A040844 A040844 A040821 A040821 A040836 A040836
001 002 001 002 001 002 001 002 001 002 001 002 001 002
Oct Oct Dec Dec Mar Mar Aug Aug Aug Aug Dec Dec Mar Mar
19, 19, 22, 22, 21, 21, 31, 31, 18, 18, 29, 29, 05, 05,
2011 2011 2004 2004 2008 2008 2006 2006 2009 2009 2008 2008 2009 2009
GONADOTROPIN, CHORIONIC
INJECTABLE; INJECTION CHORIONIC GONADOTROPIN AP + APP PHARMS AP + FERRING PREGNYL AP + ORGANON USA INC
1.75MG BASE/ML;10,000
A060582 001
GRANISETRON
N022198 001
GRANISETRON HYDROCHLORIDE
INJECTABLE; INJECTION GRANISETRON HYDROCHLORIDE AKORN INC EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) APP PHARMS EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) BAXTER HLTHCARE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) BEDFORD LABS EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) CLARIS LIFESCIENCES EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) DR REDDYS LABS INC EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) EBEWE PHARMA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) LUITPOLD EQ 1MG BASE/ML (EQ 1MG BASE/ML) SAGENT STRIDES EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) SANDOZ EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) + TEVA PARENTERAL EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) + EQ 1MG BASE/ML (EQ 1MG BASE/ML) + EQ 4MG BASE/4ML (EQ 1MG BASE/ML) WATSON LABS EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) WOCKHARDT USA EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML) GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE APP PHARMS EQ 1MG BASE/ML (EQ 1MG BASE/ML)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A079119 A079078 A079078 A078522 A078090 A077177 A077913 A077186 A077187 A078197 A078198 A078198 A078863 A078880 A078808 A078835 A078835 A091274 A091136 A091136 A091137 A078534 A078531 A078531 A078392 A077963 A077297 A078262 A078258 A078258 A078566 A078564 A078565
001 002 001 001 001 001 001 001 001 001 001 002 001 001 001 001 002 001 001 002 002 001 001 002 001 001 001 001 001 002 001 001 001
Sep Sep Sep Dec Jun Dec Jun Jun Jun Dec Jun Jun Jun Jun Apr Jun Jun Sep Apr Apr Apr Apr Apr Apr Dec Jan Jun Dec Jun Jun Feb Jun Jun
10, 14, 14, 31, 30, 31, 26, 30, 30, 31, 30, 30, 30, 30, 29, 30, 30, 22, 09, 09, 09, 30, 30, 30, 31, 03, 30, 31, 30, 30, 29, 30, 30,
2009 2009 2009 2007 2008 2007 2008 2008 2008 2007 2008 2008 2008 2008 2008 2008 2008 2010 2010 2010 2010 2009 2009 2009 2007 2008 2008 2007 2008 2008 2008 2008 2008
A078096 001
AP AP AP AP
SOLUTION; ORAL
GRANISETRON HYDROCHLORIDE
EQ 2MG BASE/10ML XX + PEDIATRX TABLET; ORAL GRANISETRON HYDROCHLORIDE APOTEX INC EQ CIPLA LTD EQ COREPHARMA EQ DR REDDYS LABS LTD EQ MYLAN EQ NATCO PHARMA EQ ORCHID HLTHCARE EQ ROXANE EQ TARO EQ EQ + TEVA PHARMS
A078334 001
AB AB AB AB AB AB AB AB AB AB
1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A078843 A078037 A078260 A078846 A078725 A078969 A078678 A077842 A090817 A078080
001 001 001 001 001 001 001 001 001 001
Feb Feb Dec Feb Jan Jun Feb Dec May Dec
27, 27, 31, 27, 30, 22, 13, 31, 28, 31,
2008 2008 2007 2009 2008 2009 2008 2007 2010 2007
GRISEOFULVIN
SUSPENSION; ORAL GRISEOFULVIN VINTAGE AB
125MG/5ML
A065438 001
GRISEOFULVIN, MICROCRYSTALLINE
SUSPENSION; ORAL GRIFULVIN V + ORTHONEUTROGENA GRISEOFULVIN ACTAVIS MID ATLANTIC IVAX SUB TEVA PHARMS PERRIGO CO TENNESSEE
AB AB AB AB
Jan 26, 1984 Jul 06, 2007 Sep 10, 2007 Mar 02, 2005
TABLET; ORAL
GRIFULVIN V
XX + ORTHONEUTROGENA
500MG
A062279 003
GRISEOFULVIN, ULTRAMICROCRYSTALLINE
TABLET; ORAL
GRIS-PEG
PEDINOL
XX XX +
125MG 250MG
N050475 001
N050475 002
GUANABENZ ACETATE
TABLET; ORAL GUANABENZ ACETATE IVAX SUB TEVA PHARMS XX XX +
A074149 001
A074149 002
GUANFACINE HYDROCHLORIDE
TABLET; ORAL GUANFACINE HYDROCHLORIDE AMNEAL PHARM AB EQ 1MG BASE AB EQ 2MG BASE EPIC PHARMA AB EQ 1MG BASE
AB AB AB AB AB AB AB
TABLET, EXTENDED RELEASE; ORAL INTUNIV SHIRE EQ 1MG XX EQ 2MG XX EQ 3MG XX EQ 4MG XX +
GUANIDINE HYDROCHLORIDE
TABLET; ORAL
GUANIDINE HYDROCHLORIDE
SCHERING 125MG XX
N001546 001
HALCINONIDE
CREAM; TOPICAL
HALOG
XX + RANBAXY OINTMENT; TOPICAL
HALOG
XX + RANBAXY
0.1%
N017556 001
0.1%
N017824 001
HALOBETASOL PROPIONATE
CREAM; TOPICAL HALOBETASOL PROPIONATE ALTANA G AND W LABS PERRIGO ISRAEL TARO ULTRAVATE + RANBAXY OINTMENT; TOPICAL HALOBETASOL PROPIONATE ALTANA G AND W LABS PERRIGO TARO ULTRAVATE + RANBAXY
AB AB AB AB AB
N019967 001
AB AB AB AB AB
N019968 001
HALOPERIDOL
TABLET; ORAL HALOPERIDOL MYLAN AB AB AB AB AB AB SANDOZ AB
HALOPERIDOL DECANOATE
INJECTABLE; INJECTION HALDOL AO + JANSSEN PHARMS AO + HALOPERIDOL DECANOATE APP PHARMS AO AO BEDFORD AO AO CLARIS LIFESCIENCES AO AO TEVA PARENTERAL AO AO
EQ 50MG BASE/ML EQ 100MG BASE/ML EQ EQ EQ EQ EQ EQ EQ EQ 50MG BASE/ML 100MG BASE/ML 50MG BASE/ML 100MG BASE/ML 50MG BASE/ML 100MG BASE/ML 50MG BASE/ML 100MG BASE/ML
N018701 001 N018701 002 A074893 A074893 A074811 A075305 A075440 A075440 A075393 A075393 001 002 001 001 001 002 001 002
Jan 14, 1986 Jan 31, 1997 Dec Dec Jan Sep Feb Feb May May 19, 19, 30, 28, 28, 28, 11, 11, 1997 1997 1998 1998 2000 2000 1999 1999
HALOPERIDOL LACTATE
CONCENTRATE; ORAL HALOPERIDOL PHARM ASSOC AA SILARX AA AA + TEVA PHARMS INJECTABLE; INJECTION HALDOL + JANSSEN PHARMS HALOPERIDOL APP PHARMS BEDFORD CLARIS LIFESCIENCES GLAND PHARMA LTD PFIZER SAGENT PHARMS TEVA PARENTERAL
AP AP AP AP AP AP AP AP AP AP
EQ 5MG BASE/ML EQ EQ EQ EQ EQ EQ EQ EQ EQ 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
N015923 001 A075689 A075858 A076791 A076828 A076774 A078347 A091637 A200742 A076035 001 001 001 001 001 001 001 001 001 Mar Jun Aug Aug Aug Sep Sep Sep Aug 09, 18, 25, 25, 25, 14, 02, 02, 29, 2001 2001 2004 2004 2004 2009 2011 2011 2001
HEPARIN SODIUM
INJECTABLE; INJECTION HEPARIN SODIUM + APP PHARMS + + + + BAXTER HLTHCARE + + HOSPIRA HOSPIRA INC
AP AP AP AP AP AP AP AP AP AP
1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 5,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML
N017029 N017651 N017029 N017029 N017037 N017037 N017037 A088100 A090571 A090571
001 006 003 004 001 002 003 001 001 002
003 001 002 003 001 001 001 002 001 001 001 010 003 002 011 001 001 001 003 004 004 005 004 002 002 013 014 015 016 010 001 001 001 002 003 001 006 007 008 004
Apr 28, 1982 Jul 20, 1992 Jun 23, 1989 Mar 27, 1985 Apr 28, 1982 Jun 23, 1989 Oct 31, 1983 Jul 20, 1992 Jan 25, 1989 Jul 09, 1985 Jul 02, 1987 Jul Jul Mar Jan Mar Dec Dec Dec Dec 20, 20, 27, 25, 27, 05, 05, 05, 05, 1992 1992 1985 1989 1985 1985 1985 1985 1985
Apr 28, 1986 May 04, 1987 Jun 30, 2010 Jul 21, 2011 Jul 21, 2011 Jul 21, 2011 Mar 27, 1985 Jan 31, 1984 Jan 31, 1984 Jan 31, 1984 Jul 21, 2011
3%
N006882 001
480MG 480MG
HEXAMINOLEVULINATE HYDROCHLORIDE
N022555 001
HISTRELIN ACETATE
IMPLANT; SUBCUTANEOUS
SUPPRELIN LA
XX + ENDO PHARM VANTAS XX + ENDO PHARM
50MG 50MG
HYALURONIDASE
INJECTABLE; INJECTION
AMPHADASE
XX + AMPHASTAR PHARM HYDASE XX + AKORN INC VITRASE XX + ISTA PHARMS
INJECTABLE; INJECTION
HYLENEX RECOMBINANT
XX + HALOZYME THERAP
150 UNITS/ML
N021859 001
HYDRALAZINE HYDROCHLORIDE
INJECTABLE; INJECTION HYDRALAZINE HYDROCHLORIDE AKORN AP 20MG/ML APP PHARMS AP 20MG/ML AP + LUITPOLD 20MG/ML TABLET; ORAL HYDRALAZINE HYDROCHLORIDE GLENMARK PHARMS LTD AA 10MG AA 25MG AA 50MG
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA
A090527 A086242 A086242 A086242 A086242 A040901 A040901 A040901 A040901 A090255 A090255 A090255 A090255 A090413 A090413 A090413 A090413 A087836 A086961 A086962 A088391 A089097 A088467 A088468 A089098 A084504 A084503 A040858 A040858 A040858 A040858
004 001 003 002 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 001 001 001 001 001 001 001 001 001 002 003 004
Feb Sep Sep Sep Sep Dec Dec Dec Dec Dec Dec Dec Dec Oct
04, 12, 12, 12, 12, 15, 15, 15, 15, 08, 08, 08, 08, 05,
2010 2008 2008 2008 2008 2008 2008 2008 2008 2010 2010 2010 2010 1982
25MG;25MG 50MG;50MG
37.5MG;20MG
N020727 001
HYDROCHLOROTHIAZIDE
CAPSULE; ORAL HYDROCHLOROTHIAZIDE ALEMBIC PHARMS LTD APOTEX AUROBINDO PHARMA IPCA LABS LTD IVAX SUB TEVA PHARMS JUBILANT CADISTA MYLAN UNICHEM VINTAGE PHARMS WEST WARD
AB AB AB AB AB AB AB AB AB AB
12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG 12.5MG
A200645 A078389 A078164 A079237 A077005 A078391 A075640 A090510 A075907 A077885
001 001 001 001 001 001 001 001 001 001
Nov May Sep Apr Jul Feb Jan Jan Sep Nov
30, 16, 18, 02, 13, 11, 28, 19, 17, 26,
2010 2008 2007 2009 2005 2008 2000 2010 2002 2007
12.5MG
N020504 001
12.5MG 25MG 50MG 25MG 50MG 12.5MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 12.5MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 12.5MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 25MG 50MG 50MG
A040707 A040774 A040774 A040780 A040780 A040857 A040810 A040810 A087059 A087068 A040702 A040702 A085182 A085182 A040807 A040807 A040807 A083177 A083177 A040809 A040809 A084325 A084324 A040770 A040735 A040735 A040907 A040907 A040412 A040412 A081189 A084878 A084878
001 001 002 001 002 001 001 002 001 001 001 002 002 001 001 002 003 001 002 001 002 001 001 001 002 003 001 002 001 002 001 002 001
N011971 002
HYDROCHLOROTHIAZIDE; IRBESARTAN
TABLET; ORAL
AVALIDE
XX + SANOFI AVENTIS XX
12.5MG;150MG 12.5MG;300MG
HYDROCHLOROTHIAZIDE; LISINOPRIL
TABLET; ORAL LISINOPRIL AND HYDROCHLOROTHIAZIDE APOTEX INC AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG AUROBINDO AB 12.5MG;10MG AB 12.5MG;20MG AB 25MG;20MG IVAX SUB TEVA PHARMS 12.5MG;10MG AB AB 12.5MG;20MG AB 25MG;20MG
A077912 A077912 A077912 A076113 A076113 A076113 A076230 A076230 A076230 A076007 A076007 A076007 A076262 A076262 A076262 A076194 A076194 A076194 A076265 A076265 A076265
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 003 001 002 001 002 003
Sep Sep Sep Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul
27, 27, 27, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 08, 08, 08,
2006 2006 2006 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002
N019778 003 N019778 001 N019888 003 N019888 001 N019888 002
Nov 18, 1993 Feb 16, 1989 Nov 18, 1993 Sep 20, 1990 Jul 20, 1989
N020387 001 N020387 003 N020387 002 A090150 A090150 A090150 A091629 A091629 A091629 A078245 A078245 A078245 A091652 A091652 A091652 A077732 A077732 A077732 A077948 A077948 A077948 A077157 A077157 A077157 001 002 003 001 002 003 001 002 003 001 002 003 002 001 003 001 003 002 001 002 003
Apr 28, 1995 Oct 20, 2005 Nov 10, 1998 Oct Aug Oct Oct Oct Jan Oct May Oct Oct Apr Oct Oct Apr Oct Oct Aug Oct Apr Apr Apr 06, 11, 06, 06, 06, 06, 06, 21, 06, 06, 06, 06, 06, 06, 06, 06, 19, 06, 06, 06, 06, 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010
HYDROCHLOROTHIAZIDE; METHYLDOPA
TABLET; ORAL METHYLDOPA AND HYDROCHLOROTHIAZIDE MYLAN 15MG;250MG XX 25MG;250MG XX +
N018303 001 N018303 002 A076792 001 A076792 002 A076792 003
Dec 31, 1984 Dec 31, 1984 Aug 20, 2004 Aug 20, 2004 Aug 20, 2004
12.5MG;EQ 10MG BASE 12.5MG;EQ 20MG BASE 25MG;EQ 20MG BASE AND HYDROCHLOROTHIAZIDE 12.5MG;EQ 10MG BASE 12.5MG;EQ 20MG BASE 25MG;EQ 20MG BASE 12.5MG;10MG 12.5MG;20MG 25MG;20MG 12.5MG;EQ 10MG BASE 12.5MG;EQ 20MG BASE 25MG;EQ 20MG BASE 12.5MG;EQ 10MG BASE 12.5MG;EQ 20MG BASE 25MG;EQ 20MG BASE 12.5MG;EQ 10MG BASE 12.5MG;EQ 20MG BASE 25MG;EQ 20MG BASE
N020125 001 N020125 002 N020125 003 A078450 A078450 A078450 A201356 A201356 A201356 A077093 A077093 A077093 A078211 A078211 A078211 001 002 003 001 002 003 001 002 003 001 002 003
Dec 28, 1999 Dec 28, 1999 Dec 28, 1999 Aug Aug Aug Apr Apr Apr Mar Mar Mar Mar Mar Mar 24, 24, 24, 20, 20, 20, 28, 28, 28, 04, 04, 04, 2007 2007 2007 2011 2011 2011 2005 2005 2005 2009 2009 2009
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
TABLET; ORAL ALDACTAZIDE GD SEARLE LLC 25MG;25MG SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE MUTUAL PHARM 25MG;25MG MYLAN 25MG;25MG WATSON LABS 25MG;25MG ALDACTAZIDE + GD SEARLE LLC 50MG;50MG
AB AB AB AB XX
N012616 004 A089534 001 A086513 001 A087398 001 N012616 005
HYDROCHLOROTHIAZIDE; TELMISARTAN
TABLET; ORAL MICARDIS HCT BOEHRINGER INGELHEIM XX XX XX +
HYDROCHLOROTHIAZIDE; TRIAMTERENE
CAPSULE; ORAL DYAZIDE + GLAXOSMITHKLINE LLC 25MG;37.5MG TRIAMTERENE AND HYDROCHLOROTHIAZIDE DURAMED PHARMS BARR 25MG;37.5MG IVAX SUB TEVA PHARMS 25MG;50MG LANNETT HOLDINGS INC 25MG;37.5MG MYLAN 25MG;37.5MG SANDOZ 25MG;37.5MG
AB AB AB AB AB AB
N016042 003 A075052 A074259 A201407 A074701 A074821 001 001 001 001 001
Mar 03, 1994 Jun Mar Dec Jun Jun 18, 30, 09, 07, 05, 1999 1995 2011 1996 1997
A073191 001
N019129 001 N019129 003 A071251 A071251 A074026 A073467 A073281 A072011 A073449 A071851 A071969 002 001 001 001 001 001 001 001 001
Oct 22, 1984 May 13, 1988 May Apr Apr Jan Apr Jun Sep Nov Apr 05, 17, 26, 31, 30, 17, 23, 30, 17, 1998 1988 1996 1996 1992 1988 1993 1988 1988
HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET; ORAL DIOVAN HCT NOVARTIS XX XX XX XX XX +
5MG/5ML;60MG/5ML
N022442 001
HYDROCORTISONE
CREAM; TOPICAL ALA-CORT CROWN LABS AT ANUSOL HC SALIX PHARMS AT HYDROCORTISONE ACTAVIS MID ATLANTIC AT AT
1% 2.5% 1% 2.5%
A080706 006 A088250 001 A087795 001 A089682 001 Jun 06, 1984 May 03, 1983 Mar 10, 1988
AT AT AT AT AT AT AT AT AT
ENEMA; RECTAL COLOCORT PADDOCK LLC AB CORTENEMA AB + ANI PHARMS HYDROCORTISONE TEVA PHARMS AB LOTION; TOPICAL ALA-CORT CROWN LABS HYDROCORTISONE + ALTANA TARO VINTAGE PHARMS NUTRACORT CORIA STIE-CORT PERRIGO ALA-SCALP
CROWN LABS OINTMENT; TOPICAL HYDROCORTISONE ACTAVIS MID ATLANTIC + ALTANA + FOUGERA PERRIGO NEW YORK TARO
AT AT AT AT AT AT AT AT XX
A083201 001 A040351 001 A040247 001 A040417 001 A080443 003 A087644 001 A089066 001 A089074 001 A083231 001
Jul 25, 2000 Jul 23, 1999 Jul 30, 2003
AT AT AT AT AT AT AT
A088138 001
A085982 001
2.5%
A081271 001
N008697 003 N008697 001 N008697 002 A040646 001 A040646 002 Mar 30, 2007 Mar 30, 2007
A083365 001
HYDROCORTISONE ACETATE
AEROSOL, METERED; RECTAL
CORTIFOAM
XX + MEDA PHARMS
10%
N017351 001
CREAM; TOPICAL
HYDROCORTISONE ACETATE
2.5%
XX + FERNDALE LABS MICORT-HC
2%
XX + FERNDALE LABS 2.5%
XX PASTE; TOPICAL
ORABASE HCA
COLGATE XX
0.5%
A083205 001
A085981 001
N050218 001
0.5%;1%
1%;1%
A083778 001
A085368 001
1%;1%
2.5%;1%
A085980 001
A085979 001
1%;10% 1%;10%
HYDROCORTISONE BUTYRATE
CREAM; TOPICAL HYDROCORTISONE BUTYRATE TARO PHARM INDS AB 0.1%
A076654 001
0.1% 0.1%
0.1%
N022076 001
OINTMENT; TOPICAL HYDROCORTISONE BUTYRATE TARO AB 0.1% LOCOID AB + TRIAX PHARMS LLC 0.1% SOLUTION; TOPICAL HYDROCORTISONE BUTYRATE TARO PHARM INDS AT 0.1% LOCOID AT + TRIAX PHARMS LLC 0.1%
HYDROCORTISONE PROBUTATE
CREAM; TOPICAL
PANDEL
XX + FOUGERA PHARMS
0.1%
N020453 001
AP AP AP AP AP
EQ 100MG BASE/VIAL EQ EQ EQ EQ 100MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
A040666 001 N009866 N009866 N009866 N009866 001 002 003 004
HYDROCORTISONE VALERATE
CREAM; TOPICAL HYDROCORTISONE VALERATE PERRIGO NEW YORK AB 0.2% TARO AB 0.2% WESTCORT AB + RANBAXY 0.2% OINTMENT; TOPICAL HYDROCORTISONE VALERATE ALTANA AB 0.2% TARO AB 0.2% WESTCORT AB + RANBAXY 0.2%
AT AT AT AT
N050479 001 A062423 001 A064053 001 A065216 001 Aug 25, 1983 Dec 29, 1995 Oct 31, 2005
A062874 001
AT AT AT AT AT
A060613 001 A062488 001 A065219 001 A064065 001 A062822 001 Nov 06, 1985 May 01, 2006 Aug 28, 1996 Sep 29, 1987
HYDROFLUMETHIAZIDE
TABLET; ORAL SALURON AB + SHIRE
50MG
N011949 001
HYDROMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION DILAUDID + PURDUE PHARM PRODS 1MG/ML 2MG/ML + 4MG/ML + DILAUDID-HP + PURDUE PHARM PRODS 10MG/ML HYDROMORPHONE HYDROCHLORIDE AKORN 10MG/ML 10MG/ML BARR 10MG/ML HOSPIRA 10MG/ML HOSPIRA INC 1MG/ML 2MG/ML 4MG/ML 10MG/ML DILAUDID-HP + PURDUE PHARM PRODS 250MG/VIAL
AP AP AP AP AP AP AP AP AP AP AP AP XX
N019034 003 N019034 004 N019034 005 N019034 001 A078228 A078261 A076444 A074598 N200403 N200403 N200403 A078591 001 001 001 001 001 002 003 001
Apr 30, 2009 Apr 30, 2009 Apr 30, 2009 Jan 11, 1984 Apr Apr Apr Jun Dec Dec Dec Jun 14, 14, 25, 19, 01, 01, 01, 17, 2010 2010 2003 1997 2011 2011 2011 2008
N019034 002
SOLUTION; ORAL DILAUDID AA + PURDUE PHARM PRODS 5MG/5ML HYDROMORPHONE HYDROCHLORIDE ROXANE AA 5MG/5ML TABLET; ORAL DILAUDID PURDUE PHARM PRODS AB 2MG AB 4MG AB + 8MG HYDROMORPHONE HYDROCHLORIDE ELITE LABS 8MG AB LANNETT 2MG AB 4MG AB 8MG AB MALLINCKRODT 8MG AB MALLINCKRODT INC 2MG AB 4MG AB NESHER PHARMS 2MG AB 4MG AB 8MG AB
N019892 003 N019892 002 N019892 001 A076723 A078439 A078439 A077471 A076855 A078273 A078273 A077311 A077311 A077311 001 001 002 001 001 001 002 001 002 003
Nov 09, 2007 Nov 09, 2007 Dec 07, 1992 Oct Dec Dec Dec Dec Sep Sep Nov Nov Nov 18, 09, 09, 09, 23, 19, 19, 09, 09, 09, 2005 2009 2009 2009 2004 2007 2007 2005 2005 2005
HYDROXOCOBALAMIN
INJECTABLE; INJECTION
CYANOKIT
XX + MERCK SANTE SAS HYDROXOCOBALAMIN XX + WATSON LABS
N019261 001
HYDROXYCHLOROQUINE SULFATE
TABLET; ORAL HYDROXYCHLOROQUINE SULFATE IPCA LABS LTD AB 200MG MYLAN AB 200MG SANDOZ AB 200MG AB 200MG TEVA PHARMS AB 200MG WATSON LABS AB 200MG WEST WARD AB 200MG ZYDUS PHARMS USA INC 200MG AB PLAQUENIL AB + SANOFI AVENTIS US 200MG
N009768 001
HYDROXYPROGESTERONE CAPROATE
SOLUTION; INTRAMUSCULAR
MAKENA
XX + KV PHARM
1250MG/5ML (250MG/ML)
N021945 001
HYDROXYPROPYL CELLULOSE
INSERT; OPHTHALMIC
LACRISERT
XX + ATON
5MG
N018771 001
HYDROXYUREA
CAPSULE; ORAL HYDREA + BRISTOL MYERS SQUIBB HYDROXYUREA BARR PAR PHARM DROXIA BRISTOL MYERS SQUIBB
AB AB AB XX XX XX
N016295 001 A075143 001 A075340 001 N016295 002 N016295 003 N016295 004 Oct 16, 1998 Feb 24, 1999 Feb 25, 1998 Feb 25, 1998 Feb 25, 1998
AP AP AP AP
SYRUP; ORAL HYDROXYZINE HYDROCHLORIDE AA + HI TECH PHARMA 10MG/5ML AA + VINTAGE PHARMS 10MG/5ML AA + WOCKHARDT 10MG/5ML TABLET; ORAL HYDROXYZINE HYDROCHLORIDE AMNEAL PHARM 10MG 25MG 50MG HERITAGE PHARMS INC 10MG 25MG 50MG HETERO LABS UNIT III 10MG 25MG 50MG INVAGEN PHARMS 10MG 25MG 50MG KVK TECH 10MG 25MG 50MG MUTUAL PHARM 10MG 25MG 50MG MYLAN 10MG 25MG 50MG NORTHSTAR HLTHCARE 10MG 25MG 50MG + PLIVA 10MG + 25MG + 50MG SUN PHARM INDS INC 10MG 25MG 50MG VINTAGE PHARMS 10MG 25MG 50MG WATSON LABS 10MG 10MG 25MG 25MG 50MG 50MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A040808 A040808 A040808 A040804 A040804 A040804 A040805 A040805 A040805 A040812 A040812 A040812 A040786 A040787 A040788 A089381 A089382 A089383 A091176 A091176 A091176 A040841 A040842 A040840 A088617 A088618 A088619 A040899 A040899 A040899 A040579 A040574 A040580 A081149 A088348 A081150 A088349 A081151 A088350
001 002 003 001 002 003 001 002 003 001 002 003 001 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 001 001
Sep Sep Sep Jun Jun Jun May May May Mar Mar Mar Mar Mar Mar May May May Jun Jun Jun Mar Mar Mar Jan Jan Jan Jun Jun Jun May May May Mar Sep Mar Sep Mar Sep
24, 24, 24, 30, 30, 30, 29, 29, 29, 12, 12, 12, 20, 20, 20, 19, 19, 19, 07, 07, 07, 31, 31, 31, 10, 10, 10, 10, 10, 10, 27, 27, 27, 18, 15, 18, 15, 18, 15,
2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2007 2007 2007 1986 1986 1986 2010 2010 2010 2008 2008 2008 1986 1986 1986 2008 2008 2008 2005 2005 2005 1994 1983 1994 1983 1994 1983
HYDROXYZINE PAMOATE
CAPSULE; ORAL HYDROXYZINE PAMOATE BARR AB AB SANDOZ AB
EQ EQ EQ EQ
EQ 25MG HCL/5ML
N011795 001
IBANDRONATE SODIUM
INJECTABLE; INTRAVENOUS
BONIVA
XX + ROCHE
TABLET; ORAL
BONIVA
XX + ROCHE
EQ 3MG BASE/3ML
N021858 001
EQ 150MG BASE
N021455 002
IBUPROFEN
SOLUTION; INTRAVENOUS CALDOLOR CUMBERLAND PHARMS XX XX + SUSPENSION; ORAL IBUPROFEN AB + ACTAVIS MID ATLANTIC PERRIGO R AND D AB TABLET; ORAL IBUPROFEN AMNEAL PHARMS NY AB AB AB AB AB AB CONTRACT PHARMACAL AB AB AB DR REDDYS LA AB AB AB + DR REDDYS LABS INC AB AB AB MARKSANS PHARMA AB AB AB NORTHSTAR HLTHCARE AB AB AB OHM LABS AB PERRIGO R AND D AB AB
100MG/5ML 100MG/5ML
400MG 400MG 600MG 600MG 800MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 600MG 800MG 400MG 400MG 600MG
A071334 A078558 A071335 A078558 A071935 A078558 A071267 A071268 A072300 A075682 A075682 A075682 A076112 A076112 A076112 A090796 A090796 A090796 A078132 A078132 A078132 A070818 A077114 A077114
001 001 001 002 001 003 001 001 001 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002
Nov Jun Nov Jun Oct Jun Oct Oct Jul Nov Nov Nov Oct Oct Oct Dec Dec Dec Sep Sep Sep Dec Jul Jul
25, 18, 25, 18, 13, 18, 15, 15, 01, 14, 14, 14, 31, 31, 31, 21, 21, 21, 10, 10, 10, 26, 18, 18,
1986 2007 1986 2007 1987 2007 1986 1986 1988 2001 2001 2001 2001 2001 2001 2010 2010 2010 2007 2007 2007 1985 2005 2005
800MG 400MG 600MG 800MG 300MG 400MG 400MG 600MG 800MG 400MG 600MG 400MG 600MG
A077114 A078329 A078329 A078329 A071230 A071231 A071644 A071232 A072004 A070436 A070437
003 001 002 003 001 001 001 001 001 001 001
Jul Feb Feb Feb Oct Oct Feb Oct Nov Aug Aug
18, 05, 05, 05, 22, 22, 01, 22, 18, 21, 21,
2005 2009 2009 2009 1986 1986 1988 1986 1987 1985 1985
IBUPROFEN LYSINE
INJECTABLE; INTRAVENOUS
NEOPROFEN
XX + LUNDBECK INC
N021903 001
IBUTILIDE FUMARATE
INJECTABLE; INJECTION CORVERT AP + PHARMACIA AND UPJOHN IBUTILIDE FUMARATE BIONICHE PHARMA USA AP AP LUITPOLD AP
Dec 28, 1995 Jan 11, 2010 Jan 11, 2010 Jan 11, 2010
ICATIBANT ACETATE
INJECTABLE; SUBCUTANEOUS
FIRAZYR
XX + SHIRE ORPHAN THERAP
N022150 001
ICODEXTRIN
SOLUTION; INTRAPERITONEAL
EXTRANEAL
7.5GM/100ML XX + BAXTER HLTHCARE
N021321 001
IDARUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION IDAMYCIN PFS + PHARMACIA AND UPJOHN 1MG/ML IDARUBICIN HYDROCHLORIDE APP PHARMS 1MG/ML BEDFORD LABS 1MG/ML 1MG/ML SANDOZ 1MG/ML
AP AP AP AP AP
N050734 001 A065440 A065275 A065288 A091293 001 001 001 001
Feb 17, 1997 Aug Dec May Mar 04, 14, 15, 29, 2009 2006 2007 2011
AP XX XX XX
May 01, 2002 May 01, 2002 May 01, 2002 May 01, 2002
IDOXURIDINE
SOLUTION/DROPS; OPHTHALMIC DENDRID AT + ALCON 0.1% HERPLEX AT + ALLERGAN 0.1%
IFOSFAMIDE
INJECTABLE; INJECTION IFEX BAXTER HLTHCARE AP AP IFOSFAMIDE AP + APP PHARMS AP AP + AP BEDFORD LABS AP AP AP + TEVA PARENTERAL AP +
1GM/VIAL 3GM/VIAL 1GM/VIAL 1GM/20ML (50MG/ML) 3GM/VIAL 3GM/60ML (50MG/ML) 1GM/20ML(50MG/ML) 3GM/60ML(50MG/ML) 1GM/20ML (50MG/ML) 3GM/60ML (50MG/ML)
N019763 001 N019763 002 A076078 A090181 A076078 A090181 A076619 A076619 A076657 A076657 001 001 002 002 001 002 001 002
Dec 30, 1988 Dec 30, 1988 May Sep May Sep Jun Jun Apr Apr 28, 22, 28, 22, 29, 29, 04, 04, 2002 2009 2002 2009 2011 2011 2007 2007
IFOSFAMIDE; MESNA
INJECTABLE; INTRAVENOUS
IFOSFAMIDE/MESNA KIT
XX + TEVA PARENTERAL XX +
ILOPERIDONE
TABLET; ORAL
FANAPT
XX + NOVARTIS XX XX XX XX XX XX
ILOPROST
SOLUTION; INHALATION
VENTAVIS
XX + ACTELION PHARMS LTD XX +
IMATINIB MESYLATE
TABLET; ORAL GLEEVEC NOVARTIS XX XX +
IMIPRAMINE HYDROCHLORIDE
TABLET; ORAL IMIPRAMINE HYDROCHLORIDE LUPIN LTD 10MG 25MG 50MG MUTUAL PHARM 10MG 25MG 50MG PAR PHARM 10MG 10MG 25MG SANDOZ 10MG 25MG 50MG TOFRANIL MALLINCKRODT INC 10MG 25MG + 50MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A090443 A090442 A090441 A081048 A081049 A081050 A088292 A089422 A088262 A084936 A083745 A084937
001 001 001 001 001 001 001 001 001 002 001 001
IMIPRAMINE PAMOATE
CAPSULE; ORAL IMIPRAMINE PAMOATE LUPIN LTD AB AB AB AB ROXANE AB AB AB AB TOFRANIL-PM AB + MALLINCKRODT INC AB AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
75MG HCL 100MG HCL 125MG HCL 150MG HCL 75MG HCL 100MG HCL 125MG HCL 150MG HCL 75MG HCL 100MG HCL 125MG HCL 150MG HCL
A090444 A090444 A090444 A090444 A091099 A091099 A091099 A091099 N017090 N017090 N017090 N017090
001 002 003 004 001 002 003 004 001 004 003 002
IMIQUIMOD
CREAM; TOPICAL ALDARA + MEDICIS IMIQUIMOD NYCOMED US PERRIGO ISRAEL TARO TEVA PHARMS USA TOLMAR ZYCLARA + MEDICIS +
AB AB AB AB AB AB XX XX
5% 5% 5% 5% 5% 5% 2.5% 3.75%
N020723 001 A078548 A078837 A200173 A200481 A091044 001 001 001 001 001
Feb 27, 1997 Feb Sep Apr Apr Feb 25, 07, 15, 18, 28, 2010 2010 2011 2011 2011
EQ 5MG BASE/ML
A075513 001
INDACATEROL MALEATE
POWDER; INHALATION
ARCAPTA NEOHALER
XX + NOVARTIS
EQ 75MCG BASE
N022383 001
INDAPAMIDE
TABLET; ORAL INDAPAMIDE ACTAVIS ELIZABETH AB AB ALPHAPHARM AB AB IVAX SUB TEVA PHARMS AB AB MYLAN AB AB + SANDOZ AB AB WATSON LABS AB AB
1.25MG 2.5MG 1.25MG 2.5MG 1.25MG 2.5MG 1.25MG 2.5MG 1.25MG 2.5MG 1.25MG 2.5MG
A074722 A074722 A075105 A075105 A074299 A074299 A074461 A074461 A074594 A074594 A074585 A074585
001 002 001 002 002 001 002 001 001 002 001 002
Jun Jun Jul Jul Apr Jul Mar Mar May May Sep Sep
17, 17, 23, 23, 29, 27, 26, 27, 23, 23, 26, 26,
1996 1996 1998 1998 1996 1995 1997 1996 1996 1996 1996 1996
INDINAVIR SULFATE
CAPSULE; ORAL CRIXIVAN MERCK SHARP DOHME XX XX XX +
2mCi/0.2ML 5mCi/0.5ML
N019044 001
INJECTABLE; INTRATHECAL
MPI INDIUM DTPA IN 111
1mCi/ML XX + GE HEALTHCARE
N017707 001
INJECTABLE; INJECTION
OCTREOSCAN
XX + MALLINCKRODT
3mCi/ML
N020314 001
INDOCYANINE GREEN
INJECTABLE; INJECTION IC-GREEN AP + AKORN
25MG/VIAL
N011525 001
25MG/VIAL
A040811 001
INDOMETHACIN
CAPSULE; ORAL INDOMETHACIN GLENMARK GENERICS AB AB HERITAGE PHARMS INC AB AB HETERO LABS UNIT III AB AB IVAX SUB TEVA PHARMS AB AB MYLAN AB AB + SANDOZ AB AB ZYDUS PHARMS USA INC AB AB
25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG
A091276 A091276 N018851 N018851 A091240 A091240 A070719 A070756 N018858 A070624 A070673 A070674 A090403 A090403
001 002 001 002 001 002 001 001 001 001 001 001 001 002
Dec Dec May May Apr Apr Feb Feb Apr Sep Apr Apr Nov Nov
22, 22, 18, 18, 12, 12, 12, 12, 20, 04, 29, 29, 15, 15,
2010 2010 1984 1984 2011 2011 1986 1986 1984 1985 1987 1987 2010 2010
AB AB AB AB
CAPSULE, EXTENDED RELEASE; ORAL INDOMETHACIN AMNEAL PHARMS 75MG AVANTHI INC 75MG PADDOCK LLC 75MG + SANDOZ 75MG
INJECTABLE; INJECTION
INDOMETHACIN
XX + APP PHARMS
SUPPOSITORY; RECTAL
INDOMETHACIN
XX + G AND W LABS
SUSPENSION; ORAL
INDOCIN
XX + IROKO PHARMS
EQ 1MG BASE/VIAL
N022536 001
50MG
A073314 001
25MG/5ML
N018332 001
INDOMETHACIN SODIUM
INJECTABLE; INJECTION INDOCIN AP + LUNDBECK INC INDOMETHACIN SODIUM BEDFORD AP
INJECTABLE; SUBCUTANEOUS
NOVOLOG MIX 70/30
XX + NOVO NORDISK INC
70 UNITS/ML;30 UNITS/ML
N021172 001
100 UNITS/ML
N020986 001
INJECTABLE; SUBCUTANEOUS
LEVEMIR
XX + NOVO NORDISK INC
100 UNITS/ML
N021536 001
100 UNITS/ML
N021081 001
300 UNITS/3ML
N021629 003
XX XX XX XX XX XX
UNITS/ML;50 UNITS/ML UNITS/ML;50 UNITS/ML UNITS/ML;50 UNITS/ML UNITS/ML;25 UNITS/ML UNITS/ML;25 UNITS/ML UNITS/ML;25 UNITS/ML
N021018 001 N021018 002 N021018 003 N021017 001 N021017 002 N021017 003
Dec 22, 1999 Sep 06, 2007 Dec 22, 1999 Dec 22, 1999 Sep 06, 2007 Dec 22, 1999
500 UNITS/ML
N018780 004
10MCI/5ML (2MCI/ML)
N022290 001
IODIPAMIDE MEGLUMINE
INJECTABLE; INJECTION
CHOLOGRAFIN MEGLUMINE
XX + BRACCO
52%
N009321 003
INJECTABLE; INJECTION
VISIPAQUE 270
XX + GE HEALTHCARE XX VISIPAQUE 320 XX + GE HEALTHCARE XX
Mar 22, 1996 Aug 29, 1997 Mar 22, 1996 Aug 29, 1997
IOFLUPANE I-123
SOLUTION; INTRAVENOUS
DATSCAN
XX + GE HLTHCARE INC
5MCI/2.5ML (2MCI/ML)
N022454 001
IOHEXOL
INJECTABLE; INJECTION
OMNIPAQUE 140
XX + GE HEALTHCARE
30.2%
N018956 005
N018956 001 N018956 002 N020608 001 N018956 003 N020608 002
Dec 26, 1985 Dec 26, 1985 Oct 24, 1995 Dec 26, 1985 Oct 24, 1995
IOPAMIDOL
INJECTABLE; INJECTION IOPAMIDOL-250 APP PHARMS IOPAMIDOL-300 APP PHARMS IOPAMIDOL-370 APP PHARMS ISOVUE-200 + BRACCO ISOVUE-250 + BRACCO + ISOVUE-300 + BRACCO + ISOVUE-370 + BRACCO + SCANLUX-300 SANOCHEMIA CORP USA SCANLUX-370 SANOCHEMIA CORP USA ISOVUE-M 200 + BRACCO ISOVUE-M 300 + BRACCO
AP AP AP AP AP AP AP AP AP AP AP AP XX XX
51% 61% 76% 41% 51% 51% 61% 61% 76% 76% 61% 76% 41% 61%
A074679 001 A074679 002 A074679 003 N018735 006 N018735 007 N020327 002 N018735 002 N020327 003 N018735 003 N020327 004 A090394 001 A090394 002 N018735 001 N018735 004
Apr 02, 1997 Apr 02, 1997 Apr 02, 1997 Jul 07, 1987 Jul 06, 1992 Oct 12, 1994 Dec 31, 1985 Oct 12, 1994 Dec 31, 1985 Oct 12, 1994 Jun 18, 2010 Jun 18, 2010 Dec 31, 1985 Dec 31, 1985
XX XX XX XX XX XX XX XX
N021425 003 N021425 001 N021425 002 N020220 004 N020220 003 N020220 002 N020220 005 N020220 001
Mar 12, 2004 Sep 20, 2002 Sep 20, 2002 May 10, 1995 May 10, 1995 May 10, 1995 Nov 18, 2008 May 10, 1995
IOTHALAMATE MEGLUMINE
INJECTABLE; INJECTION
CONRAY
XX + MALLINCKRODT CONRAY 30
XX + MALLINCKRODT CONRAY 43
XX + MALLINCKRODT SOLUTION; INTRAVESICAL
CYSTO-CONRAY II
MALLINCKRODT XX
N013295 001
N016983 001
N013295 002
17.2%
N017057 002
IOVERSOL
INJECTABLE; INJECTION
OPTIRAY 240
+ MALLINCKRODT OPTIRAY 300 + MALLINCKRODT + OPTIRAY 320 + MALLINCKRODT OPTIRAY 350 + MALLINCKRODT +
XX XX XX XX XX XX
N019710 002 N019710 004 N020923 004 N019710 001 N019710 005 N020923 003
Dec 30, 1988 Jan 22, 1992 May 13, 1999 Dec 30, 1988 Jan 22, 1992 May 28, 1998
39.3%;19.6%
N018905 002
IOXILAN
INJECTABLE; INJECTION OXILAN-300 GUERBET XX OXILAN-350 GUERBET XX
62% 73%
IPRATROPIUM BROMIDE
AEROSOL, METERED; INHALATION
ATROVENT HFA
XX + BOEHRINGER INGELHEIM 0.021MG/INH
N021527 001
AN AN AN AN AN AN AN AN
SPRAY, METERED; NASAL ATROVENT AB + BOEHRINGER INGELHEIM AB + IPRATROPIUM BROMIDE BAUSCH AND LOMB AB AB DEY AB AB NOVEX AB AB ROXANE AB AB
0.021MG/SPRAY 0.042MG/SPRAY 0.021MG/SPRAY 0.042MG/SPRAY 0.021MG/SPRAY 0.042MG/SPRAY 0.021MG/SPRAY 0.042MG/SPRAY 0.021MG/SPRAY 0.042MG/SPRAY
N020393 001 N020394 001 A076025 A076103 A075552 A075553 A076156 A076155 A076664 A076598 001 001 001 001 001 001 001 001
Oct 20, 1995 Oct 20, 1995 Mar Mar Mar Mar Apr Apr Nov Nov 31, 31, 31, 31, 18, 18, 05, 05, 2003 2003 2003 2003 2003 2003 2003 2003
IRBESARTAN
TABLET; ORAL AVAPRO SANOFI AVENTIS US XX XX XX +
IRINOTECAN HYDROCHLORIDE
INJECTABLE; INJECTION CAMPTOSAR 40MG/2ML (20MG/ML) + PFIZER INC 100MG/5ML (20MG/ML) + IRINOTECAN HYDROCHLORIDE ACCORD HLTHCARE 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) ACTAVIS TOTOWA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) AKORN 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) APP PHARMS 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) BEDFORD LABS 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) BIONICHE PHARMA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) DR REDDYS LABS LTD 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) EBEWE PHARMA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) FRESENIUS KABI ONCOL 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) HIKMA FARMACEUTICA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML) HOSPIRA 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N020571 001 N020571 002 A079068 A079068 A078589 A078589 A090726 A090726 A077776 A077776 A078753 A078753 A090393 A090393 A078953 A078953 A090137 A090137 A078188 A078188 A091032 A091032 A077915 A077915 001 002 001 002 001 002 001 002 001 002 002 003 001 002 001 002 001 002 001 002 001 002
Jun 14, 1996 Jun 14, 1996 Nov Nov Feb Feb Sep Sep Feb Feb Dec Dec May May Apr Apr Nov Nov Feb Feb Dec Dec Feb Feb 21, 21, 27, 27, 16, 16, 27, 27, 24, 24, 13, 13, 15, 15, 12, 12, 27, 27, 20, 20, 27, 27, 2008 2008 2008 2008 2009 2009 2008 2008 2008 2008 2011 2011 2010 2010 2009 2009 2008 2008 2010 2010 2008 2008
AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX
A078796 A090675 A090675 A078122 A078122 A078805 A078805 A077260 A077260 A090101 A077219 A077219 A090016 A090016
001 002 001 001 002 001 002 001 002 001 001 002 001 002
Feb Dec Dec Oct Oct Apr Apr Feb Feb Nov Feb Feb Jan Jan
27, 16, 16, 31, 31, 21, 21, 27, 27, 26, 20, 20, 28, 28,
2008 2011 2011 2008 2008 2008 2008 2008 2008 2008 2008 2008 2009 2009
N020571 003
IRON DEXTRAN
INJECTABLE; INJECTION DEXFERRUM BP LUITPOLD INFED BP + WATSON LABS (UTAH) PROFERDEX BP NEW RIVER
IRON SUCROSE
INJECTABLE; INTRAVENOUS VENOFER LUITPOLD XX XX + XX
EQ 50MG BASE/2.5ML (EQ 20MG BASE/ML) EQ 100MG BASE/5ML (EQ 20MG BASE/ML) EQ 200MG BASE/10ML (EQ 20MG BASE/ML)
ISOCARBOXAZID
TABLET; ORAL
MARPLAN
XX + VALIDUS PHARMS INC
10MG
N011961 001
ISOFLURANE
LIQUID; INHALATION FORANE + BAXTER HLTHCARE CORP ISOFLURANE HALOCARBON PRODS HOSPIRA PIRAMAL CRITICAL RHODIA
AN AN AN AN AN
N017624 001 A075225 A074097 A074416 A074502 001 001 001 001 Oct Jan Sep Jun 20, 25, 30, 27, 1999 1993 1994 1995
ISONIAZID
INJECTABLE; INJECTION
ISONIAZID
XX + SANDOZ SYRUP; ORAL
ISONIAZID
XX + CAROLINA MEDCL
100MG/ML
A040648 001
50MG/5ML
A088235 001
50MG;300MG;120MG
N050705 001
ISONIAZID; RIFAMPIN
CAPSULE; ORAL RIFAMATE AB + SANOFI AVENTIS US RIFAMPIN AND ISONIAZID WESTWARD AB
150MG;300MG 150MG;300MG
ISOPROTERENOL HYDROCHLORIDE
INJECTABLE; INJECTION ISOPROTERENOL HYDROCHLORIDE INTL MEDICATION AP 0.2MG/ML ISUPREL AP + HOSPIRA 0.2MG/ML
ISOSORBIDE DINITRATE
CAPSULE, EXTENDED RELEASE; ORAL
DILATRATE-SR
40MG XX + SCHWARZ PHARMA TABLET; ORAL ISORDIL VALEANT INTL AB AB AB AB + ISOSORBIDE DINITRATE PAR PHARM AB AB AB AB SANDOZ AB AB AB WATSON LABS AB AB WEST WARD AB AB AB AB ISORDIL XX + VALEANT INTL
N019790 001
5MG 10MG 20MG 30MG 5MG 10MG 20MG 30MG 5MG 10MG 20MG 5MG 10MG 5MG 10MG 20MG 30MG 40MG
N012093 N012093 N012093 N012093 A086923 A086925 A087537 A087946 A086221 A086223 A089367 A086034 A086032 A086067 A086066 A088088 A040591
007 002 006 005 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul Jul Jul Jul Mar Mar Oct Jan Jan Jan Apr Jan Jan Oct Oct Nov Jan
29, 29, 29, 29, 12, 12, 02, 12, 07, 07, 07, 06, 07, 29, 29, 02, 10,
1988 1988 1988 1988 1987 1987 1987 1988 1988 1988 1988 1988 1988 1987 1987 1987 2007
N012093 001
TABLET, EXTENDED RELEASE; ORAL ISOSORBIDE DINITRATE AB + CARACO 40MG COREPHARMA AB 40MG
ISOSORBIDE MONONITRATE
TABLET; ORAL ISOSORBIDE MONONITRATE ACTAVIS ELIZABETH AB AB TEVA AB WEST WARD AB MONOKET UCB INC AB AB +
TABLET, EXTENDED RELEASE; ORAL ISOSORBIDE MONONITRATE ACTAVIS ELIZABETH AB 30MG AB 60MG BRIGHTSTONE AB 60MG DEXCEL LTD AB 60MG ELAN PHARM AB 60MG KREMERS URBAN PHARMS 30MG AB AB 60MG AB + 120MG NESHER PHARMS AB 30MG AB 60MG AB 120MG TORRENT PHARMS AB 30MG AB 60MG AB 120MG VINTAGE PHARMS AB 30MG AB 60MG AB 120MG WEST WARD AB 30MG AB 60MG
A075306 A075306 A075166 A075522 A075041 A075155 A075155 A075155 A075395 A075395 A075395 A200270 A200495 A200495 A090598 A090598 A090598 A076813 A076813
001 002 001 001 001 002 001 003 001 002 003 001 001 002 001 002 003 002 001
Dec Dec Oct Apr Sep Jan Oct Aug Mar Mar Mar Jun Jun Jun Aug Aug Aug Mar Jan
31, 31, 07, 17, 22, 13, 30, 04, 16, 16, 16, 03, 03, 03, 11, 11, 11, 30, 07,
1998 1998 1999 2000 1998 2000 1998 2000 2000 2000 2000 2011 2011 2011 2010 2010 2010 2006 2005
ISOSULFAN BLUE
INJECTABLE; INJECTION ISOSULFAN BLUE SYNERX AP LYMPHAZURIN AP + COVIDIEN
1% 1%
ISOTRETINOIN
CAPSULE; ORAL AMNESTEEM MYLAN + + CLARAVIS BARR
AB AB AB AB
Nov 08, 2002 Nov 08, 2002 Nov 08, 2002 Apr 11, 2003
A076135 002 A076135 003 A076135 001 A076041 A076041 A076503 A076041 001 002 001 003
Apr 11, 2003 May 11, 2006 Apr 11, 2003 Dec Dec Jun Dec 24, 24, 20, 24, 2002 2002 2003 2002
ISRADIPINE
CAPSULE; ORAL ISRADIPINE MIKAH PHARMA AB AB WATSON LABS AB AB +
ITRACONAZOLE
CAPSULE; ORAL ITRACONAZOLE SANDOZ AB SPORANOX AB + JANSSEN PHARMS
SOLUTION; ORAL
SPORANOX
XX + JANSSEN PHARMS
TABLET; ORAL
ONMEL
XX + STIEFEL LABS INC
100MG 100MG
10MG/ML
N020657 001
200MG
N022484 001
IVERMECTIN
TABLET; ORAL
STROMECTOL
XX + MERCK
3MG
N050742 002
IXABEPILONE
INJECTABLE; IV (INFUSION)
IXEMPRA KIT
XX + BRISTOL MYERS SQUIBB 15MG/VIAL XX + 45MG/VIAL
KANAMYCIN SULFATE
INJECTABLE; INJECTION KANAMYCIN SULFATE APP PHARMS XX XX +
KETAMINE HYDROCHLORIDE
INJECTABLE; INJECTION KETALAR AP + JHP PHARMS AP +
EQ 100MG BASE/ML EQ EQ EQ EQ EQ EQ EQ 50MG BASE/ML 100MG BASE/ML 10MG BASE/ML 50MG BASE/ML 100MG BASE/ML 50MG BASE/ML 100MG BASE/ML
N016812 003 A074524 A074524 A076092 A076092 A076092 A074549 A074549 001 002 001 002 003 001 002 Mar Mar Sep Dec Oct Jun Jun 22, 22, 30, 28, 25, 27, 27, 1996 1996 2008 2001 2002 1996 1996
KETOCONAZOLE
AEROSOL, FOAM; TOPICAL EXTINA AT + STIEFEL LABS INC KETOCONAZOLE PERRIGO ISRAEL AT CREAM; TOPICAL KETOCONAZOLE ALTANA AB AB + TEVA KETOZOLE TARO AB GEL; TOPICAL
XOLEGEL
XX + AQUA PHARMS SHAMPOO; TOPICAL KETOCONAZOLE PERRIGO NEW YORK AB TOLMAR AB NIZORAL AB + JANSSEN PHARMS TABLET; ORAL KETOCONAZOLE APOTEX MUTUAL PHARMA MYLAN PLIVA TARO TEVA NIZORAL + ORTHO MCNEIL JANSSEN
2% 2%
2% 2% 2%
2%
N021946 001
2% 2% 2%
AB AB AB AB AB AB AB
N018533 001
KETOPROFEN
CAPSULE; ORAL KETOPROFEN HERITAGE PHARMS INC AB AB MYLAN AB AB TEVA AB AB + KETOPROFEN HERITAGE PHARMS INC XX
A074014 001
A074879 001
KETOROLAC TROMETHAMINE
INJECTABLE; INJECTION KETOROLAC TROMETHAMINE APP PHARMS AP AP BAXTER HLTHCARE AP AP BAXTER HLTHCARE CORP AP AP AP + BEDFORD AP + AP + CLARIS LIFESCIENCES AP AP HOSPIRA AP AP AP AP LUITPOLD AP AP PFIZER AP AP SANDOZ AP AP SUN PHARMA GLOBAL AP AP WOCKHARDT AP AP AP
15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 15MG/ML 30MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 30MG/ML
A075784 A075784 A075772 A075772 A075299 A075299 A075222 A075222 A075228 A075631 A075631 A074802 A074993 A074802 A074993 A078145 A078145 A078299 A078299 A076271 A076271 A078737 A078737 A077942 A077942 A077943
001 002 001 002 001 002 001 002 001 002 001 001 001 002 002 001 002 001 002 001 002 001 002 001 002 001
Jan Jan Jul Jul Nov Nov Apr Apr Apr Jun Jun Jun Jan Jun Jan Jan Jan Jul Jul Oct Oct Oct Oct Mar Mar Mar
11, 11, 21, 21, 03, 03, 26, 26, 26, 29, 29, 05, 27, 05, 27, 14, 14, 16, 16, 06, 06, 06, 06, 27, 27, 27,
2002 2002 2004 2004 1999 1999 1999 1999 1999 2001 2001 1997 1999 1997 1999 2008 2008 2007 2007 2004 2004 2008 2008 2007 2007 2007
AT AT AT AT AT AT AT AT AT XX XX
SOLUTION/DROPS; OPHTHALMIC ACULAR + ALLERGAN 0.5% ACULAR LS + ALLERGAN 0.4% KETOROLAC TROMETHAMINE AKORN 0.4% 0.5% ALCON PHARMS LTD 0.4% 0.5% APOTEX INC 0.4% 0.5% SUN PHARMA GLOBAL 0.5% ACULAR PRESERVATIVE FREE + ALLERGAN 0.5% ACUVAIL + ALLERGAN 0.45%
N019700 001 N021528 001 A078399 A078434 A078721 A076583 A077308 A076109 A090017 001 001 001 001 001 001 001
Nov 09, 1992 May 30, 2003 Nov Nov Nov Nov Nov Nov Nov 05, 05, 05, 05, 05, 05, 05, 2009 2009 2009 2009 2009 2009 2009
15.75MG/SPRAY
N022382 001
LABETALOL HYDROCHLORIDE
INJECTABLE; INJECTION LABETALOL HYDROCHLORIDE BEDFORD CLARIS LIFESCIENCES + HOSPIRA + TAYLOR LABETALOL HYDROCLORIDE SAGENT STRIDES
AP AP AP AP AP AP AP
A079134 001
TABLET; ORAL LABETALOL HYDROCHLORIDE IVAX SUB TEVA PHARMS 100MG AB AB 200MG AB 300MG SANDOZ AB 100MG AB 200MG AB 300MG WATSON LABS AB 100MG AB 200MG AB 300MG TRANDATE PROMETHEUS LABS AB 100MG AB + 200MG
LACOSAMIDE
SOLUTION; INTRAVENOUS
VIMPAT
XX + UCB INC SOLUTION; ORAL
VIMPAT
XX + UCB INC TABLET; ORAL VIMPAT UCB INC XX XX XX XX +
200MG/20ML (10MG/ML)
N022254 001
10MG/ML
N022255 001
LACTULOSE
FOR SOLUTION; ORAL
LACTULOSE
XX + INALCO XX + SOLUTION; ORAL CONSTILAC ALRA AA CONSTULOSE AA + ACTAVIS MID ATLANTIC LACTULOSE ANI PHARMS AA
10GM/PACKET 20GM/PACKET
AA AA AA AA AA AA AA
AA AA AA AA AA AA
A071331 001 A071548 001 A074603 001 A090426 001 A074077 001 A076645 001
Jul 26, 1988 Aug 15, 1988 Oct 31, 1996 Nov 21, 2008 Jul 03, 1995 Jul 28, 2003
LAMIVUDINE
SOLUTION; ORAL
EPIVIR
XX + VIIV HLTHCARE EPIVIR-HBV XX + GLAXOSMITHKLINE TABLET; ORAL EPIVIR VIIV HLTHCARE AB AB + LAMIVUDINE APOTEX AB AB AUROBINDO PHARMA LTD AB AB EPIVIR-HBV XX + GLAXOSMITHKLINE
10MG/ML 5MG/ML
N020564 001 N020564 003 A091606 A091606 A202032 A202032 001 002 001 002
Nov 17, 1995 Jun 24, 2002 Dec Dec Nov Nov 02, 02, 17, 17, 2011 2011 2011 2011
N021003 001
LAMIVUDINE; ZIDOVUDINE
TABLET; ORAL COMBIVIR AB + VIIV HLTHCARE 150MG;300MG LAMIVUDINE AND ZIDOVUDINE TEVA PHARMS AB 150MG;300MG
LAMOTRIGINE
TABLET; ORAL LAMICTAL AB + GLAXOSMITHKLINE AB AB AB LAMOTRIGINE ACTAVIS TOTOWA AB AB AB AB ALEMBIC PHARMS LTD AB
100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG
A090607 A090607 A090607 A078625 A078625 A078625 A078625 A078956 A078956 A078956 A078956 A079132 A079132 A079132 A079132 A076708 A076708 A076708 A076708 A078134 A078134 A078134 A078134 A078691 A078691 A078691 A078691 A077420 A077420 A077420 A077420 A078645 A078645 A078645 A078645 A078525 A078525 A078525 A078525 A076388 A076388 A076388 A076388 A078947 A078947 A078947 A078947 A090170 A090170 A090170 A090170 A078310 A078310 A078310 A078310 A077783 A077783
002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002
Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Apr Apr Apr Apr Jun Jun Jun Jun Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Aug Aug Aug Aug Jan Jan Jan Jan Oct Oct Oct Oct Feb Feb Feb Feb Nov Nov
13, 13, 13, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 19, 19, 19, 19, 01, 01, 01, 01, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 30, 30, 30, 30, 27, 27, 27, 27, 06, 06, 06, 06, 04, 04, 04, 04, 01, 01,
2011 2011 2011 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2011 2011 2011 2011 2010 2010 2010 2010 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2006 2006 2006 2006 2009 2009 2009 2009 2011 2011 2011 2011 2009 2009 2009 2009 2010 2010
2MG 5MG 25MG 5MG 25MG 5MG 25MG 5MG 25MG 5MG 25MG 5MG 25MG 5MG 25MG 5MG 25MG 2MG 5MG 25MG 5MG 25MG
N020764 004 N020764 001 N020764 002 A090401 A090401 A076701 A076701 A079099 A079099 A200220 A200220 A076630 A076630 A079204 A079204 A076420 A076420 A076928 A076928 A076928 A078009 A078009 002 003 001 002 001 002 001 002 001 002 001 002 001 002 001 002 003 002 003
Sep 08, 2000 Aug 24, 1998 Aug 24, 1998 Nov Nov Jan Jan Feb Feb Feb Feb Jan Jan Feb Feb Jun Jun Jan Jan Jan Jan Jan 04, 04, 22, 22, 19, 19, 28, 28, 22, 22, 04, 04, 21, 21, 22, 22, 22, 22, 22, 2009 2009 2009 2009 2009 2009 2011 2011 2009 2009 2009 2009 2006 2006 2009 2009 2009 2009 2009
TABLET, EXTENDED RELEASE; ORAL LAMICTAL XR SMITHKLINE BEECHAM 25MG XX 50MG XX + 100MG XX 200MG XX 250MG XX 300MG XX TABLET, ORALLY DISINTEGRATING; ORAL LAMICTAL ODT SMITHKLINE BEECHAM 25MG XX 50MG XX + 100MG XX 200MG XX
LANREOTIDE ACETATE
INJECTABLE; SUBCUTANEOUS
SOMATULINE DEPOT
XX + IPSEN PHARMS XX + XX +
AB AB AB AB AB AB AB AB AB AB
TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING; ORAL LANSOPRAZOLE TEVA PHARMS 15MG AB 30MG AB PREVACID TAKEDA PHARMS NA AB 15MG AB + 30MG
Oct 15, 2010 Oct 15, 2010 Aug 30, 2002 Aug 30, 2002
LANTHANUM CARBONATE
TABLET, CHEWABLE; ORAL FOSRENOL SHIRE XX XX XX +
LAPATINIB DITOSYLATE
TABLET; ORAL
TYKERB
XX + SMITHKLINE BEECHAM
EQ 250MG BASE
N022059 001
LATANOPROST
SOLUTION/DROPS; OPHTHALMIC LATANOPROST ALCON RES 0.005% APOTEX 0.005% BAUSCH AND LOMB 0.005% LUITPOLD 0.005% MYLAN 0.005% PADDOCK LLC 0.005% XALATAN + PHARMACIA AND UPJOHN 0.005%
AT AT AT AT AT AT AT
N020597 001
LEFLUNOMIDE
TABLET; ORAL ARAVA SANOFI AVENTIS US AB AB + LEFLUNOMIDE ALEMBIC PHARMS LTD AB AB APOTEX INC AB AB BARR AB AB HERITAGE PHARMS INC AB
N020905 001 N020905 002 A091369 A091369 A077090 A077090 A077083 A077083 A077086 001 002 001 002 001 002 001
Sep 10, 1998 Sep 10, 1998 Nov Nov Sep Sep Sep Sep Sep 21, 21, 13, 13, 13, 13, 13, 2011 2011 2005 2005 2005 2005 2005
N020905 003
LENALIDOMIDE
CAPSULE; ORAL REVLIMID CELGENE XX XX XX XX + XX +
LEPIRUDIN RECOMBINANT
INJECTABLE; INJECTION
REFLUDAN
XX + BAYER HLTHCARE
50MG/VIAL
N020807 001
LETROZOLE
TABLET; ORAL FEMARA + NOVARTIS PHARMS LETROZOLE ACCORD HLTHCARE ACTAVIS TOTOWA DR REDDYS LABS LTD ENDO PHARMS FRESENIUS KABI ONCOL IMPAX LABS INDICUS PHARMA KUDCO IRELAND MYLAN NATCO PHARMA LTD ROXANE SUN PHARM INDS LTD TEVA PHARMS
AB AB AB AB AB AB AB AB AB AB AB AB AB AB
2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG 2.5MG
N020726 001 A090934 A090292 A091191 A090789 A090491 A091638 A201804 A091098 A078190 A200161 A090838 A091466 A090289 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul 25, 1997 Jun Jul Jun Jun Jun Jun Jun Jun Dec Jun Jun Jun Jun 03, 13, 03, 03, 03, 03, 03, 03, 24, 03, 03, 03, 03, 2011 2011 2011 2011 2011 2011 2011 2011 2008 2011 2011 2011 2011
LEUCOVORIN CALCIUM
INJECTABLE; INJECTION LEUCOVORIN CALCIUM AP + BEDFORD EQ 50MG BASE/VIAL AP + EQ 100MG BASE/VIAL TEVA PARENTERAL AP EQ 50MG BASE/VIAL AP EQ 100MG BASE/VIAL AP EQ 350MG BASE/VIAL LEUCOVORIN CALCIUM PRESERVATIVE FREE APP PHARMS AP EQ 200MG BASE/VIAL AP + BEDFORD EQ 200MG BASE/VIAL AP + EQ 350MG BASE/VIAL LUITPOLD AP EQ 50MG BASE/VIAL LEUCOVORIN CALCIUM PRESERVATIVE FREE EQ 500MG BASE/VIAL XX + APP PHARMS EQ 10MG BASE/ML XX + BEDFORD
EQ EQ EQ EQ EQ
5MG BASE 25MG BASE 5MG BASE 15MG BASE 25MG BASE
EQ 10MG BASE
A072734 001
LEUPROLIDE ACETATE
INJECTABLE; INJECTION LEUPROLIDE ACETATE + SANDOZ SUN PHARMA GLOBAL TEVA PARENTERAL LUPRON DEPOT + ABBOTT ENDOCRINE + + ABBOTT LABS + + LUPRON DEPOT-PED + ABBOTT ENDOCRINE + + + + INJECTABLE; SUBCUTANEOUS
ELIGARD
+ TOLMAR THERAP + + +
AP AP AP XX XX XX XX XX XX XX XX XX XX XX
1MG/0.2ML 1MG/0.2ML 1MG/0.2ML 22.5MG/VIAL 30MG/VIAL 45MG/VIAL 3.75MG/VIAL 7.5MG/VIAL 11.25MG/VIAL 7.5MG/VIAL 11.25MG/VIAL 11.25MG/VIAL 15MG/VIAL 30MG/VIAL
A074728 001 A078885 001 A075471 001 N020517 N020517 N020517 N020011 N019732 N020708 N020263 N020263 N020263 N020263 N020263 001 002 003 001 001 001 002 005 007 006 008
Aug 04, 1998 Mar 09, 2009 Oct 25, 2000 Dec May Jun Oct Jan Mar Apr Jan Aug Jan Aug 22, 30, 17, 22, 26, 07, 16, 21, 15, 21, 15, 1995 1997 2011 1990 1989 1997 1993 1994 2011 1994 2011
XX XX XX XX
LEVALBUTEROL HYDROCHLORIDE
SOLUTION; INHALATION LEVALBUTEROL HYDROCHLORIDE DEY EQ WATSON LABS INC EQ EQ EQ XOPENEX + SUNOVION EQ + EQ + EQ + EQ
AN AN AN AN AN AN AN AN
0.25% BASE 0.0103% BASE 0.021% BASE 0.042% BASE 0.0103% BASE 0.021% BASE 0.042% BASE 0.25% BASE
LEVALBUTEROL TARTRATE
AEROSOL, METERED; INHALATION
XOPENEX HFA
EQ 0.045MG BASE/INH XX + SUNOVION
N021730 001
LEVETIRACETAM
INJECTABLE; IV (INFUSION) KEPPRA AP + UCB INC 500MG/5ML (100MG/ML)
N021872 001
AP AP AP AP XX XX XX
500MG/5ML(100MG/ML) 500MG/5ML (100MG/ML) 500MG/5ML (100MG/ML) 500MG/5ML (100MG/ML) CHLORIDE 500MG/100ML (5MG/ML) 1000MG/100ML (10MG/ML) 1500MG/100ML (15MG/ML)
AA AA AA AA AA AA AA AA AA AA AA AA AA
100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML
N021505 001 A078976 A090992 A090187 A079063 A079120 A090893 A078582 A090263 A078774 A079107 A090461 A090028 001 001 001 001 001 001 001 001 001 001 001 001
Jul 15, 2003 Jan Oct Aug Jan Jan Oct Jan Apr Feb Jan Sep Mar 15, 27, 05, 15, 16, 17, 15, 03, 10, 15, 30, 03, 2009 2009 2011 2009 2009 2011 2009 2009 2009 2009 2010 2010
TABLET; ORAL KEPPRA UCB INC AB AB AB AB + LEVETIRACETAM ACCORD HLTHCARE AB AB AB AB AJANTA PHARMA AB AB AB AB APOTEX INC AB AB AB AB AUROBINDO PHARMA AB AB AB AB BIOKEY AB BOCA PHARMA AB AB AB BRECKENRIDGE PHARM AB AB AB AB COBALT LABS INC AB AB
250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 500MG 250MG 500MG 750MG 250MG 500MG 750MG 1GM 250MG 500MG
N021035 N021035 N021035 N021035 A090843 A090843 A090843 A090843 A201293 A201293 A201293 A201293 A078869 A078869 A078869 A078869 A078993 A078993 A078993 A078993 A090906 A077319 A077319 A077319 A090511 A090511 A090511 A090511 A077384 A077384
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 001 002 003 001 002 003 004 001 002
Nov Nov Nov Jan Feb Feb Feb Feb Jun Jun Jun Jun Mar Mar Mar Mar Jan Jan Jan Jan Nov Mar Mar Mar Aug Aug Aug Aug Jan Jan
30, 30, 30, 06, 14, 14, 14, 14, 14, 14, 14, 14, 13, 13, 13, 13, 15, 15, 15, 15, 05, 20, 20, 20, 18, 18, 18, 18, 15, 15,
1999 1999 1999 2006 2011 2011 2011 2011 2011 2011 2011 2011 2009 2009 2009 2009 2009 2009 2009 2009 2010 2009 2009 2009 2011 2011 2011 2011 2009 2009
750MG 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 250MG 500MG 750MG 1GM 1GM
A077384 A076920 A076920 A076920 A078904 A090515 A090515 A090515 A090515 A078234 A078234 A078234 A078154 A078154 A078154 A090025 A090767 A090767 A090767 A090767 A076919 A076919 A076919 A090261 A078526 A078526 A078526 A090484 A078042 A078042 A078042 A078042 A077324 A077324 A077324 A077324 A078106 A078106 A078106 A078106 A078960 A078960 A078960 A078960 A078101 A078101 A078101 A078101 A078858 A078858 A078858 A078858 A091491 A091491 A091491 A091491 A078797
003 001 002 003 001 001 002 003 004 001 002 003 001 002 003 001 001 002 003 004 001 002 003 001 001 002 003 001 001 002 003 004 001 002 003 004 001 002 003 004 004 003 002 001 001 002 003 004 001 002 003 004 001 002 003 004 001
Jan Jan Jan Jan Jan Oct Oct Oct Oct Jan Jan Jan Jan Jan Jan Jan Jul Jul Jul Jul Nov Nov Nov Dec Jan Jan Jan Aug Jan Jan Jan Jan Jan Jan Jan Jan Feb Feb Feb Feb Feb Feb Feb Feb Jan Jan Jan Jan Jan Jan Jan Jan Dec Dec Dec Dec Jan
15, 15, 15, 15, 15, 08, 08, 08, 08, 15, 15, 15, 15, 15, 15, 15, 28, 28, 28, 28, 04, 04, 04, 08, 15, 15, 15, 05, 15, 15, 15, 15, 15, 15, 15, 15, 10, 10, 10, 10, 01, 01, 01, 01, 15, 15, 15, 15, 15, 15, 15, 15, 14, 14, 14, 14, 15,
2009 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2008 2008 2008 2009 2009 2009 2009 2010 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2009
250MG 500MG 750MG 1GM 250MG 1GM ORAL 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG
N022285 001 N022285 002 A091557 A091557 A091360 A091360 A091261 A091261 A091399 A091399 A091285 A091285 A200475 A200475 A091291 A091291 A091430 A091430 A091093 A091093 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Sep 12, 2008 Feb 12, 2009 Sep Sep Oct Oct Sep Sep Sep Sep Sep Sep Dec Dec Sep Sep Sep Sep Sep Sep 12, 12, 04, 04, 12, 12, 12, 12, 12, 12, 19, 19, 12, 12, 12, 12, 12, 12, 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011
LEVOBUNOLOL HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AKBETA AKORN AT 0.25% AT 0.5% BETAGAN AT + ALLERGAN 0.25% AT + 0.5% LEVOBUNOLOL HYDROCHLORIDE BAUSCH AND LOMB AT 0.25% AT 0.5% FALCON PHARMS AT 0.25% AT 0.5% NOVEX AT 0.25% AT 0.5%
A074779 001 A074780 001 N019814 001 N019219 002 A074307 A074326 A074851 A074850 A075473 A075475 001 001 001 001 001 001
Oct 29, 1996 Oct 29, 1996 Jun 28, 1989 Dec 19, 1985 Mar Mar Oct Oct Aug Aug 04, 04, 28, 28, 03, 03, 1994 1994 1996 1996 2000 2000
LEVOCARNITINE
INJECTABLE; INJECTION CARNITOR + SIGMA TAU LEVOCARNITINE BEDFORD LUITPOLD TEVA PARENTERAL
AP AP AP AP
Dec 16, 1992 Mar 29, 2001 Jun 22, 2001 Mar 29, 2001
1GM/10ML
N019257 001
330MG 330MG
LEVOCETIRIZINE DIHYDROCHLORIDE
SOLUTION; ORAL LEVOCETIRIZINE DIHYDROCHLORIDE SYNTHON PHARMS AA 2.5MG/5ML XYZAL AA + UCB INC 2.5MG/5ML TABLET; ORAL LEVOCETIRIZINE DIHYDROCHLORIDE DR REDDYS LABS LTD 5MG GLENMARK GENERICS 5MG SYNTHON PHARMS 5MG TEVA PHARMS 5MG XYZAL + UCB INC 5MG
AB AB AB AB AB
N022064 001
LEVOFLOXACIN
INJECTABLE; INJECTION LEVAQUIN + JANSSEN PHARMS EQ 500MG/20ML (EQ 25MG/ML) + EQ 750MG/30ML (EQ 25MG/ML) LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER + JANSSEN PHARMS EQ 250MG/50ML (EQ 5MG/ML) + EQ 500MG/100ML (EQ 5MG/ML) + EQ 750MG/150ML (EQ 5MG/ML) LEVOFLOXACIN AKORN EQ 500MG/20ML (EQ 25MG/ML) EQ 750MG/30ML (EQ 25MG/ML) SAGENT PHARMS EQ 500MG/20ML (EQ 25MG/ML) EQ 750MG/30ML (EQ 25MG/ML) LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER ACS DOBFAR INFO SA EQ 250MG/50ML (EQ 5MG/ML) EQ 500MG/100ML (EQ 5MG/ML) EQ 750MG/150ML (EQ 5MG/ML) HIKMA FARMACEUTICA EQ 250MG/50ML (EQ 5MG/ML) EQ 500MG/100ML (EQ5MG/ML) EQ 750MG/150ML (EQ 5MG/ML)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N020635 001 N020635 004 N020635 002 N020635 003 N020635 005 A091644 A091644 A200560 A200560 A090343 A090343 A090343 A091375 A091375 A091375 001 002 001 002 001 002 003 001 002 003
Dec 20, 1996 Dec 20, 1996 Dec 20, 1996 Dec 20, 1996 Dec 20, 1996 Jun Jun Jun Jun Jul Jul Jul Sep Sep Sep 20, 20, 20, 20, 07, 07, 07, 16, 16, 16, 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011
250MG/10ML 250MG/10ML
SOLUTION/DROPS; OPHTHALMIC LEVOFLOXACIN AKORN AT 0.5% APOTEX AT 0.5% HI TECH PHARMA AT 0.5%
250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG 250MG 500MG 750MG
N020634 001 N020634 002 N020634 003 A090787 A090787 A090787 A201043 A201043 A201043 A076710 A076710 A076710 A200250 A200250 A200250 A078424 A078424 A078424 A076276 A076276 A077097 A077438 A077438 A077438 A076361 A076361 A076361 A090722 A090722 A090722 A090367 A090367 A090367 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 001 001 002 003 001 002 003 001 002 003 001 002 003
Dec 20, 1996 Dec 20, 1996 Sep 08, 2000 Sep Sep Sep Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun 29, 29, 29, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011
LEVOLEUCOVORIN CALCIUM
POWDER; IV (INFUSION)
FUSILEV
XX + SPECTRUM PHARMS SOLUTION; IV (INFUSION)
FUSILEV
XX + SPECTRUM PHARMS XX +
EQ 50MG BASE/VIAL
N020140 001
EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) EQ 250MG BASE/25ML (EQ 10MG BASE/ML)
N021225 001
A090740 001 A078665 001 A078666 001 N021045 002 N021998 001
Dec 30, 2010 Aug 28, 2009 Jun 24, 2009 Aug 24, 2006 Jul 10, 2009
LEVORPHANOL TARTRATE
TABLET; ORAL LEVORPHANOL TARTRATE ROXANE XX
2MG
A074278 001
LEVOTHYROXINE SODIUM**
**Refer to Preface Section 1.8 Levothyroxine Sodium for amplifying information**
0.013MG 0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG
N022121 N021924 N021924 N021924 N021924 N021924 N021924 N021924 N021924 N021924
001 002 003 004 010 005 008 006 009 007
Aug Oct Oct Oct Oct Oct Oct Oct Oct Oct
01, 13, 13, 13, 02, 13, 02, 13, 02, 13,
2007 2006 2006 2006 2009 2006 2009 2006 2009 2006
--> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> -->
AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB2,AB3 AB2,AB3 AB2,AB3 AB2,AB3 AB2,AB3 AB2,AB3
0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG
N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 N021342 A076752 A076752 A076752 A076752 A076752 A076752
001 002 003 004 005 006 007 012 008 009 010 011 001 002 003 004 005 006
Mar Mar Mar Mar Mar Mar Mar Dec Mar Mar Mar Mar Jun Jun Jun Jun Jun Jun
01, 01, 01, 01, 01, 01, 01, 08, 01, 01, 01, 01, 16, 16, 16, 16, 16, 16,
2002 2002 2002 2002 2002 2002 2002 2003 2002 2002 2002 2002 2005 2005 2005 2005 2005 2005
TABLET; ORAL LEVOTHYROXINE SODIUM --> MERCK KGAA --> --> --> --> --> MYLAN --> --> --> --> --> --> --> --> --> --> --> LEVOXYL --> KING PHARMS --> --> --> --> --> --> --> --> --> --> + SYNTHROID --> ABBOTT --> --> --> --> --> --> --> --> --> --> --> + UNITHROID --> STEVENS J --> --> --> --> --> --> --> --> --> --> --> +
--> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> --> -->
AB2,AB3 0.125MG AB2,AB3 0.15MG AB2,AB3 0.175MG AB2,AB3 0.2MG AB2,AB3 0.3MG AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB2,AB3,AB4 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB3 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 AB1,AB2 0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG
0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG
A076752 A076752 A076752 A076752 A076752 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 A076187 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021301 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021402 N021210 N021210 N021210 N021210 N021210 N021210 N021210 N021210 N021210 N021210 N021210 N021210
007 008 009 010 011 001 002 003 004 005 006 007 012 008 009 010 011 001 002 003 004 005 006 007 008 009 010 011 001 002 003 004 005 006 007 008 009 010 012 011 001 002 003 004 005 006 007 012 008 009 010 011
Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Dec Jun Jun Jun Jun May May May May May May May May May May May Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Aug Aug Aug Aug Aug Aug Aug Feb Aug Aug Aug Aug
16, 16, 16, 16, 16, 05, 05, 05, 05, 05, 05, 05, 13, 05, 05, 05, 05, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24, 21, 21, 21, 21, 21, 21, 21, 08, 21, 21, 21, 21,
2005 2005 2005 2005 2005 2002 2002 2002 2002 2002 2002 2002 2006 2002 2002 2002 2002 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2000 2000 2000 2000 2000 2000 2000 2008 2000 2000 2000 2000
AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3 AB1,AB2,AB3
0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG
TABLET; ORAL LEVOTHROID LLOYD AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 AB4 +
0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG
N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116 N021116
001 002 003 010 004 011 005 012 006 007 008 009
Oct Oct Oct Oct Oct Oct Oct Dec Oct Oct Oct Oct
24, 24, 24, 24, 24, 24, 24, 07, 24, 24, 24, 24,
2002 2002 2002 2002 2002 2002 2002 2004 2002 2002 2002 2002
LIDOCAINE
OINTMENT; TOPICAL LIDOCAINE AT + FOUGERA NOVOCOL INC AT TARO AT PATCH; TOPICAL
LIDODERM
XX + TEIKOKU PHARMA USA
5% 5% 5%
5%
N020612 001
LIDOCAINE HYDROCHLORIDE
GEL; OPHTHALMIC
AKTEN
XX + AKORN INJECTABLE; INJECTION LIDOCAINE HYDROCHLORIDE HOSPIRA AP AP AP AP AP AP AP LUITPOLD AP AP STRIDES ARCOLAB LTD AP AP AP AP LIDOCAINE HYDROCHLORIDE B BRAUN AP BAXTER HLTHCARE AP LIDOCAINE HYDROCHLORIDE B BRAUN AP BAXTER HLTHCARE AP LIDOCAINE HYDROCHLORIDE HOSPIRA AP LIDOCAINE HYDROCHLORIDE B BRAUN AP BAXTER HLTHCARE AP LIDOCAINE HYDROCHLORIDE HOSPIRA AP
3.5%
N022221 001
0.5% 1% 1% 2% 2% 2% 20% 1% 2% 0.5% 0.5% 1% 1% 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER 200MG/100ML 200MG/100ML 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER 400MG/100ML 400MG/100ML 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER 400MG/100ML 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER 800MG/100ML 800MG/100ML 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER 800MG/100ML
A088328 A083158 A088329 A040078 A083158 A088294 A083158 A080850 A083198 A091056 A091058 A091056 A091058
001 001 001 001 002 001 003 001 001 001 001 002 002
May 17, 1984 May 17, 1984 Jun 23, 1995 May 17, 1984
N019830 002 N018461 002 N019830 003 N018461 003 N018388 002 N019830 004 N018461 004 N018388 003
A088586 A088325 A088299 A088327 N017584 N017584 A080404 A080404 A080408 A080408 A088295 N017702 A090665
001 001 001 001 001 002 002 003 001 002 001 001 001
May 17, 1984 Sep 27, 2010 Sep 28, 1998 Sep 28, 1998
A040302 001 A040302 002 N017549 001 N006488 N006488 N006488 N006488 008 007 010 002
N010417 001 N021380 001 N016801 N016801 N016801 N016801 N016801 005 001 002 003 004 Jan 19, 1988
A083914 001
AT AT AT AT AT AT
2% 2% 2% 2% 2% 2%
A080429 001 A040433 A040837 A086283 A081318 001 001 001 001 Feb 12, 2003 Mar 23, 2011 Apr 29, 1993
N008816 001
AT AT AT AT AT
2% 2% VISCOUS 2% 2% 2%
A040014 001 A087872 001 A040708 001 A088802 001 N009470 001
Jul 10, 1995 Nov 18, 1982 Feb 27, 2007 Apr 26, 1985
AT AT AT AT AT AT
A086364 001 A088803 001 A040710 001 A087881 001 A080409 001 N010417 002 Apr 03, 1985 Feb 27, 2007 Nov 18, 1982
LIDOCAINE; PRILOCAINE
CREAM; TOPICAL EMLA + OAK PHARMS 2.5%;2.5% LIDOCAINE AND PRILOCAINE HI TECH PHARMA 2.5%;2.5% NYCOMED US 2.5%;2.5% TOLMAR 2.5%;2.5%
AB AB AB AB
Dec 30, 1992 Sep 25, 2003 Aug 18, 2003 Aug 27, 2003
GEL; PERIODONTAL
ORAQIX
XX + DENTSPLY PHARM
2.5%;2.5%
N021451 001
LIDOCAINE; TETRACAINE
CREAM; TOPICAL
LIDOCAINE AND TETRACAINE
7%;7% XX + GALDERMA LABS LP PATCH; TOPICAL
SYNERA
XX + ZARS PHARM
N021717 001
70MG;70MG
N021623 001
LINAGLIPTIN
TABLET; ORAL
TRADJENTA
XX + BOEHRINGER INGELHEIM
5MG
N201280 001
LINCOMYCIN HYDROCHLORIDE
INJECTABLE; INJECTION
LINCOCIN
XX + PHARMACIA AND UPJOHN
EQ 300MG BASE/ML
N050317 001
LINDANE
LOTION; TOPICAL LINDANE OLTA PHARMS AT AT + WOCKHARDT SHAMPOO; TOPICAL LINDANE OLTA PHARMS AT AT + WOCKHARDT
1% 1%
1% 1%
LINEZOLID
FOR SUSPENSION; ORAL
ZYVOX
XX + PHARMACIA AND UPJOHN
100MG/5ML
N021132 001
200MG/100ML
N021131 001
600MG
N021130 002
LIOTHYRONINE SODIUM
INJECTABLE; INJECTION LIOTHYRONINE SODIUM X GEN PHARMS AP TRIOSTAT AP + JHP PHARMS TABLET; ORAL CYTOMEL KING PHARMS AB AB AB + LIOTHYRONINE SODIUM COASTAL PHARMS AB AB AB MYLAN AB AB AB
EQ 0.005MG BASE EQ 0.025MG BASE EQ 0.05MG BASE EQ EQ EQ EQ EQ EQ 0.005MG BASE 0.025MG BASE 0.05MG BASE 0.005MG BASE 0.025MG BASE 0.05MG BASE
N010379 001 N010379 002 N010379 003 A090097 A090097 A090097 A090326 A090326 A090326 001 002 003 001 002 003 Mar Mar Mar Jul Jul Jul 20, 20, 20, 14, 14, 14, 2009 2009 2009 2009 2009 2009
LIOTRIX (T4;T3)
TABLET; ORAL
THYROLAR-0.25
FOREST LABS THYROLAR-0.5
FOREST LABS THYROLAR-1
FOREST LABS THYROLAR-2
FOREST LABS THYROLAR-3
+ FOREST LABS
XX XX XX XX XX
N016807 001
N016807 005
N016807 004
N016807 002
N016807 003
LIRAGLUTIDE RECOMBINANT
SOLUTION; SUBCUTANEOUS
VICTOZA
XX + NOVO NORDISK INC
18MG/3ML (6MG/ML)
N022341 001
LISDEXAMFETAMINE DIMESYLATE
CAPSULE; ORAL VYVANSE XX SHIRE DEVELOPMENT XX XX XX XX XX +
LISINOPRIL
TABLET; ORAL LISINOPRIL APOTEX INC AB
2.5MG
A076102 001
5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 2.5MG 5MG 5MG 10MG 10MG 20MG 20MG 30MG 30MG
A076102 A076102 A076102 A076102 A076102 A077622 A077622 A077622 A077622 A077622 A077622 A075752 A075752 A075752 A075752 A075752 A075752 A075999 A075999 A075999 A075999 A075999 A075999 A077321 A077321 A077321 A077321 A077321 A077321 A076071 A076071 A076071 A076071 A076071 A076071 A076180 A076180 A076180 A076164 A076164 A076164 A075944 A075944 A075944 A075944 A075944 A075944 A075903 A075994 A075903 A075994 A075903 A075994 A075903 A075994 A075903 A075994
002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 001 002 003 001 002 003 004 006 005 001 001 002 002 003 003 004 004 005 005
Sep Sep Sep Sep Sep Feb Feb Feb Feb Feb Feb Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Sep Sep Sep Sep Sep Sep Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Feb Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul
30, 30, 30, 30, 30, 22, 22, 22, 22, 22, 22, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 09, 09, 09, 09, 09, 09, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 11, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01,
2002 2002 2002 2002 2002 2006 2006 2006 2006 2006 2006 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2005 2005 2005 2005 2005 2005 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2003 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002
40MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG 5MG 10MG 20MG 40MG 2.5MG 5MG 10MG 20MG 30MG 40MG
A075903 A075994 A075743 A075743 A075743 A075743 A075743 A075743 A076059 A076059 A076059 A076059 A076059 A076059 A076063 A076063 A076063 A076063 A076063 A076063 A078402 A078402 A078402 A078402 A078402 A078402 N019558 N019558 N019558 N019558 N019777 N019777 N019777 N019777 N019777 N019777
006 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 006 005 001 002 003 004 005 006 001 002 003 004 005 001 002 003 006 004
Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jun Jul Apr Apr Apr Apr Apr Apr Dec Dec Dec Oct Apr May May May Jan May
01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 01, 27, 01, 19, 19, 19, 19, 19, 19, 29, 29, 29, 25, 29, 19, 19, 19, 20, 19,
2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2003 2002 2007 2007 2007 2007 2007 2007 1987 1987 1987 1988 1993 1988 1988 1988 1999 1988
LITHIUM CARBONATE
CAPSULE; ORAL
LITHIUM CARBONATE ALEMBIC LTD AB AB AB APOTEX INC AB GLENMARK GENERICS AB AB AB HETERO DRUGS LTD AB AB AB ROXANE AB AB AB + WEST WARD AB AB
150MG 300MG 600MG 300MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG
A079159 A079159 A079159 A076795 A079139 A079139 A079139 A090702 A090702 A090702 N017812 N017812 N017812 A076243 A076243
001 002 003 001 001 002 003 001 002 003 002 001 003 002 001
Jan Jan Jan Nov Feb Feb Feb Sep Sep Sep Jan
12, 12, 12, 22, 03, 03, 03, 25, 25, 25, 28,
2009 2009 2009 2004 2009 2009 2009 2009 2009 2009 1987
600MG
A078763 001
TABLET, EXTENDED RELEASE; ORAL LITHIUM CARBONATE GLENMARK GENERICS AB 300MG AB 450MG ROXANE AB 300MG AB + 450MG WEST WARD AB 450MG LITHOBID AB + NOVEN THERAP 300MG
N018027 001
LITHIUM CITRATE
SYRUP; ORAL LITHIUM CITRATE AA + ROXANE WOCKHARDT AA
LODOXAMIDE TROMETHAMINE
SOLUTION/DROPS; OPHTHALMIC
ALOMIDE
XX + ALCON EQ 0.1% BASE
N020191 001
LOMUSTINE
CAPSULE; ORAL
CEENU
BRISTOL MYERS SQUIBB XX XX XX +
N017588 001
N017588 002
N017588 003
LOPERAMIDE HYDROCHLORIDE
CAPSULE; ORAL IMODIUM AB + MCNEIL CONS 2MG LOPERAMIDE HYDROCHLORIDE MYLAN AB 2MG TEVA AB 2MG
N017694 001 A072741 001 A073192 001 Sep 18, 1991 Apr 30, 1992
LOPINAVIR; RITONAVIR
CAPSULE; ORAL
KALETRA
XX + ABBOTT
SOLUTION; ORAL
KALETRA
XX + ABBOTT TABLET; ORAL KALETRA XX ABBOTT XX +
133.3MG;33.3MG
N021226 001
80MG/ML;20MG/ML
N021251 001
100MG;25MG 200MG;50MG
AA AA AA AA
Dec 23, 2009 Apr 28, 2009 Jun 15, 2010 Jun 28, 1991
INJECTABLE; INJECTION ATIVAN AP + BAXTER HLTHCARE CORP 2MG/ML AP + 4MG/ML LORAZEPAM BEDFORD 2MG/ML AP 4MG/ML AP HOSPIRA 2MG/ML AP 2MG/ML AP 2MG/ML AP 4MG/ML AP 4MG/ML AP INTL MEDICATION SYS AP 2MG/ML TAYLOR AP 2MG/ML WATSON LABS AP 2MG/ML AP 4MG/ML LORAZEPAM PRESERVATIVE FREE BEDFORD LABS AP 2MG/ML AP 4MG/ML TABLET; ORAL ATIVAN VALEANT INTL AB AB AB + LORAZEPAM ACTAVIS ELIZABETH AB AB AB AMNEAL PHARMS AB AB AB EXCELLIUM AB AB AB IVAX SUB TEVA PHARMS AB AB AB MYLAN AB AB AB AB AB AB RANBAXY AB AB AB SANDOZ AB AB AB VINTAGE PHARMS AB AB AB
N018140 001 N018140 002 A077076 A077076 A074243 A074282 A074300 A074243 A074282 A076150 A075025 A074276 A074276 001 002 001 001 001 002 002 001 001 001 002 Jul Jul Apr May Apr Apr May Nov Jul Apr Apr 13, 13, 12, 27, 12, 12, 27, 15, 23, 15, 15, 2005 2005 1994 1994 1994 1994 1994 2004 1998 1994 1994
0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 0.5MG 1MG 1MG 2MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG
N017794 001 N017794 002 N017794 003 A071403 A071404 A071141 A078826 A078826 A078826 A078203 A078203 A078203 A077396 A077396 A077396 A071589 A077657 A071590 A077657 A071591 A077657 A076045 A076045 A076045 A071193 A071194 A071195 A077754 A077754 A077754 001 001 001 001 002 003 001 002 003 001 002 003 001 001 001 002 001 003 001 002 003 001 001 001 001 002 003 Apr Apr Apr Jun Jun Jun Jul Jul Jul Dec Dec Dec Oct Mar Oct Mar Oct Mar Aug Aug Aug Apr Apr Apr May May May 21, 21, 21, 23, 23, 23, 30, 30, 30, 13, 13, 13, 13, 16, 13, 16, 13, 16, 29, 29, 29, 15, 15, 15, 10, 10, 10, 1987 1987 1987 2010 2010 2010 2007 2007 2007 2006 2006 2006 1987 2006 1987 2006 1987 2006 2001 2001 2001 1988 1988 1988 2006 2006 2006
LOSARTAN POTASSIUM
TABLET; ORAL COZAAR MERCK AB AB AB + LOSARTAN POTASSIUM ACTAVIS INC AB AB AB ALEMBIC PHARMS LTD AB AB AB APOTEX CORP AB AB AB AUROBINDO PHARMA AB AB AB LUPIN LTD AB AB AB MYLAN AB AB AB PRINSTON INC AB AB AB ROXANE AB AB AB SANDOZ AB AB AB TEVA AB AB AB TORRENT PHARMS AB AB AB UPSHER SMITH AB AB AB WATSON LABS AB AB AB ZYDUS PHARMS USA INC AB AB AB
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG
N020386 001 N020386 002 N020386 003 A090382 A090382 A090382 A090428 A090428 A090428 A090790 A090790 A090790 A090083 A090083 A090083 A078232 A078232 A078232 A091590 A091590 A091590 A091497 A091497 A091497 A077459 A077459 A077459 A077424 A077424 A077424 A076958 A076958 A076958 A090467 A090467 A090467 A090544 A090544 A090544 A091129 A091129 A091129 A078243 A078243 A078243 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Apr 14, 1995 Apr 14, 1995 Oct 13, 1998 Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Jun Jun Jun Oct Oct Oct Oct Oct Oct Apr Apr Apr Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2011 2011 2011 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010
OINTMENT; OPHTHALMIC
LOTEMAX
XX + BAUSCH AND LOMB
0.5%
N200738 001
SUSPENSION/DROPS; OPHTHALMIC
ALREX
0.2% XX + BAUSCH AND LOMB LOTEMAX 0.5% XX + BAUSCH AND LOMB
N050804 001
LOVASTATIN
TABLET; ORAL LOVASTATIN ACTAVIS ELIZABETH AB AB AB APOTEX INC AB AB AB CARLSBAD AB AB AB LUPIN AB AB AB MUTUAL PHARM AB AB AB MYLAN AB AB AB AB AB AB SANDOZ AB AB AB AB AB AB TEVA AB AB AB MEVACOR MERCK AB AB +
10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 10MG 20MG 20MG 40MG 40MG 10MG 10MG 20MG 20MG 40MG 40MG 10MG 20MG 40MG 20MG 40MG
A075828 A075828 A075828 A077748 A077748 A077748 A075991 A075991 A075991 A078296 A078296 A078296 A077520 A077520 A077520 A075451 A075935 A075451 A075935 A075451 A075935 A075300 A075636 A075300 A075636 A075300 A075636 A075551 A075551 A075551
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 001 002 002 003 003 003 002 001
Dec Dec Dec Feb Feb Feb Jun Jun Jun Mar Nov Nov Apr Apr Apr Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec
17, 17, 17, 28, 28, 28, 05, 05, 05, 14, 01, 01, 14, 14, 14, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17, 17,
2001 2001 2001 2007 2007 2007 2002 2002 2002 2008 2007 2007 2006 2006 2006 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001
TABLET, EXTENDED RELEASE; ORAL ALTOPREV ANDRX LABS LLC 20MG XX 40MG XX 60MG XX +
XX XX XX XX
LOXAPINE SUCCINATE
CAPSULE; ORAL LOXAPINE SUCCINATE LANNETT HOLDINGS INC AB AB AB AB MYLAN AB AB AB AB WATSON LABS AB AB AB + AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 25MG BASE 50MG BASE 5MG BASE 10MG BASE 25MG BASE 50MG BASE 5MG BASE 10MG BASE 25MG BASE 50MG BASE
A090695 A090695 A090695 A090695 A076762 A076762 A076762 A076762 A072204 A072205 A072206 A072062
001 002 003 004 001 002 003 004 001 001 001 001
Sep Sep Sep Sep Nov Nov Nov Nov Jun Jun Jun Jun
26, 26, 26, 26, 01, 01, 01, 01, 15, 15, 15, 15,
2011 2011 2011 2011 2004 2004 2004 2004 1988 1988 1988 1988
LUBIPROSTONE
CAPSULE; ORAL AMITIZA SUCAMPO PHARMS XX XX +
8MCG 24MCG
LURASIDONE HYDROCHLORIDE
TABLET; ORAL LATUDA SUNOVION XX XX +
40MG 80MG
LUTROPIN ALFA
INJECTABLE; SUBCUTANEOUS
LUVERIS
XX + EMD SERONO
75 IU/VIAL
N021322 001
MAFENIDE ACETATE
CREAM; TOPICAL
SULFAMYLON
XX + UDL LABS
FOR SOLUTION; TOPICAL
SULFAMYLON
XX + UDL LABS
EQ 85MG BASE/GM
N016763 001
5%
N019832 003
N019047 001
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION
ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
30MG/100ML;37MG/100ML;0.82MG/100ML;370M XX + B BRAUN G/100ML;530MG/100ML;500MG/100ML;12MG/10 0ML
N019696 001
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE; INJECTION PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG /100ML;502MG/100ML PLASMA-LYTE A IN PLASTIC CONTAINER BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG /100ML;502MG/100ML ISOLYTE S IN PLASTIC CONTAINER B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML;530MG /100ML;500MG/100ML NORMOSOL-R IN PLASTIC CONTAINER HOSPIRA 30MG/100ML;37MG/100ML;222MG/100ML;526MG /100ML;502MG/100ML
AP
N017378 001
AP
N017378 002
XX
N019711 001
XX
N017586 001
SOLUTION; IRRIGATION PHYSIOLYTE IN PLASTIC CONTAINER B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML;530MG XX /100ML;500MG/100ML PHYSIOSOL IN PLASTIC CONTAINER HOSPIRA 30MG/100ML;37MG/100ML;222MG/100ML;526MG XX /100ML;502MG/100ML
N019024 001
N017637 002
SOLUTION; INJECTION
NORMOCARB HF 25
XX + DIALYSIS SUPS NORMOCARB HF 35 XX + DIALYSIS SUPS
0.21GM/100ML;2.8GM/100ML;9.07GM/100ML 0.21GM/100ML;3.97GM/100ML;8.3GM/100ML
MAGNESIUM SULFATE
INJECTABLE; INJECTION MAGNESIUM SULFATE + ABRAXIS PHARM 500MG/ML HOSPIRA 500MG/ML MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER + HOSPIRA 1GM/100ML + 2GM/100ML MAGNESIUM SULFATE IN PLASTIC CONTAINER
HOSPIRA 2GM/50ML (40MG/ML)
+ 4GM/100ML (40MG/ML) + 4GM/50ML (80MG/ML)
AP AP XX XX XX XX XX
N019316 001 A075151 001 N020488 001 N020488 002 N020309 003 N020309 001 N020309 002
Sep 08, 1986 Apr 25, 2000 Jul 11, 1995 Jul 11, 1995 Jan 26, 2007 Jun 24, 1994 Jun 24, 1994
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT
N022372 001
MAGNESIUM SULFATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM PHOSPHATE
SOLUTION; IRRIGATION TIS-U-SOL BAXTER HLTHCARE AT
AT
N018508 001
N018336 001
MALATHION
LOTION; TOPICAL MALATHION SYNERX PHARMA AT OVIDE AT + TARO PHARMS NORTH
0.5% 0.5%
MANGANESE CHLORIDE
INJECTABLE; INJECTION MANGANESE CHLORIDE IN PLASTIC CONTAINER HOSPIRA EQ 0.1MG MANGANESE/ML XX
N018962 001
MANNITOL
INJECTABLE; INJECTION MANNITOL 10% B BRAUN 10GM/100ML MANNITOL 10% IN PLASTIC CONTAINER B BRAUN 10GM/100ML HOSPIRA 10GM/100ML MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER B BRAUN 10GM/100ML MANNITOL 15% B BRAUN 15GM/100ML MANNITOL 15% IN PLASTIC CONTAINER B BRAUN 15GM/100ML HOSPIRA 15GM/100ML MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45% B BRAUN 15GM/100ML MANNITOL 20% B BRAUN 20GM/100ML 20GM/100ML MANNITOL 20% IN PLASTIC CONTAINER B BRAUN 20GM/100ML HOSPIRA 20GM/100ML MANNITOL 25% APP PHARMS 12.5GM/50ML HOSPIRA 12.5GM/50ML INTL MEDICATION 12.5GM/50ML LUITPOLD 12.5GM/50ML MANNITOL 5% B BRAUN 5GM/100ML MANNITOL 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML HOSPIRA 5GM/100ML MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12% B BRAUN 5GM/100ML OSMITROL 10% IN WATER BAXTER HLTHCARE 10GM/100ML OSMITROL 10% IN WATER IN PLASTIC CONTAINER BAXTER HLTHCARE 10GM/100ML
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N016080 002 N020006 002 N019603 002 N016080 006 N016080 003 N020006 003 N019603 003 N016080 005 N014738 001 N016080 004 N020006 004 N019603 004 A080677 N016269 A083051 A087409 001 006 001 001 Jul 26, 1993 Jan 08, 1990 Jul 26, 1993 Jan 08, 1990 Jul 26, 1993 Jan 08, 1987
N016080 001 N020006 001 N019603 001 N016080 007 N013684 002 N013684 006 Jul 26, 1993 Jan 08, 1987
AP AP AP AP AP AP
N013684 004 N013684 008 N013684 003 N013684 007 N013684 001 N013684 005
POWDER; INHALATION
ARIDOL KIT
XX + PHARMAXIS
N/A,5MG,10MG,20MG,40MG
N022368 001
SOLUTION; IRRIGATION
RESECTISOL IN PLASTIC CONTAINER
B BRAUN 5GM/100ML XX
N016772 002
MANNITOL; SORBITOL
SOLUTION; IRRIGATION
SORBITOL-MANNITOL IN PLASTIC CONTAINER
XX HOSPIRA 540MG/100ML;2.7GM/100ML
N018316 001
MAPROTILINE HYDROCHLORIDE
TABLET; ORAL MAPROTILINE HYDROCHLORIDE MYLAN 25MG XX 50MG XX + 75MG XX
MARAVIROC
TABLET; ORAL SELZENTRY VIIV HLTHCARE XX XX +
150MG 300MG
MEBENDAZOLE
TABLET, CHEWABLE; ORAL
MEBENDAZOLE
XX + TEVA PHARMS
100MG
A073580 001
MECASERMIN RECOMBINANT
INJECTABLE; SUBCUTANEOUS
INCRELEX
XX + TERCICA
40MG/4ML (10MG/ML)
N021839 001
MECHLORETHAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
MUSTARGEN
XX + LUNDBECK INC
10MG/VIAL
N006695 001
MECLIZINE HYDROCHLORIDE
TABLET; ORAL ANTIVERT AA + PFIZER AA +
12.5MG 25MG
N010721 001 A201451 A201451 A201451 A040659 A040659 A087127 A087128 A089674 A084843 A084092 A040179 A040179 A085740 001 002 003 001 002 001 001 001 002 003 001 002 001
Jan 20, 1982 Feb Feb Feb Jun Jun 23, 23, 23, 04, 04, 2011 2011 2011 2010 2010
MECLOFENAMATE SODIUM
CAPSULE; ORAL MECLOFENAMATE SODIUM MYLAN AB AB + WATSON LABS AB AB
EQ EQ EQ EQ
MEDROXYPROGESTERONE ACETATE
INJECTABLE; INJECTION DEPO-PROVERA + PHARMACIA AND UPJOHN 150MG/ML MEDROXYPROGESTERONE ACETATE SANDOZ 150MG/ML TEVA PARENTERAL 150MG/ML 150MG/ML DEPO-PROVERA + PHARMACIA AND UPJOHN 400MG/ML
AB AB AB AB XX
N020246 001 A078711 001 A076552 001 A076553 001 N012541 003
Oct 29, 1992 May 20, 2009 Oct 27, 2004 Jul 28, 2004
INJECTABLE; SUBCUTANEOUS
DEPO-SUBQ PROVERA 104
XX + PHARMACIA AND UPJOHN
104MG/0.65ML
N021583 001
TABLET; ORAL MEDROXYPROGESTERONE ACETATE BARR AB 2.5MG AB 5MG AB 10MG PROVERA PHARMACIA AND UPJOHN 2.5MG AB AB 5MG AB + 10MG MEDROXYPROGESTERONE ACETATE BP USL PHARMA 10MG
A040159 001 A040159 002 A040159 003 N011839 001 N011839 003 N011839 004 A088484 001
MEFENAMIC ACID
CAPSULE; ORAL MEFENAMIC ACID LUPIN LTD AB MICRO LABS LTD AB PONSTEL AB + SHIONOGI INC
AB AB AB AB
MEGESTROL ACETATE
SUSPENSION; ORAL MEGACE + BRISTOL MYERS SQUIBB MEGESTROL ACETATE APOTEX INC PAR PHARM ROXANE TEVA PHARMS WOCKHARDT MEGACE ES + PAR PHARM
AB AB AB AB AB AB XX
N020264 001 A077404 A075671 A075997 A075681 A076721 001 001 001 001 001
Sep 10, 1993 Feb Jul Feb May Nov 16, 25, 15, 05, 01, 2006 2001 2002 2003 2004
N021778 001
MELOXICAM
SUSPENSION; ORAL
MOBIC
XX + BOEHRINGER INGELHEIM TABLET; ORAL MELOXICAM APOTEX INC AB AB AUROBINDO PHARMA AB AB BEIJING DOUBLE CRANE AB AB BRECKENRIDGE PHARM AB AB CARACO AB AB CARLSBAD AB AB COREPHARMA AB AB DR REDDYS LABS INC AB AB GLENMARK GENERICS AB AB LUPIN PHARMS AB AB MYLAN AB AB AB AB PURACAP PHARM AB
7.5MG/5ML
N021530 001
7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 7.5MG 15MG 15MG 7.5MG
A077882 A077882 A078008 A078008 A078039 A078039 A077920 A077920 A077937 A077937 A077918 A077918 A077930 A077930 A077931 A077931 A077932 A077932 A077944 A077944 A077923 A077934 A077923 A077934 A077938
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 001 002 002 001
Jul Jul Oct Oct Dec Dec Jul Jul Jul Jul Dec Dec Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul
20, 20, 02, 02, 14, 14, 19, 19, 19, 19, 07, 07, 19, 19, 25, 25, 19, 19, 19, 19, 19, 20, 19, 20, 19,
2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006
15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG 7.5MG 15MG
A077938 A077928 A077928 A078102 A078102 A077936 A077936 A077927 A077927 A077929 A077929 A077921 A077921
002 001 002 001 002 001 002 001 002 001 002 001 002
Jul May May Nov Nov Jul Jul Dec Dec Jul Jul Jul Jul
19, 13, 13, 07, 07, 19, 19, 20, 20, 19, 19, 19, 19,
2006 2009 2009 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006
MELPHALAN
TABLET; ORAL
ALKERAN
XX + GLAXOSMITHKLINE
2MG
N014691 002
MELPHALAN HYDROCHLORIDE
INJECTABLE; INJECTION ALKERAN + GLAXOSMITHKLINE MELPHALAN HYDROCHLORIDE BEDFORD LABS BIONICHE PHARMA USA SYNERX
AP AP AP AP
Nov 18, 1992 Oct 28, 2010 Oct 27, 2009 Jun 09, 2009
MEMANTINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL NAMENDA XR FOREST LABS 7MG XX 14MG XX 21MG XX 28MG XX + SOLUTION; ORAL
NAMENDA
XX + FOREST LABS TABLET; ORAL NAMENDA XX FOREST LABS XX +
2MG/ML
N021627 001
5MG 10MG
MENOTROPINS (FSH;LH)
INJECTABLE; IM-SC
REPRONEX
XX + FERRING
INJECTABLE; SUBCUTANEOUS
MENOPUR
XX + FERRING
75 IU/VIAL;75 IU/VIAL
N021047 001
75 IU/VIAL;75 IU/VIAL
N021663 001
25MG
N010679 003
MEPERIDINE HYDROCHLORIDE
INJECTABLE; INJECTION DEMEROL + HOSPIRA 25MG/ML + 50MG/ML + 75MG/ML + 100MG/ML MEPERIDINE HYDROCHLORIDE BAXTER HLTHCARE CORP 25MG/ML 50MG/ML 75MG/ML 100MG/ML ELKINS SINN 25MG/ML 50MG/ML 75MG/ML 100MG/ML WATSON LABS 50MG/ML 100MG/ML MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE BAXTER HLTHCARE CORP 10MG/ML + HOSPIRA 10MG/ML INTL MEDICATION 10MG/ML WATSON LABS 10MG/ML
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
N021171 N021171 N021171 N021171 A080455 A080455 A080455 A080455 A080445 A080445 A080445 A080445 A073444 A073445 A081002 A088432 A081309 A073443
001 002 003 004 007 008 009 010 001 002 003 004 001 001 001 001 001 001
Mar 17, 1992 Mar 17, 1992 Jul Aug Aug Mar 30, 16, 30, 17, 1993 1984 1993 1992
SYRUP; ORAL
MEPERIDINE HYDROCHLORIDE
50MG/5ML XX + ROXANE TABLET; ORAL DEMEROL + SANOFI AVENTIS US 50MG + 100MG MEPERIDINE HYDROCHLORIDE BARR 50MG 100MG CARACO 50MG 100MG EPIC PHARMA 50MG 100MG MALLINCKRODT 50MG 100MG MIKART 50MG 100MG ROXANE 50MG 100MG VINTAGE PHARMS 50MG 100MG WATSON LABS 50MG 100MG MEPERIDINE HYDROCHLORIDE MIKART 75MG 150MG
A088744 001
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA XX XX
N005010 001 N005010 004 A088639 A088640 A040446 A040446 A040331 A040331 A040352 A040352 A040893 A040893 A040110 A040110 A040191 A040191 A040186 A040186 001 001 001 002 001 002 001 002 001 003 001 002 001 002 001 002 Jul Sep Aug Aug May May Jun Jun Jun Jun Mar Mar Dec Dec Jun Jun 02, 19, 08, 08, 28, 28, 13, 13, 24, 24, 12, 12, 17, 17, 30, 30, 1984 1984 2002 2002 1999 1999 2000 2000 2009 2009 1997 1997 1998 1998 1997 1997
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION CARBOCAINE AP + HOSPIRA
1%
N012250 001
AP AP AP AP AP AP AP AP AP AP AP AP AP
N012250 005 N012250 002 A080925 001 A040806 001 A088769 001 A088770 001 A089407 001 A089410 001 A088653 001 A089406 001 A089408 001 A089409 001 A088387 001 Apr 28, 2008 Nov 20, 1984 Nov 20, 1984 Dec 01, 1986 Dec 01, 1986 Aug 21, 1984 Dec 01, 1986 Dec 01, 1986 Dec 01, 1986 Oct 10, 1984
MEPROBAMATE
TABLET; ORAL MEPROBAMATE ALEMBIC PHARMS LTD AA AA INVAGEN PHARMS AA AA TARO AA AA AA + WATSON LABS AA +
MEQUINOL; TRETINOIN
SOLUTION; TOPICAL
SOLAGE
XX + AQUA PHARMS
2%;0.01%
N020922 001
MERCAPTOPURINE
TABLET; ORAL MERCAPTOPURINE MYLAN PROMETHEUS LABS ROXANE PURINETHOL + TEVA
AB AB AB AB
MEROPENEM
INJECTABLE; INJECTION MEROPENEM ACS DOBFAR AP AP HOSPIRA INC AP AP SANDOZ AP AP MERREM AP + ASTRAZENECA AP +
AB AB AB AB
Sep 17, 2004 Sep 30, 2004 Dec 24, 1987 Jun 20, 2008
SUPPOSITORY; RECTAL
CANASA
XX + AXCAN
1GM
N021252 002
MESNA
INJECTABLE; INTRAVENOUS MESNA APP PHARMS BEDFORD SAGENT STRIDES TEVA PARENTERAL MESNEX + BAXTER HLTHCARE
AP AP AP AP AP
N019884 001
TABLET; ORAL
MESNEX
XX + BAXTER HLTHCARE
400MG
N020855 001
MESTRANOL; NORETHINDRONE
TABLET; ORAL-28
NORINYL 1+50 28-DAY
XX + WATSON LABS
0.05MG;1MG
N016659 001
METAPROTERENOL SULFATE
SOLUTION; INHALATION METAPROTERENOL SULFATE AN + DEY AN + NOVEX AN AN WOCKHARDT AN AN SYRUP; ORAL METAPROTERENOL SULFATE NOVEX AA AA + SILARX
10MG/5ML 10MG/5ML
METARAMINOL BITARTRATE
INJECTABLE; INJECTION
METARAMINOL BITARTRATE
EQ 10MG BASE/ML XX + APP PHARMS
A080722 001
METAXALONE
TABLET; ORAL METAXALONE SANDOZ AB SKELAXIN AB + KING PHARMS
800MG 800MG
METFORMIN HYDROCHLORIDE
SOLUTION; ORAL
RIOMET
XX + RANBAXY TABLET; ORAL GLUCOPHAGE BRISTOL MYERS SQUIBB AB AB AB + METFORMIN HYDROCHLORIDE ALKEM AB AB AB ALPHAPHARM AB AB AB ALVOGEN AB AB AB AMNEAL PHARMS NY AB AB AB APOTEX AB AB AB AB AB AB AUROBINDO AB AB AB CARACO AB AB AB DR REDDYS LABS INC AB AB AB GLENMARK GENERICS AB AB AB
500MG/5ML
N021591 001
500MG 850MG 1GM 500MG 850MG 1GM 500MG 850MG 1GM 500MG 850MG 1GM 500MG 850MG 1GM 500MG 500MG 850MG 850MG 1GM 1GM 500MG 850MG 1GM 500MG 850MG 1GM 500MG 850MG 1GM 500MG 850MG 1GM
N020357 001 N020357 002 N020357 005 A091184 A091184 A091184 A075969 A075969 A075969 A076033 A076033 A076033 A077880 A077880 A077880 A075984 A090666 A075984 A090666 A075984 A090666 A077095 A077095 A077095 A075967 A075967 A075967 A077787 A077787 A077787 A078170 A078170 A078170 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 002 003 001 002 003
Mar 03, 1995 Mar 03, 1995 Nov 05, 1998 Nov Nov Nov Jan Jan Jan Jan Jan Jan Jun Jun Jun Apr Dec Apr Dec Apr Dec Jan Jan Jan Jan Jan Jan Aug Aug Aug May May May 01, 01, 01, 29, 29, 29, 24, 24, 24, 05, 05, 05, 23, 07, 23, 07, 23, 07, 14, 14, 14, 29, 29, 29, 23, 23, 23, 23, 23, 23, 2010 2010 2010 2002 2002 2002 2002 2002 2002 2006 2006 2006 2002 2011 2002 2011 2002 2011 2005 2005 2005 2002 2002 2002 2006 2006 2006 2008 2008 2008
A090564 A090564 A090564 A079148 A079148 A079148 A075972 A075972 A075972 A076038 A076038 A076038 A075973 A075976 A075973 A075976 A075973 A075976 A077853 A077853 A077853 A075965 A075985 A075965 A075985 A075965 A075985 A075978 A075978 A075978 A077711 A077711 A077711 A075979 A075979 A075979 A075961 A075961 A075961 A077064 A077064 A077064
001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Apr Apr Apr Nov Nov Nov Jan Jan Jan Feb Feb Feb Jan Jan Jan Jan Jan Jan Jul Jul Jul Jan Jan Jan Jan Jan Jan Jan Jan Nov Jan Jan Jan Jan Jan Jan Jan Jan Jan Apr Apr Apr
22, 22, 22, 25, 25, 25, 24, 24, 24, 21, 21, 21, 25, 24, 25, 24, 25, 24, 28, 28, 28, 25, 25, 25, 25, 25, 25, 25, 25, 05, 24, 24, 24, 24, 24, 24, 25, 25, 25, 18, 18, 18,
2010 2010 2010 2008 2008 2008 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2006 2006 2006 2002 2002 2002 2002 2002 2002 2002 2002 2002 2007 2007 2007 2002 2002 2002 2002 2002 2002 2005 2005 2005
AB AB AB AB AB AB AB AB
N021574 002 N021202 004 A078321 A078596 A076706 A076863 A076985 A090692 002 002 002 001 001 002
Apr 27, 2004 Apr 11, 2003 Apr Jan Dec Oct Sep Jun 17, 03, 29, 14, 13, 29, 2008 2008 2005 2004 2005 2011
N021202 001 A078321 A078596 A076706 A076249 A076650 A076756 A076413 A076873 A077336 A076269 A090014 A076172 A076818 A077060 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Oct 13, 2000 Apr Jan Dec Jul Sep Jul Jun Dec Feb Jun Dec Jun Dec Apr 17, 03, 14, 30, 13, 26, 18, 14, 09, 18, 30, 16, 14, 20, 2008 2008 2004 2004 2005 2006 2004 2004 2006 2004 2009 2004 2004 2005
Apr 27, 2004 Jun 29, 2011 Jun 03, 2005 Jun 03, 2005
AB AB AB AB
Aug 29, 2005 Aug 29, 2005 Feb 25, 2011 Feb 25, 2011
TABLET, EXTENDED RELEASE; ORAL ACTOPLUS MET XR TAKEDA GLOBAL 1GM;EQ 15MG BASE XX 1GM;EQ 30MG BASE XX +
500MG;1MG 500MG;2MG
N021410 005
METHACHOLINE CHLORIDE
FOR SOLUTION; INHALATION
PROVOCHOLINE
XX + METHAPHARM
100MG/VIAL
N019193 001
METHADONE HYDROCHLORIDE
CONCENTRATE; ORAL METHADONE HYDROCHLORIDE ROXANE VISTAPHARM METHADONE HYDROCHLORIDE ROXANE METHADOSE + MALLINCKRODT
AA AA AA AA
INJECTABLE; INJECTION
DOLOPHINE HYDROCHLORIDE
10MG/ML XX + MYLAN INSTITUTIONAL POWDER; FOR RX COMPOUNDING
METHADONE HYDROCHLORIDE
MALLINCKRODT 50GM/BOT XX 100GM/BOT XX 500GM/BOT XX SOLUTION; ORAL METHADONE HYDROCHLORIDE AA + ROXANE 5MG/5ML AA + 10MG/5ML VISTAPHARM AA 5MG/5ML AA 10MG/5ML TABLET; ORAL DOLOPHINE HYDROCHLORIDE AA + ROXANE 5MG AA + 10MG METHADONE HYDROCHLORIDE MALLINCKRODT AA 5MG AA 10MG AA 40MG AA + ROXANE 40MG SANDOZ AA 10MG AA 40MG THE PHARMANETWORK AA 10MG
N021624 001
N006383 002
N006383 003
N006383 004
N006134 002 N006134 010 A040517 A040517 A077142 N017058 A040241 A075082 A090635 001 002 001 001 002 001 001 Apr 27, 2004 Apr 27, 2004 Jul 12, 2005 May 29, 1998 Mar 25, 1998 Nov 25, 2009
METHAMPHETAMINE HYDROCHLORIDE
TABLET; ORAL DESOXYN AA + LUNDBECK INC 5MG METHAMPHETAMINE HYDROCHLORIDE COASTAL PHARMS AA 5MG
METHAZOLAMIDE
TABLET; ORAL METHAZOLAMIDE MIKART AB AB + SANDOZ AB AB TEVA PHARMS AB AB
METHENAMINE HIPPURATE
TABLET; ORAL HIPREX AB + SANOFI AVENTIS US METHENAMINE HIPPURATE COREPHARMA AB UREX CNTY LINE PHARMS AB
METHIMAZOLE
TABLET; ORAL METHIMAZOLE CARACO AB AB CEDAR PHARMS AB AB EMCURE PHARMS USA AB AB MYLAN AB AB + SANDOZ AB AB TAPAZOLE KING PHARMS AB AB
5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG
A040870 A040870 A040547 A040547 A040734 A040734 A040350 A040350 A040411 A040411
001 002 001 002 001 002 001 002 001 002
Sep Sep Feb Feb Dec Dec Mar Mar Mar Mar
25, 25, 18, 18, 14, 14, 29, 29, 27, 27,
2007 2007 2005 2005 2007 2007 2000 2000 2001 2001
METHOCARBAMOL
INJECTABLE; INJECTION METHOCARBAMOL WATSON LABS AP ROBAXIN AP + BAXTER HLTHCARE CORP TABLET; ORAL METHOCARBAMOL AUSTARPHARMA LLC AA
100MG/ML 100MG/ML
500MG
A200958 001
750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 500MG 750MG 750MG 500MG 750MG 500MG 750MG
A200958 A090200 A090200 A084756 A084756 A084616 A084615 A040489 A040489 A084277 A085180 A084276 A085192 A085159 A085123
002 001 002 002 001 001 001 001 002 001 001 002 001 001 001
METHOHEXITAL SODIUM
INJECTABLE; INJECTION
BREVITAL SODIUM
XX + JHP PHARMS XX +
500MG/VIAL 2.5GM/VIAL
METHOTREXATE SODIUM
INJECTABLE; INJECTION METHOTREXATE SODIUM + APP PHARMS EQ 50MG BASE/2ML (EQ 25MG BASE/ML) + EQ 250MG BASE/10ML (EQ 25MG BASE/ML) + HOSPIRA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM PRESERVATIVE FREE + BEDFORD EQ 50MG BASE/2ML (EQ 25MG BASE/ML) + EQ 250MG BASE/10ML (EQ 25MG BASE/ML) + BIONICHE PHARMA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) + BIONICHE PHARMA USA EQ 250MG BASE/10ML (EQ 25MG BASE/ML) + EQ 1GM BASE/40ML (EQ 25MG BASE/ML) EBEWE PHARMA EQ 50MG BASE/2ML (EQ 25MG BASE/ML) EQ 250MG BASE/10ML (EQ 25MG BASE/ML) EQ 1GM BASE/40ML (EQ 25MG BASE/ML) + HOSPIRA EQ 1GM BASE/40ML (EQ 25MG BASE/ML) PHARMACHEMIE BV EQ 50MG BASE/2ML (EQ 25MG BASE/ML) EQ 250MG/10ML (EQ 25MG BASE/ML) EQ 1GM BASE/40ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM + BEDFORD EQ 100MG BASE/4ML (EQ 25MG BASE/ML) + EQ 200MG BASE/8ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM PRESERVATIVE FREE + BEDFORD EQ 1GM BASE/VIAL TABLET; ORAL METHOTREXATE SODIUM BARR + DAVA PHARMS INC MYLAN ROXANE
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX XX
A040263 001 A040263 002 N011719 010 A089340 A089343 A040767 A040768 A040716 A090039 A090039 A090029 N011719 A040850 A040853 A040843 001 001 001 001 001 001 002 001 012 001 001 001
Feb 26, 1999 Feb 26, 1999 Dec 15, 2004 Sep Sep Apr Apr Apr Mar Mar Mar Apr Jan Jan Jan 16, 16, 30, 30, 30, 31, 31, 31, 13, 11, 11, 11, 1986 1986 2007 2007 2007 2009 2009 2009 2005 2010 2010 2010
AB AB AB AB
EQ EQ EQ EQ
EQ EQ EQ EQ
METHOXSALEN
CAPSULE; ORAL
8-MOP
XX + VALEANT PHARM INTL OXSORALEN-ULTRA
XX + VALEANT PHARM INTL INJECTABLE; INJECTION
UVADEX
XX + THERAKOS LOTION; TOPICAL
OXSORALEN
XX + VALEANT PHARM INTL
10MG 10MG
N009048 001
N019600 001 Oct 30, 1986
0.02MG/ML
N020969 001
1%
N009048 002
METHSCOPOLAMINE BROMIDE
TABLET; ORAL METHSCOPOLAMINE BROMIDE BOCA PHARMA AA 2.5MG AA 5MG BRECKENRIDGE PHARM AA 2.5MG AA 5MG PAMINE AA + FOUGERA PHARMS 2.5MG PAMINE FORTE AA + FOUGERA PHARMS 5MG
METHSUXIMIDE
CAPSULE; ORAL
CELONTIN
PARKE DAVIS XX XX +
150MG 300MG
N010596 007
N010596 008
METHYCLOTHIAZIDE
TABLET; ORAL ENDURON + ABBOTT METHYCLOTHIAZIDE MYLAN WATSON LABS ENDURON
ABBOTT
AB AB AB XX
EQ 16.8% BASE
N021415 001
METHYLDOPA
TABLET; ORAL METHYLDOPA ACCORD HLTH AB AB
250MG 500MG
METHYLDOPATE HYDROCHLORIDE
INJECTABLE; INJECTION METHYLDOPATE HYDROCHLORIDE AP + LUITPOLD 50MG/ML TEVA PARENTERAL AP 50MG/ML
METHYLERGONOVINE MALEATE
INJECTABLE; INJECTION METHERGINE AP + NOVARTIS 0.2MG/ML METHYLERGONOVINE MALEATE ERGOJECT AP 0.2MG/ML LUITPOLD AP 0.2MG/ML TABLET; ORAL METHERGINE AB + NOVARTIS 0.2MG METHYLERGONOVINE MALEATE NOVEL LABS INC AB 0.2MG
N006035 004 A040889 001 A090193 001 Sep 13, 2010 Nov 24, 2008
METHYLNALTREXONE BROMIDE
INJECTABLE; SUBCUTANEOUS RELISTOR XX PROGENICS SOLUTION; SUBCUTANEOUS
RELISTOR
XX + PROGENICS
8MG/0.4ML
N021964 002
12MG/0.6ML (12MG/0.6ML)
N021964 001
METHYLPHENIDATE
FILM, EXTENDED RELEASE; TRANSDERMAL DAYTRANA XX NOVEN PHARMS INC 10MG/9HR (1.1MG/HR) XX 15MG/9HR (1.6MG/HR) XX 20MG/9HR (2.2MG/HR) XX + 30MG/9HR (3.3MG/HR)
METHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL METHYLPHENIDATE HYDROCHLORIDE ACTAVIS AB 20MG AB 30MG AB 40MG RITALIN LA NOVARTIS AB 20MG AB 30MG AB + 40MG METADATE CD BX UCB INC 10MG BX 20MG BX 30MG BX 40MG
A078458 001 A078458 002 A078458 003 N021284 001 N021284 002 N021284 003 N021259 N021259 N021259 N021259 003 001 002 004
Dec 01, 2011 Dec 01, 2011 Dec 01, 2011 Jun 05, 2002 Jun 05, 2002 Jun 05, 2002 May Apr Jun Feb 27, 03, 19, 19, 2003 2001 2003 2006
AA AA AA AA
Dec 19, 2002 Dec 19, 2002 Jul 23, 2010 Jul 23, 2010
TABLET; ORAL METHYLPHENIDATE HYDROCHLORIDE MALLINCKRODT 5MG AB 10MG AB 20MG AB UCB INC 5MG AB AB 10MG AB 20MG WATSON LABS AB 5MG AB 10MG AB 20MG RITALIN NOVARTIS AB 5MG AB 10MG AB + 20MG TABLET, CHEWABLE; ORAL METHYLIN MALLINCKRODT XX XX XX +
TABLET, EXTENDED RELEASE; ORAL METADATE ER UCB INC AB 10MG AB + 20MG METHYLIN ER MALLINCKRODT AB 10MG AB 20MG METHYLPHENIDATE HYDROCHLORIDE WATSON LABS AB 20MG RITALIN-SR NOVARTIS AB 20MG CONCERTA JANSSEN PHARMS 18MG XX 27MG XX 36MG XX 54MG XX +
A040306 001 A089601 001 A075629 001 A075629 002 A040410 001 N018029 001 N021121 N021121 N021121 N021121 001 004 002 003
Oct 20, 1999 Jun 01, 1988 May 09, 2000 May 09, 2000 Feb 09, 2001 Mar 30, 1982 Aug Apr Aug Dec 01, 01, 01, 08, 2000 2002 2000 2000
METHYLPREDNISOLONE
TABLET; ORAL MEDROL PHARMACIA AND UPJOHN AB AB AB AB + METHYLPREDNISOLONE DURAMED PHARMS BARR AB
A088497 001
METHYLPREDNISOLONE ACETATE
INJECTABLE; INJECTION DEPO-MEDROL + PHARMACIA AND UPJOHN 40MG/ML + 80MG/ML METHYLPREDNISOLONE ACETATE SANDOZ 40MG/ML 40MG/ML 80MG/ML 80MG/ML TEVA PARENTERAL 40MG/ML 40MG/ML 80MG/ML 80MG/ML DEPO-MEDROL + PHARMACIA AND UPJOHN 20MG/ML
AB AB AB AB AB AB AB AB AB AB XX
N011757 001 N011757 004 A040719 A040794 A040719 A040794 A040557 A040620 A040557 A040620 001 001 002 002 001 001 002 002 Jan Mar Jan Mar Feb Oct Feb Oct 29, 05, 29, 05, 23, 27, 23, 27, 2009 2009 2009 2009 2005 2006 2005 2006
N011757 002
A040793 A040827 A040664 A040665 A040583 A040583 A040612 A040662 A040641 A040641 A040709 A040641 A040709 A040888 A040888 A040888 A040888 A040888 A081266 N011856 N011856 N011856 N011856 N011856
001 001 001 001 001 002 001 001 002 003 001 004 002 001 002 003 004 005 001 003 004 005 006 007
Nov Nov Dec Dec Jul Jul Aug Feb Feb Feb Feb Feb Feb Jul Jul Jul Jul Jul Nov
25, 25, 20, 20, 30, 30, 12, 21, 21, 21, 21, 21, 21, 18, 18, 18, 18, 18, 30,
2008 2008 2005 2005 2004 2004 2004 2007 2007 2007 2007 2007 2007 2011 2011 2011 2011 2011 1992
CAPSULE; ORAL
TESTRED
XX + VALEANT PHARM INTL TABLET; ORAL ANDROID 10 BP VALEANT PHARM INTL ANDROID 25 BP + VALEANT PHARM INTL METHYLTESTOSTERONE BP IMPAX LABS BP
10MG
A083976 001
METIPRANOLOL HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC METIPRANOLOL FALCON PHARMS AT 0.3% OPTIPRANOLOL AT + BAUSCH AND LOMB 0.3%
METOCLOPRAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION METOCLOPRAMIDE HYDROCHLORIDE HOSPIRA AP EQ 5MG BASE/ML TEVA PARENTERAL AP EQ 5MG BASE/ML REGLAN AP + BAXTER HLTHCARE CORP EQ 5MG BASE/ML SOLUTION; ORAL METOCLOPRAMIDE HYDROCHLORIDE ANI PHARMS EQ 5MG PHARM ASSOC EQ 5MG SILARX EQ 5MG VISTAPHARM EQ 5MG + WOCKHARDT EQ 5MG
AA AA AA AA AA
AB AB AB AB AB AB AB AB AB AB AB AB AB AB
TABLET; ORAL METOCLOPRAMIDE HYDROCHLORIDE ACTAVIS ELIZABETH EQ 10MG BASE IPCA LABS LTD EQ 5MG BASE EQ 10MG BASE MUTUAL PHARM EQ 5MG BASE NORTHSTAR HLTHCARE EQ 5MG BASE EQ 10MG BASE TEVA EQ 5MG BASE EQ 10MG BASE VINTAGE PHARMS EQ 5MG BASE EQ 10MG BASE WATSON LABS EQ 5MG BASE EQ 10MG BASE REGLAN ANI PHARMS EQ 5MG BASE + EQ 10MG BASE
A070581 A078807 A078807 A071536 A078374 A078374 A072801 A070184 A077878 A077878 A072750 A071250
001 001 002 002 001 002 001 001 001 002 001 001
Oct Jun Jun Jan Nov Nov Jun Jul Aug Aug Dec Feb
17, 12, 12, 16, 30, 30, 15, 29, 28, 28, 28, 03,
1985 2008 2008 1997 2007 2007 1993 1985 2006 2006 1995 1988
TABLET, ORALLY DISINTEGRATING; ORAL METOZOLV ODT SALIX PHARMS EQ 5MG BASE XX EQ 10MG BASE XX +
2.5MG 5MG 10MG 2.5MG 5MG 10MG 2.5MG 5MG 10MG 2.5MG 5MG 10MG
METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE; ORAL METOPROLOL SUCCINATE MYLAN PHARMS INC AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB EQ 200MG TARTRATE NESHER PHARMS AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB EQ 200MG TARTRATE SANDOZ AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB EQ 200MG TARTRATE WATSON LABS FLORIDA AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB EQ 200MG TARTRATE WOCKHARDT AB EQ 25MG TARTRATE AB EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB EQ 200MG TARTRATE TOPROL-XL ASTRAZENECA AB EQ 25MG TARTRATE AB + EQ 50MG TARTRATE AB EQ 100MG TARTRATE AB + EQ 200MG TARTRATE
A202033 A202033 A202033 A202033 A077779 A077176 A076640 A076640 A076969 A076969 A076969 A076969 A077118 A076862 A077298 A077298 A090615 A090615 A090615 A090615 N019962 N019962 N019962 N019962
001 002 003 004 001 001 002 001 001 002 003 004 001 001 001 002 001 002 003 004 004 001 002 003
Dec Dec Dec Dec Mar May May May Jul May Mar Mar Aug Aug Apr Apr Jul Jul Jul Jul Feb Jan Jan Jan
15, 15, 15, 15, 20, 14, 18, 18, 31, 18, 20, 20, 03, 03, 15, 15, 22, 22, 22, 22, 05, 10, 10, 10,
2011 2011 2011 2011 2008 2008 2007 2007 2006 2007 2008 2008 2009 2009 2010 2010 2010 2010 2010 2010 2001 1992 1992 1992
METOPROLOL TARTRATE
INJECTABLE; INJECTION LOPRESSOR + NOVARTIS METOPROLOL TARTRATE APP PHARMS BEDFORD LABS HIKMA FARMACEUTICA HOSPIRA
AP AP AP AP AP AP AP AP AP AP
1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML
N018704 001 A091045 A076495 A077761 A074133 A075160 A078085 A090386 A091307 A090317 001 001 001 001 001 001 001 001 001
Mar 30, 1984 Oct Jul May Dec Jul Apr Sep Dec Apr 25, 07, 30, 21, 06, 29, 30, 29, 19, 2010 2003 2007 1993 1998 2008 2009 2010 2010
1MG/ML 1MG/ML
50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG
N017963 001 N017963 002 A077739 A077739 A077739 A076670 A074644 A074644 A078459 A078459 A078459 A073654 A073653 A073654 A076704 A076704 A076704 A073288 A073289 A074141 A074141 A074217 A074217 001 002 003 001 001 002 001 002 003 002 001 001 001 002 003 001 001 001 002 001 002 Sep Sep Sep Jan Dec Dec Jun Jun Jun Jul Dec Dec Jan Jan Jan Mar Mar Jan Jan May May 11, 11, 11, 15, 10, 10, 17, 17, 17, 15, 21, 21, 16, 16, 16, 25, 25, 31, 31, 27, 27, 2007 2007 2007 2004 1996 1996 2008 2008 2008 2009 1993 1993 2004 2004 2004 1994 1994 1995 1995 1994 1994
METRONIDAZOLE
CAPSULE; ORAL FLAGYL AB + GD SEARLE LLC METRONIDAZOLE ALEMBIC LTD AB PAR PHARM AB CREAM; TOPICAL METROCREAM + GALDERMA LABS LP METRONIDAZOLE ALTANA G AND W LABS NORITATE + SANOFI AVENTIS US GEL; TOPICAL METROGEL + GALDERMA LABS LP + METRONIDAZOLE ALTANA G AND W LABS INC TARO TOLMAR
AB AB AB XX
Sep 20, 1995 May 28, 2004 Dec 19, 2007 Sep 26, 1997
AB AB AB AB AB AB AB
N019737 001 N021789 001 A077018 A078178 A077819 A077547 A090903 001 001 001 001 001
Nov 22, 1988 Jun 30, 2005 Jun Jan Jul Jul Jul 06, 19, 18, 13, 22, 2006 2011 2006 2006 2011
AP AP AP AP AP
INJECTABLE; INJECTION FLAGYL I.V. RTU IN PLASTIC CONTAINER + BAXTER HLTHCARE 500MG/100ML + PFIZER 500MG/100ML METRO I.V. IN PLASTIC CONTAINER + B BRAUN 500MG/100ML METRONIDAZOLE IN PLASTIC CONTAINER CLARIS LIFESCIENCES 500MG/100ML + HOSPIRA 500MG/100ML
N018657 001 N018353 002 N018900 001 A078084 001 N018890 002 Sep 29, 1983 Mar 31, 2008 Nov 18, 1983
LOTION; TOPICAL METROLOTION AB + GALDERMA LABS LP METRONIDAZOLE ALTANA AB TABLET; ORAL FLAGYL GD SEARLE LLC AB AB + METRONIDAZOLE ALEMBIC PHARMS LTD AB AB MUTUAL PHARM AB AB PLIVA AB AB TEVA AB WATSON LABS AB AB AB
0.75% 0.75%
250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 500MG 250MG 250MG 500MG
N012623 001 N012623 003 A079067 A079067 A070772 A070773 A070027 A070033 A070044 A070035 N018764 N018764 001 002 001 001 001 001 001 001 001 002 Mar Mar Jul Jul Nov Dec Feb Dec Sep Dec 13, 13, 16, 16, 06, 06, 08, 20, 17, 20, 2009 2009 1986 1986 1984 1984 1985 1984 1982 1982
TABLET, EXTENDED RELEASE; ORAL FLAGYL ER AB + GD SEARLE LLC 750MG METRONIDAZOLE ALEMBIC LTD AB 750MG
METYRAPONE
CAPSULE; ORAL
METOPIRONE
XX + NOVARTIS
250MG
N012911 002
METYROSINE
CAPSULE; ORAL
DEMSER
XX + ATON
250MG
N017871 001
MEXILETINE HYDROCHLORIDE
CAPSULE; ORAL MEXILETINE HYDROCHLORIDE TEVA AB 150MG AB 200MG AB + 250MG
AB AB AB AB AB AB
MICAFUNGIN SODIUM
INJECTABLE; IV (INFUSION)
MYCAMINE
XX + ASTELLAS 50MG/VIAL XX + 100MG/VIAL
MICONAZOLE
TABLET; BUCCAL
ORAVIG
XX + BIOALLIANCE PHARMA
50MG
N022404 001
MICONAZOLE NITRATE
SUPPOSITORY; VAGINAL MICONAZOLE NITRATE ACTAVIS MID ATLANTIC AB MONISTAT 3 AB + INSIGHT PHARMS
200MG 200MG
OINTMENT; TOPICAL
VUSION
XX + STIEFEL LABS INC
0.25%;81.35%;15%
N021026 001
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION MIDAZOLAM HYDROCHLORIDE APP PHARMS AP EQ AP EQ BAXTER HLTHCARE AP EQ AP EQ BAXTER HLTHCARE CORP EQ AP AP EQ BEDFORD AP EQ AP EQ BEN VENUE AP EQ AP EQ CLARIS LIFESCIENCES AP EQ AP EQ AP + HOSPIRA EQ AP EQ AP + EQ AP EQ INTL MEDICATED AP EQ AP EQ INTL MEDICATION AP EQ AP EQ TAYLOR AP EQ AP EQ AP EQ
1MG 5MG 1MG 5MG 1MG 5MG 1MG 5MG 1MG 5MG 1MG 5MG 1MG 1MG 5MG 5MG 1MG 5MG 1MG 5MG 1MG 5MG 5MG
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A075154 A075154 A075243 A075243 A075324 A075324 A075247 A075247 A075421 A075421 A075637 A075637 A075293 A075856 A075293 A075856 A076144 A076144 A076020 A076020 A075494 A075481 A075494
002 001 001 002 001 002 002 001 002 001 001 002 001 001 002 002 001 002 001 002 001 001 002
Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Oct Oct Jun Jun Jun Jun Jan Jan Jul Jul Jun Jun Jun
20, 20, 20, 20, 20, 20, 23, 23, 20, 20, 31, 31, 20, 13, 20, 13, 26, 26, 16, 16, 30, 30, 30,
2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2002 2000 2002 2005 2005 2004 2004 2000 2000 2000
AA AA AA AA AA
EQ EQ EQ EQ EQ
MIDODRINE HYDROCHLORIDE
TABLET; ORAL MIDODRINE HYDROCHLORIDE APOTEX INC 2.5MG AB 5MG AB 10MG AB IMPAX PHARMS 2.5MG AB 5MG AB 10MG AB MYLAN 2.5MG AB 5MG AB 10MG AB SANDOZ 2.5MG AB 5MG AB 10MG AB ORVATEN UPSHER SMITH AB 2.5MG AB 5MG AB 10MG PROAMATINE SHIRE AB 2.5MG AB + 5MG AB 10MG
A077746 A077746 A077746 A076449 A076449 A076449 A076577 A076577 A076577 A076514 A076514 A076514
001 002 003 001 002 003 001 002 003 001 002 003
Sep Sep Sep May May Dec Sep Sep Sep Sep Sep Jul
12, 12, 12, 27, 27, 16, 10, 10, 10, 11, 11, 02,
2006 2006 2006 2004 2004 2005 2003 2003 2003 2003 2003 2004
A076725 001 A076725 002 A076725 003 N019815 001 N019815 002 N019815 003
Nov 03, 2004 Nov 03, 2004 Nov 03, 2004 Sep 06, 1996 Sep 06, 1996 Mar 20, 2002
MIFEPRISTONE
TABLET; ORAL
MIFEPREX
XX + DANCO LABS LLC
200MG
N020687 001
MIGLITOL
TABLET; ORAL GLYSET XX PHARMACIA AND UPJOHN XX XX +
100MG
N021348 001
MILNACIPRAN HYDROCHLORIDE
TABLET; ORAL SAVELLA CYPRESS BIOSCIENCE XX XX XX + XX
MILRINONE LACTATE
INJECTABLE; INJECTION MILRINONE LACTATE APP PHARMS EQ 1MG BASE/ML BAXTER HLTHCARE EQ 1MG BASE/ML + BEDFORD EQ 1MG BASE/ML CLARIS LIFESCIENCES EQ 1MG BASE/ML GLAND PHARMA LTD EQ 1MG BASE/ML HIKMA FARMACEUTICA EQ 1MG BASE/ML INTL MEDICATED EQ 1MG BASE/ML MILRINONE LACTATE IN DEXTROSE 5% CLARIS LIFESCIENCES EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) + BAXTER HLTHCARE EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) + EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) BEDFORD LABS EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) CLARIS LIFESCIENCES EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) HOSPIRA EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML) MILRINONE LACTATE IN PLASTIC CONTAINER HIKMA FARMACEUTICA EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A077151 002 A076414 A075834 A075834 A078113 A078113 A077151 A075885 A075885 001 001 002 001 002 001 001 002
Jul 20, 2005 Aug May May May May Jul May May 18, 28, 28, 21, 21, 20, 28, 28, 2004 2002 2002 2008 2008 2005 2002 2002
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL DYNACIN MEDICIS AB EQ AB EQ MINOCIN TRIAX PHARMS LLC AB EQ AB EQ MINOCYCLINE HYDROCHLORIDE AUROBINDO PHARMA AB EQ AB EQ AB EQ IMPAX LABS AB EQ AB EQ AB EQ RANBAXY AB EQ AB EQ AB EQ TEVA AB EQ AB EQ AB + EQ WATSON LABS AB EQ
75MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE 50MG BASE
A063067 002 A063067 001 N050649 001 N050649 002 A065470 A065470 A065470 A065005 A065005 A065005 A065062 A065062 A065062 A063011 A063009 A063009 A063181 001 002 003 001 003 002 001 002 003 001 002 001 001
Sep 15, 1999 Jul 31, 1990 May 31, 1990 May 31, 1990 Mar Mar Mar Mar Apr Mar Nov Nov Nov Mar Aug Mar Dec 11, 11, 11, 23, 18, 23, 30, 30, 30, 02, 12, 02, 30, 2008 2008 2008 1999 2001 1999 2000 2000 2000 1992 2003 1992 1991
EQ 100MG BASE/VIAL
N050444 001
N050781 001
50MG BASE 75MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE 50MG BASE 75MG BASE 100MG BASE
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB XX XX XX XX XX
TABLET, EXTENDED RELEASE; ORAL MINOCYCLINE HYDROCHLORIDE BARR EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE IMPAX LABS INC EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE LUPIN LTD EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE MATRIX LABS LTD EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE SANDOZ EQ 45MG BASE EQ 90MG BASE EQ 135MG BASE SOLODYN MEDICIS EQ 45MG BASE EQ 90MG BASE + EQ 135MG BASE SOLODYN MEDICIS EQ 55MG BASE EQ 65MG BASE EQ 80MG BASE EQ 105MG BASE EQ 115MG BASE
A065485 A065485 A065485 A090024 A090024 A090024 A091424 A091424 A091424 A090911 A090911 A090911 A090422 A090422 A090422
001 002 003 001 002 003 001 003 004 001 002 003 001 002 003
Mar Mar Mar Feb Feb Feb Nov Nov Nov Jul Jul Jul Aug Aug Aug
17, 17, 17, 03, 03, 03, 30, 30, 30, 20, 20, 20, 13, 13, 13,
2009 2009 2009 2009 2009 2009 2011 2011 2011 2010 2010 2010 2009 2009 2009
N050808 001 N050808 002 N050808 003 N050808 N050808 N050808 N050808 N050808 008 004 007 006 005
May 08, 2006 May 08, 2006 May 08, 2006 Aug Jul Aug Aug Jul 27, 23, 27, 27, 23, 2010 2009 2010 2010 2009
MINOXIDIL
TABLET; ORAL MINOXIDIL MUTUAL PHARM AB AB PAR PHARM AB AB WATSON LABS AB AB +
15MG 30MG 45MG 15MG 30MG 45MG 7.5MG 15MG 30MG 45MG 7.5MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG 15MG 30MG 45MG
A076176 A076176 A076176 A077666 A077666 A077666 A076921 A076921 A076921 A076921 A076541 A076541 A076541 A076541 A076122 A076122 A076122 A076219 A076219 A076219 A076119 A076119 A076119 A076312 A076312 A076312 A076336 A076336 A076336
001 002 003 001 002 003 001 002 003 004 004 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jun Jun Jun Aug Aug Aug Oct Oct Oct Oct Apr Apr Apr Apr Jun Jun Jun Jun Jun Jun Jan Jan Jun Jun Jun Jun Jun Jun Jun
19, 19, 19, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 19, 19, 19, 19, 19, 19, 24, 24, 19, 19, 19, 19, 20, 20, 20,
2003 2003 2003 2007 2007 2007 2004 2004 2004 2004 2004 2004 2004 2004 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
TABLET, ORALLY DISINTEGRATING; ORAL MIRTAZAPINE ACTAVIS ELIZABETH 15MG 30MG 45MG AUROBINDO PHARMA LTD 15MG 30MG 45MG TEVA 15MG 30MG 45MG WATSON LABS 15MG 30MG 45MG REMERON SOLTAB + ORGANON USA INC 15MG 30MG 45MG
A077959 A077959 A077959 A077376 A077376 A077376 A076901 A076901 A076901 A076307 A076307 A076307
001 002 003 002 003 004 001 002 003 001 002 003
Feb Feb Feb Dec Dec Feb Jun Jun Jun Dec Dec Feb
14, 14, 14, 08, 08, 28, 28, 28, 28, 17, 17, 28,
2011 2011 2011 2005 2005 2006 2005 2005 2005 2003 2003 2006
MISOPROSTOL
TABLET; ORAL CYTOTEC GD SEARLE LLC AB AB +
0.1MG 0.2MG
0.1MG 0.2MG
MITOMYCIN
INJECTABLE; INJECTION MITOMYCIN + ACCORD HLTHCARE + + BAXTER HLTHCARE BEDFORD
AP AP AP AP AP AP AP
MITOTANE
TABLET; ORAL
LYSODREN
XX + BRISTOL MYERS SQUIBB
500MG
N016885 001
MITOXANTRONE HYDROCHLORIDE
INJECTABLE; INJECTION MITOXANTRONE HYDROCHLORIDE APP PHARMS EQ EQ EQ BEDFORD EQ EQ EQ FRESENIUS KABI ONCOL EQ EQ EQ + HOSPIRA EQ + EQ + EQ MYLAN INSTITUTIONAL EQ EQ TEVA PARENTERAL EQ EQ EQ
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
20MG 25MG 30MG 20MG 25MG 30MG 20MG 25MG 30MG 20MG 25MG 30MG 20MG 30MG 20MG 25MG 30MG
BASE/10ML (EQ 2MG BASE/ML) BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML) BASE/10ML (EQ 2MG BASE/ML) BASE/12.5ML (EQ 2MG BASE/ML) BASE/15ML (EQ 2MG BASE/ML)
A077496 A077496 A077496 A076611 A076611 A076611 A078606 A078606 A078606 A076871 A076871 A076871 A078980 A078980 A077356 A077356 A077356
001 002 003 001 002 003 001 002 003 001 002 003 001 002 001 002 003
Apr Apr Apr Apr Apr Apr May May May Apr Apr Apr Apr Apr Apr Apr Apr
11, 11, 11, 11, 11, 11, 14, 14, 14, 11, 11, 11, 13, 13, 11, 11, 11,
2006 2006 2006 2006 2006 2006 2008 2008 2008 2006 2006 2006 2009 2009 2006 2006 2006
MODAFINIL
TABLET; ORAL PROVIGIL CEPHALON XX XX +
100MG 200MG
MOEXIPRIL HYDROCHLORIDE
TABLET; ORAL MOEXIPRIL HYDROCHLORIDE APOTEX INC AB 7.5MG AB 15MG GLENMARK GENERICS AB 7.5MG AB 15MG PADDOCK LLC AB 7.5MG AB 15MG TEVA AB 7.5MG
MOMETASONE FUROATE
CREAM; TOPICAL ELOCON + SCHERING MOMETASONE FUROATE ALTANA G AND W LABS GLENMARK GENERICS TARO TOLMAR LOTION; TOPICAL ELOCON + SCHERING MOMETASONE FUROATE G AND W LABS GLENMARK GENERICS NYCOMED US PERRIGO TARO TOLMAR OINTMENT; TOPICAL ELOCON + SCHERING MOMETASONE FUROATE ALTANA G AND W LABS GLENMARK GENERICS PERRIGO NEW YORK TARO TOLMAR
AB AB AB AB AB AB
N019625 001 A076171 A077447 A078541 A076679 A076591 001 001 001 001 001
May 06, 1987 Apr May May Dec Apr 08, 22, 28, 21, 18, 2005 2006 2008 2004 2007
AB AB AB AB AB AB AB
N019796 001 A077678 A090506 A075919 A077180 A076788 A076499 001 001 001 001 001 001
Mar 30, 1989 Nov Aug Nov Apr Mar Nov 21, 09, 29, 06, 15, 21, 2007 2010 2007 2005 2006 2007
AB AB AB AB AB AB AB
N019543 001 A077061 A077401 A078571 A076067 A076624 A076481 001 001 001 001 001 001
Apr 30, 1987 Mar Jun May Mar Dec Nov 28, 20, 28, 18, 03, 14, 2005 2006 2008 2002 2004 2003
0.11MG/INH 0.22MG/INH
EQ 0.05MG BASE/SPRAY
N020762 001
MONTELUKAST SODIUM
GRANULE; ORAL
SINGULAIR
XX + MERCK TABLET; ORAL
SINGULAIR
XX + MERCK TABLET, CHEWABLE; ORAL SINGULAIR MERCK XX XX +
EQ 4MG BASE/PACKET
N021409 001
EQ 10MG BASE
N020829 002
AB AB AB AB AB AB AB AB AB AB AB AB BX BX XX XX XX XX XX XX
N020616 N020616 N020616 N020616 N020616 N020616 A200812 A200812 A200812 A200812 A200812 A200812
001 004 002 005 006 003 001 002 003 004 005 006
Jul Mar Jul Mar Oct Jul Nov Nov Nov Nov Nov Nov
03, 09, 03, 09, 27, 03, 10, 10, 10, 10, 10, 10,
1996 2001 1996 2001 2006 1996 2011 2011 2011 2011 2011 2011
N021260 001 N021260 002 N021260 N021260 N021260 N021260 005 006 003 004
Mar 20, 2002 Mar 20, 2002 Dec Dec Mar Mar 18, 18, 20, 20, 2008 2008 2002 2002
INJECTABLE; INJECTION ASTRAMORPH PF APP PHARMS AP AP AP AP DURAMORPH PF AP + BAXTER HLTHCARE AP + MORPHINE SULFATE HOSPIRA AP AP AP AP AP + WATSON LABS AP AP AP AP INFUMORPH XX + BAXTER HLTHCARE XX + MORPHINE SULFATE XX + HOSPIRA XX + HOSPIRA INC XX + XX + XX + XX + XX + MERIDIAN MEDCL TECHN
0.5MG/ML 0.5MG/ML 1MG/ML 1MG/ML 0.5MG/ML 1MG/ML 0.5MG/ML 0.5MG/ML 1MG/ML 1MG/ML 1MG/ML 0.5MG/ML 0.5MG/ML 1MG/ML 1MG/ML 10MG/ML 25MG/ML 5MG/ML 2MG/ML 4MG/ML 8MG/ML 10MG/ML 15MG/ML 15MG/ML
N018565 001 N018565 002 A071849 A073509 A071850 A073510 N019916 A073373 A073375 A073374 A073376 001 001 001 001 001 001 001 001 001
Sep 18, 1984 Sep 18, 1984 May Sep May Sep Oct Sep Sep Sep Sep 11, 30, 11, 30, 30, 30, 30, 30, 30, 1988 1992 1988 1992 1992 1991 1991 1991 1991
N018565 003 N018565 004 N019916 N202515 N202515 N202515 N202515 N202515 N019999 002 001 002 003 004 005 001
Jul 19, 1991 Jul 19, 1991 Oct Nov Nov Nov Nov Nov Jul 27, 14, 14, 14, 14, 14, 12, 2006 2011 2011 2011 2011 2011 1990
N021671 001
N201517 001
15MG 30MG
TABLET, EXTENDED RELEASE; ORAL MORPHINE SULFATE CLONMEL HLTHCARE AB 15MG ENDO PHARMS AB 15MG AB 30MG AB 60MG AB 100MG AB 200MG MALLINCKRODT AB 15MG AB 30MG AB 60MG AB 100MG AB 200MG MYLAN PHARMS INC AB 15MG AB 30MG AB 60MG AB 100MG AB 200MG NESHER PHARMS AB 15MG AB 30MG AB 60MG AB 100MG AB 200MG RHODES PHARMS AB 15MG AB 30MG AB 60MG AB 100MG AB 200MG MS CONTIN PURDUE PHARMA LP AB 15MG AB 30MG AB 60MG AB + 100MG AB 200MG ORAMORPH SR BC XANODYNE PHARM 15MG BC 30MG BC 60MG BC + 100MG
A075407 A075295 A075295 A075295 A075295 A075295 A076412 A076412 A076412 A076438 A076438 A200824 A200824 A200824 A200824 A200824 A076733 A076720 A076720 A077855 A077855 A074862 A074862 A074862 A074769 A074769 N019516 N019516 N019516 N019516 N019516 N019977 N019977 N019977 N019977
001 001 002 003 004 005 001 002 003 001 002 001 002 003 004 005 001 002 001 001 002 001 002 003 001 002 003 001 002 004 005 004 001 002 003
Jan Oct Oct Oct Sep Sep Jul Jul Jul Jul Jul Oct Oct Oct Oct Oct May Dec May Sep Sep Jul Jul Jul Jul Jul Sep May Apr Jan Nov Nov Aug Aug Aug
28, 28, 28, 28, 15, 15, 31, 31, 31, 03, 03, 18, 18, 18, 18, 18, 19, 23, 19, 27, 27, 07, 07, 07, 02, 02, 12, 29, 08, 16, 08, 23, 15, 15, 15,
2000 1998 1998 1998 2000 2000 2003 2003 2003 2003 2003 2011 2011 2011 2011 2011 2004 2005 2004 2007 2007 1998 1998 1998 1998 1998 1989 1987 1988 1990 1993 1994 1991 1991 1991
MOXIFLOXACIN HYDROCHLORIDE
INJECTABLE; IV (INFUSION)
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
160MG/100ML XX + BAYER HLTHCARE SOLUTION/DROPS; OPHTHALMIC
MOXEZA
XX + ALCON PHARMS LTD EQ 0.5% BASE VIGAMOX EQ 0.5% BASE XX + ALCON PHARMS LTD TABLET; ORAL
AVELOX
XX + BAYER HLTHCARE
N021277 001
EQ 400MG BASE
N021085 001
MUPIROCIN
OINTMENT; TOPICAL BACTROBAN + GLAXOSMITHKLINE MUPIROCIN ALTANA GLENMARK PHARMS PERRIGO NEW YORK TARO TEVA CENTANY PERRIGO NEW YORK
AB AB AB AB AB AB BX
2% 2% 2% 2% 2% 2% 2%
N050591 001 A065192 A090480 A065123 A065170 A065085 001 001 001 001 001
Dec 31, 1987 Nov Jun Nov Sep Nov 30, 08, 07, 23, 07, 2005 2011 2003 2005 2003
N050788 001
MUPIROCIN CALCIUM
CREAM; TOPICAL
BACTROBAN
XX + GLAXOSMITHKLINE
OINTMENT; NASAL
BACTROBAN
XX + GLAXOSMITHKLINE
EQ 2% BASE
N050746 001
EQ 2% BASE
N050703 001
MYCOPHENOLATE MOFETIL
CAPSULE; ORAL CELLCEPT + ROCHE PALO MYCOPHENOLATE MOFETIL ACCORD HLTHCARE INC APOTEX CORP DR REDDYS LABS LTD ENDO PHARMS MYLAN ROXANE SANDOZ STRIDES ARCOLAB LTD TEVA PHARMS ZYDUS PHARMS USA INC
AB AB AB AB AB AB AB AB AB AB AB
250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG
N050722 001 A090253 A090419 A091315 A090111 A065520 A065410 A065379 A090055 A065491 A065433 001 001 001 001 001 001 001 001 001 001
May 03, 1995 May Apr Oct Dec May Jul Oct Jun May May 04, 22, 27, 22, 04, 29, 15, 10, 06, 04, 2009 2009 2011 2009 2009 2008 2008 2010 2009 2009
200MG/ML
N050759 001
AB AB AB AB AB AB AB AB AB AB AB
500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG
N050723 001 A065416 A091249 A090499 A090606 A065521 A065413 A065451 A090456 A065457 A065477 001 001 001 001 001 001 001 001 001 001
Jun 19, 1997 May Nov Apr Jul May Jul Oct Jun May May 04, 04, 22, 16, 04, 29, 15, 10, 04, 04, 2009 2011 2009 2010 2009 2008 2008 2010 2009 2009
500MG/VIAL
N050758 001
MYCOPHENOLIC ACID
TABLET, DELAYED RELEASE; ORAL MYFORTIC NOVARTIS 180MG XX 360MG XX +
NABILONE
CAPSULE; ORAL
CESAMET
XX + MEDA PHARMS
1MG
N018677 001
NABUMETONE
TABLET; ORAL NABUMETONE APOTEX INC AB AB DR REDDYS LABS LTD AB AB INVAGEN PHARMS AB AB LUPIN LTD AB AB MATRIX LABS LTD AB AB PAR PHARM AB AB SANDOZ AB AB TEVA AB AB + WATSON LABS AB AB
500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG
A090427 A090427 A078420 A078420 A078671 A078671 A090445 A090445 A090516 A090516 A076009 A076009 A075280 A075280 A075189 A075189 A091083 A091083
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Dec Dec Sep Sep Mar Mar Jan Jan Jul Jul Jan Jan Feb Feb May Sep Jun Jun
30, 30, 24, 24, 07, 07, 12, 12, 12, 12, 24, 24, 25, 25, 26, 24, 13, 13,
2011 2011 2008 2008 2008 2008 2011 2011 2010 2010 2003 2003 2002 2002 2000 2001 2011 2011
20MG 40MG 80MG 20MG 40MG 80MG 20MG 40MG 80MG 20MG 40MG 80MG
N018063 005 N018063 001 N018063 002 A074229 A074229 A074255 A074172 A074172 A074172 A074501 A074501 A074501 001 002 001 001 002 003 001 002 003
NAFARELIN ACETATE
SPRAY, METERED; NASAL
SYNAREL
XX + GD SEARLE LLC
EQ 0.2MG BASE/SPRAY
N019886 001
NAFCILLIN SODIUM
INJECTABLE; INJECTION NAFCILLIN SODIUM ACIC FINE CHEMS AP EQ 1GM BASE AP EQ 2GM BASE IBI AP EQ 1GM BASE/VIAL AP EQ 2GM BASE/VIAL INSTITUTO BIOCHEMICO EQ 10GM BASE/VIAL AP AP + SANDOZ EQ 1GM BASE/VIAL AP + EQ 1GM BASE/VIAL AP + EQ 2GM BASE/VIAL AP + EQ 2GM BASE/VIAL AP + EQ 10GM BASE/VIAL NALLPEN IN PLASTIC CONTAINER EQ 20MG BASE/ML XX + BAXTER HLTHCARE EQ 2GM BASE/100ML XX +
A090560 A090560 A090002 A090002 A090005 A062527 A062732 A062527 A062732 A062527
001 002 001 002 001 002 001 003 002 004
Oct Oct Jun Jun Apr Aug Dec Aug Dec Aug
03, 03, 30, 30, 20, 02, 23, 02, 23, 02,
2011 2011 2011 2011 2011 1984 1986 1984 1986 1984
NAFTIFINE HYDROCHLORIDE
CREAM; TOPICAL
NAFTIN
XX + MERZ PHARMS
GEL; TOPICAL
NAFTIN
XX + MERZ PHARMS
1%
N019599 001
1%
N019356 001
NALBUPHINE HYDROCHLORIDE
INJECTABLE; INJECTION NALBUPHINE HYDROCHLORIDE + HOSPIRA 10MG/ML + 10MG/ML + 20MG/ML + 20MG/ML
AP AP AP AP
NALOXONE HYDROCHLORIDE
INJECTABLE; INJECTION NALOXONE HYDROCHLORIDE AP + HOSPIRA
0.4MG/ML
A070172 001
INJECTABLE; INJECTION
NALOXONE HYDROCHLORIDE + HOSPIRA + + INTL MEDICATION +
AP AP AP AP AP
NALTREXONE
FOR SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
VIVITROL
380MG/VIAL XX + ALKERMES
N021897 001
NALTREXONE HYDROCHLORIDE
TABLET; ORAL NALTREXONE HYDROCHLORIDE ACCORD HLTHCARE 50MG BARR 50MG ELITE LABS 50MG MALLINCKRODT 50MG SANDOZ 50MG REVIA + DURAMED 50MG NALTREXONE HYDROCHLORIDE MALLINCKRODT 25MG 100MG
AB AB AB AB AB AB XX XX
NANDROLONE DECANOATE
INJECTABLE; INJECTION
NANDROLONE DECANOATE
XX + PHARMAFORCE
200MG/ML
A091252 001
NAPHAZOLINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC ALBALON AT + ALLERGAN 0.1% NAPHAZOLINE HYDROCHLORIDE TAYLOR AT 0.1%
NAPROXEN
SUSPENSION; ORAL NAPROSYN AB + ROCHE PALO NAPROXEN ROXANE AB TABLET; ORAL NAPROSYN ROCHE PALO AB AB AB +
25MG/ML 25MG/ML
250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG 250MG 375MG 500MG
A075927 A075927 A075927 A200429 A200429 A200429 A074410 A074410 A074410 A078250 A078250 A078250 A091305 A091305 A091305 A091416 A091416 A091416 A074121 A074121 A074121 A077339 A077339 A077339 A074140 A074140 A074140 A074201 A074201 A074201 A074457 A074457 A074457 A076494 A076494 A076494 A078620 A078620 A078620
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Dec Dec Dec Nov Nov Nov Apr Apr Apr Mar Mar Mar Aug Aug Aug Feb Feb Feb Dec Dec Dec Apr Apr Apr Dec Dec Dec Dec Dec Dec May May May Jan Jan Jan Jun Jun Jun
18, 18, 18, 08, 08, 08, 28, 28, 28, 28, 28, 28, 24, 24, 24, 14, 14, 14, 21, 21, 21, 27, 27, 27, 21, 21, 21, 21, 21, 21, 31, 31, 31, 14, 14, 14, 07, 07, 07,
2001 2001 2001 2011 2011 2011 1995 1995 1995 2007 2007 2007 2011 2011 2011 2011 2011 2011 1993 1993 1993 2005 2005 2005 1993 1993 1993 1993 1993 1993 1995 1995 1995 2004 2004 2004 2007 2007 2007
TABLET, DELAYED RELEASE; ORAL EC-NAPROSYN AB + ROCHE PALO 375MG AB + 500MG NAPROXEN ALPHAPHARM AB 375MG AB 500MG INVAGEN PHARMS AB 375MG AB 500MG PLIVA AB 375MG AB 500MG SANDOZ AB 375MG AB 500MG TEVA AB 375MG AB 500MG
N020067 002 N020067 003 A075390 A075390 A091432 A091432 A075337 A075337 A075061 A075061 A075227 A075227 001 002 001 002 001 002 001 002 001 002
Oct 14, 1994 Oct 14, 1994 Apr Apr Sep Sep May May Feb Feb Jun Jun 19, 19, 19, 19, 26, 26, 18, 18, 30, 30, 2001 2001 2011 2011 1999 1999 1998 1998 1998 1998
EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N018164 001 N018164 003 A078432 A078432 A200629 A200629 A078486 A078486 A078314 A078314 A074480 A074480 A074198 A074198 A074455 A074455 001 002 001 002 001 002 001 002 002 001 001 002 001 002 Sep 30, 1987 Apr Apr Oct Oct Jul Jul Apr Apr Feb May Dec Dec May May 25, 25, 31, 31, 26, 26, 27, 27, 18, 14, 21, 21, 31, 31, 2007 2007 2011 2011 2007 2007 2007 2007 1998 1996 1993 1993 1995 1995
TABLET, EXTENDED RELEASE; ORAL NAPRELAN STAT TRADE EQ 375MG BASE XX EQ 500MG BASE XX EQ 750MG BASE XX +
N021926 001
NARATRIPTAN
TABLET; ORAL NARATRIPTAN APOTEX CORP AB AB SUN PHARM INDS LTD AB
NARATRIPTAN HYDROCHLORIDE
TABLET; ORAL AMERGE GLAXOSMITHKLINE AB AB + NARATRIPTAN HERITAGE PHARMS INC AB AB PADDOCK LLC AB AB ROXANE AB AB SANDOZ AB AB TEVA PHARMS AB AB
EQ 1MG BASE EQ 2.5MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE 1MG BASE 2.5MG BASE
N020763 002 N020763 001 A200502 A200502 A091326 A091326 A090381 A090381 A090288 A090288 A078751 A078751 001 002 001 002 001 002 001 002 001 002
Feb 10, 1998 Feb 10, 1998 Feb Feb Jul Jul Jul Jul Jul Jul Jul Jul 28, 28, 08, 08, 07, 07, 07, 07, 07, 07, 2011 2011 2010 2010 2010 2010 2010 2010 2010 2010
SUSPENSION; OPHTHALMIC
NATACYN
XX + ALCON
5%
N050514 001
NATEGLINIDE
TABLET; ORAL NATEGLINIDE DR REDDYS LABS LTD AB AB PAR PHARM AB AB TEVA PHARMS AB AB WATSON LABS AB AB STARLIX NOVARTIS AB AB +
60MG 120MG 60MG 120MG 60MG 120MG 60MG 120MG 60MG 120MG
NEBIVOLOL HYDROCHLORIDE
TABLET; ORAL BYSTOLIC FOREST LABS XX XX XX XX +
EQ EQ EQ EQ
NEDOCROMIL SODIUM
SOLUTION/DROPS; OPHTHALMIC
ALOCRIL
XX + ALLERGAN 2%
N021009 001
NEFAZODONE HYDROCHLORIDE
TABLET; ORAL NEFAZODONE HYDROCHLORIDE RANBAXY AB 50MG AB 100MG AB 150MG AB 200MG AB 250MG TEVA AB 50MG AB 100MG AB 150MG AB 200MG AB + 250MG NEFAZODONE HYDROCHLORIDE BX DR REDDYS LABS INC 50MG BX 100MG BX 150MG BX 200MG BX 250MG
A076409 A076409 A076409 A076409 A076409 A076037 A076037 A076037 A076037 A076037 A076309 A076309 A076309 A076309 A076309
001 002 003 004 005 001 002 003 004 005 001 002 003 004 005
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16,
2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
NELARABINE
INJECTABLE; IV (INFUSION)
ARRANON
XX + SMITHKLINE BEECHAM 250MG/50ML (5MG/ML)
N021877 001
POWDER; ORAL
VIRACEPT
XX + AGOURON
TABLET; ORAL
VIRACEPT
XX + AGOURON XX +
EQ 50MG BASE/SCOOPFUL
N020778 001
NEOMYCIN SULFATE
A061579 001
EQ 87.5MG BASE/5ML
A065010 001
SUSPENSION/DROPS; OPHTHALMIC
POLY-PRED
EQ 0.35% BASE;10,000 UNITS/ML;0.5% XX + ALLERGAN
N050081 002
NEPAFENAC
SUSPENSION/DROPS; OPHTHALMIC
NEVANAC
XX + ALCON PHARMS LTD 0.1%
N021862 001
NESIRITIDE RECOMBINANT
N020920 001
NEVIRAPINE
SUSPENSION; ORAL
VIRAMUNE
XX + BOEHRINGER INGELHEIM
TABLET; ORAL
VIRAMUNE
XX + BOEHRINGER INGELHEIM
50MG/5ML
N020933 001
200MG
N020636 001
N201152 001
500MG 500MG
NIACIN; SIMVASTATIN
XX XX XX XX XX
NICARDIPINE HYDROCHLORIDE
CAPSULE; ORAL CARDENE EKR THERAP 20MG + 30MG NICARDIPINE HYDROCHLORIDE BARR 20MG 30MG EPIC PHARMA 20MG 30MG MYLAN 20MG 30MG TEVA 20MG 30MG WATSON LABS 20MG 30MG
AB AB AB AB AB AB AB AB AB AB AB AB
N019488 001 N019488 002 A074439 A074439 A074928 A074928 A074642 A074642 A074540 A074540 A074670 A074670 001 002 001 002 001 002 001 002 001 002
Dec 21, 1988 Dec 21, 1988 Dec Dec Mar Mar Jul Jul Oct Oct Oct Oct 10, 10, 19, 19, 18, 18, 28, 28, 28, 28, 1996 1996 1998 1998 1996 1996 1996 1996 1996 1996
AP AP AP AP AP AP AP AP
N019734 001 A078714 A090664 N022276 A090125 A090534 N078405 A090671 001 001 001 001 001 001 001
Jan 30, 1992 Dec Nov Jul Nov Nov Nov Nov 28, 17, 24, 17, 17, 17, 17, 2009 2009 2008 2009 2009 2009 2009
INJECTABLE; INTRAVENOUS
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
40MG/200ML (0.2MG/ML) XX + EKR THERAP CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER 20MG/200ML (0.1MG/ML) XX + EKR THERAP CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER 20MG/200ML (0.1MG/ML) XX + EKR THERAP
N019734 005
NICOTINE
INHALANT; ORAL
NICOTROL
XX + PHARMACIA AND UPJOHN SPRAY, METERED; NASAL
NICOTROL
XX + PFIZER INC
4MG/CARTRIDGE
N020714 001
0.5MG/SPRAY
N020385 001
NIFEDIPINE
CAPSULE; ORAL NIFEDIPINE ACTAVIS ELIZABETH CATALENT INTERGEL PHARM PROCARDIA + PFIZER NIFEDIPINE ACTAVIS ELIZABETH
AB AB AB AB XX
10MG 10MG 10MG 10MG 20MG ORAL 30MG 60MG 90MG 30MG 60MG 30MG 60MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 90MG 30MG 60MG 30MG 60MG 90MG
A072579 001 A073250 001 A072781 001 N018482 001 A072556 001
TABLET, EXTENDED RELEASE; ADALAT CC BAYER HLTHCARE AB1 AB1 + AB1 + AFEDITAB CR WATSON LABS AB1 AB1 NIFEDIPINE ACTAVIS AB1 AB1 MYLAN AB1 AB1 AB1 VALEANT INTL AB1 AB1 AB1 NIFEDIPINE MATRIX LABS LTD AB2 AB2 AB2 MYLAN AB2 AB2 AB2 OSMOTICA PHARM AB2 AB2 AB2 VALEANT INTL AB2 AB2 PROCARDIA XL PFIZER AB2 AB2 AB2 +
N020198 001 N020198 002 N020198 003 A075128 001 A075659 001 A077899 A077899 A201071 A201071 A201071 A075269 A075269 A076070 A090602 A090602 A090602 A090649 A090649 A090649 A077127 A077127 A077410 A075289 A075289 001 002 001 002 003 001 002 001 001 002 003 001 002 003 001 002 001 002 001
Apr 21, 1993 Apr 21, 1993 Apr 21, 1993 Mar 10, 2000 Oct 26, 2001 Dec Dec Dec Dec Dec Dec Dec Aug Sep Sep Sep Jun Jun Jun Nov Nov Oct Feb Sep 13, 13, 03, 03, 03, 04, 04, 16, 13, 13, 13, 21, 21, 21, 21, 21, 03, 06, 27, 2006 2006 2010 2010 2010 2000 2000 2002 2010 2010 2010 2010 2010 2010 2005 2005 2007 2001 2000
NILUTAMIDE
TABLET; ORAL
NILANDRON
XX + SANOFI AVENTIS US
150MG
N020169 002
NIMODIPINE
CAPSULE; ORAL NIMODIPINE BANNER PHARMACAPS AB BARR LABS INC AB AB + SUN PHARM INDS INC
NISOLDIPINE
TABLET, EXTENDED RELEASE; ORAL NISOLDIPINE MYLAN AB 8.5MG AB 17MG AB 25.5MG AB 34MG SULAR AB + SHIONOGI INC 8.5MG AB + 17MG AB 25.5MG AB + 34MG NISOLDIPINE 20MG XX + MYLAN 30MG XX + 40MG XX +
NITAZOXANIDE
FOR SUSPENSION; ORAL
ALINIA
XX + ROMARK TABLET; ORAL
ALINIA
XX + ROMARK
100MG/5ML
N021498 001
500MG
N021497 001
NITISINONE
CAPSULE; ORAL ORFADIN RARE DIS XX XX XX +
NITRIC OXIDE
GAS; INHALATION INOMAX INO XX XX +
100PPM 800PPM
25MG/5ML 25MG/5ML
NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE; ORAL MACRODANTIN ALVOGEN AB AB AB + NITROFURANTOIN IVAX SUB TEVA PHARMS AB AB MYLAN AB AB WATSON LABS AB AB AB
25MG 50MG 100MG 50MG 100MG 50MG 100MG 25MG 50MG 100MG
N016620 003 N016620 001 N016620 002 A073671 A073652 A074967 A077025 A073696 A073696 A073696 001 001 001 001 001 002 003 Jan Jan Jul Aug Dec Dec Dec 28, 28, 09, 18, 31, 31, 31, 1993 1993 1997 2004 1992 1992 1992
AB AB AB AB
Dec 24, 1991 Mar 22, 2004 Mar 30, 2005 Apr 05, 2005
NITROGLYCERIN
AEROSOL, METERED; SUBLINGUAL
NITROMIST
0.4MG/SPRAY XX + NOVADEL FILM, EXTENDED RELEASE; TRANSDERMAL MINITRAN GRACEWAY AB1 0.1MG/HR AB1 0.2MG/HR AB1 0.4MG/HR AB1 0.6MG/HR NITRO-DUR AB1 + KEY PHARMS 0.1MG/HR AB1 + 0.2MG/HR AB1 + 0.4MG/HR AB1 + 0.6MG/HR NITROGLYCERIN KREMERS URBAN PHARMS 0.2MG/HR AB1 AB1 0.4MG/HR NITROGLYCERIN HERCON LABS AB2 0.2MG/HR AB2 0.4MG/HR AB2 0.6MG/HR AB2 + MYLAN TECHNOLOGIES 0.2MG/HR AB2 + 0.4MG/HR AB2 + 0.6MG/HR NITRO-DUR 0.3MG/HR XX + KEY PHARMS 0.8MG/HR XX +
N021780 001
A075115 001 A075115 002 A089884 A089885 A089886 A074559 A074559 A074559 001 001 001 003 002 001
Aug 10, 2004 Aug 10, 2004 Oct Oct Oct Aug Aug Aug 30, 30, 30, 30, 30, 30, 1998 1998 1998 1996 1996 1996
A074559 004
AP AP AP AP AP AP AP AP
N018531 001 A072034 001 N019970 N019970 N019970 A071846 A071847 A071848 001 002 003 001 001 001
May 24, 1988 Dec Dec Dec Aug Aug Aug 29, 29, 29, 31, 31, 31, 1989 1989 1989 1990 1990 1990
OINTMENT; INTRA-ANAL
RECTIV
XX + PROSTRAKAN INC OINTMENT; TRANSDERMAL
NITROGLYCERIN
XX + FOUGERA
0.4%
N021359 001
2%
A087355 001
N018705 002
NIZATIDINE
CAPSULE; ORAL AXID SMITHKLINE BEECHAM AB AB + NIZATIDINE APOTEX AB AB DR REDDYS LABS LTD AB AB GLENMARK GENERICS AB AB MYLAN AB AB AB AB SANDOZ AB AB TEVA AB AB WATSON LABS AB AB SOLUTION; ORAL AXID AA + BRAINTREE NIZATIDINE AMNEAL PHARMS AA
150MG 300MG 150MG 300MG 150MG 300MG 150MG 300MG 150MG 150MG 300MG 300MG 150MG 300MG 150MG 300MG 150MG 300MG
N019508 001 N019508 002 A076383 A076383 A077314 A077314 A090618 A090618 A075806 A075934 A075806 A075934 A076178 A076178 A075668 A075668 A075616 A075616 001 002 001 002 001 002 001 001 002 002 001 002 001 002 001 002
Apr 12, 1988 Apr 12, 1988 Jan Jan Sep Sep Jul Jul Jul Jul Jul Jul Jul Jul Sep Sep Jul Jul 23, 23, 15, 15, 15, 15, 05, 09, 05, 09, 05, 05, 12, 12, 09, 09, 2003 2003 2005 2005 2011 2011 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002
15MG/ML 15MG/ML
N007513 001 A040462 001 A040455 001 Oct 31, 2003 Mar 03, 2003
NORETHINDRONE
TABLET; ORAL-28 CAMILA BARR AB1 HEATHER GLENMARK GENERICS AB1 NORETHINDRONE LUPIN LTD AB1 NOR-QD AB1 + WATSON LABS (UTAH) ERRIN BARR AB2 MICRONOR AB2 + JANSSEN PHARMS NORETHIDRONE GLENMARK GENERICS AB2
A076177 001 A090454 001 A091325 001 N017060 001 A076225 001 N016954 001 A091209 001
NORETHINDRONE ACETATE
TABLET; ORAL AYGESTIN AB + DURAMED RES NORETHINDRONE ACETATE BARR AB GLENMARK GENERICS AB
NORFLOXACIN
TABLET; ORAL
NOROXIN
XX + MERCK
400MG
N019384 002
NORTRIPTYLINE HYDROCHLORIDE
CAPSULE; ORAL NORTRIPTYLINE HYDROCHLORIDE MYLAN AB EQ 10MG AB EQ 25MG AB EQ 50MG AB EQ 75MG TARO AB EQ 10MG AB EQ 25MG AB EQ 50MG AB EQ 75MG TEVA AB EQ 10MG AB EQ 25MG AB EQ 50MG AB EQ 75MG WATSON LABS AB EQ 10MG AB EQ 25MG AB EQ 50MG AB EQ 75MG PAMELOR MALLINCKRODT LLC AB EQ 10MG AB EQ 25MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A074234 A074234 A074234 A074234 A075520 A075520 A075520 A075520 A074132 A074132 A074132 A074132 A073553 A073554 A073555 A073556
001 002 003 004 004 003 001 002 001 002 003 004 001 001 001 001
Jul Jul Jul Jul May May May May Mar Mar Mar Mar Mar Mar Mar Mar
26, 26, 26, 26, 08, 08, 08, 08, 27, 27, 27, 27, 30, 30, 30, 30,
1993 1993 1993 1993 2000 2000 2000 2000 1995 1995 1995 1995 1992 1992 1992 1992
SOLUTION; ORAL AVENTYL HYDROCHLORIDE AA + RANBAXY EQ 10MG BASE/5ML NORTRIPTYLINE HYDROCHLORIDE PHARM ASSOC AA EQ 10MG BASE/5ML TARO AA EQ 10MG BASE/5ML
N014685 001 A075606 001 A077965 001 Aug 28, 2000 Jun 20, 2006
NYSTATIN
CREAM; TOPICAL NYSTATIN ACTAVIS MID ATLANTIC ALTANA PERRIGO NEW YORK TARO VINTAGE
AT AT AT AT AT
OINTMENT; TOPICAL NYSTATIN ACTAVIS MID ATLANTIC AT AT + ALTANA PERRIGO NEW YORK AT POWDER; TOPICAL NYSTATIN + COASTAL PHARMS NESHER PHARMS PAR PHARM UPSHER SMITH X GEN PHARMS NYSTOP PADDOCK LLC SUSPENSION; ORAL NILSTAT + GLENMARK GENERICS NYSTATIN ACTAVIS MID ATLANTIC FOUGERA HI TECH PHARMA TARO VINTAGE PHARMS VISTAPHARM + WOCKHARDT
AT AT AT AT AT AT
100,000 UNITS/GM
A064118 001
AA AA AA AA AA AA AA AA AA
100,000 UNITS/ML 100,000 100,000 100,000 100,000 100,000 100,000 100,000 100,000 UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML
N050299 001 A062349 A062517 A064042 A062876 A065148 A064142 A065422 A062512 001 001 001 001 001 001 001 001 Jul Jun Feb Feb Jun Jun Mar Oct 14, 07, 28, 29, 28, 25, 07, 29, 1982 1984 1994 1988 2005 1998 2011 1984
100,000 UNITS
A062615 001
OCTREOTIDE ACETATE
INJECTABLE; INJECTION OCTREOTIDE ACETATE APP PHARMS AP EQ 0.2MG BASE/ML AP EQ 1MG BASE/ML AP + BEDFORD EQ 0.2MG BASE/ML AP + EQ 1MG BASE/ML SUN PHARM INDS AP EQ 0.05MG BASE/ML AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.2MG BASE/ML AP EQ 0.2MG BASE/ML AP EQ 0.5MG BASE/ML AP EQ 0.5MG BASE/ML AP EQ 1MG BASE/ML AP EQ 1MG BASE/ML TEVA PARENTERAL AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.2MG BASE/ML AP EQ 0.5MG BASE/ML AP EQ 1MG BASE/ML WOCKHARDT USA AP EQ 0.2MG BASE/ML AP EQ 1MG BASE/ML OCTREOTIDE ACETATE (PRESERVATIVE FREE) APP PHARMS AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.5MG BASE/ML AP + BEDFORD EQ 0.05MG BASE/ML AP + EQ 0.1MG BASE/ML AP + EQ 0.5MG BASE/ML MYLAN INSTITUTIONAL AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.5MG BASE/ML WOCKHARDT USA AP EQ 0.05MG BASE/ML AP EQ 0.1MG BASE/ML AP EQ 0.5MG BASE/ML SANDOSTATIN AP + NOVARTIS EQ 0.05MG BASE/ML AP + EQ 0.1MG BASE/ML AP + EQ 0.2MG BASE/ML AP + EQ 0.5MG BASE/ML AP + EQ 1MG BASE/ML SANDOSTATIN LAR NOVARTIS EQ 10MG BASE/VIAL XX EQ 20MG BASE/VIAL XX EQ 30MG BASE/VIAL XX +
A077450 A077450 A076330 A076330 A077329 A077372 A077329 A077372 A077330 A077373 A077329 A077372 A077331 A077373 A075957 A075957 A075959 A075957 A075959 A090986 A090986 A077457 A077457 A077457 A076313 A076313 A076313 A079198 A079198 A079198 A090985 A090985 A090985 N019667 N019667 N019667 N019667 N019667
001 002 001 002 001 001 002 002 001 001 003 003 001 002 001 002 001 003 002 001 002 001 002 003 001 003 002 001 002 003 001 002 003 001 002 004 003 005
Feb Feb Apr Apr Mar Aug Mar Aug Mar Aug Mar Aug Mar Aug Oct Oct Nov Oct Nov May May Feb Feb Feb Mar Mar Mar Feb Feb Feb May May May Oct Oct Jun Oct Jun
10, 10, 08, 08, 04, 14, 04, 14, 04, 14, 04, 14, 04, 14, 03, 03, 21, 03, 21, 11, 11, 10, 10, 10, 28, 28, 28, 10, 10, 10, 11, 11, 11, 21, 21, 12, 21, 12,
2006 2006 2005 2005 2008 2007 2008 2007 2008 2007 2008 2007 2008 2007 2005 2005 2005 2005 2005 2011 2011 2006 2006 2006 2005 2005 2005 2011 2011 2011 2011 2011 2011 1988 1988 1991 1988 1991
OFLOXACIN
SOLUTION/DROPS; OPHTHALMIC OCUFLOX AT + ALLERGAN 0.3% OFLOXACIN AKORN AT 0.3%
AT AT AT AT AT AT AT
AT AT AT AT AT AT
N020799 001 A078222 A076527 A076128 A090395 A076616 001 001 001 001 001
Dec 16, 1997 Mar Sep Mar Aug Mar 17, 28, 17, 11, 17, 2008 2007 2008 2009 2008
OLANZAPINE
INJECTABLE; INTRAMUSCULAR OLANZAPINE INNOPHARMA LLC AP 10MG/VIAL ZYPREXA AP + LILLY 10MG/VIAL TABLET; ORAL OLANZAPINE DR REDDYS LABS LTD AB TEVA PHARMS AB AB AB AB AB ZYPREXA LILLY AB AB + AB AB AB AB
20MG 2.5MG 5MG 7.5MG 10MG 15MG 2.5MG 5MG 7.5MG 10MG 15MG 20MG
A076133 A076000 A076000 A076000 A076000 A076000 N020592 N020592 N020592 N020592 N020592 N020592
002 001 002 003 004 005 001 002 003 004 005 006
Oct Oct Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep
24, 24, 24, 24, 24, 24, 30, 30, 30, 30, 09, 09,
2011 2011 2011 2011 2011 2011 1996 1996 1996 1996 1997 1997
TABLET, ORALLY DISINTEGRATING; ORAL OLANZAPINE APOTEX INC AB 5MG AB 10MG AB 15MG AB 20MG DR REDDYS LABS LTD AB 5MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A076534 A076534 A076534 A078109 A078109 A078109 A078109 A091415 A091415 A091415 A091415 N021086 N021086 N021086 N021086
002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Apr Apr Apr Apr
24, 24, 24, 24, 24, 24, 24, 25, 25, 25, 25, 06, 06, 06, 06,
2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2000 2000 2000 2000
OLANZAPINE PAMOATE
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR ZYPREXA RELPREVV ELI LILLY CO EQ 210MG BASE/VIAL XX EQ 300MG BASE/VIAL XX EQ 405MG BASE/VIAL XX +
OLMESARTAN MEDOXOMIL
TABLET; ORAL BENICAR XX DAIICHI SANKYO XX XX +
OLOPATADINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC
PATADAY
XX + ALCON PHARMS LTD EQ 0.2% BASE PATANOL XX + ALCON EQ 0.1% BASE SPRAY, METERED; NASAL
PATANASE
XX + ALCON PHARMS LTD
0.665MG/SPRAY
N021861 001
OLSALAZINE SODIUM
CAPSULE; ORAL
DIPENTUM
XX + MEDA PHARMS
250MG
N019715 001
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
N021654 001
OMEPRAZOLE
CAPSULE, DELAYED REL PELLETS; ORAL OMEPRAZOLE APOTEX AB 10MG
A076048 001
A076048 A076048 A078490 A075576 A078693 A075576 A078693 A075576 A075785 A075785 A075785 A075410 A075410 A075410 A075757 A075757 A075876 A075876 A075876 A076515 A075347 A075347 A075347
002 003 001 003 001 002 002 001 001 002 003 001 002 003 001 002 001 002 003 001 001 002 003
Oct Jan Apr Oct Mar Oct Mar Jan Oct Oct Jan Nov Nov Jan Jan Jan May May Jan Jan May May May
22, 21, 17, 22, 16, 22, 16, 21, 22, 22, 21, 01, 01, 23, 28, 28, 29, 29, 21, 21, 30, 30, 30,
2007 2009 2009 2007 2009 2007 2009 2009 2007 2007 2009 2002 2002 2009 2003 2003 2003 2003 2009 2009 2008 2008 2008
OMEPRAZOLE MAGNESIUM
FOR SUSPENSION, DELAYED RELEASE; ORAL PRILOSEC ASTRAZENECA EQ 2.5MG BASE/PACKET XX EQ 10MG BASE/PACKET XX +
May 25, 2010 May 25, 2010 Feb 27, 2006 Feb 27, 2006
20MG/PACKET;1.68GM/PACKET 40MG/PACKET;1.68GM/PACKET
ONDANSETRON
FILM; ORAL ZUPLENZ MONOSOL RX LLC XX XX +
4MG 8MG
A076693 A076693 A078152 A078152 A078139 A078139 A077717 A077717 A076506 A076506 A078602 A078602 A078050 A078050 A077557 A077557 A076810 A076810
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Jun Jun Jun Jun Jun Jun Jun Jun Dec Dec Feb Feb Aug Aug Aug Aug Jun Jun
25, 25, 27, 27, 25, 25, 25, 25, 26, 26, 24, 24, 13, 13, 02, 02, 25, 25,
2007 2007 2007 2007 2007 2007 2007 2007 2006 2006 2011 2011 2007 2007 2007 2007 2007 2007
Jan 27, 1999 Jan 27, 1999 Dec 26, 2006 Dec 26, 2006
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION ONDANSETRON HYDROCHLORIDE APOTEX EQ 2MG BASE/ML A077368 APP PHARMS EQ 2MG BASE/ML A076974 BAXTER HLTHCARE EQ 2MG BASE/ML A077365 BEDFORD EQ 2MG BASE/ML A076967 EMCURE PHARMS EQ 2MG BASE/ML A090424 GLAND PHARMA LTD EQ 2MG BASE/ML A079224 HIKMA FARMACEUTICA EQ 2MG BASE/ML A076781 HOSPIRA EQ 2MG BASE/ML A077473 EQ 2MG BASE/ML A077840 LANNETT EQ 2MG BASE/ML A090116 EQ 2MG BASE/ML A090883 LUITPOLD EQ 2MG BASE/ML A077582 EQ 2MG BASE/ML A079039 PFIZER EQ 2MG BASE/ML A078257 PLIVA HRVATSKA DOO EQ 2MG BASE/ML A077544 SANDOZ EQ 2MG BASE/ML A077430 SPECTRUM PHARMS EQ 2MG BASE/ML A078180 SUN PHARM INDS (IN) EQ 2MG BASE/ML A077172 TEVA EQ 2MG BASE/ML A076876 WOCKHARDT EQ 2MG BASE/ML A077577 ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER BEDFORD LABS EQ 0.64MG BASE/ML A078291 CLARIS LIFESCIENCES EQ 0.64MG BASE/ML A078308 + HOSPIRA EQ 0.64MG BASE/ML A077348 TEVA PHARMS EQ 0.64MG BASE/ML A077480 ONDANSETRON HYDROCHLORIDE AND SODIUM CHLORIDE IN PLASTIC CONTAINER + BAXTER HLTHCARE EQ 0.64MG BASE/ML N021915 ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE APOTEX INC EQ 2MG BASE/ML A077343
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001
Dec Dec Dec Dec Apr Sep Dec Dec Jan Apr Aug Dec Nov Apr Dec Jun Mar Dec Nov Dec Apr Mar Feb Nov
26, 26, 26, 26, 16, 25, 26, 26, 19, 14, 05, 26, 18, 23, 26, 27, 26, 26, 22, 26, 13, 17, 01, 22,
2006 2006 2006 2006 2010 2009 2006 2006 2007 2010 2010 2006 2008 2008 2006 2007 2007 2006 2006 2006 2009 2008 2007 2006
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
A076972 A077541 A077011 A076780 A077548 A077387 A079032 A078244 A077551 A077173 A078014 A076759 A077716
001 001 001 001 001 001 001 001 001 001 001 001 001
Dec Dec Dec Dec Dec Dec Nov Apr Jun Dec Mar Nov Dec
26, 26, 26, 26, 26, 26, 18, 23, 27, 26, 21, 22, 26,
2006 2006 2006 2006 2006 2006 2008 2008 2007 2006 2008 2006 2006
AA AA AA AA AA AA AA
4MG BASE/5ML
N020605 001
TABLET; ORAL ONDANSETRON HYDROCHLORIDE APOTEX AB EQ AB EQ AUROBINDO PHARMA AB EQ AB EQ AB EQ DR REDDYS LABS LTD AB EQ AB EQ AB EQ GLENMARK GENERICS AB EQ AB EQ AB EQ MYLAN AB EQ AB EQ AB EQ NATCO PHARMA LTD AB EQ AB EQ PAR PHARM AB EQ AB EQ AB EQ PLIVA HRVATSKA DOO AB EQ AB EQ AB EQ SANDOZ AB EQ AB EQ AB EQ SUN PHARM INDS (IN) AB EQ AB EQ TARO AB EQ
4MG BASE 8MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 4MG BASE
A077306 A077306 A078539 A078539 A078539 A076183 A076183 A076183 A077535 A077535 A077535 A076930 A076930 A076930 A077851 A077851 A077303 A077303 A077303 A077112 A077112 A077112 A077517 A077517 A077517 A077050 A077050 A077729
001 002 001 002 003 003 002 001 001 002 003 001 002 004 001 002 001 002 004 001 002 003 001 002 003 001 002 001
Jun Jun Jul Jul Jul Dec Dec Dec Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Mar
25, 25, 31, 31, 31, 26, 26, 26, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25, 28,
2007 2007 2007 2007 2007 2006 2006 2006 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2011
8MG BASE 24MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 24MG BASE 4MG BASE 8MG BASE 24MG BASE 16MG BASE
Dec 31, 1992 Dec 31, 1992 Aug 27, 1999 Dec 26, 2006
ORLISTAT
CAPSULE; ORAL
XENICAL
XX + HOFFMANN LA ROCHE
120MG
N020766 001
ORPHENADRINE CITRATE
INJECTABLE; INJECTION NORFLEX + MEDICIS ORPHENADRINE CITRATE AKORN BEDFORD LABS SAGENT PHARMS WATSON LABS TABLET, EXTENDED RELEASE; ORPHENADRINE CITRATE GAVIS PHARMS IMPAX PHARMS KIEL + SANDOZ
AP AP AP AP AP AP
30MG/ML 30MG/ML 30MG/ML 30MG/ML 30MG/ML 30MG/ML ORAL 100MG 100MG 100MG 100MG
N013055 001 A040484 A040463 A090585 A084779 A087062 001 001 001 001 001 May Mar Aug Mar 24, 04, 30, 15, 2006 2003 2011 1982
AB AB AB AB
OSELTAMIVIR PHOSPHATE
CAPSULE; ORAL TAMIFLU ROCHE XX XX XX + FOR SUSPENSION; ORAL TAMIFLU ROCHE XX
EQ 6MG BASE/ML
N021246 002
OXACILLIN SODIUM
INJECTABLE; INJECTION OXACILLIN SODIUM AP + SANDOZ AP AP + AP AP +
EQ EQ EQ EQ EQ
1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
OXALIPLATIN
INJECTABLE; IV (INFUSION) ELOXATIN AP + SANOFI AVENTIS US 50MG/10ML (5MG/ML) AP + 100MG/20ML (5MG/ML) OXALIPLATIN APP PHARMS AP 50MG/VIAL AP 100MG/VIAL EBEWE PHARMA AP 50MG/10ML (5MG/ML) AP 100MG/20ML (5MG/ML) FRESENIUS KABI ONCOL 50MG/10ML (5MG/ML) AP AP 100MG/20ML (5MG/ML) AP 50MG/VIAL AP 100MG/VIAL HOSPIRA INC AP 50MG/VIAL AP 100MG/VIAL HOSPIRA WORLDWIDE AP 50MG/10ML (5MG/ML) AP 100MG/20ML (5MG/ML) SANDOZ AP 50MG/10ML (5MG/ML) AP 50MG/VIAL AP 100MG/20ML (5MG/ML) AP 100MG/VIAL AP + SUN PHARMA GLOBAL 50MG/VIAL AP + 100MG/VIAL TEVA PARENTERAL AP 50MG/10ML (5MG/ML) AP 100MG/20ML (5MG/ML) ELOXATIN 200MG/40ML (5MG/ML) XX + SANOFI AVENTIS US
N021759 001 N021759 002 A078819 A078819 A078812 A078812 A078811 A078811 A078810 A078810 A078815 A078815 A078813 A078813 A078817 A090849 A078817 A090849 A078818 A078818 N022160 N022160 001 002 001 002 001 002 001 002 001 002 001 002 001 001 002 002 001 002 001 002
Jan 31, 2005 Jan 31, 2005 Jun Jun Aug Aug Jun Jun Aug Aug Sep Sep Aug Aug Jan Apr Jan Apr Aug Aug Aug Aug 02, 02, 07, 07, 10, 10, 07, 07, 30, 30, 07, 07, 24, 28, 24, 28, 07, 07, 07, 07, 2010 2010 2009 2009 2010 2010 2009 2009 2009 2009 2009 2009 2011 2011 2011 2011 2009 2009 2009 2009
N021759 003
OXANDROLONE
TABLET; ORAL OXANDRIN SAVIENT PHARMS AB AB + OXANDROLONE PAR PHARM AB AB SANDOZ AB AB UPSHER SMITH AB AB
N013718 001 N013718 002 A077827 A077827 A076897 A076897 A076761 A078033 001 002 001 002 001 001
Nov 05, 2001 Jun Jun Dec Dec Dec Mar 22, 22, 01, 01, 01, 22, 2007 2007 2006 2006 2006 2007
OXAPROZIN
TABLET; ORAL DAYPRO + GD SEARLE OXAPROZIN APOTEX INC CARACO DR REDDYS LABS LTD IVAX SUB TEVA PHARMS MYLAN SANDOZ TEVA
AB AB AB AB AB AB AB AB
N018841 004 A075987 A075844 A075855 A075846 A075847 A075845 A075849 001 001 001 001 001 001 001
Oct 29, 1992 Sep Jan Jan May Feb Jan Jul 02, 03, 31, 13, 28, 31, 03, 2004 2002 2001 2002 2001 2001 2002
600MG
A075848 001
OXAZEPAM
CAPSULE; ORAL OXAZEPAM ACTAVIS ELIZABETH AB AB AB IVAX SUB TEVA PHARMS AB AB AB + SANDOZ AB AB AB WATSON LABS AB AB AB
10MG 15MG 30MG 10MG 15MG 30MG 10MG 15MG 30MG 10MG 15MG 30MG
A072251 A072252 A072253 A070943 A070944 A070945 A071813 A071756 A071814 A072952 A072953 A072954
001 001 001 001 001 001 001 001 001 001 001 001
Apr Apr Apr Aug Aug Aug Apr Apr Apr Sep Sep Sep
14, 14, 14, 03, 03, 03, 19, 19, 19, 28, 28, 28,
1988 1988 1988 1987 1987 1987 1988 1988 1988 1990 1990 1990
OXCARBAZEPINE
SUSPENSION; ORAL OXCARBAZEPINE RANBAXY AB TRILEPTAL AB + NOVARTIS TABLET; ORAL OXCARBAZEPINE APOTEX INC AB AB AB BRECKENRIDGE PHARM AB AB AB CADISTA PHARMS AB AB AB GLENMARK GENERICS AB AB AB ROXANE AB AB AB SUN PHARM INDS AB AB AB TARO AB AB AB TEVA PHARMS AB AB AB TRILEPTAL NOVARTIS AB AB AB +
300MG/5ML 300MG/5ML
150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG 150MG 300MG 600MG
A077747 A077747 A077747 A078069 A078069 A078069 A090239 A090239 A090239 A077802 A077802 A077802 A077795 A077795 A077795 A077794 A077794 A077794 A077801 A077801 A077801 A078005 A078005 A078005
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Apr Apr Apr Jan Jan Jan Jan Jan Jan Oct Oct Oct Oct Oct Oct Oct Oct Oct Nov Nov Nov Dec Dec Dec
09, 09, 09, 11, 11, 11, 25, 25, 25, 09, 09, 09, 09, 09, 09, 09, 09, 09, 15, 15, 15, 11, 11, 11,
2008 2008 2008 2008 2008 2008 2010 2010 2010 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007
EQ 1% BASE
N019828 001
EQ 1% BASE
N020209 001
OXTRIPHYLLINE
OXYBUTYNIN
N021351 002
N202513 001
OXYBUTYNIN CHLORIDE
GEL; TRANSDERMAL
GELNIQUE
XX + WATSON LABS SYRUP; ORAL OXYBUTYNIN CHLORIDE MIKART NOVEX PHARM ASSOC SILARX VINTAGE PHARMS + WOCKHARDT TABLET; ORAL DITROPAN + JANSSEN PHARMS OXYBUTYNIN CHLORIDE PLIVA USL PHARMA VINTAGE PHARMS
10%(100MG/PACKET)
N022204 001
AA AA AA AA AA AA
AB AB AB AB
N017577 001 A071655 001 A074625 001 A075079 001 Nov 14, 1988 Jul 31, 1996 Oct 31, 1997
TABLET, EXTENDED RELEASE; ORAL DITROPAN XL JANSSEN PHARMS AB 5MG AB 10MG AB + 15MG OXYBUTYNIN CHLORIDE IMPAX PHARMS AB 5MG AB 10MG AB 15MG MYLAN AB 5MG AB 10MG AB 15MG OSMOTICA PHARM AB 5MG AB 10MG AB 15MG
N020897 001 N020897 002 N020897 003 A076745 A076745 A076745 A076702 A076644 A078293 A078503 A078503 A078503 002 003 001 001 001 001 001 002 003
Dec 16, 1998 Dec 16, 1998 Jun 22, 1999 May May Nov Nov Nov May Feb Feb Feb 09, 09, 09, 09, 09, 10, 04, 04, 04, 2007 2007 2006 2006 2006 2007 2009 2009 2009
N200534 001
N200535 001
A076636 A076636 A202116 A202116 A202116 A091393 A091393 A091393 A091393 A091393 A091313 A091313 A091313 A090895 A090895 A090895 A076758 A076758 A078206 A077290 A077290 A077290 A077290 A077290 A091490 A091490 A091490 A091490 A091490 A090659 A090659 A090659 A077712 A077712 A077712
001 002 001 002 003 001 002 003 004 005 001 002 003 001 002 003 001 002 001 001 002 003 004 005 001 002 003 004 005 001 002 003 003 001 002
Feb Feb Dec Dec Dec Aug Aug Aug Aug Aug Feb Feb Feb Aug Aug Aug Jun Jun Mar Dec Dec Dec Dec Dec Mar Mar Mar Mar Mar Apr Apr Apr Mar Jan Jan
06, 06, 30, 30, 30, 31, 31, 31, 31, 31, 18, 18, 18, 24, 24, 24, 30, 30, 19, 08, 08, 08, 08, 08, 09, 09, 09, 09, 09, 10, 10, 10, 02, 31, 31,
2004 2004 2011 2011 2011 2009 2009 2009 2009 2009 2011 2011 2011 2009 2009 2009 2004 2004 2007 2005 2005 2005 2005 2005 2011 2011 2011 2011 2011 2009 2009 2009 2009 2007 2007
N021011 003 N021011 001 N021011 002 N202080 001 N202080 002
May 15, 2009 Aug 31, 2000 Aug 31, 2000 Jun 17, 2011 Jun 17, 2011
50MG
N016848 001
OXYMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION
OPANA
XX + ENDO PHARMS
1MG/ML
N011707 002
AB AB AB AB AB AB
TABLET; ORAL OPANA ENDO PHARMS 5MG + 10MG OXYMORPHONE HYDROCHLORIDE ROXANE 5MG 10MG TEVA 5MG 10MG
N021611 001 N021611 002 A090964 A090964 A091443 A091443 001 002 002 001
Jun 22, 2006 Jun 22, 2006 Sep Sep Feb Feb 27, 27, 15, 15, 2010 2010 2011 2011
TABLET, EXTENDED RELEASE; ORAL OPANA ER ENDO PHARMS AB 5MG AB 10MG AB 20MG AB 30MG AB + 40MG OXYMORPHONE HYDROCHLORIDE ACTAVIS AB 7.5MG AB 15MG IMPAX LABS AB 5MG AB 7.5MG AB 10MG AB 15MG AB 20MG AB 30MG AB 40MG OPANA ER ENDO PHARMS 5MG XX 7.5MG XX 10MG XX 15MG XX 20MG XX 30MG XX 40MG XX
N021610 N021610 N021610 N021610 N021610 A079046 A079046 A079087 A079087 A079087 A079087 A079087 A079087 A079087 N201655 N201655 N201655 N201655 N201655 N201655 N201655
001 002 003 007 004 001 002 001 002 003 004 005 006 007 001 002 003 004 005 006 007
Jun Jun Jun Feb Jun Dec Dec Jun Dec Jun Dec Jun Jul Jun Dec Dec Dec Dec Dec Dec Dec
22, 22, 22, 29, 22, 13, 13, 14, 21, 14, 21, 14, 22, 14, 09, 09, 09, 09, 09, 09, 09,
2006 2006 2006 2008 2006 2010 2010 2010 2010 2010 2010 2010 2010 2010 2011 2011 2011 2011 2011 2011 2011
A061015 001
OXYTOCIN
INJECTABLE; INJECTION OXYTOCIN + APP PHARMS + + BAXTER HLTHCARE CORP + TEVA PARENTERAL
AP AP AP AP AP AP
10USP UNITS/ML (10USP UNITS/ML) 100USP UNITS/10ML (10USP UNITS/ML) 10USP UNITS/ML (10USP UNITS/ML) 100USP UNITS/10ML (10USP UNITS/ML) 10USP UNITS/ML (10USP UNITS/ML) 100USP UNITS/10ML (10USP UNITS/ML)
10USP UNITS/ML (10USP UNITS/ML) 100USP UNITS/10ML (10USP UNITS/ML) 300USP UNITS/30ML (10USP UNITS/ML)
PACLITAXEL
FOR SUSPENSION; IV (INFUSION)
ABRAXANE
XX + ABRAXIS BIOSCIENCE 100MG/VIAL INJECTABLE; INJECTION PACLITAXEL ACCORD HLTHCARE INC ACTAVIS TOTOWA BEDFORD EBEWE PHARMA FRESENIUS KABI ONCOL + HOSPIRA MYLAN ONCO THERAPIES LTD TEVA PARENTERAL
N021660 001
AP AP AP AP AP AP AP AP AP
PALIPERIDONE
TABLET, EXTENDED RELEASE; ORAL INVEGA JANSSEN PHARMS 1.5MG XX 3MG XX 6MG XX + 9MG XX
PALIPERIDONE PALMITATE
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR INVEGA SUSTENNA JANSSEN PHARMS 39MG/0.25ML (39MG/0.25ML) XX 78MG/0.5ML (78MG/0.5ML) XX 117MG/0.75ML (117MG/0.75ML) XX + 156MG/ML (156MG/ML) XX 234MG/1.5ML (156MG/ML) XX
PALONOSETRON HYDROCHLORIDE
INJECTABLE; INTRAVENOUS
ALOXI
XX + HELSINN HLTHCARE XX +
EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
PAMIDRONATE DISODIUM
INJECTABLE; INJECTION AREDIA AP + NOVARTIS PAMIDRONATE DISODIUM APP PHARMS AP AP AP AP AREVA PHARMS AP AP
N020036 001 A075773 A076207 A075773 A076207 A077433 A077433 001 001 002 002 001 002
Oct 31, 1991 May May May May Nov Nov 06, 17, 06, 17, 26, 26, 2002 2002 2002 2002 2008 2008
90MG/VIAL 30MG/VIAL 30MG/10ML 90MG/VIAL 90MG/10ML 30MG/10ML 60MG/10ML 90MG/10ML 30MG/10ML 90MG/10ML 30MG/VIAL 90MG/VIAL 30MG/10ML 90MG/10ML 30MG/10ML 90MG/10ML 30MG/10ML 60MG/10ML 90MG/10ML 30MG/VIAL 90MG/VIAL 30MG/10ML 90MG/10ML
(3MG/ML) (9MG/ML)
A077433 A075290 N021113 A075290 N021113 A075841 A075841 A075841 A078942 A078942 A078300 A078300 A078373 A078373 A078520 A078520 A078156 A078156 A078156 A077703 A077703 A076153 A076153
003 001 001 003 002 001 002 003 001 002 001 002 001 002 001 002 001 002 003 001 002 001 002
Nov Apr Mar Apr Mar Jun Jun Jun Jul Jul Mar Mar Dec Dec Oct Oct Aug Aug Aug Dec Dec Mar Mar
26, 30, 04, 30, 04, 27, 27, 27, 25, 25, 10, 10, 23, 23, 31, 31, 19, 19, 19, 24, 24, 27, 27,
2008 2001 2002 2001 2002 2002 2002 2002 2008 2008 2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2002 2002
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
CAPSULE, DELAYED RELEASE; ORAL CREON ABBOTT PRODS 30,000USP UNITS;6,000USP XX UNITS;19,000USP UNITS 60,000USP UNITS;12,000USP XX UNITS;38,000USP UNITS 120,000USP UNITS;24,000USP XX + UNITS;76,000USP UNITS PANCREAZE JANSSEN PHARMS 17,500USP/ UNITS;4,200USP/ XX UNITS;10,000USP/ UNITS 43,750USP/ UNITS;10,500USP/ XX UNITS;25,000USP/ UNITS 70,000USP/ UNITS;16,800USP/ XX UNITS;40,000USP/ UNITS 61,000USP/ UNITS;21,000USP/ XX + UNITS;37,000USP/ UNITS ZENPEP APTALIS PHARMA US 27,000USP UNITS;5,000USP XX UNITS;17,000USP UNITS 55,000USP UNITS;10,000USP XX UNITS;34,000USP UNITS 82,000USP UNITS;15,000USP XX UNITS;51,000USP UNITS 109,000USP UNITS;20,000USP XX + UNITS;68,000USP UNITS
Apr 12, 2010 Apr 12, 2010 Apr 12, 2010 Apr 12, 2010
Aug 27, 2009 Aug 27, 2009 Aug 27, 2009 Aug 27, 2009
PANCURONIUM BROMIDE
INJECTABLE; INJECTION PANCURONIUM BROMIDE HOSPIRA AP AP + TEVA PARENTERAL AP +
N022020 001
N020988 001
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A090797 A090797 A077619 A077619 A090901 A090901 A078281 A078281 A090970 A090970 A077058 A077058 A077056 A077056 A090074 A090074 A091231 A091231
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Feb Feb Jan Jan Aug Aug Jan Jan Jan Jan Sep Sep Aug Aug Jan Jan Jan Jan
07, 07, 19, 19, 30, 30, 20, 20, 19, 19, 10, 10, 02, 02, 19, 19, 19, 19,
2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2007 2007 2007 2007 2011 2011 2011 2011
PARICALCITOL
CAPSULE; ORAL ZEMPLAR ABBOTT XX XX XX + INJECTABLE; INJECTION PARICALCITOL SANDOZ CANADA INC AP AP ZEMPLAR AP + ABBOTT AP +
Jul 27, 2011 Jul 27, 2011 Feb 01, 2000 Apr 17, 1998
PAROMOMYCIN SULFATE
CAPSULE; ORAL PAROMOMYCIN SULFATE AA + CARACO HERITAGE PHARMS INC AA
PAROXETINE HYDROCHLORIDE
SUSPENSION; ORAL PAROXETINE HYDROCHLORIDE APOTEX INC AB EQ 10MG BASE/5ML PAXIL AB + GLAXOSMITHKLINE EQ 10MG BASE/5ML
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A075716 A075716 A075716 A075716 A075356 A075356 A075356 A075356 A078406 A078406 A078406 A078406 A078194 A078194 A078194 A078194 A078902 A078902 A078902 A078902 A076618 A076618 A076618 A076618 A077584 A077584 A077584 A077584 N020031 N020031 N020031 N020031
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 005
Mar Mar Mar Mar Jul Jul Jul Jul Jul Jul Jul Jul Jun Jun Jun Jun Mar Mar Mar Mar Aug Aug Aug Aug Mar Mar Mar Mar Dec Dec Dec Dec
08, 08, 08, 08, 30, 30, 30, 30, 25, 25, 25, 25, 29, 29, 29, 29, 13, 13, 13, 13, 15, 15, 15, 15, 07, 07, 07, 07, 29, 29, 29, 29,
2004 2004 2004 2004 2003 2003 2003 2003 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2008 2008 2005 2005 2005 2005 2007 2007 2007 2007 1992 1992 1992 1992
AB AB AB AB AB AB
TABLET, EXTENDED RELEASE; ORAL PAROXETINE HYDROCHLORIDE MYLAN EQ 12.5MG BASE EQ 25MG BASE EQ 37.5MG BASE PAXIL CR GLAXOSMITHKLINE EQ 12.5MG BASE EQ 25MG BASE + EQ 37.5MG BASE
A077873 001 A077873 002 A091427 001 N020936 001 N020936 002 N020936 003
Jun 29, 2007 Jun 29, 2007 Apr 14, 2011 Feb 16, 1999 Feb 16, 1999 Dec 06, 2000
PAROXETINE MESYLATE
TABLET; ORAL PEXEVA NOVEN THERAP XX XX XX XX +
EQ EQ EQ EQ
PAZOPANIB HYDROCHLORIDE
TABLET; ORAL VOTRIENT GLAXOSMITHKLINE XX XX +
250 UNITS/ML
N019818 001
PEGAPTANIB SODIUM
INJECTABLE; INTRAVITREAL
MACUGEN
XX + EYETECH INC
EQ 0.3MG ACID/0.09ML
N021756 001
PEGVISOMANT
INJECTABLE; SUBCUTANEOUS
SOMAVERT
XX + PHARMACIA AND UPJOHN XX + XX +
PEMETREXED DISODIUM
INJECTABLE; IV (INFUSION)
ALIMTA
XX + LILLY
EQ 100MG BASE/VIAL XX +
EQ 500MG BASE/VIAL
PEMIROLAST POTASSIUM
SOLUTION/DROPS; OPHTHALMIC
ALAMAST
0.1% XX + SANTEN
N021079 001
PENBUTOLOL SULFATE
TABLET; ORAL
LEVATOL
XX + SCHWARZ PHARMA
20MG
N018976 004
PENCICLOVIR SODIUM
CREAM; TOPICAL
DENAVIR
XX + DENCO ASSET
1%
N020629 001
PENICILLAMINE
CAPSULE; ORAL
CUPRIMINE
XX + ATON TABLET; ORAL
DEPEN
XX + MEDA PHARMS
250MG
N019853 001
250MG
N019854 001
PENICILLIN G BENZATHINE
INJECTABLE; INJECTION BICILLIN L-A BC + KING PHARMS PERMAPEN BC PFIZER BICILLIN L-A XX + KING PHARMS
PENICILLIN G POTASSIUM
INJECTABLE; INJECTION PENICILLIN G POTASSIUM APP PHARMS AP 5,000,000 UNITS/VIAL AP 20,000,000 UNITS/VIAL HANFORD GC AP 5,000,000 UNITS/VIAL AP 20,000,000 UNITS/VIAL SANDOZ AP 5,000,000 UNITS/VIAL AP 20,000,000 UNITS/VIAL PFIZERPEN AP + PFIZER 5,000,000 UNITS/VIAL AP + 20,000,000 UNITS/VIAL PENICILLIN G POTASSIUM HANFORD GC 1,000,000 UNITS/VIAL XX PENICILLIN G POTASSIUM IN PLASTIC CONTAINER 20,000 UNITS/ML XX + BAXTER HLTHCARE 40,000 UNITS/ML XX + 60,000 UNITS/ML XX +
A060657 002 A060657 003 A065149 001 N050638 001 N050638 002 N050638 003 Jul 23, 2009 Jun 25, 1990 Jun 25, 1990 Jun 25, 1990
PENICILLIN G PROCAINE
INJECTABLE; INJECTION
PENICILLIN G PROCAINE
XX + KING PHARMS XX +
PENICILLIN G SODIUM
INJECTABLE; IM-IV
PENICILLIN G SODIUM
XX + SANDOZ
5,000,000 UNITS/VIAL
A065068 001
PENICILLIN V POTASSIUM
FOR SOLUTION; ORAL PENICILLIN V POTASSIUM DAVA PHARMS INC AA AA PENICILLIN-VK TEVA AA AA + TABLET; ORAL PENICILLIN V POTASSIUM AUROBINDO PHARMA AB AB DAVA PHARMS INC AB AB SANDOZ AB AB + PENICILLIN-VK TEVA AB AB
EQ EQ EQ EQ EQ EQ
300MG/VIAL
N019887 001
INJECTABLE; INJECTION PENTAM AP + APP PHARMS 300MG/VIAL PENTAMIDINE ISETHIONATE WATSON LABS AP 300MG/VIAL
PENTAZOCINE LACTATE
INJECTABLE; INJECTION
TALWIN
XX + HOSPIRA
EQ 30MG BASE/ML
N016194 001
PENTOBARBITAL SODIUM
INJECTABLE; INJECTION
NEMBUTAL SODIUM
XX + LUNDBECK INC
50MG/ML
A083246 001
100MG
N020193 001
PENTOSTATIN
INJECTABLE; INJECTION NIPENT AP + HOSPIRA INC PENTOSTATIN BEDFORD LABS AP
10MG/VIAL 10MG/VIAL
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE; PENTOXIFYLLINE APOTEX IMPAX LABS MYLAN PLIVA VALEANT INTL WATSON LABS PENTOXIL UPSHER SMITH TRENTAL + SANOFI AVENTIS US ORAL 400MG 400MG 400MG 400MG 400MG 400MG 400MG 400MG A075191 A075093 A074425 A074874 A075028 A075107 001 001 001 001 001 001 Jun Aug Jul May Jul Sep 09, 10, 08, 25, 20, 04, 1999 1999 1997 1999 1998 1998
AB AB AB AB AB AB AB AB
PERFLUTREN
INJECTABLE; INTRAVENOUS
DEFINITY
XX + LANTHEUS MEDCL
6.52MG/ML
N021064 001
PERINDOPRIL ERBUMINE
TABLET; ORAL ACEON ABBOTT PRODS AB AB AB + PERINDOPRIL ERBUMINE APOTEX AB
Dec 30, 1993 Dec 30, 1993 Dec 30, 1993 Aug 30, 2010
4MG 8MG 2MG 4MG 8MG 2MG 4MG 8MG 2MG 4MG 8MG 2MG 4MG 8MG
A090463 A090463 A079070 A079070 A079070 A078138 A078138 A078138 A078263 A078263 A078263 A090072 A090072 A090072
002 003 001 002 003 001 002 003 001 002 003 001 002 003
Aug Aug Nov Nov Nov Nov Nov Nov Jan Jan Jan Nov Nov Nov
30, 30, 10, 10, 10, 10, 10, 10, 27, 27, 27, 10, 10, 10,
2010 2010 2009 2009 2009 2009 2009 2009 2010 2010 2010 2009 2009 2009
PERMETHRIN
CREAM; TOPICAL ELIMITE AB + ALLERGAN PERMETHRIN ACTAVIS MID ATLANTIC AB PERRIGO NEW YORK AB
5% 5% 5%
PERPHENAZINE
TABLET; ORAL PERPHENAZINE SANDOZ AB AB AB AB + VINTAGE PHARMS AB AB AB AB
PHENDIMETRAZINE TARTRATE
CAPSULE, EXTENDED RELEASE; ORAL BONTRIL BC VALEANT 105MG PHENDIMETRAZINE TARTRATE BC + SANDOZ 105MG TABLET; ORAL BONTRIL PDM + VALEANT 35MG PHENDIMETRAZINE TARTRATE KVK TECH 35MG MIKAH PHARMA 35MG MIKART 35MG SANDOZ 35MG
AA AA AA AA AA
A085272 001 A091042 A040762 A089452 A085588 001 001 001 001 Aug 31, 2010 Jan 28, 2008 Oct 30, 1991
PHENELZINE SULFATE
TABLET; ORAL NARDIL AB + PARKE DAVIS PHENELZINE SULFATE NOVEL LABS INC AB
10MG
N008708 001
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL ADIPEX-P AA + TEVA 37.5MG PHENTERMINE HYDROCHLORIDE BARR AA 15MG AA 30MG KVK TECH AA 15MG AA 30MG AA 30MG AA 37.5MG LANNETT AA 30MG AA 30MG LANNETT HOLDINGS INC 37.5MG AA MUTUAL PHARM AA 30MG AA + SANDOZ 15MG AA + 30MG AA + 30MG TABLET; ORAL ADIPEX-P + TEVA 37.5MG PHENTERMINE HYDROCHLORIDE ACTAVIS ELIZABETH 37.5MG BARR 37.5MG CARACO 37.5MG ELITE LABS 37.5MG KVK TECH 37.5MG LANNETT 37.5MG MUTUAL PHARM 37.5MG VINTAGE PHARMS 37.5MG PHENTERMINE HYDROCHLORIDE + SANDOZ 30MG
A088023 001 A090591 A090591 A040886 A040875 A040886 A040887 A087022 A091359 A201961 A040525 A087190 A086945 A087190 001 002 002 001 001 001 001 001 001 001 002 001 001
Aug 02, 1983 Mar Mar Mar Mar Mar Apr Feb Jul Jul Oct 18, 18, 31, 21, 31, 24, 03, 16, 20, 23, 2010 2010 2008 2008 2008 2008 1983 2010 2011 2003
AA AA AA AA AA AA AA AA AA XX
A085128 001 A040276 A090470 A040790 A200272 A040876 A040555 A040526 A040377 001 001 001 001 001 001 001 001 Nov Aug Aug Jan Mar Apr Oct Jan 25, 31, 21, 31, 31, 15, 23, 04, 1998 2009 2007 2011 2008 2005 2003 2002
A088605 001
PHENTOLAMINE MESYLATE
INJECTABLE; INJECTION PHENTOLAMINE MESYLATE BEDFORD AP REGITINE AP + NOVARTIS ORAVERSE XX + SEPTODONT HOLDING
PHENYTOIN
SUSPENSION; ORAL DILANTIN-125 AB + PARKE DAVIS PHENYTOIN TARO AB VISTAPHARM AB AB WOCKHARDT AB TABLET, CHEWABLE; ORAL
DILANTIN
XX + PFIZER PHARMS
N008762 001 A040521 A040342 A040610 A040420 001 001 001 001 Mar Jan Aug Apr 08, 31, 18, 19, 2004 2001 2005 2002
50MG
A084427 001
PHENYTOIN SODIUM
CAPSULE; ORAL DILANTIN + PARKE DAVIS 30MG EXTENDED + 100MG EXTENDED EXTENDED PHENYTOIN SODIUM AMNEAL PHARMS NY 100MG EXTENDED MYLAN 100MG EXTENDED SUN PHARM INDS 200MG EXTENDED 300MG EXTENDED SUN PHARM INDS (IN) 100MG EXTENDED TARO 100MG EXTENDED WOCKHARDT 30MG EXTENDED WOCKHARDT USA 100MG EXTENDED PHENYTEK MYLAN 200MG EXTENDED + 300MG EXTENDED
AB AB AB AB AB AB AB AB AB AB AB AB
A084349 001 A084349 002 A040765 A040298 A040731 A040731 A040621 A040684 A040759 A040732 001 001 001 002 001 001 001 001 Nov Dec Jun Jun Dec Sep Dec Jan 12, 28, 30, 30, 11, 05, 18, 30, 2008 1998 2008 2008 2006 2006 2007 2008
INJECTABLE; INJECTION PHENYTOIN SODIUM AP + BAXTER HLTHCARE HOSPIRA AP AP LUITPOLD AP X-GEN PHARMS AP
PHYTONADIONE
INJECTABLE; INJECTION PHYTONADIONE BP INTL MEDICATION VITAMIN K1 BP + HOSPIRA VITAMIN K1 XX + HOSPIRA TABLET; ORAL
MEPHYTON
XX + BIOVAIL TECHNOLOGIES
A083722 001 A087954 001 A087955 001 Jul 25, 1983 Jul 25, 1983
5MG
N010104 003
GEL; OPHTHALMIC
PILOPINE HS
XX + ALCON SOLUTION; OPHTHALMIC ISOPTO CARPINE ALCON RES XX XX XX +
4%
N018796 001
1% 2% 4%
AB AB AB AB AB AB AB AB AB
TABLET; ORAL PILOCARPINE HYDROCHLORIDE COREPHARMA 5MG IMPAX LABS 5MG 7.5MG LANNETT 5MG 7.5MG ROXANE 5MG 7.5MG SALAGEN EISAI INC 5MG + 7.5MG
PIMECROLIMUS
CREAM; TOPICAL
ELIDEL
XX + VALEANT INTL
1%
N021302 001
PIMOZIDE
TABLET; ORAL ORAP TEVA XX XX +
1MG 2MG
PINDOLOL
TABLET; ORAL PINDOLOL MYLAN AB AB + WATSON LABS AB AB
PIOGLITAZONE HYDROCHLORIDE
TABLET; ORAL ACTOS TAKEDA PHARMS NA XX XX XX +
PIPERACILLIN SODIUM
INJECTABLE; INJECTION
PIPERACILLIN
+ ISTITUTO BIOCHIMICO + + +
XX XX XX XX
EQ EQ EQ EQ
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX XX
A065498 A065498 A065498 A065386 A065386 A065386 A065446 A065523 A065523 A065523 A090498 A065362 A065363 A065362 A065363 A065362 A065363 N050684 N050684 N050684 N050684
001 002 003 001 002 003 001 001 002 003 001 001 001 002 002 003 003 001 002 003 004
May May May Sep Sep Sep Sep May May May May Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct
23, 23, 23, 15, 15, 15, 15, 31, 31, 31, 31, 21, 21, 21, 21, 21, 21, 22, 22, 22, 22,
2011 2011 2011 2009 2009 2009 2009 2011 2011 2011 2011 2010 2010 2010 2010 2010 2010 1993 1993 1993 1993
PIRBUTEROL ACETATE
N020014 001
PIROXICAM
CAPSULE; ORAL FELDENE PFIZER + PIROXICAM MUTUAL PHARM MYLAN NOSTRUM LABS TEVA WATSON LABS
AB AB AB AB AB AB AB AB AB AB AB AB AB
10MG 20MG 10MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 10MG 20MG 20MG
N018147 002 N018147 003 A073535 A074102 A074102 A074116 A074118 A074131 A074131 A074287 A074460 A074287 A074460 001 001 002 001 001 001 002 001 001 002 002
Apr 06, 1982 Apr 06, 1982 Mar Jul Jul Jun Jun Dec Dec May Sep May Sep 12, 31, 31, 15, 15, 11, 11, 16, 29, 16, 29, 1993 1992 1992 1993 1993 1992 1992 1996 1995 1996 1995
PITAVASTATIN CALCIUM
TABLET; ORAL LIVALO KOWA CO XX XX XX +
24MG/1.2ML (20MG/ML)
N022311 001
PODOFILOX
GEL; TOPICAL
CONDYLOX
XX + WATSON PHARMS SOLUTION; TOPICAL CONDYLOX AT + WATSON PHARMS PODOFILOX PADDOCK LLC AT PRECISION DERMAT AT
0.5%
N020529 001
POLIDOCANOL
SOLUTION; INTRAVENOUS ASCLERA CHEMISCH FBRK KRSSLR XX XX +
AA AA AA AA
Jul 02, 2004 May 26, 2006 Sep 27, 2006 May 26, 2006
A079232 001
N019797 001
N019797 002
A076491 001
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
FOR SOLUTION; ORAL CLENZ-LYTE PADDOCK LLC AA
236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ BOT;22.74GM/BOT
A090769 001
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS
FOR SOLUTION; ORAL COLYTE AA + MEDA PHARMS AA +
AA
AA AA
AA
AA AA AA
AA
XX
COLYTE WITH FLAVOR PACKS + MEDA PHARMS 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ BOT;22.72GM/BOT COLYTE-FLAVORED + MEDA PHARMS 227.1GM/BOT;2.82GM/BOT;6.36GM/BOT;5.53G M/BOT;21.5GM/BOT + 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ BOT;22.72GM/BOT GOLYTELY + BRAINTREE 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ BOT;22.74GM/BOT PEG 3350 AND ELECTROLYTES MYLAN 236GM;2.97GM;6.74GM;5.86GM;22.74GM NOVEL LABS INC 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ BOT;22.74GM/BOT 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ BOT;22.72GM/BOT POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES PADDOCK LLC 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ BOT;22.72GM/BOT GOLYTELY + BRAINTREE 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC KET;5.53GM/PACKET;21.5GM/PACKET
N018983 012
N019011 001
A090712 001
N019011 002
POLYMYXIN B SULFATE
INJECTABLE; INJECTION POLYMYCIN B SULFATE SAGENT STRIDES POLYMYXIN B SULFATE APP PHARMS + BEDFORD X GEN PHARMS
AP AP AP AP
A061578 001
AT AT AT AT
Oct 20, 1988 Feb 14, 1997 Apr 13, 1998 Dec 17, 1998
PORACTANT ALFA
SUSPENSION; INTRATRACHEAL
CUROSURF
XX + CORNERSTONE THERAP 80MG/ML
N020744 001
PORFIMER SODIUM
INJECTABLE; INJECTION PHOTOFRIN XX PINNACLE BIOLGS
75MG/VIAL
N020451 001
40MG/ML
N022003 001
POTASSIUM ACETATE
INJECTABLE; INJECTION
POTASSIUM ACETATE IN PLASTIC CONTAINER
2MEQ/ML XX + HOSPIRA
N018896 001
POTASSIUM CHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL MICRO-K NESHER PHARMS 8MEQ MICRO-K 10 NESHER PHARMS 10MEQ POTASSIUM CHLORIDE PADDOCK LLC 8MEQ 10MEQ WATSON LABS FLORIDA 8MEQ + 10MEQ INJECTABLE; INJECTION POTASSIUM CHLORIDE APP PHARMS 2MEQ/ML B BRAUN 2MEQ/ML BAXTER HLTHCARE 2MEQ/ML + HOSPIRA 2MEQ/ML INTL MEDICATION 2MEQ/ML POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER + BAXTER HLTHCARE 14.9MG/ML + 746MG/100ML HOSPIRA 14.9MG/ML 745MG/100ML POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER + BAXTER HLTHCARE 29.8MG/ML + 1.49GM/100ML + HOSPIRA 29.8MG/ML 1.49GM/100ML POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.24GM/100ML + HOSPIRA 2.24GM/100ML POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER + BAXTER HLTHCARE 2.98GM/100ML + HOSPIRA 2.98GM/100ML POTASSIUM CHLORIDE IN PLASTIC CONTAINER APP PHARMS 2MEQ/ML 2MEQ/ML POTASSIUM CHLORIDE + APP PHARMS 3MEQ/ML TABLET, EXTENDED RELEASE; KLOR-CON M10 UPSHER SMITH KLOR-CON M20 UPSHER SMITH POTASSIUM CHLORIDE EURAND NESHER PHARMS SCHERING + WATSON LABS FLORIDA ORAL 10MEQ 20MEQ 20MEQ 20MEQ 10MEQ 20MEQ 10MEQ A074726 002 A074726 001 A076368 A076044 N019439 N019439 A075604 001 001 002 001 001 Aug 09, 2000 Nov 20, 1998 Aug Apr Jun Jun Apr 18, 05, 13, 13, 10, 2004 2002 1986 1986 2002
AB AB AB AB AB AB
N018238 001 N018238 002 A200185 A200185 A077419 A077419 001 002 001 002 May 14, 1984 May May Jun Jun 18, 18, 02, 02, 2011 2011 2008 2008
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX
A080225 A085870 A085499 A080205 A083163 N019904 N019904 N020161 N020161 N019904 N019904 N020161 N020161
001 001 001 001 001 001 005 005 001 002 006 006 002 Dec Dec Nov Nov Dec Dec Aug Nov 26, 17, 30, 30, 26, 17, 11, 30, 1989 1990 1992 1992 1989 1990 1998 1992
N019904 003 N020161 003 N019904 004 N020161 004 A088901 001 A088908 001 A080225 003
Dec 26, 1989 Aug 11, 1998 Dec 26, 1989 Aug 11, 1998 Jan 25, 1985 Jan 25, 1985
AB AB AB AB AB AB AB
AB BC BC BC BC BC BC BC XX
A075604 002 A070999 001 N017046 002 N019123 001 N019123 002 N017850 001 N018279 001 N018279 002 A074726 003
AP AP AP AP AP AP AP XX
POTASSIUM CITRATE
TABLET, EXTENDED RELEASE; ORAL POTASSIUM CITRATE COREPHARMA AB 5MEQ AB 10MEQ UROCIT-K MISSION PHARMA AB 5MEQ AB 10MEQ UROCIT-K 15MEQ XX + MISSION PHARMA
A077440 001 A077440 002 N019071 001 N019071 002 N019071 003
Jun 09, 2006 Jun 09, 2006 Aug 30, 1985 Aug 31, 1992 Dec 30, 2009
POVIDONE-IODINE
SOLUTION/DROPS; OPHTHALMIC
BETADINE
XX + ALCON PHARMS LTD 5%
N018634 001
PRALATREXATE
SOLUTION; INTRAVENOUS FOLOTYN ALLOS XX XX +
300MG/ML 1GM/VIAL
PRAMIPEXOLE DIHYDROCHLORIDE
TABLET; ORAL MIRAPEX BOEHRINGER INGELHEIM 0.125MG AB AB + 0.25MG AB 0.5MG AB 0.75MG AB 1MG AB 1.5MG PRAMIPEXOLE DIHYDROCHLORIDE ACTAVIS PHARMA AB 0.125MG AB 0.25MG AB 0.5MG AB 0.75MG AB 1MG AB 1.5MG ALEMBIC LTD AB 0.125MG AB 0.25MG AB 0.5MG AB 1MG AB 1.5MG BARR AB 0.125MG AB 0.25MG AB 0.5MG AB 1MG AB 1.5MG BRECKENRIDGE PHARM AB 0.125MG AB 0.25MG AB 0.5MG AB 1MG AB 1.5MG GLENMARK GENERICS AB 0.125MG AB 0.25MG AB 0.5MG AB 1MG AB 1.5MG MYLAN AB 0.125MG AB 0.25MG AB 0.5MG AB 0.75MG AB 1MG AB 1.5MG SANDOZ AB 0.125MG AB 0.25MG AB 0.5MG AB 0.75MG AB 1MG AB 1.5MG TEVA PHARMS AB 0.125MG AB 0.25MG AB 0.5MG AB 0.75MG AB 1MG
N020667 N020667 N020667 N020667 N020667 N020667 A091254 A091254 A091254 A091254 A091254 A091254 A078894 A078894 A078894 A078894 A078894 A077724 A077724 A077724 A077724 A077724 A091450 A091450 A091450 A091450 A091450 A090781 A090781 A090781 A090781 A090781 A077854 A077854 A077854 A090764 A077854 A077854 A090190 A090190 A090190 A090190 A090190 A090190 A090241 A090241 A090241 A090241 A090241
001 002 006 007 003 005 001 002 003 004 005 006 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 001 004 005 001 002 003 006 004 005 001 002 003 004 005
Jul Jul Feb Jul Jul Jul Nov Nov Nov Nov Nov Nov Oct Oct Oct Oct Oct Feb Feb Feb Feb Feb Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Apr Oct Oct Jul Jul Jul Oct Jul Jul Oct Oct Oct Oct Oct
01, 01, 12, 30, 01, 01, 30, 30, 30, 30, 30, 30, 08, 08, 08, 08, 08, 19, 19, 19, 19, 19, 08, 08, 08, 08, 08, 08, 08, 08, 08, 08, 08, 08, 08, 09, 08, 08, 06, 06, 06, 08, 06, 06, 08, 08, 08, 08, 08,
1997 1997 1998 2007 1997 1997 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2008 2008 2008 2008 2008 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A090241 A090865 A090865 A090865 A090865 A090865 A090865 A078551 A078551 A078551 A078551 A078551 A078920 A078920 A078920 A078920 A078920
006 001 002 003 004 005 006 001 002 003 004 005 001 002 003 004 005
Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Jul Jul Jul Jul Jul
08, 08, 08, 08, 08, 08, 08, 08, 08, 08, 08, 08, 06, 06, 06, 06, 06,
2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010
PRAMLINTIDE ACETATE
INJECTABLE; SUBCUTANEOUS SYMLIN XX AMYLIN XX XX +
EQ 1.5MG BASE/1.5ML (EQ 1MG BASE/ML) EQ 2.7MG BASE/2.7ML (EQ 1MG BASE/ML) EQ 3MG BASE/5ML (EQ 600MCG BASE/ML)
PRASUGREL HYDROCHLORIDE
TABLET; ORAL EFFIENT ELI LILLY AND CO XX XX +
PRAVASTATIN SODIUM
TABLET; ORAL PRAVACHOL BRISTOL MYERS SQUIBB AB AB AB AB + PRAVASTATIN SODIUM APOTEX AB AB AB AB DR REDDYS LABS INC AB AB AB AB GLENMARK GENERICS AB
10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG
N019898 N019898 N019898 N019898 A076341 A076341 A076341 A076341 A076714 A076714 A076714 A076714 A077987
002 003 004 008 001 002 003 004 001 002 003 004 001
Oct Oct Mar Dec Oct Oct Oct Dec Oct Oct Oct Dec May
31, 31, 22, 18, 23, 23, 23, 28, 23, 23, 23, 28, 11,
1991 1991 1993 2001 2006 2006 2006 2007 2006 2006 2006 2007 2007
20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 10MG 20MG 40MG 80MG 10MG 20MG 40MG 80MG 10MG 10MG 20MG 20MG 40MG 40MG 80MG 10MG 20MG 40MG 80MG 30MG
A077987 A077987 A077987 A076397 A076397 A076397 A077491 A077917 A077917 A077917 A077917 A079187 A079187 A079187 A079187 A077013 A077013 A077013 A077013 A077730 A077730 A077730 A076445 A076445 A076445 A076445 A076056 A076056 A076056 A077793 A076939 A077904 A076939 A077904 A076939 A077904 A076939 A077751 A077751 A077751 A077751
002 003 004 003 002 001 001 001 002 003 004 001 002 003 004 001 002 003 004 001 002 005 001 002 003 004 001 002 003 001 004 001 003 002 002 003 001 001 002 003 004
May May Dec Oct Oct Oct Feb Jan Jan Jan Jan May May May May Oct Oct Oct Dec Nov Nov Nov Apr Apr Apr Apr Apr Apr Apr Jan Oct Oct Oct Oct Oct Oct Dec Apr Apr Apr Apr
11, 11, 28, 23, 23, 23, 11, 08, 08, 08, 08, 27, 27, 27, 27, 23, 23, 23, 28, 21, 21, 21, 23, 23, 23, 23, 24, 24, 24, 15, 23, 23, 23, 23, 23, 23, 28, 30, 30, 30, 30,
2007 2007 2007 2006 2006 2006 2008 2008 2008 2008 2008 2010 2010 2010 2010 2006 2006 2006 2007 2006 2006 2006 2007 2007 2007 2007 2006 2006 2006 2008 2006 2006 2006 2006 2006 2006 2007 2008 2008 2008 2008
A077730 003
PRAZIQUANTEL
TABLET; ORAL
BILTRICIDE
XX + BAYER PHARMA AG
600MG
N018714 001
PRAZOSIN HYDROCHLORIDE
CAPSULE; ORAL MINIPRESS PFIZER AB AB + AB PRAZOSIN HYDROCHLORIDE IVAX SUB TEVA PHARMS AB
N017442 002 N017442 003 N017442 001 A071994 001 Sep 12, 1988
EQ EQ EQ EQ EQ
PREDNICARBATE
CREAM; TOPICAL DERMATOP E EMOLLIENT AB + SANOFI AVENTIS US PREDNICARBATE ALTANA AB OINTMENT; TOPICAL DERMATOP AB + SANOFI AVENTIS US PREDNICARBATE ALTANA AB
0.1% 0.1%
0.1% 0.1%
PREDNISOLONE
SYRUP; ORAL PREDNISOLONE ALPHARMA AA APOTEX INC AA AA HI TECH PHARMA AA AA + NESHER PHARMS AA + PHARM ASSOC AA VINTAGE AA WOCKHARDT AA PRELONE TEVA AA TABLET; ORAL
PREDNISOLONE
XX + WATSON LABS
15MG/5ML 5MG/5ML 15MG/5ML 15MG/5ML 5MG/5ML 15MG/5ML 15MG/5ML 15MG/5ML 15MG/5ML 15MG/5ML
A089081 001
5MG
A080354 001
PREDNISOLONE ACETATE
SUSPENSION; ORAL
FLO-PRED
XX + TARO
EQ 15MG BASE/5ML
N022067 002
SUSPENSION/DROPS; OPHTHALMIC OMNIPRED ALCON AB 1% PRED FORTE AB + ALLERGAN 1% PRED MILD 0.12% XX + ALLERGAN
OINTMENT; OPHTHALMIC
BLEPHAMIDE S.O.P.
XX + ALLERGAN
SUSPENSION; OPHTHALMIC
BLEPHAMIDE
XX + ALLERGAN
0.2%;10%
A087748 001
0.2%;10%
N012813 002
AA AA AA AA AA AA AA AA AA AA AA AA AA XX XX XX
A075117 001 N019157 001 A078345 A075183 A076982 A076988 A075988 A076123 A076913 A079010 A075250 A075099 A076895 001 001 001 001 001 001 001 001 001 001 001
Dec 14, 2000 May 28, 1986 Mar Mar May May May Dec Apr May Jul Jun Oct 10, 26, 24, 24, 25, 23, 25, 26, 12, 28, 04, 2009 2003 2005 2005 2004 2002 2005 2009 2002 2002 2004
SOLUTION/DROPS; OPHTHALMIC
PREDNISOLONE SODIUM PHOSPHATE
XX + BAUSCH AND LOMB EQ 0.9% PHOSPHATE TABLET, ORALLY DISINTEGRATING; ORAL ORAPRED ODT XX SHIONOGI INC EQ 10MG BASE XX EQ 15MG BASE XX + EQ 30MG BASE
A040070 001
PREDNISONE
SOLUTION; ORAL
PREDNISONE
XX + ROXANE PREDNISONE INTENSOL XX + ROXANE TABLET; ORAL PREDNISONE CONTRACT PHARMACAL AB JUBILANT CADISTA AB AB AB AB MUTUAL PHARM AB AB AB AB + ROXANE AB + AB + AB +
5MG/5ML 5MG/ML
5MG 1MG 5MG 10MG 20MG 5MG 10MG 20MG 1MG 2.5MG 5MG 10MG
A080209 A040611 A040362 A040362 A040362 A089245 A089246 A089247 A087800 A087801 A080352 A084122
001 001 002 001 003 001 001 001 001 001 001 001
20MG 50MG 1MG 2.5MG 5MG 10MG 20MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 1MG
A087342 A084283 A040584 A040581 A040256 A040256 A040392 A080356 A085162 A085161 A040538 A080292 A088832 A083677 A040890
001 001 001 001 001 002 001 001 001 001 001 001 001 001 001
PREGABALIN
CAPSULE; ORAL LYRICA CPPI CV XX XX XX XX XX XX XX XX +
SOLUTION; ORAL
LYRICA
XX + CPPI CV
20MG/ML
N022488 001
PRILOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION CITANEST PLAIN DENTAL AP + DENTSPLY PHARM 4% PRILOCAINE HYDROCHLORIDE SEPTODONT INC AP 4%
PRIMAQUINE PHOSPHATE
TABLET; ORAL
PRIMAQUINE
XX + SANOFI AVENTIS US
EQ 15MG BASE
N008316 001
PRIMIDONE
TABLET; ORAL MYSOLINE AB + VALEANT AB PRIMIDONE AMNEAL PHARM AB AB DR REDDYS LABS LTD AB AB IMPAX LABS AB AB LANNETT AB
N009170 003 N009170 002 A040866 A040866 A040862 A040862 A040717 A040717 A084903 001 002 001 002 001 002 002 Apr Apr Oct Oct Feb Feb May 23, 23, 03, 03, 12, 12, 24, 2008 2008 2008 2008 2008 2008 2001
PROBENECID
TABLET; ORAL PROBALAN LANNETT PROBENECID IVAX SUB TEVA PHARMS + MYLAN WATSON LABS
AB AB AB AB
A080966 001 A083740 001 A084211 002 A084442 004 May 09, 1984 Mar 29, 1983
PROCAINAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION PROCAINAMIDE HYDROCHLORIDE + HOSPIRA 100MG/ML + 500MG/ML INTL MEDICATION 100MG/ML 500MG/ML
AP AP AP AP
PROCARBAZINE HYDROCHLORIDE
CAPSULE; ORAL
MATULANE
XX + SIGMA TAU
EQ 50MG BASE
N016785 001
PROCHLORPERAZINE
SUPPOSITORY; RECTAL COMPRO PADDOCK LLC AB PROCHLORPERAZINE AB + G AND W LABS
25MG 25MG
PROCHLORPERAZINE EDISYLATE
INJECTABLE; INJECTION PROCHLORPERAZINE EDISYLATE AP + BAXTER HLTHCARE EQ 5MG BASE/ML BEDFORD AP EQ 5MG BASE/ML
PROCHLORPERAZINE MALEATE
TABLET; ORAL PROCHLORPERAZINE MALEATE MYLAN AB EQ AB EQ SANDOZ AB EQ AB + EQ TEVA PHARMS AB EQ AB EQ PROCOMP JUBILANT CADISTA AB EQ AB EQ
5MG BASE 10MG BASE 5MG BASE 10MG BASE 5MG BASE 10MG BASE 5MG BASE 10MG BASE
100MG 200MG
4% 8%
AO AO AO AO
INSERT; VAGINAL
ENDOMETRIN
XX + FERRING
100MG
N022057 001
PROMETHAZINE HYDROCHLORIDE
INJECTABLE; INJECTION PROMETHAZINE HYDROCHLORIDE BAXTER HLTHCARE 25MG/ML 50MG/ML HOSPIRA 25MG/ML LUITPOLD 25MG/ML + TEVA PARENTERAL 25MG/ML + 50MG/ML WOCKHARDT 25MG/ML 50MG/ML X-GEN PHARMS 25MG/ML 50MG/ML SUPPOSITORY; RECTAL PROMETHAZINE HYDROCHLORIDE G AND W LABS 12.5MG + 25MG PADDOCK LLC 12.5MG 25MG PERRIGO NEW YORK 12.5MG 25MG TARO 12.5MG 25MG PROMETHEGAN + G AND W LABS 50MG SYRUP; ORAL PROMETHAZINE HYDROCHLORIDE AMNEAL PHARMS 6.25MG/5ML HI TECH PHARMA 6.25MG/5ML SUN PHARM INDS INC 6.25MG/5ML TARO 6.25MG/5ML VINTAGE 6.25MG/5ML PROMETHAZINE PLAIN + WOCKHARDT 6.25MG/5ML TABLET; ORAL PROMETHAZINE HYDROCHLORIDE AMNEAL PHARMS NY 12.5MG 25MG 50MG EMCURE PHARMS USA 12.5MG
AP AP AP AP AP AP AP AP AP AP
A083312 A083312 A040372 A040515 A040454 A040454 A040785 A040785 A040737 A040737
001 002 001 001 001 002 001 002 001 002
AB AB AB AB AB AB AB AB XX
A087165 001
AA AA AA AA AA AA
A087953 001
AB AB AB AB
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A040673 A040673 A040724 A040724 A040791 A040712 A040712 A040713 A091054 A091054 A091054 A084234 A084176 A040863 A040863 A040863 A040622 A040622 A040622 A083426 A083711 A040596 A040596 A040596
002 003 001 002 001 002 001 001 001 002 003 001 001 001 002 003 001 002 003 001 001 001 002 003
Mar Mar Feb Feb May May Jul Jul Aug Aug Aug
05, 05, 12, 12, 20, 04, 31, 31, 30, 30, 30,
2008 2008 2008 2008 2008 2007 2006 2006 2011 2011 2011
PROPAFENONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL PROPAFENONE HYDROCHLORIDE PAR PHARM 225MG 325MG 425MG RYTHMOL SR GLAXOSMITHKLINE LLC 225MG 325MG + 425MG TABLET; ORAL PROPAFENONE HYDROCHLORIDE MUTUAL PHARM 150MG 225MG 300MG NESHER PHARMS 150MG 225MG 300MG PLIVA 150MG 225MG 300MG VINTAGE PHARMS 150MG 225MG 300MG WATSON LABS 150MG 225MG RYTHMOL GLAXOSMITHKLINE LLC 150MG 225MG + 300MG
AB AB AB AB AB AB
A078540 001 A078540 002 A078540 003 N021416 001 N021416 002 N021416 003
Oct 18, 2010 Oct 18, 2010 Oct 18, 2010 Sep 04, 2003 Sep 04, 2003 Sep 04, 2003
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
A075998 A075998 A075998 A076193 A076193 A076193 A076550 A076550 A076550 A075938 A075938 A075938 A075203 A075203
001 002 003 001 002 003 001 002 003 001 002 003 001 002
Nov Nov Nov Feb Feb Feb Apr Apr Apr Oct Oct Oct Oct Oct
29, 29, 29, 07, 07, 07, 23, 23, 23, 17, 17, 17, 24, 24,
2001 2001 2001 2002 2002 2002 2004 2004 2004 2002 2002 2002 2000 2000
15MG
A080927 002
PROPARACAINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC ALCAINE ALCON 0.5% OPHTHAINE + APOTHECON 0.5% OPHTHETIC + ALLERGAN 0.5% PROPARACAINE HYDROCHLORIDE BAUSCH AND LOMB 0.5% TAYLOR PHARMA 0.5%
AT AT AT AT AT
A080027 001 N008883 001 N012583 001 A040074 001 A040277 001 Sep 29, 1995 Mar 16, 2000
PROPOFOL
INJECTABLE; INJECTION DIPRIVAN AB + APP PHARMS PROPOFOL HOSPIRA AB TEVA PARENTERAL AB
PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL INDERAL LA AKRIMAX PHARMS 60MG 80MG 120MG + 160MG PROPRANOLOL HYDROCHLORIDE ACTAVIS ELIZABETH 60MG 80MG 120MG 160MG GLAXOSMITHKLINE 60MG 80MG 120MG 160MG MYLAN 60MG 80MG 120MG 160MG PAR PHARM 60MG 80MG 120MG 160MG UPSHER SMITH 60MG 80MG 120MG 160MG ZYDUS PHARMS USA INC 60MG 80MG 120MG 160MG INNOPRAN XL GLAXOSMITHKLINE LLC 80MG 120MG
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB BX BX
N018553 N018553 N018553 N018553 A078494 A078494 A078494 A078494 A078703 A078703 A078703 A078703 A078022 A078022 A078022 A078022 A078065 A078065 A078065 A078065 A078311 A078311 A078311 A078311 A090321 A090321 A090321 A090321
004 002 003 001 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Mar Apr Apr Apr Aug Aug Aug Aug Jul Jul Jul Jul Feb Feb Feb Feb Jan Jan Jan Jan Mar Mar Mar Mar Mar Mar Mar Mar
18, 19, 19, 19, 10, 10, 10, 10, 15, 15, 15, 15, 15, 15, 15, 15, 26, 26, 26, 26, 06, 06, 06, 06, 25, 25, 25, 25,
1987 1983 1983 1983 2007 2007 2007 2007 2011 2011 2011 2011 2007 2007 2007 2007 2007 2007 2007 2007 2009 2009 2009 2009 2011 2011 2011 2011
AP AP AP AP AP
Aug 31, 2001 Aug 29, 2000 Jan 31, 2008 Feb 26, 2003
SOLUTION; ORAL
PROPRANOLOL HYDROCHLORIDE
20MG/5ML XX + ROXANE 40MG/5ML XX + TABLET; ORAL INDERAL AKRIMAX PHARMS AB 40MG AB 60MG AB + 80MG PROPRANOLOL HYDROCHLORIDE IPCA LABS LTD AB 10MG AB 20MG AB 40MG AB 60MG AB 80MG MYLAN AB 10MG AB 20MG AB 40MG AB 60MG AB 80MG NORTHSTAR HLTHCARE AB 10MG AB 20MG AB 40MG AB 60MG AB 80MG PLIVA AB 10MG AB 20MG AB 40MG AB 60MG AB + 80MG VINTAGE PHARMS AB 10MG AB 20MG AB 40MG AB 60MG AB 80MG WATSON LABS AB 10MG AB 20MG AB 40MG AB 80MG
N016418 002 N016418 009 N016418 004 A078955 A078955 A078955 A078955 A078955 A070213 A070213 A070213 A070213 A070213 A078213 A078213 A078213 A078213 A078213 A071972 A071973 A071974 A071975 A071976 A070217 A070218 A070219 A070220 A070221 A070175 A070176 A070177 A070178 001 002 003 004 005 002 003 001 005 004 001 002 003 004 005 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jun Jun Jun Jun Jun Nov Nov Nov Apr Nov Jan Jan Jan Jan Jan Apr Apr Apr Apr Apr Aug Aug Aug Sep Apr May May May May
02, 02, 02, 02, 02, 19, 19, 19, 08, 19, 10, 10, 10, 10, 10, 06, 06, 06, 06, 06, 01, 01, 01, 24, 14, 13, 13, 13, 13,
2008 2008 2008 2008 2008 1985 1985 1985 2011 1985 2008 2008 2008 2008 2008 1988 1988 1988 1988 1988 1986 1986 1986 1986 1986 1986 1986 1986 1986
PROPYLTHIOURACIL
TABLET; ORAL PROPYLTHIOURACIL BD ACTAVIS ELIZABETH BD + DAVA PHARMS INC BD WEST WARD
PROTAMINE SULFATE
INJECTABLE; INJECTION
PROTAMINE SULFATE
XX + APP PHARMS
10MG/ML
A089454 001
PYRAZINAMIDE
TABLET; ORAL PYRAZINAMIDE AB + DAVA PHARMS INC MIKART AB
500MG 500MG
PYRIDOSTIGMINE BROMIDE
INJECTABLE; INJECTION MESTINON AP + VALEANT PHARM INTL REGONOL SANDOZ AP SYRUP; ORAL
MESTINON
XX + VALEANT PHARM INTL TABLET; ORAL MESTINON AB + VALEANT PHARM INTL PYRIDOSTIGMINE BROMIDE COREPHARMA AB IMPAX LABS AB
5MG/ML 5MG/ML
60MG/5ML
N015193 001
N009829 002 A040457 001 A040502 001 Dec 26, 2002 Apr 24, 2003
N011665 001
PYRIDOXINE HYDROCHLORIDE
INJECTABLE; INJECTION
PYRIDOXINE HYDROCHLORIDE
100MG/ML XX + APP PHARMS
A080618 001
PYRIMETHAMINE
TABLET; ORAL
DARAPRIM
XX + COREPHARMA
25MG
N008578 001
QUAZEPAM
TABLET; ORAL
DORAL
XX + QUESTCOR PHARMS
15MG
N018708 001
QUETIAPINE FUMARATE
TABLET; ORAL
SEROQUEL
XX + ASTRAZENECA XX XX XX XX +
EQ EQ EQ EQ EQ
25MG BASE 50MG BASE 100MG BASE 200MG BASE 300MG BASE
EQ 400MG BASE
N020639 006
TABLET, EXTENDED RELEASE; ORAL SEROQUEL XR ASTRAZENECA EQ 50MG BASE XX EQ 150MG BASE XX EQ 200MG BASE XX + EQ 300MG BASE XX EQ 400MG BASE XX
QUINAPRIL HYDROCHLORIDE
TABLET; ORAL ACCUPRIL PFIZER PHARMS AB AB AB AB + QUINAPRIL HYDROCHLORIDE APOTEX AB AB AB AB INVAGEN PHARMS AB AB AB AB LUPIN AB AB AB AB MYLAN AB AB AB AB AB AB AB AB RANBAXY AB AB AB AB SANDOZ AB AB AB AB SUN PHARM INDS LTD AB AB AB AB TEVA AB AB AB AB WATSON LABS FLORIDA AB AB AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 5MG BASE 10MG BASE 10MG BASE 20MG BASE 20MG BASE 40MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE 5MG BASE 10MG BASE 20MG BASE 40MG BASE
N019885 N019885 N019885 N019885 A076240 A076240 A076240 A076240 A078457 A078457 A078457 A078457 A077690 A077690 A077690 A077690 A076036 A076694 A076036 A076694 A076036 A076694 A076036 A076694 A076607 A076607 A076607 A076607 A076803 A076803 A076803 A076803 A090800 A090800 A090800 A090800 A075504 A075504 A075504 A075504 A076049 A076049 A076049 A076049
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Nov Nov Nov Nov Jan Jan Jan Jan Aug Aug Aug Aug Jun Jun Jun Jun Jan Dec Jan Dec Jan Dec Jan Dec Dec Dec Dec Dec Mar Mar Mar Mar Jun Jun Jun Jun Aug Aug Aug Aug Jan Jan Jan Jan
19, 19, 19, 19, 26, 26, 26, 26, 24, 24, 24, 24, 20, 20, 20, 20, 28, 23, 28, 23, 28, 23, 28, 23, 15, 15, 15, 15, 02, 02, 02, 02, 18, 18, 18, 18, 24, 24, 24, 24, 14, 14, 14, 14,
1991 1991 1991 1991 2006 2006 2006 2006 2007 2007 2007 2007 2006 2006 2006 2006 2005 2004 2005 2004 2005 2004 2005 2004 2004 2004 2004 2004 2005 2005 2005 2005 2009 2009 2009 2009 2007 2007 2007 2007 2005 2005 2005 2005
80MG/ML
N007529 002
TABLET, EXTENDED RELEASE; ORAL QUINIDINE GLUCONATE BX + MUTUAL PHARM 324MG BX WATSON LABS 324MG
QUINIDINE SULFATE
TABLET; ORAL QUINIDINE SULFATE MUTUAL PHARM AB AB SANDOZ AB AB AB + WATSON LABS AB +
A040045 001
QUININE SULFATE
CAPSULE; ORAL
QUALAQUIN
XX + AR HOLDING CO INC
324MG
N021799 001
RABEPRAZOLE SODIUM
TABLET, DELAYED RELEASE; ORAL
ACIPHEX
20MG XX + EISAI INC
N020973 002
RALOXIFENE HYDROCHLORIDE
TABLET; ORAL
EVISTA
XX + LILLY
60MG
N020815 001
RALTEGRAVIR POTASSIUM
TABLET; ORAL
ISENTRESS
XX + MERCK SHARP DOHME TABLET, CHEWABLE; ORAL ISENTRESS MERCK SHARP DOHME XX XX +
EQ 400MG BASE
N022145 001
RAMELTEON
TABLET; ORAL
ROZEREM
XX + TAKEDA GLOBAL
8MG
N021782 001
RAMIPRIL
CAPSULE; ORAL ALTACE KING PHARMS AB AB AB AB +
1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG 1.25MG 2.5MG 5MG 10MG
A079116 A079116 A079116 A079116 A091604 A091604 A091604 A091604 A077004 A077004 A077004 A077004 A078191 A078191 A078191 A078191 A078745 A078745 A078745 A078745 A077626 A077626 A077626 A077626 A078849 A078849 A077900 A077900 A077900 A077900 A077514 A077514 A077514 A077514 A077470 A077470 A077470 A077470 A076549 A076549 A076549 A076549 A078832 A078832 A078832 A078832
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Jun Jun Jun Jun Jun Jun Jun Jun Aug Aug Aug Aug Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Mar Mar Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Oct Oct Oct Oct Sep Sep Sep Sep
20, 20, 20, 20, 08, 08, 08, 08, 07, 07, 07, 07, 18, 18, 18, 18, 18, 18, 18, 18, 09, 09, 09, 09, 06, 06, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 24, 24, 24, 24, 02, 02, 02, 02,
2008 2008 2008 2008 2011 2011 2011 2011 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2005 2005 2005 2005 2008 2008 2008 2008
RANITIDINE HYDROCHLORIDE
CAPSULE; ORAL RANITIDINE HYDROCHLORIDE DR REDDYS LABS LTD EQ EQ SANDOZ EQ + EQ
AB AB AB AB
AP AP AP XX
INJECTABLE; INJECTION RANITIDINE HYDROCHLORIDE BEDFORD EQ 25MG BASE/ML BEN VENUE EQ 25MG BASE/ML ZANTAC + GLAXOSMITHKLINE EQ 25MG BASE/ML ZANTAC IN PLASTIC CONTAINER + GLAXOSMITHKLINE EQ 1MG BASE/ML SYRUP; ORAL RANITIDINE HYDROCHLORIDE ACTAVIS MID ATLANTIC EQ AMNEAL PHARMS EQ APOTEX EQ AUROBINDO PHARM EQ CYPRESS PHARM EQ DR REDDYS LABS LTD EQ HI TECH PHARMA EQ PHARM ASSOC EQ RANBAXY EQ SILARX EQ SUN PHARM INDS INC EQ TARO EQ TOLMAR EQ VINTAGE PHARMS EQ WOCKHARDT EQ EQ ZANTAC + GLAXOSMITHKLINE EQ TABLET; ORAL RANITIDINE HYDROCHLORIDE AMNEAL PHARMS NY EQ EQ APOTEX EQ EQ DR REDDYS LABS INC EQ EQ GLENMARK GENERICS EQ EQ IVAX SUB TEVA PHARMS EQ EQ MYLAN EQ EQ PAR PHARM EQ EQ SANDOZ EQ
Feb 16, 2006 Mar 02, 2005 Oct 19, 1984 Sep 27, 1991
AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA AA
15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG 15MG
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A076124 A078312 A077602 A090623 A078684 A090102 A091078 A077405 A078448 A091288 A091091 A077476 A090054 A078890 A079211 A079212
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Feb Sep Sep Jul Aug May Mar Sep Dec Dec Sep Jun Nov Jul May Feb
21, 02, 17, 28, 27, 26, 22, 21, 13, 09, 20, 13, 15, 01, 26, 23,
2007 2008 2007 2010 2009 2009 2011 2007 2007 2010 2011 2011 2010 2010 2009 2009
15MG BASE/ML
N019675 001
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
150MG 300MG 150MG 300MG 150MG 300MG 150MG 300MG 150MG 300MG 150MG 300MG 150MG 300MG 150MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A077824 A077824 A074680 A074680 A076705 A076705 A078542 A078542 A075165 A075165 A074023 A074023 A075180 A075180 A074467
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001
Oct Oct Sep Sep Jul Jul Nov Nov Sep Sep Aug Aug Jan Jan Aug
13, 13, 12, 12, 27, 27, 19, 19, 30, 30, 22, 22, 28, 28, 29,
2006 2006 1997 1997 2005 2005 2008 2008 1998 1998 1997 1997 1999 1999 1997
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A074467 A074488 A074488 A074864 A077426 A074864 A077426 A075208 A078701 A075208 A078701
002 001 002 001 001 002 002 001 001 002 002
Aug Jul Jul Oct Dec Oct Dec Dec Nov Dec Dec
29, 31, 31, 20, 19, 20, 19, 17, 12, 17, 11,
1997 1997 1997 1997 2005 1997 2005 1998 2009 1998 2009
N020251 003
RANOLAZINE
TABLET, EXTENDED RELEASE; ORAL RANEXA GILEAD 500MG XX 1GM XX +
RASAGILINE MESYLATE
TABLET; ORAL AZILECT TEVA XX XX +
REGADENOSON
SOLUTION; INTRAVENOUS
LEXISCAN
XX + ASTELLAS
0.4MG/5ML (0.08MG/ML)
N022161 001
REMIFENTANIL HYDROCHLORIDE
INJECTABLE; INJECTION
ULTIVA
MYLAN INSTITUTIONAL XX XX XX +
REPAGLINIDE
TABLET; ORAL PRANDIN NOVO NORDISK INC XX XX XX +
RESERPINE
TABLET; ORAL RESERPINE BP SANDOZ BP +
0.1MG 0.25MG
0.1MG 0.25MG
RETAPAMULIN
OINTMENT; TOPICAL
ALTABAX
XX + GLAXO GRP LTD
1%
N022055 001
RIBAVIRIN
CAPSULE; ORAL REBETOL + SCHERING PLOUGH RES RIBASPHERE THREE RIVERS PHARMS RIBAVARIN AUROBINDO PHARMA RIBAVIRIN SANDOZ TEVA ZYDUS PHARMS USA REBETOL + SCHERING PLOUGH RES
AB AB AB AB AB AB XX
N020903 002 A076203 001 A079117 001 A076192 001 A076277 001 A077224 001 N020903 001
Jul 25, 2001 Apr 06, 2004 Sep 17, 2009 Apr 06, 2004 Oct 04, 2004 Oct 28, 2005 Jun 03, 1998
6GM/VIAL
N018859 001
40MG/ML
N021546 001
AB AB AB AB AB AB AB AB AB AB XX
200MG 200MG 200MG 200MG 200MG 400MG 600MG 200MG 400MG 600MG 500MG
N021511 001 A079111 A077743 A077053 A077456 A077456 A077456 A077094 A077094 A077094 001 001 001 001 002 003 001 002 003
Dec 03, 2002 Sep Oct Dec Dec Dec Dec Dec Mar Mar 17, 03, 05, 05, 05, 05, 05, 16, 16, 2009 2006 2005 2005 2005 2005 2005 2007 2007
A077094 004
RIFABUTIN
CAPSULE; ORAL
MYCOBUTIN
XX + PHARMACIA AND UPJOHN
150MG
N050689 001
RIFAMPIN
CAPSULE; ORAL RIFADIN SANOFI AVENTIS US AB AB + RIFAMPIN LANNETT AB
AP AP AP AP
May 25, 1989 Oct 29, 1999 May 22, 2008 Sep 21, 2010
RIFAPENTINE
TABLET; ORAL
PRIFTIN
XX + SANOFI AVENTIS US
150MG
N021024 001
RIFAXIMIN
TABLET; ORAL
XIFAXAN
XX + SALIX PHARMS XX +
200MG 550MG
RILPIVIRINE HYDROCHLORIDE
TABLET; ORAL
EDURANT
XX + TIBOTEC
EQ 25MG BASE
N202022 001
RILUZOLE
TABLET; ORAL RILUTEK AB + SANOFI AVENTIS US RILUZOLE IMPAX LABS AB
50MG 50MG
RIMANTADINE HYDROCHLORIDE
TABLET; ORAL FLUMADINE AB + CARACO 100MG RIMANTADINE HYDROCHLORIDE COREPHARMA AB 100MG IMPAX LABS AB 100MG
RIMEXOLONE
SUSPENSION/DROPS; OPHTHALMIC
VEXOL
XX + ALCON 1%
N020474 001
RISEDRONATE SODIUM
TABLET; ORAL ACTONEL WARNER CHILCOTT AB AB AB +
Oct 05, 2007 Oct 05, 2007 Oct 05, 2007 Apr 22, 2008
N022560 001
RISPERIDONE
INJECTABLE; INTRAMUSCULAR RISPERDAL CONSTA JANSSEN PHARMS 12.5MG/VIAL XX 25MG/VIAL XX + 37.5MG/VIAL XX 50MG/VIAL XX SOLUTION; ORAL RISPERDAL + JANSSEN PHARMS RISPERIDONE AMNEAL PHARMS APOTEX INC AUROBINDO PHARMA DR REDDYS LABS LTD PRECISION DOSE ROXANE TARO TEVA VINTAGE WOCKHARDT
AA AA AA AA AA AA AA AA AA AA AA
1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML
N020588 001 A091384 A077719 A078452 A078909 A076797 A076904 A090347 A076440 A079158 A078744 001 001 001 001 001 001 001 001 001 001
Jun 10, 1996 May Jul Sep Jul Jun Jul Feb Jan Dec Oct 25, 29, 04, 29, 28, 29, 07, 30, 03, 08, 2011 2009 2009 2009 2010 2009 2011 2009 2010 2009
TABLET; ORAL RISPERDAL JANSSEN PHARMS AB AB AB + AB AB AB RISPERIDONE AJANTA PHARMA LTD AB AB AB AB AB AB APOTEX INC AB AB AB AB AB AB AUROBINDO PHARMA AB AB AB AB AB AB
0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG
N020272 N020272 N020272 N020272 N020272 N020272 A201003 A201003 A201003 A201003 A201003 A201003 A077953 A077953 A077953 A077953 A077953 A077953 A078269 A078269 A078269 A078269 A078269 A078269
008 007 001 002 003 004 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006
May Jan Dec Dec Dec Dec Aug Aug Aug Aug Aug Aug Sep Sep Sep Sep Sep Sep Oct Oct Oct Oct Oct Oct
10, 27, 29, 29, 29, 29, 24, 24, 24, 24, 24, 24, 15, 15, 15, 15, 15, 15, 08, 08, 08, 08, 08, 08,
1999 1999 1993 1993 1993 1993 2011 2011 2011 2011 2011 2011 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008
0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG
A077543 A077543 A077543 A077543 A077543 A077543 A076879 A076879 A076879 A076879 A076879 A076879 A076288 A076288 A076288 A076288 A076288 A076288 A077769 A077769 A077769 A077769 A077769 A077769 A077493 A077493 A077493 A077493 A077493 A077493 A078528 A078528 A078528 A078528 A078528 A078528 A076228 A076228 A076228 A076228 A076228 A076228 A079088 A079088 A079088 A079088 A079088 A079088 A078707 A078707 A078707 A078707 A078707 A078707 A077860 A077860 A077860
001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003
May May May May May May Oct Oct Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Oct Oct Oct Oct Oct Oct Nov Nov Nov Nov Nov Nov Oct Oct Oct Oct Oct Oct Jun Jun Jun Jun Jun Jun Oct Oct Oct Oct Oct Oct Dec Dec Dec Dec Dec Dec Dec Dec Dec
18, 18, 18, 18, 18, 18, 24, 24, 24, 24, 24, 24, 15, 15, 15, 15, 15, 15, 16, 16, 16, 16, 16, 16, 29, 29, 29, 29, 29, 29, 16, 16, 16, 16, 16, 16, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 30, 29, 29, 29, 29, 29, 29, 05, 05, 05,
2011 2011 2011 2011 2011 2011 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2011 2011 2011 2011 2011 2011 2009 2009 2009 2009 2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008
2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG
A077860 A077860 A077860 A078740 A078740 A078740 A078740 A078740 A078740 A078871 A078871 A078871 A078871 A078871 A078871 A078040 A078040 A078040 A078040 A078040 A078040
004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006
Dec Dec Dec May May May May May May Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct
05, 05, 05, 29, 29, 29, 29, 29, 29, 09, 09, 09, 09, 09, 09, 16, 16, 16, 16, 16, 16,
2008 2008 2008 2009 2009 2009 2009 2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
TABLET, ORALLY DISINTEGRATING; ORAL RISPERDAL JANSSEN PHARMS 0.5MG + 1MG 2MG 3MG 4MG RISPERIDONE DR REDDYS LABS LTD 0.5MG 1MG 2MG JUBILANT ORGANOSYS 0.5MG 1MG 2MG 3MG 4MG MYLAN 0.5MG 1MG 2MG 3MG 4MG PAR PHARM 0.5MG 1MG 2MG 3MG 4MG RANBAXY 0.5MG 1MG 2MG 3MG 4MG SANDOZ 0.5MG 1MG 2MG 3MG 4MG
N021444 N021444 N021444 N021444 N021444 A077328 A077328 A077328 A090839 A090839 A090839 A090839 A090839 A091537 A091537 A091537 A091537 A091537 A077494 A077494 A077494 A077494 A077494 A077542 A077542 A077542 A078474 A078474 A078116 A078116 A078116 A078116 A078116
001 002 003 004 005 001 002 003 001 002 003 004 005 001 002 003 004 005 002 003 004 005 006 001 002 003 001 002 001 002 003 004 005
Apr Apr Apr Dec Dec Feb Oct Feb Nov Nov Nov Nov Nov Mar Mar Mar Mar Mar Apr Oct Apr Apr Apr Aug Aug Aug Aug Aug Dec Dec Dec Dec Dec
02, 02, 02, 23, 23, 24, 05, 24, 04, 04, 04, 04, 04, 30, 30, 30, 30, 30, 30, 26, 30, 30, 30, 06, 06, 06, 06, 06, 22, 22, 22, 22, 22,
2003 2003 2003 2004 2004 2009 2009 2009 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2009 2009 2009 2009 2009 2010 2010 2010 2010 2010 2009 2009 2009 2009 2009
AB AB AB AB AB AB AB XX
A077494 001
RITONAVIR
CAPSULE; ORAL
NORVIR
XX + ABBOTT SOLUTION; ORAL
NORVIR
XX + ABBOTT TABLET; ORAL
NORVIR
XX + ABBOTT LABS
100MG
N020945 001
80MG/ML
N020659 001
100MG
N022417 001
RIVAROXABAN
TABLET; ORAL
XARELTO
XX + JANSSEN PHARMS XX XX +
RIVASTIGMINE
FILM, EXTENDED RELEASE; TRANSDERMAL EXELON XX NOVARTIS 4.6MG/24HR XX + 9.5MG/24HR
RIVASTIGMINE TARTRATE
CAPSULE; ORAL EXELON AB + NOVARTIS AB AB AB RIVASTIGMINE TARTRATE DR REDDYS LABS INC AB AB AB AB SUN PHARM INDS AB AB AB AB WATSON LABS AB AB AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE 1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE 1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE 1.5MG BASE 3MG BASE 4.5MG BASE 6MG BASE
N020823 N020823 N020823 N020823 A077130 A077130 A077130 A077130 A077131 A077131 A077131 A077131 A077129 A077129 A077129 A077129
003 004 005 006 001 002 003 004 001 002 003 004 001 002 003 004
Apr Apr Apr Apr Oct Oct Oct Oct Oct Oct Oct Oct Jan Jan Jan Jan
21, 21, 21, 21, 31, 31, 31, 31, 22, 22, 22, 22, 08, 08, 08, 08,
2000 2000 2000 2000 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2008 2008
EQ 2MG BASE/ML
N021025 001
RIZATRIPTAN BENZOATE
TABLET; ORAL MAXALT MERCK XX XX +
TABLET, ORALLY DISINTEGRATING; ORAL MAXALT-MLT XX MERCK EQ 5MG BASE XX + EQ 10MG BASE
ROCURONIUM BROMIDE
INJECTABLE; INJECTION ROCURONIUM BROMIDE APP PHARMS AP AP BIONICHE PHARMA USA AP AP HOSPIRA AP AP SAGENT STRIDES AP AP SANDOZ AP AP TEVA PARENTERAL AP AP ZEMURON AP + SCHERING AP +
50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML) 50MG/5ML (10MG/ML) 100MG/10ML (10MG/ML)
A078651 A078651 A079199 A079199 A078519 A078519 A091458 A091458 A079195 A079195 A078717 A078717
001 002 001 002 001 002 001 002 001 002 001 002
Dec Dec Nov Nov Nov Nov Jul Jul Dec Dec Nov Nov
29, 29, 26, 26, 26, 26, 28, 28, 05, 05, 26, 26,
2008 2008 2008 2008 2008 2008 2010 2010 2008 2008 2008 2008
ROFLUMILAST
TABLET; ORAL
DALIRESP
XX + FOREST RES INST INC
500MCG
N022522 001
ROMIDEPSIN
POWDER; IV (INFUSION)
ISTODAX
XX + CELGENE
10MG/VIAL
N022393 001
ROPINIROLE HYDROCHLORIDE
TABLET; ORAL REQUIP AB + GLAXOSMITHKLINE EQ AB EQ AB EQ AB EQ AB EQ AB EQ AB EQ ROPINIROLE HYDROCHLORIDE ALEMBIC LTD AB EQ AB EQ AB EQ AB EQ
0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE
N020658 N020658 N020658 N020658 N020658 N020658 N020658 A090429 A090429 A090429 A090429
001 002 003 004 006 007 005 001 002 003 004
Sep Sep Sep Sep Jan Jan Sep Mar Mar Mar Mar
19, 19, 19, 19, 27, 27, 19, 24, 24, 24, 24,
1997 1997 1997 1997 1999 1999 1997 2010 2010 2010 2010
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE 4MG BASE 5MG BASE 0.25MG BASE 0.5MG BASE 1MG BASE 2MG BASE 3MG BASE
A090429 A090429 A090429 A078230 A078230 A078230 A078230 A078230 A078230 A078230 A090135 A090135 A090135 A090135 A090135 A090135 A090135 A078881 A078881 A078881 A078881 A078881 A078881 A078881 A078110 A078110 A078110 A078110 A078110 A078110 A078110 A077852 A077852 A077852 A077852 A077852 A077852 A077852 A077460 A077460 A077460 A077460 A077460 A077460 A077460 A079050 A079050 A079050 A079050 A079050 A079050 A079050 A090411 A090411 A090411 A090411 A090411
005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004 005
Mar Mar Mar May May May May May May May Feb Feb Feb Feb Feb Feb Feb May May May May May May May May May May May May May Jul May May May May May May May May May May May May May May May May May May May May May Jun Jun Jun Jun Jun
24, 24, 24, 20, 20, 20, 20, 20, 20, 20, 25, 25, 25, 25, 25, 25, 25, 05, 05, 05, 05, 05, 05, 19, 05, 05, 05, 05, 05, 05, 11, 05, 05, 05, 05, 05, 05, 19, 05, 05, 05, 05, 05, 05, 19, 29, 29, 29, 29, 29, 29, 29, 01, 01, 01, 01, 01,
2010 2010 2010 2008 2008 2008 2008 2008 2008 2008 2010 2010 2010 2010 2010 2010 2010 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2009 2009 2009 2009 2009
ROSIGLITAZONE MALEATE
TABLET; ORAL AVANDIA SB PHARMCO XX XX XX +
ROSUVASTATIN CALCIUM
TABLET; ORAL CRESTOR XX IPR XX XX XX +
N/A
N019414 001
RUFINAMIDE
SUSPENSION; ORAL
BANZEL
XX + EISAI INC TABLET; ORAL BANZEL XX EISAI INC XX +
40MG/ML
N201367 001
200MG 400MG
RUXOLITINIB PHOSPHATE
TABLET; ORAL JAKAFI INCYTE CORP XX XX XX XX XX +
EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 15MG BASE 20MG BASE 25MG BASE
SOLUTION; ORAL
SUCRAID
XX + QOL MEDCL
8,500 IU/ML
N020772 001
INJECTABLE; INJECTION
LIPOSYN II 10%
XX + HOSPIRA LIPOSYN II 20% XX + HOSPIRA
SALMETEROL XINAFOATE
POWDER; INHALATION
SEREVENT
XX + GLAXO GRP LTD
EQ 0.05MG BASE/INH
N020692 001
50mCi/ML
N020570 001
SAPROPTERIN DIHYDROCHLORIDE
TABLET; ORAL
KUVAN
XX + BIOMARIN PHARM
100MG
N022181 001
SAQUINAVIR MESYLATE
CAPSULE; ORAL
INVIRASE
XX + HOFFMANN LA ROCHE TABLET; ORAL
INVIRASE
XX + ROCHE
EQ 200MG BASE
N020628 001
EQ 500MG BASE
N021785 001
SAXAGLIPTIN HYDROCHLORIDE
TABLET; ORAL
ONGLYZA
BRISTOL MYERS SQUIBB XX XX +
SCOPOLAMINE
FILM, EXTENDED RELEASE; TRANSDERMAL
TRANSDERM SCOP
1MG/72HR XX + NOVARTIS
N017874 001
SECOBARBITAL SODIUM
CAPSULE; ORAL
SECONAL SODIUM
XX + MARATHON PHARMS XX +
50MG 100MG
SELEGILINE HYDROCHLORIDE
CAPSULE; ORAL ELDEPRYL AB + SOMERSET 5MG SELEGILINE HYDROCHLORIDE APOTEX AB 5MG DAVA PHARMS INC AB 5MG TABLET; ORAL SELEGILINE HYDROCHLORIDE + APOTEX INC 5MG DAVA PHARMS INC 5MG MYLAN 5MG STASON 5MG
AB AB AB AB
N021479 001
SELENIUM SULFIDE
LOTION/SHAMPOO; TOPICAL SELENIUM SULFIDE PERRIGO NEW YORK AT WOCKHARDT AT SELSUN AT + CHATTEM
SERTACONAZOLE NITRATE
CREAM; TOPICAL
ERTACZO
XX + ORTHO JANSSEN
2%
N021385 001
SERTRALINE HYDROCHLORIDE
CONCENTRATE; ORAL SERTRALINE HYDROCHLORIDE AUROBINDO PHARMA AA EQ 20MG BASE/ML RANBAXY AA EQ 20MG BASE/ML ZOLOFT AA + PFIZER EQ 20MG BASE/ML TABLET; ORAL SERTRALINE HYDROCHLORIDE APOTEX INC EQ EQ EQ AUROBINDO PHARMA EQ EQ EQ AUSTARPHARMA LLC EQ EQ EQ DR REDDYS LABS LTD EQ EQ EQ HIKMA PHARMS EQ
AB AB AB AB AB AB AB AB AB AB AB AB AB
25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE
A076882 A076882 A076882 A077206 A077206 A077206 A078677 A078677 A078677 A076442 A076442 A076442 A077864
001 002 003 001 002 003 001 002 003 001 002 003 001
Feb Feb Feb Feb Feb Feb Mar Mar Mar Apr Apr Apr Aug
06, 06, 06, 06, 06, 06, 04, 04, 04, 30, 30, 30, 10,
2007 2007 2007 2007 2007 2007 2009 2009 2009 2007 2007 2007 2009
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB XX XX
50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 25MG BASE 50MG BASE 50MG BASE 100MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 150MG BASE 200MG BASE
A077864 A077864 A077397 A077397 A077397 A077670 A077670 A077670 A078626 A078626 A078626 A076540 A076671 A076540 A076671 A076540 A076671 A077977 A077977 A077977 A078108 A078108 A078108 A076465 A076465 A076465 A077765 A077765 A077765 A077663 A077663 A077663 A078403 A078403 A078403 A077106 A077106 A077106
002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Aug Aug Feb Feb Feb Feb Feb Feb Jan Jan Jan Mar Feb Mar Feb Mar Feb Feb Feb Feb Feb Feb Feb Aug Aug Aug Feb Feb Feb Feb Feb Feb Jan Jan Jan Feb Feb Feb
10, 10, 06, 06, 06, 06, 06, 06, 31, 31, 31, 20, 06, 20, 06, 20, 06, 06, 06, 06, 06, 06, 06, 11, 11, 11, 06, 06, 06, 06, 06, 06, 08, 08, 08, 06, 06, 06,
2009 2009 2007 2007 2007 2007 2007 2007 2008 2008 2008 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2006 2006 2006 2007 2007 2007 2007 2007 2007 2008 2008 2008 2007 2007 2007
N019839 005 N019839 001 N019839 002 A077977 004 A077977 005
Mar 06, 1996 Dec 30, 1991 Dec 30, 1991 Feb 06, 2007 Feb 06, 2007
SEVELAMER CARBONATE
FOR SUSPENSION; ORAL RENVELA GENZYME XX XX + TABLET; ORAL
RENVELA
XX + GENZYME
800MG/PACKET 2.4GM/PACKET
800MG
N022127 001
400MG 800MG
SEVOFLURANE
LIQUID; INHALATION SEVOFLURANE BAXTER HLTHCARE HALOCARBON PRODS SOJOURN PIRAMAL CRITICAL ULTANE + ABBOTT
AN AN AN AN
Jul 02, 2002 Nov 19, 2007 May 02, 2007 Jun 07, 1995
SILDENAFIL CITRATE
SOLUTION; INTRAVENOUS
REVATIO
XX + PFIZER TABLET; ORAL
REVATIO
XX + PFIZER VIAGRA PFIZER IRELAND XX XX XX +
N022473 001
Jun 03, 2005 Mar 27, 1998 Mar 27, 1998 Mar 27, 1998
SILODOSIN
CAPSULE; ORAL RAPAFLO WATSON LABS XX XX +
4MG 8MG
SILVER SULFADIAZINE
CREAM; TOPICAL SILVADENE + KING PHARMS SSD DR REDDYS LA THERMAZENE COVIDIEN SSD AF DR REDDYS LA
AB AB AB BX
1% 1% 1% 1%
N017381 001 N018578 001 N018810 001 N018578 003 Feb 25, 1982 Dec 23, 1985 Jul 11, 1990
SIMVASTATIN
TABLET; ORAL SIMVASTATIN ACCORD HLTHCARE AB AB AB AB AUROBINDO PHARMA AB AB AB AB AB BLU CARIBE AB AB
10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG
A078155 A078155 A078155 A078155 A077691 A077691 A077691 A077691 A077691 A078034 A078034
002 003 004 001 001 002 003 004 005 001 002
Feb Feb Feb Feb Dec Dec Dec Dec Dec Dec Dec
26, 26, 26, 26, 20, 20, 20, 20, 20, 20, 20,
2008 2008 2008 2008 2006 2006 2006 2006 2006 2006 2006
20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG 5MG 10MG 20MG 40MG 80MG
A078034 A078034 A078034 A077752 A077752 A077752 A077752 A077752 A076052 A076052 A076052 A076052 A076052 A078103 A078103 A078103 A078103 A078103 A090868 A090868 A090868 A090868 A090868 A090383 A090383 A090383 A090383 A090383 A076285 A076285 A076285 A076285 A076285 A076685 A076685 A076685 A076685 A076685 A077837 A077837 A077837 A077837 A077837 N019766 N019766 N019766 N019766 N019766
003 004 005 005 001 002 003 004 001 002 003 004 005 005 001 002 003 004 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005
Dec Dec Dec Jan Dec Dec Dec Dec Jun Jun Jun Jun Dec Apr May May May May Jun Jun Jun Jun Jun Sep Sep Sep Sep Sep Dec Dec Dec Dec Jun Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec Jul
20, 20, 20, 23, 20, 20, 20, 20, 23, 23, 23, 23, 20, 14, 11, 11, 11, 11, 08, 08, 08, 08, 08, 16, 16, 16, 16, 16, 20, 20, 20, 20, 23, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 23, 23, 23, 23, 10,
2006 2006 2006 2008 2006 2006 2006 2006 2006 2006 2006 2006 2006 2009 2007 2007 2007 2007 2010 2010 2010 2010 2010 2011 2011 2011 2011 2011 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 2006 1991 1991 1991 1991 1998
0.005MG/VIAL
N017697 001
SINECATECHINS
OINTMENT; TOPICAL
VEREGEN
XX + MEDIGENE AG
15%
N021902 001
SIROLIMUS
SOLUTION; ORAL
RAPAMUNE
XX + WYETH PHARMS INC TABLET; ORAL RAPAMUNE WYETH PHARMS INC XX XX XX +
1MG/ML
N021083 001
SITAGLIPTIN PHOSPHATE
TABLET; ORAL JANUVIA MERCK CO INC XX XX XX +
N018893 001
10%;10% (5GM/50ML;5GM/50ML)
N020645 001
SODIUM BICARBONATE
INJECTABLE; INJECTION
SODIUM BICARBONATE
XX + HOSPIRA XX +
0.9MEQ/ML 1MEQ/ML
SODIUM CHLORIDE
INJECTABLE; INJECTION BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER APP PHARMS 9MG/ML + HOSPIRA 9MG/ML SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 450MG/100ML BAXTER HLTHCARE 450MG/100ML HOSPIRA 450MG/100ML 450MG/100ML SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 9MG/ML + APP PHARMS 900MG/100ML + B BRAUN 900MG/100ML + 9MG/ML + BAXTER HLTHCARE 9MG/ML
AP AP AP AP AP AP AP AP AP AP AP
A088911 001 N018800 001 N019635 N018016 N018090 N019759 A088912 N017464 N019635 N016677 N020178 001 001 001 001 001 001 002 004 002
Jun 08, 1988 Jan 10, 1985 Mar 09, 1988 Oct 30, 1985 Dec 07, 1992
AP AP AP AP AP AP AP AP AP AP AP XX XX XX XX XX
N016677 N020178 A078177 A076316 N018803 N019217 N019465 N016366 N019465 N019480 A077407
001 001 001 001 001 001 002 001 001 001 001
Jul 15, 1985 Sep 17, 1985 Aug 11, 2006 Jul 27, 2006 Jul 27, 2006 Nov 01, 1983 Nov 01, 1983 Jul 20, 1984
N021569 001 N021569 002 N019022 001 N019022 002 N018897 001
SOLUTION FOR SLUSH; IRRIGATION SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER BAXTER HLTHCARE 900MG/100ML XX SOLUTION; IRRIGATION SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE 450MG/100ML SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 900MG/100ML BAXTER HLTHCARE 900MG/100ML 900MG/100ML HOSPIRA 900MG/100ML 900MG/100ML
N019319 002
AT AT AT AT AT AT
N017864 001 N016733 N017427 N017867 N017514 N018314 001 001 001 001 001
200uCi/ML
N013993 001
2mCi/ML
N017630 002
N016517 001
N021305 006 N021305 004 May 19, 2005 Nov 18, 2004
XX XX XX XX
SODIUM LACTATE
INJECTABLE; INJECTION SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER BAXTER HLTHCARE AP 1.87GM/100ML SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER B BRAUN AP 1.87GM/100ML SODIUM LACTATE IN PLASTIC CONTAINER 5MEQ/ML XX + HOSPIRA
N016692 001 N020004 001 N018947 001 Apr 21, 1992 Sep 05, 1984
N201444 001
SODIUM NITROPRUSSIDE
INJECTABLE; INJECTION
NITROPRESS
XX + HOSPIRA
25MG/ML
A071961 001
SODIUM OXYBATE
SOLUTION; ORAL
XYREM
XX + JAZZ
500MG/ML
N021196 001
SODIUM PHENYLBUTYRATE
POWDER; ORAL
BUPHENYL
XX + MEDICIS TABLET; ORAL BUPHENYL AB + MEDICIS SODIUM PHENYLBUTYRATE AMPOLGEN AB
3GM/TEASPOONFUL
N020573 001
500MG 500MG
TABLET; ORAL
VISICOL
XX + SALIX PHARMS
0.398GM;1.102GM
N021097 001
A079247 001
0.398GM;1.102GM
N021892 001
N018892 001
AA AA AA AA AA AA
A040905 001 N011287 001 A040029 001 A089910 001 A090313 001 A040909 001
Feb 06, 1998 Jan 19, 1989 Dec 21, 2011 Dec 03, 2008
AA AA AA AA
Sep 17, 2007 May 13, 2011 Nov 17, 1986 Dec 08, 1982
SOLIFENACIN SUCCINATE
TABLET; ORAL VESICARE ASTELLAS XX XX +
5MG 10MG
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION GENOTROPIN BX + PHARMACIA AND UPJOHN GENOTROPIN PRESERVATIVE BX PHARMACIA AND UPJOHN HUMATROPE BX + LILLY BX NORDITROPIN BX NOVO NORDISK INC BX NORDITROPIN FLEXPRO BX NOVO NORDISK INC BX NORDITROPIN NORDIFLEX BX NOVO NORDISK INC
5.8MG/VIAL FREE 1.5MG/VIAL 5MG/VIAL 6MG/VIAL 5MG/1.5ML 10MG/1.5ML 5MG/1.5ML 10MG/1.5ML 5MG/1.5ML
N020280 006 N020280 004 N019640 004 N019640 005 N021148 001 N021148 002 N021148 008 N021148 009 N021148 004
Aug 24, 1995 Aug 24, 1995 Mar 08, 1987 Feb 04, 1999 Jun 20, 2000 Jun 20, 2000 Mar 01, 2010 Mar 01, 2010 Oct 01, 2004
10MG/1.5ML 5MG/VIAL 1.5MG/VIAL 5MG/1.5ML 5.8MG/VIAL 10MG/1.5ML 5MG/VIAL 4MG/VIAL 5MG/VIAL 6MG/VIAL 5MG/VIAL 5MG/VIAL 13.8MG/VIAL FREE 0.2MG/VIAL 0.4MG/VIAL 0.6MG/VIAL 0.8MG/VIAL 1MG/VIAL 1.2MG/VIAL 1.4MG/VIAL 1.6MG/VIAL 1.8MG/VIAL 2MG/VIAL 12MG/VIAL 24MG/VIAL 15MG/1.5ML 15MG/1.5ML 15MG/1.5ML 30MG/3ML 10MG/VIAL 5MG/2ML (2.5MG/ML) 10MG/2ML (5MG/ML) 20MG/2ML (10MG/ML) 10MG/2ML (5MG/ML) 8.8MG/VIAL 8.8MG/VIAL
N021148 005 N020168 001 N021426 N021426 N021426 N021426 002 003 001 004
Oct 01, 2004 Nov 17, 1993 May Jan May Aug 30, 16, 30, 25, 2006 2008 2006 2008
N019764 002 N020604 003 N020604 002 N020604 001 N019774 002 N021905 001 N020280 007 N020280 N020280 N020280 N020280 N020280 N020280 N020280 N020280 N020280 N020280 001 002 003 005 008 009 010 011 012 013
Oct 08, 1996 Jul 25, 1997 Aug 23, 1996 Aug 23, 1996 Jan 04, 2002 Apr 19, 2007 Oct 23, 1996 Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 1998 1998 1998 1998 1998 1998 1998 1998 1998 1998
N019640 006 N019640 007 N021148 003 N021148 010 N021148 006 N021148 007 N020168 002 N020522 003 N020522 001 N020522 004 N020522 002 N019764 003 N021597 004
Feb 04, 1999 Feb 04, 1999 Jun 20, 2000 Mar 01, 2010 Oct 01, 2004 Mar 10, 2009 Nov 17, 1993 Jan 03, 2008 Dec 29, 1995 Jan 03, 2008 Apr 22, 2002 Aug 29, 2000 Dec 01, 2003
SORAFENIB TOSYLATE
TABLET; ORAL
NEXAVAR
XX + BAYER HLTHCARE
EQ 200MG BASE
N021923 001
N017863 001
N016741 001
SOTALOL HYDROCHLORIDE
SOLUTION; INTRAVENOUS
SOTALOL HYDROCHLORIDE
XX + ACADEMIC PHARMS TABLET; ORAL BETAPACE BAYER HLTHCARE AB1 AB1 AB1 + AB1 SORINE UPSHER SMITH AB1 AB1 AB1 AB1 SOTALOL HYDROCHLORIDE APOTEX INC AB1 AB1 AB1 AB1 IMPAX PHARMS AB1 AB1 AB1 AB1 MYLAN AB1 AB1 AB1 AB1 AB1 AB1 AB1 AB1 SANDOZ AB1 AB1 AB1 AB1 TEVA AB1 AB1 AB1 AB1 VINTAGE PHARMS AB1 AB1 AB1 AB1 BETAPACE AF BAYER HLTHCARE AB2 AB2 AB2 + SOTALOL HYDROCHLORIDE AMNEAL PHARM AB2 AB2 AB2 APOTEX AB2
150MG/10ML (15MG/ML)
N022306 001
80MG 120MG 160MG 240MG 80MG 120MG 160MG 240MG 80MG 120MG 160MG 240MG 80MG 120MG 160MG 240MG 80MG 80MG 120MG 120MG 160MG 160MG 240MG 240MG 80MG 120MG 160MG 240MG 80MG 120MG 160MG 240MG 80MG 120MG 160MG 240MG 80MG 120MG 160MG 80MG 120MG 160MG 80MG
N019865 N019865 N019865 N019865 A075500 A075500 A075500 A075500 A076140 A076140 A076140 A076140 A075663 A075663 A075663 A075663 A075237 A075725 A075237 A075725 A075237 A075725 A075237 A075725 A075366 A075366 A075366 A075366 A075429 A075429 A075429 A075429 A075563 A075563 A075563 A075563
001 005 002 003 001 004 002 003 001 002 003 004 001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004 001 002 003 004 001 002 003 004
Oct Apr Oct Oct Apr Apr Apr Apr Sep Sep Sep Sep Nov Nov Nov Nov May Dec May Dec May Dec May Dec May May May May May May May May Nov Nov Nov Nov
30, 20, 30, 30, 27, 27, 27, 27, 26, 26, 26, 26, 07, 07, 07, 07, 01, 19, 01, 19, 01, 19, 01, 19, 01, 01, 01, 01, 01, 01, 01, 01, 07, 07, 07, 07,
1992 1994 1992 1992 2001 2001 2001 2001 2002 2002 2002 2002 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2003 2003 2003 2003
N021151 001 N021151 002 N021151 003 A077070 A077070 A077070 A076214 001 002 003 001
Feb 22, 2000 Feb 22, 2000 Feb 22, 2000 Nov Nov Nov Aug 04, 04, 04, 27, 2005 2005 2005 2003
SOYBEAN OIL
INJECTABLE; INJECTION INTRALIPID 10% + FRESENIUS INTRALIPID 20% + FRESENIUS + INTRALIPID 30% + FRESENIUS LIPOSYN III 10% + HOSPIRA LIPOSYN III 20% + HOSPIRA LIPOSYN III 30% + HOSPIRA NUTRILIPID 10% + B BRAUN NUTRILIPID 20% + B BRAUN
AP AP AP AP AP AP AP AP AP
N017643 001 N018449 001 N020248 001 N019942 001 N018969 001 N018970 001 N020181 001 N019531 001 N019531 002
Aug 07, 1996 Dec 30, 1993 Sep 24, 1984 Sep 25, 1984 Jan 13, 1998 May 28, 1993 May 28, 1993
SPINOSAD
SUSPENSION; TOPICAL
NATROBA
XX + PARAPRO PHARMS
0.9%
N022408 001
SPIRONOLACTONE
TABLET; ORAL ALDACTONE GD SEARLE LLC AB AB AB + SPIRONOLACTONE ACTAVIS ELIZABETH AB AB AB AMNEAL PHARMS AB AB AB MUTUAL PHARM AB AB AB MYLAN AB AB AB SANDOZ AB VINTAGE AB AB AB
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 25MG 50MG 100MG
N012151 009 N012151 008 N012151 010 A040353 A040353 A040353 A091426 A091426 A091426 A089424 A089424 A089424 A040424 A040424 A040424 A086809 A040750 A040750 A040750 003 001 002 001 002 003 001 002 003 001 002 003 001 001 002 003
Dec 30, 1983 Dec 30, 1982 Dec 30, 1983 Mar Jul Jul Jun Jun Jun Jul Aug Aug Aug Aug Aug 15, 29, 29, 08, 08, 08, 23, 11, 11, 20, 20, 20, 2006 1999 1999 2010 2010 2010 1986 1999 1999 2001 2001 2001
15MG 20MG 30MG 40MG 15MG 20MG 30MG 40MG 30MG 40MG 15MG 20MG 30MG 40MG 15MG 20MG 30MG 40MG
A077672 A077672 A077672 A077672 A078957 A078957 A078957 A078957 A078775 A078775 A079069 A079069 A079069 A079069 N020412 N020412 N020412 N020412
003 004 001 002 001 002 003 004 001 002 001 002 003 004 002 003 004 005
Dec Dec Dec Dec Dec Dec Dec Dec Jan Jan Dec Dec Dec Dec Jun Jun Jun Jun
29, 29, 29, 29, 29, 29, 29, 29, 05, 05, 29, 29, 29, 29, 24, 24, 24, 24,
2008 2008 2008 2008 2008 2008 2008 2008 2009 2009 2008 2008 2008 2008 1994 1994 1994 1994
AP AP AP AP AP AP AP AP AP
N018802 001 A088400 N019633 N018632 N018632 N018233 N018801 N019869 A077393 001 001 002 001 001 001 001 001
Oct 27, 1982 Jan Feb Apr Jun 16, 29, 19, 30, 1984 1988 1988 1982
AT AT AT AT AT
N017428 001 N016734 N017866 N017513 N018313 001 001 001 001
STREPTOMYCIN SULFATE
INJECTABLE; INJECTION
STREPTOMYCIN SULFATE
XX + X GEN PHARMS
EQ 1GM BASE/VIAL
A064210 001
1GM/VIAL
N050577 001
SUCCIMER
CAPSULE; ORAL
CHEMET
XX + LUNDBECK INC
100MG
N019998 002
SUCCINYLCHOLINE CHLORIDE
INJECTABLE; INJECTION ANECTINE + SANDOZ 20MG/ML QUELICIN + HOSPIRA 20MG/ML QUELICIN PRESERVATIVE FREE + HOSPIRA 20MG/ML QUELICIN PRESERVATIVE FREE + HOSPIRA 100MG/ML
AP AP AP XX
SUCRALFATE
SUSPENSION; ORAL
CARAFATE
XX + APTALIS PHARMA US TABLET; ORAL CARAFATE AB + APTALIS PHARMA US SUCRALFATE NOSTRUM LABS AB TEVA AB
1GM/10ML
N019183 001
N018333 001 A074415 001 A070848 001 Jun 08, 1998 Mar 29, 1996
SUFENTANIL CITRATE
INJECTABLE; INJECTION SUFENTA PRESERVATIVE FREE AP + AKORN EQ 0.05MG BASE/ML SUFENTANIL CITRATE BAXTER HLTHCARE AP EQ 0.05MG BASE/ML HOSPIRA AP EQ 0.05MG BASE/ML
SULCONAZOLE NITRATE
CREAM; TOPICAL
EXELDERM
XX + RANBAXY
SOLUTION; TOPICAL
EXELDERM
XX + RANBAXY
1%
N018737 001
1%
N018738 001
SULFACETAMIDE SODIUM
LOTION; TOPICAL KLARON AB + SANOFI AVENTIS US
10%
N019931 001
10% 10%
SOLUTION/DROPS; OPHTHALMIC BLEPH-10 AT + ALLERGAN 10% SULFACETAMIDE SODIUM ALCON UNIVERSAL AT 10% BAUSCH AND LOMB AT 10%
A080028 001 A089560 001 A040066 001 Oct 18, 1988 Dec 28, 1994
SULFADIAZINE
TABLET; ORAL
SULFADIAZINE
XX + SANDOZ
500MG
A040091 001
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE; INJECTION
SULFAMETHOXAZOLE AND TRIMETHOPRIM
80MG/ML;16MG/ML XX + TEVA PARENTERAL SUSPENSION; ORAL SULFAMETHOXAZOLE AND TRIMETHOPRIM AUROBINDO PHARMA 200MG/5ML;40MG/5ML + HI TECH PHARMA 200MG/5ML;40MG/5ML VINTAGE 200MG/5ML;40MG/5ML SULFATRIM PEDIATRIC ACTAVIS MID ATLANTIC 200MG/5ML;40MG/5ML TABLET; ORAL BACTRIM MUTUAL PHARM 400MG;80MG BACTRIM DS + MUTUAL PHARM 800MG;160MG SEPTRA MONARCH PHARMS 400MG;80MG SEPTRA DS MONARCH PHARMS 800MG;160MG SULFAMETHOPRIM NOVEL LABS INC 400MG;80MG SULFAMETHOPRIM-DS NOVEL LABS INC 800MG;160MG SULFAMETHOXAZOLE AND TRIMETHOPRIM AMNEAL PHARMS NY 400MG;80MG 800MG;160MG AUROBINDO PHARMA 400MG;80MG 800MG;160MG GLENMARK GENERICS 400MG;80MG 800MG;160MG MUTUAL PHARM 800MG;160MG VINTAGE 400MG;80MG 800MG;160MG VISTA PHARMS 400MG;80MG 800MG;160MG
A073303 001
AB AB AB AB
Jun 08, 2010 Dec 29, 1997 Jan 24, 2007 Jan 07, 1983
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
N017377 001 N017377 002 N017376 001 N017376 002 A070022 001 A070032 001 A076899 A076899 A090624 A090624 A090828 A090828 A071017 A078060 A078060 A076817 A076817 001 002 001 002 002 001 001 002 001 001 002 Feb 15, 1985 Feb 15, 1985 Jan Jan Feb Feb Dec Dec Aug Jan Jan Oct Oct 27, 27, 16, 16, 22, 22, 25, 25, 25, 07, 07, 2005 2005 2010 2010 2010 2010 1986 2007 2007 2005 2005
SULFANILAMIDE
CREAM; VAGINAL
AVC
XX + AZUR PHARMA
15%
N006530 003
SULFASALAZINE
SUSPENSION; ORAL
AZULFIDINE
XX + PHARMACIA AND UPJOHN TABLET; ORAL AZULFIDINE AB + PHARMACIA AND UPJOHN SULFASALAZINE VINTAGE PHARMS AB WATSON LABS AB AB
250MG/5ML
A086983 001
N007073 001 A040349 001 A085828 001 A087197 001 Jan 11, 2002
TABLET, DELAYED RELEASE; ORAL AZULFIDINE EN-TABS AB + PHARMACIA AND UPJOHN 500MG SULFASALAZINE VINTAGE PHARMS AB 500MG
SULINDAC
TABLET; ORAL CLINORIL AB + MERCK SULINDAC EPIC PHARMA AB AB MUTUAL PHARM AB AB MYLAN AB AB WATSON LABS AB AB
N017911 002 A072710 A072711 A072050 A072051 A073039 A073039 A071891 A071795 001 001 001 001 002 001 001 001 Mar Mar Apr Apr Jun Jun Apr Apr 25, 25, 17, 17, 22, 22, 03, 03, 1991 1991 1991 1991 1993 1993 1990 1990
SUMATRIPTAN
SPRAY; NASAL
IMITREX
XX + GLAXOSMITHKLINE XX +
5MG/SPRAY 20MG/SPRAY
SUMATRIPTAN SUCCINATE
INJECTABLE; SUBCUTANEOUS IMITREX STATDOSE AB + GLAXOSMITHKLINE SUMATRIPTAN SUCCINATE SUN PHARM INDS INC AB IMITREX AP + GLAXOSMITHKLINE
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
6MG 6MG 4MG 6MG 6MG 6MG 6MG 6MG 6MG 4MG 6MG 6MG 6MG
BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML BASE/0.5ML
(EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ (EQ
12MG BASE/ML) 12MG BASE/ML) 8MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 8MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML) 12MG BASE/ML)
A079242 A079240 A079240 A079123 A090310 A077871 A077332 A090314 A090641 A078067 A078067 A077907 A078593
001 002 001 001 001 001 001 001 001 002 001 001 001
Mar Sep Sep Feb Aug Jul Oct Jun Jul Feb Feb Feb Feb
02, 18, 18, 06, 11, 09, 09, 10, 28, 06, 06, 06, 06,
2009 2009 2009 2009 2010 2009 2009 2010 2010 2009 2009 2009 2009
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
EQ 25MG BASE EQ 50MG BASE EQ 100MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 25MG BASE 50MG BASE 50MG BASE 100MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE
N020132 002 N020132 003 N020132 001 A078327 A078327 A078327 A076847 A076847 A076847 A077163 A077744 A077163 A077744 A077163 A077744 A078284 A078284 A078284 A076554 A076554 A076572 A076976 A076976 A076976 A078295 A078295 A078295 A076840 A076840 A076840 A076933 A076933 A076933 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 001 001 002 003 001 002 003 001 002 003 001 002 003
Jun 01, 1995 Jun 01, 1995 Jun 01, 1995 Aug Aug Aug Aug Aug Aug Nov Aug Nov Aug Nov Aug Aug Aug Aug Aug Aug Feb Aug Aug Aug Aug Aug Aug Feb Feb Feb Aug Aug Aug 10, 10, 10, 10, 10, 10, 02, 10, 02, 10, 02, 10, 10, 10, 10, 10, 10, 09, 10, 10, 10, 10, 10, 10, 09, 09, 09, 10, 10, 10, 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
EQ EQ EQ EQ
TACROLIMUS
CAPSULE; ORAL PROGRAF ASTELLAS AB AB AB + TACROLIMUS ACCORD HLTHCARE AB AB AB DR REDDYS LABS LTD AB AB AB MYLAN AB AB AB SANDOZ AB AB AB WATSON LABS AB INJECTABLE; INJECTION
PROGRAF
XX + ASTELLAS OINTMENT; TOPICAL PROTOPIC ASTELLAS XX XX +
EQ 0.5MG BASE EQ 1MG BASE EQ 5MG BASE 0.5MG 1MG 5MG EQ 0.5MG BASE EQ 1MG BASE EQ 5MG BASE EQ 0.5MG BASE EQ 1MG BASE EQ 5MG BASE EQ 0.5MG BASE EQ 1MG BASE EQ 5MG BASE EQ 5MG BASE
N050708 003 N050708 001 N050708 002 A091195 A091195 A091195 A090509 A090509 A090509 A090596 A090596 A090596 A065461 A065461 A065461 A090402 001 002 003 001 002 003 001 002 003 001 002 003 001
Aug 24, 1998 Apr 08, 1994 Apr 08, 1994 Aug Aug Aug May May May Sep Sep Sep Aug Aug Aug Jul 31, 31, 31, 12, 12, 12, 17, 17, 17, 10, 10, 10, 01, 2011 2011 2011 2010 2010 2010 2010 2010 2010 2009 2009 2009 2010
EQ 5MG BASE/ML
N050709 001
0.03% 0.1%
TADALAFIL
TABLET; ORAL
ADCIRCA
XX + ELI LILLY CO CIALIS LILLY XX XX XX XX +
N022332 001 N021368 N021368 N021368 N021368 004 001 002 003
May 22, 2009 Jan Nov Nov Nov 07, 21, 21, 21, 2008 2003 2003 2003
TALC
AEROSOL, METERED; INTRAPLEURAL
SCLEROSOL
400MG/SPRAY XX + BRYAN POWDER; INTRAPLEURAL
TALC
XX + BRYAN
N020587 001
5GM/BOT
N021388 001
TAMOXIFEN CITRATE
TABLET; ORAL TAMOXIFEN CITRATE AEGIS PHARMS AB AB
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A090878 A090878 A074732 A074732 A075797 A074858 A070929 A070929 A076179 A076179
001 002 002 001 001 001 001 002 001 002
Sep Sep Feb Feb Feb Feb Feb Feb Feb Feb
23, 23, 20, 20, 20, 20, 20, 20, 20, 20,
2011 2011 2003 2003 2003 2003 2003 2003 2003 2003
TAMSULOSIN HYDROCHLORIDE
CAPSULE; ORAL FLOMAX + BOEHRINGER INGELHEIM 0.4MG TAMSULOSIN HYDROCHLORIDE IMPAX LABS 0.4MG MYLAN 0.4MG SANDOZ 0.4MG SUN PHARM INDS LTD 0.4MG SYNTHON PHARMS 0.4MG TEVA PHARMS 0.4MG WOCKHARDT 0.4MG ZYDUS PHARMS USA INC 0.4MG
AB AB AB AB AB AB AB AB AB
N020579 001 A090377 A090408 A078015 A090931 A078801 A077630 A078938 A078225 001 001 001 001 001 001 001 001
Apr 15, 1997 Mar Apr Apr Jul Apr Apr Apr Apr 02, 27, 27, 15, 27, 27, 27, 27, 2010 2010 2010 2010 2010 2010 2010 2010
TAPENTADOL HYDROCHLORIDE
TABLET; ORAL NUCYNTA JANSSEN PHARMS XX XX XX +
TABLET, EXTENDED RELEASE; ORAL NUCYNTA ER JANSSEN PHARMS EQ 50MG BASE XX EQ 100MG BASE XX EQ 150MG BASE XX EQ 200MG BASE XX EQ 250MG BASE XX +
TAZAROTENE
CREAM; TOPICAL
AVAGE
XX + ALLERGAN TAZORAC XX + ALLERGAN XX + GEL; TOPICAL
TAZORAC
XX + ALLERGAN XX +
0.05% 0.1%
N/A
N017776 001
N017881 001
N/A
N020256 001
N/A
N018467 001
N/A
N019829 001
N/A
N018035 002
N/A N/A
N/A
N019882 001
N/A
N018321 001
N/A N/A
N/A N/A
N/A
N019981 001
AP AP AP AP AP
N019785 001 A078809 001 A078806 001 A079157 001 A078098 001
Dec 21, 1990 Apr 28, 2009 Apr 29, 2009 Jul 10, 2009 Sep 22, 2008
N017771 001
N017243 002
N017944 001
N017858 001
N/A N/A
TELAPREVIR
TABLET; ORAL
INCIVEK
XX + VERTEX PHARMS
375MG
N201917 001
TELAVANCIN HYDROCHLORIDE
POWDER; IV (INFUSION) VIBATIV THERAVANCE INC XX XX +
600MG
N022011 001
TELITHROMYCIN
TABLET; ORAL KETEK SANOFI AVENTIS US XX XX +
300MG 400MG
TELMISARTAN
TABLET; ORAL MICARDIS XX BOEHRINGER INGELHEIM XX XX +
TEMAZEPAM
CAPSULE; ORAL RESTORIL MALLINCKRODT INC AB AB AB AB + TEMAZEPAM ACTAVIS ELIZABETH AB AB MUTUAL PHARM AB AB MYLAN AB AB AB AB NOVEL LABS INC AB AB SANDOZ AB AB WATSON LABS AB AB
7.5MG 15MG 22.5MG 30MG 15MG 30MG 7.5MG 22.5MG 7.5MG 15MG 22.5MG 30MG 15MG 30MG 15MG 30MG 15MG 30MG
N018163 N018163 N018163 N018163 A071638 A071620 A078581 A071175 A070920 A070920 A070920 A070920 A071456 A071457 A071427 A071428 A071446 A071447
003 001 004 002 001 001 001 002 002 004 003 001 001 001 001 001 001 001
Aug Aug Sep Sep May Jul Jun Jul Apr Apr Jan Jan May May
07, 07, 08, 14, 21, 07, 12, 10, 21, 21, 12, 12, 21, 21,
1987 1987 2009 2009 2010 1986 2009 1986 1987 1987 1988 1988 1993 1993
TEMOZOLOMIDE
CAPSULE; ORAL TEMODAR SCHERING AB AB AB AB AB AB + TEMOZOLOMIDE BARR AB AB AB AB AB AB
5MG 20MG 100MG 140MG 180MG 250MG 5MG 20MG 100MG 140MG 180MG 250MG
N021029 N021029 N021029 N021029 N021029 N021029 A078879 A078879 A078879 A078879 A078879 A078879
001 002 003 005 006 004 001 002 003 005 006 004
Aug Aug Aug Oct Oct Aug Mar Mar Mar Mar Mar Mar
11, 11, 11, 19, 19, 11, 01, 01, 01, 01, 01, 01,
1999 1999 1999 2006 2006 1999 2010 2010 2010 2010 2010 2010
100MG/VIAL
N022277 001
TEMSIROLIMUS
SOLUTION; INTRAVENOUS
TORISEL
XX + WYETH PHARMS INC
25MG/ML (25MG/ML)
N022088 001
TENIPOSIDE
INJECTABLE; INJECTION
VUMON
XX + BRISTOL MYERS SQUIBB
10MG/ML
N020119 001
300MG
N021356 001
TERAZOSIN HYDROCHLORIDE
CAPSULE; ORAL HYTRIN ABBOTT AB AB + AB AB TERAZOSIN HYDROCHLORIDE APOTEX AB AB AB AB IVAX SUB TEVA PHARMS AB AB AB AB JUBILANT CADISTA AB AB AB AB MYLAN AB AB AB AB RANBAXY AB AB AB AB SANDOZ AB AB AB AB TABLET; ORAL HYTRIN ABBOTT XX XX + XX XX
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE
N020347 N020347 N020347 N020347 A075498 A075498 A075498 A075498 A075614 A075614 A075614 A075614 A075317 A075317 A075317 A075317 A075140 A075140 A075140 A075140 A076021 A076021 A076021 A076021 A074823 A074823 A074823 A074823
001 002 003 004 001 002 003 004 002 001 003 004 001 002 003 004 002 003 001 004 001 002 003 004 001 002 003 004
Dec Dec Dec Dec Apr Apr Apr Apr Jan Jan Jan Jan Dec Dec Dec Dec Feb Feb Feb Feb Aug Aug Aug Aug Mar Mar Mar Mar
14, 14, 14, 14, 12, 12, 12, 12, 30, 30, 30, 30, 20, 20, 20, 20, 11, 11, 11, 11, 22, 22, 22, 22, 30, 30, 30, 30,
1994 1994 1994 1994 2001 2001 2001 2001 2001 2001 2001 2001 2004 2004 2004 2004 2000 2000 2000 2000 2002 2002 2002 2002 1998 1998 1998 1998
EQ EQ EQ EQ
AB AB AB AB AB AB AB AB AB AB AB AB AB AB
TABLET; ORAL LAMISIL + NOVARTIS EQ TERBINAFINE HYDROCHLORIDE APOTEX EQ AUROBINDO PHARMA EQ BRECKENRIDGE PHARM EQ DR REDDYS LABS INC EQ GLENMARK GENERICS EQ HARRIS PHARM EQ INVAGEN PHARMS EQ MYLAN EQ EQ ORCHID HLTHCARE EQ TEVA EQ WATSON LABS EQ WOCKHARDT EQ
250MG BASE 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG 250MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N020539 001 A078199 A078297 A077714 A076390 A078157 A077919 A077533 A077136 A077195 A078163 A076377 A077137 A078229 001 001 001 001 001 001 001 001 001 001 001 001 001
May 10, 1996 Jul Jul Jun Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul 02, 02, 04, 02, 02, 02, 02, 02, 02, 02, 02, 02, 02, 2007 2007 2010 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007
TERBUTALINE SULFATE
INJECTABLE; INJECTION TERBUTALINE SULFATE AKORN APP PHARMS + BEDFORD HIKMA FARMACEUTICA TEVA PARENTERAL
AP AP AP AP AP
TERCONAZOLE
CREAM; VAGINAL TERAZOL 3 + JANSSEN PHARMS TERAZOL 7 + JANSSEN PHARMS TERCONAZOLE ALTANA TARO TERCONAZOLE + NYCOMED US SUPPOSITORY; VAGINAL TERAZOL 3 + JANSSEN PHARMS TERCONAZOLE ALTANA PERRIGO NEW YORK TARO
AB AB AB AB AB BX
N019964 001 N019579 001 A076712 001 A076043 001 A075953 001 N021735 001
Feb 21, 1991 Dec 31, 1987 Feb 18, 2005 Jan 19, 2005 Apr 06, 2004 Oct 01, 2004
AB AB AB AB
May 24, 1988 Jul 12, 2006 Mar 17, 2006 Mar 09, 2007
0.6MG/2.4ML (0.25MG/ML)
N021318 002
TESAMORELIN ACETATE
POWDER; SUBCUTANEOUS
EGRIFTA
XX + THERATECHNOLOGIES
EQ 1MG BASE/VIAL
N022505 001
TESTOSTERONE
FILM, EXTENDED RELEASE; TRANSDERMAL
ANDRODERM
XX + WATSON LABS
2MG/24HR XX +
4MG/24HR GEL; TRANSDERMAL ANDROGEL BX + ABBOTT LABS TESTIM BX + AUXILIUM PHARMS ANDROGEL ABBOTT LABS XX
75MG
A080911 001
N022504 001
N021543 001
TESTOSTERONE CYPIONATE
INJECTABLE; INJECTION DEPO-TESTOSTERONE AO + PHARMACIA AND UPJOHN AO + TESTOSTERONE CYPIONATE BEDFORD AO AO PADDOCK LLC AO SANDOZ AO AO SYNERX PHARMA AO WATSON LABS AO
A085635 002 A085635 003 A090387 A090387 A040530 A040615 A040615 A040652 A086030 001 002 001 001 002 001 001 Jul Jul Jan Aug Aug Dec 15, 15, 31, 10, 10, 11, 2010 2010 2005 2006 2006 2006
TESTOSTERONE ENANTHATE
INJECTABLE; INJECTION DELATESTRYL AO + ENDO PHARM TESTOSTERONE ENANTHATE PADDOCK LLC AO SYNERX PHARMA AO
N009165 003 A040575 001 A040647 001 Jun 14, 2006 Oct 05, 2009
200MG/ML
A085598 001
TETRABENAZINE
TABLET; ORAL XENAZINE VALEANT INTL XX XX +
12.5MG 25MG
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL TETRACYCLINE HYDROCHLORIDE IMPAX LABS AB 250MG AB 500MG IVAX SUB TEVA PHARMS 250MG AB AB + 500MG WATSON LABS AB 250MG AB 500MG
TETRACYCLINE HYDROCHLORIDE
IMPAX LABS 100MG XX
A060469 002
TETRAHYDROZOLINE HYDROCHLORIDE
SOLUTION; NASAL
TYZINE
XX + NYCOMED US XX
SPRAY; NASAL
TYZINE
XX + NYCOMED US
0.05% 0.1%
A086576 002
A086576 001
0.1%
A086576 003
THALIDOMIDE
CAPSULE; ORAL THALOMID CELGENE XX XX XX XX +
THEOPHYLLINE
CAPSULE, EXTENDED RELEASE; ORAL THEO-24 BC UCB INC 100MG BC 200MG BC 300MG THEOPHYLLINE BC INWOOD LABS 100MG
Aug 22, 1983 Aug 22, 1983 Aug 22, 1983 Feb 14, 1994
BC BC XX XX
Feb 14, 1994 Feb 14, 1994 Feb 28, 1992 Feb 14, 1994
ELIXIR; ORAL
ELIXOPHYLLIN
XX + CARACO
80MG/15ML
A085186 001
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP
INJECTABLE; INJECTION THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 40MG/100ML THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 80MG/100ML THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 160MG/100ML THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER + B BRAUN 320MG/100ML THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER + BAXTER HLTHCARE 4MG/ML + 40MG/100ML + 80MG/100ML + 160MG/100ML + 200MG/100ML + 320MG/100ML + 400MG/100ML THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER + HOSPIRA INC 4MG/ML + 40MG/100ML + 160MG/100ML + 320MG/100ML
N019826 001 N019826 002 N019826 003 N019826 006 N018649 N018649 N018649 N018649 N018649 N018649 N018649 N019211 N019211 N019211 N019211 007 001 002 003 004 006 005 007 001 003 006
Aug 14, 1992 Aug 14, 1992 Aug 14, 1992 Aug 14, 1992 Jul Jul Jul Jul Jul Nov Jul Dec Dec Dec Jan 26, 26, 26, 26, 26, 13, 26, 14, 14, 14, 20, 1982 1982 1982 1982 1982 1985 1982 1984 1984 1984 1988
SOLUTION; ORAL
THEOPHYLLINE
XX + SILARX TABLET; ORAL
THEOLAIR
XX + GRACEWAY XX +
80MG/15ML
A091156 001
125MG 250MG
TABLET, EXTENDED RELEASE; ORAL THEOCHRON CARACO AB 100MG AB 200MG AB 300MG THEOPHYLLINE ALEMBIC LTD AB 300MG AB 450MG GLENMARK GENERICS AB 400MG AB 600MG INWOOD LABS AB 450MG NOSTRUM AB 400MG AB + 600MG AB + PLIVA 100MG AB + 200MG AB 300MG AB + 450MG
A088320 001 A088321 001 A087400 002 A090430 A090430 A090355 A090355 A040034 A040595 A040560 A089807 A089808 A089763 A081236 001 002 001 002 001 001 002 001 001 001 001
Feb 21, 1985 Feb 21, 1985 Jan 11, 1983 Oct Oct Jul Jul Apr Apr Apr Apr Apr Apr Nov 27, 27, 13, 13, 28, 21, 21, 30, 30, 30, 09, 2010 2010 2010 2010 1995 2006 2006 1990 1990 1990 1992
THIOGUANINE
TABLET; ORAL
THIOGUANINE
XX + GLAXOSMITHKLINE
40MG
N012429 001
THIORIDAZINE HYDROCHLORIDE
TABLET; ORAL THIORIDAZINE HYDROCHLORIDE MUTUAL PHARM 10MG 25MG 50MG 100MG MYLAN 10MG 25MG 50MG + 100MG
AB AB AB AB AB AB AB AB
THIOTEPA
INJECTABLE; INJECTION THIOTEPA XX BEDFORD
15MG/VIAL
A075547 001
THIOTHIXENE
CAPSULE; ORAL NAVANE PFIZER AB AB AB + AB THIOTHIXENE MYLAN AB AB AB AB SANDOZ AB AB AB AB WATSON LABS AB AB
1MG 2MG 5MG 10MG 1MG 2MG 5MG 10MG 1MG 2MG 5MG 10MG 2MG 5MG
N016584 N016584 N016584 N016584 A071093 A071093 A071093 A071093 A071610 A071570 A071529 A071530 A070601 A070602
001 002 003 004 002 003 004 001 001 001 001 001 001 001 Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun 23, 23, 23, 23, 24, 24, 24, 24, 05, 05, 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987
THYROTROPIN ALFA
INJECTABLE; INJECTION
THYROGEN
XX + GENZYME
1.1MG/VIAL
N020898 001
TIAGABINE HYDROCHLORIDE
TABLET; ORAL GABITRIL CEPHALON AB AB +
2MG 4MG
A077555 001 A077555 002 N020646 N020646 N020646 N020646 N020646 006 007 008 002 003
Nov 04, 2011 Nov 04, 2011 Nov Nov Nov Sep Sep 29, 29, 29, 30, 30, 2005 2005 2005 1997 1997
TICAGRELOR
TABLET; ORAL
BRILINTA
XX + ASTRAZENECA LP
90MG
N022433 001
TICLOPIDINE HYDROCHLORIDE
TABLET; ORAL TICLOPIDINE HYDROCHLORIDE APOTEX 250MG CARACO 250MG MYLAN 250MG SANDOZ 250MG + TEVA 250MG
AB AB AB AB AB
TIGECYCLINE
INJECTABLE; IV (INFUSION)
TYGACIL
50MG/VIAL XX + WYETH PHARMS INC
N021821 001
TILUDRONATE DISODIUM
TABLET; ORAL
SKELID
XX + SANOFI AVENTIS US
EQ 200MG BASE
N020707 001
TIMOLOL
SOLUTION/DROPS; OPHTHALMIC
BETIMOL
XX + SANTEN OY EQ 0.25% BASE XX + EQ 0.5% BASE
TIMOLOL MALEATE
SOLUTION, GEL FORMING/DROPS; TIMOLOL MALEATE FALCON PHARMS EQ EQ TIMOPTIC-XE + ATON EQ + EQ SOLUTION/DROPS; OPHTHALMIC TIMOLOL MALEATE AKORN EQ EQ EQ APOTEX INC EQ EQ BAUSCH AND LOMB EQ EQ OPHTHALMIC 0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE N020963 001 N020963 002 N020330 001 N020330 002 Oct 21, 1998 Oct 21, 1998 Nov 04, 1993 Nov 04, 1993
AB AB AB AB
AT AT AT AT AT AT AT
0.25% BASE 0.5% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE
AT AT AT AT AT AT AT AT AT AT AT BT XX XX
0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.25% BASE 0.5% BASE 0.5% BASE 0.25% BASE 0.5% BASE
N018086 001 N018086 002 N021516 001 N019463 001 N019463 002 Jun 04, 2004 Nov 05, 1986 Nov 05, 1986
TINIDAZOLE
TABLET; ORAL TINDAMAX MISSION PHARMA XX XX +
250MG 500MG
TINZAPARIN SODIUM
INJECTABLE; INJECTION
INNOHEP
XX + LEO PHARMA AS
20,000 IU/ML
N020484 001
TIOPRONIN
TABLET; ORAL
TIOPRONIN
XX + MISSION PHARMA
100MG
N019569 001
EQ 0.018MG BASE/INH
N021395 001
TIPRANAVIR
CAPSULE; ORAL
APTIVUS
XX + BOEHRINGER INGELHEIM SOLUTION; ORAL
APTIVUS
XX + BOEHRINGER INGELHEIM
250MG
N021814 001
100MG/ML
N022292 001
TIROFIBAN HYDROCHLORIDE
INJECTABLE; INJECTION AGGRASTAT MEDICURE XX
N020913 002
N020913 003
TIZANIDINE HYDROCHLORIDE
CAPSULE; ORAL
ZANAFLEX
XX ACORDA
XX XX +
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
TABLET; ORAL TIZANIDINE HYDROCHLORIDE ALPHAPHARM EQ EQ APOTEX EQ EQ CARACO EQ EQ COREPHARMA EQ EQ DR REDDYS LABS INC EQ EQ MYLAN EQ EQ SANDOZ EQ EQ TEVA EQ EQ ZANAFLEX EQ + ACORDA
2MG 4MG 2MG 4MG 2MG 4MG 2MG 4MG 2MG 4MG 2MG 4MG 2MG 4MG 2MG 4MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A076282 A076282 A076533 A076533 A076416 A076416 A076347 A076347 A076286 A076286 A076354 A076354 A076399 A076280 A076284 A076284
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Dec Dec Jan Jan Sep Sep Oct Oct Jul Jul Mar Mar Nov Jun Jul Jul
16, 16, 16, 16, 29, 29, 11, 11, 03, 03, 28, 28, 26, 27, 03, 03,
2003 2003 2004 2004 2003 2003 2002 2002 2002 2002 2003 2003 2002 2002 2002 2002
4MG BASE
N020397 001
TOBRAMYCIN
OINTMENT; OPHTHALMIC
TOBREX
XX + ALCON
SOLUTION; INHALATION
TOBI
XX + NOVARTIS PHARMS
0.3%
N050555 001
300MG/5ML
N050753 001
AT AT AT AT AT AT
SOLUTION/DROPS; OPHTHALMIC AKTOB AKORN 0.3% TOBRAMYCIN BAUSCH AND LOMB 0.3% FERA PHARMS 0.3% NOVEX 0.3% TOBREX ALCON 0.3% 0.3% + FALCON PHARMS
A064096 001 A064052 001 A065026 001 A065087 001 A062535 001 N050541 001
Jan 31, 1996 Nov 29, 1993 Sep 11, 2001 Feb 25, 2002 Dec 13, 1984
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION TOBRAMYCIN SULFATE AKORN STRIDES APOTHECON APP PHARMS +
AP AP AP AP AP
EQ EQ EQ EQ EQ
40MG BASE/ML 10MG BASE/ML 10MG BASE/ML 40MG BASE/ML 1.2GM BASE/VIAL
Nov 29, 2002 Jul 31, 1990 Jun 02, 1993 Jul 31, 1990
TOLAZAMIDE
TABLET; ORAL TOLAZAMIDE MYLAN AB AB + WATSON LABS AB AB
TOLBUTAMIDE
TABLET; ORAL TOLBUTAMIDE MYLAN AB AB + WATSON LABS AB
TOLCAPONE
TABLET; ORAL
TASMAR
XX + VALEANT PHARM INTL
100MG
N020697 001
TOLMETIN SODIUM
CAPSULE; ORAL TOLMETIN SODIUM MYLAN AB AB + TEVA TABLET; ORAL TOLMETIN SODIUM MUTUAL PHARM AB AB + MYLAN
TOLTERODINE TARTRATE
CAPSULE, EXTENDED RELEASE; ORAL DETROL LA XX PHARMACIA AND UPJOHN 2MG XX + 4MG TABLET; ORAL DETROL XX PHARMACIA AND UPJOHN XX +
1MG 2MG
15MG 30MG
TOPIRAMATE
CAPSULE; ORAL TOPAMAX JANSSEN PHARMS AB AB + TOPIRAMATE MYLAN AB AB SANDOZ AB AB TEVA AB AB WATSON LABS AB AB ZYDUS PHARMS USA INC AB AB TABLET; ORAL TOPAMAX AB + JANSSEN PHARMS AB AB AB TOPIRAMATE ACCORD HLTHCARE AB AB AB AB APOTEX INC AB AB AB AB AUROBINDO PHARMA AB AB AB AB CIPLA LTD AB AB AB AB GLENMARK GENERICS AB AB AB AB INVAGEN PHARMS AB AB AB AB MYLAN AB AB AB AB RANBAXY AB AB AB
15MG 25MG 15MG 25MG 15MG 25MG 15MG 25MG 15MG 25MG 15MG 25MG
N020844 001 N020844 002 A078418 A078418 A079206 A079206 A076575 A076575 A077868 A077868 A078877 A078877 001 002 001 002 001 002 001 002 001 002
Oct 26, 1998 Oct 26, 1998 Oct Oct Oct Oct Apr Apr Apr Apr Oct Oct 14, 14, 14, 14, 17, 17, 15, 15, 14, 14, 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 100MG 200MG
N020505 N020505 N020505 N020505 A076311 A076311 A076311 A076311 A077733 A077733 A077733 A077733 A078462 A078462 A078462 A078462 A076343 A076343 A076343 A076343 A077627 A077627 A077627 A077627 A079162 A079162 A079162 A079162 A076314 A076314 A076314 A076314 A076327 A076327 A076327
004 005 001 002 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003
Dec Dec Dec Dec Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar
24, 24, 24, 24, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27,
1996 1996 1996 1996 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG
A090278 A090278 A090278 A090278 A076317 A076317 A076317 A076317 A079153 A079153 A079153 A079153 A090162 A090162 A090162 A078499 A078499 A078499 A078499 A077643 A077643 A077643 A077643 A090353 A090353 A090353 A090353 A078235 A078235 A078235 A078235
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Jan Jan Jan Jan Mar Mar Mar Mar Sep Sep Sep Sep Mar Mar Mar Mar
27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 07, 07, 07, 07, 27, 27, 27, 27, 01, 01, 01, 01, 27, 27, 27, 27,
2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2009 2010 2010 2010 2010 2009 2009 2009 2009
TOPOTECAN HYDROCHLORIDE
CAPSULE; ORAL HYCAMTIN SMITHKLINE BEECHAM XX XX + INJECTABLE; INJECTION HYCAMTIN + GLAXOSMITHKLINE TOPOTECAN HYDROCHLORIDE ACTAVIS TOTOWA APP PHARMS DR REDDYS LABS LTD FRESENIUS KABI ONCOL SAGENT PHARMS THREE RIVERS PHARMS
AP AP AP AP AP AP AP
EQ 4MG BASE/VIAL EQ EQ EQ EQ EQ EQ 4MG 4MG 4MG 4MG 4MG 4MG BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL BASE/VIAL
N020671 001 A090620 A091089 A201191 A091376 A091284 A091199 001 001 001 001 001 001
May 28, 1996 Dec Nov Mar Nov Jan Dec 02, 29, 09, 29, 26, 01, 2010 2010 2011 2010 2011 2010
SOLUTION; INTRAVENOUS
TOPOTECAN
XX + HOSPIRA INC
N200582 001
TOREMIFENE CITRATE
TABLET; ORAL
FARESTON
XX + GTX INC
EQ 60MG BASE
N020497 001
5MG 10MG 20MG 100MG 5MG 10MG 20MG 100MG 5MG 10MG 20MG 100MG 5MG 10MG 20MG 100MG 5MG 10MG 20MG 100MG 5MG 10MG 20MG 100MG 5MG 10MG 20MG 5MG 10MG 20MG 100MG 5MG 10MG 20MG 100MG 5MG 10MG 20MG 100MG
N020136 N020136 N020136 N020136 A076894 A076894 A076894 A076894 A078249 A078249 A078249 A078249 A079234 A079234 A079234 A079234 A076226 A076226 A076226 A076226 A076346 A076346 A076346 A076346 A076943 A076943 A076943 A078478 A078478 A078478 A078478 A076110 A076110 A076110 A076110 A090613 A090613 A090613 A090613
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 001 002 003 004 001 002 003 004 001 002 003 004
Aug Aug Aug Aug May May May May Oct Oct Oct Oct Jan Jan Jan Jan May May May May May May May Oct Mar Mar Mar Feb Feb Feb Feb May May May May Mar Mar Mar Mar
23, 23, 23, 23, 31, 31, 31, 31, 17, 17, 17, 17, 27, 27, 27, 27, 27, 27, 27, 27, 30, 30, 30, 19, 01, 01, 01, 26, 26, 26, 26, 14, 14, 14, 14, 22, 22, 22, 22,
1993 1993 1993 1993 2005 2005 2005 2005 2007 2007 2007 2007 2009 2009 2009 2009 2003 2003 2003 2003 2003 2003 2003 2004 2005 2005 2005 2008 2008 2008 2008 2002 2002 2002 2002 2011 2011 2011 2011
TRAMADOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
CONZIP
100MG XX + CIPHER PHARMS INC 150MG XX 200MG XX 300MG XX TABLET; ORAL TRAMADOL HYDROCHLORIDE ALPHAPHARM AB
50MG
A075980 001
AB AB AB AB AB AB AB AB AB AB AB AB AB AB
50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG ORAL 100MG 200MG 300MG 100MG 200MG 300MG 100MG 200MG 300MG 100MG 200MG 300MG 100MG 200MG 300MG 100MG 200MG 300MG
A202075 A076003 A075981 A075964 A075983 A076100 A075986 A078935 A075982 A075968 A075977 A075962 A090404
001 001 001 001 001 001 001 001 001 001 001 001 001
Nov Jun Jul Jun Jun Jun Jun May Jul Jun Jun Jun Jan
28, 20, 10, 19, 25, 20, 21, 26, 01, 25, 19, 24, 31,
2011 2002 2002 2002 2002 2002 2002 2010 2002 2002 2002 2002 2011
N020281 002
TABLET, EXTENDED RELEASE; TRAMADOL HYDROCHLORIDE LUPIN LTD AB1 AB1 AB1 PAR PHARM AB1 AB1 AB1 SUN PHARMA GLOBAL AB1 AB1 AB1 ULTRAM ER AB1 + VALEANT INTL AB1 AB1 RYZOLT AB2 + PURDUE PHARMA AB2 AB2 TRAMADOL HYDROCHLORIDE SUN PHARMA GLOBAL AB2 AB2 AB2
N021692 001 N021692 002 N021692 003 N021745 001 N021745 002 N021745 003 A091607 001 A091607 002 A091607 003
Sep 08, 2005 Sep 08, 2005 Sep 08, 2005 Dec 30, 2008 Dec 30, 2008 Dec 30, 2008 Dec 30, 2011 Dec 30, 2011 Dec 30, 2011
N021693 001
TRANDOLAPRIL
TABLET; ORAL MAVIK ABBOTT AB AB AB + TRANDOLAPRIL AUROBINDO PHARMA AB AB AB CIPLA AB AB AB COREPHARMA AB AB
1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG
N020528 001 N020528 002 N020528 003 A078438 A078438 A078438 A077307 A077307 A077307 A077256 A077256 001 002 003 002 001 003 001 002
Apr 26, 1996 Apr 26, 1996 Apr 26, 1996 Jun Jun Jun Jun Jun Jun Jun Jun 12, 12, 12, 12, 12, 12, 12, 12, 2007 2007 2007 2007 2007 2007 2007 2007
4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG 1MG 2MG 4MG
A077256 A078493 A078493 A078493 A078508 A078508 A078508 A078320 A078320 A078320 A077522 A077522 A077522 A078346 A078346 A078346 A077489 A077489 A077489 A077805 A077805 A077805
003 001 002 003 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jun Aug Aug Aug Jun Jun Jun Jun Jun Jun Jun Jun Jun Apr Apr Apr Dec Dec Dec Jun Jun Jun
12, 25, 25, 25, 18, 18, 18, 12, 12, 12, 12, 12, 12, 28, 28, 28, 12, 12, 12, 12, 12, 12,
2007 2008 2008 2008 2008 2008 2008 2007 2007 2007 2007 2007 2007 2008 2008 2008 2006 2006 2006 2007 2007 2007
TRANEXAMIC ACID
INJECTABLE; INJECTION CYKLOKAPRON + PHARMACIA AND UPJOHN TRANEXAMIC ACID MYLAN INSTITUTIONAL PHARMAFORCE VERSAPHARM INC
AP AP AP AP
Dec 30, 1986 Nov 03, 2011 Aug 10, 2011 Nov 17, 2011
TABLET; ORAL
LYSTEDA
XX + FERRING PHARMS AS
650MG
N022430 001
TRANYLCYPROMINE SULFATE
TABLET; ORAL PARNATE AB + GLAXOSMITHKLINE EQ 10MG BASE TRANYLCYPROMINE SULFATE PAR PHARM AB EQ 10MG BASE
N021994 001
TRAZODONE HYDROCHLORIDE
TABLET; ORAL TRAZODONE HYDROCHLORIDE ALVOGEN AB 50MG AB 100MG APOTEX AB 50MG AB + APOTEX INC 100MG AB 150MG AB 300MG MATRIX LABS LTD AB 50MG AB 100MG AB 150MG AB 300MG MUTUAL PHARM AB 50MG AB 100MG AB 150MG PLIVA AB 50MG AB 100MG AB 150MG VINTAGE AB 50MG AB 100MG WATSON LABS AB 50MG AB 100MG TABLET, EXTENDED RELEASE; ORAL
OLEPTRO
150MG XX + ANGELINI LLC 300MG XX
A071636 A071514 A071258 A071196 A071196 A071196 A090514 A090514 A090514 A090514 A073137 A073137 A073137 A071523 A071524 A071525 A072192 A072193 A070857 A070858
001 001 001 001 002 003 001 002 003 004 002 001 003 001 001 001 001 001 001 001
Apr Apr Mar Mar Apr Apr Jun Jun Jun Jun Mar Mar Dec Dec Dec Mar Feb Feb Oct Oct
18, 18, 25, 25, 26, 26, 02, 02, 02, 02, 24, 24, 22, 11, 11, 09, 02, 02, 10, 10,
1988 1988 1987 1987 1999 1999 2009 2009 2009 2009 1993 1993 1995 1987 1987 1988 1989 1989 1986 1986
TREPROSTINIL SODIUM
INJECTABLE; IV (INFUSION)-SC REMODULIN UNITED THERAP 1MG/ML 2.5MG/ML 5MG/ML + 10MG/ML
XX XX XX XX
SOLUTION; INHALATION
TYVASO
XX + UNITED THERAP
EQ 0.6MG BASE/ML
N022387 001
TRETINOIN
CAPSULE; ORAL
TRETINOIN
XX + BARR CREAM; TOPICAL AVITA MYLAN BERTEK RETIN-A + ORTHO JANSSEN + TRETINOIN TRIAX PHARMS LLC
10MG
A077684 001
AB AB AB AB AB
N020404 003 N019049 001 N017340 001 A075264 001 A075213 001 N017522 001
A075265 001 N019963 001 A076498 001 N021108 001 A090098 001
Dec 24, 1998 Dec 29, 1995 Sep 15, 2005 Aug 31, 2000 Mar 22, 2010
N017955 001 N017579 002 A075589 001 A075529 001 N020400 001 N022070 001 N020475 002 N020475 001 Jun 11, 2002 Feb 22, 2000 Jan 29, 1998 Jul 26, 2007 May 10, 2002 Feb 07, 1997
0.05% 0.05%
TRIAMCINOLONE ACETONIDE
N018117 001
0.025% 0.1% 0.025% 0.5% 0.025% 0.1% 0.5% 0.025% 0.025% 0.1% 0.5% 0.025% 0.1% 0.1% 0.5% 0.025% 0.1% 0.1%
N011601 003 N011601 006 A084908 001 A084908 003 A085692 A085692 A085692 A089797 A086415 A086414 A086413 A086277 A040039 A086276 A086275 A040671 A040671 001 003 002 001 001 001 001 001 001 001 001 001 002
A088042 001
N012041 001 N014901 001 A090166 001 A090164 001 May 27, 2009 May 27, 2009
N022220 001
40MG/ML (40MG/ML)
N022048 001
LOTION; TOPICAL TRIAMCINOLONE ACETONIDE ALTANA AT 0.025% AT 0.1% MORTON GROVE AT 0.025% TARO AT 0.1% VINTAGE AT 0.1% AT + WOCKHARDT 0.1% OINTMENT; TOPICAL KENALOG APOTHECON AT AT TRIAMCINOLONE ACETONIDE NYCOMED US AT AT AT AT + PERRIGO NEW YORK AT + AT + TARO AT AT AT AT AT TRIAMCINOLONE ACETONIDE XX + CAROLINA MEDCL
0.025% 0.1% 0.025% 0.1% 0.5% 0.025% 0.1% 0.5% 0.025% 0.025% 0.1% 0.1% 0.5% IN ABSORBASE 0.05%
N011600 003 N011600 001 A085691 A085691 A085691 A087356 A087357 A087385 A040040 A040374 A040037 A087902 A040386 001 003 002 001 001 001 001 001 001 001 001
A089595 001
0.147MG/GM
N012104 001
SPRAY, METERED; NASAL NASACORT AQ AB + SANOFI AVENTIS US 0.055MG/SPRAY TRIAMCINOLONE ACETONIDE TEVA BRANDED PHARM AB 0.055MG/SPRAY
TRIAMCINOLONE HEXACETONIDE
INJECTABLE; INJECTION
ARISTOSPAN
XX + SANDOZ XX +
5MG/ML 20MG/ML
50MG 100MG
N013174 001
N013174 002
TRIAZOLAM
TABLET; ORAL HALCION PHARMACIA AND UPJOHN AB AB + TRIAZOLAM ALPHAPHARM AB AB ROXANE AB AB WATSON LABS AB AB
N017892 003 N017892 001 A074031 A074031 A074224 A074224 A074445 A074445 001 002 001 002 001 002
Apr 26, 1985 Nov 15, 1982 Mar Mar Jun Jun Oct Oct 25, 25, 01, 01, 20, 20, 1994 1994 1994 1994 1995 1995
TRIENTINE HYDROCHLORIDE
CAPSULE; ORAL
SYPRINE
XX + ATON
250MG
N019194 001
TRIFLUOPERAZINE HYDROCHLORIDE
TABLET; ORAL TRIFLUOPERAZINE HYDROCHLORIDE MYLAN AB EQ 1MG BASE AB EQ 2MG BASE AB EQ 5MG BASE AB + EQ 10MG BASE SANDOZ AB EQ 1MG BASE AB EQ 2MG BASE AB EQ 5MG BASE AB EQ 10MG BASE
TRIFLURIDINE
SOLUTION/DROPS; OPHTHALMIC TRIFLURIDINE ALCON AT 1% VIROPTIC AT + MONARCH PHARMS 1%
TRIHEXYPHENIDYL HYDROCHLORIDE
ELIXIR; ORAL TRIHEXYPHENIDYL HYDROCHLORIDE MIKART AA 2MG/5ML AA + PHARM ASSOC 2MG/5ML TABLET; ORAL TRIHEXYPHENIDYL HYDROCHLORIDE NATCO PHARMA LTD 2MG 5MG VINTAGE PHARMS 2MG 5MG WATSON LABS 2MG + 2MG 5MG + 5MG WEST WARD 2MG
AA AA AA AA AA AA AA AA AA
A040337 001
TRIMETHADIONE
TABLET; ORAL
TRIDIONE
XX + ABBOTT
150MG
N005856 009
TRIMETHOBENZAMIDE HYDROCHLORIDE
CAPSULE; ORAL TIGAN AB + KING PHARMS 300MG TRIMETHOBENZAMIDE HYDROCHLORIDE GAVIS PHARMS AB 300MG MUTUAL PHARMA AB 300MG INJECTABLE; INJECTION TIGAN + JHP PHARMS 100MG/ML TRIMETHOBENZAMIDE HYDROCHLORIDE HOSPIRA 100MG/ML LUITPOLD 100MG/ML TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE LUITPOLD 100MG/ML
AP AP AP AP
N017530 001 A088804 001 A091330 001 A091329 001 Apr 03, 1987 Mar 08, 2011 Mar 08, 2011
TRIMETHOPRIM
TABLET; ORAL TRIMETHOPRIM NOVEL LABS INC TEVA WATSON LABS TRIMETHOPRIM + TEVA
AB AB AB XX
Jun 15, 2011 Jul 30, 1982 Jun 06, 1985 Jun 18, 1987
TRIMETHOPRIM HYDROCHLORIDE
SOLUTION; ORAL
PRIMSOL
XX + FSC
EQ 50MG BASE/5ML
N074973 001
TRIMIPRAMINE MALEATE
CAPSULE; ORAL SURMONTIL ODYSSEY PHARMS AB AB AB + TRIMIPRAMINE MALEATE MIKAH PHARMA AB AB AB
EQ 25MG BASE EQ 50MG BASE EQ 100MG BASE EQ 25MG BASE EQ 50MG BASE EQ 100MG BASE
N016792 001 N016792 002 N016792 003 A077361 001 A077361 002 A077361 003
Sep 15, 1982 Aug 02, 2006 Aug 02, 2006 Aug 02, 2006
TRIPTORELIN PAMOATE
INJECTABLE; INTRAMUSCULAR TRELSTAR EQ 3.75MG BASE/VIAL XX + WATSON LABS EQ 11.25MG BASE/VIAL XX + EQ 22.5MG BASE/VIAL XX +
INJECTABLE; INJECTION
THAM
XX + HOSPIRA
3.6GM/100ML
N013025 002
TROPICAMIDE
SOLUTION/DROPS; OPHTHALMIC MYDRIACYL AT + ALCON 0.5% AT + 1% TROPICACYL AKORN AT 0.5% AT 1% TROPICAMIDE BAUSCH AND LOMB AT 0.5% AT 1%
A084305 001 A084306 001 A040314 001 A040315 001 A040067 001 A040064 001 Sep 29, 2000 Sep 29, 2000 Jul 27, 1994 Jul 27, 1994
TROSPIUM CHLORIDE
N022103 001
AB AB AB AB
May 28, 2004 Dec 06, 2011 Aug 13, 2010 Nov 17, 2010
TRYPAN BLUE
SOLUTION; OPHTHALMIC
MEMBRANEBLUE
XX + DORC VISIONBLUE XX + DORC
0.15% 0.06%
ULIPRISTAL ACETATE
TABLET; ORAL
ELLA
XX + LAB HRA PHARMA
30MG
N022474 001
UREA C-13
N020586 002
UREA, C-14
CAPSULE; ORAL
PYTEST
XX + AVENT PYTEST KIT XX + AVENT
1uCi 1uCi
UROFOLLITROPIN
N021289 001
AB AB AB AB AB AB
N019594 002 A077895 A075517 A079082 A090530 A075592 001 001 001 001 001
Dec 31, 1987 Jul Mar Dec Feb May 27, 14, 15, 17, 25, 2006 2000 2008 2010 2000
TABLET; ORAL URSO 250 APTALIS PHARMA US AB URSO FORTE AB + APTALIS PHARMA US URSODIOL GLENMARK GENERICS AB AB TEVA PHARMS AB AB WATSON LABS INC AB AB
N020675 001 N020675 002 A090801 A090801 A079184 A079184 A200826 A200826 001 002 001 002 001 002
Dec 10, 1997 Jul 21, 2004 Jul Jul May May Dec Dec 12, 12, 13, 13, 23, 23, 2011 2011 2009 2009 2011 2011
VALACYCLOVIR HYDROCHLORIDE
TABLET; ORAL VALACYCLOVIR HYDROCHLORIDE ACTAVIS PHARMA EQ EQ AUROBINDO PHARMA EQ EQ DR REDDYS LABS LTD EQ EQ MATRIX LABS LTD EQ EQ MYLAN EQ EQ RANBAXY EQ EQ ROXANE EQ EQ SANDOZ EQ EQ TEVA PHARMS EQ EQ WATSON LABS EQ EQ WOCKHARDT EQ EQ VALTREX GLAXOSMITHKLINE EQ + EQ
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE 500MG BASE 1GM BASE
A090370 A090370 A090682 A090682 A079012 A079012 A078518 A078518 A078070 A078070 A076588 A076588 A078656 A078656 A077478 A077478 A077655 A077655 A077135 A077135 A090216 A090216
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Mar Mar May May May May May May May May Jan Jan May May May May May May May May May May
16, 16, 24, 24, 24, 24, 24, 24, 24, 24, 31, 31, 24, 24, 24, 24, 24, 24, 24, 24, 24, 24,
2011 2011 2010 2010 2010 2010 2010 2010 2010 2010 2007 2007 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010
VALGANCICLOVIR HYDROCHLORIDE
FOR SOLUTION; ORAL
VALCYTE
XX + ROCHE PALO TABLET; ORAL
VALCYTE
XX + ROCHE PALO
50MG/ML
N022257 001
EQ 450MG BASE
N021304 001
AP AP AP AP
Dec 30, 1996 Jun 26, 2003 Nov 14, 2002 Feb 17, 2010
VALPROIC ACID
CAPSULE; ORAL DEPAKENE AB + ABBOTT VALPROIC ACID BANNER PHARMACAPS AB CATALENT AB
N018081 001 A073484 001 A073229 001 Jun 29, 1993 Oct 29, 1991
CAPSULE, DELAYED RELEASE; ORAL STAVZOR BANNER PHARMACAPS 125MG XX 250MG XX 500MG XX + SYRUP; ORAL DEPAKENE + ABBOTT VALPROIC ACID ALPHARMA HIGH TECH PHARMA PHARM ASSOC SUN PHARM INDS INC TEVA PHARMS VINTAGE WOCKHARDT
AA AA AA AA AA AA AA AA
N018082 001 A075782 A074060 A075379 A090517 A073178 A077960 A070868 001 001 001 001 001 001 001 Dec Jan Dec May Aug Oct Jul 22, 13, 15, 28, 25, 13, 01, 2000 1995 2000 2010 1992 2006 1986
VALRUBICIN
SOLUTION; INTRAVESICAL
VALSTAR PRESERVATIVE FREE
40MG/ML XX + ENDO PHARM
N020892 001
VALSARTAN
TABLET; ORAL DIOVAN NOVARTIS XX XX XX XX +
VANCOMYCIN HYDROCHLORIDE
CAPSULE; ORAL VANCOCIN HYDROCHLORIDE VIROPHARMA XX XX +
AP AP AP AP AP AP
500MG BASE/VIAL 1GM BASE/VIAL 5GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
AP AP AP AP AP AP AP AP AP AP AP AP AP AP AP XX XX
A062911 A062931 A062912 A062933 A062912 A062933 A063076 A065455 A065397 A065397 A065432 A091469 A090250 A090250 A091554
001 001 002 002 001 001 001 001 001 002 001 001 001 002 001
Aug Oct Jan May Aug Oct Dec Apr Dec Dec Dec Jul Apr Apr Sep
04, 29, 07, 27, 04, 29, 21, 29, 30, 30, 30, 01, 27, 27, 19,
1988 1992 2009 2009 1988 1992 1990 2009 2008 2008 2008 2011 2010 2010 2011
VANDETANIB
TABLET; ORAL VANDETANIB IPR PHARMS INC XX XX +
100MG 300MG
VARDENAFIL HYDROCHLORIDE
TABLET; ORAL LEVITRA BAYER HLTHCARE XX XX XX XX +
N200179 001
VARENICLINE TARTRATE
TABLET; ORAL CHANTIX PFIZER INC XX XX +
VECURONIUM BROMIDE
INJECTABLE; INJECTION VECURONIUM BROMIDE AP + BEDFORD AP + HOSPIRA AP AP MUSTAFA NEVZAT AP AP PFIZER AP AP SUN PHARMA GLOBAL AP AP TEVA PARENTERAL AP
10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL 20MG/VIAL 10MG/VIAL
A075549 A075549 A075164 A075164 A078274 A078274 A090243 A090243 A079001 A079001 A074688
001 002 001 002 001 002 001 002 001 002 001
Jun Jun Oct Oct Dec Dec May May Jun Jun Aug
13, 13, 21, 21, 29, 29, 11, 11, 17, 17, 25,
2000 2000 1999 1999 2008 2008 2010 2010 2009 2009 1999
VELAGLUCERASE ALFA
INJECTABLE; IV (INFUSION) VPRIV SHIRE HUMAN GENETIC 400 UNITS/VIAL XX
N022575 001
VEMURAFENIB
TABLET; ORAL
ZELBORAF
XX + HOFFMANN LA ROCHE
240MG
N202429 001
VENLAFAXINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL EFFEXOR XR WYETH PHARMS INC EQ 37.5MG BASE EQ 75MG BASE + EQ 150MG BASE VENLAFAXINE HYDROCHLORIDE AUROBINDO PHARMA LTD EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE DR REDDYS LABS LTD EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE MYLAN EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE ORCHID HLTHCARE EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE TEVA EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE TORRENT PHARMS LLC EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE VALEANT INTL EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE WOCKHARDT EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE ZYDUS PHARMS USA INC EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE TABLET; ORAL VENLAFAXINE HYDROCHLORIDE ACTAVIS TOTOWA EQ EQ EQ EQ EQ ALEMBIC PHARMS LTD EQ EQ
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
N020699 001 N020699 002 N020699 004 A200834 A200834 A200834 A078421 A078421 A078421 A078789 A078789 A078789 A091123 A091123 A091123 A076565 A076565 A076565 A090899 A090899 A090899 A090071 A090071 A090071 A078865 A078865 A078865 A090174 A090174 A090174 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Oct 20, 1997 Oct 20, 1997 Oct 20, 1997 Apr Apr Apr May May May Jun Jun Jun Jul Jul Jul Jun Jun Jun Jun Jun Jun Apr Apr Apr Apr Apr Apr Apr Apr Apr 14, 14, 14, 06, 06, 06, 01, 01, 01, 11, 11, 11, 28, 28, 28, 01, 01, 01, 15, 15, 15, 14, 14, 14, 14, 14, 14, 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2010 2010 2010 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011
AB AB AB AB AB AB AB
25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE
A078932 A078932 A078932 A079098 A079098 A079098 A079098 A079098 A090555 A090555 A090555 A090555 A090555 A078627 A078627 A078627 A078627 A078627 A078301 A078301 A078301 A078301 A078301 A077166 A077166 A077166 A077166 A077166 A076690 A076690 A076690 A076690 A076690 A090027 A090027 A090027 A090027 A090027 A077653 A077653 A077653 A077653 A077653
003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005
Dec Dec Dec May May May May May Apr Apr Apr Apr Apr Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Jun Jun Jun Jun Jun
14, 14, 14, 11, 11, 11, 11, 11, 07, 07, 07, 07, 07, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 03, 03, 03, 03, 03, 04, 04, 04, 04, 04, 13, 13, 13, 13, 13,
2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2010 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008 2006 2006 2006 2006 2006 2010 2010 2010 2010 2010 2008 2008 2008 2008 2008
AB AB AB AB AB AB XX
TABLET, EXTENDED RELEASE; ORAL VENLAFAXINE HYDROCHLORIDE OSMOTICA PHARM EQ 37.5MG BASE EQ 75MG BASE + EQ 150MG BASE SUN PHARMA GLOBAL EQ 37.5MG BASE EQ 75MG BASE EQ 150MG BASE VENLAFAXINE HYDROCHLORIDE OSMOTICA PHARM EQ 225MG BASE
N022104 004
AB AB AB AB AB AB AB AB AB AB AB AB XX
N019614 001 N019614 003 N019614 002 N020943 001 N020943 002 N020943 003 N019614 004
May 29, 1990 Jan 09, 1992 May 29, 1990 Nov 25, 1998 Nov 25, 1998 Nov 25, 1998 May 10, 1996
INJECTABLE; INJECTION VERAPAMIL HYDROCHLORIDE HOSPIRA AP AP AP INTL MEDICATION AP TABLET; ORAL CALAN GD SEARLE LLC AB AB AB + VERAPAMIL HYDROCHLORIDE MYLAN AB AB WATSON LABS AB AB AB AB AB AB AB AB TABLET, EXTENDED RELEASE; ISOPTIN SR + PFIZER + + VERAPAMIL HYDROCHLORIDE GLENMARK GENERICS
40MG 80MG 120MG 80MG 120MG 40MG 40MG 80MG 80MG 80MG 120MG 120MG 120MG ORAL 120MG 180MG 240MG 120MG 180MG 240MG 120MG 180MG 240MG 120MG 180MG 240MG 120MG 240MG 120MG 180MG
N018817 003 N018817 001 N018817 002 A071482 A071483 A072923 A072924 A070855 A070995 A071366 A070856 A070994 A071367 001 001 001 001 001 001 001 001 001 001
Feb 23, 1988 Sep 10, 1984 Sep 10, 1984 Feb Feb Jun Jun Sep Oct Oct Sep Oct Oct 15, 15, 29, 29, 24, 01, 01, 24, 01, 01, 1989 1989 1993 1993 1986 1986 1986 1986 1986 1986
AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB AB
N019152 003 N019152 002 N019152 001 A090700 A090700 A078906 A073568 A074330 A073568 A074587 A074587 A074587 A075072 A075072 A090529 A090529 001 002 001 002 001 001 002 003 001 001 003 001 002
Mar 06, 1991 Dec 15, 1989 Dec 16, 1986 Aug Aug Sep Oct Jan Jul Feb Sep Mar May May Dec Dec 03, 03, 17, 10, 31, 31, 21, 09, 23, 25, 25, 30, 30, 2011 2011 2009 1997 1994 1992 1997 1997 1996 1999 1999 2011 2011
MYLAN
VERTEPORFIN
INJECTABLE; INJECTION
VISUDYNE
XX + QLT
15MG/VIAL
N021119 001
VIGABATRIN
FOR SOLUTION; ORAL
SABRIL
XX + LUNDBECK INC TABLET; ORAL
SABRIL
XX + LUNDBECK INC
500MG/PACKET
N022006 001
500MG
N020427 001
VILAZODONE HYDROCHLORIDE
TABLET; ORAL VIIBRYD FOREST LABS INC XX XX XX +
VINBLASTINE SULFATE
INJECTABLE; INJECTION
VINBLASTINE SULFATE
XX + APP PHARMS XX + BEDFORD
1MG/ML 10MG/VIAL
VINCRISTINE SULFATE
INJECTABLE; INJECTION VINCRISTINE SULFATE PFS AP + HOSPIRA 1MG/ML TEVA PARENTERAL AP 1MG/ML
VINORELBINE TARTRATE
INJECTABLE; INJECTION NAVELBINE + PIERRE FABRE VINORELBINE TARTRATE ACTAVIS TOTOWA APP PHARMS BAXTER HLTHCARE BEDFORD EBEWE PHARMA HOSPIRA TEVA PARENTERAL
AP AP AP AP AP AP AP AP
EQ 10MG BASE/ML EQ EQ EQ EQ EQ EQ EQ 10MG 10MG 10MG 10MG 10MG 10MG 10MG BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
N020388 001 A078011 A076849 A075992 A076461 A078408 A076827 A076028 001 001 001 001 001 001 001
Dec 23, 1994 Jul Apr Jun Dec Feb Jun Feb 22, 18, 10, 11, 13, 02, 03, 2009 2005 2003 2003 2008 2005 2003
VITAMIN A PALMITATE
INJECTABLE; INJECTION
AQUASOL A
XX + HOSPIRA
N006823 001
200MG/5ML
N021630 001
INJECTABLE; IV (INFUSION)
VFEND
XX + PFIZER 200MG/VIAL TABLET; ORAL VFEND PFIZER AB AB + VORICONAZOLE MATRIX LABS LTD AB AB SANDOZ INC AB AB
N021267 001
N021266 001 N021266 002 A090547 A090547 A200265 A200265 001 002 001 002
May 24, 2002 May 24, 2002 Apr Apr Dec Dec 22, 22, 12, 12, 2010 2010 2011 2011
VORINOSTAT
CAPSULE; ORAL
ZOLINZA
XX + MERCK
100MG
N021991 001
WARFARIN SODIUM
INJECTABLE; INJECTION
COUMADIN
XX + BRISTOL MYERS SQUIBB TABLET; ORAL COUMADIN BRISTOL MYERS SQUIBB AB AB AB AB AB AB AB AB AB + JANTOVEN USL PHARMA AB AB AB AB AB AB AB AB AB WARFARIN SODIUM BARR AB AB AB AB AB AB AB AB AB INVAGEN PHARMS AB AB
5MG/VIAL
N009218 024
1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG
N009218 N009218 N009218 N009218 N009218 N009218 N009218 N009218 N009218 A040416 A040416 A040416 A040416 A040416 A040416 A040416 A040416 A040416 A040145 A040145 A040145 A040145 A040145 A040145 A040145 A040145 A040145 A090935 A090935
022 013 018 025 023 007 026 016 005 001 002 003 004 005 006 007 008 009 001 002 003 008 004 005 009 006 007 001 002
Oct Oct Oct Oct Oct Oct Oct Oct Oct Mar Mar Mar Nov Mar Mar Nov Mar Mar May May
02, 02, 02, 02, 02, 02, 02, 02, 02, 26, 26, 26, 05, 26, 26, 05, 26, 26, 25, 25,
2003 2003 2003 2003 2003 2003 2003 2003 2003 1997 1997 1997 1998 1997 1997 1998 1997 1997 2011 2011
2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG
A090935 A090935 A090935 A090935 A090935 A090935 A090935 A040415 A040415 A040415 A040415 A040415 A040415 A040415 A040415 A040415 A040616 A040616 A040616 A040616 A040616 A040616 A040616 A040616 A040616 A040301 A040301 A040301 A040301 A040301 A040301 A040301 A040301 A040301 A040663 A040663 A040663 A040663 A040663 A040663 A040663 A040663 A040663
003 004 005 006 007 008 009 001 002 003 004 005 006 007 008 009 009 001 002 003 004 005 006 007 008 002 003 004 005 006 007 008 009 001 001 002 003 004 005 006 007 008 009
May May May May May May May Sep Sep Sep Sep Sep Sep Sep Sep Sep Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul May May May May May May May May May
25, 25, 25, 25, 25, 25, 25, 27, 27, 29, 27, 27, 27, 27, 27, 27, 05, 05, 05, 05, 05, 05, 05, 05, 05, 15, 15, 15, 15, 15, 15, 15, 15, 15, 30, 30, 30, 30, 30, 30, 30, 30, 30,
2011 2011 2011 2011 2011 2011 2011 2004 2004 2004 2004 2004 2004 2004 2004 2004 2006 2006 2006 2006 2006 2006 2006 2006 2006 1999 1999 1999 1999 1999 1999 1999 1999 1999 2006 2006 2006 2006 2006 2006 2006 2006 2006
XENON XE-133
GAS; INHALATION XENON XE 133 LANTHEUS MEDCL AA XENON XE 133 XX LANTHEUS MEDCL
20mCi/VIAL 10mCi/VIAL
ZAFIRLUKAST
TABLET; ORAL ACCOLATE ASTRAZENECA AB AB +
10MG 20MG
10MG 20MG
ZALEPLON
CAPSULE; ORAL SONATA KING PHARMS AB AB + ZALEPLON AUROBINDO PHARMA AB AB CIPLA LTD AB AB MYLAN AB AB ORCHID HLTHCARE AB AB ROXANE AB AB TEVA PHARMS AB AB UNICHEM AB AB UPSHER SMITH AB AB WEST WARD AB AB
5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG
N020859 001 N020859 002 A078829 A078829 A077505 A077505 A077238 A077238 A090374 A090374 A077237 A077237 A077239 A077239 A078989 A078989 A078706 A078706 A078147 A078147 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Aug 13, 1999 Aug 13, 1999 Jun Jun Jun Jun Jun Jun Sep Sep Jun Jun Jun Jun Jun Jun Jun Jun Nov Nov 06, 06, 20, 20, 06, 06, 17, 17, 06, 06, 06, 06, 06, 06, 06, 06, 25, 25, 2008 2008 2008 2008 2008 2008 2009 2009 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008
ZANAMIVIR
POWDER; INHALATION
RELENZA
XX + GLAXOSMITHKLINE
5MG
N021036 001
ZICONOTIDE ACETATE
INJECTABLE; INTRATHECAL
PRIALT
XX + AZUR PHARMA II XX + XX +
ZIDOVUDINE
CAPSULE; ORAL RETROVIR AB + VIIV HLTHCARE ZIDOVUDINE AUROBINDO PHARMA LTD AB CIPLA LTD AB INJECTABLE; INJECTION RETROVIR AP + VIIV HLTHCARE ZIDOVUDINE LUITPOLD AP SYRUP; ORAL RETROVIR AA + VIIV HLTHCARE
10MG/ML 10MG/ML
50MG/5ML
N019910 001
50MG/5ML 50MG/5ML
AB AB AB AB AB AB AB AB
N020518 002 A077267 A090561 A202058 A090092 A078922 A077327 A076844 001 001 001 001 001 001 001
Oct 04, 1996 Sep Oct Oct Apr Feb Sep Sep 19, 27, 07, 25, 14, 19, 19, 2005 2010 2011 2008 2008 2005 2005
ZILEUTON
TABLET; ORAL
ZYFLO
XX + CORNERSTONE THERAP
600MG
N020471 003
N022052 001
ZINC ACETATE
CAPSULE; ORAL GALZIN TEVA XX XX +
ZINC CHLORIDE
INJECTABLE; INJECTION
ZINC CHLORIDE IN PLASTIC CONTAINER
XX + HOSPIRA EQ 1MG ZINC/ML
N018959 001
ZIPRASIDONE HYDROCHLORIDE
CAPSULE; ORAL
GEODON
XX + PFIZER XX XX XX
SUSPENSION; ORAL
GEODON
XX + PFIZER INC
EQ EQ EQ EQ
EQ 10MG BASE/ML
N021483 001
ZIPRASIDONE MESYLATE
INJECTABLE; INTRAMUSCULAR
GEODON
EQ 20MG BASE/ML XX + PFIZER
N020919 001
ZOLEDRONIC ACID
INJECTABLE; IV (INFUSION)
RECLAST
XX + NOVARTIS EQ 5MG BASE/100ML ZOMETA XX + NOVARTIS EQ 4MG BASE/5ML XX + EQ 4MG BASE/100ML
SPRAY; NASAL
ZOMIG
XX + ASTRAZENECA TABLET; ORAL ZOMIG IPR XX XX +
5MG/SPRAY
N021450 004
2.5MG 5MG
ZOLPIDEM TARTRATE
5MG/SPRAY
N022196 001
5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 5MG 10MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG
N019908 001 N019908 002 A077884 A077884 A078413 A078413 A077359 A077359 A077990 A077990 A077985 A077985 A078129 A078129 A078184 A078184 A077322 A077322 A076578 A078016 A076578 A078016 A078055 A078055 A077214 A077214 A076410 A076410 A077903 A077903 A078616 A078616 A077773 A077773 A078426 A078426 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 001 002 002 001 002 001 002 001 002 001 002 001 002 001 002 001 002
Dec 16, 1992 Dec 16, 1992 Apr Apr May May Apr Apr Apr Apr Apr Apr Apr Apr Sep Sep Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Apr Aug Aug Nov Nov Apr Apr May May 23, 23, 04, 04, 23, 23, 23, 23, 23, 23, 30, 30, 07, 07, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 23, 17, 17, 21, 21, 23, 23, 15, 15, 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2008 2008 2007 2007 2007 2007
5MG
N021997 001
10MG 1.75MG 3.5MG ORAL 6.25MG 12.5MG 6.25MG 6.25MG 12.5MG 6.25MG 12.5MG 6.25MG 12.5MG 12.5MG
AB AB AB AB AB AB AB AB AB AB
N021774 002 N021774 001 A078179 A078148 A078148 A090107 A090107 A078483 A078483 002 002 001 001 002 001 002
Sep 02, 2005 Sep 02, 2005 Oct Apr Dec Jul Jul Apr Jun 13, 14, 03, 01, 01, 12, 06, 2010 2011 2010 2011 2011 2011 2011
A078179 001
ZONISAMIDE
CAPSULE; ORAL ZONEGRAN EISAI INC AB AB AB + ZONISAMIDE ALPHAPHARM AB AB AB APOTEX INC AB AB AB BANNER PHARMACAPS AB AB AB BARR AB AB AB COREPHARMA AB AB AB DR REDDYS LABS LTD AB AB AB GLENMARK GENERICS AB AB AB INVAGEN PHARMS AB AB AB MYLAN AB AB AB SANDOZ AB AB AB SUN PHARM INDS (IN) AB
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG
N020789 003 N020789 002 N020789 001 A077647 A077647 A077647 A077642 A077642 A077642 A077813 A077813 A077813 A077639 A077639 A077639 A077876 A077876 A077876 A077645 A077645 A077645 A077651 A077651 A077651 A077869 A077869 A077869 A077637 A077637 A077637 A077644 A077644 A077644 A077634 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 002 003 001 001 002 003 001 002 003 001 002 003 001 002 003 001
Aug 22, 2003 Aug 22, 2003 Mar 27, 2000 Dec Dec Dec Dec Dec Dec Aug Aug Aug Dec Dec Dec Feb Feb Feb Sep Sep Dec Jan Jan Jan May May May Dec Dec Dec Dec Dec Dec Mar 22, 22, 22, 22, 22, 22, 16, 16, 16, 22, 22, 22, 21, 21, 21, 29, 29, 22, 30, 30, 30, 31, 31, 31, 22, 22, 22, 22, 22, 22, 17, 2005 2005 2005 2005 2005 2005 2006 2006 2006 2005 2005 2005 2007 2007 2007 2006 2006 2005 2006 2006 2006 2006 2006 2006 2005 2005 2005 2005 2005 2005 2006
4 - 1 (of 19)
120MG 325MG 325MG 650MG 650MG 120MG 325MG 650MG 120MG 650MG 80MG 120MG ORAL 650MG 650MG 650MG 650MG 650MG
N018060 A072344 N018060 A072237 N018060 N018337 N018337 N018337 A070607 A070608 N018337 N016401
001 001 003 001 002 003 002 001 001 001 004 001
ACETAMINOPHEN ACTAVIS MID ATLANTIC + PERRIGO NEW YORK INFANTS' FEVERALL ACTAVIS MID ATLANTIC NEOPAP POLYMEDICA TABLET, EXTENDED RELEASE; ACETAMINOPHEN OHM LABS PERRIGO RANBAXY LABS LTD TYLENOL (CAPLET) + MCNEIL CONS TYLENOL (GELTAB) + MCNEIL CONS
Mar 19, 2002 Feb 25, 2000 Dec 14, 2011 Jun 08, 1994 Jan 11, 2001
A075794 N020802
001 001
N021082
001
N019453
001
61%;1%
N021074
001
2%;2%;10% 2%;3%;10%
N021502 N021501
001 001
4 - 2 (of 19)
3%;7.5%;3%
N020045
001
BENTOQUATAM
LOTION; TOPICAL
IVY BLOCK
+ STAND HOMEOPATH
5%
N020532
001
BUTENAFINE HYDROCHLORIDE
CREAM; TOPICAL
LOTRIMIN ULTRA
+ SCHERING PLOUGH
1%
N021307
001
BUTOCONAZOLE NITRATE
CREAM; VAGINAL
FEMSTAT 3
+ BAYER
2%
N020421
001
A077355 N020958
001 001
CETIRIZINE HYDROCHLORIDE
CAPSULE; ORAL CETIRIZINE HYDROCHLORIDE ALLERGY BANNER PHARMACAPS 5MG + 10MG CETIRIZINE HYDROCHLORIDE HIVES RELIEF BANNER PHARMACAPS 5MG + 10MG SYRUP; ORAL CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY AMNEAL PHARMS 5MG/5ML APOTEX 5MG/5ML AUROBINDO PHARMA 5MG/5ML CYPRESS PHARM 5MG/5ML DR REDDYS LABS LTD 5MG/5ML PERRIGO R AND D 5MG/5ML RANBAXY 5MG/5ML SILARX 5MG/5ML SUN PHARM INDS INC 5MG/5ML TARO 5MG/5ML 5MG/5ML CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF AMNEAL PHARMS 5MG/5ML APOTEX 5MG/5ML AUROBINDO PHARMA 5MG/5ML CYPRESS PHARM 5MG/5ML DR REDDYS LABS LTD 5MG/5ML PERRIGO R AND D 5MG/5ML RANBAXY 5MG/5ML
Jul 23, 2009 Jul 23, 2009 Jul 23, 2009 Jul 23, 2009
A090765 A090188 A090750 A090300 A090474 A090254 A090183 A091130 A091327 A090182 A201546 A090765 A090188 A090750 A090300 A090474 A090254 A090183
002 002 002 001 002 002 002 001 001 002 001 001 001 001 002 001 001 001
Oct Apr Feb Oct Mar Apr Apr Apr Oct Apr May Oct Apr Feb Oct Mar Apr Apr
07, 22, 02, 10, 30, 09, 24, 22, 17, 22, 20, 07, 22, 02, 10, 30, 09, 24,
2009 2008 2010 2008 2009 2008 2008 2011 2011 2008 2011 2009 2008 2010 2008 2009 2008 2008
4 - 3 (of 19)
A077631 A077631 A078692 A078692 A077631 A077631 A090142 A090142 A090142 A090142 N021621 N021621 N021621 N021621
004 003 001 002 001 002 001 002 003 004 003 004 005 006
Jan 11, 2008 Jan 11, 2008 Aug 30, 2011 Aug 30, 2011 Aug 30, 2011 Aug 30, 2011 Nov 16, 2007 Nov 16, 2007 Nov 16, 2007 Nov 16, 2007
N022578
001
A078615 A078615 A078780 A078780 A078317 A078317 A078933 A078933 A077499 A077499 A076047 A076047 A078343 A078343 A076677 A076677 A078862 A078862 A078336 A078336 A077498 A077498 A077946 A077946 A078072 A078072 A079191 A079191
003 004 001 004 001 002 001 002 001 002 001 002 004 003 001 002 001 002 001 002 001 002 001 002 001 003 001 004
Dec Dec Jan Jan Dec Dec Jun Jun Dec Dec Dec Dec Jan Jan Dec Dec Feb Feb Dec Dec Dec Dec Dec Dec Jul Jul Apr Apr
28, 28, 21, 21, 27, 27, 15, 15, 27, 27, 27, 27, 15, 15, 27, 27, 19, 19, 27, 27, 27, 27, 27, 27, 22, 22, 15, 15,
2007 2007 2010 2010 2007 2007 2010 2010 2007 2007 2007 2007 2008 2008 2007 2007 2009 2009 2007 2007 2007 2007 2007 2007 2009 2009 2010 2010
4 - 4 (of 19)
A078680 A078680 A077829 A077829 A078427 A078427 A078933 A078933 A077499 A077499 A078343 A078343 A076677 A076677 A078862 A078862 A078336 A078336 A077498 A077498 A078680 A078680 A077829 A077829 A078780 A078780 A078072 A078072 A079191 A079191 N019835 N019835 N019835 N019835
003 004 001 004 003 004 003 004 003 004 001 002 004 003 003 004 003 004 003 004 001 002 003 002 003 002 002 004 003 002 003 004 005 006
Jun Jun Aug Aug Dec Dec Jun Jun Dec Dec Jan Jan Dec Dec Feb Feb Dec Dec Dec Dec Jun Jun Aug Aug Jan Jan Jul Jul Apr Apr
26, 26, 26, 26, 28, 28, 15, 15, 27, 27, 15, 15, 27, 27, 19, 19, 27, 27, 27, 27, 26, 26, 26, 26, 21, 21, 22, 22, 15, 15,
2009 2009 2009 2009 2007 2007 2010 2010 2007 2007 2008 2008 2007 2007 2009 2009 2007 2007 2007 2007 2009 2009 2009 2009 2010 2010 2009 2009 2010 2010
Nov 16, 2007 Nov 16, 2007 Nov 16, 2007 Nov 16, 2007
CHLORHEXIDINE GLUCONATE
AEROSOL, METERED; TOPICAL
EXIDINE
+ XTTRIUM CLOTH; TOPICAL
CHLORHEXIDINE GLUCONATE
+ SAGE PRODS SOLUTION; TOPICAL BRIAN CARE SOAPCO CHG SCRUB ECOLAB CIDA-STAT ECOLAB
4%
N019127
001
2%
N021669
001
4% 4% 2%
4 - 5 (of 19)
0.75% 2% 4% 4% 0.5%
4% 4% 4%
Jul 14, 2000 Aug 20, 2003 Nov 21, 2006 Apr 26, 2002 May 03, 2005 Apr 03, 2006 Oct 10, 2006
Oct 07, 2002 May 10, 2005 Jun 10, 2009 Jun 03, 2005 Jun 03, 2005 Jun 03, 2005
CHLORPHENIRAMINE MALEATE
TABLET, EXTENDED RELEASE; ORAL CHLORPHENIRAMINE MALEATE AVANTHI INC 12MG CHLOR-TRIMETON + SCHERING PLOUGH 12MG
A040829 N007638
001 002
TABLET; ORAL
ADVIL ALLERGY AND CONGESTION RELIEF
+ PFIZER CONS HLTHCARE 4MG;200MG;10MG
N022113
001
SUSPENSION; ORAL
CHILDREN'S ADVIL ALLERGY SINUS
+ WYETH CONS 1MG/5ML;100MG/5ML;15MG/5ML
TABLET; ORAL
ADVIL ALLERGY SINUS
+ WYETH CONS 2MG;200MG;30MG
N021587
001
N021441
001
4 - 6 (of 19)
N018397
001
CIMETIDINE
TABLET; ORAL CIMETIDINE APOTEX CONTRACT PHARMACAL IVAX SUB TEVA PHARMS PERRIGO WATSON LABS TAGAMET HB + GLAXOSMITHKLINE
CLEMASTINE FUMARATE
TABLET; ORAL CLEMASTINE FUMARATE PERRIGO SANDOZ TAVIST-1 + NOVARTIS
CLOTRIMAZOLE
CREAM, TABLET; TOPICAL, VAGINAL
GYNE-LOTRIMIN 3 COMBINATION PACK
+ SCHERING PLOUGH 1%,200MG GYNE-LOTRIMIN COMBINATION PACK + SCHERING PLOUGH 1%,100MG MYCELEX-7 COMBINATION PACK BAYER PHARMS 1%,100MG CREAM; VAGINAL CLOTRIMAZOLE ACTAVIS MID ATLANTIC 1% TARO 1% GYNE-LOTRIMIN + SCHERING PLOUGH 1% GYNE-LOTRIMIN 3 + SCHERING PLOUGH 2% MYCELEX-7 BAYER PHARMS 1% TRIVAGIZOLE 3 TARO 2% TABLET; VAGINAL
GYNE-LOTRIMIN
+ SCHERING PLOUGH 100MG GYNE-LOTRIMIN 3 + SCHERING PLOUGH 200MG MYCELEX-7 BAYER PHARMS 100MG
Jul 16, 1993 Dec 04, 1995 Nov 30, 1990 Nov 24, 1998 Dec 26, 1991 Apr 12, 2000
CROMOLYN SODIUM
SPRAY, METERED; NASAL
CROMOLYN SODIUM
+ BAUSCH AND LOMB HH AND P PERRIGO
4 - 7 (of 19)
N013483 N013483
004 003
N021620 N021620
002 001
DEXTROMETHORPHAN POLISTIREX
SUSPENSION, EXTENDED RELEASE; ORAL
DELSYM
+ RECKITT BENCKISER EQ 30MG HBR/5ML
N018658
001
25MG;EQ 200MG FREE ACID AND POTASSIUM SALT IBUPROFEN AND DIPHENHYDRAMINE BANNER PHARMACAPS 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT
N021393
001
A090397
001
DOCOSANOL
CREAM; TOPICAL
ABREVA
+ GLAXOSMITHKLINE
10%
N020941
001
DOXYLAMINE SUCCINATE
TABLET; ORAL DOXYLAMINE SUCCINATE LNK PERRIGO UNISOM + CHATTEM
EPINEPHRINE
AEROSOL, METERED; INHALATION EPINEPHRINE ARMSTRONG PHARMS 0.2MG/INH
A087907
001
FAMOTIDINE
TABLET, CHEWABLE; ORAL FAMOTIDINE PERRIGO PEPCID AC + MERCK SHARP DOHME TABLET; ORAL FAMOTIDINE DR REDDYS LABS LTD IVAX SUB TEVA PHARMS
10MG 20MG
A075715 N020801
001 002
4 - 8 (of 19)
10MG 10MG 20MG 10MG 20MG 10MG 10MG 10MG 10MG 20MG 10MG 20MG 10MG
A075674 A075400 A077351 A090283 A090283 A076101 A075312 A075404 A077146 A090837 N020325 N020325 N020902
001 001 001 001 002 001 001 001 001 001 001 002 001
Dec Mar Sep Nov Nov Oct May Nov Mar Aug
21, 18, 25, 17, 17, 21, 31, 28, 07, 04,
2001 2005 2006 2009 2009 2002 2001 2001 2005 2010
FEXOFENADINE HYDROCHLORIDE
SUSPENSION; ORAL
CHILDREN'S ALLEGRA ALLERGY
+ SANOFI AVENTIS US 30MG/5ML CHILDREN'S ALLEGRA HIVES + SANOFI AVENTIS US 30MG/5ML TABLET, ORALLY DISINTEGRATING; ORAL
CHILDREN'S ALLEGRA ALLERGY
+ SANOFI AVENTIS US 30MG CHILDREN'S ALLEGRA HIVES + SANOFI AVENTIS US 30MG TABLET; ORAL ALLEGRA ALLERGY SANOFI AVENTIS US 60MG + 180MG ALLEGRA HIVES SANOFI AVENTIS US 60MG + 180MG CHILDREN'S ALLEGRA ALLERGY SANOFI AVENTIS US 30MG CHILDREN'S ALLEGRA HIVES SANOFI AVENTIS US 30MG CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY DR REDDYS LABS LTD 30MG MYLAN 30MG TEVA 30MG CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES DR REDDYS LABS LTD 30MG MYLAN 30MG TEVA 30MG FEXOFENADINE HYDROCHLORIDE ALLERGY DR REDDYS LABS LTD 60MG 180MG MYLAN 60MG 180MG TEVA 60MG 180MG FEXOFENADINE HYDROCHLORIDE HIVES DR REDDYS LABS LTD 60MG 180MG MYLAN 60MG 180MG TEVA 60MG 180MG
N201373 N201373
001 002
N021909 N021909
002 003
N020872 N020872 N020872 N020872 N020872 N020872 A076502 A077081 A076447 A076502 A077081 A076447 A076502 A076502 A077081 A077081 A076447 A076447 A076502 A076502 A077081 A077081 A076447 A076447
007 010 008 009 005 006 004 004 004 005 005 005 006 008 006 008 006 008 007 009 007 009 007 009
Jan 24, 2011 Jan 24, 2011 Jan 24, 2011 Jan 24, 2011 Jan 24, 2011 Jan 24, 2011 Apr 12, 2011 Jul 21, 2011 Apr 13, 2011 Apr 12, 2011 Jul 21, 2011 Apr 13, 2011 Apr Apr Jul Jul Apr Apr Apr Apr Jul Jul Apr Apr 12, 12, 21, 21, 13, 13, 12, 12, 21, 21, 13, 13, 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011 2011
4 - 9 (of 19)
GUAIFENESIN
TABLET, EXTENDED RELEASE; GUAIFENESIN PERRIGO R AND D MUCINEX RECKITT BENCKISER + ORAL 600MG 600MG 1.2GM A078912 N021282 N021282 001 001 002 Nov 23, 2011 Jul 12, 2002 Dec 18, 2002
N021585 N021585
001 002
IBUPROFEN
CAPSULE; ORAL
ADVIL LIQUI-GELS
+ WYETH CONS EQ 200MG FREE ADVIL MIGRAINE LIQUI-GELS + WYETH CONS EQ 200MG FREE IBUPROFEN AMNEAL PHARMS EQ 200MG FREE BANNER PHARMACAPS EQ 200MG FREE + CONTRACT PHARMACAL 200MG DR REDDYS LABS LTD EQ 200MG FREE MARKSANS PHARMA EQ 200MG FREE MIDOL LIQUID GELS + BANNER PHARMACAPS 200MG
SUSPENSION/DROPS; ORAL
CHILDREN'S MOTRIN
+ MCNEIL CONS 40MG/ML IBUPROFEN PERRIGO 40MG/ML TRIS PHARMA INC 40MG/ML PEDIATRIC ADVIL + WYETH CONS 100MG/2.5ML SUSPENSION; ORAL CHILDREN'S ADVIL WYETH CONS 100MG/5ML CHILDREN'S ADVIL-FLAVORED WYETH CONS 100MG/5ML CHILDREN'S ELIXSURE ALTERNA TCHP LLC 100MG/5ML CHILDREN'S IBUPROFEN PERRIGO 100MG/5ML CHILDREN'S MOTRIN + MCNEIL 100MG/5ML IBUPROFEN ACTAVIS MID ATLANTIC 100MG/5ML AMNEAL PHARMS 100MG/5ML TABLET, CHEWABLE; ORAL CHILDREN'S ADVIL WYETH CONS 50MG CHILDREN'S MOTRIN MCNEIL CONS 50MG
ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT ACID AND POTASSIUM SALT
Apr 20, 1995 Mar 16, 2000 Dec Mar Jul Jul Jun 23, 24, 06, 10, 26, 2011 2009 1998 2009 2009
Jun 10, 1996 Dec 16, 1998 Aug 31, 2009 Jan 30, 1998
Jun 27, 1996 Nov 07, 1997 Jan 07, 2004 Dec 22, 1998 Jun 16, 1995 Apr 30, 1999 Aug 18, 2011
N020944 N020601
001 001
4 - 10 (of 19)
Jan 16, 2004 Jan 16, 2004 Dec 18, 1998 Nov 15, 1996
200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 100MG 200MG 100MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG
N018989 A071333 A072199 A076460 A071732 A071735 A072299 A073691 A074931 A075661 A076117 A079174 A076741 A075010 A075139 A091237 A091239 A073019 A070985 A071163 A070481 A072096 A075995 A077349 A079129 A091355 A071229 A071639 A070435 A071214 A071057 N020267 A075367 N020602 N019012 N019012 A071265 A072095
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 003 004 001 001
May 18, 1984 Feb May Nov Sep Sep Jul Feb Jul Dec Nov Dec Jun Mar Mar Feb Feb Mar Oct Jul Sep Dec Mar Jun Mar Apr Apr Feb Mar 17, 23, 26, 10, 10, 01, 25, 20, 12, 20, 10, 17, 01, 01, 08, 01, 30, 02, 15, 24, 08, 14, 21, 28, 04, 01, 02, 05, 1987 1988 2003 1987 1987 1988 1994 1998 2001 2001 2010 2004 1999 1999 2011 2011 1994 1987 1986 1986 1987 2002 2005 2011 2011 1987 1988 1986
MARKSANS PHARMA MCNEIL MERRO PHARM OHM PAR PHARM PERRIGO PERRIGO R AND D SVADS HOLDINGS SA VINTAGE PHARMS
WATSON LABS IBUPROHM OHM LABS 200MG IBU-TAB 200 ALRA 200MG JUNIOR STRENGTH ADVIL WYETH CONS 100MG JUNIOR STRENGTH IBUPROFEN PERRIGO 100MG JUNIOR STRENGTH MOTRIN MCNEIL CONS 100MG MOTRIN IB + MCNEIL 200MG MOTRIN MIGRAINE PAIN + MCNEIL 200MG PROFEN CONTRACT PHARMACAL 200MG TAB-PROFEN PERRIGO 200MG
Dec 01, 1986 Aug 11, 1988 Dec 13, 1996 Apr 22, 1999 Jun 10, 1996 Dec 17, 1990 Feb 25, 2000 Oct 15, 1986 Dec 08, 1987
TABLET; ORAL
ADVIL CONGESTION RELIEF
+ WYETH CONS 200MG;10MG
N022565
001
4 - 11 (of 19)
N021374
001
SUSPENSION; ORAL CHILDREN'S ADVIL COLD WYETH CONS 100MG/5ML;15MG/5ML CHILDREN'S MOTRIN COLD + MCNEIL CONS 100MG/5ML;15MG/5ML IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE PERRIGO 100MG/5ML;15MG/5ML TABLET; ORAL
ADVIL COLD AND SINUS
+ WYETH CONS 200MG;30MG IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE CONTRACT PHARMACAL 200MG;30MG DR REDDYS LABS LTD 200MG;30MG IBUPROHM COLD AND SINUS OHM LABS 200MG;30MG SINE-AID IB MCNEIL CONS 200MG;30MG
Sep 19, 1989 Apr 08, 2002 Aug 14, 2006 Apr 17, 2001 Dec 31, 1992
INJECTABLE; INJECTION
HUMULIN R
+ LILLY HUMULIN R PEN + LILLY NOVOLIN R + NOVO NORDISK INC
INJECTABLE; INJECTION
HUMULIN 70/30
+ LILLY HUMULIN 70/30 PEN + LILLY NOVOLIN 70/30 + NOVO NORDISK INC
INJECTABLE; INJECTION
HUMULIN N
+ LILLY NOVOLIN N + NOVO NORDISK INC
N018781 N019959
001 001
SPONGE; TOPICAL
DURAPREP
+ 3M +
N021586 N021586
001 002
KETOCONAZOLE
SHAMPOO; TOPICAL
NIZORAL A-D
+ MCNEIL CONS
1%
N020310
001
KETOPROFEN
FILM; ORAL
NEXCEDE
+ NOVARTIS
12.5MG
N022470
001
4 - 12 (of 19)
0.025% BASE 0.025% BASE 0.025% BASE 0.025% BASE 0.025% BASE
Dec 01, 2006 Jul 26, 2007 Sep 02, 2008 May 09, 2006 Oct 19, 2006
LANSOPRAZOLE
CAPSULE, DELAYED REL PELLETS; ORAL
PREVACID 24 HR
+ NOVARTIS 15MG
N022327
001
LEVONORGESTREL
TABLET; ORAL LEVONORGESTREL PERRIGO R AND D + WATSON LABS PLAN B + TEVA WOMENS PLAN B ONE-STEP + DURAMED
Dec 30, 2010 Aug 28, 2009 Aug 24, 2006 Jul 10, 2009
LOPERAMIDE HYDROCHLORIDE
CAPSULE; ORAL LOPERAMIDE HYDROCHLORIDE BANNER PHARMACAPS 1MG + 2MG
SOLUTION; ORAL
IMODIUM A-D
+ MCNEIL CONS 1MG/5ML LOPERAMIDE HYDROCHLORIDE HI TECH PHARMA 1MG/5ML PERRIGO 1MG/5ML ROXANE 1MG/5ML WOCKHARDT 1MG/5ML
SUSPENSION; ORAL
IMODIUM A-D
+ MCNEIL CONS 1MG/7.5ML LOPERAMIDE HYDROCHLORIDE PERRIGO R AND D 1MG/7.5ML
TABLET, CHEWABLE; ORAL
IMODIUM A-D EZ CHEWS
+ MCNEIL 2MG
TABLET; ORAL
IMODIUM A-D
+ MCNEIL CONS 2MG LOPERAMIDE HYDROCHLORIDE CONTRACT PHARMACAL 2MG LNK 2MG OHM LABS 2MG PERRIGO 2MG
N021855 N021855
001 002
Mar 01, 1988 Nov Jan Apr Aug 17, 21, 30, 28, 1995 1992 1992 1997
N019487 A091292
002 001
N020448
001
Nov 22, 1989 Jul Jun Dec Jan 30, 10, 10, 06, 1993 2003 1992 2000
N020606 A076029
001 001
4 - 13 (of 19)
N021140 A077500
001 001
LORATADINE
CAPSULE; ORAL
CLARITIN
+ SCHERING PLOUGH 10MG SUSPENSION; ORAL
LORATADINE
+ TARO 1MG/ML SYRUP; ORAL
CLARITIN
+ SCHERING PLOUGH 1MG/ML LORATADINE APOTEX INC 1MG/ML PERRIGO 1MG/ML RANBAXY 1MG/ML SILARX 1MG/ML TARO 1MG/ML TEVA 1MG/ML WOCKHARDT 1MG/ML TABLET, CHEWABLE; ORAL
CHILDREN'S CLARITIN
+ SCHERING PLOUGH 5MG TABLET, ORALLY DISINTEGRATING; ORAL ALAVERT WYETH CONS 10MG CLARITIN HIVES RELIEF REDITAB + SCHERING PLOUGH 10MG CLARITIN REDITABS + SCHERING PLOUGH 5MG + 10MG LORATADINE IMPAX LABS 10MG WATSON LABS FLORIDA 10MG WYETH CONS 10MG LORATADINE REDIDOSE RANBAXY 10MG TABLET; ORAL CLARITIN + SCHERING PLOUGH 10MG CLARITIN HIVES RELIEF + SCHERING PLOUGH 10MG LORATADINE APOTEX INC 10MG MYLAN 10MG 10MG 10MG PERRIGO 10MG RANBAXY 10MG SANDOZ 10MG
N021952
001
N021734
001
Nov 27, 2002 Oct Aug Aug Jun Aug Nov Aug 05, 20, 20, 29, 20, 07, 20, 2004 2004 2004 2006 2004 2003 2004
N021891
001
Dec 19, 2002 Nov 19, 2003 Dec 12, 2006 Nov 27, 2002 Sep 29, 2003 Nov 03, 2003 Feb 10, 2003 Apr 11, 2007
Nov 27, 2002 Nov 19, 2003 Feb Nov Aug Aug Jun Aug Jan 14, 07, 20, 12, 25, 18, 21, 2006 2008 2003 2011 2004 2003 2003
Nov 27, 2002 Nov 27, 2002 Jan 30, 2003 Mar 04, 2004
4 - 14 (of 19)
3%;10%
N022029
001
MICONAZOLE NITRATE
CREAM, SUPPOSITORY; TOPICAL, VAGINAL MICONAZOLE 7 COMBINATION PACK G AND W LABS 2%,100MG MICONAZOLE NITRATE PERRIGO R AND D 2%,1.2GM MICONAZOLE NITRATE COMBINATION PACK PERRIGO 2%,200MG MONISTAT 1 COMBINATION PACK + INSIGHT PHARMS 2%,1.2GM MONISTAT 7 COMBINATION PACK + INSIGHT PHARMS 2%,100MG MONISTAT-3 COMBINATION PACK + INSIGHT PHARMS 2%,200MG M-ZOLE 3 COMBINATION PACK ACTAVIS MID ATLANTIC 2%,200MG CREAM; TOPICAL, VAGINAL MICONAZOLE 3 COMBINATION PACK PERRIGO 2%,4% MONISTAT 3 COMBINATION PACK INSIGHT PHARMS 2%,4% MONISTAT 3 COMBINATION PACK (PREFILLED) + INSIGHT PHARMS 2%,4% CREAM; VAGINAL MICONAZOLE 3 TARO 4% MICONAZOLE 7 ACTAVIS MID ATLANTIC 2% MICONAZOLE NITRATE G AND W LABS 2% PERRIGO 2% PERRIGO R AND D 4% TARO 2% MONISTAT 3 + INSIGHT PHARMS 4% MONISTAT 7 + INSIGHT PHARMS 2% SUPPOSITORY; VAGINAL MICONAZOLE NITRATE ACTAVIS MID ATLANTIC 100MG G AND W LABS 100MG + PERRIGO 100MG MONISTAT 7 + INSIGHT PHARMS 100MG
Mar 26, 2004 Jun 02, 2010 Apr 20, 1999 Jun 29, 2001 Apr 26, 1993 Apr 16, 1996 Apr 16, 1999
Mar 02, 2005 Mar 29, 1996 Feb May Jan Jan 22, 15, 15, 13, 1996 1997 2010 1997
Nov 19, 1993 Apr 30, 1997 Mar 20, 1997 Feb 15, 1991
MINOXIDIL
AEROSOL, FOAM; TOPICAL
MEN'S ROGAINE
+ JOHNSON AND JOHNSON MINOXIDIL PERRIGO ISRAEL
5% 5%
N021812 A091344
001 001
4 - 15 (of 19)
A074588 A074731 A074924 A075357 A074767 A074731 A074924 A075357 A075518 A075619 A075839 A075598 A075737 A075438 N019501 N019501 N020834 A078176 A076239
001 001 001 001 001 002 002 002 001 001 001 001 001 001 002 003 001 001 001
May 11, 2005 Apr 29, 1998 Jul 30, 1999 Nov Nov Oct Jun Mar Feb 17, 17, 01, 13, 15, 27, 2000 2000 2001 2001 2002 2003
Feb 09, 1996 Feb 09, 1996 Nov 14, 1997 Nov 09, 2007 Aug 24, 2004
Sep 27, 2010 Jun 08, 1994 Jun 08, 1994 Jan 31, 1996
NAPROXEN SODIUM
CAPSULE; ORAL
NAPROXEN SODIUM
+ BANNER PHARMACAPS
TABLET; ORAL
ALEVE
+ BAYER NAPROXEN SODIUM AMNEAL PHARMS NY CONTRACT PHARMACAL DR REDDYS LABS INC GRANULES INDIA MARKSANS PHARMA PERRIGO RANBAXY LABS LTD SANDOZ
EQ 200MG BASE
N021920
001
EQ 200MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG BASE BASE BASE BASE BASE BASE BASE BASE BASE
N020204 A079096 A074635 A074789 A075168 A091353 A090545 A074661 A091183 A074646
002 001 001 001 001 001 001 001 001 001
Jan 11, 1994 Dec Jan Feb Jul Sep Mar Jan May Jan 16, 13, 27, 28, 20, 16, 13, 20, 13, 2008 1997 1997 1998 2011 2011 1997 2011 1997
N021076 A077381
001 001
4 - 16 (of 19)
A076518
001
NICOTINE
FILM, EXTENDED RELEASE; TRANSDERMAL
HABITROL
+ NOVARTIS 7MG/24HR + 14MG/24HR + 21MG/24HR NICODERM CQ + SANOFI AVENTIS US 7MG/24HR + 14MG/24HR + 21MG/24HR NICOTINE AVEVA 7MG/24HR 14MG/24HR 21MG/24HR
Nov 12, 1999 Nov 12, 1999 Nov 12, 1999 Aug 02, 1996 Aug 02, 1996 Aug 02, 1996 Oct 20, 1997 Oct 20, 1997 Oct 20, 1997
NICOTINE POLACRILEX
EQ EQ EQ EQ
N018612 N018612 N020066 N020066 N018612 N020066 A076880 A077850 A076775 A076776 A076777 A076778 A076779 A076789 A078325 A078547 A078967 A091349 A078326 A078546 A078968 A091354 A074507 A076569 A078699 A079044 A079216 A074707 A076568 A078697 A079038 A079219 A077658 A077656
002 004 002 004 003 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001
EQ 2MG BASE EQ 4MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 2MG 4MG 2MG 2MG 2MG 4MG 4MG 4MG 2MG 2MG 2MG 2MG 4MG 4MG 4MG 4MG 2MG 2MG 2MG 2MG 2MG 4MG 4MG 4MG 4MG 4MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
Dec 23, 1998 Dec 23, 1998 Feb Feb Sep Sep Sep Sep Sep Sep Oct May Apr Jul Oct May Apr Jul Mar Jul Dec Jul Jul Mar Jul Dec Jul Jul 18, 18, 16, 16, 16, 16, 16, 16, 30, 24, 23, 20, 30, 24, 23, 20, 15, 29, 29, 08, 08, 19, 29, 29, 08, 08, 2009 2009 2004 2004 2004 2004 2004 2004 2006 2007 2008 2011 2006 2007 2008 2011 1999 2004 2008 2009 2009 1999 2004 2008 2009 2009
PERRIGO R AND D
WATSON LABS
N021330 N021330
001 002
4 - 17 (of 19)
EQ 2MG BASE EQ 4MG BASE EQ EQ EQ EQ EQ EQ 2MG 2MG 2MG 4MG 4MG 4MG BASE BASE BASE BASE BASE BASE
May 18, 2009 May 18, 2009 Jan Jul Jul Jan Jul Jul 31, 10, 10, 31, 10, 10, 2006 2009 2009 2006 2009 2009
NIZATIDINE
TABLET; ORAL
AXID AR
+ WYETH CONS
75MG
N020555
001
NONOXYNOL-9
SPONGE; VAGINAL
TODAY
+ AZTIQ PHARMA
1GM
N018683
001
OMEPRAZOLE
TABLET, DELAYED RELEASE; ORAL
OMEPRAZOLE
+ DEXCEL PHARMA 20MG
N022032
001
OMEPRAZOLE MAGNESIUM
CAPSULE, DELAYED RELEASE; ORAL
OMEPRAZOLE MAGNESIUM
+ DR REDDYS LABS LTD EQ 20MG BASE TABLET, DELAYED RELEASE; ORAL
PRILOSEC OTC
+ ASTRAZENECA EQ 20MG BASE
A078878
001
N021229
001
20MG;1.1GM
N022281
001
ORLISTAT
CAPSULE; ORAL
ALLI
+ GLAXOSMITHKLINE CONS
60MG
N021887
001
OXYMETAZOLINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC OCUCLEAR SCHERING PLOUGH 0.025% VISINE L.R. + JOHNSON AND JOHNSON 0.025%
N018471 N019407
001 001
PERMETHRIN
LOTION; TOPICAL
NIX
+ INSIGHT PHARMS PERMETHRIN ACTAVIS MID ATLANTIC PERRIGO NEW YORK
1% 1% 1%
4 - 18 (of 19)
N021043
001
17GM/PACKET 17GM/SCOOPFUL
A090600 A090600 N022015 A078915 A078915 A090812 A091077 A090567 A090685 A090685
001 002 001 001 002 001 001 001 001 002
Oct 06, 2009 Oct 06, 2009 Oct 06, 2006 Oct Oct Oct Oct Oct Oct Oct 06, 06, 07, 06, 15, 06, 06, 2009 2009 2009 2009 2009 2009 2009
MIRALAX + SCHERING PLOUGH 17GM/SCOOPFUL POLYETHYLENE GLYCOL 3350 MYLAN 17GM/PACKET 17GM/SCOOPFUL NEXGEN PHARMA 17GM/SCOOPFUL NOVEL LABS INC 17GM/SCOOPFUL PADDOCK LLC 17GM/SCOOPFUL PERRIGO R AND D 17GM/PACKET 17GM/SCOOPFUL
POTASSIUM IODIDE
SOLUTION; ORAL
THYROSHIELD
+ FLEMING TABLET; ORAL IOSAT ANBEX + THYROSAFE + RECIP
65MG/ML
A077218
001
POVIDONE-IODINE
SOLUTION; TOPICAL
POVIDONE IODINE
+ ALLEGIANCE HLTHCARE SPONGE; TOPICAL
E-Z SCRUB 201
+ BECTON DICKINSON E-Z SCRUB 241 + BECTON DICKINSON
1%
N019522
001
20% 10%
N019240 N019476
001 001
PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL PSEUDOEPHEDRINE HYDROCHLORIDE PERRIGO 120MG RANBAXY 120MG SUDAFED 12 HOUR + MCNEIL CONS 120MG SUDAFED 24 HOUR + MCNEIL CONS 240MG
Feb 26, 1999 Sep 28, 2005 Oct 31, 1991 Dec 15, 1992
PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
AFRINOL
+ SCHERING PLOUGH 120MG
N018191
001
PURIFIED WATER
SOLUTION; OPHTHALMIC
PUR-WASH
+ NIAGARA PHARMS
98.3%
N022305
001
4 - 19 (of 19)
75MG BASE 75MG BASE 150MG BASE 75MG BASE 75MG BASE 75MG BASE 150MG BASE 150MG BASE 150MG BASE 75MG BASE 75MG BASE 75MG BASE 75MG BASE 150MG BASE 150MG BASE 150MG BASE 75MG BASE
A075094 A075294 A078192 A075296 A075497 A076195 A091429 A091429 A200536 A075167 A075212 A076760 A078884 A078653 N021698 N021698 N020520
001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 002 001
Jun Mar Aug Jan Jan Aug May May Jun May Jan Feb Jul Nov
21, 28, 31, 14, 14, 30, 11, 11, 28, 04, 14, 24, 31, 26,
1999 2000 2007 2000 2000 2002 2011 2011 2011 2000 2000 2006 2008 2007
SODIUM CHLORIDE
AEROSOL, METERED; INHALATION
BRONCHO SALINE
+ BLAIREX 0.9%
N019912
001
0.24%;0.3%
N020231
001
TERBINAFINE
GEL; TOPICAL
LAMISIL AT
+ NOVARTIS
1%
N021958
001
TERBINAFINE HYDROCHLORIDE
CREAM; TOPICAL
LAMISIL
+ NOVARTIS 1% TERBINAFINE HYDROCHLORIDE TARO 1% SOLUTION; TOPICAL
LAMISIL AT
+ NOVARTIS 1% SPRAY; TOPICAL
LAMISIL AT
+ NOVARTIS 1%
N020980 A077511
001 001
N021124
001
N021124
002
TIOCONAZOLE
OINTMENT; VAGINAL TIOCONAZOLE PERRIGO VAGISTAT-1 + NOVARTIS
6.5% 6.5%
A075915 N020676
001 001
5 - 1 of 5
N760305
N000127
N780519 N820528
N940404
N800077
N900223
5 - 2 of 5
Dec 06, 1977 Jun 28, 1983 May 16, 1973 Aug 23, 1982 Jun 22, 1970 Jun 10, 1981
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP WITH: AS-1: DEXTROSE USP; SODIUM CHLORIDE USP; MANNITOL USP; ADENINE
INJECTABLE; INJECTION ADSOL RED BLOOD CELL PRESERVATIVE SOLUTION FENWAL INC
N811104
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION USP WITH: AS-5: DEXTROSE USP; SODIUM CHLORIDE USP; MANNITOL USP; ADENINE
INJECTABLE; INJECTION OPTISOL RED BLOOD CELL PRESERVATIVE SOLUTION TERUMO MEDICAL CORP
N880217
INJECTABLE; INJECTION AS-3 NUTRICEL ADDITIVE SYSTEM MEDSEP CORP 0.042GM/100ML;0.276GM/100ML; 0.410GM/100ML;0.30GM/100ML; 1.10GM/100ML;0.588GM/100ML
N820915
INJECTABLE; INJECTION AS-2 NUTRICEL ADDITIVE SYSTEM MEDSEP CORP 0.042GM/100ML;0.285GM/100ML; 0.718GM/100ML;0.017GM/100ML; 0.396GM/100ML;0.588GM/100ML
N820915
N090480
N770822
5 - 3 of 5
N980123
N010409
N830715
Feb 22, 1985 Oct 30, 1992 Apr Jul Jan Sep Nov 06, 25, 18, 23, 14, 1970 1967 1967 1969 1972
Feb 22, 1985 Oct 30, 1992 Apr Jul Jan Sep Nov 06, 25, 18, 23, 14, 1970 1967 1967 1969 1972
DEXTRAN 40, 10% W/V DEXTRAN 40 IN 0.8% NACL 500 ML PVC BAGS
INJECTABLE; INJECTION RHEOMACRODEX MEDA AB
N830527
5 - 4 of 5
N830627
6GM/100ML;5GM/100ML
N060826
Jan 26, 1970 Jun 08, 1954 Aug 18, 1969 Mar 13, 1953
N830613
N830629
6GM/100ML;0.9GM/100ML 6GM/100ML;0.9GM/100ML
N080564 N160759
6GM/100ML
N200952
ANDA
ANDA ANDA
6GM/100ML;0.9 GM/100ML
A720746
ANDA
5 - 5 of 5
6GM/100ML;0.9GM/100ML
N070012
NDA
PERFLUORODECALIN; PERFLUOROTRI-N-PROPYLAMINE
INJECTABLE; INJECTION FLUOSOL ALPHA THERAPEUTIC CORP
17.5GM/100ML;7.5GM/100ML
N860909
N950522
SODIUM CHLORIDE; SODIUM ACETATE; SODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, DIABASIC ANHYDROUS; SODIUM PHOSPHATE MONOBASIC, MONOHYDRATE
INJECTABLE; INJECTION INTERSOL SOLUTION FENWAL INC.
N080041
NDA
6 - 1 (of 346)
N021320
001
ACETAMINOPHEN
INJECTABLE; INJECTION INJECTAPAP ORTHO MCNEIL PHARM SUPPOSITORY; RECTAL ACEPHEN G AND W LABS ACETAMINOPHEN ABLE
100MG/ML
N017785
001
Mar 27, 1992 Feb Feb Feb May May 27, 27, 27, 12, 12, 1995 1995 1995 1987 1987
A090205
001
ACETAMINOPHEN; BUTALBITAL
CAPSULE; ORAL BANCAP FOREST PHARMS 325MG;50MG BUCET MALLINCKRODT 650MG;50MG TENCON MALLINCKRODT 650MG;50MG TRIAPRIN DUNHALL 325MG;50MG TABLET; ORAL BUTALBITAL AND ACETAMINOPHEN HALSEY 325MG;50MG WATSON LABS 325MG;50MG SEDAPAP MAYRAND 650MG;50MG
Jan 16, 1986 Jun 28, 1985 May 15, 1990 Jul 02, 1987
Oct 01, 1986 Jul 18, 1985 Mar 27, 1985 Apr 19, 1985
6 - 2 (of 346)
Mar 27, 1985 Dec 05, 1984 Jun 19, 1985 Jan 14, 1986 Jun 19, 1985
A076528
001
A088584 A089166
001 001
A040637
001
6 - 3 (of 346)
A085883
001
A040452 A040459 A089478 A089481 A089479 A089482 A089480 A089483 A040223 A088353 A040223 A088354 A040223 A088355 A085217 A083871 A083872 A086549 A085288 A085365 A085364 A085363 A087141 A089244 A085795 A089671 A085794 A089672 A087653 A089673 A087762 A086681 A089080 A086683 A084659 A084656 A084667 A089511 A089512 A089513 A087433 A081250 A085291 A085917 A081249 A085964 A087423 A089183 A089184 A089253 A089185 A089254 A087919 A087920 A085896 A085676 A085992
001 001 001 001 001 001 001 001 001 001 002 001 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Aug Aug Mar Mar Mar Mar Mar Mar Nov Feb Nov Feb Nov Feb
01, 01, 03, 03, 03, 03, 03, 03, 18, 06, 18, 06, 18, 06,
2002 2002 1987 1987 1987 1987 1987 1987 1997 1984 1997 1984 1997 1984
Feb 25, 1986 Feb 10, 1988 Feb Apr Feb Dec 10, 13, 10, 10, 1988 1982 1988 1982
Apr 25, 1989 Apr 25, 1989 Apr 25, 1989 Jul 16, 1992
6 - 4 (of 346)
A085218 A087306 A087277 A089997 A087276 A089998 A087275 A089999 A040443 A040443 A040443 A084360 A085607 A083643 A040447 A040441 A040488 A083951 A083951 A088037 A088715 A085856 A085056 A085056 A085056 A085056 A085055 A085055
002 001 001 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 002 001 001 001 001 002 003 004 001 002
A088898 A089907 A087961 A089360 A088956 A089006 A081068 A081069 A081070 A087336
001 001 001 001 001 001 001 001 001 001
Mar 27, 1985 Jan 13, 1989 Mar 17, 1983 Mar 02, 1988 Jul Aug Nov Nov Nov 19, 09, 30, 30, 30, 1985 1985 1989 1989 1989
A040508
001
6 - 5 (of 346)
A081226 A089557
001 001
A087809 A040478 A040464 A040464 A040477 A040490 A040473 A040474 A040476 A040469 A040307 A040308 A088577 A040307 A040309 A040307 A040307 A040308 A040281 A040280 A040280 A040280 A040281 A089554 A089696 A089271 A089697 A040236 A040240 A040240 A040236 A040825 A040824 A040826 A040822 A040149 A040149 A040210 A040134 A089290 A089291 A089831 A040248 A040248 A040123 A040122 A040123 A040123 A040123 A040122 A040493 A040494 A087677
001 001 001 002 001 001 001 001 001 001 001 001 001 002 001 003 004 002 001 001 002 003 002 001 001 001 001 001 002 001 002 001 001 001 001 001 002 001 001 001 001 001 001 002 003 001 004 001 002 002 001 001 001
Mar 17, 1983 Nov Oct Oct Nov May Nov Jan Oct Oct Jul Jul Dec Jul Jul Jul Jul Jul Sep Sep Sep Sep Sep Jun Apr Jul Jan Sep Nov Nov Sep Aug Aug Aug Aug Jan Jan Aug Nov May May Sep Apr Apr Mar Mar Mar Mar Mar Mar May May 08, 23, 23, 06, 21, 06, 02, 23, 25, 26, 26, 21, 26, 26, 26, 26, 26, 30, 30, 30, 30, 30, 12, 21, 16, 28, 25, 26, 26, 25, 16, 16, 16, 16, 27, 27, 13, 21, 29, 29, 07, 28, 28, 04, 04, 04, 04, 04, 04, 28, 28, 2002 2002 2002 2002 2003 2002 2003 2002 2002 2000 2000 1984 2000 2000 2000 2000 2000 1998 1998 1998 1998 1998 1987 1988 1986 1992 1997 1997 1997 1997 2007 2007 2007 2007 1997 1997 1997 1996 1987 1987 1988 2000 2000 1996 1996 1996 1996 1996 1996 2003 2003
6 - 6 (of 346)
A040680
001
001 001 001 001 001 002 Mar 15, 1999 Jun 30, 1998
500MG;4.5MG;0.38MG
A085375
001
N018458
001
500MG;100MG
A076429
001
6 - 7 (of 346)
N017122 N017122 A070107 A075838 A070910 A076743 A076750 A072105 A072106 A070146 A075738 A077821 A070115 A070116 A070615 A070771 A070775 A072195 A070145 A070443 A071319 A070732 A074119 A074843 A074843 A070398 A070399 A077196 A076609 A077677 A077677
002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 002 Jun 12, 1985 Jul Jan May Jun May May Aug Feb Feb Jun Jun Mar Mar Mar Feb Jun Jan Jan Jan Dec Feb Feb Dec Dec Jun Nov Mar Mar 11, 02, 07, 28, 13, 13, 02, 02, 11, 12, 12, 21, 21, 21, 16, 12, 23, 06, 03, 19, 15, 12, 18, 18, 28, 16, 16, 16, 2001 1987 2004 2004 1988 1988 1985 2001 2008 1985 1985 1986 1986 1986 1988 1985 1986 1987 1986 1994 2001 1997 1986 1986 2005 2004 2007 2007
ACETAZOLAMIDE
TABLET; ORAL ACETAZOLAMIDE ALRA ASCOT MUTUAL PHARM VANGARD WATSON LABS DIAMOX DURAMED PHARMS BARR
ACETAZOLAMIDE SODIUM
INJECTABLE; INJECTION ACETAZOLAMIDE SODIUM HOSPIRA
EQ 500MG BASE/VIAL
A040108
001
2% 2% 2%
6 - 8 (of 346)
2%;0.79% 2%;0.79%
A088606 A084476
001 001
2%;0.05%
N017914
001
001 001 001 001 Oct 31, 1994 Aug 30, 1996
N050238
001
ACETOHEXAMIDE
TABLET; ORAL ACETOHEXAMIDE BARR USL PHARMA DYMELOR LILLY
ACETOPHENAZINE MALEATE
TABLET; ORAL TINDAL SCHERING
20MG
N012254
002
ACETRIZOATE SODIUM
SOLUTION; INTRAUTERINE SALPIX ORTHO MCNEIL PHARM
53%
N009008
001
ACETYLCHOLINE CHLORIDE
FOR SOLUTION; OPHTHALMIC MIOCHOL NOVARTIS
20MG/VIAL
N016211
001
ACETYLCYSTEINE
SOLUTION; INHALATION, ORAL ACETYLCYSTEINE HOSPIRA 10% 20% ROXANE 10% 20% MUCOMYST APOTHECON 10% 20%
6 - 9 (of 346)
A070575 A070576
001 001
N017366
001
ACETYLDIGITOXIN
TABLET; ORAL ACYLANID NOVARTIS
0.1MG
N009436
001
ACRISORCIN
CREAM; TOPICAL AKRINOL SCHERING
2MG/GM
N012470
001
ACYCLOVIR
CAPSULE; ORAL ACYCLOVIR ACTAVIS ELIZABETH BELCHER PHARMS DAVA PHARMS INC IVAX SUB TEVA PHARMS LEK PHARM ROXANE TEVA TEVA PHARMS TABLET; ORAL ACYCLOVIR ACTAVIS ELIZABETH BELCHER PHARMS DAVA PHARMS INC IVAX SUB TEVA PHARMS LEK PHARM TEVA TEVA PHARMS
400MG 800MG 400MG 800MG 400MG 800MG 400MG 800MG 400MG 800MG 200MG 400MG 800MG
A074870 A074870 A074891 A074891 A074834 A074834 A074836 A074836 A074658 A074658 A074556 A075021 A075021
001 002 001 002 001 002 001 002 001 002 001 001 002
Jun Jun Oct Oct Apr Apr Apr Apr Apr Apr Apr Mar Mar
05, 05, 31, 31, 24, 24, 22, 22, 22, 22, 22, 18, 18,
1997 1997 1997 1997 1997 1997 1997 1997 1997 1997 1997 1998 1998
ACYCLOVIR SODIUM
INJECTABLE; INJECTION ACYCLOVIR ABBOTT ACYCLOVIR SODIUM APOTHECON HOSPIRA
EQ 50MG BASE/ML EQ EQ EQ EQ EQ EQ EQ EQ EQ 500MG BASE/VIAL 1GM BASE/VIAL 25MG BASE/ML 50MG BASE/ML 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 50MG BASE/ML
A075114 A074897 A074897 A074720 A075065 A074663 A074758 A074663 A074758 A075627
001 001 002 001 001 001 001 002 002 001
Jul 26, 1999 Feb Feb Apr Feb Apr Apr Apr Apr Mar 27, 27, 22, 25, 22, 22, 22, 22, 28, 1998 1998 1997 1999 1997 1997 1997 1997 2001
TEVA PARENTERAL
6 - 10 (of 346)
EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
Aug 26, 1997 Aug 26, 1997 Aug 30, 1983 Oct 22, 1982 Jun 29, 1989
ADAPALENE
SOLUTION; TOPICAL DIFFERIN GALDERMA LABS LP
0.1%
N020338
001
ADENOSINE
INJECTABLE; INJECTION ADENOSINE BAXTER HLTHCARE
3MG/ML
A076501
001
ALATROFLOXACIN MESYLATE
INJECTABLE; INJECTION TROVAN PRESERVATIVE FREE PFIZER EQ 200MG BASE/VIAL EQ 300MG BASE/VIAL
N020760 N020760
001 002
ALBUTEROL
AEROSOL, METERED; INHALATION ALBUTEROL ARMSTRONG PHARMS 0.09MG/INH GENPHARM 0.09MG/INH IVAX SUB TEVA PHARMS 0.09MG/INH PLIVA 0.09MG/INH PROVENTIL SCHERING 0.09MG/INH VENTOLIN GLAXOSMITHKLINE 0.09MG/INH
6 - 11 (of 346)
EQ 0.2MG BASE
N019489
001
EQ EQ EQ EQ EQ
0.083% BASE 0.083% BASE 0.083% BASE 0.5% BASE 0.083% BASE
Jan 14, 1987 Jan 14, 1987 Apr 23, 1992 Jan 16, 1987
EQ 2MG BASE/5ML EQ 2MG BASE/5ML EQ 2MG BASE/5ML EQ 2MG BASE/5ML EQ 2MG BASE/5ML
Mar 30, 1999 Sep 30, 1994 Apr 29, 1993 Jan 19, 1983 Jun 10, 1987
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
2MG 4MG 2MG 4MG 2MG 4MG 2MG 4MG 2MG 4MG 2MG 2MG 2MG 4MG 4MG 4MG 2MG 4MG 2MG 4MG 2MG 4MG 4MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A072449 A072450 A072966 A072967 A072859 A072860 A072316 A072317 A072151 A072152 A072619 A072779 A072938 A072620 A072780 A072939 A073120 A073121 A072817 A072818 A072629 A072630 A072765 N017853 N017853 N019112 N019112
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 002
Dec Dec Nov Nov Dec Dec Dec Dec Dec Dec Dec Jun Mar Dec Jun Mar Sep Sep Jan Jan Jan Jan Aug
05, 05, 22, 22, 20, 20, 05, 05, 05, 05, 05, 25, 30, 05, 25, 30, 29, 29, 09, 09, 31, 31, 28,
1989 1989 1991 1991 1989 1989 1989 1989 1989 1989 1989 1993 1990 1989 1993 1990 1992 1992 1990 1990 1991 1991 1991
May 07, 1982 May 07, 1982 Jul 10, 1986 Jul 10, 1986
EQ 2MG BASE EQ 4MG BASE TABLET, EXTENDED RELEASE; ORAL PROVENTIL SCHERING EQ 4MG BASE VOLMAX MURO EQ 4MG BASE EQ 8MG BASE
6 - 12 (of 346)
A083483
001
ALCOHOL; DEXTROSE
INJECTABLE; INJECTION ALCOHOL 5% IN D5-W HOSPIRA 5ML/100ML;5GM/100ML ALCOHOL 5% IN DEXTROSE 5% IN WATER BAXTER HLTHCARE 5ML/100ML;5GM/100ML
A083263 A083256
001 001
ALENDRONATE SODIUM
TABLET; ORAL ALENDRONATE SODIUM SANDOZ
TEVA PHARMS
EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 35MG BASE 40MG BASE 70MG BASE 35MG BASE 70MG BASE
ALGLUCERASE
INJECTABLE; INJECTION CEREDASE GENZYME
10 UNITS/ML
N020057
004
ALKAVERVIR
TABLET; ORAL VERILOID 3M
2MG 3MG
N007336 N007336
002 003
ALLOPURINOL
TABLET; ORAL ALLOPURINOL MUTUAL PHARM PURACAP PHARM PUREPAC PHARM SANDOZ SUPERPHARM WATSON LABS
100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 300MG 100MG 100MG 300MG 300MG 100MG 300MG
A070466 A070467 A070150 A070147 A070579 A070580 A070268 A070269 A070950 A070951 N018241 N018785 N018241 N018785 N018297 N018297
001 001 001 001 001 001 001 001 001 001 001 001 002 002 001 002
Dec Dec Dec Dec Apr Apr Dec Dec Nov Nov Nov Sep Nov Sep
24, 24, 10, 10, 14, 14, 31, 31, 30, 30, 16, 28, 16, 28,
1985 1985 1985 1985 1986 1986 1985 1985 1988 1988 1984 1984 1984 1984
LOPURIN ABBOTT
ALPRAZOLAM
SOLUTION; ORAL ALPRAZOLAM ROXANE TABLET; ORAL ALPRAZOLAM IVAX SUB TEVA PHARMS
0.5MG/5ML
A074314
001
0.25MG 0.5MG
A074294 A074294
001 002
6 - 13 (of 346)
TEVA
WATSON LABS
1MG 2MG 0.25MG 0.5MG 1MG 0.25MG 0.5MG 1MG 2MG 0.25MG 0.25MG 0.5MG 0.5MG 1MG 1MG
A074294 A074294 A074199 A074199 A074199 A074085 A074085 A074085 A074085 A074456 A074479 A074456 A074479 A074456 A074479
003 004 001 002 003 001 002 003 004 001 001 002 002 003 003
Jul Jul Oct Oct Oct Feb Feb Feb Feb Aug Jan Aug Jan Aug Jan
29, 29, 19, 19, 19, 16, 16, 16, 26, 31, 21, 31, 21, 31, 21,
1994 1994 1993 1993 1993 1994 1994 1994 1996 1995 1997 1995 1997 1995 1997
ALPROSTADIL
INJECTABLE; INJECTION CAVERJECT PFIZER
Oct 31, 1997 Oct 01, 1997 Oct 01, 1997 Jun 12, 1997
ALSEROXYLON
TABLET; ORAL RAUTENSIN NOVARTIS RAUWILOID 3M
2MG 2MG
N009215 N008867
001 001
A089449 A072687
001 001
AMANTADINE HYDROCHLORIDE
CAPSULE; ORAL AMANTADINE HYDROCHLORIDE ACTAVIS TOTOWA 100MG WATSON LABS 100MG SYMADINE SOLVAY 100MG SYMMETREL ENDO PHARMS 100MG SYRUP; ORAL AMANTADINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 50MG/5ML TEVA PHARMS 50MG/5ML SYMMETREL ENDO PHARMS 50MG/5ML TABLET; ORAL SYMMETREL ENDO PHARMS 100MG
N018101
001
6 - 14 (of 346)
0.025% 0.1%
N018116 N018116
001 002
0.1%
N019729
001
0.1%
N018498
001
AMDINOCILLIN
INJECTABLE; INJECTION COACTIN ROCHE
AMIFOSTINE
INJECTABLE; INJECTION ETHYOL MEDIMMUNE
375MG/VIAL
N020221
002
AMIKACIN SULFATE
INJECTABLE; INJECTION AMIKACIN SULFATE ABBOTT
EQ 250MG BASE/ML EQ 250MG BASE/ML ASTRAZENECA EQ 50MG BASE/ML EQ 250MG BASE/ML BAXTER HLTHCARE EQ 50MG BASE/ML EQ 250MG BASE/ML HOSPIRA EQ 50MG BASE/ML EQ 62.5MG BASE/ML EQ 250MG BASE/ML EQ 250MG BASE/ML EQ 250MG BASE/ML TEVA PARENTERAL EQ 50MG BASE/ML AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA EQ 500MG BASE/100ML AMIKIN APOTHECON EQ 50MG BASE/ML EQ 50MG BASE/ML EQ 50MG BASE/ML EQ 250MG BASE/ML EQ 250MG BASE/ML EQ 250MG BASE/ML AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER APOTHECON EQ 5MG BASE/ML EQ 10MG BASE/ML
A063265 A063266 A063167 A063169 A063274 A063275 A063350 A063283 A063350 A064098 A064099 A064045 A064146 A062311 A062562 N050495 A062311 A062562 N050495 N050618 N050618
001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 002 002 002 002 001
Nov Oct Dec Dec May May Jul Oct Jul Jun Jun Sep
30, 31, 14, 14, 18, 18, 30, 31, 30, 26, 20, 28,
1994 1994 1995 1995 1992 1992 1993 1994 1993 1995 1995 1993
Nov 27, 1991 Apr 17, 1988 Jul 19, 1991 Dec 25, 1990
6 - 15 (of 346)
N018901 N018804 N018875 N019438 N019491 N019438 N019400 N018678 N016822 N016822 N018792 N017957 N017957 N020107 N017957
001 001 001 001 001 002 001 001 001 002 001 003 004 001 002
Apr 06, 1984 May 15, 1984 Aug 08, 1984 Apr 03, 1986 Oct 10, 1986 Apr 03, 1986 Jul 23, 1986 Sep 28, 1984
Jan 17, 1984 Aug 09, 1982 Nov 28, 1986 Feb 05, 1993 Aug 09, 1982
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER ABBOTT 3.5%;36.8MG/100ML;25GM/100ML;51MG/100ML N019714 001 Sep ;22.4MG/100ML;261MG/100ML;205MG/100ML HOSPIRA INC 3.5%;36.8MG/100ML;25GM/100ML;51MG/100ML N019683 001 Nov ;22.4MG/100ML;261MG/100ML;205MG/100ML AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER ABBOTT 4.25%;36.8MG/100ML;20GM/100ML;51MG/100M N019714 002 Sep L;22.4MG/100ML;261MG/100ML;205MG/100ML HOSPIRA INC 4.25%;36.8MG/100ML;20GM/100ML;51MG/100M N019683 002 Nov L;22.4MG/100ML;261MG/100ML;205MG/100ML AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER ABBOTT 4.25%;36.8MG/100ML;25GM/100ML;51MG/100M N019714 004 Sep L;22.4MG/100ML;261MG/100ML;205MG/100ML HOSPIRA INC 4.25%;36.8MG/100ML;25GM/100ML;51MG/100M N019683 003 Nov L;22.4MG/100ML;261MG/100ML;205MG/100ML AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER ABBOTT 5%;36.8MG/100ML;25GM/100ML;51MG/100ML;2 N019714 003 Sep 2.4MG/100ML;261MG/100ML;205MG/100ML HOSPIRA INC 5%;36.8MG/100ML;25GM/100ML;51MG/100ML;2 N019683 004 Nov 2.4MG/100ML;261MG/100ML;205MG/100ML
6 - 16 (of 346)
N019505 N019713 N019681 N019506 N019713 N019681 N019713 N019681 N019713 N019681 N019504 N019713 N019681 N019565 N019713 N019681 N019520 N019520 N019520 N019520 N019520 N019520 N019520 N019520 N019520 N019520
002 006 001 001 002 002 001 004 004 005 002 005 003 001 003 006 002 003 004 005 001 007 008 009 010 006
Nov 07, 1986 Sep 09, 1988 Nov 01, 1988 Nov 07, 1986 Sep 09, 1988 Nov 01, 1988 Sep 09, 1988 Nov 01, 1988 Sep 09, 1988 Nov 01, 1988 Nov 07, 1986 Sep 09, 1988 Nov 01, 1988 Dec 17, 1986 Sep 09, 1988 Nov 01, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988 Sep 23, 1988
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER ABBOTT 4.25%;10GM/100ML;51MG/100ML;176.5MG/100 N019712 002 Sep 08, 1988 ML;22.4MG/100ML;104.5MG/100ML;205MG/100 ML HOSPIRA INC 4.25%;10GM/100ML;51MG/100ML;176.5MG/100 N019682 003 Nov 01, 1988 ML;22.4MG/100ML;104.5MG/100ML;205MG/100 ML
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 3.5%;25GM/100ML;51MG/100ML;22.4MG/100ML N019564 ;261MG/100ML;205MG/100ML AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER ABBOTT 4.25%;25GM/100ML;51MG/100ML;22.4MG/100M N019564 L;261MG/100ML;205MG/100ML
002
004
6 - 17 (of 346)
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER ABBOTT 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 0MG/100ML;49.3MG/100ML 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 0MG/100ML;49.3MG/100ML HOSPIRA INC 3.5%;5GM/100ML;30MG/100ML;97MG/100ML;12 0MG/100ML;49.3MG/100ML AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER ABBOTT 4.25%;10GM/100ML;30MG/100ML;97MG/100ML; 120MG/100ML;49.3MG/100ML HOSPIRA INC 4.25%;5GM/100ML;30MG/100ML;97MG/100ML;1 20MG/100ML;49.3MG/100ML
N019564 N019682
003 002
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;10GM/100ML;51MG/100ML;261MG/100ML N020147 002 Oct ;216MG/100ML;112MG/100ML TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;15GM/100ML;51MG/100ML;261MG/100ML N020147 003 Oct ;216MG/100ML;112MG/100ML TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;20GM/100ML;51MG/100ML;261MG/100ML N020147 004 Oct ;216MG/100ML;112MG/100ML TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;25GM/100ML;51MG/100ML;261MG/100ML N020147 005 Oct ;216MG/100ML;112MG/100ML TRAVASOL 2.75% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 2.75%;5GM/100ML;51MG/100ML;261MG/100ML; N020147 001 Oct 216MG/100ML;112MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;10GM/100ML;51MG/100ML;261MG/100ML N020147 007 Oct ;297MG/100ML;77MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;15GM/100ML;51MG/100ML;261MG/100ML N020147 008 Oct ;297MG/100ML;77MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;20GM/100ML;51MG/100ML;261MG/100ML N020147 009 Oct ;297MG/100ML;77MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;25GM/100ML;51MG/100ML;261MG/100ML N020147 010 Oct ;297MG/100ML;77MG/100ML TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 4.25%;5GM/100ML;51MG/100ML;261MG/100ML; N020147 006 Oct 297MG/100ML;77MG/100ML
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
23, 1995
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
AMINOSYN 3.5% M IN PLASTIC CONTAINER
ABBOTT 3.5%;21MG/100ML;40MG/100ML;128MG/100ML; N018804 234MG/100ML 3.5%;21MG/100ML;40MG/100ML;128MG/100ML; N018875 234MG/100ML
002 002
3.5%;21MG/100ML;128MG/100ML;234MG/100ML N017789
005
6 - 18 (of 346)
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION AMINOSYN II 3.5% M IN PLASTIC CONTAINER ABBOTT 3.5%;32MG/100ML;128MG/100ML;222MG/100ML N019493 ;49MG/100ML
001
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE
INJECTABLE; INJECTION VEINAMINE 8% HOSPIRA INC
001
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION AMINOSYN II 7% W/ ELECTROLYTES HOSPIRA 7%;102MG/100ML;45MG/100ML;522MG/100ML;4 N019437 10MG/100ML
006
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION AMINOSYN II 3.5% M HOSPIRA
007
AMINOCAPROIC ACID
INJECTABLE; INJECTION
AMICAR
XANODYNE PHARM AMINOCAPROIC ACID ABRAXIS PHARM BAXTER HLTHCARE HOSPIRA
002
001 001 001 Jun 17, 1986 Oct 29, 1982 Jun 16, 1988
AMINOGLUTETHIMIDE
TABLET; ORAL
CYTADREN
NOVARTIS
250MG
N018202
001
AMINOPHYLLINE
ENEMA; RECTAL SOMOPHYLLIN FISONS INJECTABLE; INJECTION AMINOPHYLLIN GD SEARLE LLC AMINOPHYLLINE ABRAXIS PHARM
300MG/5ML
N018232
001
25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML 25MG/ML
A087243 A087621 A084568 A087200 A087250 A087886 A088407 A087239 A087601 A087867 A087868 A086606 A087240 A087431 A087387 A088429
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jan 06, 1982 Aug 30, 1983 Jan 25, 1984 Jul 23, 1982 Nov 10, 1983 Nov 10, 1983
ELKINS SINN HOSPIRA INTL MEDICATION KING PHARMS LUITPOLD LYPHOMED PHARMA SERVE NY SMITH AND NEPHEW
6 - 19 (of 346)
25MG/ML 25MG/ML CHLORIDE 0.45% 100MG/100ML 200MG/100ML AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER HOSPIRA 100MG/100ML 200MG/100ML 400MG/100ML 500MG/100ML SOLUTION; ORAL AMINOPHYLLINE MORTON GROVE 105MG/5ML ROXANE 105MG/5ML AMINOPHYLLINE DYE FREE ACTAVIS MID ATLANTIC 105MG/5ML SOMOPHYLLIN FISONS 105MG/5ML SOMOPHYLLIN-DF FISONS 105MG/5ML SUPPOSITORY; RECTAL TRUPHYLLINE G AND W LABS 250MG 500MG TABLET; ORAL AMINOPHYLLIN GD SEARLE LLC 100MG 200MG AMINOPHYLLINE ASCOT 100MG 200MG BARR 100MG 200MG DURAMED PHARMS BARR 100MG 200MG HALSEY 100MG IMPAX LABS 100MG 200MG KV PHARM 100MG 200MG LANNETT 100MG 200MG PAL PAK 100MG PANRAY 100MG 200MG PUREPAC PHARM 100MG 200MG ROXANE 100MG 200MG SANDOZ 100MG 100MG 200MG VALEANT PHARM INTL 200MG VANGARD 100MG 200MG VINTAGE PHARMS 100MG 200MG WATSON LABS 100MG 200MG
May 30, 1985 Sep 25, 1991 May 03, 1983 May 03, 1983 Dec Dec Dec Dec 12, 12, 12, 12, 1984 1984 1984 1984
A085498 A085498
001 002
N002386 N002386 A087522 A087523 A088297 A088298 A088182 A088183 A084674 A084574 A084576 A085284 A085289 A084588 A084588 A084533 A084552 A084552 A084699 A085333 A087500 A087501 A085261 A085262 A085261 A084563 A088314 A088319 A085409 A085410 A085567 A085564
002 003 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 002 001 001 001 001 003 002 002 001 001 001 001 001 001 001 Feb Feb Aug Aug Mar Mar 12, 12, 19, 19, 31, 31, 1982 1982 1983 1983 1983 1983
6 - 20 (of 346)
A086760
001
AMINOSALICYLATE SODIUM
POWDER; ORAL
P.A.S. SODIUM
CENTURY PHARMS 4GM/PACKET
SODIUM AMINOSALICYLATE
HEXCEL 100%
TABLET; ORAL
PARASAL SODIUM
PANRAY 500MG 1GM
SODIUM P.A.S.
LANNETT 500MG
TEEBACIN
CONSOLIDATED MIDLAND 500MG
A080947 A080097
001
001
006
011
002
002
846MG;112MG
A080059
002
AMINOSALICYLIC ACID
TABLET; ORAL PARASAL PANRAY
500MG 1GM
N006811 N006811
001 002
EQ 500MG BASE/GM
N009052
001
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION AMIODARONE HYDROCHLORIDE BEN VENUE 50MG/ML HOSPIRA 50MG/ML INTL MEDICATION SYS 50MG/ML CORDARONE WYETH PHARMS INC 50MG/ML TABLET; ORAL AMIODARONE HYDROCHLORIDE TEVA 200MG
Oct 15, 2002 Oct 15, 2002 Feb 04, 2004 Aug 03, 1995
A074895
001
AMITRIPTYLINE HYDROCHLORIDE
CONCENTRATE; ORAL ENDEP ROCHE 40MG/ML INJECTABLE; INJECTION AMITRIPTYLINE HYDROCHLORIDE WATSON LABS 10MG/ML
A085749
001
A085594
001
6 - 21 (of 346)
10MG/ML
N012704
001
A086454 A086454 A086454 A086454 A086454 A083939 A083937 A083938 A084957 A085093 A086295 A088672 A088673 A088674 A088675 A088421 A088422 A088423 A088424 A088425 A088426 A085923 A085922 A085925 A087557 A085926 A085927 A086744 A087366 A086746 A087367 A086743 A087181 A086745 A087369 A086747 A087368 A087370 A085744 A085627 A085745 A085743 A085742 A089423 A088697 A088698 A088699 A088700 A088701 A088702 A088883 A088884 A088885 A088886 A088887
001 002 003 004 005 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 Nov Nov Nov Nov Apr Apr Apr Apr Apr Apr 20, 20, 20, 20, 30, 30, 30, 30, 30, 30, 1984 1984 1984 1984 1984 1984 1984 1984 1984 1984
10MG 25MG 50MG 75MG 100MG 150MG AMITRIPTYLINE HYDROCHLORIDE AM THERAP 25MG 50MG 75MG 100MG COPLEY PHARM 10MG 25MG 50MG 75MG 100MG 150MG HALSEY 10MG 25MG 50MG 50MG 75MG 100MG LEDERLE 10MG 10MG 25MG 25MG 50MG 50MG 75MG 75MG 100MG 100MG 150MG MUTUAL PHARM 10MG 25MG 50MG 75MG 100MG 150MG PAR PHARM 10MG 25MG 50MG 75MG 100MG 150MG PLIVA 10MG 25MG 50MG 75MG 100MG
Mar 05, 1982 May 20, 1983 May 20, 1983 Jan 04, 1982 May 03, 1982 Jan 04, 1982 Jan 04, 1982 May 03, 1982 Jan 04, 1982
May Feb Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
11, 17, 25, 25, 25, 25, 25, 25, 26, 26, 26, 26, 26,
1982 1987 1984 1984 1984 1984 1984 1984 1984 1984 1984 1984 1984
6 - 22 (of 346)
A088888 A088075 A088084 A088076 A088085 A088077 A088105 A088078 A088106 A088079 A088107 A086002 A086144 A085944 A086145 A085945 A086143 A086004 A086147 A086003 A086146 A086090 A086148 A088853 A088854 A088855 A088856 A088857 A084910 A086610 A085031 A086859 A085032 A086857 A085030 A086860 A085836 A086854 A086853 A085864 A085935 A085936 A086337 A086336 A086335 A087775 A087632 A087616 A087617 A087639 A085816 A088620 A085817 A088621 A085815 A088622 A085819 A088633 A085820 A088634
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Sep Jul May Jul Sep Jul Sep Jul Sep Jul
26, 16, 18, 20, 18, 16, 18, 16, 18, 16, 18,
1984 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983
Mar 02, 1984 Mar 02, 1984 Mar 02, 1984 Mar 02, 1984 Mar 02, 1984
6 - 23 (of 346)
A085821 A088635 A087647 A087278 N012703 N012703 N012703 N012703 N012703 N012703 A083639 A083639 A083639 A083639 A083639 A085303
001 001 001 001 001 003 004 005 006 007 001 002 003 004 005 001
N014713 N014713 N014713 N014713 A070935 A070937 A070936 A070938 A070939 A071077 A071078 A070297 A071079 A070565 A070620 A070621 A070595 A070574 A071062 A071862 A071063 A071064
007 004 002 006 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Sep Sep Sep Sep Sep Nov Nov Nov Nov Sep Sep Sep Sep Sep Nov Dec Nov Nov 11, 11, 11, 11, 12, 12, 12, 12, 12, 11, 11, 11, 11, 11, 27, 21, 27, 27, 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1987 1987 1987 1987
6 - 24 (of 346)
A071863 A070373 A072539 A073007 A070375 A072540 A073009 A070374 A072541 A073008 A070376 A072134 A073010 A070377 A071558 A072135 N014715 N014715 N014715 N014715 N014715
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 004 002 003 005 006
Dec Aug Feb Oct Aug Feb Oct Aug Feb Oct Aug Feb Oct Nov Mar Feb
21, 25, 15, 17, 25, 15, 17, 25, 15, 17, 25, 15, 17, 04, 02, 15,
1987 1986 1989 1991 1986 1989 1991 1986 1989 1991 1986 1989 1991 1986 1987 1989
AMLEXANOX
PATCH; TOPICAL AMLEXANOX ULURU
2MG
N021727
001
AMLODIPINE BESYLATE
TABLET; ORAL AMLODIPINE BESYLATE GEDEON RICHTER USA
EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE GENPHARM EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE MUTUAL PHARMA EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE SYNTHON PHARMS EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE TABLET, ORALLY DISINTEGRATING; ORAL AMLODIPINE BESYLATE SYNTHON PHARMS EQ 2.5MG BASE EQ 5MG BASE EQ 10MG BASE
A077333 A077333 A077333 A077362 A077362 A077362 A078081 A078081 A078081 A077080 A077080 A077080
001 002 003 001 002 003 001 002 003 001 002 003
Jul Jul Jul Jul Jul Jul Jan Jan Jan Jun Jun Jun
17, 17, 17, 09, 09, 09, 31, 31, 31, 27, 27, 27,
2007 2007 2007 2007 2007 2007 2008 2008 2008 2007 2007 2007
AMLODIPINE MALEATE
TABLET; ORAL AMVAZ DR REDDYS LABS INC
6 - 25 (of 346)
AMODIAQUINE HYDROCHLORIDE
TABLET; ORAL CAMOQUIN HYDROCHLORIDE PARKE DAVIS
EQ 200MG BASE
N006441
001
AMOXAPINE
TABLET; ORAL AMOXAPINE SANDOZ
WATSON LABS
25MG 50MG 100MG 150MG 25MG 50MG 100MG 150MG 25MG 50MG 100MG 150MG
A072943 A072944 A072878 A072879 A072418 A072419 A072420 A072421 N018021 N018021 N018021 N018021
001 001 001 001 001 001 001 001 001 002 003 004
ASENDIN LEDERLE
AMOXICILLIN
CAPSULE; ORAL AMOXICILLIN LABS ATRAL MYLAN TEVA
250MG 500MG 250MG 500MG 250MG 250MG 500MG 500MG 250MG 500MG 250MG 250MG 250MG 250MG 500MG 500MG 500MG 500MG 250MG 500MG 250MG 500MG
A062528 A062528 A062067 A062067 A062853 A063030 A062854 A063031 N050459 N050459 A061885 A062098 A062152 A063099 A061885 A062098 A062152 A063099 A062107 A062107 A062120 A062120
001 002 001 002 001 001 001 001 001 002 001 001 001 001 002 002 002 002 001 002 001 002
6 - 26 (of 346)
125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 50MG/ML 125MG/5ML 250MG/5ML 50MG/ML 125MG/5ML 125MG/5ML 250MG/5ML 250MG/5ML 50MG/ML 125MG/5ML 125MG/5ML 125MG/5ML 125MG/5ML 250MG/5ML 250MG/5ML 250MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML 125MG/5ML 250MG/5ML
A062059 A062059 A062090 A062090 A062946 A063001 N050460 N050460 N050460 N050460 A061851 A062323 A061851 A062323 A061886 A061886 A062099 A062154 A062885 A061886 A062099 A062154 A062885 A062127 A062127 A062131 A062131
001
002
001
002
001 001 005
001
002
006
001
001
002
002
001 002 001 001 001 003 002 002 002
001
002
001
002
LAROTID
GLAXOSMITHKLINE POLYMOX
APOTHECON
TRIMOX APOTHECON
UTIMOX
PARKE DAVIS
WYMOX
WYETH AYERST
TABLET, CHEWABLE; ORAL
AMOXICILLIN
APOTHECON
125MG 250MG TEVA 125MG 250MG TABLET, FOR SUSPENSION; ORAL DISPERMOX RANBAXY LABS LTD 200MG 400MG
A065080 A065080
002 001
001
002
003
004
TABLET; ORAL
DELCOBESE
TEVA
004
003
002
001
6 - 27 (of 346)
007 012 013 008 010 009 011 001 002 003 004 005 006 007 001 002 003 004 005 006 007 001 002 003 004
Feb 13, 1996 Aug 31, 2000 Aug 31, 2000 Feb 13, 1996 May 12, 1997 May 12, 1997 Aug 31, 2000 Oct Oct Oct Oct Oct Oct Oct Sep Sep Sep Sep Sep Sep Sep May May May May 07, 07, 07, 07, 07, 07, 07, 09, 09, 09, 09, 09, 09, 09, 06, 06, 06, 06, 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
007
003
009
AMPHETAMINE SULFATE
TABLET; ORAL AMPHETAMINE SULFATE LANNETT
5MG 10MG
A083901 A083901
001 002
AMPHOTERICIN B
CREAM; TOPICAL FUNGIZONE APOTHECON INJECTABLE; INJECTION AMPHOTERICIN B ABBOTT ABRAXIS PHARM TEVA PARENTERAL FUNGIZONE APOTHECON
3%
N050314
001
6 - 28 (of 346)
3%
A060570
001
3%
N050313
001
100MG/ML
N050341
003
AMPICILLIN SODIUM
INJECTABLE; INJECTION AMPICILLIN SODIUM APOTHECON
BAXTER HLTHCARE
CONSOLIDATED PHARM
HANFORD GC
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL 125MG BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL
A062860 A062860 A062860 A062860 A062860 A062692 A062692 A062692 A062692 A062692 A062692 A061936 A061936 A061936 A061936 A061936 A063143 A063147 A063139 A063141 A062634 A062634 A062565 A062565 A062565 A062816 A062816 A062816 A062816 A062816 A062994 A060626 A062718 A060626 A062718 A060626 A062718 A060626 A062718 A060626 A062718 N050072 N050072 N050072 N050072 N050072 N050072
001 002 003 004 005 001 002 003 004 005 006 005 001 002 003 004 001 001 001 001 002 003 001 002 003 001 002 003 004 005 001 001 001 002 002 003 003 004 004 005 005 001 002 003 004 005 006
Feb Feb Feb Feb Feb Jun Jun Jun Jun Jun Jun
05, 05, 05, 05, 05, 24, 24, 24, 24, 24, 24,
1988 1988 1988 1988 1988 1986 1986 1986 1986 1986 1986
Apr Apr Apr Apr Jan Jan Apr Apr Jun Oct Oct Oct Oct Oct Sep
15, 15, 15, 15, 09, 09, 04, 04, 24, 24, 24, 24, 24, 24, 15,
1993 1993 1993 1993 1987 1987 1985 1985 1986 1988 1988 1988 1988 1988 1988
Dec 16, 1986 Dec 16, 1986 Dec 16, 1986 Dec 16, 1986 Dec 16, 1986
6 - 29 (of 346)
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
N050309 N050309 N050309 N050309 N050309 A060677 A060677 A060677 A060677 A062727 A060677 A062727 A060677
001 002 003 004 005 001 002 003 004 001 005 002 006
TOTACILLIN-N GLAXOSMITHKLINE
N050608
003
AMPICILLIN/AMPICILLIN TRIHYDRATE
CAPSULE; ORAL AMCILL PARKE DAVIS AMPICILLIN TRIHYDRATE AM ANTIBIOTICS IVAX SUB TEVA PHARMS LEDERLE MYLAN PUREPAC PHARM TEVA VITARINE OMNIPEN (AMPICILLIN) WYETH AYERST PENBRITIN WYETH AYERST PFIZERPEN-A PFIZER POLYCILLIN BRISTOL PRINCIPEN APOTHECON BRISTOL MYERS SQUIBB PRINCIPEN '250' APOTHECON
EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A062041 A062041 A061602 A061602 A060765 A060765 A062208 A062208 A061755 A061755 A061853 A061853 A061502 A061502 A061387 A061387 A060624 A060624 A060908 A060908 A062050 A062050 N050310 N050310 A062888 A062888 A061392 A061392 A062157 N050056
001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 003 001 002 001 002 001 002 001 002 001 002 001 002 002 001 Mar 04, 1988 Mar 04, 1988
250MG 500MG EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ 250MG 500MG 250MG 500MG BASE BASE BASE BASE
6 - 30 (of 346)
EQ 500MG BASE EQ 500MG BASE EQ EQ EQ EQ 250MG 250MG 500MG 500MG BASE BASE BASE BASE
FOR SUSPENSION; ORAL AMCILL PARKE DAVIS AMPICILLIN TRIHYDRATE AM ANTIBIOTICS MYLAN PUREPAC PHARM TEVA OMNIPEN (AMPICILLIN) WYETH AYERST
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ EQ EQ EQ EQ EQ EQ EQ 125MG 250MG 125MG 250MG 125MG 250MG 125MG 250MG BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062030 A062030 A061601 A061601 A061829 A061829 A061980 A061980 A061370 A061370 A060625 A060625 A060625 A060625 N050019 N050019 N050019 A062049 A062049 A062297 A062297 N050308 N050308 N050308 N050308 A061394 A061394 A061394 A060127 A062151 A060127 A062151 A060666 A062223 A060666 A062223
001 002 001 002 002 001 001 002 001 002 001 002 003 004 001 002 003 001 002 001 002 004 001 002 003 001 002 003 002 001 001 002 001 001 002 002
100MG/ML 125MG/5ML 250MG/5ML 500MG/5ML EQ 100MG BASE/ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ EQ EQ EQ EQ EQ 125MG 250MG 100MG 125MG 250MG 500MG BASE/5ML BASE/5ML BASE/ML BASE/5ML BASE/5ML BASE/5ML
PRINCIPEN APOTHECON
EQ 100MG BASE/ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 250MG BASE/5ML EQ EQ EQ EQ 125MG 125MG 250MG 250MG BASE/5ML BASE/5ML BASE/5ML BASE/5ML
EQ 125MG BASE
N050093
001
6 - 31 (of 346)
A062150 N050488
001 001
AMPRENAVIR
CAPSULE; ORAL AGENERASE GLAXOSMITHKLINE SOLUTION; ORAL AGENERASE GLAXOSMITHKLINE
50MG 150MG
N021007 N021007
001 002
15MG/ML
N021039
001
ANAGRELIDE HYDROCHLORIDE
CAPSULE; ORAL AGRYLIN SHIRE EQ 1MG BASE ANAGRELIDE HYDROCHLORIDE ROXANE EQ 0.5MG BASE EQ 1MG BASE
ANASTROZOLE
TABLET; ORAL ANASTROZOLE SYNTHON PHARMS
1MG
A078322
001
ANILERIDINE HYDROCHLORIDE
TABLET; ORAL LERITINE MERCK
EQ 25MG BASE
N010585
002
ANILERIDINE PHOSPHATE
INJECTABLE; INJECTION LERITINE MERCK
25MG/ML
N010520
003
ANISINDIONE
TABLET; ORAL MIRADON SCHERING
50MG
N010909
003
ANISOTROPINE METHYLBROMIDE
TABLET; ORAL ANISOTROPINE METHYLBROMIDE WATSON LABS 50MG VALPIN 50 ENDO PHARMS 50MG
A086046 N013428
001 001
N018746
002
6 - 32 (of 346)
20MG/2ML (10MG/ML)
N021264
001
ARBUTAMINE HYDROCHLORIDE
INJECTABLE; INJECTION GENESA GENSIA AUTOMEDICS
0.05MG/ML
N020420
001
ARDEPARIN SODIUM
INJECTABLE; INJECTION NORMIFLO PHARMACIA AND UPJOHN
N020227 N020227
002 001
ARGATROBAN
SOLUTION; IV (INFUSION) ARGATROBAN IN DEXTROSE SANDOZ
125MG/125ML (1MG/ML)
N201743
001
ARIPIPRAZOLE
TABLET, ORALLY DISINTEGRATING; ORAL ABILIFY OTSUKA 20MG 30MG
N021729 N021729
004 005
ARMODAFINIL
TABLET; ORAL NUVIGIL CEPHALON
100MG 200MG
N021875 N021875
002 005
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN E
INJECTABLE; INJECTION BEROCCA PN ROCHE
003
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
INJECTABLE; INJECTION M.V.C. 9+3 ABRAXIS PHARM
10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N018440 0 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ ML;0.3MG/ML;330 UNITS/ML;1 IU/ML 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N008809 0 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ ML;0.3MG/ML;330 UNITS/ML;1 IU/ML 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;2 N018439 0 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ ML;0.3MG/ML;330 UNITS/ML;1 IU/ML
002
M.V.I.-12 HOSPIRA
004
002
6 - 33 (of 346)
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
INJECTABLE; INJECTION
M.V.I.-12
HOSPIRA
005
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE; VITAMIN A; VITAMIN E
INJECTABLE; INJECTION
M.V.I.-12 LYOPHILIZED
ASTRAZENECA
002
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN E
INJECTABLE; INJECTION
VITAPED
HOSPIRA
N/A,80MG/VIAL;N/A,0.02MG/VIAL;N/A,0.001 N020176 MG/VIAL;400 IU/10ML,N/A;N/A,0.14MG/VIAL;N/A,17MG/VI AL;N/A,5MG/VIAL;0.2MG/10ML,N/A;N/A,1MG/ VIAL;N/A,1.4MG/VIAL;N/A,1.2MG/VIAL;EQ 2,300 UNITS BASE/10ML,N/A;7 IU/10ML,N/A
001
ASPIRIN
TABLET; ORAL BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN BAYER 500MG TABLET, EXTENDED RELEASE; ORAL 8-HOUR BAYER BAYER 650MG MEASURIN BAYER 650MG
N021317
001
N016030 N016030
001 002
ASPIRIN; BUTALBITAL
TABLET; ORAL AXOTAL SAVAGE LABS
650MG;50MG
A088305
001
A078149 A086231
001 002
6 - 34 (of 346)
A075351
001
385MG;30MG;25MG 770MG;60MG;50MG
A075141 A075141
001 002
Aug 17, 1983 Mar 08, 1983 Mar 08, 1983 Dec 07, 1984 Sep 16, 1983 Mar 29, 1985 Jun 24, 1985 Sep 03, 1984
ASPIRIN; CARISOPRODOL
TABLET; ORAL CARISOPRODOL COMPOUND WATSON LABS
325MG;200MG
A088809
001
500MG;5MG 500MG;5MG
A089420 A086333
001 001
ASPIRIN; MEPROBAMATE
TABLET; ORAL EQUAGESIC CARACO MEPRO-ASPIRIN SANDOZ MEPROBAMATE AND ASPIRIN PAR PHARM MICRAININ MEDPOINTE PHARM HLC Q-GESIC QUANTUM PHARMICS
ASPIRIN; METHOCARBAMOL
TABLET; ORAL METHOCARBAMOL AND ASPIRIN IVAX SUB TEVA PHARMS 325MG;400MG MCNEIL 325MG;400MG PAR PHARM 325MG;400MG ROBAXISAL ROBINS AH 325MG;400MG
6 - 35 (of 346)
325MG;4.5MG;0.38MG
Jul 01, 1982 Jul 17, 1998 May 26, 1982 Jun 04, 1982
325MG;4.5MG;0.38MG 325MG;4.5MG;0.38MG OXYCODONE AND ASPIRIN (HALF-STRENGTH) ROXANE 325MG;2.25MG;0.19MG PERCODAN ENDO PHARMS 325MG;4.5MG;0.38MG PERCODAN-DEMI ENDO PHARMS 325MG;2.25MG;0.19MG ROXIPRIN ROXANE 325MG;4.5MG;0.38MG
N016891
001
N021387
006
325MG;65MG
N010996
005
325MG;100MG
N016829
001
325MG;100MG
N016863
001
ATENOLOL
INJECTABLE; INJECTION TENORMIN ASTRAZENECA TABLET; ORAL ATENOLOL ABLE
0.5MG/ML
N019058
001
SANDOZ
25MG 50MG 100MG 50MG 100MG 50MG 100MG 25MG 50MG 100MG 25MG
A076907 A076907 A076907 A073317 A073318 A074127 A074127 A074101 A074101 A074101 A074265
001 002 003 001 001 001 002 001 002 003 001
Jul Jul Jul Mar Mar Feb Feb Jul Jul Jul Feb
30, 30, 30, 20, 20, 21, 21, 17, 17, 17, 28,
2004 2004 2004 1992 1992 1995 1995 1997 1997 1997 1994
6 - 36 (of 346)
ATENOLOL; CHLORTHALIDONE
TABLET; ORAL ATENOLOL AND CHLORTHALIDONE NOSTRUM LABS 50MG;25MG 100MG;25MG PLIVA 50MG;25MG 100MG;25MG
ATOMOXETINE HYDROCHLORIDE
CAPSULE; ORAL ATOMOXETINE HYDROCHLORIDE ACTAVIS ELIZABETH 10MG 18MG 25MG 40MG 60MG 80MG 100MG STRATTERA LILLY 5MG
ATOVAQUONE
TABLET; ORAL MEPRON GLAXOSMITHKLINE LLC
250MG
N020259
001
ATRACURIUM BESYLATE
INJECTABLE; INJECTION ATRACURIUM BESYLATE BAXTER HLTHCARE BAXTER HLTHCARE CORP HOSPIRA
10MG/ML 10MG/ML 10MG/ML 10MG/ML MARSAM PHARMS LLC 10MG/ML TEVA PARENTERAL 10MG/ML ATRACURIUM BESYLATE PRESERVATIVE FREE BAXTER HLTHCARE 10MG/ML BAXTER HLTHCARE CORP 10MG/ML HOSPIRA 10MG/ML 10MG/ML 10MG/ML MARSAM PHARMS LLC 10MG/ML TRACRIUM HOSPIRA 10MG/ML TRACRIUM PRESERVATIVE FREE HOSPIRA 10MG/ML
A074824 A074753 A074632 A074740 A074945 A074784 A074825 A074768 A074633 A074639 A074741 A074944 N018831 N018831
001 001 001 001 001 001 001 001 001 001 001 001 002 001
Sep Jan Dec Mar Jul Jun Sep Jan Dec Mar Mar Jul
30, 23, 23, 28, 28, 11, 30, 23, 23, 25, 28, 28,
1997 1997 1996 1997 1998 1997 1997 1997 1996 1997 1997 1998
ATROPINE
INJECTABLE; INJECTION ATROPINE SOLVAY
EQ 2MG SULFATE/0.7ML
A071295
001
6 - 37 (of 346)
N020056
001
0.025MG;0.5MG
N017744
001
A086440
001
A085735 A085746
001 001
A085737 A085266 A040395 A087934 A086798 A085509 A086727 A085659 A086950 A085506 A087131 A085766 A085035 A086057 A086173 A087842 A087195 A085876 A087765 A088962 A088009 A085211
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Nov 27, 2000 Jul 19, 1983
Mar 29, 1982 Feb 16, 1982 Mar 15, 1982 May 10, 1985 Mar 25, 1983
0.14MG/ML;10MG/ML
N019677
001
0.4MG/ML;50MG/ML 0.4MG/ML;75MG/ML 0.4MG/ML;100MG/ML MEPERIDINE AND ATROPINE SULFATE WYETH AYERST 0.4MG/ML;50MG/ML 0.4MG/ML;75MG/ML
6 - 38 (of 346)
A085121
003
N021175
001
AZATADINE MALEATE
TABLET; ORAL OPTIMINE SCHERING
1MG
N017601
001
N018506
001
AZATHIOPRINE
TABLET; ORAL IMURAN PROMETHEUS LABS
25MG
N016324
002
AZATHIOPRINE SODIUM
INJECTABLE; INJECTION IMURAN PROMETHEUS LABS
EQ 100MG BASE/VIAL
N017391
001
AZELASTINE HYDROCHLORIDE
SPRAY, METERED; NASAL ASTEPRO MEDA PHARMS
EQ 0.125MG BASE/SPRAY
N022203
001
AZITHROMYCIN
CAPSULE; ORAL ZITHROMAX PFIZER
EQ 250MG BASE
N050670
001
N050762
001
AZLOCILLIN SODIUM
INJECTABLE; INJECTION AZLIN BAYER PHARMS
EQ EQ EQ EQ EQ EQ EQ EQ EQ
AZTREONAM
INJECTABLE; INJECTION AZACTAM BRISTOL MYERS SQUIBB
500MG/VIAL
N050580
001
6 - 39 (of 346)
N050632
003
BACAMPICILLIN HYDROCHLORIDE
FOR SUSPENSION; ORAL SPECTROBID PFIZER TABLET; ORAL SPECTROBID PFIZER
125MG/5ML
N050556
001
400MG 800MG
N050520 N050520
001 002
BACITRACIN
INJECTABLE; INJECTION BACITRACIN PFIZER 50,000 UNITS/VIAL OINTMENT; OPHTHALMIC BACIGUENT PHARMACIA AND UPJOHN 500 UNITS/GM BACITRACIN LILLY 500 UNITS/GM PHARMADERM 500 UNITS/GM PHARMAFAIR 500 UNITS/GM OINTMENT; TOPICAL BACITRACIN COMBE 500 UNITS/GM NASKA 500 UNITS/GM POWDER; FOR RX COMPOUNDING BACITRACIN APOTHEKERNES 5,000,000 UNITS/BOT PADDOCK LLC 5,000,000 UNITS/BOT
A060282
001
A062799 A062857
001 001
A061699 A062456
001 001
BACITRACIN ZINC
POWDER; FOR RX COMPOUNDING
ZIBA-RX
X GEN PHARMS 500,000 UNITS/BOT
A061737
001
002
001
001
A062499
001
A062386
001
6 - 40 (of 346)
A062167
001
A060647
001
N050417
001
A062833
001
N050167
002
A062430 A061229
001 001
A062849
001
OINTMENT; OPHTHALMIC
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
ALTANA 400 UNITS/GM;1%;EQ 3.5MG
BASE/GM;10,000 UNITS/GM
A060731
002
A061048
001
N050598
001
BACLOFEN
TABLET; ORAL BACLOFEN TEVA USL PHARMA WATSON LABS
A073043 A073044 A071260 A071261 A073092 A074698 A073093 A074698 N017851 N017851
001 001 001 001 001 001 001 002 001 003
10MG 20MG TABLET, ORALLY DISINTEGRATING; ORAL KEMSTRO SCHWARZ PHARMA 10MG 20MG
LIORESAL NOVARTIS
N021589 N021589
001 002
6 - 41 (of 346)
N018584 N018521
001 001
N019589 N020469
001 001
BENAZEPRIL HYDROCHLORIDE
TABLET; ORAL BENAZEPRIL HYDROCHLORIDE GENPHARM 5MG 10MG 20MG 40MG
BENDROFLUMETHIAZIDE
TABLET; ORAL NATURETIN-10 APOTHECON NATURETIN-2.5 APOTHECON NATURETIN-5 APOTHECON
BENOXINATE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC BENOXINATE HYDROCHLORIDE SOLA BARNES HIND 0.4%
A084149
001
BENTIROMIDE
SOLUTION; ORAL CHYMEX SAVAGE LABS
500MG/7.5ML
N018366
001
BENZPHETAMINE HYDROCHLORIDE
TABLET; ORAL DIDREX PHARMACIA AND UPJOHN
25MG
N012427
003
BENZQUINAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION
EMETE-CON
PFIZER SUPPOSITORY; RECTAL
EMETE-CON
ROERIG
EQ 50MG BASE/VIAL
N016820
001
EQ 100MG BASE
N016818
006
6 - 42 (of 346)
BENZTROPINE MESYLATE
TABLET; ORAL BENZTROPINE MESYLATE ACTAVIS TOTOWA
USL PHARMA
0.5MG 1MG 2MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG
A040699 A040705 A040706 A081264 A081265 A088514 A088510 A088511 A089211 A089212 A089213 N009193 N009193 N009193
001 001 001 001 001 001 001 001 001 001 001 004 003 002
Feb Feb Feb Jan Jan Jan Jan Jan Jun Jun Jun
14, 14, 14, 23, 23, 31, 31, 31, 14, 14, 14,
2008 2008 2008 1992 1992 1984 1984 1984 1988 1988 1988
COGENTIN MERCK
BENZYL BENZOATE
EMULSION; TOPICAL BENZYL BENZOATE LANNETT
50%
A084535
001
BEPRIDIL HYDROCHLORIDE
TABLET; ORAL BEPADIN MEDPOINTE PHARM HLC
Dec 28, 1990 Dec 28, 1990 Dec 28, 1990 Dec 28, 1990 Dec 28, 1990 Dec 28, 1990
BETA CAROTENE
CAPSULE; ORAL SOLATENE ROCHE
30MG
N017589
001
BETAMETHASONE
CREAM; TOPICAL CELESTONE SCHERING TABLET; ORAL CELESTONE SCHERING
0.2%
N014762
001
0.6MG
N012657
003
6 - 43 (of 346)
0.025%
N016998
002
0.025%
N017244
001
0.025%
N017528
001
0.025%
N018089
001
BETAMETHASONE DIPROPIONATE
CREAM; TOPICAL ALPHATREX SAVAGE LABS EQ 0.05% BASE BETAMETHASONE DIPROPIONATE PERRIGO NEW YORK EQ 0.05% BASE EQ 0.05% BASE PHARMADERM EQ 0.05% BASE TARO EQ 0.05% BASE TEVA EQ 0.05% BASE DIPROSONE SCHERING EQ 0.05% BASE CREAM, AUGMENTED; TOPICAL DIPROLENE SCHERING EQ 0.05% BASE DISC; TOPICAL DIPROSONE SCHERING EQ 0.1% BASE GEL, AUGMENTED; TOPICAL DIPROLENE SCHERING EQ 0.05% BASE LOTION; TOPICAL ALPHATREX SAVAGE LABS EQ 0.05% BASE BETAMETHASONE DIPROPIONATE ALPHARMA US PHARMS EQ 0.05% BASE PHARMADERM EQ 0.05% BASE TARO EQ 0.05% BASE EQ 0.05% BASE TEVA PHARMS EQ 0.05% BASE DIPROSONE SCHERING EQ 0.05% BASE OINTMENT; TOPICAL ALPHATREX SAVAGE LABS EQ 0.05% BASE BETAMETHASONE DIPROPIONATE PERRIGO NEW YORK EQ 0.05% BASE PHARMADERM EQ 0.05% BASE TEVA EQ 0.05% BASE DIPROSONE SCHERING EQ 0.05% BASE
Jun 26, 1984 Jan Nov Jun Jun Aug 31, 26, 26, 17, 10, 1990 1997 1984 1987 1987
N019408
001
N017829
001
N019408
002
Aug 12, 1985 Feb Aug Aug Sep Jun 03, 12, 24, 30, 06, 1987 1985 1988 1994 1988
Sep 04, 1984 Jan 31, 1990 Sep 04, 1984 Aug 10, 1987
A085738 N017561
001 001
6 - 44 (of 346)
EQ 0.1% BASE EQ EQ EQ EQ 0.1% 0.1% 0.1% 0.1% BASE BASE BASE BASE
Jun 30, 1983 Jun Aug May May 10, 31, 29, 14, 1986 1983 1987 1985
EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE
Aug 31, 1983 May 29, 1987 Apr 22, 1988 Aug 31, 1983
EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE
Dec 23, 1987 Aug 31, 1983 May 29, 1987 Aug 31, 1983 Dec 19, 1985
BETAXOLOL HYDROCHLORIDE
TABLET; ORAL KERLONE SANOFI AVENTIS US
10MG 20MG
N019507 N019507
001 002
5MG;12.5MG 10MG;12.5MG
N019807 N019807
001 002
N020619
001
BETAZOLE HYDROCHLORIDE
INJECTABLE; INJECTION HISTALOG LILLY
50MG/ML
N009344
001
BETHANECHOL CHLORIDE
INJECTABLE; INJECTION URECHOLINE ODYSSEY PHARMS
5MG/ML
N006536
001
6 - 45 (of 346)
ACTAVIS TOTOWA
SANDOZ
WATSON LABS
5MG 10MG 25MG 50MG 5MG 10MG 25MG 50MG 10MG 25MG 25MG 5MG 10MG 25MG 5MG 10MG 10MG 25MG 25MG 5MG 5MG 5MG 10MG 10MG 10MG 25MG 25MG 25MG 50MG 50MG 5MG 10MG 25MG 5MG 10MG 25MG 50MG
A040492 A040483 A040485 A040509 A040552 A040553 A040554 A040551 A088288 A088289 A084689 A084702 A084712 A084074 A084353 A084378 A084379 A084383 A084384 A084402 A085230 A085841 A084408 A085228 A085842 A084441 A085229 A085839 A087397 A087444 A084188 A084188 A084188 N006536 N006536 N006536 N006536
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 003 004 003 002 004 005
Jul Jul Jul Jul Oct Oct Oct Oct Jun Jun
27, 27, 27, 27, 28, 28, 28, 28, 08, 08,
2004 2004 2004 2004 2004 2004 2004 2004 1983 1983
MYOTONACHOL GLENWOOD
BETHANIDINE SULFATE
TABLET; ORAL TENATHAN ROBINS AH
10MG 25MG
N017675 N017675
001 002
BIPERIDEN LACTATE
INJECTABLE; INJECTION AKINETON ABBOTT
5MG/ML
N012418
002
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
FOR SOLUTION, TABLET, DELAYED RELEASE; ORAL HALFLYTELY BRAINTREE 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM N021551 ;N/A,5.6GM
002
6 - 46 (of 346)
5MG 10MG
A075474 A075474
001 002
A075672 A075672 A075672 A075642 A075642 A075642 A075632 A075632 A075632 A075527 A075527 A075527 A075686 A075686 A075686
001 002 003 002 001 003 001 002 003 001 003 002 001 002 003
Sep Sep Sep Dec Dec Dec Sep Sep Sep Sep Sep Sep Jan Jan Jan
25, 25, 25, 27, 27, 27, 27, 27, 27, 25, 25, 25, 19, 19, 19,
2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2001 2001 2001
BITOLTEROL MESYLATE
AEROSOL, METERED; INHALATION TORNALATE SANOFI AVENTIS US 0.37MG/INH SOLUTION; INHALATION TORNALATE SANOFI AVENTIS US 0.2%
N018770
001
N019548
001
BLEOMYCIN SULFATE
INJECTABLE; INJECTION BLENOXANE BRISTOL MYERS SQUIBB BLEOMYCIN SULFATE TEVA PARENTERAL
BRETYLIUM TOSYLATE
INJECTABLE; INJECTION BRETYLIUM TOSYLATE ABRAXIS PHARM
50MG/ML 100MG/ML ASTRAZENECA 50MG/ML 50MG/ML 50MG/ML BAXTER HLTHCARE 50MG/ML 50MG/ML HOSPIRA 50MG/ML 50MG/ML INTL MEDICATION 50MG/ML LUITPOLD 50MG/ML BRETYLIUM TOSYLATE IN DEXTROSE 5% ABBOTT 200MG/100ML 400MG/100ML 800MG/100ML BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 200MG/100ML 400MG/100ML
A070134 A071298 A071151 A071152 A071153 A070545 A070546 N019030 N019033 A070119 A070891 N019005 N019005 N019005 N019837 N019837
001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 001
Apr Feb Aug Aug Aug May May Apr Apr Apr Jul
29, 13, 10, 10, 10, 14, 14, 29, 29, 29, 26,
1986 1987 1987 1987 1987 1986 1986 1986 1986 1986 1988
Apr 29, 1986 Apr 29, 1986 Apr 29, 1986 Apr 12, 1989 Apr 12, 1989
6 - 47 (of 346)
BRIMONIDINE TARTRATE
SOLUTION/DROPS; OPHTHALMIC ALPHAGAN ALLERGAN 0.2% 0.5% BRIMONIDINE TARTRATE TEVA PARENTERAL 0.2%
BROMFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC XIBROM ISTA PHARMS INC 0.09%
N021664
001
BROMOCRIPTINE MESYLATE
CAPSULE; ORAL BROMOCRIPTINE MESYLATE LEK PHARM
EQ 5MG BASE
A075100
001
BROMODIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE; ORAL AMBODRYL PARKE DAVIS
25MG
N007984
001
BROMPHENIRAMINE MALEATE
ELIXIR; ORAL BROMPHENIRAMINE MALEATE ALPHARMA US PHARMS KV PHARM PHARM ASSOC USL PHARMA INJECTABLE; INJECTION BROMPHENIRAMINE MALEATE WATSON LABS DIMETANE-TEN WYETH AYERST TABLET; ORAL BROMPHENIRAMINE MALEATE BARR IVAX SUB TEVA PHARMS NEWTRON PHARMS NEXGEN PHARMA INC PAR PHARM PIONEER PHARMS SANDOZ
6 - 48 (of 346)
N010799 N010799
010 011
A071099 N012436
001 003
N019672
001
BUCLIZINE HYDROCHLORIDE
TABLET; ORAL BUCLADIN-S STUART PHARMS
50MG
N010911
006
BUDESONIDE
AEROSOL, METERED; NASAL
RHINOCORT
ASTRAZENECA 0.032MG/INH POWDER, METERED; INHALATION PULMICORT ASTRAZENECA 0.32MG/INH
N020233
001
N020441
003
6 - 49 (of 346)
0.064MG/INH
N020746
002
BUMETANIDE
INJECTABLE; INJECTION BUMETANIDE HOSPIRA TEVA PARENTERAL BUMEX VALIDUS PHARMS INC TABLET; ORAL BUMEX VALIDUS PHARMS INC
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
BUPIVACAINE HYDROCHLORIDE KIT
HOSPIRA 0.075% 0.114% 0.23%
INJECTABLE; INJECTION
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
HOSPIRA 0.25%;0.005MG/ML 0.5%;0.005MG/ML 0.75%;0.005MG/ML
N021496
001
BUPROPION HYDROCHLORIDE
TABLET; ORAL BUPROPION HYDROCHLORIDE SANDOZ 75MG 100MG WELLBUTRIN GLAXOSMITHKLINE 50MG TABLET, EXTENDED RELEASE; ORAL BUPROPION HYDROCHLORIDE SANDOZ 100MG 150MG 150MG WELLBUTRIN SR GLAXOSMITHKLINE 50MG ZYBAN GLAXOSMITHKLINE 100MG
Jul 14, 2005 Jul 14, 2005 Jul 14, 2005 Oct 04, 1996 May 14, 1997
BUSPIRONE HYDROCHLORIDE
CAPSULE; ORAL
BUSPAR
BRISTOL MYERS SQUIBB 5MG 7.5MG 10MG 15MG
6 - 50 (of 346)
N018731 N018731 N018731 N018731 A075388 A075388 A075388 A078302 A075385 A075385 A075385 A075413 A075413 A075413
001 002 003 004 001 002 003 001 001 002 003 001 002 003
Sep Sep Apr Apr May May May Dec Mar Mar Mar Mar Mar Mar
29, 29, 22, 22, 09, 09, 09, 17, 01, 01, 01, 19, 19, 19,
1986 1986 1996 1996 2002 2002 2002 2007 2002 2002 2002 2002 2002 2002
BUSPIRONE HYDROCHLORIDE ACTAVIS TOTOWA 5MG 10MG 15MG 30MG IVAX SUB TEVA PHARMS 5MG 10MG 15MG SANDOZ 5MG 10MG 15MG
BUTABARBITAL SODIUM
CAPSULE; ORAL BUTICAPS MEDPOINTE PHARM HLC
ELIXIR; ORAL BUTABARB ALPHARMA US PHARMS BUTABARBITAL SODIUM WOCKHARDT BUTALAN LANNETT SARISOL HALSEY TABLET; ORAL BUTABARBITAL BUNDY BUTABARBITAL SODIUM SANDOZ
30MG 15MG 15MG 30MG 30MG 16.2MG 32.4MG 48.6MG 97.2MG 15MG 30MG 15MG 30MG 15MG 30MG 15MG 100MG 15MG 30MG 15MG 30MG
A085550 A084292 A085938 A084272 A085934 A083606 A083898 A083897 A083896 A088632 A088631 A085764 A085772 A083325 A083337 N000793 N000793 A084719 A084719 A083484 A084040
001 003 001 002 001 001 001 001 001 001 001 001 001 002 001 002 005 001 002 001 001 Feb 09, 1982
SOLVAY
TEVA WATSON LABS WHITEWORTH TOWN PLSN BUTISOL SODIUM MEDA PHARMS SARISOL NO. 1 HALSEY SARISOL NO. 2 HALSEY SODIUM BUTABARBITAL IVAX SUB TEVA PHARMS
6 - 51 (of 346)
BUTOCONAZOLE NITRATE
CREAM; VAGINAL FEMSTAT ROCHE PALO SUPPOSITORY; VAGINAL FEMSTAT ROCHE PALO
2%
N019215
001
100MG
N019359
001
BUTORPHANOL TARTRATE
INJECTABLE; INJECTION BUTORPHANOL TARTRATE HOSPIRA
1MG/ML 1MG/ML 2MG/ML 2MG/ML BUTORPHANOL TARTRATE PRESERVATIVE FREE HOSPIRA 1MG/ML 1MG/ML 2MG/ML 2MG/ML SPRAY, METERED; NASAL STADOL BRISTOL MYERS SQUIBB 1MG/SPRAY
N019890
001
CABERGOLINE
TABLET; ORAL DOSTINEX PHARMACIA AND UPJOHN
0.5MG
N020664
001
100MG;2MG
N009000
002
100MG;1MG 100MG;1MG
N006620 A086562
001 001
CALCIFEDIOL
CAPSULE; ORAL CALDEROL ORGANON USA INC
0.02MG 0.05MG
N018312 N018312
001 002
CALCIPOTRIENE
OINTMENT; TOPICAL DOVONEX LEO PHARM
0.005%
N020273
001
6 - 52 (of 346)
0.5MG/VIAL
N018470
001
CALCITONIN SALMON
INJECTABLE; INJECTION CALCIMAR SANOFI AVENTIS US CALCITONIN-SALMON ASTRAZENECA MIACALCIN NOVARTIS
001 001 001 001 Apr 14, 1995 Jul 03, 1986
CALCITRIOL
INJECTABLE; INJECTION
CALCITRIOL
HOSPIRA TEVA PARENTERAL
CALCIUM ACETATE
CAPSULE; ORAL PHOSLO FRESENIUS MEDCL TABLET; ORAL CALCIUM ACETATE ROXANE PHOSLO FRESENIUS MEDCL
N021160 N021160
001 002
A077693 N019976
001 001
N021823
001
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
INJECTABLE; INJECTION PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER GAMBRO RENAL PRODS 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML; 3.05GM/1000ML;0.157GM/1000ML;2.21GM/100 0ML;7.07GM/1000ML PRISMASOL BGK 4/0 IN PLASTIC CONTAINER GAMBRO RENAL PRODS N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.0 5GM/1000ML;0.314GM/1000ML;3.09GM/1000ML ;6.46GM/1000ML PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER GAMBRO RENAL PRODS 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML; 2.03GM/1000ML;0.314GM/1000ML;3.09GM/100 0ML;6.46GM/1000ML PRISMASOL BK 0/0 IN PLASTIC CONTAINER GAMBRO RENAL PRODS N/A/1000ML;N/A/1000ML;5.4GM/1000ML;3.05 GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46 GM/1000ML PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER GAMBRO RENAL PRODS 3.68GM/1000ML;N/A/1000ML;5.4GM/1000ML;3 .05GM/1000ML;0.314GM/1000ML;3.09GM/1000 ML;6.46GM/1000ML
N021703
012
N021703
005
N021703
008
N021703
007
N021703
009
6 - 53 (of 346)
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 37MG/100ML;5GM/100ML;31MG/100ML;120MG/1 N018271 00ML;330MG/100ML;88MG/100ML
001
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
INJECTABLE; INJECTION ISOLYTE E W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 35MG/100ML;5GM/100ML;30MG/100ML;74MG/10 N018269 0ML;640MG/100ML;500MG/100ML;74MG/100ML
002
006
001
003
002
008
004
001
N019634
002
N017510 N018499
001 001
PLASTIC CONTAINER N019685 005 Oct 17, 1988 N019685 006 Oct 17, 1988
PLASTIC CONTAINER N019685 007 Oct 17, 1988 PLASTIC CONTAINER N019685 003 Oct 17, 1988
6 - 54 (of 346)
001
002
003
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION TPN ELECTROLYTES IN PLASTIC CONTAINER ABBOTT 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML; N019399 16.1MG/ML
001
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE
INJECTABLE; INJECTION ISOLYTE E IN PLASTIC CONTAINER B BRAUN 35MG/100ML;30MG/100ML;74MG/100ML;640MG/ N018899 100ML;500MG/100ML;74MG/100ML
001
001
N018721
001
N018462
001
CALCIUM GLUCEPTATE
INJECTABLE; INJECTION CALCIUM GLUCEPTATE ABBOTT ABRAXIS PHARM LILLY
EQ EQ EQ EQ
6 - 55 (of 346)
0.78MG/ML;75.9MG/ML;0.15MG/ML;16.6MG/ML N016847
001
0.35MG/ML;140.1MG/ML;461.8MG/ML
N017506
001
CANDICIDIN
OINTMENT; VAGINAL VANOBID SANOFI AVENTIS US TABLET; VAGINAL VANOBID SANOFI AVENTIS US
0.6MG/GM
A061596
001
3MG
A061613
001
CAPTOPRIL
TABLET; ORAL CAPOTEN PAR PHARM
37.5MG 75MG 150MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 12.5MG 25MG 25MG 50MG 50MG 100MG 100MG 12.5MG 25MG
N018343 N018343 N018343 A074472 A074472 A074472 A074472 A074423 A074423 A074423 A074423 A074748 A074748 A074748 A074748 A074418 A074418 A074418 A074418 A074590 A074590 A074590 A074590 A074493 A074493 A074493 A074493 A074640 A074640 A074640 A074640 A074481 A074519 A074481 A074519 A074481 A074519 A074481 A074519 A074433 A074433
006 007 004 001 002 003 004 001 002 003 004 004 002 001 003 001 002 003 004 004 002 001 003 001 002 003 004 001 002 003 004 001 001 002 002 003 003 004 004 001 002
Sep 17, 1986 Jun 13, 1995 Jun 13, 1995 Mar Mar Mar Mar Feb Feb Feb Feb May May May May Feb Feb Feb Feb Aug Aug Aug Aug Feb Feb Feb Feb Mar Mar Mar Mar Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb 31, 31, 31, 31, 13, 13, 13, 13, 29, 29, 29, 29, 13, 13, 13, 13, 30, 30, 30, 30, 13, 13, 13, 13, 31, 31, 31, 31, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13, 1995 1995 1995 1995 1996 1996 1996 1996 1997 1997 1997 1997 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996 1997 1997 1997 1997 1996 1996 1996 1996 1996 1996 1996 1996 1996 1996
CAPTOPRIL APOTHECON
CLONMEL HLTHCARE
EGIS PHARMS
ENDO LABS
PAR PHARM
PUREPAC PHARM
SANDOZ
TEVA
6 - 56 (of 346)
WATSON LABS
50MG 100MG 12.5MG 25MG 50MG 100MG 12.5MG 25MG 50MG 100MG
A074433 A074433 A074462 A074462 A074462 A074462 A074576 A074576 A074576 A074576
003 004 001 002 003 004 001 002 003 004
Feb Feb Feb Feb Feb Feb Apr Apr Apr Apr
13, 13, 13, 13, 13, 13, 23, 23, 23, 23,
1996 1996 1996 1996 1996 1996 1996 1996 1996 1996
CAPTOPRIL; HYDROCHLOROTHIAZIDE
TABLET; ORAL CAPTOPRIL AND HYDROCHLOROTHIAZIDE ENDO LABS 25MG;15MG 25MG;25MG 50MG;15MG 50MG;25MG IVAX SUB TEVA PHARMS 25MG;15MG 25MG;25MG 50MG;15MG 50MG;25MG WATSON LABS 50MG;25MG
CARBACHOL
SOLUTION; INTRAOCULAR CARBACHOL PHARMAFAIR CARBASTAT NOVARTIS
0.01% 0.01%
A070292 A073677
001 001
CARBAMAZEPINE
SUSPENSION; ORAL CARBAMAZEPINE TARO TABLET; ORAL CARBAMAZEPINE ACTAVIS ELIZABETH INWOOD LABS PLIVA USL PHARMA WARNER CHILCOTT TERIL TARO TABLET, CHEWABLE; ORAL CARBAMAZEPINE JUBILANT CADISTA
100MG/5ML
A075875
001
100MG
A071940
001
CARBENICILLIN DISODIUM
INJECTABLE; INJECTION GEOPEN ROERIG
EQ EQ EQ EQ EQ
1GM BASE/VIAL 2GM BASE/VIAL 5GM BASE/VIAL 10GM BASE/VIAL 30GM BASE/VIAL
PYOPEN GLAXOSMITHKLINE
6 - 57 (of 346)
N050298 N050298
006 007
EQ 382MG BASE
N050435
001
CARBIDOPA; LEVODOPA
TABLET; ORAL CARBIDOPA AND LEVODOPA SANDOZ
10MG;100MG 25MG;100MG 25MG;250MG SCS 10MG;100MG 25MG;100MG 25MG;250MG WATSON LABS 10MG;100MG 25MG;100MG 25MG;250MG TABLET, EXTENDED RELEASE; ORAL CARBIDOPA AND LEVODOPA KV PHARM 50MG;200MG TABLET, FOR SUSPENSION; ORAL CARBILEV RANBAXY 10MG;100MG 25MG;100MG 25MG;250MG
A076663
001
CARBINOXAMINE MALEATE
ELIXIR; ORAL CLISTIN MCNEIL TABLET; ORAL CLISTIN ORTHO MCNEIL PHARM
4MG/5ML
N008955
001
4MG
N008915
001
CARBOPLATIN
INJECTABLE; INJECTION CARBOPLATIN HOSPIRA
Oct 27, 2004 Oct 27, 2004 Oct 27, 2004 Mar 03, 1989 Mar 03, 1989 Mar 03, 1989
INJECTABLE; IV (INFUSION) CARBOPLATIN APP PHARMS 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) SAGENT PHARMS 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) TEVA PARENTERAL 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML) PARAPLATIN BRISTOL MYERS SQUIBB 50MG/5ML (10MG/ML) 150MG/15ML (10MG/ML) 450MG/45ML (10MG/ML)
A077247 A077247 A077096 A077096 A077096 A077389 A077389 A077389 N020452 N020452 N020452
001 002 001 002 003 001 002 003 001 002 003
6 - 58 (of 346)
N020452
004
CARISOPRODOL
CAPSULE; ORAL SOMA MEDA PHARMS TABLET; ORAL CARISOPRODOL ABLE PIONEER PHARMS SANDOZ WATSON LABS
250MG
N011792
003
RELA SCHERING
CARPHENAZINE MALEATE
CONCENTRATE; ORAL PROKETAZINE WYETH AYERST TABLET; ORAL PROKETAZINE WYETH AYERST
50MG/ML
N014173
001
CARPROFEN
TABLET; ORAL RIMADYL ROCHE
100MG 150MG
N018550 N018550
002 003
CARTEOLOL HYDROCHLORIDE
TABLET; ORAL CARTROL ABBOTT
CEFACLOR
CAPSULE; ORAL CECLOR LILLY CEFACLOR CEPH INTL CLONMEL HLTHCARE IVAX SUB TEVA PHARMS MARSAM PHARMS LLC TEVA
EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 250MG 500MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N050521 N050521 A062205 A062205 A064107 A064107 A064061 A064061 A064148 A064148 A064081 A064145 A064081 A064145
001 002 001 002 001 002 001 002 001 002 001 001 002 002
Apr Apr Apr Apr May May Sep Jun Sep Jun
27, 27, 27, 27, 23, 23, 16, 24, 16, 24,
1995 1995 1995 1995 1996 1996 1996 1996 1996 1996
6 - 59 (of 346)
EQ 125MG BASE/5ML EQ 250MG BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
N050522 N050522 A064114 A064115 A064116 A064110 A062206 A062206 A062206 A062206 A064087 A064086 A064085 A064070 A064204 A064205 A064206 A064207
001 002 001 001 001 001 001 003 002 004 001 001 001 001 001 001 001 001 Apr Apr Apr Apr 28, 28, 28, 28, 1995 1995 1995 1995
EQ 125MG EQ 187MG EQ 250MG EQ 375MG FACTA FARMA EQ 125MG EQ 187MG EQ 250MG EQ 375MG IVAX SUB TEVA PHARMS EQ 125MG EQ 187MG EQ 250MG EQ 375MG MARSAM PHARMS LLC EQ 125MG EQ 187MG EQ 250MG EQ 375MG TABLET, EXTENDED RELEASE; ORAL CECLOR CD LILLY EQ 375MG EQ 500MG CEFACLOR WORLD GEN EQ 500MG
Apr 20, 1988 Apr Apr Apr Apr Apr Feb Feb Feb Feb 20, 28, 28, 28, 28, 18, 18, 18, 18, 1988 1995 1995 1995 1995 1998 1998 1998 1998
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL CEFADROXIL IVAX SUB TEVA PHARMS PUREPAC PHARM TEVA DURICEF WARNER CHILCOTT ULTRACEF BRISTOL FOR SUSPENSION; ORAL CEFADROXIL APOTHECON
EQ 500MG BASE EQ 500MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 500MG BASE
TEVA
EQ EQ EQ EQ EQ EQ
A062334 A062334 A062334 A062698 A062698 A062698 N050527 N050527 N050527 A062376 A062376 A062376
001 002 003 001 002 003 002 003 001 001 002 003
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 500MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 500MG BASE/5ML
ULTRACEF BRISTOL
6 - 60 (of 346)
EQ EQ EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
CEFAZOLIN SODIUM
INJECTABLE; INJECTION ANCEF GLAXOSMITHKLINE
EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 10MG BASE/ML EQ 20MG BASE/ML ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 10MG BASE/ML EQ 20MG BASE/ML CEFAZOLIN AND DEXTROSE B BRAUN EQ 500MG BASE/VIAL CEFAZOLIN SODIUM ABRAXIS PHARM EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL BEDFORD EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL ELKINS SINN EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL GLAXOSMITHKLINE EQ 1GM BASE/VIAL MARSAM PHARMS LLC EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL TEVA EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 5GM BASE/VIAL EQ 10GM BASE/VIAL KEFZOL ACS DOBFAR EQ 250MG BASE/VIAL EQ 20GM BASE/VIAL LILLY EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
N050461 N050461 N050461 N050461 N050461 N050566 N050566 N050566 N050566 N050779 A062688 A062688 A062688 A062688 A062894 A062894 A062894 A062894 A062894 A062807 A062807 A062807 A062807 A062807 A062807 A064033 A062988 A062988 A062988 A062989 A062989 A062989 A063016 A063016 A063016 A063018 A063018 A061773 A061773 A062557 A062557
001 002 003 004 005 003 004 001 002 001 002 003 004 005 001 002 003 004 005 001 002 003 004 005 006 001 001 002 003 001 002 003 001 002 003 001 002 001 005 001 002 Jun 08, 1983 Jun 08, 1983 Jun 08, 1983 Jun 08, 1983 Jul 27, 2000 Nov Nov Nov Aug Jul Jul Jul Jul Jul Jan Jan Jan Jan Jan Jan Oct Dec Dec Dec Dec Dec Dec Mar Mar Mar Mar Mar 17, 17, 17, 03, 21, 21, 21, 21, 21, 12, 12, 12, 12, 12, 12, 31, 29, 29, 29, 29, 29, 29, 14, 14, 14, 05, 05, 1986 1986 1986 1987 1988 1988 1988 1988 1988 1988 1988 1988 1988 1988 1988 1993 1989 1989 1989 1989 1989 1989 1989 1989 1989 1990 1990
6 - 61 (of 346)
300MG
N050739
001
125MG/5ML 250MG/5ML
N050749 N050749
001 002
CEFIXIME
FOR SUSPENSION; ORAL SUPRAX LEDERLE TABLET; ORAL SUPRAX LEDERLE
100MG/5ML
N050622
001
200MG 400MG
N050621 N050621
001 002
CEFMENOXIME HYDROCHLORIDE
INJECTABLE; INJECTION CEFMAX TAP PHARM
CEFMETAZOLE SODIUM
INJECTABLE; INJECTION ZEFAZONE PHARMACIA AND UPJOHN
EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL ZEFAZONE IN PLASTIC CONTAINER PHARMACIA AND UPJOHN EQ 20MG BASE/ML EQ 40MG BASE/ML
Dec 11, 1989 Dec 11, 1989 Dec 29, 1992 Dec 29, 1992
CEFONICID SODIUM
INJECTABLE; INJECTION MONOCID GLAXOSMITHKLINE
EQ EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
CEFOPERAZONE SODIUM
INJECTABLE; INJECTION CEFOBID PFIZER
EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL CEFOBID IN PLASTIC CONTAINER PFIZER EQ 20MG BASE/ML EQ 40MG BASE/ML
CEFORANIDE
INJECTABLE; INJECTION PRECEF APOTHECON
6 - 62 (of 346)
CEFOTAXIME SODIUM
INJECTABLE; INJECTION CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER B BRAUN EQ 2GM BASE CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER B BRAUN EQ 1GM BASE CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER SANOFI AVENTIS US EQ 20MG BASE/ML EQ 40MG BASE/ML
Jul 29, 2004 Jul 29, 2004 May 20, 1985 May 20, 1985
CEFOTETAN DISODIUM
INJECTABLE; INJECTION CEFOTAN ASTRAZENECA
EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL CEFOTAN IN PLASTIC CONTAINER ASTRAZENECA EQ 20MG BASE/ML EQ 40MG BASE/ML
CEFOTIAM HYDROCHLORIDE
INJECTABLE; INJECTION CERADON TAKEDA
EQ 1GM BASE/VIAL
N050601
001
CEFOXITIN SODIUM
INJECTABLE; INJECTION MEFOXIN BIONICHE PHARMA MYLAN
EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL INSTITUTIONAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL IN DEXTROSE 5% IN PLASTIC CONTAINER EQ 20MG BASE/ML EQ 40MG BASE/ML IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER EQ 20MG BASE/ML EQ 40MG BASE/ML
Sep 20, 1984 Sep 20, 1984 Sep 20, 1984 Sep 20, 1984
CEFPIRAMIDE SODIUM
INJECTABLE; INJECTION CEFPIRAMIDE SODIUM WYETH AYERST
CEFPODOXIME PROXETIL
FOR SUSPENSION; ORAL BANAN SANKYO
N050688 N050688
002 001
6 - 63 (of 346)
N050675 N050675
001 002
Aug 07, 1992 Aug 07, 1992 Aug 07, 1992 Aug 07, 1992
CEFPROZIL
FOR SUSPENSION; ORAL CEFZIL BRISTOL MYERS SQUIBB TABLET; ORAL CEFZIL BRISTOL MYERS SQUIBB
125MG/5ML 250MG/5ML
N050665 N050665
001 002
250MG 500MG
N050664 N050664
001 002
CEFTAZIDIME
INJECTABLE; INJECTION CEPTAZ GLAXOSMITHKLINE
500MG/VIAL 1GM/VIAL 2GM/VIAL 10GM/VIAL 1GM/VIAL 1GM/VIAL 2GM/VIAL 2GM/VIAL 6GM/VIAL 10GM/VIAL
N050646 N050646 N050646 N050646 A063322 A064006 A063322 A064006 A064008 A064008 A062655 A062655 A062739 A062739
001 002 003 004 001 001 002 002 001 002 001 002 001 002
Sep Sep Sep Sep Nov Mar Nov Mar Mar Mar
27, 27, 27, 27, 07, 31, 07, 31, 31, 31,
1990 1990 1990 1990 1995 1992 1995 1992 1992 1992
PENTACEF GLAXOSMITHKLINE
TAZIDIME LILLY
Nov 20, 1985 Nov 20, 1985 Jul 10, 1986 Jul 10, 1986
CEFTAZIDIME SODIUM
INJECTABLE; INJECTION CEFTAZIDIME SODIUM IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 10MG BASE/ML EQ 20MG BASE/ML EQ 40MG BASE/ML FORTAZ IN PLASTIC CONTAINER GLAXOSMITHKLINE EQ 10MG BASE/ML
Apr 29, 1993 Apr 29, 1993 Apr 29, 1993 Apr 28, 1989
CEFTIBUTEN DIHYDRATE
FOR SUSPENSION; ORAL CEDAX PERNIX THERAP
EQ 180MG BASE/5ML
N050686
002
CEFTIZOXIME SODIUM
INJECTABLE; INJECTION CEFIZOX ASTELLAS
N050560 A063294
001 002
6 - 64 (of 346)
EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL DEXTROSE 5% IN PLASTIC CONTAINER EQ 20MG BASE/ML EQ 40MG BASE/ML PLASTIC CONTAINER EQ 20MG BASE/ML EQ 40MG BASE/ML
Oct 03, 1984 Oct 03, 1984 Apr 13, 1995 Apr 13, 1995
CEFTRIAXONE SODIUM
INJECTABLE; ****** ROCEPHIN HOFFMANN LA ROCHE
INJECTABLE; IM-IV ROCEPHIN HOFFMANN LA ROCHE INJECTABLE; INJECTION ROCEPHIN HOFFMANN LA ROCHE
EQ 250MG BASE/VIAL
N050585
001
EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 10GM BASE/VIAL ROCHE EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER HOFFMANN LA ROCHE EQ 10MG BASE/ML EQ 20MG BASE/ML EQ 40MG BASE/ML
A063239 A062654 A062654 A062654 N050585 A062510 A062510 A062510 N050624 N050624 N050624
001 001 002 003 005 001 002 003 001 002 003
N050585 N050585
007 006
CEFUROXIME AXETIL
TABLET; ORAL CEFUROXIME AXETIL SANDOZ
A065126 A065126
001 002
CEFUROXIME SODIUM
INJECTABLE; IM-IV CEFUROXIME SODIUM MARSAM PHARMS LLC KEFUROX ACS DOBFAR INJECTABLE; INJECTION CEFUROXIME SODIUM MARSAM PHARMS LLC KEFUROX ACS DOBFAR
A064035 A062591
001 001
Feb 26, 1993 Feb 26, 1993 Jan 10, 1986 Dec 17, 1987
6 - 65 (of 346)
BASE/VIAL BASE/VIAL
A062592 A062590
002 002
BASE/VIAL BASE/VIAL
A062592 A062590
001 001
2.5GM/PACKET 300GM/BOT
N018757 N018757
002 003
CEPHALEXIN
CAPSULE; ORAL CEPHALEXIN APOTHECON
YOSHITOMI KEFLEX SHIONOGI INC FOR SUSPENSION; ORAL CEPHALEXIN APOTHECON BARR FACTA FARMA TEVA
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
250MG 250MG 250MG 500MG 500MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 500MG 250MG 250MG 500MG 500MG 250MG 500MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A062973 A063063 A063186 A062974 A063063 A063186 A062773 A062775 A061969 A061969 A062809 A062809 A062869 A062760 A062821 A062761 A062823 A062872 A062871 N050405
001 001 001 001 002 002 001 001 001 002 001 002 001 001 001 001 001 001 001 004
EQ 333MG BASE
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
125MG 250MG 125MG 250MG 100MG 125MG 125MG 250MG 250MG 125MG 250MG
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062986 A062987 A062778 A062777 A062117 A062767 A062873 A062768 A062867 A062779 A062781 N050406 N050406 N050406
001 001 001 001 001 001 001 001 001 001 001 003 001 002
Apr Jul Aug Aug Jun May Jun Apr Dec Dec
18, 25, 06, 06, 16, 23, 16, 15, 22, 22,
1991 1989 1987 1987 1987 1988 1987 1988 1987 1987
6 - 66 (of 346)
EQ 500MG BASE EQ 1GM BASE 250MG BASE 250MG BASE 500MG BASE 500MG BASE 1GM BASE
Aug 11, 1988 Aug 11, 1988 Dec 01, 1986 Feb 26, 1987 Dec 01, 1986
A065100 A065100
002 001
CEPHALEXIN HYDROCHLORIDE
TABLET; ORAL KEFTAB LILLY
CEPHALOGLYCIN
CAPSULE; ORAL KAFOCIN LILLY
250MG
N050219
001
CEPHALOTHIN SODIUM
INJECTABLE; INJECTION CEPHALOTHIN INTL MEDICATION
EQ EQ EQ EQ
A062426 A062426 A062426 A062426 A062547 A062548 A062547 A062548 A062666 A062666 A062464 A062464 A062464 A062422 A062422 A062730 A062422 A062422 A062730 A062422 A062422 N050482 N050482 N050482 N050482 A062549 A062549
001 002 003 004 001 001 002 002 002 001 001 002 003 003 005 001 004 006 002 001 002 001 002 003 007 001 002
May May May May Sep Sep Sep Sep Jun Jun May May May Jan Jul Mar Jan Jul Mar
03, 03, 03, 03, 11, 11, 11, 11, 10, 10, 07, 07, 07, 31, 16, 05, 31, 16, 05,
1985 1985 1985 1985 1985 1985 1985 1985 1987 1987 1984 1984 1984 1984 1991 1987 1984 1991 1987
EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL ABRAXIS PHARM EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL BRISTOL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 4GM BASE/VIAL CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 20MG BASE/ML EQ 20MG BASE/ML EQ 20MG BASE/ML EQ 40MG BASE/ML EQ 40MG BASE/ML EQ 40MG BASE/ML CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 20MG BASE/ML EQ 40MG BASE/ML KEFLIN LILLY EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 4GM BASE/VIAL EQ 20GM BASE/VIAL KEFLIN IN PLASTIC CONTAINER LILLY EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL
6 - 67 (of 346)
CEPHAPIRIN SODIUM
INJECTABLE; INJECTION CEFADYL APOTHECON
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 20GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 20GM BASE/VIAL
A062961 N050446 A061769 A062724 A062961 N050446 A061769 A062724 A062961 N050446 A061769 A062961 N050446 N050446 A062723 A062723 A062723 A062723 A062723 A062720 A062720 A062720 A062720
001 005 001 001 002 001 002 002 003 002 003 004 003 004 001 002 003 004 005 001 002 003 004
BAXTER HLTHCARE
CEPHRADINE
CAPSULE; ORAL ANSPOR GLAXOSMITHKLINE CEPHRADINE BARR IVAX SUB TEVA PHARMS TEVA VITARINE VELOSEF APOTHECON VELOSEF '250' ERSANA VELOSEF '500' ERSANA FOR SUSPENSION; ORAL ANSPOR GLAXOSMITHKLINE CEPHRADINE BARR
250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG
A061859 A061859 A062850 A062851 A062762 A062762 A062683 A062683 A062813 A062813 A061764 A061764 N050548 N050548
001 002 001 001 001 002 001 002 001 002 001 002 001 002 Apr Apr Mar Mar Jan Jan Feb Feb 22, 22, 06, 06, 09, 09, 25, 25, 1988 1988 1987 1987 1987 1987 1988 1988
001 002 001 001 May 19, 1988 May 19, 1988
6 - 68 (of 346)
1GM
N050530
001
CERIVASTATIN SODIUM
TABLET; ORAL BAYCOL BAYER PHARMS
CERULETIDE DIETHYLAMINE
INJECTABLE; INJECTION TYMTRAN PHARMACIA AND UPJOHN
0.02MG/ML
N018296
001
CETIRIZINE HYDROCHLORIDE
SYRUP; ORAL CETIRIZINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 5MG/5ML CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY ACTAVIS MID ATLANTIC 5MG/5ML CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF ACTAVIS MID ATLANTIC 5MG/5ML
N020044
001
CHENODIOL
TABLET; ORAL CHENIX SIGMA TAU
250MG
N018513
002
CHLOPHEDIANOL HYDROCHLORIDE
SYRUP; ORAL ULO 3M
25MG/5ML
N012126
001
CHLORAMPHENICOL
CAPSULE; ORAL AMPHICOL FERRANTE
100MG
A060058
001
6 - 69 (of 346)
MYCHEL ARMENPHARM 250MG CREAM; TOPICAL CHLOROMYCETIN PARKE DAVIS 1% FOR SOLUTION; OPHTHALMIC CHLOROMYCETIN PARKEDALE 25MG/VIAL INJECTABLE; INJECTION CHLOROMYCETIN PARKE DAVIS 250MG/ML OINTMENT; OPHTHALMIC CHLORAMPHENICOL ALTANA 1% CHLOROFAIR PHARMAFAIR 1% CHLOROMYCETIN PARKEDALE 1% CHLOROPTIC S.O.P. ALLERGAN 1% ECONOCHLOR ALCON 1% SOLUTION/DROPS; OPHTHALMIC CHLORAMPHENICOL AKORN 0.5% ALCON 0.5% CHLOROFAIR PHARMAFAIR 0.5% CHLOROPTIC ALLERGAN 0.5% ECONOCHLOR ALCON 0.5% OPHTHOCHLOR PARKEDALE 0.5% OPTOMYCIN OPTOPICS 0.5% SOLUTION/DROPS; OTIC CHLOROMYCETIN PARKEDALE 0.5%
N050183
001
N050143
001
N050153
001
N050205
001
CHLORAMPHENICOL PALMITATE
SUSPENSION; ORAL CHLOROMYCETIN PALMITATE PARKE DAVIS EQ 150MG BASE/5ML EQ 150MG BASE/5ML
A062301 N050152
001 001
6 - 70 (of 346)
EQ 1GM BASE/VIAL
A060132
001
N050294
001
N050202
001
10MG/GM;5MG/GM;10,000 UNITS/GM
N050201
002
1%;10,000 UNITS/GM
N050203
002
CHLORAMPHENICOL; PREDNISOLONE
OINTMENT; OPHTHALMIC CHLOROPTIC-P S.O.P. ALLERGAN
1%;0.5%
A061188
001
CHLORDIAZEPOXIDE
CAPSULE, EXTENDED RELEASE; ORAL LIBRELEASE VALEANT PHARM INTL 30MG TABLET; ORAL LIBRITABS VALEANT PHARM INTL 5MG 10MG 25MG
N017813
001
CHLORDIAZEPOXIDE HYDROCHLORIDE
CAPSULE; ORAL A-POXIDE ABBOTT
A085447 A085517 A085447 A085518 A085447 A085513 A085086 A084639 A085087 A087525 A087524 A087512 A085118 A085119 A085120 A085340 A085339 A084685
001 001 002 001 003 001 001 001 001 001 001 001 001 001 001 001 001 001 Jan 07, 1982 Jan 07, 1982 Jan 07, 1982
5MG 10MG 25MG CHLORDIAZEPOXIDE HYDROCHLORIDE ASCOT 5MG 10MG 25MG FERRANTE 5MG 10MG 25MG HALSEY 5MG 10MG 25MG
CHLORDIAZACHEL RACHELLE
6 - 71 (of 346)
A086213 A085113 A086212 A083741 A083742 A083570 A086892 A087234 A086876 A087037 A086893 A087231 A086217 A084886 A084601 A084887 A085163 A084598 A085164 A089533 A089558 A085155 A084939 A085144 A084706 A084700 A084705 A084678 A084919 A084041 A084920 A084679 A084823 A088987 A088986 A088988 A088705 A088706 A086494 A088707 A084644 A084645 A088129 A088010 A088130 A085014 A085000 A085294 N012249 N012249 N012249 A085107 A085009 A085108
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 003 001 001 001
N012301
001
6 - 72 (of 346)
CHLORHEXIDINE GLUCONATE
SOLUTION; TOPICAL EXIDINE XTTRIUM MICRODERM J AND J PREVACARE R J AND J STERI-STAT MATRIX MEDCL SPONGE; TOPICAL CHLORHEXIDINE GLUCONATE KENDALL IL E-Z SCRUB BECTON DICKINSON HIBICLENS MOLNLYCKE HLTH MICRODERM J AND J
2.5% 4% 0.5% 4%
Dec 17, 1985 Apr 15, 1991 Jan 28, 1992 Jul 24, 1986
4% 4% 4% 4%
CHLORMERODRIN HG-197
INJECTABLE; INJECTION CHLORMERODRIN HG 197 BRACCO
0.6-1.4mCi/ML
N017269
001
CHLORMEZANONE
TABLET; ORAL TRANCOPAL SANOFI AVENTIS US
100MG 200MG
N011467 N011467
003 005
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION NESACAINE-MPF APP PHARMS
2% 3%
N009435 N009435
003 004
CHLOROQUINE HYDROCHLORIDE
INJECTABLE; INJECTION ARALEN HYDROCHLORIDE SANOFI AVENTIS US
EQ 40MG BASE/ML
N006002
002
CHLOROQUINE PHOSPHATE
TABLET; ORAL CHLOROQUINE PHOSPHATE MD PHARM PUREPAC PHARM TEVA WATSON LABS
EQ EQ EQ EQ EQ
6 - 73 (of 346)
N014860
002
CHLOROTHIAZIDE
TABLET; ORAL CHLOROTHIAZIDE ABC HOLDING LEDERLE SANDOZ WATSON LABS
250MG 250MG 500MG 250MG 250MG 250MG 250MG 500MG 500MG 250MG 500MG
A085569 A086940 A086938 A085485 A085165 A085173 A086795 A084026 A086796 N011145 N011145
001 001 001 001 001 001 001 001 001 004 002
CHLOROTHIAZIDE; METHYLDOPA
TABLET; ORAL ALDOCLOR-150 MERCK 150MG;250MG ALDOCLOR-250 MERCK 250MG;250MG METHYLDOPA AND CHLOROTHIAZIDE PAR PHARM 150MG;250MG 250MG;250MG
001 002 001 001 Nov 06, 1987 Nov 06, 1987
CHLOROTHIAZIDE; RESERPINE
TABLET; ORAL CHLOROTHIAZIDE AND RESERPINE WEST WARD 250MG;0.125MG 500MG;0.125MG CHLOROTHIAZIDE W/ RESERPINE WATSON LABS 250MG;0.125MG 500MG;0.125MG CHLOROTHIAZIDE-RESERPINE MYLAN 250MG;0.125MG 500MG;0.125MG DIUPRES-250 MERCK 250MG;0.125MG DIUPRES-500 MERCK 500MG;0.125MG
Jun 09, 1983 May 06, 1982 May 06, 1982 Aug 26, 1987 Aug 26, 1987
CHLOROTRIANISENE
CAPSULE; ORAL CHLOROTRIANISENE BANNER PHARMACAPS TACE SANOFI AVENTIS US
CHLOROXINE
SHAMPOO; TOPICAL CAPITROL WESTWOOD SQUIBB
2%
N017594
001
6 - 74 (of 346)
400MG
N014217
002
CHLORPHENIRAMINE MALEATE
CAPSULE, EXTENDED RELEASE; ORAL CHLORPHENIRAMINE MALEATE SANDOZ 12MG TELDRIN GLAXOSMITHKLINE 8MG 12MG INJECTABLE; INJECTION CHLORPHENIRAMINE MALEATE BEL MAR 10MG/ML ELKINS SINN 10MG/ML WATSON LABS 10MG/ML 10MG/ML 100MG/ML CHLOR-TRIMETON SCHERING PLOUGH 10MG/ML 100MG/ML PYRIDAMAL 100 BEL MAR 100MG/ML SYRUP; ORAL CHLORPHENIRAMINE MALEATE PHARM ASSOC 2MG/5ML CHLOR-TRIMETON SCHERING 2MG/5ML TABLET; ORAL ANTAGONATE BAYER PHARMS 4MG CHLORPHENIRAMINE MALEATE ANABOLIC 4MG BELL PHARMA 4MG ELKINS SINN 4MG IMPAX LABS 4MG IVAX SUB TEVA PHARMS 4MG KV PHARM 4MG LEDERLE 4MG MUTUAL PHARM 4MG NEWTRON PHARMS 4MG PANRAY 4MG PHARMAVITE 4MG PHARMERAL 4MG PIONEER PHARMS 4MG PUREPAC PHARM 4MG PVT FORM 4MG ROXANE 4MG SANDOZ 4MG VITARINE 4MG WATSON LABS 4MG 4MG 4MG WEST WARD 4MG CHLOR-TRIMETON SCHERING 4MG KLOROMIN HALSEY 4MG PHENETRON LANNETT 4MG TABLET, EXTENDED RELEASE; ORAL CHLOR-TRIMETON SCHERING PLOUGH 8MG
A087520 N006921
001 006
A083381 A083078 A083062 A080938 A080809 A080779 A087164 A086941 A080700 A086519 A083243 A085104 A083753 A088556 A086306 A080786 A080626 A080961 A085837 A080696 A080791 A085139 A083787 N006921 A083629 A080846
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001
N007638
001
6 - 75 (of 346)
N019746
002
Sep 29, 1987 Jan 26, 1989 Apr 25, 1985 Apr 23, 1985
Apr 15, 1985 Mar 06, 1986 Aug Mar Mar Mar 02, 20, 18, 01, 1988 1985 1985 1989
N021369 N018928
001 001
N018050
001
CHLORPHENTERMINE HYDROCHLORIDE
TABLET; ORAL PRE-SATE PARKE DAVIS
EQ 65MG BASE
N014696
001
6 - 76 (of 346)
25MG 100MG
N009149 N009149
024 033
CHLORPROMAZINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL THORAZINE GLAXOSMITHKLINE 30MG 75MG 150MG 200MG 300MG CONCENTRATE; ORAL CHLORPROMAZINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 100MG/ML PHARM ASSOC 30MG/ML 100MG/ML WOCKHARDT 30MG/ML 100MG/ML CHLORPROMAZINE HYDROCHLORIDE INTENSOL ROXANE 30MG/ML 100MG/ML SONAZINE SANDOZ 30MG/ML 100MG/ML THORAZINE GLAXOSMITHKLINE 30MG/ML 100MG/ML INJECTABLE; INJECTION CHLORPROMAZINE HYDROCHLORIDE ABRAXIS PHARM 25MG/ML MARSAM PHARMS LLC 25MG/ML WATSON LABS 25MG/ML 25MG/ML WYETH AYERST 25MG/ML THORAZINE GLAXOSMITHKLINE 25MG/ML SYRUP; ORAL CHLORPROMAZINE HYDROCHLORIDE ALPHARMA US PHARMS 10MG/5ML SONAZINE SANDOZ 10MG/5ML THORAZINE GLAXOSMITHKLINE 10MG/5ML TABLET; ORAL CHLORPROMAZINE HYDROCHLORIDE ABBOTT 10MG 25MG 50MG 100MG 200MG IVAX SUB TEVA PHARMS 10MG 25MG 50MG 100MG 200MG KV PHARM 10MG 25MG 50MG 100MG 200MG LEDERLE 10MG
A086863 A040231 A040224 A087032 A087053 A088157 A088158 A080983 A080983 N009149 N009149
001 001 001 001 001 001 001 004 005 032 043
A084414 A084415 A084411 A084412 A084413 A083549 A083549 A083549 A083574 A083575 A085750 A085751 A085484 A085752 A085748 A084803
001 001 001 001 001 001 002 003 001 001 002 001 001 001 002 001
6 - 77 (of 346)
A084801 A084800 A084789 A084802 A080403 A080403 A080403 A080403 A080403 A080340 A080340 A080340 A085331 A085331 A085331 A085331 A085331 A088038 A087645 A087646 A085959 A085956 A085960 A085957 A085958 A087783 A087865 A087878 A087884 A087880 A086886 A084423 A086887 A086888 A086885 N009149 N009149 N009149 N009149 N009149
001 001 001 001 004 001 002 003 005 001 002 003 001 002 003 004 005 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 007 013 018 020
CHLORPROPAMIDE
TABLET; ORAL CHLORPROPAMIDE BARR
CLONMEL HLTHCARE DURAMED PHARMS BARR HALSEY IVAX PHARMS PAR PHARM
100MG 100MG 250MG 250MG 100MG 250MG 100MG 250MG 100MG 250MG 100MG 250MG 100MG 250MG
A088812 A089446 A088813 A089447 A089561 A089562 A088918 A088919 A089321 A088662 A088840 A087353 A088175 A088176
001 001 001 001 001 001 001 001 001 001 001 001 001 001
Oct Nov Oct Nov Sep Sep Oct Oct Jan Jan Oct
19, 17, 19, 17, 04, 04, 16, 16, 16, 09, 25,
1984 1986 1984 1986 1987 1987 1984 1984 1986 1986 1984
6 - 78 (of 346)
100MG 250MG 250MG 100MG 250MG 100MG 100MG 250MG 100MG 100MG 250MG 250MG 250MG
A088725 A084669 A088726 A088694 A088695 A088768 A088708 A088709 A086865 A088608 A086866 A088568 A088641
001 001 001 001 001 001 001 001 001 001 001 001 001
Aug 31, 1984 Aug Sep Sep Oct Aug Aug Sep Apr 31, 17, 17, 11, 30, 30, 24, 12, 1984 1984 1984 1984 1984 1984 1984 1984
GLUCAMIDE TEVA
CHLORPROTHIXENE
CONCENTRATE; ORAL TARACTAN ROCHE INJECTABLE; INJECTION TARACTAN ROCHE TABLET; ORAL TARACTAN ROCHE
100MG/5ML
N016149
002
12.5MG/ML
N012487
001
CHLORTETRACYCLINE HYDROCHLORIDE
OINTMENT; OPHTHALMIC AUREOMYCIN LEDERLE
1%
N050404
001
CHLORTHALIDONE
TABLET; ORAL CHLORTHALIDONE ABBOTT ASCOT CLONMEL HLTHCARE IVAX PHARMS
25MG 50MG 25MG 50MG 25MG 50MG 25MG 25MG 50MG 50MG 25MG 50MG 25MG 25MG 25MG 50MG 50MG 50MG 50MG 25MG 50MG 25MG 50MG
A087364 A087384 A087698 A087699 A087451 A087450 A087555 A088164 A087176 A087947 A087311 A087312 A087292 A089285 A089738 A087293 A089286 A089739 A089591 A088139 A088140 A087380 A087118
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul 21, 1986 Sep 19, 1988 Jul Sep Jul Jul Aug 21, 19, 21, 16, 11, 1986 1988 1988 1986 1983
6 - 79 (of 346)
50MG 25MG 50MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 25MG 25MG 25MG 50MG 50MG 50MG 50MG 25MG 50MG 25MG 25MG
A087381 A087473 A087247 A088651 A089051 A089052 A088012 A088073 A087515 A087516 A087050 A087100 A087296 A087706 A087029 A087082 A087521 A087689 N012283 N012283 A088051 N019574
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 004 003 001 002
25MG;100MG 25MG;200MG
N019451 N019451
001 002
CHLORTHALIDONE; RESERPINE
TABLET; ORAL DEMI-REGROTON SANOFI AVENTIS US REGROTON SANOFI AVENTIS US
25MG;0.125MG 50MG;0.25MG
N015103 N015103
002 001
CHLORZOXAZONE
TABLET; ORAL CHLORZOXAZONE ACTAVIS TOTOWA MUTUAL PHARM OHM LABS PAR PHARM PIONEER PHARMS
6 - 80 (of 346)
May 04, 1988 May 04, 1988 Aug 09, 1982 Jul 29, 1991
CHOLESTYRAMINE
BAR, CHEWABLE; ORAL CHOLYBAR PARKE DAVIS POWDER; ORAL CHOLESTYRAMINE IVAX SUB TEVA PHARMS TEVA TEVA PHARMS CHOLESTYRAMINE LIGHT TEVA TEVA PHARMS QUESTRAN BRISTOL MYERS QUESTRAN LIGHT BRISTOL MYERS TABLET; ORAL QUESTRAN APOTHECON
A071621 A071739
001 001
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
4GM 4GM 4GM 4GM 4GM 4GM 4GM 4GM 4GM 4GM
RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL RESIN/PACKET RESIN/SCOOPFUL
A074771 A074771 A074347 A074347 A074554 A074554 A074348 A074348 A074555 A074555 N016640 N016640 N019669 N019669
001 002 001 002 001 002 001 002 001 002 001 003 001 003
Jul Jul May May Oct Oct May May Sep Sep
09, 09, 28, 28, 02, 02, 28, 28, 30, 30,
1997 1997 1998 1998 1996 1996 1998 1998 1998 1998
A073403 A073403
002 001
CHORIOGONADOTROPIN ALFA
INJECTABLE; INJECTION OVIDREL EMD SERONO
0.25MG/VIAL
N021149
001
CHROMIC CHLORIDE
INJECTABLE; INJECTION CHROMIC CHLORIDE ABRAXIS PHARM
EQ 0.004MG CHROMIUM/ML
N019271
001
5mCi/ML
N017084
001
CHYMOPAPAIN
INJECTABLE; INJECTION CHYMODIACTIN CHART MEDCL
N018663 N018663
002 001
6 - 81 (of 346)
12,500 UNITS/VIAL
N018625
001
CHYMOTRYPSIN
FOR SOLUTION; OPHTHALMIC ALPHA CHYMAR SOLA BARNES HIND CATARASE CIBA NOVARTIS ZOLYSE ALCON
EQ 750MG BASE/VIAL;750MG/VIAL
N050630
002
CILOSTAZOL
TABLET; ORAL CILOSTAZOL ACTAVIS TOTOWA IVAX SUB TEVA PHARMS MUTUAL PHARM
CIMETIDINE
SUSPENSION; ORAL TAGAMET HB 200 GLAXOSMITHKLINE TABLET; ORAL CIMETIDINE ENDO PHARMS
200MG/20ML
N020951
001
LEK PHARMS
PERRIGO ROXANE
SANDOZ
TEVA
200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 100MG 200MG 200MG 300MG 400MG 800MG 100MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 200MG 300MG 400MG 800MG 100MG
A074281 A074281 A074281 A074329 A074401 A074401 A074401 A074402 A075122 A074250 A075122 A074250 A074250 A074250 A074972 A074361 A074361 A074371 A074100 A074100 A074100 A074100 A074365 A074365 A074365 A074365 N020238
001 002 003 001 001 002 003 001 001 001 002 002 003 004 001 001 002 001 001 002 003 004 001 002 003 004 001
May May May May May May May May Jun Jun Jun Jun Jun Jun Jun Dec Dec Dec Jan Jan Jan Jan Feb Feb Feb Feb
17, 17, 17, 17, 30, 30, 30, 30, 19, 29, 19, 29, 29, 29, 19, 23, 23, 23, 31, 31, 31, 31, 28, 28, 28, 28,
1994 1994 1994 1994 1995 1995 1995 1995 1998 1995 1998 1995 1995 1995 1998 1994 1994 1994 1995 1995 1995 1995 1995 1995 1995 1995
TAGAMET HB GLAXOSMITHKLINE
6 - 82 (of 346)
001 001 001 001 001 001 001 005 006 003 004 001 002 002 001
Aug Mar Mar Jan Dec Nov Dec Dec Dec Dec Dec Dec Dec
31, 28, 28, 31, 20, 26, 27, 29, 29, 29, 29, 29, 29,
1994 1997 1997 1995 1994 1997 1994 1994 1994 1994 1994 1994 1994
CINOXACIN
CAPSULE; ORAL CINOBAC LILLY CINOXACIN TEVA
001 002 001 001 Feb 28, 1992 Feb 28, 1992
CIPROFLOXACIN
INJECTABLE; INJECTION CIPRO BAYER HLTHCARE 1200MG/120ML (10MG/ML) CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BAYER PHARMS 200MG/100ML CIPROFLOXACIN APP PHARMS 200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) BEDFORD LABS 200MG/20ML (10MG/ML) 400MG/40ML (10MG/ML) 1200MG/120ML (10MG/ML) CIPROFLOXACIN IN DEXTROSE 5% HIKMA FARMACEUTICA 200MG/100ML CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER BEDFORD 200MG/100ML 400MG/200ML TEVA PHARMS 200MG/100ML 400MG/200ML
N019847 N019858 A076484 A076484 A076992 A076992 A076993 A076757 A078114 A078114 A077138 A077138
003 001 001 002 001 002 001 001 001 002 001 002
Dec 26, 1990 Dec 26, 1990 Aug Aug Aug Aug Aug 28, 28, 28, 28, 28, 2006 2006 2006 2006 2006
Apr 21, 2008 Mar Mar Mar Mar 18, 18, 18, 18, 2008 2008 2008 2008
6 - 83 (of 346)
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A074124 A074124 A074124 A076138 A076138 A076138 A075939 A075939 A076593 A075939 A076593 A075939 A076593 A076136 A076136 A076136
001 002 003 001 002 003 001 002 002 003 003 004 004 001 002 003
Jun Jun Jun Jun Jun Jun Mar Jun Jun Jun Jun Jun Jun Jun Jun Jun
09, 09, 09, 09, 09, 09, 03, 09, 09, 09, 09, 09, 09, 09, 09, 09,
2004 2004 2004 2004 2004 2004 2005 2004 2004 2004 2004 2004 2004 2004 2004 2004
BASE
N021744
001
A078712
001
CISAPRIDE MONOHYDRATE
SUSPENSION; ORAL PROPULSID JANSSEN PHARMS TABLET; ORAL PROPULSID JANSSEN PHARMS
EQ 1MG BASE/ML
N020398
001
EQ 10MG BASE EQ 20MG BASE TABLET, ORALLY DISINTEGRATING; ORAL PROPULSID QUICKSOLV JANSSEN PHARMA EQ 20MG BASE
N020210 N020210
001 002
N020767
001
CISPLATIN
INJECTABLE; INJECTION CISPLATIN BEDFORD PLATINOL CORDEN PHARMA PLATINOL-AQ CORDEN PHARMA
CITALOPRAM HYDROBROMIDE
SOLUTION; ORAL CITALOPRAM HYDROBROMIDE APOTEX INC EQ 10MG BASE/5ML TABLET; ORAL CELEXA FOREST LABS EQ 60MG BASE CITALOPRAM HYDROBROMIDE ACTAVIS ELIZABETH EQ 10MG BASE EQ 20MG BASE EQ 40MG BASE MUTUAL PHARM EQ 10MG BASE
A077601
001
Jul 17, 1998 Oct Oct Oct Jul 28, 28, 28, 03, 2004 2004 2004 2006
6 - 84 (of 346)
A077052 A077052 A077041 A077041 A077041 A077040 A077040 A077040 A077278 A077278 A077278 A077213 A077213 A077213
002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jul Jul Nov Nov Nov Aug Aug Aug Mar Mar Mar Mar Mar Mar
03, 03, 23, 23, 23, 17, 17, 17, 22, 22, 22, 31, 31, 31,
2006 2006 2004 2004 2004 2005 2005 2005 2006 2006 2006 2006 2006 2006
N018519 N018904
001 001
CLARITHROMYCIN
FOR SUSPENSION; ORAL BIAXIN ABBOTT TABLET; ORAL CLARITHROMYCIN IVAX SUB TEVA PHARMS
187MG/5ML
N050698
003
A065137 A065137
001 002
A065210
001
CLEMASTINE FUMARATE
SYRUP; ORAL CLEMASTINE FUMARATE ACTAVIS MID ATLANTIC TEVA PHARMS TAVIST NOVARTIS TABLET; ORAL CLEMASTINE FUMARATE TEVA TAVIST NOVARTIS TAVIST-1 NOVARTIS
N018298 N018298
001 002
6 - 85 (of 346)
N020640
001
CLIDINIUM BROMIDE
CAPSULE; ORAL QUARZAN ROCHE
2.5MG 5MG
N010355 N010355
001 002
CLINDAMYCIN HYDROCHLORIDE
CAPSULE; ORAL CLEOCIN PHARMACIA AND UPJOHN
001 002 001 001 Sep 20, 1989 Jul 31, 1991
EQ 75MG BASE/5ML
A061827
001
CLINDAMYCIN PHOSPHATE
CREAM; VAGINAL CLEOCIN PHARMACIA AND UPJOHN INJECTABLE; INJECTION CLEOCIN PHOSPHATE PHARMACIA AND UPJOHN CLINDAMYCIN PHOSPHATE ABRAXIS PHARM ASTRAZENECA BAXTER HLTHCARE
EQ 2% BASE
N050680
001
EQ 150MG BASE/ML
A061839 A062747 A062928 A062806 A062953 A063068 A063163 A062908 A062905 A062913 A062819 A062852 A063041 A063282 A062900 A063079 N050636 A065027 A065027 A065027 N050648 N050648 N050648
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 003 Jun Feb Oct Apr Aug Jun Feb May Oct Mar Mar Dec May Jun Mar 03, 13, 15, 21, 28, 30, 01, 09, 20, 15, 17, 29, 29, 08, 05, 1988 1989 1987 1988 1989 1994 1989 1988 1988 1988 1988 1989 1992 1988 1990
EQ 150MG BASE/ML EQ 150MG BASE/ML EQ 150MG BASE/ML EQ 150MG BASE/ML EQ 150MG BASE/ML BEDFORD EQ 150MG BASE/ML BRISTOL MYERS SQUIBB EQ 150MG BASE/ML LOCH EQ 150MG BASE/ML MARSAM PHARMS LLC EQ 150MG BASE/ML SOLOPAK EQ 150MG BASE/ML EQ 150MG BASE/ML TEVA PARENTERAL EQ 150MG BASE/ML EQ 150MG BASE/ML WATSON LABS EQ 150MG BASE/ML EQ 150MG BASE/ML CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% ABRAXIS PHARM EQ 12MG BASE/ML CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER ABBOTT EQ 6MG BASE/ML EQ 12MG BASE/ML EQ 18MG BASE/ML BAXTER HLTHCARE EQ 6MG BASE/ML EQ 12MG BASE/ML EQ 900MG BASE/100ML SOLUTION; TOPICAL CLEOCIN T PHARMACIA AND UPJOHN EQ 1% BASE CLINDAMYCIN PHOSPHATE ACTAVIS MID ATLANTIC EQ 1% BASE BOCA PHARMA EQ 1% BASE
Dec 22, 1989 Jun Jun Jun Dec Dec Dec 29, 29, 29, 29, 29, 29, 2001 2001 2001 1989 1989 1989
6 - 86 (of 346)
EQ 1% BASE EQ 1% BASE
A062944 A064108
001 001
CLIOQUINOL; NYSTATIN
OINTMENT; TOPICAL NYSTAFORM BAYER PHARMS
10MG/GM;100,000 UNITS/GM
N050235
001
CLOBETASOL PROPIONATE
CREAM; TOPICAL CLOBETASOL PROPIONATE ACTAVIS MID ATLANTIC 0.05% COREPHARMA 0.05% CLOBETASOL PROPIONATE (EMOLLIENT) COREPHARMA 0.05% OINTMENT; TOPICAL CLOBETASOL PROPIONATE ACTAVIS MID ATLANTIC 0.05% COREPHARMA 0.05% SOLUTION; TOPICAL CLOBETASOL PROPIONATE ACTAVIS MID ATLANTIC 0.05%
A074128 A075057
001 001
A074331
001
CLOFAZIMINE
CAPSULE; ORAL LAMPRENE NOVARTIS
100MG
N019500
001
CLOFIBRATE
CAPSULE; ORAL ATROMID-S WYETH AYERST CLOFIBRATE BANNER PHARMACAPS SANDOZ TEVA USL PHARMA WATSON LABS
002 001 001 001 001 001 Mar May Jul Jun Sep 20, 02, 25, 16, 18, 1992 1988 1991 1986 1987
CLOMIPHENE CITRATE
TABLET; ORAL MILOPHENE MILEX
50MG
A072196
001
CLOMIPRAMINE HYDROCHLORIDE
CAPSULE; ORAL CLOMIPRAMINE HYDROCHLORIDE SANDOZ 25MG 50MG 75MG TEVA 25MG 50MG 75MG WATSON LABS 25MG 25MG 50MG 50MG 75MG 75MG
A074953 A074953 A074953 A074849 A074849 A074849 A074600 A074751 A074600 A074751 A074600 A074751
001 002 003 001 002 003 001 001 002 002 003 003
Jun Jun Jun Apr Apr Apr Nov Sep Nov Sep Nov Sep
25, 25, 25, 04, 04, 04, 27, 30, 27, 30, 27, 30,
1997 1997 1997 1997 1997 1997 1996 1998 1996 1998 1996 1998
6 - 87 (of 346)
TEVA
0.125MG 0.25MG TABLET, ORALLY DISINTEGRATING; ORAL KLONOPIN RAPIDLY DISINTEGRATING ROCHE 0.125MG 0.25MG 0.5MG 1MG 2MG
KLONOPIN ROCHE
CLONIDINE
SUSPENSION, EXTENDED RELEASE; ORAL CLONIDINE TRIS PHARMA INC EQ 0.09MG BASE/ML TABLET, EXTENDED RELEASE; ORAL CLONIDINE TRIS PHARMA INC EQ 0.17MG BASE EQ 0.26MG BASE
N022499
001
N022500 N022500
001 002
CLONIDINE HYDROCHLORIDE
TABLET; ORAL CLONIDINE HYDROCHLORIDE AM THERAP 0.1MG 0.2MG 0.3MG DURAMED PHARMS BARR 0.1MG 0.2MG 0.3MG INTERPHARM 0.1MG 0.2MG 0.3MG PAR PHARM 0.1MG 0.2MG 0.3MG SANDOZ 0.1MG 0.2MG 0.3MG TEVA 0.1MG 0.2MG 0.3MG WARNER CHILCOTT 0.1MG 0.2MG 0.3MG WATSON LABS 0.1MG 0.1MG 0.2MG 0.2MG 0.3MG TABLET, EXTENDED RELEASE; ORAL JENLOGA SHIONOGI INC 0.1MG 0.2MG KAPVAY SHIONOGI INC 0.2MG
A070881 A070882 A070883 A071103 A071102 A071101 A071252 A071253 A071254 A070461 A070460 A070459 A070887 A070886 A071294 A070747 A070702 A070659 A072138 A072139 A072140 A070395 A070965 A070396 A070964 A070397
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul Jul Jul Aug Aug Aug Oct Oct Oct Jul Jul Jul Aug Aug Aug Jul Jul Jul Jun Jun Jun Mar Jul Mar Jul Mar
08, 08, 08, 14, 14, 14, 01, 01, 01, 08, 08, 08, 31, 31, 31, 08, 08, 08, 13, 13, 13, 23, 08, 23, 08, 23,
1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1988 1988 1988 1986 1986 1986 1988 1988 1988 1987 1986 1987 1986 1987
6 - 88 (of 346)
EQ 75MG BASE
A076273
001
CLORAZEPATE DIPOTASSIUM
CAPSULE; ORAL CLORAZEPATE DIPOTASSIUM ABLE 3.75MG 7.5MG 15MG AM THERAP 3.75MG 7.5MG 15MG CLONMEL HLTHCARE 3.75MG 7.5MG 15MG GD SEARLE LLC 3.75MG 7.5MG 15MG MYLAN 3.75MG 7.5MG 15MG PUREPAC PHARM 3.75MG 7.5MG 15MG QUANTUM PHARMICS 3.75MG 7.5MG 15MG SANDOZ 3.75MG 7.5MG 15MG USL PHARMA 3.75MG 7.5MG 15MG WARNER CHILCOTT 3.75MG 7.5MG 15MG WATSON LABS 3.75MG 7.5MG 15MG TRANXENE LUNDBECK INC 3.75MG 7.5MG 15MG TABLET; ORAL CLORAZEPATE DIPOTASSIUM ABLE 3.75MG 7.5MG 15MG AM THERAP 3.75MG 7.5MG 15MG LEDERLE 3.75MG 7.5MG 15MG PUREPAC PHARM 3.75MG 7.5MG 15MG QUANTUM PHARMICS 3.75MG 7.5MG 15MG SANDOZ 3.75MG
A071777 A071778 A071779 A071429 A071430 A071431 A071742 A071743 A071744 A071727 A071728 A071729 A071509 A071510 A071511 A071924 A071925 A071926 A071549 A071550 A071522 A072219 A072220 A072112 A071242 A071243 A071244 A071774 A071775 A071776 A071878 A071879 A071860 N017105 N017105 N017105
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003
Jul Jul Jul Jun Jun Jun Dec Dec Dec Dec Dec Dec Oct Oct Oct Apr Apr Apr Sep Sep Sep Aug Aug Aug Jun Jun Jun Mar Mar Mar Mar Mar Mar
14, 14, 14, 23, 23, 23, 14, 14, 14, 18, 18, 18, 19, 19, 19, 25, 25, 25, 12, 12, 12, 26, 26, 26, 23, 23, 23, 01, 01, 01, 15, 15, 15,
1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1988 1988 1988 1988 1988 1988 1988 1988 1988 1987 1987 1987 1988 1988 1988 1988 1988 1988
A071780 A071781 A071782 A071747 A071748 A071749 A072013 A072014 A072015 A072330 A072331 A072332 A071730 A071731 A071702 A072512
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jun Jun Jun Jun Jun Jun Dec Dec Dec Aug Aug Aug Oct Oct Oct May
26, 26, 26, 23, 23, 23, 15, 15, 15, 08, 08, 08, 26, 26, 26, 11,
1987 1987 1987 1987 1987 1987 1987 1987 1987 1988 1988 1988 1987 1987 1987 1990
6 - 89 (of 346)
CLOTRIMAZOLE
CREAM; TOPICAL LOTRIMIN SCHERING PLOUGH MYCELEX BAYER PHARMS LOTION; TOPICAL LOTRIMIN SCHERING SOLUTION; TOPICAL LOTRIMIN SCHERING PLOUGH TABLET; VAGINAL GYNIX TEVA PHARMS MYCELEX-G BAYER PHARMS
1% 1%
N017619 N018183
001 001
1%
N018813
001
1%
N017613
001
100MG 500MG
A073249 N019069
001 001
CLOXACILLIN SODIUM
CAPSULE; ORAL CLOXACILLIN SODIUM APOTHECON TEVA CLOXAPEN GLAXOSMITHKLINE
EQ EQ EQ EQ EQ EQ EQ EQ
CLOZAPINE
TABLET; ORAL CLOZAPINE PAR PHARM
25MG 100MG SANDOZ 25MG 100MG TABLET, ORALLY DISINTEGRATING; ORAL FAZACLO ODT AZUR PHARMA INTL 50MG
N021590
003
6 - 90 (of 346)
N/A;N/A;N/A;N/A
N016089
001
N/A;N/A;N/A;N/A
N016090
001
Apr 02, 1984 Mar 02, 1987 Nov 22, 1985 Jan 04, 1985
COLCHICINE; PROBENECID
TABLET; ORAL COLBENEMID MERCK 0.5MG;500MG PROBEN-C WATSON LABS 0.5MG;500MG PROBENECID AND COLCHICINE BEECHAM 0.5MG;500MG IMPAX LABS 0.5MG;500MG IVAX SUB TEVA PHARMS 0.5MG;500MG SANDOZ 0.5MG;500MG PROBENECID W/ COLCHICINE LEDERLE 0.5MG;500MG WATSON LABS 0.5MG;500MG
COLESEVELAM HYDROCHLORIDE
CAPSULE; ORAL WELCHOL DAIICHI SANKYO
375MG
N021141
001
COLISTIN SULFATE
SUSPENSION; ORAL COLY-MYCIN S PARKE DAVIS
EQ 25MG BASE/5ML
N050355
001
6 - 91 (of 346)
N021697
001
COPPER
INTRAUTERINE DEVICE; INTRAUTERINE CU-7 GD SEARLE LLC 89MG TATUM-T GD SEARLE LLC 120MG
N017408 N018205
001 001
CORTICOTROPIN
INJECTABLE; INJECTION ACTH PARKEDALE ACTHAR SANOFI AVENTIS US CORTICOTROPIN ORGANICS LAGRANGE
N008317 N008317 N007504 N007504 N010831 N010831 A088772 N008372 N008975 N008975
CORTICOTROPIN-ZINC HYDROXIDE
INJECTABLE; INJECTION CORTROPHIN-ZINC ORGANON USA INC
40 UNITS/ML
N009854
001
CORTISONE ACETATE
INJECTABLE; INJECTION CORTISONE ACETATE PHARMACIA AND UPJOHN WATSON LABS
CORTONE MERCK TABLET; ORAL CORTISONE ACETATE BARR ELKINS SINN EVERYLIFE HEATHER IMPAX LABS INWOOD LABS IVAX SUB TEVA PHARMS LANNETT PANRAY PHARMACIA AND UPJOHN
PUREPAC PHARM
25MG 25MG 25MG 25MG 25MG 25MG 25MG 25MG 25MG 5MG 25MG 5MG 10MG 25MG 25MG
A083471 A080836 A084246 A085736 N009458 A080731 A080630 A083536 A080694 N008284 N008284 N008126 N008126 N008126 A080493
001 001 001 001 001 001 001 001 001 002 001 003 004 001 001
6 - 92 (of 346)
CROMOLYN SODIUM
CAPSULE; INHALATION INTAL SANOFI AVENTIS US 20MG CAPSULE; ORAL GASTROCROM UCB INC 100MG CONCENTRATE; ORAL CROMOLYN SODIUM GENERA PHARMS 100MG/5ML SOLUTION; INHALATION CROMOLYN SODIUM ACTAVIS MID ATLANTIC 10MG/ML PHARMASCIENCE INC 10MG/ML ROXANE 10MG/ML INTAL KING PHARMS 10MG/ML SOLUTION/DROPS; OPHTHALMIC CROMOPTIC KING PHARMS 4% SPRAY, METERED; NASAL CROMOLYN SODIUM ACTAVIS MID ATLANTIC 5.2MG/SPRAY NASALCROM BLACKSMITH BRANDS 5.2MG/SPRAY
N016990
001
N019188
001
A090954
001
Jul 19, 1999 Apr 21, 2000 Sep 30, 1999 May 28, 1982
A075088
001
A074800 N020463
001 001
CRYPTENAMINE ACETATES
INJECTABLE; INJECTION UNITENSEN MEDPOINTE PHARM HLC
260CSR UNIT/ML
N008814
001
CRYPTENAMINE TANNATES
TABLET; ORAL UNITENSEN MEDPOINTE PHARM HLC
260CSR UNIT
N009217
001
CUPRIC SULFATE
INJECTABLE; INJECTION CUPRIC SULFATE ABRAXIS PHARM
EQ 0.4MG COPPER/ML
N019350
001
CYANOCOBALAMIN
GEL, METERED; NASAL NASCOBAL PAR PHARM INJECTABLE; INJECTION BERUBIGEN PHARMACIA AND UPJOHN BETALIN 12 LILLY COBAVITE WATSON LABS
0.5MG/INH
N019722
001
6 - 93 (of 346)
0.03MG/ML 0.1MG/ML 1MG/ML 1MG/ML 0.1MG/ML 1MG/ML 1MG/ML 0.03MG/ML 0.1MG/ML 1MG/ML 0.03MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML 0.1MG/ML 0.1MG/ML 1MG/ML 1MG/ML 0.1MG/ML 1MG/ML 1MG/ML 0.03MG/ML 0.05MG/ML 0.1MG/ML 0.12MG/ML 1MG/ML 0.1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/ML
A080510 A080510 A080510 A087969 A080557 A080515 A040451 A080689 A080689 A080689 A080668 A083075 A080564 A087551 N007085 A080573 A083120 A080573 A083120 A080554 A080554 N006668 N010791 N010791 N010791 N010791 N010791 N006799 N006799 N006799 A080570 N007012
003 001 002 001 002 002 001 001 002 003 001 001 001 001 002 002 001 001 002 001 002 010 004 001 002 005 003 002 004 010 002 002
RUVITE SAVAGE LABS VI-TWEL BAYER HLTHCARE SPRAY, METERED; NASAL CALOMIST PAR PHARM TABLET; ORAL CYANOCOBALAMIN WEST WARD
25MCG/SPRAY
N022102
001
1MG
A084264
001
CYANOCOBALAMIN CO-57
CAPSULE; ORAL RUBRATOPE-57 BRACCO
0.5-1uCi
N016089
002
CYANOCOBALAMIN CO-60
CAPSULE; ORAL RUBRATOPE-60 BRACCO
0.5-1uCi
N016090
002
N/A;N/A;N/A
N017406
001
6 - 94 (of 346)
N016635
001
0.5MG/ML;2.3MG/ML;1MG/ML
N011208
001
CYCLACILLIN
FOR SUSPENSION; ORAL CYCLAPEN-W WYETH AYERST
CYCLIZINE LACTATE
INJECTABLE; INJECTION MAREZINE GLAXOSMITHKLINE
50MG/ML
N009495
001
CYCLOBENZAPRINE HYDROCHLORIDE
TABLET; ORAL CYCLOBENZAPRINE HYDROCHLORIDE SANDOZ 10MG WATSON LABS 10MG 10MG
CYCLOPENTOLATE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC AK-PENTOLATE AKORN 1% CYCLOPENTOLATE HYDROCHLORIDE ALCON UNIVERSAL 1% SOLA BARNES HIND 1% 1% PENTOLAIR PHARMAFAIR 0.5% 1%
CYCLOPHOSPHAMIDE
INJECTABLE; INJECTION CYCLOPHOSPHAMIDE BAXTER HLTHCARE
100MG/VIAL 200MG/VIAL 500MG/VIAL 1GM/VIAL 100MG/VIAL 200MG/VIAL 100MG/VIAL 200MG/VIAL 500MG/VIAL 1GM/VIAL
A088371 A088372 A088373 A088374 N012142 N012142 N012142 N012142 N012142 N012142
001 001 001 001 001 002 006 007 008 010
6 - 95 (of 346)
2GM/VIAL 100MG/VIAL 100MG/VIAL 200MG/VIAL 200MG/VIAL 500MG/VIAL 500MG/VIAL 1GM/VIAL 1GM/VIAL 2GM/VIAL 2GM/VIAL
N012142 A040015 A087442 A040015 A087442 A040015 A087442 A040015 A087442 A040015 A087442
009 001 001 002 002 003 003 004 004 005 005
Dec 10, 1985 Apr Feb Apr Feb Apr Feb Apr Jul Apr Mar 29, 16, 29, 16, 29, 16, 29, 08, 29, 30, 1993 1982 1993 1982 1993 1982 1993 1983 1993 1989
25MG 50MG
N012141 N012141
002 001
CYCLOSPORINE
CAPSULE; ORAL NEORAL NOVARTIS
50MG
N050715
003
CYCLOTHIAZIDE
TABLET; ORAL ANHYDRON LILLY FLUIDIL PHARMACIA AND UPJOHN
2MG 2MG
N013157 N018173
002 001
CYCRIMINE HYDROCHLORIDE
TABLET; ORAL PAGITANE LILLY
1.25MG 2.5MG
N008951 N008951
001 002
CYPROHEPTADINE HYDROCHLORIDE
SYRUP; ORAL CYPROHEPTADINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 2MG/5ML HALSEY 2MG/5ML MORTON GROVE 2MG/5ML NASKA 2MG/5ML PERIACTIN MERCK 2MG/5ML TABLET; ORAL CYPROHEPTADINE HYDROCHLORIDE AM THERAP 4MG ASCOT 4MG DURAMED PHARMS BARR 4MG HALSEY 4MG KV PHARM 4MG MD PHARM 4MG MYLAN 4MG PIONEER PHARMS 4MG PLIVA 4MG SANDOZ 4MG SUPERPHARM 4MG TG UNITED LABS 4MG VITARINE 4MG WATSON LABS 4MG
A088798 A087685 A088232 A089057 A086737 A087566 A086678 A087839 A088205 A086808 A087405 A088212 A087284 A085245
001 001 001 001 001 001 001 001 001 001 001 001 001 001
6 - 96 (of 346)
CYSTEINE HYDROCHLORIDE
INJECTABLE; INJECTION CYSTEINE HYDROCHLORIDE HOSPIRA
7.25%
N019523
001
CYTARABINE
INJECTABLE; INJECTION CYTARABINE TEVA PARENTERAL
DACARBAZINE
INJECTABLE; INJECTION DACARBAZINE ABRAXIS PHARM
100MG/VIAL 200MG/VIAL
A070962 A070990
001 001
DALFOPRISTIN; QUINUPRISTIN
INJECTABLE; IV (INFUSION) SYNERCID KING PHARMS 420MG/VIAL;180MG/VIAL
N050748
002
DALTEPARIN SODIUM
INJECTABLE; INJECTION FRAGMIN EISAI INC
7,500 IU/0.75ML
N020287
008
DANAPAROID SODIUM
INJECTABLE; INJECTION ORGARAN ORGANON USA INC
750 UNITS/0.6ML
N020430
001
DANAZOL
CAPSULE; ORAL DANAZOL AM THERAP DANOCRINE SANOFI AVENTIS US
DANTROLENE SODIUM
CAPSULE; ORAL DANTROLENE SODIUM ACTAVIS TOTOWA
DAPIPRAZOLE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC REV-EYES FERA PHARMS 0.5%
N019849
001
6 - 97 (of 346)
N021572
001
DARUNAVIR ETHANOLATE
TABLET; ORAL PREZISTA TIBOTEC
EQ 300MG BASE
N021976
001
DAUNORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION CERUBIDINE SANOFI AVENTIS US EQ WYETH AYERST EQ DAUNORUBICIN HYDROCHLORIDE TEVA PARENTERAL EQ EQ
001 001 001 002 Jun 23, 1998 May 03, 1999
DECAMETHONIUM BROMIDE
INJECTABLE; INJECTION SYNCURINE GLAXOSMITHKLINE
1MG/ML
N006931
002
DEMECARIUM BROMIDE
SOLUTION/DROPS; OPHTHALMIC HUMORSOL MERCK 0.125% 0.25%
N011860 N011860
002 001
DEMECLOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL DECLOMYCIN LEDERLE SYRUP; ORAL DECLOMYCIN LEDERLE TABLET; ORAL DECLOMYCIN COREPHARMA
150MG
N050262
001
75MG/5ML
N050257
001
75MG
N050261
001
DESERPIDINE
TABLET; ORAL HARMONYL ABBOTT
0.1MG 0.25MG
N010796 N010796
001 002
DESERPIDINE; HYDROCHLOROTHIAZIDE
TABLET; ORAL ORETICYL 25 ABBOTT ORETICYL 50 ABBOTT ORETICYL FORTE ABBOTT
DESERPIDINE; METHYCLOTHIAZIDE
TABLET; ORAL ENDURONYL ABBOTT ENDURONYL FORTE ABBOTT
0.25MG;5MG 0.5MG;5MG
N012775 N012775
001 002
6 - 98 (of 346)
A088486 A088452
001 001
DESIPRAMINE HYDROCHLORIDE
CAPSULE; ORAL PERTOFRANE SANOFI AVENTIS US
25MG 50MG
N013621 N013621
001 002
TABLET; ORAL DESIPRAMINE HYDROCHLORIDE PLIVA 25MG 50MG 75MG 100MG 150MG USL PHARMA 25MG 50MG 75MG 100MG
DESLANOSIDE
INJECTABLE; INJECTION CEDILANID-D NOVARTIS
0.2MG/ML
N009282
002
DESMOPRESSIN ACETATE
INJECTABLE; INJECTION DDAVP SANOFI AVENTIS US 0.015MG/ML DESMOPRESSIN ACETATE BEDFORD 0.004MG/ML DESMOPRESSIN ACETATE PRESERVATIVE FREE BEDFORD 0.004MG/ML SOLUTION; NASAL CONCENTRAID FERRING 0.01% SPRAY, METERED; NASAL DDAVP SANOFI AVENTIS US 0.01MG/SPRAY STIMATE CSL BEHRING 0.15MG/SPRAY
N019776
001
N017922 N020355
002 001
DESONIDE
CREAM; TOPICAL DESONIDE TEVA PHARMS
0.05%
A074027
001
DESOXIMETASONE
OINTMENT; TOPICAL DESOXIMETASONE ALTANA
0.25%
A073440
001
6 - 99 (of 346)
5MG/ML
N001104
001
125MG
N005151
001
DESOXYCORTICOSTERONE PIVALATE
INJECTABLE; INJECTION PERCORTEN NOVARTIS
25MG/ML
N008822
001
DEXAMETHASONE
AEROSOL; TOPICAL AEROSEB-DEX ALLERGAN HERBERT 0.01% DECASPRAY MERCK 0.04% ELIXIR; ORAL DECADRON MERCK 0.5MG/5ML DEXAMETHASONE ALPHARMA US PHARMS 0.5MG/5ML HEXADROL ORGANON USA INC 0.5MG/5ML GEL; TOPICAL DECADERM MERCK 0.1% SUSPENSION/DROPS; OPHTHALMIC DEXAMETHASONE WATSON LABS 0.1% TABLET; ORAL DECADRON MERCK 0.25MG 0.5MG 0.75MG 1.5MG 4MG 6MG DEXAMETHASONE IMPAX LABS 0.75MG MUTUAL PHARM 0.25MG 0.25MG 0.5MG 0.5MG 0.75MG 0.75MG 1.5MG 1.5MG PAR PHARM 0.25MG PHOENIX LABS NY 0.75MG PVT FORM 0.75MG ROXANE 0.25MG SANDOZ 0.75MG UPSHER SMITH 0.75MG 1.5MG WATSON LABS 0.25MG 0.5MG 0.75MG 0.75MG 0.75MG 1.5MG 1.5MG
A083296 N012731
002 002
N013538
001
A089170
001
N011664 N011664 N011664 N011664 N011664 N011664 A085376 A084013 A084764 A084084 A084766 A084081 A084765 A084086 A084763 A088149 A083806 A083420 A084614 A080399 A087534 A087533 A085455 A085458 A080968 A084457 A085818 A085456 A085840
004 001 002 003 005 006 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
DEXAMETHASONE ACETATE
INJECTABLE; INJECTION DECADRON-LA MERCK DEXAMETHASONE ACETATE WATSON LABS
N014242
001
N013413
001
N011983
002
N012071 N012071 A084342 A088448 A088469 A084493 A084282 A084752 A083161 A088522 A087065 A081125 A081126 A083702 A084355 A089169 A087668 A085606 A085641 N014694 N014694 N014694
002 004 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 004 Jan 25, 1984 Jan 25, 1984
N011984
001
A084855
001
EQ 4MG PHOSPHATE/ML;10MG/ML
N013334
002
N050324
001
001 001 001 001 Oct 30, 1995 Jul 21, 1986 Jan 10, 1985
A062566 A062411
001 001
A062544 A062428
001 001
DEXBROMPHENIRAMINE MALEATE
SYRUP; ORAL DISOMER SCHERING TABLET; ORAL DISOMER SCHERING
2MG/5ML
N011814
002
2MG
N011814
001
2MG;60MG
N012394
002
DEXCHLORPHENIRAMINE MALEATE
SYRUP; ORAL POLARAMINE SCHERING 2MG/5ML TABLET; ORAL DEXCHLORPHENIRAMINE MALEATE PLIVA 2MG POLARAMINE SCHERING 2MG
A086837
001
A088682 A086835
001 001
DEXTROAMPHETAMINE SULFATE
CAPSULE; ORAL DEXAMPEX TEVA 15MG CAPSULE, EXTENDED RELEASE; ORAL DEXTROAMPHETAMINE SULFATE ABLE 5MG 10MG 15MG ELIXIR; ORAL DEXEDRINE GLAXOSMITHKLINE 5MG/5ML TABLET; ORAL DEXAMPEX TEVA 5MG 10MG DEXEDRINE GLAXOSMITHKLINE 5MG DEXTROAMPHETAMINE SULFATE ENDO PHARMS 5MG HALSEY 10MG LANNETT 5MG 10MG 15MG MAST MM 5MG PUREPAC PHARM 5MG SANDOZ 5MG 10MG VITARINE 5MG 10MG DEXTROSTAT SHIRE 5MG 10MG FERNDEX FERNDALE LABS 5MG
A085355
001
A083902
001
A083735 A083735 A084935 A040299 A083930 A083903 A083903 A085652 A086521 A084125 A085370 A085371 A084986 A085892 A084051 A084051 A084001
001 002 001 001 001 001 003 001 001 001 001 001 001 001 001 002 001 May 13, 1999
A088913 N011265
001 002
N018046 N018504 N018358 N019626 N018923 N019971 N017995 N017995 N020047 N019346 N019626
001 001 001 001 001 001 002 001 002 001 003
Feb 02, 1988 Sep 19, 1984 Sep 28, 1995 Sep 22, 1982
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
INJECTABLE; INJECTION ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;31MG/100ML;130MG/100ML;26MG/1 N019025 00ML;320MG/100ML
001
001
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE; INJECTION ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;30MG/100ML;37MG/100ML;370MG/1 N018274 00ML;530MG/100ML;500MG/100ML
001
Sep 29, 1989 Sep 29, 1989 Sep 29, 1989 Sep 29, 1989
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS
INJECTABLE; INJECTION IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA 5GM/100ML;111MG/100ML;256MG/100ML;146MG N019514 /100ML;207MG/100ML
001
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML;150MG/100ML;130MG/100ML;280MG N018270 /100ML;91MG/100ML
001
CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.075% 5GM/100ML;75MG/100ML;200MG/100ML N018268 009 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER 5GM/100ML;150MG/100ML;200MG/100ML N018268 004 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;200MG/100ML N018268 005 CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;200MG/100ML N018268 006 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER 5GM/100ML;75MG/100ML;330MG/100ML N018268 011 Jan 18, 1986 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER 5GM/100ML;150MG/100ML;330MG/100ML N018268 012 Jan 18, 1986 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;330MG/100ML N018268 013 Jan 18, 1986 CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.30% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;330MG/100ML N018268 014 Jan 18, 1986 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.075% 5GM/100ML;75MG/100ML;450MG/100ML N018268 010 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER 5GM/100ML;150MG/100ML;450MG/100ML N018268 001 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER 5GM/100ML;220MG/100ML;450MG/100ML N018268 002 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;450MG/100ML N018268 003 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER 5GM/100ML;224MG/100ML;450MG/100ML N018008 003 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER 5GM/100ML;300MG/100ML;450MG/100ML N018008 001 CHLORIDE 0.45% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER 5GM/100ML;75MG/100ML;450MG/100ML N018008 002
N018386 N018229 N018047 N018030 N018096 N018376 N018055 N018030 N018030 N018399 N019482 N019486 N018501 N018030 N019484 N018030
001 001 001 001 001 001 001 005 004 001 001 001 001 003 001 002 Oct 04, 1985 Oct 04, 1985 Oct 04, 1985
DEXTROTHYROXINE SODIUM
TABLET; ORAL CHOLOXIN ABBOTT
DEZOCINE
INJECTABLE; INJECTION DALGAN ASTRAZENECA
DIATRIZOATE MEGLUMINE
INJECTABLE; INJECTION ANGIOVIST 282 BAYER HLTHCARE CARDIOGRAFIN BRACCO DIATRIZOATE MEGLUMINE BRACCO HYPAQUE GE HEALTHCARE
RENO-60 BRACCO 60% RENO-DIP BRACCO 30% UROVIST MEGLUMINE DIU/CT BAYER HLTHCARE 30% SOLUTION; URETERAL RENO-30 BRACCO 30% UROVIST CYSTO BAYER HLTHCARE 30% UROVIST CYSTO PEDIATRIC BAYER HLTHCARE 30% SOLUTION; URETHRAL HYPAQUE-CYSTO GE HEALTHCARE 30%
N016403
003
003 002 001 001 001 006 020 019 Jun 01, 1988
66%;10%
A087728
001
DIATRIZOATE SODIUM
FOR SOLUTION; ORAL, RECTAL HYPAQUE GE HEALTHCARE 100% INJECTABLE; INJECTION HYPAQUE GE HEALTHCARE 25% 50% MD-50 MALLINCKRODT 50% UROVIST SODIUM 300 BAYER HLTHCARE 50% SOLUTION; ORAL, RECTAL HYPAQUE GE HEALTHCARE 40% SOLUTION; URETERAL HYPAQUE SODIUM 20% GE HEALTHCARE 20%
N011386
001
N011386
003
N009561
002
DIAZEPAM
CAPSULE, EXTENDED RELEASE; ORAL VALRELEASE ROCHE 15MG GEL; RECTAL DIASTAT VALEANT 5MG/ML (5MG/ML) 10MG/2ML (5MG/ML) 15MG/3ML (5MG/ML) 20MG/4ML (5MG/ML) INJECTABLE; INJECTION DIAZEPAM ABRAXIS PHARM 5MG/ML BAXTER HLTHCARE 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML 5MG/ML MARSAM PHARMS LLC 5MG/ML 5MG/ML 5MG/ML PARENTA PHARMS 5MG/ML
N018179
001
A070662 A070311 A070312 A070313 A071308 A071309 A071310 A072370 A072371 A072397 A076815
001 001 001 001 001 001 001 001 001 001 001
Jun Dec Dec Dec Jul Jul Jul Jan Jan Jan Apr
25, 16, 16, 16, 17, 17, 17, 29, 29, 29, 15,
1986 1985 1985 1985 1987 1987 1987 1993 1993 1993 2004
DIZAC PHARMACIA AND UPJOHN VALIUM ROCHE TABLET; ORAL DIAZEPAM ACTAVIS ELIZABETH
FERNDALE LABS
HALSEY
PIONEER PHARMS
ROXANE
SANDOZ
WATSON LABS
2MG 5MG 10MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 5MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 2MG 5MG 5MG 10MG 10MG
A070781 A070706 A070707 A070227 A070228 A070894 A070895 A070896 A070903 A070904 A070905 A070987 A070996 A070956 A070360 A070361 A070362 A072402 A070462 A070463 A070464 A070787 A070788 A070776 A070356 A070357 A070358 A070302 A070303 A070304 A070153 A070209 A070210 A070222 A070456 A070457 A070458 A070423 A072431 A070424 A072432 A070425 A072433
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Mar Mar Mar Sep Sep Aug Aug Aug Apr Apr Apr Aug Aug Aug Sep Sep Sep Apr Feb Feb Feb Aug Aug Aug Jun Jun Jun Dec Dec Dec Nov Sep Sep Sep Nov Nov Nov Dec Apr Dec Apr Dec Apr
19, 19, 19, 26, 26, 27, 27, 27, 01, 01, 01, 15, 15, 15, 04, 04, 04, 25, 25, 25, 25, 02, 02, 02, 17, 17, 17, 20, 20, 20, 01, 04, 04, 04, 01, 01, 01, 12, 29, 12, 29, 12, 29,
1986 1986 1986 1985 1985 1986 1986 1986 1987 1987 1987 1986 1986 1986 1985 1985 1985 1989 1986 1986 1986 1988 1988 1988 1986 1986 1986 1985 1985 1985 1985 1985 1985 1985 1985 1985 1985 1985 1988 1985 1988 1985 1988
50MG 100MG
N017425 N017425
001 002
15MG/ML 15MG/ML
A071519 N016996
001 001
DIBUCAINE HYDROCHLORIDE
INJECTABLE; INJECTION HEAVY SOLUTION NUPERCAINE NOVARTIS 2.5MG/ML
N006203
001
DICHLORPHENAMIDE
TABLET; ORAL DARANIDE TARO
50MG
N011366
001
DICLOFENAC POTASSIUM
TABLET; ORAL CATAFLAM NOVARTIS DICLOFENAC POTASSIUM MUTUAL PHARM SANDOZ WATSON LABS
Nov 24, 1993 Feb 21, 2002 Feb 23, 2001 Nov 27, 1998
DICLOFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC DICLOFENAC SODIUM FALCON PHARMS 0.1% TABLET, DELAYED RELEASE; ORAL DICLOFENAC SODIUM NOSTRUM LABS 50MG 75MG PLIVA 50MG 75MG ROXANE 25MG 50MG 75MG TEVA 50MG 75MG TEVA PHARMS 25MG 50MG 75MG VOLTAREN NOVARTIS 25MG 50MG 75MG
N020809
001
A074986 A074986 A074432 A074432 A074391 A074391 A074391 A074723 A074390 A074459 A074459 A074459 N019201 N019201 N019201
001 002 002 003 001 002 003 001 001 001 002 003 001 002 003
Feb Feb Jul Jul Jun Jun Jun Mar Aug Jun Jun Jun
26, 26, 29, 29, 29, 29, 29, 30, 15, 25, 25, 25,
1999 1999 1999 1999 1995 1995 1995 1999 1996 1997 1997 1997
DICLOXACILLIN SODIUM
CAPSULE; ORAL DYCILL GLAXOSMITHKLINE
EQ EQ EQ EQ
DICUMAROL
CAPSULE; ORAL DICUMAROL LILLY TABLET; ORAL DICUMAROL ABBOTT
25MG 50MG
N005509 N005509
003 001
DICYCLOMINE HYDROCHLORIDE
CAPSULE; ORAL DICYCLOMINE HYDROCHLORIDE MUTUAL PHARM 10MG PIONEER PHARMS 10MG WATSON LABS 10MG INJECTABLE; INJECTION DICYCLOMINE HYDROCHLORIDE WATSON LABS 10MG/ML SYRUP; ORAL DICYCLOMINE HYDROCHLORIDE ALPHARMA US PHARMS 10MG/5ML TABLET; ORAL DICYCLOMINE HYDROCHLORIDE MUTUAL PHARM 20MG PIONEER PHARMS 20MG WATSON LABS 20MG
A080614
001
A084479
001
DIDANOSINE
FOR SOLUTION; ORAL VIDEX BRISTOL MYERS SQUIBB
DIENESTROL
CREAM; VAGINAL DIENESTROL ORTHO MCNEIL PHARM DV SANOFI AVENTIS US ESTRAGUARD SOLVAY SUPPOSITORY; VAGINAL DV SANOFI AVENTIS US
0.7MG
A083517
001
50MG
N006459
001
DIETHYLPROPION HYDROCHLORIDE
TABLET; ORAL DIETHYLPROPION HYDROCHLORIDE SANDOZ 25MG TEVA 25MG TG UNITED LABS 25MG 25MG UCB INC 25MG WATSON LABS 25MG TENUATE SANOFI AVENTIS US 25MG TEPANIL 3M 25MG TABLET, EXTENDED RELEASE; ORAL TENUATE SANOFI AVENTIS US 75MG TEPANIL TEN-TAB 3M 75MG
N017669 N017956
001 001
DIETHYLSTILBESTROL
INJECTABLE; INJECTION STILBESTROL BRISTOL MYERS SQUIBB
SUPPOSITORY; VAGINAL DIETHYLSTILBESTROL LILLY STILBESTROL BRISTOL MYERS SQUIBB TABLET; ORAL DIETHYLSTILBESTROL LILLY
N004041 N004041 N004041 N004041 A083004 A083002 A083006 N004056 N004056 N004056 N004056 N004056
002 003 004 005 001 001 001 007 017 008 009 010
STILBESTROL TABLICAPS
0.1MG 0.25MG 0.5MG 1MG 5MG TABLET, DELAYED RELEASE; ORAL DIETHYLSTILBESTROL LILLY 0.1MG 0.25MG 0.5MG 1MG 5MG STILBESTROL TABLICAPS 0.5MG 1MG
DIETHYLSTILBESTROL DIPHOSPHATE
INJECTABLE; INJECTION STILPHOSTROL BAYER PHARMS TABLET; ORAL STILPHOSTROL BAYER PHARMS
250MG/5ML
N010010
001
50MG
N010010
002
DIFLORASONE DIACETATE
CREAM; TOPICAL FLORONE PHARMACIA AND UPJOHN FLORONE E PHARMACIA AND UPJOHN PSORCON SANOFI AVENTIS US OINTMENT; TOPICAL PSORCON PHARMACIA AND UPJOHN PSORCON E PHARMACIA AND UPJOHN
0.05% 0.05%
N019260 N017994
001 001
DIFLUNISAL
TABLET; ORAL DIFLUNISAL PUREPAC PHARM ROXANE SANDOZ TEVA WATSON LABS DOLOBID MERCK
250MG 500MG 250MG 500MG 500MG 250MG 250MG 500MG 250MG 500MG
A074285 A074285 A073562 A073563 A074604 A073679 A074400 A074400 N018445 N018445
001 002 001 001 001 001 001 002 001 002
DIGITOXIN
INJECTABLE; INJECTION CRYSTODIGIN LILLY
0.2MG/ML
A084100
005
DIGOXIN
CAPSULE; ORAL LANOXICAPS GLAXOSMITHKLINE LLC
0.25MG/ML 0.25MG/ML
A083217 A040206
001 001
0.25MG/ML 0.1MG/ML
A084386 A040092
Dec 23, 1999 Dec 23, 1999 Sep Sep Sep Sep 30, 30, 30, 30, 1997 1997 1997 1997
N018885 N018885
001 002
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL CARDIZEM SR BIOVAIL 60MG 90MG 120MG 180MG DILTIAZEM HYDROCHLORIDE BIOVAIL 60MG 90MG 120MG 120MG 180MG 240MG 300MG 360MG 420MG TEVA 60MG 90MG 120MG INJECTABLE; INJECTION CARDIZEM BIOVAIL 100MG/VIAL BIOVAIL LABS INTL 5MG/ML 25MG/VIAL DILTIAZEM HYDROCHLORIDE HOSPIRA 5MG/ML 5MG/ML TABLET; ORAL DILTIAZEM HYDROCHLORIDE APOTHECON 30MG 60MG 90MG 120MG IVAX SUB TEVA PHARMS 30MG 60MG 90MG 120MG TEVA 30MG 60MG
N019471 N019471 N019471 N019471 A074845 A074845 A074845 N020939 N020939 N020939 N020939 N020939 N020939 A074079 A074079 A074079
001 002 003 004 001 002 003 001 002 003 004 005 006 001 002 003
Jan Jan Jan Jan Sep Sep Sep Jan Jan Jan Jan Sep Sep Nov Nov Nov
23, 23, 23, 23, 15, 15, 15, 28, 28, 28, 28, 14, 14, 30, 30, 30,
1989 1989 1989 1989 1999 1999 1999 2000 2000 2000 2000 2001 2001 1993 1993 1993
Sep 05, 1997 Oct 24, 1991 Aug 18, 1995 Feb 16, 2000 Apr 29, 1999
A074051 A074051 A074051 A074051 A074168 A074168 A074168 A074168 A074084 A074084
001 002 003 004 001 002 003 004 001 002
Mar Mar Mar Mar Mar Mar Mar Mar Feb Feb
31, 31, 31, 31, 03, 03, 03, 03, 25, 25,
1993 1993 1993 1993 1995 1995 1995 1995 1994 1994
DILTIAZEM MALATE
TABLET, EXTENDED RELEASE; ORAL TIAMATE MERCK EQ 120MG HCL EQ 180MG HCL EQ 240MG HCL
N020507
001
DIMENHYDRINATE
INJECTABLE; INJECTION DIMENHYDRINATE BAXTER HLTHCARE WATSON LABS WYETH AYERST LIQUID; ORAL DIMENHYDRINATE ALRA TABLET; ORAL DIMENHYDRINATE HEATHER NEXGEN PHARMA INC WATSON LABS
12.5MG/4ML
A080715
001
0.92MG/VIAL;0.092MG/VIAL
N021191
001
DINOPROST TROMETHAMINE
INJECTABLE; INJECTION PROSTIN F2 ALPHA PHARMACIA AND UPJOHN
EQ 5MG BASE/ML
N017434
001
DIPHEMANIL METHYLSULFATE
TABLET; ORAL PRANTAL SCHERING
100MG
N008114
004
DIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE; ORAL BENADRYL MCNEIL CONS
25MG 50MG DIPHENHYDRAMINE HYDROCHLORIDE ALRA 25MG 50MG ANABOLIC 50MG ELKINS SINN 25MG 50MG HALSEY 50MG HEATHER 25MG
A083953 A080807 A080807 A080762 A080762 A080868 A080868 A086874 A086875 A087977 A087978 A083087 A083087 A084506 A089488 A089489 A086543 A086544 A083634 A083061 A083061 A089101 A088880 A085156 A085150 A083027 A083027 A080635 A080832 A080845 A080832 A080845 A089040 A089041 A085874 A085874 A080596 A080592 A088034 A087630 A080728 A083797 A085138 A080727 A083797 A085083 A083567 A083441 A080800
001 001 002 001 002 001 002 001 001 001 001 001 002 001 001 001 001 001 001 001 002 001 001 001 001 001 002 001 001 002 002 001 001 001 001 002 001 001 001 001 001 001 001 001 002 001 001 001 001
A087941 A085621 A080939 A086937 A083088 A088680 A083063 A083237 A085287 A080643 A080763
001 001 002 001 002 001 001 001 001 001 002
A071292 A089179 N006514 A070118 A070497 A073611 A072416 A070205 A072646 A070524
001 001 004 001 001 001 001 001 001 001
Oct 01, 1985 Apr 25, 1989 Aug 20, 1992 Sep 28, 1990 Jan 28, 1986 Feb 27, 1992 Jan 14, 1987
12.5MG/5ML;30MG/5ML
N019014
001
DIPHENIDOL HYDROCHLORIDE
TABLET; ORAL VONTROL GLAXOSMITHKLINE
EQ 25MG BASE
N016033
001
DIPHENYLPYRALINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL HISPRIL GLAXOSMITHKLINE 5MG
N011945
001
A074188
001
DIPYRIDAMOLE
INJECTABLE; INJECTION DIPYRIDAMOLE HOSPIRA IV PERSANTINE BOEHRINGER INGELHEIM TABLET; ORAL DIPYRIDAMOLE PUREPAC PHARM SANDOZ
5MG/ML 5MG/ML
A074601 N019817
001 001
DIRITHROMYCIN
TABLET, DELAYED RELEASE; ORAL DYNABAC LILLY RES LABS 250MG
N050678
001
DISOPYRAMIDE PHOSPHATE
CAPSULE; ORAL DISOPYRAMIDE PHOSPHATE INTERPHARM IVAX SUB TEVA PHARMS MUTUAL PHARM MYLAN SANDOZ SUPERPHARM WATSON LABS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
100MG 150MG 100MG 150MG 100MG 150MG 100MG 150MG 100MG 150MG 100MG 150MG 100MG 150MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A071190 A071191 A070186 A070187 A070351 A070352 A070138 A070139 A070470 A070471 A070940 A070941 A070240 A070241
001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jan Jan Nov Nov Dec Dec Jun Jun Dec Dec Feb Feb Feb Feb
15, 15, 18, 18, 17, 17, 14, 14, 10, 10, 09, 09, 02, 02,
1987 1987 1985 1985 1985 1985 1985 1985 1985 1985 1987 1987 1986 1986
DISULFIRAM
TABLET; ORAL ANTABUSE TEVA WOMENS DISULFIRAM PAR PHARM WATSON LABS
003 002 001 001 001 001 001 001 Aug 14, 1984 Aug 14, 1984 Aug 05, 1983 Aug 05, 1983
DIVALPROEX SODIUM
TABLET, DELAYED RELEASE; ORAL DEPAKOTE CP ABBOTT EQ 250MG BASE EQ 500MG BASE
N019794 N019794
001 002
12.5MG BASE/ML
DOCETAXEL
INJECTABLE; INJECTION TAXOTERE SANOFI AVENTIS US
40MG/ML
N020449
001
DONEPEZIL HYDROCHLORIDE
SOLUTION; ORAL ARICEPT EISAI INC 5MG/5ML TABLET, ORALLY DISINTEGRATING; ORAL DONEPEZIL HYDROCHLORIDE MUTUAL PHARM 5MG 10MG
N021719
001
A077975 A077975
002 001
DOPAMINE HYDROCHLORIDE
INJECTABLE; INJECTION DOPAMINE HYDROCHLORIDE ABBOTT
40MG/ML 80MG/ML ABRAXIS PHARM 40MG/ML 40MG/ML 80MG/ML 80MG/ML 160MG/ML ASTRAZENECA 40MG/ML 40MG/ML 80MG/ML 80MG/ML 80MG/ML 160MG/ML 160MG/ML 160MG/ML BAXTER HLTHCARE 40MG/ML 80MG/ML HOSPIRA 40MG/ML INTL MEDICATION 40MG/ML LYPHOMED 40MG/ML SMITH AND NEPHEW 40MG/ML 40MG/ML 80MG/ML TEVA PARENTERAL 40MG/ML 80MG/ML WARNER CHILCOTT 40MG/ML 40MG/ML 80MG/ML DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% HOSPIRA 1.6MG/ML INTROPIN HOSPIRA 40MG/ML 80MG/ML
A070656 A070657 A070012 A070058 A070013 A070059 A070364 A070087 N018656 A070089 A070090 A070091 A070092 A070093 A070094 N018398 N018398 A074403 N018014 N018549 A070011 A070046 A070047 A072999 A073000 A070558 N018138 A070559 N020542 N017395 N017395
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 002
Jan Jan Jun Mar Jun Mar Dec Oct Jun Oct Oct Oct Oct Oct Oct
24, 24, 12, 20, 12, 20, 04, 23, 28, 23, 23, 23, 23, 23, 23,
1989 1989 1985 1985 1985 1985 1985 1985 1983 1985 1985 1985 1985 1985 1985
Mar 22, 1982 May 23, 1996 Mar Aug Aug Aug Oct Oct Sep 11, 29, 29, 29, 23, 23, 20, 1983 1985 1985 1985 1991 1991 1985
160MG/ML
N017395
003
DOXACURIUM CHLORIDE
INJECTABLE; INJECTION NUROMAX ABBOTT
EQ 1MG BASE/ML
N019946
001
DOXAZOSIN MESYLATE
TABLET; ORAL DOXAZOSIN MESYLATE ACTAVIS ELIZABETH
GENPHARM
SANDOZ
TEVA
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
1MG 2MG 4MG 8MG 1MG 2MG 4MG 8MG 1MG 2MG 4MG 8MG 1MG 1MG 2MG 2MG 4MG 4MG 8MG 8MG 1MG 2MG 4MG 8MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A075574 A075574 A075574 A075574 A075466 A075466 A075466 A075466 A075453 A075453 A075453 A075453 A075432 A075646 A075432 A075646 A075432 A075646 A075432 A075646 A075353 A075353 A075353 A075353
001 002 003 004 001 002 003 004 001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004
Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Jan Jan Jan Jan
18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 12, 12, 12, 12,
2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2001 2001 2001 2001
DOXEPIN HYDROCHLORIDE
CAPSULE; ORAL DOXEPIN HYDROCHLORIDE CLONMEL HLTHCARE
MUTUAL PHARM
NEW RIVER
PUREPAC PHARM
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE
A071685 A071686 A071673 A071674 A071675 A071676 A071502 A071653 A071654 A071521 N016987 N016987 N016987 N016987 N016987 N016987 A073054 A072109 A073055 A072386 A072110 A072387
001 001 001 001 001 001 001 001 001 001 001 002 003 006 004 007 001 001 001 001 001 001
Jan Jan Jan Jan Jan Jan Feb Feb Feb Feb
05, 05, 05, 05, 05, 05, 18, 18, 18, 18,
1988 1988 1988 1988 1988 1988 1988 1988 1988 1988
SANDOZ
WATSON LABS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 10MG BASE 10MG BASE 25MG BASE 25MG BASE 50MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE 10MG BASE 25MG BASE 50MG BASE 75MG BASE 100MG BASE 150MG BASE
A070972 A070973 A070931 A070932 A072375 A072376 A071487 A070827 A070828 A070825 A071562 A070952 A072985 A070953 A072986 A070954 A072987 A071763 A070955 A071764 N016798 N016798 N016798 N016798 N016798 N016798
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 003 001 002 006 005 007
Sep Sep Sep Sep Mar Mar Mar May May May Mar Mar Mar May Mar May Mar Feb May Feb
29, 29, 29, 29, 15, 15, 02, 15, 15, 15, 02, 04, 29, 15, 29, 15, 29, 09, 15, 09,
1987 1987 1987 1987 1989 1989 1987 1986 1986 1986 1987 1987 1991 1986 1991 1986 1991 1988 1986 1988
SINEQUAN PFIZER
EQ 10MG BASE/ML
N017516
001
DOXORUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION ADRIAMYCIN PFS PHARMACIA AND UPJOHN
2MG/ML 2MG/ML 200MG/100ML 200MG/100ML 10MG/VIAL 20MG/VIAL 50MG/VIAL 150MG/VIAL 10MG/VIAL 50MG/VIAL 100MG/VIAL
A063165 N050629 A063165 N050629 N050467 N050467 N050467 N050467 A062926 A062926 A062926
001 001 002 002 001 003 002 004 001 002 003
May 20, 1985 Jul 22, 1987 Apr 13, 1989 Apr 13, 1989 Apr 13, 1989
DOXYCYCLINE
CAPSULE; ORAL DOXYCYCLINE PAR PHARM FOR SUSPENSION; ORAL DOXYCHEL RACHELLE TABLET; ORAL DOXYCYCLINE MUTUAL PHARM
EQ 75MG BASE
A065055
004
EQ 25MG BASE/5ML
A061720
001
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 50MG BASE 100MG BASE 100MG BASE
A062119 A062119 A062463 A062463 A062763 A062763 A062418 A062418 A062337 A062337 A062434 A062442 A062631 A062631 A062479 A062479 A062469 A062469 A062594 A062594 A061717 A062142 A061717 A062142 A062497 A062497 N050744
002 001 001 002 001 002 001 002 001 002 001 001 001 002 001 002 001 002 001 002 001 001 002 002 001 002 001
May May Dec Dec Sep Sep Jan Jan Mar Mar Oct Dec Jul Jul Dec Dec Oct Oct Dec Dec
24, 24, 07, 07, 02, 02, 28, 28, 29, 29, 19, 22, 24, 24, 23, 23, 31, 31, 05, 05,
1985 1985 1983 1983 1988 1988 1983 1983 1982 1982 1984 1983 1986 1986 1983 1983 1984 1984 1985 1985
DOXY-LEMMON TEVA
PERIOSTAT COLLAGENEX EQ 20MG BASE CAPSULE, COATED PELLETS; ORAL DOXYCYCLINE HYCLATE PLIVA EQ 100MG BASE CAPSULE, DELAYED RELEASE; ORAL DORYX MAYNE PHARMA INTL EQ 75MG BASE EQ 100MG BASE WARNER CHILCOTT EQ 100MG BASE INJECTABLE; INJECTION DOXYCHEL HYCLATE RACHELLE EQ 100MG BASE/VIAL DOXYCYCLINE BAXTER HLTHCARE EQ 100MG BASE/VIAL EQ 200MG BASE/VIAL BEDFORD EQ 200MG BASE/VIAL DOXYCYCLINE HYCLATE BAXTER HLTHCARE EQ 100MG BASE/VIAL EQ 200MG BASE/VIAL VIBRAMYCIN PFIZER EQ 100MG BASE/VIAL EQ 200MG BASE/VIAL TABLET; ORAL DOXYCYCLINE HYCLATE HEATHER EQ 100MG BASE INTERPHARM EQ 100MG BASE LARKEN LABS EQ 20MG BASE MUTUAL PHARM EQ 100MG BASE MYLAN EQ 100MG BASE SUPERPHARM EQ 100MG BASE TRUXTON INC EQ 50MG BASE EQ 100MG BASE WARNER CHILCOTT EQ 100MG BASE
A063187
001
001 001 002 002 001 002 002 001 Oct 27, 1983 Oct 27, 1983 Mar 09, 1988 Feb 16, 1989 Feb 16, 1989
DOXYLAMINE SUCCINATE
CAPSULE; ORAL UNISOM PFIZER TABLET; ORAL DECAPRYN SANOFI AVENTIS US DOXYLAMINE SUCCINATE COPLEY PHARM QUANTUM PHARMICS DOXY-SLEEP-AID PAR PHARM
25MG
N019440
001
015 014 002 001 001 Feb 12, 1988 Aug 07, 1984 Jul 02, 1987
N010598
002
DROMOSTANOLONE PROPIONATE
INJECTABLE; INJECTION DROLBAN LILLY
50MG/ML
N012936
001
DROPERIDOL
INJECTABLE; INJECTION DROPERIDOL ABRAXIS PHARM ASTRAZENECA
2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML 2.5MG/ML
A070992 A070993 A072018 A072019 A072020 A072021 A071645 A072272 A072335 A071750 A071754 A071755 A073520 A073521 A073523
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Nov Nov Oct Oct Oct Oct Apr Aug Oct Sep Sep Sep Nov Nov Nov
17, 17, 20, 19, 19, 19, 07, 31, 24, 06, 06, 06, 27, 27, 27,
1986 1986 1988 1988 1988 1988 1988 1995 1988 1988 1988 1988 1991 1991 1991
0.05MG BASE/ML
0.5% 1%
N009925 N009925
002 001
DYDROGESTERONE
TABLET; ORAL GYNOREST SOLVAY
5MG 10MG
N017388 N017388
001 002
DYPHYLLINE
ELIXIR; ORAL NEOTHYLLINE TEVA INJECTABLE; INJECTION NEOTHYLLINE TEVA TABLET; ORAL DILOR SAVAGE LABS DILOR-400 SAVAGE LABS NEOTHYLLINE TEVA
160MG/15ML
N007794
003
250MG/ML
N009088
001
ECHOTHIOPHATE IODIDE
FOR SOLUTION; OPHTHALMIC PHOSPHOLINE IODIDE WYETH PHARMS INC
ECONAZOLE NITRATE
CREAM; TOPICAL SPECTAZOLE ORTHO JANSSEN
1%
N018751
001
N008922
002
EDETATE DISODIUM
INJECTABLE; INJECTION DISODIUM EDETATE WATSON LABS EDETATE DISODIUM WATSON LABS SODIUM VERSENATE 3M
EDROPHONIUM CHLORIDE
INJECTABLE; INJECTION EDROPHONIUM CHLORIDE HOSPIRA 10MG/ML WATSON LABS 10MG/ML EDROPHONIUM CHLORIDE PRESERVATIVE FREE WATSON LABS 10MG/ML REVERSOL ORGANON USA INC 10MG/ML
Feb 24, 1998 Mar 20, 1996 Mar 20, 1996 May 13, 1988
100MG
N020972
002
300MG
N021360
001
EFLORNITHINE HYDROCHLORIDE
INJECTABLE; INJECTION ORNIDYL SANOFI AVENTIS US
200MG/ML
N019879
002
ENALAPRIL MALEATE
TABLET; ORAL ENALAPRIL MALEATE APOTHECON
RANBAXY
SANDOZ
2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG 2.5MG 5MG 10MG 20MG
A075583 A075583 A075583 A075583 A075482 A075482 A075482 A075482 A075370 A075370 A075369 A075369 A075556 A075556 A075556 A075556 A075048 A075048 A075048 A075048
001 002 003 004 001 002 003 004 001 002 001 002 001 002 003 004 001 002 003 004
Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug
22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22,
2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000
N020668 N020668
002 001
A075736 A075736
001 002
ENALAPRILAT
INJECTABLE; INJECTION ENALAPRILAT HOSPIRA VASOTEC BIOVAIL LABS INTL
ENFLURANE
LIQUID; INHALATION ENFLURANE ABBOTT
99.9%
A070803
001
200MG 400MG
N019616 N019616
004 005
ENOXAPARIN SODIUM
INJECTABLE; SUBCUTANEOUS LOVENOX (PRESERVATIVE FREE) SANOFI AVENTIS US 90MG/0.6ML (150MG/ML)
N020164
006
EPINEPHRINE
AEROSOL, METERED; INHALATION BRONKAID MIST STERLING 0.25MG/INH PRIMATENE MIST WYETH CONS 0.2MG/INH INJECTABLE; INJECTION SUS-PHRINE SULFITE-FREE FOREST LABS 1.5MG/AMP 5MG/ML INJECTABLE; INTRAMUSCULAR EPI E Z PEN JR MERIDIAN MEDCL TECHN 0.15MG/DELIVERY EPIPEN E Z PEN MERIDIAN MEDCL TECHN 0.3MG/DELIVERY
N016803 N016126
001 001
N007942 N007942
003 001
N019430 N019430
004 003
EPINEPHRINE BITARTRATE
AEROSOL, METERED; INHALATION BRONITIN MIST WYETH CONS 0.3MG/INH MEDIHALER-EPI 3M 0.3MG/INH
N016126 N010374
002 003
0.005MG/ML;4%
N014763
008
0.005MG/ML;0.5%
N017751
004
A083154 A080820 A080757 A083389 A083390 A086402 A080377 A085463 A080377 A084729 A084728 N006488 N010418 N010418 N010418
001 001 001 001 001 001 003 001 004 001 001 003 006 010 008 Aug 17, 1983 Aug 17, 1983
N021504
001
N020530
001
N021486
001
A080758 A080759
001 001
EPIRUBICIN HYDROCHLORIDE
INJECTABLE; IV (INFUSION) EPIRUBICIN HYDROCHLORIDE HOSPIRA 200MG/VIAL
N050807
002
EPLERENONE
TABLET; ORAL INSPRA GD SEARLE LLC
100MG
N021437
003
EPROSARTAN MESYLATE
TABLET; ORAL TEVETEN ABBOTT
EQ 300MG BASE
N020738
004
ERGOCALCIFEROL
CAPSULE; ORAL DELTALIN LILLY VITAMIN D CHASE CHEM EVERYLIFE IMPAX LABS LANNETT VITARINE WEST WARD
1MG
N018706
001
1MG/ML
N018418
001
Nov 01, 1985 May 27, 1982 Aug 16, 1982 Mar 22, 1984
0.5MG 1MG 0.5MG 1MG 1MG 0.5MG 0.5MG 1MG 1MG 0.5MG 1MG 0.5MG 1MG 0.5MG 1MG 0.5MG 1MG 0.5MG 1MG 1MG 0.5MG 1MG
A085153 A087417 A084868 A085809 A085020 A085899 A086265 A085900 A086264 A086984 A086985 A087407 A087552 A089233 A089234 A088013 A088014 A084930 A085177 A087183 A086189 A086188 N009087 N009087 A087186 A087185
001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001
ERGOTAMINE TARTRATE
AEROSOL, METERED; INHALATION MEDIHALER ERGOTAMINE 3M 0.36MG/INH TABLET; SUBLINGUAL ERGOSTAT PARKE DAVIS 2MG WIGRETTES ORGANON USA INC 2MG
N012102
001
A088337 A086750
001 001
Jul 25, 1985 Sep 25, 1985 Oct 24, 1985 Jul 22, 1985 May 04, 1989
A063107
001
A062467
001
N050610
001
A062405 A062468 A062290 A062508 A062328 A062326 A062327 A062342 A062957 A064039 A064127 N050532 A062485 A062616 A062522 N050526 A062436
001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul 11, 1985 Apr Apr Apr Feb Jul Jan Feb 19, 19, 19, 25, 21, 27, 14, 1982 1982 1982 1982 1988 1994 1997
Jul 30, 1993 Feb 15, 1985 Jul 03, 1996 Jul 23, 1987
A063028
001
ERYTHROMYCIN ESTOLATE
CAPSULE; ORAL ERYTHROMYCIN ESTOLATE BARR IVAX SUB TEVA PHARMS WATSON LABS ILOSONE LILLY FOR SUSPENSION; ORAL ILOSONE DISTA SUSPENSION; ORAL ERYTHROMYCIN ESTOLATE ALPHARMA US PHARMS BARR LIFE LABS ILOSONE LILLY
EQ EQ EQ EQ
EQ 125MG BASE/5ML
A061893
001
EQ EQ EQ EQ EQ EQ EQ EQ EQ
SUSPENSION/DROPS; ORAL ILOSONE LILLY TABLET; ORAL ILOSONE LILLY TABLET, CHEWABLE; ORAL ILOSONE DISTA
EQ 100MG BASE/ML
A061894
003
EQ 500MG BASE
A061896
001
A061895 A061895
001 002
N050599
001
ERYTHROMYCIN ETHYLSUCCINATE
GRANULE; ORAL ERYTHROMYCIN ETHYLSUCCINATE BARR EQ 200MG BASE/5ML PEDIAMYCIN ROSS LABS EQ 200MG BASE/5ML
A062055 A062305
001 001
EQ 200MG EQ 400MG ERYTHROMYCIN ETHYLSUCCINATE ALPHARMA US PHARMS EQ 200MG EQ 400MG DISTA EQ 200MG EQ 400MG NASKA EQ 400MG PARKE DAVIS EQ 200MG EQ 400MG PHARMAFAIR EQ 200MG EQ 400MG WYAMYCIN E WYETH AYERST EQ 200MG EQ 400MG SUSPENSION/DROPS; ORAL PEDIAMYCIN ROSS LABS EQ 100MG TABLET; ORAL E.E.S. 400
ARBOR PHARMS INC EQ 400MG ERYTHROMYCIN ETHYLSUCCINATE BARR EQ 400MG MYLAN EQ 400MG TABLET, CHEWABLE; ORAL E.E.S. ARBOR PHARMS INC EQ 200MG ERYPED ARBOR PHARMS INC EQ 200MG PEDIAMYCIN
ROSS LABS EQ 200MG
BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062198 A062198 A062200 A062200 A062177 A062177 A062674 A062231 A062231 A062559 A062558 A062123 A062123
001 002 001 002 001 002 001 001 002 001 001 002 001
BASE/2.5ML
A062305
002
001
001 001
A062758 N050529
001 001
ERYTHROMYCIN GLUCEPTATE
INJECTABLE; INJECTION ILOTYCIN GLUCEPTATE DISTA
ERYTHROMYCIN LACTOBIONATE
INJECTABLE; INJECTION ERYTHROCIN ABBOTT HOSPIRA
EQ EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
Sep 24, 1986 Mar 28, 1985 Mar 28, 1985 Nov 24, 1986 Nov 24, 1986
ERYTHROMYCIN STEARATE
TABLET; ORAL BRISTAMYCIN BRISTOL ERYPAR PARKE DAVIS WARNER CHILCOTT ERYTHROCIN STEARATE ARBOR PHARMS INC ERYTHROMYCIN STEARATE BARR IVAX SUB TEVA PHARMS LEDERLE MYLAN PUREPAC PHARM WATSON LABS ETHRIL 250 BRISTOL MYERS SQUIBB ETHRIL 500 BRISTOL MYERS SQUIBB PFIZER-E PFIZER WYAMYCIN S WYETH AYERST
EQ 250MG BASE EQ 250MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 125MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 250MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A061304 A061887 A062032 A062032 A062322 A060359 A060359 A061591 A063179 A061461 A061461 A062089 A062089 A061505 A061505 A061743 A062121 A062121 A061605 A061605 A061791 A061791 A061675 A061675
001 001 001 002 001 002 003 001 001 001 002 001 002 001 002 001 002 001 001 002 001 002 001 002
EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE
ESCITALOPRAM OXALATE
CAPSULE; ORAL ESCITALOPRAM OXALATE MYLAN PHARMS INC
ESMOLOL HYDROCHLORIDE
INJECTABLE; INJECTION BREVIBLOC BAXTER HLTHCARE CORP
10MG/ML 20MG/ML
N019386 N019386
003 007
ESTAZOLAM
TABLET; ORAL PROSOM ABBOTT
1MG 2MG
N019080 N019080
001 002
N020847 N020847 N020847 N020847 N020847 N021048 N021048 N021048 N020417 N020323 N020323 N020323
001 002 003 004 005 001 002 003 001 005 001 003
Sep 20, 1999 Sep 20, 1999 Sep 20, 1999 Dec 03, 1996 Aug 16, 2000 Oct 28, 1994 Oct 28, 1994
N021166
001
A081295 A040138 A040138 A040138 A040275 A040275 A040275 A040212 A040212 A040212 A040212 A040312 A040312 A040312
001 001 002 003 001 002 003 001 002 003 004 001 002 003
Jun 30, 1993 Jan Jan Jan Dec Dec Dec Dec Dec Dec Dec 30, 30, 30, 29, 29, 29, 29, 29, 29, 29, 1998 1998 1998 1998 1998 1998 1997 1997 1997 1997
N020908
001
ESTRADIOL CYPIONATE
INJECTABLE; INJECTION DEPO-ESTRADIOL PHARMACIA AND UPJOHN
1MG/ML 3MG/ML
A085470 A085470
001 002
N020874
001
N017968 A085603
10MG/ML
A083546
001
ESTROGENS, CONJUGATED
TABLET; ORAL PREMARIN WYETH PHARMS INC
2.5MG
N004782
002
N020303 N020303
002 001
ESTROGENS, ESTERIFIED
TABLET; ORAL AMNESTROGEN BRISTOL MYERS SQUIBB
0.3MG 0.625MG 1.25MG 2.5MG 0.625MG 1.25MG 2.5MG 1.25MG 0.3MG 0.625MG 1.25MG 2.5MG 0.625MG 1.25MG 0.625MG 1.25MG 2.5MG
A083266 A083266 A083266 A083266 A083414 A083765 A085907 A085302 A086715 A083209 A083856 A083857 A084215 A083376 A085076 A085008 A085007
001 002 003 004 001 001 001 001 001 001 001 001 001 002 001 001 001
ESTROPIPATE
CREAM; VAGINAL OGEN PHARMACIA AND UPJOHN TABLET; ORAL ESTROPIPATE DURAMED PHARMS BARR
1.5MG/GM
A084710
001
MYLAN
ESZOPICLONE
TABLET; ORAL ESZOPICLONE LUPIN LTD
TEVA
WOCKHARDT LTD
ETHACRYNIC ACID
TABLET; ORAL EDECRIN ATON
50MG
N016092
002
ETHAMBUTOL HYDROCHLORIDE
TABLET; ORAL MYAMBUTOL STI PHARMA LLC
200MG 500MG
N016320 N016320
002 004
ETHCHLORVYNOL
CAPSULE; ORAL ETHCHLORVYNOL BANNER PHARMACAPS
PLACIDYL ABBOTT
500MG
N009750
001
ETHINYL ESTRADIOL
TABLET; ORAL ESTINYL SCHERING
001 001 001 001 Dec 30, 1991 Dec 30, 1991
0.035MG;1MG 0.05MG;1MG
N018160 N016936
001 001
0.035MG;75MG;1MG
N018926
001
TABLET; ORAL-28
NORLESTRIN FE 1/50
PARKE DAVIS
NORLESTRIN FE 2.5/50
PARKE DAVIS
0.05MG;75MG;1MG 0.05MG;75MG;2.5MG
N016766 N016854
001
001
N020946
001
Dec 13, 1993 May 10, 1982 May 23, 2002 Nov 01, 1984
001
TABLET; ORAL-28 ALESSE WYETH PHARMS 0.02MG;0.1MG LEVLITE BAYER HLTHCARE 0.02MG;0.1MG LEVONORGESTREL AND ETHINYL ESTRADIOL BARR 0.02MG;0.1MG TRIPHASIL-28 WYETH PHARMS INC 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.1 25MG
Mar 27, 1997 Jul 13, 1998 Apr 29, 2003 Nov 01, 1984
A076198 N017566 A072694 N017488 A071541 A071545 A070684 A072692 N017489 N018354 N019004 N018985
001 001 001 001 001 001 001 001 002 001 001 001
Dec 14, 1987 Feb 09, 1989 Jan 29, 1987 Feb 28, 1992
001 001
001 Apr 13, 1984
A072697 A071542
001 001
0.05MG;1MG
N016723
001
0.035MG;0.25MG
N019653
001 002
0.05MG;0.5MG
N016806
001
ETHIODIZED OIL
OIL; INTRALYMPHATIC
ETHIODOL
GUERBET
99%
N009190
001
ETHOPROPAZINE HYDROCHLORIDE
TABLET; ORAL
PARSIDOL
PARKE DAVIS
003
006
008
ETHOTOIN
TABLET; ORAL
PEGANONE
LUNDBECK INC
500MG
N010841
003
ETHOXZOLAMIDE
TABLET; ORAL
CARDRASE
PHARMACIA AND UPJOHN
62.5MG 125MG
N011047 N011047
002
001
125MG
N016144
001
ETHYLESTRENOL
ELIXIR; ORAL MAXIBOLIN ORGANON USA INC TABLET; ORAL MAXIBOLIN ORGANON USA INC
2MG/5ML
N014006
002
2MG
N014005
002
1MG;0.1MG
N016029
002
1MG;0.1MG
N016029
003
1MG;0.1MG
N016705
001
ETIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION DURANEST ASTRAZENECA
0.5% 1%
N017751 N017751
003 005
ETIDRONATE DISODIUM
INJECTABLE; INJECTION DIDRONEL MGI PHARMA INC
50MG/ML
N019545
001
ETODOLAC
CAPSULE; ORAL ETODOLAC AAIPHARMA LLC ENDO PHARMS IVAX SUB TEVA PHARMS MYLAN
SANDOZ
TEVA WATSON LABS LODINE WYETH PHARMS INC TABLET; ORAL ETODOLAC AAIPHARMA LLC ACTAVIS ELIZABETH ENDO PHARMS
300MG 200MG 300MG 200MG 300MG 200MG 200MG 300MG 300MG 200MG 200MG 300MG 300MG 200MG 200MG 300MG 200MG 300MG
A074929 A074842 A074842 A074899 A074899 A074932 A075071 A074932 A075071 A074840 A074942 A074840 A074942 A075126 A074844 A074844 N018922 N018922
001 001 002 001 002 001 001 002 002 001 001 002 002 001 001 002 002 003
Jan Jul Jul Jul Jul May Sep May Sep Aug Sep Aug Sep Sep Dec Dec
30, 17, 17, 08, 08, 16, 30, 16, 30, 29, 30, 29, 30, 16, 23, 23,
1998 1997 1997 1997 1997 1997 1998 1997 1998 1997 1997 1997 1997 1999 1997 1997
400MG 500MG 400MG 500MG 400MG 500MG 400MG 400MG 400MG 500MG 400MG 400MG 500MG
A074883 A074883 A075012 A075012 A075226 A075226 A074839 A074846 A074847 A074847 A074892 A075069 A074892 N018922 N018922
001 002 001 002 001 002 001 001 001 002 001 001 002 004 005
Feb Nov Sep Sep Nov Nov Jul Feb Apr Apr Apr Apr Oct
28, 20, 30, 30, 24, 24, 11, 28, 23, 23, 16, 16, 29,
1997 1998 1998 1998 1998 1998 1997 1997 1999 1999 1997 1998 1998
400MG 500MG TABLET, EXTENDED RELEASE; ORAL ETODOLAC POINT HOLDINGS 400MG SANDOZ 400MG 500MG 600MG WATSON LABS FLORIDA 400MG 500MG LODINE XL WYETH PHARMS INC 400MG 500MG 600MG
ETOPOSIDE
CAPSULE; ORAL VEPESID BRISTOL MYERS SQUIBB INJECTABLE; INJECTION ETOPOSIDE HOSPIRA MARSAM PHARMS LLC PIERRE FABRE TEVA PARENTERAL WATSON LABS TOPOSAR TEVA PARENTERAL VEPESID BRISTOL MYERS SQUIBB
50MG 100MG
N019557 N019557
001 002
ETOPOSIDE PHOSPHATE
INJECTABLE; INJECTION ETOPOPHOS PRESERVATIVE FREE BRISTOL MYERS SQUIBB EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
N020906 N020906
001 002
ETRETINATE
CAPSULE; ORAL TEGISON ROCHE
10MG 25MG
N019369 N019369
001 002
0.5%
N008041
001
FAMOTIDINE
INJECTABLE; INJECTION FAMOTIDINE APOTEX INC APOTHECON HOSPIRA
10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML FAMOTIDINE PRESERVATIVE FREE APOTHECON 10MG/ML HOSPIRA 10MG/ML FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER ABBOTT 0.4MG/ML PEPCID MERCK 10MG/ML PEPCID PRESERVATIVE FREE MERCK 10MG/ML PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER MERCK 0.4MG/ML TABLET; ORAL FAMOTIDINE ACTAVIS ELIZABETH 20MG 40MG APOTEX 10MG MUTUAL PHARM 20MG 40MG SANDOZ 20MG 20MG 40MG 40MG TABLET, CHEWABLE; ORAL PEPCID AC MERCK SHARP DOHME 10MG TABLET, ORALLY DISINTEGRATING; ORAL FLUXID SCHWARZ PHARMA 20MG 40MG PEPCID RPD MERCK 20MG 40MG
A075942 A075707 A075705 A075870 A075905 A075708 A075669 A075729 N019510 N019510 N020249
001 001 001 001 001 001 001 001 001 004 001
Apr 16, 2001 Apr 16, 2001 Dec 17, 2001 Nov 04, 1986 Nov 04, 1986 Feb 18, 1994
N020801
001
Sep 24, 2004 Sep 24, 2004 May 28, 1998 May 28, 1998
FENOFIBRATE
CAPSULE; ORAL ANTARA (MICRONIZED) LUPIN ATLANTIS LIPIDIL ABBOTT LIPOFEN CIPHER PHARMS INC TRICOR (MICRONIZED) ABBOTT
Nov 30, 2004 Dec 31, 1993 Jan 11, 2006 Feb 09, 1998 Jun 30, 1999 Jun 30, 1999
A076656 A077826
001 001
FENOPROFEN CALCIUM
CAPSULE; ORAL FENOPROFEN CALCIUM AM THERAP HALSEY PAR PHARM QUANTUM PHARMICS SANDOZ WARNER CHILCOTT WATSON LABS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
200MG 300MG 200MG 300MG 200MG 300MG 200MG 300MG 200MG 300MG 200MG 300MG 200MG 200MG 300MG 300MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A072307 A072308 A072355 A072356 A072437 A072438 A072214 A071738 A072394 A072395 A072946 A072472 A072294 A072981 A072293 A072982 N017604
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002
Aug Aug Aug Aug Aug Aug Aug Aug Oct Oct Apr Apr Aug Aug Aug Aug
22, 22, 17, 17, 22, 22, 17, 17, 17, 17, 30, 30, 17, 19, 17, 19,
1988 1988 1988 1988 1988 1988 1988 1988 1988 1988 1991 1991 1988 1991 1988 1991
NALFON PEDINOL TABLET; ORAL FENOPROFEN CALCIUM ACTAVIS ELIZABETH AM THERAP CLONMEL HLTHCARE HALSEY MUTUAL PHARM PAR PHARM QUANTUM PHARMICS SANDOZ USL PHARMA WATSON LABS
EQ 300MG BASE
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
600MG 600MG 600MG 600MG 600MG 600MG 600MG 600MG 600MG 600MG 600MG 600MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A072274 A072309 A072326 A072357 A072902 A072429 A072194 A072396 A072362 A072165 A072407 A072602 N017710
001 001 001 001 001 001 001 001 001 001 001 001 001
May Aug Aug Aug Dec Aug Aug Oct Aug Aug Aug Oct
02, 17, 17, 17, 21, 17, 17, 17, 17, 17, 17, 11,
1988 1988 1988 1988 1990 1988 1988 1988 1988 1988 1988 1988
NALFON DISTA
EQ 600MG BASE
FENTANYL CITRATE
INJECTABLE; INJECTION FENTANYL CITRATE ABBOTT
EQ 0.05MG BASE/ML EQ 0.05MG BASE/ML WATSON LABS EQ 0.05MG BASE/ML FENTANYL CITRATE PRESERVATIVE FREE MARSAM PHARMS LLC EQ 0.05MG BASE/ML TABLET; BUCCAL FENTORA CEPHALON EQ 0.3MG BASE TROCHE/LOZENGE; ORAL FENTANYL CEPHALON EQ 0.1MG BASE EQ 0.2MG BASE EQ 0.3MG BASE EQ 0.4MG BASE
Apr 30, 1990 Apr 30, 1990 Jun 30, 1992 Feb 03, 1998
N021947
006
N021338
001
600MG/PACKET
N020292
001
25uCi/ML
N016729
001
182MG;0.33MG
N006012
003
FEXOFENADINE HYDROCHLORIDE
CAPSULE; ORAL ALLEGRA SANOFI AVENTIS US 60MG FEXOFENADINE HYDROCHLORIDE BARR 60MG
N020625 A076169
001 001
FIBRINOGEN, I-125
INJECTABLE; INJECTION IBRIN GE HEALTHCARE 154uCi/VIAL RADIONUCLIDE-LABELED (125 I) FIBRINOGEN (HUMAN) SENSOR ABBOTT 140uCi/ML
N017879 N017787
001 001
FINASTERIDE
TABLET; ORAL FINASTERIDE IVAX SUB TEVA PHARMS
5MG
A076340
001
FLAVOXATE HYDROCHLORIDE
TABLET; ORAL URISPAS ORTHO MCNEIL JANSSEN
100MG
N016769
001
FLECAINIDE ACETATE
TABLET; ORAL FLECAINIDE ACETATE SANDOZ
Oct 28, 2002 Oct 28, 2002 Oct 28, 2002 Oct 31, 1985
TAMBOCOR MEDICIS
FLOXURIDINE
INJECTABLE; INJECTION FUDR HOSPIRA
500MG/VIAL
N016929
001
FLUCONAZOLE
INJECTABLE; INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
APOTEX INC 200MG/100ML (2MG/ML) 400MG/200ML (2MG/ML)
A076889 A076889
001 002
A076617 A076617
001 002
A076432 A076432 A076432 A076432 A076213 A076213 A076213 A076213 A076086 A076086 A076086 A076086
001 002 003 004 001 002 003 004 001 002 003 004
Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul Jul
29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29, 29,
2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004 2004
FLUDEOXYGLUCOSE F-18
INJECTABLE; INJECTION FLUDEOXYGLUCOSE F 18 DOWNSTATE CLINCL
4-40mCi/ML 4-90mCi/ML
N020306 N020306
001 002
FLUDROCORTISONE ACETATE
TABLET; ORAL FLORINEF KING PHARMS
0.1MG
N010060
001
FLUMETHASONE PIVALATE
CREAM; TOPICAL LOCORTEN NOVARTIS
0.03%
N016379
001
FLUNISOLIDE
SPRAY, METERED; NASAL NASALIDE IVAX RES NASAREL TEVA BRANDED PHARM
0.025MG/SPRAY 0.029MG/SPRAY
N018148 N020409
FLUOCINOLONE ACETONIDE
CREAM; TOPICAL FLUOCET ALPHARMA US PHARMS FLUOCINOLONE ACETONIDE ALPHARMA US PHARMS PERRIGO NEW YORK PHARMADERM PHARMAFAIR TARO
0.025% 0.01% 0.01% 0.025% 0.01% 0.025% 0.01% 0.025% 0.01% 0.01% 0.025% 0.01% 0.025% 0.025%
A088360 A088361 A086810 A086811 A088047 A088045 A088499 A088506 A040035 A087102 A040042 A088757 A088756 A087156
001 001 001 001 001 001 001 001 001 001 001 001 001 002
Jan 16, 1984 Jan Mar Mar Dec Dec Aug Aug Oct Apr Oct Feb Mar 16, 04, 04, 16, 16, 02, 02, 31, 27, 31, 11, 28, 1984 1982 1982 1982 1982 1984 1984 1994 1982 1994 1985 1985
0.025%
A087300
001
Dec 16, 1982 Feb 27, 1984 Feb 08, 1985 Sep 06, 1984 Mar 09, 1983
A060700
001
FLUOCINONIDE
CREAM; TOPICAL FLUOCINONIDE PERRIGO NEW YORK TARO FLUOCINONIDE EMULSIFIED ACTAVIS MID ATLANTIC SOLUTION; TOPICAL FLUOCINONIDE TARO TEVA PHARMS
0.05% 0.05%
A072857 A072522
001 001
FLUORESCEIN SODIUM
INJECTABLE; INJECTION FUNDUSCEIN-25 NOVARTIS INJECTABLE; INTRAVENOUS AK-FLUOR 25% AKORN
25%
N017869
001
N022186
002
FLUOROMETHOLONE
CREAM; TOPICAL OXYLONE PHARMACIA AND UPJOHN 0.025% SUSPENSION/DROPS; OPHTHALMIC FLUOR-OP NOVARTIS 0.1%
N011748
001
A070185
001
N050628
001
N019525
001
FLUOROURACIL
INJECTABLE; INJECTION ADRUCIL PHARMACIA AND UPJOHN TEVA PARENTERAL FLUOROURACIL ABIC ABRAXIS PHARM
50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML 500MG/10ML (50MG/ML) 50MG/ML
A081222 N017959 A040023 A081225 A088929 A089152 A089428 A089519 A040291 A040379 A089508 A087791 A088766 A088767 A089434 N012209 A087792
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jun 28, 1991 Oct 18, 1991 Aug 28, 1991 Mar Mar Jan Mar Mar Nov Jan Jan Dec Dec Mar 04, 21, 12, 12, 24, 15, 26, 18, 28, 28, 26, 1986 1986 1987 1987 1999 2000 1988 1983 1984 1984 1987
1%
N016765
001
FLUOXETINE HYDROCHLORIDE
CAPSULE; ORAL FLUOXETINE MUTUAL PHARMA WATSON LABS
EQ EQ EQ EQ
10MG 20MG 10MG 20MG 40MG 10MG 20MG 40MG 10MG 20MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A075787 A075787 A075662 A075662 A076251 A076922 A076922 A076922 A075807 A075807 N018936
001 002 001 002 001 001 002 003 001 002 004
Jan Jan Jan Jan May Dec Dec Dec Jan Jan
29, 29, 29, 29, 18, 16, 16, 16, 29, 29,
2002 2002 2002 2002 2005 2004 2004 2004 2002 2002
FLUOXETINE HYDROCHLORIDE BARR EQ PAR PHARM EQ EQ EQ SANDOZ EQ EQ PROZAC LILLY EQ SOLUTION; ORAL FLUOXETINE HYDROCHLORIDE ACTAVIS MID ATLANTIC EQ HI TECH PHARMA EQ PROZAC LILLY EQ TABLET; ORAL FLUOXETINE HYDROCHLORIDE BARR EQ IVAX SUB TEVA PHARMS EQ EQ SANDOZ EQ
60MG BASE
N020974 N020974
001 002
FLUOXYMESTERONE
TABLET; ORAL ANDROID-F VALEANT PHARM INTL FLUOXYMESTERONE VALEANT PHARM INTL WATSON LABS
10MG 10MG 2MG 5MG 10MG 2MG 5MG 10MG 2MG 5MG
A087196 A088221 A088260 A088265 A088309 N010611 N010611 N010611 N011359 N011359
001 001 001 001 001 002 006 010 001 002 May Dec Dec Dec 05, 06, 06, 06, 1983 1983 1983 1983
FLUPHENAZINE DECANOATE
INJECTABLE; INJECTION FLUPHENAZINE DECANOATE HOSPIRA TEVA PARENTERAL PROLIXIN DECANOATE BRISTOL MYERS SQUIBB
FLUPHENAZINE ENANTHATE
INJECTABLE; INJECTION PROLIXIN ENANTHATE APOTHECON
25MG/ML
N016110
001
FLUPHENAZINE HYDROCHLORIDE
CONCENTRATE; ORAL FLUPHENAZINE HYDROCHLORIDE TEVA PHARMS 5MG/ML PERMITIL SCHERING 5MG/ML PROLIXIN APOTHECON 5MG/ML ELIXIR; ORAL FLUPHENAZINE HYDROCHLORIDE TEVA PHARMS 2.5MG/5ML PROLIXIN APOTHECON 2.5MG/5ML INJECTABLE; INJECTION PROLIXIN APOTHECON 2.5MG/ML TABLET; ORAL FLUPHENAZINE HYDROCHLORIDE WATSON LABS 1MG 2.5MG 5MG 10MG PERMITIL SCHERING 0.25MG 2.5MG 5MG 10MG
A081310 N012145
001 003
N011751
005
1MG 2.5MG 5MG 10MG TABLET, EXTENDED RELEASE; ORAL PERMITIL SCHERING 1MG
N012419
004
FLUPREDNISOLONE
TABLET; ORAL ALPHADROL PHARMACIA AND UPJOHN
1.5MG
N012259
002
FLURANDRENOLIDE
CREAM; TOPICAL CORDRAN SP WATSON PHARMS LOTION; TOPICAL FLURANDRENOLIDE ALPHARMA US PHARMS OINTMENT; TOPICAL CORDRAN WATSON PHARMS
0.05%
N012806
002
0.05%
A087203
001
0.025% 0.05%
N012806 N012806
004 001
N050346
001
N050345
001
FLURAZEPAM HYDROCHLORIDE
CAPSULE; ORAL DALMANE VALEANT PHARM INTL
15MG 30MG
N016721 N016721 A071808 A071809 A070454 A070455 A070444 A070445 A071927 A071551 A071716 A071717 A071659 A071660 A070562 A070563 A071767 A071768 A072368
001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Jan Jan Aug Aug Mar Mar Sep Sep Jul Jul Aug Aug Jul Jul Dec Dec Mar 07, 07, 04, 04, 20, 20, 09, 09, 31, 31, 04, 04, 09, 09, 04, 04, 30, 1988 1988 1986 1986 1986 1986 1987 1987 1991 1991 1988 1988 1987 1987 1987 1987 1989
FLURAZEPAM HYDROCHLORIDE HALSEY 15MG 30MG MUTUAL PHARM 15MG 30MG PAR PHARM 15MG 30MG PUREPAC PHARM 15MG 30MG SANDOZ 15MG 30MG SUPERPHARM 15MG 30MG USL PHARMA 15MG 30MG WARNER CHILCOTT 15MG 30MG WATSON LABS 15MG
FLUTAMIDE
CAPSULE; ORAL EULEXIN SCHERING
125MG
N018554
001
FLUTICASONE PROPIONATE
AEROSOL, METERED; INHALATION FLOVENT GLAXOSMITHKLINE 0.044MG/INH 0.11MG/INH 0.22MG/INH OINTMENT; TOPICAL FLUTICASONE PROPIONATE TARO PHARM INDS 0.005% POWDER; INHALATION FLOVENT GLAXOSMITHKLINE 0.044MG/INH 0.088MG/INH 0.22MG/INH
A077145
001
FLUVOXAMINE MALEATE
TABLET; ORAL FLUVOXAMINE MALEATE ACTAVIS ELIZABETH
MUTUAL PHARM
MYLAN SANDOZ
SYNTHON PHARMS
WATSON LABS
25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 25MG 50MG 100MG 150MG
A075901 A075901 A075901 A075898 A075898 A075898 A076125 A076125 A076125 A075950 A075950 A075887 A075887 A075887 A075899 A075899 A075899 A075894 A075894 A075894 N020243 N020243 N020243 N020243
001 002 003 001 002 003 001 002 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 004
Dec Dec Dec Mar Mar Mar Apr Apr Apr Oct Oct Jan Jan Jan Jan Jan Jan Apr Apr Apr Dec Dec Dec Dec
28, 28, 28, 12, 12, 12, 29, 29, 29, 15, 15, 05, 05, 05, 17, 17, 17, 18, 18, 18, 05, 05, 05, 05,
2000 2000 2000 2001 2001 2001 2002 2002 2002 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 2001 1994 1994 1994 1994
LUVOX SOLVAY
5MG/ML 5MG/ML
A081066 N005897
001 008
1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG 1MG
A089177 A080755 A083598 A080686 A083000 A080816 N006135 A083526 A040582 A084915 A084158 A088949 A080784 A084472 A083133 A088199 A087828 A080903 A088730 A086296 A083141 A085141 A080691 A087438 N005897
001 001 001 001 001 001 003 001 001 001 001 001 001 001 002 001 001 001 001 001 001 002 002 001 004
FOLLITROPIN ALFA/BETA
INJECTABLE; IM-SC FOLLISTIM ORGANON USA INC INJECTABLE; SUBCUTANEOUS FOLLISTIM AQ ORGANON USA INC GONAL-F EMD SERONO
N020582 N020582
001 002
150 IU/0.18ML 37.5 IU/VIAL 37.5 IU/VIAL 75 IU/VIAL 150 IU/VIAL 150 IU/VIAL
Feb 11, 2004 May Mar Sep Sep Mar 25, 25, 29, 29, 25, 2000 2004 1997 1997 2004
FOMIVIRSEN SODIUM
INJECTABLE; INJECTION VITRAVENE PRESERVATIVE FREE NOVARTIS 6.6MG/ML
N020961
001
FORMOTEROL FUMARATE
POWDER; INHALATION FORADIL CERTIHALER NOVARTIS
0.0085MG/INH
N021592
001
FOSPHENYTOIN SODIUM
INJECTABLE; INJECTION CEREBYX PARKE DAVIS
N020450
001
FURAZOLIDONE
SUSPENSION; ORAL FUROXONE SHIRE TABLET; ORAL FUROXONE SHIRE
50MG/15ML
N011323
002
100MG
N011270
002
FUROSEMIDE
INJECTABLE; INJECTION FUROSEMIDE ABRAXIS PHARM ASTRAZENECA
BAXTER HLTHCARE HOSPIRA MARSAM PHARMS LLC ORGANON USA INC SMITH AND NEPHEW WARNER CHILCOTT WATSON LABS WYETH AYERST LASIX SANOFI AVENTIS US SOLUTION; ORAL LASIX SANOFI AVENTIS US TABLET; ORAL FUROSEMIDE INTL MEDICATION KALAPHARM MUTUAL PHARM
10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML 10MG/ML
N018507 N019036 A070014 A070095 A070096 A071439 N018267 A072080 A074337 A074017 A070017 A070023 A070078 N018420 A070019 A070604 N018670 N016363
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul Aug Sep Sep Sep Sep Aug Oct Jun Dec Feb Feb Feb Sep Jan Jul
30, 13, 09, 09, 09, 14, 13, 31, 30, 15, 05, 05, 26, 22, 02, 20,
1982 1984 1985 1985 1985 1990 1991 1994 1994 1986 1986 1986 1982 1986 1987 1982
10MG/ML
N017688
001
WATSON LABS
40MG 80MG 40MG 20MG 40MG 20MG 40MG 80MG 20MG 40MG 40MG
N018790 A070100 N018750 N018370 N018370 N018419 N018419 N018419 N018369 A070413 N018369
001 001 002 002 001 001 002 003 001 001 002
Nov Jan Jul Jun Feb Jan Jan Nov May Feb May
29, 26, 30, 26, 10, 31, 31, 13, 14, 26, 14,
1983 1988 1984 1984 1983 1983 1983 1984 1982 1986 1982
GABAPENTIN
CAPSULE; ORAL GABAPENTIN IVAX SUB TEVA PHARMS
MUTUAL PHARM
SANDOZ
100MG 300MG 400MG 100MG 300MG 400MG 100MG 100MG 300MG 300MG 400MG 400MG
A075477 A075477 A075477 A076537 A076537 A076537 A075428 A075539 A075428 A075539 A075428 A075539
001 002 003 001 002 003 001 001 002 002 003 003
Mar Mar Mar Jun Jun Jun Jan Apr Jan Apr Jan Apr
23, 23, 23, 30, 30, 30, 24, 06, 24, 06, 24, 06,
2005 2005 2005 2005 2005 2005 2006 2005 2006 2005 2006 2005
TEVA
GADODIAMIDE
INJECTABLE; INJECTION OMNISCAN GE HEALTHCARE
14.35GM/50ML (287MG/ML)
N022066
001
GALANTAMINE HYDROBROMIDE
TABLET; ORAL GALANTAMINE HYDROBROMIDE ACTAVIS ELIZABETH EQ EQ EQ YABAO BIOPHARMS EQ EQ EQ
4MG BASE 8MG BASE 12MG BASE 4MG BASE 8MG BASE 12MG BASE
GALLAMINE TRIETHIODIDE
INJECTABLE; INJECTION FLAXEDIL DAVIS AND GECK
20MG/ML 100MG/ML
N007842 N007842
001 002
1mCi/ML 2mCi/ML
N017700 N017655
001 001
GANCICLOVIR
CAPSULE; ORAL CYTOVENE ROCHE PALO
250MG 500MG
N020460 N020460
001 002
GANCICLOVIR SODIUM
INJECTABLE; INJECTION GANCICLOVIR SODIUM BEDFORD
EQ 500MG BASE/VIAL
A076222
001
GEFITINIB
TABLET; ORAL IRESSA ASTRAZENECA
250MG
N021399
001
GEMFIBROZIL
CAPSULE; ORAL GEMFIBROZIL MYLAN PUREPAC PHARM LOPID PFIZER PHARMS TABLET; ORAL GEMFIBROZIL MYLAN PUREPAC PHARM SANDOZ WATSON LABS
GEMTUZUMAB OZOGAMICIN
INJECTABLE; INJECTION MYLOTARG WYETH PHARMS INC
5MG/VIAL
N021174
001
GENTAMICIN SULFATE
CREAM; TOPICAL GARAMYCIN SCHERING GENTAFAIR PHARMAFAIR GENTAMICIN SULFATE ALPHARMA US PHARMS BAUSCH AND LOMB PHARMADERM INJECTABLE; INJECTION APOGEN KING PHARMS BRISTAGEN
BRISTOL
GARAMYCIN
SCHERING
EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 0.1% BASE EQ 1MG BASE/GM
001 001 001 001 001 Sep 01, 1983 Sep 27, 1983 Apr 29, 1994 Jul 05, 1984
EQ 10MG BASE/ML EQ 40MG BASE/ML EQ 40MG BASE/ML EQ 1MG BASE/ML EQ 10MG BASE/ML EQ 40MG BASE/ML
A062493 A062325 A062325 A062325 A062413 A062413 A062413 A062413 A062413 A062413 A062413 A062413 A062413 A062413 A062251 A062251 A062354 A062340 A062507 A062507 A063149 A063106 A062318 A062318 A062264 A062264 A062588 A062588 A062588 A062588 A062588 A062588 A062588 A062588 A062588 A062588 A062248 A062248
001 003 001 004 001 002 003 004 005 006 007 008 009 010 002 001 001 001 001 002 001 002 002 001 001 002 001 002 003 004 005 006 007 008 009 010 001 002
Aug 28, 1985 Jun 23, 1982 Jun 23, 1982 Aug Aug Aug Aug Aug Aug Aug Aug Aug Aug 11, 11, 11, 11, 11, 11, 11, 11, 11, 11, 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983
EQ 1.2MG BASE/ML EQ 1.4MG BASE/ML EQ 1.6MG BASE/ML EQ 1.8MG BASE/ML EQ 2MG BASE/ML EQ 60MG BASE/100ML EQ 70MG BASE/100ML EQ 80MG BASE/100ML EQ 90MG BASE/100ML EQ 100MG BASE/100ML BAXTER HLTHCARE EQ 10MG BASE/ML EQ 40MG BASE/ML KALAPHARM EQ 40MG BASE/ML PHARM SPEC EQ 40MG BASE/ML SOLOPAK EQ 10MG BASE/ML EQ 40MG BASE/ML TEVA PARENTERAL EQ 10MG BASE/ML EQ 40MG BASE/ML WATSON LABS EQ 10MG BASE/ML EQ 40MG BASE/ML WYETH AYERST EQ 10MG BASE/ML EQ 40MG BASE/ML GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER HOSPIRA EQ 1.2MG BASE/ML EQ 1.4MG BASE/ML EQ 1.6MG BASE/ML EQ 1.8MG BASE/ML EQ 2MG BASE/ML EQ 60MG BASE/100ML EQ 70MG BASE/100ML EQ 80MG BASE/100ML EQ 90MG BASE/100ML EQ 100MG BASE/100ML U-GENCIN PHARMACIA AND UPJOHN EQ 10MG BASE/ML EQ 40MG BASE/ML INJECTABLE; INTRATHECAL GARAMYCIN SCHERING EQ 2MG BASE/ML OINTMENT; OPHTHALMIC GARAMYCIN SCHERING EQ 0.3% BASE GENTACIDIN NOVARTIS EQ 0.3% BASE GENTAFAIR PHARMAFAIR EQ 3MG BASE/GM OINTMENT; TOPICAL GARAMYCIN SCHERING EQ 0.1% BASE GENTAFAIR PHARMAFAIR EQ 0.1% BASE GENTAMICIN SULFATE ALPHARMA US PHARMS EQ 0.1% BASE BAUSCH AND LOMB EQ 0.1% BASE PHARMADERM EQ 0.1% BASE
Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan
06, 06, 06, 06, 06, 06, 06, 06, 06, 06,
1986 1986 1986 1986 1986 1986 1986 1986 1986 1986
N050505
001
001 001 001 001 001 May 26, 1983 Mar 14, 1984 Apr 29, 1994 Oct 10, 1984
0.3% BASE 0.3% BASE 0.3% BASE 0.3% BASE 3MG BASE/ML
002 001 001 001 001 Mar 30, 1984 May 03, 1983 Nov 25, 1985 Nov 07, 1988
GENTIAN VIOLET
SUPPOSITORY; VAGINAL GVS SAVAGE LABS TAMPON; VAGINAL GENAPAX KEY PHARMS
0.4%
A083513
001
5MG
A085017
001
GLATIRAMER ACETATE
FOR SOLUTION; SUBCUTANEOUS COPAXONE TEVA 20MG/VIAL
N020622
001
GLIMEPIRIDE
TABLET; ORAL GLIMEPIRIDE RANBAXY
3MG 6MG
A077366 A077366
001 002
GLIPIZIDE
TABLET; ORAL GLIPIZIDE ENDO PHARMS PLIVA SANDOZ TEVA GLUCOTROL PFIZER
GLUCAGON HYDROCHLORIDE
INJECTABLE; INJECTION GLUCAGON LILLY
N012122 N012122
001 002
GLUTETHIMIDE
CAPSULE; ORAL DORIDEN SANOFI AVENTIS US
500MG
N009519
008
250MG 500MG 250MG 500MG 250MG 500MG 500MG 500MG 500MG 500MG 500MG
N009519 N009519 A089458 A089459 A083475 A085571 A083234 A085171 A087297 A084362 A085763
002 005 001 001 001 001 002 001 001 001 001 Oct 10, 1986 Oct 10, 1986
GLYBURIDE
TABLET; ORAL GLYBURIDE ACTAVIS TOTOWA
1.5MG 3MG 6MG 1.5MG 3MG 1.5MG 3MG 6MG 4.5MG 1.25MG 2.5MG 5MG
A075947 A075947 A075947 A075174 A075174 N020055 N020055 N020055 N020051 N017498 N017498 N017498
001 002 003 001 002 001 002 003 003 001 002 003
Nov 14, 2002 Nov 14, 2002 Nov 14, 2002 Jun Jun Apr Apr Mar 22, 22, 17, 17, 08, 1998 1998 1992 1992 2000
Sep 24, 1993 May 01, 1984 May 01, 1984 May 01, 1984
GLYCINE
SOLUTION; IRRIGATION GLYCINE 1.5% IN PLASTIC CONTAINER BAXTER HLTHCARE 1.5GM/100ML HOSPIRA 1.5GM/100ML
N018522 N017633
001 001
GLYCOPYRROLATE
INJECTABLE; INJECTION GLYCOPYRROLATE ABRAXIS PHARM HOSPIRA TEVA PARENTERAL WATSON LABS ROBINUL ROBINS AH TABLET; ORAL GLYCOPYRROLATE WATSON LABS
2MG
A086900
001
GONADORELIN ACETATE
INJECTABLE; INJECTION LUTREPULSE KIT FERRING
0.8MG/VIAL 3.2MG/VIAL
N019687 N019687
001 002
GONADORELIN HYDROCHLORIDE
INJECTABLE; INJECTION
FACTREL
HIKMA (MAPLE)
GONADOTROPIN, CHORIONIC
INJECTABLE; INJECTION A.P.L. FERRING
5,000 UNITS/VIAL 10,000 UNITS/VIAL 20,000 UNITS/VIAL 5,000 UNITS/VIAL 15,000 UNITS/VIAL 20,000 UNITS/VIAL 5,000 UNITS/VIAL 10,000 UNITS/VIAL 2,000 UNITS/VIAL 2,000 UNITS/VIAL 5,000 UNITS/VIAL 15,000 UNITS/VIAL 20,000 UNITS/VIAL 10,000 UNITS/VIAL
N017055 N017055 N017055 N017067 N017067 N017067 N017054 N017054 N017016 N017016 N017016 N017016 N017016 N017056
001
002
003
001
004
003
001
002
009 011 006 010 004
001
FOLLUTEIN
BRISTOL MYERS SQUIBB
A062818 A062788
001 001
A062383
001
A060427
001
GRANISETRON HYDROCHLORIDE
INJECTABLE; INJECTION
KYTRIL
ROCHE
EQ EQ EQ EQ
0.1MG BASE/ML (EQ 0.1MG BASE/ML) 1MG BASE/ML (EQ 1MG BASE/ML) 3MG BASE/ML 4MG BASE/4ML (EQ 1MG BASE/ML)
EQ 2MG BASE/10ML
N021238
001
GREPAFLOXACIN HYDROCHLORIDE
TABLET; ORAL RAXAR OTSUKA
GRISEOFULVIN, MICROCRYSTALLINE
CAPSULE; ORAL GRISACTIN WYETH AYERST SUSPENSION; ORAL GRIFULVIN V JOHNSON AND JOHNSON TABLET; ORAL FULVICIN-U/F ELORAC GRIFULVIN V J AND J
125MG 250MG
N050051 N050051
002 001
125MG/5ML
N050448
001
GRISEOFULVIN, ULTRAMICROCRYSTALLINE
TABLET; ORAL FULVICIN P/G ELORAC FULVICIN P/G 165 ELORAC FULVICIN P/G 330 ELORAC GRISACTIN ULTRA WYETH AYERST
125MG 250MG 165MG 330MG 125MG 165MG 250MG 330MG 165MG 330MG
A061996 A061996 A061996 A061996 A062178 A062438 A062178 A062438 A062645 A062646
001 002 003 004 001 001 002 002 001 001 Apr 06, 1982 Apr 06, 1982
Nov 17, 1983 Nov 17, 1983 Jun 30, 1992 Jun 30, 1992
GUANABENZ ACETATE
TABLET; ORAL GUANABENZ ACETATE SANDOZ TEVA PHARMS WATSON LABS
EQ EQ EQ EQ EQ
Feb 28, 1994 Sep 07, 1982 Sep 07, 1982 Sep 07, 1982
GUANADREL SULFATE
TABLET; ORAL HYLOREL PHARMACIA AND UPJOHN
10MG 25MG
N018104 N018104
001 002
GUANETHIDINE MONOSULFATE
TABLET; ORAL GUANETHIDINE MONOSULFATE WATSON LABS EQ EQ ISMELIN NOVARTIS EQ EQ
10MG;25MG
N013553
001
GUANFACINE HYDROCHLORIDE
TABLET; ORAL GUANFACINE HYDROCHLORIDE WATSON LABS EQ 1MG BASE EQ 2MG BASE TENEX PROMIUS PHARMA EQ 3MG BASE
HALAZEPAM
TABLET; ORAL PAXIPAM SCHERING
20MG 40MG
N017736 N017736
003 004
HALCINONIDE
CREAM; TOPICAL HALOG WESTWOOD SQUIBB HALOG-E RANBAXY OINTMENT; TOPICAL HALOG BRISTOL MYERS SQUIBB SOLUTION; TOPICAL HALOG RANBAXY
0.025% 0.1%
N017818 N018234
001 001
0.025%
N018125
001
0.1%
N017823
001
HALOBETASOL PROPIONATE
OINTMENT; TOPICAL HALOBETASOL PROPIONATE ACTAVIS MID ATLANTIC
0.05%
A077109
001
250MG
N020250
001
HALOPERIDOL
TABLET; ORAL HALDOL ORTHO MCNEIL
0.5MG 1MG 2MG 5MG 10MG 20MG 1MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG 20MG 0.5MG 1MG 2MG 5MG 10MG
N015921 N015921 N015921 N015921 N015921 N015921 N017079 A071216 A071217 A071218 A071219 A071220 A071221 A072727 A072728 A072729 A072730 A072731 A072732 A071156 A071157 A071172 A071212 A071173 A071177 A071328 A071071 A071072 A071073 A071074 A071075 A071076 A071255 A071269 A071256 A071257 A071128 A071129 A071130 A071131 A071132 A071133 A071722 A071723 A071724 A071725 A072121 A072122 A070720 A070721 A070722 A070723 A070724
001 002 003 004 005 006 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
LEDERLE
MUTUAL PHARM
QUANTUM PHARMICS
ROXANE
ROYCE LABS
SCS
Dec Dec Dec Dec Jul Jul Sep Sep Sep Sep Sep Sep Jan Jan Jan Jan Jan Jan Jul Nov Nov Nov Nov Aug Aug Feb Feb Feb Feb Feb Feb Feb Feb May May Dec Dec Dec Dec Dec Dec Jun Jun Jun Jun Jun
04, 04, 04, 04, 07, 07, 19, 19, 19, 19, 19, 19, 02, 02, 02, 07, 07, 07, 20, 03, 03, 03, 03, 04, 04, 17, 17, 17, 17, 17, 17, 17, 17, 12, 12, 24, 24, 24, 24, 24, 24, 10, 10, 10, 10, 10,
1986 1986 1986 1986 1987 1987 1989 1989 1989 1989 1989 1989 1987 1987 1987 1988 1988 1988 1987 1986 1986 1986 1986 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987 1986 1986 1986 1986 1986
WATSON LABS
20MG 0.5MG 1MG 2MG 5MG 10MG 0.5MG 0.5MG 1MG 1MG 2MG 2MG 5MG 5MG 10MG 10MG 20MG 20MG
A070725 A071233 A071234 A071235 A071236 A071237 A070981 A071571 A070982 A071572 A070983 A071573 A070984 A071374 A071375 A072113 A071376 A072353
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Nov Nov Nov Nov Jul Mar Jun Mar Jun Mar Jun Mar Jun Jun Aug Jun Aug
24, 03, 03, 03, 03, 20, 06, 03, 06, 03, 06, 03, 06, 03, 03, 27, 03, 27,
1986 1986 1986 1986 1986 1987 1987 1988 1987 1988 1987 1988 1987 1988 1988 1991 1988 1991
HALOPERIDOL DECANOATE
INJECTABLE; INJECTION HALOPERIDOL DECANOATE HOSPIRA SANDOZ
EQ EQ EQ EQ
HALOPERIDOL LACTATE
CONCENTRATE; ORAL HALDOL ORTHO MCNEIL HALOPERIDOL ALPHARMA MORTON GROVE SCS TEVA HALOPERIDOL INTENSOL ROXANE INJECTABLE; INJECTION HALOPERIDOL ABRAXIS PHARM MARSAM PHARMS LLC SANDOZ SMITH AND NEPHEW SOLOPAK
EQ 2MG BASE/ML EQ EQ EQ EQ 2MG 2MG 2MG 2MG BASE/ML BASE/ML BASE/ML BASE/ML
001 001 001 001 001 001 Apr Mar Jun Aug 11, 07, 10, 25, 1986 1986 1986 1987
EQ 2MG BASE/ML
WATSON LABS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A071187 A072516 A072517 A076464 A070802 A070800 A070801 A070864 A070713 A070714 A070744
001 001 001 001 001 001 001 001 001 001 001
Jan Feb Feb Sep Dec Dec Dec Dec May May May
20, 25, 25, 29, 14, 14, 14, 14, 17, 17, 17,
1987 1993 1993 2004 1987 1987 1987 1987 1988 1988 1988
EQ 1MG BASE/ML
A074536
001
HALOPROGIN
CREAM; TOPICAL HALOTEX WESTWOOD SQUIBB
1%
N016942
001
1%
N016943
001
HALOTHANE
LIQUID; INHALATION FLUOTHANE WYETH AYERST HALOTHANE BH HALOCARBON HOSPIRA
HEPARIN CALCIUM
INJECTABLE; INJECTION CALCIPARINE SANOFI AVENTIS US
25,000 UNITS/ML
N018237
001
HEPARIN SODIUM
INJECTABLE; INJECTION HEPARIN LOCK FLUSH HOSPIRA INTL MEDICATION LUITPOLD PARKE DAVIS SMITH AND NEPHEW
SOLOPAK
100 UNITS/ML 10 UNITS/ML 500 UNITS/ML 10 UNITS/ML 100 UNITS/ML 10 UNITS/ML 10 UNITS/ML 10 UNITS/ML 10 UNITS/ML 10 UNITS/ML 100 UNITS/ML 100 UNITS/ML 100 UNITS/ML 100 UNITS/ML 10 UNITS/ML 10 UNITS/ML 100 UNITS/ML 100 UNITS/ML 1,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 40,000 UNITS/ML 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 5,000 UNITS/0.5ML 1,000 UNITS/ML 2,500 UNITS/ML 5,000 UNITS/ML 5,000 UNITS/0.5ML 7,500 UNITS/ML 10,000 UNITS/ML 15,000 UNITS/ML 20,000 UNITS/ML
N005264 A086357 A086357 A089063 A089064 N017346 A087904 A087958 A088458 A088580 A087906 A087959 A088460 A088581 A087903 A088457 A087905 A088459 N017033 N017979 N017979 N017979 N017486 N017486 N017486 N017486 N017486 N017651 N017029 N017651 N017651 N017037 N017007 N017007 N017007 N017007 N017007 N017007 N017007 N017007
010 001 002 001 001 006 001 001 001 001 001 001 001 001 001 001 001 001 001 001 003 002 001 002 003 004 005 005 002 003 008 013 001 007 002 010 003 004 005 006
Oct 09, 1985 Oct 09, 1985 Apr Apr Jul Oct Apr Apr Jul Oct Apr Oct Apr Jul 20, 20, 26, 25, 20, 20, 26, 25, 20, 25, 20, 26, 1983 1983 1984 1984 1983 1983 1984 1984 1983 1984 1983 1984
AKORN
APP PHARMS
1,000 UNITS/ML N017130 5,000 UNITS/ML N017130 10,000 UNITS/ML N017130 20,000 UNITS/ML N017130 DELL LABS 1,000 UNITS/ML N017540 5,000 UNITS/ML N017540 10,000 UNITS/ML N017540 20,000 UNITS/ML N017540 40,000 UNITS/ML N017540 HOSPIRA 2,500 UNITS/ML A088099 10,000 UNITS/ML A040095 LILLY 1,000 UNITS/ML N005521 10,000 UNITS/ML N005521 20,000 UNITS/ML N005521 LUITPOLD 1,000 UNITS/ML A087452 MARSAM PHARMS LLC 1,000 UNITS/ML A040007 1,000 UNITS/ML A040008 ORGANON USA INC 1,000 UNITS/ML N000552 5,000 UNITS/ML N000552 10,000 UNITS/ML N000552 PARKE DAVIS 1,000 UNITS/ML N017346 5,000 UNITS/ML N017346 7,500 UNITS/ML N017346 10,000 UNITS/ML N017346 20,000 UNITS/ML N017346 PHARM SPEC 1,000 UNITS/ML N017780 5,000 UNITS/ML N017780 10,000 UNITS/ML N017780 20,000 UNITS/ML N017780 40,000 UNITS/ML N017780 PHARMACIA AND UPJOHN 1,000 UNITS/ML N004570 5,000 UNITS/ML N004570 10,000 UNITS/ML N004570 SMITH AND NEPHEW 1,000 UNITS/ML A088239 SOLOPAK 1,000 UNITS/ML A087043 5,000 UNITS/ML A087077 5,000 UNITS/0.5ML A087395 10,000 UNITS/ML A087107 10,000 UNITS/0.5ML A087363 WATSON LABS 1,000 UNITS/ML N017064 2,500 UNITS/ML N017064 3,000 UNITS/ML N017064 4,000 UNITS/ML N017064 5,000 UNITS/ML N017064 6,000 UNITS/ML N017064 7,500 UNITS/ML N017064 10,000 UNITS/ML N017064 20,000 UNITS/ML N017064 40,000 UNITS/ML N017064 HEPARIN SODIUM 1,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER MCGAW 200 UNITS/100ML N019130 HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER B BRAUN 200 UNITS/100ML N019042 HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% HOSPIRA 10,000 UNITS/100ML N018911 HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE 2,000 UNITS/100ML N018814 HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45% HOSPIRA 10,000 UNITS/100ML N018911 10,000 UNITS/100ML N018916
001 002 003 004 001 002 003 004 005 001 001 001 002 004 001 001 001 008 009 010 001 002 003 004 005 001 002 003 004 005 001 002 003 001 001 001 001 001 001 002 015 016 017 003 018 019 004 005 006 001 001 006 002 001 005
Dec 31, 1984 Mar 29, 1985 Jan 30, 1985 Jul 09, 1985 Jan 30, 1985 Jan 31, 1984
003 002 007 001 005 003 003 002 009 008 001 005 002 004 001 003 009 003 002 002 004 001 004 013 014 001 001 001 006 002 008 010 003 009 011 004 007 005 007 004 003
Jan 30, 1985 Jan 31, 1984 Jan 30, 1985 Jul 20, 1992 Jan 30, 1985 Jan 31, 1984 Dec 31, 1984 Mar 29, 1985 Jan 30, 1985 Jan 30, 1985 Mar 29, 1985 Jul 20, 1992 Jul 20, 1992 Jan 30, 1985 Mar 29, 1985 Jul 20, 1992 Jan 31, 1984 Apr 28, 1982 Dec 31, 1984 Jan 30, 1985 Jan 31, 1984 Jan 31, 1984 Mar 29, 1985 Apr 07, 1986 Apr 07, 1986 Jun 03, 1986
10,000 UNITS/ML 20,000 UNITS/ML 40,000 UNITS/ML LIQUAEMIN SODIUM PRESERVATIVE FREE ORGANON USA INC 1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML PANHEPRIN
HOSPIRA
1,000 UNITS/ML 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML 40,000 UNITS/ML SODIUM HEPARIN ABRAXIS PHARM 5,000 UNITS/ML 10,000 UNITS/ML 20,000 UNITS/ML BAXTER HLTHCARE 1,000 UNITS/ML
N000552 N000552 N000552 N000552 N000552 N000552 N005264 N005264 N005264 N005264 N005264 N017033 N017033 N017033 N017036
005 001 002 011 012 013 004 006 007 008 009 002 003 004 001 Apr 11, 1986 Apr 11, 1986 Apr 11, 1986
HETACILLIN
FOR SUSPENSION; ORAL VERSAPEN BRISTOL
EQ EQ EQ EQ
HETACILLIN POTASSIUM
CAPSULE; ORAL VERSAPEN-K BRISTOL
A061396 A061396
001 002
HEXACHLOROPHENE
AEROSOL; TOPICAL SEPTISOL VESTAL LABS TURGEX XTTRIUM EMULSION; TOPICAL HEXA-GERM HUNTINGTON LABS PHISOHEX SANOFI AVENTIS US SOY-DOME BAYER PHARMS TURGEX XTTRIUM SOAP; TOPICAL GAMOPHEN ARBROOK SOLUTION; TOPICAL DIAL DIAL GERMA-MEDICA HUNTINGTON LABS GERMA-MEDICA "MG" HUNTINGTON LABS SEPTI-SOFT CALGON
0.23% 3%
N017424 N018375
001 001
3% 3% 3% 3%
2%
N006270
003
N017423
001
HEXAFLUORENIUM BROMIDE
INJECTABLE; INJECTION MYLAXEN MEDPOINTE PHARM HLC
20MG/ML
N009789
003
HEXOCYCLIUM METHYLSULFATE
TABLET; ORAL TRAL ABBOTT
25MG
N010599
001
HEXYLCAINE HYDROCHLORIDE
SOLUTION; TOPICAL CYCLAINE MERCK
5%
N008472
001
HISTAMINE PHOSPHATE
INJECTABLE; INJECTION HISTAMINE PHOSPHATE LILLY
HISTRELIN ACETATE
INJECTABLE; INJECTION SUPPRELIN SHIRE
HOMATROPINE METHYLBROMIDE
TABLET; ORAL HOMAPIN-10 MISSION PHARMA HOMAPIN-5 MISSION PHARMA TABLET, CHEWABLE; ORAL EQUIPIN MISSION PHARMA
10MG 5MG
A086308 A086309
001 001
3MG
A086310
001
A040295 N005213
001 001
HYALURONIDASE
INJECTABLE; INJECTION VITRASE ISTA PHARMS WYDASE BAXTER HLTHCARE
HYDRALAZINE HYDROCHLORIDE
INJECTABLE; INJECTION APRESOLINE NOVARTIS 20MG/ML HYDRALAZINE HYDROCHLORIDE ABRAXIS PHARM 20MG/ML SMITH AND NEPHEW 20MG/ML SOLOPAK 20MG/ML TEVA PARENTERAL 20MG/ML TABLET; ORAL APRESOLINE NOVARTIS 10MG 25MG 50MG 100MG DRALZINE TEVA 25MG HYDRALAZINE HYDROCHLORIDE ACTAVIS TOTOWA 25MG 50MG ASCOT 25MG 50MG HALSEY 10MG 25MG 50MG 100MG IMPAX LABS 25MG 50MG IVAX SUB TEVA PHARMS 10MG 25MG 50MG 100MG MUTUAL PHARM 10MG 10MG 25MG 25MG 50MG 50MG 100MG PUREPAC PHARM 25MG 50MG QUANTUM PHARMICS 10MG 25MG 50MG 100MG SANDOZ 10MG 25MG
003 001 001 001 001 Aug Apr Aug Feb 11, 20, 22, 23, 1987 1984 1985 2000
N008303 N008303 N008303 N008303 A084301 A088560 A088649 A088310 A088311 A089218 A089130 A089222 A089178 A084922 A084923 A084443 A084437 A084469 A084581 A088728 A089359 A084106 A089258 A084107 A089259 A088729 A088177 A088178 A088671 A088657 A088652 A088686 A083241 A083560
004 001 002 005 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 002 001 002 001 001 001 001 001 001 001 001 001 001 Oct Oct Dec Dec Jan Jan Jan Jan 04, 18, 19, 19, 22, 15, 22, 15, 1984 1984 1984 1984 1986 1986 1986 1986
Apr 11, 1985 Jul 25, 1986 May 05, 1986 May Apr Jul Aug May Jun May May 05, 11, 29, 15, 01, 15, 08, 01, 1986 1985 1983 1983 1984 1984 1984 1984
A083561 A085088 A088787 A088788 A088789 A088846 A088847 A088848 A088849 A087780 A087751 A087712 A087908 A086088 A085532 A085533 A088240 A088241
001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 002 001 001
May 07, 1982 May May May May 24, 25, 27, 27, 1982 1982 1983 1983
25MG;25MG 50MG;50MG 100MG;50MG HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE SOLVAY 25MG;25MG 50MG;50MG 100MG;50MG SUPERPHARM 25MG;25MG 50MG;50MG WATSON LABS 25MG;25MG 50MG;50MG 100MG;50MG HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50 IVAX PHARMS 100MG;50MG HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/25 IVAX PHARMS 25MG;25MG HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/50 IVAX PHARMS 50MG;50MG HYDRA-ZIDE PAR PHARM 100MG;50MG TABLET; ORAL APRESOLINE-ESIDRIX NOVARTIS 25MG;15MG HYDRALAZINE AND HYDROCHLORTHIAZIDE WATSON LABS 25MG;15MG HYDROCHLOROTHIAZIDE W/ HYDRALAZINE WATSON LABS 25MG;15MG
A084735 A084810 A084811 A087608 A087213 A087609 A089200 A089201 A085457 A085446 A085440 A088358 A088356 A088357 A088961
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Feb Feb Feb Feb Feb Mar Mar Mar 08, 08, 08, 09, 09, 04, 04, 04, 1982 1982 1982 1987 1987 1982 1982 1982
Apr 10, 1984 Apr 10, 1984 Apr 10, 1984 Oct 21, 1985
A084876 A083770 A083877 A088570 A088376 A085549 A087556 A087709 A087210 N012193 A085893 A086298
001 001 001 001 001 001 001 001 001 005 001 001 Apr 10, 1984 Oct 28, 1983
HYDROCHLOROTHIAZIDE
SOLUTION; ORAL HYDROCHLOROTHIAZIDE MORTON GROVE 50MG/5ML ROXANE 50MG/5ML HYDROCHLOROTHIAZIDE INTENSOL ROXANE 100MG/ML TABLET; ORAL ESIDRIX NOVARTIS 25MG 50MG 100MG HYDROCHLOROTHIAZIDE ABC HOLDING 50MG ACTAVIS ELIZABETH 25MG 50MG ALRA 25MG 50MG ASCOT 25MG 50MG BARR 50MG DAVA PHARMS INC 100MG ELKINS SINN 50MG HEATHER 50MG IMPAX LABS 25MG 50MG 100MG INWOOD LABS 25MG 25MG 50MG IVAX SUB TEVA PHARMS 50MG 100MG
N011793 N011793 N011793 A085672 A085054 A085208 A086369 A083554 A087539 A087540 A084771 A087060 A085152 A084135 A084029 A083607 A085098 A084776 A085067 A084776 A084658 A085022
005 008 009 001 002 001 001 001 001 001 001 001 002 001 001 002 001 001 001 002 001 001
SANDOZ
SOLVAY SUPERPHARM
TEVA TG UNITED LABS USL PHARMA VANGARD WARNER CHILCOTT WATSON LABS
25MG 50MG 25MG 50MG 100MG 25MG 50MG 50MG 25MG 50MG 50MG 25MG 25MG 50MG 50MG 25MG 25MG 50MG 100MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 50MG 25MG 25MG 50MG 50MG 50MG 50MG 50MG 100MG 100MG 100MG 25MG 25MG 50MG 100MG 25MG 50MG 25MG 50MG 100MG 25MG 50MG
A086192 A086192 A083972 A083972 A083972 A084880 A085112 A086597 A085004 A084536 A085005 A083899 A087565 A084912 A085219 A085323 A088827 A088828 A088829 A088924 A088923 A085683 A083965 A087827 A087752 A087638 A087610 A087586 A087587 A083458 A085232 A083232 A083456 A085233 A086087 A086594 A081190 A085099 A087002 A084899 A083809 A083809 A085347 A086504 A083891 N011835 N011835 N011835 N011971 A083925
001 002 001 002 003 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 002 001 001 001 002 003 006 007 001 001
HYDROCHLOROTHIAZIDE; IRBESARTAN
TABLET; ORAL AVALIDE SANOFI AVENTIS
12.5MG;75MG 25MG;300MG
N020758 N020758
001 004
HYDROCHLOROTHIAZIDE; LISINOPRIL
TABLET; ORAL LISINOPRIL AND HYDROCHLOROTHIAZIDE SANDOZ 12.5MG;10MG 12.5MG;20MG 25MG;20MG TEVA 12.5MG;10MG 12.5MG;20MG 25MG;20MG PRINZIDE MERCK 25MG;20MG
HYDROCHLOROTHIAZIDE; METHYLDOPA
TABLET; ORAL ALDORIL 15 MERCK 15MG;250MG ALDORIL 25 MERCK 25MG;250MG ALDORIL D30 MERCK 30MG;500MG ALDORIL D50 MERCK 50MG;500MG METHYLDOPA AND HYDROCHLOROTHIAZIDE CLONMEL HLTHCARE 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG IVAX SUB TEVA PHARMS 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG PAR PHARM 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG PARKE DAVIS 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG PUREPAC PHARM 15MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG SANDOZ 15MG;250MG 15MG;250MG 25MG;250MG 25MG;250MG 30MG;500MG 50MG;500MG TEVA 15MG;250MG
N013402 N013402 N013402 N013402 A072507 A072508 A072509 A072510 A071458 A071459 A071460 A071461 A070616 A070612 A070613 A070614 A071897 A071898 A071899 A071900 A070853 A070688 A070854 A070689 A070182 A070829 A070183 A070830 A070543 A070544 A071819
001 002 003 004 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Jun Jun Jun Jun Mar Mar Mar Mar Feb Feb Feb Feb Nov Nov Nov Nov Oct Apr Oct Apr Jan Mar Jan Mar Jan Jan Apr 02, 02, 02, 02, 08, 08, 08, 08, 02, 02, 02, 02, 23, 23, 23, 23, 08, 24, 08, 24, 15, 09, 15, 09, 15, 15, 08, 1989 1989 1989 1989 1988 1988 1988 1988 1987 1987 1987 1987 1987 1987 1987 1987 1986 1986 1986 1986 1986 1987 1986 1987 1986 1986 1988
A071820 A071821 A071822 A070365 A070958 A071920 A070366 A070959 A071921 A070367 A071069 A071922 A070368 A070960 A071923
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Apr Apr Apr Mar Feb Aug Apr Jan Aug Mar Jan Aug Apr Feb Aug
08, 08, 08, 19, 06, 29, 16, 19, 29, 19, 19, 29, 16, 06, 29,
1988 1988 1988 1986 1989 1988 1986 1989 1988 1986 1989 1988 1986 1989 1988
50MG;100MG
N018303
003
HYDROCHLOROTHIAZIDE; PINDOLOL
TABLET; ORAL VISKAZIDE NOVARTIS
25MG;5MG 25MG;10MG
N018872 N018872
001 002
N018031 A071126 A071127 A070851 A070852 A070704 A070705 A071552 A071553 A071060 A071061 A071771 A071772 A071498
002 001 001 001 001 001 001 001 001 001 001 001 001 001 Mar 02, 1987 Mar 02, 1987 May May Oct Oct Dec Dec Aug Aug Jan Jan Dec 15, 15, 01, 01, 01, 01, 26, 26, 26, 26, 18, 1986 1986 1986 1986 1988 1988 1987 1987 1988 1988 1991
A071501
001
HYDROCHLOROTHIAZIDE; RESERPINE
TABLET; ORAL H.R.-50 WHITEWORTH TOWN PLSN 50MG;0.125MG HYDROCHLOROTHIAZIDE W/ RESERPINE IVAX SUB TEVA PHARMS 25MG;0.1MG 25MG;0.125MG 50MG;0.1MG 50MG;0.125MG PHARMERAL 25MG;0.125MG 50MG;0.125MG ROXANE
50MG;0.125MG WATSON LABS
25MG;0.125MG 25MG;0.125MG 25MG;0.125MG 50MG;0.125MG 50MG;0.125MG 50MG;0.125MG HYDROPRES 25 MERCK 25MG;0.125MG HYDROPRES 50 MERCK 50MG;0.125MG HYDRO-RESERP ABC HOLDING 50MG;0.125MG HYDRO-SERP "25" SANDOZ 25MG;0.125MG HYDRO-SERP "50" SANDOZ 50MG;0.125MG RESERPINE AND HYDROCHLOROTHIAZIDE BARR 25MG;0.125MG 50MG;0.125MG SANDOZ 50MG;0.125MG RESERPINE AND HYDROCHLOROTHIAZIDE-50 WEST WARD 50MG;0.125MG SERPASIL-ESIDRIX #1 NOVARTIS 25MG;0.1MG SERPASIL-ESIDRIX #2 NOVARTIS 50MG;0.1MG
A085338 A083572 A083571 A083568 A083573 A085421 A085420 A084603 A084466 A085317 A086330 A083666 A084467 A086331 N011958 N011958 A084714 A084827 A085213 A084580 A084579 A088200 A088189 N011878 N011878
001 001 001 001 001 001 001 001 001 001 002 001 001 001 002 003 002 001 001 001 001 001 001 003 005 Jun 29, 1982
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
TABLET; ORAL SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE ASCOT 25MG;25MG MUTUAL PHARM 25MG;25MG PUREPAC PHARM 25MG;25MG SANDOZ 25MG;25MG SUPERPHARM 25MG;25MG SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE IVAX PHARMS 25MG;25MG LEDERLE 25MG;25MG PARKE DAVIS 25MG;25MG PUREPAC PHARM 25MG;25MG UPSHER SMITH 25MG;25MG USL PHARMA 25MG;25MG VANGARD 25MG;25MG WATSON LABS 25MG;25MG 25MG;25MG
A088025 A087267 A087999 A086881 A089137 A087004 A087511 A087948 A088054 A087553 A087651 A087655 A085974 A086026
001 001 001 001 001 002 001 001 001 001 001 001 001 001
Nov 23, 1984 Nov 06, 1985 Aug 26, 1985 May 24, 1982 Feb 22, 1983 Aug 18, 1983
25MG;10MG
N018061
001
HYDROCHLOROTHIAZIDE; TRIAMTERENE
CAPSULE; ORAL DYAZIDE GLAXOSMITHKLINE LLC 25MG;50MG TRIAMTERENE AND HYDROCHLOROTHIAZIDE BARR 25MG;37.5MG NOVARTIS 25MG;37.5MG VITARINE 25MG;50MG TABLET; ORAL TRIAMTERENE AND HYDROCHLOROTHIAZIDE AM THERAP 50MG;75MG QUANTUM PHARMICS 50MG;75MG
002 001 001 001 Jan 06, 1998 Sep 09, 1997 Feb 12, 1988
A072022 A071980
001 001
HYDROCORTAMATE HYDROCHLORIDE
OINTMENT; TOPICAL MAGNACORT PFIZER
0.5%
N010554
001
HYDROCORTISONE
AEROSOL; TOPICAL AEROSEB-HC ALLERGAN HERBERT CREAM; TOPICAL CORT-DOME BAYER PHARMS DERMACORT MONARCH PHARMS ELDECORT VALEANT PHARM INTL FLEXICORT WESTWOOD SQUIBB
0.5%
A085805
001
0.5% 1% 1% 1% 2.5% 0.5% 1% 2.5% 0.5% 1% 0.5% 1% 0.5% 2.5% 2.5% 0.5%
N009585 N009585 A083011 A080459 A084055 A087136 A087136 A087136 A080438 A080438 A080482 A080482 A086823 A080483 A089754 A080848
003 001 002 001 001 003 002 001 001 002 003 004 001 001 001 002 Feb 01, 1989 Apr 08, 1982 Apr 08, 1982 Apr 08, 1982
HC #1 BAYER PHARMS HC #4 BAYER PHARMS HC (HYDROCORTISONE) C AND M PHARMA H-CORT PHARM ASSOC HI-COR C AND M PHARMA HYDROCORTISONE ALPHARMA US PHARMS ALTANA
TOPIDERM USL PHARMA WHITEWORTH TOWN PLSN HYTONE SANOFI AVENTIS US NOGENIC HC IVAX PHARMS NUTRACORT CORIA PENECORT ALLERGAN HERBERT PROCTOCORT MONARCH PHARMS SYNACORT MEDICIS GEL; TOPICAL NUTRACORT HEALTHPOINT PENECORT ALLERGAN HERBERT INJECTABLE; INJECTION CORTEF PHARMACIA AND UPJOHN LOTION; TOPICAL ACTICORT BAKER NORTON BALNEOL-HC SOLVAY BETA-HC BETA DERMAC CETACORT CORIA CORT-DOME BAYER PHARMS
1% 1% 2.5% 0.5% 1% 1% 0.5% 1% 1% 1% 0.5% 1% 1% 2.5% 1% 1% 0.5% 0.5% 0.5% 1% 1% 2.5% 1% 1% 2.5% 1% 1% 2.5% 1% 0.5% 1% 1% 1% 0.5%
A080848 A086080 A086271 A080452 A080452 A084059 A080456 A080456 A085733 A089706 A084970 A085026 A088845 A089413 A087838 A086170 A085527 A086154 A080400 A080400 A085191 A080400 A089273 A088027 A088029 A080496 A080472 A080472 A087427 A080442 A080442 A088216 A083011 A087459
003 001 001 001 002 001 002 003 001 001 002 001 001 001 001 001 001 001 002 003 001 004 001 001 001 002 003 004 001 002 003 001 001 001
1% 1%
A084698 A088215
50MG/ML
N009864
001
1% 1% 1% 0.5% 1% 0.5% 1%
001 001 001 002 001 003 001 Dec 03, 1982 Jan 25, 1988
A084573 A086462 A083219 A087489 A086824 A087317 A087315 A085282 A085282 A089705 A085662 A085663 A089024 A080473 A080473 A080443
002 001 002 001 001 001 001 001 002 001 001 001 001 003 004 002 Jun 07, 1982 Jun 07, 1982 Feb 26, 1987 Apr 25, 1988 Oct 03, 1983
N009176 N009176 A080481 A080481 A080489 A080489 A086079 A086272 A089704 A084969 A085028 A088842 A086256 A088061 A088039 A080474 A080474 A088217
001 002 001 002 002 003 001 001 001 003 001 001 001 001 001 003 004 001 Jun 06, 1984
PENECORT ALLERGAN HERBERT 2.5% POWDER; FOR RX COMPOUNDING H-CORT TORCH 100% HYDROCORTISONE PADDOCK LLC 100% SOLUTION; TOPICAL PENECORT ALLERGAN HERBERT 1% TEXACORT MISSION PHARMA 1% TABLET; ORAL CORTRIL PFIZER 10MG 20MG
A087834 A088082
001 001
A088214 A080425
001 001
N009127 N009127
005 003
ROXANE SANDOZ WATSON LABS WHITEWORTH TOWN PLSN HYDROCORTONE MERCK TABLET; VAGINAL CORTRIL PFIPHARMECS
20MG 20MG 10MG 20MG 20MG 20MG 20MG 20MG 10MG 20MG 20MG 10MG 20MG 20MG 10MG 20MG 20MG 10MG 20MG 10MG 20MG
A083999 A080624 A080568 A080568 A080781 A080732 A085070 A083140 N009659 N009659 A084243 A084247 A080395 A084247 A088539 A080642 A080355 A080344 A080344 N008506 N008506
001 001 001 002 001 001 001 001 001 002 001 003 001 002 001 002 001 001 002 007 011
10MG
N009796
001
HYDROCORTISONE ACETATE
CREAM; TOPICAL HEMSOL-HC ABLE HYDROCORTISONE ACETATE CENCI PARKE DAVIS PUREPAC PHARM INJECTABLE; INJECTION CORTEF ACETATE PHARMACIA AND UPJOHN CORTRIL PFIZER HYDROCORTISONE ACETATE AKORN BEL MAR WATSON LABS
1% 1% 1% 0.5% 1%
50MG/ML 25MG/ML 25MG/ML 50MG/ML 25MG/ML 50MG/ML 25MG/ML 25MG/ML 50MG/ML 50MG/ML 25MG/ML 50MG/ML
N009378 N009164 N009637 N009637 A083739 A083739 A083128 A083759 A083759 A085214 N008228 N008228
002 001 001 002 001 002 001 001 002 001 001 004
HYDROCORTONE MERCK
LOTION; TOPICAL DRICORT INGRAM PHARM 0.5% OINTMENT; OPHTHALMIC HYDROCORTISONE ACETATE FERA PHARMS 0.5% OINTMENT; OPHTHALMIC, OTIC HYDROCORTONE MERCK 1.5%
A086207
001
A080828
001
N009018
003
1% 2.5%
N008917 N008917
002 001
A061049 A061049
001 002
A060610 A060610
001 002
0.5%;EQ 3.5MG BASE/GM 1%;EQ 3.5MG BASE/GM 2.5%;EQ 3.5MG BASE/GM SUSPENSION/DROPS; OPHTHALMIC COR-OTICIN AKORN 1.5%;EQ 3.5MG BASE/ML NEO-CORTEF PHARMACIA AND UPJOHN 0.5%;EQ 3.5MG BASE/ML 1.5%;EQ 3.5MG BASE/ML
A061016
001
A089440
001
A083213
002
HYDROCORTISONE BUTYRATE
CREAM; TOPICAL LOCOID YAMANOUCHI OINTMENT; TOPICAL LOCOID YAMANOUCHI SOLUTION; TOPICAL LOCOID YAMANOUCHI
0.1%
N018795
001
0.1%
N019106
001
0.1%
N019819
001
HYDROCORTISONE CYPIONATE
SUSPENSION; ORAL CORTEF PHARMACIA AND UPJOHN
EQ 10MG BASE/5ML
N009900
001
EQ 50MG BASE/ML
N012052
001
EQ 100MG BASE/VIAL EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL HOSPIRA EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL HYDROCORTISONE SODIUM SUCCINATE ABRAXIS PHARM EQ 100MG BASE/VIAL EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL BAXTER HLTHCARE EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL INTL MEDICATION EQ 100MG BASE/VIAL WATSON LABS EQ 100MG BASE/VIAL EQ 100MG BASE/VIAL EQ 250MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
A085928 A089577 A089578 A089579 A089580 A085929 A085930 A085931 A085932 A088667 A088712 A088668 A088669 A088670 A086619 A087567 A087568 A087569 A087532 A084737 A084738 A084737 A084747 A084748
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001
HYDROCORTISONE VALERATE
CREAM; TOPICAL HYDROCORTISONE VALERATE TEVA PHARMS 0.2%
A074489
001
N050237 N050237
006 005
A062394 A060730
001 002
N050169 A062623
A062302 A061606
001 001
1.5%;1%
N050272
001
HYDROCORTISONE; UREA
CREAM; TOPICAL ALPHADERM BIOGLAN CALMURID HC PHARMACIA AND UPJOHN
1%;10% 1%;10%
A086008 A083947
001 001
HYDROFLUMETHIAZIDE
TABLET; ORAL DIUCARDIN WYETH AYERST HYDROFLUMETHIAZIDE PAR PHARM WATSON LABS
001 001 001 001 May 31, 1985 Apr 06, 1983 Aug 15, 1984
HYDROFLUMETHIAZIDE; RESERPINE
TABLET; ORAL HYDROFLUMETHIAZIDE AND RESERPINE USL PHARMA 50MG;0.125MG WATSON LABS 25MG;0.125MG 50MG;0.125MG RESERPINE AND HYDROFLUMETHIAZIDE IVAX PHARMS 50MG;0.125MG PAR PHARM 50MG;0.125MG SALUTENSIN SHIRE 50MG;0.125MG SALUTENSIN-DEMI SHIRE 25MG;0.125MG
Oct 26, 1983 Mar 22, 1983 Mar 22, 1983 Jan 11, 1985 Sep 20, 1985
HYDROMORPHONE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL PALLADONE PURDUE PHARMA LP 12MG 16MG 24MG 32MG INJECTABLE; INJECTION HYDROMORPHONE HYDROCHLORIDE WATSON LABS 10MG/ML
A074317
001
HYDROXOCOBALAMIN
INJECTABLE; INJECTION ALPHAREDISOL MERCK CYANOKIT MERCK SANTE SAS HYDROXOCOBALAMIN ABRAXIS PHARM WATSON LABS
1MG/ML
A084629
001
HYDROXYAMPHETAMINE HYDROBROMIDE
SOLUTION/DROPS; OPHTHALMIC PAREDRINE PHARMICS 1%
N000004
004
HYDROXYPROGESTERONE CAPROATE
INJECTABLE; INJECTION DELALUTIN BRISTOL MYERS SQUIBB
125MG/ML 125MG/ML 250MG/ML 250MG/ML HYDROXYPROGESTERONE CAPROATE AKORN 125MG/ML WATSON LABS 125MG/ML 250MG/ML
HYDROXYSTILBAMIDINE ISETHIONATE
INJECTABLE; INJECTION HYDROXYSTILBAMIDINE ISETHIONATE SANOFI AVENTIS US 225MG/AMP
N009166
001
HYDROXYUREA
CAPSULE; ORAL HYDROXYUREA BARR DURAMED PHARMS BARR ROXANE TABLET; ORAL HYDROXYUREA BARR
1GM
A075734
001
HYDROXYZINE HYDROCHLORIDE
INJECTABLE; INJECTION HYDROXYZINE BAXTER HLTHCARE 50MG/ML HYDROXYZINE HYDROCHLORIDE ALTANA 25MG/ML 50MG/ML APP PHARMS 25MG/ML 50MG/ML BAXTER HLTHCARE 25MG/ML HOSPIRA 25MG/ML 50MG/ML 50MG/ML PHARMAFAIR 25MG/ML 25MG/ML 50MG/ML 50MG/ML SMITH AND NEPHEW 25MG/ML SOLOPAK 25MG/ML 25MG/ML 50MG/ML 50MG/ML 50MG/ML 50MG/ML WATSON LABS 25MG/ML
A085551 A087273 A087273 A088184 A088185 A085551 A087416 A086821 A087546 A088862 A089106 A088881 A089107 A087592 A086822 A087591 A087310 A087593 A087595 A087596 A085778
002 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Apr Apr Mar Mar 20, 20, 31, 31, 1982 1982 1983 1983
N010392 N010392 N010392 N010392 A040559 A040562 A040563 A040600 A089071 A040602 A089072 A040604 A089073 A089366 A089117 A089396 A087216 A087410 A087411 A087819 A087820 A087821 A087822 A088409 A087857 A087860 A087862 A081054 A088120 A088121 A088122 A088540 A088551 A088529 A087246 A087869 A085247 A087870 A087245 A087871
001 004 006 005 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 Jul Jul Jul Dec Jul Dec Jul Dec Jul May May May 22, 22, 22, 28, 22, 28, 22, 28, 22, 02, 02, 02, 2004 2004 2004 2004 1986 2004 1986 2004 1986 1988 1988 1988
Jun Jun Jun Jun Nov Apr Apr Apr Sep Sep Sep Sep Oct Oct Oct
23, 23, 23, 23, 15, 18, 18, 18, 25, 25, 25, 25, 22, 22, 22,
1982 1982 1982 1982 1983 1983 1983 1983 1995 1984 1984 1984 1985 1985 1985
A088794 A088795 A088796 A089121 A089122 A089123 A087602 A087603 A087604 A086827 A086829 A086836
001 001 001 001 001 001 001 001 001 001 001 001
HYDROXYZINE PAMOATE
CAPSULE; ORAL HYDROXYZINE PAMOATE DURAMED PHARMS BARR
SANDOZ
SUPERPHARM
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
25MG HCL 50MG HCL 100MG HCL 25MG HCL 50MG HCL 25MG HCL 25MG HCL 50MG HCL 50MG HCL 100MG HCL 25MG HCL 50MG HCL 100MG HCL 25MG HCL 50MG HCL 100MG HCL 25MG HCL 50MG HCL 25MG HCL 25MG HCL 50MG HCL 50MG HCL 50MG HCL 100MG HCL 100MG HCL 100MG HCL
A088593 A088594 A088595 A087761 A087760 A087656 A089145 A087657 A089146 A087658 A081127 A081128 A081129 A089031 A089032 A089033 A088392 A088393 A086698 A086840 A086695 A086705 A087767 A086697 A086728 A087790 A088713 N011459
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 006
Feb Feb Feb Mar Mar Jun Mar Jun Mar Jun Jun Jun Jun Jan Jan Jan Sep Sep
29, 29, 29, 05, 05, 11, 17, 11, 17, 11, 28, 28, 28, 02, 02, 02, 19, 19,
1984 1984 1984 1982 1982 1982 1986 1982 1986 1982 1991 1991 1991 1987 1987 1987 1983 1983
Jul 01, 1982 Jul 01, 1982 Aug 16, 1982 Oct 05, 1982 Aug 16, 1982 Mar 04, 1985
IBANDRONATE SODIUM
TABLET; ORAL BONIVA ROCHE
EQ 2.5MG BASE
N021455
001
IBUPROFEN
CAPSULE; ORAL MIDOL BAYER SUSPENSION; ORAL CHILDREN'S ADVIL WYETH CONS
200MG 200MG
A070626 A071002
001 001
100MG/5ML
N019833
002
100MG/5ML 100MG/5ML
N019784 N019842
001 001
40MG/ML
N020476
001
200MG 200MG 400MG 400MG 600MG 600MG 800MG 200MG 600MG 800MG 200MG 300MG 400MG 600MG 800MG 200MG 200MG 200MG 200MG 200MG 400MG 600MG 800MG 400MG 600MG 300MG 400MG 600MG 200MG 200MG 200MG 400MG 600MG 800MG 200MG 400MG 600MG 800MG 200MG 300MG 400MG 600MG 800MG 200MG 400MG 600MG 800MG 200MG 200MG
A071065 A072097 A070083 N018197 A070088 A070099 A070745 A071773 A070556 A071264 A071027 A071028 A071029 A071030 A072137 A071144 A071154 A072040 A072901 A072903 A071145 A071146 A071769 A070629 A070630 A071266 A070081 A070476 A070493 A070908 A071462 A070079 A070080 A071448 A071870 A070045 A070057 A071999 A071575 A070328 A070329 A070330 A070986 A072098 A071666 A071667 A071668 A071122 A071664
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
May 28, 1987 Dec 08, 1987 Feb 22, 1985 Feb 08, 1985 Mar 29, 1985 Jul 23, 1986 Jul 16, 1987 Jun Jul Sep Mar Mar Mar Feb Jan Oct Apr Dec Dec Sep Sep May Sep Sep Oct Jun Jun Dec Sep Oct Jul Jul Feb May Sep Sep Dec May Aug Aug Aug Jul Dec Jun Jun Jun Oct Feb 14, 25, 29, 23, 23, 23, 05, 20, 27, 29, 19, 19, 23, 23, 08, 19, 19, 15, 16, 16, 24, 26, 02, 24, 24, 18, 05, 24, 24, 03, 08, 06, 06, 06, 25, 08, 18, 18, 18, 03, 03, 1985 1986 1987 1987 1987 1987 1988 1987 1987 1988 1991 1991 1986 1986 1987 1986 1986 1986 1986 1986 1985 1986 1986 1985 1985 1987 1988 1985 1985 1987 1987 1985 1985 1985 1986 1987 1987 1987 1987 1986 1987
MYLAN
PAR PHARM
PERRIGO PLIVA
PUREPAC PHARM
SANDOZ
SUPERPHARM TEVA
300MG 400MG 600MG 800MG 200MG 200MG 200MG 200MG 300MG 400MG 400MG 600MG 600MG 800MG 800MG 600MG 200MG 400MG 600MG 800MG 200MG 200MG 200MG 300MG 400MG 600MG 800MG 800MG 400MG 800MG 200MG 200MG 200MG 200MG 300MG 400MG 600MG 800MG 100MG 200MG 200MG 200MG 200MG 600MG
A071123 A071124 A071125 A071964 A070733 A071807 A074525 A074533 A070734 A070735 A072064 A070736 A072065 A071938 A072169 A070709 A073141 A073343 A073344 A073345 A072249 A071765 A071905 A071338 A070038 A070041 A071547 A071911 A070469 A071965 A070475 A071215 A070591 A071001 N017463 N017463 N017463 N017463 N020418 A072035 A072036 N019012 N019012 N018197
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 003 002 004 005 001 001 001 001 002 002
Sep Sep Sep Feb Sep Feb Dec Dec Jun Jun Jan Jun Jan Jan Dec Apr May Jun Jun Jun Jan Sep Mar Dec Sep Sep Jul Oct
19, 19, 19, 01, 19, 25, 15, 15, 12, 12, 14, 12, 14, 14, 11, 25, 29, 30, 30, 30, 10, 04, 08, 01, 06, 06, 02, 13,
1986 1986 1986 1988 1986 1988 1995 1995 1986 1986 1988 1986 1988 1988 1987 1986 1992 1992 1992 1992 1989 1987 1988 1986 1985 1985 1987 1987
IBUPROHM OHM LABS IBU-TAB ALRA MEDIPREN MCNEIL MIDOL BAYER MOTRIN MCNEIL CONSUMER
Aug 29, 1985 Aug 11, 1988 Feb 06, 1986 Jun 26, 1986 Sep 02, 1987 Sep 02, 1987
MCNEIL PED NUPRIN BRISTOL MYERS MCNEIL RUFEN BASF TABLET, CHEWABLE; ORAL MOTRIN MCNEIL PED
May 22, 1985 Nov 16, 1994 Feb Feb May Jul 16, 16, 18, 29, 1988 1988 1984 1987
50MG 100MG
N020135 N020135
001 002
400MG;5MG
N021378
001
IDOXURIDINE
OINTMENT; OPHTHALMIC STOXIL GLAXOSMITHKLINE 0.5% SOLUTION/DROPS; OPHTHALMIC STOXIL GLAXOSMITHKLINE 0.1%
N015868
001
N013934
001
IFOSFAMIDE; MESNA
INJECTABLE; INJECTION IFEX/MESNEX KIT BAXTER HLTHCARE
1GM/VIAL;100MG/ML 3GM/VIAL;100MG/ML
N019763 N019763
003 004
ILOPROST
SOLUTION; INHALATION VENTAVIS ACTELION PHARMS LTD
20MCG/2ML (10MCG/ML)
N021779
001
IMATINIB MESYLATE
CAPSULE; ORAL GLEEVEC NOVARTIS
N021335 N021335
001 002
IMIPRAMINE HYDROCHLORIDE
CONCENTRATE; ORAL IMIPRAMINE HYDROCHLORIDE NOVARTIS 25MG/ML INJECTABLE; INJECTION TOFRANIL NOVARTIS 12.5MG/ML TABLET; ORAL IMIPRAMINE HYDROCHLORIDE ACTAVIS TOTOWA 10MG 25MG 50MG LEDERLE 10MG 25MG 50MG PAR PHARM 25MG 50MG ROXANE 10MG 25MG 50MG SANDOZ 10MG 25MG 50MG TEVA 10MG 25MG 50MG USL PHARMA 25MG VANGARD 10MG 25MG 50MG WATSON LABS 10MG
A086765
001
N011838
002
A040753 A040752 A040751 A086269 A086267 A086268 A089497 A088276 A083799 A083799 A083799 A085200 A084869 A085133 A083729 A083729 A083729 A087776 A088036 A087619 A087631 A085220
001 001 001 001 001 001 001 001 001 002 003 001 002 001 001 004 003 001 001 001 001 001
A085875 A084252 A085878 A085221 A085877 A088222 A088223 N017895 N017895 N017895 A083827 A083827 A083827 N011836 N011836 N011836
001 002 001 001 001 001 001 001 002 003 001 002 003 006 003 007
INAMRINONE LACTATE
INJECTABLE; INJECTION AMRINONE LACTATE BAXTER HLTHCARE CORP HOSPIRA INOCOR SANOFI AVENTIS US
INDAPAMIDE
TABLET; ORAL INDAPAMIDE CADISTA PHARMS TEVA
INDECAINIDE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL DECABID LILLY EQ 50MG BASE EQ 75MG BASE EQ 100MG BASE
INDINAVIR SULFATE
CAPSULE; ORAL CRIXIVAN MERCK SHARP DOHME
EQ 333MG BASE
N020685
005
INDOCYANINE GREEN
INJECTABLE; INJECTION IC-GREEN AKORN
N016059 N016059 A070266 A070267 A076666 A076666 A070326 A070327 A070782 A070635 N018730 N018730 A070067 A070899 A070068 A070900 N018858 N018806 N018806 A070813 A070592 A071148 A071149 A070353 A070354 A070487 A070488 A071342 A071343 N018829 A070651 N018829 A070529 A070784 A072996 N018690 A070530 A070785 A071635 A072997 N018690
001 002 001 001 001 002 001 001 001 001 001 002 001 001 001 001 002 001 002 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 002 Nov 07, 1985 Nov 07, 1985 Dec Dec Oct Oct Jun Jun May May Oct Feb Oct Feb Apr Nov Nov Aug Aug Mar Mar Jun Jun Oct Oct Apr Apr Aug Mar Aug Oct Aug Jul Jul Oct Aug May Jul Jul 17, 17, 18, 18, 03, 03, 04, 04, 03, 09, 03, 09, 20, 23, 23, 11, 11, 18, 18, 18, 18, 10, 10, 18, 18, 06, 05, 06, 18, 20, 31, 31, 18, 20, 18, 31, 31, 2003 2003 1985 1985 1987 1987 1984 1984 1986 1987 1986 1987 1984 1984 1984 1986 1986 1987 1987 1985 1985 1986 1986 1988 1988 1984 1986 1984 1985 1986 1991 1984 1985 1986 1987 1991 1984
25MG 50MG DURAMED PHARMS BARR 25MG 50MG HALSEY 25MG 50MG IVAX SUB TEVA PHARMS 25MG 50MG MUTUAL PHARM 25MG 25MG 50MG 50MG MYLAN 50MG PARKE DAVIS 25MG 50MG PIONEER PHARMS 25MG 50MG PLIVA 25MG 50MG ROXANE 25MG 50MG SUPERPHARM 25MG 50MG TEVA 25MG 50MG VINTAGE 25MG 50MG 50MG WATSON LABS 25MG 25MG 25MG 25MG 50MG 50MG 50MG 50MG 50MG CAPSULE, EXTENDED RELEASE; ORAL INDOCIN SR IROKO PHARMS 75MG INDOMETHACIN ABLE 75MG INWOOD LABS 75MG SUPPOSITORY; RECTAL INDOCIN IROKO PHARMS 50MG SUSPENSION; ORAL INDOMETHACIN ROXANE 25MG/5ML
N017814
001
A071412
001
50 UNITS/ML;50 UNITS/ML
N021810
001
001
001
003
100 UNITS/ML
N018478
001
002
001
001
001
N018195
001
N019529 N021028
001 001
1MG/INH 3MG/INH
N021868 N021868
001 002
50 UNITS/ML;50 UNITS/ML
N020100
001
N018778 N019450
001 001
INSULIN RECOMBINANT PURIFIED HUMAN; INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN
INJECTABLE; INJECTION MIXTARD HUMAN 70/30 BAYER PHARMS NOVOLIN 70/30 NOVO NORDISK INC
N019585 N019441
001 001
N017929 N017929
001 003
N017936 N017936
001 002
100 UNITS/ML
N018479
001
N019449 N019065
001 001
N017932 N017932
001 002
N018346
001
N017998 N017998
001 003
100 UNITS/ML
N017997
003
100 UNITS/ML
N018385
001
N019571 N019571
001 002
100 UNITS/ML
N017996
003
100 UNITS/ML
N018382
001
100 UNITS/ML
N018477
001
100 UNITS/ML
N018384
001
N018383 N018347
001 001
N019377 N019965
002 001
100 UNITS/ML
N018777
001
INULIN
INJECTABLE; INJECTION INULIN AND SODIUM CHLORIDE ISO TEX 100MG/ML
N002282
001
INVERT SUGAR
INJECTABLE; INJECTION TRAVERT 10% IN PLASTIC CONTAINER BAXTER HLTHCARE 10GM/100ML
N016717
001
N020084
001
IOCETAMIC ACID
TABLET; ORAL CHOLEBRINE MALLINCKRODT
750MG
N017129
001
IODAMIDE MEGLUMINE
INJECTABLE; INJECTION RENOVUE-65 BRACCO RENOVUE-DIP BRACCO
65% 24%
N017902 N017903
001 001
IODIPAMIDE MEGLUMINE
INJECTABLE; INJECTION CHOLOGRAFIN MEGLUMINE BRACCO
10.3%
N009321
007
IODIPAMIDE SODIUM
INJECTABLE; INJECTION CHOLOGRAFIN SODIUM BRACCO
20%
N009321
001
1mCi/ML
N018289
001
IODOXAMATE MEGLUMINE
INJECTABLE; INJECTION CHOLOVUE BRACCO
9.9% 40.3%
N018077 N018076
001 001
1mCi/ML
N019432
001
IOHEXOL
INJECTABLE; INJECTION OMNIPAQUE 210 GE HEALTHCARE SOLUTION; URETHRAL OMNIPAQUE 70 GE HEALTHCARE
45.3%
N018956
006
15.1%
N018956
007
HOSPIRA
A074629 A074629 A074629 A074629 A074734 A074734 A074881 A074898 A074636 A074881 A074898 A075005 A074636 A074638 A074881 A074898 A075005 A074636 A074637 A074881 A074898 A075005 A074636 N018735 N020327
001 004 002 003 001 002 001 001 001 002 002 001 002 001 003 003 002 003 001 004 004 003 004 005 001
IOPAMIDOL-200 COOK IMAGING 41% HOSPIRA 41% IOPAMIDOL-200 IN PLASTIC CONTAINER HOSPIRA 41% IOPAMIDOL-250 COOK IMAGING 51% HOSPIRA 51% 51% IOPAMIDOL-250 IN PLASTIC CONTAINER HOSPIRA 51% IOPAMIDOL-300 ABBOTT 61% COOK IMAGING 61% HOSPIRA 61% 61% IOPAMIDOL-300 IN PLASTIC CONTAINER HOSPIRA 61% 61% IOPAMIDOL-370 COOK IMAGING 76% HOSPIRA 76% 76% IOPAMIDOL-370 IN PLASTIC CONTAINER HOSPIRA 76% ISOVUE-128 BRACCO 26% ISOVUE-200 BRACCO 41%
Jul 28, 2000 Dec 30, 1997 Dec 30, 1997 Jul 28, 2000 Dec 30, 1997 Feb 24, 1998 Dec 30, 1997 Apr Jul Dec Feb 30, 28, 30, 24, 1997 2000 1997 1998
Dec 30, 1997 Apr 03, 1997 Jul 28, 2000 Dec 30, 1997 Feb 24, 1998 Dec 30, 1997 Oct 21, 1986 Oct 12, 1994
IOPANOIC ACID
TABLET; ORAL TELEPAQUE GE HEALTHCARE
500MG
N008032
001
IOPHENDYLATE
INJECTABLE; INJECTION PANTOPAQUE ALCON
100%
N005319
001
52%;26%
N016783
001
IOTHALAMATE SODIUM
INJECTABLE; INJECTION ANGIO-CONRAY MALLINCKRODT CONRAY 325 MALLINCKRODT CONRAY 400 MALLINCKRODT
250-300uCi/ML
N017279
001
IOTROLAN
INJECTABLE; INTRATHECAL OSMOVIST 190 BAYER HLTHCARE OSMOVIST 240 BAYER HLTHCARE
40.6% 51.3%
N019580 N019580
001 002
IOVERSOL
INJECTABLE; INJECTION OPTIRAY 160 MALLINCKRODT OPTIRAY 240 MALLINCKRODT OPTIRAY 320 MALLINCKRODT
IPODATE CALCIUM
GRANULE; ORAL ORAGRAFIN CALCIUM BRACCO
3GM/PACKET
N012968
001
IPODATE SODIUM
CAPSULE; ORAL BILIVIST BAYER HLTHCARE ORAGRAFIN SODIUM BRACCO
500MG 500MG
A087768 N012967
001 001
IPRATROPIUM BROMIDE
AEROSOL, METERED; INHALATION ATROVENT BOEHRINGER INGELHEIM 0.018MG/INH SOLUTION; INHALATION ATROVENT BOEHRINGER INGELHEIM 0.02% IPRATROPIUM BROMIDE ACTAVIS MID ATLANTIC 0.02% PHARMASCIENCE INC 0.02% ROXANE 0.02%
N019085
001
Sep 29, 1993 Apr 22, 1999 Jan 19, 2001 Jul 22, 2002
IRINOTECAN HYDROCHLORIDE
INJECTABLE; INJECTION IRINOTECAN HYDROCHLORIDE SANDOZ 40MG/2ML (20MG/ML) 100MG/5ML (20MG/ML)
A077994 A077994
001 002
IRON DEXTRAN
INJECTABLE; INJECTION IRON DEXTRAN SANOFI AVENTIS US
EQ 50MG IRON/ML
N010787
002
IRON SUCROSE
INJECTABLE; INTRAVENOUS VENOFER LUITPOLD
N021135
003
1%
A086711 N012339 N012339 A087101 A087937 A089614 A087938 A089615 A088470 A089616 A088471 A089617 A088472 A089618 A088144 A088145 A088146 A088187 A087389 A087390 A088188 A086763 A086651 A086651 A086651 A086651 A086651 A086651 A086651 A086651 A085997 A085889 A087396 A087025 A088226 A087324 A088275 A086899 A089817 A089818 A089819 A089820 A089252
001 009 008 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 004 005 006 007 008 001 001 001 001 001 001 001 001 001 001 001 001 001
0.25% 1% ISOETHARINE HYDROCHLORIDE ALPHARMA US PHARMS 1% ASTRAZENECA 0.062% 0.062% 0.125% 0.125% 0.167% 0.167% 0.2% 0.2% 0.25% 0.25% BAXTER HLTHCARE 0.08% 0.14% 0.25% DEY 0.08% 0.1% 0.17% 0.25% 1% INTL MEDICATION 0.077% 0.08% 0.1% 0.143% 0.167% 0.2% 0.25% 1% PARKE DAVIS 0.5% 1% ROXANE 0.1% 0.125% 0.167% 0.2% 0.25% 1% ISOETHARINE HYDROCHLORIDE S/F DEY 0.08% 0.1% 0.17% 0.25% 1%
Nov Jun Nov Jun Mar Jun Mar Jun Mar Jun Jul Mar Aug Dec
15, 13, 15, 13, 14, 13, 14, 13, 14, 13, 29, 26, 01, 03,
1982 1991 1982 1991 1984 1991 1984 1991 1984 1991 1983 1984 1983 1982
ISOETHARINE MESYLATE
AEROSOL, METERED; INHALATION BRONKOMETER SANOFI AVENTIS US 0.34MG/INH ISOETHARINE MESYLATE ALPHARMA US PHARMS 0.34MG/INH
N012339 A087858
ISOFLURANE
LIQUID; INHALATION ISOFLURANE MARSAM PHARMS LLC
99.9%
A074393
001
0.025%
N010656
001
ISONIAZID
INJECTABLE; INJECTION NYDRAZID SANDOZ RIMIFON ROCHE SYRUP; ORAL ISONIAZID MIKART LANIAZID LANNETT RIMIFON ROCHE TABLET; ORAL DOW-ISONIAZID DOW PHARM HYZYD MEDPOINTE PHARM HLC INH NOVARTIS ISONIAZID DURAMED PHARMS BARR HALSEY IMPAX LABS IVAX SUB TEVA PHARMS LILLY MK LABS MUTUAL PHARM NEXGEN PHARMA INC PANRAY
300MG 100MG 300MG 300MG 100MG 300MG 50MG 100MG 100MG 300MG 100MG 300MG 100MG 100MG 300MG 100MG 50MG 100MG 300MG 100MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 100MG 100MG 300MG 300MG 100MG 50MG 100MG 300MG 100MG
A080330 A080134 A080134 A080935 A088231 A088119 A083632 A080153 A080270 A083610 N008499 N008499 A080941 A080136 A083633 A084050 N008428 N008428 N008428 A083060 A085091 A080368 A080368 A080132 A080132 A080522 A080401 A080523 A085790 A083178 A085784 A080120 A080140 A080140 A089776 N008392
002 003 004 001 001 001 001 001 001 001 002 003 001 001 001 001 001 002 003 001 001 001 002 003 004 001 001 001 001 001 001 002 001 002 001 003 Mar 17, 1983 Mar 17, 1983
100MG 300MG
A080126 A080126
001 002
ISOPROPAMIDE IODIDE
TABLET; ORAL DARBID GLAXOSMITHKLINE
EQ 5MG BASE
N010744
001
ISOPROTERENOL HYDROCHLORIDE
AEROSOL, METERED; INHALATION ISOPROTERENOL HYDROCHLORIDE 3M 0.12MG/INH ALPHARMA US PHARMS 0.12MG/INH ISUPREL SANOFI AVENTIS US 0.103MG/INH DISC; INHALATION NORISODRINE AEROTROL ABBOTT 0.25% INJECTABLE; INJECTION ISOPROTERENOL HYDROCHLORIDE ABRAXIS PHARM 0.2MG/ML BAXTER HLTHCARE 0.2MG/ML HOSPIRA 0.02MG/ML 0.2MG/ML SOLUTION; INHALATION AEROLONE LILLY 0.25% ISOPROTERENOL HYDROCHLORIDE ARMOUR PHARM 0.031% 0.062% DEY 0.5% PARKE DAVIS 0.25% 0.5% ISUPREL SANOFI AVENTIS US 0.5% 1% VAPO-ISO FISONS 0.5% TABLET; RECTAL, SUBLINGUAL ISUPREL SANOFI AVENTIS US 10MG 15MG
N016814
001
001 001 001 001 001 001 002 003 001 Nov 18, 1982 Nov 18, 1982 Jan 04, 1982
N006328 N006328
001 002
N013296
001
ISOPROTERENOL SULFATE
AEROSOL, METERED; INHALATION MEDIHALER-ISO 3M 0.08MG/INH POWDER; INHALATION NORISODRINE ABBOTT 10% 25%
N010375
003
N006905 N006905
003 002
ISOSORBIDE
SOLUTION; ORAL ISMOTIC ALCON
100GM/220ML
N017063
001
N012882
002
A086166 A086169 A086167 A087564 A089190 A089191 A089192 N016192 N016192 A086405 A088124 A088125
002 001 001 001 001 001 001 001 002 002 001 001
Sep Sep Sep Sep Feb Feb Feb Apr Apr Aug Aug Aug
19, 19, 19, 18, 17, 17, 17, 01, 01, 21, 21, 21,
1986 1986 1986 1986 1987 1987 1987 1996 1996 1990 1990 1990
N012940 N012940 N012940 A084204 A086168 A087545 A086225 A086222 N016191 N016191
004 003 005 001 001 001 001 001 002 001
Jul 29, 1988 Jul 29, 1988 Jul 29, 1988 Sep Sep Sep Feb Feb 18, 18, 18, 19, 19, 1986 1986 1986 1988 1988
N016776 N016776
002 003
N012882
001
ISOSORBIDE MONONITRATE
TABLET; ORAL ISMO PROMIUS PHARMA 20MG TABLET, EXTENDED RELEASE; ORAL IMDUR SCHERING PLOUGH 30MG 60MG 120MG ISOSORBIDE MONONITRATE IVAX SUB TEVA PHARMS 30MG 60MG 120MG
N019091
001
Aug 12, 1993 Aug 12, 1993 Mar 30, 1995 Aug 07, 2001 Jun 19, 2000 Aug 07, 2001
ISOTRETINOIN
CAPSULE; ORAL ACCUTANE HOFFMANN LA ROCHE
2.5MG 5MG
N019546 N019546
001 002
ITRACONAZOLE
INJECTABLE; INJECTION SPORANOX JANSSEN PHARMS
10MG/ML
N020966
001
IVERMECTIN
TABLET; ORAL STROMECTOL MERCK
6MG
N050742
001
KANAMYCIN SULFATE
CAPSULE; ORAL KANTREX APOTHECON
EQ 75MG BASE/2ML EQ 500MG BASE/2ML EQ 1GM BASE/3ML EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 75MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 500MG BASE/2ML 1GM BASE/3ML 75MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 75MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 75MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 1GM BASE/3ML 1GM BASE/3ML 75MG BASE/2ML 75MG BASE/2ML 75MG BASE/2ML 500MG BASE/2ML 500MG BASE/2ML 500MG BASE/2ML 1GM BASE/3ML 1GM BASE/3ML 1GM BASE/3ML
A062324 A062324 A062324 A062504 A062504 A062504 A062466 A062466 A063021 A063022 A063025 A062668 A062672 A062669 A062605 A062605 A062605 A063092 A062520 A061655 A061901 A062564 A061655 A061901 A062564 A061655 A061901 A062564 A062170 A062170 A062170
001 002 003 001 002 003 001 002 001 001 001 001 001 001 003 001 002 001 003 003 003 001 001 001 002 002 002 003 001 002 003 Apr Apr Apr Sep Sep Jul Jul Jul May May May Feb Feb Feb Oct May 05, 05, 05, 30, 30, 31, 31, 31, 07, 07, 07, 26, 26, 26, 11, 09, 1984 1984 1984 1983 1983 1992 1992 1992 1987 1987 1987 1986 1986 1986 1989 1985
PHARMAFAIR
SOLOPAK
KETOCONAZOLE
CREAM; TOPICAL NIZORAL JANSSEN PHARMA
2%
N019084
001
100MG/5ML
A070767
001
200MG 200MG
A075341 A074971
001 001
KETOPROFEN
CAPSULE; ORAL KETOPROFEN SANDOZ TEVA ORUDIS WYETH AYERST
Dec 29, 1995 Dec 29, 1995 Dec 22, 1992 Jul 31, 1987 Jan 09, 1986 Jan 09, 1986
25MG 50MG 75MG CAPSULE, EXTENDED RELEASE; ORAL ORUVAIL WYETH PHARMS INC 100MG 150MG 200MG TABLET; ORAL ACTRON BAYER 12.5MG KETOPROFEN PERRIGO 12.5MG ORUDIS KT WYETH CONS 12.5MG
KETOROLAC TROMETHAMINE
INJECTABLE; INJECTION KETOROLAC TROMETHAMINE AMPHASTAR PHARM APOTEX INC APOTHECON BEDFORD GLAND PHARMA LTD HOSPIRA TORADOL ROCHE PALO TABLET; ORAL KETOROLAC TROMETHAMINE ROXANE WATSON LABS TORADOL ROCHE PALO
15MG/ML 30MG/ML 30MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML 15MG/ML 30MG/ML
A076209 A076209 A075626 A077201 A075348 A075348 A075230 A075230 A076722 A076722 A074801 A074801 N019698 N019698
001 002 001 001 001 002 002 001 001 002 001 002 001 002
Jul Jul Jul Oct Nov Nov Oct Oct Jul Jul Jun Jun
21, 21, 24, 14, 28, 28, 25, 25, 27, 27, 05, 05,
2004 2004 2001 2005 2000 2000 1999 1999 2004 2004 1997 1997
KRYPTON, KR-81M
GAS; INHALATION MPI KRYPTON 81M GENERATOR GE HEALTHCARE N/A
N018088
001
Nov 29, 1999 Sep 30, 1999 Aug 01, 1984 Dec 31, 1985
MUTUAL PHARM
TEVA
100MG 200MG 300MG 100MG 200MG 300MG 100MG 200MG 300MG 100MG 200MG 300MG 400MG 300MG 400MG
A075223 A075223 A075223 A075215 A075215 A075215 A074989 A074989 A074989 N018687 N018687 N018687 N018687 N018716 N018716
001 002 003 001 002 003 001 002 003 001 002 003 004 003 004
Nov Nov Nov Jul Jul Jul Sep Sep Sep Aug Aug Aug Aug
20, 20, 20, 29, 29, 29, 30, 30, 30, 31, 01, 01, 01,
1998 1998 1998 1999 1999 1999 1998 1998 1998 1987 1984 1984 1984
NORMODYNE SCHERING
LACTULOSE
SOLUTION; ORAL CHRONULAC SANOFI AVENTIS US DUPHALAC SOLVAY EVALOSE TEVA PHARMS LACTULOSE MORTON GROVE PACO LAXILOSE NOSTRUM LABS SOLUTION; ORAL, RECTAL ACILAC NOSTRUM LABS CEPHULAC SANOFI AVENTIS US GENERLAC MORTON GROVE HEPTALAC TEVA PHARMS LACTULOSE PACO ROXANE SOLVAY PORTALAC SOLVAY
001 001 001 001 001 001 Mar 22, 1989 May 28, 1993 Sep 22, 1988 Aug 25, 1992 May 28, 1993
Sep 27, 1988 May 28, 1993 Aug 25, 1992 May 29, 1992
LAMOTRIGINE
TABLET; ORAL LAMICTAL GLAXOSMITHKLINE
50MG 250MG
N020241 N020241
006 004
MYLAN
ROXANE
WOCKHARDT
25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG 25MG 100MG 150MG 200MG
A078443 A078443 A078443 A078443 A077428 A077428 A077428 A077428 A077392 A077392 A077392 A077392 A078982 A078982 A078982 A078982
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004
Feb Feb Feb Feb Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan Jan
11, 11, 11, 11, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27, 27,
2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
LANSOPRAZOLE
FOR SUSPENSION, DELAYED RELEASE; ORAL PREVACID TAKEDA PHARMS NA 15MG/PACKET 30MG/PACKET INJECTABLE; INTRAVENOUS PREVACID IV TAKEDA PHARMS NA 30MG/VIAL
N021281 N021281
001 002
N021566
001
LANSOPRAZOLE; NAPROXEN
CAPSULE, DELAYED REL PELLETS, TABLET; ORAL PREVACID NAPRAPAC 250 (COPACKAGED) TAKEDA PHARMS NA 15MG,N/A;N/A,250MG PREVACID NAPRAPAC 375 (COPACKAGED) TAKEDA PHARMS NA 15MG,N/A;N/A,375MG PREVACID NAPRAPAC 500 (COPACKAGED) TAKEDA PHARMS NA 15MG,N/A;N/A,500MG
LANTHANUM CARBONATE
TABLET, CHEWABLE; ORAL FOSRENOL SHIRE
EQ 250MG BASE
N021468
001
0.5%;1.8%
N011914
001
LEFLUNOMIDE
TABLET; ORAL LEFLUNOMIDE SANDOZ
10MG 20MG
A077085 A077085
001 002
2.5MG
A090196
001
LEUCOVORIN CALCIUM
FOR SOLUTION; ORAL LEUCOVORIN CALCIUM HOSPIRA INJECTABLE; INJECTION LEUCOVORIN CALCIUM ABIC
EQ 60MG BASE/VIAL
N008107
003
EQ 3MG BASE/ML EQ 50MG BASE/VIAL EQ 50MG BASE/VIAL ABRAXIS PHARM ELKINS SINN EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL EQ 3MG BASE/ML HOSPIRA EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL EQ 350MG BASE/VIAL PHARMACHEMIE EQ 350MG BASE/VIAL PHARMACHEMIE USA EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL LEUCOVORIN CALCIUM PRESERVATIVE FREE EQ 10MG BASE/ML HOSPIRA EQ 10MG BASE/ML TEVA PARENTERAL WELLCOVORIN EQ 5MG BASE/ML GLAXOSMITHKLINE EQ 25MG BASE/VIAL EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL TABLET; ORAL LEUCOVORIN CALCIUM EQ 5MG BASE COREPHARMA EQ 25MG BASE EQ 5MG BASE PAR PHARM EQ 25MG BASE EQ 5MG BASE PHARMACHEMIE EQ 25MG BASE EQ 15MG BASE SANDOZ EQ 5MG BASE XANODYNE PHARM EQ 10MG BASE EQ 15MG BASE WELLCOVORIN EQ 5MG BASE GLAXOSMITHKLINE EQ 25MG BASE
A089352 A089353 A088939 A070480 A081224 N008107 N008107 N008107 N008107 A040262 A089628 A089915 A040147 A040332 A087439 A089833 A089465 A089834
001 001 001 001 001 001 002 004 005 001 001 001 001 001 001 001 001 001
Jun 25, 1997 Jun 28, 1999 Oct Jan Jan Jan 19, 23, 23, 23, 1982 1989 1989 1989
A074544 A074544 A071600 A071598 A073099 A073101 A075327 N018459 A071962 A071104 N018342 N018342
001 002 001 001 001 001 001 001 001 001 001 002
Aug Aug Oct Oct Mar Mar Mar Jan Nov Mar
28, 28, 14, 14, 28, 28, 24, 30, 19, 04,
1997 1997 1987 1987 1997 1997 1999 1986 1987 1987
LEUPROLIDE ACETATE
IMPLANT; IMPLANTATION VIADUR ORTHO MCNEIL JANSSEN INJECTABLE; INJECTION LEUPROLIDE ACETATE GENZYME LUPRON ABBOTT LABS LUPRON DEPOT-PED ABBOTT ENDOCRINE
EQ 65MG BASE
N021088
001
Nov 29, 2001 Apr 09, 1985 Apr 16, 1993 Apr 16, 1993
1MG/ML
N010423
001
LEVAMISOLE HYDROCHLORIDE
TABLET; ORAL ERGAMISOL JANSSEN PHARMA
EQ 50MG BASE
N020035
001
LEVETIRACETAM
TABLET; ORAL LEVETIRACETAM MYLAN
LEVOBETAXOLOL HYDROCHLORIDE
SUSPENSION/DROPS; OPHTHALMIC BETAXON ALCON PHARMS LTD EQ 0.5% BASE
N021114
001
LEVOBUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION CHIROCAINE PURDUE PHARMA LP
LEVOCABASTINE HYDROCHLORIDE
SUSPENSION/DROPS; OPHTHALMIC LIVOSTIN NOVARTIS EQ 0.05% BASE
N020219
001
LEVOCARNITINE
SOLUTION; ORAL CARNITOR SIGMA TAU
1GM/10ML
N018948
002
LEVODOPA
CAPSULE; ORAL BENDOPA VALEANT PHARM INTL
DOPAR SHIRE
LARODOPA ROCHE
250MG 500MG
N016912 N016912
003 004
LEVOMEPROMAZINE
INJECTABLE; INJECTION LEVOPROME IMMUNEX
20MG/ML
N015865
001
10MG/ML
N020315
001
001 002 002 001 Oct 21, 1983 Apr 14, 1988
N008592
007
LEVONORGESTREL
IMPLANT; IMPLANTATION LEVONORGESTREL WYETH PHARMS INC 75MG/IMPLANT NORPLANT POPULATION COUNCIL 36MG/IMPLANT NORPLANT II POPULATION COUNCIL 75MG/IMPLANT NORPLANT SYSTEM IN PLASTIC CONTAINER WYETH PHARMS INC 36MG/IMPLANT TABLET; ORAL PLAN B TEVA WOMENS 0.75MG
Aug 15, 1996 Dec 10, 1990 Nov 01, 1996 Dec 10, 1990
N021045
001
N012928 N012928
006 004
EQ 50MG BASE/5ML
N012928
002
LEVORPHANOL TARTRATE
INJECTABLE; INJECTION LEVO-DROMORAN VALEANT PHARM INTL TABLET; ORAL LEVO-DROMORAN VALEANT PHARM INTL
2MG/ML
N008719
001
2MG
N008720
001
0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG --> 0.3MG
N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021137 N021301 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292 N021292
001 002 003 004 005 006 007 008 009 010 011 012 012 001 002 003 004 005 006 007 008 009 010 011 012
Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun
06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06,
2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
-->
May 25, 2001 May May May May May May May May May May May May 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 31, 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002 2002
0.025MG 0.05MG 0.075MG 0.088MG 0.1MG 0.112MG 0.125MG 0.137MG 0.15MG 0.175MG 0.2MG 0.3MG
LIDOCAINE
AEROSOL; ORAL XYLOCAINE ASTRAZENECA 10% FILM, EXTENDED RELEASE; BUCCAL DENTIPATCH NOVEN 23MG/PATCH OINTMENT; TOPICAL ALPHACAINE CARLISLE 5% 5% 5% LIDOCAINE GRAHAM CHEM 5% XYLOCAINE ASTRAZENECA 5% PATCH; TOPICAL DENTIPATCH NOVEN 46.1MG/PATCH SOLUTION; TOPICAL XYLOCAINE ASTRAZENECA 5% SUPPOSITORY; RECTAL XYLOCAINE ASTRAZENECA 100MG
N014394
001
N020575
001
N020575
002
N014127
001
N013077
001
LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION ALPHACAINE HYDROCHLORIDE CARLISLE 2% LIDOCAINE HYDROCHLORIDE ABBOTT 10% 20%
001 001 005 002 004 002 001 002 004 001 002 001 002 001 001 001 001 001 001 001 002 001 001 001 001 001 002 002 001 001 002 001 002 001 002 001 001 002 002 001 002 001 001 005 001 001 002 006 003 001 001 001
Mar 30, 1984 Jul 31, 1984 Jul 31, 1984 Jul 31, 1984
001 002 002 001 005 009 007 Aug 17, 1983
N016297 N010496
A086578 A086389
001 001
Jun 10, 1983 Jun 30, 1989 Jul 31, 1984 Jul 31, 1984
N022114
001
2%;50MG/ML 2%;125MG/ML
A060567 A060567
001 002
LIDOCAINE; PRILOCAINE
DISC; TOPICAL EMLA ASTRAZENECA
2.5%;2.5%
N020962
001
LINCOMYCIN HYDROCHLORIDE
CAPSULE; ORAL LINCOCIN PHARMACIA AND UPJOHN
N050316 N050316
001 002
A063180
001
LINDANE
CREAM; TOPICAL KWELL REED AND CARNRICK LOTION; TOPICAL GAMENE SOLA BARNES HIND
1% 1%
A084218 N006309
001 001
1%
A084989
001
1% 1% 1%
1% 1% 1% 1%
LINEZOLID
TABLET; ORAL ZYVOX PHARMACIA AND UPJOHN
400MG
N021130
001
LIOTHYRONINE SODIUM
TABLET; ORAL LIOTHYRONINE SODIUM WATSON LABS
A085755 A085753
001 001
LIOTRIX (T4;T3)
TABLET; ORAL EUTHROID-0.5 PARKE DAVIS EUTHROID-1 PARKE DAVIS EUTHROID-2 PARKE DAVIS EUTHROID-3 PARKE DAVIS THYROLAR-5 FOREST LABS
LISINOPRIL
TABLET; ORAL LISINOPRIL TEVA
PRINIVIL MERCK
LITHIUM CARBONATE
CAPSULE; ORAL ESKALITH NOVEN THERAP LITHIUM CARBONATE ABLE
001 001 001 002 003 001 001 Jun Sep Jun Jun Feb Mar 29, 27, 29, 29, 01, 19, 2004 2001 2004 2004 1989 1987
300MG
N016782
001
Mar 29, 1982 Apr 21, 2003 Jun 10, 2002 Aug 21, 2003
LITHIUM CITRATE
SYRUP; ORAL LITHONATE SOLVAY
EQ 300MG CARBONATE/5ML
N017672
001
LOMEFLOXACIN HYDROCHLORIDE
TABLET; ORAL MAXAQUIN PHARMACIA
EQ 400MG BASE
N020013
001
LOPERAMIDE HYDROCHLORIDE
CAPSULE; ORAL IMODIUM MCNEIL PED 2MG LOPERAMIDE HYDROCHLORIDE ROXANE 2MG SANDOZ 2MG TEVA 2MG SOLUTION; ORAL IMODIUM JANSSEN PHARMA 1MG/5ML LOPERAMIDE HYDROCHLORIDE ALPHARMA US PHARMS 1MG/5ML DURAMED PHARMS BARR 1MG/5ML TEVA 1MG/5ML WATSON LABS 1MG/5ML TABLET; ORAL LOPERAMIDE HYDROCHLORIDE ABLE 2MG PERRIGO 2MG
001 001 001 001 Nov 27, 1991 Aug 28, 1992 Aug 30, 1991
Jul 31, 1984 Sep Dec Jun May 15, 29, 23, 28, 1992 1997 1995 1993
A073528 A074194
001 001
LORACARBEF
CAPSULE; ORAL LORABID KING PHARMS FOR SUSPENSION; ORAL LORABID KING PHARMS
200MG 400MG
N050668 N050668
001 002
100MG/5ML 200MG/5ML
N050667 N050667
001 002
1MG/ML
N020641
003
10MG
N021512
001
LORAZEPAM
INJECTABLE; INJECTION LORAZEPAM AKORN BAXTER HLTHCARE DAVA PHARMS INC HOSPIRA
2MG/ML 2MG/ML 4MG/ML 2MG/ML 4MG/ML 2MG/ML 4MG/ML 4MG/ML 1MG/0.5ML 2MG/ML 2MG/ML 4MG/ML 4MG/ML
A074974 A074496 A074496 A074793 A074793 A074280 A074280 A074300 A074551 A074535 A074551 A074535 A074551
001 001 002 001 002 001 002 003 003 001 001 002 002
Jul Sep Sep Mar Mar May May Mar Sep Sep Sep Sep Sep
23, 28, 28, 16, 16, 27, 27, 19, 12, 12, 12, 12, 12,
1998 1998 1998 2000 2000 1994 1994 1997 1996 1996 1996 1996 1996
0.5MG/5ML
A074648
001
0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 0.5MG 0.5MG 1MG 1MG 2MG 2MG 0.5MG 1MG 2MG 0.5MG 1MG 2MG 1MG 2MG 1MG 2MG 0.5MG 0.5MG 1MG 2MG 2MG
A070200 A070201 A070202 A070727 A070728 A070729 A071434 A071435 A071436 A070472 A072553 A070473 A072554 A070474 A072555 A070675 A070676 A070677 A071245 A071246 A071247 A070539 A070540 A071038 A071039 A071086 A071117 A071087 A071088 A071110
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Aug 09, 1985 Aug 09, 1985 Aug 09, 1985 Mar Mar Mar Sep Sep Sep Dec Mar Dec Mar Dec Mar Dec Dec Dec Feb Feb Feb Dec Dec Jan Jan Mar Jul Mar Mar Jul 07, 07, 07, 01, 01, 01, 10, 29, 10, 29, 10, 29, 01, 01, 01, 09, 09, 09, 22, 22, 12, 12, 23, 24, 23, 23, 24, 1986 1986 1986 1987 1987 1987 1985 1991 1985 1991 1985 1991 1986 1986 1986 1987 1987 1987 1986 1986 1988 1988 1987 1986 1987 1987 1986
LORAZEPAM AM THERAP
HALSEY
MUTUAL PHARM
PAR PHARM
SUPERPHARM
N020841
001
LOVASTATIN
TABLET; ORAL MEVACOR MERCK 10MG TABLET, EXTENDED RELEASE; ORAL ALTOPREV ANDRX LABS LLC 10MG
N019643
002
N021316
001
LOXAPINE HYDROCHLORIDE
CONCENTRATE; ORAL
LOXITANE C
WATSON LABS INJECTABLE; INJECTION
LOXITANE IM
WATSON LABS
EQ 25MG BASE/ML
N017658
001
EQ 50MG BASE/ML
N018039
001
LOXAPINE SUCCINATE
CAPSULE; ORAL
LOXAPINE SUCCINATE
ACTAVIS TOTOWA
EQ EQ EQ EQ EQ EQ EQ EQ
5MG BASE 10MG BASE 25MG BASE 50MG BASE 5MG BASE 10MG BASE 25MG BASE 50MG BASE
TABLET; ORAL
LOXITANE
WATSON LABS
006
007
008
LYPRESSIN
SOLUTION; NASAL
DIAPID
NOVARTIS
0.185MG/ML
N016755
001
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
INJECTABLE; INJECTION ISOLYTE S PH 7.4 IN PLASTIC CONTAINER B BRAUN 30MG/100ML;37MG/100ML;0.82MG/100ML;370M N019006 G/100ML;530MG/100ML;500MG/100ML;12MG/10 0ML
001
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
INJECTABLE; INJECTION ISOLYTE S IN PLASTIC CONTAINER B BRAUN 30MG/100ML;37MG/100ML;370MG/100ML;530MG N018252 /100ML;500MG/100ML SOLUTION; IRRIGATION PHYSIOSOL IN PLASTIC CONTAINER HOSPIRA INC 14MG/100ML;37MG/100ML;222MG/100ML;526MG N018406 /100ML;502MG/100ML PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER HOSPIRA INC 30MG/100ML;37MG/100ML;222MG/100ML;526MG N018406 /100ML;502MG/100ML
001
001
002
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
SOLUTION; IRRIGATION SYNOVALYTE IN PLASTIC CONTAINER BAXTER HLTHCARE 30MG/100ML;37MG/100ML;368MG/100ML;526MG N019326 /100ML;502MG/100ML
001
700MG;20MG;600MG 700MG;40MG;600MG
N021850 N021850
001 002
MANGAFODIPIR TRISODIUM
INJECTABLE; INJECTION TESLASCAN GE HEALTHCARE
37.9MG/ML
N020652
001
3.49MG/GM
N020686
001
MANGANESE SULFATE
INJECTABLE; INJECTION MANGANESE SULFATE ABRAXIS PHARM
EQ 0.1MG MANGANESE/ML
N019228
001
MANNITOL
INJECTABLE; INJECTION MANNITOL 10% HOSPIRA MILES MANNITOL 15% HOSPIRA MILES MANNITOL 20% HOSPIRA MILES MANNITOL 25% ABRAXIS PHARM ASTRAZENECA HOSPIRA MERCK WATSON LABS MANNITOL 5% HOSPIRA SOLUTION; IRRIGATION RESECTISOL B BRAUN
10GM/100ML 10GM/100ML 15GM/100ML 15GM/100ML 20GM/100ML 20GM/100ML 12.5GM/50ML 12.5GM/50ML 12.5GM/50ML 12.5GM/50ML 12.5GM/50ML 12.5GM/50ML 5GM/100ML
N016269 N016472 N016269 N016472 N016269 N016472 A086754 A089239 A089240 N016269 N005620 A087460 N016269
002 002 003 005 004 004 001 001 001 005 001 001 001
5GM/100ML
N016704
002
MANNITOL; SORBITOL
SOLUTION; IRRIGATION
SORBITOL-MANNITOL
HOSPIRA 540MG/100ML;2.7GM/100ML SORBITOL-MANNITOL IN PLASTIC CONTAINER
HOSPIRA 540MG/100ML;2.7GM/100ML
A080224 N017636
001
001
MAPROTILINE HYDROCHLORIDE
TABLET; ORAL
LUDIOMIL
NOVARTIS
25MG
N017543
001
50MG 75MG MAPROTILINE HYDROCHLORIDE AM THERAP 25MG 50MG 75MG WATSON LABS 25MG 25MG 50MG 50MG 75MG 75MG
N017543 N017543 A072129 A072130 A072131 A071943 A072162 A071944 A072163 A071945 A072164
002 003 001 001 001 001 001 001 001 001 001
Sep 30, 1982 Jan Jan Jan Dec Jun Dec Jun Dec Jun 14, 14, 14, 30, 01, 30, 01, 30, 01, 1988 1988 1988 1987 1988 1987 1988 1987 1988
MASOPROCOL
CREAM; TOPICAL ACTINEX UNIV AZ CANCER CTR
10%
N019940
001
MAZINDOL
TABLET; ORAL MAZANOR WYETH AYERST SANOREX NOVARTIS
MEBENDAZOLE
TABLET, CHEWABLE; ORAL VERMOX JANSSEN PHARMS
100MG
N017481
001
MEBUTAMATE
TABLET; ORAL DORMATE MEDPOINTE PHARM HLC
600MG
N017374
001
MECAMYLAMINE HYDROCHLORIDE
TABLET; ORAL INVERSINE TARGACEPT
2.5MG
N010251
001
36MG/0.6ML
N021884
001
MECLIZINE HYDROCHLORIDE
TABLET; ORAL MECLIZINE HYDROCHLORIDE ABC HOLDING 12.5MG 25MG ANABOLIC 25MG BUNDY 12.5MG 25MG IVAX SUB TEVA PHARMS 12.5MG 12.5MG 25MG KV PHARM 12.5MG 25MG
A085253 A085252 A085891 A084382 A084872 A083784 A084975 A084657 A085524 A085523
001 001 001 001 001 001 001 001 001 001
A088732 A088734 A089113 A089114 A088256 A088257 A087877 A087620 A085195 A085269
001 001 001 001 001 001 001 001 001 001
MECLOCYCLINE SULFOSALICYLATE
CREAM; TOPICAL MECLAN JOHNSON AND JOHNSON
1%
N050518
001
MECLOFENAMATE SODIUM
CAPSULE; ORAL MECLODIUM QUANTUM PHARMICS MECLOFENAMATE SODIUM AM THERAP BARR PAR PHARM SANDOZ USL PHARMA VITARINE WATSON LABS
EQ 50MG BASE EQ 100MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 100MG BASE 50MG BASE 50MG BASE 100MG BASE 100MG BASE
A071380 A071381 A071362 A071363 A072848 A072809 A072077 A072078 A072262 A072263 A071007 A071008 A071710 A071684 A070400 A071640 A070401 A071641 N018006 N018006
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002
Jul 14, 1987 Jul 14, 1987 Feb Feb Mar Mar Mar Mar Nov Nov Mar Mar Jun Jun Nov Aug Nov Aug 10, 10, 20, 20, 10, 10, 29, 29, 25, 25, 15, 15, 25, 11, 25, 11, 1987 1987 1989 1989 1988 1988 1988 1988 1988 1988 1988 1988 1986 1987 1986 1987
MEDROXYPROGESTERONE ACETATE
INJECTABLE; INJECTION DEPO-PROVERA PHARMACIA AND UPJOHN TABLET; ORAL AMEN AMARIN PHARMS CURRETAB SOLVAY CYCRIN ESI
100MG/ML
N012541
002
5MG 10MG MEDROXYPROGESTERONE ACETATE DURAMED PHARMS BARR 2.5MG 5MG 10MG
Oct 30, 1992 Sep 09, 1987 Dec 01, 1999 Dec 01, 1999 Dec 01, 1999
MEDRYSONE
SUSPENSION; OPHTHALMIC HMS ALLERGAN
1%
N016624
003
MEFLOQUINE HYDROCHLORIDE
TABLET; ORAL LARIAM ROCHE 250MG MEFLOQUINE HYDROCHLORIDE US ARMY WALTER REED 250MG
N019591 N019578
001 001
MEGESTROL ACETATE
TABLET; ORAL MEGACE BRISTOL MYERS SQUIBB MEGESTROL ACETATE TEVA USL PHARMA
001 002 001 001 001 Feb 27, 1998 Oct 02, 1987 Oct 02, 1987
MELOXICAM
TABLET; ORAL MELOXICAM MUTUAL PHARM ROXANE YABAO BIOPHARMS
MEMANTINE HYDROCHLORIDE
TABLET; ORAL MEMANTINE SUN PHARMA GLOBAL
5MG 10MG
May 05, 2010 May 05, 2010 Apr Apr Oct Oct 14, 14, 25, 25, 2010 2010 2011 2011
MEMANTINE HYDROCHLORIDE DR REDDYS LABS LTD 5MG 10MG TEVA PHARMS 5MG 10MG
5MG
N003718
010
MENADIONE
TABLET; ORAL MENADIONE LILLY
5MG
N002139
003
MENOTROPINS (FSH;LH)
INJECTABLE; INJECTION HUMEGON ORGANON USA INC MENOTROPINS FERRING PERGONAL SERONO REPRONEX FERRING
75 IU/VIAL;75 IU/VIAL 150 IU/VIAL;150 IU/VIAL 75 IU/VIAL;75 IU/VIAL 150 IU/VIAL;150 IU/VIAL 75 IU/AMP;75 IU/AMP 150 IU/AMP;150 IU/AMP 150 IU/VIAL;150 IU/VIAL
Sep 01, 1994 Sep 01, 1994 Jan 30, 1997 Jan 30, 1997
MEPENZOLATE BROMIDE
SOLUTION; ORAL CANTIL SANOFI AVENTIS US
25MG/5ML
N010679
004
MEPERIDINE HYDROCHLORIDE
INJECTABLE; INJECTION DEMEROL SANOFI AVENTIS US
N005010 N005010 N005010 N005010 A080388 A080385 A080387 A080389 A080386 A089781 A089782 A089783 A089784 A089785 A089786 A089787 A089788 A088279 A088280 A088281 A088282 A086332 A080364 A080364 A080364 A040305 A040163
007 002 009 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 001 001
MEPERIDINE HYDROCHLORIDE ABBOTT 25MG/ML 50MG/ML 50MG/ML 75MG/ML 100MG/ML ASTRAZENECA 25MG/ML 50MG/ML 50MG/ML 50MG/ML 75MG/ML 100MG/ML 100MG/ML 100MG/ML BAXTER HLTHCARE 25MG/ML 50MG/ML 75MG/ML 100MG/ML INTL MEDICATION 10MG/ML PARKE DAVIS 50MG/ML 75MG/ML 100MG/ML MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE HOSPIRA 10MG/ML MALLINCKRODT 10MG/ML
Mar Mar Mar Mar Mar Mar Mar Mar Jun Jun Jun Jun
31, 31, 31, 31, 31, 31, 31, 31, 15, 15, 15, 15,
1989 1989 1989 1989 1989 1989 1989 1989 1984 1984 1984 1984
N005010
005
25MG/ML;25MG/ML
N011730
001
MEPHENTERMINE SULFATE
INJECTABLE; INJECTION WYAMINE SULFATE BAXTER HLTHCARE CORP
N008248 N008248
002 001
MEPHENYTOIN
TABLET; ORAL MESANTOIN NOVARTIS
100MG
N006008
001
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION ARESTOCAINE HYDROCHLORIDE SOLVAY 3% CARBOCAINE EASTMAN KODAK 3% MEPIVACAINE HYDROCHLORIDE GRAHAM CHEM 3% INTL MEDICATION 1%
MEPREDNISONE
TABLET; ORAL BETAPAR SCHERING
4MG
N016053
002
MEPROBAMATE
CAPSULE; ORAL EQUANIL WYETH AYERST 400MG CAPSULE, EXTENDED RELEASE; ORAL MEPROSPAN MEDPOINTE PHARM HLC 200MG 400MG TABLET; ORAL AMOSENE FERNDALE LABS 400MG BAMATE ALRA 200MG 400MG EQUANIL WYETH AYERST 200MG 400MG MEPRIAM TEVA 400MG
N012455
002
N011284 N011284
001 002
IVC INDS LANNETT LEDERLE LEE KM MALLARD MK LABS MUTUAL PHARM MYLAN NEXGEN PHARMA INC PARKE DAVIS PERRIGO PHARMAVITE PUREPAC PHARM PVT FORM ROXANE SANDOZ
SCHERER LABS SOLVAY STANLABS PHARM TABLICAPS USL PHARMA VALEANT PHARM INTL VANGARD WATSON LABS
600MG 200MG 400MG 400MG 600MG 200MG 400MG 200MG 400MG 600MG 400MG 200MG 400MG 400MG 400MG 400MG 200MG 400MG 200MG 400MG 400MG 200MG 400MG 200MG 400MG 200MG 400MG 400MG 200MG 400MG 400MG 600MG 200MG 400MG 400MG 400MG 200MG 200MG 400MG 400MG 200MG 400MG 200MG 400MG 400MG 200MG 400MG 600MG 600MG 200MG 400MG 200MG 400MG 200MG 400MG 600MG 200MG 400MG
A084230 N015426 N015426 N016928 A084329 N014322 N014322 N015438 N015438 A084181 A084153 N014882 N014882 A086299 A089538 N015072 N014368 N014368 A080699 A080699 A083618 A084220 A084589 A084744 A084744 A084546 A084547 A084438 A084804 A084804 N014601 A084332 N014547 A080655 N014547 A083343 A084435 N014474 N014474 A083494 A087825 A087826 N015139 N015139 A088011 A085720 A085721 A084274 A085719 N015417 N015417 A083830 A083442 N009698 N009698 A083919 N014359 N014359
001 002 001 003 001 002 001 001 002 001 001 002 001 001 001 002 004 002 001 002 001 001 001 001 002 001 001 001 001 002 001 001 002 001 001 001 001 002 004 001 001 001 006 005 001 001 001 001 001 003 002 001 001 004 002 001 002 001
NEURAMATE HALSEY
400MG 400MG
A084369 N016249
001 001
100MG/ML;50MG/ML
A084875
001
MESALAMINE
SUPPOSITORY; RECTAL CANASA AXCAN ROWASA ALAVEN PHARM
500MG 500MG
N021252 N019919
001 001
MESORIDAZINE BESYLATE
CONCENTRATE; ORAL SERENTIL NOVARTIS INJECTABLE; INJECTION SERENTIL NOVARTIS TABLET; ORAL SERENTIL NOVARTIS
EQ 25MG BASE/ML
N016997
001
EQ 25MG BASE/ML
N016775
001
EQ EQ EQ EQ
MESTRANOL; NORETHINDRONE
TABLET; ORAL-20 NORINYL WATSON LABS 0.1MG;2MG TABLET; ORAL-21 NORETHIN 1/50M-21 WATSON LABS 0.05MG;1MG NORETHINDRONE AND MESTRANOL WATSON LABS 0.05MG;1MG NORINYL 1+50 21-DAY WATSON LABS 0.05MG;1MG NORINYL 1+80 21-DAY GD SEARLE LLC 0.08MG;1MG ORTHO-NOVUM 1/50 21 ORTHO MCNEIL PHARM 0.05MG;1MG ORTHO-NOVUM 1/80 21 ORTHO MCNEIL PHARM 0.08MG;1MG ORTHO-NOVUM 10-21 ORTHO MCNEIL PHARM 0.06MG;10MG ORTHO-NOVUM 2-21 ORTHO MCNEIL PHARM 0.1MG;2MG TABLET; ORAL-28 NORETHIN 1/50M-28 WATSON LABS 0.05MG;1MG NORETHINDRONE AND MESTRANOL WATSON LABS 0.05MG;1MG NORINYL 1+80 28-DAY GD SEARLE LLC 0.08MG;1MG ORTHO-NOVUM 1/50 28 ORTHO MCNEIL JANSSEN 0.05MG;1MG ORTHO-NOVUM 1/80 28 ORTHO MCNEIL PHARM 0.08MG;1MG
N013625
004
0.075MG;5MG 0.15MG;9.85MG
N010976 N010976
008 005
0.075MG;5MG 0.1MG;2.5MG
N010976 N010976
004 006
0.1MG;2.5MG
N010976
007
METAPROTERENOL SULFATE
AEROSOL, METERED; INHALATION ALUPENT BOEHRINGER INGELHEIM 0.65MG/INH SOLUTION; INHALATION ALUPENT BOEHRINGER INGELHEIM 0.4% 0.6% 5% METAPROTERENOL SULFATE ASTRAZENECA 0.4% 0.6% DEY 0.33% 0.5% 5% NEPHRON 0.4% 0.6% WOCKHARDT 5% PROMETA MURO 5% SYRUP; ORAL ALUPENT BOEHRINGER INGELHEIM 10MG/5ML METAPROTERENOL SULFATE MORTON GROVE 10MG/5ML TEVA 10MG/5ML TEVA PHARMS 10MG/5ML WOCKHARDT 10MG/5ML PROMETA MURO 10MG/5ML TABLET; ORAL ALUPENT BOEHRINGER INGELHEIM 10MG 20MG METAPROTERENOL SULFATE AM THERAP 10MG 20MG TEVA 10MG 20MG USL PHARMA 10MG 20MG
N016402
001
N018761 N018761 N017659 A071275 A071018 A071806 A071805 A070805 A071855 A071726 A072190 A073340
002 001 001 001 001 001 001 001 001 001 001 001
001 001 001 001 001 001 Oct Feb Aug Mar 13, 27, 30, 24, 1987 1992 1991 1997
002 001 001 001 001 001 001 001 Jun Jun Mar Mar Jan Jan 23, 23, 30, 30, 25, 25, 1988 1988 1990 1990 1988 1988
METARAMINOL BITARTRATE
INJECTABLE; INJECTION ARAMINE MERCK METARAMINOL BITARTRATE ABRAXIS PHARM ELKINS SINN GD SEARLE LLC
EQ 20MG BASE/ML
A086418
002
METAXALONE
TABLET; ORAL SKELAXIN KING PHARMS
400MG
N013217
001
METFORMIN HYDROCHLORIDE
TABLET; ORAL GLUCOPHAGE BRISTOL MYERS SQUIBB
625MG 750MG
N020357 N020357 A075971 A075971 A075971 A078422 A078422 A078422 A075975 A075975 A075975 A075975 A075975 A076328 A076328 A076328
003 004 001 002 003 001 002 003 001 004 005 002 003 001 002 003
Nov 05, 1998 Nov 05, 1998 Jan Jan Jan Aug Aug Aug Jan Jan Jan Jan Jan Dec Dec Dec 25, 25, 25, 06, 06, 06, 24, 24, 24, 24, 24, 16, 16, 16, 2002 2002 2002 2007 2007 2007 2002 2002 2002 2002 2002 2002 2002 2002
METFORMIN HYDROCHLORIDE BARR 500MG 850MG 1GM IPCA LABS LTD 500MG 850MG 1GM IVAX SUB TEVA PHARMS 500MG 625MG 750MG 850MG 1GM TEVA 500MG 850MG 1GM TABLET, EXTENDED RELEASE; ORAL METFORMIN HYDROCHLORIDE ACTAVIS ELIZABETH 500MG 750MG BARR 500MG IVAX SUB TEVA PHARMS 500MG MUTUAL PHARM 500MG SANDOZ 500MG
N021410
001
METHACYCLINE HYDROCHLORIDE
CAPSULE; ORAL RONDOMYCIN MEDPOINTE PHARM HLC SYRUP; ORAL RONDOMYCIN MEDPOINTE PHARM HLC
A060641 A060641
001 002
EQ 70MG BASE/5ML
A060641
003
METHADONE HYDROCHLORIDE
SYRUP; ORAL DOLOPHINE HYDROCHLORIDE ROXANE 10MG/30ML TABLET; ORAL METHADONE HYDROCHLORIDE ROXANE 5MG 10MG 40MG SANDOZ 5MG
N006134
004
N017108
001
METHAMPHETAMINE HYDROCHLORIDE
TABLET; ORAL METHAMPEX TEVA 10MG METHAMPHETAMINE HYDROCHLORIDE ABLE 5MG REXAR 5MG 10MG TEVA 5MG TABLET, EXTENDED RELEASE; ORAL DESOXYN LUNDBECK INC 5MG 10MG 15MG
METHANTHELINE BROMIDE
TABLET; ORAL BANTHINE SHIRE
50MG
N007390
001
METHARBITAL
TABLET; ORAL GEMONIL ABBOTT
100MG
N008322
001
METHAZOLAMIDE
TABLET; ORAL METHAZOLAMIDE APPLIED ANAL SANDOZ NEPTAZANE LEDERLE
METHDILAZINE
TABLET, CHEWABLE; ORAL TACARYL WESTWOOD SQUIBB
3.6MG
N011950
009
METHDILAZINE HYDROCHLORIDE
SYRUP; ORAL METHDILAZINE HYDROCHLORIDE ALPHARMA US PHARMS 4MG/5ML TACARYL WESTWOOD SQUIBB 4MG/5ML TABLET; ORAL TACARYL WESTWOOD SQUIBB 8MG
A087122 N011950
001 007
N011950
006
EQ EQ EQ EQ EQ EQ
METHIMAZOLE
TABLET; ORAL METHIMAZOLE CEDAR PHARMS MYLAN TAPAZOLE KING PHARMS
METHIXENE HYDROCHLORIDE
TABLET; ORAL TREST NOVARTIS
1MG
N013420
001
METHOCARBAMOL
INJECTABLE; INJECTION METHOCARBAMOL MARSAM PHARMS LLC TABLET; ORAL DELAXIN FERNDALE LABS FORBAXIN FOREST LABS METHOCARBAMOL ABLE AM THERAP ASCOT CLONMEL HLTHCARE HEATHER IMPAX LABS INWOOD LABS IVAX SUB TEVA PHARMS KV PHARM MUTUAL PHARM MYLAN NYLOS PIONEER PHARMS PURACAP PHARM PUREPAC PHARM
100MG/ML
A089849
001
500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG
A085454 A085136 A040413 A040413 A089417 A089418 A087660 A087661 A085961 A085963 A084675 A084924 A084927 A084928 A085137 A084648 A084649 A085660 A085658 A084488 A084486 A084259 A084323 A085033 A088731 A089082 A084231 A084471 A085718 A085718
001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 002 Mar Mar Feb Feb Oct Oct 17, 17, 11, 11, 27, 27, 2003 2003 1987 1987 1982 1982
500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 750MG 500MG 500MG 750MG 500MG 750MG
A088646 A088647 A087283 A087282 A086989 A086988 A084448 A084449 A087589 A087590 A084846 A087453 A087454 A083605 A083605
001 001 001 001 001 001 001 001 001 001 001 001 001 001 002
METHOHEXITAL SODIUM
INJECTABLE; INJECTION BREVITAL SODIUM JHP PHARMS
5GM/VIAL
N011559
003
METHOTREXATE SODIUM
INJECTABLE; INJECTION ABITREXATE ABIC
EQ EQ EQ EQ EQ EQ EQ EQ
25MG BASE/ML 50MG BASE/VIAL 100MG BASE/VIAL 250MG BASE/VIAL 25MG BASE/VIAL 50MG BASE/VIAL 100MG BASE/VIAL 250MG BASE/VIAL
A089161 A089354 A089355 A089356 A087695 A087695 A087695 A088954 A081242 A089180 N011719 A040265 A040266 N011719 N011719 N011719 A089323 A088935 A089263 A089322 A088936 A088937 N011719 N011719 N011719 N011719 N011719 A088648 A089158 N011719
001 001 001 001 001 002 003 001 001 001 007 001 001 014 013 011 001 001 001 001 001 001 004 001 005 003 006 001 001 009
Aug 23, 1991 Jan 03, 1986 Mar 31, 1982 Feb Feb Apr Apr Apr Jun Oct Jun Jun Oct Oct 26, 26, 13, 13, 13, 13, 11, 13, 13, 11, 11, 1999 1999 2005 2005 2005 1986 1985 1986 1986 1985 1985
METHOTREXATE LPF HOSPIRA EQ 25MG BASE/ML METHOTREXATE PRESERVATIVE FREE APP PHARMS EQ 25MG BASE/ML EQ 1GM BASE/VIAL HOSPIRA EQ 20MG BASE/2ML (EQ 10MG BASE/ML) EQ 500MG BASE/20ML (EQ 25MG BASE/ML) EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML) METHOTREXATE SODIUM ABRAXIS PHARM EQ 2.5MG BASE/ML EQ 20MG BASE/VIAL EQ 25MG BASE/ML EQ 25MG BASE/ML EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL HOSPIRA EQ 2.5MG BASE/ML EQ 20MG BASE/VIAL EQ 25MG BASE/ML EQ 50MG BASE/VIAL EQ 100MG BASE/VIAL NORBROOK EQ 25MG BASE/ML PHARMACHEMIE USA EQ 25MG BASE/ML METHOTREXATE SODIUM PRESERVATIVE FREE HOSPIRA EQ 1GM BASE/VIAL
EQ EQ EQ EQ
001 002 003 004 001 001 Feb 14, 1985 Apr 14, 1989
MEXATE-AQ BRISTOL MYERS MEXATE-AQ PRESERVED BRISTOL MYERS SQUIBB TABLET; ORAL METHOTREXATE SODIUM DURAMED PHARMS BARR
EQ 2.5MG BASE
A040233
001
METHOXAMINE HYDROCHLORIDE
INJECTABLE; INJECTION VASOXYL GLAXOSMITHKLINE
10MG/ML 20MG/ML
N006772 N006772
002 001
METHOXSALEN
CAPSULE; ORAL METHOXSALEN SANDOZ
10MG
A087781
001
METHSCOPOLAMINE BROMIDE
TABLET; ORAL METHSCOPOLAMINE BROMIDE PVT FORM 2.5MG
A080970
001
METHYCLOTHIAZIDE
TABLET; ORAL AQUATENSEN MEDPOINTE PHARM HLC METHYCLOTHIAZIDE IVAX PHARMS MYLAN PAR PHARM SANDOZ USL PHARMA WATSON LABS
5MG 2.5MG 5MG 2.5MG 2.5MG 5MG 2.5MG 5MG 5MG 2.5MG 2.5MG 5MG
N017364 A087913 A087786 A087671 A089135 A089136 A089835 A089837 A088745 A085487 A088750 A085476
001 001 001 001 001 001 001 001 001 001 001 001 Jun May Aug Feb Feb Aug Aug Mar Mar Sep Mar 03, 18, 17, 12, 12, 18, 18, 21, 11, 06, 11, 1982 1982 1982 1986 1986 1988 1988 1985 1982 1984 1982
5MG;25MG
N016047
001
METHYCLOTHIAZIDE; RESERPINE
TABLET; ORAL DIUTENSEN-R MEDPOINTE PHARM HLC
2.5MG;0.1MG
N012708
005
METHYLDOPA
SUSPENSION; ORAL ALDOMET MERCK
250MG/5ML
N018389
001
125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 125MG 250MG 500MG 250MG 500MG 125MG 250MG 500MG 125MG 125MG 250MG 250MG 250MG 500MG 500MG
N013400 N013400 N013400 A070070 A071006 A071009 A071751 A071752 A071753 A070073 A070060 A070074 A070535 A070536 A070537 A070331 A070332 A070333 A072126 A072127 A072128 A070749 A070750 A070452 A070192 A070193 A070194 A071700 N018934 N018934 A070669 A070670 A071105 A071106 A071067 A070245 A070260 A070246 A070261 A070703 A070247 A070262
003 001 002 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 Oct Dec Dec Mar Mar Mar Oct Oct Oct Jan Jan Jan Apr Apr Apr Jul Jul Jul Feb Feb Feb Apr Apr Apr Mar Jun Jun Jun Jun Dec Dec Dec Feb Jun Feb Jun Jun Feb Jun 15, 16, 16, 28, 28, 28, 09, 09, 09, 02, 02, 02, 15, 15, 15, 07, 07, 07, 07, 07, 07, 25, 25, 25, 02, 29, 29, 23, 23, 05, 05, 05, 25, 24, 25, 24, 06, 25, 24, 1985 1986 1986 1988 1988 1988 1986 1986 1986 1987 1987 1987 1986 1986 1986 1988 1988 1988 1986 1986 1986 1986 1986 1986 1988 1984 1984 1989 1989 1986 1986 1986 1986 1985 1986 1985 1986 1986 1985
MUTUAL PHARM
PAR PHARM
PARKE DAVIS
PLIVA
PUREPAC PHARM
ROXANE
SANDOZ
SUPERPHARM TEVA
WATSON LABS
METHYLDOPATE HYDROCHLORIDE
INJECTABLE; INJECTION ALDOMET MERCK 50MG/ML METHYLDOPATE HYDROCHLORIDE ABRAXIS PHARM 50MG/ML BAXTER HLTHCARE 50MG/ML HOSPIRA 50MG/ML 50MG/ML 50MG/ML 50MG/ML MARSAM PHARMS LLC 50MG/ML SMITH AND NEPHEW 50MG/ML
001 001 001 001 001 001 001 001 001 Jun Jul Jun Jun Jun Jun Dec Jan 03, 01, 19, 15, 15, 19, 22, 02, 1986 1986 1987 1987 1987 1987 1987 1987
A076032 A075450
001 001
METHYLPREDNISOLONE
TABLET; ORAL MEDROL PHARMACIA AND UPJOHN METHYLPREDNISOLONE HEATHER PAR PHARM
Apr 25, 1988 Apr 25, 1988 Apr 25, 1988 Feb 09, 1982 Feb 09, 1982
METHYLPREDNISOLONE ACETATE
ENEMA; RECTAL MEDROL PHARMACIA AND UPJOHN 40MG/BOT INJECTABLE; INJECTION METHYLPREDNISOLONE ACETATE AKORN 40MG/ML 80MG/ML WATSON LABS 20MG/ML 20MG/ML 40MG/ML 40MG/ML 80MG/ML 80MG/ML M-PREDROL BEL MAR 40MG/ML 80MG/ML OINTMENT; TOPICAL MEDROL ACETATE PHARMACIA AND UPJOHN 0.25% 1%
N018102
001
A086903 A086903 A085597 A087248 A085374 A085600 A085595 A086507 A086666 A087135
001 002 001 001 001 001 001 001 001 001
N012421 N012421
001 002
A060611 A060611
002 001
EQ EQ EQ EQ
EQ EQ EQ EQ EQ EQ
40MG BASE/VIAL 125MG BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL
A085853 A085855 A085854 A089173 A085852 A089174 A086906 A086906 A086906 A087535 A087535 A088676 A089143 A088677 A089144 A088678 A089186 A089187 A088679 A089188 A089189 A086906 A087812 A087813 A087851 A087852 A081267 A081268 A086953 A087030 A088523 A088524
001 001 001 001 001 001 002 003 004 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL ORGANON USA INC EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL METHYLPREDNISOLONE SODIUM SUCCINATE ABRAXIS PHARM EQ 40MG BASE/VIAL EQ 40MG BASE/VIAL EQ 125MG BASE/VIAL EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL EQ 1GM BASE/VIAL ELKINS SINN EQ 40MG BASE/VIAL INTL MEDICATION EQ 40MG BASE/VIAL EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL TEVA PARENTERAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL WATSON LABS EQ 40MG BASE/VIAL EQ 125MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL
Jun 25, 1982 Jun 25, 1982 Jun Mar Jun Mar Jun Mar Mar Jun Mar Mar Feb Feb Feb Feb Nov Nov Jul Jul Jul Jul 08, 28, 08, 28, 08, 28, 28, 08, 28, 28, 09, 09, 09, 09, 30, 30, 22, 22, 24, 24, 1984 1986 1984 1986 1984 1986 1986 1984 1986 1986 1983 1983 1983 1983 1992 1992 1982 1982 1984 1984
A060645
001
METHYLTESTOSTERONE
CAPSULE; ORAL METHYLTESTOSTERONE HEATHER VIRILON STAR PHARMS FL TABLET; BUCCAL ANDROID 5 VALEANT PHARM INTL ORETON SCHERING TABLET; BUCCAL/SUBLINGUAL METANDREN NOVARTIS METHYLTESTOSTERONE IMPAX LABS LILLY PUREPAC PHARM
10MG 10MG
A084967 A087750
5MG 10MG
A087222 A080281
001 001
METHYLTESTOSTERONE
TABLET; BUCCAL/SUBLINGUAL METHYLTESTOSTERONE PVT FORM TABLICAPS USL PHARMA TABLET; ORAL METANDREN NOVARTIS METHYLTESTOSTERONE INWOOD LABS KV PHARM LANNETT LILLY PARKE DAVIS PUREPAC PHARM
10MG 25MG 10MG 25MG 10MG 10MG 25MG 25MG 10MG 25MG 10MG 10MG 25MG 25MG 5MG 10MG 25MG 10MG 25MG 10MG 25MG 10MG 25MG 25MG 10MG 25MG
N003240 N003240 A080839 A080973 A084312 A087092 A087111 A080256 A084244 A084241 A080309 A080475 A080310 A080475 A080214 A080214 A080214 A080313 A085270 A080933 A080931 A084331 A084331 A084642 N003158 N003158
001 003 001 001 001 001 001 002 001 001 001 002 001 003 001 002 003 001 001 001 001 001 002 001 001 002
PVT FORM
METHYPRYLON
CAPSULE; ORAL NOLUDAR ROCHE ELIXIR; ORAL NOLUDAR ROCHE TABLET; ORAL NOLUDAR ROCHE
300MG
N009660
008
50MG/5ML
N009660
007
50MG 200MG
N009660 N009660
002 004
METHYSERGIDE MALEATE
TABLET; ORAL SANSERT NOVARTIS
2MG
N012516
001
METOCLOPRAMIDE HYDROCHLORIDE
CONCENTRATE; ORAL METOCLOPRAMIDE INTENSOL ROXANE EQ 10MG BASE/ML INJECTABLE; INJECTION METOCLOPRAMIDE HYDROCHLORIDE BEDFORD EQ 5MG BASE/ML EQ 5MG BASE/ML EQ 5MG BASE/ML HOSPIRA EQ 5MG BASE/ML
A072995
001
A070506 A070847 A071291 A071990 A073117 A074147 A070293 A070892 A070623 A070622 N017862
001 001 001 001 001 001 001 001 001 001 004
Jun Nov Mar Jan Jan Aug Jan Aug Mar Mar
22, 07, 03, 18, 17, 02, 24, 26, 02, 02,
1989 1988 1989 1989 1991 1996 1986 1988 1987 1987
A072384 A070294 A070632 A070106 A072639 A070906 A071213 A070660 A071536 A070342 A072436 A074478 A070850 A072215 A074478 A070598 A070926 A070339 A070363 A070453 A070511 A070645
001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001
Jun 02, 1988 Jul 29, 1985 Oct 28, 1985 Mar 04, 1986 May Oct Sep Feb Apr Mar Jun Oct Feb Jan Oct Feb Jun Jul Mar Jun Jan May 09, 28, 24, 10, 28, 25, 22, 05, 03, 30, 05, 02, 26, 29, 02, 06, 22, 11, 1991 1986 1986 1987 1993 1986 1989 1995 1987 1990 1995 1987 1987 1985 1987 1986 1986 1987
N021793 N021793
001 002
METOCURINE IODIDE
INJECTABLE; INJECTION METUBINE IODIDE LILLY
2MG/ML
N006632
003
001 002 003 002 001 001 Apr 29, 2004 Jul 21, 2004 Oct 30, 1987
METOPROLOL FUMARATE
TABLET, EXTENDED RELEASE; ORAL LOPRESSOR NOVARTIS EQ 100MG EQ 200MG EQ 300MG EQ 400MG
METOPROLOL TARTRATE
TABLET; ORAL METOPROLOL TARTRATE APOTHECON MYLAN PUREPAC PHARM SOLCO HLTHCARE TEVA TEVA PHARMS
50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG
A074258 A074258 A073666 A073666 A074380 A074380 A074453 A074453 A074143 A074143 A074333 A074333
001 002 001 002 001 002 001 002 001 002 001 002
Jan Jan Dec Dec Jul Jul Apr Apr Sep Sep Jan Jan
27, 27, 21, 21, 29, 29, 27, 27, 30, 30, 27, 27,
1994 1994 1993 1993 1994 1994 1995 1995 1994 1994 1994 1994
METRIZAMIDE
INJECTABLE; INJECTION AMIPAQUE GE HEALTHCARE
METRONIDAZOLE
CAPSULE; ORAL METRONIDAZOLE ABLE INJECTABLE; INJECTION METRO I.V. B BRAUN METRONIDAZOLE ABBOTT ABRAXIS PHARM ELKINS SINN INTL MEDICATION WATSON LABS TABLET; ORAL METROMIDOL LABS AF
375MG
A076505
001
Aug 31, 1982 Nov Dec Mar May Dec Apr 18, 03, 30, 08, 20, 01, 1983 1984 1984 1985 1984 1986
250MG 500MG
A074523 A074523
001 002
SUPERPHARM WATSON LABS WORLD GEN PROTOSTAT ORTHO MCNEIL PHARM SATRIC SAVAGE LABS
250MG 500MG 250MG 500MG 250MG 500MG 250MG 250MG 500MG 250MG 500MG 250MG 250MG 500MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG 250MG 500MG
A076519 A076519 A070021 A070593 N018517 N018517 N019029 N018818 N018818 N018845 N018930 N018620 N018740 N018620 N018740 A070008 A070009 N018599 N018599 A070040 A070039 N018871 N018871 A070029 A070731
001 002 001 001 001 002 001 001 002 001 001 001 001 002 002 001 001 001 002 001 001 001 002 001 001
Jun Jun Apr Feb May Apr Feb Feb Aug Aug Mar Oct Jun Oct Dec Dec Sep Feb Jan Jan
27, 27, 02, 27, 05, 10, 16, 16, 18, 18, 04, 22, 02, 22, 11, 11, 17, 13, 29, 29,
2003 2003 1985 1986 1982 1984 1983 1983 1983 1983 1982 1982 1983 1982 1984 1984 1982 1984 1985 1985
Mar 02, 1983 Mar 02, 1983 Mar 19, 1985 Jun 08, 1987
A076462
001
METRONIDAZOLE HYDROCHLORIDE
INJECTABLE; INJECTION FLAGYL I.V. PFIZER EQ 500MG BASE/VIAL METRONIDAZOLE HYDROCHLORIDE ABRAXIS PHARM EQ 500MG BASE/VIAL
N018353 A070295
METYRAPONE
TABLET; ORAL METOPIRONE NOVARTIS
250MG
N012911
001
MEXILETINE HYDROCHLORIDE
CAPSULE; ORAL MEXILETINE HYDROCHLORIDE SANDOZ 150MG 200MG 250MG MEXITIL BOEHRINGER INGELHEIM 150MG 200MG 250MG
May 16, 1996 May 16, 1996 May 16, 1996 Dec 30, 1985 Dec 30, 1985 Dec 30, 1985
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
2GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 20GM BASE/VIAL 20GM BASE/VIAL
A062333 A062372 N050549 A062333 A062372 A062697 N050549 A062333 A062372 A062697 N050549 A062372 N050549
002 001 002 003 002 001 003 004 003 002 004 004 005
May 13, 1982 Jan 22, 1987 Mar 02, 1988 Mar 02, 1988
MICONAZOLE
INJECTABLE; INJECTION MONISTAT JANSSEN PHARMA
10MG/ML
N018040
001
MICONAZOLE NITRATE
CREAM; TOPICAL MONISTAT-DERM INSIGHT PHARMS 2% CREAM; VAGINAL MICONAZOLE NITRATE TEVA 2% TEVA PHARMS 2% CREAM, SUPPOSITORY; TOPICAL, VAGINAL M-ZOLE 7 DUAL PACK ACTAVIS MID ATLANTIC 2%,100MG LOTION; TOPICAL MONISTAT-DERM INSIGHT PHARMS 2% TAMPON; VAGINAL MONISTAT 5 PERSONAL PRODS 100MG
N017494
001
A074136 A074030
001 001
A074586
001
N017739
001
N018592
001
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION MIDAZOLAM HYDROCHLORIDE APOTHECON EQ EQ EQ ASTRAZENECA EQ BEDFORD EQ BEN VENUE EQ HOSPIRA EQ EQ EQ HOSPIRA INC EQ EQ VERSED HLR EQ EQ SYRUP; ORAL VERSED ROCHE EQ
1MG 5MG 5MG 5MG 5MG 5MG 1MG 5MG 5MG 1MG 5MG
BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A075620 A075620 A075641 A075263 A075249 A075455 A075396 A075396 A075484 A075409 A075409 N018654 N018654
001 002 001 001 001 001 001 002 001 002 001 002 001
Nov Nov Oct Jun Jun Jun Jun Jun Jun Jun Jun
01, 01, 19, 26, 23, 20, 20, 20, 20, 20, 20,
2000 2000 2000 2000 2000 2000 2000 2000 2000 2000 2000
2MG BASE/ML
N020942
001
EQ 1MG BASE/ML EQ 1MG BASE/ML EQ 1MG BASE/ML EQ 1MG BASE/ML MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER BAXTER HLTHCARE EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) PRIMACOR SANOFI AVENTIS US EQ 1MG BASE/ML PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER SANOFI AVENTIS US EQ 10MG BASE/100ML EQ 15MG BASE/100ML EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)
A075852 A076428 A075830 A075884 A075510 A076259 N019436 N020343 N020343 N020343 N020343
001 001 001 001 001 001 001 001 002 003 004
May 28, 2002 Aug 08, 2002 Dec 31, 1987 Aug Aug Aug Aug 09, 09, 09, 09, 1994 1994 1994 1994
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL DYNACIN MEDICIS MINOCIN TRIAX PHARMS
TRIAX PHARMS LLC INJECTABLE; INJECTION MINOCIN LEDERLE EQ 100MG BASE/VIAL SUSPENSION; ORAL MINOCIN TRIAX PHARMS EQ 50MG BASE/5ML TABLET; ORAL MINOCYCLINE HYDROCHLORIDE TRIAX PHARMS EQ 50MG BASE EQ 100MG BASE TABLET, EXTENDED RELEASE; ORAL MINOCYCLINE HYDROCHLORIDE LUPIN LTD EQ 55MG BASE
A062139
001
N050445
001
N050451 N050451
003 002
A091424
002
MINOXIDIL
SOLUTION; TOPICAL MINOXIDIL (FOR MEN) BAUSCH AND LOMB COPLEY PHARM SIGHT PHARMS TEVA MINOXIDIL (FOR WOMEN) SIGHT PHARMS TABLET; ORAL LONITEN PHARMACIA AND UPJOHN MINODYL QUANTUM PHARMICS MINOXIDIL ROYCE LABS USL PHARMA
2% 2% 2% 2% 2%
001 003 001 001 001 001 001 Jul 13, 1988 Mar 19, 1987 Nov 10, 1987 Nov 10, 1987 Dec 16, 1988
15MG 30MG 45MG ACTAVIS TOTOWA 15MG 30MG 45MG IVAX SUB TEVA PHARMS 15MG 30MG 45MG ROXANE 15MG 30MG 45MG SANDOZ 15MG 30MG 45MG TABLET, ORALLY DISINTEGRATING; ORAL MIRTAZAPINE ACTAVIS TOTOWA 15MG 30MG 45MG
A076308 A076308 A076308 A076241 A076241 A076241 A076244 A076244 A076244 A076270 A076270 A076270 A076189 A076189 A076189
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003
Jun Jun Jun Jun Jun Jun Dec Dec Dec Jun Jun Jun Jun Jun Jun
20, 20, 20, 25, 25, 25, 22, 22, 22, 19, 19, 19, 19, 19, 19,
2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
MITOMYCIN
INJECTABLE; INJECTION MITOMYCIN HOSPIRA MITOZYTREX SUPERGEN MUTAMYCIN BRISTOL BRISTOL MYERS
MITOXANTRONE HYDROCHLORIDE
INJECTABLE; INJECTION NOVANTRONE EMD SERONO
EQ 20MG BASE/10ML (EQ 2MG BASE/ML) EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) EQ 30MG BASE/15ML (EQ 2MG BASE/ML)
MIVACURIUM CHLORIDE
INJECTABLE; INJECTION MIVACRON ABBOTT EQ MIVACRON IN DEXTROSE 5% IN ABBOTT EQ EQ MIVACURIUM CHLORIDE PISGAH LABS EQ
2MG BASE/ML PLASTIC CONTAINER 0.5MG BASE/ML 50MG BASE/100ML 2MG BASE/ML
Jan 22, 1992 Jan 22, 1992 Jan 22, 1992 Apr 30, 2009
MOLINDONE HYDROCHLORIDE
CAPSULE; ORAL MOBAN ENDO PHARMS
20MG/ML
N017938
001
MONOBENZONE
CREAM; TOPICAL BENOQUIN VALEANT PHARM INTL
20%
N008173
003
MONOCTANOIN
LIQUID; PERFUSION, BILIARY MOCTANIN ETHITEK 100%
N019368
001
MORICIZINE HYDROCHLORIDE
TABLET; ORAL ETHMOZINE SHIRE
MORPHINE SULFATE
INJECTABLE; INJECTION MORPHINE SULFATE HOSPIRA MALLINCKRODT
0.5MG/ML 1MG/ML 2MG/ML INJECTABLE, LIPOSOMAL; EPIDURAL DEPODUR EKR THERAP 15MG/1.5ML (10MG/ML) 20MG/2ML (10MG/ML) TABLET, EXTENDED RELEASE; ORAL MORPHINE SULFATE WATSON LABS 100MG
N021671 N021671
002 003
A075656
001
MOXALACTAM DISODIUM
INJECTABLE; INJECTION MOXAM LILLY
EQ EQ EQ EQ EQ
250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
MYCOPHENOLATE MOFETIL
TABLET; ORAL MYCOPHENOLATE MOFETIL DR REDDYS LABS LTD
500MG
A090464
001
NABUMETONE
TABLET; ORAL NABUMETONE ACTAVIS ELIZABETH COPLEY PHARM SANDOZ
500MG 750MG
N019583 N019583
001 002
NADOLOL
TABLET; ORAL CORGARD KING PHARMS NADOLOL IVAX SUB TEVA PHARMS TEVA PHARMS
003 004 002 003 001 002 003 Jan Jan Aug Aug Aug 24, 24, 31, 31, 31, 1996 1996 1994 1994 1994
NAFCILLIN SODIUM
CAPSULE; ORAL UNIPEN WYETH AYERST FOR SOLUTION; ORAL UNIPEN WYETH AYERST INJECTABLE; INJECTION NAFCILLIN SODIUM APOTHECON
EQ 250MG BASE
N050111
001
EQ 250MG BASE/5ML
N050199
001
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1.5GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 10GM BASE/VIAL
A061984 A061984 A061984 A061984 A062844 A062844 A062844 A062844 A062844 A063008 A062527 A061999 A061999 A062755 A061999 A062755 A061999 A062717 N050320 A062717 A062717 N050320 N050320 N050320 N050320 N050320
001 002 003 005 001 002 003 004 005 001 001 001 002 001 003 002 004 001 001 002 004 003 004 005 006 002
EQ 500MG BASE/VIAL EQ 500MG BASE/VIAL EQ 1GM BASE/VIAL EQ 2GM BASE/VIAL EQ 2GM BASE/VIAL EQ 4GM BASE/VIAL EQ 10GM BASE/VIAL EQ 20GM BASE/VIAL UNIPEN IN PLASTIC CONTAINER WYETH AYERST EQ 1GM BASE/VIAL TABLET; ORAL UNIPEN WYETH AYERST EQ 500MG BASE
N050462
001
10MG/ML 20MG/ML
A070751 A070752 N020200 A070917 A072070 A072071 A072072 A072073 A072074 A072075 A074471 A074471 N018024 N018024
001 001 001 001 001 001 001 001 001 001 001 002 001 002
Jul 02, 1986 Sep 24, 1986 Mar Feb Apr Apr Apr Apr Apr Apr Mar Mar 12, 03, 10, 10, 10, 10, 10, 10, 19, 19, 1993 1989 1989 1989 1989 1989 1989 1989 1998 1998
NALBUPHINE HYDROCHLORIDE 1.5MG/ML ABBOTT 20MG/ML 10MG/ML ASTRAZENECA 10MG/ML 10MG/ML 20MG/ML 20MG/ML 20MG/ML BARR 10MG/ML 20MG/ML NUBAIN ENDO PHARMS 10MG/ML 20MG/ML
NALIDIXIC ACID
SUSPENSION; ORAL NEGGRAM SANOFI AVENTIS US TABLET; ORAL NALIDIXIC ACID MUTUAL PHARM
250MG/5ML
N017430
001
WATSON LABS
NALMEFENE HYDROCHLORIDE
INJECTABLE; INJECTION REVEX BAXTER HLTHCARE CORP
N020459 N020459
001 002
NALOXONE HYDROCHLORIDE
INJECTABLE; INJECTION NALOXONE BAXTER HLTHCARE
WYETH AYERST
0.4MG/ML 0.4MG/ML 0.4MG/ML 0.02MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 0.02MG/ML 0.02MG/ML 0.4MG/ML 1MG/ML 0.02MG/ML 0.02MG/ML 0.02MG/ML 0.02MG/ML 0.02MG/ML
A070298 A070299 A070496 A070188 A070189 A070190 A070191 A070648 A070661 A070649 A071604 A072081 A072082 A072083 A072084 A072085
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Sep Sep Sep Sep Sep Sep Nov Nov Nov Dec Apr Apr Apr Apr Apr
24, 24, 24, 24, 24, 24, 24, 17, 17, 17, 16, 11, 11, 11, 11, 11,
1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1988 1989 1989 1989 1989 1989
ASTRAZENECA
BAXTER HLTHCARE
HOSPIRA
0.4MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 1MG/ML 1MG/ML 1MG/ML 0.02MG/ML 1MG/ML 1MG/ML 1MG/ML 0.02MG/ML 0.02MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 1MG/ML 0.4MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 0.02MG/ML 0.4MG/ML 0.4MG/ML 0.4MG/ML 1MG/ML 1MG/ML 0.02MG/ML 0.4MG/ML 1MG/ML
A072086 A072087 A072088 A072089 A072090 A072091 A072092 A072093 A071272 A071273 A071274 A071287 A070171 A070252 A070253 A070255 A070417 A072115 A071811 A071671 A071681 A071682 A071672 A071683 A071339 A071083 A071084 A071311 N016636 N016636 N016636
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 003
Apr Apr Apr Apr Apr Apr Apr Apr May May May May Sep Jan Jan Jan Sep Apr Jul Nov Nov Nov Nov Nov Nov
11, 11, 11, 11, 11, 11, 11, 11, 24, 24, 24, 24, 24, 16, 16, 07, 24, 27, 19, 17, 17, 17, 17, 17, 18,
1989 1989 1989 1989 1989 1989 1989 1989 1988 1988 1988 1988 1986 1987 1987 1987 1986 1988 1988 1987 1987 1987 1987 1987 1987
ENDO PHARMS
N018733
001
NANDROLONE DECANOATE
INJECTABLE; INJECTION DECA-DURABOLIN ORGANON USA INC
50MG/ML 100MG/ML 200MG/ML 100MG/ML 200MG/ML 100MG/ML 50MG/ML 50MG/ML 50MG/ML 100MG/ML 100MG/ML 200MG/ML
N013132 N013132 N013132 A088290 A088317 A087519 A086385 A087598 A088554 A086598 A087599 A088128
001 002 003 001 001 001 001 001 001 001 001 001
Jun 12, 1986 Jun 12, 1986 Jun 12, 1986 Oct Oct Sep Jan Oct Feb Jan Oct Dec 03, 14, 28, 13, 06, 10, 13, 06, 05, 1983 1983 1983 1984 1983 1986 1984 1983 1983
NANDROLONE PHENPROPIONATE
INJECTABLE; INJECTION DURABOLIN ORGANON USA INC
25MG/ML 50MG/ML
N011891 N011891
001 002
A086386 A087488
001 001
NAPHAZOLINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC NAFAZAIR BAUSCH AND LOMB 0.1% PHARMAFAIR 0.1% NAPHCON FORTE ALCON 0.1% OPCON BAUSCH AND LOMB 0.1% VASOCON NOVARTIS 0.1%
NAPROXEN
TABLET; ORAL NAPROXEN DAVA PHARMS INC
250MG 375MG 500MG HAMILTON PHARMS 250MG 375MG 500MG IVAX SUB TEVA PHARMS 250MG 375MG 500MG PLIVA 250MG 375MG 500MG PUREPAC PHARM 250MG 375MG 500MG ROXANE 250MG 375MG 500MG TEVA 250MG 250MG 375MG 375MG 500MG 500MG TEVA PHARMS 250MG 375MG 500MG WATSON LABS 250MG 375MG 500MG TABLET, DELAYED RELEASE; ORAL NAPROXEN ACTAVIS ELIZABETH 375MG 500MG
A074105 A074105 A074105 A074110 A074110 A074110 A074111 A074111 A074111 A074182 A074182 A074182 A074263 A074263 A074263 A074211 A074211 A074211 A074129 A074216 A074129 A074216 A074129 A074216 A074207 A074207 A074207 A074163 A074163 A074163
001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 001 001 002 002 003 003 001 002 003 001 002 003
Dec Dec Dec Oct Oct Oct Feb Feb Feb Jun Jun Jun Dec Dec Dec Feb Feb Feb Dec Apr Dec Apr Dec Apr Dec Dec Dec Feb Feb Feb
21, 21, 21, 30, 30, 30, 28, 28, 28, 27, 27, 27, 21, 21, 21, 28, 28, 28, 21, 11, 21, 11, 21, 11, 21, 21, 21, 10, 10, 10,
1993 1993 1993 1992 1992 1992 1995 1995 1995 1996 1996 1996 1993 1993 1993 1994 1994 1994 1993 1996 1993 1996 1993 1996 1993 1993 1993 1995 1995 1995
A074936 A074936
001 002
NAPROXEN SODIUM
TABLET; ORAL NAPROXEN SODIUM ABLE HAMILTON PHARMS
EQ EQ EQ EQ
EQ 250MG EQ 500MG MYLAN EQ 250MG EQ 500MG PLIVA EQ 250MG EQ 500MG PUREPAC PHARM EQ 250MG EQ 500MG ROXANE EQ 250MG EQ 500MG SANDOZ EQ 250MG EQ 250MG EQ 500MG EQ 500MG TEVA EQ 250MG EQ 500MG TEVA PHARMS EQ 250MG EQ 500MG WATSON LABS EQ 250MG EQ 500MG TABLET, EXTENDED RELEASE; ORAL NAPROXEN SODIUM WATSON LABS FLORIDA EQ 375MG EQ 500MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A074230 A074230 A074367 A074367 A074242 A074242 A074319 A074319 A074257 A074257 A074162 A074495 A074162 A074495 A074142 A074142 A074289 A074289 A074195 A074195
001 002 001 002 001 002 001 002 001 002 001 001 002 002 001 002 001 002 001 002
Mar Mar Aug Aug Jun Jun Mar Mar Dec Dec Dec Dec Dec Dec Dec Dec Jan Jan Dec Dec
14, 14, 31, 31, 20, 20, 20, 20, 21, 21, 21, 05, 21, 05, 21, 21, 27, 27, 21, 21,
1995 1995 1994 1994 1996 1996 1995 1995 1993 1993 1993 1994 1993 1994 1993 1993 1994 1994 1993 1993
BASE BASE
A075416 A075416
002 001
NEDOCROMIL SODIUM
AEROSOL, METERED; INHALATION TILADE KING PHARMS 1.75MG/INH SOLUTION; INHALATION TILADE SANOFI AVENTIS US 0.5%
N019660
001
N020750
001
NEFAZODONE HYDROCHLORIDE
TABLET; ORAL NEFAZODONE HYDROCHLORIDE IVAX SUB TEVA PHARMS 50MG 100MG 150MG 200MG 250MG MYLAN 100MG 150MG 200MG 250MG ROXANE 50MG 100MG 150MG 200MG 250MG SANDOZ 50MG 50MG 100MG 100MG 150MG 150MG 200MG 200MG 250MG 250MG
A075763 A075763 A075763 A075763 A075763 A076129 A076129 A076129 A076129 A076196 A076196 A076196 A076196 A076196 A076072 A076302 A076072 A076302 A076072 A076302 A076072 A076302 A076072 A076302
001 002 003 004 005 002 003 004 005 001 002 003 004 005 001 001 002 002 003 003 004 004 005 005
Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16,
2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003 2003
A076073 A076073 A076073 A076073 N020152 N020152 N020152 N020152 N020152 N020152
002 003 004 005 001 002 003 004 005 006
Sep Sep Sep Sep Dec Dec Dec Dec Dec Dec
16, 16, 16, 16, 22, 22, 22, 22, 22, 22,
2003 2003 2003 2003 1994 1994 1994 1994 1994 1994
NEOMYCIN SULFATE
SOLUTION; ORAL MYCIFRADIN PHARMACIA AND UPJOHN TABLET; ORAL MYCIFRADIN PHARMACIA AND UPJOHN NEOBIOTIC PFIZER NEOMYCIN SULFATE BRISTOL MYERS SQUIBB LANNETT LILLY ROXANE SANDOZ
EQ 87.5MG BASE/5ML
N050285
001
N050176
002
N050344
002
A062339 N050456
001 001
EQ 3.5MG BASE/GM;0.25% EQ 3.5MG BASE/GM;0.5% SUSPENSION/DROPS; OPHTHALMIC NEO-DELTA-CORTEF PHARMACIA AND UPJOHN EQ 3.5MG BASE/ML;0.25%
A061039 A061039
002 001
A061037
001
N050378
001
A062598 A062600
001 001
A062595
001
NETILMICIN SULFATE
INJECTABLE; INJECTION NETROMYCIN SCHERING
NIACIN
CAPSULE; ORAL WAMPOCAP MEDPOINTE PHARM HLC TABLET; ORAL NIACIN EVERYLIFE HALSEY IMPAX LABS IVAX SUB TEVA PHARMS MK LABS PUREPAC PHARM SANDOZ TABLICAPS WATSON LABS
500MG
N011073
003
WEST WARD NICOLAR SANOFI AVENTIS US 500MG TABLET, EXTENDED RELEASE; ORAL NIACIN BARR 500MG 750MG 1GM NIASPAN ABBOTT 375MG NIASPAN TITRATION STARTER PACK ABBOTT 375MG;500MG;750MG
500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG
A083203 A083453 A083115 A083180 A083525 A083271 A083306 A084237 A083136 A083305 A085172 A083718 A083823
001 001 001 001 001 001 001 001 001 001 001 001 001
Apr 26, 2005 Apr 26, 2005 Apr 14, 2005 Jul 28, 1997 Jul 28, 1997
15MG/5ML;3.75MG/5ML;600MG/5ML
N008378
003
NICARDIPINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL CARDENE SR EKR THERAP 45MG
N020005
002
NICLOSAMIDE
TABLET, CHEWABLE; ORAL NICLOCIDE BAYER PHARMS
500MG
N018669
001
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL NICOTINE POLACRILEX WATSON LABS
A076568 A076569
001 002
NIFEDIPINE
CAPSULE; ORAL ADALAT BAYER PHARMS NIFEDIPINE CATALENT CHASE LABS NJ TEVA PROCARDIA PFIZER TABLET, EXTENDED RELEASE; NIFEDIPINE MARTEC USA LLC MYLAN
10MG 20MG 20MG 10MG 20MG 10MG 20MG ORAL 90MG 30MG
Nov 27, 1985 Sep 17, 1986 Apr Jul Jun Feb 30, 04, 19, 19, 1992 1990 1991 1992
A075414 A075108
003 001
NILUTAMIDE
TABLET; ORAL NILANDRON SANOFI AVENTIS US
50MG
N020169
001
NIMODIPINE
CAPSULE; ORAL NIMOTOP BAYER PHARMS
30MG
N018869
001
NISOLDIPINE
TABLET, EXTENDED RELEASE; ORAL SULAR SHIONOGI INC 10MG 20MG 30MG 40MG
NITROFURANTOIN
CAPSULE; ORAL NITROFURANTOIN WATSON LABS TABLET; ORAL FURADANTIN PROCTER AND GAMBLE FURALAN LANNETT NITROFURANTOIN ELKINS SINN
50MG 100MG
A084326 A084326
001 002
100MG 50MG 100MG 50MG 100MG 50MG 50MG 100MG 100MG 100MG
A080003 A080078 A080078 A080043 A080043 A080447 A085797 A080447 A085796 A084085
002 002 001 001 002 001 001 002 001 002
NITROFURANTOIN SODIUM
INJECTABLE; INJECTION IVADANTIN PROCTER AND GAMBLE
EQ 180MG BASE/VIAL
N012402
001
NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE; ORAL NITROFURANTOIN MYLAN SANDOZ
100MG 25MG 50MG 100MG NITROFURANTOIN MACROCRYSTALLINE WATSON LABS 50MG 100MG
NITROFURAZONE
CREAM; TOPICAL FURACIN SHIRE DRESSING; TOPICAL ACTIN-N SHERWOOD MEDCL OINTMENT; TOPICAL FURACIN SHIRE NITROFURAZONE AMBIX LANNETT PERRIGO NEW YORK TARO WENDT POWDER; TOPICAL FURACIN SHIRE SOLUTION; TOPICAL NITROFURAZONE PERRIGO NEW YORK WENDT
0.2%
A083789
001
0.2%
N017343
001
0.2%
A083791
001
0.2% 0.2%
A085130 A087081
001 001
NITROGLYCERIN
AEROSOL; SUBLINGUAL
NITROLINGUAL
POHL BOSKAMP 0.4MG/SPRAY FILM, EXTENDED RELEASE; TRANSDERMAL NITROGLYCERIN MYLAN TECHNOLOGIES 0.1MG/HR 0.2MG/HR 0.4MG/HR 0.6MG/HR
N018705
001
N018672 N018621 A071159 A070077 A071203 A070026 A071492 A070633 A070634 A074083 N018774 N018672 N018588 A070863 N018588 A070871 A070872 N018537 N018537
002 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 002 001
Aug 30, 1983 Jan 05, 1982 Feb 28, 1990 Dec May Sep May Jun Jun 13, 08, 10, 24, 19, 19, 1985 1987 1985 1988 1986 1986
NIZATIDINE
CAPSULE; ORAL NIZATIDINE IVAX SUB TEVA PHARMS
150MG 300MG
A075461 A075461
001 002
NONOXYNOL-9
AEROSOL; VAGINAL DELFEN PERSONAL PRODS
12.5%
N014349
002
NOREPINEPHRINE BITARTRATE
INJECTABLE; INJECTION NOREPINEPHRINE BITARTRATE METRICS PHARM EQ 1MG BASE/ML
A040522
001
N008592
003
NORETHINDRONE
TABLET; ORAL NORLUTIN PARKE DAVIS
5MG
N010895
002
5MG
N012184
002
NORFLOXACIN
SOLUTION/DROPS; OPHTHALMIC CHIBROXIN MERCK 0.3%
N019757
001
NORGESTREL
TABLET; ORAL OVRETTE WYETH PHARMS
0.075MG
N017031
001
NORTRIPTYLINE HYDROCHLORIDE
CAPSULE; ORAL AVENTYL HYDROCHLORIDE LILLY
EQ 10MG EQ 25MG NORTRIPTYLINE HYDROCHLORIDE SANDOZ EQ 10MG EQ 10MG EQ 25MG EQ 25MG EQ 50MG EQ 50MG EQ 75MG EQ 75MG TEVA EQ 10MG EQ 25MG EQ 50MG EQ 75MG SOLUTION; ORAL PAMELOR MALLINCKRODT INC EQ 10MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
N014684 N014684 A074054 A074835 A074054 A074835 A074054 A074835 A074054 A074835 A073667 A073667 A073667 A073667
001 002 001 001 002 002 003 003 004 004 001 002 003 004 Dec Jun Dec Jun Dec Jun Dec Jun Apr Apr Apr Apr 31, 30, 31, 30, 31, 30, 31, 30, 11, 11, 11, 11, 1992 1997 1992 1997 1992 1997 1992 1997 1996 1996 1996 1996
BASE/5ML
N018012
001
NYSTATIN
CREAM; TOPICAL CANDEX BAYER PHARMS MYCOSTATIN BRISTOL MYERS SQUIBB MYKINAC ALPHARMA US PHARMS NILSTAT LEDERLE NYSTATIN TARO TEVA LOTION; TOPICAL CANDEX BAYER PHARMS OINTMENT; TOPICAL MYCOSTATIN WESTWOOD SQUIBB MYKINAC ALPHARMA US PHARMS NILSTAT LEDERLE PASTILLE; ORAL MYCOSTATIN BRISTOL MYERS SQUIBB
100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM 100,000 UNITS/GM
001 001 001 001 001 001 Jul 28, 1983 Jul 29, 1982
100,000 UNITS/ML
N050233
001
200,000 UNITS
N050619
001
100,000 UNITS/GM
A060578
001
100,000 UNITS
N050478
001
100,000 UNITS/ML 100,000 100,000 100,000 100,000 100,000 100,000 100,000 UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML UNITS/ML
001 001 001 001 001 001 001 001 001 Oct Nov Jul Jan Dec Jun Dec 29, 19, 06, 16, 27, 18, 17, 1985 1987 1984 1985 1991 1987 1987
100,000 UNITS/ML
500,000 UNITS 500,000 UNITS 500,000 500,000 500,000 500,000 500,000 UNITS UNITS UNITS UNITS UNITS
001 001 001 001 001 001 001 Dec 22, 1983 Oct 29, 1984 Nov 26, 1985 Dec 16, 1982
100,000 UNITS 100,000 UNITS 100,000 UNITS 100,000 100,000 100,000 100,000 100,000 100,000 UNITS UNITS UNITS UNITS UNITS UNITS
001 001 001 001 001 001 001 001 001 Nov 09, 1983 Nov 09, 1983 Apr 03, 1984 Dec 23, 1983
100,000 UNITS/GM;0.1% 100,000 UNITS/GM;0.1% 100,000 UNITS/GM;0.1% 100,000 UNITS/GM;0.1% 100,000 UNITS/GM;0.1%
May 01, 1985 May 15, 1985 Sep 20, 1985 May 28, 1985 Oct 08, 1985
Jun 28, 1985 Nov 26, 1985 Mar 09, 1987 Oct 09, 1985 Oct 10, 1985 Jul 30, 1986 Oct 09, 1985
OFLOXACIN
INJECTABLE; INJECTION FLOXIN ORTHO MCNEIL PHARM
20MG/ML 40MG/ML
Mar 31, 1992 Mar 31, 1992 Mar 31, 1992 Mar 31, 1992 Mar 31, 1992 Jan 16, 2002
FLOXIN IN DEXTROSE 5% ORTHO MCNEIL PHARM 400MG/100ML FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER ORTHO MCNEIL PHARM 4MG/ML 400MG/100ML OFLOXACIN BEDFORD 40MG/ML TABLET; ORAL FLOXIN JANSSEN PHARMS 200MG 300MG 400MG OFLOXACIN LARKEN LABS 200MG 300MG 400MG
Dec 28, 1990 Dec 28, 1990 Dec 28, 1990 Sep 02, 2003 Sep 02, 2003 Sep 02, 2003
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION ONDANSETRON HYDROCHLORIDE HOSPIRA EQ 2MG BASE/ML ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER HOSPIRA EQ 0.64MG BASE/ML ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE HOSPIRA EQ 2MG BASE/ML ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER GLAXOSMITHKLINE EQ 0.64MG BASE/ML
Dec 26, 2006 Feb 26, 2007 Dec 26, 2006 Jan 31, 1995
ORPHENADRINE CITRATE
TABLET, EXTENDED RELEASE; ORAL NORFLEX MEDICIS 100MG ORPHENADRINE CITRATE ASCOT 100MG
N012157 A088067
A085046 A084303
001 001
ORPHENADRINE HYDROCHLORIDE
TABLET; ORAL DISIPAL 3M
50MG
N010653
001
OSELTAMIVIR PHOSPHATE
FOR SUSPENSION; ORAL TAMIFLU ROCHE
EQ 12MG BASE/ML
N021246
001
OXACILLIN SODIUM
CAPSULE; ORAL BACTOCILL GLAXOSMITHKLINE
EQ EQ EQ EQ EQ EQ EQ EQ
OXACILLIN SODIUM APOTHECON TEVA PROSTAPHLIN APOTHECON FOR SOLUTION; ORAL BACTOCILL GLAXOSMITHKLINE OXACILLIN SODIUM APOTHECON TEVA PROSTAPHLIN APOTHECON INJECTABLE; INJECTION BACTOCILL GLAXOSMITHKLINE
EQ 500MG BASE
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 10GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL 10GM BASE/VIAL 125MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
A061334 A061334 A062736 A061334 A062736 A061334 A061334 N050195 N050195 N050195 N050195 N050195 A062711 A062711 A062711 A062711 A062711 A062711 A062798 A062798 A062798 A062798
009 006 001 007 002 008 010 001 002 003 004 005 001 002 003 004 005 006 003 004 005 001
ELKINS SINN
IBI
Feb Feb Feb Feb Feb Feb Dec Dec Dec Dec
03, 03, 03, 03, 03, 03, 11, 11, 11, 11,
1989 1989 1989 1989 1989 1989 1995 1995 1995 1995
EQ EQ EQ EQ EQ EQ EQ EQ EQ
2GM BASE/VIAL 10GM BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 250MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 4GM BASE/VIAL
OXALIPLATIN
INJECTABLE; IV (INFUSION) ELOXATIN 50MG/VIAL SANOFI AVENTIS US 100MG/VIAL
N021492 N021492
001 002
OXAMNIQUINE
CAPSULE; ORAL VANSIL PFIZER
250MG
N018069
001
OXANDROLONE
TABLET; ORAL OXANDROLONE ROXANE
2.5MG 10MG
A077249 A077249
001 002
OXAPROZIN
TABLET; ORAL OXAPROZIN ACTAVIS ELIZABETH MYLAN SANDOZ
OXAPROZIN POTASSIUM
TABLET; ORAL DAYPRO ALTA GD SEARLE
600MG
N020776
001
OXAZEPAM
CAPSULE; ORAL OXAZEPAM AM THERAP
MUTUAL PHARM
MYLAN
10MG 15MG 30MG 10MG 15MG 30MG 10MG 15MG 30MG 10MG 15MG 30MG 10MG 15MG 30MG
A071955 A071956 A071957 A071026 A071026 A071026 A071713 A071714 A071715 N015539 N015539 N015539 A070650 A070640 A070641
001 001 001 002 003 001 001 001 001 002 004 006 001 001 001
OXPRENOLOL HYDROCHLORIDE
CAPSULE; ORAL TRASICOR NOVARTIS
OXTRIPHYLLINE
SOLUTION; ORAL CHOLEDYL PARKE DAVIS 100MG/5ML OXTRIPHYLLINE MORTON GROVE 100MG/5ML SYRUP; ORAL CHOLEDYL PARKE DAVIS 50MG/5ML OXTRIPHYLLINE PEDIATRIC MORTON GROVE 50MG/5ML TABLET, DELAYED RELEASE; ORAL CHOLEDYL PARKE DAVIS 100MG 200MG OXTRIPHYLLINE WATSON LABS 100MG 200MG
N009268 A088243
012 001
N009268 A088242
003 007 001 001 Aug 25, 1983 Aug 25, 1983
OXYBUTYNIN CHLORIDE
SYRUP; ORAL DITROPAN ORTHO MCNEIL JANSSEN TABLET; ORAL OXYBUTYNIN CHLORIDE QUANTUM PHARMICS USL PHARMA WATSON LABS
5MG/5ML
N018211
001
OXYCODONE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL OXYCONTIN PURDUE PHARMA LP 10MG 15MG 20MG 30MG 40MG 60MG 80MG 160MG ROXICODONE ROXANE 10MG 30MG
N020553 N020553 N020553 N020553 N020553 N020553 N020553 N020553 N020932 N020932
001 006 002 007 003 008 004 005 001 002
1.5MG/ML
N011707
001
N011738
004
N021610 N021610
005 006
OXYPHENBUTAZONE
TABLET; ORAL OXYPHENBUTAZONE WATSON LABS TANDEARIL NOVARTIS
100MG 100MG
A088399 N012542
001 004
OXYPHENCYCLIMINE HYDROCHLORIDE
TABLET; ORAL DARICON PFIZER
10MG
N011612
001
OXYPHENONIUM BROMIDE
TABLET; ORAL ANTRENYL NOVARTIS
5MG
N008492
002
OXYTETRACYCLINE
TABLET; ORAL TERRAMYCIN PFIZER
250MG
N050287
001
OXYTETRACYCLINE CALCIUM
SYRUP; ORAL TERRAMYCIN PFIZER
EQ 125MG BASE/5ML
A060595
001
OXYTETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL OXY-KESSO-TETRA FERRANTE EQ 250MG OXYTETRACYCLINE HYDROCHLORIDE IMPAX LABS EQ 250MG PROTER EQ 250MG PUREPAC PHARM EQ 250MG WEST WARD EQ 250MG TERRAMYCIN PFIZER EQ 125MG EQ 250MG INJECTABLE; INJECTION TERRAMYCIN PFIZER EQ 250MG EQ 500MG
BASE/VIAL BASE/VIAL
A060586 A060586
001 002
A061841
001
A061009
001
Mar 29, 1985 Mar 29, 1985 Mar 29, 1985 Mar 29, 1985
N012285
001
PACLITAXEL
INJECTABLE; INJECTION PACLITAXEL HOSPIRA PLIVA LACHEMA TEVA PARENTERAL TAXOL BRISTOL MYERS SQUIBB
Aug 01, 2002 Mar 12, 2008 Jan 25, 2002 Dec 29, 1992
PALIPERIDONE
TABLET, EXTENDED RELEASE; ORAL INVEGA JANSSEN PHARMS 12MG
N021999
004
PALONOSETRON HYDROCHLORIDE
CAPSULE; ORAL ALOXI HELSINN HLTHCARE
EQ 0.5MG BASE
N022233
001
PAMIDRONATE DISODIUM
INJECTABLE; INJECTION AREDIA NOVARTIS PAMIDRONATE DISODIUM AESGEN
May 06, 1993 May 06, 1993 May 06, 2002 May 06, 2002
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
CAPSULE; ORAL COTAZYM ORGANON USA INC
N020580
001
PANCURONIUM BROMIDE
INJECTABLE; INJECTION
PANCURONIUM BROMIDE
ASTRAZENECA
ELKINS SINN
1MG/ML 2MG/ML 2MG/ML 2MG/ML 1MG/ML 2MG/ML 2MG/ML 2MG/ML 1MG/ML 2MG/ML
A072210 A072211 A072212 A072213 A072058 A072059 A072060 A072321 N017015 N017015
001 001 001 001 001 001 001 001 002 001
150MG 300MG
N006800 N006800
003 001
300MG/ML
N006800
002
PARAMETHASONE ACETATE
TABLET; ORAL HALDRONE LILLY
1MG 2MG
N012772 N012772
005 006
PARGYLINE HYDROCHLORIDE
TABLET; ORAL EUTONYL ABBOTT
PAROMOMYCIN SULFATE
CAPSULE; ORAL HUMATIN KING PFIZER PARKEDALE SYRUP; ORAL HUMATIN PARKE DAVIS
A062310 A060521
001 001
EQ 125MG BASE/5ML
A060522
001
PAROXETINE HYDROCHLORIDE
CAPSULE; ORAL PAXIL GLAXOSMITHKLINE
EQ EQ EQ EQ
TABLET; ORAL PAROXETINE HYDROCHLORIDE ACTAVIS ELIZABETH EQ EQ EQ EQ ROXANE EQ EQ EQ EQ SANDOZ EQ EQ EQ EQ EQ TEVA PHARMS EQ EQ EQ PAXIL GLAXOSMITHKLINE EQ
10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG 10MG 20MG 30MG 40MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A076968 A076968 A076968 A076968 A078026 A078026 A078026 A078026 A075566 A075566 A075566 A075566 A077082 A077082 A077082 A077082 N020031
001 002 003 004 001 002 003 004 001 002 003 004 001 002 003 004 004
Jun Jun Jun Jun Jun Jun Jun Jun Mar Mar Mar Mar Jun Jun Jun Jun
21, 21, 21, 21, 29, 29, 29, 29, 08, 08, 08, 08, 29, 29, 29, 29,
2010 2010 2010 2010 2007 2007 2007 2007 2004 2004 2004 2004 2007 2007 2007 2007
50MG BASE
PEMOLINE
TABLET; ORAL CYLERT ABBOTT
18.75MG
N016832
001
37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG 18.75MG 37.5MG 75MG
N016832 N016832 A075595 A075595 A075595 A075726 A075726 A075726 A075286 A075286 A075286 A075030 A075030 A075030 A075328 A075328 A075328 A075287 A075287 A075287
002 003 001 002 003 003 002 001 001 002 003 003 001 002 001 002 003 001 002 003 Feb Feb Feb Mar Mar Mar Dec Jun Jun Feb Jan Jan Apr Apr Apr Jun Sep Sep 28, 28, 28, 30, 30, 30, 27, 30, 30, 22, 29, 29, 19, 19, 19, 13, 18, 18, 2000 2000 2000 2001 2001 2001 1999 1999 1999 2000 1999 1999 2000 2000 2000 2001 2000 2000
MALLINCKRODT
SANDOZ
TEVA PHARMS
VINTAGE PHARMS
WATSON LABS
TABLET, CHEWABLE; ORAL CYLERT ABBOTT PEMOLINE ACTAVIS TOTOWA TEVA PHARMS
PENBUTOLOL SULFATE
TABLET; ORAL LEVATOL SCHWARZ PHARMA
10MG
N018976
001
PENICILLAMINE
CAPSULE; ORAL CUPRIMINE ATON
125MG
N019853
002
PENICILLIN G BENZATHINE
INJECTABLE; INJECTION BICILLIN L-A WYETH AYERST SUSPENSION; ORAL BICILLIN WYETH AYERST TABLET; ORAL BICILLIN WYETH AYERST
300,000 UNITS/ML
N050131
001
300,000 UNITS/5ML
N050126
002
200,000 UNITS
N050128
001
PENICILLIN G POTASSIUM
FOR SOLUTION; ORAL PENICILLIN TEVA PENICILLIN G POTASSIUM MYLAN
200,000 UNITS/5ML 400,000 UNITS/5ML 200,000 250,000 400,000 250,000 400,000 UNITS/5ML UNITS/5ML UNITS/5ML UNITS/5ML UNITS/5ML
PUREPAC PHARM
CONSOLIDATED PHARM
LILLY
1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 10,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 500,000 UNITS/VIAL 1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 10,000,000 UNITS/VIAL 200,000 UNITS/VIAL 500,000 UNITS/VIAL 1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 10,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL 5,000,000 UNITS/VIAL 20,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL 1,000,000 UNITS/VIAL
A060362 A060362 A060362 A060362 A060806 A060806 A060806 A060806 A060384 A060384 A060384 A060384 A060384 A060601 A062991 A062991 A062991 A062991 A062003 A062003 A060074 A065079 A060657
001 003 004 002 001 002 003 004 004 003 002 001 005 001 001 002 003 004 001 002 003 001 001
PUREPAC PHARM
TEVA
WYETH AYERST
250,000 400,000 250,000 200,000 250,000 400,000 500,000 800,000 200,000 250,000 400,000 200,000 250,000 400,000 500,000 200,000 250,000 400,000
UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS
A060392 A060073 A060403 A060781 A060781 A060781 A060781 A060781 A061588 A061588 A061588 A060306 A060306 A060306 A060306 A060413 A060413 A060413 A062155 A062155 A060392 A062155
003 004 001 001 002 003 005 004 001 002 003 001 002 003 004 001 002 003 001 002 004 003
PENTIDS '200'
APOTHECON
PENTIDS '250'
APOTHECON
PENTIDS '400'
APOTHECON
800,000 UNITS 800,000 UNITS 50,000 UNITS 100,000 UNITS 200,000 UNITS 250,000 UNITS 400,000 UNITS 800,000 UNITS
PENICILLIN G PROCAINE
INJECTABLE; INJECTION DURACILLIN A.S. LILLY PENICILLIN G PROCAINE CONSOLIDATED PHARM PARKE DAVIS PFIZER PFIZERPEN-AS PFIZER
300,000 UNITS/ML 300,000 UNITS/ML 600,000 UNITS/1.2ML 300,000 UNITS/ML 300,000 UNITS/VIAL 1,500,000 UNITS/VIAL 300,000 UNITS/ML 600,000 UNITS/ML
PENICILLIN G SODIUM
INJECTABLE; IM-IV PENICILLIN G SODIUM MARSAM PHARMS LLC INJECTABLE; INJECTION PENICILLIN G SODIUM BRISTOL MYERS SQUIBB COPANOS PHARMACIA AND UPJOHN
5,000,000 UNITS/VIAL
A063014
001
PENICILLIN V
FOR SUSPENSION; ORAL V-CILLIN LILLY
125MG/0.6ML
A060002
001
PENICILLIN V POTASSIUM
FOR SOLUTION; ORAL BEEPEN-VK GLAXOSMITHKLINE BETAPEN-VK APOTHECON LEDERCILLIN VK LEDERLE PENAPAR-VK PARKE DAVIS PENICILLIN V POTASSIUM AM ANTIBIOTICS MYLAN PUREPAC PHARM
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ EQ EQ EQ EQ EQ 125MG 250MG 125MG 250MG 125MG 250MG BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML BASE/5ML
A062270 A062270 A061149 A061149 A060136 A060136 A062002 A062002 A061529 A061529 A061624 A061624 A061758 A061758
001 002 001 002 001 002 001 002 001 002 002 001 001 002
EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 125MG BASE/5ML EQ 125MG BASE/5ML EQ 250MG BASE/5ML EQ 250MG BASE/5ML
A060007 A060007 A061815 A061815 A060004 A060004 A061410 A061410 A061206 A062153 A061206 A062153
001 002 001 002 001 002 001 002 001 001 002 002
EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 250MG 500MG 125MG 250MG 500MG 250MG 500MG 125MG 250MG 500MG BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A062273 A062273 A061150 A061150 A060134 A060134 A062001 A062001 A061528 A061528 A060518 A060518 A060518 A061530 A061530 A061571 A061571 A061571 A060006 A060006 A060006 A061836 A061836 A061651 A061651 A060003 A060003 A060003 A061411 A061411 A061164
001 002 001 002 001 002 001 002 001 002 001 002 003 001 002 001 002 003 001 002 003 001 002 001 002 001 002 003 001 002 001
EQ 125MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 125MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE EQ 500MG BASE EQ 250MG BASE
PENTAGASTRIN
INJECTABLE; INJECTION PEPTAVLON WYETH AYERST
0.25MG/ML
N017048
001
PENTAMIDINE ISETHIONATE
FOR SOLUTION; INHALATION NEBUPENT APP PHARMS INJECTABLE; INJECTION PENTACARINAT ARMOUR PHARM PENTAMIDINE ISETHIONATE BAXTER HLTHCARE HOSPIRA
600MG/VIAL
N019887
002
PENTAZOCINE HYDROCHLORIDE
TABLET; ORAL TALWIN 50 SANOFI AVENTIS US
EQ 50MG BASE
N016732
001
N021749
001
2mCi/ML
N017518
001
N021751
001
PENTOBARBITAL
ELIXIR; ORAL NEMBUTAL OVATION PHARMS
18.2MG/5ML
A083244
001
PENTOBARBITAL SODIUM
CAPSULE; ORAL NEMBUTAL SODIUM OVATION PHARMS
PENTOBARBITAL SODIUM LANNETT VITARINE WHITEWORTH TOWN PLSN SODIUM PENTOBARBITAL ANABOLIC ELKINS SINN
100MG 100MG 50MG 100MG 100MG 100MG 100MG 100MG 100MG 100MG
A083259 A084677 A083461 A083461 A084156 A084560 A083301 A083264 A085791 A083239
001 001 001 002 001 001 001 001 001 001
50MG/ML 50MG/ML
A083270 A083261
001 001
TABLET; ORAL PENTOBARBITAL SODIUM VITARINE SODIUM PENTOBARBITAL NEXGEN PHARMA INC
100MG 100MG
A083285 A084238
001 001
PENTOLINIUM TARTRATE
INJECTABLE; INJECTION ANSOLYSEN WYETH AYERST
10MG/ML
N009372
001
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE; PENTOXIFYLLINE ACTAVIS ELIZABETH HERITAGE PHARMS INC TEVA ORAL 400MG 400MG 400MG A074878 A074877 A075199 001 001 001 Jul 09, 1997 Jul 08, 1997 Sep 03, 1999
PERFLUBRON
LIQUID; ORAL IMAGENT ALLIANCE PHARM
100%
N020091
001
N021084
001
PERGOLIDE MESYLATE
TABLET; ORAL PERGOLIDE MESYLATE IVAX SUB TEVA PHARMS
PAR PHARM
EQ EQ EQ EQ EQ EQ
0.05MG BASE 0.25MG BASE 1MG BASE 0.05MG BASE 0.25MG BASE 1MG BASE
EQ 0.05MG BASE
N019385 N019385
002 003
PERMETHRIN
LOTION; TOPICAL NIX GLAXOSMITHKLINE
1%
N019435
001
PERPHENAZINE
CONCENTRATE; ORAL PERPHENAZINE PHARM ASSOC TRILAFON SCHERING INJECTABLE; INJECTION TRILAFON SCHERING SYRUP; ORAL TRILAFON SCHERING TABLET; ORAL PERPHENAZINE IVAX PHARMS
16MG/5ML 16MG/5ML
A040360 N011557
001 001
5MG/ML
N011213
002
2MG/5ML
N011294
002
2MG 4MG 8MG 16MG TABLET, EXTENDED RELEASE; ORAL TRILAFON SCHERING 8MG
TRILAFON SCHERING
N011361
002
PHENACEMIDE
TABLET; ORAL PHENURONE ABBOTT
500MG
N007707
001
100MG;500MG
N013294
001
001
50MG;500MG
N019358
001
PHENDIMETRAZINE TARTRATE
CAPSULE; ORAL PHENAZINE MAST MM
35MG 35MG
A086523 A086524
001 001
A086525 A085633 A085694 A085695 A085702 A085634 A085645 A085670 A086403 A086408 A086410 A087424 A085897 A085507 A087394
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Sep 22, 1982
A087487 A087214 A088020 A088028 A088062 A088063 A088111 A087378 A088024 A087371
001 001 001 001 001 001 001 001 001 001
Oct 13, 1982 May Aug Aug Sep Sep Oct 26, 16, 16, 13, 10, 18, 1982 1982 1982 1982 1982 1982
A083655 A085034 A085511 A085756 A083922 A085318 A085320 A085321 A085698 A083790 A083754 A087305 A085512 A083644 A083684 A083686 A083687
001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001
PHENDIMETRAZINE TARTRATE
TABLET; ORAL PHENDIMETRAZINE TARTRATE BARR 35MG 35MG 35MG FERNDALE LABS 35MG INWOOD LABS 35MG 35MG 35MG 35MG IVAX PHARMS 35MG 35MG IVAX SUB TEVA PHARMS 35MG KV PHARM 35MG 35MG 35MG MFG CHEMISTS 35MG NEXGEN PHARMA INC 35MG NUMARK 35MG PVT FORM 35MG 35MG SANDOZ 35MG 35MG 35MG 35MG 35MG SOLVAY 35MG TG UNITED LABS 35MG 35MG USL PHARMA 35MG 35MG 35MG VITARINE 35MG 35MG 35MG WATSON LABS 35MG 35MG 35MG 35MG PLEGINE
WYETH AYERST
35MG STATOBEX
TEVA
35MG STATOBEX-G
TEVA
35MG X-TROZINE
SHIRE RICHWOOD 35MG 35MG 35MG 35MG 35MG
A084831 A084834 A084835 A086834 A084740 A084741 A084742 A084743 A085611 A085612 A083682 A084138 A084141 A085525 A085914 A086020 A083790 A085199 A085697 A085402 A085497 A085830 A086365 A086370 A083993 A085761 A085941 A083805 A084398 A084399 A085519 A086005 A086106 A085767 A085768 A085770 A085773 N012248 A086013 A085095 A086550 A086551 A086552 A086553 A086554
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
PHENINDIONE
TABLET; ORAL HEDULIN SANOFI AVENTIS US
50MG
N008767
002
PHENMETRAZINE HYDROCHLORIDE
TABLET; ORAL PRELUDIN BOEHRINGER INGELHEIM
25MG
N010460
005
N011752 N011752
004 003
PHENPROCOUMON
TABLET; ORAL LIQUAMAR ORGANON USA INC
3MG
N011228
001
PHENSUXIMIDE
CAPSULE; ORAL MILONTIN PARKE DAVIS
500MG
N008855
004
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL FASTIN GLAXOSMITHKLINE OBESTIN-30 FERNDALE LABS OBY-TRIM SHIRE RICHWOOD ONA-MAST MAST MM
N017352 A087144 A087764 A086511 A086516 A085411 A040497 A040403 A040427 A040460 A040227 A040448 A040228 A086735 A087226 A088948 A086329 A040527 A087208 A087223 A088414 A086911 A087126 A087777 A088612 A088613 A088614 A040083 A088576 A085417 A086732 A087215 A087915 A087918 A087930 A088610 A088611 A088625 A084487 A088430
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 Mar 18, 1982
30MG 30MG PHENTERMINE HYDROCHLORIDE ABC HOLDING 30MG ABLE 15MG 30MG 30MG ACTAVIS TOTOWA 15MG 30MG 30MG 37.5MG CAMALL 15MG 30MG DURAMED PHARMS BARR 30MG IVAX PHARMS 30MG MUTUAL PHARM 37.5MG SANDOZ 30MG 30MG 37.5MG TEVA 30MG 30MG 30MG 30MG 30MG 30MG TG UNITED INC 30MG TG UNITED LABS 18.75MG 30MG 30MG 30MG 37.5MG 37.5MG 37.5MG 37.5MG 37.5MG 37.5MG USL PHARMA 30MG 30MG
A086260 A040402 A040190 A085553 A085671 A085689 A083923 A085319 A087805 A088596 A083804 A088910 A088917 A086453 A086456 A085739 A084035 N012737
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Aug 30, 2001 May 30, 1997
Dec 06, 1982 Apr 04, 1984 Jul 17, 1985 Jul 17, 1985
PHENYL AMINOSALICYLATE
POWDER; ORAL PHENY-PAS-TEBAMIN PHARM RES ASSOC TABLET; ORAL PHENY-PAS-TEBAMIN PHARM RES ASSOC
50%
N011695
002
500MG
N011695
003
PHENYLBUTAZONE
CAPSULE; ORAL AZOLID SANOFI AVENTIS US BUTAZOLIDIN NOVARTIS PHENYLBUTAZONE IVAX PHARMS MUTUAL PHARM SANDOZ WATSON LABS TABLET; ORAL AZOLID SANOFI AVENTIS US BUTAZOLIDIN NOVARTIS
001 009 001 001 001 001 Jun Dec Jun Dec 24, 04, 16, 17, 1983 1985 1982 1982
100MG 100MG
A087091 N008319
001 008
Apr 02, 1984 Mar 02, 1987 Nov 22, 1985 Jan 04, 1985
N007953
001
PHENYTOIN
SUSPENSION; ORAL DILANTIN-30 PARKE DAVIS PHENYTOIN ACTAVIS MID ATLANTIC
30MG/5ML 125MG/5ML
N008762 A089892
PHENYTOIN SODIUM
CAPSULE; ORAL DIPHENYLAN SODIUM LANNETT
30MG PROMPT 100MG PROMPT EXTENDED PHENYTOIN SODIUM BARR 100MG EXTENDED PLIVA 100MG EXTENDED PHENYTEX WATSON LABS 100MG EXTENDED PHENYTOIN SODIUM PHARMERAL 100MG PROMPT WATSON LABS 100MG PROMPT PROMPT PHENYTOIN SODIUM IVAX SUB TEVA PHARMS 100MG PROMPT WATSON LABS 100MG PROMPT INJECTABLE; INJECTION DILANTIN PARKE DAVIS 50MG/ML PHENYTOIN SODIUM APP PHARMS 50MG/ML MARSAM PHARMS LLC 50MG/ML 50MG/ML SMITH AND NEPHEW 50MG/ML 50MG/ML SOLOPAK 50MG/ML WARNER CHILCOTT 50MG/ML WATSON LABS 50MG/ML
001 002 001 001 001 001 001 001 001 Jun 20, 2003 Dec 18, 1986 Dec 21, 1984
001 001 001 001 001 001 001 001 001 May Oct Nov Dec Dec Dec Mar 31, 13, 27, 19, 18, 17, 30, 1985 1987 1992 1984 1984 1984 1990
PHYTONADIONE
INJECTABLE; INJECTION AQUAMEPHYTON BIOVAIL TECHNOLOGIES
1MG/0.5ML
N012223
002
PILOCARPINE
INSERT, EXTENDED RELEASE; OPHTHALMIC OCUSERT PILO-20 AKORN 5MG OCUSERT PILO-40 AKORN 11MG
N017431 N017548
001 001
PINACIDIL
CAPSULE, EXTENDED RELEASE; ORAL PINDAC LEO PHARM 12.5MG 25MG
N019456 N019456
001 002
PINDOLOL
TABLET; ORAL PINDOLOL GENPHARM IVAX SUB TEVA PHARMS MUTUAL PHARM NOSTRUM LABS PUREPAC PHARM SANDOZ TEVA
5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 10MG 5MG 5MG 10MG 10MG 5MG 10MG
A074013 A074018 A073687 A073687 A074063 A074063 A074474 A074474 A074125 A074125 A073608 A073609 A073661 A074123 A073661 A074123 N018285 N018285
001 001 001 002 001 002 001 002 001 002 001 001 001 001 002 002 001 002
Sep Sep Feb Feb Jan Jan Oct Oct Apr Apr Mar Mar Oct Apr Oct Apr
24, 24, 26, 26, 27, 27, 28, 28, 28, 28, 29, 29, 31, 17, 31, 17,
1992 1992 1993 1993 1994 1994 1996 1996 1993 1993 1993 1993 1993 1997 1993 1997
VISKEN NOVARTIS
PIPECURONIUM BROMIDE
INJECTABLE; INJECTION ARDUAN ORGANON USA INC
10MG/VIAL
N019638
001
PIPERACETAZINE
TABLET; ORAL QUIDE DOW PHARM
10MG 25MG
N013615 N013615
001 002
EQ EQ EQ EQ EQ EQ EQ
2GM BASE/VIAL 2GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 4GM BASE/VIAL 4GM BASE/VIAL 40GM BASE/VIAL
Oct 13, 1987 Oct 13, 1987 Oct 13, 1987 Sep 30, 1985
PIPERAZINE CITRATE
SYRUP; ORAL ANTEPAR GLAXOSMITHKLINE BRYREL SANOFI AVENTIS US MULTIFUGE BLULINE PIPERAZINE CITRATE ALPHARMA US PHARMS LANNETT LUITPOLD VERMIDOL SOLVAY TABLET; ORAL ANTEPAR GLAXOSMITHKLINE PIPERAZINE CITRATE IMPAX LABS
EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML EQ 500MG BASE/5ML
N009102 A080874
003 001
PIPOBROMAN
TABLET; ORAL VERCYTE ABBOTT
10MG 25MG
N016245 N016245
001 002
PIRBUTEROL ACETATE
AEROSOL, METERED; INHALATION MAXAIR EQ 0.2MG BASE/INH MEDICIS
N019009
001
PIROXICAM
CAPSULE; ORAL
PIROXICAM
EGIS
IVAX SUB TEVA PHARMS MUTUAL PHARM MYLAN ROXANE SCS TEVA TEVA PHARMS
10MG 20MG 10MG 20MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG 10MG 20MG
A074808 A074808 A074148 A074148 A073536 A074043 A074043 A073651 A073651 A074036 A074036 A073637 A073638 A074103 A074103
001 002 001 002 001 001 002 001 002 001 002 001 001 001 002
Jul Jul Jun Jun Mar Sep Sep Feb Feb May May Jan Jan Aug Aug
08, 08, 03, 03, 12, 22, 22, 26, 26, 29, 29, 28, 28, 28, 28,
1997 1997 1996 1996 1993 1992 1992 1993 1993 1992 1992 1994 1994 1992 1992
2.5MG/VIAL
N050109
001
POLYESTRADIOL PHOSPHATE
INJECTABLE; INJECTION
ESTRADURIN
WYETH AYERST
40MG/AMP
N010753
001
A077445
001
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE
SOLUTION; ORAL OCL HOSPIRA
001
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS
FOR SOLUTION; ORAL COLYTE MEDA PHARMS
FOR SUSPENSION; ORAL CO-LAV BOCA PHARMA COLOVAGE DYNAPHARM E-Z-EM PREP LYTE E Z EM GLYCOPREP GOLDLINE GO-EVAC BOCA PHARMA PEG-LYTE SANDOZ
240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/ A073428 BOT;22.72GM/BOT 227.1GM/PACKET;2.82GM/PACKET;6.36GM/PAC A071320 KET;5.53GM/PACKET;21.5GM/PACKET 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A071278 BOT;22.74GM/BOT 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A072319 BOT;22.74GM/BOT 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A073433 BOT;22.74GM/BOT 236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/ A073098 BOT;22.74GM/BOT
001
001
001
001
001
001
POLYMYXIN B SULFATE
INJECTABLE; INJECTION AEROSPORIN GLAXOSMITHKLINE EQ 500,000 U BASE/VIAL POWDER; FOR RX COMPOUNDING POLYMYXIN B SULFATE PADDOCK LLC 100,000,000 UNITS/BOT
A062036
001
A062455
001
POLYTHIAZIDE
TABLET; ORAL
RENESE
PFIZER
001
002
003
POLYTHIAZIDE; RESERPINE
TABLET; ORAL RENESE-R PFIZER
2MG;0.25MG
N013636
001
POTASSIUM AMINOSALICYLATE
CAPSULE; ORAL PASKALIUM GLENWOOD 500MG POWDER; ORAL POTASSIUM AMINOSALICYLATE HEXCEL 100% TABLET; ORAL PASKALIUM GLENWOOD 1GM
N009395
004
A080098
001
N009395
003
POTASSIUM CHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL K-LEASE SAVAGE LABS 8MEQ 10MEQ POTASSIUM CHLORIDE NESHER PHARMS 10MEQ TEVA 8MEQ 10MEQ FOR SUSPENSION, EXTENDED RELEASE; ORAL MICRO-K LS KV PHARM 20MEQ/PACKET INJECTABLE; INJECTION POTASSIUM CHLORIDE ABRAXIS PHARM 2MEQ/ML 2MEQ/ML 2MEQ/ML 2MEQ/ML 2MEQ/ML 2MEQ/ML AKORN 2MEQ/ML APP PHARMS 2MEQ/ML BAXTER HLTHCARE 2MEQ/ML GD SEARLE LLC 1MEQ/ML 2MEQ/ML 2MEQ/ML 3MEQ/ML 3MEQ/ML 4MEQ/ML HOSPIRA 1MEQ/ML 1MEQ/ML 1.5MEQ/ML 2MEQ/ML 2.4MEQ/ML 3.2MEQ/ML LILLY 2MEQ/ML LUITPOLD 2MEQ/ML 2MEQ/ML 2MEQ/ML 2MEQ/ML MILES 1MEQ/ML
Jan 28, 1992 Mar 28, 1990 Feb 17, 1987 Apr 26, 1996 Apr 26, 1996
N019561
003
A080204 A084290 A086713 A086714 A087787 A087885 A088286 A087817 A080203 A086219 A086219 A086220 A086219 A086220 A086219 A080205 A083345 A083345 A083345 A080205 A080205 N007865 A080221 A080736 A087584 A087585 A080195
001 001 001 001 001 001 001 001 001 001 002 002 003 001 004 003 003 001 002 004 005 002 001 001 001 001 002
2MEQ/ML 3MEQ/ML 4MEQ/ML PHARMA SERVE NY 2MEQ/ML 2MEQ/ML WATSON LABS 2MEQ/ML 2MEQ/ML 2MEQ/ML 3MEQ/ML TABLET, EXTENDED RELEASE; ORAL K+8 FUTURE PAK 8MEQ KAON CL SAVAGE LABS 6.7MEQ POTASSIUM CHLORIDE COPLEY PHARM 8MEQ SLOW-K NOVARTIS 8MEQ TEN-K NOVARTIS 10MEQ
001 002 003 005 006 001 004 002 003 004
Sep 29, 1989 Sep 29, 1989 Sep 29, 1989 Sep 29, 1989 Sep 29, 1989 Nov 09, 1982
370MG/VIAL;1.75GM/VIAL;36GM/VIAL
N013025
001
POTASSIUM CITRATE
FOR SOLUTION; ORAL POTASSIUM CITRATE UNIV TX SW MEDCTR
10MEQ/PACKET 20MEQ/PACKET
N019647 N019647
002 001
POTASSIUM IODIDE
SOLUTION; ORAL POTASSIUM IODIDE ROXANE
1GM/ML
N018551
001
130MG
N018307
001
POTASSIUM PERCHLORATE
CAPSULE; ORAL PERCHLORACAP MALLINCKRODT
200MG
N017551
001
POVIDONE-IODINE
SOLUTION; TOPICAL E-Z PREP CLINIPAD SPONGE; TOPICAL E-Z PREP CLINIPAD E-Z PREP 220 CLINIPAD
10%
N019382
001
5% 5%
N019382 N019382
002 003
PRALIDOXIME CHLORIDE
INJECTABLE; INJECTION PRALIDOXIME CHLORIDE BAXTER HLTHCARE CORP TABLET; ORAL PROTOPAM CHLORIDE WYETH AYERST
300MG/ML
N018799
001
500MG
N014122
002
PRAMIPEXOLE DIHYDROCHLORIDE
TABLET; ORAL MIRAPEX BOEHRINGER INGELHEIM
1.25MG
N020667
004
PRAZEPAM
CAPSULE; ORAL CENTRAX PARKE DAVIS
10MG
N017415
001
PRAZOSIN HYDROCHLORIDE
CAPSULE; ORAL PRAZOSIN HYDROCHLORIDE AM THERAP
CLONMEL HLTHCARE
PUREPAC PHARM
SANDOZ
WATSON LABS
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
1MG 2MG 5MG 1MG 2MG 5MG 1MG 2MG 5MG 1MG 2MG 5MG 1MG 2MG
BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A072782 A072783 A072784 A072705 A072706 A072707 A072991 A072921 A072992 A072576 A072577 A072578 A072352 A072333
001 001 001 001 001 001 001 001 001 001 001 001 001 001
May May May May May May May May May May May May May May
16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16, 16,
1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989 1989
A072609
001
N019775 N019775
001 002
PREDNISOLONE
CREAM; TOPICAL METI-DERM SCHERING SYRUP; ORAL PREDNISOLONE IVAX SUB TEVA PHARMS TEVA PHARMS WE PHARMS PRELONE MURO TABLET; ORAL CORTALONE HALSEY
0.5%
N010209
002
May 28, 1999 Jan 19, 2000 May 28, 1998 Jan 17, 1989
1MG 2.5MG 5MG 5MG 5MG 5MG 5MG 5MG 1MG 2.5MG 5MG 2.5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 1MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 1MG 2.5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG 5MG
A080304 A080304 A080304 N009987 A083941 A084426 A083675 A080625 A084439 A084439 A084439 A080562 A080562 A080326 A080780 A080748 A080378 A080531 A080307 A080351 A080351 A084542 A080322 A080325 A080211 A080327 A080339 A084773 A080358 A080358 A080358 A088892 A085170 A080398 A087987 A080236 A080534 A085085 A085415
003 002 001 004 001 002 001 001 001 002 003 001 002 001 001 001 001 002 001 001 002 001 001 001 001 002 001 001 001 002 003 001 001 001 001 001 001 002 001
DELTA-CORTEF PHARMACIA AND UPJOHN FERNISOLONE-P FERNDALE LABS PREDNISOLONE BARR BUNDY ELKINS SINN EVERYLIFE
FERRANTE HEATHER IMPAX LABS INWOOD LABS IVAX SUB TEVA PHARMS LANNETT MARSHALL PHARMA PANRAY PERRIGO PHOENIX LABS NY PUREPAC PHARM PVT FORM ROXANE SANDOZ SPERTI
SUPERPHARM TABLICAPS TEVA UDL VALEANT PHARM INTL VITARINE WATSON LABS
PREDNISOLONE ACETATE
INJECTABLE; INJECTION METICORTELONE SCHERING PREDNISOLONE ACETATE AKORN BEL MAR CENT PHARMS WATSON LABS
25MG/ML 25MG/ML 50MG/ML 25MG/ML 50MG/ML 25MG/ML 50MG/ML 25MG/ML 25MG/ML 40MG/ML 50MG/ML 50MG/ML
N010255 A083032 A084492 A083738 A083738 A084717 A084717 A083398 A083654 A083767 A083764 A085781 N011446
002 001 001 001 002 001 002 001 001 001 001 001 001
STERANE PFIZER 25MG/ML SUSPENSION; ORAL FLO-PRED TARO EQ 5MG BASE/5ML SUSPENSION/DROPS; OPHTHALMIC ECONOPRED ALCON 0.125%
N022067
001
N017468
001
Aug 06, 1993 Sep 09, 1984 Apr 15, 1983 Oct 05, 1984
A087547
001
001 001 001 001 001 Jul 29, 1983 Apr 19, 1983 Dec 24, 1985 Dec 28, 1982
EQ 20MG PHOSPHATE/ML
N011583
002
A080517
001
N011028
001
A078416 A075181
001 001
A080751 A080751 A083834 A088415 A088165 A083358 A083358 A081043 A081044 A040065 A084171 A084168 A084169 A084172
002 001 001 001 001 001 002 001 001 001 001 001 001 001 Feb 29, 1984 Mar 28, 1983
A074511
001
PREDNISOLONE TEBUTATE
INJECTABLE; INJECTION HYDELTRA-TBA MERCK PREDNISOLONE TEBUTATE WATSON LABS
20MG/ML 20MG/ML
N010562 A083362
PREDNISONE
SOLUTION; ORAL PREDNISONE WOCKHARDT SYRUP; ORAL LIQUID PRED MURO TABLET; ORAL CORTAN HALSEY DELTA-DOME BAYER PHARMS DELTASONE PHARMACIA AND UPJOHN
5MG/5ML
A089726
001
5MG/5ML
A087611
002
5MG 1MG 5MG 1MG 5MG 10MG 20MG 50MG 5MG 5MG 5MG 10MG 20MG 5MG 10MG 20MG 5MG 5MG 10MG 20MG 5MG 20MG 1MG 2.5MG 5MG 2.5MG 5MG 5MG 5MG 10MG 20MG 20MG 50MG 5MG 1MG 2.5MG 5MG 5MG 10MG 20MG 5MG 5MG 20MG 5MG 5MG 5MG 10MG 20MG 50MG 5MG 1MG 2.5MG 5MG 5MG 5MG
A083364 N009766 N009766 A083009 A083009 A083009 A083009 A085999 N010962 A084655 A089387 A089388 A089389 A089597 A089598 A089599 A083676 A088394 A088395 A088396 A080491 A085811 A084440 A084440 A084440 A080563 A080563 A080300 A080320 A084341 A084417 A085543 A086946 A080782 A080328 A080306 A080279 A080283 A084133 A084134 A084236 A080514 A084275 A086968 A080301 A080701 A086595 A084634 A086596 A085115 A080350 A080350 A080350 A083059 A084662
001 002 001 001 002 003 004 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 003 001 002 Nov Nov Nov Oct Oct Oct 06, 06, 06, 05, 05, 05, 1986 1986 1986 1987 1987 1987
AMNEAL PHARMS NY
NYLOS PANRAY
PERRIGO PHARMAVITE
SUPERPHARM
TEVA UDL
5MG 20MG 5MG 10MG 20MG 20MG 5MG 20MG 25MG 5MG 5MG 10MG 20MG 50MG 5MG 1MG 2.5MG 5MG 5MG 10MG 20MG 5MG 5MG 10MG 20MG 5MG 20MG 5MG 5MG 20MG 5MG 5MG 5MG 10MG 20MG 50MG 50MG 50MG 2.5MG 5MG 10MG 20MG 5MG
A080321 A083807 A080353 A086062 A086061 A085151 A080232 N017109 A087833 A080336 A084774 A089983 A085813 A089984 A080371 A080359 A080359 A080359 A088865 A088866 A088867 A080397 A087984 A087985 A087986 A087471 A087470 A080237 A087682 A087701 A080334 A080506 A085084 A087773 A086813 A086867 A087772 A088465 A084913 A080343 A089028 A084913 A080223
001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 002 001
Oct 25, 1984 Oct 25, 1984 Oct 25, 1984 Jan 18, 1983 Jan 18, 1983 Jan 18, 1983
SERVISONE LEDERLE
PRILOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION CITANEST ASTRAZENECA
1% 2% 3% 4%
PRIMIDONE
SUSPENSION; ORAL MYSOLINE NURO PHARMA
250MG/5ML
N010401
001
250MG
A085052
001
PROBENECID
TABLET; ORAL BENEMID MERCK PROBENECID LEDERLE WATSON LABS
PROBUCOL
TABLET; ORAL LORELCO SANOFI AVENTIS US
250MG 500MG
N017535 N017535
001 002
PROCAINAMIDE HYDROCHLORIDE
CAPSULE; ORAL PROCAINAMIDE HYDROCHLORIDE ASCOT 250MG 375MG 500MG IVAX SUB TEVA PHARMS 250MG 375MG 500MG LANNETT 250MG 500MG LEDERLE 250MG 375MG 500MG ROXANE 250MG 500MG SANDOZ 250MG 375MG 500MG VANGARD 250MG 500MG WATSON LABS 250MG 250MG 250MG 375MG 375MG 500MG 500MG 500MG PROCAN PARKE DAVIS 250MG 375MG 500MG PROCAPAN PANRAY 250MG PRONESTYL APOTHECON 250MG 375MG 500MG INJECTABLE; INJECTION PROCAINAMIDE HYDROCHLORIDE ABRAXIS PHARM 100MG/ML 500MG/ML BAXTER HLTHCARE 100MG/ML
A087542 A087697 A087543 A084604 A084595 A084606 A083693 A084696 A086942 A086952 A086943 A088989 A088990 A089219 A089220 A089221 A087643 A087875 A083287 A083795 A085167 A084403 A087020 A084280 A084357 A087021 A085804 A087502 A085079 A083553 N007335 N007335 N007335
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 004 003
A089030 A089537 A088824 A088830 A088530 A088531 A088532 A089528 A089529 A087079 A087080 N007335 N007335
001 001 001 001 001 001 001 001 001 001 001 002 005
001
002
003
A088974 A089438 A040111 A089840 A088958 A088959 A089369 A089284 A089370 A089371 A088533 A089026 A088534 A089027 A088535 A089042 A089520 A086468 A086065 A087510 A088489 N020545 N020545 A087361
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
001
001 001 001 002 001
Jul Mar Dec Mar Dec Dec Aug Jun Jan Aug Dec Oct Dec Oct Nov Oct Jan
22, 23, 13, 06, 02, 02, 14, 23, 09, 14, 03, 22, 03, 22, 03, 22, 15,
1985 1987 1996 1989 1985 1985 1987 1986 1987 1987 1984 1985 1984 1985 1984 1985 1987
Apr 01, 1982 Jan 16, 1985 Jan 31, 1996 Jan 31, 1996
PROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION NOVOCAIN HOSPIRA
1% 2% 10% 1% 1% 2% 2%
1% 2% 1% 2% 1% 2% 1% 2% 1% 2% 1% 1% 2% 2%
A080711 A080756 A083315 A083315 A086202 A086202 A080416 A080416 A080415 A080415 A080658 A083535 A080658 A083535
001 001 001 002 001 002 001 002 001 002 001 001 002 002
100MG/ML;50MG/ML
N008869
001
PROCHLORPERAZINE
SUPPOSITORY; RECTAL COMPAZINE GLAXOSMITHKLINE
003 001 002 001 002 003 Jul 11, 2001 Jul 11, 2001 Jul 11, 2001
PROCHLORPERAZINE ABLE
PROCHLORPERAZINE EDISYLATE
CONCENTRATE; ORAL COMPAZINE GLAXOSMITHKLINE EQ PROCHLORPERAZINE ALPHARMA US PHARMS EQ PROCHLORPERAZINE EDISYLATE MORTON GROVE EQ INJECTABLE; INJECTION COMPAZINE GLAXOSMITHKLINE EQ PROCHLORPERAZINE BAXTER HLTHCARE EQ PROCHLORPERAZINE EDISYLATE BAXTER HLTHCARE EQ HOSPIRA EQ MARSAM PHARMS LLC EQ SMITH AND NEPHEW EQ TEVA PARENTERAL EQ WATSON LABS EQ
5MG BASE/ML 5MG BASE/ML 5MG 5MG 5MG 5MG 5MG 5MG BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
002 001 001 001 001 001 001 001 Oct 01, 1982 May Apr Dec Dec May Jul 03, 07, 05, 04, 30, 08, 1988 1988 1988 1986 2003 1987
PROCHLORPERAZINE MALEATE
CAPSULE, EXTENDED RELEASE; ORAL COMPAZINE GLAXOSMITHKLINE EQ 10MG BASE EQ 10MG BASE EQ 15MG BASE EQ 15MG BASE EQ 30MG BASE EQ 75MG BASE TABLET; ORAL COMPAZINE GLAXOSMITHKLINE EQ 5MG BASE EQ 10MG BASE EQ 25MG BASE PROCHLORPERAZINE WATSON LABS EQ 5MG BASE EQ 10MG BASE EQ 25MG BASE PROCHLORPERAZINE MALEATE DURAMED PHARMS BARR EQ 5MG BASE EQ 5MG BASE EQ 10MG BASE EQ 10MG BASE EQ 25MG BASE IVAX SUB TEVA PHARMS EQ 5MG BASE EQ 10MG BASE SANDOZ EQ 25MG BASE
N010571 N010571 N010571 A085580 A085178 A085579 A040207 A089484 A040207 A089485 A089486 A040162 A040162 A040101
001 002 003 001 001 001 001 001 002 001 001 001 002 003 May Jan May Jan Jan Jan Jan Jul 01, 20, 01, 20, 20, 20, 20, 19, 1997 1987 1997 1987 1987 1998 1998 1996
PROCYCLIDINE HYDROCHLORIDE
TABLET; ORAL KEMADRIN MONARCH PHARMS
2MG 5MG
N009818 N009818
005 003
PROGESTERONE
CAPSULE; ORAL PROMETRIUM ABBOTT LABS INJECTABLE; INJECTION PROGESTERONE LILLY
300MG
N019781
003
N009238 N009238
002 001
N017553
001
PROMAZINE HYDROCHLORIDE
CONCENTRATE; ORAL SPARINE WYETH AYERST
30MG/ML 100MG/ML
N010942 N010942
001 004
N010942
003
PROMETHAZINE HYDROCHLORIDE
INJECTABLE; INJECTION PHENERGAN WYETH AYERST
25MG/ML 50MG/ML PROMETHAZINE HYDROCHLORIDE ABBOTT 25MG/ML 50MG/ML AKORN 25MG/ML 50MG/ML BEDFORD LABS 25MG/ML 50MG/ML BIONICHE PHARMA 25MG/ML HOSPIRA 50MG/ML 50MG/ML MARSAM PHARMS LLC 25MG/ML 50MG/ML SANDOZ 25MG/ML 50MG/ML WATSON LABS 25MG/ML 25MG/ML 50MG/ML 50MG/ML ZIPAN-25 ALTANA 25MG/ML ZIPAN-50 ALTANA 50MG/ML SUPPOSITORY; RECTAL PHENERGAN SHIONOGI INC 12.5MG 25MG 50MG PROMETHACON POLYMEDICA 25MG 50MG PROMETHAZINE HYDROCHLORIDE ABLE 12.5MG 25MG 50MG SYRUP; ORAL MYMETHAZINE FORTIS USL PHARMA 25MG/5ML PROMETH FORTIS ALPHARMA US PHARMS 25MG/5ML
N008857 N008857 A084223 A084222 A083955 A083955 A040524 A040524 A040471 A040372 A083838 A089463 A089477 A040593 A040593 A083532 A084591 A080629 A083532 A083997 A083997
002 003 001 001 002 001 001 002 001 002 002 001 001 001 002 001 001 002 002 001 002
002 001 001 001 001 001 002 001 Apr 11, 2003 Apr 11, 2003 Feb 27, 2003
A087996 A084772
001 001
001 001 001 001 001 001 004 003 Apr 18, 1984 Sep 20, 1985
N007935 N007935 N007935 A084160 A084166 A084539 A040558 A040558 A040558 A084214 A083604 A083603 A083613 A080949 A080949 A080949 A084555 A084554 A084557 A083214 A083658 A084176 A084233 A085146 A085146 A084080 A084027 A089109 A083401 A083712 A085986 A083204 A085684 A083403 A085664 A083176 A083176
002 003 004 001 001 001 001 002 003 002 001 001 001 001 002 003 001 001 001 001 001 002 001 001 002 001 001 001 001 001 001 001 001 001 001 002 001
PROPANTHELINE BROMIDE
INJECTABLE; INJECTION PRO-BANTHINE GD SEARLE LLC TABLET; ORAL PRO-BANTHINE SHIRE
30MG/VIAL
N008843
001
7.5MG
N008732
003
15MG 15MG 15MG 15MG 15MG 15MG 15MG 7.5MG 15MG 15MG 15MG 15MG
N008732 A087663 A085780 A084541 A083706 A088377 A080977 A080927 A080928 A084428 A083029 A083151
002 001 001 002 001 001 001 001 001 001 002 001 Oct 25, 1982
PROPARACAINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC KAINAIR PHARMAFAIR 0.5% PARACAINE OPTOPICS 0.5% PROPARACAINE HYDROCHLORIDE SOLA BARNES HIND 0.5% 0.5%
PROPIOLACTONE
SOLUTION; IRRIGATION BETAPRONE FOREST LABS
N/A
N011657
001
PROPIOMAZINE HYDROCHLORIDE
INJECTABLE; INJECTION LARGON BAXTER HLTHCARE CORP
20MG/ML
N012382
002
PROPOFOL
INJECTABLE; INJECTION DIPRIVAN APP PHARMS PROPOFOL BEDFORD TEVA PARENTERAL
PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL DARVON XANODYNE PHARM
32MG 65MG
N010997 N010997 A080530 A083544 A083538 A083184 A083317 A083597 A083186 A083528 A040569
001 003 001 001 002 001 001 001 001 001 001
DOLENE HERITAGE PHARMS INC 65MG KESSO-GESIC MK LABS 65MG PROPHENE 65 HALSEY 65MG PROPOXYPHENE HYDROCHLORIDE ALRA 65MG IMPAX LABS 65MG IVAX SUB TEVA PHARMS 32MG MUTUAL PHARM 65MG MYLAN 32MG 65MG
A083299 A083185 A080269 A083278 A083464 A083113 A083089 A083089 A084014 A083125 A083688 A083870 A086495 A088615 A080783 A040908 A080908 A085190 A083501 A084551 A083786
001 001 001 001 001 001 001 002 001 002 001 002 001 001 001 001 002 001 001 001 001
PROPOXYPHENE NAPSYLATE
SUSPENSION; ORAL DARVON-N AAIPHARMA LLC TABLET; ORAL DARVON-N XANODYNE PHARM
50MG/5ML
N016861
001
100MG
N016862
002
PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL PROPRANOLOL HYDROCHLORIDE INWOOD LABS 60MG 80MG 120MG 160MG CONCENTRATE; ORAL PROPRANOLOL HYDROCHLORIDE INTENSOL ROXANE 80MG/ML INJECTABLE; INJECTION PROPRANOLOL HYDROCHLORIDE SMITH AND NEPHEW 1MG/ML 1MG/ML SOLOPAK 1MG/ML SOLUTION; ORAL PROPRANOLOL HYDROCHLORIDE MORTON GROVE 20MG/5ML 40MG/5ML SUSPENSION; ORAL INDERAL WYETH AYERST 10MG/ML TABLET; ORAL INDERAL AKRIMAX PHARMS 10MG 20MG 90MG PROPRANOLOL HYDROCHLORIDE CLONMEL HLTHCARE 10MG 20MG
A071388
001
A071984 A071985
001 001
N019536
001
A070127 A071495 A070128 A071496 A070306 A070307 A070308 A070309 A070310 A071327 A071368 A071369 A071370 A071371 A072063 A072066 A072067 A072068 A072069 A072117 A072118 A072119 A072120 A070319 A070320 A070103 A070321 A070322 A072275 A071288 A071977 A070814 A070815 A070816 A070817 A070757 A070516 A070517 A070518 A070519 A070520 A070521 A070663 A071658 A070664 A071687 A070665 A071688 A070666 A072197 A070667 A071689 A072198 A070120 A070121 A070122 A070123 A070124 A071515 A071516
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jul Dec Jul Dec Sep Sep Sep Oct Sep Oct May May May May Jul Jul Jul Jul Jul Jun Jun Jun Jun Oct Oct Oct Sep Aug Jun Oct Apr Nov Nov Nov Nov Nov Jul Jul Jul Sep Jul Sep Jun Jul Jun Jul Jun Jul Oct Jul Jun Jul Jul Aug Aug Aug Oct Aug Jun Jun
30, 31, 30, 31, 09, 09, 09, 01, 09, 01, 05, 05, 05, 05, 29, 29, 29, 29, 29, 23, 23, 23, 23, 22, 22, 22, 24, 04, 09, 22, 06, 03, 03, 03, 03, 03, 07, 07, 07, 24, 07, 24, 13, 05, 13, 05, 13, 05, 10, 05, 13, 05, 05, 06, 06, 06, 29, 06, 08, 08,
1985 1987 1985 1987 1985 1985 1985 1986 1985 1986 1987 1987 1987 1987 1988 1988 1988 1988 1988 1988 1988 1988 1988 1985 1985 1985 1986 1986 1989 1986 1988 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1986 1988 1986 1988 1986 1988 1986 1988 1986 1988 1988 1985 1985 1985 1986 1985 1988 1988
A071517 A071518 A070232 A070233 A070234 A070438 A070439 A070440 A070441 A070442 A070140 A070378 A070548 A070141 A070379 A070549 A070142 A070380 A070550 A070143 A070381 A071098 A071791 A070144 A070382 A070551 A071183 A071792
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Jun Jun Oct Jun Jun Sep Sep Sep Sep Sep Jul Mar Jul Jul Mar Apr Jul Mar Apr Jan Mar Oct Jul Jul Mar Jul Oct Jul
08, 08, 07, 23, 23, 15, 15, 15, 24, 15, 30, 19, 10, 30, 19, 11, 30, 19, 11, 15, 19, 06, 15, 30, 19, 10, 06, 15,
1988 1988 1987 1986 1986 1986 1986 1986 1986 1986 1985 1987 1986 1985 1987 1986 1985 1987 1986 1987 1987 1986 1987 1985 1987 1986 1986 1987
PROPYLIODONE
SUSPENSION; INTRATRACHEAL DIONOSIL AQUEOUS GLAXOSMITHKLINE 50% DIONOSIL OILY GLAXOSMITHKLINE 60%
N009309 N009309
001 002
PROPYLTHIOURACIL
TABLET; ORAL PROPYLTHIOURACIL ABBOTT ANABOLIC HALSEY IMPAX LABS IVAX SUB TEVA PHARMS LANNETT LILLY MUTUAL PHARM PERRIGO TABLICAPS WATSON LABS
50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG 50MG
A084075 A080285 A080015 A080159 A080215 A080016 N006213 A083982 A084543 A080840 A080932 A085201
001 001 001 001 001 001 001 001 001 001 001 001
PROTAMINE SULFATE
INJECTABLE; INJECTION PROTAMINE SULFATE BAXTER HLTHCARE LILLY PHARMACIA AND UPJOHN
5% 5%
N005932 N006170
012 003
PROTIRELIN
INJECTABLE; INJECTION THYPINONE ABBOTT THYREL TRH FERRING
0.5MG/ML 0.5MG/ML
N017638 N018087
001 001
PROTOKYLOL HYDROCHLORIDE
TABLET; ORAL VENTAIRE SANOFI AVENTIS US
2MG
A083459
001
PROTRIPTYLINE HYDROCHLORIDE
TABLET; ORAL VIVACTIL ODYSSEY PHARMS
5MG 10MG
N016012 N016012
001 002
PSEUDOEPHEDRINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL NOVAFED SANOFI AVENTIS US 120MG SUDAFED 12 HOUR GLAXOSMITHKLINE 120MG
N017603 N017941
001 002
N018996 A071798
001 001
Feb 09, 1984 Apr 20, 1984 Mar 04, 1983 Feb 12, 1985
Jan 31, 1985 Apr 11, 1985 May 17, 1983 Jan 09, 1985 May 17, 1984 Jan 13, 1984 Apr 19, 1983 Dec 12, 1984
A088578
001
A072758
001
PSEUDOEPHEDRINE POLISTIREX
SUSPENSION, EXTENDED RELEASE; ORAL PSEUDO-12 UCB INC EQ 60MG HCL/5ML
N019401
001
PYRIDOSTIGMINE BROMIDE
TABLET; ORAL PYRIDOSTIGMINE BROMIDE BARR SOLVAY US ARMY
PYRIDOXINE HYDROCHLORIDE
INJECTABLE; INJECTION HEXA-BETALIN LILLY 100MG/ML PYRIDOXINE HYDROCHLORIDE AKORN 100MG/ML BEL MAR 100MG/ML DELL LABS 50MG/ML 100MG/ML ELKINS SINN 100MG/ML LUITPOLD 100MG/ML WATSON LABS 100MG/ML 100MG/ML
001 001 001 001 001 001 001 001 001 Oct 01, 1982
PYRILAMINE MALEATE
TABLET; ORAL PYRILAMINE MALEATE IMPAX LABS WATSON LABS
25MG 25MG
A080808 A085231
001 001
PYRIMETHAMINE; SULFADOXINE
TABLET; ORAL FANSIDAR ROCHE
25MG;500MG
N018557
001
PYRITHIONE ZINC
LOTION; TOPICAL HEAD & SHOULDERS CONDITIONER WARNER CHILCOTT 0.3%
N019412
002
PYRVINIUM PAMOATE
SUSPENSION; ORAL POVAN PARKE DAVIS TABLET; ORAL POVAN PARKE DAVIS
EQ 50MG BASE/5ML
N011964
001
EQ 50MG BASE
N012485
002
QUAZEPAM
TABLET; ORAL DORAL QUESTCOR PHARMS
7.5MG
N018708
003
EQ 150MG BASE
N020639
004
QUINAPRIL HYDROCHLORIDE
TABLET; ORAL QUINAPRIL HYDROCHLORIDE ACTAVIS TOTOWA EQ EQ EQ EQ
QUINESTROL
TABLET; ORAL ESTROVIS PARKE DAVIS
0.1MG 0.2MG
N016768 N016768
002 003
QUINETHAZONE
TABLET; ORAL HYDROMOX LEDERLE
50MG
N013264
001
QUINETHAZONE; RESERPINE
TABLET; ORAL HYDROMOX R LEDERLE
50MG;0.125MG
N013927
001
QUINIDINE GLUCONATE
TABLET; ORAL QUINACT BAYER HLTHCARE
266MG 400MG TABLET, EXTENDED RELEASE; ORAL DURAQUIN WARNER CHILCOTT 330MG QUINAGLUTE BAYER HLTHCARE 324MG QUINALAN LANNETT 324MG QUINATIME WATSON LABS 324MG QUINIDINE GLUCONATE ASCOT 324MG HALSEY 324MG ROXANE 324MG SANDOZ 324MG SUPERPHARM 324MG WATSON LABS 324MG
A085978 A086099
001 001
N017917 N016647 A088081 A087448 A088582 A089476 A088431 A089894 A089164 A087785
001 001 001 001 001 001 001 001 001 001 Jun Apr Jan Dec Nov Jan 17, 10, 06, 15, 21, 24, 1985 1987 1984 1988 1985 1983 Feb 10, 1986
QUINIDINE POLYGALACTURONATE
TABLET; ORAL CARDIOQUIN PHARM RES ASSOC
275MG
N011642
002
QUINIDINE SULFATE
CAPSULE; ORAL CIN-QUIN SOLVAY QUINIDINE SULFATE LILLY
100MG 200MG 300MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 100MG 200MG 200MG 200MG 200MG 300MG 200MG 200MG 300MG 200MG 200MG 200MG 200MG 200MG 200MG 200MG 100MG 200MG 200MG 200MG 200MG 300MG ORAL 300MG
A085299 A084932 A085298 A084177 A087011 A083808 A083622 A083439 A083583 A083347 A084549 A085175 A085276 A083743 A086176 A085038 A081029 A085322 A084627 A084003 A083640 A085632 A084631 A084914 A089839 A085068 A088973 A087837 A083393 A087909 A083963 A083879 A085584 A085140 A083862 A085444 A083576 A085222
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001
QUINIDINE SULFATE BARR CLONMEL HLTHCARE CONTRACT PHARMACAL ELKINS SINN EVERYLIFE HALSEY IMPAX LABS IVAX SUB TEVA PHARMS KING PHARMS KV PHARM LANNETT LEDERLE LILLY MUTUAL PHARM PERRIGO PHARMAVITE PUREPAC PHARM ROXANE SANDOZ
Sep 29, 1988 Apr 10, 1985 Apr 14, 1982 Jul 13, 1982
SCHERER LABS SUPERPHARM USL PHARMA VALEANT PHARM INTL VANGARD VINTAGE PHARMS WARNER CHILCOTT WATSON LABS WEST WARD WHITEWORTH TOWN PLSN QUINORA KEY PHARMS SCHERING TABLET, EXTENDED RELEASE; QUINIDEX WYETH PHARMS INC
N012796
002
RABEPRAZOLE SODIUM
TABLET, DELAYED RELEASE; ORAL ACIPHEX EISAI INC 10MG
N020973
001
RAMIPRIL
CAPSULE; ORAL RAMIPRIL ACTAVIS ELIZABETH
400MG
N020559
001
RANITIDINE HYDROCHLORIDE
CAPSULE; ORAL RANITIDINE HYDROCHLORIDE MYLAN EQ 150MG BASE EQ 300MG BASE TEVA EQ 150MG BASE EQ 300MG BASE ZANTAC 150 GLAXOSMITHKLINE EQ 150MG BASE ZANTAC 300 GLAXOSMITHKLINE EQ 300MG BASE GRANULE, EFFERVESCENT; ORAL ZANTAC 150 GLAXOSMITHKLINE EQ 150MG BASE/PACKET INJECTABLE; INJECTION RANITIDINE HYDROCHLORIDE BEDFORD EQ 25MG BASE/ML ZANTAC IN PLASTIC CONTAINER GLAXOSMITHKLINE EQ 50MG BASE/100ML TABLET; ORAL RANITIDINE HYDROCHLORIDE BOEHRINGER INGELHEIM EQ 150MG BASE EQ 300MG BASE MYLAN EQ 150MG BASE EQ 300MG BASE RANBAXY EQ 75MG BASE EQ 75MG BASE EQ 150MG BASE EQ 150MG BASE EQ 300MG BASE EQ 300MG BASE SANDOZ EQ 75MG BASE TABLET, EFFERVESCENT; ORAL ZANTAC 150 GLAXOSMITHKLINE EQ 150MG BASE ZANTAC 75 BOEHRINGER INGELHEIM EQ 75MG BASE
N020251
002
A074764 N019593
001 001
A074662 A074662 A074552 A074552 A075132 A075254 A075000 A075439 A075000 A075439 A075519
001 002 001 002 001 001 001 001 002 002 001
Aug Aug Jul Jul Jan Jan Jan Apr Jan Apr Sep
29, 29, 30, 30, 14, 14, 30, 19, 30, 19, 26,
1997 1997 1998 1998 2000 2000 1998 2000 1998 2000 2002
N020251 N020745
001 001
RAPACURONIUM BROMIDE
INJECTABLE; INJECTION RAPLON ORGANON USA INC
100MG/VIAL 200MG/VIAL
N020984 N020984
001 002
50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG 50MG 100MG
N009926 N009926 N009108 N009108 N009477 N009477 A080498 A080498 N009273 N009273 N011521 N011521 A080842 A080842 A080583 A080583 A080500 A080500 A083867 A083444 N009668 N009668 A080907 A080914 N009255 N009255
002 004 002 004 001 002 001 002 001 002 001 002 001 002 001 002 001 002 001 001 001 002 001 001 008 006
RESCINNAMINE
CAPSULE; ORAL CINNASIL PANRAY TABLET; ORAL MODERIL PFIZER
0.5MG
A084736
001
0.25MG 0.5MG
N010686 N010686
003 006
RESERPINE
ELIXIR; ORAL SERPASIL NOVARTIS INJECTABLE; INJECTION SANDRIL LILLY SERPASIL NOVARTIS TABLET; ORAL HISERPIA BOWMAN PHARMS RAU-SED BRISTOL MYERS SQUIBB
0.2MG/4ML
N009115
005
2.5MG/ML 2.5MG/ML
N010012 N009434
001 002
HALSEY
IMPAX LABS IVAX SUB TEVA PHARMS MARSHALL PHARMA MK LABS MYLAN PHARMAVITE PUREPAC PHARM PVT FORM
REXALL ROXANE SOLVAY TABLICAPS TEVA VALEANT PHARM INTL WATSON LABS
WEST WARD
0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.5MG 1MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.25MG 1MG 0.25MG 0.1MG 0.25MG 0.25MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.1MG 0.25MG 0.25MG 1MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG 1MG 0.1MG 0.25MG
N009663 N009663 A083145 A083145 N010441 N010441 N010441 N010441 A080457 A080457 A080457 N009627 N009627 N011185 N011185 A080492 A080492 A080525 A080525 A084974 A084663 A080753 A080753 A086117 A080582 A085775 A080582 A080637 N009859 N009859 A080446 A085207 A089020 A089019 N009667 N009667 A080679 A080393 A085401 A080749 A080975 A080975 A080975 A080723 A080723 A080723 N009376 N009376 N009391 N009391 N009391 N009115 N009115 N009115 N009453 N009453
001 003 001 002 001 002 003 004 002 001 003 001 002 001 002 001 002 002 001 001 001 002 001 001 001 001 002 001 001 002 001 001 001 001 001 002 001 001 001 001 001 002 003 001 002 003 004 001 001 002 004 001 003 004 001 002
SERPASIL NOVARTIS
SERPATE VALE
0.25MG
N009645
002
RESERPINE; TRICHLORMETHIAZIDE
TABLET; ORAL METATENSIN #2 SANOFI AVENTIS US 0.1MG;2MG METATENSIN #4 SANOFI AVENTIS US 0.1MG;4MG NAQUIVAL SCHERING 0.1MG;4MG TRICHLORMETHIAZIDE W/ RESERPINE WATSON LABS 0.1MG;4MG
RIBAVIRIN
TABLET; ORAL COPEGUS ROCHE
400MG
N021511
002
RIFAMPIN
CAPSULE; ORAL RIMACTANE PROSAM LABS
300MG
N050429
001
RIMANTADINE HYDROCHLORIDE
SYRUP; ORAL FLUMADINE FOREST LABS 50MG/5ML TABLET; ORAL RIMANTADINE HYDROCHLORIDE ACTAVIS TOTOWA 100MG
N019650
001
A076375
001
RISEDRONATE SODIUM
TABLET; ORAL ACTONEL WARNER CHILCOTT
75MG
N020835
004
RISPERIDONE
TABLET; ORAL RISPERDAL JANSSEN PHARMS RISPERIDONE ACTAVIS TOTOWA
5MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG 0.5MG 1MG 2MG 3MG 4MG 0.25MG
N020272 A078071 A078071 A078071 A078071 A078071 A078071 A078828 A078828 A078828 A078828 A078828 A078828 A077784 A077784 A077784 A077784 A077784 A077784 A078187
005 001 002 003 004 005 006 001 002 003 004 005 006 001 002 003 004 005 006 001
Dec 29, 1993 Jun Jun Jun Jun Jun Jun Mar Mar Mar Mar Mar Mar Jun Jun Jun Jun Jun Jun Oct 17, 17, 17, 17, 17, 17, 23, 23, 23, 23, 23, 23, 08, 08, 08, 08, 08, 08, 22, 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2010 2010 2010 2010 2010 2010 2009
CADISTA PHARMS
RATIOPHARM
SYNTHON PHARMS
RITODRINE HYDROCHLORIDE
INJECTABLE; INJECTION RITODRINE HYDROCHLORIDE ABRAXIS PHARM 10MG/ML 15MG/ML HOSPIRA 10MG/ML 15MG/ML RITODRINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER HOSPIRA 30MG/100ML YUTOPAR ASTRAZENECA 10MG/ML 15MG/ML TABLET; ORAL YUTOPAR ASTRAZENECA 10MG
N018555
001
RITONAVIR
CAPSULE; ORAL NORVIR ABBOTT
100MG
N020680
001
ROCURONIUM BROMIDE
INJECTABLE; INJECTION ZEMURON SCHERING
10MG/ML (10MG/ML)
N020214
002
ROFECOXIB
SUSPENSION; ORAL VIOXX MERCK TABLET; ORAL VIOXX MERCK
12.5MG/5ML 25MG/5ML
N021052 N021052
001 002
ROPINIROLE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL REQUIP XL SMITHKLINE BEECHAM EQ 3MG BASE
N022008
002
RUFINAMIDE
TABLET; ORAL BANZEL EISAI INC
100MG
N021911
001
SAFFLOWER OIL
INJECTABLE; INJECTION LIPOSYN 10% ABBOTT LIPOSYN 20% ABBOTT
N018203 N018614
001 001
SALMETEROL XINAFOATE
AEROSOL, METERED; INHALATION SEREVENT GLAXOSMITHKLINE EQ 0.021MG BASE/INH
N020236
001
SAQUINAVIR
CAPSULE; ORAL FORTOVASE HOFFMANN LA ROCHE
200MG
N020828
001
SARALASIN ACETATE
INJECTABLE; INJECTION SARENIN PROCTER AND GAMBLE
EQ 0.6MG BASE/ML
N018009
001
SECOBARBITAL SODIUM
CAPSULE; ORAL SECOBARBITAL SODIUM ANABOLIC BARR EVERYLIFE HALSEY IVAX PHARMS KV PHARM LANNETT PARKE DAVIS PERRIGO PUREPAC PHARM VALEANT PHARM INTL VITARINE WATSON LABS WEST WARD WHITEWORTH TOWN PLSN WYETH AYERST INJECTABLE; INJECTION SECOBARBITAL SODIUM ELKINS SINN WYETH AYERST SECONAL SODIUM LILLY
100MG 100MG 100MG 100MG 100MG 100MG 50MG 100MG 100MG 100MG 100MG 100MG 100MG 100MG 100MG 100MG 100MG 100MG
A084422 A084225 A085895 A084676 A085869 A085285 A085909 A085903 A084762 A084561 A085867 A085477 A085898 A086273 A085792 A084926 A085798 A086390
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
SECRETIN
INJECTABLE; INJECTION SECRETIN-FERRING FERRING
75CU/VIAL
N018290
001
N021136
001
SELEGILINE HYDROCHLORIDE
CAPSULE; ORAL SELEGILINE HYDROCHLORIDE AAIPHARMA LLC 5MG TABLET; ORAL SELEGILINE HYDROCHLORIDE ENDO PHARMS 5MG IVAX SUB TEVA PHARMS 5MG SIEGFRIED 5MG SOMERSET 5MG TEVA 5MG 5MG
A075145
001
SELENIUM SULFIDE
LOTION/SHAMPOO; TOPICAL EXSEL ALLERGAN HERBERT SELENIUM SULFIDE ACTAVIS MID ATLANTIC IVAX PHARMS TARO
SELENOMETHIONINE SE-75
INJECTABLE; INJECTION SELENOMETHIONINE SE 75 GE HEALTHCARE MALLINCKRODT PHARMALUCENCE SETHOTOPE BRACCO
SERACTIDE ACETATE
INJECTABLE; INJECTION ACTHAR GEL-SYNTHETIC ARMOUR PHARM
40 UNITS/ML 80 UNITS/ML
N017861 N017861
001 002
SERMORELIN ACETATE
INJECTABLE; INJECTION GEREF EMD SERONO
20MG BASE/ML
A076934
001
25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 25MG BASE 50MG BASE 100MG BASE 150MG BASE 200MG BASE
A077345 A077345 A077345 A078175 A078175 A078175 A075719 A075719 A075719 A077818 A077818 A077818 A077299 A077299 A077299 A076881 A076881 A076881 A077713 A077713 A077713 A077162 A077162 A077162 N019839 N019839
001 002 003 001 002 003 003 001 002 001 002 003 001 002 003 001 002 003 001 002 003 001 002 003 003 004
Feb Feb Feb Jul Jul Jul Jun Jun Jun Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb Feb
06, 06, 06, 21, 21, 21, 30, 30, 30, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06, 06,
2007 2007 2007 2010 2010 2010 2006 2006 2006 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007 2007
SEVELAMER HYDROCHLORIDE
CAPSULE; ORAL RENAGEL GENZYME
403MG
N020926
001
SIBUTRAMINE HYDROCHLORIDE
CAPSULE; ORAL MERIDIA ABBOTT
SILVER SULFADIAZINE
DRESSING; TOPICAL SILDAFLO FRANKLIN PHARMS
1%
N019608
001
SIMETHICONE-CELLULOSE
SUSPENSION; ORAL SONORX BRACCO
7.5MG/ML
N020773
001
SIMVASTATIN
TABLET; ORAL SIMVASTATIN ACTAVIS TOTOWA
80MG 5MG 10MG 20MG 40MG 80MG TABLET, ORALLY DISINTEGRATING; ORAL SIMVASTATIN SYNTHON PHARMS 10MG 20MG 40MG 80MG
SIROLIMUS
TABLET; ORAL RAPAMUNE WYETH PHARMS INC
5MG
N021110
003
100MG/ML;100MG/ML
N019530
001
SODIUM BICARBONATE
INJECTABLE; INJECTION SODIUM BICARBONATE IN PLASTIC CONTAINER ABBOTT 0.9MEQ/ML 1MEQ/ML
N019443 N019443
001 002
N018509
001
SODIUM CHLORIDE
INJECTABLE; INJECTION BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ABRAXIS PHARM 9MG/ML SODIUM CHLORIDE ABBOTT 20GM/100ML B BRAUN 20GM/100ML SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER B BRAUN 450MG/100ML MILES 450MG/100ML SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ABBOTT 9MG/ML MILES 900MG/100ML SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER ABRAXIS PHARM 234MG/ML SODIUM CHLORIDE 3% IN PLASTIC CONTAINER B BRAUN 3GM/100ML SODIUM CHLORIDE 5% IN PLASTIC CONTAINER B BRAUN 5GM/100ML SOLUTION; IRRIGATION SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER BAXTER HLTHCARE 450MG/100ML HOSPIRA 450MG/100ML 450MG/100ML SODIUM CHLORIDE IN PLASTIC CONTAINER MILES 900MG/100ML
A088909 N017013 N017038 N018184 N018503 N019218 N018502 N019329 N019635 N019635
001 001 001 001 001 001 001 001 003 004
2mCi/VIAL 100uCi/ML
N013993 N016708
002 001
2mCi/ML 10-200mCi/ML
N017042 N022494
400uCi
N018671
003
7-106mCi/BOT 50mCi/ML
N010929 N017315
002 001
SODIUM LACTATE
INJECTABLE; INJECTION SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER B BRAUN 1.87GM/100ML HOSPIRA 1.87GM/100ML
N018186 N018249
001 001
SODIUM MONOFLUOROPHOSPHATE
GEL; DENTAL EXTRA-STRENGTH AIM CHESEBROUGH PONDS PASTE; DENTAL EXTRA-STRENGTH AIM CHESEBROUGH PONDS
1.2%
N019518
002
1.2%
N019518
001
SODIUM NITROPRUSSIDE
INJECTABLE; INJECTION NIPRIDE ROCHE NITROPRESS ABBOTT HOSPIRA SODIUM NITROPRUSSIDE ABRAXIS PHARM BAXTER HLTHCARE TEVA PARENTERAL
001 001 001 001 001 001 001 Nov 16, 1987 Jun 09, 1986 Jan 17, 1985 Jul 28, 1982 Mar 30, 1992
A088786
001
A088717 A088453
001 001
SODIUM SUCCINATE
INJECTABLE; INJECTION SODIUM SUCCINATE ELKINS SINN
30%
A080516
001
1% 3%
N005970 N005970
004 005
SODIUM THIOSULFATE
INJECTABLE; INJECTION SODIUM THIOSULFATE US ARMY
250MG/ML
N020166
001
SOMATREM
INJECTABLE; INJECTION PROTROPIN GENENTECH
5MG/VIAL 10MG/VIAL
N019107 N019107
001 002
SOMATROPIN
INJECTABLE; INJECTION ASELLACRIN 10 SERONO ASELLACRIN 2 SERONO CRESCORMON GENENTECH
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION ACCRETROPIN CANGENE BIO-TROPIN FERRING HUMATROPE LILLY NORDITROPIN NOVO NORDISK INC NUTROPIN DEPOT GENENTECH
Jan 23, 2008 May 25, 1995 Jun 23, 1987 May 08, 1995 May 08, 1995 Dec 22, 1999 Dec 22, 1999 Dec 22, 1999
Jan 16, 2007 Oct 08, 1996 Sep 06, 2001 Dec 01, 2003 Dec 01, 2003 Dec 01, 2003
6MG/0.5ML (6MG/0.5ML)
N020604
005
SORBITOL
SOLUTION; IRRIGATION SORBITOL 3% IN PLASTIC CONTAINER BAXTER HLTHCARE 3GM/100ML
N018512
001
SOTALOL HYDROCHLORIDE
TABLET; ORAL BETAPACE BAYER HLTHCARE BETAPACE AF BAYER HLTHCARE
320MG 40MG 60MG 100MG 80MG 80MG 120MG 120MG 160MG 160MG 240MG 80MG 120MG 160MG 240MG
N019865 N021151 N021151 N021151 A075515 A076576 A075515 A076576 A075515 A076576 A075515 A075238 A075238 A075238 A075238
004 006 007 005 001 001 004 002 002 003 003 001 002 003 004
Oct 30, 1992 Apr 02, 2003 Apr 02, 2003 Mar 14, 2003 Oct Apr Oct Apr Oct Apr Oct Jul Jul Jul Jul 15, 08, 15, 08, 15, 08, 15, 13, 13, 13, 13, 2001 2004 2001 2004 2001 2004 2001 2000 2000 2000 2000
WATSON LABS
SOYBEAN OIL
INJECTABLE; INJECTION SOYACAL 10% ALPHA THERA SOYACAL 20% ALPHA THERA TRAVAMULSION 10% BAXTER HLTHCARE TRAVAMULSION 20% BAXTER HLTHCARE
Jun 29, 1983 Jun 29, 1983 Feb 26, 1982 Feb 15, 1983
SPARFLOXACIN
TABLET; ORAL ZAGAM MYLAN
200MG
N020677
001
SPECTINOMYCIN HYDROCHLORIDE
INJECTABLE; INJECTION TROBICIN PFIZER
N050347 N050347
001 002
SPIRONOLACTONE
TABLET; ORAL SPIRONOLACTONE ASCOT IVAX PHARMS LEDERLE MUTUAL PHARM MYLAN PUREPAC PHARM SUPERPHARM UPSHER SMITH VANGARD WARNER CHILCOTT WATSON LABS
25MG 25MG 25MG 25MG 25MG 25MG 25MG 25MG 25MG 25MG 25MG 25MG 25MG
A087687 A087108 A087634 A087265 A087086 A087998 A088053 A089364 A087554 A087648 A087952 A086898 A087078
001 001 001 001 001 001 001 001 001 001 001 002 001
Oct 14, 1983 Aug 25, 1983 Nov 07, 1986 Feb 01, 1982 Nov 18, 1982 Mar 02, 1982
STANOZOLOL
TABLET; ORAL WINSTROL LUNDBECK INC
2MG
N012885
001
STAVUDINE
CAPSULE; ORAL ZERIT BRISTOL MYERS SQUIBB 5MG CAPSULE, EXTENDED RELEASE; ORAL ZERIT XR BRISTOL MYERS SQUIBB 37.5MG 50MG 75MG 100MG
N020412
001
N018246
001
STREPTOMYCIN SULFATE
INJECTABLE; INJECTION STREPTOMYCIN SULFATE COPANOS LILLY
PFIZER
EQ EQ EQ EQ EQ EQ
500MG BASE/ML 1GM BASE/VIAL 1GM BASE/2ML 5GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/2.5ML
EQ 5GM BASE/VIAL
A060076
002
SUCCINYLCHOLINE CHLORIDE
INJECTABLE; INJECTION ANECTINE SANDOZ
50MG/ML 500MG/VIAL 1GM/VIAL QUELICIN PRESERVATIVE FREE HOSPIRA 50MG/ML SUCCINYLCHOLINE CHLORIDE INTL MEDICATION 100MG/VIAL ORGANON USA INC 20MG/ML SUCOSTRIN APOTHECON 20MG/ML 100MG/ML
003 001 004 002 001 001 001 003 Feb 04, 1982
SUFENTANIL CITRATE
INJECTABLE; INJECTION SUFENTANIL CITRATE WATSON LABS
EQ 0.05MG BASE/ML
A074406
001
SULFACETAMIDE SODIUM
OINTMENT; OPHTHALMIC BLEPH-10 ALLERGAN 10% SODIUM SULAMYD SCHERING 10% SULFAIR 10 PHARMAFAIR 10% SOLUTION/DROPS; OPHTHALMIC BLEPH-30 ALLERGAN 30% ISOPTO CETAMIDE ALCON 15% OCUSULF-10 MIZA PHARMS USA 10% OCUSULF-30 MIZA PHARMS USA 30% SODIUM SULAMYD SCHERING 10% 30% SODIUM SULFACETAMIDE AKORN 10% 15% 30% SOLA BARNES HIND 10% 10% 30% 30% SULF-10 NOVARTIS 10% SULF-15 NOVARTIS 15% SULFACEL-15 OPTOPICS 15% SULFACETAMIDE SODIUM AKORN 10% 30% ALCON PHARMS LTD 30%
A080028 A080020 A080660 A080660 N005963 N005963 A083021 A083021 A083021 A084143 A084145 A084146 A084147 A080025 A089047 A080024 A040215 A040216 A089068
002 002 001 002 001 003 001 002 003 001 001 001 001 001 001 001 001 001 001 May 25, 1999 May 25, 1999 May 05, 1987 Oct 31, 1995
May 17, 1985 Dec 13, 1982 Oct 13, 1983 May 25, 1983 Feb 03, 1983
SULFACYTINE
TABLET; ORAL RENOQUID GLENWOOD
250MG
N017569
001
SULFADIAZINE
TABLET; ORAL SULFADIAZINE ABBOTT EVERYLIFE IMPAX LABS LANNETT LEDERLE LILLY
SULFADIAZINE SODIUM
INJECTABLE; INJECTION SULFADIAZINE SODIUM LEDERLE
250MG/ML
N004054
002
SULFADIAZINE; SULFAMERAZINE
SUSPENSION; ORAL SULFONAMIDES DUPLEX LILLY
250MG/5ML;250MG/5ML
N006317
007
SULFAMETER
TABLET; ORAL SULLA BAYER HLTHCARE
500MG
N016000
002
SULFAMETHIZOLE
TABLET; ORAL MICROSUL FOREST PHARMS PROKLAR FOREST PHARMS THIOSULFIL WYETH AYERST
SULFAMETHOXAZOLE
SUSPENSION; ORAL GANTANOL ROCHE TABLET; ORAL GANTANOL ROCHE GANTANOL-DS ROCHE
500MG/5ML
N013664
002
500MG 1GM
N012715 N012715
002 003
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE; INJECTION BACTRIM MUTUAL PHARM 80MG/ML;16MG/ML SEPTRA MONARCH PHARMS 80MG/ML;16MG/ML SULFAMETHOXAZOLE AND TRIMETHOPRIM ABRAXIS PHARM 80MG/ML;16MG/ML BAXTER HLTHCARE 80MG/ML;16MG/ML 80MG/ML;16MG/ML BEDFORD 80MG/ML;16MG/ML HOSPIRA 80MG/ML;16MG/ML WATSON LABS 80MG/ML;16MG/ML SUSPENSION; ORAL BACTRIM MUTUAL PHARM 200MG/5ML;40MG/5ML BACTRIM PEDIATRIC MUTUAL PHARM 200MG/5ML;40MG/5ML SEPTRA MONARCH PHARMS 200MG/5ML;40MG/5ML SEPTRA GRAPE MONARCH PHARMS 200MG/5ML;40MG/5ML SULFAMETHOXAZOLE AND TRIMETHOPRIM TEVA 200MG/5ML;40MG/5ML 200MG/5ML;40MG/5ML 200MG/5ML;40MG/5ML TEVA PHARMS 200MG/5ML;40MG/5ML SULFATRIM ACTAVIS MID ATLANTIC 200MG/5ML;40MG/5ML SULMEPRIM USL PHARMA 200MG/5ML;40MG/5ML SULMEPRIM PEDIATRIC USL PHARMA 200MG/5ML;40MG/5ML TRIMETH/SULFA ALPHARMA US PHARMS 200MG/5ML;40MG/5ML 200MG/5ML;40MG/5ML NASKA 200MG/5ML;40MG/5ML TABLET; ORAL COTRIM TEVA 400MG;80MG COTRIM D.S. TEVA 800MG;160MG SULFAMETHOXAZOLE AND TRIMETHOPRIM HEATHER 400MG;80MG 800MG;160MG INTERPHARM 400MG;80MG 800MG;160MG MARTEC USA LLC 400MG;80MG MUTUAL PHARM 400MG;80MG 400MG;80MG PLIVA 400MG;80MG
001 001 001 001 001 001 001 001 Dec Dec Dec Apr Sep Dec 29, 29, 29, 29, 11, 29, 1987 1987 1987 1992 1992 1987
N017560 N017560 N017598 N017598 A070028 N018812 N018812 A077612 N018615 A070063 A070064 A072289 A072398 A072399
001 002 001 002 001 001 002 001 002 001 001 001 001 001 Feb 12, 1986 Jun Jan Jun Nov 02, 28, 10, 13, 1987 1983 1983 2006
Jan 07, 1983 Aug 01, 1986 Aug 01, 1986 May 23, 1988 May 23, 1988 May 23, 1988
A070034 A070048 N018946 N018946 A071299 A071300 A072408 A070006 A071016 A070215
001 001 001 002 001 001 001 001 001 001
May 16, 1985 Mar 18, 1985 Aug Aug Oct Oct Dec Nov Aug Sep 10, 10, 27, 27, 07, 14, 25, 10, 1984 1984 1987 1987 1988 1984 1986 1985
A070216 A072768 A070889 N018598 A070890 N018242 N018242 A070203 A070204 A070002 N018852 A070000 A072417 A070007 A072769 N018854 A070066 A070065 A071816 A071815
001 001 001 003 001 001 002 001 001 001 001 001 001 001 001 001 001 002 001 001
Jun 24, 1985 Jun 24, 1985 Sep 28, 1987 Sep 28, 1987
SULFANILAMIDE
CREAM; VAGINAL SULFANILAMIDE TEVA SUPPOSITORY; VAGINAL AVC AZUR PHARMA
15%
A088718
001
1.05GM
N006530
004
SULFAPHENAZOLE
SUSPENSION; ORAL SULFABID PHARM RES ASSOC TABLET; ORAL SULFABID PURDUE FREDERICK
500MG/5ML
N013093
001
500MG
N013092
002
SULFAPYRIDINE
TABLET; ORAL SULFAPYRIDINE LILLY
500MG
N000159
001
SULFASALAZINE
SUSPENSION; ORAL AZULFIDINE PHARMACIA AND UPJOHN TABLET; ORAL S.A.S.-500 SOLVAY SULFASALAZINE HERITAGE PHARMS INC MUTUAL PHARM SANDOZ SUPERPHARM WATSON LABS
250MG/5ML
N018605
001
A088052
001
SULFINPYRAZONE
CAPSULE; ORAL ANTURANE NOVARTIS SULFINPYRAZONE BARR IVAX PHARMS PAR PHARM VANGARD TABLET; ORAL ANTURANE NOVARTIS SULFINPYRAZONE BARR IVAX PHARMS PAR PHARM WATSON LABS
004 001 001 001 001 Sep Nov Sep Feb 17, 19, 06, 17, 1982 1982 1985 1984
003 001 001 001 001 Sep Jun Sep May 17, 01, 06, 26, 1982 1982 1985 1982
SULFISOXAZOLE
TABLET; ORAL GANTRISIN ROCHE SOSOL MK LABS SOXAZOLE ALRA SULFALAR PARKE DAVIS SULFISOXAZOLE BARR HEATHER IMPAX LABS IVAX SUB TEVA PHARMS LANNETT LEDERLE PHARMERAL PUREPAC PHARM ROXANE SANDOZ VALEANT PHARM INTL VITARINE WATSON LABS WEST WARD SULSOXIN SOLVAY
500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG
N006525 A080036 A080366 A084955 A084031 A080189 A080109 A080142 A080085 A087649 A084385 A080087 A080082 A085628 A080268 A087332 A085534 A080379 A080040
001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001
SULFISOXAZOLE ACETYL
EMULSION; ORAL LIPO GANTRISIN ROCHE SUSPENSION; ORAL GANTRISIN PEDIATRIC ROCHE SYRUP; ORAL GANTRISIN ROCHE
EQ 1GM BASE/5ML
N009182
009
EQ 500MG BASE/5ML
N009182
004
EQ 500MG BASE/5ML
N009182
002
400MG BASE/ML
N006917
001
4% BASE
N008414
002
4% BASE 4% BASE
N007757 A084148
002 001
SULFOXONE SODIUM
TABLET, DELAYED RELEASE; ORAL DIASONE SODIUM ABBOTT 165MG
N006044
003
SULFUR
POWDER; TOPICAL BENSULFOID POYTHRESS
33.32%
N002918
001
SULINDAC
TABLET; ORAL CLINORIL MERCK SULINDAC HERITAGE PHARMS INC SANDOZ TEVA
001 002 001 001 001 001 001 Sep Sep Aug Aug Feb Feb 06, 06, 30, 30, 28, 28, 1991 1991 1991 1991 1992 1992
SUMATRIPTAN
SPRAY; NASAL IMITREX GLAXOSMITHKLINE
10MG/SPRAY
N020626
002
SUMATRIPTAN SUCCINATE
INJECTABLE; SUBCUTANEOUS SUMATRIPTAN SUCCINATE TEVA PARENTERAL TABLET; ORAL SUMATRIPTAN SUCCINATE ROXANE
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
A078318 A078318
001 002
SUPROFEN
SOLUTION/DROPS; OPHTHALMIC PROFENAL ALCON 1%
N019387
001
SUTILAINS
OINTMENT; TOPICAL TRAVASE ABBOTT
82,000 UNITS/GM
N012828
001
EQ EQ EQ EQ
TALBUTAL
TABLET; ORAL LOTUSATE SANOFI AVENTIS US
120MG
N009410
005
TAMOXIFEN CITRATE
SOLUTION; ORAL SOLTAMOX ROSEMONT TABLET; ORAL NOLVADEX ASTRAZENECA TAMOXIFEN CITRATE IVAX SUB TEVA PHARMS PHARMACHEMIE ROXANE TEVA
EQ 10MG BASE/5ML
N021807
001
EQ 10MG BASE EQ 20MG BASE EQ EQ EQ EQ EQ EQ EQ 10MG 20MG 10MG 10MG 20MG 10MG 20MG BASE BASE BASE BASE BASE BASE BASE
Mar 21, 1994 Feb Feb Mar Feb Feb Apr Apr 20, 20, 31, 20, 20, 28, 28, 2003 2003 2003 2003 2003 2003 2003
5mCi/ML
N017848
001
N/A
N018263
001
N/A
N017775
001
N/A
N017832
001
N/A
N020887
001
N/A
N021012
001
N/A
N017045
001
N/A N/A
N017907 N018272
N/A
N018489
001
N/A
N018035
001
N/A
N017255
001
N017264
002
N017664
001
N/A
N017684
001
N/A
N017680
001
N/A
N020063
001
N/A
N019785
003
N017339 N017693
001 001
N017456
001
N017724
001
N/A
N019928
001
TEGASEROD MALEATE
TABLET; ORAL ZELNORM NOVARTIS
N021200 N021200
001 002
TELBIVUDINE
SOLUTION; ORAL TYZEKA NOVARTIS
100MG/5ML
N022154
001
TEMAZEPAM
CAPSULE; ORAL TEMAZ QUANTUM PHARMICS TEMAZEPAM DURAMED PHARMS BARR MUTUAL PHARM USL PHARMA WATSON LABS
15MG 30MG 15MG 30MG 15MG 30MG 15MG 30MG 15MG 30MG
A070564 A070547 A071708 A071709 A071174 A071175 A070489 A070490 A070383 A070384
001 001 001 001 001 001 001 001 001 001
Oct 15, 1985 Oct 15, 1985 Sep Sep Jul Jul Jul Jul Mar Mar 29, 29, 10, 10, 07, 07, 23, 23, 1988 1988 1986 1986 1986 1986 1987 1987
TERAZOSIN HYDROCHLORIDE
CAPSULE; ORAL TERAZOSIN HYDROCHLORIDE MYLAN TECHNOLOGIES EQ EQ EQ EQ SANDOZ EQ EQ EQ EQ TABLET; ORAL TERAZOSIN HYDROCHLORIDE IVAX SUB TEVA PHARMS EQ EQ EQ EQ SANDOZ EQ EQ EQ EQ EQ EQ EQ EQ TEVA EQ EQ EQ EQ
1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE
1MG BASE 2MG BASE 5MG BASE 10MG BASE 1MG BASE 1MG BASE 2MG BASE 2MG BASE 5MG BASE 5MG BASE 10MG BASE 10MG BASE 1MG BASE 2MG BASE 5MG BASE 10MG BASE
A074530 A074530 A074530 A074530 A074315 A074657 A074315 A074657 A074315 A074657 A074315 A074657 A074446 A074446 A074446 A074446
001 002 003 004 001 001 002 002 003 003 004 004 001 002 003 004
Apr Apr Apr Apr Dec Apr Dec Apr Dec Apr Dec Apr May May May May
21, 21, 21, 21, 31, 28, 31, 28, 31, 28, 31, 28, 18, 18, 18, 18,
2000 2000 2000 2000 1998 2000 1998 2000 1998 2000 1998 2000 2000 2000 2000 2000
1%
N020846
001
TERBINAFINE HYDROCHLORIDE
CREAM; TOPICAL LAMISIL NOVARTIS 1% SOLUTION; TOPICAL LAMISIL NOVARTIS 1% TABLET; ORAL TERBINAFINE HYDROCHLORIDE GEDEON RICHTER USA EQ 250MG BASE ROXANE EQ 250MG BASE
N020192
001
N020749
001
A077065 A077223
001 001
TERBUTALINE SULFATE
AEROSOL, METERED; INHALATION BRETHAIRE NOVARTIS 0.2MG/INH BRICANYL SANOFI AVENTIS US 0.2MG/INH INJECTABLE; INJECTION BRETHINE AAIPHARMA LLC 1MG/ML BRICANYL SANOFI AVENTIS US 1MG/ML TABLET; ORAL BRETHINE LEHIGH VALLEY 2.5MG 5MG BRICANYL SANOFI AVENTIS US 2.5MG 5MG
N018762 N018000
001 001
N018571 N017466
001 001
TERIPARATIDE ACETATE
INJECTABLE; INJECTION PARATHAR SANOFI AVENTIS US
200 UNITS/VIAL
N019498
001
0.75MG/3ML (0.25MG/ML)
N021318
001
TESTOLACTONE
INJECTABLE; INJECTION TESLAC BRISTOL MYERS SQUIBB TABLET; ORAL TESLAC BRISTOL MYERS SQUIBB
100MG/ML
N016119
001
50MG 250MG
N016118 N016118
001 002
TESTOSTERONE
FILM, EXTENDED RELEASE; TRANSDERMAL ANDRODERM WATSON LABS 2.5MG/24HR 5MG/24HR TESTODERM ALZA 4MG/24HR 6MG/24HR
Sep 29, 1995 May 02, 1997 Oct 12, 1993 Oct 12, 1993
N020791
001
TESTOSTERONE CYPIONATE
INJECTABLE; INJECTION DEPO-TESTOSTERONE PHARMACIA AND UPJOHN TESTOSTERONE CYPIONATE WATSON LABS
TESTOSTERONE ENANTHATE
INJECTABLE; INJECTION DELATESTRYL ENDO PHARM TESTOSTERONE ENANTHATE WATSON LABS
TESTOSTERONE PROPIONATE
INJECTABLE; INJECTION TESTOSTERONE PROPIONATE BEL MAR 25MG/ML 50MG/ML 100MG/ML ELKINS SINN 25MG/ML LILLY 50MG/ML WATSON LABS 25MG/ML 25MG/ML 50MG/ML 50MG/ML 100MG/ML 100MG/ML
A080741 A080742 A080743 A080276 A080254 A080188 A085490 A080188 A085490 A080188 A083595
001 001 001 001 002 001 001 002 002 003 003
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL ACHROMYCIN V HERITAGE PHARMS INC BRISTACYCLINE BRISTOL
500MG 500MG 250MG 250MG 500MG 250MG 500MG 100MG 125MG 250MG 500MG
A061725 A062332 A060347 A061443 A061443 A061734 A061734 A060429 A060429 A060429 A060429 A060343 A060343 A061802 A061802 A060059 A060173 A060173 A061148 A061148 A062752 A062752 A062085 A060736 A060736 A060783 A060783 A060290 A060290 A062686 A062686 A061214 A061471 A062540 A062540 A060471 A060471 A062300 A062300 A062103 A062343 A062103 A062343 A060768 A060768 A061685 A061685 A060082 A060082
002 002 001 001 002 001 002 002 004 001 003 001 003 001 002 001 001 002 001 002 001 002 001 001 002 001 002 001 002 001 002 002 001 001 002 001 002 001 002 001 001 002 002 001 002 001 002 003 004
250MG 500MG TETRACYCLINE HYDROCHLORIDE ABBOTT 250MG 500MG ELKINS SINN 250MG FERRANTE 125MG 250MG HEATHER 250MG 500MG LABS ATRAL 250MG 500MG MAST MM 250MG MUTUAL PHARM 250MG 500MG MYLAN 250MG 500MG PUREPAC PHARM 250MG 500MG PVT FORM 250MG 500MG ROXANE 500MG SANDOZ 250MG SUPERPHARM 250MG 500MG VALEANT PHARM INTL 250MG 500MG WARNER CHILCOTT 250MG 500MG WATSON LABS 250MG 250MG 500MG 500MG WEST WARD 250MG 500MG WYETH AYERST 250MG 500MG TETRACYN PFIPHARMECS 250MG 500MG FIBER, EXTENDED RELEASE; PERIODONTAL ACTISITE SCHIFF AND CO 12.7MG/FIBER
TETRACHEL ANGUS
N050653
001
2.2MG/ML
N050493
001
OINTMENT; OPHTHALMIC ACHROMYCIN STORZ 10MG/GM SUSPENSION; ORAL ACHROMYCIN V LEDERLE 125MG/5ML SUMYCIN PAR PHARM 125MG/5ML TETRACYCLINE HYDROCHLORIDE ALPHARMA US PHARMS 125MG/5ML FERRANTE 125MG/5ML PROTER 125MG/5ML PUREPAC PHARM 125MG/5ML TETRACYN PFIPHARMECS 125MG/5ML TETRAMED IVAX SUB TEVA PHARMS 125MG/5ML SUSPENSION/DROPS; OPHTHALMIC ACHROMYCIN STORZ 1% TABLET; ORAL PANMYCIN PHARMACIA AND UPJOHN 250MG 500MG SUMYCIN PAR PHARM 50MG 100MG 250MG 500MG
N050266
001
N050268
001
EQ EQ EQ EQ EQ EQ EQ
N018548 A075569
001 001
THEOPHYLLINE
CAPSULE; ORAL BRONKODYL SANOFI AVENTIS US
100MG 200MG
A085264 A085264
001 002
A085545 A083921 A087155 A087155 A087155 A085263 A085263 A084731 A084731 A084731
001 001 001 002 003 001 002 002 001 003
Jul 31, 1984 Jul 31, 1984 Feb 25, 1985 Feb 25, 1985 Feb 25, 1985
100MG 200MG SCHERER RP 100MG 200MG 250MG CAPSULE, EXTENDED RELEASE; ORAL AEROLATE III FLEMING PHARMS 65MG AEROLATE JR FLEMING PHARMS 130MG AEROLATE SR FLEMING PHARMS 260MG ELIXOPHYLLIN SR FOREST LABS 125MG 250MG SLO-BID SANOFI AVENTIS US 50MG 75MG 100MG 125MG 200MG 300MG SLO-PHYLLIN SANOFI AVENTIS US 60MG 125MG 250MG SOMOPHYLLIN-CRT GRAHAM DM 50MG 100MG 200MG 250MG 300MG THEOBID WHITBY 260MG THEOBID JR. WHITBY 130MG THEOCLEAR L.A.-130 SCHWARZ PHARMA 130MG THEOCLEAR L.A.-260 SCHWARZ PHARMA 260MG THEO-DUR SCHERING 50MG 75MG 125MG 200MG THEOPHYLLINE CENT PHARMS 125MG 250MG HOSPIRA 100MG 200MG 300MG SANDOZ 260MG
THEOPHYLLINE KV PHARM
A085075 A085075 A085075 A086826 A086826 A088269 A089539 A087892 A089540 A087893 A087894 A085206 A085203 A085205 A087763 A087194 A088382 A087193 A088383 A085983 A087854 A086569 A086569 A088022 A088015 A088016 A087995 A088654 A088689 A089976 A089977 A089932 A087462
003 002 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001 001 001
Nov 24, 1986 Nov 24, 1986 Nov 24, 1986 Jan 29, 1985 Jan 29, 1985 Jan May Jan May Jan Jan 31, 10, 31, 10, 31, 31, 1985 1989 1985 1989 1985 1985
May 24, 1982 May 24, 1982 May 24, 1982 Feb 27, 1985 Feb 27, 1985 Feb 27, 1985 Mar 20, 1985 Mar 20, 1985 May 27, 1982 May 27, 1982 Sep Sep Sep Sep Feb Feb Jan Jan Jan May 10, 10, 10, 10, 12, 12, 04, 04, 04, 11, 1985 1985 1985 1985 1985 1985 1995 1995 1995 1982
Jun 12, 1986 Feb 08, 1985 Feb 08, 1985 Jan 31, 1985 Jan 31, 1985
A088303 A084578 A084559 A086485 A089223 A087679 A085169 A085952 A086720 A085863 A084739 A089626 A086748
001 001 001 001 001 001 001 001 001 001 001 001 001
N019083 N019083 N019083 N019212 N019826 N019212 N019212 N019826 N019211 N019211 N019211
001 002 003 001 004 003 002 005 002 004 005
Nov 07, 1984 Nov 07, 1984 Nov 07, 1984 Nov 07, 1984 Aug 14, 1992 Nov 07, 1984 Nov 07, 1984 Aug 14, 1992 Dec 14, 1984 Dec 14, 1984 Dec 14, 1984
A085502
001
100MG ORAL 100MG 200MG 300MG 250MG 300MG 100MG 300MG 100MG 200MG 300MG 450MG 200MG 250MG 300MG 500MG 300MG 400MG 450MG 600MG 200MG 400MG 600MG 400MG 600MG
A086506
001
A088503 A088504 A088505 A087225 A087563 A085665 A085665 A085328 A086998 A085328 A089131 A088369 A086363 A088364 A089132 A040548 A040543 A040546 A040539 A088253 A089822 A089823 A087571 A040086
001 001 001 001 001 001 002 001 001 002 001 001 002 001 001 001 001 001 001 001 001 001 001 001
LABID WARNER CHILCOTT QUIBRON-T/SR MONARCH PHARMS SUSTAIRE ROERIG THEO-DUR SCHERING
Jun 25, 1986 Jul Jul Jul Jul Apr Apr Apr Apr 16, 16, 16, 16, 30, 27, 30, 27, 1987 1987 1987 1987 2004 2004 2004 2004
THEOLAIR-SR 3M
THEOPHYLLINE ABLE
T-PHYL PHARM RES ASSOC UNI-DUR SCHERING UNIPHYL PURDUE PHARM PRODS
Aug 17, 1983 Jan 04, 1995 Jan 04, 1995 Sep 01, 1982 Apr 15, 1996
EQ 165MG BASE/15ML
N006333
008
EQ 150MG BASE
A085148
001
THIABENDAZOLE
SUSPENSION; ORAL MINTEZOL MERCK TABLET, CHEWABLE; ORAL MINTEZOL MERCK
500MG/5ML
N016097
001
500MG
N016096
001
THIAMINE HYDROCHLORIDE
INJECTABLE; INJECTION BETALIN S LILLY THIAMINE HYDROCHLORIDE ABRAXIS PHARM AKORN BAXTER HLTHCARE BEL MAR DELL LABS HOSPIRA LUITPOLD PARKE DAVIS WATSON LABS WYETH AYERST
100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 200MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 100MG/ML 200MG/ML 100MG/ML
A080853 A080509 A087968 A080575 A080718 A080712 A083775 A040079 A080667 A080770 A083534 A083534 A080553
001 001 001 001 001 001 001 001 001 001 001 002 001
THIAMYLAL SODIUM
INJECTABLE; INJECTION SURITAL PARKEDALE
THIETHYLPERAZINE MALATE
INJECTABLE; INJECTION TORECAN NOVARTIS
5MG/ML
N012754
002
THIETHYLPERAZINE MALEATE
SUPPOSITORY; RECTAL TORECAN NOVARTIS TABLET; ORAL TORECAN NOVARTIS
10MG
N013247
001
10MG
N012753
001
THIOPENTAL SODIUM
SUSPENSION; RECTAL PENTOTHAL ABBOTT
400MG/GM
N011679
001
THIORIDAZINE
SUSPENSION; ORAL MELLARIL-S NOVARTIS
N017923 N017923
001 002
30MG/ML 100MG/ML THIORIDAZINE HYDROCHLORIDE ACTAVIS MID ATLANTIC 100MG/ML ALPHARMA US PHARMS 30MG/ML HI TECH PHARMA 30MG/ML 100MG/ML PHARM ASSOC 30MG/ML 100MG/ML SANDOZ 30MG/ML 100MG/ML TEVA PHARMS 30MG/ML 100MG/ML WOCKHARDT 30MG/ML 100MG/ML THIORIDAZINE HYDROCHLORIDE INTENSOL ROXANE 30MG/ML 100MG/ML TABLET; ORAL MELLARIL NOVARTIS 10MG 15MG 25MG 50MG 100MG 150MG 200MG THIORIDAZINE HYDROCHLORIDE IVAX PHARMS 10MG 15MG 25MG 50MG 100MG MUTUAL PHARM 10MG 15MG 25MG 50MG 100MG 150MG 200MG MYLAN 10MG 25MG 50MG 100MG PAR PHARM 10MG 15MG 25MG 50MG 100MG 150MG 200MG ROXANE 10MG 25MG 50MG 100MG SANDOZ 10MG 15MG 25MG 50MG 100MG
N011808 N011808 A088229 A087766 A040125 A040126 A040187 A040213 A088307 A088308 A089602 A089603 A088258 A088227 A088941 A088942
012 018 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Aug Apr Aug Aug Aug May Nov Nov Nov Nov Jul Jul 23, 26, 16, 16, 28, 29, 23, 23, 09, 09, 25, 05, 1983 1983 1996 1996 1997 1998 1983 1983 1987 1987 1983 1983
N011808 N011808 N011808 N011808 N011808 N011808 N011808 A088270 A088271 A088272 A088194 A088273 A088375 A088461 A087264 A088370 A088379 A088737 A088738 A088332 A088333 A088334 A088335 A088351 A088352 A088336 A088322 A088480 A089764 A089765 A088663 A088664 A088665 A089048 A088131 A088132 A088133 A088134 A088135
003 016 006 011 009 017 015 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Apr Apr Apr Apr Oct Nov Nov Nov Nov Nov Sep Oct Jun Jun Jun Nov Dec Dec Dec Dec Dec Feb Feb Mar Mar Mar Feb Aug Aug Aug Aug Nov 14, 14, 14, 14, 03, 18, 18, 18, 18, 16, 26, 16, 27, 27, 27, 18, 05, 05, 05, 05, 29, 09, 09, 15, 15, 15, 26, 30, 30, 30, 30, 20, 1983 1983 1983 1983 1983 1983 1983 1983 1983 1983 1984 1984 1983 1983 1983 1983 1983 1983 1983 1983 1983 1988 1988 1984 1984 1984 1985 1983 1983 1983 1983 1984
A088136 A088137 A089103 A089104 A089105 A088493 A088456 A088412 A088476 A088561 A088345 A088477 A088562 A088296 A088478 A088567 A088755 A088323 A088479 A088563 A088284 A088564 A088736 A088410 A088869 A088381 A088872 A088658 A088659 A088660 A088661
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
Sep Sep Jul Jul Jul May May Sep Nov May Jul Nov May Jul Nov May Jul Jul Nov May Aug May Jul Mar Jun Mar Apr Mar Mar Mar Mar
17, 17, 02, 02, 02, 17, 17, 12, 08, 11, 28, 08, 11, 28, 08, 11, 24, 28, 08, 11, 25, 11, 24, 05, 28, 14, 26, 26, 26, 26, 26,
1986 1986 1985 1985 1985 1985 1985 1983 1983 1984 1983 1983 1984 1983 1983 1984 1984 1983 1983 1984 1983 1984 1984 1984 1985 1984 1985 1984 1984 1984 1984
THIOTEPA
INJECTABLE; INJECTION THIOPLEX IMMUNEX THIOTEPA APP PHARMS IMMUNEX TEVA PARENTERAL
Dec 22, 1994 Sep 20, 2001 Apr 20, 2001 Apr 20, 2001
THIOTHIXENE
CAPSULE; ORAL NAVANE PFIZER THIOTHIXENE AM THERAP
20MG 1MG 2MG 5MG 10MG 20MG 1MG 2MG 5MG 10MG 10MG
N016584 A071884 A071885 A071886 A071887 A072200 A070600 A071626 A071627 A070603 A071628
005 001 001 001 001 001 001 001 001 001 001 Aug Aug Aug Aug Dec Jun Jun Jun Jun Jun 12, 12, 12, 12, 17, 05, 25, 25, 05, 25, 1987 1987 1987 1987 1987 1987 1987 1987 1987 1987
WATSON LABS
001 001 001 001 001 001 001 Oct Sep Dec Jun Oct 16, 20, 16, 22, 16, 1987 1989 1988 1987 1987
N016904 N016904
001 002
THYROGLOBULIN
TABLET; ORAL PROLOID PARKE DAVIS
THYROTROPIN
INJECTABLE; INJECTION THYTROPAR SANOFI AVENTIS US
10 IU/VIAL
N008682
001
TIAGABINE HYDROCHLORIDE
TABLET; ORAL GABITRIL CEPHALON
20MG
N020646
004
TICARCILLIN DISODIUM
INJECTABLE; INJECTION TICAR GLAXOSMITHKLINE
EQ EQ EQ EQ EQ EQ
1GM BASE/VIAL 3GM BASE/VIAL 3GM BASE/VIAL 6GM BASE/VIAL 20GM BASE/VIAL 30GM BASE/VIAL
TICLOPIDINE HYDROCHLORIDE
TABLET; ORAL TICLID ROCHE PALO
125MG 250MG TICLOPIDINE HYDROCHLORIDE ACTAVIS ELIZABETH 250MG MYLAN 250MG SANDOZ 250MG WATSON LABS 250MG
Mar 24, 1993 Oct 31, 1991 Aug Nov Aug Apr 20, 02, 20, 26, 1999 1999 1999 2000
N018017 N018017 N018017 A072466 A072467 A072468 A072550 A072551 A072552 A072648 A072649 A072650 A072001 A072002 A072003 A072269 A072917 A072270 A072918 A072271 A072919
001 002 004 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 May May May Apr Apr Apr Jun Jun Jun Apr Apr Apr Apr Jul Apr Jul Apr Jul 19, 19, 19, 13, 13, 13, 16, 16, 16, 11, 11, 11, 11, 31, 11, 31, 11, 31, 1989 1989 1989 1989 1989 1989 1993 1993 1993 1989 1989 1989 1989 1991 1989 1991 1989 1991
TIOCONAZOLE
CREAM; TOPICAL TZ-3 PFIZER
1%
N018682
001
TIROFIBAN HYDROCHLORIDE
INJECTABLE; INJECTION AGGRASTAT MEDICURE
EQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML) N020912 EQ 25MG BASE/500ML (EQ 0.05MG BASE/ML) N020913
001 001
TIZANIDINE HYDROCHLORIDE
TABLET; ORAL TIZANIDINE HYDROCHLORIDE ACTAVIS ELIZABETH EQ EQ ACTAVIS TOTOWA EQ EQ BARR EQ EQ IVAX SUB TEVA PHARMS EQ EQ ZANAFLEX ACORDA EQ
2MG BASE
TOBRAMYCIN
SOLUTION/DROPS; OPHTHALMIC TOBRAMYCIN ALCON UNIVERSAL 0.3%
A063176
001
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
10MG BASE/ML 10MG BASE/ML 10MG BASE/ML 40MG BASE/ML 1.2GM BASE/VIAL 40MG 40MG 10MG 40MG 40MG 40MG 10MG 10MG 40MG 40MG 10MG 40MG 40MG BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML BASE/ML
A062008 A062707 N050477 A062008 N050519 A064021 A064026 A063119 A063120 A063121 A063122 A063113 A063128 A063118 A063127 A063080 A063161 A062945
004 001 005 001 001 002 001 001 001 001 001 001 001 001 001 001 001 002
BAXTER HLTHCARE
May May Oct Oct Oct Oct Apr Nov Jul Nov Apr May Aug
31, 31, 31, 31, 31, 31, 26, 27, 29, 27, 30, 29, 09,
1994 1994 1994 1994 1994 1994 1991 1991 1991 1991 1991 1991 1989
TOCAINIDE HYDROCHLORIDE
TABLET; ORAL TONOCARD ASTRAZENECA
400MG 600MG
N018257 N018257
001 002
TOLAZAMIDE
TABLET; ORAL TOLAZAMIDE BARR
MUTUAL PHARM
PAR PHARM
SANDOZ
WATSON LABS
100MG 250MG 500MG 100MG 250MG 500MG 250MG 500MG 100MG 250MG 500MG 100MG 250MG 500MG 100MG 250MG 500MG 100MG 250MG 500MG 250MG 500MG 100MG 250MG 500MG 100MG 100MG 250MG 500MG 100MG
A070162 A070163 A070164 A070165 A070166 A070167 A071270 A071271 N018894 N018894 N018894 A071357 A071358 A071359 A070159 A070160 A070161 A071633 A070289 A070290 A070763 A070764 A071355 A070168 A070169 A070242 A070513 A070243 A070244 N015500
001 001 001 001 001 001 001 001 001 002 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002
Jan Jan Jan Jan Jan Jan Sep Sep Nov Nov Nov Jul Jul Jul Jan Jan Jan Dec Mar Mar Jun Jun Jan Apr Apr Aug Jan Aug Aug
14, 14, 14, 10, 10, 10, 23, 23, 02, 02, 02, 16, 16, 16, 06, 06, 06, 09, 13, 13, 16, 16, 11, 02, 02, 01, 09, 01, 01,
1986 1986 1986 1986 1986 1986 1986 1986 1984 1984 1984 1987 1987 1987 1986 1986 1986 1987 1986 1986 1986 1986 1988 1986 1986 1986 1986 1986 1986
TOLAZAMIDE
TABLET; ORAL TOLINASE PHARMACIA AND UPJOHN
250MG 500MG
N015500
004 N015500
005
TOLAZOLINE HYDROCHLORIDE
INJECTABLE; INJECTION PRISCOLINE NOVARTIS
25MG/ML
N006403
005
TOLBUTAMIDE
TABLET; ORAL ORINASE PHARMACIA AND UPJOHN TOLBUTAMIDE ALRA ASCOT BARR CLONMEL HLTHCARE IVAX PHARMS PARKE DAVIS PUREPAC PHARM SANDOZ SUPERPHARM VANGARD WATSON LABS
250MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 500MG 250MG 500MG
N010670
002 N010670
001 A086141 A087541 A087121 A086926 A087093 A086047 A088950 A086574 N012678 A088893 A087876 A089110 A089111 001 001 001 001 001 001 001 001 001 001 001 001 001
TOLBUTAMIDE SODIUM
INJECTABLE; INJECTION ORINASE DIAGNOSTIC PHARMACIA AND UPJOHN
EQ 1GM BASE/VIAL
N012095
001
TOLCAPONE
TABLET; ORAL TASMAR VALEANT PHARM INTL
200MG
N020697
002
TOLMETIN SODIUM
CAPSULE; ORAL TOLECTIN DS ORTHO MCNEIL JANSSEN TOLMETIN SODIUM ACTAVIS ELIZABETH IVAX SUB TEVA PHARMS MUTUAL PHARM SANDOZ TEVA TABLET; ORAL TOLECTIN ORTHO MCNEIL JANSSEN TOLECTIN 600 ORTHO MCNEIL JANSSEN TOLMETIN SODIUM ACTAVIS ELIZABETH IVAX SUB TEVA PHARMS SANDOZ TEVA
EQ 400MG BASE EQ EQ EQ EQ EQ 400MG 400MG 400MG 400MG 400MG BASE BASE BASE BASE BASE
001 001 001 001 001 001 Jan Jan Nov Apr May 24, 24, 27, 30, 29, 1992 1992 1991 1992 1992
EQ 200MG BASE EQ 600MG BASE EQ EQ EQ EQ EQ 600MG 600MG 200MG 600MG 600MG BASE BASE BASE BASE BASE
001 002 001 001 001 001 001 Mar 08, 1989 Jun Mar Jul Sep Feb 30, 28, 31, 27, 27, 1992 1996 1992 1993 1997
60MG
N022275
003
TOPIRAMATE
CAPSULE; ORAL TOPAMAX SPRINKLE JANSSEN PHARMS TOPIRAMATE BARR TABLET; ORAL TOPAMAX JANSSEN PHARMS TOPIRAMATE BARR
300MG 400MG 25MG 100MG 200MG 25MG 50MG 100MG 200MG 25MG 50MG 100MG 200MG
N020505 N020505 A076315 A076315 A076315 A077905 A077905 A077905 A077905 A076306 A076306 A076306 A076306
003 006 001 002 003 001 002 003 004 001 002 003 004
Dec 24, 1996 Dec 24, 1996 Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar Mar 27, 27, 27, 30, 30, 30, 30, 27, 27, 27, 27, 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009 2009
ROXANE
TOPOTECAN HYDROCHLORIDE
SOLUTION; INTRAVENOUS TOPOTECAN SANDOZ INC
EQ 1MG BASE/ML (EQ 1MG BASE/ML) EQ 3MG BASE/3ML (EQ 1MG BASE/ML) EQ 4MG BASE/4ML (EQ 1MG BASE/ML)
TORSEMIDE
INJECTABLE; INJECTION DEMADEX ROCHE
N020137 N020137
002 001
TRAMADOL HYDROCHLORIDE
TABLET; ORAL TRAMADOL HYDROCHLORIDE ACTAVIS ELIZABETH ASTA IVAX SUB TEVA PHARMS ULTRAM JANSSEN PHARMS
Jun 19, 2002 Jul 12, 2002 Jul 03, 2002 Mar 03, 1995
TRANEXAMIC ACID
TABLET; ORAL CYKLOKAPRON PHARMACIA AND UPJOHN
500MG
N019280
001
TRAVOPROST
SOLUTION/DROPS; OPHTHALMIC TRAVATAN ALCON PHARMS LTD 0.004%
N021257
001
N018207 N018207 N018207 N018207 A071139 A071140 A071405 A071406 A070921 A072484 A072483 A074357 A070491 A070492 A071112 A071113 A070942
001 002 003 004 001 001 001 001 001 001 001 001 001 001 001 001 001
Mar 25, 1985 Nov 07, 1988 Oct Oct Feb Feb Dec Apr Apr Apr Apr Apr Nov Nov 29, 29, 27, 27, 01, 30, 30, 30, 29, 29, 17, 17, 1986 1986 1991 1991 1986 1990 1990 1997 1987 1987 1986 1986
TRAZODONE HYDROCHLORIDE AM THERAP 50MG 100MG MYLAN 50MG 100MG QUANTUM PHARMICS 100MG 50MG SANDOZ 100MG 150MG TEVA 50MG USL PHARMA 100MG 50MG WATSON LABS 100MG TRIALODINE QUANTUM PHARMICS 50MG
TRETINOIN
CAPSULE; ORAL VESANOID ROCHE SOLUTION; TOPICAL TRETINOIN TEVA PHARMS SWAB; TOPICAL RETIN-A ORTHO JANSSEN
10MG
N020438
001
0.05%
A074873
001
0.05%
N016921
002
TRIAMCINOLONE
TABLET; ORAL ARISTOCORT ASTELLAS
1MG 2MG 4MG 8MG 16MG 1MG 2MG 4MG 8MG 2MG 2MG 4MG 4MG 8MG 8MG 4MG 4MG 2MG 2MG 4MG 2MG 4MG 8MG 4MG
N011161 N011161 N011161 N011161 N011161 N011283 N011283 N011283 N011283 A084286 A084318 A084267 A084319 A084268 A084320 A084340 A083750 A084406 A084020 A084020 A084708 A084709 A084707 A085601
009 004 007 011 010 003 008 006 010 001 001 001 001 001 001 001 001 001 002 003 001 001 001 001
TRIAMCINOLONE BARR
IMPAX LABS IVAX SUB TEVA PHARMS MYLAN PUREPAC PHARM ROXANE
SANDOZ
TRIAMCINOLONE ACETONIDE
AEROSOL, METERED; NASAL NASACORT SANOFI AVENTIS US CREAM; TOPICAL ARISTOCORT ASTELLAS
0.055MG/INH
N019798
001
0.025% 0.1% 0.5% 0.025% 0.025% 0.1% 0.1% 0.5% 0.5% 0.025% 0.1% 0.5% 0.5% 0.1% 0.1% 0.1% 0.1% 0.025% 0.025% 0.1% 0.025% 0.1% 0.5% 0.025% 0.1% 0.5% 0.025% 0.1% 0.5% 0.025% 0.025% 0.1% 0.5% 0.025% 0.1% 0.5% 0.025% 0.1% 0.5%
A083017 A083016 A083015 A083017 A088818 A083016 A088819 A083015 A088820 A085539 A085539 A085539 A083943 A086240 A084908 A087113 A087798 A087797 A087932 A089798 A088094 A088095 A088096 A087990 A087991 A087992 A087921 A087912 A087922 A040038 A089274 A089275 A089276 A087430 A087429 A087428 A088196 A088197 A088198
003 004 002 004 001 005 001 003 001 001 002 003 001 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Jun Jun May May Sep Sep Sep Jul Jul Jul Aug Aug Aug Oct Feb Feb Feb 04, 07, 09, 31, 01, 01, 01, 07, 07, 07, 10, 10, 10, 26, 21, 21, 21, 1982 1982 1983 1991 1983 1983 1983 1983 1983 1983 1982 1982 1982 1994 1989 1989 1989
ARISTOCORT A ASTELLAS
KENALOG APOTHECON KENALOG-H APOTHECON TRIACET TEVA TRIACORT SOLVAY TRIAMCINOLONE ACETONIDE ACTAVIS MID ATLANTIC ALPHARMA US PHARMS AMBIX G AND W LABS MORTON GROVE
PHARMADERM
PHARMAFAIR
TARO TOPIDERM
Nov 01, 1988 Nov 01, 1988 Nov 01, 1988 Mar 25, 1983 Mar 25, 1983 Mar 25, 1983
0.1%
A083380
001
3MG/ML 40MG/ML
N019503 A085825
001 001
001 002 003 001 001 001 Sep 08, 1982 Sep 08, 1982
TRIAMCINOLONE ACETONIDE ALPHARMA US PHARMS 0.025% 0.1% OINTMENT; TOPICAL ARISTOCORT ASTELLAS 0.1% 0.5% ARISTOCORT A ASTELLAS 0.1% 0.1% 0.5% 0.5% FLUTEX IVAX PHARMS 0.025% 0.1% 0.5% KENALOG APOTHECON 0.5% TRIAMCINOLONE ACETONIDE ACTAVIS MID ATLANTIC 0.1% ALPHARMA US PHARMS 0.5% G AND W LABS 0.025% 0.1% MORTON GROVE 0.025% 0.1% 0.5% PHARMADERM 0.025% 0.1% TRYMEX SAVAGE LABS 0.025% 0.1% PASTE; DENTAL KENALOG IN ORABASE APOTHECON 0.1% ORALONE TARO 0.1% SPRAY, METERED; NASAL ALLERNAZE LUPIN ATLANTIS 0.05MG/SPRAY NASACORT HFA SANOFI AVENTIS US 0.055MG/SPRAY
A080750 A080745 A080750 A088780 A080745 A088781 A087375 A087377 A087376 A083944 A087799 A089913 A089795 A089796 A088090 A088091 A088092 A088692 A088690 A088693 A088691
004 002 003 001 003 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 Jun Dec Dec Dec Sep Sep Sep Aug Aug 07, 23, 23, 23, 01, 01, 01, 02, 02, 1982 1988 1988 1988 1983 1983 1983 1984 1984
Oct 01, 1984 Oct 05, 1984 Nov 01, 1988 Nov 01, 1988 Nov 01, 1988
N012097 A071383
N020120 N020784
001 001
TRIAMCINOLONE DIACETATE
INJECTABLE; INJECTION ARISTOCORT SANDOZ
25MG/ML 40MG/ML
A084072 A085529
001 001
N011960 N012515
004 001
TRIAZOLAM
TABLET; ORAL HALCION PHARMACIA AND UPJOHN
0.5MG
N017892
002
TRICHLORMETHIAZIDE
TABLET; ORAL METAHYDRIN SANOFI AVENTIS US NAQUA SCHERING TRICHLOREX LANNETT TRICHLORMAS MAST MM TRICHLORMETHIAZIDE IMPAX LABS PAR PHARM SANDOZ TG UNITED LABS WATSON LABS
2MG 4MG 2MG 4MG 4MG 4MG 4MG 4MG 2MG 4MG 4MG 4MG 2MG 2MG 4MG 4MG 4MG
N012594 N012594 N012265 N012265 A083436 A085630 A086259 A083967 A087007 A087005 A086171 A085568 A083847 A086458 A083462 A083855 A085962
001 002 001 002 001 001 001 001 001 001 001 001 001 001 001 001 001
TRICLOFOS SODIUM
SOLUTION; ORAL TRICLOS SANOFI AVENTIS US TABLET; ORAL TRICLOS SANOFI AVENTIS US
1.5GM/15ML
N016830
001
750MG
N016809
002
TRIDIHEXETHYL CHLORIDE
INJECTABLE; INJECTION PATHILON LEDERLE TABLET; ORAL PATHILON LEDERLE
10MG/ML
N009729
001
25MG
N009489
005
TRIFLUOPERAZINE HYDROCHLORIDE
CONCENTRATE; ORAL STELAZINE GLAXOSMITHKLINE EQ 10MG BASE/ML TRIFLUOPERAZINE HYDROCHLORIDE SANDOZ EQ 10MG BASE/ML
N011552 A085787
A088143
001
N011552
005
N011552 N011552 N011552 N011552 A088967 A088968 A088969 A088970 A087612 A087613 A087328 A087614 A040153 A040153 A040153 A040153 A085975 A085976 A085973 A088710
001 002 003 004 001 001 001 001 001 001 001 001 001 002 003 004 001 001 001 001 Apr Apr Apr Apr Nov Nov Nov Nov Oct Oct Oct Oct Jun Jun Jun Jun 23, 23, 23, 23, 19, 19, 19, 19, 25, 25, 25, 25, 23, 23, 23, 23, 1985 1985 1985 1985 1982 1982 1982 1982 1996 1996 1996 1996 1988 1988 1988 1988
TRIFLUPROMAZINE
SUSPENSION; ORAL VESPRIN APOTHECON
EQ 50MG HCL/5ML
N011491
004
TRIFLUPROMAZINE HYDROCHLORIDE
INJECTABLE; INJECTION VESPRIN APOTHECON
TRIHEXYPHENIDYL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL ARTANE LEDERLE 5MG 5MG ELIXIR; ORAL ARTANE LEDERLE 2MG/5ML TRIHEXYPHENIDYL HYDROCHLORIDE PHARM VENTURES 2MG/5ML TABLET; ORAL ARTANE LEDERLE 2MG 5MG TREMIN SCHERING 2MG
N006773 N012947
010 001
N006773 A089514
TRILOSTANE
CAPSULE; ORAL MODRASTANE BIOENVISION
30MG 60MG
N018719 N018719
002 001
TRIMEPRAZINE TARTRATE
CAPSULE, EXTENDED RELEASE; ORAL TEMARIL ALLERGAN HERBERT EQ 5MG BASE SYRUP; ORAL TEMARIL ALLERGAN HERBERT EQ 2.5MG BASE/5ML TRIMEPRAZINE TARTRATE ALPHARMA US PHARMS EQ 2.5MG BASE/5ML MORTON GROVE EQ 2.5MG BASE/5ML TABLET; ORAL TEMARIL ALLERGAN HERBERT EQ 2.5MG BASE
N011316
004
N011316
001
TRIMETHADIONE
CAPSULE; ORAL TRIDIONE ABBOTT SOLUTION; ORAL TRIDIONE ABBOTT
300MG
N005856
005
200MG/5ML
N005856
002
TRIMETHAPHAN CAMSYLATE
INJECTABLE; INJECTION ARFONAD ROCHE
50MG/ML
N008983
001
TRIMETHOBENZAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION TRIMETHOBENZAMIDE HYDROCHLORIDE SMITH AND NEPHEW 100MG/ML 100MG/ML SOLOPAK 100MG/ML WATSON LABS 100MG/ML 100MG/ML
TRIMETHOPRIM
TABLET; ORAL PROLOPRIM MONARCH PHARMS TRIMETHOPRIM MUTUAL PHARM TRIMPEX ROCHE
200MG
N017952
002
TRIMETHOPRIM HYDROCHLORIDE
SOLUTION; ORAL PRIMSOL FSC
EQ 25MG BASE/5ML
A074374
001
TRIMETREXATE GLUCURONATE
INJECTABLE; INJECTION NEUTREXIN MEDIMMUNE ONCOLOGY
N020326 N020326
001 002
TRIMIPRAMINE MALEATE
CAPSULE; ORAL TRIMIPRAMINE MALEATE USL PHARMA
TRIOXSALEN
TABLET; ORAL TRISORALEN VALEANT PHARM INTL
5MG
N012697
001
TRIPELENNAMINE CITRATE
ELIXIR; ORAL PBZ NOVARTIS
EQ 25MG HCL/5ML
N005914
004
TRIPELENNAMINE HYDROCHLORIDE
TABLET; ORAL PBZ NOVARTIS
25MG 50MG TRIPELENNAMINE HYDROCHLORIDE ANABOLIC 50MG BARR 50MG HEATHER 50MG IMPAX LABS 50MG LANNETT 50MG NYLOS 50MG PARKE DAVIS 25MG 50MG WATSON LABS 50MG 50MG 50MG TABLET, EXTENDED RELEASE; ORAL PBZ-SR NOVARTIS 50MG 100MG
A083149 N005914 A083037 A080744 A083989 A080785 A083557 A085412 A083625 A083626 A080713 A080790 A085188
001 002 001 001 001 001 001 001 001 001 001 001 001
N010533 N010533
002 001
TRIPROLIDINE HYDROCHLORIDE
SYRUP; ORAL ACTIDIL GLAXOSMITHKLINE 1.25MG/5ML MYIDYL USL PHARMA 1.25MG/5ML TRIPROLIDINE HYDROCHLORIDE ALPHARMA US PHARMS 1.25MG/5ML HALSEY 1.25MG/5ML PHARM ASSOC 1.25MG/5ML TABLET; ORAL ACTIDIL GLAXOSMITHKLINE 2.5MG TRIPROLIDINE HYDROCHLORIDE VITARINE 2.5MG WATSON LABS 2.5MG
TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE)
SUSPENSION; ORAL LANTRISUL LANNETT NEOTRIZINE LILLY SULFALOID FOREST PHARMS SULFOSE WYETH AYERST TERFONYL BRISTOL MYERS SQUIBB TRIPLE SULFA ALPHARMA US PHARMS TRIPLE SULFAS LEDERLE TABLET; ORAL NEOTRIZINE LILLY SULFALOID FOREST PHARMS SULFA-TRIPLE #2 IMPAX LABS SULFOSE WYETH AYERST TERFONYL BRISTOL MYERS SQUIBB TRIPLE SULFA PUREPAC PHARM TRIPLE SULFAS LEDERLE
167MG;167MG;167MG
A080094
001
TROGLITAZONE
TABLET; ORAL PRELAY SANKYO
Jan 29, 1997 Aug 04, 1997 Jan 29, 1997 Jan 29, 1997 Aug 04, 1997 Jan 29, 1997
10%
N011340
002
TROLEANDOMYCIN
CAPSULE; ORAL TAO PFIZER SUSPENSION; ORAL TAO PFIZER
EQ 250MG BASE
N050336
002
EQ 125MG BASE/5ML
N050332
001
TROPICAMIDE
SOLUTION/DROPS; OPHTHALMIC MYDRIACYL ALCON 0.5% 1% MYDRIAFAIR PHARMAFAIR 0.5% 1% TROPICAMIDE AKORN 1% ALCON UNIVERSAL 1% MIZA PHARMS USA 0.5% 1% WATSON LABS 0.5%
002 004 001 001 001 001 001 001 001 Sep 16, 1983 Sep 16, 1983 Aug Dec Jul Aug Dec 28, 28, 30, 09, 28, 1985 1990 1982 1982 1990
TROVAFLOXACIN MESYLATE
TABLET; ORAL TROVAN PFIZER
N020759 N020759
001 002
TUBOCURARINE CHLORIDE
INJECTABLE; INJECTION TUBOCURARINE CHLORIDE BRISTOL MYERS SQUIBB HOSPIRA LILLY
TYROPANOATE SODIUM
CAPSULE; ORAL BILOPAQUE GE HEALTHCARE
750MG
N013731
001
N021214
001
URACIL MUSTARD
CAPSULE; ORAL URACIL MUSTARD SHIRE
1MG
N012892
001
UREA
INJECTABLE; INJECTION STERILE UREA HOSPIRA UREAPHIL HOSPIRA
40GM/VIAL 40GM/VIAL
N017698 N012154
001 001
UREA C-13
FOR SOLUTION; ORAL HELICOSOL METABOLIC SOLUTIONS 125MG/VIAL MERETEK UBT KIT (W/ PRANACTIN) OTSUKA AMERICA 125MG/VIAL PYLORI-CHEK BREATH TEST DXS DEVICES 100MG/VIAL
UROFOLLITROPIN
INJECTABLE; INTRAMUSCULAR METRODIN SERONO 75 IU/AMP 150 IU/AMP INJECTABLE; SUBCUTANEOUS FERTINEX SERONO 75 IU/AMP 150 IU/AMP
N019415 N019415
002 003
N019415 N019415
005 004
UROKINASE
INJECTABLE; INJECTION KINLYTIC MICROBIX BIOSYSTEMS
URSODIOL
CAPSULE; ORAL ACTIGALL WATSON PHARMS
150MG
N019594
001
VALDECOXIB
TABLET; ORAL BEXTRA GD SEARLE
10MG 20MG
N021341 N021341
002 003
VALPROIC ACID
CAPSULE; ORAL VALPROIC ACID PAR PHARM SCHERER RP USL PHARMA SYRUP; ORAL VALPROIC ACID APOTEX INC
250MG/5ML
A077105
001
80MG 160MG
N020665 N020665
001 002
VANCOMYCIN HYDROCHLORIDE
FOR SOLUTION; ORAL VANCOCIN HYDROCHLORIDE VIROPHARMA VANCOLED LEDERLE INJECTABLE; INJECTION VANCOCIN HYDROCHLORIDE VIROPHARMA
EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ
500MG BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 1GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 2GM BASE/VIAL 5GM BASE/VIAL 10GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL 500MG BASE/VIAL 1GM BASE/VIAL
A060180 A062476 A062716 A062812 A060180 A062476 A062716 A062812 A062812 A062682 A062682 A062682 A062682 A062682 A062879 A062879 A062956 A062956
001 001 001 001 002 002 002 002 003 001 002 003 004 005 001 002 001 002
Mar Mar Nov Mar Mar Mar Nov Nov Jul Mar May May May
15, 13, 17, 21, 21, 13, 17, 17, 22, 30, 11, 11, 11,
1984 1987 1987 1986 1986 1987 1987 1987 1986 1988 1988 1988 1988
Aug 02, 1988 Aug 02, 1988 Aug 01, 1988 Aug 01, 1988
VASOPRESSIN TANNATE
INJECTABLE; INJECTION PITRESSIN TANNATE PARKE DAVIS
5PRESSOR UNITS/ML
N003402
001
VECURONIUM BROMIDE
INJECTABLE; INJECTION NORCURON ORGANON USA INC VECURONIUM BROMIDE BAXTER HLTHCARE HOSPIRA
Apr 30, 1984 Jan 03, 1992 Aug 23, 1999 Aug 23, 1999 Sep 11, 2001
VELAGLUCERASE ALFA
POWDER; IV (INFUSION) VPRIV SHIRE HUMAN GENETIC
200 UNITS/VIAL
N022575
002
VENLAFAXINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL EFFEXOR XR WYETH PHARMS INC EQ 100MG BASE
N020699
003
12.5MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE 25MG BASE 37.5MG BASE 50MG BASE 75MG BASE 100MG BASE
N020151 N020151 N020151 N020151 N020151 N020151 A078517 A078517 A078517 A078517 A078517 A077515 A077515 A077515 A077515 A077515
001 002 006 003 004 005 001 002 003 004 005 001 002 003 004 005
Dec Dec Dec Dec Dec Dec Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun
28, 28, 28, 28, 28, 28, 13, 13, 13, 13, 13, 13, 13, 13, 13, 13,
1993 1993 1993 1993 1993 1993 2008 2008 2008 2008 2008 2008 2008 2008 2008 2008
VERAPAMIL HYDROCHLORIDE
INJECTABLE; INJECTION CALAN GD SEARLE LLC
2.5MG/ML 2.5MG/ML
N018925 N019038 N018485 A070348 A072888 A070577 A070739 A070740 A070225 A070617 A072233 A073485 A070696 A070697 A070695
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001
ISOPTIN FSC 2.5MG/ML VERAPAMIL HYDROCHLORIDE ABRAXIS PHARM 2.5MG/ML BEDFORD 2.5MG/ML HOSPIRA 2.5MG/ML 2.5MG/ML 2.5MG/ML LUITPOLD 2.5MG/ML 2.5MG/ML MARSAM PHARMS LLC 2.5MG/ML 2.5MG/ML SMITH AND NEPHEW 2.5MG/ML 2.5MG/ML SOLOPAK 2.5MG/ML TABLET; ORAL CALAN GD SEARLE LLC 160MG ISOPTIN FSC 40MG 80MG 120MG VERAPAMIL HYDROCHLORIDE ACTAVIS ELIZABETH 80MG 120MG HERITAGE PHARMS INC 80MG 120MG MUTUAL PHARM 80MG 80MG 120MG 120MG PLIVA 40MG 80MG 120MG SANDOZ 40MG 80MG 120MG
May Jul Feb May May Nov Nov Feb Sep Jul Jul Jul
01, 28, 02, 06, 06, 12, 12, 26, 27, 31, 31, 31,
1986 1995 1987 1987 1987 1985 1985 1993 1993 1987 1987 1987
N018817 N018593 N018593 N018593 A071019 A070468 A071880 A071881 A070482 A071489 A070483 A071489 A072751 A072124 A072125 A073168 A071423 A071424
004 003 001 002 001 001 001 001 001 002 001 001 001 001 001 001 001 001
Feb 23, 1988 Nov 23, 1987 Mar 08, 1982 Mar 08, 1982 Sep Sep Apr Apr Sep Jan Sep Jan Feb Jan Jan Jul May May 24, 24, 05, 05, 24, 13, 24, 13, 23, 26, 26, 31, 24, 25, 1986 1986 1988 1988 1986 1988 1986 1988 1996 1989 1989 1992 1988 1988
A072922
001
130CSR UNIT
N005691
002
VIDARABINE
INJECTABLE; INJECTION VIRA-A PARKEDALE OINTMENT; OPHTHALMIC VIRA-A PARKEDALE
EQ 187.4MG BASE/ML
N050523
001
3%
N050486
001
VINBLASTINE SULFATE
INJECTABLE; INJECTION VELBAN LILLY VINBLASTINE SULFATE ABRAXIS PHARM HOSPIRA
VINCRISTINE SULFATE
INJECTABLE; INJECTION ONCOVIN LILLY
1MG/VIAL 1MG/ML 5MG/VIAL 1MG/ML 5MG/VIAL 1MG/ML 1MG/ML 1MG/ML 1MG/ML 1MG/VIAL 2MG/VIAL 5MG/VIAL
N014103 N014103 N014103 A071426 A070867 A070873 A070411 A076296 A076401 A071559 A071560 A071561
001 003 002 001 001 001 001 001 001 001 001 001
VINCASAR PFS TEVA PARENTERAL VINCREX BRISTOL MYERS SQUIBB VINCRISTINE SULFATE ABIC ABRAXIS PHARM APP PHARMS HOSPIRA
Jul 17, 1987 Jul 12, 1988 Feb Sep Dec Oct Apr Apr Apr 19, 10, 20, 28, 11, 11, 11, 1987 1986 2002 2003 1988 1988 1988
VIOMYCIN SULFATE
INJECTABLE; INJECTION VIOCIN SULFATE PFIZER
A061086 A061086
001 002
VITAMIN A
CAPSULE; ORAL AQUASOL A ASTRAZENECA VITAMIN A BANNER PHARMACAPS
VITAMIN A PALMITATE
CAPSULE; ORAL AFAXIN STERLING WINTHROP ALPHALIN LILLY DEL-VI-A DEL RAY LABS VI-DOM-A BAYER PHARMS VITAMIN A BANNER PHARMACAPS BRISTOL MYERS SQUIBB CHASE CHEM ELKINS SINN EVERYLIFE IMPAX LABS IVAX SUB TEVA PHARMS MK LABS WEST WARD WHARTON LABS VITAMIN A PALMITATE ARCUM BANNER PHARMACAPS VITAMIN A SOLUBILIZED TEVA INJECTABLE; INJECTION VITAMIN A PALMITATE BEL MAR
EQ 50,000 UNITS BASE EQ 50,000 UNITS BASE EQ 50,000 UNITS BASE EQ 50,000 UNITS BASE EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ EQ 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 25,000 50,000 50,000 50,000 50,000 50,000 50,000 50,000 UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS UNITS BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE BASE
A083187 A080883 A080830 A080972 A080702 A080860 A080746 A083207 A085479 A080943 A083114 A080953 A080955 A083035 A083190 A083457 A083457 A080967 A083665 A083311 A083321 A083948 A083981 A080921
001 001 001 001 001 001 001 001 001 001 001 001 001 001 001 002 001 001 001 001 001 001 001 001
A080819
001
WARFARIN POTASSIUM
TABLET; ORAL ATHROMBIN-K PHARM RES ASSOC
WARFARIN SODIUM
INJECTABLE; INJECTION COUMADIN BRISTOL MYERS SQUIBB TABLET; ORAL ATHROMBIN PHARM RES ASSOC
50MG/VIAL 75MG/VIAL
N009218 N009218
020 012
2MG 2.5MG 5MG 7.5MG 10MG 1MG 2MG 2.5MG 3MG 4MG 5MG 6MG 7.5MG 10MG 2MG 2.5MG 5MG 2MG 2.5MG 5MG 7.5MG 10MG
N017020 N017020 N017020 N017020 N017020 A040196 A040196 A040196 A040196 A040196 A040196 A040196 A040196 A040196 A088719 A088720 A088721 A086123 A086120 A086119 A086118 A086122
001 002 003 004 005 001 002 003 008 004 005 009 006 007 001 001 001 001 001 001 001 001 Sep Sep Sep Jul Sep Sep Jul Sep Sep Jun Aug Jul Aug Aug Aug Aug Aug 30, 30, 30, 26, 30, 30, 26, 30, 30, 27, 06, 02, 17, 17, 17, 17, 17, 1997 1997 1997 2000 1997 1997 2000 1997 1997 1985 1985 1985 1982 1982 1982 1982 1982
USL PHARMA
WATSON LABS
XENON XE-127
GAS; INHALATION XENON XE 127 MALLINCKRODT
5mCi/VIAL 10mCi/VIAL
N018536 N018536
001 002
XENON XE-133
GAS; INHALATION XENON XE 133 GE HEALTHCARE
XENON XE 133-V.S.S. GE HEALTHCARE 10mCi/VIAL INJECTABLE; INJECTION XENON XE 133 GE HEALTHCARE 1.3-1.7 CI/AMP LANTHEUS MEDCL 6.3mCi/ML SOLUTION; INHALATION, INJECTION XENEISOL MALLINCKRODT 18-25mCi/AMP
N017256 N017283
001 001
N017262
002
XYLOSE
POWDER; ORAL XYLO-PFAN SAVAGE LABS XYLOSE LYNE
25GM/BOT 25GM/BOT
N017605 N018856
0.375MG 0.75MG
N020199 N020199
001 002
ZALEPLON
CAPSULE; ORAL ZALEPLON SANDOZ
5MG 10MG
A078095 A078095
001 002
ZICONOTIDE
INJECTABLE; INTRATHECAL PRIALT AZUR PHARMA II
200MCG/2ML (100MCG/ML)
N021060
003
ZIDOVUDINE
TABLET; ORAL RETROVIR VIIV HLTHCARE ZIDOVUDINE AUROBINDO PHARMA MATRIX LABS LTD
ZILEUTON
TABLET; ORAL ZYFLO CORNERSTONE THERAP
300MG
N020471
001
ZINC SULFATE
INJECTABLE; INJECTION ZINC SULFATE ABRAXIS PHARM
EQ 1MG ZINC/ML
N019229
002
ZOLEDRONIC ACID
INJECTABLE; IV (INFUSION) ZOMETA NOVARTIS EQ 4MG BASE/VIAL
N021223
001
ZOLPIDEM TARTRATE
TABLET; ORAL ZOLPIDEM TARTRATE MUTUAL PHARMA
5MG 10MG SYNTHON PHARMS 5MG 10MG WORLD GEN 5MG 10MG TABLET, ORALLY DISINTEGRATING; ORAL TOVALT ODT BIOVAIL LABS INTL 5MG 10MG
N021412 N021412
001 002
ZONISAMIDE
CAPSULE; ORAL ZONISAMIDE MUTUAL PHARM
ROXANE
WATSON LABS
7-1
8-1
ACETAMINOPHEN; ASPIRIN; BUTALBITAL CAPSULE OR TABLET; ORAL 160-165MG; 160-165MG; 50MG ACETAMINOPHEN; ASPIRIN; BUTALBITAL CAPSULE OR TABLET; ORAL 325MG; 325MG; 50MG ACETAMINOPHEN; ASPIRIN; BUTALBITAL; CAFFEINE CAPSULE OR TABLET; ORAL 160-165MG; 160-165MG; 50MG; 40MG ACETAMINOPHEN; ASPIRIN; BUTALBITAL; CAFFEINE CAPSULE OR TABLET; ORAL 325MG; 325MG; 50MG; 40MG ACETAMINOPHEN; BUTALBITAL CAPSULE OR TABLET; ORAL 325MG; 50MG 650MG; 50MG ACETAMINOPHEN; BUTALBITAL; CAFFEINE CAPSULE OR TABLET; ORAL 325MG; 50MG; 40MG 650MG; 50MG; 40MG 500MG; 50MG; 40MG AMINOPHYLLINE TABLET; ORAL 100MG; 200MG ASPIRIN; BUTALBITAL CAPSULE OR TABLET; ORAL 325MG; 50MG 650MG; 50MG ASPIRIN; BUTALBITAL; CAFFEINE CAPSULE OR TABLET; ORAL 325MG; 50MG; 40MG 650MG; 50MG; 40MG
ASPIRIN; CAFFEINE; CARISOPRODOL TABLET; ORAL 160MG; 32MG; 200MG ASPIRIN; CAFFEINE; CARISOPRODOL; CODEINE PHOSPHATE TABLET; ORAL 160MG; 32MG; 200MG; 16MG ASPIRIN; CARISOPRODOL TABLET; ORAL 325MG; 200MG ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET; ORAL 325MG; 200MG; 16MG ASPIRIN; MEPROBAMATE TABLET; ORAL 325MG; 200MG ASPIRIN; METHOCARBAMOL TABLET; ORAL 325MG; 400MG CHLOROTHIAZIDE TABLET; ORAL 250MG HYDROXYZINE HYDROCHLORIDE TABLET; ORAL 10MG; 25MG; 50MG; 100MG PREDNISONE TABLET; ORAL 1MG; 2.5MG; 5MG; 10MG; 20MG; 25MG; 50MG
APPENDIX A
**
A - 1
**
8-MOP, METHOXSALEN
**
**
**
ABELCET, AMPHOTERICIN B ABILIFY, ARIPIPRAZOLE ABLAVAR, GADOFOSVESET TRISODIUM ABRAXANE, PACLITAXEL ABREVA, DOCOSANOL (OTC) ABSTRAL, FENTANYL CITRATE ACANYA, BENZOYL PEROXIDE ACARBOSE, ACARBOSE ACCOLATE, ZAFIRLUKAST ACCUNEB, ALBUTEROL SULFATE ACCUPRIL, QUINAPRIL HYDROCHLORIDE ACCURETIC, HYDROCHLOROTHIAZIDE ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE ACEON, PERINDOPRIL ERBUMINE ACEPHEN, ACETAMINOPHEN (OTC) ACETADOTE, ACETYLCYSTEINE ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN ACETASOL HC, ACETIC ACID, GLACIAL ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM ACETAZOLAMIDE, ACETAZOLAMIDE ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE, ACETIC ACID, GLACIAL ACETIC ACID, ACETIC ACID, GLACIAL ACETOHEXAMIDE, ACETOHEXAMIDE ACETYLCYSTEINE, ACETYLCYSTEINE ACIPHEX, RABEPRAZOLE SODIUM ACLOVATE, ALCLOMETASONE DIPROPIONATE ACTHREL, CORTICORELIN OVINE TRIFLUTATE ACTIGALL, URSODIOL ACTIQ, FENTANYL CITRATE ACTIVELLA, ESTRADIOL ACTONEL, RISEDRONATE SODIUM ACTOPLUS MET XR, METFORMIN HYDROCHLORIDE ACTOPLUS MET, METFORMIN HYDROCHLORIDE ACTOS, PIOGLITAZONE HYDROCHLORIDE ACULAR LS, KETOROLAC TROMETHAMINE ACULAR PRESERVATIVE FREE, KETOROLAC TROMETHAMINE ACULAR, KETOROLAC TROMETHAMINE ACUVAIL, KETOROLAC TROMETHAMINE ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE, ACYCLOVIR SODIUM ACYCLOVIR SODIUM, ACYCLOVIR SODIUM ACYCLOVIR, ACYCLOVIR ACZONE, DAPSONE ADAGEN, PEGADEMASE BOVINE ADALAT CC, NIFEDIPINE ADAPALENE, ADAPALENE ADCIRCA, TADALAFIL ADDERALL XR 10, AMPHETAMINE ASPARTATE ADDERALL XR 15, AMPHETAMINE ASPARTATE ADDERALL XR 20, AMPHETAMINE ASPARTATE ADDERALL XR 25, AMPHETAMINE ASPARTATE ADDERALL XR 30, AMPHETAMINE ASPARTATE
APPENDIX A
**
A - 2
ADDERALL XR 5, AMPHETAMINE ASPARTATE ADENOCARD, ADENOSINE ADENOSCAN, ADENOSINE ADENOSINE, ADENOSINE ADIPEX-P, PHENTERMINE HYDROCHLORIDE ADRENACLICK, EPINEPHRINE ADREVIEW, IOBENGUANE SULFATE I-123 ADVAIR DISKUS 100/50, FLUTICASONE PROPIONATE ADVAIR DISKUS 250/50, FLUTICASONE PROPIONATE ADVAIR DISKUS 500/50, FLUTICASONE PROPIONATE ADVAIR HFA, FLUTICASONE PROPIONATE ADVICOR, LOVASTATIN ADVIL ALLERGY AND CONGESTION RELIEF, CHLORPHENIRAMINE MALEATE ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE (OTC) ADVIL COLD AND SINUS, IBUPROFEN (OTC) ADVIL CONGESTION RELIEF, IBUPROFEN (OTC) ADVIL LIQUI-GELS, IBUPROFEN (OTC) ADVIL MIGRAINE LIQUI-GELS, IBUPROFEN (OTC) ADVIL PM, DIPHENHYDRAMINE CITRATE (OTC) ADVIL PM, DIPHENHYDRAMINE HYDROCHLORIDE (OTC) ADVIL, IBUPROFEN (OTC) AEROBID, FLUNISOLIDE AEROSPAN HFA, FLUNISOLIDE AFEDITAB CR, NIFEDIPINE AFINITOR, EVEROLIMUS AFRINOL, PSEUDOEPHEDRINE SULFATE (OTC) AGGRASTAT, TIROFIBAN HYDROCHLORIDE AGGRENOX, ASPIRIN AGRYLIN, ANAGRELIDE HYDROCHLORIDE A-HYDROCORT, HYDROCORTISONE SODIUM SUCCINATE AKBETA, LEVOBUNOLOL HYDROCHLORIDE AK-FLUOR 10%, FLUORESCEIN SODIUM AKINETON, BIPERIDEN HYDROCHLORIDE AKNE-MYCIN, ERYTHROMYCIN AKPENTOLATE, CYCLOPENTOLATE HYDROCHLORIDE AKPRO, DIPIVEFRIN HYDROCHLORIDE AKTEN, LIDOCAINE HYDROCHLORIDE AKTOB, TOBRAMYCIN ALA-CORT, HYDROCORTISONE ALAMAST, PEMIROLAST POTASSIUM ALA-SCALP, HYDROCORTISONE ALAVERT, LORATADINE (OTC) ALAWAY, KETOTIFEN FUMARATE (OTC) ALBALON, NAPHAZOLINE HYDROCHLORIDE ALBENZA, ALBENDAZOLE ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE ALBUTEROL SULFATE, ALBUTEROL SULFATE ALCAINE, PROPARACAINE HYDROCHLORIDE ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE ALCOHOL 10% AND DEXTROSE 5%, ALCOHOL ALCOHOL 5% AND DEXTROSE 5%, ALCOHOL ALDACTAZIDE, HYDROCHLOROTHIAZIDE ALDACTONE, SPIRONOLACTONE ALDARA, IMIQUIMOD ALENDRONATE SODIUM, ALENDRONATE SODIUM ALEVE, NAPROXEN SODIUM (OTC) ALEVE-D SINUS & COLD, NAPROXEN SODIUM (OTC) ALFENTA, ALFENTANIL HYDROCHLORIDE ALFENTANIL, ALFENTANIL HYDROCHLORIDE ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE ALIMTA, PEMETREXED DISODIUM ALINIA, NITAZOXANIDE ALKERAN, MELPHALAN
(OTC)
APPENDIX A
**
A - 3
ALKERAN, MELPHALAN HYDROCHLORIDE ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA, FEXOFENADINE HYDROCHLORIDE ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE (OTC) ALLI, ORLISTAT (OTC) ALLOPURINOL SODIUM, ALLOPURINOL SODIUM ALLOPURINOL, ALLOPURINOL ALOCRIL, NEDOCROMIL SODIUM ALOMIDE, LODOXAMIDE TROMETHAMINE ALOPRIM, ALLOPURINOL SODIUM ALORA, ESTRADIOL ALOXI, PALONOSETRON HYDROCHLORIDE ALPHAGAN P, BRIMONIDINE TARTRATE ALPRAZOLAM, ALPRAZOLAM ALPROSTADIL, ALPROSTADIL ALREX, LOTEPREDNOL ETABONATE ALSUMA, SUMATRIPTAN SUCCINATE ALTABAX, RETAPAMULIN ALTACE, RAMIPRIL ALTAVERA, ETHINYL ESTRADIOL ALTOPREV, LOVASTATIN ALVESCO, CICLESONIDE AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMARYL, GLIMEPIRIDE AMBIEN CR, ZOLPIDEM TARTRATE AMBIEN, ZOLPIDEM TARTRATE AMBISOME, AMPHOTERICIN B AMCINONIDE, AMCINONIDE AMERGE, NARATRIPTAN HYDROCHLORIDE A-METHAPRED, METHYLPREDNISOLONE SODIUM SUCCINATE AMICAR, AMINOCAPROIC ACID AMIDATE, ETOMIDATE AMIFOSTINE, AMIFOSTINE AMIKACIN SULFATE, AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER, GLYCINE AMINOCAPROIC ACID IN PLASTIC CONTAINER, AMINOCAPROIC ACID AMINOCAPROIC ACID, AMINOCAPROIC ACID AMINOCAPROIC, AMINOCAPROIC ACID AMINOHIPPURATE SODIUM, AMINOHIPPURATE SODIUM AMINOPHYLLINE, AMINOPHYLLINE AMINOSYN 10% (PH6), AMINO ACIDS AMINOSYN 10%, AMINO ACIDS AMINOSYN 3.5% M, AMINO ACIDS AMINOSYN 3.5%, AMINO ACIDS AMINOSYN 5%, AMINO ACIDS AMINOSYN 7% (PH6), AMINO ACIDS AMINOSYN 7% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN 7%, AMINO ACIDS AMINOSYN 8.5% (PH6), AMINO ACIDS AMINOSYN 8.5% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN 8.5%, AMINO ACIDS AMINOSYN II 10% IN PLASTIC CONTAINER, AMINO ACIDS AMINOSYN II 10% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN II 10%, AMINO ACIDS AMINOSYN II 15% IN PLASTIC CONTAINER, AMINO ACIDS AMINOSYN II 7%, AMINO ACIDS AMINOSYN II 8.5% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN II 8.5%, AMINO ACIDS AMINOSYN-HBC 7%, AMINO ACIDS
APPENDIX A
**
A - 4
AMINOSYN-HF 8%, AMINO ACIDS AMINOSYN-PF 10%, AMINO ACIDS AMINOSYN-PF 7%, AMINO ACIDS AMINOSYN-RF 5.2%, AMINO ACIDS AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMITIZA, LUBIPROSTONE AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMMONIA N 13, AMMONIA, N-13 AMMONIUM CHLORIDE IN PLASTIC CONTAINER, AMMONIUM CHLORIDE AMMONIUM LACTATE, AMMONIUM LACTATE AMMONUL, SODIUM BENZOATE AMNESTEEM, ISOTRETINOIN AMOXAPINE, AMOXAPINE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN PEDIATRIC, AMOXICILLIN AMOXICILLIN, AMOXICILLIN AMOXIL, AMOXICILLIN AMPHADASE, HYALURONIDASE AMPHOTEC, AMPHOTERICIN B AMPHOTERICIN B, AMPHOTERICIN B AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM AMPICILLIN SODIUM, AMPICILLIN SODIUM AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE AMPYRA, DALFAMPRIDINE AMRINONE LACTATE, INAMRINONE LACTATE AMRIX, CYCLOBENZAPRINE HYDROCHLORIDE AMTURNIDE, ALISKIREN HEMIFUMARATE ANADROL-50, OXYMETHOLONE ANAFRANIL, CLOMIPRAMINE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ANAPROX DS, NAPROXEN SODIUM ANAPROX, NAPROXEN SODIUM ANASTROZOLE, ANASTROZOLE ANCEF IN PLASTIC CONTAINER, CEFAZOLIN SODIUM ANCOBON, FLUCYTOSINE ANDRODERM, TESTOSTERONE ANDROGEL, TESTOSTERONE ANDROID 10, METHYLTESTOSTERONE ANDROID 25, METHYLTESTOSTERONE AN-DTPA, TECHNETIUM TC-99M PENTETATE KIT ANECTINE, SUCCINYLCHOLINE CHLORIDE ANESTACON, LIDOCAINE HYDROCHLORIDE ANEXSIA 5/325, ACETAMINOPHEN ANEXSIA 7.5/325, ACETAMINOPHEN ANEXSIA 7.5/650, ACETAMINOPHEN ANEXSIA, ACETAMINOPHEN ANGELIQ, DROSPIRENONE ANGIOMAX, BIVALIRUDIN ANSAID, FLURBIPROFEN AN-SULFUR COLLOID, TECHNETIUM TC-99M SULFUR COLLOID KIT ANTABUSE, DISULFIRAM ANTARA (MICRONIZED), FENOFIBRATE ANTHELIOS 20, AVOBENZONE (OTC) ANTHELIOS 40, AVOBENZONE (OTC) ANTHELIOS SX, AVOBENZONE (OTC) ANTIVERT, MECLIZINE HYDROCHLORIDE ANTIZOL, FOMEPIZOLE ANTUROL, OXYBUTYNIN ANUSOL HC, HYDROCORTISONE ANZEMET, DOLASETRON MESYLATE APHTHASOL, AMLEXANOX
APPENDIX A
**
A - 5
APIDRA SOLOSTAR, INSULIN GLULISINE RECOMBINANT APIDRA, INSULIN GLULISINE RECOMBINANT APLENZIN, BUPROPION HYDROBROMIDE APOKYN, APOMORPHINE HYDROCHLORIDE APRACLONIDINE HYDROCHLORIDE, APRACLONIDINE HYDROCHLORIDE APRISO, MESALAMINE APTIVUS, TIPRANAVIR AQUASOL A, VITAMIN A PALMITATE ARALEN, CHLOROQUINE PHOSPHATE ARANELLE, ETHINYL ESTRADIOL ARAVA, LEFLUNOMIDE ARCAPTA NEOHALER, INDACATEROL MALEATE AREDIA, PAMIDRONATE DISODIUM ARESTIN, MINOCYCLINE HYDROCHLORIDE ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN ARGATROBAN, ARGATROBAN ARICEPT ODT, DONEPEZIL HYDROCHLORIDE ARICEPT, DONEPEZIL HYDROCHLORIDE ARIDOL KIT, MANNITOL ARIMIDEX, ANASTROZOLE ARISTOSPAN, TRIAMCINOLONE HEXACETONIDE ARIXTRA, FONDAPARINUX SODIUM AROMASIN, EXEMESTANE ARRANON, NELARABINE ARTHROTEC, DICLOFENAC SODIUM ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, ARTICAINE HYDROCHLORIDE ARTICAINE HYDROCHLORIDE WITH EPINEPHRINE, ARTICAINE HYDROCHLORIDE ASACOL HD, MESALAMINE ASACOL, MESALAMINE ASCLERA, POLIDOCANOL ASMANEX TWISTHALER, MOMETASONE FUROATE ASPIRIN AND DIPYRIDAMOLE, ASPIRIN ASTELIN, AZELASTINE HYDROCHLORIDE ASTEPRO, AZELASTINE HYDROCHLORIDE ASTRAMORPH PF, MORPHINE SULFATE ATACAND HCT, CANDESARTAN CILEXETIL ATACAND, CANDESARTAN CILEXETIL ATELVIA, RISEDRONATE SODIUM ATENOLOL AND CHLORTHALIDONE, ATENOLOL ATENOLOL, ATENOLOL ATIVAN, LORAZEPAM ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE ATRACURIUM BESYLATE, ATRACURIUM BESYLATE ATRALIN, TRETINOIN ATRIDOX, DOXYCYCLINE HYCLATE ATRIPLA, EFAVIRENZ ATROPEN, ATROPINE ATROPINE SULFATE ANSYR PLASTIC SYRINGE, ATROPINE SULFATE ATROVENT HFA, IPRATROPIUM BROMIDE ATROVENT, IPRATROPIUM BROMIDE AUGMENTIN '125', AMOXICILLIN AUGMENTIN '200', AMOXICILLIN AUGMENTIN '250', AMOXICILLIN AUGMENTIN '400', AMOXICILLIN AUGMENTIN '500', AMOXICILLIN AUGMENTIN '875', AMOXICILLIN AUGMENTIN ES-600, AMOXICILLIN AUGMENTIN XR, AMOXICILLIN AVAGARD, ALCOHOL (OTC) AVAGE, TAZAROTENE
APPENDIX A
**
A - 6
AVALIDE, HYDROCHLOROTHIAZIDE AVANDAMET, METFORMIN HYDROCHLORIDE AVANDARYL, GLIMEPIRIDE AVANDIA, ROSIGLITAZONE MALEATE AVAPRO, IRBESARTAN AVC, SULFANILAMIDE AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER, MOXIFLOXACIN HYDROCHLORIDE AVELOX, MOXIFLOXACIN HYDROCHLORIDE AVENTYL HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE AVIANE-28, ETHINYL ESTRADIOL AVINZA, MORPHINE SULFATE AVITA, TRETINOIN AVODART, DUTASTERIDE AXERT, ALMOTRIPTAN MALATE AXID AR, NIZATIDINE (OTC) AXID, NIZATIDINE AXIRON, TESTOSTERONE AYGESTIN, NORETHINDRONE ACETATE AZACTAM IN PLASTIC CONTAINER, AZTREONAM AZACTAM, AZTREONAM AZASAN, AZATHIOPRINE AZASITE, AZITHROMYCIN AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM AZATHIOPRINE, AZATHIOPRINE AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE AZELEX, AZELAIC ACID AZILECT, RASAGILINE MESYLATE AZITHROMYCIN, AZITHROMYCIN AZMACORT, TRIAMCINOLONE ACETONIDE AZOPT, BRINZOLAMIDE AZOR, AMLODIPINE BESYLATE AZTREONAM, AZTREONAM AZULFIDINE EN-TABS, SULFASALAZINE AZULFIDINE, SULFASALAZINE
**
**
BACIIM, BACITRACIN BACI-RX, BACITRACIN BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC BACITRACIN, BACITRACIN BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE, BACITRACIN BACLOFEN, BACLOFEN BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION BACTOCILL IN PLASTIC CONTAINER, OXACILLIN SODIUM BACTRIM DS, SULFAMETHOXAZOLE BACTRIM, SULFAMETHOXAZOLE BACTROBAN, MUPIROCIN BACTROBAN, MUPIROCIN CALCIUM BAL, DIMERCAPROL BALANCED SALT, CALCIUM CHLORIDE BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM BALZIVA-28, ETHINYL ESTRADIOL BANZEL, RUFINAMIDE BARACLUDE, ENTECAVIR BECONASE AQ, BECLOMETHASONE DIPROPIONATE MONOHYDRATE BENADRYL PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE BENADRYL, DIPHENHYDRAMINE HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BENICAR HCT, HYDROCHLOROTHIAZIDE BENICAR, OLMESARTAN MEDOXOMIL BENTYL PRESERVATIVE FREE, DICYCLOMINE HYDROCHLORIDE
APPENDIX A
**
A - 7
BENTYL, DICYCLOMINE HYDROCHLORIDE BENZACLIN, BENZOYL PEROXIDE BENZAMYCIN PAK, BENZOYL PEROXIDE BENZAMYCIN, BENZOYL PEROXIDE BENZONATATE, BENZONATATE BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE BEPREVE, BEPOTASTINE BESILATE BESIVANCE, BESIFLOXACIN HYDROCHLORIDE BETADINE, POVIDONE-IODINE BETAGAN, LEVOBUNOLOL HYDROCHLORIDE BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE, BETAMETHASONE ACETATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE BETAMETHASONE VALERATE, BETAMETHASONE VALERATE BETAPACE AF, SOTALOL HYDROCHLORIDE BETAPACE, SOTALOL HYDROCHLORIDE BETA-VAL, BETAMETHASONE VALERATE BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE BETIMOL, TIMOLOL BETOPTIC S, BETAXOLOL HYDROCHLORIDE BETOPTIC, BETAXOLOL HYDROCHLORIDE BEYAZ, DROSPIRENONE BIAXIN XL, CLARITHROMYCIN BIAXIN, CLARITHROMYCIN BICALUTAMIDE, BICALUTAMIDE BICILLIN C-R 900/300, PENICILLIN G BENZATHINE BICILLIN C-R, PENICILLIN G BENZATHINE BICILLIN L-A, PENICILLIN G BENZATHINE BICNU, CARMUSTINE BIDIL, HYDRALAZINE HYDROCHLORIDE BILTRICIDE, PRAZIQUANTEL BIOSCRUB, CHLORHEXIDINE GLUCONATE (OTC) BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE BISOPROLOL FUMARATE, BISOPROLOL FUMARATE BLEOMYCIN SULFATE, BLEOMYCIN SULFATE BLEPH-10, SULFACETAMIDE SODIUM BLEPHAMIDE S.O.P., PREDNISOLONE ACETATE BLEPHAMIDE, PREDNISOLONE ACETATE BONIVA, IBANDRONATE SODIUM BONTRIL PDM, PHENDIMETRAZINE TARTRATE BONTRIL, PHENDIMETRAZINE TARTRATE BRANCHAMIN 4% IN PLASTIC CONTAINER, AMINO ACIDS BRAVELLE, UROFOLLITROPIN BREATHTEK UBT FOR H-PYLORI, UREA C-13 BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER, BRETYLIUM TOSYLATE BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE BREVIBLOC IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE BREVIBLOC, ESMOLOL HYDROCHLORIDE BREVICON 28-DAY, ETHINYL ESTRADIOL BREVITAL SODIUM, METHOHEXITAL SODIUM BRIAN CARE, CHLORHEXIDINE GLUCONATE (OTC) BRIELLYN, ETHINYL ESTRADIOL BRILINTA, TICAGRELOR BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE BROMDAY, BROMFENAC SODIUM BROMFED-DM, BROMPHENIRAMINE MALEATE BROMFENAC SODIUM, BROMFENAC SODIUM BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE BRONCHO SALINE, SODIUM CHLORIDE (OTC) BROVANA, ARFORMOTEROL TARTRATE BSS PLUS, CALCIUM CHLORIDE BSS, CALCIUM CHLORIDE
APPENDIX A
**
A - 8
BUDESONIDE, BUDESONIDE BUMETANIDE, BUMETANIDE BUPHENYL, SODIUM PHENYLBUTYRATE BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE BUPRENEX, BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE BUSULFEX, BUSULFAN BUTALBITAL AND ACETAMINOPHEN, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN BUTALBITAL, ASPIRIN AND CAFFEINE, ASPIRIN BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN BUTAPAP, ACETAMINOPHEN BUTISOL SODIUM, BUTABARBITAL SODIUM BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE BUTRANS, BUPRENORPHINE BYETTA, EXENATIDE SYNTHETIC BYSTOLIC, NEBIVOLOL HYDROCHLORIDE
**
**
CABERGOLINE, CABERGOLINE CADUET, AMLODIPINE BESYLATE CAFCIT, CAFFEINE CITRATE CAFERGOT, CAFFEINE CAFFEINE CITRATE, CAFFEINE CITRATE CALAN, VERAPAMIL HYDROCHLORIDE CALCIJEX, CALCITRIOL CALCIPOTRIENE, CALCIPOTRIENE CALCITONIN-SALMON, CALCITONIN SALMON CALCITRIOL, CALCITRIOL CALCIUM ACETATE, CALCIUM ACETATE CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE, CALCIUM CARBONATE CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER, CALCIUM CHLORIDE CALCIUM DISODIUM VERSENATE, EDETATE CALCIUM DISODIUM CALDOLOR, IBUPROFEN CAMBIA, DICLOFENAC POTASSIUM CAMILA, NORETHINDRONE CAMPRAL, ACAMPROSATE CALCIUM CAMPTOSAR, IRINOTECAN HYDROCHLORIDE CANASA, MESALAMINE CANCIDAS, CASPOFUNGIN ACETATE CANTIL, MEPENZOLATE BROMIDE CAPASTAT SULFATE, CAPREOMYCIN SULFATE CAPEX, FLUOCINOLONE ACETONIDE CAPITAL AND CODEINE, ACETAMINOPHEN CAPITAL SOLEIL 15, AVOBENZONE (OTC) CAPOTEN, CAPTOPRIL CAPOZIDE 25/15, CAPTOPRIL CAPOZIDE 25/25, CAPTOPRIL CAPOZIDE 50/15, CAPTOPRIL CAPOZIDE 50/25, CAPTOPRIL CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAPTOPRIL CAPTOPRIL, CAPTOPRIL CARAC, FLUOROURACIL CARAFATE, SUCRALFATE CARBAGLU, CARGLUMIC ACID CARBAMAZEPINE, CARBAMAZEPINE
(OTC)
APPENDIX A
**
A - 9
CARBATROL, CARBAMAZEPINE CARBIDOPA AND LEVODOPA, CARBIDOPA CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE CARBOCAINE, MEPIVACAINE HYDROCHLORIDE CARBOPLATIN, CARBOPLATIN CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE SR, NICARDIPINE HYDROCHLORIDE CARDENE, NICARDIPINE HYDROCHLORIDE CARDIOGEN-82, RUBIDIUM CHLORIDE RB-82 CARDIOLITE, TECHNETIUM TC-99M SESTAMIBI KIT CARDIOPLEGIC IN PLASTIC CONTAINER, CALCIUM CHLORIDE CARDIZEM CD, DILTIAZEM HYDROCHLORIDE CARDIZEM LA, DILTIAZEM HYDROCHLORIDE CARDIZEM, DILTIAZEM HYDROCHLORIDE CARDURA XL, DOXAZOSIN MESYLATE CARDURA, DOXAZOSIN MESYLATE CARISOPRODOL AND ASPIRIN, ASPIRIN CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN CARISOPRODOL, CARISOPRODOL CARMOL HC, HYDROCORTISONE ACETATE CARNITOR SF, LEVOCARNITINE CARNITOR, LEVOCARNITINE CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE CARTIA XT, DILTIAZEM HYDROCHLORIDE CARVEDILOL, CARVEDILOL CASODEX, BICALUTAMIDE CATAFLAM, DICLOFENAC POTASSIUM CATAPRES, CLONIDINE HYDROCHLORIDE CATAPRES-TTS-1, CLONIDINE CATAPRES-TTS-2, CLONIDINE CATAPRES-TTS-3, CLONIDINE CAVERJECT IMPULSE, ALPROSTADIL CAVERJECT, ALPROSTADIL CAYSTON, AZTREONAM CEDAX, CEFTIBUTEN DIHYDRATE CEENU, LOMUSTINE CEFACLOR, CEFACLOR CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFAZOLIN AND DEXTROSE, CEFAZOLIN SODIUM CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFDINIR, CEFDINIR CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER, CEFEPIME HYDROCHLORIDE CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE CEFEPIME IN PLASTIC CONTAINER, CEFEPIME HYDROCHLORIDE CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFOTAXIME, CEFOTAXIME SODIUM CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER, CEFOTETAN DISODIUM CEFOTETAN, CEFOTETAN DISODIUM CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER, CEFOXITIN SODIUM CEFOXITIN, CEFOXITIN CEFOXITIN, CEFOXITIN SODIUM CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL CEFTAZIDIME IN DEXTROSE CONTAINER, CEFTAZIDIME CEFTAZIDIME, CEFTAZIDIME CEFTIN, CEFUROXIME AXETIL CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER, CEFTRIAXONE SODIUM CEFTRIAXONE IN PLASTIC CONTAINER, CEFTRIAXONE SODIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER, CEFUROXIME SODIUM
APPENDIX A
**
A - 10
CEFUROXIME AXETIL, CEFUROXIME AXETIL CEFUROXIME SODIUM IN PLASTIC CONTAINER, CEFUROXIME SODIUM CEFUROXIME SODIUM, CEFUROXIME SODIUM CELEBREX, CELECOXIB CELESTONE SOLUSPAN, BETAMETHASONE ACETATE CELESTONE, BETAMETHASONE CELEXA, CITALOPRAM HYDROBROMIDE CELLCEPT, MYCOPHENOLATE MOFETIL CELLCEPT, MYCOPHENOLATE MOFETIL HYDROCHLORIDE CELONTIN, METHSUXIMIDE CENESTIN, ESTROGENS, CONJUGATED SYNTHETIC A CENTANY, MUPIROCIN CEPHALEXIN, CEPHALEXIN CEREDASE, ALGLUCERASE CERETEC, TECHNETIUM TC-99M EXAMETAZIME KIT CEREZYME, IMIGLUCERASE CERUBIDINE, DAUNORUBICIN HYDROCHLORIDE CERVIDIL, DINOPROSTONE CESAMET, NABILONE CETAMIDE, SULFACETAMIDE SODIUM CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CETRAXAL, CIPROFLOXACIN HYDROCHLORIDE CETROTIDE, CETRORELIX CEVIMELINE, CEVIMELINE HYDROCHLORIDE CHANTIX, VARENICLINE TARTRATE CHEMET, SUCCIMER CHENODIOL, CHENODIOL CHG SCRUB, CHLORHEXIDINE GLUCONATE (OTC) CHILDREN'S ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE (OTC) CHILDREN'S ADVIL COLD, IBUPROFEN (OTC) CHILDREN'S ADVIL, IBUPROFEN (OTC) CHILDREN'S ADVIL-FLAVORED, IBUPROFEN (OTC) CHILDREN'S ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CLARITIN, LORATADINE (OTC) CHILDREN'S ELIXSURE, IBUPROFEN (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S IBUPROFEN, IBUPROFEN (OTC) CHILDREN'S MOTRIN COLD, IBUPROFEN (OTC) CHILDREN'S MOTRIN, IBUPROFEN (OTC) CHILDREN'S ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CHIRHOSTIM, SECRETIN SYNTHETIC HUMAN CHLORAMPHENICOL SODIUM SUCCINATE, CHLORAMPHENICOL SODIUM SUCCINATE CHLORAPREP ONE-STEP FREPP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP ONE-STEP SEPP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP ONE-STEP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP SINGLE SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP TRIPLE SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP WITH TINT, CHLORHEXIDINE GLUCONATE (OTC) CHLORASCRUB MAXI SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORASCRUB SWAB, CHLORHEXIDINE GLUCONATE (OTC) CHLORASCRUB SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC) CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE
(OTC)
APPENDIX A
**
A - 11
CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE (OTC) CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM CHLOROTHIAZIDE, CHLOROTHIAZIDE CHLORPHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE (OTC) CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE CHLORPROPAMIDE, CHLORPROPAMIDE CHLORTHALIDONE, CHLORTHALIDONE CHLOR-TRIMETON, CHLORPHENIRAMINE MALEATE (OTC) CHLORZOXAZONE, CHLORZOXAZONE CHOLAC, LACTULOSE CHOLEDYL SA, OXTRIPHYLLINE CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE CHOLESTYRAMINE, CHOLESTYRAMINE CHOLETEC, TECHNETIUM TC-99M MEBROFENIN KIT CHOLOGRAFIN MEGLUMINE, IODIPAMIDE MEGLUMINE CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC CHROMIC CHLORIDE IN PLASTIC CONTAINER, CHROMIC CHLORIDE CHROMITOPE SODIUM, SODIUM CHROMATE CR-51 CIALIS, TADALAFIL CICLOPIROX, CICLOPIROX CIDA-STAT, CHLORHEXIDINE GLUCONATE (OTC) CILOSTAZOL, CILOSTAZOL CILOXAN, CIPROFLOXACIN HYDROCHLORIDE CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CIMETIDINE, CIMETIDINE CIMETIDINE, CIMETIDINE (OTC) CIPRO HC, CIPROFLOXACIN HYDROCHLORIDE CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPRO XR, CIPROFLOXACIN CIPRO, CIPROFLOXACIN CIPRO, CIPROFLOXACIN HYDROCHLORIDE CIPRODEX, CIPROFLOXACIN CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPROFLOXACIN, CIPROFLOXACIN CIS-MDP, TECHNETIUM TC-99M MEDRONATE KIT CISPLATIN, CISPLATIN CIS-PYRO, TECHNETIUM TC-99M PYROPHOSPHATE KIT CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CITANEST FORTE DENTAL, EPINEPHRINE BITARTRATE CITANEST PLAIN DENTAL, PRILOCAINE HYDROCHLORIDE CLADRIBINE, CLADRIBINE CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER, CEFOTAXIME SODIUM CLAFORAN, CEFOTAXIME SODIUM CLARAVIS, ISOTRETINOIN CLARINEX D 24 HOUR, DESLORATADINE CLARINEX, DESLORATADINE CLARINEX-D 12 HOUR, DESLORATADINE CLARITHROMYCIN, CLARITHROMYCIN CLARITIN HIVES RELIEF REDITAB, LORATADINE (OTC) CLARITIN HIVES RELIEF, LORATADINE (OTC) CLARITIN REDITABS, LORATADINE (OTC) CLARITIN, LORATADINE (OTC) CLARITIN-D 24 HOUR, LORATADINE (OTC) CLARITIN-D, LORATADINE (OTC) CLEMASTINE FUMARATE, CLEMASTINE FUMARATE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE (OTC) CLENZ-LYTE, POLYETHYLENE GLYCOL 3350 CLEOCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLINDAMYCIN PHOSPHATE
APPENDIX A
**
A - 12
CLEOCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLEOCIN T, CLINDAMYCIN PHOSPHATE CLEOCIN, CLINDAMYCIN PALMITATE HYDROCHLORIDE CLEOCIN, CLINDAMYCIN PHOSPHATE CLEVIPREX, CLEVIDIPINE BUTYRATE CLIMARA PRO, ESTRADIOL CLIMARA, ESTRADIOL CLINDA-DERM, CLINDAMYCIN PHOSPHATE CLINDAGEL, CLINDAMYCIN PHOSPHATE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PALMITATE HYDROCHLORIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, CLINDAMYCIN PHOSPHATE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLINDESSE, CLINDAMYCIN PHOSPHATE CLINDETS, CLINDAMYCIN PHOSPHATE CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS CLINORIL, SULINDAC CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOBEX, CLOBETASOL PROPIONATE CLODERM, CLOCORTOLONE PIVALATE CLOLAR, CLOFARABINE CLOMID, CLOMIPHENE CITRATE CLOMIPHENE CITRATE, CLOMIPHENE CITRATE CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CLONIDINE, CLONIDINE
APPENDIX A
**
A - 13
CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM CLORPRES, CHLORTHALIDONE CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE CLOTRIMAZOLE, CLOTRIMAZOLE (OTC) CLOZAPINE, CLOZAPINE CLOZARIL, CLOZAPINE COARTEM, ARTEMETHER CODEINE SULFATE, CODEINE SULFATE COGENTIN, BENZTROPINE MESYLATE CO-GESIC, ACETAMINOPHEN COLAZAL, BALSALAZIDE DISODIUM COLCRYS, COLCHICINE COLESTID, COLESTIPOL HYDROCHLORIDE COLESTIPOL HYDROCHLORIDE, COLESTIPOL HYDROCHLORIDE COLGATE TOTAL, SODIUM FLUORIDE (OTC) COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM COLOCORT, HYDROCORTISONE COL-PROBENECID, COLCHICINE COLY-MYCIN M, COLISTIMETHATE SODIUM COLY-MYCIN S, COLISTIN SULFATE COLYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350 COLYTE, POLYETHYLENE GLYCOL 3350 COLYTE-FLAVORED, POLYETHYLENE GLYCOL 3350 COMBIGAN, BRIMONIDINE TARTRATE COMBIPATCH, ESTRADIOL COMBIVENT RESPIMAT, ALBUTEROL SULFATE COMBIVENT, ALBUTEROL SULFATE COMBIVIR, LAMIVUDINE COMMIT, NICOTINE POLACRILEX (OTC) COMPLERA, EMTRICITABINE COMPRO, PROCHLORPERAZINE COMTAN, ENTACAPONE CONCERTA, METHYLPHENIDATE HYDROCHLORIDE CONDYLOX, PODOFILOX CONRAY 30, IOTHALAMATE MEGLUMINE CONRAY 43, IOTHALAMATE MEGLUMINE CONRAY, IOTHALAMATE MEGLUMINE CONSTILAC, LACTULOSE CONSTULOSE, LACTULOSE CONZIP, TRAMADOL HYDROCHLORIDE COPAXONE, GLATIRAMER ACETATE COPEGUS, RIBAVIRIN CORDARONE, AMIODARONE HYDROCHLORIDE CORDRAN SP, FLURANDRENOLIDE CORDRAN, FLURANDRENOLIDE COREG CR, CARVEDILOL PHOSPHATE COREG, CARVEDILOL CORGARD, NADOLOL CORLOPAM, FENOLDOPAM MESYLATE CORMAX, CLOBETASOL PROPIONATE CORTEF, HYDROCORTISONE CORTENEMA, HYDROCORTISONE CORTIFOAM, HYDROCORTISONE ACETATE CORTISONE ACETATE, CORTISONE ACETATE CORTISPORIN, BACITRACIN ZINC CORTISPORIN, HYDROCORTISONE CORTISPORIN, HYDROCORTISONE ACETATE CORTROSYN, COSYNTROPIN CORVERT, IBUTILIDE FUMARATE CORZIDE, BENDROFLUMETHIAZIDE COSMEGEN, DACTINOMYCIN COSOPT, DORZOLAMIDE HYDROCHLORIDE
APPENDIX A
**
A - 14
COSYNTROPIN, COSYNTROPIN COUMADIN, WARFARIN SODIUM COVERA-HS, VERAPAMIL HYDROCHLORIDE COZAAR, LOSARTAN POTASSIUM CREON, LIPASE CRESTOR, ROSUVASTATIN CALCIUM CRINONE, PROGESTERONE CRIXIVAN, INDINAVIR SULFATE CROLOM, CROMOLYN SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM (OTC) CROTAN, CROTAMITON CRYSELLE, ETHINYL ESTRADIOL CUBICIN, DAPTOMYCIN CUPRIC CHLORIDE IN PLASTIC CONTAINER, CUPRIC CHLORIDE CUPRIMINE, PENICILLAMINE CUROSURF, PORACTANT ALFA CUTIVATE, FLUTICASONE PROPIONATE CUVPOSA, GLYCOPYRROLATE CYANOCOBALAMIN, CYANOCOBALAMIN CYANOKIT, HYDROXOCOBALAMIN CYCLAFEM 1/35, ETHINYL ESTRADIOL CYCLAFEM 7/7/7, ETHINYL ESTRADIOL CYCLESSA, DESOGESTREL CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYCLOGYL, CYCLOPENTOLATE HYDROCHLORIDE CYCLOMYDRIL, CYCLOPENTOLATE HYDROCHLORIDE CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE CYCLOSET, BROMOCRIPTINE MESYLATE CYCLOSPORINE, CYCLOSPORINE CYKLOKAPRON, TRANEXAMIC ACID CYMBALTA, DULOXETINE HYDROCHLORIDE CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE CYSTADANE, BETAINE HYDROCHLORIDE CYSTAGON, CYSTEAMINE BITARTRATE CYSTO-CONRAY II, IOTHALAMATE MEGLUMINE CYSTOGRAFIN DILUTE, DIATRIZOATE MEGLUMINE CYSTOGRAFIN, DIATRIZOATE MEGLUMINE CYSVIEW KIT, HEXAMINOLEVULINATE HYDROCHLORIDE CYTARABINE, CYTARABINE CYTOMEL, LIOTHYRONINE SODIUM CYTOSAR-U, CYTARABINE CYTOTEC, MISOPROSTOL CYTOVENE, GANCICLOVIR SODIUM CYTOXAN, CYCLOPHOSPHAMIDE
**
**
D.H.E. 45, DIHYDROERGOTAMINE MESYLATE DACARBAZINE, DACARBAZINE DACOGEN, DECITABINE DACTINOMYCIN, DACTINOMYCIN DALIRESP, ROFLUMILAST DANAZOL, DANAZOL DANTRIUM, DANTROLENE SODIUM DANTROLENE SODIUM, DANTROLENE SODIUM DAPSONE, DAPSONE DARAPRIM, PYRIMETHAMINE DASETTA 1/35, ETHINYL ESTRADIOL DASETTA 7/7/7, ETHINYL ESTRADIOL DATSCAN, IOFLUPANE I-123 DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE DAUNOXOME, DAUNORUBICIN CITRATE DAYPRO, OXAPROZIN
APPENDIX A
**
A - 15
DAYTRANA, METHYLPHENIDATE DDAVP (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE DDAVP, DESMOPRESSIN ACETATE DECLOMYCIN, DEMECLOCYCLINE HYDROCHLORIDE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DEFINITY, PERFLUTREN DELATESTRYL, TESTOSTERONE ENANTHATE DELESTROGEN, ESTRADIOL VALERATE DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELSYM, DEXTROMETHORPHAN POLISTIREX (OTC) DEMADEX, TORSEMIDE DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE DEMEROL, MEPERIDINE HYDROCHLORIDE DEMSER, METYROSINE DENAVIR, PENCICLOVIR SODIUM DENDRID, IDOXURIDINE DEPACON, VALPROATE SODIUM DEPAKENE, VALPROIC ACID DEPAKOTE ER, DIVALPROEX SODIUM DEPAKOTE, DIVALPROEX SODIUM DEPEN, PENICILLAMINE DEPOCYT, CYTARABINE DEPODUR, MORPHINE SULFATE DEPO-ESTRADIOL, ESTRADIOL CYPIONATE DEPO-MEDROL, METHYLPREDNISOLONE ACETATE DEPO-PROVERA, MEDROXYPROGESTERONE ACETATE DEPO-SUBQ PROVERA 104, MEDROXYPROGESTERONE ACETATE DEPO-TESTOSTERONE, TESTOSTERONE CYPIONATE DERMABET, BETAMETHASONE VALERATE DERMA-SMOOTHE/FS, FLUOCINOLONE ACETONIDE DERMATOP E EMOLLIENT, PREDNICARBATE DERMATOP, PREDNICARBATE DERMOTIC, FLUOCINOLONE ACETONIDE DESFERAL, DEFEROXAMINE MESYLATE DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR, DESLORATADINE DESLORATADINE, DESLORATADINE DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DESOGEN, DESOGESTREL DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL DESONATE, DESONIDE DESONIDE, DESONIDE DESOWEN, DESONIDE DESOXIMETASONE, DESOXIMETASONE DESOXYN, METHAMPHETAMINE HYDROCHLORIDE DETROL LA, TOLTERODINE TARTRATE DETROL, TOLTERODINE TARTRATE DEXAMETHASONE INTENSOL, DEXAMETHASONE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE
APPENDIX A
**
A - 16
DEXAMETHASONE, DEXAMETHASONE DEXASPORIN, DEXAMETHASONE DEXCHLORPHENIRAMINE MALEATE, DEXCHLORPHENIRAMINE MALEATE DEXEDRINE, DEXTROAMPHETAMINE SULFATE DEXFERRUM, IRON DEXTRAN DEXILANT, DEXLANSOPRAZOLE DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE DEXRAZOXANE HYDROCHLORIDE, DEXRAZOXANE HYDROCHLORIDE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE ASPARTATE DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 25%, DEXTROSE DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, DEXTROSE
APPENDIX A
**
A - 17
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 60% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE DIABETA, GLYBURIDE DIABINESE, CHLORPROPAMIDE DIALYTE CONCENTRATE W/ DEXTROSE 30% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIAMOX, ACETAZOLAMIDE DIAMOX, ACETAZOLAMIDE SODIUM DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIASTAT ACUDIAL, DIAZEPAM DIASTAT, DIAZEPAM DIAZEPAM INTENSOL, DIAZEPAM DIAZEPAM, DIAZEPAM DIBENZYLINE, PHENOXYBENZAMINE HYDROCHLORIDE DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM DICLOFENAC SODIUM, DICLOFENAC SODIUM DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE), DICYCLOMINE HYDROCHLORIDE DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DIDANOSINE, DIDANOSINE DIDREX, BENZPHETAMINE HYDROCHLORIDE DIDRONEL, ETIDRONATE DISODIUM DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE DIFFERIN, ADAPALENE DIFICID, FIDAXOMICIN DIFLORASONE DIACETATE, DIFLORASONE DIACETATE DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE DIFLUCAN IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE DIFLUCAN, FLUCONAZOLE DIFLUNISAL, DIFLUNISAL DIGOXIN, DIGOXIN DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE DILACOR XR, DILTIAZEM HYDROCHLORIDE DILANTIN, PHENYTOIN DILANTIN, PHENYTOIN SODIUM DILANTIN-125, PHENYTOIN DILATRATE-SR, ISOSORBIDE DINITRATE DILAUDID, HYDROMORPHONE HYDROCHLORIDE DILAUDID-HP, HYDROMORPHONE HYDROCHLORIDE DILT-CD, DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE
APPENDIX A
**
A - 18
DILTZAC, DILTIAZEM HYDROCHLORIDE DIMENHYDRINATE, DIMENHYDRINATE DIMETHYL SULFOXIDE, DIMETHYL SULFOXIDE DIOVAN HCT, HYDROCHLOROTHIAZIDE DIOVAN, VALSARTAN DIPENTUM, OLSALAZINE SODIUM DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE DIPIVEFRIN HYDROCHLORIDE, DIPIVEFRIN HYDROCHLORIDE DIPRIVAN, PROPOFOL DIPROLENE AF, BETAMETHASONE DIPROPIONATE DIPROLENE, BETAMETHASONE DIPROPIONATE DIPYRIDAMOLE, DIPYRIDAMOLE DISOPHROL, DEXBROMPHENIRAMINE MALEATE (OTC) DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE DISPERMOX, AMOXICILLIN DISULFIRAM, DISULFIRAM DITROPAN XL, OXYBUTYNIN CHLORIDE DITROPAN, OXYBUTYNIN CHLORIDE DIURIL, CHLOROTHIAZIDE DIURIL, CHLOROTHIAZIDE SODIUM DIVALPROEX SODIUM, DIVALPROEX SODIUM DIVIGEL, ESTRADIOL DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%, DOBUTAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE DOCEFREZ, DOCETAXEL DOCETAXEL, DOCETAXEL DOLOPHINE HYDROCHLORIDE, METHADONE HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE DOPRAM, DOXAPRAM HYDROCHLORIDE DORAL, QUAZEPAM DORIBAX, DORIPENEM DORYX, DOXYCYCLINE HYCLATE DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE DOVONEX, CALCIPOTRIENE DOXAPRAM HYDROCHLORIDE, DOXAPRAM HYDROCHLORIDE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE DOXERCALCIFEROL, DOXERCALCIFEROL DOXIL, DOXORUBICIN HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE DOXY 100, DOXYCYCLINE HYCLATE DOXY 200, DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DOXYCYCLINE, DOXYCYCLINE DOXYCYCLINE, DOXYCYCLINE HYCLATE DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE (OTC) DRAXIMAGE MDP-25, TECHNETIUM TC-99M MEDRONATE DRISDOL, ERGOCALCIFEROL DRIXORAL PLUS, ACETAMINOPHEN (OTC) DRIXORAL, DEXBROMPHENIRAMINE MALEATE (OTC) DRONABINOL, DRONABINOL DROPERIDOL, DROPERIDOL DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE DROXIA, HYDROXYUREA DTIC-DOME, DACARBAZINE
APPENDIX A
DTPA, TECHNETIUM TC-99M PENTETATE KIT DUAC, BENZOYL PEROXIDE DUETACT, GLIMEPIRIDE DUEXIS, FAMOTIDINE DULERA, FORMOTEROL FUMARATE DUODOTE, ATROPINE DUONEB, ALBUTEROL SULFATE DURACLON, CLONIDINE HYDROCHLORIDE DURAGESIC-100, FENTANYL DURAGESIC-12, FENTANYL DURAGESIC-25, FENTANYL DURAGESIC-50, FENTANYL DURAGESIC-75, FENTANYL DURAMORPH PF, MORPHINE SULFATE DURAPREP, IODINE POVACRYLEX (OTC) DUREZOL, DIFLUPREDNATE DUTASTERIDE, DUTASTERIDE DUVOID, BETHANECHOL CHLORIDE DYAZIDE, HYDROCHLOROTHIAZIDE DYNACIN, MINOCYCLINE HYDROCHLORIDE DYNACIRC CR, ISRADIPINE DYNA-HEX, CHLORHEXIDINE GLUCONATE (OTC) DYRENIUM, TRIAMTERENE
**
A - 19
**
E.E.S. 200, ERYTHROMYCIN ETHYLSUCCINATE E.E.S. 400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE EDARBI, AZILSARTAN KAMEDOXOMIL EDARBYCLOR, AZILSARTAN KAMEDOXOMIL EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDEX, ALPROSTADIL EDLUAR, ZOLPIDEM TARTRATE EDURANT, RILPIVIRINE HYDROCHLORIDE EFFEXOR XR, VENLAFAXINE HYDROCHLORIDE EFFIENT, PRASUGREL HYDROCHLORIDE EFUDEX, FLUOROURACIL E-GLADES, ERYTHROMYCIN EGRIFTA, TESAMORELIN ACETATE ELDEPRYL, SELEGILINE HYDROCHLORIDE ELESTAT, EPINASTINE HYDROCHLORIDE ELESTRIN, ESTRADIOL ELIDEL, PIMECROLIMUS ELIGARD, LEUPROLIDE ACETATE ELIMITE, PERMETHRIN ELIPHOS, CALCIUM ACETATE ELIXOPHYLLIN, THEOPHYLLINE ELLA, ULIPRISTAL ACETATE ELLENCE, EPIRUBICIN HYDROCHLORIDE ELLIOTTS B SOLUTION, CALCIUM CHLORIDE ELMIRON, PENTOSAN POLYSULFATE SODIUM ELOCON, MOMETASONE FUROATE ELOXATIN, OXALIPLATIN EMADINE, EMEDASTINE DIFUMARATE EMBEDA, MORPHINE SULFATE EMBELINE E, CLOBETASOL PROPIONATE EMBELINE, CLOBETASOL PROPIONATE EMCYT, ESTRAMUSTINE PHOSPHATE SODIUM EMEND, APREPITANT EMEND, FOSAPREPITANT DIMEGLUMINE
**
APPENDIX A
**
A - 20
EMLA, LIDOCAINE EMOQUETTE, DESOGESTREL EMSAM, SELEGILINE EMTRIVA, EMTRICITABINE ENABLEX, DARIFENACIN HYDROBROMIDE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ENALAPRIL MALEATE, ENALAPRIL MALEATE ENALAPRILAT, ENALAPRILAT ENDOMETRIN, PROGESTERONE ENDOSOL EXTRA, CALCIUM CHLORIDE ENDURON, METHYCLOTHIAZIDE ENFLURANE, ENFLURANE ENJUVIA, ESTROGENS, CONJUGATED SYNTHETIC B ENLON, EDROPHONIUM CHLORIDE ENLON-PLUS, ATROPINE SULFATE ENOXAPARIN SODIUM (PRESERVATIVE FREE), ENOXAPARIN SODIUM ENOXAPARIN SODIUM, ENOXAPARIN SODIUM ENPRESSE-28, ETHINYL ESTRADIOL ENTEREG, ALVIMOPAN ENTOCORT EC, BUDESONIDE ENULOSE, LACTULOSE EOVIST, GADOXETATE DISODIUM EPIDUO, ADAPALENE EPIFOAM, HYDROCORTISONE ACETATE EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE EPINEPHRINE, EPINEPHRINE (OTC) EPIPEN JR., EPINEPHRINE EPIPEN, EPINEPHRINE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE EPITOL, CARBAMAZEPINE EPIVIR, LAMIVUDINE EPIVIR-HBV, LAMIVUDINE EPLERENONE, EPLERENONE EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM EPROSARTAN MESYLATE, EPROSARTAN MESYLATE EPZICOM, ABACAVIR SULFATE EQUETRO, CARBAMAZEPINE ERAXIS, ANIDULAFUNGIN ERGOCALCIFEROL, ERGOCALCIFEROL ERGOLOID MESYLATES, ERGOLOID MESYLATES ERGOMAR, ERGOTAMINE TARTRATE ERGOTAMINE TARTRATE AND CAFFEINE, CAFFEINE ERRIN, NORETHINDRONE ERTACZO, SERTACONAZOLE NITRATE ERYC, ERYTHROMYCIN ERYGEL, ERYTHROMYCIN ERYPED, ERYTHROMYCIN ETHYLSUCCINATE ERY-TAB, ERYTHROMYCIN ERYTHRA-DERM, ERYTHROMYCIN ERYTHROCIN STEARATE, ERYTHROMYCIN STEARATE ERYTHROCIN, ERYTHROMYCIN LACTOBIONATE ERYTHROMYCIN AND BENZOYL PEROXIDE, BENZOYL PEROXIDE ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL, ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN, ERYTHROMYCIN ERYTHRO-STATIN, ERYTHROMYCIN ESGIC-PLUS, ACETAMINOPHEN ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE ESTAZOLAM, ESTAZOLAM ESTRACE, ESTRADIOL ESTRADERM, ESTRADIOL ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL ESTRADIOL AND NORGESTIMATE, ESTRADIOL
APPENDIX A
**
A - 21
ESTRADIOL CYPIONATE, ESTRADIOL CYPIONATE ESTRADIOL VALERATE, ESTRADIOL VALERATE ESTRADIOL, ESTRADIOL ESTRASORB, ESTRADIOL HEMIHYDRATE ESTRING, ESTRADIOL ESTROGEL, ESTRADIOL ESTRONE, ESTRONE ESTROPIPATE, ESTROPIPATE ESTROSTEP FE, ETHINYL ESTRADIOL ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE ETHAMOLIN, ETHANOLAMINE OLEATE ETHOSUXIMIDE, ETHOSUXIMIDE ETHRANE, ENFLURANE ETHYOL, AMIFOSTINE ETIDRONATE DISODIUM, ETIDRONATE DISODIUM ETODOLAC, ETODOLAC ETOMIDATE, ETOMIDATE ETOPOPHOS PRESERVATIVE FREE, ETOPOSIDE PHOSPHATE ETOPOSIDE, ETOPOSIDE EURAX, CROTAMITON EVAMIST, ESTRADIOL EVISTA, RALOXIFENE HYDROCHLORIDE EVOCLIN, CLINDAMYCIN PHOSPHATE EVOXAC, CEVIMELINE HYDROCHLORIDE EXALGO, HYDROMORPHONE HYDROCHLORIDE EXCEDRIN (MIGRAINE), ACETAMINOPHEN (OTC) EXELDERM, SULCONAZOLE NITRATE EXELON, RIVASTIGMINE EXELON, RIVASTIGMINE TARTRATE EXEMESTANE, EXEMESTANE EXFORGE HCT, AMLODIPINE BESYLATE EXFORGE, AMLODIPINE BESYLATE EXIDINE, CHLORHEXIDINE GLUCONATE (OTC) EXJADE, DEFERASIROX EXPAREL, BUPIVACAINE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM EXTINA, KETOCONAZOLE EXTRANEAL, ICODEXTRIN E-Z SCRUB 201, POVIDONE-IODINE (OTC) E-Z SCRUB 241, POVIDONE-IODINE (OTC)
**
**
FACTIVE, GEMIFLOXACIN MESYLATE FAMCICLOVIR, FAMCICLOVIR FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK), FAMOTIDINE FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER, FAMOTIDINE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FAMVIR, FAMCICLOVIR FANAPT, ILOPERIDONE FARESTON, TOREMIFENE CITRATE FASLODEX, FULVESTRANT FAZACLO ODT, CLOZAPINE FELBAMATE, FELBAMATE FELBATOL, FELBAMATE FELDENE, PIROXICAM FELODIPINE, FELODIPINE FEMARA, LETROZOLE FEMCON FE, ETHINYL ESTRADIOL FEMHRT, ETHINYL ESTRADIOL FEMRING, ESTRADIOL ACETATE FEMSTAT 3, BUTOCONAZOLE NITRATE (OTC)
APPENDIX A
**
A - 22
FEMTRACE, ESTRADIOL ACETATE FENOFIBRATE (MICRONIZED), FENOFIBRATE FENOFIBRATE, FENOFIBRATE FENOGLIDE, FENOFIBRATE FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE FENOPROFEN CALCIUM, FENOPROFEN CALCIUM FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE FENTANYL CITRATE, FENTANYL CITRATE FENTANYL-100, FENTANYL FENTANYL-12, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL FENTORA, FENTANYL CITRATE FERAHEME, FERUMOXYTOL FERIDEX I.V., FERUMOXIDES FERRIPROX, DEFERIPRONE FERRLECIT, SODIUM FERRIC GLUCONATE COMPLEX FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FIBRICOR, FENOFIBRIC ACID FINACEA, AZELAIC ACID FINASTERIDE, FINASTERIDE FIORICET W/ CODEINE, ACETAMINOPHEN FIORICET, ACETAMINOPHEN FIORINAL W/CODEINE, ASPIRIN FIORINAL, ASPIRIN FIRAZYR, ICATIBANT ACETATE FIRMAGON, DEGARELIX ACETATE FLAGYL ER, METRONIDAZOLE FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLAGYL, METRONIDAZOLE FLAREX, FLUOROMETHOLONE ACETATE FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLECTOR, DICLOFENAC EPOLAMINE FLEXERIL, CYCLOBENZAPRINE HYDROCHLORIDE FLOLAN, EPOPROSTENOL SODIUM FLOMAX, TAMSULOSIN HYDROCHLORIDE FLONASE, FLUTICASONE PROPIONATE FLO-PRED, PREDNISOLONE ACETATE FLOVENT DISKUS 100, FLUTICASONE PROPIONATE FLOVENT DISKUS 250, FLUTICASONE PROPIONATE FLOVENT DISKUS 50, FLUTICASONE PROPIONATE FLOVENT HFA, FLUTICASONE PROPIONATE FLOXIN OTIC, OFLOXACIN FLOXURIDINE, FLOXURIDINE FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUCONAZOLE, FLUCONAZOLE FLUCYTOSINE, FLUCYTOSINE FLUDARA, FLUDARABINE PHOSPHATE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FLUDEOXYGLUCOSE F 18, FLUDEOXYGLUCOSE F-18 FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18 FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE FLUMADINE, RIMANTADINE HYDROCHLORIDE
(OTC)
APPENDIX A
**
A - 23
FLUMAZENIL, FLUMAZENIL FLUNISOLIDE, FLUNISOLIDE FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE FLUOCINONIDE, FLUOCINONIDE FLUORESCITE, FLUORESCEIN SODIUM FLUOROPLEX, FLUOROURACIL FLUOROURACIL, FLUOROURACIL FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUOXYMESTERONE, FLUOXYMESTERONE FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE FLURBIPROFEN SODIUM, FLURBIPROFEN SODIUM FLURBIPROFEN, FLURBIPROFEN FLUTAMIDE, FLUTAMIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE FML FORTE, FLUOROMETHOLONE FML, FLUOROMETHOLONE FOAMCOAT, ALUMINUM HYDROXIDE (OTC) FOCALIN XR, DEXMETHYLPHENIDATE HYDROCHLORIDE FOCALIN, DEXMETHYLPHENIDATE HYDROCHLORIDE FOLIC ACID, FOLIC ACID FOLLISTIM AQ, FOLLITROPIN ALFA/BETA FOLOTYN, PRALATREXATE FOMEPIZOLE, FOMEPIZOLE FONDAPARINUX SODIUM, FONDAPARINUX SODIUM FORADIL, FORMOTEROL FUMARATE FORANE, ISOFLURANE FORFIVO XL, BUPROPION HYDROCHLORIDE FORTAMET, METFORMIN HYDROCHLORIDE FORTAZ IN PLASTIC CONTAINER, CEFTAZIDIME SODIUM FORTAZ, CEFTAZIDIME FORTEO, TERIPARATIDE RECOMBINANT HUMAN FORTESTA, TESTOSTERONE FORTICAL, CALCITONIN SALMON RECOMBINANT FOSAMAX PLUS D, ALENDRONATE SODIUM FOSAMAX, ALENDRONATE SODIUM FOSCARNET SODIUM, FOSCARNET SODIUM FOSCAVIR, FOSCARNET SODIUM FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FOSRENOL, LANTHANUM CARBONATE FRAGMIN, DALTEPARIN SODIUM FREAMINE HBC 6.9%, AMINO ACIDS FREAMINE III 10%, AMINO ACIDS FREAMINE III 3% W/ ELECTROLYTES, AMINO ACIDS FREAMINE III 8.5% W/ ELECTROLYTES, AMINO ACIDS FREAMINE III 8.5%, AMINO ACIDS FROVA, FROVATRIPTAN SUCCINATE FULCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE FURADANTIN, NITROFURANTOIN FUROSEMIDE, FUROSEMIDE FUSILEV, LEVOLEUCOVORIN CALCIUM FUZEON, ENFUVIRTIDE
**
GABAPENTIN, GABAPENTIN GABITRIL, TIAGABINE HYDROCHLORIDE GABLOFEN, BACLOFEN
**
APPENDIX A
**
A - 24
GADAVIST, GADOBUTROL GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67 GALZIN, ZINC ACETATE GANCICLOVIR, GANCICLOVIR GANCICLOVIR, GANCICLOVIR SODIUM GANIRELIX ACETATE INJECTION, GANIRELIX ACETATE GANITE, GALLIUM NITRATE GASTROCROM, CROMOLYN SODIUM GASTROGRAFIN, DIATRIZOATE MEGLUMINE GASTROMARK, FERUMOXSIL GATIFLOXACIN, GATIFLOXACIN GAVISCON, ALUMINUM HYDROXIDE (OTC) GELNIQUE, OXYBUTYNIN CHLORIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GEMCITABINE, GEMCITABINE HYDROCHLORIDE GEMFIBROZIL, GEMFIBROZIL GEMZAR, GEMCITABINE HYDROCHLORIDE GENERLAC, LACTULOSE GENGRAF, CYCLOSPORINE GENOPTIC, GENTAMICIN SULFATE GENOTROPIN PRESERVATIVE FREE, SOMATROPIN RECOMBINANT GENOTROPIN, SOMATROPIN RECOMBINANT GENTAK, GENTAMICIN SULFATE GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, GENTAMICIN SULFATE GENTAMICIN SULFATE, GENTAMICIN SULFATE GEN-XENE, CLORAZEPATE DIPOTASSIUM GEODON, ZIPRASIDONE HYDROCHLORIDE GEODON, ZIPRASIDONE MESYLATE GILDESS FE 1.5/30, ETHINYL ESTRADIOL GILDESS FE 1/20, ETHINYL ESTRADIOL GILENYA, FINGOLIMOD GLEEVEC, IMATINIB MESYLATE GLIADEL, CARMUSTINE GLIMEPIRIDE, GLIMEPIRIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GLIPIZIDE, GLIPIZIDE GLUCAGEN, GLUCAGON HYDROCHLORIDE RECOMBINANT GLUCAGON, GLUCAGON RECOMBINANT GLUCOPHAGE XR, METFORMIN HYDROCHLORIDE GLUCOPHAGE, METFORMIN HYDROCHLORIDE GLUCOTROL XL, GLIPIZIDE GLUCOTROL, GLIPIZIDE GLUCOVANCE, GLYBURIDE GLUMETZA, METFORMIN HYDROCHLORIDE GLYBURIDE (MICRONIZED), GLYBURIDE GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE GLYBURIDE, GLYBURIDE GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE GLYCOLAX, POLYETHYLENE GLYCOL 3350 GLYCOLAX, POLYETHYLENE GLYCOL 3350 (OTC) GLYCOPYRROLATE, GLYCOPYRROLATE GLYNASE, GLYBURIDE GLYSET, MIGLITOL GOLYTELY, POLYETHYLENE GLYCOL 3350 GONAL-F RFF PEN, FOLLITROPIN ALFA/BETA GONAL-F RFF, FOLLITROPIN ALFA/BETA GONAL-F, FOLLITROPIN ALFA/BETA GRALISE, GABAPENTIN GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE GRANISTERON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE GRIFULVIN V, GRISEOFULVIN, MICROCRYSTALLINE
APPENDIX A
**
A - 25
GRISEOFULVIN, GRISEOFULVIN GRISEOFULVIN, GRISEOFULVIN, MICROCRYSTALLINE GRIS-PEG, GRISEOFULVIN, ULTRAMICROCRYSTALLINE GUAIFENESIN, GUAIFENESIN (OTC) GUANABENZ ACETATE, GUANABENZ ACETATE GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE GUANIDINE HYDROCHLORIDE, GUANIDINE HYDROCHLORIDE GYNAZOLE-1, BUTOCONAZOLE NITRATE GYNE-LOTRIMIN 3 COMBINATION PACK, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN 3, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN COMBINATION PACK, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN, CLOTRIMAZOLE (OTC)
**
**
H.P. ACTHAR GEL, CORTICOTROPIN HABITROL, NICOTINE (OTC) HALAVEN, ERIBULIN MESYLATE HALCION, TRIAZOLAM HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALFLYTELY, BISACODYL HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE HALOG, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL HALOPERIDOL, HALOPERIDOL LACTATE HEATHER, NORETHINDRONE HECTOROL, DOXERCALCIFEROL HELIDAC, BISMUTH SUBSALICYLATE HEMABATE, CARBOPROST TROMETHAMINE HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM HEPATAMINE 8%, AMINO ACIDS HEPATASOL 8%, AMINO ACIDS HEPATOLITE, TECHNETIUM TC-99M DISOFENIN KIT HEPSERA, ADEFOVIR DIPIVOXIL HERPLEX, IDOXURIDINE HEXABRIX, IOXAGLATE MEGLUMINE HEXALEN, ALTRETAMINE HIBICLENS, CHLORHEXIDINE GLUCONATE (OTC) HIBISTAT, CHLORHEXIDINE GLUCONATE (OTC) HICON, SODIUM IODIDE I-131 HIPREX, METHENAMINE HIPPURATE HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, HOMATROPINE METHYLBROMIDE HORIZANT, GABAPENTIN ENACARBIL HUMALOG KWIKPEN, INSULIN LISPRO RECOMBINANT HUMALOG MIX 50/50 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 50/50 PEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 50/50, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT
APPENDIX A
**
A - 26
HUMALOG MIX 75/25 PEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG PEN, INSULIN LISPRO RECOMBINANT HUMALOG, INSULIN LISPRO RECOMBINANT HUMATROPE, SOMATROPIN RECOMBINANT HUMULIN 70/30 PEN, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN 70/30, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (OTC) HUMULIN R PEN, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN R, INSULIN RECOMBINANT HUMAN HUMULIN R, INSULIN RECOMBINANT HUMAN (OTC) HYCAMTIN, TOPOTECAN HYDROCHLORIDE HYDASE, HYALURONIDASE HYDERGINE, ERGOLOID MESYLATES HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDRA-ZIDE, HYDRALAZINE HYDROCHLORIDE HYDREA, HYDROXYUREA HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX, CHLORPHENIRAMINE POLISTIREX HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE HYDROCORTISONE AND ACETIC ACID, ACETIC ACID, GLACIAL HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE HYDROCORTISONE IN ABSORBASE, HYDROCORTISONE HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE HYDROCORTISONE, HYDROCORTISONE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE HYDRO-RX, HYDROCORTISONE HYDROXOCOBALAMIN, HYDROXOCOBALAMIN HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE HYDROXYUREA, HYDROXYUREA HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE HYLENEX RECOMBINANT, HYALURONIDASE RECOMBINANT HUMAN HYTRIN, TERAZOSIN HYDROCHLORIDE HYZAAR, HYDROCHLOROTHIAZIDE
**
**
IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE (OTC) IBUPROFEN AND DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE (OTC) IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN (OTC) IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) IBUPROHM COLD AND SINUS, IBUPROFEN (OTC) IBUPROHM, IBUPROFEN (OTC) IBU-TAB 200, IBUPROFEN (OTC) IBU-TAB, IBUPROFEN IBUTILIDE FUMARATE, IBUTILIDE FUMARATE IC-GREEN, INDOCYANINE GREEN IDAMYCIN PFS, IDARUBICIN HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE PFS, IDARUBICIN HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IDKIT:HP, UREA C-13 IFEX, IFOSFAMIDE IFOSFAMIDE, IFOSFAMIDE IFOSFAMIDE/MESNA KIT, IFOSFAMIDE IMIPENEM AND CILASTATIN, CILASTATIN SODIUM IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE IMIQUIMOD, IMIQUIMOD IMITREX STATDOSE, SUMATRIPTAN SUCCINATE
APPENDIX A
**
A - 27
IMITREX, SUMATRIPTAN IMITREX, SUMATRIPTAN SUCCINATE IMODIUM A-D EZ CHEWS, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM A-D, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM, LOPERAMIDE HYDROCHLORIDE IMPLANON, ETONOGESTREL IMURAN, AZATHIOPRINE INAPSINE, DROPERIDOL INCIVEK, TELAPREVIR INCRELEX, MECASERMIN RECOMBINANT INDAPAMIDE, INDAPAMIDE INDERAL LA, PROPRANOLOL HYDROCHLORIDE INDERAL, PROPRANOLOL HYDROCHLORIDE INDERIDE-40/25, HYDROCHLOROTHIAZIDE INDICLOR, INDIUM IN-111 CHLORIDE INDIUM IN 111 CHLORIDE, INDIUM IN-111 CHLORIDE INDIUM IN-111 OXYQUINOLINE, INDIUM IN-111 OXYQUINOLINE INDOCIN, INDOMETHACIN INDOCIN, INDOMETHACIN SODIUM INDOCYANINE GREEN, INDOCYANINE GREEN INDOMETHACIN SODIUM, INDOMETHACIN SODIUM INDOMETHACIN, INDOMETHACIN INFANTS' FEVERALL, ACETAMINOPHEN (OTC) INFASURF PRESERVATIVE FREE, CALFACTANT INFED, IRON DEXTRAN INFUMORPH, MORPHINE SULFATE INFUVITE ADULT, ALPHA-TOCOPHEROL ACETATE INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), ASCORBIC ACID INFUVITE PEDIATRIC, ASCORBIC ACID INNOHEP, TINZAPARIN SODIUM INNOPRAN XL, PROPRANOLOL HYDROCHLORIDE INOMAX, NITRIC OXIDE INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE INSPRA, EPLERENONE INTAL, CROMOLYN SODIUM INTEGRILIN, EPTIFIBATIDE INTELENCE, ETRAVIRINE INTERMEZZO, ZOLPIDEM TARTRATE INTRALIPID 10%, SOYBEAN OIL INTRALIPID 20%, SOYBEAN OIL INTRALIPID 30%, SOYBEAN OIL INTROVALE, ETHINYL ESTRADIOL INTUNIV, GUANFACINE HYDROCHLORIDE INVAGESIC FORTE, ASPIRIN INVAGESIC, ASPIRIN INVANZ, ERTAPENEM SODIUM INVEGA SUSTENNA, PALIPERIDONE PALMITATE INVEGA, PALIPERIDONE INVIRASE, SAQUINAVIR MESYLATE IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE IOPAMIDOL-250, IOPAMIDOL IOPAMIDOL-300, IOPAMIDOL IOPAMIDOL-370, IOPAMIDOL IOPIDINE, APRACLONIDINE HYDROCHLORIDE IOSAT, POTASSIUM IODIDE (OTC) IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE IPRIVASK, DESIRUDIN RECOMBINANT IQUIX, LEVOFLOXACIN
APPENDIX A
**
A - 28
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE ISENTRESS, RALTEGRAVIR POTASSIUM ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN, LEVONORDEFRIN ISOCAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE ISOFLURANE, ISOFLURANE ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE E IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE S IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE ISOLYTE S PH 7.4 IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE ISONIAZID, ISONIAZID ISOPROTERENOL HYDROCHLORIDE, ISOPROTERENOL HYDROCHLORIDE ISOPTIN SR, VERAPAMIL HYDROCHLORIDE ISOPTO CARPINE, PILOCARPINE HYDROCHLORIDE ISORDIL, ISOSORBIDE DINITRATE ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE ISOSULFAN BLUE, ISOSULFAN BLUE ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER, GENTAMICIN SULFATE ISOVUE-200, IOPAMIDOL ISOVUE-250, IOPAMIDOL ISOVUE-300, IOPAMIDOL ISOVUE-370, IOPAMIDOL ISOVUE-M 200, IOPAMIDOL ISOVUE-M 300, IOPAMIDOL ISRADIPINE, ISRADIPINE ISTALOL, TIMOLOL MALEATE ISTODAX, ROMIDEPSIN ISUPREL, ISOPROTERENOL HYDROCHLORIDE ITRACONAZOLE, ITRACONAZOLE IVY BLOCK, BENTOQUATAM (OTC) IXEMPRA KIT, IXABEPILONE
**
JAKAFI, RUXOLITINIB PHOSPHATE JALYN, DUTASTERIDE JANTOVEN, WARFARIN SODIUM JANUMET, METFORMIN HYDROCHLORIDE JANUVIA, SITAGLIPTIN PHOSPHATE JEANATOPE, ALBUMIN IODINATED I-125 SERUM JEVTANA KIT, CABAZITAXEL JUNEL 1.5/30, ETHINYL ESTRADIOL JUNEL 1/20, ETHINYL ESTRADIOL JUNEL FE 1.5/30, ETHINYL ESTRADIOL JUNEL FE 1/20, ETHINYL ESTRADIOL JUNIOR STRENGTH ADVIL, IBUPROFEN (OTC) JUNIOR STRENGTH IBUPROFEN, IBUPROFEN (OTC) JUNIOR STRENGTH MOTRIN, IBUPROFEN (OTC) JUVISYNC, SIMVASTATIN
**
**
K+10, POTASSIUM CHLORIDE KADIAN, MORPHINE SULFATE KALETRA, LOPINAVIR KALEXATE, SODIUM POLYSTYRENE SULFONATE KANAMYCIN SULFATE, KANAMYCIN SULFATE KAON CL-10, POTASSIUM CHLORIDE KAPVAY, CLONIDINE HYDROCHLORIDE
**
APPENDIX A
**
A - 29
KARIVA, DESOGESTREL KAYEXALATE, SODIUM POLYSTYRENE SULFONATE KEFLEX, CEPHALEXIN KEFZOL, CEFAZOLIN SODIUM KELNOR, ETHINYL ESTRADIOL KENALOG, TRIAMCINOLONE ACETONIDE KENALOG-10, TRIAMCINOLONE ACETONIDE KENALOG-40, TRIAMCINOLONE ACETONIDE KEPPRA XR, LEVETIRACETAM KEPPRA, LEVETIRACETAM KETALAR, KETAMINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE KETEK, TELITHROMYCIN KETOCONAZOLE, KETOCONAZOLE KETOPROFEN, KETOPROFEN KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE KETOTIFEN FUMARATE, KETOTIFEN FUMARATE (OTC) KETOZOLE, KETOCONAZOLE KINEVAC, SINCALIDE KIONEX, SODIUM POLYSTYRENE SULFONATE KLARON, SULFACETAMIDE SODIUM KLONOPIN, CLONAZEPAM KLOR-CON M10, POTASSIUM CHLORIDE KLOR-CON M15, POTASSIUM CHLORIDE KLOR-CON M20, POTASSIUM CHLORIDE KLOR-CON, POTASSIUM CHLORIDE KLOTRIX, POTASSIUM CHLORIDE KOMBIGLYZE XR, METFORMIN HYDROCHLORIDE K-TAB, POTASSIUM CHLORIDE KUVAN, SAPROPTERIN DIHYDROCHLORIDE
**
**
LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LABETALOL HYDROCLORIDE, LABETALOL HYDROCHLORIDE LAC-HYDRIN, AMMONIUM LACTATE LACRISERT, HYDROXYPROPYL CELLULOSE LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE LACTULOSE, LACTULOSE LAMICTAL CD, LAMOTRIGINE LAMICTAL ODT, LAMOTRIGINE LAMICTAL XR, LAMOTRIGINE LAMICTAL, LAMOTRIGINE LAMISIL AT, TERBINAFINE (OTC) LAMISIL AT, TERBINAFINE HYDROCHLORIDE (OTC) LAMISIL, TERBINAFINE HYDROCHLORIDE LAMISIL, TERBINAFINE HYDROCHLORIDE (OTC) LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE LAMIVUDINE, LAMIVUDINE LAMOTRIGINE, LAMOTRIGINE LAMPRENE, CLOFAZIMINE LANORINAL, ASPIRIN LANOXIN PEDIATRIC, DIGOXIN LANOXIN, DIGOXIN LANSOPRAZOLE, LANSOPRAZOLE LANTUS, INSULIN GLARGINE RECOMBINANT LAROTID, AMOXICILLIN LARYNG-O-JET KIT, LIDOCAINE HYDROCHLORIDE LASIX, FUROSEMIDE LASTACAFT, ALCAFTADINE LATANOPROST, LATANOPROST LATISSE, BIMATOPROST LATUDA, LURASIDONE HYDROCHLORIDE
APPENDIX A
**
A - 30
LAX-LYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350 LAZANDA, FENTANYL CITRATE LEFLUNOMIDE, LEFLUNOMIDE LESCOL XL, FLUVASTATIN SODIUM LESCOL, FLUVASTATIN SODIUM LESSINA-28, ETHINYL ESTRADIOL LETAIRIS, AMBRISENTAN LETROZOLE, LETROZOLE LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM LEUKERAN, CHLORAMBUCIL LEUPROLIDE ACETATE, LEUPROLIDE ACETATE LEUSTATIN, CLADRIBINE LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN LEVAQUIN, LEVOFLOXACIN LEVATOL, PENBUTOLOL SULFATE LEVEMIR, INSULIN DETEMIR RECOMBINANT LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM LEVETIRACETAM, LEVETIRACETAM LEVITRA, VARDENAFIL HYDROCHLORIDE LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE LEVOCARNITINE, LEVOCARNITINE LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN LEVOFLOXACIN, LEVOFLOXACIN LEVONEST, ETHINYL ESTRADIOL LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL, LEVONORGESTREL LEVONORGESTREL, LEVONORGESTREL (OTC) LEVOPHED, NOREPINEPHRINE BITARTRATE LEVORA 0.15/30-28, ETHINYL ESTRADIOL LEVORPHANOL TARTRATE, LEVORPHANOL TARTRATE LEVO-T, LEVOTHYROXINE SODIUM LEVOTHROID, LEVOTHYROXINE SODIUM LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM LEVOXYL, LEVOTHYROXINE SODIUM LEVULAN, AMINOLEVULINIC ACID HYDROCHLORIDE LEXAPRO, ESCITALOPRAM OXALATE LEXISCAN, REGADENOSON LEXIVA, FOSAMPRENAVIR CALCIUM LIALDA, MESALAMINE LIBRIUM, CHLORDIAZEPOXIDE HYDROCHLORIDE LIDEX, FLUOCINONIDE LIDEX-E, FLUOCINONIDE LIDOCAINE AND PRILOCAINE, LIDOCAINE LIDOCAINE AND TETRACAINE, LIDOCAINE LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, EPINEPHRINE LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE VISCOUS, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LIDOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE LIDOCAINE, LIDOCAINE LIDODERM, LIDOCAINE
APPENDIX A
**
A - 31
LIDOPEN, LIDOCAINE HYDROCHLORIDE LIGNOSPAN FORTE, EPINEPHRINE BITARTRATE LIGNOSPAN STANDARD, EPINEPHRINE BITARTRATE LIMBITROL DS, AMITRIPTYLINE HYDROCHLORIDE LIMBITROL, AMITRIPTYLINE HYDROCHLORIDE LINCOCIN, LINCOMYCIN HYDROCHLORIDE LINDANE, LINDANE LIORESAL, BACLOFEN LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM LIPITOR, ATORVASTATIN CALCIUM LIPOFEN, FENOFIBRATE LIPOSYN II 10%, SAFFLOWER OIL LIPOSYN II 20%, SAFFLOWER OIL LIPOSYN III 10%, SOYBEAN OIL LIPOSYN III 20%, SOYBEAN OIL LIPOSYN III 30%, SOYBEAN OIL LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LITHIUM CARBONATE, LITHIUM CARBONATE LITHIUM CITRATE, LITHIUM CITRATE LITHOBID, LITHIUM CARBONATE LITHOSTAT, ACETOHYDROXAMIC ACID LIVALO, PITAVASTATIN CALCIUM LO LOESTRIN FE, ETHINYL ESTRADIOL LO/OVRAL-28, ETHINYL ESTRADIOL LOCHOLEST LIGHT, CHOLESTYRAMINE LOCHOLEST, CHOLESTYRAMINE LOCOID LIPOCREAM, HYDROCORTISONE BUTYRATE LOCOID, HYDROCORTISONE BUTYRATE LODOSYN, CARBIDOPA LOESTRIN 21 1.5/30, ETHINYL ESTRADIOL LOESTRIN 21 1/20, ETHINYL ESTRADIOL LOESTRIN 24 FE, ETHINYL ESTRADIOL LOESTRIN FE 1.5/30, ETHINYL ESTRADIOL LOESTRIN FE 1/20, ETHINYL ESTRADIOL LOMOTIL, ATROPINE SULFATE LONOX, ATROPINE SULFATE LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) LOPID, GEMFIBROZIL LOPRESSOR HCT, HYDROCHLOROTHIAZIDE LOPRESSOR, METOPROLOL TARTRATE LOPROX, CICLOPIROX LOPURIN, ALLOPURINOL LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE (OTC) LORATADINE REDIDOSE, LORATADINE (OTC) LORATADINE, LORATADINE (OTC) LORAZEPAM INTENSOL, LORAZEPAM LORAZEPAM PRESERVATIVE FREE, LORAZEPAM LORAZEPAM, LORAZEPAM LORTAB, ACETAMINOPHEN LORYNA, DROSPIRENONE LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOSEASONIQUE, ETHINYL ESTRADIOL LOTEMAX, LOTEPREDNOL ETABONATE LOTENSIN HCT, BENAZEPRIL HYDROCHLORIDE LOTENSIN, BENAZEPRIL HYDROCHLORIDE LOTREL, AMLODIPINE BESYLATE LOTRIMIN ULTRA, BUTENAFINE HYDROCHLORIDE (OTC) LOTRISONE, BETAMETHASONE DIPROPIONATE LOTRONEX, ALOSETRON HYDROCHLORIDE
(OTC)
APPENDIX A
**
A - 32
LOVASTATIN, LOVASTATIN LOVAZA, OMEGA-3-ACID ETHYL ESTERS LOVENOX (PRESERVATIVE FREE), ENOXAPARIN SODIUM LOVENOX, ENOXAPARIN SODIUM LOW-OGESTREL-21, ETHINYL ESTRADIOL LOW-OGESTREL-28, ETHINYL ESTRADIOL LOXAPINE SUCCINATE, LOXAPINE SUCCINATE LTA II KIT, LIDOCAINE HYDROCHLORIDE LUFYLLIN, DYPHYLLINE LUMIGAN, BIMATOPROST LUNESTA, ESZOPICLONE LUPRON DEPOT, LEUPROLIDE ACETATE LUPRON DEPOT-PED, LEUPROLIDE ACETATE LUSEDRA, FOSPROPOFOL DISODIUM LUVERIS, LUTROPIN ALFA LUVOX CR, FLUVOXAMINE MALEATE LUVOX, FLUVOXAMINE MALEATE LUXIQ, BETAMETHASONE VALERATE LYBREL, ETHINYL ESTRADIOL LYMPHAZURIN, ISOSULFAN BLUE LYRICA, PREGABALIN LYSODREN, MITOTANE LYSTEDA, TRANEXAMIC ACID
**
**
M.V.I. ADULT (PHARMACY BULK PACKAGE), ASCORBIC ACID M.V.I. ADULT, ASCORBIC ACID M.V.I. PEDIATRIC, ASCORBIC ACID M.V.I.-12 (WITHOUT VITAMIN K), ASCORBIC ACID MACROBID, NITROFURANTOIN MACRODANTIN, NITROFURANTOIN, MACROCRYSTALLINE MACUGEN, PEGAPTANIB SODIUM MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE, MAGNESIUM HYDROXIDE MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MAGNESIUM SULFATE MAGNESIUM SULFATE IN PLASTIC CONTAINER, MAGNESIUM SULFATE MAGNESIUM SULFATE, MAGNESIUM SULFATE MAGNEVIST, GADOPENTETATE DIMEGLUMINE MAKENA, HYDROXYPROGESTERONE CAPROATE MALARONE PEDIATRIC, ATOVAQUONE MALARONE, ATOVAQUONE MALATHION, MALATHION MANGANESE CHLORIDE IN PLASTIC CONTAINER, MANGANESE CHLORIDE MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER, MANNITOL MANNITOL 10%, MANNITOL MANNITOL 15% IN PLASTIC CONTAINER, MANNITOL MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%, MANNITOL MANNITOL 15%, MANNITOL MANNITOL 20% IN PLASTIC CONTAINER, MANNITOL MANNITOL 20%, MANNITOL MANNITOL 25%, MANNITOL MANNITOL 5% IN PLASTIC CONTAINER, MANNITOL MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%, MANNITOL MANNITOL 5%, MANNITOL MAPROTILINE HYDROCHLORIDE, MAPROTILINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE W/ EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE MARCAINE, BUPIVACAINE HYDROCHLORIDE MARINOL, DRONABINOL MARPLAN, ISOCARBOXAZID MATULANE, PROCARBAZINE HYDROCHLORIDE
APPENDIX A
**
A - 33
MAVIK, TRANDOLAPRIL MAXAIR, PIRBUTEROL ACETATE MAXALT, RIZATRIPTAN BENZOATE MAXALT-MLT, RIZATRIPTAN BENZOATE MAXIDEX, DEXAMETHASONE MAXIPIME, CEFEPIME HYDROCHLORIDE MAXITROL, DEXAMETHASONE MAXZIDE, HYDROCHLOROTHIAZIDE MAXZIDE-25, HYDROCHLOROTHIAZIDE MD-76R, DIATRIZOATE MEGLUMINE MD-GASTROVIEW, DIATRIZOATE MEGLUMINE MDP-BRACCO, TECHNETIUM TC-99M MEDRONATE KIT MEBENDAZOLE, MEBENDAZOLE MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE MECLOFENAMATE SODIUM, MECLOFENAMATE SODIUM MEDROL, METHYLPREDNISOLONE MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE MEFENAMIC ACID, MEFENAMIC ACID MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE MEFOXIN IN PLASTIC CONTAINER, CEFOXITIN SODIUM MEGACE ES, MEGESTROL ACETATE MEGACE, MEGESTROL ACETATE MEGATOPE, ALBUMIN IODINATED I-131 SERUM MEGESTROL ACETATE, MEGESTROL ACETATE MELOXICAM, MELOXICAM MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE MEMBRANEBLUE, TRYPAN BLUE MENEST, ESTROGENS, ESTERIFIED MENOPUR, LUTEINIZING HORMONE MENOSTAR, ESTRADIOL MEN'S ROGAINE, MINOXIDIL (OTC) MENTAX, BUTENAFINE HYDROCHLORIDE MENTAX-TC, BUTENAFINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE MEPHYTON, PHYTONADIONE MEPIVACAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE MEPROBAMATE, MEPROBAMATE MEPRON, ATOVAQUONE MERCAPTOPURINE, MERCAPTOPURINE MEROPENEM, MEROPENEM MERREM, MEROPENEM MESALAMINE, MESALAMINE MESNA, MESNA MESNEX, MESNA MESTINON, PYRIDOSTIGMINE BROMIDE METADATE CD, METHYLPHENIDATE HYDROCHLORIDE METADATE ER, METHYLPHENIDATE HYDROCHLORIDE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METARAMINOL BITARTRATE, METARAMINOL BITARTRATE METASTRON, STRONTIUM CHLORIDE SR-89 METAXALONE, METAXALONE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHADONE HYDROCHLORIDE INTENSOL, METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METHADOSE, METHADONE HYDROCHLORIDE METHAMPHETAMINE HYDROCHLORIDE, METHAMPHETAMINE HYDROCHLORIDE METHAZOLAMIDE, METHAZOLAMIDE METHENAMINE HIPPURATE, METHENAMINE HIPPURATE METHERGINE, METHYLERGONOVINE MALEATE METHIMAZOLE, METHIMAZOLE METHOCARBAMOL AND ASPIRIN, ASPIRIN METHOCARBAMOL, METHOCARBAMOL
APPENDIX A
**
A - 34
METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM METHOTREXATE SODIUM, METHOTREXATE SODIUM METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE METHYCLOTHIAZIDE, METHYCLOTHIAZIDE METHYLDOPA AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE METHYLDOPA, METHYLDOPA METHYLDOPATE HYDROCHLORIDE, METHYLDOPATE HYDROCHLORIDE METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE METHYLIN ER, METHYLPHENIDATE HYDROCHLORIDE METHYLIN, METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE METHYLPREDNISOLONE, METHYLPREDNISOLONE METHYLTESTOSTERONE, METHYLTESTOSTERONE METIPRANOLOL, METIPRANOLOL HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOLAZONE, METOLAZONE METOPIRONE, METYRAPONE METOPROLOL SUCCINATE, METOPROLOL SUCCINATE METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE METOZOLV ODT, METOCLOPRAMIDE HYDROCHLORIDE METRO I.V. IN PLASTIC CONTAINER, METRONIDAZOLE METROCREAM, METRONIDAZOLE METROGEL, METRONIDAZOLE METROGEL-VAGINAL, METRONIDAZOLE METROLOTION, METRONIDAZOLE METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE METRONIDAZOLE, METRONIDAZOLE METVIXIA, METHYL AMINOLEVULINATE HYDROCHLORIDE MEVACOR, LOVASTATIN MEXILETINE HYDROCHLORIDE, MEXILETINE HYDROCHLORIDE MIACALCIN, CALCITONIN SALMON MICARDIS HCT, HYDROCHLOROTHIAZIDE MICARDIS, TELMISARTAN MICONAZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE 3, MICONAZOLE NITRATE (OTC) MICONAZOLE 7 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE 7, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) MICORT-HC, HYDROCORTISONE ACETATE MICROGESTIN 1.5/30, ETHINYL ESTRADIOL MICROGESTIN 1/20, ETHINYL ESTRADIOL MICROGESTIN FE 1.5/30, ETHINYL ESTRADIOL MICROGESTIN FE 1/20, ETHINYL ESTRADIOL MICRO-K 10, POTASSIUM CHLORIDE MICRO-K, POTASSIUM CHLORIDE MICRONOR, NORETHINDRONE MICROZIDE, HYDROCHLOROTHIAZIDE MIDAMOR, AMILORIDE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE MIDOL LIQUID GELS, IBUPROFEN (OTC) MIDOZALAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MIFEPREX, MIFEPRISTONE MIGERGOT, CAFFEINE MIGRANAL, DIHYDROERGOTAMINE MESYLATE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE MILRINONE LACTATE IN DEXTROSE 5%, MILRINONE LACTATE
APPENDIX A
**
A - 35
MILRINONE LACTATE IN PLASTIC CONTAINER, MILRINONE LACTATE MILRINONE LACTATE, MILRINONE LACTATE MINIPRESS, PRAZOSIN HYDROCHLORIDE MINIRIN, DESMOPRESSIN ACETATE MINITRAN, NITROGLYCERIN MINOCIN, MINOCYCLINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL (FOR WOMEN), MINOXIDIL (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) MINOXIDIL, MINOXIDIL MINOXIDIL, MINOXIDIL (OTC) MIOCHOL-E, ACETYLCHOLINE CHLORIDE MIOSTAT, CARBACHOL MIRALAX, POLYETHYLENE GLYCOL 3350 (OTC) MIRAPEX ER, PRAMIPEXOLE DIHYDROCHLORIDE MIRAPEX, PRAMIPEXOLE DIHYDROCHLORIDE MIRCETTE, DESOGESTREL MIRENA, LEVONORGESTREL MIRTAZAPINE, MIRTAZAPINE MISOPROSTOL, MISOPROSTOL MITOMYCIN, MITOMYCIN MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE MOBIC, MELOXICAM MODICON 28, ETHINYL ESTRADIOL MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE MOMETASONE FUROATE, MOMETASONE FUROATE MONISTAT 1 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MONISTAT 3 COMBINATION PACK (PREFILLED), MICONAZOLE NITRATE (OTC) MONISTAT 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MONISTAT 3, MICONAZOLE NITRATE MONISTAT 3, MICONAZOLE NITRATE (OTC) MONISTAT 7 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MONISTAT 7, MICONAZOLE NITRATE (OTC) MONISTAT-3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS MONODOX, DOXYCYCLINE MONOKET, ISOSORBIDE MONONITRATE MONOPRIL, FOSINOPRIL SODIUM MONUROL, FOSFOMYCIN TROMETHAMINE MORPHINE SULFATE, MORPHINE SULFATE MOTOFEN, ATROPINE SULFATE MOTRIN IB, IBUPROFEN (OTC) MOTRIN MIGRAINE PAIN, IBUPROFEN (OTC) MOVIPREP, ASCORBIC ACID MOXATAG, AMOXICILLIN MOXEZA, MOXIFLOXACIN HYDROCHLORIDE MOZOBIL, PLERIXAFOR MPI DMSA KIDNEY REAGENT, TECHNETIUM TC-99M SUCCIMER KIT MPI INDIUM DTPA IN 111, INDIUM IN-111 PENTETATE DISODIUM MS CONTIN, MORPHINE SULFATE MUCINEX D, GUAIFENESIN (OTC) MUCINEX DM, DEXTROMETHORPHAN HYDROBROMIDE (OTC) MUCINEX, GUAIFENESIN (OTC) MULTAQ, DRONEDARONE HYDROCHLORIDE MULTIHANCE MULTIPACK, GADOBENATE DIMEGLUMINE MULTIHANCE, GADOBENATE DIMEGLUMINE MUPIROCIN, MUPIROCIN MUSE, ALPROSTADIL MUSTARGEN, MECHLORETHAMINE HYDROCHLORIDE MYAMBUTOL, ETHAMBUTOL HYDROCHLORIDE MYCAMINE, MICAFUNGIN SODIUM
APPENDIX A
**
A - 36
MYCELEX, CLOTRIMAZOLE MYCELEX-7 COMBINATION PACK, CLOTRIMAZOLE (OTC) MYCELEX-7, CLOTRIMAZOLE (OTC) MYCOBUTIN, RIFABUTIN MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL MYDRIACYL, TROPICAMIDE MYFORTIC, MYCOPHENOLIC ACID MYLERAN, BUSULFAN MYOVIEW 30ML, TECHNETIUM TC-99M TETROFOSMIN KIT MYOVIEW, TECHNETIUM TC-99M TETROFOSMIN KIT MYSOLINE, PRIMIDONE MYTELASE, AMBENONIUM CHLORIDE M-ZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC)
**
**
NABUMETONE, NABUMETONE NADOLOL AND BENDROFLUMETHAZIDE, BENDROFLUMETHIAZIDE NADOLOL AND BENDROFLUMETHIAZIDE, BENDROFLUMETHIAZIDE NADOLOL, NADOLOL NAFCILLIN SODIUM, NAFCILLIN SODIUM NAFTIN, NAFTIFINE HYDROCHLORIDE NALBUPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE NALFON, FENOPROFEN CALCIUM NALLPEN IN PLASTIC CONTAINER, NAFCILLIN SODIUM NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE NAMENDA XR, MEMANTINE HYDROCHLORIDE NAMENDA, MEMANTINE HYDROCHLORIDE NANDROLONE DECANOATE, NANDROLONE DECANOATE NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE, NAPHAZOLINE HYDROCHLORIDE (OTC) NAPHAZOLINE HYDROCHLORIDE, NAPHAZOLINE HYDROCHLORIDE NAPHCON-A, NAPHAZOLINE HYDROCHLORIDE (OTC) NAPRELAN, NAPROXEN SODIUM NAPROSYN, NAPROXEN NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NAPROXEN, NAPROXEN NARATRIPTAN, NARATRIPTAN NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NARDIL, PHENELZINE SULFATE NAROPIN, ROPIVACAINE HYDROCHLORIDE MONOHYDRATE NASACORT AQ, TRIAMCINOLONE ACETONIDE NASCOBAL, CYANOCOBALAMIN NASONEX, MOMETASONE FUROATE MONOHYDRATE NATACYN, NATAMYCIN NATAZIA, ESTRADIOL VALERATE NATEGLINIDE, NATEGLINIDE NATRECOR, NESIRITIDE RECOMBINANT NATROBA, SPINOSAD NAVANE, THIOTHIXENE NAVELBINE, VINORELBINE TARTRATE NAVSTEL, CALCIUM CHLORIDE NEBUPENT, PENTAMIDINE ISETHIONATE NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE NEMBUTAL SODIUM, PENTOBARBITAL SODIUM NEO-FRADIN, NEOMYCIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, BACITRACIN ZINC
APPENDIX A
**
A - 37
NEOMYCIN SULFATE, NEOMYCIN SULFATE NEOPAP, ACETAMINOPHEN (OTC) NEOPROFEN, IBUPROFEN LYSINE NEORAL, CYCLOSPORINE NEO-RX, NEOMYCIN SULFATE NEOSPORIN G.U. IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, GRAMICIDIN NEPHRAMINE 5.4%, AMINO ACIDS NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE HYDROCHLORIDE NEUROLITE, TECHNETIUM TC-99M BICISATE KIT NEURONTIN, GABAPENTIN NEVANAC, NEPAFENAC NEXAVAR, SORAFENIB TOSYLATE NEXCEDE, KETOPROFEN (OTC) NEXIUM IV, ESOMEPRAZOLE SODIUM NEXIUM, ESOMEPRAZOLE MAGNESIUM NEXPLANON, ETONOGESTREL NEXTERONE, AMIODARONE HYDROCHLORIDE NIACIN, NIACIN NIACOR, NIACIN NIASPAN, NIACIN NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NICODERM CQ, NICOTINE (OTC) NICORETTE (MINT), NICOTINE POLACRILEX (OTC) NICORETTE, NICOTINE POLACRILEX (OTC) NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) NICOTINE, NICOTINE (OTC) NICOTROL, NICOTINE NIFEDIPINE, NIFEDIPINE NILANDRON, NILUTAMIDE NILSTAT, NYSTATIN NIMBEX PRESERVATIVE FREE, CISATRACURIUM BESYLATE NIMBEX, CISATRACURIUM BESYLATE NIMODIPINE, NIMODIPINE NIPENT, PENTOSTATIN NIRAVAM, ALPRAZOLAM NISOLDIPINE, NISOLDIPINE NITHIODOTE, SODIUM NITRITE NITRO-DUR, NITROGLYCERIN NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN NITROFURANTOIN, NITROFURANTOIN NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN NITROGLYCERIN, NITROGLYCERIN NITROLINGUAL PUMPSPRAY, NITROGLYCERIN NITROMIST, NITROGLYCERIN NITROPRESS, SODIUM NITROPRUSSIDE NITROSTAT, NITROGLYCERIN NIX, PERMETHRIN (OTC) NIZATIDINE, NIZATIDINE NIZORAL A-D, KETOCONAZOLE (OTC) NIZORAL, KETOCONAZOLE NORCO, ACETAMINOPHEN NORDETTE-28, ETHINYL ESTRADIOL NORDITROPIN FLEXPRO, SOMATROPIN RECOMBINANT NORDITROPIN NORDIFLEX, SOMATROPIN RECOMBINANT NORDITROPIN, SOMATROPIN RECOMBINANT NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE NORETHIDRONE, NORETHINDRONE NORETHIN 1/35E-21, ETHINYL ESTRADIOL NORETHIN 1/35E-28, ETHINYL ESTRADIOL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL
APPENDIX A
**
A - 38
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORETHINDRONE ACETATE, NORETHINDRONE ACETATE NORETHINDRONE AND ETHINYL ESTRADIOL (10/11), ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL (7/14), ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORETHINDRONE, NORETHINDRONE NORFLEX, ORPHENADRINE CITRATE NORGESIC FORTE, ASPIRIN NORGESIC, ASPIRIN NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORINYL 1+35 21-DAY, ETHINYL ESTRADIOL NORINYL 1+35 28-DAY, ETHINYL ESTRADIOL NORINYL 1+50 28-DAY, MESTRANOL NORITATE, METRONIDAZOLE NORMOCARB HF 25, MAGNESIUM CHLORIDE NORMOCARB HF 35, MAGNESIUM CHLORIDE NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE NORMOSOL-R IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE NOROXIN, NORFLOXACIN NORPACE CR, DISOPYRAMIDE PHOSPHATE NORPACE, DISOPYRAMIDE PHOSPHATE NORPRAMIN, DESIPRAMINE HYDROCHLORIDE NOR-QD, NORETHINDRONE NORTREL 0.5/35-28, ETHINYL ESTRADIOL NORTREL 1/35-21, ETHINYL ESTRADIOL NORTREL 1/35-28, ETHINYL ESTRADIOL NORTREL 7/7/7, ETHINYL ESTRADIOL NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE NORVASC, AMLODIPINE BESYLATE NORVIR, RITONAVIR NOVOLIN 70/30, INSULIN RECOMBINANT HUMAN (OTC) NOVOLIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (OTC) NOVOLIN R, INSULIN RECOMBINANT HUMAN (OTC) NOVOLOG MIX 70/30, INSULIN ASPART PROTAMINE RECOMBINANT NOVOLOG, INSULIN ASPART RECOMBINANT NOXAFIL, POSACONAZOLE NUCYNTA ER, TAPENTADOL HYDROCHLORIDE NUCYNTA, TAPENTADOL HYDROCHLORIDE NUEDEXTA, DEXTROMETHORPHAN HYDROBROMIDE NULYTELY, POLYETHYLENE GLYCOL 3350 NULYTELY-FLAVORED, POLYETHYLENE GLYCOL 3350 NUTRACORT, HYDROCORTISONE NUTRESTORE, GLUTAMINE NUTRILIPID 10%, SOYBEAN OIL NUTRILIPID 20%, SOYBEAN OIL NUTROPIN AQ PEN, SOMATROPIN RECOMBINANT NUTROPIN AQ, SOMATROPIN RECOMBINANT NUTROPIN, SOMATROPIN RECOMBINANT NUVARING, ETHINYL ESTRADIOL NUVIGIL, ARMODAFINIL NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN NYSTATIN, NYSTATIN NYSTOP, NYSTATIN
**
**
OCTOCAINE, EPINEPHRINE OCTREOSCAN, INDIUM IN-111 PENTETREOTIDE KIT OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE OCUCLEAR, OXYMETAZOLINE HYDROCHLORIDE (OTC) OCUFEN, FLURBIPROFEN SODIUM
APPENDIX A
**
A - 39
OCUFLOX, OFLOXACIN OCUPRESS, CARTEOLOL HYDROCHLORIDE OFIRMEV, ACETAMINOPHEN OFLOXACIN, OFLOXACIN OFORTA, FLUDARABINE PHOSPHATE OGEN .625, ESTROPIPATE OGEN 1.25, ESTROPIPATE OGEN 2.5, ESTROPIPATE OGEN 5, ESTROPIPATE OGESTREL 0.5/50-28, ETHINYL ESTRADIOL OLANZAPINE, OLANZAPINE OLEPTRO, TRAZODONE HYDROCHLORIDE OLUX E, CLOBETASOL PROPIONATE OLUX, CLOBETASOL PROPIONATE OMEPRAZOLE AND SODIUM BICARBONATE, OMEPRAZOLE OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM (OTC) OMEPRAZOLE, OMEPRAZOLE OMEPRAZOLE, OMEPRAZOLE (OTC) OMNARIS, CICLESONIDE OMNIPAQUE 140, IOHEXOL OMNIPAQUE 180, IOHEXOL OMNIPAQUE 240, IOHEXOL OMNIPAQUE 300, IOHEXOL OMNIPAQUE 350, IOHEXOL OMNIPRED, PREDNISOLONE ACETATE OMNISCAN, GADODIAMIDE OMNITROPE, SOMATROPIN RECOMBINANT ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE AND SODIUM CHLORIDE IN PLASTIC CONTAINER, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON ONFI, CLOBAZAM ONGLYZA, SAXAGLIPTIN HYDROCHLORIDE ONMEL, ITRACONAZOLE ONSOLIS, FENTANYL CITRATE OPANA ER, OXYMORPHONE HYDROCHLORIDE OPANA, OXYMORPHONE HYDROCHLORIDE OPCON-A, NAPHAZOLINE HYDROCHLORIDE (OTC) OPHTHAINE, PROPARACAINE HYDROCHLORIDE OPHTHETIC, PROPARACAINE HYDROCHLORIDE OPTICROM, CROMOLYN SODIUM OPTIMARK IN PLASTIC CONTAINER, GADOVERSETAMIDE OPTIMARK, GADOVERSETAMIDE OPTIPRANOLOL, METIPRANOLOL HYDROCHLORIDE OPTIRAY 240, IOVERSOL OPTIRAY 300, IOVERSOL OPTIRAY 320, IOVERSOL OPTIRAY 350, IOVERSOL OPTISON, ALBUMIN HUMAN OPTIVAR, AZELASTINE HYDROCHLORIDE ORABASE HCA, HYDROCORTISONE ACETATE ORACEA, DOXYCYCLINE ORAMORPH SR, MORPHINE SULFATE ORAP, PIMOZIDE ORAPRED ODT, PREDNISOLONE SODIUM PHOSPHATE ORAPRED, PREDNISOLONE SODIUM PHOSPHATE ORAQIX, LIDOCAINE ORAVERSE, PHENTOLAMINE MESYLATE ORAVIG, MICONAZOLE ORETIC, HYDROCHLOROTHIAZIDE ORFADIN, NITISINONE ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ASPIRIN
APPENDIX A
**
A - 40
ORPHENADRINE CITRATE, ORPHENADRINE CITRATE ORSYTHIA, ETHINYL ESTRADIOL ORTHO CYCLEN-28, ETHINYL ESTRADIOL ORTHO EVRA, ETHINYL ESTRADIOL ORTHO TRI-CYCLEN LO, ETHINYL ESTRADIOL ORTHO TRI-CYCLEN, ETHINYL ESTRADIOL ORTHO-CEPT, DESOGESTREL ORTHO-EST, ESTROPIPATE ORTHO-NOVUM 1/35-28, ETHINYL ESTRADIOL ORTHO-NOVUM 7/7/7-28, ETHINYL ESTRADIOL ORVATEN, MIDODRINE HYDROCHLORIDE OSMITROL 10% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 10% IN WATER, MANNITOL OSMITROL 15% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 15% IN WATER, MANNITOL OSMITROL 20% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 20% IN WATER, MANNITOL OSMITROL 5% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 5% IN WATER, MANNITOL OSMOPREP, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS OTICAIR, HYDROCORTISONE OVCON-35, ETHINYL ESTRADIOL OVCON-50, ETHINYL ESTRADIOL OVIDE, MALATHION OVIDREL, CHORIOGONADOTROPIN ALFA OXACILLIN SODIUM, OXACILLIN SODIUM OXALIPLATIN, OXALIPLATIN OXANDRIN, OXANDROLONE OXANDROLONE, OXANDROLONE OXAPROZIN, OXAPROZIN OXAZEPAM, OXAZEPAM OXCARBAZEPINE, OXCARBAZEPINE OXECTA, OXYCODONE HYDROCHLORIDE OXILAN-300, IOXILAN OXILAN-350, IOXILAN OXISTAT, OXICONAZOLE NITRATE OXSORALEN, METHOXSALEN OXSORALEN-ULTRA, METHOXSALEN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE OXYCET, ACETAMINOPHEN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE AND ASPIRIN, ASPIRIN OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE OXYCONTIN, OXYCODONE HYDROCHLORIDE OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE OXYTOCIN, OXYTOCIN OXYTROL, OXYBUTYNIN OZURDEX, DEXAMETHASONE
**
PACERONE, AMIODARONE HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAMELOR, NORTRIPTYLINE HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PAMINE FORTE, METHSCOPOLAMINE BROMIDE PAMINE, METHSCOPOLAMINE BROMIDE PANCREAZE, LIPASE PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PANDEL, HYDROCORTISONE PROBUTATE PANRETIN, ALITRETINOIN PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PARAFON FORTE DSC, CHLORZOXAZONE
**
APPENDIX A
**
A - 41
PARAGARD T 380A, COPPER PARCOPA, CARBIDOPA PAREMYD, HYDROXYAMPHETAMINE HYDROBROMIDE PARICALCITOL, PARICALCITOL PARLODEL, BROMOCRIPTINE MESYLATE PARNATE, TRANYLCYPROMINE SULFATE PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PASER, AMINOSALICYLIC ACID PATADAY, OLOPATADINE HYDROCHLORIDE PATANASE, OLOPATADINE HYDROCHLORIDE PATANOL, OLOPATADINE HYDROCHLORIDE PAXIL CR, PAROXETINE HYDROCHLORIDE PAXIL, PAROXETINE HYDROCHLORIDE PCE, ERYTHROMYCIN PEDIAMYCIN 400, ERYTHROMYCIN ETHYLSUCCINATE PEDIAMYCIN, ERYTHROMYCIN ETHYLSUCCINATE PEDIAPRED, PREDNISOLONE SODIUM PHOSPHATE PEDIATRIC ADVIL, IBUPROFEN (OTC) PEDIOTIC, HYDROCORTISONE PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350 PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL 3350 PEGANONE, ETHOTOIN PENICILLIN G POTASSIUM IN PLASTIC CONTAINER, PENICILLIN G POTASSIUM PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM PENICILLIN G PROCAINE, PENICILLIN G PROCAINE PENICILLIN G SODIUM, PENICILLIN G SODIUM PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM PENICILLIN-VK, PENICILLIN V POTASSIUM PENLAC, CICLOPIROX PENNSAID, DICLOFENAC SODIUM PENTAM, PENTAMIDINE ISETHIONATE PENTAMIDINE ISETHIONATE, PENTAMIDINE ISETHIONATE PENTASA, MESALAMINE PENTAZOCINE AND NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE PENTAZOCINE AND NALOXONE HYDROCHLORIDES, NALOXONE HYDROCHLORIDE PENTOLAIR, CYCLOPENTOLATE HYDROCHLORIDE PENTOSTATIN, PENTOSTATIN PENTOXIFYLLINE, PENTOXIFYLLINE PENTOXIL, PENTOXIFYLLINE PEPCID AC (GELTAB), FAMOTIDINE (OTC) PEPCID AC, FAMOTIDINE (OTC) PEPCID COMPLETE, CALCIUM CARBONATE (OTC) PEPCID, FAMOTIDINE PERCOCET, ACETAMINOPHEN PERCODAN, ASPIRIN PERFOROMIST, FORMOTEROL FUMARATE PERIDEX, CHLORHEXIDINE GLUCONATE PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE PERIOCHIP, CHLORHEXIDINE GLUCONATE PERIOGARD, CHLORHEXIDINE GLUCONATE PERIOSTAT, DOXYCYCLINE HYCLATE PERMAPEN, PENICILLIN G BENZATHINE PERMETHRIN, PERMETHRIN PERMETHRIN, PERMETHRIN (OTC) PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE PERPHENAZINE, PERPHENAZINE PERSANTINE, DIPYRIDAMOLE PEXEVA, PAROXETINE MESYLATE PFIZERPEN, PENICILLIN G POTASSIUM PHARMASEAL SCRUB CARE, CHLORHEXIDINE GLUCONATE (OTC) PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENELZINE SULFATE, PHENELZINE SULFATE
APPENDIX A
**
A - 42
PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PHENTERMINE RESIN COMPLEX, PHENTERMINE RESIN COMPLEX PHENTOLAMINE MESYLATE, PHENTOLAMINE MESYLATE PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE PHENYTEK, PHENYTOIN SODIUM PHENYTOIN SODIUM, PHENYTOIN SODIUM PHENYTOIN, PHENYTOIN PHILITH, ETHINYL ESTRADIOL PHISOHEX, HEXACHLOROPHENE PHOSLO GELCAPS, CALCIUM ACETATE PHOSLYRA, CALCIUM ACETATE PHOSPHOLINE IODIDE, ECHOTHIOPHATE IODIDE PHOTOFRIN, PORFIMER SODIUM PHRENILIN FORTE, ACETAMINOPHEN PHRENILIN WITH CAFFEINE AND CODEINE, ACETAMINOPHEN PHRENILIN, ACETAMINOPHEN PHYSIOLYTE IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PHYSIOSOL IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PHYTONADIONE, PHYTONADIONE PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE PILOPINE HS, PILOCARPINE HYDROCHLORIDE PINDOLOL, PINDOLOL PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM PIPERACILLIN, PIPERACILLIN SODIUM PIROXICAM, PIROXICAM PITOCIN, OXYTOCIN PLAN B ONE-STEP, LEVONORGESTREL PLAN B ONE-STEP, LEVONORGESTREL (OTC) PLAN B, LEVONORGESTREL PLAN B, LEVONORGESTREL (OTC) PLAQUENIL, HYDROXYCHLOROQUINE SULFATE PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASMA-LYTE 56 IN PLASTIC CONTAINER, MAGNESIUM ACETATE TETRAHYDRATE PLASMA-LYTE A IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE PLASMA-LYTE R IN PLASTIC CONTAINER, CALCIUM CHLORIDE PLAVIX, CLOPIDOGREL BISULFATE PLEGISOL IN PLASTIC CONTAINER, CALCIUM CHLORIDE PLENDIL, FELODIPINE PLETAL, CILOSTAZOL PODOFILOX, PODOFILOX POLOCAINE, MEPIVACAINE HYDROCHLORIDE POLOCAINE-MPF, MEPIVACAINE HYDROCHLORIDE POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) POLYMYCIN B SULFATE, POLYMYXIN B SULFATE POLYMYXIN B SULFATE, POLYMYXIN B SULFATE POLY-PRED, NEOMYCIN SULFATE POLY-RX, POLYMYXIN B SULFATE POLYTRIM, POLYMYXIN B SULFATE PONSTEL, MEFENAMIC ACID PORTIA-28, ETHINYL ESTRADIOL POTASSIUM ACETATE IN PLASTIC CONTAINER, POTASSIUM ACETATE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE
APPENDIX A
POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM DEXTROSE POTASSIUM POTASSIUM DEXTROSE POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM POTASSIUM CHLORIDE POTASSIUM POTASSIUM POTASSIUM CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE 0.037% 0.037% 0.037% 0.075% 0.075% IN IN IN IN IN DEXTROSE DEXTROSE DEXTROSE DEXTROSE DEXTROSE
**
A - 43
5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,
CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE 0.224% IN SODIUM CHLORIDE 0.9%, POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM
CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE
APPENDIX A
**
A - 44
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE POTASSIUM CITRATE, POTASSIUM CITRATE POTIGA, EZOGABINE POVIDONE IODINE, POVIDONE-IODINE (OTC) PRADAXA, DABIGATRAN ETEXILATE MESYLATE PRALIDOXIME CHLORIDE, PRALIDOXIME CHLORIDE PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PRAMOSONE, HYDROCORTISONE ACETATE PRANDIMET, METFORMIN HYDROCHLORIDE PRANDIN, REPAGLINIDE PRAVACHOL, PRAVASTATIN SODIUM PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE PRECEDEX, DEXMEDETOMIDINE HYDROCHLORIDE PRECOSE, ACARBOSE PRED FORTE, PREDNISOLONE ACETATE PRED MILD, PREDNISOLONE ACETATE PRED-G, GENTAMICIN SULFATE PREDNICARBATE, PREDNICARBATE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PREDNISOLONE, PREDNISOLONE PREDNISONE INTENSOL, PREDNISONE
APPENDIX A
**
A - 45
PREDNISONE, PREDNISONE PREFEST, ESTRADIOL PREGNYL, GONADOTROPIN, CHORIONIC PRELONE, PREDNISOLONE PREMARIN, ESTROGENS, CONJUGATED PREMASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS PREMASOL 6% IN PLASTIC CONTAINER, AMINO ACIDS PREMPHASE 14/14, ESTROGENS, CONJUGATED PREMPRO, ESTROGENS, CONJUGATED PRE-OP II, HEXACHLOROPHENE PRE-OP, HEXACHLOROPHENE PRE-PEN, BENZYLPENICILLOYL POLYLYSINE PREPIDIL, DINOPROSTONE PREVACID 24 HR, LANSOPRAZOLE (OTC) PREVACID, LANSOPRAZOLE PREVALITE, CHOLESTYRAMINE PREVIFEM, ETHINYL ESTRADIOL PREVPAC, AMOXICILLIN PREZISTA, DARUNAVIR ETHANOLATE PRIALT, ZICONOTIDE ACETATE PRIFTIN, RIFAPENTINE PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, EPINEPHRINE BITARTRATE PRILOCAINE HYDROCHLORIDE, PRILOCAINE HYDROCHLORIDE PRILOSEC OTC, OMEPRAZOLE MAGNESIUM (OTC) PRILOSEC, OMEPRAZOLE PRILOSEC, OMEPRAZOLE MAGNESIUM PRIMAQUINE, PRIMAQUINE PHOSPHATE PRIMAXIN, CILASTATIN SODIUM PRIMIDONE, PRIMIDONE PRIMSOL, TRIMETHOPRIM HYDROCHLORIDE PRINIVIL, LISINOPRIL PRINZIDE, HYDROCHLOROTHIAZIDE PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISTIQ, DESVENLAFAXINE SUCCINATE PROAIR HFA, ALBUTEROL SULFATE PROAMATINE, MIDODRINE HYDROCHLORIDE PROBALAN, PROBENECID PROBENECID AND COLCHICINE, COLCHICINE PROBENECID, PROBENECID PROCAINAMIDE HYDROCHLORIDE, PROCAINAMIDE HYDROCHLORIDE PROCALAMINE, AMINO ACIDS PROCARDIA XL, NIFEDIPINE PROCARDIA, NIFEDIPINE PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE PROCHLORPERAZINE, PROCHLORPERAZINE PROCOMP, PROCHLORPERAZINE MALEATE PROCTOFOAM HC, HYDROCORTISONE ACETATE PROFEN, IBUPROFEN (OTC) PROFERDEX, IRON DEXTRAN PROGESTERONE, PROGESTERONE PROGLYCEM, DIAZOXIDE PROGRAF, TACROLIMUS PROHANCE MULTIPACK, GADOTERIDOL
APPENDIX A
**
A - 46
PROHANCE, GADOTERIDOL PROMACTA, ELTROMBOPAG OLAMINE PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETH VC PLAIN, PHENYLEPHRINE HYDROCHLORIDE PROMETH VC W/ CODEINE, CODEINE PHOSPHATE PROMETH W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE DM, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROMETHAZINE PLAIN, PROMETHAZINE HYDROCHLORIDE PROMETHAZINE W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE WITH CODEINE, CODEINE PHOSPHATE PROMETHEGAN, PROMETHAZINE HYDROCHLORIDE PROMETRIUM, PROGESTERONE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE PROPANTHELINE BROMIDE, PROPANTHELINE BROMIDE PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE PROPECIA, FINASTERIDE PROPINE, DIPIVEFRIN HYDROCHLORIDE PROPOFOL, PROPOFOL PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE PROPYLTHIOURACIL, PROPYLTHIOURACIL PROSCAR, FINASTERIDE PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS PROSTIN E2, DINOPROSTONE PROSTIN VR PEDIATRIC, ALPROSTADIL PROTAMINE SULFATE, PROTAMINE SULFATE PROTONIX IV, PANTOPRAZOLE SODIUM PROTONIX, PANTOPRAZOLE SODIUM PROTOPAM CHLORIDE, PRALIDOXIME CHLORIDE PROTOPIC, TACROLIMUS PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE PROVENTIL-HFA, ALBUTEROL SULFATE PROVERA, MEDROXYPROGESTERONE ACETATE PROVIGIL, MODAFINIL PROVOCHOLINE, METHACHOLINE CHLORIDE PROZAC WEEKLY, FLUOXETINE HYDROCHLORIDE PROZAC, FLUOXETINE HYDROCHLORIDE PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) PULMICORT FLEXHALER, BUDESONIDE PULMICORT RESPULES, BUDESONIDE PULMICORT, BUDESONIDE PULMOLITE, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT PURINETHOL, MERCAPTOPURINE PUR-WASH, PURIFIED WATER (OTC) PYLERA, BISMUTH SUBCITRATE POTASSIUM PYRAZINAMIDE, PYRAZINAMIDE PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE PYTEST KIT, UREA, C-14 PYTEST, UREA, C-14
**
**
QUADRAMET, SAMARIUM SM-153 LEXIDRONAM PENTASODIUM QUALAQUIN, QUININE SULFATE QUASENSE, ETHINYL ESTRADIOL QUELICIN PRESERVATIVE FREE, SUCCINYLCHOLINE CHLORIDE QUELICIN, SUCCINYLCHOLINE CHLORIDE QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE
APPENDIX A
QUINARETIC, HYDROCHLOROTHIAZIDE QUINIDINE GLUCONATE, QUINIDINE GLUCONATE QUINIDINE SULFATE, QUINIDINE SULFATE QUIXIN, LEVOFLOXACIN QUTENZA, CAPSAICIN QVAR 40, BECLOMETHASONE DIPROPIONATE QVAR 80, BECLOMETHASONE DIPROPIONATE
**
A - 47
**
**
RADIOGARDASE (PRUSSIAN BLUE), FERRIC HEXACYANOFERRATE(II) RAMIPRIL, RAMIPRIL RANEXA, RANOLAZINE RANICLOR, CEFACLOR RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RAPAFLO, SILODOSIN RAPAMUNE, SIROLIMUS RAZADYNE ER, GALANTAMINE HYDROBROMIDE RAZADYNE, GALANTAMINE HYDROBROMIDE REBETOL, RIBAVIRIN RECLAST, ZOLEDRONIC ACID RECTIV, NITROGLYCERIN REFLUDAN, LEPIRUDIN RECOMBINANT REGITINE, PHENTOLAMINE MESYLATE REGLAN, METOCLOPRAMIDE HYDROCHLORIDE REGONOL, PYRIDOSTIGMINE BROMIDE RELENZA, ZANAMIVIR RELISTOR, METHYLNALTREXONE BROMIDE RELPAX, ELETRIPTAN HYDROBROMIDE REMERON SOLTAB, MIRTAZAPINE REMERON, MIRTAZAPINE REMODULIN, TREPROSTINIL SODIUM RENACIDIN, CITRIC ACID RENAGEL, SEVELAMER HYDROCHLORIDE RENAMIN W/O ELECTROLYTES, AMINO ACIDS RENOGRAFIN-76, DIATRIZOATE MEGLUMINE RENOVA, TRETINOIN RENVELA, SEVELAMER CARBONATE REPREXAIN, HYDROCODONE BITARTRATE REPRONEX, LUTEINIZING HORMONE REQUIP XL, ROPINIROLE HYDROCHLORIDE REQUIP, ROPINIROLE HYDROCHLORIDE RESCRIPTOR, DELAVIRDINE MESYLATE RESECTISOL IN PLASTIC CONTAINER, MANNITOL RESERPINE, RESERPINE RESTASIS, CYCLOSPORINE RESTORIL, TEMAZEPAM RETIN-A MICRO, TRETINOIN RETIN-A, TRETINOIN RETISERT, FLUOCINOLONE ACETONIDE RETROVIR, ZIDOVUDINE REVATIO, SILDENAFIL CITRATE REVIA, NALTREXONE HYDROCHLORIDE REVLIMID, LENALIDOMIDE REYATAZ, ATAZANAVIR SULFATE REZIRA, HYDROCODONE BITARTRATE R-GENE 10, ARGININE HYDROCHLORIDE RHINOCORT, BUDESONIDE RIBASPHERE, RIBAVIRIN RIBAVARIN, RIBAVIRIN RIBAVIRIN, RIBAVIRIN RID MOUSSE, PIPERONYL BUTOXIDE (OTC) RIDAURA, AURANOFIN
APPENDIX A
**
A - 48
RIFADIN, RIFAMPIN RIFAMATE, ISONIAZID RIFAMPIN AND ISONIAZID, ISONIAZID RIFAMPIN, RIFAMPIN RIFATER, ISONIAZID RILUTEK, RILUZOLE RILUZOLE, RILUZOLE RIMANTADINE HYDROCHLORIDE, RIMANTADINE HYDROCHLORIDE RIMSO-50, DIMETHYL SULFOXIDE RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE RIOMET, METFORMIN HYDROCHLORIDE RISEDRONATE SODIUM, RISEDRONATE SODIUM RISPERDAL CONSTA, RISPERIDONE RISPERDAL, RISPERIDONE RISPERIDONE, RISPERIDONE RITALIN LA, METHYLPHENIDATE HYDROCHLORIDE RITALIN, METHYLPHENIDATE HYDROCHLORIDE RITALIN-SR, METHYLPHENIDATE HYDROCHLORIDE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE ROBAXIN, METHOCARBAMOL ROBAXIN-750, METHOCARBAMOL ROBINUL FORTE, GLYCOPYRROLATE ROBINUL, GLYCOPYRROLATE ROCALTROL, CALCITRIOL ROCEPHIN, CEFTRIAXONE SODIUM ROCURONIUM BROMIDE, ROCURONIUM BROMIDE ROGAINE (FOR MEN), MINOXIDIL (OTC) ROGAINE (FOR WOMEN), MINOXIDIL (OTC) ROGAINE EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) ROMAZICON, FLUMAZENIL ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE ROWASA, MESALAMINE ROXICET 5/500, ACETAMINOPHEN ROXICET, ACETAMINOPHEN ROXICODONE, OXYCODONE HYDROCHLORIDE ROXILOX, ACETAMINOPHEN ROZEREM, RAMELTEON RYTHMOL SR, PROPAFENONE HYDROCHLORIDE RYTHMOL, PROPAFENONE HYDROCHLORIDE RYZOLT, TRAMADOL HYDROCHLORIDE
**
SABRIL, VIGABATRIN SAFYRAL, DROSPIRENONE SAIZEN, SOMATROPIN RECOMBINANT SALAGEN, PILOCARPINE HYDROCHLORIDE SALONPAS, MENTHOL (OTC) SALURON, HYDROFLUMETHIAZIDE SAMSCA, TOLVAPTAN SANCTURA XR, TROSPIUM CHLORIDE SANCTURA, TROSPIUM CHLORIDE SANCUSO, GRANISETRON SANDIMMUNE, CYCLOSPORINE SANDOSTATIN LAR, OCTREOTIDE ACETATE SANDOSTATIN, OCTREOTIDE ACETATE SAPHRIS, ASENAPINE MALEATE SARAFEM, FLUOXETINE HYDROCHLORIDE SAVELLA, MILNACIPRAN HYDROCHLORIDE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCANLUX-300, IOPAMIDOL SCANLUX-370, IOPAMIDOL SCLEROSOL, TALC
**
APPENDIX A
**
A - 49
SEASONALE, ETHINYL ESTRADIOL SEASONIQUE, ETHINYL ESTRADIOL SECONAL SODIUM, SECOBARBITAL SODIUM SECTRAL, ACEBUTOLOL HYDROCHLORIDE SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE SELENIUM SULFIDE, SELENIUM SULFIDE SELSUN, SELENIUM SULFIDE SELZENTRY, MARAVIROC SEMPREX-D, ACRIVASTINE SENSIPAR, CINACALCET HYDROCHLORIDE SENSORCAINE, BUPIVACAINE HYDROCHLORIDE SEPTOCAINE, ARTICAINE HYDROCHLORIDE SEPTRA DS, SULFAMETHOXAZOLE SEPTRA, SULFAMETHOXAZOLE SEREVENT, SALMETEROL XINAFOATE SEROMYCIN, CYCLOSERINE SEROPHENE, CLOMIPHENE CITRATE SEROQUEL XR, QUETIAPINE FUMARATE SEROQUEL, QUETIAPINE FUMARATE SEROSTIM, SOMATROPIN RECOMBINANT SERPALAN, RESERPINE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SEVOFLURANE, SEVOFLURANE SFROWASA, MESALAMINE SHADE UVAGUARD, AVOBENZONE (OTC) SILENOR, DOXEPIN HYDROCHLORIDE SILVADENE, SILVER SULFADIAZINE SIMCOR, NIACIN SIMVASTATIN, SIMVASTATIN SINE-AID IB, IBUPROFEN (OTC) SINEMET CR, CARBIDOPA SINEMET, CARBIDOPA SINGULAIR, MONTELUKAST SODIUM SINOGRAFIN, DIATRIZOATE MEGLUMINE SKELAXIN, METAXALONE SKELID, TILUDRONATE DISODIUM SODIUM ACETATE IN PLASTIC CONTAINER, SODIUM ACETATE ANHYDROUS SODIUM BICARBONATE, SODIUM BICARBONATE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 3% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 5% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE, SODIUM FERRIC GLUCONATE COMPLEX SODIUM IODIDE I 123, SODIUM IODIDE I-123 SODIUM IODIDE I 131, SODIUM IODIDE I-131 SODIUM IODIDE I-131, SODIUM IODIDE I-131 SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE SODIUM LACTATE IN PLASTIC CONTAINER, SODIUM LACTATE SODIUM PHENYLBUTYRATE, SODIUM PHENYLBUTYRATE SODIUM PHOSPHATES IN PLASTIC CONTAINER, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE SOJOURN, SEVOFLURANE SOLAGE, MEQUINOL SOLARAZE, DICLOFENAC SODIUM SOLODYN, MINOCYCLINE HYDROCHLORIDE SOLU-CORTEF, HYDROCORTISONE SODIUM SUCCINATE SOLU-MEDROL, METHYLPREDNISOLONE SODIUM SUCCINATE SOMA COMPOUND W/ CODEINE, ASPIRIN SOMA COMPOUND, ASPIRIN SOMA, CARISOPRODOL
APPENDIX A
**
A - 50
SOMATULINE DEPOT, LANREOTIDE ACETATE SOMAVERT, PEGVISOMANT SONATA, ZALEPLON SORBITOL 3% IN PLASTIC CONTAINER, SORBITOL SORBITOL 3.3% IN PLASTIC CONTAINER, SORBITOL SORBITOL-MANNITOL IN PLASTIC CONTAINER, MANNITOL SORIATANE, ACITRETIN SORILUX, CALCIPOTRIENE SORINE, SOTALOL HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SOTRADECOL, SODIUM TETRADECYL SULFATE SOTRET, ISOTRETINOIN SPECTRACEF, CEFDITOREN PIVOXIL SPIRIVA, TIOTROPIUM BROMIDE MONOHYDRATE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE SPIRONOLACTONE, SPIRONOLACTONE SPORANOX, ITRACONAZOLE SPRINTEC, ETHINYL ESTRADIOL SPRIX, KETOROLAC TROMETHAMINE SPRYCEL, DASATINIB SPS, SODIUM POLYSTYRENE SULFONATE SSD AF, SILVER SULFADIAZINE SSD, SILVER SULFADIAZINE STADOL PRESERVATIVE FREE, BUTORPHANOL TARTRATE STADOL, BUTORPHANOL TARTRATE STALEVO 100, CARBIDOPA STALEVO 125, CARBIDOPA STALEVO 150, CARBIDOPA STALEVO 200, CARBIDOPA STALEVO 50, CARBIDOPA STALEVO 75, CARBIDOPA STARLIX, NATEGLINIDE STAVUDINE, STAVUDINE STAVZOR, VALPROIC ACID STAXYN, VARDENAFIL HYDROCHLORIDE STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION STERILE WATER, STERILE WATER FOR IRRIGATION STIE-CORT, HYDROCORTISONE STIMATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE STRATTERA, ATOMOXETINE HYDROCHLORIDE STREPTOMYCIN SULFATE, STREPTOMYCIN SULFATE STRIANT, TESTOSTERONE STROMECTOL, IVERMECTIN STRONTIUM CHLORIDE SR-89, STRONTIUM CHLORIDE SR-89 SUBLIMAZE PRESERVATIVE FREE, FENTANYL CITRATE SUBOXONE, BUPRENORPHINE SUBOXONE, BUPRENORPHINE HYDROCHLORIDE SUBUTEX, BUPRENORPHINE HYDROCHLORIDE SUCRAID, SACROSIDASE SUCRALFATE, SUCRALFATE SUDAFED 12 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) SUDAFED 24 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) SUFENTA PRESERVATIVE FREE, SUFENTANIL CITRATE SUFENTANIL CITRATE, SUFENTANIL CITRATE SULAR, NISOLDIPINE SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM SULFADIAZINE, SULFADIAZINE SULFAMETHOPRIM, SULFAMETHOXAZOLE SULFAMETHOPRIM-DS, SULFAMETHOXAZOLE SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH, SULFAMETHOXAZOLE
APPENDIX A
**
A - 51
SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE SULFAMYLON, MAFENIDE ACETATE SULFASALAZINE, SULFASALAZINE SULFATRIM PEDIATRIC, SULFAMETHOXAZOLE SULINDAC, SULINDAC SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE SUMAVEL DOSEPRO, SUMATRIPTAN SUCCINATE SUPPRELIN LA, HISTRELIN ACETATE SUPRANE, DESFLURANE SUPRAX, CEFIXIME SUPRENZA, PHENTERMINE HYDROCHLORIDE SUPREP BOWEL PREP KIT, MAGNESIUM SULFATE ANHYDROUS SURMONTIL, TRIMIPRAMINE MALEATE SURVANTA, BERACTANT SUSTIVA, EFAVIRENZ SUTENT, SUNITINIB MALATE SYEDA, DROSPIRENONE SYMBICORT, BUDESONIDE SYMBYAX, FLUOXETINE HYDROCHLORIDE SYMLIN, PRAMLINTIDE ACETATE SYNACORT, HYDROCORTISONE SYNALAR, FLUOCINOLONE ACETONIDE SYNALGOS-DC, ASPIRIN SYNAREL, NAFARELIN ACETATE SYNERA, LIDOCAINE SYNERCID, DALFOPRISTIN SYNTHETIC CONJUGATED ESTROGENS A, ESTROGENS, CONJUGATED SYNTHETIC A SYNTHROID, LEVOTHYROXINE SODIUM SYPRINE, TRIENTINE HYDROCHLORIDE
**
**
TAB-PROFEN, IBUPROFEN (OTC) TACLONEX SCALP, BETAMETHASONE DIPROPIONATE TACLONEX, BETAMETHASONE DIPROPIONATE TACROLIMUS, TACROLIMUS TAGAMET HB, CIMETIDINE (OTC) TAGAMET, CIMETIDINE TALC, TALC TALWIN, PENTAZOCINE LACTATE TAMBOCOR, FLECAINIDE ACETATE TAMIFLU, OSELTAMIVIR PHOSPHATE TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TAPAZOLE, METHIMAZOLE TARCEVA, ERLOTINIB HYDROCHLORIDE TARGRETIN, BEXAROTENE TARKA, TRANDOLAPRIL TASIGNA, NILOTINIB HYDROCHLORIDE MONOHYDRATE TASMAR, TOLCAPONE TAVIST ALLERGY/SINUS/HEADACHE, ACETAMINOPHEN (OTC) TAVIST-1, CLEMASTINE FUMARATE (OTC) TAXOTERE, DOCETAXEL TAZICEF, CEFTAZIDIME TAZORAC, TAZAROTENE TAZTIA XT, DILTIAZEM HYDROCHLORIDE TECHNELITE, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR TECHNESCAN MAG3, TECHNETIUM TC-99M MERTIATIDE KIT TECHNESCAN PYP KIT, TECHNETIUM TC-99M PYROPHOSPHATE KIT TECHNESCAN, TECHNETIUM TC-99M OXIDRONATE KIT TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT TECHNETIUM TC-99 SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT TECHNETIUM TC-99M MEBROFENIN, TECHNETIUM TC-99M MEBROFENIN KIT
APPENDIX A
**
A - 52
TEFLARO, CEFTAROLINE FOSAMIL TEGRETOL, CARBAMAZEPINE TEGRETOL-XR, CARBAMAZEPINE TEKAMLO, ALISKIREN HEMIFUMARATE TEKTURNA HCT, ALISKIREN HEMIFUMARATE TEKTURNA, ALISKIREN HEMIFUMARATE TEMAZEPAM, TEMAZEPAM TEMODAR, TEMOZOLOMIDE TEMOVATE E, CLOBETASOL PROPIONATE TEMOVATE, CLOBETASOL PROPIONATE TEMOZOLOMIDE, TEMOZOLOMIDE TENEX, GUANFACINE HYDROCHLORIDE TENORETIC 100, ATENOLOL TENORETIC 50, ATENOLOL TENORMIN, ATENOLOL TENSILON PRESERVATIVE FREE, EDROPHONIUM CHLORIDE TENSILON, EDROPHONIUM CHLORIDE TENUATE DOSPAN, DIETHYLPROPION HYDROCHLORIDE TENUATE, DIETHYLPROPION HYDROCHLORIDE TERAZOL 3, TERCONAZOLE TERAZOL 7, TERCONAZOLE TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE (OTC) TERBUTALINE SULFATE, TERBUTALINE SULFATE TERCONAZOLE, TERCONAZOLE TERIL, CARBAMAZEPINE TERRAMYCIN W/ POLYMYXIN B SULFATE, OXYTETRACYCLINE HYDROCHLORIDE TESSALON, BENZONATATE TESTIM, TESTOSTERONE TESTOPEL, TESTOSTERONE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE TESTRED, METHYLTESTOSTERONE TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE TEVETEN HCT, EPROSARTAN MESYLATE TEVETEN, EPROSARTAN MESYLATE TEV-TROPIN, SOMATROPIN RECOMBINANT TEXACORT, HYDROCORTISONE THALITONE, CHLORTHALIDONE THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201 THALOMID, THALIDOMIDE THAM, TROMETHAMINE THEO-24, THEOPHYLLINE THEOCHRON, THEOPHYLLINE THEOLAIR, THEOPHYLLINE THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE, THEOPHYLLINE THERMAZENE, SILVER SULFADIAZINE THEROXIDIL, MINOXIDIL (OTC) THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE THIOGUANINE, THIOGUANINE THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE THIOTEPA, THIOTEPA THIOTHIXENE, THIOTHIXENE THRIVE, NICOTINE POLACRILEX (OTC) THYROGEN, THYROTROPIN ALFA THYROLAR-0.25, LIOTHYRONINE SODIUM
APPENDIX A
**
A - 53
THYROLAR-0.5, LIOTHYRONINE SODIUM THYROLAR-1, LIOTHYRONINE SODIUM THYROLAR-2, LIOTHYRONINE SODIUM THYROLAR-3, LIOTHYRONINE SODIUM THYROSAFE, POTASSIUM IODIDE (OTC) THYROSHIELD, POTASSIUM IODIDE (OTC) TIAGABINE HYDROCHLORIDE, TIAGABINE HYDROCHLORIDE TIAZAC, DILTIAZEM HYDROCHLORIDE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE TIKOSYN, DOFETILIDE TIMENTIN IN PLASTIC CONTAINER, CLAVULANATE POTASSIUM TIMENTIN, CLAVULANATE POTASSIUM TIMOLOL MALEATE, TIMOLOL MALEATE TIMOPTIC IN OCUDOSE, TIMOLOL MALEATE TIMOPTIC, TIMOLOL MALEATE TIMOPTIC-XE, TIMOLOL MALEATE TINDAMAX, TINIDAZOLE TIOCONAZOLE, TIOCONAZOLE (OTC) TIOPRONIN, TIOPRONIN TIROSINT, LEVOTHYROXINE SODIUM TIS-U-SOL IN PLASTIC CONTAINER, MAGNESIUM SULFATE TIS-U-SOL, MAGNESIUM SULFATE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TOBI, TOBRAMYCIN TOBRADEX ST, DEXAMETHASONE TOBRADEX, DEXAMETHASONE TOBRAMYCIN AND DEXAMETHASONE, DEXAMETHASONE TOBRAMYCIN SULFATE (PHARMACY BULK), TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE TOBRAMYCIN, TOBRAMYCIN TOBREX, TOBRAMYCIN TODAY, NONOXYNOL-9 (OTC) TOFRANIL, IMIPRAMINE HYDROCHLORIDE TOFRANIL-PM, IMIPRAMINE PAMOATE TOLAZAMIDE, TOLAZAMIDE TOLBUTAMIDE, TOLBUTAMIDE TOLMETIN SODIUM, TOLMETIN SODIUM TOPAMAX, TOPIRAMATE TOPICORT LP, DESOXIMETASONE TOPICORT, DESOXIMETASONE TOPIRAMATE, TOPIRAMATE TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE TOPOTECAN, TOPOTECAN HYDROCHLORIDE TOPROL-XL, METOPROLOL SUCCINATE TORISEL, TEMSIROLIMUS TORSEMIDE, TORSEMIDE TOTECT, DEXRAZOXANE HYDROCHLORIDE TOVIAZ, FESOTERODINE FUMARATE TPN ELECTROLYTES IN PLASTIC CONTAINER, CALCIUM CHLORIDE TRACLEER, BOSENTAN TRADJENTA, LINAGLIPTIN TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRANDATE, LABETALOL HYDROCHLORIDE TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE, TRANDOLAPRIL TRANDOLAPRIL, TRANDOLAPRIL TRANEXAMIC ACID, TRANEXAMIC ACID TRANSDERM SCOP, SCOPOLAMINE TRANXENE, CLORAZEPATE DIPOTASSIUM TRANYLCYPROMINE SULFATE, TRANYLCYPROMINE SULFATE TRASYLOL, APROTININ
APPENDIX A
**
A - 54
TRAVASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 10% W/O ELECTROLYTES, AMINO ACIDS TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 3.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 5.5% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 5.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 5.5% W/O ELECTROLYTES, AMINO ACIDS TRAVASOL 8.5% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 8.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 8.5% W/O ELECTROLYTES, AMINO ACIDS TRAVATAN Z, TRAVOPROST TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TREANDA, BENDAMUSTINE HYDROCHLORIDE TRECATOR, ETHIONAMIDE TRELSTAR, TRIPTORELIN PAMOATE TRENTAL, PENTOXIFYLLINE TRETINOIN, TRETINOIN TREXALL, METHOTREXATE SODIUM TREXIMET, NAPROXEN SODIUM TRI LO SPRINTEC, ETHINYL ESTRADIOL TRIACET, TRIAMCINOLONE ACETONIDE TRIACIN-C, CODEINE PHOSPHATE TRIAMCINOLONE ACETONIDE IN ABSORBASE, TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE TRIAZOLAM, TRIAZOLAM TRIBENZOR, AMLODIPINE BESYLATE TRICOR, FENOFIBRATE TRIDERM, TRIAMCINOLONE ACETONIDE TRIDIONE, TRIMETHADIONE TRIESENCE, TRIAMCINOLONE ACETONIDE TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE TRIFLURIDINE, TRIFLURIDINE TRIGLIDE, FENOFIBRATE TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE TRI-LEGEST 21, ETHINYL ESTRADIOL TRI-LEGEST FE, ETHINYL ESTRADIOL TRILEPTAL, OXCARBAZEPINE TRILIPIX, CHOLINE FENOFIBRATE TRI-LUMA, FLUOCINOLONE ACETONIDE TRILYTE, POLYETHYLENE GLYCOL 3350 TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE, TRIMETHOBENZAMIDE HYDROCHLORIDE TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE TRIMETHOPRIM, TRIMETHOPRIM TRIMIPRAMINE MALEATE, TRIMIPRAMINE MALEATE TRI-NORINYL 28-DAY, ETHINYL ESTRADIOL TRIOSTAT, LIOTHYRONINE SODIUM TRI-PREVIFEM, ETHINYL ESTRADIOL TRISENOX, ARSENIC TRIOXIDE TRI-SPRINTEC, ETHINYL ESTRADIOL TRIVAGIZOLE 3, CLOTRIMAZOLE (OTC) TRIVARIS, TRIAMCINOLONE ACETONIDE TRIVORA-28, ETHINYL ESTRADIOL TRIZIVIR, ABACAVIR SULFATE TROPHAMINE 10%, AMINO ACIDS TROPHAMINE, AMINO ACIDS TROPICACYL, TROPICAMIDE TROPICAMIDE, TROPICAMIDE TROSPIUM CHLORIDE, TROSPIUM CHLORIDE TRUSOPT, DORZOLAMIDE HYDROCHLORIDE
APPENDIX A
**
A - 55
TRUVADA, EMTRICITABINE TUSSICAPS, CHLORPHENIRAMINE POLISTIREX TUSSIGON, HOMATROPINE METHYLBROMIDE TUSSIONEX PENNKINETIC, CHLORPHENIRAMINE POLISTIREX TWINJECT 0.15, EPINEPHRINE TWINJECT 0.3, EPINEPHRINE TWYNSTA, AMLODIPINE BESYLATE TYGACIL, TIGECYCLINE TYKERB, LAPATINIB DITOSYLATE TYLENOL (CAPLET), ACETAMINOPHEN (OTC) TYLENOL (GELTAB), ACETAMINOPHEN (OTC) TYLENOL W/ CODEINE NO. 3, ACETAMINOPHEN TYLENOL W/ CODEINE NO. 4, ACETAMINOPHEN TYLOX, ACETAMINOPHEN TYVASO, TREPROSTINIL SODIUM TYZEKA, TELBIVUDINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE
**
**
U-CORT, HYDROCORTISONE ACETATE ULESFIA, BENZYL ALCOHOL ULORIC, FEBUXOSTAT ULTANE, SEVOFLURANE ULTIVA, REMIFENTANIL HYDROCHLORIDE ULTRACET, ACETAMINOPHEN ULTRAM ER, TRAMADOL HYDROCHLORIDE ULTRAM, TRAMADOL HYDROCHLORIDE ULTRATAG, TECHNETIUM TC-99M RED BLOOD CELL KIT ULTRA-TECHNEKOW FM, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR ULTRAVATE, HALOBETASOL PROPIONATE ULTRAVIST (PHARMACY BULK), IOPROMIDE ULTRAVIST 150, IOPROMIDE ULTRAVIST 240, IOPROMIDE ULTRAVIST 300 IN PLASTIC CONTAINER, IOPROMIDE ULTRAVIST 300, IOPROMIDE ULTRAVIST 370, IOPROMIDE UNASYN, AMPICILLIN SODIUM UNIRETIC, HYDROCHLOROTHIAZIDE UNISOM, DOXYLAMINE SUCCINATE (OTC) UNITHROID, LEVOTHYROXINE SODIUM UNIVASC, MOEXIPRIL HYDROCHLORIDE URECHOLINE, BETHANECHOL CHLORIDE UREX, METHENAMINE HIPPURATE UROCIT-K, POTASSIUM CITRATE UROXATRAL, ALFUZOSIN HYDROCHLORIDE URSO 250, URSODIOL URSO FORTE, URSODIOL URSODIOL, URSODIOL UVADEX, METHOXSALEN
**
**
VAGIFEM, ESTRADIOL VAGISTAT-1, TIOCONAZOLE (OTC) VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VALCYTE, VALGANCICLOVIR HYDROCHLORIDE VALIUM, DIAZEPAM VALNAC, BETAMETHASONE VALERATE VALPROATE SODIUM, VALPROATE SODIUM VALPROIC ACID, VALPROIC ACID VALSTAR PRESERVATIVE FREE, VALRUBICIN VALTREX, VALACYCLOVIR HYDROCHLORIDE VALTROPIN, SOMATROPIN RECOMBINANT
APPENDIX A
**
A - 56
VALTURNA, ALISKIREN HEMIFUMARATE VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER, VANCOMYCIN HYDROCHLORIDE VANCOCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VANDAZOLE, METRONIDAZOLE VANDETANIB, VANDETANIB VANIQA, EFLORNITHINE HYDROCHLORIDE VANOS, FLUOCINONIDE VANTAS, HISTRELIN ACETATE VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER, CONIVAPTAN HYDROCHLORIDE VASERETIC, ENALAPRIL MALEATE VASOCIDIN, PREDNISOLONE SODIUM PHOSPHATE VASOTEC, ENALAPRIL MALEATE VECTICAL, CALCITRIOL VECURONIUM BROMIDE, VECURONIUM BROMIDE VELCADE, BORTEZOMIB VELETRI, EPOPROSTENOL SODIUM VELIVET, DESOGESTREL VELTIN, CLINDAMYCIN PHOSPHATE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE VENOFER, IRON SUCROSE VENTAVIS, ILOPROST VENTOLIN HFA, ALBUTEROL SULFATE VERAMYST, FLUTICASONE FUROATE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE VERDESO, DESONIDE VEREGEN, SINECATECHINS VERELAN PM, VERAPAMIL HYDROCHLORIDE VERELAN, VERAPAMIL HYDROCHLORIDE VESICARE, SOLIFENACIN SUCCINATE VEXOL, RIMEXOLONE VFEND, VORICONAZOLE VIAGRA, SILDENAFIL CITRATE VIBATIV, TELAVANCIN HYDROCHLORIDE VIBISONE, CYANOCOBALAMIN VIBRAMYCIN, DOXYCYCLINE VIBRAMYCIN, DOXYCYCLINE CALCIUM VIBRAMYCIN, DOXYCYCLINE HYCLATE VICODIN ES, ACETAMINOPHEN VICODIN HP, ACETAMINOPHEN VICODIN, ACETAMINOPHEN VICOPROFEN, HYDROCODONE BITARTRATE VICTOZA, LIRAGLUTIDE RECOMBINANT VICTRELIS, BOCEPREVIR VIDAZA, AZACITIDINE VIDEX EC, DIDANOSINE VIDEX, DIDANOSINE VIGAMOX, MOXIFLOXACIN HYDROCHLORIDE VIIBRYD, VILAZODONE HYDROCHLORIDE VIMOVO, ESOMEPRAZOLE MAGNESIUM VIMPAT, LACOSAMIDE VINBLASTINE SULFATE, VINBLASTINE SULFATE VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE VINORELBINE TARTRATE, VINORELBINE TARTRATE VIRACEPT, NELFINAVIR MESYLATE VIRAMUNE XR, NEVIRAPINE VIRAMUNE, NEVIRAPINE VIRAZOLE, RIBAVIRIN VIREAD, TENOFOVIR DISOPROXIL FUMARATE VIROPTIC, TRIFLURIDINE VISICOL, SODIUM PHOSPHATE, DIBASIC ANHYDROUS VISINE L.R., OXYMETAZOLINE HYDROCHLORIDE (OTC) VISINE-A, NAPHAZOLINE HYDROCHLORIDE (OTC)
APPENDIX A
VISIONBLUE, TRYPAN BLUE VISIPAQUE 270, IODIXANOL VISIPAQUE 320, IODIXANOL VISTARIL, HYDROXYZINE PAMOATE VISTIDE, CIDOFOVIR VISUDYNE, VERTEPORFIN VITAMIN D, ERGOCALCIFEROL VITAMIN K1, PHYTONADIONE VITRASE, HYALURONIDASE VITRASERT, GANCICLOVIR VIVACTIL, PROTRIPTYLINE HYDROCHLORIDE VIVELLE, ESTRADIOL VIVELLE-DOT, ESTRADIOL VIVITROL, NALTREXONE VOLTAREN, DICLOFENAC SODIUM VOLTAREN-XR, DICLOFENAC SODIUM VORICONAZOLE, VORICONAZOLE VOSOL HC, ACETIC ACID, GLACIAL VOSOL, ACETIC ACID, GLACIAL VOSPIRE ER, ALBUTEROL SULFATE VOTRIENT, PAZOPANIB HYDROCHLORIDE VPRIV, VELAGLUCERASE ALFA VUMON, TENIPOSIDE VUSION, MICONAZOLE NITRATE VYTORIN, EZETIMIBE VYVANSE, LISDEXAMFETAMINE DIMESYLATE
**
A - 57
**
WARFARIN SODIUM, WARFARIN SODIUM WELCHOL, COLESEVELAM HYDROCHLORIDE WELLBUTRIN SR, BUPROPION HYDROCHLORIDE WELLBUTRIN XL, BUPROPION HYDROCHLORIDE WELLBUTRIN, BUPROPION HYDROCHLORIDE WESTCORT, HYDROCORTISONE VALERATE
**
**
**
XALATAN, LATANOPROST XALKORI, CRIZOTINIB XANAX XR, ALPRAZOLAM XANAX, ALPRAZOLAM XARELTO, RIVAROXABAN XELODA, CAPECITABINE XENAZINE, TETRABENAZINE XENICAL, ORLISTAT XENON XE 133, XENON XE-133 XERESE, ACYCLOVIR XIFAXAN, RIFAXIMIN XOLEGEL, KETOCONAZOLE XOPENEX HFA, LEVALBUTEROL TARTRATE XOPENEX, LEVALBUTEROL HYDROCHLORIDE XYLOCAINE 4% PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE XYLOCAINE DENTAL WITH EPINEPHRINE, EPINEPHRINE XYLOCAINE DENTAL, LIDOCAINE HYDROCHLORIDE XYLOCAINE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE XYLOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE XYLOCAINE W/ EPINEPHRINE, EPINEPHRINE XYLOCAINE, LIDOCAINE HYDROCHLORIDE XYREM, SODIUM OXYBATE XYZAL, LEVOCETIRIZINE DIHYDROCHLORIDE
**
YASMIN, DROSPIRENONE
**
APPENDIX A
YAZ, DROSPIRENONE
**
A - 58
**
**
ZADITOR, KETOTIFEN FUMARATE (OTC) ZAFIRLUKAST, ZAFIRLUKAST ZALEPLON, ZALEPLON ZANAFLEX, TIZANIDINE HYDROCHLORIDE ZANOSAR, STREPTOZOCIN ZANTAC 150, RANITIDINE HYDROCHLORIDE ZANTAC 150, RANITIDINE HYDROCHLORIDE (OTC) ZANTAC 25, RANITIDINE HYDROCHLORIDE ZANTAC 300, RANITIDINE HYDROCHLORIDE ZANTAC 75, RANITIDINE HYDROCHLORIDE (OTC) ZANTAC IN PLASTIC CONTAINER, RANITIDINE HYDROCHLORIDE ZANTAC, RANITIDINE HYDROCHLORIDE ZARONTIN, ETHOSUXIMIDE ZAROXOLYN, METOLAZONE ZAVESCA, MIGLUSTAT ZEBETA, BISOPROLOL FUMARATE ZEGERID OTC, OMEPRAZOLE (OTC) ZEGERID, OMEPRAZOLE ZELAPAR, SELEGILINE HYDROCHLORIDE ZELBORAF, VEMURAFENIB ZEMPLAR, PARICALCITOL ZEMURON, ROCURONIUM BROMIDE ZENPEP, LIPASE ZERIT, STAVUDINE ZESTORETIC, HYDROCHLOROTHIAZIDE ZESTRIL, LISINOPRIL ZETIA, EZETIMIBE ZIAC, BISOPROLOL FUMARATE ZIAGEN, ABACAVIR SULFATE ZIANA, CLINDAMYCIN PHOSPHATE ZIDOVUDINE, ZIDOVUDINE ZINACEF IN PLASTIC CONTAINER, CEFUROXIME SODIUM ZINACEF, CEFUROXIME SODIUM ZINC CHLORIDE IN PLASTIC CONTAINER, ZINC CHLORIDE ZINECARD, DEXRAZOXANE HYDROCHLORIDE ZIPSOR, DICLOFENAC POTASSIUM ZIRGAN, GANCICLOVIR ZITHROMAX, AZITHROMYCIN ZMAX, AZITHROMYCIN ZOCOR, SIMVASTATIN ZOFRAN ODT, ONDANSETRON ZOFRAN PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ZOFRAN, ONDANSETRON HYDROCHLORIDE ZOLADEX, GOSERELIN ACETATE ZOLINZA, VORINOSTAT ZOLOFT, SERTRALINE HYDROCHLORIDE ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE ZOLPIDEM TATRATE, ZOLPIDEM TARTRATE ZOLPIMIST, ZOLPIDEM TARTRATE ZOMETA, ZOLEDRONIC ACID ZOMIG, ZOLMITRIPTAN ZOMIG-ZMT, ZOLMITRIPTAN ZONALON, DOXEPIN HYDROCHLORIDE ZONEGRAN, ZONISAMIDE ZONISAMIDE, ZONISAMIDE ZORBTIVE, SOMATROPIN RECOMBINANT ZORTRESS, EVEROLIMUS ZOSYN IN PLASTIC CONTAINER, PIPERACILLIN SODIUM ZOSYN, PIPERACILLIN SODIUM ZOVIA 1/35E-28, ETHINYL ESTRADIOL
APPENDIX A
**
A - 59
ZOVIA 1/50E-28, ETHINYL ESTRADIOL ZOVIRAX, ACYCLOVIR ZUPLENZ, ONDANSETRON ZUTRIPRO, CHLORPHENIRAMINE MALEATE ZYBAN, BUPROPION HYDROCHLORIDE ZYCLARA, IMIQUIMOD ZYDONE, ACETAMINOPHEN ZYFLO CR, ZILEUTON ZYFLO, ZILEUTON ZYLET, LOTEPREDNOL ETABONATE ZYLOPRIM, ALLOPURINOL ZYMAR, GATIFLOXACIN ZYMAXID, GATIFLOXACIN ZYPREXA RELPREVV, OLANZAPINE PAMOATE ZYPREXA ZYDIS, OLANZAPINE ZYPREXA, OLANZAPINE ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ZYRTEC, CETIRIZINE HYDROCHLORIDE ZYRTEC-D 12 HOUR, CETIRIZINE HYDROCHLORIDE (OTC) ZYTIGA, ABIRATERONE ACETATE ZYVOX, LINEZOLID
B - 1
APPENDIX B
B - 2
APPENDIX B
* ABBOTT ENDOCRINE INC LUPRON DEPOT-PED, LEUPROLIDE ACETATE ABBOTT LABS * ABBOTT ENDOCRINE INC SUB ABBOTT LABORATORIES LUPRON DEPOT, LEUPROLIDE ACETATE * ABBOTT LABORATORIES ANDROGEL, TESTOSTERONE NORVIR, RITONAVIR PROMETRIUM, PROGESTERONE
TRILIPIX, CHOLINE FENOFIBRATE
ABBOTT LABS PHARM * ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV TRICOR, FENOFIBRATE ABBOTT PRODS * ABBOTT PRODUCTS INC ACEON, PERINDOPRIL ERBUMINE CREON, LIPASE
MARINOL, DRONABINOL
ABRAXIS BIOSCIENCE * ABRAXIS BIOSCIENCE LLC ABRAXANE, PACLITAXEL ABRAXIS PHARM * ABRAXIS PHARMACEUTICAL PRODUCTS CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%, CLINDAMYCIN PHOSPHATE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE
MAGNESIUM SULFATE, MAGNESIUM SULFATE
ACADEMIC PHARMS * ACADEMIC PHARMACEUTICALS INC SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE ACCORD HLTH * ACCORD HEALTH CARE INC METHYLDOPA, METHYLDOPA ACCORD HLTHCARE * ACCORD HEALTHCARE INC DOCETAXEL, DOCETAXEL DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GLIMEPIRIDE, GLIMEPIRIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM MITOMYCIN, MITOMYCIN MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN
TACROLIMUS, TACROLIMUS
TOPIRAMATE, TOPIRAMATE
ACCORD HLTHCARE INC * ACCORD HEALTHCARE INC USA ANASTROZOLE, ANASTROZOLE BICALUTAMIDE, BICALUTAMIDE CLONAZEPAM, CLONAZEPAM ETOPOSIDE, ETOPOSIDE FINASTERIDE, FINASTERIDE GLIPIZIDE, GLIPIZIDE
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL
PACLITAXEL, PACLITAXEL
ACIC FINE CHEMS * ACIC FINE CHEMICALS INC AMPICILLIN SODIUM, AMPICILLIN SODIUM
B - 3
APPENDIX B
* ACIC FINE CHEMICALS INC NAFCILLIN SODIUM, NAFCILLIN SODIUM ACORDA * ACORDA THERAPEUTICS INC AMPYRA, DALFAMPRIDINE
ZANAFLEX, TIZANIDINE HYDROCHLORIDE
ACS DOBFAR * ACS DOBFAR SPA AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE CEFOXITIN, CEFOXITIN SODIUM CEFTAZIDIME, CEFTAZIDIME CEFTRIAXONE, CEFTRIAXONE SODIUM IMIPENEM AND CILASTATIN, CILASTATIN SODIUM KEFZOL, CEFAZOLIN SODIUM
MEROPENEM, MEROPENEM
ACS DOBFAR INFO SA * ACS DOBFAR INFO SA CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN FLUCANAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN ACTAVIS * ACTAVIS SOUTH ATLANTIC LLC METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE * ACTAVIS SOUTHATLANTIC LLC BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL
NIFEDIPINE, NIFEDIPINE
OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE
ACTAVIS ELIZABETH * ACTAVIS ELIZABETH LLC ALPRAZOLAM, ALPRAZOLAM CARBIDOPA AND LEVODOPA, CARBIDOPA CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE GABAPENTIN, GABAPENTIN GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE INDAPAMIDE, INDAPAMIDE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE KADIAN, MORPHINE SULFATE LEVETIRACETAM, LEVETIRACETAM LORAZEPAM, LORAZEPAM LOVASTATIN, LOVASTATIN METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE NIFEDIPINE, NIFEDIPINE OXAZEPAM, OXAZEPAM OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE PROPYLTHIOURACIL, PROPYLTHIOURACIL
SPIRONOLACTONE, SPIRONOLACTONE
TEMAZEPAM, TEMAZEPAM
(OTC)
B - 4
APPENDIX B
ACTAVIS INC * ACTAVIS INC LOSARTAN POTASSIUM,
LOSARTAN POTASSIUM
ACTAVIS MID ATLANTIC * ACTAVIS MID ATLANTIC LLC ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETASOL HC, ACETIC ACID, GLACIAL ACYCLOVIR, ACYCLOVIR ALBUTEROL SULFATE, ALBUTEROL SULFATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE BETAMETHASONE VALERATE, BETAMETHASONE VALERATE CICLOPIROX, CICLOPIROX CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE (OTC) CONSTULOSE, LACTULOSE ENULOSE, LACTULOSE FLUOCINONIDE, FLUOCINONIDE GRISEOFULVIN, GRISEOFULVIN, MICROCRYSTALLINE HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE HYDROCORTISONE, HYDROCORTISONE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) INFANTS' FEVERALL, ACETAMINOPHEN (OTC) LEVETIRACETAM, LEVETIRACETAM MICONAZOLE 7, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) M-ZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) NYSTATIN, NYSTATIN PERMETHRIN, PERMETHRIN PERMETHRIN, PERMETHRIN (OTC) PROMETH VC PLAIN, PHENYLEPHRINE HYDROCHLORIDE PROMETH VC W/ CODEINE, CODEINE PHOSPHATE PROMETH W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
SULFATRIM PEDIATRIC, SULFAMETHOXAZOLE
VALNAC, BETAMETHASONE VALERATE
ACTAVIS PHARMA * ACTAVIS PHARMA MANUFACTURING PRIVATE LTD DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE
ACTAVIS S ATLANTIC * ACTAVIS SOUTH ATLANTIC LLC
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
ZOLPIDEM TATRATE, ZOLPIDEM TARTRATE
ACTAVIS TOTOWA * ACTAVIS TOTOWA LLC BICALUTAMIDE, BICALUTAMIDE DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE FINASTERIDE, FINASTERIDE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE
LETROZOLE, LETROZOLE
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
B - 5
APPENDIX B
* ACTAVIS TOTOWA LLC PACLITAXEL, PACLITAXEL PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
VINORELBINE TARTRATE, VINORELBINE TARTRATE
ACTELION * ACTELION LTD TRACLEER, BOSENTAN
VELETRI, EPOPROSTENOL SODIUM
ACTELION PHARMS LTD * ACTELION PHARMACEUTICALS LTD VENTAVIS, ILOPROST
ZAVESCA, MIGLUSTAT
ACTIENT PHARMS * ACTIENT PHARMACEUTICALS LLC STRIANT, TESTOSTERONE ACTON PHARMS * ACTON PHARMACEUTICALS INC AEROSPAN HFA, FLUNISOLIDE ADOLOR * ADOLOR CORP ENTEREG, ALVIMOPAN ADVENT PHARMS * ADVENT PHARMACEUTICALS INC CARISOPRODOL, CARISOPRODOL AEGIS PHARMS * AEGIS PHARMACEUTICALS INC TAMOXIFEN CITRATE, TAMOXIFEN CITRATE AGOURON * AGOURON PHARMACEUTICALS INC VIRACEPT, NELFINAVIR MESYLATE AJANTA PHARMA * AJANTA PHARMA LTD LEVETIRACETAM, LEVETIRACETAM AJANTA PHARMA LTD * AJANTA PHARMA LTD RISPERIDONE, RISPERIDONE AKORN * AKORN INC ADENOSINE, ADENOSINE AKBETA, LEVOBUNOLOL HYDROCHLORIDE AK-FLUOR 10%, FLUORESCEIN SODIUM AKPENTOLATE, CYCLOPENTOLATE HYDROCHLORIDE AKPRO, DIPIVEFRIN HYDROCHLORIDE AKTEN, LIDOCAINE HYDROCHLORIDE AKTOB, TOBRAMYCIN ALFENTA, ALFENTANIL HYDROCHLORIDE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC BAL, DIMERCAPROL BALANCED SALT, CALCIUM CHLORIDE BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE CALCITRIOL, CALCITRIOL CAPASTAT SULFATE, CAPREOMYCIN SULFATE CARBOPLATIN, CARBOPLATIN CROMOLYN SODIUM, CROMOLYN SODIUM DICLOFENAC SODIUM, DICLOFENAC SODIUM
ENDOSOL EXTRA, CALCIUM CHLORIDE
B - 6
APPENDIX B
** A **
* AKORN INC ERYTHROMYCIN, ERYTHROMYCIN GENTAK, GENTAMICIN SULFATE GENTAMICIN SULFATE, GENTAMICIN SULFATE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE IC-GREEN, INDOCYANINE GREEN IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE KETOTIFEN FUMARATE, KETOTIFEN FUMARATE (OTC) LEVOFLOXACIN, LEVOFLOXACIN LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC OFLOXACIN, OFLOXACIN ORPHENADRINE CITRATE, ORPHENADRINE CITRATE PAREMYD, HYDROXYAMPHETAMINE HYDROBROMIDE SUBLIMAZE PRESERVATIVE FREE, FENTANYL CITRATE SUFENTA PRESERVATIVE FREE, SUFENTANIL CITRATE TERBUTALINE SULFATE, TERBUTALINE SULFATE TIMOLOL MALEATE, TIMOLOL MALEATE
TROPICACYL, TROPICAMIDE
AKORN INC * AKORN INC APRACLONIDINE HYDROCHLORIDE, APRACLONIDINE HYDROCHLORIDE CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HYDASE, HYALURONIDASE
INAPSINE, DROPERIDOL
AKORN STRIDES * AKORN STRIDES LLC TOBRAMYCIN SULFATE,
TOBRAMYCIN SULFATE
AKRIMAX PHARMS * AKRIMAX PHARMACEUTICALS LLC INDERAL LA, PROPRANOLOL HYDROCHLORIDE INDERAL, PROPRANOLOL HYDROCHLORIDE
INDERIDE-40/25, HYDROCHLOROTHIAZIDE
ALARA PHARM * ALARA PHARMACEUTICAL CORPORATION LEVO-T, LEVOTHYROXINE SODIUM ALCON * ALCON INC TRIESENCE, TRIAMCINOLONE ACETONIDE * ALCON LABORATORIES INC ALCAINE, PROPARACAINE HYDROCHLORIDE ALOMIDE, LODOXAMIDE TROMETHAMINE BETOPTIC S, BETAXOLOL HYDROCHLORIDE BETOPTIC, BETAXOLOL HYDROCHLORIDE BSS PLUS, CALCIUM CHLORIDE BSS, CALCIUM CHLORIDE CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE CETAMIDE, SULFACETAMIDE SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM CYCLOGYL, CYCLOPENTOLATE HYDROCHLORIDE CYCLOMYDRIL, CYCLOPENTOLATE HYDROCHLORIDE DENDRID, IDOXURIDINE EMADINE, EMEDASTINE DIFUMARATE FLAREX, FLUOROMETHOLONE ACETATE IOPIDINE, APRACLONIDINE HYDROCHLORIDE MAXIDEX, DEXAMETHASONE MAXITROL, DEXAMETHASONE
MIOSTAT, CARBACHOL
B - 7
APPENDIX B
** A **
* ALCON LABORATORIES INC MYDRIACYL, TROPICAMIDE NAPHCON-A, NAPHAZOLINE HYDROCHLORIDE (OTC) NATACYN, NATAMYCIN NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, OMNIPRED, PREDNISOLONE ACETATE PATANOL, OLOPATADINE HYDROCHLORIDE PILOPINE HS, PILOCARPINE HYDROCHLORIDE TOBRADEX, DEXAMETHASONE TOBREX, TOBRAMYCIN TRIFLURIDINE, TRIFLURIDINE
VEXOL, RIMEXOLONE
ALCON PHARMA * ALCON RESEARCH LTD ZADITOR, KETOTIFEN FUMARATE
HYDROCORTISONE
(OTC)
ALCON PHARMS LTD * ALCON PHARMACEUTICALS LTD AZOPT, BRINZOLAMIDE BETADINE, POVIDONE-IODINE BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE CILOXAN, CIPROFLOXACIN HYDROCHLORIDE CIPRO HC, CIPROFLOXACIN HYDROCHLORIDE CIPRODEX, CIPROFLOXACIN DICLOFENAC SODIUM, DICLOFENAC SODIUM DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE DUREZOL, DIFLUPREDNATE FLUORESCITE, FLUORESCEIN SODIUM KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE KETOTIFEN FUMARATE, KETOTIFEN FUMARATE (OTC) MOXEZA, MOXIFLOXACIN HYDROCHLORIDE NAVSTEL, CALCIUM CHLORIDE NEVANAC, NEPAFENAC OFLOXACIN, OFLOXACIN PATADAY, OLOPATADINE HYDROCHLORIDE PATANASE, OLOPATADINE HYDROCHLORIDE SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, TOBRADEX ST, DEXAMETHASONE TRAVATAN Z, TRAVOPROST
VIGAMOX, MOXIFLOXACIN HYDROCHLORIDE
ALCON RES * ALCON RESEARCH LTD DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, ISOPTO CARPINE, PILOCARPINE HYDROCHLORIDE
LATANOPROST, LATANOPROST
DORZOLAMIDE HYDROCHLORIDE
ALCON UNIVERSAL * ALCON UNIVERSAL LTD DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE
SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM
ALDOPHARMA USA * ALKOPHARMA USA INC AMPHOTEC, AMPHOTERICIN B ALEMBIC LTD * ALEMBIC LTD LITHIUM CARBONATE, LITHIUM CARBONATE METRONIDAZOLE, METRONIDAZOLE PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE
THEOPHYLLINE, THEOPHYLLINE
B - 8
APPENDIX B
ALEMBIC PHARMS LTD * ALEMBIC PHARMACEUTICALS LTD CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE FAMOTIDINE, FAMOTIDINE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LAMOTRIGINE, LAMOTRIGINE LEFLUNOMIDE, LEFLUNOMIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MEPROBAMATE, MEPROBAMATE
METRONIDAZOLE, METRONIDAZOLE
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
ALKEM * ALKEM LABORATORIES LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CEPHALEXIN, CEPHALEXIN
GABAPENTIN, GABAPENTIN
METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
ALKEM LABS LTD * ALKEM LABORATORIES LTD
CEFUROXIME AXETIL, CEFUROXIME AXETIL
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL
ALKERMES * ALKERMES INC VIVITROL, NALTREXONE ALKERMES GAINESVILLE * ALKERMES GAINESVILLE LLC VERELAN, VERAPAMIL HYDROCHLORIDE ALLEGIANCE HLTHCARE * ALLEGIANCE HEALTHCARE CORP POVIDONE IODINE, POVIDONE-IODINE
(OTC)
ALLERGAN * ALLERGAN ACULAR LS, KETOROLAC TROMETHAMINE ALPHAGAN P, BRIMONIDINE TARTRATE BLEPH-10, SULFACETAMIDE SODIUM
GENOPTIC, GENTAMICIN SULFATE
ZYMAXID, GATIFLOXACIN
* ALLERGAN INC ACULAR PRESERVATIVE FREE, KETOROLAC TROMETHAMINE ACULAR, KETOROLAC TROMETHAMINE ACUVAIL, KETOROLAC TROMETHAMINE ACZONE, DAPSONE ALBALON, NAPHAZOLINE HYDROCHLORIDE ALOCRIL, NEDOCROMIL SODIUM ALPHAGAN P, BRIMONIDINE TARTRATE AVAGE, TAZAROTENE AZELEX, AZELAIC ACID COMBIGAN, BRIMONIDINE TARTRATE ELESTAT, EPINASTINE HYDROCHLORIDE ELIMITE, PERMETHRIN LASTACAFT, ALCAFTADINE LATISSE, BIMATOPROST LUMIGAN, BIMATOPROST OCUFLOX, OFLOXACIN OPTICROM, CROMOLYN SODIUM OZURDEX, DEXAMETHASONE POLYTRIM, POLYMYXIN B SULFATE RESTASIS, CYCLOSPORINE
SANCTURA XR, TROSPIUM CHLORIDE
SANCTURA, TROSPIUM CHLORIDE
B - 9
APPENDIX B
** A **
B - 10
APPENDIX B
ALTAIRE PHARMS INC * ALTAIRE PHARMACEUTICALS INC NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE,
NAPHAZOLINE HYDROCHLORIDE
(OTC)
ALTANA * ALTANA INC ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE AMCINONIDE, AMCINONIDE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CUTIVATE, FLUTICASONE PROPIONATE DESONIDE, DESONIDE DIFLORASONE DIACETATE, DIFLORASONE DIACETATE ECONAZOLE NITRATE, ECONAZOLE NITRATE ERYTHROMYCIN, ERYTHROMYCIN FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE FLUOCINONIDE, FLUOCINONIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE HYDROCORTISONE, HYDROCORTISONE KETOCONAZOLE, KETOCONAZOLE METRONIDAZOLE, METRONIDAZOLE MOMETASONE FUROATE, MOMETASONE FUROATE MUPIROCIN, MUPIROCIN NYSTATIN, NYSTATIN OXISTAT, OXICONAZOLE NITRATE PREDNICARBATE, PREDNICARBATE SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM
TERCONAZOLE, TERCONAZOLE
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
ALTANA PHARMA * ALTANA PHARMA AG CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, ALTERNA TCHP LLC * ALTERNA TCHP LLC CHILDREN'S ELIXSURE,
BETAMETHASONE DIPROPIONATE
IBUPROFEN
(OTC)
ALVOGEN * ALVOGEN INC MACROBID, NITROFURANTOIN MACRODANTIN, NITROFURANTOIN, MACROCRYSTALLINE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
ALVOGEN INC * ALVOGEN INC OXYCODONE HYDROCHLORIDE, AM ANTIBIOTICS * AMERICAN ANTIBIOTICS LLC AMOXICILLIN, AMOXICILLIN AMAG PHARMS INC * AMAG PHARMACEUTICALS INC FERAHEME, FERUMOXYTOL
FERIDEX I.V., FERUMOXIDES
GASTROMARK, FERUMOXSIL
OXYCODONE HYDROCHLORIDE
B - 11
APPENDIX B
AMGEN * AMGEN INC SENSIPAR,
CINACALCET HYDROCHLORIDE
AMNEAL PHARM * AMNEAL PHARMACEUTICAL ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLUCONAZOLE, FLUCONAZOLE FOLIC ACID, FOLIC ACID GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE
PRIMIDONE, PRIMIDONE
SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE
AMNEAL PHARMS * AMNEAL PHARMACEUTICALS ALBUTEROL SULFATE, ALBUTEROL SULFATE CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) FELBAMATE, FELBAMATE IBUPROFEN, IBUPROFEN (OTC) INDOMETHACIN, INDOMETHACIN LEVETIRACETAM, LEVETIRACETAM LORAZEPAM, LORAZEPAM MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE NITROFURANTOIN, NITROFURANTOIN NIZATIDINE, NIZATIDINE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN HYDROBROMIDE PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RISPERIDONE, RISPERIDONE SPIRONOLACTONE, SPIRONOLACTONE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE * AMNEAL PHARMACEUTICALS LLC TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE AMNEAL PHARMS NY * AMNEAL PHARMACEUTICALS NY LLC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ALPRAZOLAM, ALPRAZOLAM AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM GABAPENTIN, GABAPENTIN HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NAPROXEN, NAPROXEN
OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN
PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
B - 12
APPENDIX B
* AMNEAL PHARMACEUTICALS NY LLC RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE REPREXAIN, HYDROCODONE BITARTRATE
SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE
AMPHASTAR PHARM * AMPHASTAR PHARMACEUTICAL INC AMPHADASE, HYALURONIDASE
ENOXAPARIN SODIUM (PRESERVATIVE FREE), AMPHASTAR PHARMS INC * AMPHASTAR PHARMACEUTICALS INC CORTROSYN, COSYNTROPIN AMPOLGEN * AMPOLGEN PHARMACEUTICALS LLC SODIUM PHENYLBUTYRATE, SODIUM PHENYLBUTYRATE AMYLIN * AMYLIN PHARMACEUTICALS INC
BYETTA, EXENATIDE SYNTHETIC
SYMLIN, PRAMLINTIDE ACETATE
ANBEX * ANBEX INC IOSAT, POTASSIUM IODIDE
ENOXAPARIN SODIUM
(OTC)
B - 13
APPENDIX B
B - 14
APPENDIX B
APOTEX CORP * APOTEX CORP ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AZITHROMYCIN, AZITHROMYCIN CICLOPIROX, CICLOPIROX CLARITHROMYCIN, CLARITHROMYCIN GATIFLOXACIN, GATIFLOXACIN LOSARTAN POTASSIUM, LOSARTAN POTASSIUM
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL
NARATRIPTAN, NARATRIPTAN
APOTEX INC * APOTEX INC ALBUTEROL SULFATE, ALBUTEROL SULFATE ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE ALPRAZOLAM, ALPRAZOLAM AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE CALCITONIN-SALMON, CALCITONIN SALMON CARBAMAZEPINE, CARBAMAZEPINE CARBIDOPA AND LEVODOPA, CARBIDOPA CEFPROZIL, CEFPROZIL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CEVIMELINE, CEVIMELINE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LOVASTATIN, LOVASTATIN MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE NABUMETONE, NABUMETONE OFLOXACIN, OFLOXACIN OLANZAPINE, OLANZAPINE OXCARBAZEPINE, OXCARBAZEPINE PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE TIMOLOL MALEATE, TIMOLOL MALEATE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
* APOTEX INC ETOBICOKE SITE ACYCLOVIR, ACYCLOVIR ALLOPURINOL, ALLOPURINOL AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CARBAMAZEPINE, CARBAMAZEPINE CARVEDILOL, CARVEDILOL CILOSTAZOL, CILOSTAZOL CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DILTZAC, DILTIAZEM HYDROCHLORIDE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ETODOLAC, ETODOLAC FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GABAPENTIN, GABAPENTIN
KETOTIFEN FUMARATE, KETOTIFEN FUMARATE (OTC)
LEFLUNOMIDE, LEFLUNOMIDE
B - 15
APPENDIX B
** A **
* APOTEX INC ETOBICOKE SITE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LITHIUM CARBONATE, LITHIUM CARBONATE LORATADINE, LORATADINE (OTC) MELOXICAM, MELOXICAM MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE OXAPROZIN, OXAPROZIN SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE TORSEMIDE, TORSEMIDE
ZONISAMIDE, ZONISAMIDE
* APOTEX INC RICHMOND HILL ALBUTEROL SULFATE, ALBUTEROL SULFATE AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE DICLOFENAC SODIUM, DICLOFENAC SODIUM DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE FLUNISOLIDE, FLUNISOLIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LORATADINE, LORATADINE (OTC) MEGESTROL ACETATE, MEGESTROL ACETATE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE PREDNISOLONE, PREDNISOLONE
RISPERIDONE, RISPERIDONE
* APOTEX INC. GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE APOTHECON * APOTHECON INC DIV BRISTOL MYERS SQUIBB CAPOZIDE 25/15, CAPTOPRIL CAPOZIDE 25/25, CAPTOPRIL CAPOZIDE 50/15, CAPTOPRIL CAPOZIDE 50/25, CAPTOPRIL KENALOG, TRIAMCINOLONE ACETONIDE KENALOG-10, TRIAMCINOLONE ACETONIDE KENALOG-40, TRIAMCINOLONE ACETONIDE KLOTRIX, POTASSIUM CHLORIDE OPHTHAINE, PROPARACAINE HYDROCHLORIDE STADOL PRESERVATIVE FREE, BUTORPHANOL TARTRATE
STADOL, BUTORPHANOL TARTRATE
TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE
APP PHARMS * APP PHARMACEUTICALS GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM
PROTAMINE SULFATE, PROTAMINE SULFATE
* APP PHARMACEUTICALS LLC ACYCLOVIR SODIUM, ACYCLOVIR SODIUM ADENOSINE, ADENOSINE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE ASTRAMORPH PF, MORPHINE SULFATE AZITHROMYCIN, AZITHROMYCIN AZTREONAM, AZTREONAM BACITRACIN, BACITRACIN BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE BLEOMYCIN SULFATE, BLEOMYCIN SULFATE
B - 16
APPENDIX B
* APP PHARMACEUTICALS LLC CAFFEINE CITRATE, CAFFEINE CITRATE CALCITRIOL, CALCITRIOL CARBOPLATIN, CARBOPLATIN CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFOTAXIME, CEFOTAXIME SODIUM CEFOXITIN, CEFOXITIN SODIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME SODIUM, CEFUROXIME SODIUM CHLORAMPHENICOL SODIUM SUCCINATE, CHLORAMPHENICOL SODIUM SUCCINATE CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC CISPLATIN, CISPLATIN CLADRIBINE, CLADRIBINE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM CYTARABINE, CYTARABINE DACARBAZINE, DACARBAZINE DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DIMENHYDRINATE, DIMENHYDRINATE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPRIVAN, PROPOFOL DIPYRIDAMOLE, DIPYRIDAMOLE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE DOXY 100, DOXYCYCLINE HYCLATE DOXY 200, DOXYCYCLINE HYCLATE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE ETOPOSIDE, ETOPOSIDE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FLOXURIDINE, FLOXURIDINE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FLUMAZENIL, FLUMAZENIL FLUOROURACIL, FLUOROURACIL FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE FOLIC ACID, FOLIC ACID FUROSEMIDE, FUROSEMIDE GANCICLOVIR, GANCICLOVIR SODIUM GENTAMICIN SULFATE, GENTAMICIN SULFATE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL LACTATE HEPARIN SODIUM IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IFOSFAMIDE, IFOSFAMIDE INDOMETHACIN, INDOMETHACIN IOPAMIDOL-250, IOPAMIDOL IOPAMIDOL-300, IOPAMIDOL IOPAMIDOL-370, IOPAMIDOL KANAMYCIN SULFATE, KANAMYCIN SULFATE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE
MANNITOL 25%, MANNITOL
MESNA, MESNA
B - 17
APPENDIX B
** A **
* APP PHARMACEUTICALS LLC METARAMINOL BITARTRATE, METARAMINOL BITARTRATE METHOTREXATE SODIUM, METHOTREXATE SODIUM METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE, MILRINONE LACTATE MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE NAROPIN, ROPIVACAINE HYDROCHLORIDE MONOHYDRATE NEBUPENT, PENTAMIDINE ISETHIONATE NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE HYDROCHLORIDE OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXALIPLATIN, OXALIPLATIN OXYTOCIN, OXYTOCIN PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM PENTAM, PENTAMIDINE ISETHIONATE POLOCAINE, MEPIVACAINE HYDROCHLORIDE POLOCAINE-MPF, MEPIVACAINE HYDROCHLORIDE POLYMYXIN B SULFATE, POLYMYXIN B SULFATE POTASSIUM CHLORIDE IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PROGESTERONE, PROGESTERONE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE SENSORCAINE, BUPIVACAINE HYDROCHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBUTALINE SULFATE, TERBUTALINE SULFATE THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE TOBRAMYCIN SULFATE (PHARMACY BULK), TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE VALPROATE SODIUM, VALPROATE SODIUM VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VIBISONE, CYANOCOBALAMIN VINBLASTINE SULFATE, VINBLASTINE SULFATE VINORELBINE TARTRATE, VINORELBINE TARTRATE XYLOCAINE 4% PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE XYLOCAINE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE XYLOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE
XYLOCAINE W/ EPINEPHRINE, EPINEPHRINE
XYLOCAINE, LIDOCAINE HYDROCHLORIDE
* APP PHARMACEUTICALS, LLC--A CO. OF THE FRESENIUS KABI GROUP ACYCLOVIR SODIUM, ACYCLOVIR SODIUM CEFOTETAN, CEFOTETAN DISODIUM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE
FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE
APTALIS PHARMA US * APTALIS PHARMA US INC BENTYL PRESERVATIVE FREE, DICYCLOMINE HYDROCHLORIDE BENTYL, DICYCLOMINE HYDROCHLORIDE CARAFATE, SUCRALFATE PYLERA, BISMUTH SUBCITRATE POTASSIUM
URSO 250, URSODIOL
URSO FORTE, URSODIOL
B - 18
APPENDIX B
* APTALIS PHARMA US INC ZENPEP, LIPASE AQUA PHARMS * AQUA PHARMACEUTICALS LLC SOLAGE, MEQUINOL
XOLEGEL, KETOCONAZOLE
CONIVAPTAN HYDROCHLORIDE
(OTC)
B - 19
APPENDIX B
** A **
* ASTRAZENECA LP PULMICORT RESPULES, BUDESONIDE RHINOCORT, BUDESONIDE SEROQUEL, QUETIAPINE FUMARATE SYMBICORT, BUDESONIDE TENORMIN, ATENOLOL
TOPROL-XL, METOPROLOL SUCCINATE
* ASTRAZENECA PHARMACEUTICALS LP ATACAND HCT, CANDESARTAN CILEXETIL ATACAND, CANDESARTAN CILEXETIL FASLODEX, FULVESTRANT PLENDIL, FELODIPINE PULMICORT, BUDESONIDE SEROQUEL XR, QUETIAPINE FUMARATE TENORETIC 100, ATENOLOL TENORETIC 50, ATENOLOL ZOMIG, ZOLMITRIPTAN
ZOMIG-ZMT, ZOLMITRIPTAN
* ASTRAZENECA UK LTD ACCOLATE, ZAFIRLUKAST ARIMIDEX, ANASTROZOLE CASODEX, BICALUTAMIDE MERREM, MEROPENEM ZESTORETIC, HYDROCHLOROTHIAZIDE ZESTRIL, LISINOPRIL
ZOLADEX, GOSERELIN ACETATE
ASTRAZENECA LP * ASTRAZENECA LP BRILINTA, TICAGRELOR
VIMOVO, ESOMEPRAZOLE MAGNESIUM
ATON * ATON PHARMA INC CUPRIMINE, PENICILLAMINE DEMSER, METYROSINE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID LACRISERT, HYDROXYPROPYL CELLULOSE LODOSYN, CARBIDOPA SYPRINE, TRIENTINE HYDROCHLORIDE TIMOPTIC IN OCUDOSE, TIMOLOL MALEATE
TIMOPTIC, TIMOLOL MALEATE
TIMOPTIC-XE, TIMOLOL MALEATE
AUROBINDO * AUROBINDO PHARMA LTD AMOXICILLIN, AMOXICILLIN CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
MIRTAZAPINE, MIRTAZAPINE
ZIDOVUDINE, ZIDOVUDINE
AUROBINDO PHARM * AUROBINDO PHARMA USA INC ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE GABAPENTIN, GABAPENTIN LEVETIRACETAM, LEVETIRACETAM
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
B - 20
APPENDIX B
AUROBINDO PHARMA * AUROBINDO PHARMA AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM * AUROBINDO PHARMA LTD ALENDRONATE SODIUM, ALENDRONATE SODIUM AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXICILLIN, AMOXICILLIN AMPICILLIN SODIUM, AMPICILLIN SODIUM ATENOLOL, ATENOLOL BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BISOPROLOL FUMARATE, BISOPROLOL FUMARATE CARISOPRODOL, CARISOPRODOL CARVEDILOL, CARVEDILOL CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFDINIR, CEFDINIR CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL CEFTAZIDIME, CEFTAZIDIME CEFTRIAXONE, CEFTRIAXONE SODIUM CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DIDANOSINE, DIDANOSINE FINASTERIDE, FINASTERIDE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE GLYBURIDE, GLYBURIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MELOXICAM, MELOXICAM METOPROLOL TARTRATE, METOPROLOL TARTRATE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE RIBAVARIN, RIBAVIRIN RIBAVIRIN, RIBAVIRIN RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN STAVUDINE, STAVUDINE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE TORSEMIDE, TORSEMIDE TRANDOLAPRIL, TRANDOLAPRIL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
ZALEPLON, ZALEPLON
B - 21
APPENDIX B
* AUROBINDO PHARMA LTD ZOLPIDEM TARTRATE,
ZOLPIDEM TARTRATE
AUROBINDO PHARMA LTD * AUROBINDO PHARMA LIMITED DIVALPROEX SODIUM, DIVALPROEX SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE LEVOFLOXACIN, LEVOFLOXACIN
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
* AUROBINDO PHARMA LTD AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN FAMCICLOVIR, FAMCICLOVIR GABAPENTIN, GABAPENTIN LAMIVUDINE, LAMIVUDINE NAPROXEN SODIUM, NAPROXEN SODIUM PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM
RAMIPRIL, RAMIPRIL
* AUROBINDO PHARMA LTD INC CEFPROZIL, CEFPROZIL CEFUROXIME AXETIL, CEFUROXIME AXETIL CEPHALEXIN, CEPHALEXIN CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE MIRTAZAPINE, MIRTAZAPINE
ZIDOVUDINE, ZIDOVUDINE
AUROBINDO PHARMA USA * AUROBINDO PHARMA USA INC ALPRAZOLAM, ALPRAZOLAM
NAPROXEN, NAPROXEN
AUROSAL PHARMS * AUROSAL PHARMACEUTICALS LLC AMIODARONE HYDROCHLORIDE,
AMIODARONE HYDROCHLORIDE
MINOXIDIL
(OTC)
AVANIR PHARMS * AVANIR PHARMACEUTICALS INC NUEDEXTA, DEXTROMETHORPHAN HYDROBROMIDE AVANTHI INC * AVANTHI INC CHLORPHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE (OTC) DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE
INDOMETHACIN, INDOMETHACIN
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
AVEMA PHARMA * AVEMA PHARMA SOLUTIONS IBUPROFEN, IBUPROFEN
(OTC)
B - 22
APPENDIX B
(OTC)
B - 23
APPENDIX B
* B BRAUN MEDICAL INC DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%, DOPAMINE HYDROCHLORIDE FREAMINE HBC 6.9%, AMINO ACIDS FREAMINE III 10%, AMINO ACIDS FREAMINE III 3% W/ ELECTROLYTES, AMINO ACIDS FREAMINE III 8.5% W/ ELECTROLYTES, AMINO ACIDS FREAMINE III 8.5%, AMINO ACIDS GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, GENTAMICIN SULFATE GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPATAMINE 8%, AMINO ACIDS ISOLYTE E IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE E IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE ISOLYTE S IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE ISOLYTE S PH 7.4 IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER, MANNITOL MANNITOL 10%, MANNITOL MANNITOL 15% IN PLASTIC CONTAINER, MANNITOL MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%, MANNITOL MANNITOL 15%, MANNITOL MANNITOL 20% IN PLASTIC CONTAINER, MANNITOL MANNITOL 20%, MANNITOL MANNITOL 5% IN PLASTIC CONTAINER, MANNITOL MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%, MANNITOL MANNITOL 5%, MANNITOL METRO I.V. IN PLASTIC CONTAINER, METRONIDAZOLE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE NEPHRAMINE 5.4%, AMINO ACIDS NUTRILIPID 10%, SOYBEAN OIL NUTRILIPID 20%, SOYBEAN OIL PHYSIOLYTE IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE
B - 24
APPENDIX B
* B BRAUN MEDICAL INC POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC
CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE
B - 25
APPENDIX B
* B BRAUN MEDICAL INC POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.22% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PROCALAMINE, AMINO ACIDS RESECTISOL IN PLASTIC CONTAINER, MANNITOL RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM LACTATE 1/6 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE SORBITOL 3.3% IN PLASTIC CONTAINER, SORBITOL STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE TROPHAMINE 10%, AMINO ACIDS TROPHAMINE, AMINO ACIDS BANNER PHARMACAPS * BANNER PHARMACAPS INC AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE BENZONATATE, BENZONATATE CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ETHOSUXIMIDE, ETHOSUXIMIDE IBUPROFEN AND DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE (OTC) IBUPROFEN, IBUPROFEN (OTC) LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) MIDOL LIQUID GELS, IBUPROFEN (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NIMODIPINE, NIMODIPINE STAVZOR, VALPROIC ACID VALPROIC ACID, VALPROIC ACID
VITAMIN D, ERGOCALCIFEROL
ZONISAMIDE, ZONISAMIDE
BARR * BARR LABORATORIES INC ALPRAZOLAM, ALPRAZOLAM AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE
ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE
ARANELLE, ETHINYL ESTRADIOL
B - 26
APPENDIX B
* BARR LABORATORIES INC ASPIRIN AND DIPYRIDAMOLE, ASPIRIN BALZIVA-28, ETHINYL ESTRADIOL BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE CAMILA, NORETHINDRONE CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORZOXAZONE, CHLORZOXAZONE CLARAVIS, ISOTRETINOIN CLONAZEPAM, CLONAZEPAM CLONIDINE, CLONIDINE DANAZOL, DANAZOL DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE ASPARTATE DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE DIAZEPAM, DIAZEPAM DIDANOSINE, DIDANOSINE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE DUTASTERIDE, DUTASTERIDE ERRIN, NORETHINDRONE ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL, ERYTHROMYCIN ETHYLSUCCINATE ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL ESTRADIOL AND NORGESTIMATE, ESTRADIOL ESTRADIOL, ESTRADIOL ESTROPIPATE, ESTROPIPATE ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE FENTANYL CITRATE, FENTANYL CITRATE FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE HYDROXYUREA, HYDROXYUREA HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE ISONIAZID, ISONIAZID JUNEL 1.5/30, ETHINYL ESTRADIOL JUNEL 1/20, ETHINYL ESTRADIOL JUNEL FE 1.5/30, ETHINYL ESTRADIOL JUNEL FE 1/20, ETHINYL ESTRADIOL KARIVA, DESOGESTREL KELNOR, ETHINYL ESTRADIOL LEFLUNOMIDE, LEFLUNOMIDE LESSINA-28, ETHINYL ESTRADIOL MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE MEGESTROL ACETATE, MEGESTROL ACETATE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHOTREXATE SODIUM, METHOTREXATE SODIUM MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORETHINDRONE ACETATE, NORETHINDRONE ACETATE NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORTREL 0.5/35-28, ETHINYL ESTRADIOL NORTREL 1/35-21, ETHINYL ESTRADIOL NORTREL 1/35-28, ETHINYL ESTRADIOL
B - 27
APPENDIX B
* BARR LABORATORIES INC NORTREL 7/7/7, ETHINYL ESTRADIOL ONDANSETRON, ONDANSETRON PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PORTIA-28, ETHINYL ESTRADIOL PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE SPRINTEC, ETHINYL ESTRADIOL TEMOZOLOMIDE, TEMOZOLOMIDE TRETINOIN, TRETINOIN TREXALL, METHOTREXATE SODIUM TRI LO SPRINTEC, ETHINYL ESTRADIOL TRI-LEGEST 21, ETHINYL ESTRADIOL TRI-LEGEST FE, ETHINYL ESTRADIOL TRI-SPRINTEC, ETHINYL ESTRADIOL WARFARIN SODIUM, WARFARIN SODIUM
ZONISAMIDE, ZONISAMIDE
* BARR PHARMACEUTICALS LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM BARR LABS INC * BARR LABORATORIES INC NIMODIPINE, NIMODIPINE
OXYCODONE HYDROCHLORIDE AND IBUPROFEN,
IBUPROFEN
BAUSCH AND LOMB * BAUSCH AND LOMB INC ALAWAY, KETOTIFEN FUMARATE (OTC) ALBUTEROL SULFATE, ALBUTEROL SULFATE ALREX, LOTEPREDNOL ETABONATE BESIVANCE, BESIFLOXACIN HYDROCHLORIDE CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE FLURBIPROFEN SODIUM, FLURBIPROFEN SODIUM IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE LATANOPROST, LATANOPROST LOTEMAX, LOTEPREDNOL ETABONATE MIOCHOL-E, ACETYLCHOLINE CHLORIDE OFLOXACIN, OFLOXACIN OPCON-A, NAPHAZOLINE HYDROCHLORIDE (OTC) RETISERT, FLUOCINOLONE ACETONIDE TIMOLOL MALEATE, TIMOLOL MALEATE VITRASERT, GANCICLOVIR
ZIRGAN, GANCICLOVIR
ZYLET, LOTEPREDNOL ETABONATE
* BAUSCH AND LOMB PHARMACEUTICALS INC ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE, ACETIC ACID, GLACIAL BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CROLOM, CROMOLYN SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM CROMOLYN SODIUM, CROMOLYN SODIUM (OTC) DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DEXASPORIN, DEXAMETHASONE ERYTHROMYCIN, ERYTHROMYCIN FLUNISOLIDE, FLUNISOLIDE GENTAMICIN SULFATE, GENTAMICIN SULFATE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE
B - 28
APPENDIX B
* BAUSCH AND LOMB PHARMACEUTICALS INC NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE, BACITRACIN ZINC OFLOXACIN, OFLOXACIN OPTIPRANOLOL, METIPRANOLOL HYDROCHLORIDE OTICAIR, HYDROCORTISONE PENTOLAIR, CYCLOPENTOLATE HYDROCHLORIDE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM TIMOLOL MALEATE, TIMOLOL MALEATE TOBRAMYCIN AND DEXAMETHASONE, DEXAMETHASONE TOBRAMYCIN, TOBRAMYCIN TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE
TROPICAMIDE, TROPICAMIDE
BAXTER HLTHCARE * BAXTER HEALTHCARE CORP ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL ADENOSINE, ADENOSINE AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER, GLYCINE ANCEF IN PLASTIC CONTAINER, CEFAZOLIN SODIUM BACTOCILL IN PLASTIC CONTAINER, OXACILLIN SODIUM BRANCHAMIN 4% IN PLASTIC CONTAINER, AMINO ACIDS CARDIOPLEGIC IN PLASTIC CONTAINER, CALCIUM CHLORIDE CEFEPIME IN PLASTIC CONTAINER, CEFEPIME HYDROCHLORIDE CEFTRIAXONE IN PLASTIC CONTAINER, CEFTRIAXONE SODIUM CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 2.75/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/20 SULFITE-FREE W/ ELECT IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 4.25/5 SULFITE-FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/10 SULFITE-FREE W/ ELECT IN DEXTROSE 10% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/15 SULFITE-FREE W/ ELECT IN DEXTROSE 15% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/20 SULFITE-FREE W/ ELECT IN 20% DEXTROSE W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/25 SULFITE-FREE W/ ELECT IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CLINIMIX E 5/35 SULFITE-FREE W/ ELECT IN DEXTROSE 35% W/ CALCIUM IN PLASTIC CONTAINER, AMINO ACIDS CYTOXAN, CYCLOPHOSPHAMIDE
B - 29
APPENDIX B
* BAXTER HEALTHCARE CORP DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND ELECTROLYTE NO 75 IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND ELECTROLYTE NO.48 IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.224% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 10MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 15MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 30MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ (K), DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 5MEQ, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 15MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 20MEQ (K) IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 60% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE EXTRANEAL, ICODEXTRIN FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE
B - 30
APPENDIX B
* BAXTER HEALTHCARE CORP FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPATASOL 8%, AMINO ACIDS IFEX, IFOSFAMIDE ISOTONIC GENTAMICIN SULFATE IN PLASTIC CONTAINER, GENTAMICIN SULFATE LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE MESNEX, MESNA MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE NALLPEN IN PLASTIC CONTAINER, NAFCILLIN SODIUM NEXTERONE, AMIODARONE HYDROCHLORIDE NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN ONDANSETRON HYDROCHLORIDE AND SODIUM CHLORIDE IN PLASTIC CONTAINER, ONDANSETRON HYDROCHLORIDE OSMITROL 10% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 10% IN WATER, MANNITOL OSMITROL 15% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 15% IN WATER, MANNITOL OSMITROL 20% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 20% IN WATER, MANNITOL OSMITROL 5% IN WATER IN PLASTIC CONTAINER, MANNITOL OSMITROL 5% IN WATER, MANNITOL PENICILLIN G POTASSIUM IN PLASTIC CONTAINER, PENICILLIN G POTASSIUM PHENYTOIN SODIUM, PHENYTOIN SODIUM PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE PLASMA-LYTE 56 IN PLASTIC CONTAINER, MAGNESIUM ACETATE TETRAHYDRATE PLASMA-LYTE A IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE PLASMA-LYTE R IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 0.3% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE
B - 31
APPENDIX B
* BAXTER HEALTHCARE CORP POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,
CALCIUM CHLORIDE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,
CALCIUM CHLORIDE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,
DEXTROSE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PREMASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS PREMASOL 6% IN PLASTIC CONTAINER, AMINO ACIDS RENAMIN W/O ELECTROLYTES, AMINO ACIDS RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE SEVOFLURANE, SEVOFLURANE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 3% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 5% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER, SODIUM LACTATE SORBITOL 3% IN PLASTIC CONTAINER, SORBITOL STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION STERILE WATER, STERILE WATER FOR IRRIGATION THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE TIS-U-SOL IN PLASTIC CONTAINER, MAGNESIUM SULFATE TIS-U-SOL, MAGNESIUM SULFATE TRAVASOL 10% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 10% W/O ELECTROLYTES, AMINO ACIDS TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 3.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 5.5% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 5.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 5.5% W/O ELECTROLYTES, AMINO ACIDS TRAVASOL 8.5% IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 8.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER, AMINO ACIDS TRAVASOL 8.5% W/ ELECTROLYTES, AMINO ACIDS TRAVASOL 8.5% W/O ELECTROLYTES, AMINO ACIDS VANCOCIN HYDROCHLORIDE IN PLASTIC CONTAINER, VANCOMYCIN HYDROCHLORIDE * BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE, ACYCLOVIR SODIUM ACYCLOVIR SODIUM, ACYCLOVIR SODIUM AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM BUMETANIDE, BUMETANIDE CEFOXITIN, CEFOXITIN SODIUM CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DIGOXIN, DIGOXIN DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE
DOPRAM, DOXAPRAM HYDROCHLORIDE
DURAMORPH PF, MORPHINE SULFATE
B - 32
APPENDIX B
** B **
* BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE FLUMAZENIL, FLUMAZENIL FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HEPARIN SODIUM, HEPARIN SODIUM INFUMORPH, MORPHINE SULFATE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE, MILRINONE LACTATE MITOMYCIN, MITOMYCIN ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE ROBINUL, GLYCOPYRROLATE SUFENTANIL CITRATE, SUFENTANIL CITRATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE
VINORELBINE TARTRATE, VINORELBINE TARTRATE
* BAXTER HEALTHCARE INTERNATI0NAL SPECIALTY THERAPIES DIV FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER, FAMOTIDINE
PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, AMINO ACIDS
BAXTER HLTHCARE CORP * BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE * BAXTER HEALTHCARE CORP ANESTHESIA CRITICAL CARE ATIVAN, LORAZEPAM BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE BREVIBLOC IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE BREVIBLOC, ESMOLOL HYDROCHLORIDE ETHRANE, ENFLURANE FORANE, ISOFLURANE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE OXYTOCIN, OXYTOCIN PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE PROTOPAM CHLORIDE, PRALIDOXIME CHLORIDE REGLAN, METOCLOPRAMIDE HYDROCHLORIDE
ROBAXIN, METHOCARBAMOL
SUPRANE, DESFLURANE
BAYER * BAYER HEALTHCARE LLC ALEVE, NAPROXEN SODIUM (OTC)
ALEVE-D SINUS & COLD, NAPROXEN SODIUM (OTC)
FEMSTAT 3, BUTOCONAZOLE NITRATE (OTC)
BAYER HLTHCARE * BAYER HEALTHCARE CONSUMER CARE RID MOUSSE, PIPERONYL BUTOXIDE (OTC) * BAYER HEALTHCARE PHARMACEUTICALS INC ADALAT CC, NIFEDIPINE ANGELIQ, DROSPIRENONE AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER, MOXIFLOXACIN HYDROCHLORIDE AVELOX, MOXIFLOXACIN HYDROCHLORIDE BETAPACE AF, SOTALOL HYDROCHLORIDE BETAPACE, SOTALOL HYDROCHLORIDE BEYAZ, DROSPIRENONE CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPRO XR, CIPROFLOXACIN
CIPRO, CIPROFLOXACIN
CIPRO, CIPROFLOXACIN HYDROCHLORIDE
B - 33
APPENDIX B
* BAYER HEALTHCARE PHARMACEUTICALS INC CLIMARA PRO, ESTRADIOL CLIMARA, ESTRADIOL DTIC-DOME, DACARBAZINE EOVIST, GADOXETATE DISODIUM GADAVIST, GADOBUTROL LEVITRA, VARDENAFIL HYDROCHLORIDE MAGNEVIST, GADOPENTETATE DIMEGLUMINE MENOSTAR, ESTRADIOL MIRENA, LEVONORGESTREL MYCELEX, CLOTRIMAZOLE NATAZIA, ESTRADIOL VALERATE NEXAVAR, SORAFENIB TOSYLATE PRECOSE, ACARBOSE REFLUDAN, LEPIRUDIN RECOMBINANT SAFYRAL, DROSPIRENONE STAXYN, VARDENAFIL HYDROCHLORIDE TRASYLOL, APROTININ ULTRAVIST (PHARMACY BULK), IOPROMIDE ULTRAVIST 150, IOPROMIDE ULTRAVIST 240, IOPROMIDE ULTRAVIST 300 IN PLASTIC CONTAINER, IOPROMIDE ULTRAVIST 300, IOPROMIDE ULTRAVIST 370, IOPROMIDE YASMIN, DROSPIRENONE
YAZ, DROSPIRENONE
BAYER PHARMA AG * BAYER PHARMA AG BILTRICIDE, PRAZIQUANTEL BAYER PHARMS * BAYER PHARMACEUTICALS CORP MYCELEX-7 COMBINATION PACK, CLOTRIMAZOLE MYCELEX-7, CLOTRIMAZOLE (OTC)
(OTC)
BECTON DICKINSON * BECTON DICKINSON AND CO CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE E-Z SCRUB 201, POVIDONE-IODINE (OTC)
E-Z SCRUB 241, POVIDONE-IODINE (OTC)
(OTC)
BEDFORD * BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM ACETYLCYSTEINE, ACETYLCYSTEINE ACYCLOVIR SODIUM, ACYCLOVIR SODIUM ADENOSINE, ADENOSINE ALPROSTADIL, ALPROSTADIL AMIKACIN SULFATE, AMIKACIN SULFATE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMRINONE LACTATE, INAMRINONE LACTATE ATRACURIUM BESYLATE PRESERVATIVE FREE, ATRACURIUM BESYLATE ATRACURIUM BESYLATE, ATRACURIUM BESYLATE AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM AZTREONAM, AZTREONAM BLEOMYCIN SULFATE, BLEOMYCIN SULFATE BUMETANIDE, BUMETANIDE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CARBOPLATIN, CARBOPLATIN CEFTRIAXONE, CEFTRIAXONE SODIUM CERUBIDINE, DAUNORUBICIN HYDROCHLORIDE CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE
CISPLATIN, CISPLATIN
B - 34
APPENDIX B
* BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC CLADRIBINE, CLADRIBINE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CYCLOSPORINE, CYCLOSPORINE CYTARABINE, CYTARABINE DACARBAZINE, DACARBAZINE DACTINOMYCIN, DACTINOMYCIN DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DEXRAZOXANE HYDROCHLORIDE, DEXRAZOXANE HYDROCHLORIDE DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE-FREE), DICYCLOMINE HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE DOXAPRAM HYDROCHLORIDE, DOXAPRAM HYDROCHLORIDE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE DOXYCYCLINE, DOXYCYCLINE HYCLATE ENALAPRILAT, ENALAPRILAT EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE ETOMIDATE, ETOMIDATE ETOPOSIDE, ETOPOSIDE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FLOXURIDINE, FLOXURIDINE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL LACTATE INDOMETHACIN SODIUM, INDOMETHACIN SODIUM KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM LEVOCARNITINE, LEVOCARNITINE LORAZEPAM, LORAZEPAM MESNA, MESNA METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM METHOTREXATE SODIUM, METHOTREXATE SODIUM MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE, MILRINONE LACTATE MITOMYCIN, MITOMYCIN MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PHENTOLAMINE MESYLATE, PHENTOLAMINE MESYLATE POLYMYXIN B SULFATE, POLYMYXIN B SULFATE PROCHLORPERAZINE EDISYLATE, PROCHLORPERAZINE EDISYLATE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RIFAMPIN, RIFAMPIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBUTALINE SULFATE, TERBUTALINE SULFATE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE THIOTEPA, THIOTEPA VALPROATE SODIUM, VALPROATE SODIUM
VECURONIUM BROMIDE, VECURONIUM BROMIDE
VINBLASTINE SULFATE, VINBLASTINE SULFATE
B - 35
APPENDIX B
* BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC VINORELBINE TARTRATE, VINORELBINE TARTRATE BEDFORD LABS * BEDFORD LABORATORIES ALLOPURINOL SODIUM, ALLOPURINOL SODIUM AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE CARBOPLATIN, CARBOPLATIN DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUMAZENIL, FLUMAZENIL GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IFOSFAMIDE, IFOSFAMIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LORAZEPAM PRESERVATIVE FREE, LORAZEPAM MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE METOPROLOL TARTRATE, METOPROLOL TARTRATE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ORPHENADRINE CITRATE, ORPHENADRINE CITRATE PENTOSTATIN, PENTOSTATIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE
TORSEMIDE, TORSEMIDE
BEIJING DOUBLE CRANE * BEIJING DOUBLE CRANE PHARMACEUTICAL CO LTD FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE
MELOXICAM, MELOXICAM
BELCHER PHARMS * BELCHER PHARMACEUTICALS LLC CEPHALEXIN, CEPHALEXIN BEN VENUE * BEN VENUE LABORATORIES INC FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
BEXIMCO USA * BEXIMCO PHARMACEUTICALS USA INC CARVEDILOL, CARVEDILOL BIO NUCLEONICS * BIO NUCLEONICS INC STRONTIUM CHLORIDE SR-89, BIOALLIANCE PHARMA * BIOALLIANCE PHARMA ORAVIG, MICONAZOLE BIOKEY * BIOKEY INC BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE
LEVETIRACETAM, LEVETIRACETAM
BIOMARIN PHARM * BIOMARIN PHARMACEUTICAL INC KUVAN, SAPROPTERIN DIHYDROCHLORIDE BIONICHE PHARMA * BIONICHE PHARMA USA LLC AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM
COSYNTROPIN, COSYNTROPIN
B - 36
APPENDIX B
* BIONICHE PHARMA USA LLC DIMETHYL SULFOXIDE, DIMETHYL SULFOXIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE ENLON, EDROPHONIUM CHLORIDE ESMOLOL HYDROCHLORIDE, ESMOLOL HYDROCHLORIDE FLUOROURACIL, FLUOROURACIL IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE MEFOXIN IN PLASTIC CONTAINER, CEFOXITIN SODIUM METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM RIMSO-50, DIMETHYL SULFOXIDE
SOTRADECOL, SODIUM TETRADECYL SULFATE
BIONICHE PHARMA USA * BIONICHE PHARMA USA LLC CARBOPLATIN, CARBOPLATIN DURACLON, CLONIDINE HYDROCHLORIDE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FOMEPIZOLE, FOMEPIZOLE IBUTILIDE FUMARATE, IBUTILIDE FUMARATE MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE
BIOVAIL TECHNOLOGIES * BIOVAIL TECHNOLOGIES LTD MEPHYTON, PHYTONADIONE BLAIREX * BLAIREX LABORATORIES INC BRONCHO SALINE, SODIUM CHLORIDE BLU CARIBE * BLU CARIBE INC GEMFIBROZIL, SIMVASTATIN,
(OTC)
GEMFIBROZIL
SIMVASTATIN
BOCA PHARMA * BOCA PHARMACAL INC ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN ALPRAZOLAM, ALPRAZOLAM CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE GLYCOPYRROLATE, GLYCOPYRROLATE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN
LEVETIRACETAM, LEVETIRACETAM
METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE
BOEHRINGER INGELHEIM * BOEHRINGER INGELHEIM CATAPRES, CLONIDINE HYDROCHLORIDE CATAPRES-TTS-1, CLONIDINE CATAPRES-TTS-2, CLONIDINE CATAPRES-TTS-3, CLONIDINE MICARDIS HCT, HYDROCHLOROTHIAZIDE MICARDIS, TELMISARTAN MIRAPEX, PRAMIPEXOLE DIHYDROCHLORIDE
ZANTAC 150, RANITIDINE HYDROCHLORIDE (OTC)
ZANTAC 75, RANITIDINE HYDROCHLORIDE (OTC)
* BOEHRINGER INGELHEIM PHARMACEUTICALS INC AGGRENOX, ASPIRIN APTIVUS, TIPRANAVIR ATROVENT HFA, IPRATROPIUM BROMIDE ATROVENT, IPRATROPIUM BROMIDE
COMBIVENT RESPIMAT, ALBUTEROL SULFATE
COMBIVENT, ALBUTEROL SULFATE
B - 37
APPENDIX B
* BOEHRINGER INGELHEIM PHARMACEUTICALS INC FLOMAX, TAMSULOSIN HYDROCHLORIDE MIRAPEX ER, PRAMIPEXOLE DIHYDROCHLORIDE MOBIC, MELOXICAM PERSANTINE, DIPYRIDAMOLE PRADAXA, DABIGATRAN ETEXILATE MESYLATE SPIRIVA, TIOTROPIUM BROMIDE MONOHYDRATE TRADJENTA, LINAGLIPTIN TWYNSTA, AMLODIPINE BESYLATE VIRAMUNE XR, NEVIRAPINE
VIRAMUNE, NEVIRAPINE
BRACCO * BRACCO DIAGNOSTICS INC CARDIOGEN-82, RUBIDIUM CHLORIDE RB-82 CHOLETEC, TECHNETIUM TC-99M MEBROFENIN KIT CHOLOGRAFIN MEGLUMINE, IODIPAMIDE MEGLUMINE CHROMITOPE SODIUM, SODIUM CHROMATE CR-51 CYSTOGRAFIN DILUTE, DIATRIZOATE MEGLUMINE CYSTOGRAFIN, DIATRIZOATE MEGLUMINE GASTROGRAFIN, DIATRIZOATE MEGLUMINE ISOVUE-200, IOPAMIDOL ISOVUE-250, IOPAMIDOL ISOVUE-300, IOPAMIDOL ISOVUE-370, IOPAMIDOL ISOVUE-M 200, IOPAMIDOL ISOVUE-M 300, IOPAMIDOL KINEVAC, SINCALIDE MDP-BRACCO, TECHNETIUM TC-99M MEDRONATE KIT MULTIHANCE MULTIPACK, GADOBENATE DIMEGLUMINE MULTIHANCE, GADOBENATE DIMEGLUMINE PROHANCE MULTIPACK, GADOTERIDOL PROHANCE, GADOTERIDOL
RENOGRAFIN-76, DIATRIZOATE MEGLUMINE
SINOGRAFIN, DIATRIZOATE MEGLUMINE
BRAINTREE * BRAINTREE LABORATORIES INC AXID, NIZATIDINE GOLYTELY, POLYETHYLENE GLYCOL 3350 HALFLYTELY, BISACODYL
NULYTELY, POLYETHYLENE GLYCOL 3350
NULYTELY-FLAVORED, POLYETHYLENE GLYCOL 3350
BRAINTREE LABS * BRAINTREE LABORATORIES INC SUPREP BOWEL PREP KIT, MAGNESIUM SULFATE ANHYDROUS BRECKENRIDGE PHARM * BRECKENRIDGE PHARMACEUTICAL INC CILOSTAZOL, CILOSTAZOL ESTRADIOL AND NORETHINDRONE ACETATE, ESTRADIOL LEVETIRACETAM, LEVETIRACETAM MELOXICAM, MELOXICAM METHSCOPOLAMINE BROMIDE, METHSCOPOLAMINE BROMIDE OXCARBAZEPINE, OXCARBAZEPINE POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350
PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE
TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE
BRIGHTSTONE * BRIGHTSTONE PHARMA INC ISOSORBIDE MONONITRATE,
ISOSORBIDE MONONITRATE
B - 38
APPENDIX B
BRISTOL MYERS SQUIBB * BRISTOL MYERS SQUIBB AZACTAM, AZTREONAM BARACLUDE, ENTECAVIR GLUCOVANCE, GLYBURIDE KOMBIGLYZE XR, METFORMIN HYDROCHLORIDE LYSODREN, MITOTANE
MEGACE, MEGESTROL ACETATE
PRAVACHOL, PRAVASTATIN SODIUM
* BRISTOL MYERS SQUIBB CO AZACTAM IN PLASTIC CONTAINER, AZTREONAM CEENU, LOMUSTINE DROXIA, HYDROXYUREA GLUCOPHAGE XR, METFORMIN HYDROCHLORIDE HYDREA, HYDROXYUREA IXEMPRA KIT, IXABEPILONE ONGLYZA, SAXAGLIPTIN HYDROCHLORIDE REYATAZ, ATAZANAVIR SULFATE SPRYCEL, DASATINIB
SUSTIVA, EFAVIRENZ
VIDEX EC, DIDANOSINE
* BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE ESTRACE, ESTRADIOL ETOPOPHOS PRESERVATIVE FREE, ETOPOSIDE PHOSPHATE GLUCOPHAGE, METFORMIN HYDROCHLORIDE MONOPRIL, FOSINOPRIL SODIUM VIDEX, DIDANOSINE
VUMON, TENIPOSIDE
ZERIT, STAVUDINE
* BRISTOL MYERS SQUIBB PHARMA CO
COUMADIN, WARFARIN SODIUM
SUSTIVA, EFAVIRENZ
BRYAN * BRYAN CORP
SCLEROSOL, TALC
TALC, TALC
CADENCE PHARMS * CADENCE PHARMACEUTICALS INC OFIRMEV, ACETAMINOPHEN CADISTA PHARMS * CADISTA PHARMACEUTICALS INC ALENDRONATE SODIUM, ALENDRONATE SODIUM CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC)
LAMOTRIGINE, LAMOTRIGINE
OXCARBAZEPINE, OXCARBAZEPINE
CANYON * CANYON PHARMACEUTICALS INC IPRIVASK, DESIRUDIN RECOMBINANT CARACO * CARACO PHARMACEUTICAL LABORATORIES LTD ALLOPURINOL, ALLOPURINOL AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ATENOLOL, ATENOLOL BACLOFEN, BACLOFEN CARVEDILOL, CARVEDILOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC)
CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE
CLONAZEPAM, CLONAZEPAM
B - 39
APPENDIX B
** C **
* CARACO PHARMACEUTICAL LABORATORIES LTD CLOZAPINE, CLOZAPINE DIGOXIN, DIGOXIN ELIXOPHYLLIN, THEOPHYLLINE FLUMADINE, RIMANTADINE HYDROCHLORIDE FLURBIPROFEN, FLURBIPROFEN FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GLIPIZIDE, GLIPIZIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE MELOXICAM, MELOXICAM MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHIMAZOLE, METHIMAZOLE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIRTAZAPINE, MIRTAZAPINE OXAPROZIN, OXAPROZIN PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE SYNALGOS-DC, ASPIRIN THEOCHRON, THEOPHYLLINE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
CARDINAL HEALTH 414 * CARDINAL HEALTH 414 LLC TECHNETIUM TC 99M SESTAMIBI,
CARDINAL HLTH * CARDINAL HEALTH CHLORAPREP ONE-STEP SEPP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP SINGLE SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC)
CHLORAPREP TRIPLE SWABSTICK, CHLORHEXIDINE GLUCONATE (OTC)
CAREFUSION * CAREFUSION 213 LLC CHLORAPREP ONE-STEP FREPP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP ONE-STEP, CHLORHEXIDINE GLUCONATE (OTC) CHLORAPREP WITH TINT, CHLORHEXIDINE GLUCONATE (OTC)
PHARMASEAL SCRUB CARE, CHLORHEXIDINE GLUCONATE (OTC)
CARLSBAD * CARLSBAD TECHNOLOGY INC ACYCLOVIR, ACYCLOVIR CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM FAMOTIDINE, FAMOTIDINE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE GLIMEPIRIDE, GLIMEPIRIDE LOVASTATIN, LOVASTATIN
MELOXICAM, MELOXICAM
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
CAROLINA MEDCL * CAROLINA MEDICAL PRODUCTS CO AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE HYDROCORTISONE IN ABSORBASE, HYDROCORTISONE ISONIAZID, ISONIAZID SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE SPS, SODIUM POLYSTYRENE SULFONATE
TRIAMCINOLONE ACETONIDE IN ABSORBASE, TRIAMCINOLONE ACETONIDE
B - 40
APPENDIX B
CEFTAROLINE FOSAMIL
(OTC)
CHEMISCH FBRK KRSSLR * CHEMISCHE FABRIK KREUSSLER & CO. GMBH ASCLERA, POLIDOCANOL CHIRHOCLIN * CHIRHOCLIN INC CHIRHOSTIM, SECRETIN SYNTHETIC HUMAN CIPHER PHARMS INC * CIPHER PHARMACEUTICALS INC
CONZIP, TRAMADOL HYDROCHLORIDE
LIPOFEN, FENOFIBRATE
CIPLA * CIPLA LTD RAMIPRIL, RAMIPRIL RISPERIDONE, RISPERIDONE
TRANDOLAPRIL, TRANDOLAPRIL
ZIDOVUDINE, ZIDOVUDINE
CIPLA LTD * CIPLA LTD DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE STAVUDINE, STAVUDINE TOPIRAMATE, TOPIRAMATE
ZALEPLON, ZALEPLON
ZIDOVUDINE, ZIDOVUDINE
B - 41
APPENDIX B
CITIUS PHARMS * CITIUS PHARMACEUTICALS LLC SUPRENZA, PHENTERMINE HYDROCHLORIDE CITRUSPHRMA * CITRUSPHRMA LLC SODIUM POLYSTYRENE SULFONATE,
CLARIS LIFESCIENCES * CLARIS LIFESCIENCES LTD AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPROFLOXACIN, CIPROFLOXACIN DIPYRIDAMOLE, DIPYRIDAMOLE FAMOTIDINE PRESERVATIVE FREE (PHARMACY BULK), FAMOTIDINE FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUMAZENIL, FLUMAZENIL FLUPHENAZINE DECANOATE, FLUPHENAZINE DECANOATE FULCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL LACTATE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE MILRINONE LACTATE IN DEXTROSE 5%, MILRINONE LACTATE MILRINONE LACTATE, MILRINONE LACTATE ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER, ONDANSETRON HYDROCHLORIDE CLINIGEN HLTHCARE * CLINIGEN HEALTHCARE LTD FOSCAVIR, FOSCARNET SODIUM CLINTEC NUTR * CLINTEC NUTRITION CO SUB CLINIQUE CLINISOL 15% SULFITE FREE IN PLASTIC CONTAINER, CLONMEL HLTHCARE * CLONMEL HEALTHCARE LTD MORPHINE SULFATE, MORPHINE SULFATE CNS THERAPS INC * CNS THERAPEUTICS INC GABLOFEN, BACLOFEN CNTY LINE PHARMS * COUNTY LINE PHARMACEUTICALS LLC UREX, METHENAMINE HIPPURATE COASTAL PHARMS * COASTAL PHARMACEUTICALS BROMFENAC SODIUM, BROMFENAC SODIUM
NYSTATIN, NYSTATIN
OXYCODONE AND ASPIRIN, ASPIRIN
* COASTAL PHARMACEUTICALS INC LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM METHAMPHETAMINE HYDROCHLORIDE, METHAMPHETAMINE HYDROCHLORIDE
OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
COBALT LABS INC * COBALT LABORATORIES INC LEVETIRACETAM, LEVETIRACETAM
AMINO ACIDS
B - 42
APPENDIX B
(OTC)
CETIRIZINE HYDROCHLORIDE
(OTC)
CONTRACT PHARMACAL * CONTRACT PHARMACAL CORP CIMETIDINE, CIMETIDINE (OTC) FOLIC ACID, FOLIC ACID IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN (OTC) IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) PREDNISONE, PREDNISONE
PROFEN, IBUPROFEN (OTC)
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC)
CONTROLLED THERAP * CONTROLLED THERAPEUTICS (SCOTLAND) LTD CERVIDIL, DINOPROSTONE COREPHARMA * COREPHARMA LLC ALBENZA, ALBENDAZOLE ALPRAZOLAM, ALPRAZOLAM BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CARISOPRODOL, CARISOPRODOL CILOSTAZOL, CILOSTAZOL CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE DARAPRIM, PYRIMETHAMINE DECLOMYCIN, DEMECLOCYCLINE HYDROCHLORIDE DEXEDRINE, DEXTROAMPHETAMINE SULFATE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, ASPARTATE
DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE
DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
E-GLADES, ERYTHROMYCIN
GLIMEPIRIDE, GLIMEPIRIDE
GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE
GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE
GLYBURIDE, GLYBURIDE
GLYCOPYRROLATE, GLYCOPYRROLATE
GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE
HYDROCORTISONE, HYDROCORTISONE
ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE
LEVOCARNITINE, LEVOCARNITINE
MELOXICAM, MELOXICAM
METHENAMINE HIPPURATE, METHENAMINE HIPPURATE
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE
POTASSIUM CITRATE, POTASSIUM CITRATE
AMPHETAMINE
B - 43
APPENDIX B
* COREPHARMA LLC PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE RIMANTADINE HYDROCHLORIDE, RIMANTADINE HYDROCHLORIDE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TRANDOLAPRIL, TRANDOLAPRIL URSODIOL, URSODIOL
ZONISAMIDE, ZONISAMIDE
CORIA * CORIA LABORATORIES LTD NUTRACORT, HYDROCORTISONE CORNERSTONE THERAP * CORNERSTONE THERAPEUTICS INC CUROSURF, PORACTANT ALFA FACTIVE, GEMIFLOXACIN MESYLATE SPECTRACEF, CEFDITOREN PIVOXIL ZYFLO CR, ZILEUTON
ZYFLO, ZILEUTON
COVIDIEN * COVIDIEN LYMPHAZURIN, ISOSULFAN BLUE
THERMAZENE, SILVER SULFADIAZINE
COVIS PHARMA * COVIS PHARMA SARL LANOXIN PEDIATRIC, LANOXIN, DIGOXIN
DIGOXIN
DESMOPRESSIN ACETATE
B - 44
APPENDIX B
DAIICHI * DAIICHI PHARMACEUTICAL CORP FLOXIN OTIC, OFLOXACIN
DAIICHI SANKYO * DAIICHI SANKYO INC AZOR, AMLODIPINE BESYLATE BENICAR HCT, HYDROCHLOROTHIAZIDE BENICAR, OLMESARTAN MEDOXOMIL
TRIBENZOR, AMLODIPINE BESYLATE
WELCHOL, COLESEVELAM HYDROCHLORIDE
DAIICHI SANKYO CO * DAIICHI SANKYO CO LTD EVOXAC, CEVIMELINE HYDROCHLORIDE DANCO LABS LLC * DANCO LABORATORIES LLC MIFEPREX, MIFEPRISTONE DAVA INTL INC * DAVA INTERNATIONAL INC ALPRAZOLAM, ALPRAZOLAM DAVA PHARMS INC * DAVA PHARMACEUTICALS INC ACYCLOVIR, ACYCLOVIR AMOXICILLIN, AMOXICILLIN AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE ATENOLOL, ATENOLOL CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CIMETIDINE, CIMETIDINE CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE DIAZEPAM, DIAZEPAM DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE FUROSEMIDE, FUROSEMIDE GEMFIBROZIL, GEMFIBROZIL GLYBURIDE (MICRONIZED), GLYBURIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE METHOTREXATE SODIUM, METHOTREXATE SODIUM NAPROXEN, NAPROXEN PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM PROPYLTHIOURACIL, PROPYLTHIOURACIL PYRAZINAMIDE, PYRAZINAMIDE
SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE
VOSPIRE ER, ALBUTEROL SULFATE
DAVIS AND GECK * DAVIS AND GECK DIV AMERICAN CYANAMID CO
PRE-OP II, HEXACHLOROPHENE
PRE-OP, HEXACHLOROPHENE
DENCO ASSET * DENCO ASSET LLC DENAVIR, PENCICLOVIR SODIUM DENTSPLY PHARM * DENTSPLY PHARMACEUTICAL CITANEST PLAIN DENTAL, PRILOCAINE HYDROCHLORIDE ORAQIX, LIDOCAINE POLOCAINE, MEPIVACAINE HYDROCHLORIDE
XYLOCAINE DENTAL WITH EPINEPHRINE, EPINEPHRINE
XYLOCAINE DENTAL, LIDOCAINE HYDROCHLORIDE
* DENTSPLY PHARMACEUTICAL INC CITANEST FORTE DENTAL, EPINEPHRINE BITARTRATE
B - 45
APPENDIX B
DEPOMED INC * DEPOMED INC GRALISE, GABAPENTIN
DEPROCO * DEPROCO INC LIGNOSPAN FORTE, EPINEPHRINE BITARTRATE LIGNOSPAN STANDARD, EPINEPHRINE BITARTRATE SCANDONEST L, LEVONORDEFRIN
SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE
SEPTOCAINE, ARTICAINE HYDROCHLORIDE
DEXCEL LTD * DEXCEL LTD
DICLOFENAC SODIUM, DICLOFENAC SODIUM
ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE
DEXCEL PHARMA * DEXCEL PHARMA TECHNOLOGIES LTD
OMEPRAZOLE, OMEPRAZOLE (OTC)
PERIOCHIP, CHLORHEXIDINE GLUCONATE
DEY * DEY LP ACCUNEB, ALBUTEROL SULFATE ALBUTEROL SULFATE, ALBUTEROL SULFATE CROMOLYN SODIUM, CROMOLYN SODIUM DUONEB, ALBUTEROL SULFATE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE
LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE
METAPROTERENOL SULFATE, METAPROTERENOL SULFATE
DEY PHARMA * DEY PHARMA LP PERFOROMIST,
FORMOTEROL FUMARATE
BENZOYL PEROXIDE
AMLODIPINE BESYLATE
B - 46
APPENDIX B
** D **
* DR REDDYS LABORATORIES INC AMOXIL, AMOXICILLIN AUGMENTIN '125', AMOXICILLIN AUGMENTIN '200', AMOXICILLIN AUGMENTIN '250', AMOXICILLIN AUGMENTIN '400', AMOXICILLIN AUGMENTIN '500', AMOXICILLIN AUGMENTIN '875', AMOXICILLIN AUGMENTIN ES-600, AMOXICILLIN AUGMENTIN XR, AMOXICILLIN FINASTERIDE, FINASTERIDE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) LAROTID, AMOXICILLIN LEVOFLOXACIN, LEVOFLOXACIN MELOXICAM, MELOXICAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE SIMVASTATIN, SIMVASTATIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE
TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE
DR REDDYS LABS LTD * DR REDDYS LABORATORIES LIMITED LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE * DR REDDYS LABORATORIES LTD ALENDRONATE SODIUM, ALENDRONATE SODIUM AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ANASTROZOLE, ANASTROZOLE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE CARVEDILOL, CARVEDILOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR, DESLORATADINE DESLORATADINE, DESLORATADINE DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE (OTC)
FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC)
FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE
FINASTERIDE, FINASTERIDE
B - 47
APPENDIX B
* DR REDDYS LABORATORIES LTD FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FONDAPARINUX SODIUM, FONDAPARINUX SODIUM GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GLIMEPIRIDE, GLIMEPIRIDE GLYCOPYRROLATE, GLYCOPYRROLATE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN (OTC) IBUPROFEN, IBUPROFEN (OTC) IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE LANSOPRAZOLE, LANSOPRAZOLE LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NABUMETONE, NABUMETONE NAPROXEN SODIUM, NAPROXEN SODIUM NATEGLINIDE, NATEGLINIDE NIZATIDINE, NIZATIDINE OFLOXACIN, OFLOXACIN OLANZAPINE, OLANZAPINE OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM (OTC) OMEPRAZOLE, OMEPRAZOLE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXAPROZIN, OXAPROZIN PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PRIMIDONE, PRIMIDONE RAMIPRIL, RAMIPRIL RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE TACROLIMUS, TACROLIMUS TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE TRANDOLAPRIL, TRANDOLAPRIL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE ZAFIRLUKAST, ZAFIRLUKAST
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
ZONISAMIDE, ZONISAMIDE
(OTC)
DRAXIMAGE * DRAXIMAGE INC DRAXIMAGE MDP-25, TECHNETIUM TC-99M MEDRONATE DTPA, TECHNETIUM TC-99M PENTETATE KIT HICON, SODIUM IODIDE I-131 SODIUM IODIDE I-131, SODIUM IODIDE I-131 TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT DURAMED * DURAMED PHARMACEUTICALS INC NORDETTE-28, ETHINYL ESTRADIOL PLAN B ONE-STEP, LEVONORGESTREL
PLAN B ONE-STEP, LEVONORGESTREL (OTC)
REVIA, NALTREXONE HYDROCHLORIDE
DURAMED PHARMS BARR * DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC AVIANE-28, ETHINYL ESTRADIOL CRYSELLE, ETHINYL ESTRADIOL
DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL
DIAMOX, ACETAZOLAMIDE
B - 48
APPENDIX B
** D **
* DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC DIAMOX, ACETAZOLAMIDE SODIUM ENPRESSE-28, ETHINYL ESTRADIOL METHYLPREDNISOLONE, METHYLPREDNISOLONE OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE VELIVET, DESOGESTREL ZEBETA, BISOPROLOL FUMARATE
ZIAC, BISOPROLOL FUMARATE
DURAMED RES * DURAMED RESEARCH INC AYGESTIN, NORETHINDRONE ACETATE PARAGARD T 380A, COPPER
SEASONALE, ETHINYL ESTRADIOL
DUSA * DUSA PHARMACEUTICALS INC LEVULAN, AMINOLEVULINIC ACID HYDROCHLORIDE EAGLE PHARMS * EAGLE PHARMACEUTICALS INC ARGATROBAN IN SODIUM CHLORIDE,
ARGATROBAN
EPINEPHRINE
EBEWE PHARMA * EBEWE PHARMA GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE * EBEWE PHARMA GES MBH NFG KG CARBOPLATIN, CARBOPLATIN EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE FLUOROURACIL, FLUOROURACIL IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM OXALIPLATIN, OXALIPLATIN
PACLITAXEL, PACLITAXEL
VINORELBINE TARTRATE, VINORELBINE TARTRATE
ECOLAB * ECOLAB INC CHG SCRUB, CIDA-STAT,
(OTC)
(OTC)
ECR * ECR PHARMACEUTICALS DEXAMETHASONE, DEXAMETHASONE EDGEMONT PHARMS LLC * EDGEMONT PHARMACEUTICALS LLC FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE EGIS * EGIS PHARMACEUTICALS BUSPIRONE HYDROCHLORIDE, EI INC * EI INC THEROXIDIL,
BUSPIRONE HYDROCHLORIDE
MINOXIDIL
(OTC)
EISAI INC * EISAI INC ACIPHEX, RABEPRAZOLE SODIUM ARICEPT ODT, DONEPEZIL HYDROCHLORIDE ARICEPT, DONEPEZIL HYDROCHLORIDE BANZEL, RUFINAMIDE DACOGEN, DECITABINE FRAGMIN, DALTEPARIN SODIUM
GLIADEL, CARMUSTINE
B - 49
APPENDIX B
** E **
* EISAI INC HALAVEN, ERIBULIN MESYLATE HEXALEN, ALTRETAMINE LUSEDRA, FOSPROPOFOL DISODIUM PANRETIN, ALITRETINOIN SALAGEN, PILOCARPINE HYDROCHLORIDE TARGRETIN, BEXAROTENE
ZONEGRAN, ZONISAMIDE
EKR THERAP * EKR THERAPEUTICS INC CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER, NICARDIPINE HYDROCHLORIDE CARDENE SR, NICARDIPINE HYDROCHLORIDE CARDENE, NICARDIPINE HYDROCHLORIDE
DEPODUR, MORPHINE SULFATE
ELAN DRUG * ELAN DRUG DELIVERY INC VERELAN PM, VERAPAMIL HYDROCHLORIDE ELAN PHARM * ELAN PHARMACEUTICAL RESEARCH CORP ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE
KETOPROFEN, KETOPROFEN
ELI LILLY AND CO * ELI LILLY AND CO AXIRON, TESTOSTERONE
EFFIENT, PRASUGREL HYDROCHLORIDE
ELI LILLY CO * ELI LILLY CO ADCIRCA, TADALAFIL
ZYPREXA RELPREVV, OLANZAPINE PAMOATE
ELITE LABS * ELITE LABORATORIES INC HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE
PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE
ELKINS SINN * ELKINS SINN DIV AH ROBINS CO INC MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE EMCURE PHARMS * EMCURE PHARMACEUTICALS LTD ONDANSETRON HYDROCHLORIDE,
ONDANSETRON HYDROCHLORIDE
EMCURE PHARMS USA * EMCURE PHARMACEUTICALS USA INC FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL METHIMAZOLE, METHIMAZOLE
PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
EMCURE USA * EMCURE PHARMACEUTICALS USA INC BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE EMD SERONO * EMD SERONO INC CETROTIDE, CETRORELIX GONAL-F RFF PEN, FOLLITROPIN ALFA/BETA GONAL-F RFF, FOLLITROPIN ALFA/BETA GONAL-F, FOLLITROPIN ALFA/BETA LUVERIS, LUTROPIN ALFA OVIDREL, CHORIOGONADOTROPIN ALFA
SAIZEN, SOMATROPIN RECOMBINANT
B - 50
APPENDIX B
AMLODIPINE BESYLATE
METHYLERGONOVINE MALEATE
ETHYPHARM * ETHYPHARM BUPRENORPHINE HYDROCHLORIDE, EURAND * EURAND AMERICA INC POTASSIUM CHLORIDE,
BUPRENORPHINE HYDROCHLORIDE
POTASSIUM CHLORIDE
EUSA PHARMA USA * EUSA PHARMA (USA) INC QUADRAMET, SAMARIUM SM-153 LEXIDRONAM PENTASODIUM EXALENZ BIOSCIENCE * EXALENZ BIOSCIENCE LTD IDKIT:HP, UREA C-13 EXCELLIUM * EXCELLIUM PHARMACEUTICAL INC FOLIC ACID, FOLIC ACID
FUROSEMIDE, FUROSEMIDE
B - 51
APPENDIX B
*
EXELA PHARMA SCIENCE * EXELA PHARMA SCIENCES NICARDIPINE HYDROCHLORIDE, EYETECH INC * EYETECH INC MACUGEN, PEGAPTANIB SODIUM FACTA FARMA * FACTA FARMACEUTICI SPA CEPHALEXIN, CEPHALEXIN
NICARDIPINE HYDROCHLORIDE
FALCON PHARMS * FALCON PHARMACEUTICALS INC TIMOLOL MALEATE, TIMOLOL MALEATE * FALCON PHARMACEUTICALS LTD DIPIVEFRIN HYDROCHLORIDE, DIPIVEFRIN HYDROCHLORIDE GENTAMICIN SULFATE, GENTAMICIN SULFATE LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE MAXITROL, DEXAMETHASONE METIPRANOLOL, METIPRANOLOL HYDROCHLORIDE TIMOLOL MALEATE, TIMOLOL MALEATE
TOBREX, TOBRAMYCIN
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE
FDC LTD * FDC LTD CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE
OFLOXACIN, OFLOXACIN
TIMOLOL MALEATE, TIMOLOL MALEATE
FEINSTEIN * FEINSTEIN INSTITUTE MEDICAL RESEARCH
AMMONIA N 13, AMMONIA, N-13
FLUDEOXYGLUCOSE F18, FLUDEOXYGLUCOSE F-18
FERA PHARMS * FERA PHARMACEUTICALS LLC BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC BACITRACIN, BACITRACIN BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE, BACITRACIN ERYTHROMYCIN, ERYTHROMYCIN GENTAMICIN SULFATE, GENTAMICIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC, BACITRACIN ZINC NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, DEXAMETHASONE OFLOXACIN, OFLOXACIN
SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM
TOBRAMYCIN, TOBRAMYCIN
FERNDALE LABS * FERNDALE LABORATORIES INC HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE
MICORT-HC, HYDROCORTISONE ACETATE
PRAMOSONE, HYDROCORTISONE ACETATE
FERRING * FERRING PHARMACEUTICALS INC ACTHREL, CORTICORELIN OVINE TRIFLUTATE BRAVELLE, UROFOLLITROPIN CHORIONIC GONADOTROPIN, GONADOTROPIN, CHORIONIC DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE ENDOMETRIN, PROGESTERONE FIRMAGON, DEGARELIX ACETATE MENOPUR, LUTEINIZING HORMONE
MINIRIN, DESMOPRESSIN ACETATE
REPRONEX, LUTEINIZING HORMONE
B - 52
APPENDIX B
* FERRING PHARMACEUTICALS INC TEV-TROPIN, SOMATROPIN RECOMBINANT FERRING PHARMS AS * FERRING PHARMACEUTICALS AS LYSTEDA, TRANEXAMIC ACID FLEMING * FLEMING AND CO PHARMACEUTICALS THYROSHIELD, POTASSIUM IODIDE
(OTC)
FOREST LABS * FOREST LABORATORIES INC BYSTOLIC, NEBIVOLOL HYDROCHLORIDE CAMPRAL, ACAMPROSATE CALCIUM CELEXA, CITALOPRAM HYDROBROMIDE LEXAPRO, ESCITALOPRAM OXALATE NAMENDA XR, MEMANTINE HYDROCHLORIDE NAMENDA, MEMANTINE HYDROCHLORIDE TESSALON, BENZONATATE THYROLAR-0.25, LIOTHYRONINE SODIUM THYROLAR-0.5, LIOTHYRONINE SODIUM THYROLAR-1, LIOTHYRONINE SODIUM THYROLAR-2, LIOTHYRONINE SODIUM
THYROLAR-3, LIOTHYRONINE SODIUM
FOREST LABS INC * FOREST LABORATORIES INC VIIBRYD, VILAZODONE HYDROCHLORIDE FOREST RES INST INC * FOREST RESEARCH INSTITUTE INC DALIRESP, ROFLUMILAST FOUGERA * E FOUGERA DIV ALTANA INC BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE BETAMETHASONE VALERATE, BETAMETHASONE VALERATE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUOCINONIDE, FLUOCINONIDE GENTAMICIN SULFATE, GENTAMICIN SULFATE HYDROCORTISONE, HYDROCORTISONE LIDOCAINE, LIDOCAINE NITROGLYCERIN, NITROGLYCERIN NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN
NYSTATIN, NYSTATIN
FOUGERA PHARMS * FOUGERA PHARMACEUTICALS INC ACLOVATE, ALCLOMETASONE DIPROPIONATE CUTIVATE, FLUTICASONE PROPIONATE ERYTHROMYCIN, ERYTHROMYCIN OXISTAT, OXICONAZOLE NITRATE PAMINE FORTE, METHSCOPOLAMINE BROMIDE PAMINE, METHSCOPOLAMINE BROMIDE PANDEL, HYDROCORTISONE PROBUTATE
SOLARAZE, DICLOFENAC SODIUM
TEMOVATE E, CLOBETASOL PROPIONATE
FRESENIUS * FRESENIUS KABI DEUTSCHLAND GMBH INTRALIPID 10%, SOYBEAN OIL INTRALIPID 20%, SOYBEAN OIL
INTRALIPID 30%, SOYBEAN OIL
* FRESENIUS USA INC INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER,
B - 53
APPENDIX B
*
FRESENIUS KABI ONCOL * FRESENIUS KABI ONCOLOGY PLC ANASTROZOLE, ANASTROZOLE BICALUTAMIDE, BICALUTAMIDE CARBOPLATIN, CARBOPLATIN EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LETROZOLE, LETROZOLE MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE OXALIPLATIN, OXALIPLATIN
PACLITAXEL, PACLITAXEL
TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE
FRESENIUS MEDCL * FRESENIUS MEDICAL CARE NORTH AMERICA CALCITRIOL, CALCITRIOL DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER, CALCIUM CHLORIDE
DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
DELFLEX-LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, CALCIUM CHLORIDE
PHOSLO GELCAPS, CALCIUM ACETATE
PHOSLYRA, CALCIUM ACETATE
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE
FSC * FSC LABORATORIES INC PRIMSOL, TRIMETHOPRIM HYDROCHLORIDE FUTURE PAK * FUTURE PAK LTD K+10, POTASSIUM CHLORIDE G AND W LABS * G AND W LABORATORIES INC ACEPHEN, ACETAMINOPHEN (OTC) CICLOPIROX, CICLOPIROX FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE INDOMETHACIN, INDOMETHACIN METRONIDAZOLE, METRONIDAZOLE MICONAZOLE 7 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) MIGERGOT, CAFFEINE MOMETASONE FUROATE, MOMETASONE FUROATE PROCHLORPERAZINE, PROCHLORPERAZINE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
PROMETHEGAN, PROMETHAZINE HYDROCHLORIDE
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
B - 54
APPENDIX B
DAUNORUBICIN CITRATE
ESTRADIOL ACETATE
GAMBRO RENAL PRODS * GAMBRO RENAL PRODUCTS PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 2/0 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE
PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER, CALCIUM CHLORIDE
PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER, CALCIUM CHLORIDE
GASTROENTERO * GASTROENTERO LOGIC LLC OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN,
AMOXICILLIN
GAVIS PHARMS * GAVIS PHARMACEUTICALS LLC ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE, ACETAMINOPHEN ORPHENADRINE CITRATE, ORPHENADRINE CITRATE PENTAZOCINE AND NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE
QUINARETIC, HYDROCHLOROTHIAZIDE
TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE
B - 55
APPENDIX B
GD SEARLE * GD SEARLE LLC
CELEBREX, CELECOXIB
DAYPRO, OXAPROZIN
GD SEARLE LLC * GD SEARLE LLC ALDACTAZIDE, HYDROCHLOROTHIAZIDE ALDACTONE, SPIRONOLACTONE ARTHROTEC, DICLOFENAC SODIUM CALAN, VERAPAMIL HYDROCHLORIDE COVERA-HS, VERAPAMIL HYDROCHLORIDE CYTOTEC, MISOPROSTOL FLAGYL ER, METRONIDAZOLE FLAGYL, METRONIDAZOLE INSPRA, EPLERENONE LOMOTIL, ATROPINE SULFATE NORPACE CR, DISOPYRAMIDE PHOSPHATE
NORPACE, DISOPYRAMIDE PHOSPHATE
SYNAREL, NAFARELIN ACETATE
GE HEALTHCARE * GE HEALTHCARE ADREVIEW, IOBENGUANE SULFATE I-123 CERETEC, TECHNETIUM TC-99M EXAMETAZIME KIT CYSVIEW KIT, HEXAMINOLEVULINATE HYDROCHLORIDE INDICLOR, INDIUM IN-111 CHLORIDE INDIUM IN-111 OXYQUINOLINE, INDIUM IN-111 OXYQUINOLINE METASTRON, STRONTIUM CHLORIDE SR-89 MPI DMSA KIDNEY REAGENT, TECHNETIUM TC-99M SUCCIMER KIT MPI INDIUM DTPA IN 111, INDIUM IN-111 PENTETATE DISODIUM MYOVIEW 30ML, TECHNETIUM TC-99M TETROFOSMIN KIT MYOVIEW, TECHNETIUM TC-99M TETROFOSMIN KIT OMNIPAQUE 140, IOHEXOL OMNIPAQUE 180, IOHEXOL OMNIPAQUE 240, IOHEXOL OMNIPAQUE 300, IOHEXOL OMNIPAQUE 350, IOHEXOL OMNISCAN, GADODIAMIDE OPTISON, ALBUMIN HUMAN SODIUM IODIDE I 123, SODIUM IODIDE I-123 THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201
VISIPAQUE 270, IODIXANOL
VISIPAQUE 320, IODIXANOL
GE HLTHCARE INC * GE HEALTHCARE INC DATSCAN, IOFLUPANE I-123 GEDEON RICHTER USA * GEDEON RICHTER USA INC FINASTERIDE, FINASTERIDE GENENTECH * GENENTECH INC NUTROPIN AQ PEN, SOMATROPIN RECOMBINANT
NUTROPIN AQ, SOMATROPIN RECOMBINANT
NUTROPIN, SOMATROPIN RECOMBINANT
GENERAMEDIX * GENERAMEDIX INC SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE, GENTA * GENTA INC GANITE,
GALLIUM NITRATE
B - 56
APPENDIX B
GENZYME * GENZYME CORP CEREDASE, ALGLUCERASE CEREZYME, IMIGLUCERASE CLOLAR, CLOFARABINE FLUDARA, FLUDARABINE PHOSPHATE MOZOBIL, PLERIXAFOR RENAGEL, SEVELAMER HYDROCHLORIDE
RENVELA, SEVELAMER CARBONATE
THYROGEN, THYROTROPIN ALFA
GENZYME CORP * GENZYME CORP HECTOROL, DOXERCALCIFEROL * GENZYME CORPORATION HECTOROL, DOXERCALCIFEROL GILEAD * GILEAD SCIENCES INC ATRIPLA, EFAVIRENZ CAYSTON, AZTREONAM EMTRIVA, EMTRICITABINE HEPSERA, ADEFOVIR DIPIVOXIL LETAIRIS, AMBRISENTAN RANEXA, RANOLAZINE TRUVADA, EMTRICITABINE
VIREAD, TENOFOVIR DISOPROXIL FUMARATE
VISTIDE, CIDOFOVIR
GILEAD SCIENCES INC * GILEAD SCIENCES INC COMPLERA, EMTRICITABINE GLAND PHARMA LTD * GLAND PHARMA LTD ADENOSINE, ADENOSINE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AZITHROMYCIN, AZITHROMYCIN HALOPERIDOL, HALOPERIDOL LACTATE
MILRINONE LACTATE, MILRINONE LACTATE
ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
GLAXO GRP LTD * GLAXO GROUP LTD HORIZANT, GABAPENTIN ENACARBIL * GLAXO GROUP LTD DBA GLAXOSMITHKLINE ALTABAX, RETAPAMULIN
FLOVENT HFA, FLUTICASONE PROPIONATE
SEREVENT, SALMETEROL XINAFOATE
GLAXOSMITHKLINE * GLAXOSMITHKLINE ABREVA, DOCOSANOL (OTC) ADVAIR DISKUS 100/50, FLUTICASONE PROPIONATE ADVAIR DISKUS 250/50, FLUTICASONE PROPIONATE ADVAIR DISKUS 500/50, FLUTICASONE PROPIONATE ADVAIR HFA, FLUTICASONE PROPIONATE ALKERAN, MELPHALAN ALKERAN, MELPHALAN HYDROCHLORIDE AMERGE, NARATRIPTAN HYDROCHLORIDE ARIXTRA, FONDAPARINUX SODIUM AVODART, DUTASTERIDE BACTROBAN, MUPIROCIN BACTROBAN, MUPIROCIN CALCIUM BECONASE AQ, BECLOMETHASONE DIPROPIONATE MONOHYDRATE
CEFTIN, CEFUROXIME AXETIL
EPIVIR-HBV, LAMIVUDINE
B - 57
APPENDIX B
* GLAXOSMITHKLINE FLONASE, FLUTICASONE PROPIONATE FLOVENT DISKUS 100, FLUTICASONE PROPIONATE FLOVENT DISKUS 250, FLUTICASONE PROPIONATE FLOVENT DISKUS 50, FLUTICASONE PROPIONATE FORTAZ IN PLASTIC CONTAINER, CEFTAZIDIME SODIUM FORTAZ, CEFTAZIDIME HYCAMTIN, TOPOTECAN HYDROCHLORIDE IMITREX STATDOSE, SUMATRIPTAN SUCCINATE IMITREX, SUMATRIPTAN IMITREX, SUMATRIPTAN SUCCINATE JALYN, DUTASTERIDE LAMICTAL CD, LAMOTRIGINE LAMICTAL, LAMOTRIGINE MALARONE PEDIATRIC, ATOVAQUONE MALARONE, ATOVAQUONE NICORETTE (MINT), NICOTINE POLACRILEX (OTC) NICORETTE, NICOTINE POLACRILEX (OTC) PARNATE, TRANYLCYPROMINE SULFATE PAXIL CR, PAROXETINE HYDROCHLORIDE PAXIL, PAROXETINE HYDROCHLORIDE PROMACTA, ELTROMBOPAG OLAMINE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE RELENZA, ZANAMIVIR REQUIP, ROPINIROLE HYDROCHLORIDE TAGAMET HB, CIMETIDINE (OTC) TAGAMET, CIMETIDINE THIOGUANINE, THIOGUANINE TIMENTIN IN PLASTIC CONTAINER, CLAVULANATE POTASSIUM TIMENTIN, CLAVULANATE POTASSIUM TREXIMET, NAPROXEN SODIUM VALTREX, VALACYCLOVIR HYDROCHLORIDE VENTOLIN HFA, ALBUTEROL SULFATE VERAMYST, FLUTICASONE FUROATE VOTRIENT, PAZOPANIB HYDROCHLORIDE WELLBUTRIN SR, BUPROPION HYDROCHLORIDE WELLBUTRIN, BUPROPION HYDROCHLORIDE ZANTAC 150, RANITIDINE HYDROCHLORIDE ZANTAC 25, RANITIDINE HYDROCHLORIDE ZANTAC 300, RANITIDINE HYDROCHLORIDE ZANTAC IN PLASTIC CONTAINER, RANITIDINE HYDROCHLORIDE ZANTAC, RANITIDINE HYDROCHLORIDE ZINACEF IN PLASTIC CONTAINER, CEFUROXIME SODIUM ZINACEF, CEFUROXIME SODIUM ZOFRAN ODT, ONDANSETRON ZOFRAN PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ZOFRAN, ONDANSETRON HYDROCHLORIDE
ZOVIRAX, ACYCLOVIR
ZYBAN, BUPROPION HYDROCHLORIDE
GLAXOSMITHKLINE CONS * GLAXOSMITHKLINE CONSUMER HEALTHCARE ALLI, ORLISTAT (OTC)
COMMIT, NICOTINE POLACRILEX (OTC)
NICORETTE, NICOTINE POLACRILEX (OTC)
GLAXOSMITHKLINE LLC * GLAXOSMITHKLINE LLC DYAZIDE, HYDROCHLOROTHIAZIDE DYNACIRC CR, ISRADIPINE FLOLAN, EPOPROSTENOL SODIUM INNOPRAN XL, PROPRANOLOL HYDROCHLORIDE MEPRON, ATOVAQUONE
RYTHMOL SR, PROPAFENONE HYDROCHLORIDE
RYTHMOL, PROPAFENONE HYDROCHLORIDE
B - 58
APPENDIX B
GLENMARK GENERICS * GLENMARK GENERICS INC USA ADAPALENE, ADAPALENE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CALCIPOTRIENE, CALCIPOTRIENE DIPYRIDAMOLE, DIPYRIDAMOLE MOMETASONE FUROATE, MOMETASONE FUROATE NILSTAT, NYSTATIN NIZATIDINE, NIZATIDINE
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
ZONISAMIDE, ZONISAMIDE
* GLENMARK GENERICS LIMITED BRIELLYN, ETHINYL ESTRADIOL
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE
LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE
* GLENMARK GENERICS LTD ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, ATOVAQUONE CARVEDILOL, CARVEDILOL CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE FELODIPINE, FELODIPINE FLUCONAZOLE, FLUCONAZOLE GABAPENTIN, GABAPENTIN HEATHER, NORETHINDRONE LAMOTRIGINE, LAMOTRIGINE LEVOFLOXACIN, LEVOFLOXACIN LITHIUM CARBONATE, LITHIUM CARBONATE MELOXICAM, MELOXICAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE MOMETASONE FUROATE, MOMETASONE FUROATE NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN, NAPROXEN NORETHIDRONE, NORETHINDRONE NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON OXCARBAZEPINE, OXCARBAZEPINE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE THEOPHYLLINE, THEOPHYLLINE TOPIRAMATE, TOPIRAMATE TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE, TRANDOLAPRIL TROSPIUM CHLORIDE, TROSPIUM CHLORIDE
URSODIOL, URSODIOL
VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
* GLENMARK GENERICS LTD INDIA INDOMETHACIN, INDOMETHACIN LITHIUM CARBONATE, LITHIUM CARBONATE
NORETHINDRONE ACETATE, NORETHINDRONE ACETATE
PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE
GLENMARK PHARMS * GLENMARK PHARMACEUTICALS INC USA CICLOPIROX, CICLOPIROX
CLOTRIMAZOLE, CLOTRIMAZOLE
MUPIROCIN, MUPIROCIN
* GLENMARK PHARMACEUTICALS LTD MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, GLENMARK PHARMS LTD * GLENMARK PHARMACEUTICALS LTD HYDRALAZINE HYDROCHLORIDE,
HYDROCHLOROTHIAZIDE
HYDRALAZINE HYDROCHLORIDE
B - 59
APPENDIX B
GRACEWAY * GRACEWAY PHARMACEUTICALS LLC
MINITRAN, NITROGLYCERIN
THEOLAIR, THEOPHYLLINE
(OTC)
TOREMIFENE CITRATE
GUARDIAN DRUG * GUARDIAN DRUG CO INC FOAMCOAT, ALUMINUM HYDROXIDE GUERBET * GUERBET LLC HEXABRIX, IOXAGLATE MEGLUMINE
OXILAN-300, IOXILAN
OXILAN-350, IOXILAN
(OTC)
HAEMONETICS * HAEMONETICS CORP SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HALOCARBON PRODS * HALOCARBON PRODUCTS CORP
ISOFLURANE, ISOFLURANE
SEVOFLURANE, SEVOFLURANE
SODIUM CHLORIDE
HALOZYME THERAP * HALOZYME THERAPEUTICS INC HYLENEX RECOMBINANT, HYALURONIDASE RECOMBINANT HUMAN HANFORD GC * GC HANFORD MANUFACTURING CO AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM
AMPICILLIN SODIUM, AMPICILLIN SODIUM
PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM
HARRIS PHARM * HARRIS PHARMACEUTICAL INC TERBINAFINE HYDROCHLORIDE, HEC PHARM INC * HEC PHARM INC ZIDOVUDINE,
TERBINAFINE HYDROCHLORIDE
ZIDOVUDINE
HELSINN HLTHCARE * HELSINN HEALTHCARE SA ALOXI, PALONOSETRON HYDROCHLORIDE HEMOFARM * HEMOFARM AD A-METHAPRED,
HERCON LABS * HERCON LABORATORIES CORP NITROGLYCERIN, NITROGLYCERIN HERITAGE PHARMS INC * HERITAGE PHARMACEUTICALS INC ACETAZOLAMIDE, ACETAZOLAMIDE
CARISOPRODOL AND ASPIRIN, ASPIRIN
DOXYCYCLINE, DOXYCYCLINE
B - 60
APPENDIX B
* HERITAGE PHARMACEUTICALS INC GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GLYBURIDE, GLYBURIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE INDOMETHACIN, INDOMETHACIN KETOPROFEN, KETOPROFEN LEFLUNOMIDE, LEFLUNOMIDE NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE
PAROMOMYCIN SULFATE, PAROMOMYCIN SULFATE
HETERO DRUGS * HETERO DRUGS LTD METHOCARBAMOL, METHOCARBAMOL STAVUDINE, STAVUDINE
TORSEMIDE, TORSEMIDE
HETERO DRUGS LTD * HETERO DRUGS LTD UNIT III FINASTERIDE, FINASTERIDE LEVETIRACETAM, LEVETIRACETAM LITHIUM CARBONATE, LITHIUM CARBONATE
ZIDOVUDINE, ZIDOVUDINE
HETERO LABS UNIT III * HETERO LABS LTD UNIT III HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE
INDOMETHACIN, INDOMETHACIN
HEYL CHEMISCH * HEYL CHEMISCH PHARMAZEUTISHE FABRIK RADIOGARDASE (PRUSSIAN BLUE), FERRIC HEXACYANOFERRATE(II) HH AND P * HH AND P LLC CROMOLYN SODIUM, CROMOLYN SODIUM FLUNISOLIDE, FLUNISOLIDE
(OTC)
HI TECH PHARMA * HI TECH PHARMACAL CO INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACYCLOVIR, ACYCLOVIR ALBUTEROL SULFATE, ALBUTEROL SULFATE AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE CALCIPOTRIENE, CALCIPOTRIENE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE CICLOPIROX, CICLOPIROX CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CORMAX, CLOBETASOL PROPIONATE DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE EMBELINE E, CLOBETASOL PROPIONATE EMBELINE, CLOBETASOL PROPIONATE ERYTHRO-STATIN, ERYTHROMYCIN FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE GABAPENTIN, GABAPENTIN HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE LACTULOSE, LACTULOSE LEVOCARNITINE, LEVOCARNITINE LEVOFLOXACIN, LEVOFLOXACIN LIDOCAINE AND PRILOCAINE, LIDOCAINE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC)
MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
MINOXIDIL (FOR MEN), MINOXIDIL (OTC)
B - 61
APPENDIX B
*
HI TECH PHARMACAL CO INC MINOXIDIL (FOR WOMEN), MINOXIDIL (OTC) NYSTATIN, NYSTATIN OFLOXACIN, OFLOXACIN PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PREDNISOLONE, PREDNISOLONE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE, DEXTROMETHORPHAN HYDROBROMIDE
PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE
TIMOLOL MALEATE, TIMOLOL MALEATE
VOSOL HC, ACETIC ACID, GLACIAL
VOSOL, ACETIC ACID, GLACIAL
HIGH TECH PHARMA * HIGH TECHNOLOGY PHARMACAL CO INC VALPROIC ACID, VALPROIC ACID HIKMA * HIKMA FARMACEUTICA LDA CEFOTAXIME, CEFOTAXIME SODIUM * HIKMA PHARMACEUTICALS AMOXICILLIN, AMOXICILLIN CARVEDILOL, CARVEDILOL CEFACLOR, CEFACLOR CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEPHALEXIN, CEPHALEXIN CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE GABAPENTIN, GABAPENTIN GLYBURIDE (MICRONIZED), GLYBURIDE
NAPROXEN SODIUM, NAPROXEN SODIUM
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
HIKMA FARMACEUTICA * HIKMA FARMACEUTICA (PORTUGAL) SA AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CEFOXITIN, CEFOXITIN SODIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPROFLOXACIN, CIPROFLOXACIN CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE ENALAPRILAT, ENALAPRILAT FLUMAZENIL, FLUMAZENIL FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GLYCOPYRROLATE, GLYCOPYRROLATE GRANISTERON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, LEVOFLOXACIN METOPROLOL TARTRATE, METOPROLOL TARTRATE MILRINONE LACTATE IN PLASTIC CONTAINER, MILRINONE LACTATE MILRINONE LACTATE, MILRINONE LACTATE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PROGESTERONE, PROGESTERONE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
TERBUTALINE SULFATE, TERBUTALINE SULFATE
VALPROATE SODIUM, VALPROATE SODIUM
* HIKMA FARMACEUTICA PORTUGAL LDA CEFAZOLIN SODIUM, CEFAZOLIN SODIUM
CEFUROXIME SODIUM, CEFUROXIME SODIUM
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE
B - 62
APPENDIX B
* HIKMA FARMACEUTICA SA BUTORPHANOL TARTRATE,
BUTORPHANOL TARTRATE
HIKMA PHARMS * HIKMA PHARMACEUTICALS AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN CEPHALEXIN, CEPHALEXIN DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE GABAPENTIN, GABAPENTIN GEMFIBROZIL, GEMFIBROZIL LAMOTRIGINE, LAMOTRIGINE
SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE
HILL DERMAC * HILL DERMACEUTICALS INC DERMA-SMOOTHE/FS, FLUOCINOLONE ACETONIDE
DERMOTIC, FLUOCINOLONE ACETONIDE
HISAMITSU * HISAMITSU PHARMACEUTICAL CO INC SALONPAS, MENTHOL (OTC) HITECH PHARMA * HITECH PHARMACAL CORP CIPROFLOXACIN HYDROCHLORIDE,
CIPROFLOXACIN HYDROCHLORIDE
HI-TECH PHARMA CO * HI-TECH PHARMACAL CO INC TUSSICAPS, CHLORPHENIRAMINE POLISTIREX HOFFMANN LA ROCHE * HOFFMANN LA ROCHE INC INVIRASE, SAQUINAVIR MESYLATE ROCEPHIN, CEFTRIAXONE SODIUM ROMAZICON, FLUMAZENIL XELODA, CAPECITABINE XENICAL, ORLISTAT
ZELBORAF, VEMURAFENIB
HOPE PHARMS * HOPE PHARMACEUTICALS NITHIODOTE, SODIUM NITRITE HORIZON PHARMA * HORIZON PHARMA INC DUEXIS, FAMOTIDINE HOSPIRA * HOSPIRA INC ACETIC ACID 0.25% IN PLASTIC CONTAINER, ACETIC ACID, GLACIAL ACETYLCYSTEINE, ACETYLCYSTEINE A-HYDROCORT, HYDROCORTISONE SODIUM SUCCINATE ALFENTANIL, ALFENTANIL HYDROCHLORIDE A-METHAPRED, METHYLPREDNISOLONE SODIUM SUCCINATE AMIDATE, ETOMIDATE AMIKACIN SULFATE, AMIKACIN SULFATE AMINOCAPROIC ACID IN PLASTIC CONTAINER, AMINOCAPROIC ACID AMINOPHYLLINE, AMINOPHYLLINE AMINOSYN 10% (PH6), AMINO ACIDS AMINOSYN 10%, AMINO ACIDS AMINOSYN 3.5% M, AMINO ACIDS AMINOSYN 3.5%, AMINO ACIDS AMINOSYN 5%, AMINO ACIDS AMINOSYN 7% (PH6), AMINO ACIDS AMINOSYN 7% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN 7%, AMINO ACIDS
AMINOSYN 8.5% (PH6), AMINO ACIDS
AMINOSYN 8.5% W/ ELECTROLYTES, AMINO ACIDS
B - 63
APPENDIX B
* HOSPIRA INC AMINOSYN 8.5%, AMINO ACIDS AMINOSYN II 10% IN PLASTIC CONTAINER, AMINO ACIDS AMINOSYN II 10% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN II 10%, AMINO ACIDS AMINOSYN II 15% IN PLASTIC CONTAINER, AMINO ACIDS AMINOSYN II 7%, AMINO ACIDS AMINOSYN II 8.5% W/ ELECTROLYTES, AMINO ACIDS AMINOSYN II 8.5%, AMINO ACIDS AMINOSYN-HBC 7%, AMINO ACIDS AMINOSYN-HF 8%, AMINO ACIDS AMINOSYN-PF 10%, AMINO ACIDS AMINOSYN-PF 7%, AMINO ACIDS AMINOSYN-RF 5.2%, AMINO ACIDS AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMMONIUM CHLORIDE IN PLASTIC CONTAINER, AMMONIUM CHLORIDE AQUASOL A, VITAMIN A PALMITATE ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, ARTICAINE HYDROCHLORIDE ATROPINE SULFATE ANSYR PLASTIC SYRINGE, ATROPINE SULFATE AZITHROMYCIN, AZITHROMYCIN BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION BLEOMYCIN SULFATE, BLEOMYCIN SULFATE BUMETANIDE, BUMETANIDE BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE W/EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE BUTORPHANOL TARTRATE PRESERVATIVE FREE, BUTORPHANOL TARTRATE CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER, CALCIUM CHLORIDE CARBOCAINE, MEPIVACAINE HYDROCHLORIDE CARBOPLATIN, CARBOPLATIN CHLOROPROCAINE HYDROCHLORIDE, CHLOROPROCAINE HYDROCHLORIDE CHROMIC CHLORIDE IN PLASTIC CONTAINER, CHROMIC CHLORIDE CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, CIPROFLOXACIN CIPROFLOXACIN, CIPROFLOXACIN CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CORLOPAM, FENOLDOPAM MESYLATE CUPRIC CHLORIDE IN PLASTIC CONTAINER, CUPRIC CHLORIDE CYTARABINE, CYTARABINE DACARBAZINE, DACARBAZINE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DEMEROL, MEPERIDINE HYDROCHLORIDE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DEXTROSE 10% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 20% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 25%, DEXTROSE DEXTROSE 30% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 40% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 50% IN PLASTIC CONTAINER, DEXTROSE DEXTROSE 70% IN PLASTIC CONTAINER, DEXTROSE DIAZEPAM, DIAZEPAM DIGOXIN, DIGOXIN DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOBUTAMINE HYDROCHLORIDE
B - 64
APPENDIX B
* HOSPIRA INC DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%, DOBUTAMINE HYDROCHLORIDE DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, DOPAMINE HYDROCHLORIDE DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE DROPERIDOL, DROPERIDOL ENALAPRILAT, ENALAPRILAT EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE ERYC, ERYTHROMYCIN ERYTHROCIN, ERYTHROMYCIN LACTOBIONATE FENTANYL CITRATE PRESERVATIVE FREE, FENTANYL CITRATE FENTANYL CITRATE, FENTANYL CITRATE FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FOSCARNET SODIUM, FOSCARNET SODIUM FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FUROSEMIDE, FUROSEMIDE GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, GENTAMICIN SULFATE GENTAMICIN SULFATE, GENTAMICIN SULFATE GLYCINE 1.5% IN PLASTIC CONTAINER, GLYCINE HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE ISOFLURANE, ISOFLURANE ISUPREL, ISOPROTERENOL HYDROCHLORIDE KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LACTATED RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE LEVOPHED, NOREPINEPHRINE BITARTRATE LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, EPINEPHRINE LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LIPOSYN II 10%, SAFFLOWER OIL LIPOSYN II 20%, SAFFLOWER OIL LIPOSYN III 10%, SOYBEAN OIL LIPOSYN III 20%, SOYBEAN OIL LIPOSYN III 30%, SOYBEAN OIL
LORAZEPAM, LORAZEPAM
LTA II KIT, LIDOCAINE HYDROCHLORIDE
M.V.I. ADULT (PHARMACY BULK PACKAGE), ASCORBIC ACID M.V.I. ADULT, ASCORBIC ACID
M.V.I. PEDIATRIC, ASCORBIC ACID
M.V.I.-12 (WITHOUT VITAMIN K), ASCORBIC ACID
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MAGNESIUM SULFATE
MAGNESIUM SULFATE IN PLASTIC CONTAINER, MAGNESIUM SULFATE
MAGNESIUM SULFATE, MAGNESIUM SULFATE
B - 65
APPENDIX B
* HOSPIRA INC MANGANESE CHLORIDE IN PLASTIC CONTAINER, MANGANESE CHLORIDE MANNITOL 10% IN PLASTIC CONTAINER, MANNITOL MANNITOL 15% IN PLASTIC CONTAINER, MANNITOL MANNITOL 20% IN PLASTIC CONTAINER, MANNITOL MANNITOL 25%, MANNITOL MANNITOL 5% IN PLASTIC CONTAINER, MANNITOL MARCAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE W/ EPINEPHRINE, BUPIVACAINE HYDROCHLORIDE MARCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE MARCAINE, BUPIVACAINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE METHOTREXATE SODIUM PRESERVATIVE FREE, METHOTREXATE SODIUM METHOTREXATE SODIUM, METHOTREXATE SODIUM METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE METRONIDAZOLE IN PLASTIC CONTAINER, METRONIDAZOLE MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER, MILRINONE LACTATE MORPHINE SULFATE, MORPHINE SULFATE NALBUPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE NITROGLYCERIN IN DEXTROSE 5%, NITROGLYCERIN NITROGLYCERIN, NITROGLYCERIN NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE NORMOSOL-R IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PHENYTOIN SODIUM, PHENYTOIN SODIUM PHYSIOSOL IN PLASTIC CONTAINER, MAGNESIUM CHLORIDE PLEGISOL IN PLASTIC CONTAINER, CALCIUM CHLORIDE
POTASSIUM ACETATE IN PLASTIC CONTAINER, POTASSIUM ACETATE
POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, POTASSIUM
CHLORIDE
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,
CALCIUM CHLORIDE
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, DEXTROSE
B - 66
APPENDIX B
* HOSPIRA INC POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 20MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER,
CALCIUM CHLORIDE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER, DEXTROSE
POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 40MEQ IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER,
DEXTROSE
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, DEXTROSE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PRECEDEX, DEXMEDETOMIDINE HYDROCHLORIDE PROCAINAMIDE HYDROCHLORIDE, PROCAINAMIDE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPOFOL, PROPOFOL QUELICIN PRESERVATIVE FREE, SUCCINYLCHOLINE CHLORIDE QUELICIN, SUCCINYLCHOLINE CHLORIDE RINGER'S IN PLASTIC CONTAINER, CALCIUM CHLORIDE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE SODIUM ACETATE IN PLASTIC CONTAINER, SODIUM ACETATE ANHYDROUS SODIUM BICARBONATE, SODIUM BICARBONATE SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM CHLORIDE IN PLASTIC CONTAINER, SODIUM CHLORIDE SODIUM LACTATE IN PLASTIC CONTAINER, SODIUM LACTATE SODIUM PHOSPHATES IN PLASTIC CONTAINER, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE SORBITOL-MANNITOL IN PLASTIC CONTAINER, MANNITOL STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION STERILE WATER IN PLASTIC CONTAINER, STERILE WATER FOR IRRIGATION SUFENTANIL CITRATE, SUFENTANIL CITRATE TALWIN, PENTAZOCINE LACTATE TAZICEF, CEFTAZIDIME THAM, TROMETHAMINE TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, TOBRAMYCIN SULFATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE TPN ELECTROLYTES IN PLASTIC CONTAINER, CALCIUM CHLORIDE TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE
B - 67
APPENDIX B
* HOSPIRA INC VECURONIUM BROMIDE, VECURONIUM BROMIDE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE VINORELBINE TARTRATE, VINORELBINE TARTRATE VITAMIN K1, PHYTONADIONE
ZINC CHLORIDE IN PLASTIC CONTAINER, ZINC CHLORIDE
* HOSPIRA WORLDWIDE, INC DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE NITROPRESS, SODIUM NITROPRUSSIDE ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER, TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE
VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE
ONDANSETRON HYDROCHLORIDE
HOSPIRA INC * HOSPIRA INC AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFOXITIN, CEFOXITIN SODIUM CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME SODIUM, CEFUROXIME SODIUM DOCETAXEL, DOCETAXEL GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GEMCITABINE, GEMCITABINE HYDROCHLORIDE HEPARIN SODIUM, HEPARIN SODIUM HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE IMIPENEM AND CILASTATIN, CILASTATIN SODIUM MAXIPIME, CEFEPIME HYDROCHLORIDE MEPIVACAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE MEROPENEM, MEROPENEM MORPHINE SULFATE, MORPHINE SULFATE NIPENT, PENTOSTATIN OXALIPLATIN, OXALIPLATIN PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER, THEOPHYLLINE
TOPOTECAN, TOPOTECAN HYDROCHLORIDE
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE
HOSPIRA WORLDWIDE * HOSPIRA WORLDWIDE PTY OXALIPLATIN, OXALIPLATIN HQ SPECIALITY PHARMA * HQ SPECIALITY PHARMA LLC LEVETIRACETAM IN SODIUM CHLORIDE, HUAHAI US INC * HUAHAI US INC DONEPEZIL HYDROCHLORIDE,
LEVETIRACETAM
DONEPEZIL HYDROCHLORIDE
ANAGRELIDE HYDROCHLORIDE
B - 68
APPENDIX B
** I **
* IMPAX LABORATORIES INC BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CARBIDOPA AND LEVODOPA, CARBIDOPA CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE COLESTIPOL HYDROCHLORIDE, COLESTIPOL HYDROCHLORIDE DANTROLENE SODIUM, DANTROLENE SODIUM DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE DIGOXIN, DIGOXIN DIPYRIDAMOLE, DIPYRIDAMOLE DIVALPROEX SODIUM, DIVALPROEX SODIUM FENOFIBRATE (MICRONIZED), FENOFIBRATE FENOFIBRATE, FENOFIBRATE FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE LETROZOLE, LETROZOLE LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE (OTC) LORATADINE, LORATADINE (OTC) METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHYLTESTOSTERONE, METHYLTESTOSTERONE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NADOLOL AND BENDROFLUMETHIAZIDE, BENDROFLUMETHIAZIDE OMEPRAZOLE, OMEPRAZOLE OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE PENTOXIFYLLINE, PENTOXIFYLLINE PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE PRIMIDONE, PRIMIDONE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE RILUZOLE, RILUZOLE RIMANTADINE HYDROCHLORIDE, RIMANTADINE HYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE
TERBUTALINE SULFATE, TERBUTALINE SULFATE
TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE
IMPAX LABS INC * IMPAX LABORATORIES INC CABERGOLINE, CABERGOLINE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
DOXYCYCLINE, DOXYCYCLINE
MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE
IMPAX PHARMS * IMPAX PHARMACEUTICALS FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE GEMFIBROZIL, GEMFIBROZIL MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE ORPHENADRINE CITRATE, ORPHENADRINE CITRATE
OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE
INALCO * INALCO SPA LACTULOSE,
FEXOFENADINE HYDROCHLORIDE
LACTULOSE
INCYTE CORP * INCYTE CORP JAKAFI, RUXOLITINIB PHOSPHATE INDICUS PHARMA * INDICUS PHARMA LLC
LETROZOLE, LETROZOLE
METFORMIN HYDROCHLORIDE,
METFORMIN HYDROCHLORIDE
B - 69
APPENDIX B
(OTC)
NITRATE NITRATE
(OTC)
(OTC)
B - 70
APPENDIX B
INTL MEDICATION * INTERNATIONAL MEDICATION SYSTEM AMINOPHYLLINE, AMINOPHYLLINE DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE FUROSEMIDE, FUROSEMIDE ISOPROTERENOL HYDROCHLORIDE, ISOPROTERENOL HYDROCHLORIDE LARYNG-O-JET KIT, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE MANNITOL 25%, MANNITOL MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE PHYTONADIONE, PHYTONADIONE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE
PROCAINAMIDE HYDROCHLORIDE, PROCAINAMIDE HYDROCHLORIDE
VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
* INTERNATIONAL MEDICATION SYSTEMS LTD
DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE
MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
INTL MEDICATION SYS * INTERNATIONAL MEDICATION SYSTEMS LTD LORAZEPAM, LORAZEPAM INVAGEN PHARMS * INVAGEN PHARMACEUTICALS INC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE FOLIC ACID, FOLIC ACID FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GABAPENTIN, GABAPENTIN GEMFIBROZIL, GEMFIBROZIL GLIMEPIRIDE, GLIMEPIRIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM MEPROBAMATE, MEPROBAMATE NABUMETONE, NABUMETONE NAPROXEN, NAPROXEN QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RAMIPRIL, RAMIPRIL SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE TRANDOLAPRIL, TRANDOLAPRIL WARFARIN SODIUM, WARFARIN SODIUM
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
ZONISAMIDE, ZONISAMIDE
INWOOD LABS * INWOOD LABORATORIES INC SUB FOREST LABORATORIES INC THEOPHYLLINE, THEOPHYLLINE IPCA LABS LTD * IPCA LABORATORIES LTD ALLOPURINOL, ALLOPURINOL ATENOLOL, ATENOLOL CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE FUROSEMIDE, FUROSEMIDE
HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE
B - 71
APPENDIX B
* IPCA LABORATORIES LTD METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
IPR * IPR PHARMACEUTICALS INC ATENOLOL AND CHLORTHALIDONE, ATENOLOL ATENOLOL, ATENOLOL CRESTOR, ROSUVASTATIN CALCIUM
ZOMIG, ZOLMITRIPTAN
IPR PHARMS INC * IPR PHARMACEUTICALS INC VANDETANIB, VANDETANIB IPSEN PHARMS * IPSEN PHARMACEUTICALS INC SOMATULINE DEPOT, LANREOTIDE ACETATE IROKO PHARMS * IROKO PHARMACEUTICALS LLC INDOCIN, INDOMETHACIN ISO TEX * ISO TEX DIAGNOSTICS INC JEANATOPE, ALBUMIN IODINATED I-125 SERUM
MEGATOPE, ALBUMIN IODINATED I-131 SERUM
ISTA PHARMS * ISTA PHARMACEUTICALS BEPREVE, BEPOTASTINE BESILATE ISTALOL, TIMOLOL MALEATE
VITRASE, HYALURONIDASE
ISTA PHARMS INC * ISTA PHARMACEUTICALS INC BROMDAY, BROMFENAC SODIUM ISTITUTO BIOCHIMICO * ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI PIPERACILLIN, PIPERACILLIN SODIUM IVAX PHARMS * IVAX PHARMACEUTICALS INC PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE IVAX SUB TEVA PHARMS * IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE BACLOFEN, BACLOFEN BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BUMETANIDE, BUMETANIDE CABERGOLINE, CABERGOLINE CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE (OTC)
CIMETIDINE, CIMETIDINE
CIMETIDINE, CIMETIDINE (OTC)
CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE
CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE
CLOZAPINE, CLOZAPINE
CYCLOSPORINE, CYCLOSPORINE
CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE
DIAZEPAM, DIAZEPAM
DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
DOXYCYCLINE, DOXYCYCLINE
FAMOTIDINE, FAMOTIDINE
FAMOTIDINE, FAMOTIDINE (OTC)
B - 72
APPENDIX B
* IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA FENOPROFEN CALCIUM, FENOPROFEN CALCIUM FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUTAMIDE, FLUTAMIDE FUROSEMIDE, FUROSEMIDE GABAPENTIN, GABAPENTIN GLIPIZIDE, GLIPIZIDE GLYBURIDE AND METFORMIN HYDROCHLORIDE, GLYBURIDE GRISEOFULVIN, GRISEOFULVIN, MICROCRYSTALLINE GUANABENZ ACETATE, GUANABENZ ACETATE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE INDAPAMIDE, INDAPAMIDE INDOMETHACIN, INDOMETHACIN LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LORAZEPAM, LORAZEPAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHYLDOPA, METHYLDOPA MISOPROSTOL, MISOPROSTOL NADOLOL, NADOLOL NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE OXAPROZIN, OXAPROZIN OXAZEPAM, OXAZEPAM PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE PROBENECID, PROBENECID RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) SIMVASTATIN, SIMVASTATIN TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
JACOBUS * JACOBUS PHARMACEUTICAL CO DAPSONE, DAPSONE
PASER, AMINOSALICYLIC ACID
JANSSEN BIOTECH * JANSSEN BIOTECH INC ZYTIGA, ABIRATERONE ACETATE JANSSEN PHARMS * JANSSEN PHARMACEUTICALS INC AXERT, ALMOTRIPTAN MALATE CONCERTA, METHYLPHENIDATE HYDROCHLORIDE DITROPAN XL, OXYBUTYNIN CHLORIDE DITROPAN, OXYBUTYNIN CHLORIDE DORIBAX, DORIPENEM DURAGESIC-100, FENTANYL DURAGESIC-12, FENTANYL DURAGESIC-25, FENTANYL DURAGESIC-50, FENTANYL DURAGESIC-75, FENTANYL ELMIRON, PENTOSAN POLYSULFATE SODIUM HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE INVEGA SUSTENNA, PALIPERIDONE PALMITATE INVEGA, PALIPERIDONE LEUSTATIN, CLADRIBINE LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER,
LEVAQUIN, LEVOFLOXACIN
MICRONOR, NORETHINDRONE
LEVOFLOXACIN
B - 73
APPENDIX B
** J **
* JANSSEN PHARMACEUTICALS INC MODICON 28, ETHINYL ESTRADIOL NIZORAL, KETOCONAZOLE NUCYNTA ER, TAPENTADOL HYDROCHLORIDE NUCYNTA, TAPENTADOL HYDROCHLORIDE ORTHO CYCLEN-28, ETHINYL ESTRADIOL ORTHO EVRA, ETHINYL ESTRADIOL ORTHO TRI-CYCLEN LO, ETHINYL ESTRADIOL ORTHO TRI-CYCLEN, ETHINYL ESTRADIOL ORTHO-CEPT, DESOGESTREL ORTHO-NOVUM 1/35-28, ETHINYL ESTRADIOL ORTHO-NOVUM 7/7/7-28, ETHINYL ESTRADIOL PANCREAZE, LIPASE RAZADYNE ER, GALANTAMINE HYDROBROMIDE RAZADYNE, GALANTAMINE HYDROBROMIDE RISPERDAL CONSTA, RISPERIDONE RISPERDAL, RISPERIDONE SPORANOX, ITRACONAZOLE TERAZOL 3, TERCONAZOLE TERAZOL 7, TERCONAZOLE TOPAMAX, TOPIRAMATE TYLENOL W/ CODEINE NO. 3, ACETAMINOPHEN TYLENOL W/ CODEINE NO. 4, ACETAMINOPHEN TYLOX, ACETAMINOPHEN ULTRACET, ACETAMINOPHEN ULTRAM, TRAMADOL HYDROCHLORIDE
XARELTO, RIVAROXABAN
JANSSEN R AND D * JANSSEN RESEARCH AND DEVELOPMENT LLC FLEXERIL, CYCLOBENZAPRINE HYDROCHLORIDE
PARAFON FORTE DSC, CHLORZOXAZONE
JAZZ * JAZZ PHARMACEUTICALS LUVOX CR, FLUVOXAMINE MALEATE
XYREM, SODIUM OXYBATE
JHP PHARMS * JHP PHARMACEUTICALS LLC BREVITAL SODIUM, METHOHEXITAL SODIUM COLY-MYCIN M, COLISTIMETHATE SODIUM COLY-MYCIN S, COLISTIN SULFATE DANTRIUM, DANTROLENE SODIUM DELESTROGEN, ESTRADIOL VALERATE KETALAR, KETAMINE HYDROCHLORIDE PITOCIN, OXYTOCIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE
TRIOSTAT, LIOTHYRONINE SODIUM
JIANGSU HENGRUI MED * JIANGSU HENGRUI MEDICINE CO LTD IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE JOHN O BUTLER CO * JOHN O BUTLER CO CHLORHEXIDINE GLUCONATE,
CHLORHEXIDINE GLUCONATE
JOHNSON AND JOHNSON * JOHNSON AND JOHNSON GROUP CONSUMER COMPANIES MEN'S ROGAINE, MINOXIDIL (OTC) ROGAINE (FOR MEN), MINOXIDIL (OTC) ROGAINE (FOR WOMEN), MINOXIDIL (OTC) ROGAINE EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) VISINE L.R., OXYMETAZOLINE HYDROCHLORIDE (OTC)
VISINE-A, NAPHAZOLINE HYDROCHLORIDE (OTC)
B - 74
APPENDIX B
JUBILANT CADISTA * JUBILANT CADISTA PHARMACEUTICALS INC CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE FOLIC ACID, FOLIC ACID HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE METHYLPREDNISOLONE, METHYLPREDNISOLONE PREDNISONE, PREDNISONE
PROCOMP, PROCHLORPERAZINE MALEATE
TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE
JUBILANT LIFE * JUBILANT LIFE SCIENCES LTD
DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
LAMOTRIGINE, LAMOTRIGINE
JUBILANT ORGANOSYS * JUBILANT ORGANOSYS LTD
PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
RISPERIDONE, RISPERIDONE
KEY PHARMS * KEY PHARMACEUTICALS INC SUB SCHERING PLOUGH CORP NITRO-DUR, NITROGLYCERIN KIEL * KIEL LABORATORIES INC ORPHENADRINE CITRATE,
ORPHENADRINE CITRATE
KING PHARMS * KING PHARMACEUTICALS INC ALTACE, RAMIPRIL AVINZA, MORPHINE SULFATE BICILLIN C-R 900/300, PENICILLIN G BENZATHINE BICILLIN C-R, PENICILLIN G BENZATHINE BICILLIN L-A, PENICILLIN G BENZATHINE CORGARD, NADOLOL CORZIDE, BENDROFLUMETHIAZIDE CYTOMEL, LIOTHYRONINE SODIUM INTAL, CROMOLYN SODIUM LEVOXYL, LEVOTHYROXINE SODIUM PENICILLIN G PROCAINE, PENICILLIN G PROCAINE SILVADENE, SILVER SULFADIAZINE SKELAXIN, METAXALONE
SYNERCID, DALFOPRISTIN
TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE
* KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT INC SUB KING PHARMACEUTICALS INC SONATA, ZALEPLON
TAPAZOLE, METHIMAZOLE
TUSSIGON, HOMATROPINE METHYLBROMIDE
KING PHARMS R AND D * KING PHARMACEUTICALS RESEARCH DEVELOPMENT INC OXECTA, OXYCODONE HYDROCHLORIDE KOWA CO * KOWA CO LTD LIVALO, PITAVASTATIN CALCIUM KREMERS URBAN PHARMS * KREMERS URBAN PHARMACEUTICALS INC GLYCOLAX, POLYETHYLENE GLYCOL 3350 GLYCOLAX, POLYETHYLENE GLYCOL 3350 (OTC) ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE
NITROGLYCERIN, NITROGLYCERIN
OMEPRAZOLE, OMEPRAZOLE
B - 75
APPENDIX B
B - 76
APPENDIX B
** L **
LANNETT HOLDINGS INC * LANNETT HOLDINGS INC DIETHYLPROPION HYDROCHLORIDE, DIETHYLPROPION HYDROCHLORIDE LOXAPINE SUCCINATE, LOXAPINE SUCCINATE METHOCARBAMOL, METHOCARBAMOL MORPHINE SULFATE, MORPHINE SULFATE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PHENTERMINE RESIN COMPLEX, PHENTERMINE RESIN COMPLEX
TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
LANTHEUS MEDCL * LANTHEUS MEDICAL IMAGING INC ABLAVAR, GADOFOSVESET TRISODIUM CARDIOLITE, TECHNETIUM TC-99M SESTAMIBI KIT DEFINITY, PERFLUTREN GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67 NEUROLITE, TECHNETIUM TC-99M BICISATE KIT TECHNELITE, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201
XENON XE 133, XENON XE-133
LAVIPHARM LABS * LAVIPHARM LABORATORIES INC FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL
FENTANYL-75, FENTANYL
LEHIGH VALLEY * LEHIGH VALLEY TECHNOLOGIES INC OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE LEK PHARMS * LEK PHARMACEUTICALS D D AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE ENALAPRIL MALEATE, ENALAPRIL MALEATE LISINOPRIL, LISINOPRIL
OMEPRAZOLE, OMEPRAZOLE
LEK PHARMS DD * LEK PHARMACEUTICALS DD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN PRAVASTATIN SODIUM, PRAVASTATIN SODIUM
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
LEO PHARM * LEO PHARMACEUTICAL PRODUCTS LTD DOVONEX, CALCIPOTRIENE
TACLONEX, BETAMETHASONE DIPROPIONATE
LEO PHARM PRODS * LEO PHARMACEUTICAL PRODUCTS LTD TACLONEX SCALP, BETAMETHASONE DIPROPIONATE LEO PHARMA AS * LEO PHARMA AS INNOHEP, TINZAPARIN SODIUM LG LIFE * LG LIFE SCIENCES LTD VALTROPIN, SOMATROPIN RECOMBINANT LILLY * ELI LILLY AND CO ALIMTA, PEMETREXED DISODIUM CIALIS, TADALAFIL CYMBALTA, DULOXETINE HYDROCHLORIDE
EVISTA, RALOXIFENE HYDROCHLORIDE
B - 77
APPENDIX B
** L **
* ELI LILLY AND CO FORTEO, TERIPARATIDE RECOMBINANT HUMAN GEMZAR, GEMCITABINE HYDROCHLORIDE GLUCAGON, GLUCAGON RECOMBINANT HUMALOG KWIKPEN, INSULIN LISPRO RECOMBINANT HUMALOG MIX 50/50 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 50/50 PEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 50/50, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25 KWIKPEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25 PEN, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG MIX 75/25, INSULIN LISPRO PROTAMINE RECOMBINANT HUMALOG PEN, INSULIN LISPRO RECOMBINANT HUMALOG, INSULIN LISPRO RECOMBINANT HUMATROPE, SOMATROPIN RECOMBINANT HUMULIN 70/30 PEN, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN 70/30, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (OTC) HUMULIN R PEN, INSULIN RECOMBINANT HUMAN (OTC) HUMULIN R, INSULIN RECOMBINANT HUMAN HUMULIN R, INSULIN RECOMBINANT HUMAN (OTC) PROZAC WEEKLY, FLUOXETINE HYDROCHLORIDE QUINIDINE GLUCONATE, QUINIDINE GLUCONATE STRATTERA, ATOMOXETINE HYDROCHLORIDE SYMBYAX, FLUOXETINE HYDROCHLORIDE ZYPREXA ZYDIS, OLANZAPINE
ZYPREXA, OLANZAPINE
* LILLY RESEARCH LABORATORIES DIV ELI LILLY AND CO PROZAC, FLUOXETINE HYDROCHLORIDE
SARAFEM, FLUOXETINE HYDROCHLORIDE
LLOYD * LLOYD INC LEVOTHROID,
LEVOTHYROXINE SODIUM
LNK * LNK INTERNATIONAL INC DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE (OTC) IBUPROFEN, IBUPROFEN (OTC)
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE LOREAL USA * LOREAL USA PRODUCTS INC ANTHELIOS 20, AVOBENZONE (OTC) ANTHELIOS 40, AVOBENZONE (OTC) ANTHELIOS SX, AVOBENZONE (OTC)
CAPITAL SOLEIL 15, AVOBENZONE (OTC)
(OTC)
LUITPOLD * LUITPOLD PHARMACEUTICALS INC ACETYLCYSTEINE, ACETYLCYSTEINE ADENOSINE, ADENOSINE AMINOCAPROIC ACID, AMINOCAPROIC ACID AMINOPHYLLINE, AMINOPHYLLINE BENZTROPINE MESYLATE, BENZTROPINE MESYLATE BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE, BETAMETHASONE ACETATE BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE HYDROCHLORIDE CAFFEINE CITRATE, CAFFEINE CITRATE CALCITRIOL, CALCITRIOL CEFTRIAXONE, CEFTRIAXONE SODIUM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CYANOCOBALAMIN, CYANOCOBALAMIN CYCLOSPORINE, CYCLOSPORINE DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE DEXFERRUM, IRON DEXTRAN DOPAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE
DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE
B - 78
APPENDIX B
* LUITPOLD PHARMACEUTICALS INC DROPERIDOL, DROPERIDOL ESTRADIOL VALERATE, ESTRADIOL VALERATE ETOMIDATE, ETOMIDATE FOMEPIZOLE, FOMEPIZOLE FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FUROSEMIDE, FUROSEMIDE GLYCOPYRROLATE, GLYCOPYRROLATE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE IBUTILIDE FUMARATE, IBUTILIDE FUMARATE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LATANOPROST, LATANOPROST LEUCOVORIN CALCIUM PRESERVATIVE FREE, LEUCOVORIN CALCIUM LEVOCARNITINE, LEVOCARNITINE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE MANNITOL 25%, MANNITOL METHYLDOPATE HYDROCHLORIDE, METHYLDOPATE HYDROCHLORIDE METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE METOPROLOL TARTRATE, METOPROLOL TARTRATE NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN, GRAMICIDIN NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE, HYDROCORTISONE NITROGLYCERIN, NITROGLYCERIN ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PHENYTOIN SODIUM, PHENYTOIN SODIUM PROGESTERONE, PROGESTERONE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE SPRIX, KETOROLAC TROMETHAMINE TORSEMIDE, TORSEMIDE TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE, TRIMETHOBENZAMIDE HYDROCHLORIDE TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE
VENOFER, IRON SUCROSE
ZIDOVUDINE, ZIDOVUDINE
LUNDBECK INC * LUNDBECK INC CHEMET, SUCCIMER COGENTIN, BENZTROPINE MESYLATE COSMEGEN, DACTINOMYCIN DESOXYN, METHAMPHETAMINE HYDROCHLORIDE DIURIL, CHLOROTHIAZIDE SODIUM INDOCIN, INDOMETHACIN SODIUM MUSTARGEN, MECHLORETHAMINE HYDROCHLORIDE NEMBUTAL SODIUM, PENTOBARBITAL SODIUM NEOPROFEN, IBUPROFEN LYSINE ONFI, CLOBAZAM PEGANONE, ETHOTOIN
SABRIL, VIGABATRIN
TRANXENE, CLORAZEPATE DIPOTASSIUM
LUPIN * LUPIN LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CARVEDILOL, CARVEDILOL CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFDINIR, CEFDINIR CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFPROZIL, CEFPROZIL CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME AXETIL, CEFUROXIME AXETIL
CEPHALEXIN, CEPHALEXIN
DIVALPROEX SODIUM, DIVALPROEX SODIUM
B - 79
APPENDIX B
* LUPIN LTD ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LOVASTATIN, LOVASTATIN QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RAMIPRIL, RAMIPRIL SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN
TRANDOLAPRIL, TRANDOLAPRIL
LUPIN ATLANTIS * LUPIN ATLANTIS HOLDINGS SA ANTARA (MICRONIZED), FENOFIBRATE LUPIN LTD * LUPIN LIMITED LEVETIRACETAM, LEVETIRACETAM
LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL
* LUPIN LTD FAMOTIDINE, FAMOTIDINE FENOFIBRATE, FENOFIBRATE IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MEFENAMIC ACID, MEFENAMIC ACID METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NABUMETONE, NABUMETONE NORETHINDRONE, NORETHINDRONE PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE
SUPRAX, CEFIXIME
TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
LUPIN PHARMS * LUPIN PHARMACEUTICALS INC AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, DESLORATADINE, DESLORATADINE MELOXICAM, MELOXICAM
PRAVASTATIN SODIUM, PRAVASTATIN SODIUM
SUPRAX, CEFIXIME
AMLODIPINE BESYLATE
LYNE * LYNE LABORATORIES INC CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE DEXAMETHASONE, DEXAMETHASONE HYDROCORTISONE, HYDROCORTISONE
LEVOCARNITINE, LEVOCARNITINE
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
LYNROSE LABS * LYNROSE LABS LLC CARBINOXAMINE MALEATE,
CARBINOXAMINE MALEATE
MALLINCKRODT * MALLINCKRODT CHEMICAL INC ANEXSIA 7.5/650, ACETAMINOPHEN ANEXSIA, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN
METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE
METHADOSE, METHADONE HYDROCHLORIDE
B - 80
APPENDIX B
** M **
* MALLINCKRODT CHEMICAL INC OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN * MALLINCKRODT INC ANEXSIA 5/325, ACETAMINOPHEN ANEXSIA 7.5/325, ACETAMINOPHEN ANEXSIA, ACETAMINOPHEN DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE FENTANYL CITRATE, FENTANYL CITRATE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METHYLIN ER, METHYLPHENIDATE HYDROCHLORIDE METHYLIN, METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE OPTIMARK IN PLASTIC CONTAINER, GADOVERSETAMIDE OPTIMARK, GADOVERSETAMIDE OXYCET, ACETAMINOPHEN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE PENNSAID, DICLOFENAC SODIUM SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE TECHNETIUM TC-99 SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201
TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
* MALLINCKRODT MEDICAL INC CONRAY 30, IOTHALAMATE MEGLUMINE CONRAY 43, IOTHALAMATE MEGLUMINE CONRAY, IOTHALAMATE MEGLUMINE CYSTO-CONRAY II, IOTHALAMATE MEGLUMINE GALLIUM CITRATE GA 67, GALLIUM CITRATE GA-67 INDIUM IN 111 CHLORIDE, INDIUM IN-111 CHLORIDE MD-76R, DIATRIZOATE MEGLUMINE MD-GASTROVIEW, DIATRIZOATE MEGLUMINE OCTREOSCAN, INDIUM IN-111 PENTETREOTIDE KIT OPTIRAY 240, IOVERSOL OPTIRAY 300, IOVERSOL OPTIRAY 320, IOVERSOL OPTIRAY 350, IOVERSOL SODIUM IODIDE I 123, SODIUM IODIDE I-123 SODIUM IODIDE I 131, SODIUM IODIDE I-131 TECHNESCAN MAG3, TECHNETIUM TC-99M MERTIATIDE KIT TECHNESCAN PYP KIT, TECHNETIUM TC-99M PYROPHOSPHATE KIT TECHNESCAN, TECHNETIUM TC-99M OXIDRONATE KIT THALLOUS CHLORIDE TL 201, THALLOUS CHLORIDE TL-201 ULTRATAG, TECHNETIUM TC-99M RED BLOOD CELL KIT
ULTRA-TECHNEKOW FM, TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR
MALLINCKRODT INC * MALLINCKRODT INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE EXALGO, HYDROMORPHONE HYDROCHLORIDE FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
RESTORIL, TEMAZEPAM
TOFRANIL, IMIPRAMINE HYDROCHLORIDE
B - 81
APPENDIX B
* MALLINCKRODT INC TOFRANIL-PM, IMIPRAMINE PAMOATE MALLINCKRODT LLC * MALLINCKRODT LLC ANAFRANIL, CLOMIPRAMINE HYDROCHLORIDE
PAMELOR, NORTRIPTYLINE HYDROCHLORIDE
MARATHON PHARMS * MARATHON PHARMACEUTICALS LLC SECONAL SODIUM, SECOBARBITAL SODIUM MARKSANS PHARMA * MARKSANS PHARMA LTD GABAPENTIN, GABAPENTIN IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN, NAPROXEN
(OTC)
MARSAM PHARMS LLC * MARSAM PHARMACEUTICALS LLC TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE MATRIX LABS LTD * MATRIX LABORATORIES LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE BACLOFEN, BACLOFEN CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE DIDANOSINE, DIDANOSINE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE GABAPENTIN, GABAPENTIN LANSOPRAZOLE, LANSOPRAZOLE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NABUMETONE, NABUMETONE NIFEDIPINE, NIFEDIPINE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PRAVASTATIN SODIUM, PRAVASTATIN SODIUM RAMIPRIL, RAMIPRIL SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN STAVUDINE, STAVUDINE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE
VORICONAZOLE, VORICONAZOLE
ZIDOVUDINE, ZIDOVUDINE
MAYNE PHARMA * MAYNE PHARMA INTERNATIONAL PTY LTD DORYX, DOXYCYCLINE HYCLATE MCNEIL * MCNEIL CONSUMER PRODUCTS CO DIV MCNEILAB INC CHILDREN'S MOTRIN, IBUPROFEN (OTC) IBUPROFEN, IBUPROFEN (OTC) IMODIUM A-D EZ CHEWS, LOPERAMIDE HYDROCHLORIDE (OTC) IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE MOTRIN IB, IBUPROFEN (OTC)
MOTRIN MIGRAINE PAIN, IBUPROFEN (OTC)
ZYRTEC-D 12 HOUR, CETIRIZINE HYDROCHLORIDE (OTC)
(OTC)
MCNEIL CONS * MCNEIL CONSUMER HEALTHCARE BENADRYL PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE BENADRYL, DIPHENHYDRAMINE HYDROCHLORIDE CHILDREN'S MOTRIN COLD, IBUPROFEN (OTC) CHILDREN'S MOTRIN, IBUPROFEN (OTC) IMODIUM A-D, LOPERAMIDE HYDROCHLORIDE (OTC)
IMODIUM MULTI-SYMPTOM RELIEF, LOPERAMIDE HYDROCHLORIDE (OTC)
B - 82
APPENDIX B
** M **
* MCNEIL CONSUMER HEALTHCARE IMODIUM, LOPERAMIDE HYDROCHLORIDE JUNIOR STRENGTH MOTRIN, IBUPROFEN (OTC) NIZORAL A-D, KETOCONAZOLE (OTC) SINE-AID IB, IBUPROFEN (OTC) SUDAFED 12 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE SUDAFED 24 HOUR, PSEUDOEPHEDRINE HYDROCHLORIDE TYLENOL (CAPLET), ACETAMINOPHEN (OTC)
TYLENOL (GELTAB), ACETAMINOPHEN (OTC)
(OTC) (OTC)
MCNEIL CONSUMER * MCNEIL CONSUMER HEALTHCARE DIV MCNEIL PPC INC CHILDREN'S ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ZYRTEC ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) ZYRTEC HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC)
ZYRTEC, CETIRIZINE HYDROCHLORIDE
MEAD JOHNSON * MEAD JOHNSON AND CO CAFCIT, CAFFEINE CITRATE MEDA PHARMS * MEDA PHARMACEUTICALS EDLUAR, ZOLPIDEM TARTRATE * MEDA PHARMACEUTICALS INC ANADROL-50, OXYMETHOLONE ASTELIN, AZELASTINE HYDROCHLORIDE ASTEPRO, AZELASTINE HYDROCHLORIDE BUTISOL SODIUM, BUTABARBITAL SODIUM CESAMET, NABILONE COLYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350 COLYTE, POLYETHYLENE GLYCOL 3350 COLYTE-FLAVORED, POLYETHYLENE GLYCOL 3350 CORTIFOAM, HYDROCORTISONE ACETATE DEMADEX, TORSEMIDE DEPEN, PENICILLAMINE DIPENTUM, OLSALAZINE SODIUM EPIFOAM, HYDROCORTISONE ACETATE FELBATOL, FELBAMATE LUFYLLIN, DYPHYLLINE MUSE, ALPROSTADIL ONSOLIS, FENTANYL CITRATE OPTIVAR, AZELASTINE HYDROCHLORIDE PROCTOFOAM HC, HYDROCORTISONE ACETATE ROWASA, MESALAMINE
SFROWASA, MESALAMINE
TRILYTE, POLYETHYLENE GLYCOL 3350
* MEDA PHARMACEUTICALS MEDA PHARMACEUTICALS INC SOMA COMPOUND W/ CODEINE, ASPIRIN
SOMA COMPOUND, ASPIRIN
SOMA, CARISOPRODOL
MEDICINES CO * THE MEDICINES CO
ANGIOMAX, BIVALIRUDIN
CLEVIPREX, CLEVIDIPINE BUTYRATE
MEDICIS * MEDICIS PHARMACEUTICAL CORP ALDARA, IMIQUIMOD BUPHENYL, SODIUM PHENYLBUTYRATE CALCIUM DISODIUM VERSENATE, EDETATE CALCIUM DISODIUM DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DYNACIN, MINOCYCLINE HYDROCHLORIDE ESTRASORB, ESTRADIOL HEMIHYDRATE
LIDEX, FLUOCINONIDE
B - 83
APPENDIX B
** M **
* MEDICIS PHARMACEUTICAL CORP LIDEX-E, FLUOCINONIDE LOPROX, CICLOPIROX MAXAIR, PIRBUTEROL ACETATE METROGEL-VAGINAL, METRONIDAZOLE NORFLEX, ORPHENADRINE CITRATE NORGESIC FORTE, ASPIRIN NORGESIC, ASPIRIN SOLODYN, MINOCYCLINE HYDROCHLORIDE SYNACORT, HYDROCORTISONE TAMBOCOR, FLECAINIDE ACETATE VANOS, FLUOCINONIDE ZIANA, CLINDAMYCIN PHOSPHATE
ZYCLARA, IMIQUIMOD
MEDICURE * MEDICURE INTERNATIONAL INC AGGRASTAT, TIROFIBAN HYDROCHLORIDE MEDIGENE AG * MEDIGENE AG VEREGEN, SINECATECHINS MEDIMETRIKS PHARMS * MEDIMETRIKS PHARMACEUTICALS INC SYNALAR, FLUOCINOLONE ACETONIDE MEDIMMUNE * MEDIMMUNE ETHYOL,
AMIFOSTINE
MEDTRONIC * MEDTRONIC INC LIORESAL, BACLOFEN MERCK * MERCK AND CO INC AMINOHIPPURATE SODIUM, AMINOHIPPURATE SODIUM CANCIDAS, CASPOFUNGIN ACETATE EMEND, APREPITANT FOSAMAX PLUS D, ALENDRONATE SODIUM FOSAMAX, ALENDRONATE SODIUM HYZAAR, HYDROCHLOROTHIAZIDE INVANZ, ERTAPENEM SODIUM JANUMET, METFORMIN HYDROCHLORIDE MAXALT, RIZATRIPTAN BENZOATE MAXALT-MLT, RIZATRIPTAN BENZOATE PRIMAXIN, CILASTATIN SODIUM PROSCAR, FINASTERIDE SINGULAIR, MONTELUKAST SODIUM
STROMECTOL, IVERMECTIN
ZOLINZA, VORINOSTAT
* MERCK RESEARCH LABORATORIES DIV MERCK CO INC CLINORIL, SULINDAC COSOPT, DORZOLAMIDE HYDROCHLORIDE COZAAR, LOSARTAN POTASSIUM MEVACOR, LOVASTATIN NOROXIN, NORFLOXACIN PEPCID, FAMOTIDINE PRINIVIL, LISINOPRIL PRINZIDE, HYDROCHLOROTHIAZIDE PROPECIA, FINASTERIDE SINGULAIR, MONTELUKAST SODIUM
TRUSOPT, DORZOLAMIDE HYDROCHLORIDE
ZOCOR, SIMVASTATIN
B - 84
APPENDIX B
LEVOTHYROXINE SODIUM
MERCK SANTE SAS * MERCK SANTE SAS CYANOKIT, HYDROXOCOBALAMIN MERCK SHARP DOHME * MERCK SHARP AND DOHME CORP CRIXIVAN, INDINAVIR SULFATE ISENTRESS, RALTEGRAVIR POTASSIUM JUVISYNC, SIMVASTATIN PEPCID AC (GELTAB), FAMOTIDINE (OTC) PEPCID AC, FAMOTIDINE (OTC) PEPCID COMPLETE, CALCIUM CARBONATE (OTC)
SINEMET CR, CARBIDOPA
SINEMET, CARBIDOPA
MERIDIAN MEDCL * MERIDIAN MEDICAL TECHNOLOGIES INC DUODOTE, ATROPINE * MERIDIAN MEDICAL TECHNOLOGIES INC SUB KING PHARMACEUTICALS INC ALSUMA, SUMATRIPTAN SUCCINATE MERIDIAN MEDCL TECHN * MERIDIAN MEDICAL TECHNOLOGIES INC ATROPEN, ATROPINE EPIPEN JR., EPINEPHRINE EPIPEN, EPINEPHRINE LIDOPEN, LIDOCAINE HYDROCHLORIDE
MORPHINE SULFATE, MORPHINE SULFATE
PRALIDOXIME CHLORIDE, PRALIDOXIME CHLORIDE
MERRO PHARM * MERRO PHARMACEUTICAL CO LTD IBUPROFEN, IBUPROFEN (OTC) MERZ PHARMS * MERZ PHARMACEUTICALS LLC
ERYGEL, ERYTHROMYCIN
NAFTIN, NAFTIFINE HYDROCHLORIDE
METHAPHARM * METHAPHARM INC
LEVETIRACETAM, LEVETIRACETAM
PROVOCHOLINE, METHACHOLINE CHLORIDE
MICRO LABS LTD * MICRO LABS LTD
MEFENAMIC ACID, MEFENAMIC ACID
SIMVASTATIN, SIMVASTATIN
MIKAH PHARMA * MIKAH PHARMA LLC ISRADIPINE, ISRADIPINE
PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE
TRIMIPRAMINE MALEATE, TRIMIPRAMINE MALEATE
MIKART * MIKART INC ACETAMINOPHEN AND CODEINE PHOSPHATE,
ACETAMINOPHEN
B - 85
APPENDIX B
** M **
* MIKART INC ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, ACETAMINOPHEN AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMINOCAPROIC ACID, AMINOCAPROIC ACID AMINOCAPROIC, AMINOCAPROIC ACID BENZONATATE, BENZONATATE BENZPHETAMINE HYDROCHLORIDE, BENZPHETAMINE HYDROCHLORIDE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTAPAP, ACETAMINOPHEN CARBINOXAMINE MALEATE, CARBINOXAMINE MALEATE CHLORZOXAZONE, CHLORZOXAZONE DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE ERGOTAMINE TARTRATE AND CAFFEINE, CAFFEINE ESGIC-PLUS, ACETAMINOPHEN ETHOSUXIMIDE, ETHOSUXIMIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN ISONIAZID, ISONIAZID MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METHAZOLAMIDE, METHAZOLAMIDE OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PYRAZINAMIDE, PYRAZINAMIDE
TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE
MILLENNIUM PHARMS * MILLENNIUM PHARMACEUTICALS INC VELCADE, BORTEZOMIB MIRROR PHARMS * MIRROR PHARMACEUTICALS LLC BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN CARISOPRODOL AND ASPIRIN, ASPIRIN CARISOPRODOL, CARISOPRODOL CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN
PROBENECID AND COLCHICINE, COLCHICINE
MISSION PHARMA * MISSION PHARMACAL CO LITHOSTAT, ACETOHYDROXAMIC ACID TEXACORT, HYDROCORTISONE TINDAMAX, TINIDAZOLE TIOPRONIN, TIOPRONIN
UROCIT-K, POTASSIUM CITRATE
MN PHARMS * MN PHARMACEUTICALS PAMIDRONATE DISODIUM,
PAMIDRONATE DISODIUM
B - 86
APPENDIX B
MONOSOL RX LLC * MONOSOL RX LLC ZUPLENZ, ONDANSETRON
(OTC)
B - 87
APPENDIX B
* MUTUAL PHARMACEUTICAL CO INC QUINIDINE SULFATE, QUINIDINE SULFATE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE SPIRONOLACTONE, SPIRONOLACTONE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE SULINDAC, SULINDAC TEMAZEPAM, TEMAZEPAM THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE TOLMETIN SODIUM, TOLMETIN SODIUM TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
MUTUAL PHARM CO INC * MUTUAL PHARMACEUTICAL CO INC LEVETIRACETAM, LEVETIRACETAM MUTUAL PHARMA * MUTUAL PHARMACAL CO DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE KETOCONAZOLE, KETOCONAZOLE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE
MYLAN * MYLAN LABORATORIES INC ACYCLOVIR, ACYCLOVIR AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE CAPTOPRIL, CAPTOPRIL ETODOLAC, ETODOLAC
TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE
* MYLAN PHARMACEUTICALS METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE * MYLAN PHARMACEUTICALS INC ACARBOSE, ACARBOSE ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE ACYCLOVIR, ACYCLOVIR ALBUTEROL SULFATE, ALBUTEROL SULFATE ALENDRONATE SODIUM, ALENDRONATE SODIUM ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE ALLOPURINOL, ALLOPURINOL ALPRAZOLAM, ALPRAZOLAM AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMNESTEEM, ISOTRETINOIN ANASTROZOLE, ANASTROZOLE ATENOLOL AND CHLORTHALIDONE, ATENOLOL ATENOLOL, ATENOLOL ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE AVITA, TRETINOIN AZATHIOPRINE, AZATHIOPRINE AZITHROMYCIN, AZITHROMYCIN BACLOFEN, BACLOFEN BALSALAZIDE DISODIUM, BALSALAZIDE DISODIUM BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BICALUTAMIDE, BICALUTAMIDE BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE BISOPROLOL FUMARATE, BISOPROLOL FUMARATE BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE BUDESONIDE, BUDESONIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE
BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE
BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE
B - 88
APPENDIX B
* MYLAN PHARMACEUTICALS INC CAPTOPRIL AND HYDROCHLOROTHIAZIDE, CAPTOPRIL CARBIDOPA AND LEVODOPA, CARBIDOPA CARVEDILOL, CARVEDILOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE CHLOROTHIAZIDE, CHLOROTHIAZIDE CHLORPROPAMIDE, CHLORPROPAMIDE CHLORTHALIDONE, CHLORTHALIDONE CILOSTAZOL, CILOSTAZOL CIMETIDINE, CIMETIDINE CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLARITHROMYCIN, CLARITHROMYCIN CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM CLORPRES, CHLORTHALIDONE CLOZAPINE, CLOZAPINE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYSTAGON, CYSTEAMINE BITARTRATE DIAZEPAM, DIAZEPAM DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM DICLOFENAC SODIUM, DICLOFENAC SODIUM DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE DIVALPROEX SODIUM, DIVALPROEX SODIUM DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE DOXYCYCLINE, DOXYCYCLINE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ENALAPRIL MALEATE, ENALAPRIL MALEATE ESTRADIOL, ESTRADIOL ESTROPIPATE, ESTROPIPATE ETIDRONATE DISODIUM, ETIDRONATE DISODIUM ETOPOSIDE, ETOPOSIDE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM FAMCICLOVIR, FAMCICLOVIR FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FELODIPINE, FELODIPINE FENOFIBRATE, FENOFIBRATE FENOPROFEN CALCIUM, FENOPROFEN CALCIUM FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FINASTERIDE, FINASTERIDE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE FLURBIPROFEN, FLURBIPROFEN FLUTAMIDE, FLUTAMIDE FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FUROSEMIDE, FUROSEMIDE
GABAPENTIN, GABAPENTIN
GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE
B - 89
APPENDIX B
* MYLAN PHARMACEUTICALS INC GLIMEPIRIDE, GLIMEPIRIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GLIPIZIDE, GLIPIZIDE GLYBURIDE (MICRONIZED), GLYBURIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE INDAPAMIDE, INDAPAMIDE INDOMETHACIN, INDOMETHACIN KETOCONAZOLE, KETOCONAZOLE KETOPROFEN, KETOPROFEN KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LAMOTRIGINE, LAMOTRIGINE LATANOPROST, LATANOPROST LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE LORATADINE, LORATADINE (OTC) LORAZEPAM, LORAZEPAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOVASTATIN, LOVASTATIN LOXAPINE SUCCINATE, LOXAPINE SUCCINATE MAPROTILINE HYDROCHLORIDE, MAPROTILINE HYDROCHLORIDE MECLOFENAMATE SODIUM, MECLOFENAMATE SODIUM MELOXICAM, MELOXICAM MENTAX, BUTENAFINE HYDROCHLORIDE MENTAX-TC, BUTENAFINE HYDROCHLORIDE MERCAPTOPURINE, MERCAPTOPURINE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHIMAZOLE, METHIMAZOLE METHOTREXATE SODIUM, METHOTREXATE SODIUM METHYCLOTHIAZIDE, METHYCLOTHIAZIDE METHYLDOPA AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE METHYLDOPA, METHYLDOPA METOLAZONE, METOLAZONE METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NADOLOL AND BENDROFLUMETHAZIDE, BENDROFLUMETHIAZIDE NADOLOL, NADOLOL NAPROXEN, NAPROXEN NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NIFEDIPINE, NIFEDIPINE NISOLDIPINE, NISOLDIPINE NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE NIZATIDINE, NIZATIDINE NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE OMEPRAZOLE, OMEPRAZOLE
ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
ONDANSETRON, ONDANSETRON
B - 90
APPENDIX B
* MYLAN PHARMACEUTICALS INC OXAPROZIN, OXAPROZIN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE PACLITAXEL, PACLITAXEL PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350 PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL 3350 PENTOXIFYLLINE, PENTOXIFYLLINE PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE PHENYTEK, PHENYTOIN SODIUM PINDOLOL, PINDOLOL PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE PIROXICAM, PIROXICAM POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PRAZOSIN HYDROCHLORIDE, PRAZOSIN HYDROCHLORIDE PROBENECID, PROBENECID PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SELEGILINE HYDROCHLORIDE, SELEGILINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE SPIRONOLACTONE, SPIRONOLACTONE STAVUDINE, STAVUDINE SULINDAC, SULINDAC SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TACROLIMUS, TACROLIMUS TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TEMAZEPAM, TEMAZEPAM TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE THIORIDAZINE HYDROCHLORIDE, THIORIDAZINE HYDROCHLORIDE THIOTHIXENE, THIOTHIXENE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIMOLOL MALEATE, TIMOLOL MALEATE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TOLAZAMIDE, TOLAZAMIDE TOLBUTAMIDE, TOLBUTAMIDE TOLMETIN SODIUM, TOLMETIN SODIUM TOPIRAMATE, TOPIRAMATE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRANDOLAPRIL, TRANDOLAPRIL TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE URSODIOL, URSODIOL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE WARFARIN SODIUM, WARFARIN SODIUM ZALEPLON, ZALEPLON
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
ZONISAMIDE, ZONISAMIDE
B - 91
APPENDIX B
GRANISETRON HYDROCHLORIDE
NATCO PHARMA LTD * NATCO PHARMA LIMITED CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE * NATCO PHARMA LTD ANASTROZOLE, ANASTROZOLE CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE LETROZOLE, LETROZOLE
ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE
NAUTILUS NEUROSCIENC * NAUTILUS NEUROSCIENCES INC CAMBIA, DICLOFENAC POTASSIUM NAVINTA LLC * NAVINTA LLC FAMOTIDINE, FAMOTIDINE
FOMEPIZOLE, FOMEPIZOLE
NICARDIPINE HYDROCHLORIDE,
NICARDIPINE HYDROCHLORIDE
ALBUTEROL SULFATE
B - 92
APPENDIX B
NESHER PHARMS * NESHER PHARMACEUTICALS USA LLC BENZONATATE, BENZONATATE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE METOPROLOL SUCCINATE, METOPROLOL SUCCINATE MICRO-K 10, POTASSIUM CHLORIDE MICRO-K, POTASSIUM CHLORIDE MORPHINE SULFATE, MORPHINE SULFATE NYSTATIN, NYSTATIN ONDANSETRON, ONDANSETRON OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE, PREDNISOLONE
PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE
NEUROGESX * NEUROGESX INC QUTENZA, CAPSAICIN NEW RIVER * NEW RIVER PHARMACEUTICALS INC PROFERDEX, IRON DEXTRAN NEXGEN PHARMA * NEXGEN PHARMA INC BUTALBITAL AND ACETAMINOPHEN, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN
CHENODIOL, CHENODIOL
POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC)
NEXGEN PHARMA INC * NEXGEN PHARMA INC BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN
POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350
NEXUS PHARMS * NEXUS PHARMACEUTICALS INC BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM
LEVETIRACETAM, LEVETIRACETAM
LEVOFLOXACIN, LEVOFLOXACIN
NIAGARA PHARMS * NIAGARA PHARMACEUTICALS INC PUR-WASH, PURIFIED WATER
(OTC)
NORTHSTAR HLTHCARE * NORTHSTAR HEALTHCARE HOLDINGS LTD ALLOPURINOL, ALLOPURINOL ATENOLOL, ATENOLOL BACLOFEN, BACLOFEN GEMFIBROZIL, GEMFIBROZIL HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE IBUPROFEN, IBUPROFEN METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
B - 93
APPENDIX B
(OTC)
B - 94
APPENDIX B
* NOVARTIS PHARMACEUTICALS CORP METHERGINE, METHYLERGONOVINE MALEATE METOPIRONE, METYRAPONE MIACALCIN, CALCITONIN SALMON MYFORTIC, MYCOPHENOLIC ACID NEORAL, CYCLOSPORINE OCUPRESS, CARTEOLOL HYDROCHLORIDE PARLODEL, BROMOCRIPTINE MESYLATE RECLAST, ZOLEDRONIC ACID REGITINE, PHENTOLAMINE MESYLATE RITALIN LA, METHYLPHENIDATE HYDROCHLORIDE RITALIN, METHYLPHENIDATE HYDROCHLORIDE RITALIN-SR, METHYLPHENIDATE HYDROCHLORIDE SANDIMMUNE, CYCLOSPORINE SANDOSTATIN LAR, OCTREOTIDE ACETATE SANDOSTATIN, OCTREOTIDE ACETATE STARLIX, NATEGLINIDE TASIGNA, NILOTINIB HYDROCHLORIDE MONOHYDRATE TAVIST-1, CLEMASTINE FUMARATE (OTC) TEGRETOL, CARBAMAZEPINE TEGRETOL-XR, CARBAMAZEPINE TEKAMLO, ALISKIREN HEMIFUMARATE TEKTURNA HCT, ALISKIREN HEMIFUMARATE TEKTURNA, ALISKIREN HEMIFUMARATE TRILEPTAL, OXCARBAZEPINE TYZEKA, TELBIVUDINE VALTURNA, ALISKIREN HEMIFUMARATE VASOCIDIN, PREDNISOLONE SODIUM PHOSPHATE VIVELLE, ESTRADIOL VIVELLE-DOT, ESTRADIOL VOLTAREN, DICLOFENAC SODIUM VOLTAREN-XR, DICLOFENAC SODIUM ZOMETA, ZOLEDRONIC ACID
ZORTRESS, EVEROLIMUS
NOVARTIS PHARMS * NOVARTIS PHARMACEUTICALS CORP FEMARA, LETROZOLE
TOBI, TOBRAMYCIN
NOVAST LABS LTD * NOVAST LABORATORIES LTD DASETTA 1/35, ETHINYL ESTRADIOL DASETTA 7/7/7, ETHINYL ESTRADIOL
LEVONEST, ETHINYL ESTRADIOL
PHILITH, ETHINYL ESTRADIOL
NOVEL LABS INC * NOVEL LABORATORIES INC HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, HOMATROPINE METHYLBROMIDE METHYLERGONOVINE MALEATE, METHYLERGONOVINE MALEATE MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS PEG 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350 PEG-3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE, POLYETHYLENE GLYCOL 3350 PHENELZINE SULFATE, PHENELZINE SULFATE POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) SULFAMETHOPRIM, SULFAMETHOXAZOLE SULFAMETHOPRIM-DS, SULFAMETHOXAZOLE TEMAZEPAM, TEMAZEPAM TRIMETHOPRIM, TRIMETHOPRIM NOVEN * NOVEN PHARMACEUTICALS INC FENTANYL-100, FENTANYL
FENTANYL-25, FENTANYL
B - 95
APPENDIX B
* NOVEN PHARMACEUTICALS INC
FENTANYL-50, FENTANYL
FENTANYL-75, FENTANYL
NOVEN PHARMS INC * NOVEN PHARMACEUTICALS INC DAYTRANA, METHYLPHENIDATE NOVEN THERAP * NOVEN THERAPEUTICS LLC
LITHOBID, LITHIUM CARBONATE
PEXEVA, PAROXETINE MESYLATE
NOVEX * NOVEX PHARMA ALBUTEROL SULFATE, ALBUTEROL SULFATE BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE CARTEOLOL HYDROCHLORIDE, CARTEOLOL HYDROCHLORIDE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE CROMOLYN SODIUM, CROMOLYN SODIUM CYCLOSPORINE, CYCLOSPORINE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE LACTULOSE, LACTULOSE LEVOBUNOLOL HYDROCHLORIDE, LEVOBUNOLOL HYDROCHLORIDE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL (FOR WOMEN), MINOXIDIL (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) OFLOXACIN, OFLOXACIN
OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
TOBRAMYCIN, TOBRAMYCIN
NOVO NORDISK * NOVO NORDISK PHARMACEUTICALS INC GLUCAGEN, GLUCAGON HYDROCHLORIDE RECOMBINANT NOVO NORDISK INC * NOVO NORDISK INC ACTIVELLA, ESTRADIOL LEVEMIR, INSULIN DETEMIR RECOMBINANT NORDITROPIN FLEXPRO, SOMATROPIN RECOMBINANT NORDITROPIN NORDIFLEX, SOMATROPIN RECOMBINANT NORDITROPIN, SOMATROPIN RECOMBINANT NOVOLIN 70/30, INSULIN RECOMBINANT HUMAN (OTC) NOVOLIN N, INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (OTC) NOVOLIN R, INSULIN RECOMBINANT HUMAN (OTC) NOVOLOG MIX 70/30, INSULIN ASPART PROTAMINE RECOMBINANT NOVOLOG, INSULIN ASPART RECOMBINANT PRANDIMET, METFORMIN HYDROCHLORIDE PRANDIN, REPAGLINIDE
VAGIFEM, ESTRADIOL
VICTOZA, LIRAGLUTIDE RECOMBINANT
NOVOCOL * NOVOCOL PHARMACEUTICAL INC
ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN, LEVONORDEFRIN
ISOCAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE
NOVOCOL INC * NOVOCOL INC LIDOCAINE,
LIDOCAINE
DIVALPROEX SODIUM
B - 96
APPENDIX B
NYCOMED US * NYCOMED US INC ADAPALENE, ADAPALENE ALVESCO, CICLESONIDE CALCIPOTRIENE, CALCIPOTRIENE CARMOL HC, HYDROCORTISONE ACETATE CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE DESOXIMETASONE, DESOXIMETASONE IMIQUIMOD, IMIQUIMOD LIDOCAINE AND PRILOCAINE, LIDOCAINE MOMETASONE FUROATE, MOMETASONE FUROATE OMNARIS, CICLESONIDE TEMOVATE, CLOBETASOL PROPIONATE TERCONAZOLE, TERCONAZOLE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE
ZONALON, DOXEPIN HYDROCHLORIDE
OAK PHARMS * OAK PHARMACEUTICALS INC
EMLA, LIDOCAINE
XYLOCAINE, LIDOCAINE HYDROCHLORIDE
ODYSSEY PHARMS * ODYSSEY PHARMACEUTICALS INC ANTABUSE, DISULFIRAM NYSTATIN, NYSTATIN SURMONTIL, TRIMIPRAMINE MALEATE
URECHOLINE, BETHANECHOL CHLORIDE
VIVACTIL, PROTRIPTYLINE HYDROCHLORIDE
OHM * OHM CORP IBUPROFEN,
IBUPROFEN
(OTC)
OHM LABS * OHM LABORATORIES INC ACETAMINOPHEN, ACETAMINOPHEN (OTC) IBUPROFEN, IBUPROFEN IBUPROHM COLD AND SINUS, IBUPROFEN (OTC)
IBUPROHM, IBUPROFEN (OTC)
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE OLTA PHARMS * OLTA PHARMACEUTICALS CORP LINDANE, LINDANE OMAN PHARM PRODUCTS * OMAN PHARMACEUTICAL PRODUCTS CO LLC NEOMYCIN SULFATE, NEOMYCIN SULFATE
(OTC)
ONCO THERAPIES LTD * ONCO THERAPIES LTD CARBOPLATIN, CARBOPLATIN CLADRIBINE, CLADRIBINE CYTARABINE, CYTARABINE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE
PACLITAXEL, PACLITAXEL
ONY * ONY INC INFASURF PRESERVATIVE FREE,
CALFACTANT
B - 97
APPENDIX B
OPTIMER PHARMS * OPTIMER PHARMACEUTICALS INC DIFICID, FIDAXOMICIN
ORAPHARMA * ORAPHARMA INC ARESTIN, MINOCYCLINE HYDROCHLORIDE ORCHID HLTHCARE * ORCHID HEALTHCARE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFDINIR, CEFDINIR CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL CEFUROXIME AXETIL, CEFUROXIME AXETIL CEPHALEXIN, CEPHALEXIN CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) DESLORATADINE, DESLORATADINE DIVALPROEX SODIUM, DIVALPROEX SODIUM GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE
TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
* ORCHID HEALTHCARE DIV ORCHID CHEMICALS AND PHARMACEUTICALS LTD ZALEPLON, ZALEPLON ORGANON USA INC * ORGANON USA INC CYCLESSA, DESOGESTREL DESOGEN, DESOGESTREL FOLLISTIM AQ, FOLLITROPIN ALFA/BETA GANIRELIX ACETATE INJECTION, GANIRELIX ACETATE IMPLANON, ETONOGESTREL NEXPLANON, ETONOGESTREL NUVARING, ETHINYL ESTRADIOL PREGNYL, GONADOTROPIN, CHORIONIC REMERON SOLTAB, MIRTAZAPINE
REMERON, MIRTAZAPINE
SAPHRIS, ASENAPINE MALEATE
ORION * ORION CORP COMTAN, ENTACAPONE STALEVO 100, CARBIDOPA STALEVO 125, CARBIDOPA STALEVO 150, CARBIDOPA STALEVO 200, CARBIDOPA
STALEVO 50, CARBIDOPA
STALEVO 75, CARBIDOPA
ORIT LABS LLC * ORIT LABORATORIES LLC BENZONATATE, BENZONATATE
CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE
ERGOCALCIFEROL, ERGOCALCIFEROL
ORPHAN EUROPE * ORPHAN EUROPE CARBAGLU, CARGLUMIC ACID ORTHO BIOTECH * ORTHO BIOTECH PRODUCTS LP DOXIL, DOXORUBICIN HYDROCHLORIDE
B - 98
APPENDIX B
ORTHO JANSSEN * ORTHO DERMATOLOGICS DIV JANSSEN PHARMACEUTICALS INC ERTACZO, SERTACONAZOLE NITRATE
RENOVA, TRETINOIN
RETIN-A, TRETINOIN
ORTHO MCNEIL JANSSEN * ORTHO MCNEIL JANSSEN PHARMACEUTICALS INC NIZORAL, KETOCONAZOLE ORTHONEUTROGENA * ORTHONEUTROGENA GRIFULVIN V, GRISEOFULVIN, MICROCRYSTALLINE OSI PHARMS * OSI PHARMACEUTICALS INC TARCEVA, ERLOTINIB HYDROCHLORIDE OSMOTICA PHARM * OSMOTICA PHARMACEUTICAL CORP NIFEDIPINE, NIFEDIPINE
OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
OTSUKA * OTSUKA PHARMACEUTICAL CO LTD
ABILIFY, ARIPIPRAZOLE
PLETAL, CILOSTAZOL
* OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC ABILIFY, ARIPIPRAZOLE OTSUKA AMERICA * OTSUKA AMERICA PHARMACEUTICALS INC BREATHTEK UBT FOR H-PYLORI, UREA C-13 OTSUKA AMERICA PHARM * OTSUKA AMERICA PHARMACEUTICAL INC SAMSCA, TOLVAPTAN OTSUKA PHARM * OTSUKA PHARMACEUTICAL CO LTD BUSULFEX, BUSULFAN OUTLOOK PHARMS * OUTLOOK PHARMACEUTICALS INC DEXTROAMPHETAMINE SULFATE, PACIFIC PHARMA * PACIFIC PHARMA TIMOLOL MALEATE, * PACIFIC PHARMA INC TIMOLOL MALEATE,
DEXTROAMPHETAMINE SULFATE
BENZPHETAMINE HYDROCHLORIDE
PADDOCK LABS * PADDOCK LABORATORIES INC CLINDAMYCIN PALMITATE HYDROCHLORIDE, PADDOCK LLC * PADDOCK LABORATORIES LLC AMMONIUM LACTATE, AMMONIUM LACTATE
B - 99
APPENDIX B
* PADDOCK LABORATORIES LLC BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE CAFFEINE CITRATE, CAFFEINE CITRATE CALCIUM ACETATE, CALCIUM ACETATE CICLOPIROX, CICLOPIROX CLENZ-LYTE, POLYETHYLENE GLYCOL 3350 CLINDA-DERM, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM COLOCORT, HYDROCORTISONE COMPRO, PROCHLORPERAZINE DIHYDROERGOTAMINE MESYLATE, DIHYDROERGOTAMINE MESYLATE ERYTHRA-DERM, ERYTHROMYCIN FLAVOXATE HYDROCHLORIDE, FLAVOXATE HYDROCHLORIDE INDOMETHACIN, INDOMETHACIN KIONEX, SODIUM POLYSTYRENE SULFONATE LATANOPROST, LATANOPROST LAX-LYTE WITH FLAVOR PACKS, POLYETHYLENE GLYCOL 3350 LORAZEPAM, LORAZEPAM MIDAMOR, AMILORIDE HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NYSTOP, NYSTATIN PODOFILOX, PODOFILOX POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES, POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC) POTASSIUM CHLORIDE, POTASSIUM CHLORIDE PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE
TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE
TROSPIUM CHLORIDE, TROSPIUM CHLORIDE
PALADIN LABS * PALADIN LABS USA INC ANTIZOL, FOMEPIZOLE PAR PHARM * PAR PHARMACEUTICAL NABUMETONE, NABUMETONE OMEPRAZOLE AND SODIUM BICARBONATE, OMEPRAZOLE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
* PAR PHARMACEUTICAL INC ALPRAZOLAM, ALPRAZOLAM AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE CABERGOLINE, CABERGOLINE CALCITONIN-SALMON, CALCITONIN SALMON CAPOTEN, CAPTOPRIL CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE CHOLESTYRAMINE, CHOLESTYRAMINE CLOMIPHENE CITRATE, CLOMIPHENE CITRATE CLONAZEPAM, CLONAZEPAM CYPROHEPTADINE HYDROCHLORIDE, CYPROHEPTADINE HYDROCHLORIDE DEXAMETHASONE, DEXAMETHASONE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE
DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE
DOXYCYCLINE, DOXYCYCLINE
B - 100
APPENDIX B
** P **
* PAR PHARMACEUTICAL INC ESTAZOLAM, ESTAZOLAM FLUTAMIDE, FLUTAMIDE GLYCOPYRROLATE, GLYCOPYRROLATE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDRA-ZIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYUREA, HYDROXYUREA IBUPROFEN, IBUPROFEN (OTC) IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE LEVETIRACETAM, LEVETIRACETAM MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE MEGACE ES, MEGESTROL ACETATE MEGESTROL ACETATE, MEGESTROL ACETATE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METRONIDAZOLE, METRONIDAZOLE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MINOXIDIL, MINOXIDIL NASCOBAL, CYANOCOBALAMIN NATEGLINIDE, NATEGLINIDE NYSTATIN, NYSTATIN OLANZAPINE, OLANZAPINE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON OXANDROLONE, OXANDROLONE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RISPERIDONE, RISPERIDONE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TORSEMIDE, TORSEMIDE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRANYLCYPROMINE SULFATE, TRANYLCYPROMINE SULFATE
VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
PARAPRO PHARMS * PARAPRO PHARMACEUTICALS LLC NATROBA, SPINOSAD PARKE DAVIS * PARKE DAVIS DIV WARNER LAMBERT CO CELONTIN, METHSUXIMIDE DILANTIN, PHENYTOIN SODIUM DILANTIN-125, PHENYTOIN NARDIL, PHENELZINE SULFATE NEURONTIN, GABAPENTIN
ZARONTIN, ETHOSUXIMIDE
* PARKE DAVIS PHARMACEUTICAL RESEARCH DIV WARNER LAMBERT CO ZARONTIN, ETHOSUXIMIDE PBS * PBS REGULATORY CONSULTING SERVICES INC LEUKERAN, CHLORAMBUCIL PEDIATRX * PEDIATRX INC GRANISETRON HYDROCHLORIDE,
GRANISETRON HYDROCHLORIDE
ACETAMINOPHEN
(OTC)
B - 101
APPENDIX B
** P **
* L PERRIGO CO ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) CHILDREN'S IBUPROFEN, IBUPROFEN (OTC) CROMOLYN SODIUM, CROMOLYN SODIUM (OTC) DOXYLAMINE SUCCINATE, DOXYLAMINE SUCCINATE (OTC) FAMOTIDINE, FAMOTIDINE (OTC) IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN (OTC) IBUPROFEN, IBUPROFEN (OTC) LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE (OTC) LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) LORATADINE, LORATADINE (OTC) MICONAZOLE 3 COMBINATION PACK, MICONAZOLE NITRATE (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE, NAPROXEN SODIUM (OTC) NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) TAB-PROFEN, IBUPROFEN (OTC)
TIOCONAZOLE, TIOCONAZOLE (OTC)
* PERRIGO CO CICLOPIROX, CICLOPIROX CIMETIDINE, CIMETIDINE (OTC) CLEMASTINE FUMARATE, CLEMASTINE FUMARATE (OTC) CLINDETS, CLINDAMYCIN PHOSPHATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE ERYTHROMYCIN, ERYTHROMYCIN FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE IBUPROFEN, IBUPROFEN (OTC) JUNIOR STRENGTH IBUPROFEN, IBUPROFEN (OTC) LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) MICONAZOLE NITRATE COMBINATION PACK, MICONAZOLE NITRATE (OTC) MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL (FOR WOMEN), MINOXIDIL (OTC) MOMETASONE FUROATE, MOMETASONE FUROATE NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) STIE-CORT, HYDROCORTISONE PERRIGO CO TENNESSEE * PERRIGO CO TENNESSEE INC
GRISEOFULVIN, GRISEOFULVIN, MICROCRYSTALLINE
SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM
PERRIGO ISRAEL * PERRIGO ISRAEL PHARMACEUTICALS LTD CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE IMIQUIMOD, IMIQUIMOD KETOCONAZOLE, KETOCONAZOLE
MESALAMINE, MESALAMINE
MINOXIDIL, MINOXIDIL (OTC)
PERRIGO NEW YORK * PERRIGO NEW YORK INC ACETAMINOPHEN, ACETAMINOPHEN (OTC) AMMONIUM LACTATE, AMMONIUM LACTATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CENTANY, MUPIROCIN CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE DESONIDE, DESONIDE DESOXIMETASONE, DESOXIMETASONE
ECONAZOLE NITRATE, ECONAZOLE NITRATE
ERYTHROMYCIN, ERYTHROMYCIN
B - 102
APPENDIX B
* PERRIGO NEW YORK INC FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE GENTAMICIN SULFATE, GENTAMICIN SULFATE HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE HYDROCORTISONE, HYDROCORTISONE KETOCONAZOLE, KETOCONAZOLE MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) MOMETASONE FUROATE, MOMETASONE FUROATE MUPIROCIN, MUPIROCIN NYSTATIN, NYSTATIN PERMETHRIN, PERMETHRIN PERMETHRIN, PERMETHRIN (OTC) PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE SELENIUM SULFIDE, SELENIUM SULFIDE TERCONAZOLE, TERCONAZOLE
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
PERRIGO R AND D * PERRIGO R AND D CO CALCIUM CARBONATE, FAMOTIDINE AND MAGNESIUM HYDROXIDE, CALCIUM CARBONATE (OTC) CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) DESLORATADINE, DESLORATADINE GUAIFENESIN, GUAIFENESIN (OTC) IBUPROFEN AND DIPHENHYDRAMINE CITRATE, DIPHENHYDRAMINE CITRATE (OTC) IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) LEVONORGESTREL, LEVONORGESTREL LEVONORGESTREL, LEVONORGESTREL (OTC) MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) NAPROXEN, NAPROXEN
NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC)
POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350 (OTC)
* PERRIGO R AND D COMPANY LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC)
NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC)
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC)
PERRIGO UK FINCO * PERRIGO UK FINCO LTD PARTNERSHIP CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE PETNET * PETNET SOLUTIONS INC FLUDEOXYGLUCOSE F18,
FLUDEOXYGLUCOSE F-18
B - 103
APPENDIX B
** P **
* PFIZER INC FAMOTIDINE PRESERVATIVE FREE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE FLAGYL I.V. RTU IN PLASTIC CONTAINER, METRONIDAZOLE FLUMAZENIL, FLUMAZENIL FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GEODON, ZIPRASIDONE HYDROCHLORIDE GEODON, ZIPRASIDONE MESYLATE GLUCOTROL XL, GLIPIZIDE GLUCOTROL, GLIPIZIDE HALOPERIDOL, HALOPERIDOL LACTATE HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM ISOPTIN SR, VERAPAMIL HYDROCHLORIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LIPITOR, ATORVASTATIN CALCIUM NAVANE, THIOTHIXENE NORVASC, AMLODIPINE BESYLATE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PROCARDIA, NIFEDIPINE REVATIO, SILDENAFIL CITRATE RIFAMPIN, RIFAMPIN TOVIAZ, FESOTERODINE FUMARATE UNASYN, AMPICILLIN SODIUM VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE VECURONIUM BROMIDE, VECURONIUM BROMIDE VFEND, VORICONAZOLE XALKORI, CRIZOTINIB
ZITHROMAX, AZITHROMYCIN
* PFIZER LABORATORIES DIV PFIZER INC CARDURA, DOXAZOSIN MESYLATE DIABINESE, CHLORPROPAMIDE FELDENE, PIROXICAM MINIPRESS, PRAZOSIN HYDROCHLORIDE PERMAPEN, PENICILLIN G BENZATHINE PFIZERPEN, PENICILLIN G POTASSIUM PROCARDIA XL, NIFEDIPINE TERRAMYCIN W/ POLYMYXIN B SULFATE, OXYTETRACYCLINE HYDROCHLORIDE UNASYN, AMPICILLIN SODIUM VIBRAMYCIN, DOXYCYCLINE VIBRAMYCIN, DOXYCYCLINE CALCIUM VIBRAMYCIN, DOXYCYCLINE HYCLATE
VISTARIL, HYDROXYZINE PAMOATE
* PFIZER PHARMACEUTICALS INC ZOLOFT, SERTRALINE HYDROCHLORIDE * PFIZER PHARMACEUTICALS PRODUCTION CORP LTD TIKOSYN, DOFETILIDE PFIZER CONS HLTHCARE * PFIZER CONSUMER HEALTHCARE ADVIL ALLERGY AND CONGESTION RELIEF, CHLORPHENIRAMINE MALEATE ADVIL PM, DIPHENHYDRAMINE CITRATE (OTC)
PFIZER GLOBAL * PFIZER GLOBAL RESEARCH DEVELOPMENT ZMAX, AZITHROMYCIN PFIZER INC * PFIZER INC CAMPTOSAR, IRINOTECAN HYDROCHLORIDE CHANTIX, VARENICLINE TARTRATE ELLENCE, EPIRUBICIN HYDROCHLORIDE
GEODON, ZIPRASIDONE HYDROCHLORIDE
NICOTROL, NICOTINE
(OTC)
B - 104
APPENDIX B
DOXORUBICIN HYDROCHLORIDE
METHOTREXATE SODIUM
B - 105
APPENDIX B
* PHARMACIA AND UPJOHN CO CAVERJECT, ALPROSTADIL CLEOCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER, CLEOCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE CLEOCIN T, CLINDAMYCIN PHOSPHATE CLEOCIN, CLINDAMYCIN PALMITATE HYDROCHLORIDE CLEOCIN, CLINDAMYCIN PHOSPHATE COLESTID, COLESTIPOL HYDROCHLORIDE CORTEF, HYDROCORTISONE CORVERT, IBUTILIDE FUMARATE CYKLOKAPRON, TRANEXAMIC ACID DEPO-ESTRADIOL, ESTRADIOL CYPIONATE DEPO-MEDROL, METHYLPREDNISOLONE ACETATE DEPO-PROVERA, MEDROXYPROGESTERONE ACETATE DEPO-TESTOSTERONE, TESTOSTERONE CYPIONATE DETROL LA, TOLTERODINE TARTRATE DETROL, TOLTERODINE TARTRATE DIDREX, BENZPHETAMINE HYDROCHLORIDE EMCYT, ESTRAMUSTINE PHOSPHATE SODIUM ESTRING, ESTRADIOL FLAVORED COLESTID, COLESTIPOL HYDROCHLORIDE GENOTROPIN PRESERVATIVE FREE, SOMATROPIN RECOMBINANT GENOTROPIN, SOMATROPIN RECOMBINANT GLYNASE, GLYBURIDE GLYSET, MIGLITOL HALCION, TRIAZOLAM HEMABATE, CARBOPROST TROMETHAMINE IDAMYCIN PFS, IDARUBICIN HYDROCHLORIDE LINCOCIN, LINCOMYCIN HYDROCHLORIDE MEDROL, METHYLPREDNISOLONE MYCOBUTIN, RIFABUTIN NICOTROL, NICOTINE OGEN .625, ESTROPIPATE OGEN 1.25, ESTROPIPATE OGEN 2.5, ESTROPIPATE OGEN 5, ESTROPIPATE PREPIDIL, DINOPROSTONE PROSTIN E2, DINOPROSTONE PROSTIN VR PEDIATRIC, ALPROSTADIL PROVERA, MEDROXYPROGESTERONE ACETATE R-GENE 10, ARGININE HYDROCHLORIDE SOLU-CORTEF, HYDROCORTISONE SODIUM SUCCINATE SOLU-MEDROL, METHYLPREDNISOLONE SODIUM SUCCINATE SOMAVERT, PEGVISOMANT XALATAN, LATANOPROST XANAX, ALPRAZOLAM
ZINECARD, DEXRAZOXANE HYDROCHLORIDE
ZYVOX, LINEZOLID
* PHARMACIA AND UPJOHN SUB PFIZER INC DEPO-SUBQ PROVERA 104, MEDROXYPROGESTERONE ACETATE
CLINDAMYCIN PHOSPHATE
PHARMAFORCE * PHARMAFORCE INC CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE NANDROLONE DECANOATE, NANDROLONE DECANOATE
NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE
TRANEXAMIC ACID, TRANEXAMIC ACID
PHARMALUCENCE * PHARMALUCENCE INC AN-DTPA, TECHNETIUM TC-99M PENTETATE KIT
AN-SULFUR COLLOID, TECHNETIUM TC-99M SULFUR COLLOID KIT
CIS-MDP, TECHNETIUM TC-99M MEDRONATE KIT
B - 106
APPENDIX B
* PHARMALUCENCE INC CIS-PYRO, TECHNETIUM TC-99M PYROPHOSPHATE KIT HEPATOLITE, TECHNETIUM TC-99M DISOFENIN KIT PULMOLITE, TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT TECHNETIUM TC 99M SESTAMIBI, TECHNETIUM TC-99M SESTAMIBI KIT
TECHNETIUM TC-99M MEBROFENIN, TECHNETIUM TC-99M MEBROFENIN KIT
PHARMAX * PHARMAX GROUP INC BETHANECHOL CHLORIDE, PHARMAXIS * PHARMAXIS INC ARIDOL KIT,
BETHANECHOL CHLORIDE
MANNITOL
PIERRE FABRE * PIERRE FABRE MEDICAMENT NAVELBINE, VINORELBINE TARTRATE PIERREL * PIERREL S.P.A. ARTICAINE HYDROCHLORIDE WITH EPINEPHRINE, PINNACLE BIOLGS * PINNACLE BIOLOGICS INC PHOTOFRIN, PORFIMER SODIUM PIRAMAL CRITICAL * PIRAMAL CRITICAL CARE INC ENFLURANE, ENFLURANE
ISOFLURANE, ISOFLURANE
SOJOURN, SEVOFLURANE
PLANTEX * PLANTEX USA INC DIV IKAPHARM INC SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH,
ARTICAINE HYDROCHLORIDE
SULFAMETHOXAZOLE
PLIVA * PLIVA INC AZITHROMYCIN, AZITHROMYCIN BENZTROPINE MESYLATE, BENZTROPINE MESYLATE CARBOPLATIN, CARBOPLATIN CHLORPROPAMIDE, CHLORPROPAMIDE CHLORTHALIDONE, CHLORTHALIDONE CIMETIDINE, CIMETIDINE CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYCLOSPORINE, CYCLOSPORINE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE KETOCONAZOLE, KETOCONAZOLE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE METRONIDAZOLE, METRONIDAZOLE NAPROXEN, NAPROXEN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE PENTOXIFYLLINE, PENTOXIFYLLINE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE THEOPHYLLINE, THEOPHYLLINE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
WARFARIN SODIUM, WARFARIN SODIUM
B - 107
APPENDIX B
PLIVA HRVATSKA DOO * PLIVA HRVATSKA DOO ADAPALENE, ADAPALENE AZITHROMYCIN, AZITHROMYCIN CARVEDILOL, CARVEDILOL CILOSTAZOL, CILOSTAZOL DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
PRAVASTATIN SODIUM, PRAVASTATIN SODIUM
RISPERIDONE, RISPERIDONE
PLIVA LACHEMA * PLIVA LACHEMA AS CARBOPLATIN, CARBOPLATIN
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE
PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM
PLIVA PHARM IND * PLIVA PHARMACEUTICAL INDUSTRY INC TORSEMIDE, TORSEMIDE POHL BOSKAMP * POHL BOSKAMP NITROLINGUAL PUMPSPRAY,
NITROGLYCERIN
B - 108
APPENDIX B
VERTEPORFIN
B - 109
APPENDIX B
QUESTCOR PHARMS * QUESTCOR PHARMACEUTICALS INC DORAL, QUAZEPAM H.P. ACTHAR GEL, CORTICOTROPIN RANBAXY * RANBAXY INC GLYCOPYRROLATE, GLYCOPYRROLATE * RANBAXY LABORATORIES INC EURAX, CROTAMITON EXELDERM, SULCONAZOLE NITRATE FAMOTIDINE, FAMOTIDINE (OTC) HALOG, HALCINONIDE KENALOG, TRIAMCINOLONE ACETONIDE LAC-HYDRIN, AMMONIUM LACTATE RISPERIDONE, RISPERIDONE
ULTRAVATE, HALOBETASOL PROPIONATE
WESTCORT, HYDROCORTISONE VALERATE
* RANBAXY LABORATORIES LTD ACYCLOVIR, ACYCLOVIR AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE CARVEDILOL, CARVEDILOL CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL CEFUROXIME AXETIL, CEFUROXIME AXETIL CEPHALEXIN, CEPHALEXIN CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CLARITHROMYCIN, CLARITHROMYCIN CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DISPERMOX, AMOXICILLIN DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXYCYCLINE, DOXYCYCLINE FENOFIBRATE, FENOFIBRATE FLECAINIDE ACETATE, FLECAINIDE ACETATE FLUCONAZOLE, FLUCONAZOLE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GABAPENTIN, GABAPENTIN GANCICLOVIR, GANCICLOVIR GLIMEPIRIDE, GLIMEPIRIDE LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE (OTC) LORATADINE REDIDOSE, LORATADINE (OTC) LORATADINE, LORATADINE (OTC) LORAZEPAM, LORAZEPAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN OFLOXACIN, OFLOXACIN
ONDANSETRON, ONDANSETRON
OXCARBAZEPINE, OXCARBAZEPINE
B - 110
APPENDIX B
** R **
* RANBAXY LABORATORIES LTD PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (OTC) QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RAMIPRIL, RAMIPRIL RANICLOR, CEFACLOR RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN SOTRET, ISOTRETINOIN SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE ZIDOVUDINE, ZIDOVUDINE
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
* RANBAXY PHARMACEUTICALS INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN AVENTYL HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE CEFACLOR, CEFACLOR CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE, LOPERAMIDE HYDROCHLORIDE (OTC) PENTAZOCINE AND NALOXONE HYDROCHLORIDES, NALOXONE HYDROCHLORIDE RIOMET, METFORMIN HYDROCHLORIDE
SOTRET, ISOTRETINOIN
RANBAXY LABS LTD * RANBAXY LABORATORIES LIMITED NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) * RANBAXY LABORATORIES LTD ACETAMINOPHEN, ACETAMINOPHEN (OTC) ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM
METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
RARE DIS * RARE DISEASE THERAPEUTICS INC ORFADIN, NITISINONE RARE DIS THERAP * RARE DISEASE THERAPEUTICS INC CYSTADANE, BETAINE HYDROCHLORIDE RECIP * RECIP AB THYROSAFE,
POTASSIUM IODIDE
(OTC)
RECKITT BENCKISER * RECKITT BENCKISER DELSYM, DEXTROMETHORPHAN POLISTIREX (OTC) * RECKITT BENCKISER INC MUCINEX D, GUAIFENESIN (OTC) MUCINEX DM, DEXTROMETHORPHAN HYDROBROMIDE (OTC)
MUCINEX, GUAIFENESIN (OTC)
* RECKITT BENCKISER PHARMACEUTICALS INC BUPRENEX, BUPRENORPHINE HYDROCHLORIDE SUBOXONE, BUPRENORPHINE SUBOXONE, BUPRENORPHINE HYDROCHLORIDE
SUBUTEX, BUPRENORPHINE HYDROCHLORIDE
B - 111
APPENDIX B
REDDYS * DOCTOR REDDYS LABORATORIES LTD DESLORATADINE, DESLORATADINE RHODES PHARMS * RHODES PHARMACEUTICALS LP
MORPHINE SULFATE, MORPHINE SULFATE
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE
RHODIA * RHODIA LTD ISOFLURANE,
ISOFLURANE
B - 112
APPENDIX B
* ROXANE LABORATORIES INC CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLARITHROMYCIN, CLARITHROMYCIN CLOTRIMAZOLE, CLOTRIMAZOLE CODEINE SULFATE, CODEINE SULFATE CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE DEXAMETHASONE INTENSOL, DEXAMETHASONE DEXAMETHASONE, DEXAMETHASONE DIAZEPAM INTENSOL, DIAZEPAM DIAZEPAM, DIAZEPAM DIGOXIN, DIGOXIN DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, ATROPINE SULFATE DOLOPHINE HYDROCHLORIDE, METHADONE HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXERCALCIFEROL, DOXERCALCIFEROL EXEMESTANE, EXEMESTANE FAMCICLOVIR, FAMCICLOVIR FLECAINIDE ACETATE, FLECAINIDE ACETATE FLUCONAZOLE, FLUCONAZOLE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE FUROSEMIDE, FUROSEMIDE GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE IMIPRAMINE PAMOATE, IMIPRAMINE PAMOATE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE LACTULOSE, LACTULOSE LETROZOLE, LETROZOLE LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM LEVETIRACETAM, LEVETIRACETAM LEVORPHANOL TARTRATE, LEVORPHANOL TARTRATE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LIDOCAINE VISCOUS, LIDOCAINE HYDROCHLORIDE LITHIUM CARBONATE, LITHIUM CARBONATE LITHIUM CITRATE, LITHIUM CITRATE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) LORAZEPAM INTENSOL, LORAZEPAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE MEGESTROL ACETATE, MEGESTROL ACETATE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE MERCAPTOPURINE, MERCAPTOPURINE METHADONE HYDROCHLORIDE INTENSOL, METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METHOTREXATE SODIUM, METHOTREXATE SODIUM MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NAPROXEN, NAPROXEN NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXCARBAZEPINE, OXCARBAZEPINE OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE PREDNISONE INTENSOL, PREDNISONE PREDNISONE, PREDNISONE PROPANTHELINE BROMIDE, PROPANTHELINE BROMIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE RAMIPRIL, RAMIPRIL
RISPERIDONE, RISPERIDONE
ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE
B - 113
APPENDIX B
* ROXANE LABORATORIES INC ROXICET 5/500, ACETAMINOPHEN ROXICET, ACETAMINOPHEN ROXILOX, ACETAMINOPHEN SODIUM POLYSTYRENE SULFONATE, SODIUM POLYSTYRENE SULFONATE TORSEMIDE, TORSEMIDE TRIAZOLAM, TRIAZOLAM VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE ZALEPLON, ZALEPLON ZIDOVUDINE, ZIDOVUDINE
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
SAGE PRODS * SAGE PRODUCTS INC CHLORHEXIDINE GLUCONATE,
CHLORHEXIDINE GLUCONATE
(OTC)
SAGENT PHARMS * SAGENT PHARMACEUTICALS INC CALCITRIOL, CALCITRIOL HALOPERIDOL, HALOPERIDOL LACTATE HEPARIN SODIUM PRESERVATIVE FREE, HEPARIN SODIUM HEPARIN SODIUM, HEPARIN SODIUM LEVOFLOXACIN, LEVOFLOXACIN ORPHENADRINE CITRATE, ORPHENADRINE CITRATE
TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE
SAGENT STRIDES * SAGENT STRIDES LLC AZITHROMYCIN, AZITHROMYCIN BACITRACIN, BACITRACIN BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE, BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE LABETALOL HYDROCLORIDE, LABETALOL HYDROCHLORIDE MESNA, MESNA METOPROLOL TARTRATE, METOPROLOL TARTRATE MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE, MIDAZOLAM HYDROCHLORIDE MIDOZALAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE POLYMYCIN B SULFATE, POLYMYXIN B SULFATE
ROCURONIUM BROMIDE, ROCURONIUM BROMIDE
SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE
SALIX PHARMS * SALIX PHARMACEUTICALS INC ANUSOL HC, HYDROCORTISONE APRISO, MESALAMINE COLAZAL, BALSALAZIDE DISODIUM DIURIL, CHLOROTHIAZIDE METOZOLV ODT, METOCLOPRAMIDE HYDROCHLORIDE MOVIPREP, ASCORBIC ACID OSMOPREP, SODIUM PHOSPHATE, DIBASIC, ANHYDROUS PEPCID, FAMOTIDINE
VISICOL, SODIUM PHOSPHATE, DIBASIC ANHYDROUS
XIFAXAN, RIFAXIMIN
SAMSON MEDCL * SAMSON MEDICAL TECHNOLOGIES LLC
CEFAZOLIN SODIUM, CEFAZOLIN SODIUM
CEFUROXIME SODIUM IN PLASTIC CONTAINER,
CEFUROXIME SODIUM
SANDOZ * SANDOZ DOCETAXEL, DOCETAXEL * SANDOZ CANADA INC ANECTINE, SUCCINYLCHOLINE CHLORIDE
ARISTOSPAN, TRIAMCINOLONE HEXACETONIDE
BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE
B - 114
APPENDIX B
* SANDOZ CANADA INC COSYNTROPIN, COSYNTROPIN DIGOXIN, DIGOXIN DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE ESTRADIOL VALERATE, ESTRADIOL VALERATE FENOLDOPAM MESYLATE, FENOLDOPAM MESYLATE FLUMAZENIL, FLUMAZENIL GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE INFUVITE ADULT, ALPHA-TOCOPHEROL ACETATE INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE), ASCORBIC ACID INFUVITE PEDIATRIC, ASCORBIC ACID ISONIAZID, ISONIAZID KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE METOPROLOL TARTRATE, METOPROLOL TARTRATE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE REGONOL, PYRIDOSTIGMINE BROMIDE ROCURONIUM BROMIDE, ROCURONIUM BROMIDE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
* SANDOZ INC ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE ALPRAZOLAM, ALPRAZOLAM ALTAVERA, ETHINYL ESTRADIOL AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN AMPICILLIN AND SULBACTAM, AMPICILLIN SODIUM AMPICILLIN SODIUM, AMPICILLIN SODIUM AMPICILLIN TRIHYDRATE, AMPICILLIN/AMPICILLIN TRIHYDRATE ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ANASTROZOLE, ANASTROZOLE ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN ATENOLOL, ATENOLOL ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE AZITHROMYCIN, AZITHROMYCIN BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BICALUTAMIDE, BICALUTAMIDE BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE BISOPROLOL FUMARATE, BISOPROLOL FUMARATE BUMETANIDE, BUMETANIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CAFERGOT, CAFFEINE CAPTOPRIL, CAPTOPRIL CARBOPLATIN, CARBOPLATIN CARISOPRODOL AND ASPIRIN, ASPIRIN CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE, ASPIRIN CARVEDILOL, CARVEDILOL CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFAZOLIN SODIUM, CEFAZOLIN SODIUM CEFDINIR, CEFDINIR CEFEPIME HYDROCHLORIDE, CEFEPIME HYDROCHLORIDE CEFPODOXIME PROXETIL, CEFPODOXIME PROXETIL CEFPROZIL, CEFPROZIL
CEFTRIAXONE, CEFTRIAXONE SODIUM
CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC)
B - 115
APPENDIX B
* SANDOZ INC CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE (OTC) CHLORPROMAZINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE CHOLESTYRAMINE LIGHT, CHOLESTYRAMINE CHOLESTYRAMINE, CHOLESTYRAMINE CILOSTAZOL, CILOSTAZOL CIMETIDINE, CIMETIDINE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLARITHROMYCIN, CLARITHROMYCIN CLEMASTINE FUMARATE, CLEMASTINE FUMARATE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE (OTC) CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYCLOSPORINE, CYCLOSPORINE DESIPRAMINE HYDROCHLORIDE, DESIPRAMINE HYDROCHLORIDE DESLORATADINE, DESLORATADINE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE ASPARTATE
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM
DICLOFENAC SODIUM, DICLOFENAC SODIUM
DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM
DIVALPROEX SODIUM, DIVALPROEX SODIUM
DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE
DOXYCYCLINE, DOXYCYCLINE
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE
ENALAPRIL MALEATE, ENALAPRIL MALEATE
ENOXAPARIN SODIUM (PRESERVATIVE FREE), ENOXAPARIN SODIUM
EPLERENONE, EPLERENONE
ETODOLAC, ETODOLAC
FAMOTIDINE, FAMOTIDINE
FAMOTIDINE, FAMOTIDINE (OTC)
FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE
FLUOROURACIL, FLUOROURACIL
FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE
FLUPHENAZINE HYDROCHLORIDE, FLUPHENAZINE HYDROCHLORIDE
FLUTAMIDE, FLUTAMIDE
FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM
FOSINOPRIL SODIUM, FOSINOPRIL SODIUM
FUROSEMIDE, FUROSEMIDE
GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE
GLIPIZIDE, GLIPIZIDE
HALOPERIDOL, HALOPERIDOL
HEPARIN SODIUM, HEPARIN SODIUM
HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE
HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE
IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE
IMIPRAMINE HYDROCHLORIDE, IMIPRAMINE HYDROCHLORIDE
INDAPAMIDE, INDAPAMIDE
INDOMETHACIN, INDOMETHACIN
INTROVALE, ETHINYL ESTRADIOL
INVAGESIC FORTE, ASPIRIN
INVAGESIC, ASPIRIN
ISONIAZID, ISONIAZID
ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE
ITRACONAZOLE, ITRACONAZOLE
LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE
LAMOTRIGINE, LAMOTRIGINE
LANSOPRAZOLE, LANSOPRAZOLE
LEFLUNOMIDE, LEFLUNOMIDE
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE
B - 116
APPENDIX B
* SANDOZ INC LEVETIRACETAM, LEVETIRACETAM LEVOFLOXACIN, LEVOFLOXACIN LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LOCHOLEST LIGHT, CHOLESTYRAMINE LOCHOLEST, CHOLESTYRAMINE LONOX, ATROPINE SULFATE LORATADINE, LORATADINE (OTC) LORAZEPAM, LORAZEPAM LORYNA, DROSPIRENONE LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOVASTATIN, LOVASTATIN MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE MEROPENEM, MEROPENEM METAXALONE, METAXALONE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METHAZOLAMIDE, METHAZOLAMIDE METHIMAZOLE, METHIMAZOLE METHOCARBAMOL, METHOCARBAMOL METHYLPREDNISOLONE, METHYLPREDNISOLONE METOLAZONE, METOLAZONE METOPROLOL SUCCINATE, METOPROLOL SUCCINATE METOPROLOL TARTRATE, METOPROLOL TARTRATE MIDODRINE HYDROCHLORIDE, MIDODRINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NABUMETONE, NABUMETONE NADOLOL, NADOLOL NAFCILLIN SODIUM, NAFCILLIN SODIUM NALTREXONE HYDROCHLORIDE, NALTREXONE HYDROCHLORIDE NAPROXEN SODIUM, NAPROXEN SODIUM (OTC) NAPROXEN, NAPROXEN NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), NITROFURANTOIN NIZATIDINE, NIZATIDINE OFLOXACIN, OFLOXACIN OMEPRAZOLE, OMEPRAZOLE OMNITROPE, SOMATROPIN RECOMBINANT ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON ORPHENADRINE CITRATE, ORPHENADRINE CITRATE ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ASPIRIN OXACILLIN SODIUM, OXACILLIN SODIUM OXALIPLATIN, OXALIPLATIN OXANDROLONE, OXANDROLONE OXAPROZIN, OXAPROZIN OXAZEPAM, OXAZEPAM PENICILLIN G POTASSIUM, PENICILLIN G POTASSIUM PENICILLIN G SODIUM, PENICILLIN G SODIUM PENICILLIN V POTASSIUM, PENICILLIN V POTASSIUM PERPHENAZINE, PERPHENAZINE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE
QUINIDINE SULFATE, QUINIDINE SULFATE
B - 117
APPENDIX B
** S **
* SANDOZ INC RAMIPRIL, RAMIPRIL RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RESERPINE, RESERPINE RIBAVIRIN, RIBAVIRIN RIFAMPIN, RIFAMPIN RISPERIDONE, RISPERIDONE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SPIRONOLACTONE, SPIRONOLACTONE SULFADIAZINE, SULFADIAZINE SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE SYEDA, DROSPIRENONE TACROLIMUS, TACROLIMUS TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TEMAZEPAM, TEMAZEPAM TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE THIOTHIXENE, THIOTHIXENE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE TRIFLUOPERAZINE HYDROCHLORIDE, TRIFLUOPERAZINE HYDROCHLORIDE VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
ZONISAMIDE, ZONISAMIDE
SANDOZ CANADA INC * SANDOZ CANADA INC PARICALCITOL, PARICALCITOL SANDOZ INC * SANDOZ INC DOCETAXEL, DOCETAXEL ENOXAPARIN SODIUM, ENOXAPARIN SODIUM
VORICONAZOLE, VORICONAZOLE
SANOCHEMIA CORP USA * SANOCHEMIA CORP USA SCANLUX-300, IOPAMIDOL
SCANLUX-370, IOPAMIDOL
SANOFI AVENTIS * SANOFI AVENTIS AVALIDE, HYDROCHLOROTHIAZIDE SANOFI AVENTIS US * SANOFI AVENTIS US INC JEVTANA KIT, CABAZITAXEL * SANOFI AVENTIS US LLC ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) ALLEGRA, FEXOFENADINE HYDROCHLORIDE ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION, FEXOFENADINE HYDROCHLORIDE AMARYL, GLIMEPIRIDE AMBIEN CR, ZOLPIDEM TARTRATE AMBIEN, ZOLPIDEM TARTRATE ANZEMET, DOLASETRON MESYLATE APIDRA SOLOSTAR, INSULIN GLULISINE RECOMBINANT APIDRA, INSULIN GLULISINE RECOMBINANT ARALEN, CHLOROQUINE PHOSPHATE ARAVA, LEFLUNOMIDE AVAPRO, IRBESARTAN
BENZACLIN, BENZOYL PEROXIDE
(OTC) (OTC)
B - 118
APPENDIX B
* SANOFI AVENTIS US LLC BENZAMYCIN PAK, BENZOYL PEROXIDE BENZAMYCIN, BENZOYL PEROXIDE CANTIL, MEPENZOLATE BROMIDE CARAC, FLUOROURACIL CHILDREN'S ALLEGRA ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) CHILDREN'S ALLEGRA HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER, CEFOTAXIME SODIUM CLAFORAN, CEFOTAXIME SODIUM CLOMID, CLOMIPHENE CITRATE DDAVP (NEEDS NO REFRIGERATION), DESMOPRESSIN ACETATE DDAVP, DESMOPRESSIN ACETATE DEMEROL, MEPERIDINE HYDROCHLORIDE DERMATOP E EMOLLIENT, PREDNICARBATE DERMATOP, PREDNICARBATE DIABETA, GLYBURIDE DRISDOL, ERGOCALCIFEROL ELOXATIN, OXALIPLATIN FERRLECIT, SODIUM FERRIC GLUCONATE COMPLEX GAVISCON, ALUMINUM HYDROXIDE (OTC) HIPREX, METHENAMINE HIPPURATE KAYEXALATE, SODIUM POLYSTYRENE SULFONATE KETEK, TELITHROMYCIN KLARON, SULFACETAMIDE SODIUM LANTUS, INSULIN GLARGINE RECOMBINANT LASIX, FUROSEMIDE LOVENOX (PRESERVATIVE FREE), ENOXAPARIN SODIUM LOVENOX, ENOXAPARIN SODIUM MULTAQ, DRONEDARONE HYDROCHLORIDE MYTELASE, AMBENONIUM CHLORIDE NASACORT AQ, TRIAMCINOLONE ACETONIDE NICODERM CQ, NICOTINE (OTC) NILANDRON, NILUTAMIDE NORITATE, METRONIDAZOLE NORPRAMIN, DESIPRAMINE HYDROCHLORIDE OFORTA, FLUDARABINE PHOSPHATE PENLAC, CICLOPIROX PHISOHEX, HEXACHLOROPHENE PLAQUENIL, HYDROXYCHLOROQUINE SULFATE PLAVIX, CLOPIDOGREL BISULFATE PRIFTIN, RIFAPENTINE PRIMAQUINE, PRIMAQUINE PHOSPHATE RIFADIN, RIFAMPIN RIFAMATE, ISONIAZID RIFATER, ISONIAZID RILUTEK, RILUZOLE SKELID, TILUDRONATE DISODIUM TAXOTERE, DOCETAXEL
TRENTAL, PENTOXIFYLLINE
UROXATRAL, ALFUZOSIN HYDROCHLORIDE
SANTARUS * SANTARUS INC FENOGLIDE, FENOFIBRATE GLUMETZA, METFORMIN HYDROCHLORIDE MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE, ZEGERID, OMEPRAZOLE SANTEN * SANTEN INC ALAMAST, PEMIROLAST POTASSIUM
IQUIX, LEVOFLOXACIN
QUIXIN, LEVOFLOXACIN
MAGNESIUM HYDROXIDE
B - 119
APPENDIX B
SANTEN OY * SANTEN OY BETIMOL,
TIMOLOL
SANTOS BIOTECH * SANTOS BIOTECH INDUSTRIES INC ANASTROZOLE, ANASTROZOLE SAVAGE LABS * SAVAGE LABORATORIES INC DIV ALTANA INC KAON CL-10, POTASSIUM CHLORIDE SAVIENT PHARMS * SAVIENT PHARMACEUTICALS INC OXANDRIN, OXANDROLONE SB PHARMCO * SB PHARMCO PUERTO RICO INC AVANDAMET, METFORMIN HYDROCHLORIDE AVANDARYL, GLIMEPIRIDE
AVANDIA, ROSIGLITAZONE MALEATE
COREG CR, CARVEDILOL PHOSPHATE
SCHERING * MERCK, INC. CLARINEX D 24 HOUR, DESLORATADINE * SCHERING CLARINEX-D 12 HOUR, DESLORATADINE * SCHERING CORP ASMANEX TWISTHALER, MOMETASONE FUROATE CLARINEX, DESLORATADINE DIPROLENE AF, BETAMETHASONE DIPROPIONATE DULERA, FORMOTEROL FUMARATE GUANIDINE HYDROCHLORIDE, GUANIDINE HYDROCHLORIDE INTEGRILIN, EPTIFIBATIDE LOTRISONE, BETAMETHASONE DIPROPIONATE NOXAFIL, POSACONAZOLE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE REBETOL, RIBAVIRIN TEMODAR, TEMOZOLOMIDE
VICTRELIS, BOCEPREVIR
ZEMURON, ROCURONIUM BROMIDE
* SCHERING CORP SUB SCHERING PLOUGH CORP CELESTONE SOLUSPAN, BETAMETHASONE ACETATE CELESTONE, BETAMETHASONE
DIPROLENE, BETAMETHASONE DIPROPIONATE
ELOCON, MOMETASONE FUROATE
SCHERING PLOUGH * SCHERING PLOUGH CORP CLARINEX, DESLORATADINE * SCHERING PLOUGH HEALTHCARE PRODUCTS INC AFRINOL, PSEUDOEPHEDRINE SULFATE (OTC) CHILDREN'S CLARITIN, LORATADINE (OTC) CHLOR-TRIMETON, CHLORPHENIRAMINE MALEATE (OTC) CLARITIN HIVES RELIEF REDITAB, LORATADINE (OTC) CLARITIN HIVES RELIEF, LORATADINE (OTC) CLARITIN REDITABS, LORATADINE (OTC) CLARITIN, LORATADINE (OTC) CLARITIN-D 24 HOUR, LORATADINE (OTC) CLARITIN-D, LORATADINE (OTC) DISOPHROL, DEXBROMPHENIRAMINE MALEATE (OTC) DRIXORAL PLUS, ACETAMINOPHEN (OTC) DRIXORAL, DEXBROMPHENIRAMINE MALEATE (OTC) GYNE-LOTRIMIN 3 COMBINATION PACK, CLOTRIMAZOLE (OTC) GYNE-LOTRIMIN 3, CLOTRIMAZOLE (OTC)
GYNE-LOTRIMIN COMBINATION PACK, CLOTRIMAZOLE (OTC)
GYNE-LOTRIMIN, CLOTRIMAZOLE (OTC)
B - 120
APPENDIX B
** S **
* SCHERING PLOUGH HEALTHCARE PRODUCTS INC LOTRIMIN ULTRA, BUTENAFINE HYDROCHLORIDE (OTC) MIRALAX, POLYETHYLENE GLYCOL 3350 (OTC) NASONEX, MOMETASONE FUROATE MONOHYDRATE OCUCLEAR, OXYMETAZOLINE HYDROCHLORIDE (OTC)
SHADE UVAGUARD, AVOBENZONE (OTC)
SCHERING PLOUGH RES * SCHERING PLOUGH RESEARCH INSTITUTE LOTRISONE, BETAMETHASONE DIPROPIONATE
REBETOL, RIBAVIRIN
SCHWARZ PHARMA * SCHWARZ PHARMA AG EDEX, ALPROSTADIL * SCHWARZ PHARMA INC DILATRATE-SR, ISOSORBIDE DINITRATE LEVATOL, PENBUTOLOL SULFATE NIRAVAM, ALPRAZOLAM PARCOPA, CARBIDOPA ROBAXIN, METHOCARBAMOL
ROBAXIN-750, METHOCARBAMOL
SCIOS * SCIOS INC NATRECOR,
NESIRITIDE RECOMBINANT
SECAN PHARMS * SECAN PHARMACEUTICALS INC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE SEPTODONT * SEPTODONT INC BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, OCTOCAINE, EPINEPHRINE
SEPTODONT HOLDING * SEPTODONT HOLDING SAS ORAVERSE, PHENTOLAMINE MESYLATE SEPTODONT INC * SEPTODONT INC PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, PRILOCAINE HYDROCHLORIDE, PRILOCAINE HYDROCHLORIDE SHASUN USA * SHASUN USA INC IBUPROFEN, IBUPROFEN SHIONOGI INC * SHIONOGI INC ADRENACLICK, EPINEPHRINE CUVPOSA, GLYCOPYRROLATE FURADANTIN, NITROFURANTOIN KAPVAY, CLONIDINE HYDROCHLORIDE KEFLEX, CEPHALEXIN MOXATAG, AMOXICILLIN ORAPRED ODT, PREDNISOLONE SODIUM PHOSPHATE ORAPRED, PREDNISOLONE SODIUM PHOSPHATE PONSTEL, MEFENAMIC ACID ROBINUL FORTE, GLYCOPYRROLATE ROBINUL, GLYCOPYRROLATE SULAR, NISOLDIPINE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TWINJECT 0.15, EPINEPHRINE
TWINJECT 0.3, EPINEPHRINE
ULESFIA, BENZYL ALCOHOL
BUPIVACAINE HYDROCHLORIDE
EPINEPHRINE BITARTRATE
B - 121
APPENDIX B
SHIRE * SHIRE DEVELOPMENT INC ADDERALL XR 10, AMPHETAMINE ASPARTATE ADDERALL XR 15, AMPHETAMINE ASPARTATE ADDERALL XR 20, AMPHETAMINE ASPARTATE ADDERALL XR 25, AMPHETAMINE ASPARTATE ADDERALL XR 30, AMPHETAMINE ASPARTATE ADDERALL XR 5, AMPHETAMINE ASPARTATE AGRYLIN, ANAGRELIDE HYDROCHLORIDE CARBATROL, CARBAMAZEPINE FOSRENOL, LANTHANUM CARBONATE INTUNIV, GUANFACINE HYDROCHLORIDE LIALDA, MESALAMINE PENTASA, MESALAMINE
PROAMATINE, MIDODRINE HYDROCHLORIDE
SALURON, HYDROFLUMETHIAZIDE
SHIRE DEVELOPMENT * SHIRE DEVELOPMENT INC VYVANSE, LISDEXAMFETAMINE DIMESYLATE SHIRE HUMAN GENETIC * SHIRE HUMAN GENETIC THERAPIES INC VPRIV, VELAGLUCERASE ALFA SHIRE ORPHAN THERAP * SHIRE ORPHAN THERAPIES INC FIRAZYR, ICATIBANT ACETATE SIGMA TAU * SIGMA TAU PHARMACEUTICALS INC ABELCET, AMPHOTERICIN B ADAGEN, PEGADEMASE BOVINE CARNITOR SF, LEVOCARNITINE
CARNITOR, LEVOCARNITINE
MATULANE, PROCARBAZINE HYDROCHLORIDE
SIGMAPHARM LABS LLC * SIGMAPHARM LABORATORIES LLC AMILORIDE HYDROCHLORIDE, AMILORIDE HYDROCHLORIDE DISULFIRAM, DISULFIRAM ERGOCALCIFEROL, ERGOCALCIFEROL
FLUCYTOSINE, FLUCYTOSINE
PROTRIPTYLINE HYDROCHLORIDE, PROTRIPTYLINE HYDROCHLORIDE
SILARX * SILARX PHARMACEUTICALS INC AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL LACTATE LEVETIRACETAM, LEVETIRACETAM LORATADINE, LORATADINE (OTC) METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
THEOPHYLLINE, THEOPHYLLINE
SKINMEDICA * SKINMEDICA INC VANIQA, EFLORNITHINE HYDROCHLORIDE
B - 122
APPENDIX B
SKYEPHARMA AG * SKYEPHARMA AG TRIGLIDE, FENOFIBRATE SLATE PHARMS * SLATE PHARMACEUTICALS INC TESTOPEL, TESTOSTERONE
SMITHKLINE BEECHAM * SMITHKLINE BEECHAM LOVAZA, OMEGA-3-ACID ETHYL ESTERS * SMITHKLINE BEECHAM CORP LAMICTAL XR, LAMOTRIGINE * SMITHKLINE BEECHAM CORP DBA GLAXOSMITHKLINE ARRANON, NELARABINE AXID, NIZATIDINE COREG, CARVEDILOL HYCAMTIN, TOPOTECAN HYDROCHLORIDE LAMICTAL ODT, LAMOTRIGINE
REQUIP XL, ROPINIROLE HYDROCHLORIDE
TYKERB, LAPATINIB DITOSYLATE
SOAPCO * SOAPCO INC BRIAN CARE,
CHLORHEXIDINE GLUCONATE
(OTC)
SOLCO HLTHCARE * SOLCO HEALTHCARE US LLC LEVETIRACETAM, LEVETIRACETAM SOMAXON * SOMAXON PHARMACEUTICALS INC SILENOR, DOXEPIN HYDROCHLORIDE SOMERSET * SOMERSET PHARMACEUTICALS INC
ELDEPRYL, SELEGILINE HYDROCHLORIDE
EMSAM, SELEGILINE
SPEAR PHARMS * SPEAR PHARMACEUTICALS INC
FLUOROURACIL, FLUOROURACIL
TRETINOIN, TRETINOIN
SPECTRUM PHARMS * SPECTRUM PHARMACEUTICALS ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE * SPECTRUM PHARMACEUTICALS INC FUSILEV, LEVOLEUCOVORIN CALCIUM STAND HOMEOPATH * STANDARD HOMEOPATHIC CO IVY BLOCK, BENTOQUATAM STASON * STASON INDUSTRIAL CORP ACYCLOVIR, ACYCLOVIR
CAPTOPRIL, CAPTOPRIL
SELEGILINE HYDROCHLORIDE,
(OTC)
SELEGILINE HYDROCHLORIDE
STASON PHARMS * STASON PHARMACEUTICALS INC CYPROHEPTADINE HYDROCHLORIDE, STAT TRADE * STAT TRADE INC NAPRELAN, NAPROXEN SODIUM
CYPROHEPTADINE HYDROCHLORIDE
B - 123
APPENDIX B
* STERI PHARMA LLC CEFUROXIME SODIUM,
CEFUROXIME SODIUM
STEVENS J * JEROME STEVENS PHARMACEUTICALS INC BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN CEPHALEXIN, CEPHALEXIN DIGOXIN, DIGOXIN METHOCARBAMOL AND ASPIRIN, ASPIRIN ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE, ASPIRIN
UNITHROID, LEVOTHYROXINE SODIUM
STI PHARMA LLC * STI PHARMA LLC BETAMETHASONE VALERATE, BETAMETHASONE VALERATE DEXAMETHASONE, DEXAMETHASONE MYAMBUTOL, ETHAMBUTOL HYDROCHLORIDE
TRIACIN-C, CODEINE PHOSPHATE
STIEFEL * STIEFEL LABORATORIES INC DUAC, BENZOYL PEROXIDE STIEFEL GSK * STIEFEL A GSK CO VELTIN, CLINDAMYCIN PHOSPHATE STIEFEL LABS INC * STIEFEL LABORATORIES INC EVOCLIN, CLINDAMYCIN PHOSPHATE EXTINA, KETOCONAZOLE OLUX E, CLOBETASOL PROPIONATE OLUX, CLOBETASOL PROPIONATE ONMEL, ITRACONAZOLE SORIATANE, ACITRETIN SORILUX, CALCIPOTRIENE
VERDESO, DESONIDE
VUSION, MICONAZOLE NITRATE
STRIDES ARCOLAB * STRIDES ARCOLAB LIMITED FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM STRIDES ARCOLAB LTD * STRIDES ARCOLAB LTD ACARBOSE, ACARBOSE ADENOSINE, ADENOSINE ERGOCALCIFEROL, ERGOCALCIFEROL ETOMIDATE, ETOMIDATE LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE, LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE MELOXICAM, MELOXICAM
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE
SUCAMPO PHARMS * SUCAMPO PHARMACEUTICALS INC AMITIZA, LUBIPROSTONE SUMMERS * SUMMERS LABORATORIES INC CROTAN, CROTAMITON SUN PHARM INDS * SUN PHARMACEUTICAL INDUSTRIES LTD CARBIDOPA AND LEVODOPA, CARBIDOPA DESLORATADINE, DESLORATADINE DIVALPROEX SODIUM, DIVALPROEX SODIUM
DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE
EPINASTINE HYDROCHLORIDE, EPINASTINE HYDROCHLORIDE
B - 124
APPENDIX B
* SUN PHARMACEUTICAL INDUSTRIES LTD EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM OCTREOTIDE ACETATE, OCTREOTIDE ACETATE ONDANSETRON, ONDANSETRON OXCARBAZEPINE, OXCARBAZEPINE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TIAGABINE HYDROCHLORIDE, TIAGABINE HYDROCHLORIDE
TORSEMIDE, TORSEMIDE
SUN PHARM INDS (IN) * SUN PHARMACEUTICAL INDUSTRIES LTD CEPHALEXIN, CEPHALEXIN EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ORTHO-EST, ESTROPIPATE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE
ZONISAMIDE, ZONISAMIDE
SUN PHARM INDS INC * SUN PHARMACEUTICAL INDUSTRIES INC BENZONATATE, BENZONATATE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) ERGOCALCIFEROL, ERGOCALCIFEROL GEMFIBROZIL, GEMFIBROZIL HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE LITHIUM CARBONATE, LITHIUM CARBONATE NIMODIPINE, NIMODIPINE OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE
VALPROIC ACID, VALPROIC ACID
VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE
SUN PHARM INDS LTD * SUN PHARMACEUTICAL INDUSTRIES LTD CARISOPRODOL, CARISOPRODOL GABAPENTIN, GABAPENTIN LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM NARATRIPTAN, NARATRIPTAN ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE
TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE
TOPIRAMATE, TOPIRAMATE
* SUN PHARMACEUTICAL INDUSTRIES LTD. ANASTROZOLE, ANASTROZOLE SUN PHARMA GLOBAL * SUN PHARMA GLOBAL FZE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CAFFEINE CITRATE, CAFFEINE CITRATE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CHLOROTHIAZIDE SODIUM, CHLOROTHIAZIDE SODIUM DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DOCEFREZ, DOCETAXEL
FINASTERIDE, FINASTERIDE
GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE
B - 125
APPENDIX B
** S **
* SUN PHARMA GLOBAL FZE OXALIPLATIN, OXALIPLATIN TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
* SUN PHARMA GLOBAL INC ALENDRONATE SODIUM, ALENDRONATE SODIUM ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE ALPRAZOLAM, ALPRAZOLAM AMIFOSTINE, AMIFOSTINE ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE AZELASTINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE BICALUTAMIDE, BICALUTAMIDE CARBOPLATIN, CARBOPLATIN FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LEUPROLIDE ACETATE, LEUPROLIDE ACETATE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM
VECURONIUM BROMIDE, VECURONIUM BROMIDE
SUNOVION * SUNOVION PHARMACEUTICALS INC BROVANA, ARFORMOTEROL TARTRATE LATUDA, LURASIDONE HYDROCHLORIDE XOPENEX HFA, LEVALBUTEROL TARTRATE
XOPENEX, LEVALBUTEROL HYDROCHLORIDE
SUNOVION PHARMS INC * SUNOVION PHARMACEUTICALS INC LUNESTA, ESZOPICLONE SVADS HOLDINGS SA * SVADS HOLDINGS SA IBUPROFEN, IBUPROFEN (OTC)
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE SVC PHARMA * SVC PHARMA LP DRONABINOL,
(OTC)
DRONABINOL
SYNCOR PHARMS * SYNCOR PHARMACEUTICALS INC SODIUM IODIDE I 123, SODIUM IODIDE I-123 SYNERX * SYNERX PHARMA LLC ISOSULFAN BLUE, ISOSULFAN BLUE
MELPHALAN HYDROCHLORIDE, MELPHALAN HYDROCHLORIDE
SYNERX PHARMA * SYNERX PHARMA LLC CICLOPIROX, CICLOPIROX FOMEPIZOLE, FOMEPIZOLE MALATHION, MALATHION TESTOSTERONE CYPIONATE, TESTOSTERONE ENANTHATE,
TESTOSTERONE CYPIONATE
TESTOSTERONE ENANTHATE
SYNTHON PHARMS * SYNTHON PHARMACEUTICALS INC BICALUTAMIDE, BICALUTAMIDE LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
TAKEDA GLOBAL * TAKEDA GLOBAL RESEARCH DEVELOPMENT CENTER INC ACTOPLUS MET XR, METFORMIN HYDROCHLORIDE
B - 126
APPENDIX B
* TAKEDA GLOBAL RESEARCH DEVELOPMENT CENTER INC ACTOPLUS MET, METFORMIN HYDROCHLORIDE DUETACT, GLIMEPIRIDE
ROZEREM, RAMELTEON
TAKEDA PHARMS * TAKEDA PHARMACEUTICALS NORTH AMERICA INC DEXILANT, DEXLANSOPRAZOLE EDARBI, AZILSARTAN KAMEDOXOMIL EDARBYCLOR, AZILSARTAN KAMEDOXOMIL
ULORIC, FEBUXOSTAT
TAKEDA PHARMS NA * TAKEDA PHARMACEUTICALS NORTH AMERICA INC ACTOS, PIOGLITAZONE HYDROCHLORIDE PREVACID, LANSOPRAZOLE
PREVPAC, AMOXICILLIN
TARO * TARO PHARMACEUTICAL INDUSTRIES LTD ACETAZOLAMIDE, ACETAZOLAMIDE CARBAMAZEPINE, CARBAMAZEPINE CARVEDILOL, CARVEDILOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC) CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE ENALAPRIL MALEATE, ENALAPRIL MALEATE ETODOLAC, ETODOLAC EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM FLUCONAZOLE, FLUCONAZOLE FLUOROURACIL, FLUOROURACIL HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE IMIQUIMOD, IMIQUIMOD KETOCONAZOLE, KETOCONAZOLE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LORATADINE, LORATADINE (OTC) MELOXICAM, MELOXICAM MEPROBAMATE, MEPROBAMATE METRONIDAZOLE, METRONIDAZOLE NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE
OXCARBAZEPINE, OXCARBAZEPINE
PHENYTOIN, PHENYTOIN
* TARO PHARMACEUTICALS INC BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE CLOTRIMAZOLE, CLOTRIMAZOLE (OTC) DESOXIMETASONE, DESOXIMETASONE DIFLORASONE DIACETATE, DIFLORASONE DIACETATE FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUOCINONIDE, FLUOCINONIDE HYDROCORTISONE VALERATE, HYDROCORTISONE VALERATE MICONAZOLE NITRATE, MICONAZOLE NITRATE (OTC) NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
WARFARIN SODIUM, WARFARIN SODIUM
* TARO PHARMACEUTICALS USA INC ACETIC ACID, ACETIC ACID, GLACIAL ALCLOMETASONE DIPROPIONATE, ALCLOMETASONE DIPROPIONATE
AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE
AMMONIUM LACTATE, AMMONIUM LACTATE
B - 127
APPENDIX B
** T **
* TARO PHARMACEUTICALS USA INC BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CICLOPIROX, CICLOPIROX CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CLOBETASOL PROPIONATE (EMOLLIENT), CLOBETASOL PROPIONATE CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CLOTRIMAZOLE, CLOTRIMAZOLE DERMABET, BETAMETHASONE VALERATE DESONIDE, DESONIDE DIFLORASONE DIACETATE, DIFLORASONE DIACETATE ECONAZOLE NITRATE, ECONAZOLE NITRATE FLO-PRED, PREDNISOLONE ACETATE FLUOCINOLONE ACETONIDE, FLUOCINOLONE ACETONIDE FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE FLUOCINONIDE, FLUOCINONIDE FLUOROURACIL, FLUOROURACIL GENTAMICIN SULFATE, GENTAMICIN SULFATE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOBETASOL PROPIONATE, HALOBETASOL PROPIONATE HYDROCORTISONE AND ACETIC ACID, ACETIC ACID, GLACIAL HYDROCORTISONE, HYDROCORTISONE KETOZOLE, KETOCONAZOLE LIDOCAINE, LIDOCAINE LORATADINE, LORATADINE (OTC) MICONAZOLE 3, MICONAZOLE NITRATE (OTC) MOMETASONE FUROATE, MOMETASONE FUROATE MUPIROCIN, MUPIROCIN NYSTATIN AND TRIAMCINOLONE ACETONIDE, NYSTATIN NYSTATIN, NYSTATIN PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RISPERIDONE, RISPERIDONE SULFACETAMIDE SODIUM, SULFACETAMIDE SODIUM TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE (OTC) TERCONAZOLE, TERCONAZOLE TERIL, CARBAMAZEPINE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
TRIVAGIZOLE 3, CLOTRIMAZOLE (OTC)
U-CORT, HYDROCORTISONE ACETATE
* TARO PHARMACEUTICALS, INC. DESOXIMETASONE, DESOXIMETASONE TARO PHARM INDS * TARO PHARMACEUTICAL INDUSTRIES LTD AMCINONIDE, AMCINONIDE CARBAMAZEPINE, CARBAMAZEPINE CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ETODOLAC, ETODOLAC FLUCONAZOLE, FLUCONAZOLE
HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE
LAMOTRIGINE, LAMOTRIGINE
TARO PHARMS IRELAND * TARO PHARMACEUTICALS IRELAND LTD ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, SODIUM CHLORIDE STERILE WATER FOR INJECTION IN PLASTIC CONTAINER, STERILE WATER FOR INJECTION TARO PHARMS NORTH * TARO PHARMACEUTICALS NORTH AMERICA INC
OVIDE, MALATHION
TOPICORT LP, DESOXIMETASONE
B - 128
APPENDIX B
* TARO PHARMACEUTICALS NORTH AMERICA INC TOPICORT, DESOXIMETASONE TAYLOR * TAYLOR PHARMACEUTICALS LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LORAZEPAM, LORAZEPAM MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE
NAPHAZOLINE HYDROCHLORIDE, NAPHAZOLINE HYDROCHLORIDE
TAYLOR PHARMA * TAYLOR PHARMACAL CO DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE PROPARACAINE HYDROCHLORIDE, PROPARACAINE HYDROCHLORIDE
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE, POLYMYXIN B SULFATE
TEDOR PHARM * TEDOR PHARMA INC BENZPHETAMINE HYDROCHLORIDE, TEIKOKU PHARMA USA * TEIKOKU PHARMA USA INC LIDODERM, LIDOCAINE TERCICA * TERCICA INC INCRELEX,
BENZPHETAMINE HYDROCHLORIDE
MECASERMIN RECOMBINANT
B - 129
APPENDIX B
* TEVA PHARMACEUTICALS USA INC CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLOTRIMAZOLE, CLOTRIMAZOLE DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM DICLOXACILLIN SODIUM, DICLOXACILLIN SODIUM DIFLUNISAL, DIFLUNISAL DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE ENALAPRIL MALEATE, ENALAPRIL MALEATE EPITOL, CARBAMAZEPINE ESTAZOLAM, ESTAZOLAM ETODOLAC, ETODOLAC FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FENOFIBRATE (MICRONIZED), FENOFIBRATE FENOFIBRATE, FENOFIBRATE FEXOFENADINE HYDROCHLORIDE ALLERGY, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE HIVES, FEXOFENADINE HYDROCHLORIDE (OTC) FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE FINASTERIDE, FINASTERIDE FLUCONAZOLE, FLUCONAZOLE FLUOCINONIDE EMULSIFIED BASE, FLUOCINONIDE FLUOCINONIDE, FLUOCINONIDE FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLURBIPROFEN, FLURBIPROFEN FLUVOXAMINE MALEATE, FLUVOXAMINE MALEATE FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GALZIN, ZINC ACETATE GEMFIBROZIL, GEMFIBROZIL GLIMEPIRIDE, GLIMEPIRIDE GLYBURIDE (MICRONIZED), GLYBURIDE GLYBURIDE, GLYBURIDE HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE KETOCONAZOLE, KETOCONAZOLE KETOPROFEN, KETOPROFEN KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LAMOTRIGINE, LAMOTRIGINE LEVOFLOXACIN, LEVOFLOXACIN LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE LORATADINE, LORATADINE (OTC) LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOVASTATIN, LOVASTATIN MESALAMINE, MESALAMINE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOLAZONE, METOLAZONE METOPROLOL TARTRATE, METOPROLOL TARTRATE METRONIDAZOLE, METRONIDAZOLE MEXILETINE HYDROCHLORIDE, MEXILETINE HYDROCHLORIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MIRTAZAPINE, MIRTAZAPINE MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MOEXIPRIL HYDROCHLORIDE, MOEXIPRIL HYDROCHLORIDE MUPIROCIN, MUPIROCIN NABUMETONE, NABUMETONE
NAPROXEN SODIUM, NAPROXEN SODIUM
NAPROXEN, NAPROXEN
B - 130
APPENDIX B
** T **
* TEVA PHARMACEUTICALS USA INC NEFAZODONE HYDROCHLORIDE, NEFAZODONE HYDROCHLORIDE NEOMYCIN SULFATE, NEOMYCIN SULFATE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NIZATIDINE, NIZATIDINE NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE NYSTATIN, NYSTATIN OFLOXACIN, OFLOXACIN ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE ONDANSETRON, ONDANSETRON ORAP, PIMOZIDE OXAPROZIN, OXAPROZIN OXYMORPHONE HYDROCHLORIDE, OXYMORPHONE HYDROCHLORIDE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PENICILLIN-VK, PENICILLIN V POTASSIUM PIROXICAM, PIROXICAM PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PRELONE, PREDNISOLONE PURINETHOL, MERCAPTOPURINE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RIBAVIRIN, RIBAVIRIN RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SUCRALFATE, SUCRALFATE SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, SULFAMETHOXAZOLE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TICLOPIDINE HYDROCHLORIDE, TICLOPIDINE HYDROCHLORIDE TIZANIDINE HYDROCHLORIDE, TIZANIDINE HYDROCHLORIDE TOLMETIN SODIUM, TOLMETIN SODIUM TOPIRAMATE, TOPIRAMATE TORSEMIDE, TORSEMIDE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE TRIACET, TRIAMCINOLONE ACETONIDE TRIMETHOPRIM, TRIMETHOPRIM
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
TEVA BRANDED PHARM * TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE * TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC
QVAR 40, BECLOMETHASONE DIPROPIONATE
QVAR 80, BECLOMETHASONE DIPROPIONATE
TEVA GLOBAL * TEVA GLOBAL RESPIRATORY RESEARCH LLC
PROAIR HFA, ALBUTEROL SULFATE
PROGLYCEM, DIAZOXIDE
TEVA PARENTERAL * TEVA PARENTERAL MEDICINES INC ADENOSINE, ADENOSINE ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE ALBUTEROL SULFATE, ALBUTEROL SULFATE ALPROSTADIL, ALPROSTADIL AMIKACIN SULFATE, AMIKACIN SULFATE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE
AZITHROMYCIN, AZITHROMYCIN
BLEOMYCIN SULFATE, BLEOMYCIN SULFATE
B - 131
APPENDIX B
* TEVA PARENTERAL MEDICINES INC BUDESONIDE, BUDESONIDE CALCITRIOL, CALCITRIOL CARBOPLATIN, CARBOPLATIN CEFTRIAXONE, CEFTRIAXONE SODIUM CIPROFLOXACIN, CIPROFLOXACIN CISPLATIN, CISPLATIN CROMOLYN SODIUM, CROMOLYN SODIUM CYTOSAR-U, CYTARABINE DACARBAZINE, DACARBAZINE DAUNORUBICIN HYDROCHLORIDE, DAUNORUBICIN HYDROCHLORIDE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE ENALAPRILAT, ENALAPRILAT EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM ETOPOSIDE, ETOPOSIDE FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, FLUCONAZOLE FLUCONAZOLE IN SODIUM CHLORIDE 0.9%, FLUCONAZOLE FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE FLUMAZENIL, FLUMAZENIL FLUOROURACIL, FLUOROURACIL FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE, GRANISETRON HYDROCHLORIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL, HALOPERIDOL LACTATE IDARUBICIN HYDROCHLORIDE PFS, IDARUBICIN HYDROCHLORIDE IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE IFOSFAMIDE, IFOSFAMIDE IFOSFAMIDE/MESNA KIT, IFOSFAMIDE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM LEUPROLIDE ACETATE, LEUPROLIDE ACETATE LEVOCARNITINE, LEVOCARNITINE MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE MESNA, MESNA METHYLDOPATE HYDROCHLORIDE, METHYLDOPATE HYDROCHLORIDE METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE BITARTRATE OCTREOTIDE ACETATE, OCTREOTIDE ACETATE OXALIPLATIN, OXALIPLATIN OXYTOCIN, OXYTOCIN PACLITAXEL, PACLITAXEL PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPOFOL, PROPOFOL ROCURONIUM BROMIDE, ROCURONIUM BROMIDE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TERBUTALINE SULFATE, TERBUTALINE SULFATE TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE VECURONIUM BROMIDE, VECURONIUM BROMIDE VINCRISTINE SULFATE PFS, VINCRISTINE SULFATE
VINORELBINE TARTRATE, VINORELBINE TARTRATE
ZANOSAR, STREPTOZOCIN
B - 132
APPENDIX B
** T **
TEVA PARNTL * TEVA PARENTAL MEDICINE INC DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,
DORZOLAMIDE HYDROCHLORIDE
TEVA PHARMS * TEVA PHARMACEUTICALS USA ALENDRONATE SODIUM, ALENDRONATE SODIUM ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE ALPRAZOLAM, ALPRAZOLAM AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE ANASTROZOLE, ANASTROZOLE ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE AZITHROMYCIN, AZITHROMYCIN BISOPROLOL FUMARATE, BISOPROLOL FUMARATE CEFADROXIL, CEFADROXIL/CEFADROXIL HEMIHYDRATE CEFDINIR, CEFDINIR CEFPROZIL, CEFPROZIL CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CICLOPIROX, CICLOPIROX CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DEXMETHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE, AMPHETAMINE ASPARTATE DIVALPROEX SODIUM, DIVALPROEX SODIUM DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE HYDROCHLORIDE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE ETHOSUXIMIDE, ETHOSUXIMIDE FAMCICLOVIR, FAMCICLOVIR FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL GABAPENTIN, GABAPENTIN GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL LACTATE HYDROCORTISONE, HYDROCORTISONE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE LAMIVUDINE AND ZIDOVUDINE, LAMIVUDINE LANSOPRAZOLE, LANSOPRAZOLE LEFLUNOMIDE, LEFLUNOMIDE LETROZOLE, LETROZOLE LEVETIRACETAM, LEVETIRACETAM LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MEBENDAZOLE, MEBENDAZOLE MEGESTROL ACETATE, MEGESTROL ACETATE MELOXICAM, MELOXICAM METHAZOLAMIDE, METHAZOLAMIDE MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL NARATRIPTAN, NARATRIPTAN HYDROCHLORIDE NATEGLINIDE, NATEGLINIDE OLANZAPINE, OLANZAPINE ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER, ONDANSETRON HYDROCHLORIDE OXCARBAZEPINE, OXCARBAZEPINE PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE QUINIDINE SULFATE, QUINIDINE SULFATE RAMIPRIL, RAMIPRIL
B - 133
APPENDIX B
** T **
* TEVA PHARMACEUTICALS USA RISEDRONATE SODIUM, RISEDRONATE SODIUM TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TRANDOLAPRIL, TRANDOLAPRIL URSODIOL, URSODIOL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VALPROIC ACID, VALPROIC ACID VANDAZOLE, METRONIDAZOLE
ZALEPLON, ZALEPLON
TEVA PHARMS USA * TEVA PHARMACEUTICALS USA INC IMIQUIMOD, IMIQUIMOD TEVA WOMENS * TEVA WOMENS HEALTH INC CENESTIN, ESTROGENS, CONJUGATED SYNTHETIC A ENJUVIA, ESTROGENS, CONJUGATED SYNTHETIC B LOSEASONIQUE, ETHINYL ESTRADIOL MIRCETTE, DESOGESTREL PLAN B, LEVONORGESTREL PLAN B, LEVONORGESTREL (OTC) PREFEST, ESTRADIOL SEASONIQUE, ETHINYL ESTRADIOL
SYNTHETIC CONJUGATED ESTROGENS A, ESTROGENS, CONJUGATED SYNTHETIC A
THE PHARMA NETWORK * THE PHARMA NETWORK LLC BENZONATATE, BENZONATATE THE PHARMANETWORK * THE PHARMANETWORK LLC METHADONE HYDROCHLORIDE, THERAKOS * THERAKOS INC UVADEX, METHOXSALEN THERATECHNOLOGIES * THERATECHNOLOGIES INC EGRIFTA, TESAMORELIN ACETATE THERAVANCE INC * THERAVANCE INC VIBATIV, TELAVANCIN HYDROCHLORIDE THREE RIVERS PHARMS * THREE RIVERS PHARMACEUTICALS LLC ANASTROZOLE, ANASTROZOLE RIBASPHERE, RIBAVIRIN RIBAVIRIN, RIBAVIRIN
TOPOTECAN HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE
TIBOTEC * TIBOTEC INC EDURANT, RILPIVIRINE HYDROCHLORIDE INTELENCE, ETRAVIRINE
PREZISTA, DARUNAVIR ETHANOLATE
TOLMAR * TOLMAR INC ATRIDOX, DOXYCYCLINE HYCLATE BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE CALCIPOTRIENE, CALCIPOTRIENE CICLOPIROX, CICLOPIROX CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE ERYTHROMYCIN AND BENZOYL PEROXIDE, BENZOYL PEROXIDE
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE
IMIQUIMOD, IMIQUIMOD
METHADONE HYDROCHLORIDE
B - 134
APPENDIX B
* TOLMAR INC KETOCONAZOLE, KETOCONAZOLE LEVETIRACETAM, LEVETIRACETAM LIDOCAINE AND PRILOCAINE, LIDOCAINE METRONIDAZOLE, METRONIDAZOLE MOMETASONE FUROATE, MOMETASONE FUROATE
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
TOLMAR THERAP * TOLMAR THERAPEUTICS INC ELIGARD, LEUPROLIDE ACETATE TOPOTARGET * TOPOTARGET AS TOTECT, DEXRAZOXANE HYDROCHLORIDE TORPHARM * TORPHARM INC RANITIDINE HYDROCHLORIDE, TORRENT PHARM * TORRENT PHARMA INC METFORMIN HYDROCHLORIDE,
RANITIDINE HYDROCHLORIDE
(OTC)
METFORMIN HYDROCHLORIDE
TORRENT PHARMS * TORRENT PHARMACEUTICALS LIMITED LEVOFLOXACIN, LEVOFLOXACIN * TORRENT PHARMACEUTICALS LTD AMLODIPINE BESYLATE, AMLODIPINE BESYLATE CARBAMAZEPINE, CARBAMAZEPINE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE
TOPIRAMATE, TOPIRAMATE
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
* TORRENT PHARMACEUTICALS LTD. ALFUZOSIN HYDROCHLORIDE, ALFUZOSIN HYDROCHLORIDE TORRENT PHARMS LLC * TORRENT PHARMACEUTICALS LLC CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES RELIEF, CETIRIZINE HYDROCHLORIDE (OTC)
OLANZAPINE, OLANZAPINE
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
TORRENT PHARMS LTD * TORRENT PHARMACEUTICALS LTD FELODIPINE, FELODIPINE TRIAX PHARMS LLC * TRIAX PHARMACEUTICALS LLC LOCOID LIPOCREAM, HYDROCORTISONE BUTYRATE LOCOID, HYDROCORTISONE BUTYRATE
MINOCIN, MINOCYCLINE HYDROCHLORIDE
TRETINOIN, TRETINOIN
TRIS PHARMA INC * TRIS PHARMA INC HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX,
IBUPROFEN, IBUPROFEN (OTC)
LEVETIRACETAM, LEVETIRACETAM
CHLORPHENIRAMINE POLISTIREX
B - 135
APPENDIX B
UCB INC * UCB INC CO-GESIC, ACETAMINOPHEN KEPPRA XR, LEVETIRACETAM KEPPRA, LEVETIRACETAM LORTAB, ACETAMINOPHEN METADATE CD, METHYLPHENIDATE HYDROCHLORIDE METADATE ER, METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE MONOKET, ISOSORBIDE MONONITRATE PEDIAPRED, PREDNISOLONE SODIUM PHOSPHATE SEMPREX-D, ACRIVASTINE THEO-24, THEOPHYLLINE TUSSIONEX PENNKINETIC, CHLORPHENIRAMINE POLISTIREX UNIRETIC, HYDROCHLOROTHIAZIDE UNIVASC, MOEXIPRIL HYDROCHLORIDE VIMPAT, LACOSAMIDE XYZAL, LEVOCETIRIZINE DIHYDROCHLORIDE
ZAROXOLYN, METOLAZONE
UCYCLYD * UCYCLYD PHARMA INC AMMONUL, SODIUM BENZOATE UDL LABS * UDL LABORATORIES SULFAMYLON, MAFENIDE ACETATE ULURU * ULURU INC APHTHASOL,
AMLEXANOX
UNICHEM * UNICHEM LABORATORIES LTD BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE MELOXICAM, MELOXICAM
TOPIRAMATE, TOPIRAMATE
ZALEPLON, ZALEPLON
UNICHEM LABS LTD * UNICHEM LABORATORIES LIMITED DIVALPROEX SODIUM, DIVALPROEX SODIUM * UNICHEM LABORATORIES LTD LAMOTRIGINE, LAMOTRIGINE UNICHEM PHARMS (USA) * UNICHEM PHARMACEUTICALS (USA) INC BISOPROLOL FUMARATE, BISOPROLOL FUMARATE UNIQUE PHARM LABS * UNIQUE PHARMACEUTICAL LABORATORIES ATENOLOL, ATENOLOL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE HIVES, CETIRIZINE HYDROCHLORIDE (OTC) CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM
FLUCONAZOLE, FLUCONAZOLE
UNITED GUARDIAN * UNITED GUARDIAN INC RENACIDIN, CITRIC ACID
B - 136
APPENDIX B
B - 137
APPENDIX B
VALEANT INTL * VALEANT INTERNATIONAL BARBADOS SRL ATIVAN, LORAZEPAM CARDIZEM CD, DILTIAZEM HYDROCHLORIDE CARDIZEM LA, DILTIAZEM HYDROCHLORIDE CARDIZEM, DILTIAZEM HYDROCHLORIDE DICLOFENAC SODIUM, DICLOFENAC SODIUM DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE ELIDEL, PIMECROLIMUS ISORDIL, ISOSORBIDE DINITRATE NIFEDIPINE, NIFEDIPINE PENTOXIFYLLINE, PENTOXIFYLLINE TIAZAC, DILTIAZEM HYDROCHLORIDE ULTRAM ER, TRAMADOL HYDROCHLORIDE VASERETIC, ENALAPRIL MALEATE VASOTEC, ENALAPRIL MALEATE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE WELLBUTRIN XL, BUPROPION HYDROCHLORIDE
XERESE, ACYCLOVIR
ZOVIRAX, ACYCLOVIR
* VALEANT INTERNATIONAL SRL APLENZIN, BUPROPION HYDROBROMIDE
RETIN-A MICRO, TRETINOIN
XENAZINE, TETRABENAZINE
VALEANT PHARM INTL * VALEANT PHARMACEUTICALS INTERNATIONAL 8-MOP, METHOXSALEN ANDROID 10, METHYLTESTOSTERONE ANDROID 25, METHYLTESTOSTERONE EFUDEX, FLUOROURACIL LIBRIUM, CHLORDIAZEPOXIDE HYDROCHLORIDE LIMBITROL DS, AMITRIPTYLINE HYDROCHLORIDE LIMBITROL, AMITRIPTYLINE HYDROCHLORIDE MESTINON, PYRIDOSTIGMINE BROMIDE OXSORALEN, METHOXSALEN OXSORALEN-ULTRA, METHOXSALEN TASMAR, TOLCAPONE TENSILON PRESERVATIVE FREE, EDROPHONIUM CHLORIDE TENSILON, EDROPHONIUM CHLORIDE TESTRED, METHYLTESTOSTERONE
VIRAZOLE, RIBAVIRIN
ZELAPAR, SELEGILINE HYDROCHLORIDE
VALEANT PHARMS * VALEANT PHARMACEUTICALS NORTH AMERICA POTIGA, EZOGABINE VALIDUS PHARMS * VALIDUS PHARMACEUTICALS LLC ROCALTROL, CALCITRIOL VALIDUS PHARMS INC * VALIDUS PHARMACEUTICALS INC
EQUETRO, CARBAMAZEPINE
MARPLAN, ISOCARBOXAZID
VEROSCIENCE * VEROSCIENCE LLC CYCLOSET, BROMOCRIPTINE MESYLATE VERSAPHARM * VERSAPHARM INC CICLOPIROX, CICLOPIROX CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE
DEMECLOCYCLINE HYDROCHLORIDE, DEMECLOCYCLINE HYDROCHLORIDE
DESOXIMETASONE, DESOXIMETASONE
B - 138
APPENDIX B
B - 139
APPENDIX B
* VINTAGE PHARMACEUTICALS LLC SPIRONOLACTONE, SPIRONOLACTONE SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE TRI-PREVIFEM, ETHINYL ESTRADIOL VALPROIC ACID, VALPROIC ACID VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
VINTAGE PHARMS * VINTAGE PHARMACEUTICALS LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL ORSYTHIA, ETHINYL ESTRADIOL
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
* VINTAGE PHARMACEUTICALS INC ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ALLOPURINOL, ALLOPURINOL AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE BACLOFEN, BACLOFEN BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE, ACETAMINOPHEN CARISOPRODOL, CARISOPRODOL CLONAZEPAM, CLONAZEPAM CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE DEXAMETHASONE, DEXAMETHASONE DIAZEPAM, DIAZEPAM DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE FUROSEMIDE, FUROSEMIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE HYDROCORTISONE, HYDROCORTISONE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE LACTULOSE, LACTULOSE LEVETIRACETAM, LEVETIRACETAM LORAZEPAM, LORAZEPAM MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE METHOCARBAMOL, METHOCARBAMOL METHYLPREDNISOLONE, METHYLPREDNISOLONE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE NYSTATIN, NYSTATIN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE PERPHENAZINE, PERPHENAZINE PHENTERMINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE PREDNISONE, PREDNISONE PRIMIDONE, PRIMIDONE PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE SULFASALAZINE, SULFASALAZINE
TORSEMIDE, TORSEMIDE
TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE
VIROPHARMA * VIROPHARMA INC VANCOCIN HYDROCHLORIDE,
VANCOMYCIN HYDROCHLORIDE
B - 140
APPENDIX B
SULFAMETHOXAZOLE
VISTAPHARM * VISTAPHARM INC ALBUTEROL SULFATE, ALBUTEROL SULFATE LACTULOSE, LACTULOSE METHADONE HYDROCHLORIDE, METHADONE HYDROCHLORIDE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MORPHINE SULFATE, MORPHINE SULFATE
NYSTATIN, NYSTATIN
PHENYTOIN, PHENYTOIN
WARNER CHILCOTT * WARNER CHILCOTT BERMUDA LTD CHOLEDYL SA, OXTRIPHYLLINE * WARNER CHILCOTT CO LLC
ACTONEL, RISEDRONATE SODIUM
ATELVIA, RISEDRONATE SODIUM
* WARNER CHILCOTT INC ERYC, ERYTHROMYCIN ESTRACE, ESTRADIOL ESTROSTEP FE, ETHINYL ESTRADIOL FEMCON FE, ETHINYL ESTRADIOL FEMHRT, ETHINYL ESTRADIOL FEMTRACE, ESTRADIOL ACETATE LOESTRIN 21 1.5/30, ETHINYL ESTRADIOL LOESTRIN 21 1/20, ETHINYL ESTRADIOL LOESTRIN 24 FE, ETHINYL ESTRADIOL LOESTRIN FE 1.5/30, ETHINYL ESTRADIOL LOESTRIN FE 1/20, ETHINYL ESTRADIOL OVCON-35, ETHINYL ESTRADIOL
OVCON-50, ETHINYL ESTRADIOL
SARAFEM, FLUOXETINE HYDROCHLORIDE
WARNER CHILCOTT CO * WARNER CHILCOTT CO INC LO LOESTRIN FE, ETHINYL ESTRADIOL WARNER CHILCOTT LLC * WARNER CHILCOTT CO LLC ASACOL HD, MESALAMINE
ASACOL, MESALAMINE
ENABLEX, DARIFENACIN HYDROBROMIDE
WATSON LABS * WATSON LABORATORIES ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE, ACETAMINOPHEN ALENDRONATE SODIUM, ALENDRONATE SODIUM ANAGRELIDE HYDROCHLORIDE, ANAGRELIDE HYDROCHLORIDE ANASTROZOLE, ANASTROZOLE CARBOPLATIN, CARBOPLATIN CARVEDILOL, CARVEDILOL FOLIC ACID, FOLIC ACID LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE MICROGESTIN 1.5/30, ETHINYL ESTRADIOL MICROGESTIN 1/20, ETHINYL ESTRADIOL MICROGESTIN FE 1.5/30, ETHINYL ESTRADIOL MICROGESTIN FE 1/20, ETHINYL ESTRADIOL NORCO, ACETAMINOPHEN NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL OXAPROZIN, OXAPROZIN OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN
PROPAFENONE HYDROCHLORIDE, PROPAFENONE HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
B - 141
APPENDIX B
* WATSON LABORATORIES INC ACARBOSE, ACARBOSE ACEBUTOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE ACETAZOLAMIDE, ACETAZOLAMIDE ACETOHEXAMIDE, ACETOHEXAMIDE ACYCLOVIR, ACYCLOVIR AFEDITAB CR, NIFEDIPINE ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE, ALBUTEROL SULFATE ALBUTEROL SULFATE, ALBUTEROL SULFATE ALENDRONATE SODIUM, ALENDRONATE SODIUM ALLOPURINOL, ALLOPURINOL ALORA, ESTRADIOL AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AMOXAPINE, AMOXAPINE ANDRODERM, TESTOSTERONE ATENOLOL AND CHLORTHALIDONE, ATENOLOL ATENOLOL, ATENOLOL BACLOFEN, BACLOFEN BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BISOPROLOL FUMARATE BREVICON 28-DAY, ETHINYL ESTRADIOL BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE BUSPIRONE HYDROCHLORIDE, BUSPIRONE HYDROCHLORIDE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE, ASPIRIN CABERGOLINE, CABERGOLINE CAPTOPRIL, CAPTOPRIL CARBOPLATIN, CARBOPLATIN CARISOPRODOL, CARISOPRODOL CHLORDIAZEPOXIDE HYDROCHLORIDE, CHLORDIAZEPOXIDE HYDROCHLORIDE CHLORPROPAMIDE, CHLORPROPAMIDE CHLORZOXAZONE, CHLORZOXAZONE CICLOPIROX, CICLOPIROX CIMETIDINE, CIMETIDINE CIMETIDINE, CIMETIDINE (OTC) CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE CLONAZEPAM, CLONAZEPAM CLONIDINE HYDROCHLORIDE, CLONIDINE HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM, CLORAZEPATE DIPOTASSIUM COL-PROBENECID, COLCHICINE CORDRAN, FLURANDRENOLIDE CRINONE, PROGESTERONE CROMOLYN SODIUM, CROMOLYN SODIUM CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE CYCLOSPORINE, CYCLOSPORINE DEFEROXAMINE MESYLATE, DEFEROXAMINE MESYLATE DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE DESOGESTREL AND ETHINYL ESTRADIOL, DESOGESTREL DIAZEPAM, DIAZEPAM DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DILACOR XR, DILTIAZEM HYDROCHLORIDE DIMENHYDRINATE, DIMENHYDRINATE DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE, DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE DIPYRIDAMOLE, DIPYRIDAMOLE DISOPYRAMIDE PHOSPHATE, DISOPYRAMIDE PHOSPHATE DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE DOXAPRAM HYDROCHLORIDE, DOXAPRAM HYDROCHLORIDE DOXAZOSIN MESYLATE, DOXAZOSIN MESYLATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE
DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
DOXYCYCLINE, DOXYCYCLINE
B - 142
APPENDIX B
* WATSON LABORATORIES INC DROSPIRENONE AND ETHINYL ESTRADIOL, DROSPIRENONE ENALAPRIL MALEATE, ENALAPRIL MALEATE EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE ERGOLOID MESYLATES, ERGOLOID MESYLATES ESTAZOLAM, ESTAZOLAM ESTRADIOL CYPIONATE, ESTRADIOL CYPIONATE ESTRADIOL VALERATE, ESTRADIOL VALERATE ESTRADIOL, ESTRADIOL ESTRONE, ESTRONE ESTROPIPATE, ESTROPIPATE FAMCICLOVIR, FAMCICLOVIR FAMOTIDINE, FAMOTIDINE FAMOTIDINE, FAMOTIDINE (OTC) FENTANYL CITRATE, FENTANYL CITRATE FENTANYL-100, FENTANYL FENTANYL-25, FENTANYL FENTANYL-50, FENTANYL FENTANYL-75, FENTANYL FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE FLUTAMIDE, FLUTAMIDE FOSINOPRIL SODIUM, FOSINOPRIL SODIUM FUROSEMIDE, FUROSEMIDE GABAPENTIN, GABAPENTIN GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GELNIQUE, OXYBUTYNIN CHLORIDE GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE GEMFIBROZIL, GEMFIBROZIL GLIMEPIRIDE, GLIMEPIRIDE GLIPIZIDE, GLIPIZIDE GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE GUANFACINE HYDROCHLORIDE, GUANFACINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROXOCOBALAMIN, HYDROXOCOBALAMIN HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE HYDROXYZINE PAMOATE, HYDROXYZINE PAMOATE IBUPROFEN, IBUPROFEN IBUPROFEN, IBUPROFEN (OTC) INDAPAMIDE, INDAPAMIDE IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE ISONIAZID, ISONIAZID ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE ISRADIPINE, ISRADIPINE LABETALOL HYDROCHLORIDE, LABETALOL HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL LEVONORGESTREL, LEVONORGESTREL LEVONORGESTREL, LEVONORGESTREL (OTC) LEVORA 0.15/30-28, ETHINYL ESTRADIOL LISINOPRIL, LISINOPRIL LORAZEPAM, LORAZEPAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM LOW-OGESTREL-21, ETHINYL ESTRADIOL LOW-OGESTREL-28, ETHINYL ESTRADIOL LOXAPINE SUCCINATE, LOXAPINE SUCCINATE
MECLIZINE HYDROCHLORIDE, MECLIZINE HYDROCHLORIDE
MECLOFENAMATE SODIUM, MECLOFENAMATE SODIUM
B - 143
APPENDIX B
* WATSON LABORATORIES INC MELOXICAM, MELOXICAM MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE, MEPERIDINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE MEPIVACAINE HYDROCHLORIDE, MEPIVACAINE HYDROCHLORIDE MEPROBAMATE, MEPROBAMATE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METHOCARBAMOL, METHOCARBAMOL METHYCLOTHIAZIDE, METHYCLOTHIAZIDE METHYLDOPA, METHYLDOPA METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE METHYLPREDNISOLONE, METHYLPREDNISOLONE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE METOPROLOL TARTRATE, METOPROLOL TARTRATE METRONIDAZOLE, METRONIDAZOLE MEXILETINE HYDROCHLORIDE, MEXILETINE HYDROCHLORIDE MICROZIDE, HYDROCHLOROTHIAZIDE MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE MINOXIDIL, MINOXIDIL MIRTAZAPINE, MIRTAZAPINE MORPHINE SULFATE, MORPHINE SULFATE NABUMETONE, NABUMETONE NAPROXEN SODIUM, NAPROXEN SODIUM NAPROXEN, NAPROXEN NATEGLINIDE, NATEGLINIDE NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE NICOTINE POLACRILEX, NICOTINE POLACRILEX (OTC) NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE NIZATIDINE, NIZATIDINE NORCO, ACETAMINOPHEN NORETHIN 1/35E-21, ETHINYL ESTRADIOL NORETHIN 1/35E-28, ETHINYL ESTRADIOL NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL (10/11), ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL (7/14), ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL NORETHINDRONE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORGESTIMATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL NORINYL 1+35 21-DAY, ETHINYL ESTRADIOL NORINYL 1+35 28-DAY, ETHINYL ESTRADIOL NORINYL 1+50 28-DAY, MESTRANOL NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE OGESTREL 0.5/50-28, ETHINYL ESTRADIOL ORPHENADRINE CITRATE, ORPHENADRINE CITRATE OXAZEPAM, OXAZEPAM OXYCODONE AND ACETAMINOPHEN, ACETAMINOPHEN OXYCODONE AND ASPIRIN, ASPIRIN OXYCODONE HYDROCHLORIDE AND IBUPROFEN, IBUPROFEN PENTAMIDINE ISETHIONATE, PENTAMIDINE ISETHIONATE PENTAZOCINE AND NALOXONE HYDROCHLORIDES, NALOXONE HYDROCHLORIDE PENTOXIFYLLINE, PENTOXIFYLLINE PINDOLOL, PINDOLOL PIROXICAM, PIROXICAM PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PREDNISOLONE, PREDNISOLONE PREDNISONE, PREDNISONE PRIMIDONE, PRIMIDONE PROBENECID, PROBENECID PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
QUASENSE, ETHINYL ESTRADIOL
B - 144
APPENDIX B
* WATSON LABORATORIES INC QUINIDINE GLUCONATE, QUINIDINE GLUCONATE QUINIDINE SULFATE, QUINIDINE SULFATE RAMIPRIL, RAMIPRIL RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RAPAFLO, SILODOSIN RISPERIDONE, RISPERIDONE RIVASTIGMINE TARTRATE, RIVASTIGMINE TARTRATE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE SULFASALAZINE, SULFASALAZINE SULINDAC, SULINDAC SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TACROLIMUS, TACROLIMUS TAMOXIFEN CITRATE, TAMOXIFEN CITRATE TEMAZEPAM, TEMAZEPAM TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TESTOSTERONE CYPIONATE, TESTOSTERONE CYPIONATE TESTOSTERONE ENANTHATE, TESTOSTERONE ENANTHATE TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE THIOTHIXENE, THIOTHIXENE TOLAZAMIDE, TOLAZAMIDE TOLBUTAMIDE, TOLBUTAMIDE TOPIRAMATE, TOPIRAMATE TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN, ACETAMINOPHEN TRANDOLAPRIL, TRANDOLAPRIL TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE TRELSTAR, TRIPTORELIN PAMOATE TRIAMTERENE AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE TRIAZOLAM, TRIAZOLAM TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE TRIMETHOPRIM, TRIMETHOPRIM TRI-NORINYL 28-DAY, ETHINYL ESTRADIOL TRIVORA-28, ETHINYL ESTRADIOL VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VECURONIUM BROMIDE, VECURONIUM BROMIDE VERAPAMIL HYDROCHLORIDE, VERAPAMIL HYDROCHLORIDE ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
ZOVIA 1/35E-28, ETHINYL ESTRADIOL
ZOVIA 1/50E-28, ETHINYL ESTRADIOL
* WATSON LABS INC LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE WATSON LABS (UTAH) * WATSON LABORATORIES INC INFED, IRON DEXTRAN NOR-QD, NORETHINDRONE
OXYTROL, OXYBUTYNIN
PROGESTERONE, PROGESTERONE
WATSON LABS FLORIDA * WATSON LABORATORIES INC FLORIDA ALPRAZOLAM, ALPRAZOLAM BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE CARTIA XT, DILTIAZEM HYDROCHLORIDE CIPROFLOXACIN EXTENDED RELEASE, CIPROFLOXACIN CLARITHROMYCIN, CLARITHROMYCIN DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE DIVALPROEX SODIUM, DIVALPROEX SODIUM
DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
B - 145
APPENDIX B
** W **
* WATSON LABORATORIES INC FLORIDA FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE, FOSINOPRIL SODIUM FOSINOPRIL SODIUM, FOSINOPRIL SODIUM GLIMEPIRIDE, GLIMEPIRIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN, ACETAMINOPHEN HYDROCODONE BITARTRATE AND IBUPROFEN, HYDROCODONE BITARTRATE KETOPROFEN, KETOPROFEN LEVETIRACETAM, LEVETIRACETAM LORATADINE AND PSEUDOEPHEDRINE SULFATE, LORATADINE (OTC) LORATADINE, LORATADINE (OTC) METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE METOPROLOL SUCCINATE, METOPROLOL SUCCINATE MIRTAZAPINE, MIRTAZAPINE OMEPRAZOLE, OMEPRAZOLE POTASSIUM CHLORIDE, POTASSIUM CHLORIDE QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE RISPERIDONE, RISPERIDONE TAMOXIFEN CITRATE, TAMOXIFEN CITRATE
TAZTIA XT, DILTIAZEM HYDROCHLORIDE
WATSON LABS INC * WATSON LABORATORIES INC ALBUTEROL SULFATE, ALBUTEROL SULFATE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE FIORICET W/ CODEINE, ACETAMINOPHEN FIORINAL W/CODEINE, ASPIRIN FIORINAL, ASPIRIN LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL HYDROCHLORIDE METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, ETHINYL ESTRADIOL URSODIOL, URSODIOL WATSON PHARMS * WATSON PHARMACEUTICALS
TENUATE DOSPAN, DIETHYLPROPION HYDROCHLORIDE
TENUATE, DIETHYLPROPION HYDROCHLORIDE
* WATSON PHARMACEUTICALS INC ACTIGALL, URSODIOL CONDYLOX, PODOFILOX CORDRAN SP, FLURANDRENOLIDE CORDRAN, FLURANDRENOLIDE
FIORICET, ACETAMINOPHEN
MONODOX, DOXYCYCLINE
WE PHARMS * WE PHARMACEUTICALS INC PREDNISOLONE SODIUM PHOSPHATE,
WEILL MEDCL COLL * WEILL MEDICAL COLLEGE CORNELL UNIV FLUDEOXYGLUCOSE F 18, FLUDEOXYGLUCOSE F-18 WELLSPRING PHARM * WELLSPRING PHARMACEUTICAL CORP DIBENZYLINE, PHENOXYBENZAMINE HYDROCHLORIDE
DUVOID, BETHANECHOL CHLORIDE
DYRENIUM, TRIAMTERENE
WEST WARD * WEST WARD INC ERGOTAMINE TARTRATE AND CAFFEINE, CAFFEINE
ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE
* WEST WARD PHARMACEUTICAL CORP AMINOPHYLLINE, AMINOPHYLLINE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE,
BUTALBITAL, ASPIRIN AND CAFFEINE, ASPIRIN
CAPTOPRIL, CAPTOPRIL
ACETAMINOPHEN
B - 146
APPENDIX B
** W **
* WEST WARD PHARMACEUTICAL CORP CARISOPRODOL, CARISOPRODOL CHLOROQUINE PHOSPHATE, CHLOROQUINE PHOSPHATE CHLOROTHIAZIDE, CHLOROTHIAZIDE CORTISONE ACETATE, CORTISONE ACETATE DICYCLOMINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE DIGOXIN, DIGOXIN DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE FLURAZEPAM HYDROCHLORIDE, FLURAZEPAM HYDROCHLORIDE FOLIC ACID, FOLIC ACID GLYCOPYRROLATE, GLYCOPYRROLATE HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE HYDROCORTISONE, HYDROCORTISONE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE ISONIAZID, ISONIAZID ISOSORBIDE DINITRATE, ISOSORBIDE DINITRATE ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE LISINOPRIL AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LISINOPRIL, LISINOPRIL LITHIUM CARBONATE, LITHIUM CARBONATE MEFLOQUINE HYDROCHLORIDE, MEFLOQUINE HYDROCHLORIDE METHOCARBAMOL, METHOCARBAMOL ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PREDNISONE, PREDNISONE PRIMIDONE, PRIMIDONE PROPYLTHIOURACIL, PROPYLTHIOURACIL TRIHEXYPHENIDYL HYDROCHLORIDE, TRIHEXYPHENIDYL HYDROCHLORIDE
ZALEPLON, ZALEPLON
WEST WARD PHARM CORP * WEST WARD PHARMACEUTICAL CORP PREDNISONE, PREDNISONE WEST WARD PHARMS * WEST WARD PHARMACEUTICALS CORP RISPERIDONE, RISPERIDONE WESTWARD * WESTWARD PHARMACEUTICAL CORP NAPROXEN, NAPROXEN
RIFAMPIN AND ISONIAZID, ISONIAZID
WEST-WARD PHARM CORP * WEST-WARD PHARMACEUTICAL CORP CEFOTETAN, CEFOTETAN DISODIUM DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE
FLUDROCORTISONE ACETATE, FLUDROCORTISONE ACETATE
WOCKHARDT * WOCKHARDT AMERICAS INC CAPTOPRIL, CAPTOPRIL FAMOTIDINE, FAMOTIDINE
RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE
* WOCKHARDT EU OPERATIONS (SWISS) AG ACETAMINOPHEN AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETIC ACID, ACETIC ACID, GLACIAL ALBUTEROL SULFATE, ALBUTEROL SULFATE AMANTADINE HYDROCHLORIDE, AMANTADINE HYDROCHLORIDE AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN AMOXICILLIN, AMOXICILLIN BROMFED-DM, BROMPHENIRAMINE MALEATE CARBAMAZEPINE, CARBAMAZEPINE CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE CIMETIDINE HYDROCHLORIDE, CIMETIDINE HYDROCHLORIDE CLEMASTINE FUMARATE, CLEMASTINE FUMARATE
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE
B - 147
APPENDIX B
* WOCKHARDT EU OPERATIONS (SWISS) AG CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE CROMOLYN SODIUM, CROMOLYN SODIUM CYCLOSPORINE, CYCLOSPORINE DEXAMETHASONE, DEXAMETHASONE DEXCHLORPHENIRAMINE MALEATE, DEXCHLORPHENIRAMINE MALEATE DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE ERYTHROMYCIN, ERYTHROMYCIN FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE FUROSEMIDE, FUROSEMIDE HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE, HOMATROPINE METHYLBROMIDE HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE LEVETIRACETAM, LEVETIRACETAM LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE LINDANE, LINDANE LITHIUM CITRATE, LITHIUM CITRATE LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE (OTC) LORATADINE, LORATADINE (OTC) MEGESTROL ACETATE, MEGESTROL ACETATE METAPROTERENOL SULFATE, METAPROTERENOL SULFATE METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MINOXIDIL (FOR MEN), MINOXIDIL (OTC) MINOXIDIL EXTRA STRENGTH (FOR MEN), MINOXIDIL (OTC) NYSTATIN, NYSTATIN OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE PHENYTOIN, PHENYTOIN PREDNISOLONE SODIUM PHOSPHATE, PREDNISOLONE SODIUM PHOSPHATE PREDNISOLONE, PREDNISOLONE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE, CODEINE PHOSPHATE PROMETHAZINE PLAIN, PROMETHAZINE HYDROCHLORIDE PROMETHAZINE W/ DEXTROMETHORPHAN, DEXTROMETHORPHAN HYDROBROMIDE SELENIUM SULFIDE, SELENIUM SULFIDE TRETINOIN, TRETINOIN
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE
VALPROIC ACID, VALPROIC ACID
* WOCKHARDT LTD ADENOSINE, ADENOSINE AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE AMLODIPINE BESYLATE, AMLODIPINE BESYLATE AZITHROMYCIN, AZITHROMYCIN BETAXOLOL HYDROCHLORIDE, BETAXOLOL HYDROCHLORIDE BETHANECHOL CHLORIDE, BETHANECHOL CHLORIDE CARVEDILOL, CARVEDILOL CEFOTAXIME SODIUM, CEFOTAXIME SODIUM CEFOTAXIME, CEFOTAXIME SODIUM CEFPROZIL, CEFPROZIL CEFTAZIDIME, CEFTAZIDIME CEFTRIAXONE, CEFTRIAXONE SODIUM CEFUROXIME AXETIL, CEFUROXIME AXETIL CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE (OTC) CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE CLARITHROMYCIN, CLARITHROMYCIN DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM FAMOTIDINE, FAMOTIDINE (OTC) FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE FOSPHENYTOIN SODIUM, FOSPHENYTOIN SODIUM FUROSEMIDE, FUROSEMIDE KETOROLAC TROMETHAMINE, KETOROLAC TROMETHAMINE LEVETIRACETAM, LEVETIRACETAM
LEVOFLOXACIN, LEVOFLOXACIN
LISINOPRIL, LISINOPRIL
B - 148
APPENDIX B
** W **
* WOCKHARDT LTD METOPROLOL SUCCINATE, METOPROLOL SUCCINATE MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE NIACIN, NIACIN NICARDIPINE HYDROCHLORIDE, NICARDIPINE HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE, ONDANSETRON HYDROCHLORIDE ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE (OTC) RISPERIDONE, RISPERIDONE ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE, TERBINAFINE HYDROCHLORIDE TIMOLOL MALEATE, TIMOLOL MALEATE VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE ZOLPIDEM TARTRATE, ZOLPIDEM TARTRATE
ZONISAMIDE, ZONISAMIDE
WOCKHARDT USA * WOCKHARDT USA INC EXTENDED PHENYTOIN SODIUM, PHENYTOIN SODIUM GRANISETRON HYDROCHLORIDE, GRANISETRON HYDROCHLORIDE OCTREOTIDE ACETATE (PRESERVATIVE FREE), OCTREOTIDE ACETATE
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE
* WOCKHARDT USA LLC ENALAPRIL MALEATE, ENALAPRIL MALEATE
TOPIRAMATE, TOPIRAMATE
WORLD GEN * WORLD GEN LLC AMLODIPINE BESYLATE,
AMLODIPINE BESYLATE
WRASER PHARMS * WRASER PHARMACEUTICALS LLC CETRAXAL, CIPROFLOXACIN HYDROCHLORIDE WRASER PHARMS LLC * WRASER PHARMACEUTICALS LLC ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, WYETH CONS * WYETH CONSUMER HEALTHCARE ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE (OTC) ADVIL COLD AND SINUS, IBUPROFEN (OTC) ADVIL CONGESTION RELIEF, IBUPROFEN (OTC) ADVIL LIQUI-GELS, IBUPROFEN (OTC) ADVIL MIGRAINE LIQUI-GELS, IBUPROFEN (OTC) ADVIL PM, DIPHENHYDRAMINE HYDROCHLORIDE (OTC) ADVIL, IBUPROFEN (OTC) ALAVERT, LORATADINE (OTC) AXID AR, NIZATIDINE (OTC) CHILDREN'S ADVIL ALLERGY SINUS, CHLORPHENIRAMINE MALEATE CHILDREN'S ADVIL COLD, IBUPROFEN (OTC) CHILDREN'S ADVIL, IBUPROFEN (OTC) CHILDREN'S ADVIL-FLAVORED, IBUPROFEN (OTC) JUNIOR STRENGTH ADVIL, IBUPROFEN (OTC)
LORATADINE, LORATADINE (OTC)
PEDIATRIC ADVIL, IBUPROFEN (OTC)
WYETH PHARMS * WYETH PHARMACEUTICALS INC SUB PFIZER INC LO/OVRAL-28, ETHINYL ESTRADIOL
ACETAMINOPHEN
(OTC)
B - 149
APPENDIX B
WYETH PHARMS INC * WYETH PHARMACEUTICALS INC CORDARONE, AMIODARONE HYDROCHLORIDE EFFEXOR XR, VENLAFAXINE HYDROCHLORIDE LYBREL, ETHINYL ESTRADIOL PHOSPHOLINE IODIDE, ECHOTHIOPHATE IODIDE PREMARIN, ESTROGENS, CONJUGATED PREMPHASE 14/14, ESTROGENS, CONJUGATED PREMPRO, ESTROGENS, CONJUGATED PRISTIQ, DESVENLAFAXINE SUCCINATE PROTONIX IV, PANTOPRAZOLE SODIUM PROTONIX, PANTOPRAZOLE SODIUM RAPAMUNE, SIROLIMUS TORISEL, TEMSIROLIMUS TRECATOR, ETHIONAMIDE TYGACIL, TIGECYCLINE
ZOSYN IN PLASTIC CONTAINER, PIPERACILLIN SODIUM
ZOSYN, PIPERACILLIN SODIUM
X GEN PHARMS * X GEN PHARMACEUTICALS INC ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE SODIUM AMPHOTERICIN B, AMPHOTERICIN B BACIIM, BACITRACIN BACI-RX, BACITRACIN COLISTIMETHATE SODIUM, COLISTIMETHATE SODIUM EPIRUBICIN HYDROCHLORIDE, EPIRUBICIN HYDROCHLORIDE HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE HYDRO-RX, HYDROCORTISONE LIOTHYRONINE SODIUM, LIOTHYRONINE SODIUM NEO-FRADIN, NEOMYCIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATE, NEOMYCIN SULFATE NEOMYCIN SULFATE, NEOMYCIN SULFATE NEO-RX, NEOMYCIN SULFATE NYSTATIN, NYSTATIN POLYMYXIN B SULFATE, POLYMYXIN B SULFATE POLY-RX, POLYMYXIN B SULFATE
STREPTOMYCIN SULFATE, STREPTOMYCIN SULFATE
TOBRAMYCIN SULFATE, TOBRAMYCIN SULFATE
XANODYNE PHARM * XANODYNE PHARMACEUTICS INC AMICAR, AMINOCAPROIC ACID
ORAMORPH SR, MORPHINE SULFATE
ZIPSOR, DICLOFENAC POTASSIUM
XANODYNE PHARMS * XANODYNE PHARMACEUTICALS INC ROXICODONE, OXYCODONE HYDROCHLORIDE X-GEN PHARMS * X-GEN PHARMACEUTICALS INC IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE
PHENYTOIN SODIUM, PHENYTOIN SODIUM
PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE
XTTRIUM * XTTRIUM LABORATORIES INC CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE
DYNA-HEX, CHLORHEXIDINE GLUCONATE (OTC)
EXIDINE, CHLORHEXIDINE GLUCONATE (OTC)
YUNG SHIN PHARM * YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD
CEFACLOR, CEFACLOR
CEPHALEXIN, CEPHALEXIN
B - 150
APPENDIX B
ZAMBON SPA * ZAMBON SPA ITALY MONUROL, FOSFOMYCIN TROMETHAMINE ZARS PHARM * ZARS PHARMA INC SYNERA, LIDOCAINE ZOGENIX INC * ZOGENIX INC SUMAVEL DOSEPRO,
SUMATRIPTAN SUCCINATE
ZYDUS PHARMS USA * ZYDUS PHARMACEUTICALS USA INC AMLODIPINE BESYLATE, AMLODIPINE BESYLATE ATENOLOL, ATENOLOL AZATHIOPRINE, AZATHIOPRINE BENAZEPRIL HYDROCHLORIDE, BENAZEPRIL HYDROCHLORIDE BENZONATATE, BENZONATATE CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE HALOPERIDOL, HALOPERIDOL HYDRALAZINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE LAMOTRIGINE, LAMOTRIGINE MELOXICAM, MELOXICAM METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE NAPROXEN, NAPROXEN PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE PRAVASTATIN SODIUM, PRAVASTATIN SODIUM PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE RAMIPRIL, RAMIPRIL RIBAVIRIN, RIBAVIRIN RISPERIDONE, RISPERIDONE SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE SIMVASTATIN, SIMVASTATIN VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
WARFARIN SODIUM, WARFARIN SODIUM
ZONISAMIDE, ZONISAMIDE
ZYDUS PHARMS USA INC * ZYDUS PHARMACEUTICALS USA INC ACETAZOLAMIDE, ACETAZOLAMIDE ALPRAZOLAM, ALPRAZOLAM AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE ANASTROZOLE, ANASTROZOLE ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE BICALUTAMIDE, BICALUTAMIDE BROMOCRIPTINE MESYLATE, BROMOCRIPTINE MESYLATE CARVEDILOL, CARVEDILOL DIPYRIDAMOLE, DIPYRIDAMOLE DIVALPROEX SODIUM, DIVALPROEX SODIUM DONEPEZIL HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE FINASTERIDE, FINASTERIDE GABAPENTIN, GABAPENTIN GALANTAMINE HYDROBROMIDE, GALANTAMINE HYDROBROMIDE GLIPIZIDE AND METFORMIN HYDROCHLORIDE, GLIPIZIDE HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE INDOMETHACIN, INDOMETHACIN LAMOTRIGINE, LAMOTRIGINE LEVETIRACETAM, LEVETIRACETAM LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM, LOSARTAN POTASSIUM MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE
RAMIPRIL, RAMIPRIL
RISPERIDONE, RISPERIDONE
B - 151
APPENDIX B
* ZYDUS PHARMACEUTICALS USA INC ROPINIROLE HYDROCHLORIDE, ROPINIROLE HYDROCHLORIDE TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE TOPIRAMATE, TOPIRAMATE TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE HYDROCHLORIDE
C-1
APPENDIX C
UNIFORM TERMS
DOSAGE FORMS
AEROSOL AEROSOL, FOAM AEROSOL, METERED CAPSULE CAPSULE, DELAYED REL PELLETS CAPSULE, DELAYED RELEASE CAPSULE, EXTENDED RELEASE CLOTH CONCENTRATE CREAM CREAM, AUGMENTED ELIXIR EMULSION ENEMA FILM FILM, EXTENDED RELEASE FOR SOLUTION FOR SOLUTION, TABLET, FOR SOLUTION FOR SUSPENSION FOR SUSPENSION, DELAYED RELEASE FOR SUSPENSION, EXTENDED RELEASE GAS GEL GEL, AUGMENTED GEL, METERED GRANULE GRANULE, DELAYED RELEASE GUM, CHEWING IMPLANT INHALANT INJECTABLE INJECTABLE, LIPID COMPLEX INJECTABLE, LIPOSOMAL INSERT INSERT, EXTENDED RELEASE INTRAUTERINE DEVICE JELLY LIQUID LOTION LOTION, AUGMENTED LOTION/SHAMPOO OIL OIL/DROPS OINTMENT OINTMENT, AUGMENTED PASTE PATCH PELLET POWDER POWDER, EXTENDED RELEASE POWDER, METERED RING SHAMPOO SOLUTION SOLUTION FOR SLUSH SOLUTION, GEL FORMING/DROPS SOLUTION, METERED SOLUTION/DROPS SPONGE SPRAY SPRAY, METERED SUPPOSITORY SUSPENSION SUSPENSION, EXTENDED RELEASE SUSPENSION/DROPS SWAB SYRUP SYSTEM, EXTENDED RELEASE TABLET TABLET, CHEWABLE TABLET, COATED PARTICLES TABLET, DELAYED RELEASE TABLET, DELAYED RELEASE, ORALLY DISINTEGRATING TABLET, EFFERVESCENT TABLET, EXTENDED RELEASE TABLET, FOR SUSPENSION TABLET, ORALLY DISINTEGRATING TAPE TROCHE/LOZENGE
C-2
C-3
APPENDIX C
UNIFORM TERMS
ABBREVIATIONS
AMP AMPICIL APPROX BOT CI CSR CU DIPROP ELECT EQ ER GM HBR HCL HR INH IU KIU MCG MCI MEQ MG ML N/A PPM REL SQ CM U UCI UMOLAR USP
AMPULE AMPICILLIN APPROXIMATELY BOTTLE CURIE CAROTID SINUS REFLEX CLINICAL UNITS DIPROPIONATE ELECTROLYTE EQUIVALENT TO EXTENDED RELEASE GRAM HYDROBROMIDE HYDROCHLORIDE HOUR INHALATION INTERNATIONAL UNITS KALLIKREIN INHIBITOR UNITS MICROGRAM MILLICURIE MILLIEQUIVALENT MILLIGRAM MILLILITER NOT APPLICABLE PARTS PER MILLION RELEASE SQUARE CENTIMETER UNITS MICROCURIE MICROMOLAR UNITED STATES PHARMACOPEIA
This Addendum identifies drugs that qualify under the Drug Price Competition and Patent Term Restoration Act (1984 Amendments) for periods of exclusivity, during which abbreviated new drug applications (ANDAs) and applications described in Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act (the Act) for those drug products may, in some instances, not be submitted or made effective as described below, and provides patent information concerning the listed drug products. Those drugs that have qualified for Orphan Drug Exclusivity pursuant to Section 527 of the Act and those drugs that have qualified for Pediatric Exclusivity pursuant to Section 505A are also included in this Addendum. This section is arranged in alphabetical order by active ingredient name followed the trade name. Active ingredient headings for multiple ingredient (combination) drug products are arranged alphabetically. For an explanation of the codes used in the Addendum, see the Patent and Exclusivity Terms Section. Exclusivity prevents the submission or effective approval of ANDAs or applications described in Section 505(b)(2) of the Act. It does not prevent the submission or approval of a second 505(b)(1) application except in the case of Orphan Drug exclusivity. Applications qualifying for periods of exclusivity are: (1) A new drug application approved after September 24, 1984, for a drug product all active ingredients (including any ester or salt of the active ingredient) of which had never been approved in any other new drug application under Section 505 (b) of the Act. No subsequent ANDA or application described in Section 505(b)(2) of the Act for the same drug may be submitted for a period of five years from the date of approval of the original application, except that such an application may be submitted after four years if it contains a certification that a patent claiming the drug is invalid or will not be infringed by the product for which approval is sought. (2) A new drug application approved after September 24, 1984, for a drug product containing an active ingredient (including any ester or salt of that active ingredient) that has been approved in an earlier new drug application and that includes reports of new clinical investigations (other than bioavailability studies). Such investigations must have been conducted or sponsored by the applicant and must have been essential to approval of the application. If these requirements are met, the approval of a subsequent ANDA or an application described in Section 505(b)(2) of the Act may not be made effective for the same drug or use, if for a new indication, before the expiration of three years from the date of approval of the original application. If an applicant has exclusivity for a new application or 505(b)(2) application for the drug product with indications or use, this does not preclude the approval of an ANDA or 505(b)(2) application not covered by the exclusivity. (3) A supplement to a new drug application for a drug containing a previously approved active ingredient including (any ester or salt of the active ingredient) approved after September 24, 1984, that contains reports of new clinical investigations (other than bioavailability studies) essential to the approval of the supplement and conducted or sponsored by the applicant. The approval of a subsequent ANDA or 505(b)(2) application for a change approved in the supplement may not be
AD 1
made effective for three years from the date of approval of the original supplement.
The Act requires that patent information be filed with all newly submitted Section 505(b) drug applications. No NDA may be approved after September 24, 1984, without the submission of patent information to the Agency. Effective August 18, 2003, this information must be filed using FDA Form 3524a Patent Information Submitted with the Filing of an NDA, Amendment or Supplement. Effective August 18, 2003, upon approval of an application, patent information for purposes of listing in the Orange Book must be submitted to the agency within 30 days of approval on FDA Form 3542 Patent Information Submitted Upon and After Approval of an NDA or Supplement. Patent information on unapproved applications or on patents beyond the scope of the Act (i.e., process or manufacturing patents) will not be published. FDA form 3542 will be the only form used for the purposes of this publication. The patents that FDA regards as covered by the statutory provisions for submission of patent information are: patents that claim the active ingredient(s); drug product patents which include formulation/composition patents; use patents for a particular approved indication or method of using the product; and certain other patents as detailed on FDA Form 3542. This information, as provided by the sponsor on FDA form 3542, will be published as described above. A requirement for submission of patent information to FDA for certain old antibiotics became effective October 7, 2008 under section 4(b)(1) of the Q1 Act. A guidance for industry on this subject is available at http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Forms/UCM048345.pdf Upon approval, patent numbers and expiration dates, in addition to certain other information on appropriate patents claiming drug products that are the subject of approved applications, will be published daily in the Electronic Orange Book Query. The Addendum lists patent and exclusivity information up to January of the Edition year. The monthly Cumulative Supplements to the annual edition list patent and exclusivity information changes since the Annual Edition Addendum. Since all parts of this publication are subject to changes, additions, or deletions, the Electronic Orange Book, updated daily, should be consulted for the most recent patent and exclusivity information.
AD 2
ADA 1 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-65 U-65
EXCLUSIVITY CODE(S)
ABACAVIR SULFATE - ZIAGEN N020977 001 5034394 5034394*PED 6294540 6294540*PED ABACAVIR SULFATE - ZIAGEN N020978 001 5034394 5034394*PED 6294540 6294540*PED 6641843 6641843*PED
DS DS
DP DP DP U-65 U-65
ABACAVIR SULFATE; LAMIVUDINE - EPZICOM N021652 001 5034394 Dec 18, 5034394*PED Jun 18, 5905082 May 18, Nov 18, 5905082*PED May 14, 6294540 Nov 14, 6294540*PED Mar 28, 6417191
DS DS DS
DP DP DP DP U-257 U-257
ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE - TRIZIVIR DS N021205 001 5034394 Dec 18, 2011 5034394*PED Jun 18, 2012 DS 5905082 May 18, 2016 Nov 18, 2016 5905082*PED May 14, 2018 DS 6294540 Nov 14, 2018 6294540*PED Mar 28, 2016 6417191 ABARELIX - PLENAXIS N021320 001 5843901 5968895 6180608 6423686 6455499 6699833 ABIRATERONE ACETATE - ZYTIGA N202379 001 5604213 ACETAMINOPHEN - OFIRMEV N022450 001 6028222 6992218
DS
DP DP DP
U-549 U-549
DS DP
Feb
18, 2014
DS
DP
U-1126
NCE
Apr
28, 2016
Aug Jun
DP DP
NP
Nov
02, 2013
ACETAMINOPHEN; ASPIRIN; CAFFEINE - EXCEDRIN (MIGRAINE) N020802 001 5972916 Jul 14, 2017 U-296 ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE - ULTRACET DS N021123 001 RE39221 Aug 09, 2011 ACETYLCHOLINE CHLORIDE - MIOCHOL-E N020213 001 6261546 Apr ACYCLOVIR; HYDROCORTISONE - XERESE N022436 001 6514980 Jan 7223387 Feb RE39264 Feb ADAPALENE - DIFFERIN N021753 001 7579377 7737181 7834060 7838558 7868044 ADAPALENE - DIFFERIN N022502 001 7998467
DP
U-55
29, 2019
U-506
DP DP DP
NC
Jul
31, 2012
May
31, 2028
DP
U-1078
NDF
Mar
17, 2013
ADA 2 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
NC
ADAPALENE; BENZOYL PEROXIDE - EPIDUO N022320 001 7820186 Nov 23, 2025 7964202 Sep 01, 2024 8071644 Jul 18, 2027 8080537 Jul 18, 2027 ADEFOVIR DIPIVOXIL - HEPSERA N021449 001 5663159 6451340 ADENOSINE - ADENOSCAN N020059 001 5731296
Dec
08, 2011
Sep Jul
DS DS
DP DP
U-470
Mar
24, 2015
U-221
ALATROFLOXACIN MESYLATE - TROVAN PRESERVATIVE FREE N020760 001 5763454 Jun 15, 2015 6080756 Jul 05, 2016 6194429 Jul 23, 2018 ALATROFLOXACIN MESYLATE - TROVAN PRESERVATIVE FREE N020760 002 5763454 Jun 15, 2015 6080756 Jul 05, 2016 6194429 Jul 23, 2018 ALBUMIN HUMAN - OPTISON N020899 001 5529766 5558094 5573751 6723303 ALBUTEROL SULFATE - ACCUNEB N020949 001 6702997 ALBUTEROL SULFATE - ACCUNEB N020949 002 6702997
U-282
U-282
U-505 U-505 DP
Dec
28, 2021
U-558
Dec
28, 2021
U-558
ALBUTEROL SULFATE - PROAIR HFA N021457 001 5605674 Feb 7105152 Sep 7566445 Jun ALBUTEROL SULFATE - PROVENTIL-HFA N020503 001 5605674 Feb 5766573 Jun
DP DP DP
NPP
Sep
16, 2011
ADA 3 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP U-716 DP DP DP DP DP DP DP U-716
EXCLUSIVITY CODE(S)
ALBUTEROL SULFATE - VENTOLIN HFA N020983 001 6161724 Jan 6161724*PED Jul 6170717 Dec 6170717*PED Jun 6315173 Dec 6315173*PED Jun 6431168 Jun 6431168*PED Dec 6435372 Jan 6435372*PED Jul 6510969 Dec 6510969*PED Jun 6558651 Dec 6558651*PED Jun 6596260 Aug 6596260*PED Feb 6743413 Jun 6743413*PED Dec 6938796 Jan 6938796*PED Jul 6966467 Dec 6966467*PED Jun 6997349 Jan 6997349*PED Jul 7107986 Jun 7107986*PED Dec 7143908 Jan 7143908*PED Jul 7350676 Aug 7350676*PED Feb 7500444 Jan 7500444*PED Jul
16, 16, 23, 23, 23, 23, 08, 08, 16, 16, 23, 23, 19, 19, 10, 10, 01, 01, 16, 16, 23, 23, 16, 16, 08, 06, 16, 16, 24, 24, 04, 04,
2018 2018 2017 2018 2017 2018 2018 2018 2018 2018 2017 2018 2016 2017 2014 2015 2021 2021 2018 2018 2017 2018 2018 2018 2018 2018 2018 2018 2018 2019 2025 2025
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - COMBIVENT N020291 001 5603918 Jun 09, 2015 ALBUTEROL SULFATE; IPRATROPIUM N021747 001 5405084 5472143 5497944 5662271 5911851 5964416 6007676 6149054 6176442 6453795 6503362 6726124 6846413 6977042 6988496 7104470 7246615 7284474 7396341 7802568 7837235 7896264 7988001 BROMIDE - COMBIVENT RESPIMAT DP Apr 11, 2012 DP Sep 29, 2013 DP Mar 12, 2013 DP Sep 02, 2014 DP Sep 29, 2013 Oct 04, 2016 DP DP Sep 29, 2013 DP Dec 19, 2016 DP Oct 04, 2016 Dec 05, 2016 DP DP Sep 29, 2013 DP Oct 04, 2016 DP Aug 28, 2018 DP Aug 28, 2018 Feb 23, 2020 DP DP Oct 04, 2016 DP May 31, 2016 DP Aug 26, 2024 DP Oct 10, 2026 Feb 26, 2019 DP DP Mar 13, 2028 DP May 26, 2025 DP Aug 04, 2021
NP
Oct
07, 2014
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE - DUONEB N020950 001 6632842 Dec 28, 2021 ALCAFTADINE - LASTACAFT N022134 001 5468743
U-532
Nov
21, 2012
DS
DP
NCE
Jul
28, 2015
ADA 4 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ALCOHOL; CHLORHEXIDINE GLUCONATE - AVAGARD Jun 21, 2016 N021074 001 5897031 Jun 22, 2015 6090395 Jun 22, 2015 6534069 Jun 23, 2015 6623744 Aug 03, 2016 7081246 Jun 22, 2015 7566460 ALENDRONATE SODIUM - FOSAMAX N020560 001 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED 6194004 6194004*PED ALENDRONATE SODIUM - FOSAMAX N020560 002 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED ALENDRONATE SODIUM - FOSAMAX N020560 003 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED ALENDRONATE SODIUM - FOSAMAX N020560 004 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED ALENDRONATE SODIUM - FOSAMAX N020560 005 5358941 5358941*PED 5681590 5681590*PED 6090410 6090410*PED ALENDRONATE SODIUM - FOSAMAX N021575 001 5462932 5462932*PED 5994329 5994329*PED 6015801 6015801*PED 6225294 6225294*PED
DP DP U-1008 DP DP U-1008
Y Y Y
ALENDRONATE SODIUM; CHOLECALCIFEROL N021762 001 5358941 Dec 5358941*PED Jun 5681590 Dec 5681590*PED Jun 5994329 Jul 5994329*PED Jan 6090410 Dec 6090410*PED Jun
- FOSAMAX PLUS D 02, 2012 DP 02, 2013 DP 02, 2012 02, 2013 17, 2018 17, 2019 DP 02, 2012 DP 02, 2013
U-647
ADA 5 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ALENDRONATE SODIUM; CHOLECALCIFEROL N021762 002 5358941 Dec 5358941*PED Jun 5681590 Dec 5681590*PED Jun 6090410 Dec 6090410*PED Jun
- FOSAMAX PLUS D 02, 2012 DP 02, 2013 DP 02, 2012 02, 2013 DP 02, 2012 DP 02, 2013
ALFUZOSIN HYDROCHLORIDE - ALFUZOSIN HYDROCHLORIDE A079013 001 ALFUZOSIN HYDROCHLORIDE - ALFUZOSIN HYDROCHLORIDE A079014 001 ALFUZOSIN HYDROCHLORIDE - ALFUZOSIN HYDROCHLORIDE A079054 001 ALFUZOSIN HYDROCHLORIDE - ALFUZOSIN HYDROCHLORIDE A079056 001 ALFUZOSIN HYDROCHLORIDE - ALFUZOSIN HYDROCHLORIDE A079057 001 ALFUZOSIN HYDROCHLORIDE - UROXATRAL N021287 001 4661491*PED Jul 18, 2011 6149940 Aug 22, 2017 6149940*PED Feb 22, 2018 ALISKIREN HEMIFUMARATE - TEKTURNA N021985 001 5559111 Jul ALISKIREN HEMIFUMARATE - TEKTURNA N021985 002 5559111 Jul
PC
Jan
14, 2012
PC
Jan
14, 2012
PC
Jan
14, 2012
PC
Jan
14, 2012
PC
Jan
14, 2012
M-97 PED
Dec Jun
21, 2018
DS
DP
U-3
NCE
Mar
05, 2012
21, 2018
DS
DP
U-3
NCE
Mar
05, 2012
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO N022545 001 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO N022545 002 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO N022545 003 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE - TEKAMLO N022545 004 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 001 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 002 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 003 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 004 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE - AMTURNIDE N200045 005 5559111 Jul 21, 2018 DS DP U-3
NC NCE
Aug Mar
NC NCE
Aug Mar
NC NCE
Aug Mar
NC NCE
Aug Mar
NCE NC
Mar Dec
NCE NC
Mar Dec
NCE NC
Mar Dec
NCE NC
Mar Dec
NCE NC
Mar Dec
ADA 6 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-600 NCE
ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT N022107 001 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT N022107 002 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT N022107 003 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE - TEKTURNA HCT N022107 004 5559111 Jul 21, 2018 DS DP U-3 ALISKIREN HEMIFUMARATE; VALSARTAN - VALTURNA N022217 001 5399578 Mar 21, 2012 5559111 Jul 21, 2018 ALISKIREN HEMIFUMARATE; VALSARTAN - VALTURNA N022217 002 5399578 Mar 21, 2012 5559111 Jul 21, 2018 ALITRETINOIN - PANRETIN N020886 001 5932622 ALMOTRIPTAN MALATE - AXERT N021001 001 5565447 5565447*PED ALMOTRIPTAN MALATE - AXERT N021001 002 5565447 5565447*PED
Jul Mar
I-600 NCE
Jul Mar
I-600 NCE
Jul Mar
I-600 NCE
Jul Mar
DS DS
DP DP
U-3 U-3
NCE NC
Mar Sep
DS DS
DP DP
U-3 U-3
NCE NC
Mar Sep
Aug
03, 2016
U-562
May Nov
DS
DP
U-969
May Nov
DS
DP
U-969
ALOSETRON HYDROCHLORIDE - LOTRONEX N021107 001 5360800 Jan 6284770 Oct ALOSETRON HYDROCHLORIDE - LOTRONEX N021107 002 5360800 Jan 6284770 Oct ALPRAZOLAM - NIRAVAM N021726 001 6024981 6221392 ALPRAZOLAM - NIRAVAM N021726 002 6024981 6221392 ALPRAZOLAM - NIRAVAM N021726 003 6024981 6221392 ALPRAZOLAM - NIRAVAM N021726 004 6024981 6221392 ALPROSTADIL - CAVERJECT N020379 001 5741523 ALPROSTADIL - CAVERJECT N020379 002 5741523 ALPROSTADIL - CAVERJECT N020379 003 5741523 ALPROSTADIL - CAVERJECT N020379 004 5741523
DS
DP
U-405 U-405
DS
DP
U-405 U-405
Apr Apr
DP DP
Apr Apr
DP DP
Apr Apr
DP DP
Apr Apr
DP DP
Apr
21, 2015
Apr
21, 2015
Apr
21, 2015
Apr
21, 2015
ADA 7 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP
EXCLUSIVITY CODE(S)
ALPROSTADIL - CAVERJECT IMPULSE Apr N021212 001 5501673 Feb 5716338 ALPROSTADIL - CAVERJECT IMPULSE N021212 002 5501673 Apr 5716338 Feb ALPROSTADIL - MUSE N020700 001 5474535 5886039 ALPROSTADIL - MUSE N020700 002 5474535 5886039 ALPROSTADIL - MUSE N020700 003 5474535 5886039 ALPROSTADIL - MUSE N020700 004 5474535 5886039 ALVIMOPAN - ENTEREG N021775 001 5250542 5434171 6469030 AMBRISENTAN - LETAIRIS N022081 001 5703017 5840722 7109205 7601730 RE42462 AMBRISENTAN - LETAIRIS N022081 002 5703017 5840722 7109205 7601730 RE42462 AMIFOSTINE - ETHYOL N020221 001 5424471 5591731 5994409 AMIFOSTINE - ETHYOL N020221 002 5424471 5591731 5994409
DP DP
Dec Mar
DP
U-155 U-155
Dec Mar
DP
U-155 U-155
Dec Mar
DP
U-155 U-155
Dec Mar
DP
U-155 U-155
DS DS
DP DP
NCE
May
20, 2013
DS U-821 DS DS DP U-1080
NCE ODE
Jun Jun
DS U-821 DS DS DP U-1080
NCE ODE
Jun Jun
U-305
31, 2012 31, 2012 08, 2017 LEVULAN 30, 2013 31, 2017 01, 2018 17, 2019
U-305
AMINOLEVULINIC ACID HYDROCHLORIDE Sep N020965 001 5079262 Oct 5954703 May 6709446 Jun 7723910
M-82
Mar
12, 2013
AMIODARONE HYDROCHLORIDE - NEXTERONE N022325 001 6869939 May 04, 2022 7635773 Mar 13, 2029 AMIODARONE HYDROCHLORIDE - NEXTERONE May 04, 2022 N022325 002 6869939 Mar 13, 2029 7635773 AMIODARONE HYDROCHLORIDE - NEXTERONE May 04, 2022 N022325 003 6869939 Mar 13, 2029 7635773
DP DP
DP DP
DP DP
ADA 8 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-243
EXCLUSIVITY CODE(S)
Nov
08, 2011
AMLODIPINE BESYLATE - AMLODIPINE BESYLATE N022026 001 6828339 Nov 20, 2022 AMLODIPINE BESYLATE - AMLODIPINE BESYLATE N022026 002 6828339 Nov 20, 2022 AMLODIPINE BESYLATE - AMLODIPINE BESYLATE N022026 003 6828339 Nov 20, 2022
DS
DS
DS
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 001 5686104 Nov 11, 2014 5686104*PED May 11, 2015 5969156 Jul 08, 2016 DS 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 002 5686104 Nov 11, 2014 5686104*PED May 11, 2015 5969156 Jul 08, 2016 DS 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 003 5686104 Nov 11, 2014 5686104*PED May 11, 2015 5969156 Jul 08, 2016 DS 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 004 5686104 Nov 11, 2014 5686104*PED May 11, 2015 DS 5969156 Jul 08, 2016 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 005 5686104 Nov 11, 2014 5686104*PED May 11, 2015 DS 5969156 Jul 08, 2016 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 006 5686104 Nov 11, 2014 5686104*PED May 11, 2015 DS 5969156 Jul 08, 2016 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
ADA 9 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP U-213
EXCLUSIVITY CODE(S)
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 007 5686104 Nov 11, 2014 5686104*PED May 11, 2015 DS 5969156 Jul 08, 2016 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 008 5686104 Nov 11, 2014 5686104*PED May 11, 2015 DS 5969156 Jul 08, 2016 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 009 5686104 Nov 11, 2014 5686104*PED May 11, 2015 DS 5969156 Jul 08, 2016 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 010 5686104 Nov 11, 2014 5686104*PED May 11, 2015 DS 5969156 Jul 08, 2016 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018 AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM - CADUET N021540 011 5686104 Nov 11, 2014 5686104*PED May 11, 2015 DS 5969156 Jul 08, 2016 5969156*PED Jan 08, 2017 6126971 Jan 19, 2013 6126971*PED Jul 19, 2013 6455574 Aug 11, 2018
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
DP
U-213
DP U-552
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE A078381 005 PC Jul 02, 2011 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE A078381 006 PC Jul 02, 2011 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL N020364 002 6162802 Dec 19, 2017 U-367 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL N020364 003 6162802 Dec 19, 2017 U-367 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL N020364 004 6162802 Dec 19, 2017 U-367 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL N020364 005 6162802 Dec 19, 2017 U-367 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL N020364 006 6162802 Dec 19, 2017 DS DP U-185 AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE - LOTREL N020364 007 6162802 Dec 19, 2017 DS DP U-185
ADA 10 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NC
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR N200175 001 5616599 Apr 25, 2016 DS DP U-3 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR N200175 002 5616599 Apr 25, 2016 DS DP U-3 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR N200175 003 5616599 Apr 25, 2016 DS DP U-3 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR N200175 004 5616599 Apr 25, 2016 DS DP U-3 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - TRIBENZOR N200175 005 5616599 Apr 25, 2016 DS DP U-3 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT N022314 001 5399578 Mar 21, 2012 DS DP U-3 5399578*PED Sep 21, 2012 DP U-3 6294197 Jun 18, 2017 6294197*PED Dec 18, 2017 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT N022314 002 5399578 Mar 21, 2012 DS DP U-3 5399578*PED Sep 21, 2012 6294197 Jun 18, 2017 DP U-3 6294197*PED Dec 18, 2017 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT N022314 003 5399578 Mar 21, 2012 DS DP U-3 5399578*PED Sep 21, 2012 DP U-3 6294197 Jun 18, 2017 6294197*PED Dec 18, 2017 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT N022314 004 5399578 Mar 21, 2012 DS DP U-3 5399578*PED Sep 21, 2012 DP U-3 6294197 Jun 18, 2017 6294197*PED Dec 18, 2017 AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN - EXFORGE HCT N022314 005 5399578 Mar 21, 2012 DS DP U-3 5399578*PED Sep 21, 2012 6294197 Jun 18, 2017 DP U-3 6294197*PED Dec 18, 2017 AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR N022100 001 5616599 Apr 25, 2016 DS 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR N022100 002 5616599 Apr 25, 2016 DS 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR N022100 003 5616599 Apr 25, 2016 DS 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL - AZOR N022100 004 5616599 Apr 25, 2016 DS 5616599*PED Oct 25, 2016 AMLODIPINE BESYLATE; TELMISARTAN - TWYNSTA N022401 001 5591762 Jan 07, 2014 AMLODIPINE BESYLATE; TELMISARTAN - TWYNSTA N022401 002 5591762 Jan 07, 2014
Jul
23, 2013
NC
Jul
23, 2013
NC
Jul
23, 2013
NC
Jul
23, 2013
NC
Jul
23, 2013
NC
Apr
30, 2012
NC
Apr
30, 2012
NC
Apr
30, 2012
NC
Apr
30, 2012
NC
Apr
30, 2012
DP
U-3
DP
U-3
DP
U-3
DP
U-3
DS
DP
U-3
NC
Oct
16, 2012
DS
DP
U-3
NC
Oct
16, 2012
ADA 11 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-3
EXCLUSIVITY CODE(S)
NC
AMLODIPINE BESYLATE; TELMISARTAN - TWYNSTA N022401 003 5591762 Jan 07, 2014 AMLODIPINE BESYLATE; TELMISARTAN - TWYNSTA N022401 004 5591762 Jan 07, 2014 AMLODIPINE BESYLATE; VALSARTAN N021990 002 5399578 5399578*PED 6294197 6294197*PED 6395728 AMLODIPINE BESYLATE; VALSARTAN N021990 003 5399578 5399578*PED 6294197 6294197*PED 6395728 AMLODIPINE BESYLATE; VALSARTAN N021990 004 5399578 5399578*PED 6294197 6294197*PED 6395728 AMLODIPINE BESYLATE; VALSARTAN N021990 005 5399578 5399578*PED 6294197 6294197*PED 6395728 AMMONIA, N-13 - AMMONIA N 13 N022119 001 AMOXICILLIN - MOXATAG N050813 001 6544555 6669948 6723341 - EXFORGE Mar 21, 2012 Sep 21, 2012 Jun 18, 2017 Dec 18, 2017 Jul 08, 2019 - EXFORGE Mar 21, 2012 Sep 21, 2012 Jun 18, 2017 Dec 18, 2017 Jul 08, 2019 - EXFORGE Mar 21, 2012 Sep 21, 2012 Jun 18, 2017 Dec 18, 2017 Jul 08, 2019 - EXFORGE Mar 21, 2012 Sep 21, 2012 Jun 18, 2017 Dec 18, 2017 Jul 08, 2019
Oct
16, 2012
DS
DP
U-3
NC
Oct
16, 2012
DS
DP DP DP
U-3 U-3
DS
DP DP DP
U-3 U-3
DS
DP DP DP
U-3 U-3
DS
DP DP DP
U-3 U-3
NCE W Oct Oct Oct 13, 2020 13, 2020 13, 2020 DS DS DS DP DP DP U-897 U-897 U-897
Aug Aug
AMOXICILLIN; CLAVULANATE POTASSIUM - AUGMENTIN XR N050785 001 6746692 Apr 04, 2020 6783773 Apr 04, 2020 6878386 Apr 04, 2020 7217430 Apr 04, 2020 7250176 Apr 04, 2020
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 10 N011522 007 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 12.5 N011522 012 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 15 N011522 013 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 20 N011522 008 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021
ADA 12 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 30 N011522 010 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 5 N011522 009 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL 7.5 N011522 011 6384020 Jul 06, 2020 6384020*PED Jan 06, 2021 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 10 N021303 001 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 DP RE42096 Oct 21, 2018 RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 15 N021303 006 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 RE42096 Oct 21, 2018 DP RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 20 N021303 002 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 RE41148 Oct 21, 2018 DP RE41148*PED Apr 21, 2019 DP RE42096 Oct 21, 2018 RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 25 N021303 004 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 DP RE42096 Oct 21, 2018 RE42096*PED Apr 21, 2019 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 30 N021303 003 6322819 Oct 21, 2018 6322819*PED Apr 21, 2019 6605300 Oct 21, 2018 6605300*PED Apr 21, 2019 DP RE41148 Oct 21, 2018 RE41148*PED Apr 21, 2019 DP RE42096 Oct 21, 2018 RE42096*PED Apr 21, 2019
ADA 13 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE ADDERALL XR 5 N021303 005 6322819 Oct 21, 2018
6322819*PED Apr 21, 2019
6605300 Oct 21, 2018
6605300*PED Apr 21, 2019
DP
RE41148 Oct 21, 2018
RE41148*PED Apr 21, 2019
DP
RE42096 Oct 21, 2018
RE42096*PED Apr 21, 2019
AMPHOTERICIN B - ABELCET N050724 001 5616334 6406713 AMPHOTERICIN B - AMBISOME N050740 001 5874104 5965156 AMPRENAVIR - AGENERASE N021007 001 5585397 5646180 5723490 6730679 AMPRENAVIR - AGENERASE N021007 002 5585397 5646180 5723490 6730679 AMPRENAVIR - AGENERASE N021039 001 5585397 5646180 5723490 ANASTROZOLE - ARIMIDEX N020541 001 ANIDULAFUNGIN - ERAXIS N021632 001 5965525 6384013 6743777 6960564 7709444 ANIDULAFUNGIN - ERAXIS N021632 002 5965525 6384013 6743777 6960564 7709444 APREPITANT - EMEND N021549 001 5538982 5719147 6048859 6096742 6235735 6235735 7214692
Apr Jun
DS DS
Feb Oct
DP DP
U-922 U-922
U-257 U-257 DP
U-257 U-257 DP
U-257 U-257
M-61 PED Feb Mar Mar Apr Apr 17, 19, 19, 12, 12, 2020 2012 2012 2021 2021 DS DS DP DP DP DP U-540 U-540 U-540 U-540
Dec Jun
DS DS
DP DP DP DP
DS DS
DP DP
M-82
Mar
19, 2013
ADA 14 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-745 U-853 U-745 U-745 U-747 U-746 U-853
EXCLUSIVITY CODE(S)
M-82
APREPITANT - EMEND N021549 002 5538982 5719147 6048859 6096742 6235735 6235735 7214692 APREPITANT - EMEND N021549 003 5538982 5719147 6048859 6096742 6235735 6235735 7214692
Mar
19, 2013
DS DS
DP DP
DS DS
DP DP
M-82
Mar
19, 2013
ARBUTAMINE HYDROCHLORIDE - GENESA N020420 001 5395970 Mar ARFORMOTEROL TARTRATE - BROVANA Apr N021912 001 5795564 Nov 6040344 Apr 6068833 Nov 6472563 Apr 6589508 Nov 6720453 Apr 6866839 Nov 7145036 ARGATROBAN - ARGATROBAN N020883 001 5214052
07, 2012
Jun
30, 2014
ARGATROBAN - ARGATROBAN IN SODIUM CHLORIDE Sep 26, 2027 N022434 001 7589106 Sep 26, 2027 7687516 ARIPIPRAZOLE - ABILIFY N021436 001 5006528 5006528*PED
DP DP
U-1163 U-1164
Oct Apr
DS
DP
U-761
Oct Apr
DS
DP
U-761
Oct Apr
DS
DP
U-761
Oct Apr
DS
DP
U-761
Oct Apr
DS
DP
U-761
Oct Apr
DS
DP
U-761
ADA 15 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-761
EXCLUSIVITY CODE(S)
I-633 PED
ARIPIPRAZOLE - ABILIFY N021713 001 5006528 5006528*PED 6977257 6977257*PED ARIPIPRAZOLE - ABILIFY N021729 002 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021729 003 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021729 004 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021729 005 5006528 5006528*PED ARIPIPRAZOLE - ABILIFY N021866 001 5006528 5006528*PED 7115587 7115587*PED 7550445 7550445*PED ARMODAFINIL - NUVIGIL N021875 001 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED ARMODAFINIL - NUVIGIL N021875 002 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED ARMODAFINIL - NUVIGIL N021875 003 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED ARMODAFINIL - NUVIGIL N021875 004 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED ARMODAFINIL - NUVIGIL N021875 005 7132570 7132570*PED 7297346 7297346*PED RE37516 RE37516*PED
Feb Aug
Oct Apr
DS
DP
U-761
I-633 PED
Feb Aug
Oct Apr
DS
DP
U-761
I-633 PED
Feb Aug
Oct Apr
DS
DP
U-761
PED
Aug
27, 2011
Oct Apr
DS
DP
U-761
PED
Aug
27, 2011
DS DS
DP DP DP
U-763 U-764
I-633 PED
Feb Aug
DS
DP DP DP U-820
DS
DP DP DP U-820
DS
DP DP DP U-820
DS
DP DP DP U-820
DS
DP DP DP U-820
ADA 16 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-573 U-617 U-617 U-651 U-651
EXCLUSIVITY CODE(S)
ARSENIC TRIOXIDE - TRISENOX N021248 001 6723351 6855339 6861076 6884439 6982096
14, 2014
DP
U-977
NCE ODE
Apr Apr
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E - M.V.I.-12 (WITHOUT VITAMIN K) N008809 006 ODE Sep 09, 2011 ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE - MOVIPREP N021881 001 7169381 Sep 01, 2024 DS DP 7658914 Sep 01, 2024 DS DP ASENAPINE MALEATE - SAPHRIS N022117 001 5763476 7741358
Jun Apr
DS
DP DP
U-326 U-1064
Jun Apr
DS
DP DP
U-326 U-1064
18, 2017
U-302
ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) N021387 001 5622985 Apr 22, 2014 U-335 U-335 5622985*PED Oct 22, 2014 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) U-335 N021387 002 5622985 Apr 22, 2014 U-335 5622985*PED Oct 22, 2014 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) U-335 N021387 003 5622985 Apr 22, 2014 U-335 5622985*PED Oct 22, 2014 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) U-335 N021387 004 5622985 Apr 22, 2014 U-335 5622985*PED Oct 22, 2014 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) U-335 N021387 005 5622985 Apr 22, 2014 U-335 5622985*PED Oct 22, 2014 ASPIRIN; PRAVASTATIN SODIUM - PRAVIGARD PAC (COPACKAGED) U-335 N021387 006 5622985 Apr 22, 2014 5622985*PED Oct 22, 2014 U-335 ATAZANAVIR SULFATE - REYATAZ N021567 001 5849911 6087383 ATAZANAVIR SULFATE - REYATAZ N021567 002 5849911 6087383 ATAZANAVIR SULFATE - REYATAZ N021567 003 5849911 6087383
Jun Dec
DS DS
DP DP
U-167
D-130 D-116
Feb Sep
Jun Dec
DS DS
DP DP
U-167
D-130 D-116
Feb Sep
Jun Dec
DS DS
DP DP
U-167
D-130 D-116
Feb Sep
ADA 17 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-167
EXCLUSIVITY CODE(S)
D-130 D-116
Jun Dec
Feb Sep
ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 001 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 002 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 003 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 004 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 005 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 006 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA Nov 26, 2016 N021411 007 5658590 May 26, 2017 5658590*PED ATOMOXETINE HYDROCHLORIDE - STRATTERA N021411 008 5658590 Nov 26, 2016 5658590*PED May 26, 2017 ATORVASTATIN CALCIUM - ATORVASTATIN CALCIUM A076477 001 ATORVASTATIN CALCIUM - ATORVASTATIN CALCIUM A076477 002 ATORVASTATIN CALCIUM - ATORVASTATIN CALCIUM A076477 003 ATORVASTATIN CALCIUM - ATORVASTATIN CALCIUM A076477 004 ATORVASTATIN CALCIUM - LIPITOR N020702 001 5686104 5686104*PED 5969156 5969156*PED 6126971 6126971*PED ATORVASTATIN CALCIUM - LIPITOR N020702 002 5686104 5686104*PED 5969156 5969156*PED 6126971 6126971*PED ATORVASTATIN CALCIUM - LIPITOR N020702 003 5686104 5686104*PED 5969156 5969156*PED 6126971 6126971*PED
U-494 U-494
M-78
Jul
23, 2011
U-494 U-494
M-78
Jul
23, 2011
U-494 U-494
M-78
Jul
23, 2011
U-494 U-494
M-78
Jul
23, 2011
U-494 U-494
M-78
Jul
23, 2011
U-494 U-494
M-78
Jul
23, 2011
U-494 U-494
M-78
Jul
23, 2011
U-494 U-494
M-78
Jul
23, 2011
PC
May
28, 2012
PC
May
28, 2012
PC
May
28, 2012
PC DP DS DP U-213 U-213
May
28, 2012
DP DS DP
U-213 U-213
DP DS DP
U-213 U-213
ADA 18 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DS DP U-213 U-213
EXCLUSIVITY CODE(S)
ATORVASTATIN CALCIUM - LIPITOR N020702 004 5686104 5686104*PED 5969156 5969156*PED 6126971 6126971*PED ATOVAQUONE - MEPRON N020500 001 6649659 6649659*PED
Jul Jan
10, 2016 10, 2017 - MALARONE 25, 2013 25, 2014 25, 2013 25, 2014 25, 2013 25, 2014
DS
DP
U-69
ATOVAQUONE; PROGUANIL HYDROCHLORIDE N021078 001 5998449 Nov 5998449*PED May 6166046 Nov 6166046*PED May 6291488 Nov 6291488*PED May ATOVAQUONE; PROGUANIL HYDROCHLORIDE N021078 002 5998449 Nov 5998449*PED May 6166046 Nov 6166046*PED May 6291488 Nov 6291488*PED May
- MALARONE PEDIATRIC 25, 2013 U-990 25, 2014 25, 2013 25, 2014 U-406 25, 2013 25, 2014
AVOBENZONE; ECAMSULE; OCTOCRYLENE - ANTHELIOS SX N021502 001 5587150 Dec 24, 2013
DP
U-752
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE - ANTHELIOS 40 N022009 002 AZELAIC ACID - FINACEA N021470 001 6534070 Nov 18, 2018
NP
Oct
29, 2012
AZELASTINE HYDROCHLORIDE - ASTEPRO N022203 001 8071073 Jun AZELASTINE HYDROCHLORIDE - ASTEPRO N022371 001 8071073 Jun AZILSARTAN KAMEDOXOMIL - EDARBI N200796 001 5583141 Dec 5736555 Jun 5958961 Jun 7157584 May 7572920 Jan AZILSARTAN KAMEDOXOMIL - EDARBI N200796 002 5583141 Dec 5736555 Jun 5958961 Jun 7157584 May 7572920 Jan
04, 2028
DP
NP
Oct
15, 2011
04, 2028
DP
NP
Aug
31, 2012
DS DS DS
DP DP DP DP
NCE
Feb
25, 2016
DS DS DS
DP DP DP DP
NCE
Feb
25, 2016
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE - EDARBYCLOR N202331 001 AZITHROMYCIN - AZASITE N050810 001 6159458 6239113 6569443 6861411 7056893 AZITHROMYCIN - ZITHROMAX N050693 001 6268489
Feb Dec
Jul
31, 2018
DS
ADA 19 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS
EXCLUSIVITY CODE(S)
AZITHROMYCIN - ZITHROMAX N050710 001 6268489 AZITHROMYCIN - ZITHROMAX N050710 002 6268489 AZITHROMYCIN - ZITHROMAX N050711 001 6268489 AZITHROMYCIN - ZITHROMAX N050730 001 6268489 AZITHROMYCIN - ZITHROMAX N050733 001 6268489 AZITHROMYCIN - ZITHROMAX N050784 001 6268489 AZITHROMYCIN - ZMAX N050797 001 6068859 6268489 6984403 7887844 AZTREONAM - CAYSTON N050814 001 7208141 7214364 7427633 BACLOFEN - KEMSTRO N021589 001 6024981 6221392 BACLOFEN - KEMSTRO N021589 002 6024981 6221392 BALSALAZIDE DISODIUM - COLAZAL N020610 001 7452872 7452872*PED 7625884 7625884*PED
Jul
31, 2018
Jul
31, 2018
DS
Jul
31, 2018
DS
Jul
31, 2018
DS
Jul
31, 2018
DS
Jul
31, 2018
DS
DP DS DP DP U-282
DP DP DP
U-1031 U-1031
ODE
Feb
22, 2017
Apr Apr
DP DP
Apr Apr
DP DP
U-141 U-141
ODE PED
Dec Jun
BECLOMETHASONE DIPROPIONATE - QVAR 40 N020911 002 5605674 Feb 25, 2014 5683677 Nov 04, 2014 5776432 Jul 07, 2015 BECLOMETHASONE DIPROPIONATE - QVAR 80 N020911 001 5605674 Feb 25, 2014 5683677 Nov 04, 2014 5776432 Jul 07, 2015 BENDAMUSTINE HYDROCHLORIDE - TREANDA N022249 001
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE - ACANYA N050819 001 5733886 Mar 31, 2015 6117843 Feb 18, 2012 BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE - DUAC N050741 001 5466446 Feb 16, 2014
DS
DP
ADA 20 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-970 U-970 U-970 U-970
EXCLUSIVITY CODE(S)
NCE
Apr
09, 2014
DP
25, 2017
DS
DP
NCE
Sep
08, 2014
BESIFLOXACIN HYDROCHLORIDE - BESIVANCE N022308 001 5447926 Sep 05, 2012 Jun 29, 2021 6685958 Mar 31, 2019 6699492
DS
DP DP DP
NCE
May
28, 2014
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE DS N021852 001 5763426 Jun 09, 2015 6753013 Jan 27, 2020 6753013 Jan 27, 2020 DS RE39706 Jun 09, 2015 BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE N022185 001 6753013 Jan 27, 2020 6753013 Jan 27, 2020 6787529 Jan 27, 2020 6787529 Jan 27, 2020 DS RE39706 Jun 09, 2015 BETAMETHASONE VALERATE - LUXIQ N020934 001 6126920 Mar 7078058 May
U-484
DP
BETAXOLOL HYDROCHLORIDE; PILOCARPINE HYDROCHLORIDE - BETOPTIC PILO N020619 001 5635172 Jun 03, 2014 U-191 BEXAROTENE - TARGRETIN N021055 001 5780676 5962731 6043279 6320074 7655699 BEXAROTENE - TARGRETIN N021056 001 5780676 5962731 6043279 6320074 7655699 BICALUTAMIDE - CASODEX N020498 001 BIMATOPROST - LATISSE N022369 001 6403649 7351404 7388029 8017655 8038988 BIMATOPROST - LUMIGAN N021275 001 5688819 6403649 8017655 BIMATOPROST - LUMIGAN N022184 001 5688819 6403649 7851504 8017655
DS DS
DP
DS DS
DP
M-81 PED Sep May Jan Nov Aug 21, 25, 21, 27, 25, 2012 2024 2022 2012 2023 DS U-939 U-938 DS DS DP DP U-1208
Dec Jun
NP
Dec
24, 2011
DS DS
DP DP
U-446 U-446
DS DS DS
U-1081 U-1081 DP DP
NP
Aug
31, 2013
ADA 21 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-837
EXCLUSIVITY CODE(S)
NP
Oct
22, 2022
Jul
16, 2013
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - HALFLYTELY N021551 002 7291324 Oct 22, 2022 U-837 BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE - PYLERA N050786 001 6350468 Dec 14, 2018 U-932 U-956 6350468 Dec 14, 2018 BIVALIRUDIN - ANGIOMAX N020873 001 5196404 5196404*PED 7582727 7582727*PED 7598343 7598343*PED BOCEPREVIR - VICTRELIS N202258 001 7012066 7772178 BORTEZOMIB - VELCADE N021602 001 5780454 6083903 6297217 6297217 6297217 6617317 6713446 6747150 6958319 7119080 BOSENTAN - TRACLEER N021290 001 5292740 BOSENTAN - TRACLEER N021290 002 5292740
DS
DP DP DP
U-1040
Feb Nov
DS
DP DP
U-1128 U-1128
NCE
May
13, 2016
May Oct Oct Oct Oct Oct Jan Oct Jan Oct
03, 28, 28, 28, 28, 28, 25, 28, 25, 28,
2017 2014 2014 2014 2014 2014 2022 2014 2022 2014
DP DP
Mar
25, 2012
DS
DP DP DP DP DP
Nov
20, 2015
I-607
Aug
07, 2012
Nov
20, 2015
I-607
Aug
07, 2012
BRIMONIDINE TARTRATE - ALPHAGAN P N021262 001 5424078 Jun 5424078*PED Dec 6562873 Jul 6562873*PED Jan 6627210 Jul 6627210*PED Jan 6641834 Jul 6641834*PED Jan 6673337 Jul 6673337*PED Jan BRIMONIDINE TARTRATE - ALPHAGAN P N021770 001 5424078 Jun 5424078*PED Dec 6562873 Jul 6562873*PED Jan 6627210 Jul 6627210*PED Jan 6641834 Jul 6641834*PED Jan 6673337 Jul 6673337*PED Jan
13, 13, 10, 10, 18, 18, 28, 28, 26, 26,
2012 2012 2021 2022 2021 2022 2021 2022 2021 2022
DP DP DP
13, 13, 10, 10, 18, 18, 28, 28, 26, 26,
2012 2012 2021 2022 2021 2022 2021 2022 2021 2022
DP DP DP DP DP
BRIMONIDINE TARTRATE - BRIMONIDINE TARTRATE N021764 001 7265117 Aug 19, 2025
DP
ADA 22 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-849 U-849 DP DP U-1024
EXCLUSIVITY CODE(S)
BRIMONIDINE TARTRATE; TIMOLOL MALEATE N021398 001 7030149 Apr 19, 7320976 Apr 19, Jan 19, 7323463 Apr 19, 7642258 BRINZOLAMIDE - AZOPT N020816 001 5378703 5378703*PED 5461081 5461081*PED BROMFENAC SODIUM - BROMDAY N021664 002 BROMOCRIPTINE MESYLATE - CYCLOSET N020866 001 5468755 Nov 5679685 Oct 5716957 Feb 5756513 Nov 5866584 Nov 7888310 Jul BUDESONIDE - ENTOCORT EC N021324 001 5643602 5643602*PED
DS
DP DP
U-224 U-225
NP 21, 21, 10, 21, 21, 25, 2012 2014 2015 2012 2012 2023 U-976 DP U-976 U-976 U-976 U-976
Oct
16, 2013
NP
May
05, 2012
Jul Jan
U-655 DP
BUDESONIDE - PULMICORT FLEXHALER N021949 001 6027714 Jan 6142145 May Jan 6287540 Mar 7143764 BUDESONIDE - PULMICORT FLEXHALER N021949 002 6027714 Jan 6142145 May Jan 6287540 Mar 7143764 BUDESONIDE - PULMICORT RESPULES N020929 001 6598603 Dec 6598603*PED Jun 6899099 Dec 6899099*PED Jun 7524834 Nov 7524834*PED May BUDESONIDE - PULMICORT RESPULES N020929 002 6598603 Dec 6598603*PED Jun 6899099 Dec 6899099*PED Jun 7524834 Nov 7524834*PED May BUDESONIDE - PULMICORT RESPULES N020929 003 6598603 Dec 6598603*PED Jun 6899099 Dec 6899099*PED Jun 7524834 Nov 7524834*PED May BUDESONIDE - RHINOCORT N020746 001 6291445 6291445*PED 6686346 6686346*PED 6986904 6986904*PED
DP DP DP DP
U-787
DP DP DP DP
U-787
Y DP DP U-557 U-699 Y Y
ADA 23 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
BUDESONIDE - RHINOCORT N020746 002 6291445 6291445*PED 6686346 6686346*PED 6986904 6986904*PED
DP DP
U-557 U-699
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - SYMBICORT DP N021929 001 5349945 Nov 12, 2011 5674860 Oct 07, 2014 DP DP 5972919 Dec 17, 2012 DP 6123924 Sep 26, 2017 DP 6641800 Sep 23, 2012 DP 7367333 Nov 11, 2018 7587988 Apr 10, 2026 DP DP 7759328 Jan 29, 2023 DP 7967011 Aug 11, 2021 BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE - SYMBICORT DP N021929 002 5349945 Nov 12, 2011 DP 5674860 Oct 07, 2014 DP 5972919 Dec 17, 2012 DP 6123924 Sep 26, 2017 6641800 Sep 23, 2012 DP DP 7367333 Nov 11, 2018 DP 7587988 Apr 10, 2026 DP 7759328 Jan 29, 2023 7897646 Sep 09, 2018 7967011 Aug 11, 2021 DP BUPIVACAINE - EXPAREL N022496 001 BUPIVACAINE - EXPAREL N022496 002 BUPRENORPHINE - BUTRANS N021306 001 6264980 6344211 RE41408 RE41489 RE41571 BUPRENORPHINE - BUTRANS N021306 002 6264980 6344211 RE41408 RE41489 RE41571 BUPRENORPHINE - BUTRANS N021306 003 6264980 6344211 RE41408 RE41489 RE41571
Feb
27, 2012
U-1073
Feb
27, 2012
U-1073 U-1118
NP
Oct
28, 2014
NP Dec Dec Sep Sep Sep 18, 18, 29, 29, 29, 2015 2015 2017 2017 2017 DP U-1072 U-1072 U-1072 U-1072
Oct
28, 2014
NDF
Jun
30, 2013
NDF
Jun
30, 2013
NDF
Jun
30, 2013
BUPRENORPHINE; NALOXONE - SUBOXONE Sep N022410 001 8017150 BUPRENORPHINE; NALOXONE - SUBOXONE Sep N022410 002 8017150
10, 2023
DP
NDF
Aug
30, 2013
10, 2023
DP
NDF
Aug
30, 2013
ADA 24 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP U-997 DP DP DP DP DP DP
EXCLUSIVITY CODE(S)
BUPROPION HYDROBROMIDE - APLENZIN N022108 001 7241805 Jun 7569610 Jun 7572935 Jun 7585897 Jun 7645802 Jun 7649019 Jun 7662407 Jun 7671094 Jun BUPROPION HYDROBROMIDE - APLENZIN N022108 002 7241805 Jun 7569610 Jun 7572935 Jun 7585897 Jun 7645802 Jun 7649019 Jun 7662407 Jun 7671094 Jun BUPROPION HYDROBROMIDE - APLENZIN N022108 003 7241805 Jun 7569610 Jun 7572935 Jun 7585897 Jun 7645802 Jun 7649019 Jun 7662407 Jun 7671094 Jun
DP U-997 DP DP DP DP DP DP
DP U-997 DP DP DP DP DP DP
BUPROPION HYDROCHLORIDE - FORFIVO XL N022497 001 7674479 Jun 25, 2027 BUPROPION HYDROCHLORIDE - WELLBUTRIN SR N020358 001 5358970 Aug 12, 2013 Aug 12, 2013 5427798 Aug 12, 2013 5731000 Aug 12, 2013 5763493 BUPROPION HYDROCHLORIDE - WELLBUTRIN SR Aug 12, 2013 N020358 002 5358970 Aug 12, 2013 5427798 Aug 12, 2013 5731000 Aug 12, 2013 5763493 BUPROPION HYDROCHLORIDE - WELLBUTRIN SR Aug 12, 2013 N020358 003 5358970 Aug 12, 2013 5427798 Aug 12, 2013 5731000 Aug 12, 2013 5763493 BUPROPION HYDROCHLORIDE - WELLBUTRIN SR Aug 12, 2013 N020358 004 5358970 Aug 12, 2013 5427798 Aug 12, 2013 5731000 Aug 12, 2013 5763493 BUPROPION HYDROCHLORIDE - WELLBUTRIN XL N021515 001 6096341 Oct 30, 2018 BUPROPION HYDROCHLORIDE - WELLBUTRIN XL N021515 002 6096341 Oct 30, 2018 BUPROPION HYDROCHLORIDE - ZYBAN Aug N020711 002 5358970 Aug 5427798 Aug 5731000 Aug 5763493
DP
ADA 25 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
BUPROPION HYDROCHLORIDE - ZYBAN Aug N020711 003 5358970 Aug 5427798 Aug 5731000 Aug 5763493 BUSULFAN - BUSULFEX N020954 001 5430057 5430057*PED 5559148 5559148*PED
BUTOCONAZOLE NITRATE - GYNAZOLE-1 N019881 001 5993856 Nov CABAZITAXEL - JEVTANA KIT N201023 001 5438072 5698582 5847170 6331635 6372780 6387946 7241907 CALCIPOTRIENE - DOVONEX N020554 001 5763426 RE39706 CALCIPOTRIENE - DOVONEX N020611 001 5763426 RE39706 CALCIPOTRIENE - SORILUX N022563 001 CALCITONIN SALMON - MIACALCIN N020313 002 5733569 5759565
17, 2017
DP
U-457
DS DS
DP DP DP DP U-1067 U-1067
NCE
Jun
17, 2015
DS
Jun Jun
DS DS
DP DP
Jun Jun
DS DS
DP DP
Oct
06, 2013
CALCITONIN SALMON RECOMBINANT - FORTICAL N021406 001 6440392 Feb 02, 2021 RE40812 Feb 02, 2021 CALCITRIOL - CALCIJEX N018874 001 6051567 6051567*PED 6265392 6265392*PED 6274169 6274169*PED CALCITRIOL - CALCIJEX N018874 002 6051567 6051567*PED 6265392 6265392*PED 6274169 6274169*PED CALCITRIOL - VECTICAL N022087 001 CALCIUM ACETATE - PHOSLO N021160 002 6576665
DP DP
U-227
Jan
23, 2012
03, 2021
ADA 26 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CALCIUM CARBONATE; FAMOTIDINE; N020958 001 5229137 5229137*PED 5989588 5989588*PED 6814978 6814978*PED CALCIUM CARBONATE; RISEDRONATE N021823 001 5583122 5583122*PED 5994329 5994329*PED 6015801 6015801*PED 6096342 6096342*PED 6165513 6165513*PED 6432932 6432932*PED 6465443 6465443*PED
MAGNESIUM HYDROXIDE - PEPCID COMPLETE May 16, 2012 U-349 Nov 16, 2012 U-349 Sep 30, 2015 U-349 Mar 30, 2016 DP Aug 26, 2021 Feb 26, 2022 SODIUM Dec 10, Jun 10, Jul 17, Jan 17, Jul 17, Jan 17, Nov 21, May 21, Jun 10, Dec 10, Jul 17, Jan 17, Aug 14, Feb 14, ACTONEL WITH CALCIUM (COPACKAGED) DS DP U-353 2013 2014 U-353 2018 2019 U-353 2018 2019 DP 2011 2012 DP 2018 2018 U-595 2018 2019 2018 DP 2019
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE - NAVSTEL Apr 25, 2012 DP U-891 N022193 001 5409904 NP Jul 24, 2011 DP Apr 25, 2012 5578578 DP U-891 Nov 29, 2021 7084130 CANDESARTAN CILEXETIL - ATACAND N020838 001 5196444 Jun 5196444 Jun 5196444*PED Dec 5534534 Jul 5534534*PED Jan 5705517*PED Oct 7538133*PED Oct CANDESARTAN CILEXETIL - ATACAND N020838 002 5196444 Jun 5196444 Jun 5196444*PED Dec 5534534 Jul 5534534*PED Jan 5705517*PED Oct 7538133*PED Oct CANDESARTAN CILEXETIL - ATACAND N020838 003 5196444 Jun 5196444 Jun 5196444*PED Dec 5534534 Jul 5534534*PED Jan 5705517*PED Oct 7538133*PED Oct CANDESARTAN CILEXETIL - ATACAND N020838 004 5196444 Jun 5196444 Jun 5196444*PED Dec 5534534 Jul 5534534*PED Jan 5705517*PED Oct 7538133*PED Oct
DS DS
DP DP DP
U-660 U-3
DS DS
DP DP DP
U-3 U-660
DS DS
DP DP DP
U-3 U-660
DS DS
DP DP DP
U-660 U-3
ADA 27 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT DS DP U-3 N021093 001 5196444 Jun 04, 2012 5196444*PED Dec 04, 2012 DP 5534534 Jul 09, 2013 5534534*PED Jan 09, 2014 5705517*PED Oct 18, 2011 DP U-3 5721263 Feb 24, 2015 DP U-3 5958961 Jun 06, 2014 7538133*PED Oct 18, 2011 CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT DS DP U-3 N021093 002 5196444 Jun 04, 2012 5196444*PED Dec 04, 2012 DP 5534534 Jul 09, 2013 5534534*PED Jan 09, 2014 5705517*PED Oct 18, 2011 DP U-3 5721263 Feb 24, 2015 DP U-3 5958961 Jun 06, 2014 7538133*PED Oct 18, 2011 CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE - ATACAND HCT DS DP U-3 N021093 003 5196444 Jun 04, 2012 5196444*PED Dec 04, 2012 DP 5534534 Jul 09, 2013 5534534*PED Jan 09, 2014 5705517*PED Oct 18, 2011 DP U-3 5721263 Feb 24, 2015 DP U-3 5958961 Jun 06, 2014 7538133*PED Oct 18, 2011 CAPECITABINE - XELODA N020896 001 5472949 CAPECITABINE - XELODA N020896 002 5472949 CAPSAICIN - QUTENZA N022395 001 6239180 CARBAMAZEPINE - CARBAMAZEPINE A076697 003 CARBAMAZEPINE - CARBATROL N020712 001 5326570 5912013 CARBAMAZEPINE - CARBATROL N020712 002 5326570 5912013 CARBAMAZEPINE - CARBATROL N020712 003 5326570 5912013 CARBAMAZEPINE - EQUETRO N021710 001 5326570 5912013 6977253 CARBAMAZEPINE - EQUETRO N021710 002 5326570 5912013 6977253 CARBAMAZEPINE - EQUETRO N021710 003 5326570 5912013 6977253
Dec
14, 2013
U-271
Dec
14, 2013
U-271
Nov
06, 2016
DP
NCE ODE
Nov Nov
Nov
16, 2011
Jul Jun
U-215 U-277
Jul Jun
U-215 U-277
DP DP
U-627 U-693
DP DP
U-627 U-693
DP DP
U-627 U-693
ADA 28 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP U-219
EXCLUSIVITY CODE(S)
CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 100 N021485 002 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 125 N021485 006 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 150 N021485 003 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 200 N021485 004 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 50 N021485 001 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARBIDOPA; ENTACAPONE; LEVODOPA - STALEVO 75 N021485 005 5446194 Oct 19, 2013 6500867 Jun 29, 2020 6797732 Jun 29, 2020 CARGLUMIC ACID - CARBAGLU N022562 001 CARVEDILOL - COREG N020297 001 RE40000 RE40000*PED CARVEDILOL - COREG N020297 002 RE40000 RE40000*PED CARVEDILOL - COREG N020297 003 RE40000 RE40000*PED CARVEDILOL - COREG N020297 004 RE40000 RE40000*PED
DS DP DP U-219
DS DP DP U-219
DS DP DP U-219
DS DP DP U-219
DS DP DP U-219
Mar Mar
Jun Dec
U-233
Jun Dec
U-233
Jun Dec
U-233
CARVEDILOL PHOSPHATE - COREG CR Feb N022012 001 5902821 Feb 5902821 Aug 5902821*PED Oct 6022562 Apr 6022562*PED Jun 7268156 Jun 7268156 Dec 7268156*PED Jun RE40000 Dec RE40000*PED
07, 07, 07, 17, 17, 27, 27, 27, 07, 07,
2016 2016 2016 2015 2016 2023 2023 2023 2015 2015
ADA 29 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-313 U-777 DP DS DS DP DP U-3 U-313 U-777
EXCLUSIVITY CODE(S)
CARVEDILOL PHOSPHATE - COREG CR Feb N022012 002 5902821 Feb 5902821 Aug 5902821*PED Oct 6022562 Apr 6022562*PED Jun 7268156 Jun 7268156 Dec 7268156*PED Jun RE40000 Dec RE40000*PED CARVEDILOL PHOSPHATE - COREG CR Feb N022012 003 5902821 Feb 5902821 Aug 5902821*PED Oct 6022562 Apr 6022562*PED Jun 7268156 Jun 7268156 Dec 7268156*PED Jun RE40000 Dec RE40000*PED CARVEDILOL PHOSPHATE - COREG CR Feb N022012 004 5902821 Feb 5902821 Aug 5902821*PED Oct 6022562 Apr 6022562*PED Jun 7268156 Jun 7268156 Dec 7268156*PED Jun RE40000 Dec RE40000*PED CASPOFUNGIN ACETATE - CANCIDAS N021227 001 5378804 5378804*PED 5514650 5514650*PED 5792746 5792746*PED 5952300 5952300*PED 6136783 6136783*PED CASPOFUNGIN ACETATE - CANCIDAS N021227 002 5378804 5378804*PED 5514650 5514650*PED 5792746 5792746*PED 5952300 5952300*PED 6136783 6136783*PED CEFDINIR - OMNICEF N050739 001 4935507 CEFDINIR - OMNICEF N050749 001 4935507 CEFDINIR - OMNICEF N050749 002 4935507
07, 07, 07, 17, 17, 27, 27, 27, 07, 07,
2016 2016 2016 2015 2016 2023 2023 2023 2015 2015
07, 07, 07, 17, 17, 27, 27, 27, 07, 07,
2016 2016 2016 2015 2016 2023 2023 2023 2015 2015
07, 07, 07, 17, 17, 27, 27, 27, 07, 07,
2016 2016 2016 2015 2016 2023 2023 2023 2015 2015
Mar Sep Jan Jul Mar Sep Mar Sep Mar Sep
16, 16, 26, 26, 16, 16, 28, 28, 28, 28,
2013 2013 2015 2015 2013 2013 2017 2017 2017 2017
Mar Sep Jan Jul Mar Sep Mar Sep Mar Sep
16, 16, 26, 26, 16, 16, 28, 28, 28, 28,
2013 2013 2015 2015 2013 2013 2017 2017 2017 2017
Dec
04, 2011
DS
Dec
04, 2011
DS
Dec
04, 2011
DS
ADA 30 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CEFDITOREN PIVOXIL - SPECTRACEF N021222 001 5958915 Oct CEFDITOREN PIVOXIL - SPECTRACEF N021222 002 5958915 Oct CEFTAROLINE FOSAMIL - TEFLARO N200327 001 6417175 6906055 7419973 CEFTAROLINE FOSAMIL - TEFLARO N200327 002 6417175 6906055 7419973 CEFTIBUTEN DIHYDRATE - CEDAX N050685 002 5599557 CEFTIBUTEN DIHYDRATE - CEDAX N050686 001 5599557 5599557 CEFTIBUTEN DIHYDRATE - CEDAX N050686 002 5599557 5599557 CELECOXIB - CELEBREX N020998 001 5466823 5466823*PED 5563165 5563165*PED 5760068 5760068*PED CELECOXIB - CELEBREX N020998 002 5466823 5466823*PED 5563165 5563165*PED 5760068 5760068*PED CELECOXIB - CELEBREX N020998 003 5466823 5466823*PED 5563165 5563165*PED 5760068 5760068*PED CELECOXIB - CELEBREX N020998 004 5466823 5466823*PED 5563165 5563165*PED 5760068 5760068*PED CERIVASTATIN SODIUM - BAYCOL N020740 001 5177080 CERIVASTATIN SODIUM - BAYCOL N020740 002 5177080 CERIVASTATIN SODIUM - BAYCOL N020740 003 5177080 CERIVASTATIN SODIUM - BAYCOL N020740 004 5177080
14, 2016
14, 2016
DP
DS DS
DP DP DP
U-282
NCE
Oct
29, 2015
DS DS
DP DP DP
U-282
NCE
Oct
29, 2015
Apr
30, 2013
DP
Feb Feb
DP DP
U-282 U-578
Feb Feb
DP DP
U-578 U-282
DS DP U-672
DS DP U-672
DS DP U-672
DS DP U-672
Nov
26, 2011
Nov
26, 2011
Nov
26, 2011
Nov
26, 2011
ADA 31 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
Nov
26, 2011
CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC ALLERGY DP N021621 003 6455533 Jul 02, 2018 CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC ALLERGY DP N021621 004 6455533 Jul 02, 2018
U-295
U-295
CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC HIVES RELIEF DP U-295 N021621 005 6455533 Jul 02, 2018 CETIRIZINE HYDROCHLORIDE - CHILDREN'S ZYRTEC HIVES RELIEF DP U-295 N021621 006 6455533 Jul 02, 2018 CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ZYRTEC-D 12 HOUR Jul 13, 2019 DP U-295 N021150 002 6469009 DP Apr 08, 2016 6489329 DP Jun 10, 2022 7014867 U-295 Jun 10, 2022 7226614 CETRORELIX - CETROTIDE N021197 001 6319192 6863891 7605121 CETRORELIX - CETROTIDE N021197 002 6319192 6863891 7605121
U-426 U-426 DP
U-426 U-426 DP
07, 2013
U-309
CHLORHEXIDINE GLUCONATE - CHLORHEXIDINE GLUCONATE N021669 001 7066916 Feb 17, 2024 7427574 Apr 25, 2026 May 12, 2023 7595021 Oct 02, 2027 7935093
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP Sep 30, 2016 DP N020832 001 5690958 DP Nov 10, 2020 6536975 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP Sep 30, 2016 DP N020832 004 5690958 DP Nov 10, 2020 6536975 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP N020832 006 5690958 Sep 30, 2016 DP DP 6991394 Jan 31, 2024 DP 7182536 Dec 30, 2023 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP FREPP Aug 25, 2015 DP N020832 003 5538353 DP Sep 30, 2016 5690958 DP Apr 22, 2017 5752363 Apr 22, 2017 DP 5772346 DP Nov 25, 2011 D386849 DP Aug 11, 2012 D396911 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP ONE-STEP SEPP N021555 001 5690958 Sep 30, 2016 DP CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT N020832 002 5690958 Sep 30, 2016 DP 6729786 Mar 14, 2023 DP DP 6991393 Mar 14, 2023 DP 6991394 Jan 31, 2024 DP 7182536 Dec 30, 2023 DP 7241065 Mar 14, 2023
ADA 32 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT DP N020832 005 5690958 Sep 30, 2016 Nov 10, 2020 DP 6536975 DP Mar 14, 2023 6729786 DP Jan 31, 2024 6991393 DP Mar 14, 2023 7241065 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORAPREP WITH TINT DP N020832 007 5690958 Sep 30, 2016 Nov 10, 2020 DP 6536975 Mar 14, 2023 DP 6729786 DP Mar 14, 2023 6991393 DP Mar 14, 2023 7241065 CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL - CHLORASCRUB MAXI SWABSTICK N021524 003 D468424 Jan 07, 2017 CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE - ADVIL ALLERGY SINUS DP N021441 001 7863287 Feb 28, 2027 CHOLINE FENOFIBRATE - TRILIPIX N022224 001 7259186 Jan CHOLINE FENOFIBRATE - TRILIPIX N022224 002 7259186 Jan CHORIOGONADOTROPIN ALFA - OVIDREL N021149 001 5767251 Jun CHORIOGONADOTROPIN ALFA - OVIDREL N021149 002 5767251 Jun 6706681 Mar CICLESONIDE - ALVESCO N021658 002 5482934 5605674 5683677 5775321 6006745 6036942 6120752 6264923 CICLESONIDE - ALVESCO N021658 003 5482934 5605674 5683677 5775321 6006745 6036942 6120752 6264923 CICLESONIDE - OMNARIS N022004 001 5482934 6767901 6939559 7235247 CICLOPIROX - LOPROX N020519 001 7018656 7026337 CICLOPIROX - LOPROX N021159 001 7981909
07, 2025
DS
NP
Dec
15, 2011
07, 2025
DS
NP
Dec
15, 2011
16, 2015
DS DP
DS
DP DP DP DP DP DP DP DP
U-1002
NCE
Oct
20, 2011
DS
DP DP DP DP DP DP DP DP
U-1002
NCE
Oct
20, 2011
DS
DP DP DP DP
U-557
NCE
Oct
20, 2011
Sep Nov
DP
U-714
Sep
16, 2017
U-1162
ADA 33 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP
EXCLUSIVITY CODE(S)
I-634 M-101 ODE
CINACALCET HYDROCHLORIDE - SENSIPAR N021688 001 6011068 Mar 08, 2018 6031003 Dec 14, 2016 6211244 Oct 23, 2015 6313146 Dec 14, 2016 7829595 Sep 22, 2026 CINACALCET HYDROCHLORIDE - SENSIPAR N021688 002 6011068 Mar 08, 2018 6031003 Dec 14, 2016 6211244 Oct 23, 2015 6313146 Dec 14, 2016 7829595 Sep 22, 2026 CINACALCET HYDROCHLORIDE - SENSIPAR N021688 003 6011068 Mar 08, 2018 6031003 Dec 14, 2016 6211244 Oct 23, 2015 6313146 Dec 14, 2016 7829595 Sep 22, 2026 CIPROFLOXACIN - CIPRO N020780 001 5695784 5695784*PED 6136347 6136347*PED CIPROFLOXACIN - CIPRO N020780 002 5695784 5695784*PED 6136347 6136347*PED
DP DP
DP U-1098
U-559 U-560
DS DS DS
DP DP U-560 DP
DP U-1098
DS DS DS
DP DP DP
DP U-1098
U-559 U-560
U-362
U-362
CIPROFLOXACIN HYDROCHLORIDE - CETRAXAL N021918 001 CIPROFLOXACIN HYDROCHLORIDE - CIPRO N019537 001 5286754*PED Aug 15, 2011 CIPROFLOXACIN HYDROCHLORIDE - CIPRO N019537 002 5286754*PED Aug 15, 2011 CIPROFLOXACIN HYDROCHLORIDE - CIPRO N019537 003 5286754*PED Aug 15, 2011 CIPROFLOXACIN HYDROCHLORIDE - CIPRO N019537 004 5286754*PED Aug 15, 2011 CIPROFLOXACIN HYDROCHLORIDE - PROQUIN XR N021744 001 5972389 Sep 19, 2016 6340475 Sep 19, 2016 6488962 Jun 20, 2020 6635280 Sep 19, 2016
NDF
May
01, 2012
DP DP DP DP
CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE - CIPRO HC U-646 N020805 001 5843930 Jun 06, 2015 DP 5965549 Jun 06, 2015 CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE - CIPRO XR DP N021473 001 7709022 Jun 23, 2021 7709022*PED Dec 23, 2021 CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE - CIPRO XR DP N021473 002 7709022 Jun 23, 2021 7709022*PED Dec 23, 2021 CIPROFLOXACIN; DEXAMETHASONE - CIPRODEX N021537 001 6284804 Aug 10, 2020 6359016 Aug 10, 2020
ADA 34 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
CISAPRIDE MONOHYDRATE - PROPULSID QUICKSOLV N020767 001 5648093 Jul 15, 2014 CISATRACURIUM BESYLATE - NIMBEX Sep N020551 001 5453510
26, 2012
U-127
CISATRACURIUM BESYLATE - NIMBEX PRESERVATIVE FREE N020551 002 5453510 Sep 26, 2012 CISATRACURIUM BESYLATE - NIMBEX PRESERVATIVE FREE N020551 003 5453510 Sep 26, 2012 CLARITHROMYCIN - BIAXIN XL N050775 001 6010718 6551616
U-127
U-127
Apr Jul
DP
U-924 U-924
CLEVIDIPINE BUTYRATE - CLEVIPREX N022156 001 5739152 Apr 5856346 Jan CLEVIDIPINE BUTYRATE - CLEVIPREX N022156 002 5739152 Apr 5856346 Jan CLINDAMYCIN PHOSPHATE - CLEOCIN N050767 001 6495157 Jul CLINDAMYCIN PHOSPHATE - CLINDAGEL N050782 001 6387383 Aug CLINDAMYCIN PHOSPHATE - CLINDESSE N050793 001 5993856 Nov 6899890 Apr CLINDAMYCIN PHOSPHATE - EVOCLIN N050801 001 7141237 Jan 7374747 Aug
DS
DP DP
U-893 U-893
NCE
Aug
01, 2013
DS
DP DP
U-893 U-893
NCE
Aug
01, 2013
20, 2020
DP
03, 2020
DP
U-818
DP DP
U-137 U-137
DS DS
DP DP
U-921
CLINDAMYCIN PHOSPHATE; TRETINOIN - VELTIN N050803 001 5690923 Nov 25, 2014 CLINDAMYCIN PHOSPHATE; TRETINOIN - ZIANA N050802 001 6387383 Aug 03, 2020 RE41134 Feb 24, 2015 CLOBAZAM - ONFI N202067 001 CLOBAZAM - ONFI N202067 002 CLOBAZAM - ONFI N202067 003 CLOBETASOL PROPIONATE - CLOBEX Sep N021535 001 6106848 CLOBETASOL PROPIONATE - CLOBEX N021644 001 7316810 Jun 7700081 Jan 8066975 Jun 8066976 Jun CLOBETASOL PROPIONATE - CLOBEX N021835 001 5972920 Feb 5990100 Mar
DP
DP DP
U-916 U-1033
NCE ODE
Oct Oct
NCE ODE
Oct Oct
Oct Oct
DP U-1044 DP DP
DP DP
U-742
ADA 35 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-484
EXCLUSIVITY CODE(S)
Mar
01, 2016
CLOBETASOL PROPIONATE - OLUX E Sep N022013 001 6730288 Sep 7029659 CLOFARABINE - CLOLAR N021673 001 5661136 5661136*PED
DP DP
Jan Jul
U-626
ODE PED
Dec Jun
CLONIDINE HYDROCHLORIDE - JENLOGA N022331 001 5869100 Oct CLONIDINE HYDROCHLORIDE - JENLOGA N022331 002 5869100 Oct CLONIDINE HYDROCHLORIDE - KAPVAY N022331 003 5869100 Oct CLONIDINE HYDROCHLORIDE - KAPVAY N022331 004 5869100 Oct CLOPIDOGREL BISULFATE - PLAVIX N020839 001 4847265 4847265*PED 5576328 5576328*PED 6429210 6429210*PED 6504030 6504030*PED CLOPIDOGREL BISULFATE - PLAVIX N020839 002 4847265 4847265*PED 6429210 6429210*PED 6504030 6504030*PED CLOZAPINE - FAZACLO ODT N021590 001 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 002 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 003 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 004 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 005 6024981 6106861 6221392 CLOZAPINE - FAZACLO ODT N021590 006 6024981 6106861 6221392
13, 2013
DP
NP
Sep
29, 2012
13, 2013
DP
13, 2013
DP
NP
Sep
28, 2013
13, 2013
DP
NP
Sep
28, 2013
DS
DP U-432 Y
M-61 PED
May Nov
DS DS
DP
DS DS DS
DP DP
M-61 PED
May Nov
DP DP DP
DP DP DP
DP DP DP
DP DP DP
DP DP DP
DP DP DP
ADA 36 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-1007 U-1020 U-1020 U-1116 U-1007 U-1116 U-1007 U-1161 U-1166 U-1007 U-1161 U-1116
EXCLUSIVITY CODE(S)
I-603 ODE
COLCHICINE - COLCRYS N022352 001 7601758 7619004 7820681 7906519 7915269 7935731 7964647 7964648 7981938 8093296 8093297 8093298
Feb Dec Feb Feb Feb Dec Oct Feb Oct Oct Oct Oct
10, 03, 17, 17, 17, 03, 06, 17, 06, 06, 06, 06,
2029 2028 2029 2029 2029 2028 2028 2029 2028 2028 2028 2028
Jul Jul
COLESEVELAM HYDROCHLORIDE - WELCHOL Jun 10, 2014 N021141 001 5607669 Dec 10, 2014 5607669*PED Apr 29, 2014 5679717 Oct 29, 2014 5679717*PED Dec 02, 2014 5693675 Jun 02, 2015 5693675*PED Apr 29, 2014 5917007 Oct 29, 2014 5917007*PED Jun 10, 2014 5919832 Dec 10, 2014 5919832*PED Jun 10, 2014 6066678 Dec 10, 2014 6066678*PED Jun 10, 2014 6433026 Dec 10, 2014 6433026*PED COLESEVELAM HYDROCHLORIDE - WELCHOL Jun 10, 2014 N021176 001 5607669 Dec 10, 2014 5607669*PED Apr 29, 2014 5679717 Oct 29, 2014 5679717*PED Dec 02, 2014 5693675 Jun 02, 2015 5693675*PED Apr 29, 2014 5917007 Oct 29, 2014 5917007*PED Apr 29, 2014 5919832 Oct 29, 2014 5919832*PED Apr 29, 2014 6066678 Oct 29, 2014 6066678*PED Apr 29, 2014 6433026 Oct 29, 2014 6433026*PED Apr 29, 2014 6784254 Oct 29, 2014 6784254*PED Apr 29, 2014 7101960 Oct 29, 2014 7101960*PED Apr 17, 2022 7229613 Oct 17, 2022 7229613*PED
U-323 U-323
U-323
U-323
ADA 37 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-757 U-757
DS
DS
DS
DS
DS
DS DS
DP
DP
U-757
U-493
U-757
U-757
EXCLUSIVITY CODE(S)
I-608 PED PED
COLESEVELAM HYDROCHLORIDE - WELCHOL N022362 001 5607669 Jun 10, 2014 5607669*PED Dec 10, 2014 5679717 Apr 29, 2014 5679717*PED Oct 29, 2014
5693675 Dec 02, 2014
5693675*PED Jun 02, 2015
5917007 Apr 29, 2014
5917007*PED Oct 29, 2014
5919832 Apr 29, 2014
5919832*PED Oct 29, 2014
6066678 Apr 29, 2014
6066678*PED Oct 29, 2014
6433026 Apr 29, 2014
6433026*PED Oct 29, 2014
6784254 Apr 29, 2014
6784254*PED Oct 29, 2014
7101960 Apr 29, 2014
7101960*PED Oct 29, 2014
7229613 Apr 17, 2022
7229613*PED Oct 17, 2022
COLESEVELAM HYDROCHLORIDE - WELCHOL N022362 002 5607669 Jun 10, 2014 5607669*PED Dec 10, 2014 5679717 Apr 29, 2014
5679717*PED Oct 29, 2014
5693675 Dec 02, 2014
5693675*PED Jun 02, 2015
5917007 Apr 29, 2014 5917007*PED Oct 29, 2014
5919832 Apr 29, 2014
5919832*PED Oct 29, 2014
6066678 Apr 29, 2014 6066678*PED Oct 29, 2014
6433026 Apr 29, 2014
6433026*PED Oct 29, 2014
6784254 Apr 29, 2014
6784254*PED Oct 29, 2014
7101960 Apr 29, 2014
7101960*PED Oct 29, 2014
7229613 Apr 17, 2022
7229613*PED Oct 17, 2022
COLESTIPOL HYDROCHLORIDE - COLESTID N020222 001 5490987 Feb 13, 2013 CONIVAPTAN HYDROCHLORIDE - VAPRISOL N021697 001 5723606 Dec 15, 2019 5723606 Dec 15, 2019
U-757 U-757
DS
DS
DS
DS
DS
DS DS
DP
DP
U-757
U-493
U-757
U-757
DP
DS DS
DP DP
U-868 U-698
CONIVAPTAN HYDROCHLORIDE - VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER N021697 002 5723606 Dec 15, 2019 DS DP U-698 DS DP U-868 5723606 Dec 15, 2019 CORTICOTROPIN - H.P. ACTHAR GEL N008372 008 CRIZOTINIB - XALKORI N202570 001 7230098 7825137 7858643 CRIZOTINIB - XALKORI N202570 002 7230098 7825137 7858643
ODE Mar May Oct 01, 2025 12, 2027 08, 2029 DS U-1179 DS DP
Oct
15, 2017
NCE ODE
Aug Aug
DS U-1179 DS DP
NCE ODE
Aug Aug
ADA 38 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP U-817 U-1152
EXCLUSIVITY CODE(S)
CYCLOBENZAPRINE HYDROCHLORIDE - AMRIX N021777 001 7387793 Feb 26, 7544372 Nov 14, 7790199 Nov 14, 7820203 Nov 14, 7829121 Nov 14, CYCLOBENZAPRINE HYDROCHLORIDE - AMRIX N021777 002 7387793 Feb 26, 7544372 Nov 14, 7790199 Nov 14, 7820203 Nov 14, 7829121 Nov 14, CYCLOSPORINE - NEORAL N050715 001 5342625 5741512 5985321 6258808 6262022 CYCLOSPORINE - NEORAL N050715 002 5342625 5741512 5985321 6258808 6262022 CYCLOSPORINE - NEORAL N050715 003 5342625 5741512 5985321 6258808 6262022 CYCLOSPORINE - NEORAL N050716 001 5342625 5741512 5985321 6258808 6262022 CYCLOSPORINE - RESTASIS N050790 001 5474979 CYTARABINE - DEPOCYT N021041 001 5455044 5723147
DP U-979 DP DP U-1088
DP U-979 DP DP U-1088
DP DP DP DP DP
U-906
DP DP DP DP DP
U-906
DP DP DP DP DP
U-906
DP DP DP DP DP
U-906
May
17, 2014
DP
May Mar
DP
U-806 U-806
DABIGATRAN ETEXILATE MESYLATE - PRADAXA N022512 001 6087380 Feb 18, 2018 7866474 Aug 31, 2027 Sep 07, 2025 7932273 DABIGATRAN ETEXILATE MESYLATE - PRADAXA N022512 002 6087380 Feb 18, 2018 7866474 Aug 31, 2027 Sep 07, 2025 7932273 DALFAMPRIDINE - AMPYRA N022250 001 5370879 5540938 8007826
DS DS
DP DP DP
U-1089
NCE
Oct
19, 2015
DS DS
DP DP DP
U-1089
NCE
Oct
19, 2015
DP U-1030 U-1030
NCE ODE
Jan Jan
ADA 39 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP U-124 DP
EXCLUSIVITY CODE(S)
DAPSONE - ACZONE N021794 001 5863560 6060085 6620435 DAPTOMYCIN - CUBICIN N021572 001 6468967 6852689 8058238 DAPTOMYCIN - CUBICIN N021572 002 6468967 6852689 8003673 8058238 RE39071
U-282 U-282 DS DP
DARIFENACIN HYDROBROMIDE - ENABLEX N021513 001 5096890 Mar 6106864 Aug DARIFENACIN HYDROBROMIDE - ENABLEX Mar N021513 002 5096890 Aug 6106864 DARUNAVIR ETHANOLATE - PREZISTA Dec N021976 001 5843946 Dec 5843946 Dec 5843946 Jun 5843946*PED Jun 6037157 Dec 6037157*PED Aug 6248775 Feb 6248775*PED Aug 6335460 Aug 6335460 Aug 6335460 Feb 6335460*PED Jun 6703403 Dec 6703403*PED Jun 7470506 Dec 7470506*PED Dec 7700645 Jun 7700645*PED Oct RE42889 Apr RE42889*PED DARUNAVIR ETHANOLATE - PREZISTA N021976 002 5843946 Dec 5843946 Dec 5843946 Dec 5843946*PED Jun 6037157 Jun 6037157*PED Dec 6248775 Aug Feb 6248775*PED Aug 6335460 Aug 6335460 Aug 6335460 Feb 6335460*PED Jun 6703403 Dec 6703403*PED Jun 7470506 Dec 7470506*PED Dec 7700645 Jun 7700645*PED Oct RE42889 Apr RE42889*PED
DS
DP DP
U-631 U-630
DS
DP DP
U-631 U-630
01, 01, 01, 01, 26, 26, 13, 13, 25, 25, 25, 25, 26, 26, 23, 23, 26, 26, 19, 19,
2015 2015 2015 2016 2016 2016 2014 2015 2012 2012 2012 2013 2016 2016 2019 2019 2026 2027 2016 2017
DP DP DP
01, 01, 01, 01, 26, 26, 13, 13, 25, 25, 25, 25, 26, 26, 23, 23, 26, 26, 19, 19,
2015 2015 2015 2016 2016 2016 2014 2015 2012 2012 2012 2013 2016 2016 2019 2019 2026 2027 2016 2017
DP DP DP
ADA 40 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP U-744 U-903 U-935 U-935 DS DS DS DP DP U-935 U-903 U-935 U-935 DS DP DP
EXCLUSIVITY CODE(S)
D-129 D-119 D-118 I-578 NPP PED PED PED PED PED PED
DARUNAVIR ETHANOLATE - PREZISTA Dec N021976 003 5843946 Dec 5843946 Dec 5843946 Jun 5843946*PED Jun 6037157 Dec 6037157*PED Aug 6248775 Feb 6248775*PED Aug 6335460 Aug 6335460 Feb 6335460*PED Jun 6703403 Dec 6703403*PED Jun 7470506 Dec 7470506*PED Dec 7700645 Jun 7700645*PED Oct RE42889 Apr RE42889*PED DARUNAVIR ETHANOLATE - PREZISTA N021976 004 5843946 Dec 5843946*PED Jun 6037157 Jun 6037157*PED Dec 6248775 Aug 6248775*PED Feb 6335460 Aug 6335460*PED Feb 6703403 Jun 6703403*PED Dec 7470506 Jun 7470506*PED Dec 7700645 Dec 7700645*PED Jun RE42889 Oct RE42889*PED Apr DARUNAVIR ETHANOLATE - PREZISTA N021976 005 5843946 Dec 5843946*PED Jun 6037157 Jun 6037157*PED Dec 6248775 Aug Feb 6248775*PED Aug 6335460 Feb 6335460*PED Jun 6703403 Dec 6703403*PED Jun 7470506 Dec 7470506*PED Dec 7700645 Jun 7700645*PED Oct RE42889 Apr RE42889*PED DARUNAVIR ETHANOLATE - PREZISTA N202895 001 DASATINIB - SPRYCEL N021986 001 6596746 6596746 7125875 7125875 7153856 7491725
01, 01, 01, 01, 26, 26, 13, 13, 25, 25, 25, 26, 26, 23, 23, 26, 26, 19, 19,
2015 2015 2015 2016 2016 2016 2014 2015 2012 2012 2013 2016 2016 2019 2019 2026 2027 2016 2017
Dec Dec Oct Oct Dec Jun Dec Apr Jun Jun Apr
13, 18, 21, 21, 16, 16, 23, 21, 18, 13, 21,
2013 2011 2011 2011 2014 2015 2011 2012 2012 2014 2012
01, 01, 26, 26, 13, 13, 25, 25, 26, 26, 23, 23, 26, 26, 19, 19,
2015 2016 2016 2016 2014 2015 2012 2013 2016 2016 2019 2019 2026 2027 2016 2017
DP
U-935 U-935
01, 01, 26, 26, 13, 13, 25, 25, 26, 26, 23, 23, 26, 26, 19, 19,
2015 2016 2016 2016 2014 2015 2012 2013 2016 2016 2019 2019 2026 2027 2016 2017
DP
U-935 U-935
NDF PED Jun Jun Apr Apr Apr Mar 28, 28, 13, 13, 28, 28, 2020 2020 2020 2020 2020 2026 DS DS DP DP U-780 U-748 U-780 U-779 U-780
Dec Jun
DS
DP
ADA 41 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-780 U-748 U-780 U-779 U-780
EXCLUSIVITY CODE(S)
D-120 M-94 ODE ODE
DASATINIB - SPRYCEL N021986 002 6596746 6596746 7125875 7125875 7153856 7491725 DASATINIB - SPRYCEL N021986 003 6596746 6596746 7125875 7125875 7153856 7491725 DASATINIB - SPRYCEL N021986 004 6596746 6596746 7125875 7125875 7153856 7491725 DASATINIB - SPRYCEL N021986 005 6596746 6596746 7125875 7125875 7153856 7491725 DASATINIB - SPRYCEL N021986 006 6596746 6596746 7125875 7125875 7153856 7491725 DECITABINE - DACOGEN N021790 001 DEFERASIROX - EXJADE N021882 001 6465504 6596750 DEFERASIROX - EXJADE N021882 002 6465504 6596750 DEFERASIROX - EXJADE N021882 003 6465504 6596750 DEFERIPRONE - FERRIPROX N021825 001 DEGARELIX ACETATE - FIRMAGON N022201 001 5925730 DEGARELIX ACETATE - FIRMAGON N022201 002 5925730
DS
DP
DS DS
DP DP
DS
DP
DS DS
DP DP
DS
DP
DS DS
DP DP
DS
DP
DS DS
DP DP
DS
DP
Mar May
ODE
Nov
02, 2012
Apr Jun
DS DS
DP U-735
ODE
Nov
02, 2012
Apr Jun
DS DS
DP U-735
ODE
Nov
02, 2012
Oct Oct
NCE
Dec
24, 2013
Apr
11, 2017
DS
DP
U-943
NCE
Dec
24, 2013
08, 2013
ADA 42 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
DELAVIRDINE MESYLATE - RESCRIPTOR N020705 002 5563142 Oct 6177101 Jun DESFLURANE - SUPRANE N020118 001 5617906 5617906*PED
Apr Oct
DP
DESIRUDIN RECOMBINANT - IPRIVASK N021271 001 5733874 Mar DESLORATADINE - CLARINEX N021165 001 6100274 6100274*PED 7211582 7211582*PED 7214683 7214683*PED 7214684 7214684*PED 7405223 7405223*PED DESLORATADINE - CLARINEX N021300 001 6514520 6514520*PED 7211582 7211582*PED 7214683 7214683*PED 7214684 7214684*PED DESLORATADINE - CLARINEX N021312 001 5607697 5607697*PED 6100274 6100274*PED 7211582 7211582*PED 7214683 7214683*PED 7214684 7214684*PED 7618649 7618649*PED DESLORATADINE - CLARINEX N021312 002 5607697 5607697*PED 6100274 6100274*PED 7211582 7211582*PED 7214683 7214683*PED 7214684 7214684*PED 7618649 7618649*PED
31, 2015
Jul Jan Dec Jun Dec Jun Dec Jun Jul Jan
07, 07, 30, 30, 30, 30, 30, 30, 07, 07,
2019 2020 2014 2015 2014 2015 2014 2015 2019 2020
DP U-809 DP U-138
Jun Dec Jul Jan Dec Jun Dec Jun Dec Jun Dec Jun
07, 07, 07, 07, 30, 30, 30, 30, 30, 30, 19, 19,
2015 2015 2019 2020 2014 2015 2014 2015 2014 2015 2020 2021
Jun Dec Jul Jan Dec Jun Dec Jun Dec Jun Dec Jun
07, 07, 07, 07, 30, 30, 30, 30, 30, 30, 19, 19,
2015 2015 2019 2020 2014 2015 2014 2015 2014 2015 2020 2021
ADA 43 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
DESLORATADINE; PSEUDOEPHEDRINE SULFATE - CLARINEX D 24 HOUR N021605 001 6100274 Jul 07, 2019 DP 6100274*PED Jan 07, 2020 DP 6979463 Mar 28, 2022 DP 7214683 Dec 30, 2014 7214683*PED Jun 30, 2015 U-138 7214684 Dec 30, 2014 7214684*PED Jun 30, 2015 DP U-1017 7618649 Dec 19, 2020 7618649*PED Jun 19, 2021 DP 7820199 Mar 28, 2022 7820199*PED Sep 28, 2022 DESLORATADINE; PSEUDOEPHEDRINE SULFATE - CLARINEX-D N021313 001 6100274 Jul 07, 2019 6100274*PED Jan 07, 2020 6709676 Feb 18, 2021 7214683 Dec 30, 2014 7214683*PED Jun 30, 2015 7214684 Dec 30, 2014 7214684*PED Jun 30, 2015 7618649 Dec 19, 2020 7618649*PED Jun 19, 2021 DESMOPRESSIN ACETATE - DDAVP N017922 001 5500413 5674850 5763407 DESMOPRESSIN ACETATE - DDAVP N017922 002 5500413 5674850 5763407 DESMOPRESSIN ACETATE - DDAVP N018938 001 5500413 5763407 DESMOPRESSIN ACETATE - DDAVP N018938 002 5500413 5763407 DESMOPRESSIN ACETATE - DDAVP N019955 001 5500413 5674850 5763407 7022340 DESMOPRESSIN ACETATE - DDAVP N019955 002 5500413 5674850 5763407 7022340 12 HOUR DP DP DP U-707
U-138 DP U-1017
Jun Jun
Jun Jun
DP
DP
DESMOPRESSIN ACETATE - DDAVP (NEEDS NO REFRIGERATION) N017922 003 5482931 Jun 29, 2013 5500413 Jun 29, 2013 5674850 Dec 23, 2013 5763407 Jun 29, 2013 DESMOPRESSIN ACETATE - DESMOPRESSIN ACETATE N021795 001 7022340 Apr 30, 2023 DESMOPRESSIN ACETATE - DESMOPRESSIN ACETATE N021795 002 7022340 Apr 30, 2023 DESONIDE - DESONATE N021844 001 6387383
DP
DP
Aug
03, 2020
DS
DP
U-783
ADA 44 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP
EXCLUSIVITY CODE(S)
Sep Sep
DESVENLAFAXINE SUCCINATE - PRISTIQ N021992 001 6673838 Feb DESVENLAFAXINE SUCCINATE - PRISTIQ N021992 002 6673838 Feb DEXAMETHASONE - OZURDEX N022315 001 6726918 6726918 6899717 7033605 7767223 8034366 8034366 8034370 8043628 8063031
11, 2022
DS
DP
U-860
NCE
Mar
01, 2013
11, 2022
DS
DP
U-860
NCE
Mar
01, 2013
Oct Oct Nov Oct Nov Jan Jan Jan Oct Oct
20, 20, 01, 20, 28, 09, 09, 09, 20, 20,
2020 2020 2023 2020 2021 2023 2023 2023 2020 2020
DP DP DP DP DP DP DP DP DP
NDF ODE
Jun Sep
DEXAMETHASONE; TOBRAMYCIN - TOBRADEX ST Aug 03, 2028 N050818 001 7795316 DEXLANSOPRAZOLE - DEXILANT N022287 001 6462058 6462058 6462058 6462058*PED 6664276 6664276 6664276 6664276*PED 6939971 6939971 6939971 6939971*PED 7285668 7285668*PED 7790755 7790755*PED DEXLANSOPRAZOLE - DEXILANT N022287 002 6462058 6462058 6462058 6462058*PED 6664276 6664276 6664276 6664276*PED 6939971 6939971 6939971 6939971*PED 7285668 7285668*PED 7790755 7790755*PED
DP
U-1082
Jun Jun Jun Dec Jun Jun Jun Dec Jun Jun Jun Dec Jun Dec Aug Feb
15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 02, 02,
2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2026 2027
DS DS DS DS DS DS
DP DP DP DP DP DP
NP PED
Jan Jul
DS DP
Jun Jun Jun Dec Jun Jun Jun Dec Jun Jun Jun Dec Jun Dec Aug Feb
15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 15, 02, 02,
2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2026 2027
DS DS DS DS DS DS
DP DP DP DP DP DP
NP PED
Jan Jul
DS DP
DEXMEDETOMIDINE HYDROCHLORIDE - PRECEDEX Jul 15, 2013 N021038 001 4910214 Sep 06, 2011 5344840 Mar 31, 2019 6716867 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN N021278 001 5908850 Dec 04, 2015 6355656 Dec 04, 2015 6528530 Dec 04, 2015
DS
DP
I-577
Oct
17, 2011
U-422 DS DP
ADA 45 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-422 DS DP
EXCLUSIVITY CODE(S)
DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN N021278 002 5908850 Dec 04, 2015 6355656 Dec 04, 2015 6528530 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN N021278 003 5908850 Dec 04, 2015 6355656 Dec 04, 2015 6528530 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 001 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 002 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 003 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 004 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 005 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 006 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015
U-422 DS DP
DP DP DP DP DP DP DP U-678 U-676
D-121 M-80
Oct
23, 2012 Oct
17, 2011
U-677 U-676
DP DP DP DP DP DP DP U-678 U-676
D-121 M-80
Oct
23, 2012 Oct
17, 2011
U-677 U-676
DP DP DP DP DP DP DP U-678 U-676
D-121 M-80
Oct
23, 2012 Oct
17, 2011
U-677 U-676
DP DP DP DP DP DP DP U-678 U-676
D-121 M-80
Oct
23, 2012 Oct
17, 2011
U-677 U-676
DP DP DP DP DP DP DP DP
U-678 U-676
D-121 M-80
Oct
23, 2012 Oct
17, 2011
U-677 U-676
DP DP DP DP DP DP DP DP
D-121 M-80
Oct Oct
23, 2012
17, 2011
U-677 U-676
ADA 46 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP
EXCLUSIVITY CODE(S)
D-121 M-80
DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 007 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXMETHYLPHENIDATE HYDROCHLORIDE - FOCALIN XR N021802 008 5837284 Dec 04, 2015 5908850 Dec 04, 2015 6228398 Nov 01, 2019 6355656 Dec 04, 2015 6528530 Dec 04, 2015 6635284 Dec 04, 2015 6730325 Nov 01, 2019 7431944 Dec 04, 2015 DEXRAZOXANE HYDROCHLORIDE - TOTECT N022025 001 6727253 Mar DEXTROMETHORPHAN HYDROBROMIDE; N021620 001 6372252 6955821 7838032 DEXTROMETHORPHAN HYDROBROMIDE; N021620 002 6372252 6955821 7838032 DEXTROMETHORPHAN HYDROBROMIDE; N021879 001 5206248 7659282 RE38115
U-678 U-676
Oct Oct
U-677 U-676
DP DP DP DP DP DP DP DP
U-678 U-676
D-121 M-80
Oct Oct
U-677 U-676
13, 2020
U-829
ODE
Sep
06, 2014
GUAIFENESIN - MUCINEX DM Apr 28, 2020 DP DP U-685 Apr 28, 2020 DP Apr 28, 2020 GUAIFENESIN - MUCINEX DM Apr 28, 2020 DP DP U-685 Apr 28, 2020 DP Apr 28, 2020 QUINIDINE SULFATE - NUEDEXTA Mar 27, 2012 U-1093 U-1093 Aug 13, 2026 Jan 26, 2016 DP
NC
Oct
29, 2013
DEXTROMETHORPHAN POLISTIREX - DELSYM N018658 001 5980882 Apr 16, 2017 DIAZEPAM - DIASTAT N020648 001 5462740 DIAZEPAM - DIASTAT N020648 002 5462740 DIAZEPAM - DIASTAT N020648 003 5462740 DIAZEPAM - DIASTAT N020648 004 5462740 DIAZEPAM - DIASTAT N020648 005 5462740 DIAZEPAM - DIASTAT ACUDIAL N020648 006 5462740 DIAZEPAM - DIASTAT ACUDIAL N020648 007 5462740
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
Sep
17, 2013
DP
DICLOFENAC EPOLAMINE - FLECTOR N021234 001 5607690 Apr DICLOFENAC POTASSIUM - CAMBIA N022165 001 6974595 7482377 7759394
13, 2014
DP
DS DS
DP DP
NDF
Jun
17, 2012
ADA 47 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP U-980 U-1035 U-1111 U-980
EXCLUSIVITY CODE(S)
NDF
Jun
16, 2012
DICLOFENAC SODIUM - DICLOFENAC SODIUM N020809 001 5603929 Nov 16, 2014 5653972 Nov 16, 2014 DICLOFENAC SODIUM - PENNSAID N020947 001 DICLOFENAC SODIUM - SOLARAZE N021005 001 5639738 5792753 5852002 5914322 5929048 5985850
U-239 U-239
NDF Jun Aug Jun Aug Jun Aug 17, 11, 17, 11, 17, 11, 2014 2015 2014 2015 2014 2015 U-402 U-402 U-402 DP
Nov
04, 2012
DICLOFENAC SODIUM; MISOPROSTOL - ARTHROTEC N020607 001 5601843 Feb 11, 2014 DICLOFENAC SODIUM; MISOPROSTOL - ARTHROTEC N020607 002 5601843 Feb 11, 2014 DIDANOSINE - VIDEX N020154 002 5880106 5880106*PED DIDANOSINE - VIDEX N020154 003 5880106 5880106*PED DIDANOSINE - VIDEX N020154 004 5880106 5880106*PED DIDANOSINE - VIDEX N020154 005 5880106 5880106*PED DIDANOSINE - VIDEX N020154 006 5880106 5880106*PED
Jul Jan
Jul Jan
Jul Jan
Jul Jan
Jul Jan
DIENOGEST; ESTRADIOL VALERATE - NATAZIA Oct 25, N022252 001 6133251 Oct 25, 6133251 Oct 25, 6133251 Oct 25, 6884793 May 13, 8071577 DIFLUPREDNATE - DUREZOL N022212 001 6114319
DP DP DP DP DP
Y Y Y Y
NP
May
06, 2013
May
18, 2019
DP
NCE
Jun
23, 2013
DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 001 5364620 Nov 14, 2011 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 002 5364620 Nov 14, 2011 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 003 5364620 Nov 14, 2011 5439689 Aug 08, 2012
U-3 U-107
U-3 U-107
U-3 U-107
ADA 48 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-3 U-107
EXCLUSIVITY CODE(S)
DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 004 5364620 Nov 14, 2011 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM CD N020062 005 5439689 Aug 08, 2012 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 001 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 002 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 003 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 004 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 005 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - CARDIZEM LA N021392 006 5529791 Jun 25, 2013 6923984 Feb 25, 2021 7108866 Dec 17, 2019 DILTIAZEM HYDROCHLORIDE - DILACOR XR N020092 001 5422123 Jun 06, 2012 DILTIAZEM HYDROCHLORIDE - DILACOR XR N020092 002 5422123 Jun 06, 2012 DILTIAZEM HYDROCHLORIDE - DILACOR XR N020092 003 5422123 Jun 06, 2012 DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE N020939 001 5529791 Jun 25, 2013 DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE N020939 002 5529791 Jun 25, 2013 DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE N020939 003 5529791 Jun 25, 2013 DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE N020939 004 5529791 Jun 25, 2013 DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 001 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 002 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 003 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 004 5529791 Jun
DP
U-107
DP DP
U-107
DP DP
U-107
DP DP
U-107
DP DP
U-107
DP DP
U-107
DP DP
U-107
25, 2013
25, 2013
25, 2013
25, 2013
ADA 49 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 005 5529791 Jun DILTIAZEM HYDROCHLORIDE - TIAZAC N020401 006 5529791 Jun
25, 2013
25, 2013
DIMYRISTOYL LECITHIN; PERFLEXANE - IMAGENT Feb 25, 2014 N021191 001 5605673 May 16, 2014 5626833 5639443 Jun 17, 2014 5695741 Dec 09, 2014 5720938 Feb 24, 2015 5798091 Aug 25, 2015 6280704 Jul 30, 2013 6280705 Jul 30, 2013 6287539 Jul 30, 2013 DINOPROSTONE - CERVIDIL N020411 001 5269321 DIVALPROEX SODIUM - DEPAKOTE N019680 001 DIVALPROEX SODIUM - DEPAKOTE ER N021168 001 6419953 Dec 6419953*PED Jun 6511678 Dec 6511678*PED Jun 6528090 Dec 6528090*PED Jun 6528091 Dec 6528091*PED Jun 6713086 Dec 6713086*PED Jun 6720004 Dec 6720004*PED Jun DIVALPROEX SODIUM - DEPAKOTE ER N021168 002 6511678 Dec 6511678*PED Jun 6528090 Dec 6528090*PED Jun 6713086 Dec 6713086*PED Jun 6720004 Dec 6720004*PED Jun DOCETAXEL - TAXOTERE N020449 001 5438072 5438072*PED 5698582 5698582*PED 5714512 5714512*PED 5750561 5750561*PED DOCETAXEL - TAXOTERE N020449 003 5698582 5698582*PED 5714512 5714512*PED 5750561 5750561*PED
Jul
14, 2012
DP
U-110
PED 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 18, 2018 2019 2018 2019 2018 2019 2018 2019 2018 2019 2018 2019
Sep
24, 2011
PED
Sep
24, 2011
DP U-106 DP DP U-579
PED DP DP DP U-579
Sep
24, 2011
DP DP DP DP
M-61 PED
May Nov
DP DP DP
M-61 PED
May Nov
ADA 50 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
M-61 PED
DOCETAXEL - TAXOTERE N020449 004 5698582 5698582*PED 5714512 5714512*PED 5750561 5750561*PED DOCOSANOL - ABREVA N020941 001 4874794 5534554 DOFETILIDE - TIKOSYN N020931 001 4959366 6124363 DOFETILIDE - TIKOSYN N020931 002 4959366 6124363 DOFETILIDE - TIKOSYN N020931 003 4959366 6124363 DOLASETRON MESYLATE - ANZEMET N020623 001 4906755 DOLASETRON MESYLATE - ANZEMET N020623 002 4906755 DOLASETRON MESYLATE - ANZEMET N020624 001 4906755 DOLASETRON MESYLATE - ANZEMET N020624 002 4906755 DOLASETRON MESYLATE - ANZEMET N020624 003 4906755
May Nov
Apr Dec
DP
U-815 U-815
Sep Oct
DS
DP
U-652
Sep Oct
DS
DP
U-652
Sep Oct
DS
DP
U-652
Jul
02, 2011
Jul
02, 2011
Jul
02, 2011
Jul
02, 2011
Jul
02, 2011
DONEPEZIL HYDROCHLORIDE - ARICEPT N020690 001 5985864 Dec 6140321 Dec 6245911 Dec 6372760 Mar DONEPEZIL HYDROCHLORIDE - ARICEPT N020690 002 5985864 Dec 6140321 Dec 6245911 Dec 6372760 Mar DONEPEZIL HYDROCHLORIDE - ARICEPT N022568 001
NP DP DP U-1062
Jul
23, 2013
DONEPEZIL HYDROCHLORIDE - ARICEPT ODT N021720 001 7727548 Jun 23, 2022 7727552 Mar 26, 2018 DONEPEZIL HYDROCHLORIDE - ARICEPT ODT N021720 002 7727548 Jun 23, 2022 7727552 Mar 26, 2018 DORIPENEM - DORIBAX N022106 001 5317016 DORIPENEM - DORIBAX N022106 002 5317016
DP DP
U-1062
Jun
05, 2015
DS
DP
U-282
NCE
Oct
12, 2012
Jun
05, 2015
DS
DP
U-282
NCE
Oct
12, 2012
ADA 51 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-620 DP DP DP DP DP U-620 DP U-620
EXCLUSIVITY CODE(S)
NP
DOXEPIN HYDROCHLORIDE - SILENOR Mar N022036 001 5502047 Jan 5585115 Jan 5725884 Jan 5866166 Jan 5948438 Jan 6103219 Feb 6211229 Jan 6217909 Aug 7915307 DOXEPIN HYDROCHLORIDE - SILENOR Mar N022036 002 5502047 Jan 5585115 Jan 5725884 Jan 5866166 Jan 5948438 Jan 6103219 Feb 6211229 Jan 6217909 Aug 7915307 DOXERCALCIFEROL - HECTOROL N020862 001 5602116 5602116 6903083 DOXERCALCIFEROL - HECTOROL N020862 002 5602116 5602116 6903083 DOXERCALCIFEROL - HECTOROL N020862 003 5602116 DOXERCALCIFEROL - HECTOROL N021027 001 5602116 6903083 7148211 DOXERCALCIFEROL - HECTOROL N021027 002 5602116 7148211
Mar
17, 2013
NP
Mar
17, 2013
U-278 U-987 DS DP Y
U-278 U-987 DS DP Y
Feb
11, 2014
U-987
U-321 DS DP DP Y
Feb Sep
U-321 DP
DOXORUBICIN HYDROCHLORIDE - DOXIL N050718 001 DOXORUBICIN HYDROCHLORIDE - DOXIL N050718 002 DOXYCYCLINE - ORACEA N050805 001 5789395 5919775 7211267 7232572 7749532 DOXYCYCLINE HYCLATE - DORYX N050795 001 6958161 DOXYCYCLINE HYCLATE - DORYX N050795 002 6958161 DOXYCYCLINE HYCLATE - DORYX N050795 003 6958161
ODE
May
17, 2014
ODE 30, 30, 05, 05, 19, 2016 2016 2022 2022 2027 U-925 U-925 U-925 U-925 U-1063
May
17, 2014
DP
Dec
15, 2022
DP
U-918
Dec
15, 2022
DP
U-918
Dec
15, 2022
DP
U-918
DS
DP DP
U-992
NCE
Jul
01, 2014
ADA 52 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS
EXCLUSIVITY CODE(S)
11, 2017
DROSPIRENONE; ETHINYL ESTRADIOL - YASMIN N021098 001 5569652 Oct 29, 2013 6787531 Aug 31, 2020 Aug 11, 2017 6933395 DROSPIRENONE; ETHINYL ESTRADIOL - YAZ N021676 001 5569652 Oct 29, 5798338 Jul 10, 6787531 Aug 31, Aug 11, 6933395 Dec 20, 6958326 Dec 22, 6987101 Dec 20, 7163931 Jun 30, RE37564 Jun 30, RE37838 Jun 30, RE38253
U-1 DP DS
2013 2015 2020 2017 2021 2017 2021 2014 2014 2014
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM - BEYAZ N022532 001 5798338 Jul 10, 2015 DP DS 6441168 Apr 17, 2020 DP 6958326 Dec 30, 2021 U-1 7163931 Mar 03, 2022 DP RE37564 Jun 30, 2014 DP RE37838 Jun 30, 2014 DP RE38253 Jun 30, 2014 DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM - SAFYRAL N022574 001 5798338 Jul 10, 2015 DP DS 6441168 Apr 17, 2020 DP 6958326 Dec 20, 2021 U-1 7163931 Mar 03, 2022 DULOXETINE HYDROCHLORIDE - CYMBALTA N021427 001 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5508276 Jul 18, 2014 6596756 Sep 10, 2019 DULOXETINE HYDROCHLORIDE - CYMBALTA N021427 002 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5508276 Jul 18, 2014 6596756 Sep 10, 2019
NC NP
Sep Sep
NP
Dec
16, 2013
DS DS DS DS DS DS DS DS DS
DP DP DP DP DP DP DP DP DP DP
U-605 U-1094 U-799 U-398 U-839 U-797 U-795 U-882 U-796 U-882
I-632 I-617
Nov Nov
DS DS DS DS DS DS DS DS DS
DP DP DP DP DP DP DP DP DP DP
U-1094 U-605 U-882 U-839 U-799 U-795 U-796 U-797 U-398 U-882
I-632 I-617
Nov Nov
ADA 53 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DS DS DS DS DP DP DP DP DP DP DP DP DP DP U-799 U-605 U-1094 U-398 U-882 U-795 U-796 U-797 U-839 U-882
EXCLUSIVITY CODE(S)
I-632 I-617
DULOXETINE HYDROCHLORIDE - CYMBALTA Jun 11, 2013 N021427 004 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jun 11, 2013 5023269 Jul 18, 2014 5508276 Sep 10, 2019 6596756 DUTASTERIDE - AVODART N021319 001 5565467 5846976 5998427
Nov Nov
20, 2015 17, 2013 17, 2013 JALYN 2015 2013 2013
DS DS
DP DP U-476 U-477
DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE N022460 001 5565467 Nov 20, 5846976 Sep 17, Sep 17, 5998427 EFAVIRENZ - SUSTIVA N020972 001 5519021 5663169 5811423 6238695 6555133 6639071 6939964 EFAVIRENZ - SUSTIVA N020972 002 5519021 5663169 5811423 6238695 6555133 6639071 6939964 EFAVIRENZ - SUSTIVA N020972 003 5519021 5663169 5811423 6238695 6555133 6639071 6939964 EFAVIRENZ - SUSTIVA N021360 001 5519021 5663169 5811423 6639071 6939964 EFAVIRENZ - SUSTIVA N021360 002 5519021 5663169 5811423 6639071 6939964
DS DS
DP DP U-1065 U-1066
DS DS
DS DS
DS DS
DS DS
DS DS
DS DS
U-256 DS DS
DS
DP U-248 U-256
DS DS
ADA 54 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
EFAVIRENZ; EMTRICITABINE; TENOFOVIR N021937 001 5519021 May Sep 5663169 Aug 5811423 Sep 5814639 Mar 5814639*PED Jul 5914331 Jan 5914331*PED Jul 5922695 Jan 5922695*PED Jul 5935946 Jan 5935946*PED Jul 5977089 Jan 5977089*PED Jul 6043230 Jan 6043230*PED Feb 6639071 Nov 6642245 May 6642245*PED Mar 6703396 Sep 6703396*PED Jan 6939964
DISOPROXIL FUMARATE - ATRIPLA 21, 2013 DS DP U-750 02, 2014 U-750 07, 2012 DS DP 29, 2015 29, 2016 DS 02, 2017 02, 2018 DS U-750 25, 2017 25, 2018 DS DP U-750 25, 2017 25, 2018 DS DP U-750 25, 2017 25, 2018 U-750 25, 2017 25, 2018 DS 14, 2018 U-750 04, 2020 04, 2021 DS DP 09, 2021 09, 2021 DS 20, 2018
EFLORNITHINE HYDROCHLORIDE - VANIQA N021145 001 5648394 Jul 15, 2014 ELETRIPTAN HYDROBROMIDE - RELPAX N021016 001 5545644 Dec 6110940 Aug ELETRIPTAN HYDROBROMIDE - RELPAX N021016 002 5545644 Dec 6110940 Aug ELTROMBOPAG OLAMINE - PROMACTA N022291 001 6280959 7160870 7332481 7452874 7473686 7547719 7790704 7795293 8052993 ELTROMBOPAG OLAMINE - PROMACTA N022291 002 6280959 7160870 7332481 7452874 7473686 7547719 7790704 7795293 8052994 ELTROMBOPAG OLAMINE - PROMACTA N022291 003 6280959 7160870 7332481 7452874 7473686 7547719 7790704 7795293 8062665
U-334
DS
DP
U-876
DS
DP
U-876
DS DS DS DS DS
DP DP DP DP DP
NCE ODE
Nov Nov
DP
DS DS DS DS DS
DP DP DP DP DP
NCE ODE
Nov Nov
DP
DS DS DS DS DS
DP DP DP DP DP
NCE ODE
Nov Nov
DP
ADA 55 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DP DP DP DP DP U-930 U-930 U-930 U-930 U-930 U-930 U-930 U-930
EXCLUSIVITY CODE(S)
NCE ODE
ELTROMBOPAG OLAMINE - PROMACTA N022291 004 6280959 7160870 7332481 7452874 7473686 7547719 7790704 7795293 8071129
Nov Nov
DP
EMEDASTINE DIFUMARATE - EMADINE N020706 001 5441958 Dec EMTRICITABINE - EMTRIVA N021500 001 5814639 5814639*PED 5914331 5914331*PED 6642245 6642245 6642245*PED 6703396 6703396*PED EMTRICITABINE - EMTRIVA N021896 001 5814639 5814639*PED 5914331 5914331*PED 6642245 6642245*PED 6703396 6703396*PED
08, 2013
U-404
DS DS
DP
U-257 U-541 DS DP
DS DS
DP
U-257 DS DP
EMTRICITABINE; RILPIVIRINE; TENOFOVIR DISOPROXIL FUMARATE - COMPLERA DS DP N202123 001 5814639 Sep 29, 2015 Mar 29, 2016 5814639*PED Jul 02, 2017 5914331 DS Jan 02, 2018 5914331*PED Jul 25, 2017 DS U-257 5922695 Jan 25, 2018 5922695*PED Jul 25, 2017 DS DP U-257 5935946 Jan 25, 2018 5935946*PED DS DP Jul 25, 2017 5977089 U-257 Jan 25, 2018 5977089*PED U-257 Jul 25, 2017 6043230 Jan 25, 2018 6043230*PED U-257 Nov 04, 2020 6642245 May 04, 2021 6642245*PED Mar 09, 2021 DS DP 6703396 Sep 09, 2021 6703396*PED Feb 26, 2021 DS DP 6838464 Dec 20, 2019 DS DP 7067522 DS DP U-257 Apr 14, 2023 7125879
ADA 56 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
EMTRICITABINE; TENOFOVIR DISOPROXIL N021752 001 5814639 Sep 5814639*PED Mar 5914331 Jul 5914331*PED Jan 5922695 Jul 5922695 Jul 5922695 Jul 5922695*PED Jan 5935946 Jul 5935946 Jul 5935946 Jul 5935946*PED Jan 5977089 Jul 5977089 Jul 5977089 Jul 5977089*PED Jan 6043230 Jul 6043230 Jul 6043230 Jul 6043230*PED Jan 6642245 Nov 6642245 Nov 6642245 Nov 6642245*PED May 6703396 Mar 6703396*PED Sep ENFUVIRTIDE - FUZEON N021481 001 5464933 6133418 6475491 ENOXAPARIN SODIUM - LOVENOX N020164 009 5389618 RE38743
FUMARATE - TRUVADA 29, 2015 DS DP 29, 2016 DS DP U-248 02, 2017 DS 02, 2018 25, 2017 DS U-248 DS U-541 25, 2017 DS U-1170 25, 2017 25, 2018 DS DP U-541 25, 2017 25, 2017 DS DP U-248 DS DP U-1170 25, 2017 25, 2018 DS DP U-1170 25, 2017 DS DP U-541 25, 2017 25, 2017 DS DP U-248 25, 2018 DP U-248 25, 2017 DP U-1170 25, 2017 25, 2017 DP U-541 25, 2018 U-1170 04, 2020 U-248 04, 2020 U-541 04, 2020 04, 2021 DS DP 09, 2021 09, 2021
DS
DP U-248
Feb Feb
DS DS
DP DP
U-545 U-545
ENOXAPARIN SODIUM - LOVENOX (PRESERVATIVE FREE) DS N020164 001 5389618 Feb 14, 2012 DS RE38743 Feb 14, 2012 ENOXAPARIN SODIUM - LOVENOX (PRESERVATIVE FREE) DS N020164 002 5389618 Feb 14, 2012 RE38743 Feb 14, 2012 DS ENOXAPARIN SODIUM - LOVENOX (PRESERVATIVE FREE) DS N020164 003 5389618 Feb 14, 2012 RE38743 Feb 14, 2012 DS ENOXAPARIN SODIUM - LOVENOX (PRESERVATIVE FREE) N020164 004 5389618 Feb 14, 2012 DS DS RE38743 Feb 14, 2012 ENOXAPARIN SODIUM - LOVENOX (PRESERVATIVE FREE) DS N020164 005 5389618 Feb 14, 2012 DS RE38743 Feb 14, 2012 ENOXAPARIN SODIUM - LOVENOX (PRESERVATIVE FREE) DS N020164 006 5389618 Feb 14, 2012 DS RE38743 Feb 14, 2012 ENOXAPARIN SODIUM - LOVENOX (PRESERVATIVE FREE) DS N020164 007 5389618 Feb 14, 2012 DS RE38743 Feb 14, 2012 ENOXAPARIN SODIUM - LOVENOX (PRESERVATIVE FREE) N020164 008 5389618 Feb 14, 2012 DS DS RE38743 Feb 14, 2012
DP DP
U-545 U-545
DP DP
U-545
U-545
U-545
U-545
DP DP
DP DP
U-545 U-545
DP DP
U-545 U-545
DP DP
U-545 U-545
DP DP
U-545 U-545
DP DP
U-545 U-545
ADA 57 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-219
EXCLUSIVITY CODE(S)
ENTACAPONE - COMTAN N020796 001 5446194 6599530 ENTECAVIR - BARACLUDE N021797 001 5206244 ENTECAVIR - BARACLUDE N021797 002 5206244 ENTECAVIR - BARACLUDE N021798 001 5206244
Oct Sep
Feb
21, 2015
DS
D-127
Oct
15, 2013
Feb
21, 2015
DS
D-127
Oct
15, 2013
Feb
21, 2015
DS
D-127
Oct
15, 2013
29, 2020
U-765
EPINASTINE HYDROCHLORIDE - EPINASTINE HYDROCHLORIDE A090870 001 EPINEPHRINE - ADRENACLICK N020800 003 5665071 EPINEPHRINE - ADRENACLICK N020800 004 5665071 EPINEPHRINE - EPIPEN N019430 001 7449012 7794432 8048035 EPINEPHRINE - EPIPEN JR. N019430 002 7449012 7794432 8048035 EPINEPHRINE - TWINJECT 0.15 N020800 002 7297136 7621891 EPINEPHRINE - TWINJECT 0.3 N020800 001 7297136 7621891
PC DP
Oct
29, 2011
May
27, 2013
May
27, 2013
DP
DP DP DP
DP DP DP
Jan Feb
DP DP
Jan Feb
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE - LIDOSITE N021504 001 5246418 Sep 30, 2013 Sep 30, 2013 5873850 Sep 30, 2013 6377847 Sep 30, 2013 6385488 Jun 30, 2020 6629968 Jun 29, 2021 6635045 Sep 30, 2013 6862473
ADA 58 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-3 U-537 U-467 U-3 U-537 U-537 U-3 DP U-537 U-587 DP DP U-664 U-664
EXCLUSIVITY CODE(S)
PED
EPLERENONE - INSPRA N021437 001 6410054 6410054 6410054*PED 6410524 6410524*PED 6495165 6495165 6495165*PED 6534093 6534093 6534093*PED 6558707 6558707*PED 6747020 6747020*PED 6863902 6863902*PED 7157101 7157101*PED EPLERENONE - INSPRA N021437 002 6410054 6410054 6410054*PED 6410524 6410524*PED 6495165 6495165 6495165*PED 6534093 6534093 6534093*PED 6558707 6558707*PED 6747020 6747020*PED 6863902 6863902*PED 7157101 7157101*PED EPLERENONE - INSPRA N021437 003 6410054 6410054 6410054*PED 6410524 6410524*PED 6495165 6495165 6495165*PED 6534093 6534093 6534093*PED 6558707 6558707*PED 6747020 6747020*PED 6863902 6863902*PED 7157101 7157101*PED EPROSARTAN MESYLATE - TEVETEN N020738 004 5656650 EPROSARTAN MESYLATE - TEVETEN N020738 005 5656650
Dec Dec Jun Nov May Dec Dec Jun Dec Dec Jun Dec Jun Nov May Apr Oct Dec Jun
08, 08, 08, 05, 05, 08, 08, 08, 08, 08, 08, 08, 08, 05, 05, 10, 10, 08, 08,
2019 2019 2020 2019 2020 2019 2019 2020 2019 2019 2020 2019 2020 2019 2020 2020 2020 2019 2020
Jul
31, 2011
Dec Dec Jun Nov May Dec Dec Jun Dec Dec Jun Dec Jun Nov May Apr Oct Dec Jun
08, 08, 08, 05, 05, 08, 08, 08, 08, 08, 08, 08, 08, 05, 05, 10, 10, 08, 08,
2019 2019 2020 2019 2020 2019 2019 2020 2019 2019 2020 2019 2020 2019 2020 2020 2020 2019 2020
U-3 U-537 U-467 U-3 U-537 U-3 U-537 DP U-537 U-587 DP DP U-664 U-664
PED
Jul
31, 2011
Dec Dec Jun Nov May Dec Dec Jun Dec Dec Jun Dec Jun Nov May Apr Oct Dec Jun
08, 08, 08, 05, 05, 08, 08, 08, 08, 08, 08, 08, 08, 05, 05, 10, 10, 08, 08,
2019 2019 2020 2019 2020 2019 2019 2020 2019 2019 2020 2019 2020 2019 2020 2020 2020 2019 2020
U-3 U-537 U-467 U-3 U-537 U-3 U-537 DP U-537 U-587 DP DP U-664 U-664
Aug
12, 2014
U-3
Aug
12, 2014
U-3
ADA 59 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-3
EXCLUSIVITY CODE(S)
Aug
12, 2014
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE - TEVETEN HCT U-3 N021268 001 5656650 Aug 12, 2014 EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE - TEVETEN HCT U-3 N021268 002 5656650 Aug 12, 2014 EPTIFIBATIDE - INTEGRILIN N020718 001 5686570 5747447 5756451 5807825 5968902 EPTIFIBATIDE - INTEGRILIN N020718 002 5686570 5747447 5756451 5807825 5968902 ERIBULIN MESYLATE - HALAVEN N201532 001 6214865 6469182 7470720
U-244 U-453
U-244 U-453
DS U-1096 DP
NCE
Nov
15, 2015
ERLOTINIB HYDROCHLORIDE - TARCEVA N021743 001 5747498 Nov 6900221 Nov 6900221 Nov 6900221 Nov 7087613 Nov 7087613 Nov RE41065 Nov ERLOTINIB HYDROCHLORIDE - TARCEVA N021743 002 5747498 Nov 6900221 Nov 6900221 Nov 6900221 Nov 7087613 Nov 7087613 Nov RE41065 Nov ERLOTINIB HYDROCHLORIDE - TARCEVA N021743 003 5747498 Nov 6900221 Nov 6900221 Nov 6900221 Nov 7087613 Nov 7087613 Nov RE41065 Nov ERTAPENEM SODIUM - INVANZ N021337 001 5478820 5478820*PED 5652233 5652233*PED 5952323 5952323*PED 7342005 7342005*PED
DS DS DS DS
DP DP DP DP
I-624 M-79
Apr Sep
DS
DP
DS DS DS DS
DP DP DP DP
I-624 M-79
Apr Sep
DS
DP
DS DS DS DS
DP DP DP DP
I-624 M-79
Apr Sep
DS
DP
DS DS
DP DP DP DP
U-160 U-160
ADA 60 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP DP DP
EXCLUSIVITY CODE(S)
NPP
ESCITALOPRAM OXALATE - LEXAPRO N021323 001 6916941 6916941*PED 7420069 7420069*PED RE34712 RE34712*PED ESCITALOPRAM OXALATE - LEXAPRO N021323 002 6916941 6916941*PED 7420069 7420069*PED RE34712 RE34712*PED ESCITALOPRAM OXALATE - LEXAPRO N021323 003 6916941 6916941*PED 7420069 7420069*PED RE34712 RE34712*PED
Mar
19, 2012
DS
DS DS
DP DP DP DP
NPP
Mar
19, 2012
DS
DS DS
DP DP DP DP
NPP
Mar
19, 2012
DS
ESCITALOPRAM OXALATE - LEXAPRO N021365 001 RE34712 Sep Mar RE34712*PED ESMOLOL HYDROCHLORIDE - BREVIBLOC N019386 006 6310094 Jan 6310094*PED Jul 6528540 Jan 6528540*PED Jul ESMOLOL HYDROCHLORIDE - BREVIBLOC N019386 007 6310094 Jan 6310094*PED Jul 6528540 Jan 6528540*PED Jul
DS
DP
NPP
Mar
19, 2012
ESMOLOL HYDROCHLORIDE - BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER N019386 005 6310094 Jan 12, 2021 6310094*PED Jul 12, 2021 6528540 Jan 12, 2021 6528540*PED Jul 12, 2021 ESMOLOL HYDROCHLORIDE - BREVIBLOC IN PLASTIC CONTAINER N019386 004 6310094 Jan 12, 2021 6310094*PED Jul 12, 2021 6528540 Jan 12, 2021 6528540*PED Jul 12, 2021
ADA 61 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP DP DS DS DS U-373 U-729 U-770 U-373 U-729 U-770 U-373 U-373 U-729 U-770 U-373 U-373 U-729 U-770 U-373 U-373
EXCLUSIVITY CODE(S)
ESOMEPRAZOLE MAGNESIUM - NEXIUM N021153 001 5690960 Nov 5690960 Nov 5690960 Nov 5690960*PED May Feb 5714504 Feb 5714504 Feb 5714504 Aug 5714504*PED May 5877192 May 5877192 May 5877192 Nov 5877192*PED May 5900424 May 5900424 May 5900424 Nov 5900424*PED Oct 6147103 Apr 6147103*PED Oct 6166213 Apr 6166213*PED Oct 6191148 Apr 6191148*PED May 6369085 May 6369085 Nov 6369085*PED Nov 6428810 Nov 6428810 Nov 6428810 May 6428810*PED May 6875872 Nov 6875872*PED May 7411070 Nov 7411070*PED ESOMEPRAZOLE MAGNESIUM - NEXIUM N021153 002 5690960 Nov 5690960 Nov 5690960 Nov 5690960*PED May Feb 5714504 Feb 5714504 Feb 5714504 Aug 5714504*PED May 5877192 May 5877192 May 5877192 Nov 5877192*PED May 5900424 May 5900424 May 5900424 Nov 5900424*PED Oct 6147103 Apr 6147103*PED Oct 6166213 Apr 6166213*PED Oct 6191148 Apr 6191148*PED May 6369085 May 6369085 Nov 6369085*PED Nov 6428810 Nov 6428810 Nov 6428810 May 6428810*PED May 6875872 Nov 6875872*PED May 7411070 Nov 7411070*PED
25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 27, 27, 04, 04, 04, 04, 09, 09, 09, 09, 09, 09, 25, 25, 25, 03, 03, 03, 03, 27, 27, 25, 25,
2014 2014 2014 2015 2015 2015 2015 2015 2014 2014 2014 2014 2016 2016 2016 2016 2018 2019 2018 2019 2018 2019 2018 2018 2018 2019 2019 2019 2020 2014 2014 2018 2018
DS DS
DP DP DP DP DP
DS DS
25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 27, 27, 04, 04, 04, 04, 09, 09, 09, 09, 09, 09, 25, 25, 25, 03, 03, 03, 03, 27, 27, 25, 25,
2014 2014 2014 2015 2015 2015 2015 2015 2014 2014 2014 2014 2016 2016 2016 2016 2018 2019 2018 2019 2018 2019 2018 2018 2018 2019 2019 2019 2020 2014 2014 2018 2018
DP DP DP DP DP DP DP DP DP DS DS DS
U-770 U-373 U-729 U-373 U-770 U-729 U-373 U-373 U-770 U-729 U-373 U-373 U-770 U-373 U-729 U-373
DS DS
DP DP DP DP DP
DS DS
ADA 62 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP U-1207 U-729 U-773 U-729 U-773 U-1207 U-773 U-729 DS DS DS DS DS DS DP DP DP DP DP DP DS DS U-1207 U-729 U-773 U-729 U-773 U-1207 U-729 U-773 U-1207
EXCLUSIVITY CODE(S)
M-86 PED PED
ESOMEPRAZOLE MAGNESIUM - NEXIUM Nov N021957 001 5690960 Nov 5690960 Nov 5690960 May 5690960*PED Feb 5714504 Feb 5714504 Feb 5714504 Aug 5714504*PED May 5877192 May 5877192 Nov 5877192*PED May 5900424 May 5900424 May 5900424 Nov 5900424*PED May 6369085 May 6369085 May 6369085 Nov 6369085*PED Nov 6428810 Nov 6428810 Nov 6428810 May 6428810*PED May 6875872 Nov 6875872*PED May 7411070 Nov 7411070*PED ESOMEPRAZOLE MAGNESIUM - NEXIUM Nov N021957 002 5690960 Nov 5690960 Nov 5690960 May 5690960*PED Feb 5714504 Feb 5714504 Feb 5714504 Aug 5714504*PED May 5877192 May 5877192 Nov 5877192*PED May 5900424 May 5900424 May 5900424 Nov 5900424*PED May 6369085 May 6369085 May 6369085 Nov 6369085*PED Nov 6428810 Nov 6428810 Nov 6428810 May 6428810*PED May 6875872 Nov 6875872*PED May 7411070 Nov 7411070*PED
25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 27, 04, 04, 04, 04, 25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 25, 25,
2014 2014 2014 2015 2015 2015 2015 2015 2014 2014 2014 2016 2016 2016 2016 2018 2018 2018 2018 2019 2019 2019 2020 2014 2014 2018 2018
25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 27, 04, 04, 04, 04, 25, 25, 25, 25, 03, 03, 03, 03, 27, 27, 25, 25,
2014 2014 2014 2015 2015 2015 2015 2015 2014 2014 2014 2016 2016 2016 2016 2018 2018 2018 2018 2019 2019 2019 2020 2014 2014 2018 2018
DP DP DP DP DP DP
DS DS DS DS DS DS DP DP DP DP DP DP DS DS
ADA 63 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP U-858 U-858 U-858 DS DS DP DP DS DS U-858 U-858 U-858
EXCLUSIVITY CODE(S)
M-86 PED PED
ESOMEPRAZOLE MAGNESIUM - NEXIUM Nov N022101 001 5690960 May 5690960*PED Feb 5714504 Aug 5714504*PED May 5877192 Nov 5877192*PED May 5900424 Nov 5900424*PED May 6369085 Nov 6369085*PED Nov 6428810 May 6428810*PED May 6875872 Nov 6875872*PED May 7411070 Nov 7411070*PED
25, 25, 03, 03, 27, 27, 04, 04, 25, 25, 03, 03, 27, 27, 25, 25,
2014 2015 2015 2015 2014 2014 2016 2016 2018 2018 2019 2020 2014 2014 2018 2018
ESOMEPRAZOLE MAGNESIUM; NAPROXEN - VIMOVO Feb 03, 2015 N022511 001 5714504 Aug 03, 2015 5714504*PED May 04, 2016 5900424 Nov 04, 2016 5900424*PED May 25, 2018 6369085 Nov 25, 2018 6369085*PED May 27, 2014 6875872 Nov 27, 2014 6875872*PED Feb 28, 2023 6926907 May 25, 2018 7411070 Nov 25, 2018 7411070*PED Oct 13, 2018 7745466 ESOMEPRAZOLE MAGNESIUM; NAPROXEN - VIMOVO N022511 002 5714504 Feb 03, 2015 5714504*PED Aug 03, 2015 5900424 May 04, 2016 Nov 04, 2016 5900424*PED May 25, 2018 6369085 6369085*PED Nov 25, 2018 6875872 May 27, 2014 Nov 27, 2014 6875872*PED Feb 28, 2023 6926907 May 25, 2018 7411070 Nov 25, 2018 7411070*PED Oct 13, 2018 7745466 ESOMEPRAZOLE SODIUM - NEXIUM IV May N021689 001 5877192 Nov 5877192*PED May 6143771 ESOMEPRAZOLE SODIUM - NEXIUM IV N021689 002 5877192 May Nov 5877192*PED May 6143771 ESTRADIOL - ELESTRIN N021813 001 7198801 7470433 ESTRADIOL - EVAMIST N022014 001 6299900 6299900 6818226 6818226 6923983 6923983 6978945
DP DS DS DS DP DS DP DP
NC
Apr
30, 2013
DP DS DS DS DP DS DP DP
NC
Apr
30, 2013
U-643 DP U-643
U-643 DP U-643
Jun Aug
DP DP
DP DP DP DP DP DP DP
ADA 64 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP U-594 U-594
EXCLUSIVITY CODE(S)
ESTRADIOL - MENOSTAR N021674 001 5891868 6692763 ESTRADIOL - VAGIFEM N020908 002 7018992 ESTRADIOL - VIVELLE-DOT N020538 005 5474783 5656286 5958446 6024976 ESTRADIOL - VIVELLE-DOT N020538 006 5474783 5656286 5958446 6024976 ESTRADIOL - VIVELLE-DOT N020538 007 5474783 5656286 5958446 6024976 ESTRADIOL - VIVELLE-DOT N020538 008 5474783 5656286 5958446 6024976 ESTRADIOL - VIVELLE-DOT N020538 009 5474783 5656286 5958446 6024976 ESTRADIOL ACETATE - FEMRING N021367 001 5855906 ESTRADIOL ACETATE - FEMRING N021367 002 5855906 ESTRADIOL ACETATE - FEMTRACE N021633 001 6962908 7572779 7799771 ESTRADIOL ACETATE - FEMTRACE N021633 002 6962908 7572779 7799771 ESTRADIOL ACETATE - FEMTRACE N021633 003 6962908 7572779 7799771
Nov Nov
Sep
17, 2022
U-1023
D-122
Nov
25, 2012
DP DP DP DP
Dec
19, 2015
U-508
Dec
19, 2015
U-508
DP U-904 DP
DP U-904 DP
DP U-904 DP
31, 2015
DP
ESTRADIOL; LEVONORGESTREL - CLIMARA PRO N021258 001 5676968 Oct 14, 2014 ESTRADIOL; NORETHINDRONE ACETATE - COMBIPATCH Dec 12, 2012 N020870 001 5474783 Aug 12, 2014 5656286 Dec 12, 2012 5958446 Jan 07, 2014 6024976
DP
ADA 65 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ESTRADIOL; NORETHINDRONE ACETATE - COMBIPATCH N020870 002 5474783 Dec 12, 2012 5656286 Aug 12, 2014 Dec 12, 2012 5958446 Jan 07, 2014 6024976 ESTRADIOL; NORGESTIMATE - PREFEST N021040 001 5382573 Jan 6747019 Mar 7320970 Mar ESTROGENS, CONJUGATED - PREMARIN N020216 001 ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 001 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 002 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 003 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 004 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC A - CENESTIN N020992 005 5908638 Jul 26, 2015 ESTROGENS, CONJUGATED SYNTHETIC A - SYNTHETIC CONJUGATED ESTROGENS A N021788 001 ESTROGENS, CONJUGATED SYNTHETIC B N021443 001 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ESTROGENS, CONJUGATED SYNTHETIC B N021443 002 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ESTROGENS, CONJUGATED SYNTHETIC B N021443 003 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ESTROGENS, CONJUGATED SYNTHETIC B N021443 004 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ESTROGENS, CONJUGATED SYNTHETIC B N021443 005 6660726 Mar 6660726 Mar 6855703 Feb 6855703 Feb ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021 ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021 ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021 ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021 ENJUVIA 08, 2021 08, 2021 12, 2021 12, 2021
DP
U-311 U-844
I-579 DP
Nov
07, 2011
NP
Nov
28, 2011
DS DS DS DS
DP DP DP DP
DS DS DS DS
DP DP DP DP
DS DS DS DS
DP DP DP DP
DS DS DS DS
DP DP DP DP
DS DS DS DS
DP DP DP DP
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPHASE 14/14 N020527 002 5547948 Jan 17, 2015 ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO N020527 001 5547948 Jan 17, 2015 ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO N020527 003 5547948 Jan 17, 2015
ADA 66 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO N020527 004 5547948 Jan 17, 2015 ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE - PREMPRO N020527 005 5547948 Jan 17, 2015 ESZOPICLONE - LUNESTA N021476 001 6319926 6444673 6864257 7381724 ESZOPICLONE - LUNESTA N021476 002 6319926 6444673 6864257 7381724 ESZOPICLONE - LUNESTA N021476 003 6319926 6444673 6864257 7381724
ETHINYL ESTRADIOL; ETONOGESTREL - NUVARING N021187 001 5989581 Apr 08, 2018 ETHINYL ESTRADIOL; LEVONORGESTREL N022262 001 7615545 Jun 7855190 Dec 7858605 Jun LOSEASONIQUE 15, 2023 05, 2028 23, 2023
U-1 U-1 DP
NP
Oct
24, 2011
ETHINYL ESTRADIOL; LEVONORGESTREL - LYBREL N021864 001 6500814 Sep 03, 2018
U-1
ETHINYL ESTRADIOL; LEVONORGESTREL - PREVEN EMERGENCY CONTRACEPTIVE KIT N020946 001 6156742 Dec 05, 2020 U-374 ETHINYL ESTRADIOL; LEVONORGESTREL - SEASONALE N021544 001 5898032 Jun 23, 2017 RE39861 Jun 23, 2017 ETHINYL ESTRADIOL; LEVONORGESTREL N021840 001 7320969 Jan 7615545 Jun 7855190 Dec 7858605 Jun SEASONIQUE 30, 2024 15, 2023 05, 2028 23, 2023
U-1 U-828
ETHINYL ESTRADIOL; NORELGESTROMIN - ORTHO EVRA N021180 001 5876746 Nov 20, 2015 5972377 Jun 07, 2015 ETHINYL ESTRADIOL; NORETHINDRONE - FEMCON FE N021490 001 6667050 Apr 06, 2019
DP
U-514 U-514
DP
U-1
ETHINYL ESTRADIOL; NORETHINDRONE - NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE A078965 001 PC Sep ETHINYL ESTRADIOL; NORETHINDRONE - NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE N022573 001 5552394 Jul 22, 2014 U-828 NP Dec DP U-828 6667050 Apr 06, 2019 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - LO LOESTRIN FE N022501 001 5552394 Jul 22, 2014 U-1090 U-1090 7704984 Feb 02, 2029 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE - LOESTRIN 24 FE N021871 001 5552394 Jul 22, 2014 U-1
21, 2011
22, 2013
NP
Oct
21, 2013
ADA 67 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-112
EXCLUSIVITY CODE(S)
ETHINYL ESTRADIOL; NORGESTIMATE - ORTHO TRI-CYCLEN LO N021241 001 6214815 Jun 09, 2019 6214815*PED Dec 09, 2019 ETRAVIRINE - INTELENCE N022187 001 6878717 6878717 7037917 7037917 7887845 8003789 ETRAVIRINE - INTELENCE N022187 002 6878717 7037917 7887845 8003789 EVEROLIMUS - AFINITOR N022334 001 5665772 6004973 7297703
DS DS
DP DP DP
NCE
Jan
18, 2013
DS
DP DP
U-1016 U-1016
NCE
Jan
18, 2013
DS
DP DP DP
DS
DP DP DP
Sep
09, 2019
I-638 I-630 NCE ODE ODE DS DP DP DP U-1049 U-1049 U-1049 U-1049 U-1049
EVEROLIMUS - ZORTRESS N021560 001 5665772 6004973 6239124 6440990 6455518 EVEROLIMUS - ZORTRESS N021560 002 5665772 6004973 6239124 6440990 6455518 EVEROLIMUS - ZORTRESS N021560 003 5665772 6004973 6239124 6440990 6455518
NP NCE
Apr Mar
DS
DP DP DP
NP NCE
Apr Mar
DS
DP DP DP
NP NCE
Apr Mar
ADA 68 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-653 U-1108 U-656 U-654 DP U-687 DP DP U-1074
EXCLUSIVITY CODE(S)
EXENATIDE SYNTHETIC - BYETTA N021773 001 5424286 5424286 6858576 6872700 6902744 6956026 7297761 7521423 7741269 EXENATIDE SYNTHETIC - BYETTA N021773 002 5424286 5424286 6858576 6872700 6902744 6956026 7297761 7521423 7741269 EZETIMIBE - ZETIA N021445 001 5846966 5846966 5846966 5846966*PED 7030106 7030106*PED 7612058 7612058 7612058*PED RE37721 RE37721*PED RE42461 RE42461 RE42461*PED
Sep Sep Sep Mar Jan Jul Jan Jan Jul Oct Apr Oct Oct Apr
21, 21, 21, 21, 25, 25, 25, 25, 25, 25, 25, 25, 25, 25,
2013 2013 2013 2014 2022 2022 2022 2022 2022 2016 2017 2016 2016 2017
PED
Dec
05, 2011
EZETIMIBE; SIMVASTATIN - VYTORIN Sep N021687 001 5846966 Sep 5846966 Mar 5846966*PED Oct RE37721 Apr RE37721*PED Oct RE42461 Apr RE42461*PED EZETIMIBE; SIMVASTATIN - VYTORIN N021687 002 5846966 Sep Sep 5846966 Mar 5846966*PED Oct RE37721 Apr RE37721*PED Oct RE42461 Apr RE42461*PED EZETIMIBE; SIMVASTATIN - VYTORIN N021687 003 5846966 Sep Sep 5846966 Mar 5846966*PED Oct RE37721 Apr RE37721*PED Oct RE42461 Apr RE42461*PED
DP DP DS DS DP DP
PED
Dec
05, 2011
DP DP DS DS DP DP
PED
Dec
05, 2011
DP DP DS DS DP DP
ADA 69 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DS DS DP DP U-473 U-593 U-473 U-473
EXCLUSIVITY CODE(S)
PED
EZETIMIBE; SIMVASTATIN - VYTORIN Sep N021687 004 5846966 Sep 5846966 Mar 5846966*PED Oct RE37721 Apr RE37721*PED Oct RE42461 Apr RE42461*PED EZOGABINE - POTIGA N022345 001 EZOGABINE - POTIGA N022345 002 EZOGABINE - POTIGA N022345 003 EZOGABINE - POTIGA N022345 004 FAMCICLOVIR - FAMVIR N020363 001 5840763 5840763*PED 5866581 5866581*PED 5916893 5916893*PED 6124304 6124304*PED FAMCICLOVIR - FAMVIR N020363 002 5840763 5840763*PED 5866581 5866581*PED 5916893 5916893*PED 6124304 6124304*PED FAMCICLOVIR - FAMVIR N020363 003 5840763 5840763*PED 5866581 5866581*PED 5916893 5916893*PED 6124304 6124304*PED FAMOTIDINE - FLUXID N021712 001 6024981 6221392 FAMOTIDINE - FLUXID N021712 002 6024981 6221392 FAMOTIDINE - PEPCID AC N020325 001 5854267 5854267*PED FAMOTIDINE - PEPCID AC N020801 001 5667794 5667794*PED 5854267 5854267*PED
Dec
05, 2011
Y Y
NCE
Jun
10, 2016
NCE
Jun
10, 2016
NCE
Jun
10, 2016
NCE Sep Mar Oct Apr Sep Mar Oct Apr 01, 01, 04, 04, 01, 01, 04, 04, 2015 2016 2014 2015 2015 2016 2014 2015 U-96 U-96 U-96 U-96
Jun
10, 2016
Apr Apr
DP DP
Apr Apr
DP DP
Dec Jun
U-267 U-267
Y U-267
ADA 70 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP
EXCLUSIVITY CODE(S)
Aug Feb
FAMOTIDINE - PEPCID AC (GELTAB) N020902 001 5854267 Dec 5854267*PED Jun FAMOTIDINE; IBUPROFEN - DUEXIS N022519 001 8067033 Jul 8067451 Jul FEBUXOSTAT - ULORIC N021856 001 5614520 6225474 7361676 FEBUXOSTAT - ULORIC N021856 002 5614520 6225474 7361676
U-368 U-368
DP DP
NC U-1196
Apr
23, 2014
DS DS
DP DP
U-954
NCE
Feb
13, 2014
DS DS
DP DP
U-954
NCE
Feb
13, 2014
FENOFIBRATE - ANTARA (MICRONIZED) N021695 001 7101574 Aug 7863331 Aug 7863331 Aug FENOFIBRATE - ANTARA (MICRONIZED) N021695 003 7101574 Aug 7863331 Aug 7863331 Aug FENOFIBRATE - FENOGLIDE N022118 001 7658944 FENOFIBRATE - FENOGLIDE N022118 002 7658944 FENOFIBRATE - LIPOFEN N021612 001 5545628 FENOFIBRATE - LIPOFEN N021612 002 5545628 FENOFIBRATE - LIPOFEN N021612 003 5545628 FENOFIBRATE - TRICOR N021203 001 6074670 6277405 6589552 6652881 7037529 7041319 FENOFIBRATE - TRICOR N021203 003 6074670 6277405 6589552 6652881 7037529 7041319 FENOFIBRATE - TRICOR N021656 001 6277405 6375986 6652881 7037529 7041319 7276249 7320802
DS
DP U-1107 U-1106
DS
DP U-1106 U-1107
Dec
09, 2024
DP
Dec
09, 2024
DP
Jan
10, 2015
DP
U-701
Jan
10, 2015
DP
U-701
Jan
10, 2015
DP
U-701
DP DP DP
DP DP DP
DS DP DS DP DP DP U-847 U-615
ADA 71 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DS DP DP DP U-847 U-615
EXCLUSIVITY CODE(S)
FENOFIBRATE - TRICOR N021656 002 6277405 6375986 6652881 7037529 7041319 7276249 7320802 FENOFIBRATE - TRIGLIDE N021350 001 6696084 FENOFIBRATE - TRIGLIDE N021350 002 6696084 FENOFIBRIC ACID - FIBRICOR N022418 001 7569612 7741373 7741374 7741374 7915247 7915247 7915247 FENOFIBRIC ACID - FIBRICOR N022418 002 7569612 7741373 7741374 7741374 7915247 7915247 7915247 FENTANYL CITRATE - ABSTRAL N022510 001 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 002 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 003 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 004 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 005 6759059 6761910 7910132 FENTANYL CITRATE - ABSTRAL N022510 006 6759059 6761910 7910132 FENTANYL CITRATE - FENTORA N021947 001 6200604 6974590 7862832 7862833
Sep
11, 2021
DS
DP
U-680
Sep
11, 2021
DS
DP
U-680
DP DP DP
DP DP DP
DP DP DP
DP DP DP
DP DP DP
DP DP DP
U-767 U-767 DP DP
ADA 72 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-767 U-767 DP DP
EXCLUSIVITY CODE(S)
FENTANYL CITRATE - FENTORA N021947 002 6200604 6974590 7862832 7862833 FENTANYL CITRATE - FENTORA N021947 003 6200604 6974590 7862832 7862833 FENTANYL CITRATE - FENTORA N021947 004 6200604 6974590 7862832 7862833 FENTANYL CITRATE - FENTORA N021947 005 6200604 6974590 7862832 7862833 FENTANYL CITRATE - FENTORA N021947 006 6200604 6974590 FENTANYL CITRATE - LAZANDA N022569 001 6432440 FENTANYL CITRATE - LAZANDA N022569 002 6432440 FENTANYL CITRATE - ONSOLIS N022266 001 6159498 7579019 FENTANYL CITRATE - ONSOLIS N022266 002 6159498 7579019 FENTANYL CITRATE - ONSOLIS N022266 003 6159498 7579019 FENTANYL CITRATE - ONSOLIS N022266 004 6159498 7579019 FENTANYL CITRATE - ONSOLIS N022266 005 6159498 7579019
U-767 U-767 DP DP
U-767 U-767 DP DP
U-767 U-767 DP DP
Mar Mar
U-767 U-767
Apr
20, 2018
DP
U-1169
NDF
Jun
30, 2014
Apr
20, 2018
DP
U-1169
NDF
Jun
30, 2014
Oct Jan
DP U-767
NP
Jul
16, 2012
Oct Jan
DP U-767
NP
Jul
16, 2012
Oct Jan
DP U-767
NP
Jul
16, 2012
Oct Jan
DP U-767
NP
Jul
16, 2012
Oct Jan
DP U-767
NP
Jul
16, 2012
FENTANYL HYDROCHLORIDE - IONSYS Dec N021338 001 5697896 Dec 5843014 Jan 6169920 Jun 6171294 Nov 6181963 Jan 6195582 Jun 6216033 Jun 6317629 Jun 6425892 Jun 6842640 Apr 6881208 Apr 6975902 Jun 7018370 Sep 7027859 Jun 7302293
16, 01, 02, 05, 02, 28, 05, 02, 05, 02, 19, 01, 05, 26, 05,
2014 2015 2018 2015 2019 2019 2015 2012 2015 2015 2022 2024 2015 2014 2015
U-736
ADA 73 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP DP DP
EXCLUSIVITY CODE(S)
NP
Jun
30, 2012
FESOTERODINE FUMARATE - TOVIAZ N022030 001 6858650 May May 7384980 Jun 7807715 May 7855230 May 7985772 FESOTERODINE FUMARATE - TOVIAZ May N022030 002 6858650 May 7384980 Jun 7807715 May 7855230 May 7985772
DS DS
DP DP DP
DS
NCE
Oct
31, 2013
DS DS
DP DP DP
DS
NCE
Oct
31, 2013
FEXOFENADINE HYDROCHLORIDE - ALLEGRA Nov 26, 2013 N020625 001 5578610 May 26, 2014 5578610*PED Feb 28, 2015 5738872 Aug 28, 2015 5738872*PED Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED May 11, 2012 6187791 Nov 11, 2012 6187791*PED May 11, 2012 6399632 Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED FEXOFENADINE HYDROCHLORIDE - ALLEGRA N021963 001 5578610 Nov 26, 2013 6037353 Mar 14, 2017 6187791 May 11, 2012 May 11, 2012 6399632 May 18, 2014 7138524 Nov 18, 2014 7138524*PED FEXOFENADINE HYDROCHLORIDE - ALLEGRA ALLERGY Nov 26, 2013 N020872 007 5578610 May 26, 2014 5578610*PED Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED May 11, 2012 6187791 Nov 11, 2012 6187791*PED May 11, 2012 6399632 Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED
U-192 U-192
U-138 U-138
DS
DP
DS
DS
DP DP DP
U-1160
ADA 74 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP U-1160 DP U-1160 U-1160 DS DS U-1160 U-1160
EXCLUSIVITY CODE(S)
FEXOFENADINE HYDROCHLORIDE - ALLEGRA ALLERGY N020872 010 5578610 Nov 26, 2013 5578610*PED May 26, 2014 Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED May 11, 2012 6187791 Nov 11, 2012 6187791*PED May 11, 2012 6399632 Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED FEXOFENADINE HYDROCHLORIDE - ALLEGRA HIVES N020872 008 5578610 Nov 26, 2013 5578610*PED May 26, 2014 Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED May 11, 2012 6187791 Nov 11, 2012 6187791*PED May 11, 2012 6399632 Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED FEXOFENADINE HYDROCHLORIDE - ALLEGRA HIVES N020872 009 5578610 Nov 26, 2013 5578610*PED May 26, 2014 Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED May 11, 2012 6187791 Nov 11, 2012 6187791*PED May 11, 2012 6399632 Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED
DS
DP DP DP
U-1160
DS
DP DP DP
U-1160
ADA 75 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
ALLERGY DS DP U-1160 DP DP U-1160 DP U-1160 U-1160 DS DS U-1160
EXCLUSIVITY CODE(S)
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA Nov 26, 2013 N020872 005 5578610 May 26, 2014 5578610*PED Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED May 11, 2012 6187791 Nov 11, 2012 6187791*PED May 11, 2012 6399632 Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA ALLERGY Nov 26, 2013 DS DP U-1158 N021909 002 5578610 DP Feb 28, 2015 5738872 U-1158 Mar 14, 2017 6037353 U-1158 May 11, 2012 6187791 U-1158 May 11, 2012 6399632 DS May 18, 2014 7138524 FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA ALLERGY N201373 001 5578610 Nov 26, 2013 DS DP U-1157 5578610*PED May 26, 2014 U-1157 Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED May 11, 2012 U-1157 6187791 Nov 11, 2012 6187791*PED U-1157 May 11, 2012 6399632 Nov 11, 2012 6399632*PED DS May 18, 2014 7138524 Nov 18, 2014 7138524*PED FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA N020872 006 5578610 Nov 26, 2013 5578610*PED May 26, 2014 Feb 28, 2015 5855912 Aug 28, 2015 5855912*PED Feb 28, 2015 5932247 Aug 28, 2015 5932247*PED Mar 14, 2017 6037353 Sep 14, 2017 6037353*PED Feb 28, 2015 6113942 Aug 28, 2015 6113942*PED May 11, 2012 6187791 Nov 11, 2012 6187791*PED May 11, 2012 6399632 Nov 11, 2012 6399632*PED May 18, 2014 7135571 Nov 18, 2014 7135571*PED May 18, 2014 7138524 Nov 18, 2014 7138524*PED HIVES DS DP DP DP U-1160 DP U-1160 U-1160 DS DS U-1160
U-1160
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA HIVES N021909 003 5578610 Nov 26, 2013 DS DP DP 5738872 Feb 28, 2015 6037353 Mar 14, 2017 6187791 May 11, 2012 May 11, 2012 6399632 May 18, 2014 DS 7138524
ADA 76 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-1157 U-1157 U-1157 U-1157
EXCLUSIVITY CODE(S)
FEXOFENADINE HYDROCHLORIDE - CHILDREN'S ALLEGRA HIVES N201373 002 5578610 Nov 26, 2013 DS DP 5578610*PED May 26, 2014 6037353 Mar 14, 2017 6037353*PED Sep 14, 2017 6187791 May 11, 2012 6187791*PED Nov 11, 2012 6399632 May 11, 2012 6399632*PED Nov 11, 2012 DS 7138524 May 18, 2014 7138524*PED Nov 18, 2014
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION N020786 002 5578610 Nov 26, 2013 DS DP U-1159 5578610*PED May 26, 2014 5855912 Feb 28, 2015 DP 5855912*PED Aug 28, 2015 U-1159 6037353 Mar 14, 2017 U-138 6037353*PED Sep 14, 2017 6039974 Jul 31, 2018 DP DP 6113942 Feb 28, 2015 6113942*PED Aug 28, 2015 U-1159 6187791 May 11, 2012 U-138 6187791*PED Nov 11, 2012 6399632 May 11, 2012 U-1159 U-468 6399632*PED Nov 11, 2012 DS U-1159 7135571 May 18, 2014 7135571*PED Nov 18, 2014 DS 7138524 May 18, 2014 7138524*PED Nov 18, 2014 FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE - ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION N021704 002 5578610 Nov 26, 2013 DS DP U-1159 5578610*PED May 26, 2014 U-1159 6037353 Mar 14, 2017 6037353*PED Sep 14, 2017 U-1159 6187791 May 11, 2012 6187791*PED Nov 11, 2012 U-1159 6399632 May 11, 2012 6399632*PED Nov 11, 2012 DP U-1159 6613357 Dec 25, 2020 DS 7138524 May 18, 2014 7138524*PED Nov 18, 2014 DP RE39069 May 29, 2018 FIDAXOMICIN - DIFICID N201699 001 7378508 7863249 7906489 FINASTERIDE - PROPECIA N020788 001 5547957 5571817 5886184 FINASTERIDE - PROSCAR N020180 001 5886184 5942519 FINGOLIMOD - GILENYA N022527 001 5604229
DS DS
DP DP U-319
NCE
May
27, 2016
U-236 U-259
Nov Oct
DS U-280
Feb
18, 2014
DS
U-1086
M-106 NCE
Jul Sep
FLUDARABINE PHOSPHATE - OFORTA N022273 001 7148207 Dec 7547776 Dec FLUOCINOLONE ACETONIDE - RETISERT N021737 001 6217895 Mar 6548078 Mar
DP DS
U-944
NDF ODE
Dec Dec
DP DP
U-708 U-708
ODE
Apr
08, 2012
ADA 77 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN - TRI-LUMA DP N021112 001 7915243 Mar 22, 2026 DP 7939516 May 04, 2025 FLUOCINONIDE - VANOS N021758 001 6765001 7220424 7794738 FLUOROURACIL - CARAC N020985 001 6670335
DP U-861 U-1084
Jun
02, 2021
DP
U-68
FLUOXETINE HYDROCHLORIDE - PROZAC N018936 001 6960577 Nov FLUOXETINE HYDROCHLORIDE - PROZAC N018936 003 6960577 Nov FLUOXETINE HYDROCHLORIDE - PROZAC N018936 006 6960577 Nov
01, 2017
U-963
I-589
Mar
19, 2012
01, 2017
U-963
I-589
Mar
19, 2012
01, 2017
U-963
I-589
Mar
19, 2012
FLUOXETINE HYDROCHLORIDE - PROZAC WEEKLY N021235 001 5910319 May 29, 2017 5985322 May 29, 2017 RE39030 May 29, 2017 RE39030 May 29, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 001 5229382*PED Oct 23, 2011 6960577 Nov 01, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 002 5229382*PED Oct 23, 2011 5945416 Mar 24, 2017 6960577 Nov 01, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 003 5229382*PED Oct 23, 2011 5945416 Mar 24, 2017 6960577 Nov 01, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 004 5229382*PED Oct 23, 2011 5945416 Mar 24, 2017 6960577 Nov 01, 2017 FLUOXETINE HYDROCHLORIDE; OLANZAPINE - SYMBYAX N021520 005 5229382*PED Oct 23, 2011 5945416 Mar 24, 2017 6960577 Nov 01, 2017 FLUTICASONE FUROATE - VERAMYST N022051 001 6858596 Aug 7101866 Aug 7541350 Aug FLUTICASONE PROPIONATE - CUTIVATE N021152 001 7300669 Oct
DP DP
I-593 U-962
Mar
19, 2012
I-593 DS DP U-962 Y
Mar
19, 2012
I-593 DS DP U-962 Y
Mar
19, 2012
I-593 DS DP U-962 Y
Mar
19, 2012
I-593 DS DP U-962 Y
Mar
19, 2012
DS
DP DP DP
20, 2019 100 2011 2011 2016 2016 2011 2011 2011 2011 2011 2011
DP
U-835
FLUTICASONE PROPIONATE - FLOVENT DISKUS N020833 002 5590645*PED Sep 01, 5860419*PED Sep 01, 5873360 Feb 23, 5873360*PED Aug 23, Sep 01, 6032666*PED Sep 01, 6378519*PED Sep 01, 6536427*PED Sep 01, 6792945*PED Sep 01, 7225808*PED Sep 01, 7389775*PED
DP
ADA 78 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE - FLOVENT DISKUS N020833 003 5590645*PED Sep 01, 5860419*PED Sep 01, 5873360 Feb 23, 5873360*PED Aug 23, 6032666*PED Sep 01, 6378519*PED Sep 01, 6536427*PED Sep 01, 6792945*PED Sep 01, 7225808*PED Sep 01, 7389775*PED Sep 01, FLUTICASONE PROPIONATE - FLOVENT DISKUS N020833 001 5590645*PED Sep 01, 5860419*PED Sep 01, 5873360 Feb 23, 5873360*PED Aug 23, 6032666*PED Sep 01, 6378519*PED Sep 01, 6536427*PED Sep 01, 6792945*PED Sep 01, 7225808*PED Sep 01, 7389775*PED Sep 01, FLUTICASONE PROPIONATE - FLOVENT HFA N021433 001 5658549 Aug 19, 5658549*PED Feb 19, 5674472 Oct 07, 5674472*PED Apr 07, 6161724 Jan 16, 6161724*PED Jul 16, 6170717 Dec 23, 6170717*PED Jun 23, 6251368 Dec 04, 6251368*PED Jun 04, 6315173 Dec 23, 6315173*PED Jun 23, 6431168 Jun 08, 6431168*PED Dec 08, 6435372 Jan 16, 6435372*PED Jul 16, 6510969 Dec 23, 6510969*PED Jun 23, 6596260 Aug 10, 6596260*PED Feb 10, 6743413 Jun 01, 6743413*PED Dec 01, 6938796 Jan 16, 6938796*PED Jul 16, 6966467 Dec 23, 6966467*PED Jun 23, 6997349 Jan 16, 6997349*PED Jul 16, 7107986 Jun 08, 7107986*PED Dec 08, 7143908 Jan 16, 7143908*PED Jul 16, 7350676 Aug 24, 7350676*PED Feb 24, 7500444 Jan 04, 7500444*PED Jul 04,
DP
DP
2014 2015 2014 2015 2018 2018 2017 2018 2012 2013 2017 2018 2018 2018 2018 2018 2017 2018 2014 2015 2021 2021 2018 2018 2017 2018 2018 2018 2018 2019 2018 2018 2018 2019 2025 2025
DP DP DP DP DP DP DP DP DP DP
U-710
U-581 DP DP DP DP DP DP DP
ADA 79 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP DP DP U-581 DP DP DP DP DP DP DP U-710
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE - FLOVENT HFA Aug 19, N021433 002 5658549 Feb 19, 5658549*PED Oct 07, 5674472 Apr 07, 5674472*PED Jan 16, 6161724 Jul 16, 6161724*PED Dec 23, 6170717 Jun 23, 6170717*PED Dec 04, 6251368 Jun 04, 6251368*PED Dec 23, 6315173 Jun 23, 6315173*PED Jun 08, 6431168 Dec 08, 6431168*PED Jan 16, 6435372 Jul 16, 6435372*PED Dec 23, 6510969 Jun 23, 6510969*PED Aug 10, 6596260 Feb 10, 6596260*PED Jun 01, 6743413 Dec 01, 6743413*PED Jan 16, 6938796 Jul 16, 6938796*PED Dec 23, 6966467 Jun 23, 6966467*PED Jan 16, 6997349 Jul 16, 6997349*PED Jun 08, 7107986 Dec 08, 7107986*PED Jan 16, 7143908 Jul 16, 7143908*PED Aug 24, 7350676 Feb 24, 7350676*PED Jan 04, 7500444 Jul 04, 7500444*PED
2014 2015 2014 2015 2018 2018 2017 2018 2012 2013 2017 2018 2018 2018 2018 2018 2017 2018 2014 2015 2021 2021 2018 2018 2017 2018 2018 2018 2018 2019 2018 2018 2018 2019 2025 2025
ADA 80 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP DP DP DP DP U-581 U-581 DP DP DP DP DP DP DP U-710 U-710
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE - FLOVENT HFA N021433 003 5658549 Aug 19, Feb 19, 5658549*PED Oct 07, 5674472 Apr 07, 5674472*PED Jan 16, 6161724 Jul 16, 6161724*PED Dec 23, 6170717 Jun 23, 6170717*PED Dec 04, 6251368 Jun 04, 6251368*PED Dec 23, 6315173 Jun 23, 6315173*PED Jun 08, 6431168 Dec 08, 6431168*PED Jan 16, 6435372 Jul 16, 6435372*PED Dec 23, 6510969 Jun 23, 6510969*PED Aug 10, 6596260 Feb 10, 6596260*PED Jun 01, 6743413 Dec 01, 6743413*PED Jan 16, 6938796 Jul 16, 6938796*PED Dec 23, 6966467 Jun 23, 6966467*PED Jan 16, 6997349 Jul 16, 6997349*PED Jun 08, 7107986 Dec 08, 7107986*PED Jan 16, 7143908 Jul 16, 7143908*PED Aug 24, 7350676 Feb 24, 7350676*PED Jan 04, 7500444 Jul 04, 7500444*PED
2014 2015 2014 2015 2018 2018 2017 2018 2012 2013 2017 2018 2018 2018 2018 2018 2017 2018 2014 2015 2021 2021 2018 2018 2017 2018 2018 2018 2018 2019 2018 2018 2018 2019 2025 2025
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 100/50 N021077 001 5590645*PED Sep 01, 2011 5860419*PED Sep 01, 2011 DP 5873360 Feb 23, 2016 5873360*PED Aug 23, 2016 6032666*PED Sep 01, 2011 6378519*PED Sep 01, 2011 6536427*PED Sep 01, 2011 6792945*PED Sep 01, 2011 7225808*PED Sep 01, 2011 7389775*PED Sep 01, 2011 FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 250/50 N021077 002 5590645*PED Sep 01, 2011 5860419*PED Sep 01, 2011 DP 5873360 Feb 23, 2016 5873360*PED Aug 23, 2016 6032666*PED Sep 01, 2011 6378519*PED Sep 01, 2011 6536427*PED Sep 01, 2011 6792945*PED Sep 01, 2011 7225808*PED Sep 01, 2011 7389775*PED Sep 01, 2011
M-84
Mar
31, 2012
M-84
Mar
31, 2012
ADA 81 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
M-84
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR DISKUS 500/50 N021077 003 5590645*PED Sep 01, 2011 5860419*PED Sep 01, 2011 DP 5873360 Feb 23, 2016 5873360*PED Aug 23, 2016 6032666*PED Sep 01, 2011 6378519*PED Sep 01, 2011 6536427*PED Sep 01, 2011 6792945*PED Sep 01, 2011 7225808*PED Sep 01, 2011 7389775*PED Sep 01, 2011 FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA N021254 001 5658549 Aug 19, 2014 DP U-738 U-738 5658549*PED Feb 19, 2015 5674472 Oct 07, 2014 DP 5674472*PED Apr 07, 2015 DP 6161724 Jan 16, 2018 6161724*PED Jul 16, 2018 DP 6170717 Dec 23, 2017 6170717*PED Jun 23, 2018 DP 6251368 Dec 04, 2012 6251368*PED Jun 04, 2013 DP 6315173 Dec 23, 2017 6315173*PED Jun 23, 2018 DP 6431168 Jun 08, 2018 6431168*PED Dec 08, 2018 DP 6435372 Jan 16, 2018 6435372*PED Jul 16, 2018 6510969 Dec 23, 2017 6510969*PED Jun 23, 2018 DP 6596260 Aug 10, 2014 6596260*PED Feb 10, 2015 U-841 6743413 Jun 01, 2021 U-841 6743413*PED Dec 01, 2021 DP 6938796 Jan 16, 2018 6938796*PED Jul 16, 2018 DP 6966467 Dec 23, 2017 6966467*PED Jun 23, 2018 DP 6997349 Jan 16, 2018 6997349*PED Jul 16, 2018 DP 7107986 Jun 08, 2018 7107986*PED Dec 08, 2018 DP 7143908 Jan 16, 2018 7143908*PED Jul 16, 2018 DP 7350676 Aug 24, 2018 7350676*PED Feb 24, 2019 DP 7500444 Jan 04, 2025 7500444*PED Jul 04, 2025
Mar
31, 2012
ADA 82 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA Aug 19, 2014 DP U-738 N021254 002 5658549 Feb 19, 2015 DP U-738 5658549*PED DP Oct 07, 2014 5674472 DP Apr 07, 2015 5674472*PED Jan 16, 2018 DP 6161724 Jul 16, 2018 6161724*PED DP Dec 23, 2017 6170717 Jun 23, 2018 6170717*PED DP Dec 04, 2012 6251368 DP Jun 04, 2013 6251368*PED DP Dec 23, 2017 6315173 DP Jun 23, 2018 6315173*PED DP Jun 08, 2018 6431168 Dec 08, 2018 6431168*PED DP Jan 16, 2018 6435372 Jul 16, 2018 6435372*PED DP Dec 23, 2017 6510969 DP Jun 23, 2018 6510969*PED DP Aug 10, 2014 6596260 Feb 10, 2015 6596260*PED U-841 Jun 01, 2021 6743413 U-841 Dec 01, 2021 6743413*PED DP Jan 16, 2018 6938796 Jul 16, 2018 6938796*PED DP Dec 23, 2017 6966467 Jun 23, 2018 6966467*PED DP Jan 16, 2018 6997349 Jul 16, 2018 6997349*PED DP Jun 08, 2018 7107986 Dec 08, 2018 7107986*PED DP Jan 16, 2018 7143908 Jul 16, 2018 7143908*PED DP Aug 24, 2018 7350676 Feb 24, 2019 7350676*PED DP Jan 04, 2025 7500444 Jul 04, 2025 7500444*PED
ADA 83 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA Aug 19, 2014 DP U-738 N021254 003 5658549 Feb 19, 2015 DP U-738 5658549*PED DP Oct 07, 2014 5674472 DP Apr 07, 2015 5674472*PED Jan 16, 2018 DP 6161724 Jul 16, 2018 6161724*PED DP Dec 23, 2017 6170717 Jun 23, 2018 6170717*PED DP Dec 04, 2012 6251368 DP Jun 04, 2013 6251368*PED DP Dec 23, 2017 6315173 DP Jun 23, 2018 6315173*PED DP Jun 08, 2018 6431168 Dec 08, 2018 6431168*PED DP Jan 16, 2018 6435372 Jul 16, 2018 6435372*PED DP Dec 23, 2017 6510969 DP Jun 23, 2018 6510969*PED DP Aug 10, 2014 6596260 Feb 10, 2015 6596260*PED U-841 Jun 01, 2021 6743413 U-841 Dec 01, 2021 6743413*PED DP Jan 16, 2018 6938796 Jul 16, 2018 6938796*PED DP Dec 23, 2017 6966467 Jun 23, 2018 6966467*PED DP Jan 16, 2018 6997349 Jul 16, 2018 6997349*PED DP Jun 08, 2018 7107986 Dec 08, 2018 7107986*PED DP Jan 16, 2018 7143908 Jul 16, 2018 7143908*PED DP Aug 24, 2018 7350676 Feb 24, 2019 7350676*PED DP Jan 04, 2025 7500444 Jul 04, 2025 7500444*PED FLUVASTATIN SODIUM - LESCOL N020261 001 5354772 5354772 5354772*PED 5356896 5356896*PED FLUVASTATIN SODIUM - LESCOL N020261 002 5354772 5354772 5354772*PED 5356896 5356896*PED
U-109 U-413
U-109 U-413
FLUVASTATIN SODIUM - LESCOL XL N021192 001 5354772 Oct 5354772 Oct 5354772*PED Apr Dec 5356896 Jun 5356896*PED Apr 6242003 Oct 6242003*PED FLUVOXAMINE MALEATE - LUVOX CR N022033 001 7465462 May FLUVOXAMINE MALEATE - LUVOX CR May N022033 002 7465462 FOLLITROPIN ALFA/BETA - FOLLISTIM N020582 001 5767251 Jun
U-413 U-109
10, 2020
DP
U-929
10, 2020
DP
U-929
16, 2015
ADA 84 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
16, 2015
FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021211 001 5767251 Jun 16, 5929028 Jan 14, 7446090 Aug 23, 7563763 Aug 23, 7563763 Aug 23, FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021211 002 5767251 Jun 16, 5929028 Jan 14, 7446090 Aug 23, 7563763 Aug 23, 7563763 Aug 23, FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021211 003 5767251 Jun 16, 5929028 Jan 14, 7446090 Aug 23, 7563763 Aug 23, 7563763 Aug 23, FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021211 004 5767251 Jun 16, 5929028 Jan 14, 7446090 Aug 23, 7563763 Aug 23, 7563763 Aug 23, FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021273 001 FOLLITROPIN ALFA/BETA - FOLLISTIM AQ N021273 002 FOLLITROPIN ALFA/BETA - GONAL-F N020378 001 5767251 Jun FOLLITROPIN ALFA/BETA - GONAL-F N020378 002 5767251 Jun FOLLITROPIN ALFA/BETA - GONAL-F N020378 003 5767251 Jun FOLLITROPIN ALFA/BETA - GONAL-F N020378 004 5767067 Jun 5767251 Jun 7563763 Aug FOLLITROPIN ALFA/BETA - GONAL-F N020378 005 5767067 Jun 5767251 Jun 7563763 Aug FOLLITROPIN ALFA/BETA - GONAL-F N021765 001 5767251 Jun FOLLITROPIN ALFA/BETA - GONAL-F N021765 003 5767251 Jun
D-133 I-306
Aug Jun
D-133 I-306
Aug Jun
D-133
Aug
22, 2014
D-133 I-306
Aug Jun
I-306
Jun
28, 2013
Jun
28, 2013
16, 2015
DS
16, 2015
DS
DS DS DP
DS DS DP
16, 2015
DS
16, 2015
DS
FOLLITROPIN ALFA/BETA - GONAL-F RFF N021765 002 5767067 Jun 16, 2015 5767251 Jun 16, 2015 FOLLITROPIN ALFA/BETA - GONAL-F RFF N021684 001 5767067 Jun 5767251 Jun 7446090 Aug 7741268 Apr PEN 16, 16, 23, 02,
DS DS
DS DS DP DP
ADA 85 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP
EXCLUSIVITY CODE(S)
FOLLITROPIN ALFA/BETA - GONAL-F RFF N021684 002 5767067 Jun 5767251 Jun 7446090 Aug 7741268 Apr FOLLITROPIN ALFA/BETA - GONAL-F RFF N021684 003 5767067 Jun 5767251 Jun 7446090 Aug 7741268 Apr FOMEPIZOLE - ANTIZOL N020696 001 7553863
DS DS DP DP
Jun
30, 2027
DS
DP
FOMIVIRSEN SODIUM - VITRAVENE PRESERVATIVE FREE N020961 001 5442049 Aug 15, 2012 5595978 Aug 15, 2012 FORMOTEROL FUMARATE - FORADIL N020831 001 6488027 6887459
U-522
Mar Nov
U-762
FORMOTEROL FUMARATE - PERFOROMIST N022007 001 6667344 Jun 6814953 Jun 7348362 Jun 7462645 Jun
2021 2021 2021 2021 - DULERA 2014 2014 2014 2014 2017 2014 2020 2020 - DULERA 2014 2014 2014 2014 2017 2014 2020 2020
DP DP DP DP
U-813 U-813
FORMOTEROL FUMARATE; MOMETASONE FUROATE N022518 001 5889015 Jan 27, 5889015*PED Jul 27, 6057307 Jan 27, 6057307*PED Jul 27, 6068832 Aug 27, Jan 27, 6677323 May 21, 7067502 May 08, 7566705 FORMOTEROL FUMARATE; MOMETASONE FUROATE N022518 002 5889015 Jan 27, 5889015*PED Jul 27, 6057307 Jan 27, 6057307*PED Jul 27, 6068832 Aug 27, Jan 27, 6677323 May 21, 7067502 May 08, 7566705 FOSAMPRENAVIR CALCIUM - LEXIVA N021548 001 6436989 6436989*PED 6514953 6514953*PED
NC
Jun
22, 2013
NC
Jun
22, 2013
DS DS
DP DP
U-257 U-257
FOSAMPRENAVIR CALCIUM - LEXIVA N022116 001 6436989 Dec 6436989*PED Jun FOSAPREPITANT DIMEGLUMINE - EMEND N022023 001 5512570 Mar 5538982 Jul 5691336 Mar 5716942 Feb 7214692 Sep FOSAPREPITANT DIMEGLUMINE - EMEND N022023 002 5691336 Mar
DS
DP
U-257
NCE
Jan
25, 2013
04, 2019
DS
DP
D-128 NCE
Nov Jan
ADA 86 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP U-945
EXCLUSIVITY CODE(S)
NCE
FOSPROPOFOL DISODIUM - LUSEDRA N022244 001 6204257 Aug Aug 6872838 FROVATRIPTAN SUCCINATE - FROVA N021006 001 5464864 Nov 5616603 Apr 5637611 Jun 5827871 Oct 5962501 Dec FULVESTRANT - FASLODEX N021344 001 6774122 6774122*PED 7456160 7456160*PED GABAPENTIN - GABAPENTIN A078974 001 GABAPENTIN - GRALISE N022544 001 6340475 6488962 6635280 6723340 7438927 7731989 GABAPENTIN - GRALISE N022544 002 6340475 6488962 6635280 6723340 7438927 7731989 GABAPENTIN - NEURONTIN N020235 001 6054482 6054482*PED GABAPENTIN - NEURONTIN N020235 002 6054482 6054482*PED GABAPENTIN - NEURONTIN N020235 003 6054482 6054482*PED GABAPENTIN - NEURONTIN N020882 001 6054482 6054482*PED GABAPENTIN - NEURONTIN N020882 002 6054482 6054482*PED GABAPENTIN - NEURONTIN N021129 001 6054482 6054482*PED 7256216 7256216*PED
Dec
12, 2013
U-596 U-596
PC Sep Jun Sep Oct Feb Oct 19, 20, 19, 25, 26, 25, 2016 2020 2016 2021 2024 2022 DP DP DP DP U-1114 DP
Aug
22, 2011
NP
Jan
28, 2014
DP DP DP DP U-1114 DP
NP
Jan
28, 2014
Apr Oct
Apr Oct
Apr Oct
Apr Oct
Apr Oct
DP
GABAPENTIN ENACARBIL - HORIZANT N022399 001 6818787 Nov 8026279 Nov 8048917 Nov
DS DS DS
DP DP DP
NCE
Apr
06, 2016
ADA 87 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP DP DP
EXCLUSIVITY CODE(S)
NCE
GABAPENTIN ENACARBIL - HORIZANT N022399 002 6818787 Nov 8026279 Nov 8048917 Nov
Apr
06, 2016
GADOBENATE DIMEGLUMINE - MULTIHANCE N021357 001 4916246 Apr 10, 2012 GADOBENATE DIMEGLUMINE - MULTIHANCE Apr 10, 2012 N021357 002 4916246 GADOBENATE DIMEGLUMINE - MULTIHANCE N021357 003 4916246 Apr 10, 2012 GADOBENATE DIMEGLUMINE - MULTIHANCE Apr 10, 2012 N021357 004 4916246 GADOBENATE DIMEGLUMINE - MULTIHANCE MULTIPACK Apr 10, 2012 N021358 001 4916246 GADOBENATE DIMEGLUMINE - MULTIHANCE MULTIPACK N021358 002 4916246 Apr 10, 2012 GADOBUTROL - GADAVIST N201277 001 5980864 GADOBUTROL - GADAVIST N201277 002 5980864 GADOBUTROL - GADAVIST N201277 003 5980864 GADOBUTROL - GADAVIST N201277 004 5980864 GADOBUTROL - GADAVIST N201277 005 5980864 GADODIAMIDE - OMNISCAN N020123 001 5362475 5560903 GADODIAMIDE - OMNISCAN N022066 001 5560903 GADODIAMIDE - OMNISCAN N022066 002 5362475 5560903
DS
NPP
Mar
17, 2013
DS
NPP
Mar
17, 2013
DS
NPP
Mar
17, 2013
DS
NPP
Mar
17, 2013
DS
DS
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Nov
09, 2016
DS
DP
U-1119
NCE
Mar
14, 2016
Nov Oct
DS DP
Oct
01, 2013
DP
Nov Oct
DS DP
GADOFOSVESET TRISODIUM - ABLAVAR N021711 001 5362475 Nov 6676929 May Feb 7011815 May 7060250 May 7229606 May 8017105 GADOFOSVESET TRISODIUM - ABLAVAR Nov N021711 002 5362475 May 6676929 Feb 7011815 May 7060250 May 7229606 May 8017105
DS DP U-1112 DS U-1112 DS
NCE
Dec
22, 2013
DS DP U-1112 DS U-1112 DS
NCE
Dec
22, 2013
GADOPENTETATE DIMEGLUMINE - MAGNEVIST N019596 001 5362475 Nov 08, 2011 GADOPENTETATE DIMEGLUMINE - MAGNEVIST N021037 001 5362475 Nov 08, 2011
ADA 88 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-480 U-480
EXCLUSIVITY CODE(S)
GADOTERIDOL - PROHANCE MULTIPACK N021489 001 5474756 Dec 5846519 Dec 6143274 Dec GADOXETATE DISODIUM - EOVIST N022090 001
U-536 U-536
NCE
Jul
03, 2013
GALANTAMINE HYDROBROMIDE - RAZADYNE N021169 001 6099863 Jun 06, 2017 6358527 Jun 06, 2017 GALANTAMINE HYDROBROMIDE - RAZADYNE N021169 002 6099863 Jun 06, 2017 6358527 Jun 06, 2017 GALANTAMINE HYDROBROMIDE - RAZADYNE N021169 003 6099863 Jun 06, 2017 6358527 Jun 06, 2017 GALANTAMINE HYDROBROMIDE - RAZADYNE ER N021615 001 7160559 Dec 20, 2019 GALANTAMINE HYDROBROMIDE - RAZADYNE ER N021615 002 7160559 Dec 20, 2019 GALANTAMINE HYDROBROMIDE - RAZADYNE ER N021615 003 7160559 Dec 20, 2019 GANCICLOVIR - VITRASERT N020569 001 5378475 GANCICLOVIR - ZIRGAN N022211 001 GANIRELIX ACETATE - GANIRELIX ACETATE INJECTION DS N021057 001 4801577 Feb 05, 2012 5767082 Jun 16, 2015 GATIFLOXACIN - ZYMAR N021493 001 5880283 5880283*PED 6333045 6333045*PED GATIFLOXACIN - ZYMAXID N022548 001 5880283 5880283*PED 6333045 6333045*PED GEFITINIB - IRESSA N021399 001 5457105 5616582 5770599
DP
U-322
DP
U-322
DP
U-322
DP
DP
DP
Jan
03, 2012
NDF ODE DP
Sep Sep
DP
DS DS DP
NP
May
18, 2013
DS
DP
U-881
GEMCITABINE HYDROCHLORIDE - GEMCITABINE HYDROCHLORIDE A077983 001 GEMCITABINE HYDROCHLORIDE - GEMCITABINE HYDROCHLORIDE A077983 002 GEMCITABINE HYDROCHLORIDE - GEMZAR Nov N020509 001 5464826 May 5464826*PED
PC
Jul
24, 2011
PC U-146
Jul
24, 2011
ADA 89 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-146
EXCLUSIVITY CODE(S)
GEMCITABINE HYDROCHLORIDE - GEMZAR N020509 002 5464826 Nov 5464826*PED May GEMIFLOXACIN MESYLATE - FACTIVE N021158 001 5633262 Jun 5776944 Apr Jun 5962468 Sep 6262071 Sep 6331550 Sep 6340689 Sep 6455540 Mar 6723734 Sep 6803376 Sep 6803376 GEMTUZUMAB OZOGAMICIN - MYLOTARG Dec N021174 001 5585089 Feb 5606040 Dec 5693762 Apr 5739116 Jun 5767285 Jun 5773001 GLATIRAMER ACETATE - COPAXONE N020622 001 5981589 6054430 6342476 6362161 6620847 6939539 7199098 GLATIRAMER ACETATE - COPAXONE N020622 002 5981589 6054430 6342476 6362161 6620847 6939539 7199098
15, 04, 15, 21, 21, 14, 21, 20, 21, 21,
2015 2017 2015 2019 2019 2019 2019 2018 2019 2019
DS
DS DS DS
DP DP DP
U-608 U-609
U-320
Feb
27, 2012
Feb
27, 2012
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE - DUETACT N021925 001 6150383 Jun 19, 2016 6211205 Jun 19, 2016 6303640 Aug 09, 2016 Jun 19, 2016 6329404 Jun 19, 2016 7538125 Jan 30, 2027 7700128 Jun 08, 2028 8071130 GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE - DUETACT N021925 002 6150383 Jun 19, 2016 6211205 Jun 19, 2016 6303640 Aug 09, 2016 Jun 19, 2016 6329404 Jun 19, 2016 7538125 Jan 30, 2027 7700128 Jun 08, 2028 8071130 GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL N021700 001 5002953 Sep 17, 2011 Sep 17, 2011 5002953 Mar 17, 2012 5002953*PED Apr 21, 2015 5741803 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED
DP DP DP DP
DP DP DP DP
DS DS DS DS DS
DP DP DP DP
ADA 90 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DP DP DP DP U-690 U-781 U-690 U-781
EXCLUSIVITY CODE(S)
GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL N021700 002 5002953 Sep 17, 2011 Sep 17, 2011 5002953 Mar 17, 2012 5002953*PED Apr 21, 2015 5741803 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL N021700 003 5002953 Sep 17, 2011 Sep 17, 2011 5002953 Mar 17, 2012 5002953*PED Apr 21, 2015 5741803 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL N021700 004 5002953 Sep 17, 2011 Mar 17, 2012 5002953*PED Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED GLIMEPIRIDE; ROSIGLITAZONE MALEATE - AVANDARYL N021700 005 5002953 Sep 17, 2011 5002953*PED Mar 17, 2012 7358366 Apr 19, 2020 7358366*PED Oct 19, 2020 GLIPIZIDE - GLUCOTROL XL N020329 001 5591454 GLIPIZIDE - GLUCOTROL XL N020329 002 5591454 GLIPIZIDE - GLUCOTROL XL N020329 003 5591454 GLUTAMINE - NUTRESTORE N021667 001 5288703
DS DS DS DS DS
DP DP DP DP
DS DS
DP
U-840
DS DS
DP
U-840
Jan
07, 2014
U-150
Jan
07, 2014
U-150
Jan
07, 2014
U-111
Oct
07, 2011
U-898
GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE N021178 001 6303146 Jul 14, 2019 6303146*PED Jan 14, 2020 GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE N021178 002 6303146 Jul 14, 2019 6303146*PED Jan 14, 2020 GLYBURIDE; METFORMIN HYDROCHLORIDE - GLUCOVANCE N021178 003 6303146 Jul 14, 2019 6303146*PED Jan 14, 2020 GLYCOPYRROLATE - CUVPOSA N022571 001 7638552 7816396 GLYCOPYRROLATE - ROBINUL N012827 001 7091236
U-412 U-412
U-412 U-412
U-412 U-412
Aug Aug
U-1076 U-1076
NP
Jul
28, 2013
Apr
24, 2024
U-877
GLYCOPYRROLATE - ROBINUL FORTE N012827 002 7091236 Apr GOSERELIN ACETATE - ZOLADEX N019726 001 7118552 7220247 7500964
24, 2024
U-877
DP DP DP
ADA 91 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
GOSERELIN ACETATE - ZOLADEX N020578 001 7118552 7220247 7500964 GRANISETRON - SANCUSO N022198 001 7608282
Oct
22, 2024
DP
U-1011
NE NDF
Sep Sep
GRANISETRON HYDROCHLORIDE - KYTRIL N020239 001 5952340 Sep 6294548 May GRANISETRON HYDROCHLORIDE - KYTRIL N020239 002 5952340 Sep 6294548 May GRANISETRON HYDROCHLORIDE - KYTRIL N020239 003 GRANISETRON HYDROCHLORIDE - KYTRIL N020239 004 5952340 Sep 6294548 May
U-519
M-102
Apr
29, 2014
U-519
M-102
Apr
29, 2014
Apr
29, 2014
M-102
Apr
29, 2014
GREPAFLOXACIN HYDROCHLORIDE - RAXAR N020695 001 5563138 Oct 08, 2013 GUAIFENESIN - MUCINEX N021282 001 6372252 6955821 7838032 GUAIFENESIN - MUCINEX N021282 002 6372252 6955821 7838032
DP DP
U-489 U-489
DP DP
U-489 U-489
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE - MUCINEX D N021585 001 6372252 Apr 28, 2020 DP DP U-686 6955821 Apr 28, 2020 DP 7838032 Apr 28, 2020 GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE - MUCINEX D N021585 002 6372252 Apr 28, 2020 DP DP U-686 6955821 Apr 28, 2020 DP 7838032 Apr 28, 2020 GUANFACINE HYDROCHLORIDE - INTUNIV N022037 001 5854290 Sep 6287599 Dec 6811794 Jul GUANFACINE HYDROCHLORIDE - INTUNIV N022037 002 5854290 Sep 6287599 Dec 6811794 Jul GUANFACINE HYDROCHLORIDE - INTUNIV N022037 003 5854290 Sep 6287599 Dec 6811794 Jul GUANFACINE HYDROCHLORIDE - INTUNIV N022037 004 5854290 Sep 6287599 Dec 6811794 Jul
U-494 DP DP U-494
I-635 NP
Feb Sep
U-494 DP DP U-494
I-635 NP
Feb Sep
U-494 DP DP U-494
I-635 NP
Feb Sep
U-494 DP DP U-494
I-635 NP
Feb Sep
ADA 92 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-1087 U-1087 U-1087 U-1087
EXCLUSIVITY CODE(S)
NP
HEXAMINOLEVULINATE HYDROCHLORIDE - CYSVIEW KIT N022555 001 6034267 Mar 08, 2016 7247655 Mar 08, 2016 7348361 Apr 22, 2019 7530461 Jan 11, 2017 HISTRELIN ACETATE - SUPPRELIN LA N022058 001 8062652 Jun
May
28, 2013
DP DP DP
16, 2026
U-1197
ODE
May
03, 2014
HYALURONIDASE RECOMBINANT HUMAN - HYLENEX RECOMBINANT N021859 001 7767429 Sep 23, 2027 DS DP HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE - BIDIL U-71 N020727 001 6465463 Sep 08, 2020 U-71 6784177 Sep 08, 2020 HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE N020758 001 5270317 Sep 30, 2011 5270317*PED Mar 30, 2012 5994348 Jun 07, 2015 5994348*PED Dec 07, 2015 HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE N020758 002 5270317 Sep 30, 2011 5270317*PED Mar 30, 2012 5994348 Jun 07, 2015 5994348*PED Dec 07, 2015 HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE N020758 003 5270317 Sep 30, 2011 5270317*PED Mar 30, 2012 5994348 Jun 07, 2015 5994348*PED Dec 07, 2015 HYDROCHLOROTHIAZIDE; IRBESARTAN - AVALIDE N020758 004 5270317 Sep 30, 2011 5270317*PED Mar 30, 2012 5994348 Jun 07, 2015 5994348*PED Dec 07, 2015
DS
DP DP
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT DS DP U-500 N021532 002 5616599 Apr 25, 2016 5616599*PED Oct 25, 2016 U-3 6878703 Nov 19, 2021 6878703*PED May 19, 2022 HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT DS DP U-500 N021532 003 5616599 Apr 25, 2016 5616599*PED Oct 25, 2016 U-3 6878703 Nov 19, 2021 6878703*PED May 19, 2022 HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL - BENICAR HCT DS DP U-500 N021532 005 5616599 Apr 25, 2016 5616599*PED Oct 25, 2016 U-3 6878703 Nov 19, 2021 6878703*PED May 19, 2022 HYDROCHLOROTHIAZIDE; TELMISARTAN - MICARDIS HCT DS N021162 001 5591762 Jan 07, 2014 6358986 Jan 10, 2020 HYDROCHLOROTHIAZIDE; TELMISARTAN - MICARDIS HCT DS N021162 002 5591762 Jan 07, 2014 6358986 Jan 10, 2020 HYDROCHLOROTHIAZIDE; TELMISARTAN - MICARDIS HCT DS N021162 003 5591762 Jan 07, 2014
DP
U-3
DP
U-3
DP
U-3
ADA 93 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-3 U-3
EXCLUSIVITY CODE(S)
I-567
HYDROCHLOROTHIAZIDE; VALSARTAN N020818 001 5399578 5399578*PED 6294197 6294197*PED HYDROCHLOROTHIAZIDE; VALSARTAN N020818 002 5399578 5399578*PED 6294197 6294197*PED HYDROCHLOROTHIAZIDE; VALSARTAN N020818 003 5399578 5399578*PED 6294197 6294197*PED HYDROCHLOROTHIAZIDE; VALSARTAN N020818 004 5399578 5399578*PED 6294197 6294197*PED HYDROCHLOROTHIAZIDE; VALSARTAN N020818 005 5399578 5399578*PED 6294197 6294197*PED
Jul
31, 2011
U-3 U-3
I-567
Jul
31, 2011
U-3 U-3
I-567
Jul
31, 2011
U-3 U-3
I-567
Jul
31, 2011
U-3 U-3
I-567
Jul
31, 2011
HYDROCODONE BITARTRATE; IBUPROFEN - VICOPROFEN N020716 001 6348216 Jun 10, 2017 6599531 Jun 10, 2017 HYDROCORTISONE BUTYRATE - LOCOID N022076 001 7378405 Dec 7981877 Jan
DP DP
HYDROCORTISONE BUTYRATE - LOCOID LIPOCREAM N020769 001 5635497 Jun 03, 2014 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019034 003 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019034 004 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019034 005 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019891 001 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019892 001 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019892 002 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID N019892 003 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID-HP N019034 001 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - DILAUDID-HP N019034 002 6589960 Nov 09, 2020 HYDROMORPHONE HYDROCHLORIDE - EXALGO N021217 001 5702725 Jul 07, 2014 5914131 Jul 07, 2014
I-613
Oct
19, 2012
DS
DP
DS
DP
DS
DP
DS
DP
DS
DP
DS
DP
DS
DP
DP
DP
DP DP
U-1043 U-1043
NDF
Mar
01, 2013
ADA 94 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP U-1043 U-1043
EXCLUSIVITY CODE(S)
NDF
HYDROMORPHONE HYDROCHLORIDE - EXALGO N021217 002 5702725 Jul 07, 2014 5914131 Jul 07, 2014 HYDROMORPHONE HYDROCHLORIDE - EXALGO N021217 003 5702725 Jul 07, 2014 5914131 Jul 07, 2014 HYDROMORPHONE HYDROCHLORIDE - PALLADONE N021044 001 5958452 Nov 04, 2014 5965161 Nov 04, 2014 5968551 Dec 24, 2011 6294195 Dec 24, 2011 6335033 Nov 04, 2014 6589960 Nov 09, 2020 6706281 Nov 04, 2014 6743442 Nov 04, 2014 HYDROMORPHONE HYDROCHLORIDE - PALLADONE N021044 002 5958452 Nov 04, 2014 5965161 Nov 04, 2014 5968551 Dec 24, 2011 6294195 Dec 24, 2011 6335033 Nov 04, 2014 6589960 Nov 09, 2020 6706281 Nov 04, 2014 6743442 Nov 04, 2014 HYDROMORPHONE HYDROCHLORIDE - PALLADONE N021044 003 5958452 Nov 04, 2014 5965161 Nov 04, 2014 5968551 Dec 24, 2011 6294195 Dec 24, 2011 6335033 Nov 04, 2014 6589960 Nov 09, 2020 6706281 Nov 04, 2014 6743442 Nov 04, 2014 HYDROMORPHONE HYDROCHLORIDE - PALLADONE N021044 004 5958452 Nov 04, 2014 5965161 Nov 04, 2014 5968551 Dec 24, 2011 6294195 Dec 24, 2011 6335033 Nov 04, 2014 6589960 Nov 09, 2020 6706281 Nov 04, 2014 6743442 Nov 04, 2014 HYDROXOCOBALAMIN - CYANOKIT N022041 001 5834448 HYDROXOCOBALAMIN - CYANOKIT N022041 002 5834448
Mar
01, 2013
DP DP
U-1043 U-1043
NDF
Mar
01, 2013
DP DP DP DP DP DP DP DP
U-616
U-616 U-616
DP DP DP DP DP DP DP DP
U-616
U-616 U-616
DP DP DP DP DP DP DP DP
U-616
U-616 U-616
DP DP DP DP DP DP DP DP
U-616
U-616 U-616
Nov
14, 2016
DP
ODE
Dec
15, 2013
Nov
14, 2016
DP
U-789
ODE
Dec
15, 2013
HYDROXYPROGESTERONE CAPROATE - MAKENA N021945 001 IBANDRONATE SODIUM - BONIVA N021455 001 4927814 4927814 6143326 6294196 IBANDRONATE SODIUM - BONIVA N021455 002 4927814 4927814 6294196 7192938 7410957 7718634
Feb
03, 2018
DS DS
DP DP DP
ADA 95 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP U-700
EXCLUSIVITY CODE(S)
IBANDRONATE SODIUM - BONIVA N021858 001 4927814 5662918 IBUPROFEN - CALDOLOR N022348 001 6727286 IBUPROFEN - CALDOLOR N022348 002 6727286 IBUPROFEN - CHILDREN'S MOTRIN N020516 001 5374659 5374659*PED IBUPROFEN - CHILDREN'S MOTRIN N020603 001 5374659 5374659*PED IBUPROFEN - MIDOL LIQUID GELS N021472 001 6251426 IBUPROFEN - MOTRIN N019842 001 5374659 5374659*PED IBUPROFEN - MOTRIN N020135 001 5320855*PED IBUPROFEN - MOTRIN N020135 002 5320855*PED IBUPROFEN LYSINE - NEOPROFEN N021903 001 6342530 6342530 6344479
Mar Sep
Nov
27, 2021
DP
U-981
NP
Jun
11, 2012
Nov
27, 2021
DP
U-981
NP
Jun
11, 2012
Dec Jun
Dec Jun
Jun
25, 2018
Dec Jun
Dec
14, 2011
Dec
14, 2011
DS
DP DP DP
ODE Y
Apr
13, 2013
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE - CHILDREN'S MOTRIN COLD N021128 001 6211246 Jun 10, 2019 ICATIBANT ACETATE - FIRAZYR N022150 001 5648333 ICODEXTRIN - EXTRANEAL N021321 001 6077836 6248726 ILOPERIDONE - FANAPT N022192 001 RE39198 ILOPERIDONE - FANAPT N022192 002 RE39198 ILOPERIDONE - FANAPT N022192 003 RE39198 ILOPERIDONE - FANAPT N022192 004 RE39198 ILOPERIDONE - FANAPT N022192 005 RE39198 ILOPERIDONE - FANAPT N022192 006 RE39198 ILOPERIDONE - FANAPT N022192 007 RE39198 ILOPROST - VENTAVIS N021779 001
Jul
15, 2014
DS
DP
U-1187
NCE ODE
Aug Aug
Jun Jun
U-495 U-495
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
Nov
15, 2016
DS
DP
U-971
NCE
May
06, 2014
ODE
Dec
29, 2011
ADA 96 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ODE
ILOPROST - VENTAVIS N021779 002 ILOPROST - VENTAVIS N021779 003 IMATINIB MESYLATE - GLEEVEC N021335 001 5521184 5521184*PED 6894051 6894051*PED 6958335 6958335*PED IMATINIB MESYLATE - GLEEVEC N021335 002 5521184 5521184*PED 6894051 6894051*PED 6958335 6958335*PED IMATINIB MESYLATE - GLEEVEC N021588 001 5521184 5521184*PED 6894051 6894051*PED 6958335 6958335*PED 7544799 7544799*PED IMATINIB MESYLATE - GLEEVEC N021588 002 5521184 5521184*PED 6894051 6894051*PED 6958335 6958335*PED 7544799 7544799*PED IMIGLUCERASE - CEREZYME N020367 001 5549892 IMIGLUCERASE - CEREZYME N020367 002 5549892 IMIQUIMOD - ALDARA N020723 001 7696159 7696159 7696159*PED IMIQUIMOD - ZYCLARA N022483 001 IMIQUIMOD - ZYCLARA N022483 002 INDACATEROL MALEATE - ARCAPTA NEOHALER N022383 001 6878721 Oct 10, 2020 INDINAVIR SULFATE - CRIXIVAN N020685 001 5413999 6645961 6689761
Dec
29, 2011
ODE Jan Jul May Nov Dec Jun 04, 04, 23, 23, 19, 19, 2015 2015 2019 2019 2021 2022 DS DS DP DP U-649 U-791
Dec
29, 2011
DS DS
DP DP
DS DS
DP DP U-649 U-791
DS
DP
DS
DP
U-649 U-791
DS
DP
Aug
27, 2013
U-252
Aug
27, 2013
U-252
DS DS
U-1048 U-1047
I-636 NP
Mar Mar
NS DS DP U-1168
Jul
15, 2014
NCE
Jul
01, 2016
U-132 DP U-554
ADA 97 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
U-132 DP U-554
EXCLUSIVITY CODE(S)
INDINAVIR SULFATE - CRIXIVAN N020685 003 5413999 6645961 6689761 INDINAVIR SULFATE - CRIXIVAN N020685 005 5413999 6645961 6689761 INDINAVIR SULFATE - CRIXIVAN N020685 006 5413999 6645961 6689761
U-132 DP U-554
U-132 DP U-554
INDIUM IN-111 PENTETREOTIDE KIT - OCTREOSCAN N020314 001 5384113 Jan 24, 2012 5753627 May 19, 2015 5776894 Jul 07, 2015
DP U-1125 DS DP
INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 50/50 DS DP N021810 001 5547930 Sep 28, 2013 DS DP 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 DP U-471 5834422 Sep 28, 2013 DS DP U-471 5840680 Sep 28, 2013 DP 5866538 Jun 20, 2017 5866538*PED Dec 20, 2017 INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT - NOVOLOG MIX 70/30 DS DP N021172 001 5547930 Sep 28, 2013 DS DP 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 DP U-471 5834422 Sep 28, 2013 DS DP U-471 5840680 Sep 28, 2013 DP 5866538 Jun 19, 2017 INSULIN ASPART RECOMBINANT - NOVOLOG N020986 001 5618913 Jun 07, 2014 5618913*PED Dec 07, 2014 5866538 Jun 20, 2017 5866538*PED Dec 20, 2017 INSULIN DETEMIR RECOMBINANT - LEVEMIR N021536 001 5750497 May 16, 5866538 Jun 20, 6011007 Feb 02, 6869930 Feb 02, INSULIN GLARGINE RECOMBINANT - LANTUS N021081 001 5656722 Aug 12, 5656722*PED Feb 12, 7476652 Jul 23, 7476652*PED Jan 23, 7713930 Jun 13, 7713930*PED Dec 13, 7918833 Sep 23, 7918833*PED Mar 23, INSULIN GLULISINE RECOMBINANT - APIDRA N021629 001 6221633 Jun 18, 6960561 Jan 25, 7452860 Mar 22, 7696162 Mar 22, INSULIN GLULISINE RECOMBINANT - APIDRA N021629 002 6221633 Jun 18, 6960561 Jan 25, 7452860 Mar 22, 7696162 Mar 22,
DS
DP
DS DS DS
DP DP DP DP
DS
DP DP DP DP
U-948
DS
DP DP DP DP
NPP
Oct
24, 2011
DS
DP DP DP DP
NPP
Oct
24, 2011
ADA 98 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP U-471 U-471 U-471
EXCLUSIVITY CODE(S)
NPP
INSULIN GLULISINE RECOMBINANT - APIDRA SOLOSTAR N021629 003 6221633 Jun 18, 2018 DS 6960561 Jan 25, 2023 7452860 Mar 22, 2022 7696162 Mar 22, 2022 7918833 Sep 23, 2027
Oct
24, 2011
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT - HUMALOG MIX 50/50 N021018 001 5461031 Jun 26, 2014 5474978 Jun 16, 2014 5514646 May 07, 2013 5747642 Jun 16, 2014 INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT - HUMALOG MIX 75/25 N021017 001 5461031 Jun 16, 2014 5474978 Jun 16, 2014 5514646 May 07, 2013 5747642 Jun 16, 2014 INSULIN LISPRO RECOMBINANT - HUMALOG N020563 001 5474978 Jun 16, 2014 5514646 May 07, 2013 INSULIN LISPRO RECOMBINANT - HUMALOG PEN N020563 002 5474978 Jun 16, 2014 5514646 May 07, 2013 INSULIN RECOMBINANT HUMAN - EXUBERA N021868 001 5740794 Apr 21, 2015 5997848 Mar 07, 2014 6051256 Mar 07, 2014 6257233 May 14, 2019 6423344 Mar 07, 2014 6543448 Sep 21, 2014 6546929 May 14, 2019 6582728 Jun 24, 2020 6592904 Mar 07, 2014 6685967 Sep 11, 2018 6737045 Mar 07, 2014 INSULIN RECOMBINANT HUMAN - EXUBERA N021868 002 5740794 Apr 21, 2015 5997848 Mar 07, 2014 6051256 Mar 07, 2014 6257233 May 14, 2019 6423344 Mar 07, 2014 6543448 Sep 21, 2014 6546929 May 14, 2019 6582728 Jun 24, 2020 6592904 Mar 07, 2014 6685967 Sep 11, 2018 6737045 Mar 07, 2014 INSULIN RECOMBINANT HUMAN - HUMULIN R N018780 001 INSULIN RECOMBINANT HUMAN - HUMULIN R PEN N018780 005 IOBENGUANE SULFATE I-123 - ADREVIEW N022290 001 IODIXANOL - VISIPAQUE 270 N020351 001 5349085 5366722 RE36418
U-534 U-534
U-534 U-534
NR
Mar
25, 2014
NR
Mar
25, 2014
Sep Sep
DP DP
ADA 99 of 207
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
IODIXANOL - VISIPAQUE 270 N020808 001 5349085 5366722 RE36418 IODIXANOL - VISIPAQUE 320 N020351 002 5349085 RE36418 IODIXANOL - VISIPAQUE 320 N020808 002 5349085 RE36418 IOFLUPANE I-123 - DATSCAN N022454 001
DP DP
Sep Jul
DP
Sep Jul
DP
NCE
Jan
14, 2016
IOPROMIDE - ULTRAVIST (PHARMACY BULK) N021425 002 IOPROMIDE - ULTRAVIST 370 N020220 001 IPRATROPIUM BROMIDE - ATROVENT N021527 001 5676930 5683677 6739333 6983743 IRBESARTAN - AVAPRO N020757 001 5270317 5270317*PED 6342247 6342247*PED IRBESARTAN - AVAPRO N020757 002 5270317 5270317*PED 6342247 6342247*PED IRBESARTAN - AVAPRO N020757 003 5270317 5270317*PED 6342247 6342247*PED HFA Oct Nov May May
I-619
Dec
30, 2012
Dec
30, 2012
IRINOTECAN HYDROCHLORIDE - CAMPTOSAR Apr 28, 2020 N020571 001 6403569 Oct 28, 2020 6403569*PED May 01, 2020 6794370 Nov 01, 2020 6794370*PED IRINOTECAN HYDROCHLORIDE - CAMPTOSAR N020571 002 6403569 Apr 28, 2020 6403569*PED Oct 28, 2020 6794370 May 01, 2020 Nov 01, 2020 6794370*PED IRON DEXTRAN - DEXFERRUM A040024 001 5624668 ITRACONAZOLE - ONMEL N022484 001 6509038 7081255 ITRACONAZOLE - SPORANOX N020083 001 5633015 ITRACONAZOLE - SPORANOX N020657 001 5707975 6407079
U-449 U-606
U-449 U-606
Sep
29, 2015
May May
DP DP
U-1054 U-1054
NP
Apr
29, 2013
May
27, 2014
Jan Jun
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ITRACONAZOLE - SPORANOX N020966 001 6407079 IXABEPILONE - IXEMPRA KIT N022065 001 6670384 6670384 6670384*PED 7022330 7022330*PED 7125899 7125899*PED 7312237 7312237*PED RE41393 RE41393*PED RE41911 RE41911*PED IXABEPILONE - IXEMPRA KIT N022065 002 6670384 6670384 6670384*PED 7022330 7022330*PED 7125899 7125899*PED 7312237 7312237*PED RE41393 RE41393*PED RE41911 RE41911*PED KETOCONAZOLE - EXTINA N021738 001 7553835 KETOCONAZOLE - KETOCONAZOLE A091550 001 KETOCONAZOLE - NIZORAL A-D N020310 001 5456851 KETOCONAZOLE - XOLEGEL N021946 001 7179475
Jun
18, 2019
Jan Jan Jul Jan Jul May Nov Aug Feb Feb Aug May Nov
23, 23, 23, 23, 23, 26, 26, 21, 21, 08, 08, 26, 26,
2022 2022 2022 2022 2022 2018 2018 2024 2025 2022 2022 2018 2018
DP DP DP DS DP
DS
DP
U-961
Jan Jan Jul Jan Jul May Nov Aug Feb Feb Aug May Nov
23, 23, 23, 23, 23, 26, 26, 21, 21, 08, 08, 26, 26,
2022 2022 2022 2022 2022 2018 2018 2024 2025 2022 2022 2018 2018
DP DP DP DS DP
DS
DP
U-961
Oct
19, 2018
DP
U-245
Feb
21, 2012
Dec
04, 2018
DP
U-792
KETOROLAC TROMETHAMINE - ACULAR LS May N021528 001 8008338 KETOROLAC TROMETHAMINE - ACUVAIL Aug N022427 001 7842714 KETOROLAC TROMETHAMINE - SPRIX N022382 001 6333044 Dec 7476689 Oct LACOSAMIDE - VIMPAT N022253 001 5654301 RE38551 LACOSAMIDE - VIMPAT N022253 002 5654301 RE38551 LACOSAMIDE - VIMPAT N022253 003 5654301 RE38551 LACOSAMIDE - VIMPAT N022253 004 5654301 RE38551
24, 2027
U-1181
15, 2029
DS
DP
NP
Jul
22, 2012
DP DP
U-1057 U-1056
NDF
May
14, 2013
Aug Mar
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
Aug Mar
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
Aug Mar
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
Aug Mar
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP U-911 U-911
EXCLUSIVITY CODE(S)
NCE
LACOSAMIDE - VIMPAT N022254 001 5654301 RE38551 LACOSAMIDE - VIMPAT N022255 001 5654301 RE38551 LAMIVUDINE - EPIVIR N020564 001 5905082 5905082*PED LAMIVUDINE - EPIVIR N020564 003 5905082 5905082*PED LAMIVUDINE - EPIVIR N020596 001 6004968 6004968*PED LAMIVUDINE - EPIVIR-HBV N021003 001 5905082 5905082*PED RE39155 RE39155*PED LAMIVUDINE - EPIVIR-HBV N021004 001 6004968 6004968*PED RE39155 RE39155*PED
Aug Mar
Oct
28, 2013
Aug Mar
DS DS
DP DP
U-914 U-914
NCE
Oct
28, 2013
May Nov
DS
DP
U-248
May Nov
Mar Sep
U-250
U-250
LAMIVUDINE; ZIDOVUDINE - COMBIVIR N020857 001 5859021 May May 5905082 Nov 5905082*PED LAMOTRIGINE - LAMICTAL CD N020764 001 5698226 5698226*PED LAMOTRIGINE - LAMICTAL CD N020764 002 5698226 5698226*PED LAMOTRIGINE - LAMICTAL CD N020764 003 5698226 5698226*PED LAMOTRIGINE - LAMICTAL CD N020764 004 5698226 5698226*PED LAMOTRIGINE - LAMICTAL ODT N022251 001 7919115 LAMOTRIGINE - LAMICTAL ODT N022251 002 7919115 LAMOTRIGINE - LAMICTAL ODT N022251 003 7919115 LAMOTRIGINE - LAMICTAL ODT N022251 004 7919115 LAMOTRIGINE - LAMICTAL XR N022115 001
DS DS
DP DP
Jan Jul
Jan Jul
Jan Jul
Jan Jul
Jan
04, 2029
DS
DP
Jan
04, 2029
DS
DP
Jan
04, 2029
DS
DP
Jan
04, 2029
DS
DP
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-644 I-622 NDF PED
LANREOTIDE ACETATE - SOMATULINE DEPOT N022074 001 5595760 Mar 08, 2020
LANREOTIDE ACETATE - SOMATULINE DEPOT N022074 002 5595760 Mar 08, 2020
DP
U-831
LANREOTIDE ACETATE - SOMATULINE DEPOT N022074 003 5595760 Mar 08, 2020
DP
U-831
LANSOPRAZOLE - PREVACID N020406 001 LANSOPRAZOLE - PREVACID N020406 002 LANSOPRAZOLE - PREVACID N021281 001 LANSOPRAZOLE - PREVACID N021281 002
M-85 PED
Oct Apr
M-85 PED
Oct Apr
M-85 PED
Oct Apr
M-85 PED
Oct Apr
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
M-85 PED
LANSOPRAZOLE - PREVACID N021428 001 5464632 5464632*PED 6328994 6328994*PED 7399485 7399485*PED 7431942 7431942*PED 7875292 7875292*PED LANSOPRAZOLE - PREVACID N021428 002 5464632 5464632*PED 6328994 6328994*PED 7399485 7399485*PED 7431942 7431942*PED 7875292 7875292*PED LANSOPRAZOLE - PREVACID 24 HR N022327 001 LANSOPRAZOLE - PREVACID IV N021566 001 7396841 7396841*PED
Nov May May Nov May Nov May Nov May Nov
07, 07, 17, 17, 26, 26, 17, 17, 17, 17,
2012 2013 2019 2019 2018 2018 2019 2019 2019 2019
Oct Apr
DP DP DP
Nov May May Nov May Nov May Nov May Nov
07, 07, 17, 17, 26, 26, 17, 17, 17, 17,
2012 2013 2019 2019 2018 2018 2019 2019 2019 2019
M-85 PED DP DP DP
Oct Apr
May
18, 2012
LANTHANUM CARBONATE - FOSRENOL N021468 001 5968976 Oct 7381428 Aug Aug 7465465 LANTHANUM CARBONATE - FOSRENOL N021468 002 5968976 Oct 7381428 Aug Aug 7465465 LANTHANUM CARBONATE - FOSRENOL N021468 003 5968976 Oct 7381428 Aug Aug 7465465 LANTHANUM CARBONATE - FOSRENOL Oct N021468 004 5968976 Aug 7381428 Aug 7465465 LAPATINIB DITOSYLATE - TYKERB N022059 001 6391874 6713485 6727256 6828320 7157466
DP DP
U-613 U-890
DP DP
U-613 U-890
DP DP
U-613 U-890
DP DP
U-613 U-890
DS DS DS DS
DP DP DP DP
I-620 NCE
Jan Mar
APPL/PROD NO
PATENT NO
PATENT CODES
DS U-866 U-694 U-769 U-694 DP U-694 U-694 U-694 U-694 DP U-1079 DS DS DP DP U-1165
EXCLUSIVITY CODE(S)
ODE ODE
LENALIDOMIDE - REVLIMID N021880 001 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7855217 7968569 LENALIDOMIDE - REVLIMID N021880 002 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7855217 7968569 LENALIDOMIDE - REVLIMID N021880 003 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7968569 LENALIDOMIDE - REVLIMID N021880 004 5635517 6045501 6281230 6315720 6555554 6561976 6561977 6755784 6908432 7119106 7189740 7465800 7855217 7968569 LENALIDOMIDE - REVLIMID N021880 005
Oct Aug Jul Oct Jul Aug Oct Oct Aug Jul Apr Apr Nov Oct
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 22, 24, 07,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2026 2024 2023
Jun Dec
Oct Aug Jul Oct Jul Aug Oct Oct Aug Jul Apr Apr Nov Oct
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 22, 24, 07,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2026 2024 2023
DS
ODE ODE
Jun Dec
DS DS
DP DP U-1165
Oct Aug Jul Oct Jul Aug Oct Oct Aug Jul Apr Apr Oct
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 22, 07,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2026 2023
DS
ODE
Jun
29, 2013
DS
DP U-1165
Oct Aug Jul Oct Jul Aug Oct Oct Aug Jul Apr Apr Nov Oct
04, 28, 24, 23, 24, 28, 23, 23, 28, 24, 11, 22, 24, 07,
2019 2018 2016 2020 2016 2018 2020 2020 2018 2016 2023 2026 2024 2023
DS
ODE
Jun
29, 2013
DS DS
DP DP U-1165
ODE ODE
Dec Jun
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
LEUPROLIDE ACETATE - ELIGARD N021343 001 5324519 5599552 6395293 6565874 6626870 6773714 LEUPROLIDE ACETATE - ELIGARD N021379 001 5324519 5599552 6395293 6565874 6626870 6773714 LEUPROLIDE ACETATE - ELIGARD N021488 001 5324519 5599552 6395293 6565874 6626870 6773714 LEUPROLIDE ACETATE - ELIGARD N021731 001 5599552 6395293 6565874 6626870 6773714
DP DP DP DP
DP DP DP DP
U-801 U-801
DP DP DP DP
U-801 U-801
DP DP DP DP
LEUPROLIDE ACETATE - LUPRON DEPOT N019732 001 5575987 Sep 5631020 May Sep 5716640 Dec 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT Sep N020011 001 5575987 May 5631021 Sep 5716640 LEUPROLIDE ACETATE - LUPRON DEPOT Jan N020517 001 5480656 Sep 5575987 May 5631020 Jan 5643607 Sep 5716640 Dec 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT Jan N020517 002 5480656 Sep 5575987 May 5631020 Jan 5643607 Sep 5716640 Dec 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT N020517 003 6036976 Dec 7429559 Dec LEUPROLIDE ACETATE - LUPRON DEPOT N020708 001 5480656 Jan 5575987 Sep May 5631020 Jan 5643607 Sep 5716640 Dec 6036976
DP DP
D-132 NS
Jun Jun
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
M-107
LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 002 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 003 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 004 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 005 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 006 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED Sep 02, N020263 007 5575987 May 20, 5631020 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - LUPRON DEPOT-PED N020263 008 5480656 Jan 02, 5575987 Sep 02, May 20, 5631020 Jan 02, 5643607 Sep 02, 5716640 Dec 13, 6036976 LEUPROLIDE ACETATE - VIADUR N021088 001 5728396 5932547 5985305 6113938 6124261 6132420 6156331 6235712 6375978 6395292
Oct
08, 2014
M-107
Oct
08, 2014
M-107
Oct
08, 2014
DP DP DP DP
NP
Aug
15, 2014
DP DP DP DP DP DP
NP
Aug
15, 2014
Jan Jun Jan Jul Jun Jan Jan Jun Dec Jan
30, 13, 30, 24, 13, 30, 30, 13, 17, 30,
2017 2017 2017 2018 2017 2017 2017 2017 2018 2017
U-316
LEVALBUTEROL HYDROCHLORIDE - XOPENEX Mar 25, 2013 N020837 001 5362755 Aug 20, 2013 5547994 Mar 21, 2021 6451289 LEVALBUTEROL HYDROCHLORIDE - XOPENEX Mar 25, 2013 N020837 002 5362755 Aug 20, 2013 5547994 Mar 21, 2021 6451289 LEVALBUTEROL HYDROCHLORIDE - XOPENEX N020837 003 5362755 Mar 25, 2013 5547994 Aug 20, 2013 Mar 21, 2021 6451289
U-332 U-332
U-332 U-332
U-332 U-332
APPL/PROD NO
PATENT NO
PATENT CODES
U-332 U-332 DP
EXCLUSIVITY CODE(S)
LEVALBUTEROL HYDROCHLORIDE - XOPENEX N020837 004 5362755 Mar 25, 2013 5547994 Aug 20, 2013 Mar 21, 2021 6451289 LEVALBUTEROL TARTRATE - XOPENEX HFA N021730 001 5362755 Mar 5547994 Aug Feb 5605674 Nov 5836299 Oct 7256310 LEVETIRACETAM - KEPPRA XR N022285 001 7858122 LEVETIRACETAM - KEPPRA XR N022285 002 7858122 LEVETIRACETAM - LEVETIRACETAM A091093 001 LEVETIRACETAM - LEVETIRACETAM A091093 002 LEVETIRACETAM - LEVETIRACETAM A091261 002 LEVETIRACETAM - LEVETIRACETAM A091285 001 LEVETIRACETAM - LEVETIRACETAM A091285 002 LEVETIRACETAM - LEVETIRACETAM A091291 002 LEVETIRACETAM - LEVETIRACETAM A091399 001 LEVETIRACETAM - LEVETIRACETAM A091399 002 LEVETIRACETAM - LEVETIRACETAM A091430 001 LEVETIRACETAM - LEVETIRACETAM A091430 002 LEVETIRACETAM - LEVETIRACETAM A091557 001 LEVETIRACETAM - LEVETIRACETAM A091557 002 LEVOBETAXOLOL HYDROCHLORIDE - BETAXON N021114 001 5540918 Jul 30, 2013 5540918*PED Jan 30, 2014 LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE N020997 001 5708011 Oct 13, 2014 LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE N020997 002 5708011 Oct 13, 2014 LEVOBUPIVACAINE HYDROCHLORIDE - CHIROCAINE N020997 003 5708011 Oct 13, 2014 LEVOCARNITINE - CARNITOR N020182 001 6335369 6429230 6696493
U-636 U-636 DP DP DP
DS
U-636
Sep
17, 2028
DP
NDF
Sep
12, 2011
Sep
17, 2028
DP
NDF
Sep
12, 2011
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC
Mar
10, 2012
PC DP
Mar
10, 2012
U-276
U-276
U-276
APPL/PROD NO
PATENT NO
PATENT CODES
U-812
EXCLUSIVITY CODE(S)
NPP PED
LEVOCETIRIZINE DIHYDROCHLORIDE - XYZAL Sep 24, 2012 N022064 001 5698558 Mar 24, 2013 5698558*PED LEVOCETIRIZINE DIHYDROCHLORIDE - XYZAL Sep 24, 2012 N022157 001 5698558 Mar 24, 2013 5698558*PED LEVOFLOXACIN - LEVAQUIN N021721 001 6806256 6806256*PED
Aug Feb
U-852
NPP PED
Aug Feb
Feb Aug
DP
31, 2019
DS
DP
31, 2019
DS
DP
31, 2019
DS
DP
Dec
05, 2015
DP
I-610
Oct
01, 2012
LEVONORGESTREL - PLAN B ONE-STEP N021998 001 LEVOTHYROXINE SODIUM - LEVO-T N021342 001 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 002 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 003 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 004 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 005 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 006 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 007 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 008 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 009 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 010 6399101 LEVOTHYROXINE SODIUM - LEVO-T N021342 011 6399101
NP 30, 2020
Jul
10, 2012
Mar
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
Mar
30, 2020
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 001 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL N021301 002 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 003 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL N021301 004 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 005 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 006 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL N021301 007 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 008 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 009 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL N021301 010 6555581 Feb 7067148 Feb 7101569 Aug LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 011 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - LEVOXYL Feb N021301 012 6555581 Feb 7067148 Aug 7101569 LEVOTHYROXINE SODIUM - TIROSINT N021924 002 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 003 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 004 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 005 7723390 Mar
DP U-759
DP U-759
DP U-759
DP U-759
DP U-759
DP U-759
DP U-759
DP U-759
DP U-759
DP U-759
DP U-759
DP U-759
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
APPL/PROD NO
PATENT NO
PATENT CODES
DP
EXCLUSIVITY CODE(S)
LEVOTHYROXINE SODIUM - TIROSINT N021924 006 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 007 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 008 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 009 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N021924 010 7723390 Mar LEVOTHYROXINE SODIUM - TIROSINT N022121 001 7723390 Mar LIDOCAINE - DENTIPATCH N020575 001 5332576 LIDOCAINE - DENTIPATCH N020575 002 5332576 LIDOCAINE - LIDODERM N020612 001 5411738 5601838 5741510 5827529 LIDOCAINE HYDROCHLORIDE - AKTEN N022221 001 LIDOCAINE HYDROCHLORIDE - ZINGO May N022114 001 5630796 May 5899880 Mar 6004286 Jun 6881200 LIDOCAINE; PRILOCAINE - ORAQIX Apr N021451 001 6031007
14, 2024
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
14, 2024
DP
Jul
26, 2011
Jul
26, 2011
U-488 DP U-486
Oct
07, 2011
NPP DP DP DP
Jan
08, 2012
01, 2017
DP
U-553
LIDOCAINE; TETRACAINE - LIDOCAINE AND TETRACAINE N021717 001 5919479 Jul 28, 2015 6528086 Sep 28, 2019 LIDOCAINE; TETRACAINE - SYNERA N021623 001 5658583 Jul 5919479 Jul 6306431 Jul 6465006 Jul 6546281 Jul 6780426 Jul LINAGLIPTIN - TRADJENTA N201280 001 6303661 6890898 7078381 7407955 7459428 LINEZOLID - ZYVOX N021130 001 5688792 5688792*PED 6514529 6514529*PED 6559305 6559305*PED
DP DP
DP DP DP DP DP DP
NCE
May
02, 2016
DS DP DS
U-319
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DS U-319
EXCLUSIVITY CODE(S)
LINEZOLID - ZYVOX N021130 002 5688792 5688792*PED 6514529 6514529*PED 6559305 6559305*PED LINEZOLID - ZYVOX N021131 001 5688792 5688792*PED 6559305 6559305*PED LINEZOLID - ZYVOX N021132 001 5688792 5688792*PED 6559305 6559305*PED
U-319 DS
DS DS
U-319
LIRAGLUTIDE RECOMBINANT - VICTOZA N022341 001 6268343 Aug Aug 6458924 Aug 7235627
DS DS DS
DP DP DP
U-968 U-968
NCE
Jan
25, 2015
LISDEXAMFETAMINE DIMESYLATE - VYVANSE N021977 001 7105486 Jun 29, 7223735 Jun 29, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7671030 Feb 24, 7671031 Feb 28, 7674774 Mar 18, 7678770 Mar 25, 7678771 Mar 25, 7687466 Feb 24, 7687467 Apr 08, Jun 29, 7700561 Feb 24, 7718619 Feb 24, 7723305 LISDEXAMFETAMINE DIMESYLATE - VYVANSE Jun 29, N021977 002 7105486 Jun 29, 7223735 Feb 24, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7671030 Feb 28, 7671031 Mar 18, 7674774 Mar 25, 7678770 Mar 25, 7678771 Feb 24, 7687466 Apr 08, 7687467 Jun 29, 7700561 Feb 24, 7718619 Feb 24, 7723305
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
U-727 DP DS DS DS DP DP DP DP DP DP DP DP U-727 U-727 U-842 U-842 U-842 U-842 U-842 U-842 DP U-727 U-1034
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
U-727 DP DS DS DS DP DP DP DP DP DP DP DP U-727 U-727 U-842 U-842 U-842 U-842 U-842 U-842 DP U-727 U-1034
APPL/PROD NO
PATENT NO
PATENT CODES
U-727 DP DS DS DS DP DP DP DP DP DP DP DP U-727 U-727 U-842 U-842 U-842 U-842 U-842 U-842 DP U-727 U-1034
EXCLUSIVITY CODE(S)
M-82 NPP NCE
LISDEXAMFETAMINE DIMESYLATE - VYVANSE Jun 29, N021977 003 7105486 Jun 29, 7223735 Feb 24, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7671030 Feb 28, 7671031 Mar 18, 7674774 Mar 25, 7678770 Mar 25, 7678771 Feb 24, 7687466 Apr 08, 7687467 Jun 29, 7700561 Feb 24, 7718619 Feb 24, 7723305 LISDEXAMFETAMINE DIMESYLATE - VYVANSE N021977 004 7105486 Jun 29, 7223735 Jun 29, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7671031 Feb 28, 7678770 Mar 25, 7687466 Feb 24, 7700561 Jun 29, LISDEXAMFETAMINE DIMESYLATE - VYVANSE Jun 29, N021977 005 7105486 Jun 29, 7223735 Feb 24, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7671030 Feb 28, 7671031 Mar 18, 7674774 Mar 25, 7678770 Mar 25, 7678771 Feb 24, 7687466 Apr 08, 7687467 Jun 29, 7700561 Feb 24, 7718619 Feb 24, 7723305 LISDEXAMFETAMINE DIMESYLATE - VYVANSE N021977 006 7105486 Jun 29, 7223735 Jun 29, 7655630 Feb 24, 7659253 Feb 24, 7659254 Feb 24, 7662787 Feb 24, 7671030 Feb 24, 7671031 Feb 28, 7674774 Mar 18, 7678770 Mar 25, 7678771 Mar 25, 7687466 Feb 24, 7687467 Apr 08, Jun 29, 7700561 Feb 24, 7718619 Feb 24, 7723305 LODOXAMIDE TROMETHAMINE - ALOMIDE N020191 001 5457126 Oct
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
U-842 DP DS DS DS DP DP DP DP DP DP DP DP U-727 U-727 U-842 U-842 U-842 U-842 U-842 U-842 DP U-727 U-1034
2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023 2023
U-842 DP DS DS DS DP DP DP DP DP DP DP DP U-727 U-727 U-842 U-842 U-842 U-842 U-842 U-842 DP U-727 U-1034
10, 2012
U-117
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP
EXCLUSIVITY CODE(S)
LOPERAMIDE HYDROCHLORIDE - IMODIUM A-D EZ CHEWS N020448 001 5489436 Feb 06, 2013 6814978 Aug 26, 2021 LOPERAMIDE HYDROCHLORIDE; SIMETHICONE N020606 001 5489436 Feb 06, 5679376 Oct 21, 5716641 May 21,
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE - IMODIUM MULTI-SYMPTOM RELIEF N021140 001 6103260 Jul 17, 2017 DP LOPINAVIR; RITONAVIR - KALETRA N021226 001 5541206 5541206*PED 5648497 5648497*PED 5886036 5886036*PED 5914332 5914332*PED 5948436 5948436*PED 6037157 6037157*PED 6232333 6232333*PED 6284767 6284767 6284767*PED 6458818 6458818*PED 6521651 6521651*PED 6703403 6703403*PED 7141593 7141593*PED 7432294 7432294*PED LOPINAVIR; RITONAVIR - KALETRA N021251 001 5484801 5484801*PED 5541206 5541206 5541206*PED 5648497 5648497*PED 5886036 5886036*PED 5914332 5914332 5914332*PED 5948436 5948436*PED 6037157 6037157 6037157*PED 6284767 6284767 6284767*PED 6703403 6703403 6703403*PED 6911214 6911214*PED
Jul Jan Jul Jan Nov May Dec Jun Sep Mar Jun Dec Nov May Feb Feb Aug Nov May Nov May Jun Dec May Nov May Nov
30, 30, 15, 15, 19, 19, 13, 13, 13, 13, 26, 26, 07, 07, 15, 15, 15, 07, 07, 07, 07, 26, 26, 22, 22, 22, 22,
2013 2014 2014 2015 2013 2014 2015 2016 2013 2014 2016 2016 2017 2018 2016 2016 2016 2017 2018 2017 2018 2016 2016 2020 2020 2020 2020
DS
U-348
DS
DP U-351 DP U-346
DP DP
U-688 U-401
DP U-257 DP DP
Jan Jul Jul Jul Jan Jul Jan Nov May Dec Dec Jun Sep Mar Jun Jun Dec Feb Feb Aug Jun Jun Dec Nov May
28, 28, 30, 30, 30, 15, 15, 19, 19, 13, 13, 13, 13, 13, 26, 26, 26, 15, 15, 15, 26, 26, 26, 28, 28,
2014 2014 2013 2013 2014 2014 2015 2013 2014 2015 2015 2016 2013 2014 2016 2016 2016 2016 2016 2016 2016 2016 2016 2021 2022
DP DS DS DS DS DS DS DP DP DP DP U-895 U-346 DP DP U-895 U-401 U-257 U-895 DP U-895 U-895 U-895 U-351 DP DP U-348 U-895
D-124
Apr
27, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DP DP DP DP U-895 U-688 U-688 DP U-688 U-688 DP DP DP U-688 U-688
EXCLUSIVITY CODE(S)
D-124
LOPINAVIR; RITONAVIR - KALETRA N021906 001 5541206 5541206*PED 5648497 5648497*PED 5886036 5886036*PED 5914332 5914332*PED 6037157 6037157*PED 6284767 6284767*PED 6703403 6703403*PED 7148359 7148359*PED 7364752 7364752*PED 8025899 8025899*PED LOPINAVIR; RITONAVIR - KALETRA N021906 002 5541206 5541206*PED 5648497 5648497*PED 5886036 5886036*PED 5914332 5914332*PED 6037157 6037157*PED 6284767 6284767*PED 6703403 6703403*PED 7148359 7148359*PED 7364752 7364752*PED 8025899 8025899*PED LORATADINE - CLARITIN N020641 002 6132758
Jul Jan Jul Jan Nov May Dec Jun Jun Dec Feb Aug Jun Dec Jul Jan Nov May Sep Mar
30, 30, 15, 15, 19, 19, 13, 13, 26, 26, 15, 15, 26, 26, 19, 19, 10, 10, 26, 26,
2013 2014 2014 2015 2013 2014 2015 2016 2016 2016 2016 2016 2016 2016 2019 2020 2020 2021 2027 2028
Apr
27, 2013
Jul Jan Jul Jan Nov May Dec Jun Jun Dec Feb Aug Jun Dec Jul Jan Nov May Sep Mar
30, 30, 15, 15, 19, 19, 13, 13, 26, 26, 15, 15, 26, 26, 19, 19, 10, 10, 26, 26,
2013 2014 2014 2015 2013 2014 2015 2016 2016 2016 2016 2016 2016 2016 2019 2020 2020 2021 2027 2028
DS DS DS DS
DP DP DP DP
U-688
D-124
Apr
27, 2013
DP
U-688 U-688
DP DP DP U-688
Jun
01, 2018
LORATADINE; PSEUDOEPHEDRINE SULFATE - CLARITIN-D 24 HOUR N020470 002 5314697 Oct 23, 2012 LOTEPREDNOL ETABONATE - ALREX N020803 001 4996335 4996335*PED 5540930 5540930*PED 5747061 5747061*PED
DP
U-576
LOTEPREDNOL ETABONATE - LOTEMAX N020583 001 4996335 Mar 4996335*PED Sep 5540930 Oct 5540930*PED Apr 5747061 Oct 5747061*PED Apr LOTEPREDNOL ETABONATE - LOTEMAX N020841 001 5540930 Oct
DP
U-575
25, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NDF PED
LOTEPREDNOL ETABONATE - LOTEMAX N200738 001 LOTEPREDNOL ETABONATE; TOBRAMYCIN N050804 001 4996335 Mar 4996335*PED Sep Oct 5540930 Apr 5540930*PED Oct 5747061 Apr 5747061*PED LOVASTATIN - ALTOPREV N021316 001 5916595 6080778 6485748 LOVASTATIN - ALTOPREV N021316 002 5916595 6080778 6485748 LOVASTATIN - ALTOPREV N021316 003 5916595 6080778 6485748 LOVASTATIN - ALTOPREV N021316 004 5916595 6080778 6485748 LOVASTATIN; NIACIN - ADVICOR N021249 001 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7998506 7998506 7998506 ZYLET 09, 2012 09, 2012 25, 2013 25, 2014 25, 2013 25, 2014
Apr Oct
DS
DP DP DP
U-920
U-920
U-456 DP
U-456 DP
U-456 DP
U-456 DP
May May May May Sep Sep Sep Sep Sep Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 20, 20, 20, 20, 20, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2013 2013 2013 2013 2013 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP
DP DP
U-1134 U-1133 U-447 U-1132 U-1134 U-1133 U-448 U-1132 U-450 U-1131 U-768 U-1130 U-1129 U-548 U-1133 U-1132 U-1134 U-586 U-1136 U-1137 U-712 U-1135 U-1135 U-1136 U-1137
APPL/PROD NO
PATENT NO
PATENT CODES
U-1134 U-1132 U-1133 U-447 U-448 U-1132 U-1134 U-1133 U-450 U-1129 U-768 U-1131 U-1130 U-1134 U-548 U-1133 U-1132 U-586 U-712 U-1135 U-1137 U-1136 U-1135 U-1136 U-1137
EXCLUSIVITY CODE(S)
LOVASTATIN; NIACIN - ADVICOR N021249 002 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7998506 7998506 7998506 LOVASTATIN; NIACIN - ADVICOR N021249 003 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7998506 7998506 7998506
May May May May Sep Sep Sep Sep Sep Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 20, 20, 20, 20, 20, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2013 2013 2013 2013 2013 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP
DP DP
May May May May Sep Sep Sep Sep Sep Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 20, 20, 20, 20, 20, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2013 2013 2013 2013 2013 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP
DP DP
U-1133 U-1134 U-447 U-1132 U-1133 U-1134 U-1132 U-448 U-450 U-1131 U-1129 U-768 U-1130 U-1132 U-1134 U-1133 U-548 U-586 U-1136 U-712 U-1137 U-1135 U-1135 U-1137 U-1136
APPL/PROD NO
PATENT NO
PATENT CODES
U-1134 U-1132 U-1133 U-447 U-1133 U-1132 U-1134 U-448 U-1130 U-1129 U-1131 U-768 U-548 U-1132 U-1134 U-1133 U-586 U-1137 U-712 U-1136 U-1135 U-1135 U-1136 U-1137
EXCLUSIVITY CODE(S)
LOVASTATIN; NIACIN - ADVICOR N021249 004 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7998506 7998506 7998506 LUBIPROSTONE - AMITIZA N021908 001 5284858 6414016 6583174 7064148 7417067 8026393 8071613 8088934 LUBIPROSTONE - AMITIZA N021908 002 5284858 6414016 6583174 7064148 7064148 7417067 7795312 8026393 8071613 8088934
May May May May Sep Sep Sep Sep Sep Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 20, 20, 20, 20, 20, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2013 2013 2013 2013 2013 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP
DP DP
Jul Sep Oct Aug Aug Oct Sep Oct Sep May
14, 05, 16, 30, 30, 16, 17, 25, 05, 18,
2014 2020 2020 2022 2022 2020 2024 2027 2020 2021
LURASIDONE HYDROCHLORIDE - LATUDA N200603 001 5532372 Jul LURASIDONE HYDROCHLORIDE - LATUDA N200603 002 5532372 Jul LUTROPIN ALFA - LUVERIS N021322 001 5767251
02, 2013
DS
NCE
Oct
28, 2015
02, 2013
DS
NCE
Oct
28, 2015
Jun
16, 2015
DS
ODE
Oct
08, 2011
MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - NORMOCARB HF 25 N021910 001 5945449 Oct 31, 2017 DP U-785 7300674 Mar 04, 2023 DP U-785 MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - NORMOCARB HF 35 N021910 002 5945449 Oct 31, 2017 DP U-785
ODE
Jul
26, 2013
ODE
Jul
26, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE N022456 001 6489346 Jul 16, 6489346 Jul 16, 6645988 Jul 16, 6699885 Jul 16, 6699885 Jul 16, 7399772 Jul 16, 7399772 Jul 16, MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE N022456 002 6489346 Jul 16, 6489346 Jul 16, 6645988 Jul 16, 6699885 Jul 16, 6699885 Jul 16, 7399772 Jul 16, 7399772 Jul 16, MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM N021850 001 6489346 Jul 16, 6645988 Jul 16, 6699885 Jul 16, 7399772 Jul 16, MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM N021850 002 6489346 Jul 16, 6645988 Jul 16, 6699885 Jul 16, 7399772 Jul 16,
BICARBONATE - MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM 2016 2016 2016 2016 2016 2016 2016 DP DP DP DP DP DP DP U-588 U-1021 U-588 U-1021 U-1021 U-588
BICARBONATE - MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM 2016 2016 2016 2016 2016 2016 2016 DP DP DP DP DP DP DP U-1021 U-588 U-588 U-1021 U-588 U-1021
BICARBONATE - ZEGERID 2016 DS DP U-588 DS DP U-588 2016 U-588 2016 2016 U-588 BICARBONATE - ZEGERID 2016 DS DP U-623 DS DP U-623 2016 2016 U-623 U-623 2016
MAGNESIUM SULFATE ANHYDROUS; POTASSIUM SULFATE; SODIUM SULFATE - SUPREP BOWEL PREP KIT N022372 001 6946149 Apr 30, 2022 DP U-837 NC MALATHION - OVIDE N018613 001 7560445 7977324
Aug
05, 2013
Feb Aug
DS
DP DP
U-986
MANGAFODIPIR TRISODIUM - TESLASCAN N020652 001 4933456 Nov MANNITOL - ARIDOL KIT N022368 001 5817028 MARAVIROC - SELZENTRY N022128 001 6586430 6667314 7368460 7576097 MARAVIROC - SELZENTRY N022128 002 6586430 6667314 7368460 7576097
27, 2011
Feb
23, 2015
U-1091
NP
Oct
05, 2013
DS DS DS
DP DP
NPP NCE
May Aug
DS DS DS
DP DP
NPP NCE
May Aug
MECASERMIN RECOMBINANT - INCRELEX N021839 001 5681814 Sep 5824642 Jul 6207640 Apr
DP U-681 U-681
ODE
Aug
30, 2012
MECASERMIN RINFABATE RECOMBINANT - IPLEX N021884 001 5681818 Oct 28, 2014 MEDROXYPROGESTERONE ACETATE - DEPO-SUBQ PROVERA 104 DP N021583 001 6495534 May 15, 2020 MEGESTROL ACETATE - MEGACE N020264 001 5338732
U-697
ODE
Dec
12, 2012
Aug
16, 2011
APPL/PROD NO
PATENT NO
PATENT CODES
DP U-755
EXCLUSIVITY CODE(S)
MEGESTROL ACETATE - MEGACE ES N021778 001 6592903 7101576 MELOXICAM - MOBIC N020938 001 MELOXICAM - MOBIC N020938 002 MELOXICAM - MOBIC N021530 001 6184220 6184220*PED
Sep Apr
ODE PED
Aug Feb
Aug Feb
Aug Feb
MEMANTINE HYDROCHLORIDE - NAMENDA N021487 001 5061703 Apr MEMANTINE HYDROCHLORIDE - NAMENDA Apr N021487 002 5061703 MEMANTINE HYDROCHLORIDE - NAMENDA Apr N021627 001 5061703
11, 2015
11, 2015
U-539
11, 2015
U-539
MEMANTINE HYDROCHLORIDE - NAMENDA XR N022525 001 5061703 Apr 11, 2015 8039009 Mar 24, 2029 MEMANTINE HYDROCHLORIDE - NAMENDA XR Apr 11, 2015 N022525 002 5061703 Mar 24, 2029 8039009 MEMANTINE HYDROCHLORIDE - NAMENDA XR Apr 11, 2015 N022525 003 5061703 Mar 24, 2029 8039009 MEMANTINE HYDROCHLORIDE - NAMENDA XR Apr 11, 2015 N022525 004 5061703 Mar 24, 2029 8039009 MEQUINOL; TRETINOIN - SOLAGE N020922 001 5194247 6353029 MESALAMINE - APRISO N022301 001 6551620 MESALAMINE - ASACOL N019651 001 5541170 5541171 MESALAMINE - ASACOL HD N021830 001 5541170 5541171 6893662 MESALAMINE - LIALDA N022000 001 6773720 MESALAMINE - SFROWASA N019618 002 7645801 MESNA - MESNEX N020855 001 5252341 5262169 METAXALONE - SKELAXIN N013217 001 6407128 6683102
U-539 U-539
NDF
Jun
21, 2013
U-539 U-539
NDF
Jun
21, 2013
U-539 U-539
NDF
Jun
21, 2013
U-539 U-539
NDF
Jun
21, 2013
Dec Aug
DP
U-294
Apr
20, 2018
DS
DP
U-907
NP
Oct
31, 2011
Jul Jul
U-141 U-141
DP DP DP
Jun
08, 2020
DP
I-640
Jul
14, 2014
Jul
24, 2027
DS
DP
Jul Jul
Dec Dec
U-189 U-189
APPL/PROD NO
PATENT NO
PATENT CODES
U-189 U-189 U-915 U-1050
EXCLUSIVITY CODE(S)
METFORMIN HYDROCHLORIDE - FORTAMET N021574 001 6099859 Mar 6495162 Mar 6790459 Mar 6866866 Mar 7919116 Mar METFORMIN HYDROCHLORIDE - FORTAMET N021574 002 6099859 Mar 6495162 Mar 6790459 Mar 6866866 Mar 7919116 Mar
DP DP U-604 DP DP
DP DP U-604 DP DP
METFORMIN HYDROCHLORIDE - GLUCOPHAGE XR N021202 001 6475521 Mar 19, 2018 6660300 Mar 19, 2018 METFORMIN HYDROCHLORIDE - GLUCOPHAGE XR N021202 004 6475521 Mar 19, 2018 6660300 Mar 19, 2018 METFORMIN HYDROCHLORIDE - GLUMETZA N021748 001 6340475 Sep 6488962 Jun 6635280 Sep Oct 6723340 METFORMIN HYDROCHLORIDE - GLUMETZA N021748 002 6488962 Jun 7780987 Mar
U-542
U-542
DS DS DS DS
DP DP DP DP
U-669
DS DS
DP DP
METFORMIN HYDROCHLORIDE - METFORMIN HYDROCHLORIDE A090692 001 METFORMIN HYDROCHLORIDE - METFORMIN HYDROCHLORIDE A090692 002 METFORMIN HYDROCHLORIDE - RIOMET Sep N021591 001 6890957
PC
Mar
28, 2012
PC DP
Mar
28, 2012
14, 2023
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - ACTOPLUS MET N021842 001 5965584 DP U-1055 Jun 19, 2016 U-679 6166042 Jun 19, 2016 U-679 6166043 Jun 19, 2016 U-679 6172090 Jun 19, 2016 METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE - ACTOPLUS MET DP U-1055 N021842 002 5965584 Jun 19, 2016 U-679 6166042 Jun 19, 2016 U-679 6166043 Jun 19, 2016 U-679 6172090 Jun 19, 2016
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE N022024 001 5965584 Jun 19, 2016 6099859 Mar 20, 2018 6166042 Jun 19, 2016 6166043 Jun 19, 2016 6172090 Jun 19, 2016 6495162 Mar 20, 2018 6790459 Mar 17, 2021 6866866 Mar 17, 2021 7785627 Jul 31, 2026 7919116 Mar 20, 2018 7919116 Mar 20, 2018 7959946 Jul 31, 2026 METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE N022024 002 5965584 Jun 19, 2016 6099859 Mar 20, 2018 6166042 Jun 19, 2016 6166043 Jun 19, 2016 6172090 Jun 19, 2016 6495162 Mar 20, 2018 6790459 Mar 17, 2021 6866866 Mar 17, 2021 7785627 Jul 31, 2026 7919116 Mar 20, 2018 7919116 Mar 20, 2018 7959946 Jul 31, 2026 METFORMIN HYDROCHLORIDE; REPAGLINIDE - PRANDIMET N022386 001 6677358 Jun 12, 2018 METFORMIN HYDROCHLORIDE; REPAGLINIDE - PRANDIMET N022386 002 6677358 Jun 12, 2018
- ACTOPLUS MET XR DP U-973 DP U-973 U-973 U-973 DP U-974 DP DP U-973 U-1120 DP - ACTOPLUS MET XR DP U-973 DP U-973 U-973 U-973 DP U-974 DP DP U-973 U-1120 DP
DP
U-546
DP
U-546
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET DS DP U-493 N021410 001 5002953 Sep 17, 2011 Sep 17, 2011 DS DP U-690 5002953 DS DP U-691 Sep 17, 2011 5002953 Sep 17, 2011 DS DP U-734 5002953 Mar 17, 2012 5002953*PED DS DP U-734 Apr 21, 2015 5741803 DS DP U-493 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED U-493 Jun 19, 2016 5965584 U-493 Jun 19, 2016 6166042 U-493 Feb 11, 2017 6288095 Aug 11, 2017 6288095*PED Apr 19, 2020 DS 7358366 Oct 19, 2020 7358366*PED METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET DS DP U-690 N021410 002 5002953 Sep 17, 2011 5002953 Sep 17, 2011 DS DP U-691 Sep 17, 2011 DS DP U-734 5002953 DS DP U-493 Sep 17, 2011 5002953 Mar 17, 2012 5002953*PED DS DP U-493 Apr 21, 2015 5741803 Apr 21, 2015 DS DP U-734 5741803 Oct 21, 2015 5741803*PED Jun 19, 2016 U-493 5965584 U-493 Jun 19, 2016 6166042 U-493 Feb 11, 2017 6288095 Aug 11, 2017 6288095*PED DS Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED
Y Y Y Y Y
Y Y Y Y Y
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET DS DP U-493 N021410 003 5002953 Sep 17, 2011 Sep 17, 2011 DS DP U-691 5002953 DS DP U-690 Sep 17, 2011 5002953 Sep 17, 2011 DS DP U-734 5002953 Mar 17, 2012 5002953*PED DS DP U-493 Apr 21, 2015 5741803 DS DP U-734 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED U-493 Jun 19, 2016 5965584 U-493 Jun 19, 2016 6166042 U-493 Feb 11, 2017 6288095 Aug 11, 2017 6288095*PED Apr 19, 2020 DS 7358366 Oct 19, 2020 7358366*PED METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET DS DP U-690 N021410 004 5002953 Sep 17, 2011 Sep 17, 2011 DS DP U-691 5002953 Sep 17, 2011 DS DP U-734 5002953 DS DP U-493 Sep 17, 2011 5002953 Mar 17, 2012 5002953*PED DS DP U-493 Apr 21, 2015 5741803 DS DP U-734 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED DS Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE - AVANDAMET N021410 005 5002953 Sep 17, 2011 DS DP U-493 DS DP U-691 5002953 Sep 17, 2011 Sep 17, 2011 DS DP U-690 5002953 DS DP U-734 Sep 17, 2011 5002953 Mar 17, 2012 5002953*PED DS DP U-493 Apr 21, 2015 5741803 DS DP U-734 Apr 21, 2015 5741803 Oct 21, 2015 5741803*PED DS Apr 19, 2020 7358366 Oct 19, 2020 7358366*PED METFORMIN HYDROCHLORIDE; SAXAGLIPTIN - KOMBIGLYZE XR N200678 001 6395767 Feb 16, 2021 DS DP METFORMIN HYDROCHLORIDE; SAXAGLIPTIN - KOMBIGLYZE XR DS DP N200678 002 6395767 Feb 16, 2021 METFORMIN HYDROCHLORIDE; SAXAGLIPTIN - KOMBIGLYZE XR DS DP N200678 003 6395767 Feb 16, 2021
Y Y Y Y Y
Y Y
Y Y
U-1097
NCE
Jul
31, 2014
U-1097
NCE
Jul
31, 2014
U-1097
NCE
Jul
31, 2014
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET U-802 N022044 001 6303661 Apr 24, 2017 DS DP U-802 6699871 Jul 26, 2022 U-803 6890898 Feb 02, 2019 U-1036 6890898 Feb 02, 2019 U-1038 6890898 Feb 02, 2019 U-803 7078381 Feb 02, 2019 U-1038 7078381 Feb 02, 2019 U-1036 7078381 Feb 02, 2019 DP U-1038 7125873 Jul 26, 2022 DP U-1036 7125873 Jul 26, 2022 DP U-803 7125873 Jul 26, 2022 DS DP U-802 7326708 Apr 11, 2026
NCE
Oct
16, 2011
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NCE
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE - JANUMET U-802 N022044 002 6303661 Apr 24, 2017 DS DP U-802 6699871 Jul 26, 2022 U-803 6890898 Feb 02, 2019 U-1038 6890898 Feb 02, 2019 6890898 Feb 02, 2019 U-1036 U-1038 7078381 Feb 02, 2019 U-1036 7078381 Feb 02, 2019 U-803 7078381 Feb 02, 2019 DP U-1036 7125873 Jul 26, 2022 7125873 Jul 26, 2022 DP U-1038 DP U-803 7125873 Jul 26, 2022 DS DP U-802 7326708 Apr 11, 2026 METHYL AMINOLEVULINATE HYDROCHLORIDE - METVIXIA N021415 001 6034267 Mar 08, 2016 METHYLNALTREXONE BROMIDE - RELISTOR N021964 001 6559158 Nov 03, 2017 METHYLNALTREXONE BROMIDE - RELISTOR N021964 002 6559158 Nov 03, 2017 METHYLPHENIDATE - DAYTRANA N021514 001 5958446 6210705 6348211 METHYLPHENIDATE - DAYTRANA N021514 002 5958446 6210705 6348211 METHYLPHENIDATE - DAYTRANA N021514 003 5958446 6210705 6348211 METHYLPHENIDATE - DAYTRANA N021514 004 5958446 6210705 6348211
Oct
16, 2011
U-804
U-1185
NCE
Apr
24, 2013
U-1185
NCE
Apr
24, 2013
DP DP DP
Jun
29, 2013
DP DP DP
Jun
29, 2013
DP DP DP
Jun
29, 2013
DP DP DP
Jun
29, 2013
METHYLPHENIDATE HYDROCHLORIDE - CONCERTA N021121 001 6919373 Jul 31, 2017 6919373*PED Jan 31, 2018 6930129 Jul 31, 2017 6930129*PED Jan 31, 2018 METHYLPHENIDATE HYDROCHLORIDE - CONCERTA N021121 002 6919373 Jul 31, 2017 6919373*PED Jan 31, 2018 6930129 Jul 31, 2017 6930129*PED Jan 31, 2018 METHYLPHENIDATE HYDROCHLORIDE - CONCERTA N021121 003 6919373 Jul 31, 2017 6919373*PED Jan 31, 2018 6930129 Jul 31, 2017 6930129*PED Jan 31, 2018 METHYLPHENIDATE HYDROCHLORIDE - CONCERTA N021121 004 6919373 Jul 31, 2017 6919373*PED Jan 31, 2018 6930129 Jul 31, 2017 6930129*PED Jan 31, 2018 METHYLPHENIDATE HYDROCHLORIDE - METADATE CD N021259 001 6344215 Oct 27, 2020
U-666 U-666
M-88
Nov
04, 2012
U-666 U-666
M-88
Nov
04, 2012
U-666 U-666
M-88
Nov
04, 2012
U-666 U-666
M-88
Nov
04, 2012
DP
APPL/PROD NO
PATENT NO
PATENT CODES
DP
EXCLUSIVITY CODE(S)
METHYLPHENIDATE HYDROCHLORIDE - METADATE CD N021259 002 6344215 Oct 27, 2020 METHYLPHENIDATE HYDROCHLORIDE - METADATE CD N021259 003 6344215 Oct 27, 2020 METHYLPHENIDATE HYDROCHLORIDE - METADATE CD N021259 004 6344215 Oct 27, 2020 METHYLPHENIDATE HYDROCHLORIDE - METHYLIN N021419 001 7691880 Oct 07, 2024 METHYLPHENIDATE HYDROCHLORIDE - METHYLIN N021419 002 7691880 Oct 07, 2024 METHYLPHENIDATE HYDROCHLORIDE - RITALIN N021284 001 5837284 Dec 04, 6228398 Nov 01, 6635284 Dec 04, 7431944 Dec 04, METHYLPHENIDATE HYDROCHLORIDE - RITALIN N021284 002 5837284 Dec 04, 6228398 Nov 01, 6635284 Dec 04, 7431944 Dec 04, METHYLPHENIDATE HYDROCHLORIDE - RITALIN N021284 003 5837284 Dec 04, 6228398 Nov 01, 6635284 Dec 04, 7431944 Dec 04, METHYLPHENIDATE HYDROCHLORIDE - RITALIN N021284 004 5837284 Dec 04, 6228398 Nov 01, 6635284 Dec 04, 7431944 Dec 04, LA 2015 2019 2015 2015 LA 2015 2019 2015 2015 LA 2015 2019 2015 2015 LA 2015 2019 2015 2015
DP
DP
DP
DP
DP DP DP DP
U-472 U-591
DP DP DP DP
U-472 U-591
DP DP DP DP
U-472 U-591
DP DP DP DP
U-472 U-591
METOCLOPRAMIDE HYDROCHLORIDE - METOZOLV ODT N022246 001 6413549 Jul 11, 2017 METOCLOPRAMIDE HYDROCHLORIDE - METOZOLV ODT N022246 002 6413549 Jul 11, 2017 METOCLOPRAMIDE HYDROCHLORIDE - REGLAN ODT Apr 09, 2018 N021793 001 6024981 Apr 09, 2018 6221392 METOCLOPRAMIDE HYDROCHLORIDE - REGLAN ODT N021793 002 6024981 Apr 09, 2018 6221392 Apr 09, 2018 METRONIDAZOLE - FLAGYL ER N020868 001 6103262 METRONIDAZOLE - METROGEL N021789 001 6881726 7348317
DP
DP
DP DP
DP DP
Aug
15, 2017
DP
U-137
Feb Feb
DP DP
U-743 U-743
METRONIDAZOLE - METROGEL-VAGINAL N020208 001 5536743 Jul METRONIDAZOLE - VANDAZOLE N021806 001 7456207
16, 2013
U-137
Sep
22, 2024
DP
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DP DP DP DP DP DP DP
EXCLUSIVITY CODE(S)
MICAFUNGIN SODIUM - MYCAMINE N021506 002 5376634 6107458 6107458 6265536 6265536 6774104 6774104 MICAFUNGIN SODIUM - MYCAMINE N021506 003 5376634 6107458 6107458 6265536 6265536 6774104 6774104 MICONAZOLE - ORAVIG N022404 001 6916485 7651698
DS DS DS DS DS
DP DP DP DP DP DP DP
Sep Jan
DP
U-1051 U-1051
NDF
Apr
16, 2013
MICONAZOLE NITRATE - MONISTAT 1 COMBINATION PACK N021308 001 5514698 Mar 21, 2014 6153635 Nov 28, 2020 MIGLUSTAT - ZAVESCA N021348 001 5472969 5525616
Y Y
May Jun
MILNACIPRAN HYDROCHLORIDE - SAVELLA N022256 001 6602911 Nov 05, 2021 6992110 Nov 05, 2021 7888342 Nov 05, 2021 7994220 Sep 19, 2029 MILNACIPRAN HYDROCHLORIDE - SAVELLA N022256 002 6602911 Nov 05, 2021 6992110 Nov 05, 2021 7888342 Nov 05, 2021 7994220 Sep 19, 2029 MILNACIPRAN HYDROCHLORIDE - SAVELLA N022256 003 6602911 Nov 05, 2021 6992110 Nov 05, 2021 7888342 Nov 05, 2021 7994220 Sep 19, 2029 MILNACIPRAN HYDROCHLORIDE - SAVELLA N022256 004 6602911 Nov 05, 2021 6992110 Nov 05, 2021 7888342 Nov 05, 2021 7994220 Sep 19, 2029 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 001 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 002 5908838 Feb 19, 2018 7541347 Apr 02, 2027 Apr 02, 2027 7544373 Jun 24, 2025 7790705 Mar 07, 2027 7919483 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 003 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027
NCE
Jan
14, 2014
NCE
Jan
14, 2014
NCE
Jan
14, 2014
NCE
Jan
14, 2014
APPL/PROD NO
PATENT NO
PATENT CODES
U-917 U-1078 U-1078
EXCLUSIVITY CODE(S)
MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 004 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 005 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 006 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 007 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 MINOCYCLINE HYDROCHLORIDE - SOLODYN N050808 008 5908838 Feb 19, 2018 7790705 Jun 24, 2025 7919483 Mar 07, 2027 MINOXIDIL - MEN'S ROGAINE N021812 001 6946120 MODAFINIL - PROVIGIL N020717 001 7297346 7297346*PED RE37516 RE37516*PED MODAFINIL - PROVIGIL N020717 002 7297346 7297346*PED RE37516 RE37516*PED
Apr
20, 2019
DP
U-702
DP U-255
DP U-255
MOMETASONE FUROATE - ASMANEX TWISTHALER N021067 001 5394868 Jun 25, 2012 5394868*PED Dec 25, 2012 5687710 Nov 18, 2014 5687710*PED May 18, 2015 5829434 Nov 03, 2015 5829434*PED May 03, 2016 5889015 Jan 27, 2014 5889015*PED Jul 27, 2014 6057307 Jan 27, 2014 6057307*PED Jul 27, 2014 6240918 Feb 20, 2017 6240918*PED Aug 20, 2017 6365581 Jan 27, 2014 6365581*PED Jul 27, 2014 6503537 Mar 17, 2018 6503537*PED Sep 17, 2018 6677322 Jan 27, 2014 6677322*PED Jul 27, 2014 6949532 Jan 27, 2014 6949532*PED Jul 27, 2014
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP U-645 DP DP U-645 DP U-645 U-645 U-645
EXCLUSIVITY CODE(S)
MOMETASONE FUROATE - ASMANEX TWISTHALER Jun 25, 2012 N021067 002 5394868 Dec 25, 2012 5394868*PED Nov 18, 2014 5687710 May 18, 2015 5687710*PED Nov 03, 2015 5829434 May 03, 2016 5829434*PED Jan 27, 2014 5889015 Jul 27, 2014 5889015*PED Jan 27, 2014 6057307 Jul 27, 2014 6057307*PED Feb 20, 2017 6240918 Aug 20, 2017 6240918*PED Jan 27, 2014 6365581 Jul 27, 2014 6365581*PED Mar 17, 2018 6503537 Sep 17, 2018 6503537*PED Jan 27, 2014 6677322 Jul 27, 2014 6677322*PED Jan 27, 2014 6949532 Jul 27, 2014 6949532*PED MOMETASONE FUROATE MONOHYDRATE N020762 001 5837699 5837699*PED 6127353 6127353*PED 6723713 6723713*PED MONTELUKAST SODIUM - SINGULAIR N020829 002 5565473 5565473 5565473 5565473*PED MONTELUKAST SODIUM - SINGULAIR N020830 001 5565473 5565473 5565473 5565473*PED MONTELUKAST SODIUM - SINGULAIR N020830 002 5565473 5565473 5565473 5565473*PED MONTELUKAST SODIUM - SINGULAIR N021409 001 5565473 5565473 5565473*PED 8007830 MORPHINE SULFATE - AVINZA N021260 001 6066339 MORPHINE SULFATE - AVINZA N021260 002 6066339 MORPHINE SULFATE - AVINZA N021260 003 6066339 MORPHINE SULFATE - AVINZA N021260 004 6066339 MORPHINE SULFATE - AVINZA N021260 005 6066339 - NASONEX Jan 27, 2014 Jul 27, 2014 Oct 03, 2017 Apr 03, 2018 Jan 27, 2014 Jul 27, 2014
DP DS DP
U-625
I-626 M-99
May Jan
U-625
DS DS DS
DP DP DP
DS DS DS
DP DP DP
DS DS DS
DP DP DP
DS DS
DP DP DP
U-675 U-807
Nov
25, 2017
Nov
25, 2017
Nov
25, 2017
Nov
25, 2017
Nov
25, 2017
DP
APPL/PROD NO
PATENT NO
PATENT CODES
DP
EXCLUSIVITY CODE(S)
MORPHINE SULFATE - AVINZA N021260 006 6066339 MORPHINE SULFATE - DEPODUR N021671 001 5723147 5807572 5891467 5931809 5962016 5997899 6171613 6193998 6241999 MORPHINE SULFATE - DEPODUR N021671 002 5723147 5807572 5891467 5931809 5962016 5997899 6171613 6193998 6241999 MORPHINE SULFATE - DEPODUR N021671 003 5723147 5807572 5891467 5931809 5962016 5997899 6171613 6193998 6241999
Nov
25, 2017
DP DP DP DP DP DP DP DP
U-584
U-584 U-584
DP DP DP DP DP DP DP DP
U-584
U-584 U-584
DP DP DP DP DP DP DP DP
U-584
U-584 U-584
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 001 7682633 Jun 19, 2027 7682634 Jun 19, 2027 DP DP 7815934 Dec 12, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 002 7682633 Jun 19, 2027 7682634 Jun 19, 2027 DP DP 7815934 Dec 12, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 003 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 DP 7815934 Dec 12, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 004 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 DP 7815934 Dec 12, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 005 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 DP 7815934 Dec 12, 2027 MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE - EMBEDA N022321 006 7682633 Jun 19, 2027 DP 7682634 Jun 19, 2027 DP 7815934 Dec 12, 2027
U-443
NC
Aug
13, 2012
U-443
NC
Aug
13, 2012
U-443
NC
Aug
13, 2012
U-443
NC
Aug
13, 2012
U-443
NC
Aug
13, 2012
U-443
NC
Aug
13, 2012
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-298 U-298 U-298 U-298
EXCLUSIVITY CODE(S)
MOXIFLOXACIN HYDROCHLORIDE - AVELOX N021085 001 4990517 Dec 08, 2011 5607942 Mar 04, 2014 5849752 Dec 05, 2016 6610327 Oct 29, 2019
DP
MOXIFLOXACIN HYDROCHLORIDE - AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER DS DP U-298 N021277 001 4990517 Dec 08, 2011 U-298 5607942 Mar 04, 2014 U-298 5849752 Dec 05, 2016 DP U-298 6548079 Jul 25, 2020 MOXIFLOXACIN HYDROCHLORIDE - MOXEZA N022428 001 4990517 Dec 08, 2011 4990517*PED Jun 08, 2012 5607942 Mar 04, 2014 5607942*PED Sep 04, 2014 Sep 29, 2019 6716830 Mar 29, 2020 6716830*PED Sep 29, 2019 7671070 Mar 29, 2020 7671070*PED MOXIFLOXACIN HYDROCHLORIDE - VIGAMOX N021598 001 4990517 Dec 08, 2011 4990517*PED Jun 08, 2012 5607942 Mar 04, 2014 5607942*PED Sep 04, 2014 Sep 29, 2019 6716830 Mar 29, 2020 6716830*PED Sep 29, 2019 7671070 Mar 29, 2020 7671070*PED MUPIROCIN - CENTANY N050788 001 6013657 MUPIROCIN CALCIUM - BACTROBAN N050746 001 6025389
DS DS
DP DP DP DP
U-709 U-709
NP PED
Nov May
U-709
DS DS
DP DP DP
U-709 U-709
U-709
Jul
08, 2018
DP
Oct
20, 2014
DP
U-1122
18, 2014
DP
MYCOPHENOLATE MOFETIL HYDROCHLORIDE - CELLCEPT N050758 001 5543408 Sep 15, 2013 MYCOPHENOLIC ACID - MYFORTIC N050791 001 6025391 6172107 6306900 MYCOPHENOLIC ACID - MYFORTIC N050791 002 6025391 6172107 6306900
DP
DP DP DP
U-908 U-908
DP DP DP
U-908 U-908
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP DP DP DP DP DP DP DP DP DP DP DP DP DP DP U-1124 U-1123
EXCLUSIVITY CODE(S)
I-631
NALTREXONE - VIVITROL N021897 001 5792477 5916598 6194006 6264987 6331317 6379703 6379704 6395304 6403114 6495164 6495166 6534092 6537586 6596316 6667061 6713090 6939033 7799345 7919499 7919499 NAPROXEN SODIUM - NAPRELAN N020353 001 5637320 NAPROXEN SODIUM - NAPRELAN N020353 002 5637320 NAPROXEN SODIUM - NAPRELAN N020353 003 5637320
May May Dec May Nov Dec May Nov May May Nov May Nov Dec May Nov Nov May Oct Oct
02, 02, 30, 19, 12, 30, 19, 12, 02, 25, 12, 19, 12, 30, 25, 12, 12, 25, 15, 15,
2017 2017 2018 2020 2019 2018 2020 2019 2017 2020 2019 2020 2019 2018 2020 2019 2019 2020 2029 2029
Oct
12, 2013
Jun
10, 2014
Jun
10, 2014
Jun
10, 2014
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE - TREXIMET Aug 14, 2017 N021926 001 6060499 Aug 14, 2017 6586458 Oct 02, 2025 7332183 Aug 14, 2017 8022095 NATEGLINIDE - STARLIX N021204 001 5463116 5488150 6559188 6641841 6844008 6878749 NATEGLINIDE - STARLIX N021204 002 5463116 5488150 6559188 6641841 6844008 6878749
DP DP DP DP
DP DP DP DP
DP DP DP DP
NEBIVOLOL HYDROCHLORIDE - BYSTOLIC N021742 002 5759580 Jun 6545040 Dec NEBIVOLOL HYDROCHLORIDE - BYSTOLIC N021742 003 5759580 Jun 6545040 Dec NEBIVOLOL HYDROCHLORIDE - BYSTOLIC N021742 004 5759580 Jun 6545040 Dec NEBIVOLOL HYDROCHLORIDE - BYSTOLIC N021742 005 5759580 Jun 6545040 Dec
DP DP
NCE U-3
Dec
17, 2012
DP DP
NCE U-3
Dec
17, 2012
DP DP
NCE U-3
Dec
17, 2012
DP DP
NCE U-3
Dec
17, 2012
APPL/PROD NO
PATENT NO
PATENT CODES
U-304
EXCLUSIVITY CODE(S)
NEDOCROMIL SODIUM - ALOCRIL N021009 001 RE38628 NELARABINE - ARRANON N021877 001 5424295 5492897 5747472 5747472 5747472 5821236 NELFINAVIR MESYLATE - VIRACEPT N020778 001 5484926 5484926*PED 5952343 5952343*PED 6162812 6162812*PED NELFINAVIR MESYLATE - VIRACEPT N020779 001 5484926 5484926*PED 5952343 5952343*PED 6162812 6162812*PED NELFINAVIR MESYLATE - VIRACEPT N021503 001 5484926 5484926*PED 5952343 5952343*PED 6162812 6162812*PED NEPAFENAC - NEVANAC N021862 001 5475034 7834059 8071648
Aug
22, 2012
DS
ODE
Oct
28, 2012
2013
2014
2013 2014 2013 2014
U-100 U-1095 DP
NESIRITIDE RECOMBINANT - NATRECOR N020920 001 5114923 May NEVIRAPINE - VIRAMUNE N020636 001 5366972 5366972*PED NEVIRAPINE - VIRAMUNE N020933 001 5366972 5366972*PED NEVIRAPINE - VIRAMUNE XR N201152 001 5366972 5366972*PED NIACIN - NIASPAN N020381 001 6080428 6129930 6406715 6746691 6818229 7011848
19, 2014
DS
DP
U-855
Nov May
U-167
Nov May
Nov May
DS
DP
U-167
NDF
Mar
25, 2014
APPL/PROD NO
PATENT NO
PATENT CODES
U-1138 U-1139 U-1140 U-331 U-1141 U-1141 U-1140 U-1138 U-354 U-1139 U-450 U-1142 U-1145 U-768 U-1144 U-1143 U-1139 U-1140 U-1138 U-548 U-1146 U-586 U-1148 U-712 U-1147 U-1140 U-1141 U-1140 U-1138 U-1141 U-1139
EXCLUSIVITY CODE(S)
NIACIN - NIASPAN N020381 002 6080428 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7011848 7998506 7998506 7998506 7998506 NIACIN - NIASPAN N020381 003 6080428 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7011848 7998506 7998506 7998506 7998506
May May May May May Sep Sep Sep Sep Sep Sep Mar Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 27, 20, 20, 20, 20, 20, 20, 15, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2017 2013 2013 2013 2013 2013 2013 2018 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP DP
DP DP
May May May May May Sep Sep Sep Sep Sep Sep Mar Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 27, 20, 20, 20, 20, 20, 20, 15, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2017 2013 2013 2013 2013 2013 2013 2018 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP DP
DP DP
U-1140 U-1138 U-331 U-1139 U-1141 U-354 U-1138 U-1141 U-1139 U-1140 U-450 U-1144 U-768 U-1145 U-1143 U-1142 U-1140 U-1141 U-1146 U-1138 U-548 U-1139 U-586 U-1148 U-712 U-1147 U-1140 U-1141 U-1138 U-1140 U-1139 U-1141
APPL/PROD NO
PATENT NO
PATENT CODES
U-1140 U-331 U-1141 U-1139 U-1138 U-1139 U-354 U-1138 U-1141 U-1140 U-450 U-1143 U-768 U-1144 U-1145 U-1142 U-1140 U-548 U-1141 U-1138 U-1139 U-1146 U-586 U-1147 U-1148 U-1141 U-1140 U-712 U-1140 U-1139 U-1141 U-1138
EXCLUSIVITY CODE(S)
NIACIN - NIASPAN N020381 004 6080428 6080428 6080428 6080428 6080428 6129930 6129930 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6469035 6469035 6676967 6676967 6676967 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7011848 7011848 7998506 7998506 7998506 7998506
May May May May May Sep Sep Sep Sep Sep Sep Mar Mar Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 27, 27, 20, 20, 20, 20, 20, 20, 15, 15, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2017 2017 2013 2013 2013 2013 2013 2013 2018 2018 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP DP DP
DP DP
NIACIN - NIASPAN TITRATION STARTER PACK N020381 005 6080428 May 27, 2017 6129930 Sep 20, 2013 6406715 Sep 20, 2013 6746691 Sep 20, 2013 7011848 Sep 20, 2013 NIACIN; SIMVASTATIN - SIMCOR N022078 001 6080428 6080428 6080428 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506
May May May Sep Sep Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 20, 20, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP
U-1134 U-1132 U-862 U-1132 U-862 U-1134 U-1149 U-863 U-1129 U-1132 U-1134 U-862
APPL/PROD NO
PATENT NO
PATENT CODES
U-1134 U-1132 U-862 U-862 U-1134 U-1132 U-1129 U-863 U-1149 U-1132 U-1134 U-862 DP DP U-1150 U-862 U-1151 U-1150 U-1151
EXCLUSIVITY CODE(S)
NIACIN; SIMVASTATIN - SIMCOR N022078 002 6080428 6080428 6080428 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506 NIACIN; SIMVASTATIN - SIMCOR N022078 003 6080428 6080428 6080428 6129930 6129930 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506 NIACIN; SIMVASTATIN - SIMCOR N022078 004 6080428 6080428 6080428 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506
May May May Sep Sep Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 20, 20, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP
May May May Sep Sep Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 20, 20, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP DP DP
U-862 U-1132 U-1134 U-1132 U-862 U-1134 U-1149 U-1129 U-863 U-1132 U-1134 U-862
May May May Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP
U-1132 U-862 U-1134 U-862 U-863 U-1129 U-1149 U-1132 U-1134 U-862
APPL/PROD NO
PATENT NO
PATENT CODES
U-862 U-1134 U-1132 U-862 U-1149 U-863 U-1129 U-1134 U-1132 U-862 DP DP U-1150 U-862 U-1151 U-1151 U-1150
EXCLUSIVITY CODE(S)
NIACIN; SIMVASTATIN - SIMCOR N022078 005 6080428 6080428 6080428 6129930 6406715 6469035 6469035 6469035 6676967 6676967 6676967 6746691 6818229 7011848 7011848 7011848 7998506 7998506
May May May Sep Sep Mar Mar Mar Sep Sep Sep Sep Sep Sep Sep Sep Sep Sep
27, 27, 27, 20, 20, 15, 15, 15, 20, 20, 20, 20, 20, 20, 20, 20, 20, 20,
2017 2017 2017 2013 2013 2018 2018 2018 2013 2013 2013 2013 2013 2013 2013 2013 2013 2013
DP DP
NICARDIPINE HYDROCHLORIDE - CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER N019734 004 7612102 Dec 26, 2027 DP U-1029 7659291 Apr 18, 2027 NICARDIPINE HYDROCHLORIDE - CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER N019734 003 7612102 Dec 26, 2027 DP U-1029 7659291 Apr 18, 2027 NICARDIPINE HYDROCHLORIDE - CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER N019734 002 7612102 Dec 26, 2027 DP U-1029 7659291 Apr 18, 2027 NICARDIPINE HYDROCHLORIDE - CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER N019734 005 7612102 Dec 26, 2027 DP U-1029 7659291 Apr 18, 2027 NICOTINE - NICODERM CQ N020165 004 5508038 NICOTINE - NICODERM CQ N020165 005 5508038 NICOTINE - NICODERM CQ N020165 006 5508038 NICOTINE - NICOTROL N020385 001 5656255
Apr
16, 2013
Apr
16, 2013
Apr
16, 2013
Aug
12, 2014
NILOTINIB HYDROCHLORIDE MONOHYDRATE - TASIGNA N022068 001 7169791 Jul 04, 2023
DS
DP
U-836
NILOTINIB HYDROCHLORIDE MONOHYDRATE - TASIGNA N022068 002 7169791 Jul 04, 2023
DS
DP
U-836
NISOLDIPINE - SULAR N020356 005 5422123 5626874 NISOLDIPINE - SULAR N020356 006 5422123 5626874 NISOLDIPINE - SULAR N020356 007 5422123 5626874
Jun Nov
DP DP
Jun Nov
DP DP
Jun Nov
DP DP
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP
EXCLUSIVITY CODE(S)
NISOLDIPINE - SULAR N020356 008 5422123 5626874 NITAZOXANIDE - ALINIA N021497 001 5387598 5578621 5968961 6020353 NITAZOXANIDE - ALINIA N021498 001 5387598 5578621 5965590 5968961 6020353 6117894 NITISINONE - ORFADIN N021232 001 5550165 NITISINONE - ORFADIN N021232 002 5550165 NITISINONE - ORFADIN N021232 003 5550165 NITRIC OXIDE - INOMAX N020845 002 5485827 5485827*PED 5873359 5873359*PED NITRIC OXIDE - INOMAX N020845 003 5485827 5485827*PED 5873359 5873359*PED NITROGLYCERIN - NITROMIST N021780 001 5869082 NITROGLYCERIN - NITROSTAT N021134 001 6500456 NITROGLYCERIN - NITROSTAT N021134 002 6500456 NITROGLYCERIN - NITROSTAT N021134 003 6500456 NITROGLYCERIN - RECTIV N021359 001 7189761 NIZATIDINE - AXID N021494 001 6930119
Jun Nov
DS
DP DP DP DP
U-524 U-525
Aug
27, 2013
Aug
27, 2013
Aug
27, 2013
U-297 U-297
U-297 U-297
Apr
16, 2016
DP
Sep
16, 2018
Sep
16, 2018
Sep
16, 2018
May
27, 2014
DP
U-1198
NP
Jun
21, 2014
Jul
17, 2022
DP
OCTREOTIDE ACETATE - SANDOSTATIN May N019667 001 5753618 Nov 5753618*PED OCTREOTIDE ACETATE - SANDOSTATIN May N019667 002 5753618 Nov 5753618*PED OCTREOTIDE ACETATE - SANDOSTATIN May N019667 003 5753618 Nov 5753618*PED
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
OCTREOTIDE ACETATE - SANDOSTATIN N019667 004 5753618 May Nov 5753618*PED OCTREOTIDE ACETATE - SANDOSTATIN May N019667 005 5753618 Nov 5753618*PED
OCTREOTIDE ACETATE - SANDOSTATIN LAR Jul 23, N021008 001 5538739 Jan 23, 5538739*PED Jun 17, 5639480 Dec 17, 5639480*PED Nov 18, 5688530 May 18, 5688530*PED Jul 13, 5922338 Jan 13, 5922338*PED Jul 13, 5922682 Jan 13, 5922682*PED OCTREOTIDE ACETATE - SANDOSTATIN LAR N021008 002 5538739 Jul 23, 5538739*PED Jan 23, 5639480 Jun 17, 5639480*PED Dec 17, 5688530 Nov 18, 5688530*PED May 18, Jul 13, 5922338 Jan 13, 5922338*PED Jul 13, 5922682 Jan 13, 5922682*PED OCTREOTIDE ACETATE - SANDOSTATIN LAR N021008 003 5538739 Jul 23, 5538739*PED Jan 23, 5639480 Jun 17, 5639480*PED Dec 17, 5688530 Nov 18, 5688530*PED May 18, Jul 13, 5922338 Jan 13, 5922338*PED Jul 13, 5922682 Jan 13, 5922682*PED OFLOXACIN - FLOXIN OTIC N020799 001 5401741 OLANZAPINE - OLANZAPINE A076000 001 OLANZAPINE - OLANZAPINE A076000 002 OLANZAPINE - OLANZAPINE A076000 003 OLANZAPINE - OLANZAPINE A076000 004 OLANZAPINE - OLANZAPINE A076000 005 OLANZAPINE - OLANZAPINE A076133 002
2013 2014 2014 2014 2014 2015 2016 2017 2016 2017
DP DP U-268 DP DP
2013 2014 2014 2014 2014 2015 2016 2017 2016 2017
DP U-268 DP DP
2013 2014 2014 2014 2014 2015 2016 2017 2016 2017
DP U-268 DP DP
Mar
27, 2012
U-407
PC
Apr
21, 2012
PC
Apr
21, 2012
PC
Apr
21, 2012
PC
Apr
21, 2012
PC
Apr
21, 2012
PC
Apr
21, 2012
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-591 NPP NPP PED PED
OLANZAPINE - ZYPREXA N020592 001 5229382*PED 5605897 5605897*PED 5627178*PED 5736541 5736541*PED 5817655*PED 5817656*PED 5817657*PED 5919485 5919485*PED 6251895 6251895*PED 6960577 OLANZAPINE - ZYPREXA N020592 002 5229382*PED 5605897 5605897*PED 5627178*PED 5736541 5736541*PED 5817655*PED 5817656*PED 5817657*PED 5919485 5919485*PED 6251895 6251895*PED 6960577 OLANZAPINE - ZYPREXA N020592 003 5229382*PED 5605897 5605897*PED 5627178*PED 5736541 5736541*PED 5817655*PED 5817656*PED 5817657*PED 5919485 5919485*PED 6251895 6251895*PED 6960577 OLANZAPINE - ZYPREXA N020592 004 5229382*PED 5605897 5605897*PED 5627178*PED 5736541 5736541*PED 5817655*PED 5817656*PED 5817657*PED 5919485 5919485*PED 6251895 6251895*PED 6960577
Oct Feb Aug Oct Mar Sep Oct Oct Oct Mar Sep Sep Mar Nov
23, 25, 25, 23, 24, 24, 23, 23, 23, 24, 24, 23, 23, 01,
2011 2014 2014 2011 2015 2015 2011 2011 2011 2015 2015 2017 2018 2017
U-176
U-307
U-308
U-963
Oct Feb Aug Oct Mar Sep Oct Oct Oct Mar Sep Sep Mar Nov
23, 25, 25, 23, 24, 24, 23, 23, 23, 24, 24, 23, 23, 01,
2011 2014 2014 2011 2015 2015 2011 2011 2011 2015 2015 2017 2018 2017
U-176
U-307
U-308
U-963
Oct Feb Aug Oct Mar Sep Oct Oct Oct Mar Sep Sep Mar Nov
23, 25, 25, 23, 24, 24, 23, 23, 23, 24, 24, 23, 23, 01,
2011 2014 2014 2011 2015 2015 2011 2011 2011 2015 2015 2017 2018 2017
U-176
U-307
U-308
U-963
Oct Feb Aug Oct Mar Sep Oct Oct Oct Mar Sep Sep Mar Nov
23, 25, 25, 23, 24, 24, 23, 23, 23, 24, 24, 23, 23, 01,
2011 2014 2014 2011 2015 2015 2011 2011 2011 2015 2015 2017 2018 2017
U-176
U-307
U-308
U-963
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-591 NPP NPP PED PED
OLANZAPINE - ZYPREXA N020592 005 5229382*PED 5605897 5605897*PED 5627178*PED 5736541 5736541*PED 5817655*PED 5817656*PED 5817657*PED 5919485 5919485*PED 6251895 6251895*PED 6960577 OLANZAPINE - ZYPREXA N020592 006 5229382*PED 5605897 5605897*PED 5627178*PED 5736541 5736541*PED 5817655*PED 5817656*PED 5817657*PED 5919485 5919485*PED 6251895 6251895*PED 6960577 OLANZAPINE - ZYPREXA N021253 001 5229382*PED OLANZAPINE - ZYPREXA ZYDIS N021086 001 5229382*PED 6960577
Oct Feb Aug Oct Mar Sep Oct Oct Oct Mar Sep Sep Mar Nov
23, 25, 25, 23, 24, 24, 23, 23, 23, 24, 24, 23, 23, 01,
2011 2014 2014 2011 2015 2015 2011 2011 2011 2015 2015 2017 2018 2017
U-176
U-307
U-308
U-963
Oct Feb Aug Oct Mar Sep Oct Oct Oct Mar Sep Sep Mar Nov
23, 25, 25, 23, 24, 24, 23, 23, 23, 24, 24, 23, 23, 01,
2011 2014 2014 2011 2015 2015 2011 2011 2011 2015 2015 2017 2018 2017
U-176
U-307
U-308
U-963
Oct
23, 2011
Oct Nov
U-964
Oct Nov
U-964
Oct Nov
U-964
Oct Nov
U-964
OLANZAPINE PAMOATE - ZYPREXA RELPREVV N022173 001 5229382*PED Oct 23, 2011 6169084 Sep 30, 2018
NP DS DP U-1026
Dec
11, 2012
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
NP
OLANZAPINE PAMOATE - ZYPREXA RELPREVV Oct 23, 2011 N022173 002 5229382*PED Sep 30, 2018 6169084 OLANZAPINE PAMOATE - ZYPREXA RELPREVV Oct 23, 2011 N022173 003 5229382*PED Sep 30, 2018 6169084 OLMESARTAN MEDOXOMIL - BENICAR N021286 001 5616599 5616599*PED 6878703 6878703*PED OLMESARTAN MEDOXOMIL - BENICAR N021286 003 5616599 5616599*PED 6878703 6878703*PED OLMESARTAN MEDOXOMIL - BENICAR N021286 004 5616599 5616599*PED 6878703 6878703*PED
Dec
11, 2012
DS
DP
U-1026
NP DS DP U-1026
Dec
11, 2012
DS
DP
U-500 U-3 Y
NPP PED
Feb Aug
DS
DP
U-500 U-3 Y
NPP PED
Feb Aug
DS
DP
U-500 U-3 Y
NPP PED
Feb Aug
OLOPATADINE HYDROCHLORIDE - PATADAY N021545 001 5641805 Jun 06, 2015 5641805*PED Dec 06, 2015 6995186 Nov 12, 2023 6995186*PED May 12, 2024 7402609 Jun 19, 2022 7402609*PED Dec 19, 2022 OLOPATADINE HYDROCHLORIDE - PATANASE Feb 02, 2023 N021861 001 7977376 Aug 02, 2023 7977376*PED
U-765 DP DP U-765
DP DP
OLOPATADINE HYDROCHLORIDE - PATANOL N020688 001 5641805 Jun 06, 2015 5641805*PED Dec 06, 2015 OMEGA-3-ACID ETHYL ESTERS - LOVAZA N021654 001 5502077 Mar 5656667 Apr Jan 7732488 OMEPRAZOLE - PRILOSEC N019810 001 6147103 6147103*PED 6150380 6150380*PED 6166213 6166213*PED 6191148 6191148*PED OMEPRAZOLE - PRILOSEC N019810 002 6147103 6147103*PED 6150380 6150380*PED 6166213 6166213*PED 6191148 6191148*PED
DS DS DS
DP DP
U-822 U-822
M-87
Sep
16, 2012
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
OMEPRAZOLE - PRILOSEC N019810 003 6147103 6147103*PED 6150380 6150380*PED 6166213 6166213*PED 6191148 6191148*PED
OMEPRAZOLE MAGNESIUM - PRILOSEC Nov N022056 001 5690960 May 5900424 Nov 6428810 OMEPRAZOLE MAGNESIUM - PRILOSEC N022056 002 5690960 Nov 5900424 May Nov 6428810 OMEPRAZOLE MAGNESIUM - PRILOSEC OTC N021229 001 5690960 Nov 5753265 Jun 5817338 Oct 5900424 May Nov 6403616 Nov 6428810 OMEPRAZOLE; SODIUM BICARBONATE N021636 001 5840737 6489346 6645988 6699885 6780882 7399772 OMEPRAZOLE; SODIUM BICARBONATE N021636 002 5840737 5840737 6489346 6489346 6645988 6699885 6699885 6780882 7399772 7399772 OMEPRAZOLE; SODIUM BICARBONATE N021849 001 6489346 6645988 6699885 7399772 OMEPRAZOLE; SODIUM BICARBONATE N021849 002 6489346 6645988 6699885 7399772 OMEPRAZOLE; SODIUM BICARBONATE N022281 001 6489346 6645988 6699885 7399772
DP DS DP
PED
Sep
20, 2011
DP DS DP
PED
Sep
20, 2011
- ZEGERID Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 - ZEGERID Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 - ZEGERID Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 - ZEGERID Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 Jul 16, 2016 - ZEGERID OTC Jul 15, 2016 Jul 15, 2016 Jul 15, 2016 Jul 15, 2016
DS DS DS
DP DP DP
DS DS DS
DP DP DP
DS
DP U-623 U-624
DS DS
DP DP
DS DS
DP DP
DP DP DP
U-1025
U-1025
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ONDANSETRON - ZOFRAN ODT N020781 001 5955488 5955488*PED 6063802 6063802*PED ONDANSETRON - ZOFRAN ODT N020781 002 5955488 5955488*PED 6063802 6063802*PED
ONDANSETRON HYDROCHLORIDE - ZOFRAN N020103 001 5344658 Sep 5344658*PED Mar ONDANSETRON HYDROCHLORIDE - ZOFRAN N020103 002 5344658 Sep 5344658*PED Mar ONDANSETRON HYDROCHLORIDE - ZOFRAN N020103 003 5344658 Sep 5344658*PED Mar ONDANSETRON HYDROCHLORIDE - ZOFRAN Nov N020605 001 5854270 May 5854270*PED ORLISTAT - ALLI N021887 001 6004996 ORLISTAT - XENICAL N020766 001 6004996 6004996*PED
DP
U-44
Jan
06, 2018
DP
Jan Jul
OSELTAMIVIR PHOSPHATE - TAMIFLU N021087 001 5763483 Dec 5763483*PED Jun 5866601 Feb 5866601*PED Aug 5952375 Feb 5952375*PED Aug OSELTAMIVIR PHOSPHATE - TAMIFLU N021087 002 5763483 Dec 5763483*PED Jun 5866601 Feb 5866601*PED Aug 5952375 Feb 5952375*PED Aug OSELTAMIVIR PHOSPHATE - TAMIFLU N021087 003 5763483 Dec 5763483*PED Jun 5866601 Feb 5866601*PED Aug 5952375 Feb 5952375*PED Aug OSELTAMIVIR PHOSPHATE - TAMIFLU N021246 001 5763483 Dec 5763483 Dec 5763483*PED Jun 5866601 Feb 5866601*PED Aug Feb 5952375 Aug 5952375*PED
DS DS DS DP DP
U-1113
M-90
Feb
22, 2013
DS DS DS DP DP
U-1113
M-90
Feb
22, 2013
DS DS DS DP DP
U-1113
DS DS DS DS DP DP
U-376 U-1113
M-90
Feb
22, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP DP DP U-1113
EXCLUSIVITY CODE(S)
OSELTAMIVIR PHOSPHATE - TAMIFLU Dec N021246 002 5763483 Jun 5763483*PED Feb 5866601 Aug 5866601*PED Feb 5952375 Aug 5952375*PED OXALIPLATIN - ELOXATIN N021492 001 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED OXALIPLATIN - ELOXATIN N021492 002 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED OXALIPLATIN - ELOXATIN N021759 001 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED 5716988 5716988*PED OXALIPLATIN - ELOXATIN N021759 002 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED 5716988 5716988*PED OXALIPLATIN - ELOXATIN N021759 003 5290961 5290961*PED 5338874 5338874*PED 5420319 5420319*PED 5716988 5716988*PED OXANDROLONE - OXANDRIN N013718 001 5872147 6090799 6576659 6670351 6828313 OXANDROLONE - OXANDRIN N013718 002 5872147 6090799 6576659 6670351 6828313
DS DS DS
DS DS DS
DS DS DS DP
DS DS DS DP
DS DS DS DP
APPL/PROD NO
PATENT NO
PATENT CODES
U-724
EXCLUSIVITY CODE(S)
OXCARBAZEPINE - TRILEPTAL N021014 001 7037525 7037525*PED OXCARBAZEPINE - TRILEPTAL N021014 002 7037525 7037525*PED OXCARBAZEPINE - TRILEPTAL N021014 003 7037525 7037525*PED OXCARBAZEPINE - TRILEPTAL N021285 001 7037525 7037525*PED OXYBUTYNIN - ANTUROL N202513 001 OXYBUTYNIN - OXYTROL N021351 002 5601839 5834010 6743441 7081249 7081250 7081251 7081252 7179483 OXYBUTYNIN CHLORIDE - DITROPAN N020897 001 5674895 5674895*PED 5840754 5840754*PED 5912268 5912268*PED 6262115 6262115*PED OXYBUTYNIN CHLORIDE - DITROPAN N020897 002 5674895 5674895*PED 5840754 5840754*PED 5912268 5912268*PED 6262115 6262115*PED OXYBUTYNIN CHLORIDE - DITROPAN N020897 003 5674895 5674895*PED 5840754 5840754*PED 5912268 5912268*PED 6262115 6262115*PED
Feb Aug
Feb Aug
U-724
Feb Aug
U-724
Feb Aug
U-724
NP Apr Apr Apr Apr Apr Apr Apr Apr XL May Nov May Nov May Nov May Nov XL May Nov May Nov May Nov May Nov XL May Nov May Nov May Nov May Nov 26, 26, 26, 26, 26, 26, 26, 26, 2015 2015 2020 2020 2020 2020 2020 2020
Dec
07, 2014
DS
DP DP DP DP DP DP
U-393 U-393
U-393 U-393
U-393 U-393
OXYBUTYNIN CHLORIDE - GELNIQUE N022204 001 7029694 Apr 7179483 Apr OXYCODONE HYDROCHLORIDE - OXECTA N202080 001 7201920 Mar 7510726 Nov 7981439 Nov
DP
U-318 U-318
NDF
Jan
27, 2012
DP DP DP
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
OXYCODONE HYDROCHLORIDE - OXECTA N202080 002 7201920 Mar 7510726 Nov 7981439 Nov
OXYCODONE HYDROCHLORIDE - OXYCONTIN N020553 001 5508042 Apr 16, 2013 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 002 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN N020553 003 5508042 Apr 16, 2013 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN N020553 004 5508042 Apr 16, 2013 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 005 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN N020553 006 5508042 Apr 16, 2013 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N020553 007 5508042 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 OXYCODONE HYDROCHLORIDE - OXYCONTIN N020553 008 5508042 Apr 16, 2013 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 001 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 002 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DS DS
U-443 DP DP DS DS DP
U-443 DP DP DS DS DP
APPL/PROD NO
PATENT NO
PATENT CODES
U-443 DP DP DS DS DP
EXCLUSIVITY CODE(S)
OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N022272 003 5508042 Jun 24, 2017 6488963 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Apr 19, 2025 7776314 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 004 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N022272 005 5508042 Jun 24, 2017 6488963 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Apr 19, 2025 7776314 OXYCODONE HYDROCHLORIDE - OXYCONTIN N022272 006 5508042 Apr 16, 2013 6488963 Jun 24, 2017 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Mar 30, 2025 7776314 Apr 19, 2025 OXYCODONE HYDROCHLORIDE - OXYCONTIN Apr 16, 2013 N022272 007 5508042 Jun 24, 2017 6488963 Mar 30, 2025 7674799 Mar 30, 2025 7674800 Mar 30, 2025 7683072 Apr 19, 2025 7776314 OXYMORPHONE HYDROCHLORIDE - OPANA ER N021610 001 5662933 Sep 09, 2013 5958456 Sep 09, 2013 Feb 04, 2023 7276250 OXYMORPHONE HYDROCHLORIDE - OPANA ER Sep 09, 2013 N021610 002 5662933 Sep 09, 2013 5958456 7276250 Feb 04, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER Sep 09, 2013 N021610 003 5662933 Sep 09, 2013 5958456 7276250 Feb 04, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER Sep 09, 2013 N021610 004 5662933 Sep 09, 2013 5958456 7276250 Feb 04, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER Sep 09, 2013 N021610 005 5662933 Sep 09, 2013 5958456 Feb 04, 2023 7276250 OXYMORPHONE HYDROCHLORIDE - OPANA ER N021610 006 5662933 Sep 09, 2013 5958456 Sep 09, 2013 Feb 04, 2023 7276250
U-443 DP DP DS DS DP
U-443 DP DP DS DS DP
U-443 DP DP DS DS DP
U-443 DP DP DS DS DP
DP DP DP
U-826
DP DP DP
U-826
DP DP DP
U-826
DP DP DP
U-826
DP DP DP
U-826
DP DP DP
U-826
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP
EXCLUSIVITY CODE(S)
OXYMORPHONE HYDROCHLORIDE - OPANA ER Sep 09, 2013 N021610 007 5662933 Sep 09, 2013 5958456 Feb 04, 2023 7276250 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 001 8075872 Nov 20, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 002 8075872 Nov 20, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 003 8075872 Nov 20, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 004 8075872 Nov 20, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 005 8075872 Nov 20, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 006 8075872 Nov 20, 2023 OXYMORPHONE HYDROCHLORIDE - OPANA ER N201655 007 8075872 Nov 20, 2023 PACLITAXEL - ABRAXANE N021660 001 5439686 5498421 6096331 6506405 6537579 6749868 6753006 7820788 7923536 RE41884 PALIPERIDONE - INVEGA N021999 001
U-826
DP
DP
DP
DP
DP
DP
DP
Feb Mar Feb Feb Feb Feb Feb Mar Dec Aug
22, 12, 22, 22, 22, 22, 22, 03, 09, 14,
2013 2013 2013 2013 2013 2013 2013 2024 2023 2016
DP DP DP DP DP DP DP
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-605 I-606 NPP NCE PED PED PED PED
I-605 I-606 NPP NCE PED PED PED PED DS DP DP DP DP U-543 U-543 U-543
PALIPERIDONE PALMITATE - INVEGA SUSTENNA Oct 27, 2012 N022264 001 5254556 Apr 27, 2013 5254556*PED Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED PALIPERIDONE PALMITATE - INVEGA SUSTENNA N022264 002 5254556 Oct 27, 2012 5254556*PED Apr 27, 2013 Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED PALIPERIDONE PALMITATE - INVEGA SUSTENNA Oct 27, 2012 N022264 003 5254556 Apr 27, 2013 5254556*PED Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED PALIPERIDONE PALMITATE - INVEGA SUSTENNA Oct 27, 2012 N022264 004 5254556 Apr 27, 2013 5254556*PED Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED
DS
DP DP DP DP
U-543
U-543 U-543
DS
DP DP DP DP
U-543
U-543 U-543
DS
DP DP DP DP
U-543
U-543 U-543
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP DP U-543 U-543 U-543
EXCLUSIVITY CODE(S)
NDF NCE PED PED
PALIPERIDONE PALMITATE - INVEGA SUSTENNA Oct 27, 2012 N022264 005 5254556 Apr 27, 2013 5254556*PED Dec 16, 2012 5352459 Jun 16, 2013 5352459*PED May 12, 2017 6077843 Nov 12, 2017 6077843*PED Nov 10, 2018 6555544 May 10, 2019 6555544*PED PALONOSETRON HYDROCHLORIDE - ALOXI N021372 001 5202333 Apr 7947724 Jan 7947725 Jan 7960424 Jan PALONOSETRON HYDROCHLORIDE - ALOXI Apr N021372 002 5202333 Jan 7947724 Jan 7947725 Jan 7960424 PALONOSETRON HYDROCHLORIDE - ALOXI N022233 001 5202333 Apr
DS
DP DP DP DP
U-528
DS
DP DP DP DP
U-901
13, 2015
DS
DP
U-528
NDF
Aug
22, 2011
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE N022523 001 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE N022523 002 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE N022523 003 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - PANCREAZE N022523 004 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 001 7658918 Feb 20, 2028 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 002 7658918 Feb 20, 2028 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 003 7658918 Feb 20, 2028 PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - ZENPEP N022210 004 7658918 Feb 20, 2028 PANTOPRAZOLE SODIUM - PROTONIX N020987 001 5997903 Dec 5997903*PED Jun
NCE
Apr
12, 2015
NCE
Apr
12, 2015
NCE
Apr
12, 2015
NCE DP
Apr
12, 2015
NCE
Aug
27, 2014
DP
NCE
Aug
27, 2014
DP
NCE
Aug
27, 2014
DP
NCE
Aug
27, 2014
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
I-614 M-54 PED PED
PANTOPRAZOLE SODIUM - PROTONIX N022020 001 7544370 7544370*PED 7550153 7550153*PED 7553498 7553498*PED 7838027 7838027*PED PANTOPRAZOLE SODIUM - PROTONIX N020988 001 6780881 6780881*PED 7351723 7351723*PED PARICALCITOL - ZEMPLAR N020819 001 5246925 5246925*PED 5587497 5587497*PED 5597815 5597815*PED 6136799 6136799*PED 6361758 6361758*PED PARICALCITOL - ZEMPLAR N020819 002 5246925 5246925*PED 5587497 5587497*PED 5597815 5597815*PED 6136799 6136799*PED 6361758 6361758*PED PARICALCITOL - ZEMPLAR N021606 001 5246925 5246925*PED 5587497 5587497*PED 5597815 5597815*PED PARICALCITOL - ZEMPLAR N021606 002 5246925 5246925*PED 5587497 5587497*PED 5597815 5597815*PED PARICALCITOL - ZEMPLAR N021606 003 5246925 5246925*PED 5587497 5587497*PED 5597815 5597815*PED
Jun Dec Sep Mar Sep Mar Sep Mar IV Nov May Nov May
DP DP
Apr Oct Dec Jun Jul Jan Apr Oct Apr Oct
17, 17, 24, 24, 13, 13, 08, 08, 08, 08,
2012 2012 2013 2014 2015 2016 2018 2018 2018 2018
U-314
U-1195
DP
Apr Oct Dec Jun Jul Jan Apr Oct Apr Oct
17, 17, 24, 24, 13, 13, 08, 08, 08, 08,
2012 2012 2013 2014 2015 2016 2018 2018 2018 2018
U-314
U-1195
DP
U-671 DS U-1195
I-599
Jun
29, 2012
U-671 DS U-1195
I-599
Jun
29, 2012
U-671 DS U-1195
I-599
Jun
29, 2012
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PC
PAROXETINE HYDROCHLORIDE - PAROXETINE HYDROCHLORIDE A091427 001 PAROXETINE HYDROCHLORIDE - PAXIL N020031 001 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6113944 Dec 6113944*PED Jun 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov PAROXETINE HYDROCHLORIDE - PAXIL N020031 002 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6113944 Dec 6113944*PED Jun 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov PAROXETINE HYDROCHLORIDE - PAXIL N020031 003 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6113944 Dec 6113944*PED Jun 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov PAROXETINE HYDROCHLORIDE - PAXIL N020031 004 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6113944 Dec 6113944*PED Jun 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov
Nov
01, 2011
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PAROXETINE HYDROCHLORIDE - PAXIL N020031 005 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6113944 Dec 6113944*PED Jun 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov PAROXETINE HYDROCHLORIDE - PAXIL N020710 001 5811436 Sep 5811436*PED Mar 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov PAROXETINE HYDROCHLORIDE - PAXIL N020885 001 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6063927 Apr 6063927*PED Oct 6080759 May 6080759*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov 6172233 Jan 6172233*PED Jul PAROXETINE HYDROCHLORIDE - PAXIL N020885 002 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6063927 Apr 6063927*PED Oct 6080759 May 6080759*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov 6172233 Jan 6172233*PED Jul
19, 19, 19, 19, 14, 14, 17, 17, 17, 17, 19, 19,
2015 2015 2015 2015 2014 2015 2017 2017 2017 2017 2015 2015
22, 22, 19, 19, 19, 19, 17, 17, 17, 17, 19, 19,
2015 2016 2015 2015 2015 2015 2017 2017 2017 2017 2015 2015
19, 19, 19, 19, 23, 23, 19, 19, 17, 17, 17, 17, 19, 19, 15, 15,
2015 2015 2015 2015 2019 2019 2015 2015 2017 2017 2017 2017 2015 2015 2018 2018
19, 19, 19, 19, 23, 23, 19, 19, 17, 17, 17, 17, 19, 19, 15, 15,
2015 2015 2015 2015 2019 2019 2015 2015 2017 2017 2017 2017 2015 2015 2018 2018
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PAROXETINE HYDROCHLORIDE - PAXIL N020885 003 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6063927 Apr 6063927*PED Oct 6080759 May 6080759*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov 6172233 Jan 6172233*PED Jul PAROXETINE HYDROCHLORIDE - PAXIL N020885 004 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6062927 Apr 6063927*PED Oct 6080759 May 6080759*PED Nov 6121291 Mar 6121291 Mar 6121291*PED Sep 6121291*PED Sep 6133289 May 6133289*PED Nov 6172233 Jan 6172233*PED Jul PAROXETINE HYDROCHLORIDE - PAXIL CR N020936 001 5422123 Jun 5422123*PED Dec 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6121291 Mar 6121291*PED Sep 6133289 May 6133289*PED Nov 6548084 Jul 6548084*PED Jan 7229640 Jul PAROXETINE HYDROCHLORIDE - PAXIL CR N020936 002 5422123 Jun 5422123*PED Dec 5872132 May 5872132*PED Nov 5900423 May 5900423*PED Nov 6121291 Mar 6121291*PED Sep 6133289 May 6133289*PED Nov 6548084 Jul 6548084*PED Jan 7229640 Jul
19, 19, 19, 19, 23, 23, 19, 19, 17, 17, 17, 17, 19, 19, 15, 15,
2015 2015 2015 2015 2019 2019 2015 2015 2017 2017 2017 2017 2015 2015 2018 2018
19, 19, 19, 19, 23, 23, 19, 19, 17, 17, 17, 17, 19, 19, 15, 15,
2015 2015 2015 2015 2019 2019 2015 2015 2017 2017 2017 2017 2015 2015 2018 2018
06, 06, 19, 19, 19, 19, 17, 17, 19, 19, 19, 19, 19,
2012 2012 2015 2015 2015 2015 2017 2017 2015 2015 2016 2017 2016
DP
U-816
06, 06, 19, 19, 19, 19, 17, 17, 19, 19, 19, 19, 19,
2012 2012 2015 2015 2015 2015 2017 2017 2015 2015 2016 2017 2016
DP
U-816
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PAROXETINE HYDROCHLORIDE - PAXIL CR Jun N020936 003 5422123 Dec 5422123*PED May 5872132 Nov 5872132*PED May 5900423 Nov 5900423*PED Mar 6121291 Sep 6121291*PED May 6133289 Nov 6133289*PED Jul 6548084 Jan 6548084*PED Jul 7229640 PAROXETINE MESYLATE - PEXEVA N021299 001 5874447 5874447 5874447 6703408 7598271 PAROXETINE MESYLATE - PEXEVA N021299 002 5874447 5874447 5874447 6703408 7598271 PAROXETINE MESYLATE - PEXEVA N021299 003 5874447 5874447 5874447 6703408 7598271 PAROXETINE MESYLATE - PEXEVA N021299 004 5874447 5874447 5874447 6703408 7598271
06, 06, 19, 19, 19, 19, 17, 17, 19, 19, 19, 19, 19,
2012 2012 2015 2015 2015 2015 2017 2017 2015 2015 2016 2017 2016
DP
U-816
PAZOPANIB HYDROCHLORIDE - VOTRIENT N022465 001 7105530 Dec 7262203 Dec PAZOPANIB HYDROCHLORIDE - VOTRIENT N022465 002 7105530 Dec 7262203 Dec PEGAPTANIB SODIUM - MACUGEN N021756 001 5919455 5932462 6011020 6051698 6113906 PEGVISOMANT - SOMAVERT N021106 001 5350836 5681809 5849535 5958879 6057292 6583115
DS DS
DP DP
NCE
Oct
19, 2014
DS DS
DP DP
NCE
Oct
19, 2014
DS DS DS DS DS
U-622
APPL/PROD NO
PATENT NO
PATENT CODES
U-507 U-507 DS U-507 U-507 U-507
EXCLUSIVITY CODE(S)
PEGVISOMANT - SOMAVERT N021106 002 5350836 5681809 5849535 5958879 6057292 6583115 PEGVISOMANT - SOMAVERT N021106 003 5350836 5681809 5849535 5958879 6057292 6583115 PEMETREXED DISODIUM - ALIMTA N021462 001 5217974*PED 5344932 5344932*PED 7772209 7772209*PED
DS
DP U-1077
PEMETREXED DISODIUM - ALIMTA N021462 002 5217974*PED 5344932 5344932*PED 7772209 7772209*PED
DS
DP U-1077
PEMIROLAST POTASSIUM - ALAMAST N021079 001 5034230*PED Jul PENCICLOVIR SODIUM - DENAVIR N020629 001 5840763 5866581 5916893 6124304 6469015 6579981
02, 2011
U-184
PENTETATE CALCIUM TRISODIUM - PENTETATE CALCIUM TRISODIUM N021749 001 PENTETATE ZINC TRISODIUM - PENTETATE ZINC TRISODIUM N021751 001
ODE
Aug
11, 2011
ODE
Aug
11, 2011
PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE - SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS N021084 001 5607979 May 30, 2015 PERFLUTREN - DEFINITY N021064 001 5527521 5585112 6033645
DP DP
U-665 U-665
PHENTERMINE HYDROCHLORIDE - SUPRENZA N202088 001 6149938 Jul 23, 2018 PHENTERMINE HYDROCHLORIDE - SUPRENZA N202088 002 6149938 Jul 23, 2018
DP
DP
APPL/PROD NO
PATENT NO
PATENT CODES
U-967 DP DP U-967 DP
EXCLUSIVITY CODE(S)
PHENTOLAMINE MESYLATE - ORAVERSE N022159 001 6764678 May 6872390 May 7229630 Jun 7569230 Oct 7575757 Apr PIMECROLIMUS - ELIDEL N021302 001 5912238 5912238*PED 6352998 6352998*PED 6423722 6423722*PED
PIOGLITAZONE HYDROCHLORIDE - ACTOS N021073 001 5965584 Jun 6150383 Jun 6150384 Jun 6166042 Jun 6166043 Jun 6172090 Jun 6211205 Jun 6271243 Jun 6303640 Aug 6329404 Jun PIOGLITAZONE HYDROCHLORIDE - ACTOS N021073 002 5965584 Jun 6150383 Jun 6150384 Jun 6166042 Jun 6166043 Jun 6172090 Jun 6211205 Jun 6271243 Jun 6303640 Aug 6329404 Jun PIOGLITAZONE HYDROCHLORIDE - ACTOS N021073 003 5965584 Jun 6150383 Jun 6150384 Jun 6166042 Jun 6166043 Jun 6172090 Jun 6211205 Jun 6271243 Jun 6303640 Aug 6329404 Jun
19, 19, 19, 19, 19, 19, 19, 19, 09, 19,
2016 2016 2016 2016 2016 2016 2016 2016 2016 2016
U-753 U-418 U-419 U-414 U-415 U-416 U-410 U-411 U-425 U-753
19, 19, 19, 19, 19, 19, 19, 19, 09, 19,
2016 2016 2016 2016 2016 2016 2016 2016 2016 2016
U-753 U-418 U-419 U-414 U-415 U-416 U-410 U-411 U-425 U-753
19, 19, 19, 19, 19, 19, 19, 19, 09, 19,
2016 2016 2016 2016 2016 2016 2016 2016 2016 2016
U-753 U-418 U-419 U-414 U-415 U-416 U-410 U-411 U-425 U-753
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN N050684 001 6900184 Apr 14, 2023 7915229 Apr 14, 2023 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN N050684 002 6900184 Apr 14, 2023 7915229 Apr 14, 2023 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN N050684 003 6900184 Apr 14, 2023 7915229 Apr 14, 2023 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN N050684 004 6900184 Apr 14, 2023 7915229 Apr 14, 2023
DP DP
U-282
DP DP
U-282
DP DP
U-282
DP DP
U-282
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER DP N050750 001 6207661 Feb 22, 2019 DP U-282 6900184 Apr 14, 2023 DP Apr 14, 2023 7915229 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER N050750 002 6207661 Feb 22, 2019 DP DP U-282 6900184 Apr 14, 2023 DP 7915229 Apr 14, 2023 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM - ZOSYN IN PLASTIC CONTAINER DP N050750 003 6207661 Feb 22, 2019 DP U-282 6900184 Apr 14, 2023 DP Apr 14, 2023 7915229 PITAVASTATIN CALCIUM - LIVALO N022363 001 5753675 5854259 5856336 6465477 7022713 PITAVASTATIN CALCIUM - LIVALO N022363 002 5753675 5854259 5856336 6465477 7022713 PITAVASTATIN CALCIUM - LIVALO N022363 003 5753675 5854259 5856336 6465477 7022713 PLERIXAFOR - MOZOBIL N022311 001 6987102 7897590 RE42152 POLIDOCANOL - ASCLERA N021201 001 POLIDOCANOL - ASCLERA N021201 002 PORFIMER SODIUM - PHOTOFRIN N020451 001 5438071 POSACONAZOLE - NOXAFIL N022003 001 5661151 5703079 6958337 PRALATREXATE - FOLOTYN N022468 001 6028071 7622470 PRALATREXATE - FOLOTYN N022468 002 6028071 7622470 Aug 01, 2012
DS DS
DP DP DP
NCE
Aug
03, 2014
DS DS
DP DP DP
NCE
Aug
03, 2014
DS DS
DP DP DP
NCE
Aug
03, 2014
U-936 U-936 DP
NCE ODE
Dec Dec
NCE
Mar
30, 2015
NCE
Mar
30, 2015
DS DS DS
DP DP DP
NCE
Sep
15, 2011
Jul May
DS
DP
U-1004 U-1015
NCE ODE
Sep Sep
Jul May
DS
DP
U-1004 U-1015
NCE ODE
Sep Sep
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 001 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 002 6001861 Jan 16, 2018 6194445 Jan 16, 2018
U-784 U-784
M-104
May
13, 2014
U-784 U-784
M-104
May
13, 2014
APPL/PROD NO
PATENT NO
PATENT CODES
U-784 U-784
EXCLUSIVITY CODE(S)
M-104
PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 003 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 005 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 006 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX N020667 007 6001861 Jan 16, 2018 6194445 Jan 16, 2018 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 001 7695734 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER N022421 002 7695734 Apr 26, 2028 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER N022421 003 7695734 Apr 26, 2028 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER N022421 004 7695734 Apr 26, 2028 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER N022421 005 7695734 Apr 26, 2028 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER N022421 006 7695734 Apr 26, 2028 PRAMIPEXOLE DIHYDROCHLORIDE - MIRAPEX ER Apr 26, 2028 N022421 007 7695734 PRAMLINTIDE ACETATE - SYMLIN N021332 001 5686411 5814600 6114304 6608029 PRAMLINTIDE ACETATE - SYMLIN N021332 002 5686411 5814600 5814600 5814600 6114304 6114304 6608029 6608029 6608029
May
13, 2014
U-784 U-784
M-104
May
13, 2014
U-784 U-784
M-104
May
13, 2014
U-784 U-784
M-104
May
13, 2014
DP
I-623 NDF
Mar Feb
DP
I-623 NDF
Mar Feb
DP
I-623 NDF
Mar Feb
DP
I-623 NDF
Mar Feb
DP
I-623 NDF
Mar Feb
DP
I-623 NDF
Mar Feb
DP
Mar Feb
DS
DP
DS
DP
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-638 U-638 U-637 U-639 U-640 U-637 U-641 U-640 U-637
EXCLUSIVITY CODE(S)
PRAMLINTIDE ACETATE - SYMLIN N021332 003 5686411 5814600 5814600 5814600 6114304 6114304 6608029 6608029 6608029
PRASUGREL HYDROCHLORIDE - EFFIENT Apr N022307 001 5288726 Jul 6693115 PRASUGREL HYDROCHLORIDE - EFFIENT Apr N022307 002 5288726 Jul 6693115 PRAVASTATIN SODIUM - PRAVACHOL Apr N019898 002 5622985 Oct 5622985*PED PRAVASTATIN SODIUM - PRAVACHOL N019898 003 5622985 Apr 5622985*PED Oct PRAVASTATIN SODIUM - PRAVACHOL Apr N019898 004 5622985 Oct 5622985*PED PRAVASTATIN SODIUM - PRAVACHOL N019898 008 5622985 Apr 5622985*PED Oct PREDNISOLONE ACETATE - FLO-PRED N022067 001 5881926 Mar 6071523 Jun 6102254 Mar 6399079 Jun 6656482 Jun PREDNISOLONE ACETATE - FLO-PRED N022067 002 5881926 Mar 6071523 Jun 6102254 Mar 6399079 Jun 6656482 Jun
DS DS
DP DP
U-991 U-991
NCE
Jul
10, 2014
DS DS
DP DP
U-991 U-991
NCE
Jul
10, 2014
U-335 U-335
U-335 U-335
U-335 U-335
U-335 U-335
DP DP DP DP DP
2016 2018 2013 2018 2018 ODT 2018 2018 2019 ODT 2018 2018 2019 ODT 2018 2018 2019
DP DP DP DP DP
PREDNISOLONE SODIUM PHOSPHATE - ORAPRED N021959 001 6024981 Apr 09, 6221392 Apr 09, Nov 24, 6740341 PREDNISOLONE SODIUM PHOSPHATE - ORAPRED Apr 09, N021959 002 6024981 Apr 09, 6221392 Nov 24, 6740341 PREDNISOLONE SODIUM PHOSPHATE - ORAPRED Apr 09, N021959 003 6024981 Apr 09, 6221392 Nov 24, 6740341 PREGABALIN - LYRICA N021446 001 5563175 6001876 6001876 6197819 RE41920
DP DP DP
Y Y
DP DP DP
Y Y
DP DP DP
Y Y
APPL/PROD NO
PATENT NO
PATENT CODES
U-661 U-55 U-819 DS DP U-1099
EXCLUSIVITY CODE(S)
PREGABALIN - LYRICA N021446 002 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 003 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 004 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 005 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 006 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 007 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N021446 008 5563175 6001876 6001876 6197819 RE41920 PREGABALIN - LYRICA N022488 001 5563175 6001876 6001876 6197819 RE41920
PROCAINAMIDE HYDROCHLORIDE - PROCANBID N020545 001 5656296 Aug 12, 2014 PROCAINAMIDE HYDROCHLORIDE - PROCANBID N020545 002 5656296 Aug 12, 2014 PROGESTERONE - CRINONE N020701 001 5543150 PROGESTERONE - CRINONE N020701 002 5543150
Sep
15, 2013
U-209
Sep
15, 2013
U-209
APPL/PROD NO
PATENT NO
PATENT CODES
U-856 U-856 U-880
EXCLUSIVITY CODE(S)
DP
PROPAFENONE HYDROCHLORIDE - RYTHMOL SR N021416 001 5681588 Oct 28, 2014 PROPAFENONE HYDROCHLORIDE - RYTHMOL SR N021416 002 5681588 Oct 28, 2014 PROPAFENONE HYDROCHLORIDE - RYTHMOL SR N021416 003 5681588 Oct 28, 2014 PROPOFOL - DIPRIVAN N019627 002 5714520 5714520*PED 5731355 5731355*PED 5731356 5731356*PED 5908869 5908869*PED
PROPRANOLOL HYDROCHLORIDE - INNOPRAN XL N021438 001 6500454 Dec 31, 2022 PROPRANOLOL HYDROCHLORIDE - INNOPRAN XL N021438 002 6500454 Dec 31, 2022 QUAZEPAM - DORAL N018708 001 7608616 QUAZEPAM - DORAL N018708 003 7608616
Jun
03, 2028
U-1012
Jun
03, 2028
U-1012
DS
DP
U-550
DS
DP
U-550
DS
DP
U-550
DS
DP
U-550
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-550
EXCLUSIVITY CODE(S)
NPP NPP PED PED PED
DS
DP
U-550
DS
DP
U-550
QUETIAPINE FUMARATE - SEROQUEL N022047 001 4879288 4879288 4879288 4879288*PED 5948437 5948437 5948437 5948437*PED
DS DS DS
DP DP DP DP DP DP
QUETIAPINE FUMARATE - SEROQUEL N022047 002 4879288 4879288 4879288 4879288*PED 5948437 5948437 5948437 5948437*PED
DS DS DS
DP DP DP DP DP DP
QUETIAPINE FUMARATE - SEROQUEL N022047 003 4879288 4879288 4879288 4879288*PED 5948437 5948437 5948437 5948437*PED
DS DS DS
DP DP DP DP DP DP
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DP DP DP DP DP DP U-814 U-601 U-839 U-814 U-601 U-839
EXCLUSIVITY CODE(S)
D-117 I-618 I-576 I-575 I-574 PED PED PED PED
QUETIAPINE FUMARATE - SEROQUEL N022047 004 4879288 4879288 4879288 4879288*PED 5948437 5948437 5948437 5948437*PED
QUETIAPINE FUMARATE - SEROQUEL N022047 005 4879288 4879288 4879288 4879288*PED 5948437 5948437 5948437 5948437*PED
DS DS DS
DP DP DP DP DP DP
QUINAPRIL HYDROCHLORIDE - ACCUPRIL N019885 001 5684016 Nov 5684016*PED May QUINAPRIL HYDROCHLORIDE - ACCUPRIL N019885 002 5684016 Nov 5684016*PED May QUINAPRIL HYDROCHLORIDE - ACCUPRIL N019885 003 5684016 Nov 5684016*PED May QUINAPRIL HYDROCHLORIDE - ACCUPRIL N019885 004 5684016 Nov 5684016*PED May QUININE SULFATE - QUALAQUIN N021799 001 RABEPRAZOLE SODIUM - ACIPHEX N020973 001 5045552 RABEPRAZOLE SODIUM - ACIPHEX N020973 002 5045552
U-210 U-210
U-210 U-210
U-210 U-210
U-210 U-210
Aug
12, 2012
May
08, 2013
U-385
RALOXIFENE HYDROCHLORIDE - EVISTA N020815 001 5393763 Jul 5457117 Jul 5478847 Mar 5811120 Mar 5972383 Mar 6458811 Mar 6797719 Mar 6894064 Mar 6906086 Jul 6906086 Jul 8030330 Mar RE38968 Jul RE38968 Jul RE39049 Jul RE39049 Jul RE39050 Mar RE39050 Mar
28, 28, 02, 02, 02, 10, 10, 10, 28, 28, 10, 28, 28, 28, 28, 02, 02,
2012 2012 2014 2014 2014 2017 2017 2017 2012 2012 2017 2012 2012 2012 2012 2014 2014
U-114 U-114 U-114 U-287 U-825 U-657 U-662 U-657 U-662 U-657 U-662 U-657 U-657 U-662
Y Y Y
ODE
Sep
13, 2014
DS
DP DP DP
DP
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-257 U-900 U-257 U-257
EXCLUSIVITY CODE(S)
NPP NCE
RALTEGRAVIR POTASSIUM - ISENTRESS N022145 001 7169780 Oct 7217713 Oct 7435734 Oct 7435734 Oct 7754731 Mar RALTEGRAVIR POTASSIUM - ISENTRESS N203045 001 RALTEGRAVIR POTASSIUM - ISENTRESS N203045 002 RAMELTEON - ROZEREM N021782 001 6034239 RAMIPRIL - ALTACE N019901 001 5403856 7368469 RAMIPRIL - ALTACE N019901 002 5403856 7368469 RAMIPRIL - ALTACE N019901 003 5403856 7368469 RAMIPRIL - ALTACE N019901 004 5403856 7368469 RAMIPRIL - ALTACE N022021 001 5403856 7368469 RAMIPRIL - ALTACE N022021 002 5403856 7368469 RAMIPRIL - ALTACE N022021 003 5403856 7368469 RAMIPRIL - ALTACE N022021 004 5403856 7368469
Dec Oct
DS
DP
NDF
Dec
21, 2014
Dec
21, 2014
Jul
M-82
Oct
20, 2011
Apr Aug
U-71 U-871
Apr Aug
U-71 U-871
Apr Aug
U-71 U-871
Apr Aug
U-71 U-871
Apr Aug
U-71 U-871
Apr Aug
U-71 U-871
Apr Aug
U-71 U-871
Apr Aug
U-71 U-871
RANITIDINE BISMUTH CITRATE - TRITEC N020559 001 5403830 Apr 04, 2012 5407688 Apr 04, 2012 Oct 10, 2012 5456925 Feb 11, 2014 5601848 May 13, 2014 5629297 RANOLAZINE - RANEXA N021526 001 6303607 6369062 6479496 6503911 6525057 6562826 6617328 6620814 6852724 6864258
May May May May May May May May May May
27, 27, 27, 27, 27, 27, 27, 27, 27, 27,
2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
APPL/PROD NO
PATENT NO
PATENT CODES
U-705 DP U-705 DP U-705 U-705 DP U-705 U-705 U-705
EXCLUSIVITY CODE(S)
RANOLAZINE - RANEXA N021526 002 6303607 6369062 6479496 6503911 6525057 6562826 6617328 6620814 6852724 6864258 RAPACURONIUM BROMIDE - RAPLON N020984 001 5418226 RAPACURONIUM BROMIDE - RAPLON N020984 002 5418226 RASAGILINE MESYLATE - AZILECT N021641 001 5387612 5453446 5457133 5532415 5786390 6126968 7572834 7815942 RASAGILINE MESYLATE - AZILECT N021641 002 5387612 5453446 5457133 5532415 5786390 6126968 7572834 7815942 REGADENOSON - LEXISCAN N022161 001 6403567 6642210 7144872 7144872 7144872 7183264 7183264 7183264 7582617 7655636 7655637 7683037
May May May May May May May May May May
27, 27, 27, 27, 27, 27, 27, 27, 27, 27,
2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
Apr
14, 2013
Apr
14, 2013
U-219 U-219 DS DS DP DP DP DP DP
DS
U-219
U-219 U-219 DS DS DP DP DP DP DP
DS
U-219
Apr Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun Jun
10, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22, 22,
2022 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019 2019
DS DS DS DS DS
DP DP DP DP DP DP DP DP
DS
DP
U-869 U-869 U-870 U-869 U-116 U-870 U-869 U-116 U-1003 U-869 U-869 U-1042
NCE
Apr
10, 2013
REMIFENTANIL HYDROCHLORIDE - ULTIVA N020630 001 5866591 Sep 10, 2017 Mar 10, 2018 5866591*PED REMIFENTANIL HYDROCHLORIDE - ULTIVA N020630 002 5866591 Sep 10, 2017 Mar 10, 2018 5866591*PED REMIFENTANIL HYDROCHLORIDE - ULTIVA N020630 003 5866591 Sep 10, 2017 Mar 10, 2018 5866591*PED REPAGLINIDE - PRANDIN N020741 001 6677358 REPAGLINIDE - PRANDIN N020741 002 6677358
DP
DP
DP
Jun
12, 2018
DS
DP
U-968
Jun
12, 2018
DS
DP
U-968
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-968
EXCLUSIVITY CODE(S)
REPAGLINIDE - PRANDIN N020741 003 6677358 RETAPAMULIN - ALTABAX N022055 001 7875630 RE39128 RIBAVIRIN - COPEGUS N021511 001 RIBAVIRIN - REBETOL N020903 001 6172046 6172046 6172046*PED 6177074 6177074 6177074*PED 6461605 6461605 6461605*PED 6472373 6472373 6472373*PED 6524570 6524570 6524570*PED RIBAVIRIN - REBETOL N020903 002 6172046 6172046 6172046*PED 6177074 6177074 6177074*PED 6461605 6461605 6461605*PED 6472373 6472373 6472373*PED 6524570 6524570 6524570*PED RIBAVIRIN - REBETOL N021546 001 6172046 6172046 6172046*PED 6177074 6177074*PED 6461605 6461605 6461605*PED 6472373 6472373*PED 6524570 6524570*PED 6790837 6790837*PED RIBAVIRIN - VIRAZOLE N018859 001 6150337 RIFAXIMIN - XIFAXAN N021361 001 7045620 7612199 7902206 7906542 7928115
Jun
12, 2018
Feb Apr
DS DS
NCE DP U-805
Apr
12, 2012
NPP Sep Sep Mar Nov Nov May Nov Nov May Sep Sep Mar Nov Nov May 21, 21, 21, 01, 01, 01, 01, 01, 01, 21, 21, 21, 01, 01, 01, 2017 2017 2018 2016 2016 2017 2016 2016 2017 2017 2017 2018 2016 2016 2017 U-1014 U-377 U-377 U-1013 U-454 U-454 U-478 U-1013 U-478 U-479 U-1014 U-479 U-499 U-1013 U-499
Aug
09, 2014
Sep Sep Mar Nov Nov May Nov Nov May Sep Sep Mar Nov Nov May
21, 21, 21, 01, 01, 01, 01, 01, 01, 21, 21, 21, 01, 01, 01,
2017 2017 2018 2016 2016 2017 2016 2016 2017 2017 2017 2018 2016 2016 2017
U-377 U-1014 U-377 U-1013 U-454 U-454 U-1013 U-478 U-478 U-1014 U-479 U-479 U-499 U-1013 U-499
Sep Sep Mar Nov May Nov Nov May Sep Mar Nov May Apr Oct
21, 21, 21, 01, 01, 01, 01, 01, 21, 21, 01, 01, 05, 05,
2017 2017 2018 2016 2017 2016 2016 2017 2017 2018 2016 2017 2023 2023
U-521 U-1014 U-521 U-1013 U-521 U-1013 U-521 U-521 U-521 U-1013 DP U-1014
Nov
21, 2017
U-400
DS DS DS DS
DP DP DP DP U-1121
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS
EXCLUSIVITY CODE(S)
NP ODE
DP DP DP
Mar Mar
RILPIVIRINE HYDROCHLORIDE - EDURANT Feb 26, 2021 N202022 001 6838464 Dec 20, 2019 7067522 Apr 14, 2023 7125879 Apr 14, 2023 7638522 RILUZOLE - RILUTEK N020599 001 5527814 RISEDRONATE SODIUM - ACTONEL N020835 001 5583122 5583122*PED 6096342 6096342*PED 6165513 6165513*PED RISEDRONATE SODIUM - ACTONEL N020835 002 5583122 5583122*PED 6096342 6096342*PED 6165513 6165513*PED RISEDRONATE SODIUM - ACTONEL N020835 003 5583122 5583122 5583122*PED 5994329 5994329*PED 6015801 6015801*PED 6096342 6096342*PED 6165513 6165513*PED 6432932 6432932*PED 6465443 6465443*PED RISEDRONATE SODIUM - ACTONEL N020835 004 5583122 5583122*PED 6096342 6096342*PED 6165513 6165513*PED RISEDRONATE SODIUM - ACTONEL N020835 005 5583122 5583122*PED 6165513 6165513*PED 7192938 7192938*PED 7718634 7718634*PED
DS DS DS
DP DP DP DP
NCE U-1153
May
20, 2016
Jun
18, 2013
U-222
M-61 PED
Jul Jan
U-222
M-61 PED
Jul Jan
Dec Dec Jun Jul Jan Jul Jan Nov May Jun Dec Jul Jan Aug Feb
10, 10, 10, 17, 17, 17, 17, 22, 22, 10, 10, 17, 17, 14, 14,
2013 2013 2014 2018 2019 2018 2019 2011 2012 2018 2018 2018 2019 2018 2019
DS DS
DP DP
M-61 PED
Jul Jan
DP DP U-595 DP
DS
DP DP DP
U-353 U-353
M-61 PED
Jul Jan
DS
DP DP
U-353
U-353 U-662
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP DP DP U-662 U-662 U-662 U-662
EXCLUSIVITY CODE(S)
NDF
RISEDRONATE SODIUM - ATELVIA N022560 001 5583122 5583122*PED 5622721 7645459 7645460 RISPERIDONE - RISPERDAL N020588 001 5453425 5453425*PED 5616587 5616587*PED RE39181 RE39181*PED RISPERIDONE - RISPERDAL N021444 001 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL N021444 002 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL N021444 003 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL N021444 004 5648093 5648093*PED 6224905 6224905*PED RISPERIDONE - RISPERDAL N021444 005 5648093 5648093*PED 6224905 6224905*PED
Oct
08, 2013
DP Y DP
DP DP
DP DP
DP DP
DP DP
DP DP
APPL/PROD NO
PATENT NO
PATENT CODES
U-543 U-972 DP DP DP U-543 DP U-543 DP DP DP DP DP
EXCLUSIVITY CODE(S)
I-597 I-596
RISPERIDONE - RISPERDAL CONSTA N021346 001 5688801 5688801 5688801*PED 5792477 5792477*PED 5916598 5916598*PED 5965168 5965168*PED 6110921 6110921*PED 6194006 6194006*PED 6368632 6368632*PED 6379703 6379703*PED 6403114 6403114*PED 6596316 6596316*PED 6667061 6667061*PED 7547452 7547452*PED RISPERIDONE - RISPERDAL CONSTA N021346 002 5688801 5688801 5688801*PED 5792477 5792477*PED 5916598 5916598*PED 5965168 5965168*PED 6110921 6110921*PED 6194006 6194006*PED 6368632 6368632*PED 6379703 6379703*PED 6403114 6403114*PED 6596316 6596316*PED 6667061 6667061*PED 7547452 7547452*PED
Nov Nov May May Nov May Nov Nov May Nov May Dec Jun Nov May Dec Jun May Nov Dec Jun May Nov Nov May
18, 18, 18, 02, 02, 02, 02, 19, 19, 19, 19, 30, 30, 19, 19, 30, 30, 02, 02, 30, 30, 25, 25, 19, 19,
2014 2014 2015 2017 2017 2017 2017 2013 2014 2013 2014 2018 2019 2013 2014 2018 2019 2017 2017 2018 2019 2020 2020 2013 2014
May May
Nov Nov May May Nov May Nov Nov May Nov May Dec Jun Nov May Dec Jun May Nov Dec Jun May Nov Nov May
18, 18, 18, 02, 02, 02, 02, 19, 19, 19, 19, 30, 30, 19, 19, 30, 30, 02, 02, 30, 30, 25, 25, 19, 19,
2014 2014 2015 2017 2017 2017 2017 2013 2014 2013 2014 2018 2019 2013 2014 2018 2019 2017 2017 2018 2019 2020 2020 2013 2014
I-597 I-596
May May
APPL/PROD NO
PATENT NO
PATENT CODES
U-543 U-972 DP DP DP U-543 DP U-543 DP DP DP DP DP
EXCLUSIVITY CODE(S)
I-597 I-596
RISPERIDONE - RISPERDAL CONSTA N021346 003 5688801 5688801 5688801*PED 5792477 5792477*PED 5916598 5916598*PED 5965168 5965168*PED 6110921 6110921*PED 6194006 6194006*PED 6368632 6368632*PED 6379703 6379703*PED 6403114 6403114*PED 6596316 6596316*PED 6667061 6667061*PED 7547452 7547452*PED RISPERIDONE - RISPERDAL CONSTA N021346 004 5688801 5688801 5688801*PED 5792477 5792477*PED 5916598 5916598*PED 5965168 5965168*PED 6110503 6110503*PED 6110921 6110921*PED 6194006 6194006*PED 6368632 6368632*PED 6379703 6379703*PED 6403114 6403114*PED 6596316 6596316*PED 6667061 6667061*PED 7547452 7547452*PED
Nov Nov May May Nov May Nov Nov May Nov May Dec Jun Nov May Dec Jun May Nov Dec Jun May Nov Nov May
18, 18, 18, 02, 02, 02, 02, 19, 19, 19, 19, 30, 30, 19, 19, 30, 30, 02, 02, 30, 30, 25, 25, 19, 19,
2014 2014 2015 2017 2017 2017 2017 2013 2014 2013 2014 2018 2019 2013 2014 2018 2019 2017 2017 2018 2019 2020 2020 2013 2014
May May
Nov Nov May May Nov May Nov Nov May May Nov Nov May Dec Jun Nov May Dec Jun May Nov Dec Jun May Nov Nov May
18, 18, 18, 02, 02, 02, 02, 19, 19, 02, 02, 19, 19, 30, 30, 19, 19, 30, 30, 02, 02, 30, 30, 25, 25, 19, 19,
2014 2014 2015 2017 2017 2017 2017 2013 2014 2017 2017 2013 2014 2018 2019 2013 2014 2018 2019 2017 2017 2018 2019 2020 2020 2013 2014
I-597 I-596
May May
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
RITONAVIR - NORVIR N020659 001 5484801 5484801*PED 5541206 5541206*PED 5635523 5635523*PED 5648497 5648497*PED 5674882 5674882*PED 5948436 5948436*PED 6037157 6037157*PED 6703403 6703403*PED RITONAVIR - NORVIR N020680 001 5541206 5541206*PED 5635523 5635523*PED 5648497 5648497*PED 5948436 5948436*PED RITONAVIR - NORVIR N020945 001 5541206 5541206*PED 5635523 5635523*PED 5648497 5648497*PED 5674882 5674882*PED 5948436 5948436*PED 6037157 6037157*PED 6232333 6232333*PED 6703403 6703403*PED 7141593 7141593*PED 7432294 7432294*PED RITONAVIR - NORVIR N022417 001 5541206 5541206*PED 5635523 5635523*PED 5648497 5648497*PED 5674882 5674882*PED 6037157 6037157*PED 6703403 6703403*PED 7148359 7148359*PED 7364752 7364752*PED
Jan Jul Jul Jan Jul Jan Jul Jan Jul Jan Sep Mar Jun Dec Jun Dec
28, 28, 30, 30, 30, 30, 15, 15, 30, 30, 13, 13, 26, 26, 26, 26,
2014 2014 2013 2014 2013 2014 2014 2015 2013 2014 2013 2014 2016 2016 2016 2016
U-140 U-190
U-688 DP
U-564
U-140 U-190
Jul Jan Jul Jan Jul Jan Jul Jan Sep Mar Jun Dec Nov May Jun Dec May Nov May Nov
30, 30, 30, 30, 15, 15, 30, 30, 13, 13, 26, 26, 07, 07, 26, 26, 22, 22, 22, 22,
2013 2014 2013 2014 2014 2015 2013 2014 2013 2014 2016 2016 2017 2018 2016 2016 2020 2020 2020 2020
U-348 U-347
U-895 DP U-895
U-564 DP DP
Jul Jan Jul Jan Jul Jan Jul Jan Jun Dec Jun Dec Jul Jan Nov May
30, 30, 30, 30, 15, 15, 30, 30, 26, 26, 26, 26, 19, 19, 10, 10,
2013 2014 2013 2014 2014 2015 2013 2014 2016 2016 2016 2016 2019 2020 2020 2021
DS
DP
U-688 U-688
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP U-1167
EXCLUSIVITY CODE(S)
NCE
RIVAROXABAN - XARELTO N022406 001 7157456 7585860 7592339 RIVAROXABAN - XARELTO N202439 001 7157456 7585860 7592339 7592339 RIVAROXABAN - XARELTO N202439 002 7157456 7585860 7592339 7592339 RIVASTIGMINE - EXELON N022083 001 4948807 5602176 6316023 6335031 RIVASTIGMINE - EXELON N022083 002 4948807 5602176 6316023 6335031
Jul
01, 2016
DS DS
DP U-1167 U-1200
I-643 NCE
Nov Jul
DS DS
DP U-1167 U-1200
I-643 NCE
Nov Jul
DS DS
DP DP DP
U-322 U-322
DS DS
DP DP DP
U-322 U-322
RIVASTIGMINE TARTRATE - EXELON N020823 003 4948807 Aug 5602176 Feb RIVASTIGMINE TARTRATE - EXELON N020823 004 4948807 Aug 5602176 Feb RIVASTIGMINE TARTRATE - EXELON N020823 005 4948807 Aug 5602176 Feb RIVASTIGMINE TARTRATE - EXELON N020823 006 4948807 Aug 5602176 Feb RIVASTIGMINE TARTRATE - EXELON Aug N021025 001 4948807 Feb 5602176 RIZATRIPTAN BENZOATE - MAXALT N020864 001 5298520 5298520*PED 5602162 5602162*PED RIZATRIPTAN BENZOATE - MAXALT N020864 002 5298520 5298520*PED 5602162 5602162*PED
DS
U-322 U-322
DS
U-322 U-322
DS
U-322 U-322
DS
U-322 U-322
DS
U-322 U-322
DS
DP
U-240 Y
NPP PED
Dec Jun
DS
DP
U-240 Y
NPP PED
Dec Jun
RIZATRIPTAN BENZOATE - MAXALT-MLT N020865 001 5298520 Jun 5298520*PED Dec 5457895 Oct 5457895*PED Apr Feb 5602162 Aug 5602162*PED
DS
DP DP
U-240
NPP PED Y
Dec Jun
U-240
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP DP U-240 U-240
EXCLUSIVITY CODE(S)
NPP PED
RIZATRIPTAN BENZOATE - MAXALT-MLT Jun N020865 002 5298520 Dec 5298520*PED Oct 5457895 Apr 5457895*PED Feb 5602162 Aug 5602162*PED ROCURONIUM BROMIDE - ZEMURON N020214 001 ROCURONIUM BROMIDE - ZEMURON N020214 002 ROCURONIUM BROMIDE - ZEMURON N020214 003 ROFECOXIB - VIOXX N021042 001 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFECOXIB - VIOXX N021042 002 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFECOXIB - VIOXX N021042 003 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFECOXIB - VIOXX N021052 001 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED ROFECOXIB - VIOXX N021052 002 5474995 5474995*PED 5691374 5691374*PED 6063811 6063811*PED 6239173 6239173*PED
Dec Jun
NPP PED
Aug Feb
NPP PED
Aug Feb
NPP PED Jun Dec May Nov May Nov Jun Dec 24, 24, 18, 18, 06, 06, 24, 24, 2013 2013 2015 2015 2017 2017 2013 2013 DS DP U-602
Aug Feb
U-602 DS DP U-602
DS
DP
U-602
U-602 DS DP U-602
DS
DP
U-602
U-602 DS DP U-602
U-266
U-266
U-266
U-266
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-1115
EXCLUSIVITY CODE(S)
NCE
ROFLUMILAST - DALIRESP N022522 001 5712298 ROMIDEPSIN - ISTODAX N022393 001 4977138 7608280 7611724
Jan
27, 2015
Feb
28, 2016
DS DS DS
DP
ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 001 5422123 Jun 06, 2012 7927624 Dec 02, 2021 ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 002 5422123 Jun 06, 2012 7927624 Dec 02, 2021 ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 003 5422123 Jun 06, 2012 7927624 Dec 02, 2021 ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 004 5422123 Jun 06, 2012 7927624 Dec 02, 2021 ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 005 5422123 Jun 06, 2012 7927624 Dec 02, 2021 ROPINIROLE HYDROCHLORIDE - REQUIP XL N022008 006 5422123 Jun 06, 2012 7927624 Dec 02, 2021 ROPIVACAINE HYDROCHLORIDE MONOHYDRATE - NAROPIN N020533 001 5670524 May 26, 2014 DS DS 5834489 May 26, 2014 ROPIVACAINE HYDROCHLORIDE MONOHYDRATE - NAROPIN DS N020533 003 5670524 May 26, 2014 5834489 May 26, 2014 DS ROPIVACAINE HYDROCHLORIDE MONOHYDRATE - NAROPIN N020533 004 5670524 May 26, 2014 DS 5834489 May 26, 2014 DS ROPIVACAINE HYDROCHLORIDE MONOHYDRATE - NAROPIN DS N020533 005 5670524 May 26, 2014 May 26, 2014 DS 5834489 ROSIGLITAZONE MALEATE - AVANDIA N021071 002 5002953 Sep Sep 5002953 Sep 5002953 Mar 5002953*PED Apr 5741803 Apr 5741803 Oct 5741803*PED Feb 6288095 Aug 6288095*PED Apr 7358366 Oct 7358366*PED
DP
DP U-20
DP
DP U-20
DP DP
U-20
DP DP
U-20
DP DP
U-20
DP DP
U-20
DP DP
U-833 U-838
DP DP
U-833
U-838
DP DP
U-833 U-838
DP DP
U-833 U-838
17, 17, 17, 17, 21, 21, 21, 11, 11, 19, 19,
2011 2011 2011 2012 2015 2015 2015 2017 2017 2020 2020
DS DS DS DS DS
DP DP DP DP DP
DS
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DS DS DS DP DP DP DP DP U-840 U-329 U-628 U-628 U-329 U-420 DS
EXCLUSIVITY CODE(S)
ROSIGLITAZONE MALEATE - AVANDIA Sep N021071 003 5002953 Sep 5002953 Sep 5002953 Mar 5002953*PED Apr 5741803 Apr 5741803 Oct 5741803*PED Feb 6288095 Aug 6288095*PED Apr 7358366 Oct 7358366*PED ROSIGLITAZONE MALEATE - AVANDIA Sep N021071 004 5002953 Sep 5002953 Sep 5002953 Mar 5002953*PED Apr 5741803 Apr 5741803 Oct 5741803*PED Feb 6288095 Aug 6288095*PED Apr 7358366 Oct 7358366*PED ROSUVASTATIN CALCIUM - CRESTOR N021366 002 6316460 6316460*PED 6858618 6858618*PED 7030152 7030152*PED 7964614 7964614*PED RE37314 RE37314*PED ROSUVASTATIN CALCIUM - CRESTOR N021366 003 6316460 6316460*PED 6858618 6858618*PED 7030152 7030152*PED 7964614 7964614*PED RE37314 RE37314*PED ROSUVASTATIN CALCIUM - CRESTOR N021366 004 6316460 6316460*PED 6858618 6858618*PED 7030152 7030152*PED 7964614 7964614*PED RE37314 RE37314*PED
17, 17, 17, 17, 21, 21, 21, 11, 11, 19, 19,
2011 2011 2011 2012 2015 2015 2015 2017 2017 2020 2020
Y Y Y
17, 17, 17, 17, 21, 21, 21, 11, 11, 19, 19,
2011 2011 2011 2012 2015 2015 2015 2017 2017 2020 2020
DS DS DS DS DS
DP DP DP DP DP
DS
Aug Feb Dec Jun Apr Oct Apr Oct Jan Jul
04, 04, 17, 17, 02, 02, 02, 02, 08, 08,
2020 2021 2021 2022 2018 2018 2018 2018 2016 2016
Aug Feb Dec Jun Apr Oct Apr Oct Jan Jul
04, 04, 17, 17, 02, 02, 02, 02, 08, 08,
2020 2021 2021 2022 2018 2018 2018 2018 2016 2016
Aug Feb Dec Jun Apr Oct Apr Oct Jan Jul
04, 04, 17, 17, 02, 02, 02, 02, 08, 08,
2020 2021 2021 2022 2018 2018 2018 2018 2016 2016
APPL/PROD NO
PATENT NO
PATENT CODES
DP U-618 U-1032 U-1032 DS
EXCLUSIVITY CODE(S)
I-621 I-611 I-573 PED PED
ROSUVASTATIN CALCIUM - CRESTOR N021366 005 6316460 6316460*PED 6858618 6858618*PED 7030152 7030152*PED 7964614 7964614*PED RE37314 RE37314*PED ROTIGOTINE - NEUPRO N021829 001 6699498 6884434 7413747 ROTIGOTINE - NEUPRO N021829 002 6699498 6884434 7413747 ROTIGOTINE - NEUPRO N021829 003 6699498 6884434 7413747 RUFINAMIDE - BANZEL N021911 001 6740669 8076362 RUFINAMIDE - BANZEL N021911 002 6740669 8076362 RUFINAMIDE - BANZEL N021911 003 6740669 8076362 RUFINAMIDE - BANZEL N201367 001 6740669
Aug Feb Dec Jun Apr Oct Apr Oct Jan Jul
04, 04, 17, 17, 02, 02, 02, 02, 08, 08,
2020 2021 2021 2022 2018 2018 2018 2018 2016 2016
DP DP DP
NCE
May
09, 2012
DP DP DP
NCE
May
09, 2012
DP DP DP
NCE
May
09, 2012
Nov Jun
DS
DP DP
NCE ODE
Nov Nov
Nov Jun
DS
DP DP
NCE ODE
Nov Nov
Nov Jun
DS
DP DP
NCE ODE
Nov Nov
Aug
17, 2020
DS
DP
Nov Nov
RUXOLITINIB PHOSPHATE - JAKAFI N202192 001 7598257 Dec RUXOLITINIB PHOSPHATE - JAKAFI N202192 002 7598257 Dec RUXOLITINIB PHOSPHATE - JAKAFI N202192 003 7598257 Dec RUXOLITINIB PHOSPHATE - JAKAFI N202192 004 7598257 Dec RUXOLITINIB PHOSPHATE - JAKAFI N202192 005 7598257 Dec
24, 2027
DS
DP
NCE ODE
Nov Nov
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
24, 2027
DS
DP
U-1201
NCE ODE
Nov Nov
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
SALMETEROL XINAFOATE - SEREVENT Sep N020692 001 5590645*PED Sep 5860419*PED Feb 5873360 Aug 5873360*PED Sep 6032666*PED Sep 6378519*PED Sep 6536427*PED Sep 6792945*PED Sep 7225808*PED Sep 7389775*PED
01, 01, 23, 23, 01, 01, 01, 01, 01, 01,
2011 2011 2016 2016 2011 2011 2011 2011 2011 2011
DP
SAPROPTERIN DIHYDROCHLORIDE - KUVAN N022181 001 7566462 Nov 16, 2025 7566714 Nov 17, 2024 7612073 Nov 17, 2024 7727987 Nov 17, 2024 7947681 Nov 17, 2024 8003126 Nov 16, 2025 8067416 Nov 17, 2024 SAQUINAVIR - FORTOVASE N020828 001 6008228 6008228*PED 6352717 6352717*PED
NCE ODE
Dec Dec
SAXAGLIPTIN HYDROCHLORIDE - ONGLYZA N022350 001 6395767 Feb 16, 2021 7951400 Nov 30, 2028 SAXAGLIPTIN HYDROCHLORIDE - ONGLYZA N022350 002 6395767 Feb 16, 2021 7951400 Nov 30, 2028 SELEGILINE - EMSAM N021336 001 7070808 7150881 7638140 SELEGILINE - EMSAM N021336 002 7070808 7150881 7638140 SELEGILINE - EMSAM N021336 003 7070808 7150881 7638140
DS
DP DP
U-995
M-108 NCE
Dec Jul
DS
DP DP
U-995
M-108 NCE
Dec Jul
DS DS
DP DP DP
DS DS
DP DP DP
DS DS
DP DP DP
SELEGILINE HYDROCHLORIDE - ZELAPAR N021479 001 5648093 Jul 6423342 Mar SERTACONAZOLE NITRATE - ERTACZO N021385 001 5135943 May SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 001 5248699 Feb 5248699*PED SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 002 5248699 Feb 5248699*PED SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 003 5248699 Feb 5248699*PED
DP DP
31, 2014
DS
DP
U-786
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 004 5248699 Feb 5248699*PED SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N019839 005 5248699 Feb 5248699*PED SERTRALINE HYDROCHLORIDE - ZOLOFT Aug N020990 001 5248699 Feb 5248699*PED Oct 6727283 Apr 6727283*PED Nov 7067555 May 7067555*PED SEVELAMER CARBONATE - RENVELA N022127 001 5496545 5667775 6509013 6858203 7014846 7459151 7985418 SEVELAMER CARBONATE - RENVELA N022318 001 5496545 5667775 6509013 6858203 7014846 7459151 SEVELAMER CARBONATE - RENVELA N022318 002 5496545 5667775 6509013 6858203 7014846 7459151
DP DP
U-580
DP DP DP DP DP
DP DP DP DP
NDF
Aug
12, 2012
DP DP DP DP
NDF
Aug
12, 2012
SEVELAMER HYDROCHLORIDE - RENAGEL N020926 001 5496545 Aug 5667775 Sep 6509013 Aug SEVELAMER HYDROCHLORIDE - RENAGEL N021179 001 5496545 Aug Sep 5667775 Aug 6509013 Oct 6733780 Aug 7014846 Aug 7459151 SEVELAMER HYDROCHLORIDE - RENAGEL Aug N021179 002 5496545 Sep 5667775 Aug 6509013 Oct 6733780 Aug 7014846 Aug 7459151
U-246 U-246
U-246 U-246 DP DP
U-246 U-246
U-246 U-246 DP DP
U-246 U-246
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
SEVOFLURANE - ULTANE N020478 001 5990176 5990176*PED 6074668 6074668*PED 6288127 6288127*PED 6444859 6444859*PED
SIBUTRAMINE HYDROCHLORIDE - MERIDIA N020632 001 5436272 Jul 25, 2012 5436272*PED Jan 25, 2013 SIBUTRAMINE HYDROCHLORIDE - MERIDIA N020632 002 5436272 Jul 25, 2012 5436272*PED Jan 25, 2013 SIBUTRAMINE HYDROCHLORIDE - MERIDIA N020632 003 5436272 Jul 25, 2012 5436272*PED Jan 25, 2013 SILDENAFIL CITRATE - REVATIO N021845 001 5250534 SILDENAFIL CITRATE - REVATIO N022473 001 5250534 SILDENAFIL CITRATE - VIAGRA N020895 001 5250534 6469012 SILDENAFIL CITRATE - VIAGRA N020895 002 5250534 6469012 SILDENAFIL CITRATE - VIAGRA N020895 003 5250534 6469012 SILODOSIN - RAPAFLO N022206 001 5387603 5403847 5780485 6015819 SILODOSIN - RAPAFLO N022206 002 5387603 5403847 5780485 6015819
U-439
U-439
U-439
Mar
27, 2012
DS
DP
I-598
May
07, 2012
Mar
27, 2012
DS
DP
NDF
Nov
20, 2012
Mar Oct
U-155
Mar Oct
U-155
Mar Oct
U-155
DS
NCE
Oct
08, 2013
DS
NCE
Oct
08, 2013
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC Apr 24, 2017 N202343 001 6303661 Jul 26, 2022 6699871 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Apr 11, 2026 7326708 Feb 02, 2019 7459428
U-1188 DS DP U-1190 U-1189 U-1191 U-1188 U-1190 U-1189 U-1192 U-1193 U-1188 U-1189
DS
DP DP DP DP DP
APPL/PROD NO
PATENT NO
PATENT CODES
U-1188 DS DP U-1190 U-1189 U-1191 U-1188 U-1193 U-1190 U-1192 U-1189 U-1188 U-1189
EXCLUSIVITY CODE(S)
SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC N202343 002 6303661 Apr 24, 2017 6699871 Jul 26, 2022 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Feb 02, 2019 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7326708 Apr 11, 2026 Feb 02, 2019 7459428 SIMVASTATIN; SITAGLIPTIN PHOSPHATE - JUVISYNC N202343 003 6303661 Apr 24, 2017 6699871 Jul 26, 2022 6890898 Feb 02, 2019 6890898 Feb 02, 2019 6890898 Feb 02, 2019 7078381 Feb 02, 2019 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7125873 Jul 26, 2022 7326708 Apr 11, 2026 Feb 02, 2019 7459428 SINCALIDE - KINEVAC N017697 001 6803046 SINECATECHINS - VEREGEN N021902 001 5795911 5968973 7858662 SIROLIMUS - RAPAMUNE N021083 001 5100899 5100899*PED 5403833 5403833*PED 5536729 5536729*PED SIROLIMUS - RAPAMUNE N021110 001 5100899 5100899*PED 5145684*PED 5403833 5403833*PED 5989591 5989591*PED SIROLIMUS - RAPAMUNE N021110 002 5100899 5100899*PED 5145684*PED 5403833 5403833*PED 5989591 5989591*PED SIROLIMUS - RAPAMUNE N021110 003 5100899 5100899*PED 5145684*PED 5403833 5403833*PED 5989591 5989591*PED
DS
DP DP DP DP DP
U-1188 DS DP U-1190 U-1191 U-1189 U-1188 U-1192 U-1189 U-1193 U-1190 U-1188 U-1189
DS
DP DP DP DP DP
Aug
16, 2022
DP
DP
U-290 U-293 DP
U-290
U-293 DP
U-290
U-293 DP
U-290
U-293 DP
APPL/PROD NO
PATENT NO
PATENT CODES
U-290
EXCLUSIVITY CODE(S)
SIROLIMUS - RAPAMUNE N021110 004 5100899 5100899*PED 5145684*PED 5403833 5403833*PED 5989591 5989591*PED
U-293 DP
SITAGLIPTIN PHOSPHATE - JANUVIA N021995 001 6303661 Apr 6699871 Jul 6890898 Feb 6890898 Feb 6890898 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7125873 Jul 7125873 Jul 7125873 Jul 7125873 Jul 7326708 Apr SITAGLIPTIN PHOSPHATE - JANUVIA N021995 002 6303661 Apr 6699871 Jul 6890898 Feb 6890898 Feb 6890898 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7125873 Jul 7125873 Jul 7125873 Jul 7125873 Jul 7326708 Apr SITAGLIPTIN PHOSPHATE - JANUVIA N021995 003 6303661 Apr 6699871 Jul 6890898 Feb 6890898 Feb 6890898 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7078381 Feb 7125873 Jul 7125873 Jul 7125873 Jul 7125873 Jul 7326708 Apr
24, 26, 02, 02, 02, 02, 02, 02, 02, 26, 26, 26, 26, 11,
2017 2022 2019 2019 2019 2019 2019 2019 2019 2022 2022 2022 2022 2026
DS
DP
DS
DP
U-774 U-774 U-775 U-1039 U-1036 U-775 U-1036 U-1037 U-1038 U-775 U-1036 U-1037 U-1038 U-802
NCE
Oct
16, 2011
24, 26, 02, 02, 02, 02, 02, 02, 02, 26, 26, 26, 26, 11,
2017 2022 2019 2019 2019 2019 2019 2019 2019 2022 2022 2022 2022 2026
DS
DP
DS
DP
U-774 U-774 U-1039 U-1036 U-775 U-775 U-1038 U-1037 U-1036 U-1038 U-1036 U-1037 U-775 U-802
NCE
Oct
16, 2011
24, 26, 02, 02, 02, 02, 02, 02, 02, 26, 26, 26, 26, 11,
2017 2022 2019 2019 2019 2019 2019 2019 2019 2022 2022 2022 2022 2026
DS
DP
DS
DP
U-774 U-774 U-1039 U-1036 U-775 U-1037 U-1036 U-1038 U-775 U-1037 U-1038 U-1036 U-775 U-802
NCE
Oct
16, 2011
SODIUM BENZOATE; SODIUM PHENYLACETATE - AMMONUL N020645 001 SODIUM NITRITE; SODIUM THIOSULFATE - NITHIODOTE N201444 001
ODE
Feb
17, 2012
ODE
Jan
14, 2018
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP U-1110 U-1069 U-1070 U-1102 U-1101 U-1110
EXCLUSIVITY CODE(S)
ODE
SODIUM OXYBATE - XYREM N021196 001 6780889 7262219 7668730 7765106 7765107 7851506 7851506 7895059
Nov
18, 2012
SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE - VISICOL N021097 001 5616346 May 18, 2013 U-359 SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE - OSMOPREP N021892 001 5616346 May 18, 2013 DP U-715
7687075 Jun 22, 2028
DS DP
SOLIFENACIN SUCCINATE - VESICARE N021518 001 6017927 Nov SOLIFENACIN SUCCINATE - VESICARE N021518 002 6017927 Nov
19, 2018
DS
DP
19, 2018
DS
DP
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 001 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 DP 5716338 Feb 10, 2015 DP 6152897 Nov 20, 2018 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 002 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 DP 5716338 Feb 10, 2015 6152897 Nov 20, 2018 DP SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 003 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 5716338 Feb 10, 2015 DP DP 6152897 Nov 20, 2018 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 005 5435076 Apr 16, 2013 DP 5501673 Apr 16, 2013 DP DP 5716338 Feb 10, 2015 DP 6152897 Nov 20, 2018 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 008 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 DP 5716338 Feb 10, 2015 DP 6152897 Nov 20, 2018 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 009 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 DP 5716338 Feb 10, 2015 6152897 Nov 20, 2018 DP SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 010 5435076 Apr 16, 2013 DP 5501673 Apr 16, 2013 DP DP 5716338 Feb 10, 2015 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 011 5435076 Apr 16, 2013 DP 5501673 Apr 16, 2013 DP DP 5716338 Feb 10, 2015
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE DP N020280 012 5435076 Apr 16, 2013 DP 5501673 Apr 16, 2013 DP Feb 10, 2015 5716338 SOMATROPIN RECOMBINANT - GENOTROPIN PRESERVATIVE FREE N020280 013 5435076 Apr 16, 2013 DP DP 5501673 Apr 16, 2013 DP 5716338 Feb 10, 2015 SOMATROPIN RECOMBINANT - HUMATROPE N019640 001 SOMATROPIN RECOMBINANT - HUMATROPE N019640 004 SOMATROPIN RECOMBINANT - HUMATROPE N019640 005 SOMATROPIN RECOMBINANT - HUMATROPE N019640 006 SOMATROPIN RECOMBINANT - HUMATROPE N019640 007 SOMATROPIN RECOMBINANT - NORDITROPIN N021148 001 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN N021148 002 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN N021148 003 5633352 May 27, 2014 Dec 15, 2015 5849700 Dec 15, 2015 5849704 SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO N021148 008 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO N021148 009 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN FLEXPRO N021148 010 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX N021148 004 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX N021148 005 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX N021148 006 5849700 Dec 15, 2015 5849704 Dec 15, 2015
I-585 ODE
Mar Nov
I-585 ODE
Mar Nov
I-585 ODE
Mar Nov
I-585 ODE
Mar Nov
Mar Nov
I-572 ODE
Oct May
U-340
I-572 ODE
Oct May
U-340
I-572 ODE
Oct May
DP
U-1041 U-1041
I-572 ODE
Oct May
DP
U-1041 U-1041
I-572 ODE
Oct May
DP
U-1041 U-1041
I-572 ODE
Oct May
DP
U-340 U-340
I-572 ODE
Oct May
DP
U-340 U-340
I-572 ODE
Oct May
DP
U-340 U-340
I-572 ODE
Oct May
APPL/PROD NO
PATENT NO
PATENT CODES
U-340 U-340
EXCLUSIVITY CODE(S)
I-572 ODE
SOMATROPIN RECOMBINANT - NORDITROPIN NORDIFLEX N021148 007 5849700 Dec 15, 2015 5849704 Dec 15, 2015 SOMATROPIN RECOMBINANT - NUTROPIN AQ N020522 001 5763394 Jun 09, 2015 SOMATROPIN RECOMBINANT - NUTROPIN AQ PEN N020522 002 5763394 Jun 09, 2015 SOMATROPIN RECOMBINANT - NUTROPIN DEPOT N021075 001 5654010 Aug 05, 5656297 Jul 25, 5912015 Mar 12, 6051259 Dec 02, SOMATROPIN RECOMBINANT - NUTROPIN DEPOT N021075 002 5654010 Aug 05, 5656297 Jul 25, 5912015 Mar 12, 6051259 Dec 02, SOMATROPIN RECOMBINANT - NUTROPIN DEPOT Aug 05, N021075 003 5654010 Jul 25, 5656297 Mar 12, 5912015 Dec 02, 6051259 SOMATROPIN RECOMBINANT - SAIZEN N019764 002 5898030 Apr SOMATROPIN RECOMBINANT - SAIZEN Apr N019764 003 5898030 SOMATROPIN RECOMBINANT - SEROSTIM Apr N020604 001 5898030 SOMATROPIN RECOMBINANT - SEROSTIM Apr N020604 002 5898030 SOMATROPIN RECOMBINANT - SEROSTIM Apr N020604 003 5898030 SOMATROPIN RECOMBINANT - SEROSTIM Apr N020604 004 5898030 SOMATROPIN RECOMBINANT - ZORBTIVE Oct N021597 004 5288703 Apr 5898030 SORAFENIB TOSYLATE - NEXAVAR N021923 001 7235576 7351834 7897623
DP
Oct May
DP
DP
U-340
U-340
U-340
27, 2016
DP
27, 2016
DP
27, 2016
DP
27, 2016
DP
27, 2016
DP
27, 2016
DP
U-898 DP
DS DS
DP DP
ODE ODE
Nov Dec
SOTALOL HYDROCHLORIDE - SOTALOL HYDROCHLORIDE N022306 001 SPINOSAD - NATROBA N022408 001 5496931 6063771 6342482 7030095 STAVUDINE - ZERIT XR N021453 001 7135465 7135465*PED
Jul
02, 2016
NCE
Jan
18, 2016
Feb Aug
DP
U-167
APPL/PROD NO
PATENT NO
PATENT CODES
DP U-167
EXCLUSIVITY CODE(S)
STAVUDINE - ZERIT XR N021453 002 7135465 7135465*PED STAVUDINE - ZERIT XR N021453 003 7135465 7135465*PED STAVUDINE - ZERIT XR N021453 004 7135465 7135465*PED SUMATRIPTAN - IMITREX N020626 001 5307953 5307953*PED 5554639 5554639*PED 5705520 5705520*PED SUMATRIPTAN - IMITREX N020626 002 5307953 5307953*PED 5554639 5554639*PED 5705520 5705520*PED SUMATRIPTAN - IMITREX N020626 003 5307953 5307953*PED 5554639 5554639*PED 5705520 5705520*PED
Feb Aug
Feb Aug
DP
U-167
Feb Aug
DP
U-167
U-232 U-232
U-232 U-232
U-232 U-232
26, 2027
DP
U-1083
SUMATRIPTAN SUCCINATE - SUMAVEL DOSEPRO N022239 001 5891086 Jul 27, 5957886 Mar 08, 6135979 Mar 21, 7776007 Nov 28, 7901385 Jul 31, SUNITINIB MALATE - SUTENT N021938 001 6573293 7125905 7211600 SUNITINIB MALATE - SUTENT N021938 002 6573293 7125905 7211600 SUNITINIB MALATE - SUTENT N021938 003 6573293 7125905 7211600 SUNITINIB MALATE - SUTENT N021938 004 6573293 7125905 7211600 TACROLIMUS - PROGRAF N050708 001 TACROLIMUS - PROGRAF N050708 002
DP DP DP DP DP
DS DS
DP DP
U-1154 U-883
I-639
May
20, 2014
DS DS
DP DP
U-1154 U-883
I-639
May
20, 2014
DS DS
DP DP
U-1154 U-883
I-639
May
20, 2014
DS DS
DP DP
U-1154 U-883
I-639
May
20, 2014
ODE
Mar
29, 2013
ODE
Mar
29, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
ODE
TACROLIMUS - PROGRAF N050708 003 TACROLIMUS - PROGRAF N050709 001 TACROLIMUS - PROTOPIC N050777 001 5385907 5665727 TACROLIMUS - PROTOPIC N050777 002 5385907 5665727 TADALAFIL - ADCIRCA N022332 001 5859006 6821975 7182958 TADALAFIL - CIALIS N021368 001 5859006 6140329 6140329 6821975 6821975 6821975 6943166 6943166 6943166 7182958 7182958 TADALAFIL - CIALIS N021368 002 5859006 6140329 6821975 6821975 6943166 6943166 7182958 TADALAFIL - CIALIS N021368 003 5859006 6140329 6821975 6821975 6943166 7182958 TADALAFIL - CIALIS N021368 004 5859006 6140329 6821975 6821975 6943166 7182958 TAMOXIFEN CITRATE - SOLTAMOX N021807 001 6127425
Mar
29, 2013
Mar
29, 2013
Jan Sep
DP U-919
DS DS
DP DP DP
U-975
NP ODE
May May
Nov Jul Jul Nov Nov Nov Apr Apr Apr Apr Apr
21, 11, 11, 19, 19, 19, 26, 26, 26, 26, 26,
2017 2016 2016 2020 2020 2020 2020 2020 2020 2020 2020
DS
DS DS DS
DP DP DP DP DP DP
DP DP
U-155 U-1184 U-533 U-614 U-1184 U-155 U-1184 U-614 U-1184 U-155
I-642 I-641
Oct Oct
DS DS DS
DP DP DP DP
DP
I-642 I-641
Oct Oct
DS DS DS
DP DP DP DP DP
I-642 I-641
Oct Oct
DS DS DS
DP DP DP DP DP
I-642 I-641
Oct Oct
Jun
26, 2018
DP
TAMSULOSIN HYDROCHLORIDE - FLOMAX N020579 001 TAPENTADOL HYDROCHLORIDE - NUCYNTA N022304 001 6071970 Jun 7994364 Jun RE39593 Aug
M-54 PED 06, 2017 27, 2025 05, 2022 U-931 U-931 U-931
Dec Jun
NCE
Nov
20, 2013
DS DS
DP DP
APPL/PROD NO
PATENT NO
PATENT CODES
U-931 U-931 U-931
EXCLUSIVITY CODE(S)
NCE
TAPENTADOL HYDROCHLORIDE - NUCYNTA N022304 002 6071970 Jun 7994364 Jun RE39593 Aug TAPENTADOL HYDROCHLORIDE - NUCYNTA N022304 003 6071970 Jun 7994364 Jun RE39593 Aug
Nov
20, 2013
DS DS
DP DP
DS DS
DP DP
NCE
Nov
20, 2013
TAPENTADOL HYDROCHLORIDE - NUCYNTA ER N200533 001 6071970 Jun 06, 7994364 Jun 27, 8075872 Nov 20, RE39593 Aug 05, TAPENTADOL HYDROCHLORIDE - NUCYNTA ER N200533 002 6071970 Jun 06, 7994364 Jun 27, 8075872 Nov 20, RE39593 Aug 05, TAPENTADOL HYDROCHLORIDE - NUCYNTA ER N200533 003 6071970 Jun 06, 7994364 Jun 27, 8075872 Nov 20, RE39593 Aug 05, TAPENTADOL HYDROCHLORIDE - NUCYNTA ER N200533 004 6071970 Jun 06, 7994364 Jun 27, 8075872 Nov 20, RE39593 Aug 05, TAPENTADOL HYDROCHLORIDE - NUCYNTA ER N200533 005 6071970 Jun 06, 7994364 Jun 27, 8075872 Nov 20, RE39593 Aug 05, TAZAROTENE - TAZORAC N020600 001 5914334 6258830 TAZAROTENE - TAZORAC N020600 002 5914334 6258830
DS DS
DP DP DP
NDF NCE
Aug Nov
DS DS
DP DP DP
NDF NCE
Aug Nov
DS DS
DP DP DP
NDF NCE
Aug Nov
DS DS
DP DP DP
NDF NCE
Aug Nov
DS DS
DP DP DP
NDF NCE
Aug Nov
Jun Jun
U-517 U-517
Jun Jun
U-517 U-517
TECHNETIUM TC-99M APCITIDE - ACUTECT N020887 001 5443815 Aug 22, 2012 5508020 Apr 16, 2013 5645815 Jul 08, 2014 TECHNETIUM TC-99M BICISATE KIT - NEUROLITE N020256 001 5431900 Jul 11, 2012 TECHNETIUM TC-99M MERTIATIDE KIT - TECHNESCAN MAG3 N019882 001 5573748 Nov 12, 2013 TECHNETIUM TC-99M SESTAMIBI KIT - CARDIOLITE N019785 001 TECHNETIUM TC-99M TEBOROXIME KIT - CARDIOTEC N019928 001 6056941 Jul 28, 2019 TEGASEROD MALEATE - ZELNORM N021200 001 5510353 TEGASEROD MALEATE - ZELNORM N021200 002 5510353
U-336
DP
PED DP
Oct
30, 2011
Apr
26, 2013
U-466
Apr
26, 2013
U-466
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP
EXCLUSIVITY CODE(S)
NCE
Feb
25, 2025
May
23, 2016
TELAVANCIN HYDROCHLORIDE - VIBATIV Sep N022110 001 6635618 Aug 6858584 Jun 6872701 May 7008923 May 7208471 May 7351691 Jan 7531623 May 7544364 May 7700550 TELAVANCIN HYDROCHLORIDE - VIBATIV Sep N022110 002 6635618 Aug 6858584 Jun 6872701 May 7008923 May 7208471 May 7351691 Jan 7531623 May 7544364 May 7700550 TELBIVUDINE - TYZEKA N022011 001 6395716 6444652 6566344 6569837 6569837 7589079 7795238 7858594 TELBIVUDINE - TYZEKA N022154 001 6395716 6444652 6566344 6569837 7795238 TELITHROMYCIN - KETEK N021144 001 5635485 D459798 TELITHROMYCIN - KETEK N021144 002 5635485 D459798 TELMISARTAN - MICARDIS N020850 001 5591762 6358986 TELMISARTAN - MICARDIS N020850 002 5591762 6358986 7998953 8003679 TELMISARTAN - MICARDIS N020850 003 5591762 6358986 TEMOZOLOMIDE - TEMODAR N021029 001 5260291 5260291*PED
DS
DP DP DP DP DP DP
U-728
NCE
Sep
11, 2014
U-1005 DS DS DS U-728
U-282
DS
DP DP DP DP DP DP
U-728
NCE
Sep
11, 2014
U-1005 DS DS DS U-728
U-282
DS DS
DP DP
NCE
Oct
25, 2011
NCE
Oct
25, 2011
Apr Sep
DS
DP DP
U-578
Apr Sep
DS
DP DP
U-578
Jan Jan
U-3
DS
DP
I-612
Oct
16, 2012
Jan Jan
U-3
Aug Feb
DS
DP
U-619
ODE
Mar
15, 2012
APPL/PROD NO
PATENT NO
PATENT CODES
DS DP U-619
EXCLUSIVITY CODE(S)
ODE
TEMOZOLOMIDE - TEMODAR N021029 002 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N021029 003 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N021029 004 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N021029 005 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N021029 006 5260291 5260291*PED TEMOZOLOMIDE - TEMODAR N022277 001 5260291 5260291*PED 6987108 7786118 TEMSIROLIMUS - TORISEL N022088 001 5362718 8026276
Aug Feb
Mar
15, 2012
Aug Feb
DS
DP
U-619
ODE
Mar
15, 2012
Aug Feb
DS
DP
U-619
ODE
Mar
15, 2012
Aug Feb
DS
DP
U-619
ODE
Mar
15, 2012
Aug Feb
DS
DP
U-619
ODE
Mar
15, 2012
DS
DP DP DP
U-619
Apr Jan
DS
DP DP
TENOFOVIR DISOPROXIL FUMARATE - VIREAD N021356 001 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695 Jul 25, 5922695*PED Jan 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946 Jul 25, 5935946*PED Jan 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089 Jul 25, 5977089*PED Jan 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230 Jul 25, 6043230*PED Jan 25, TERAZOSIN HYDROCHLORIDE - HYTRIN N019057 001 5294615 Apr 5294615 Apr 5412095 Apr TERAZOSIN HYDROCHLORIDE - HYTRIN Apr N019057 002 5294615 Apr 5294615 Apr 5412095 TERAZOSIN HYDROCHLORIDE - HYTRIN N019057 003 5294615 Apr 5294615 Apr 5412095 Apr
2017 2017 2017 2017 2018 2017 2017 2017 2017 2018 2017 2017 2017 2017 2018 2017 2017 2017 2017 2018
DS DS DS DS DS DS DS DS DS DS DS DS DP DP DP DP DP DP DP DP
U-250 U-999 U-256 U-248 U-250 U-248 U-256 U-999 U-250 U-256 U-999 U-248
U-3 U-165
U-165 U-3
U-165 U-3
APPL/PROD NO
PATENT NO
PATENT CODES
U-3 U-165
EXCLUSIVITY CODE(S)
TERAZOSIN HYDROCHLORIDE - HYTRIN Apr N019057 004 5294615 Apr 5294615 Apr 5412095 TERAZOSIN HYDROCHLORIDE - HYTRIN N020347 001 5294615 Apr 5294615 Apr Apr 5412095 TERAZOSIN HYDROCHLORIDE - HYTRIN Apr N020347 002 5294615 Apr 5294615 Apr 5412095 TERAZOSIN HYDROCHLORIDE - HYTRIN N020347 003 5294615 Apr 5294615 Apr Apr 5412095 TERAZOSIN HYDROCHLORIDE - HYTRIN Apr N020347 004 5294615 Apr 5294615 Apr 5412095 TERBINAFINE - LAMISIL N020846 001 5681849 5681849*PED 5856355 5856355 5856355 5856355*PED 6005001 6005001 6005001 6005001*PED TERBINAFINE - LAMISIL AT N021958 001 5681849 5681849*PED 5856355 5856355 5856355*PED
U-165 U-3
U-165 U-3
U-3 U-165
U-3 U-165
Oct Apr May May May Nov May May May Nov
28, 28, 18, 18, 18, 18, 18, 18, 18, 18,
2014 2015 2012 2012 2012 2012 2012 2012 2012 2012
DP DP DP U-540 U-504
TERBINAFINE HYDROCHLORIDE - LAMISIL AT Oct 28, 2014 N021124 001 5681849 Apr 28, 2015 5681849*PED TERBINAFINE HYDROCHLORIDE - LAMISIL AT Oct 28, 2014 N021124 002 5681849 Apr 28, 2015 5681849*PED TERIPARATIDE RECOMBINANT HUMAN - FORTEO Dec 08, N021318 001 6770623 Aug 19, 6977077 Dec 08, 7144861 Aug 19, 7163684 Aug 19, 7351414 Dec 08, 7550434 TERIPARATIDE RECOMBINANT HUMAN - FORTEO N021318 002 6770623 Dec 08, 6977077 Aug 19, Aug 19, 6977077 Dec 08, 7144861 Aug 19, 7163684 Aug 19, 7163684 Aug 19, 7351414 Aug 19, 7351414 Dec 08, 7550434
DP DP
I-602
Jul
22, 2012
DP
DP
I-602
Jul
22, 2012
DP
DP
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP
EXCLUSIVITY CODE(S)
NCE
U-1100 U-1100
U-1100
U-1100
Nov
10, 2015
NS
Oct
20, 2014
Oct
20, 2014
Aug Mar
U-490
Aug Mar
U-490
Aug
30, 2020
U-1103
NP
Apr
29, 2014
DP DP DP DP
U-1103 U-1103
U-1103
U-1103
NP
Nov
23, 2013
Nov Nov
U-490 DP
NP
Dec
29, 2013
Aug
23, 2019
U-527
U-843
U-1009 U-1009 U-1009 U-1009 U-1009 U-1009 U-1009 U-843
Aug
15, 2016
Aug
15, 2016
10, 2019
U-440
NCE ODE
Aug Aug
NCE ODE
Aug Aug
APPL/PROD NO
PATENT NO
PATENT CODES
U-731 U-731 U-371 U-731 U-731 U-442 U-731 U-371 U-371 U-731 U-371 U-731 U-371 U-731 U-732 U-733 U-731 U-371 U-731 U-371 U-733 U-732 DP U-899 U-1058 U-1109 U-442 U-371 U-732 U-733 U-1155
EXCLUSIVITY CODE(S)
ODE
THALIDOMIDE - THALOMID N020785 001 5629327 6045501 6045501 6235756 6315720 6315720 6561976 6561976 6561977 6561977 6755784 6755784 6869399 6869399 6869399 6869399 6908432 6908432 7141018 7141018 7141018 7141018 7230012 7435745 7723361 7874984 7874984 7874984 7874984 7874984 7959566 THALIDOMIDE - THALOMID N020785 002 5629327 6045501 6045501 6235756 6315720 6315720 6561976 6561976 6561977 6561977 6755784 6755784 6869399 6869399 6869399 6869399 6908432 6908432 7141018 7141018 7141018 7141018 7230012 7435745 7723361 7874984 7874984 7874984 7874984 7874984 7959566
May Aug Aug Mar Oct Oct Aug Aug Oct Oct Oct Oct Oct Oct Oct Oct Aug Aug Oct Oct Oct Oct Dec Nov Mar Aug Aug Aug Aug Aug Oct
13, 28, 28, 01, 23, 23, 28, 28, 23, 23, 23, 23, 23, 23, 23, 23, 28, 28, 23, 23, 23, 23, 09, 03, 01, 28, 28, 28, 28, 28, 23,
2014 2018 2018 2013 2020 2020 2018 2018 2020 2020 2020 2020 2020 2020 2020 2020 2018 2018 2020 2020 2020 2020 2023 2017 2013 2018 2018 2018 2018 2018 2020
May
25, 2013
May Aug Aug Mar Oct Oct Aug Aug Oct Oct Oct Oct Oct Oct Oct Oct Aug Aug Oct Oct Oct Oct Dec Nov Mar Aug Aug Aug Aug Aug Oct
13, 28, 28, 01, 23, 23, 28, 28, 23, 23, 23, 23, 23, 23, 23, 23, 28, 28, 23, 23, 23, 23, 09, 03, 01, 28, 28, 28, 28, 28, 23,
2014 2018 2018 2013 2020 2020 2018 2018 2020 2020 2020 2020 2020 2020 2020 2020 2018 2018 2020 2020 2020 2020 2023 2017 2013 2018 2018 2018 2018 2018 2020
U-731 U-371 U-731 U-731 U-731 U-442 U-731 U-371 U-371 U-731 U-731 U-371 U-732 U-731 U-371 U-733 U-371 U-731 U-732 U-733 U-731 U-371 DP U-899 U-1058 U-371 U-1109 U-732 U-733 U-442 U-1155
ODE
May
25, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
U-731 U-731 U-371 U-731 U-731 U-442 U-371 U-731 U-731 U-371 U-371 U-731 U-731 U-732 U-733 U-371 U-371 U-731 U-731 U-732 U-371 U-733 DP U-899 U-1058 U-371 U-442 U-733 U-732 U-1109 U-1155
EXCLUSIVITY CODE(S)
ODE
THALIDOMIDE - THALOMID N020785 003 5629327 6045501 6045501 6235756 6315720 6315720 6561976 6561976 6561977 6561977 6755784 6755784 6869399 6869399 6869399 6869399 6908432 6908432 7141018 7141018 7141018 7141018 7230012 7435745 7723361 7874984 7874984 7874984 7874984 7874984 7959566 THALIDOMIDE - THALOMID N020785 004 5629327 6045501 6235756 6315720 6561976 6561977 6755784 6869399 6908432 7141018 7435745 7723361 7874984 7874984 7874984 7874984 7874984 7959566 THYROTROPIN ALFA - THYROGEN N020898 001 5840566 6365127
May Aug Aug Mar Oct Oct Aug Aug Oct Oct Oct Oct Oct Oct Oct Oct Aug Aug Oct Oct Oct Oct Dec Nov Mar Aug Aug Aug Aug Aug Oct
13, 28, 28, 01, 23, 23, 28, 28, 23, 23, 23, 23, 23, 23, 23, 23, 28, 28, 23, 23, 23, 23, 09, 03, 01, 28, 28, 28, 28, 28, 23,
2014 2018 2018 2013 2020 2020 2018 2018 2020 2020 2020 2020 2020 2020 2020 2020 2018 2018 2020 2020 2020 2020 2023 2017 2013 2018 2018 2018 2018 2018 2020
May
25, 2013
May Aug Mar Oct Aug Oct Oct Oct Aug Oct Nov Mar Aug Aug Aug Aug Aug Oct
13, 28, 01, 23, 28, 23, 23, 23, 28, 23, 03, 01, 28, 28, 28, 28, 28, 23,
2014 2018 2013 2020 2018 2020 2020 2020 2018 2020 2017 2013 2018 2018 2018 2018 2018 2020
U-731 U-731 U-731 U-731 U-731 U-731 U-731 U-731 U-731 U-731 U-899 U-1058 U-371 U-1109 U-442 U-732 U-733 U-1155
ODE
May
23, 2013
Nov Nov
ODE DS DP U-556
Dec
14, 2014
TIAGABINE HYDROCHLORIDE - GABITRIL N020646 001 5010090 Sep 5354760 Mar 5866590 Apr 5958951 Jun TIAGABINE HYDROCHLORIDE - GABITRIL N020646 002 5010090 Sep 5354760 Mar 5866590 Apr 5958951 Jun
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
TIAGABINE HYDROCHLORIDE - GABITRIL N020646 003 5010090 Sep 5354760 Mar 5866590 Apr 5958951 Jun TIAGABINE HYDROCHLORIDE - GABITRIL N020646 004 5010090 Sep 5354760 Mar 5866590 Apr 5958951 Jun TIAGABINE HYDROCHLORIDE - GABITRIL Sep N020646 005 5010090 Mar 5354760 Apr 5866590 Jun 5958951 TICAGRELOR - BRILINTA N022433 001 6251910 6525060 7250419 7265124 TIGECYCLINE - TYGACIL N021821 001 7879828 RE40086 RE40183 TIMOLOL MALEATE - ISTALOL N021516 001 6335335
DS DS DS DS
Jul
20, 2016
DP U-282 DS DP
Nov
02, 2018
DP
TIMOLOL MALEATE - TIMOLOL MALEATE N020963 001 6174524 Mar 6174524*PED Sep TIMOLOL MALEATE - TIMOLOL MALEATE N020963 002 6174524 Mar 6174524*PED Sep TIOTROPIUM BROMIDE MONOHYDRATE N021395 001 5478578 6777423 6908928 6908928 7070800 7309707 7642268 7694676 8022082 RE38912 RE39820 TIPRANAVIR - APTIVUS N021814 001 5852195 5852195*PED 6147095 6147095*PED 6169181 6169181*PED 6231887 6231887*PED TIPRANAVIR - APTIVUS N022292 001 5852195 5852195*PED 6147095 6147095*PED 6169181 6169181*PED
DP
DP
- SPIRIVA Dec 26, 2012 Sep 24, 2021 Sep 24, 2021 Sep 24, 2021 Jan 22, 2022 Sep 24, 2021 Sep 24, 2021 Mar 12, 2027 Jan 19, 2026 Oct 11, 2021 Jan 30, 2018
DS DS DS DS DS
DS
DP DP DP DP DP DP DP DP DP DP DP
Dec
17, 2012
U-1186 U-566
DS U-670 DS DP
PED
Dec
23, 2011
DS U-670 DS
PED
Dec
23, 2011
APPL/PROD NO
PATENT NO
PATENT CODES
U-230
EXCLUSIVITY CODE(S)
TIROFIBAN HYDROCHLORIDE - AGGRASTAT N020912 001 5292756 May 14, 2012 5733919 Oct 23, 2016 5965581 Oct 23, 2016 5972967 Oct 23, 2016 5978698 Oct 08, 2017 6136794 Jan 29, 2019 TIROFIBAN HYDROCHLORIDE - AGGRASTAT N020913 001 5292756 May 14, 2012 5733919 Oct 23, 2016 5965581 Oct 23, 2016 5972967 Oct 23, 2016 5978698 Oct 08, 2017 6136794 Jan 29, 2019 TIROFIBAN HYDROCHLORIDE - AGGRASTAT N020913 002 5292756 May 14, 2012 5733919 Oct 23, 2016 5965581 Oct 23, 2016 5972967 Oct 23, 2016 5978698 Oct 08, 2017 6136794 Jan 29, 2019 TIROFIBAN HYDROCHLORIDE - AGGRASTAT N020913 003 5292756 May 14, 2012 5733919 Oct 23, 2016 5965581 Oct 23, 2016 5972967 Oct 23, 2016 5978698 Oct 08, 2017 6136794 Jan 29, 2019 TIZANIDINE HYDROCHLORIDE - ZANAFLEX N021447 001 6455557 Nov 28, 2021 TIZANIDINE HYDROCHLORIDE - ZANAFLEX N021447 002 6455557 Nov 28, 2021 TIZANIDINE HYDROCHLORIDE - ZANAFLEX N021447 003 6455557 Nov 28, 2021 TOBRAMYCIN - TOBI N050753 001 5508269 TOLCAPONE - TASMAR N020697 001 5236952 5476875 TOLCAPONE - TASMAR N020697 002 5236952 5476875 TOLTERODINE TARTRATE - DETROL N020771 001 5382600 5382600*PED 5559269 5559269*PED TOLTERODINE TARTRATE - DETROL N020771 002 5382600 5382600*PED 5559269 5559269*PED
U-230
U-230
U-230
Oct
19, 2014
DP
U-909
Jan Dec
U-219
Jan Dec
U-219
U-318
U-318
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
TOLTERODINE TARTRATE - DETROL LA Mar N021228 001 5382600 Sep 5382600*PED Nov 6630162 May 6630162*PED Aug 6770295 Feb 6770295*PED Aug 6911217 Feb 6911217*PED TOLTERODINE TARTRATE - DETROL LA Mar N021228 002 5382600 Sep 5382600*PED Nov 6630162 May 6630162*PED Aug 6770295 Feb 6770295*PED Aug 6911217 Feb 6911217*PED TOLVAPTAN - SAMSCA N022275 001 5753677 TOLVAPTAN - SAMSCA N022275 002 5753677 TOLVAPTAN - SAMSCA N022275 003 5753677 TOPIRAMATE - TOPAMAX N020505 001 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020505 002 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020505 003 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020505 004 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED
DP DP DP DP
DP DP DP DP
May
19, 2015
U-978
NCE
May
19, 2014
May
19, 2015
U-978
NCE
May
19, 2014
May
19, 2015
U-978
NCE
May
19, 2014
M-54 PED
Dec Jun
M-54 PED
Dec Jun
M-54 PED
Dec Jun
M-54 PED
Dec Jun
APPL/PROD NO
PATENT NO
PATENT CODES
U-598 U-598 U-723 U-955
EXCLUSIVITY CODE(S)
M-54 PED
TOPIRAMATE - TOPAMAX N020505 005 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020505 006 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020844 001 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7125560 7125560*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX N020844 002 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7125560 7125560*PED 7498311 7498311*PED TOPIRAMATE - TOPAMAX SPRINKLE N020844 003 5998380 5998380*PED 6503884 6503884*PED 7018983 7018983*PED 7125560 7125560*PED 7498311 7498311*PED
Dec Jun
M-54 PED
Dec Jun
Oct Apr Oct Apr Oct Apr Mar Sep Oct Apr
13, 13, 13, 13, 13, 13, 01, 01, 13, 13,
2015 2016 2015 2016 2015 2016 2019 2019 2015 2016
M-54 PED
Dec Jun
Oct Apr Oct Apr Oct Apr Mar Sep Oct Apr
13, 13, 13, 13, 13, 13, 01, 01, 13, 13,
2015 2016 2015 2016 2015 2016 2019 2019 2015 2016
M-54 PED
Dec Jun
Oct Apr Oct Apr Oct Apr Mar Sep Oct Apr
13, 13, 13, 13, 13, 13, 01, 01, 13, 13,
2015 2016 2015 2016 2015 2016 2019 2019 2015 2016
M-54 PED
Dec Jun
TOPOTECAN HYDROCHLORIDE - HYCAMTIN Oct N020671 001 5674872 Apr 5674872*PED TRAMADOL HYDROCHLORIDE - CONZIP N022370 001 7858118 Apr TRAMADOL HYDROCHLORIDE - CONZIP N022370 002 7858118 Apr TRAMADOL HYDROCHLORIDE - CONZIP Apr N022370 003 7858118
U-910
11, 2022
DP
U-1104
11, 2022
DP
U-1104
11, 2022
DP
U-1104
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DP DP
EXCLUSIVITY CODE(S)
NP
TRAMADOL HYDROCHLORIDE - RYZOLT May N021745 001 5591452 May 6254887 Jun 6607748 Oct 7988998 TRAMADOL HYDROCHLORIDE - RYZOLT May N021745 002 5591452 May 6254887 Jun 6607748 Oct 7988998 TRAMADOL HYDROCHLORIDE - RYZOLT May N021745 003 5591452 May 6254887 Jun 6607748 Oct 7988998
Dec
30, 2011
DP DP DP DP
NP
Dec
30, 2011
DP DP DP DP
NP
Dec
30, 2011
TRAMADOL HYDROCHLORIDE - TRAMADOL HYDROCHLORIDE N021693 001 5464632 Mar 22, 2013 6106861 Dec 05, 2017 TRAMADOL HYDROCHLORIDE - ULTRAM Oct N020281 001 6339105 Apr 6339105*PED TRAMADOL HYDROCHLORIDE - ULTRAM Oct N020281 002 6339105 Apr 6339105*PED TRANDOLAPRIL - MAVIK N020528 001 5744496 TRANDOLAPRIL - MAVIK N020528 002 5744496 TRANDOLAPRIL - MAVIK N020528 003 5744496
DP DP
U-435 U-435
U-435 U-435
Apr
28, 2015
U-229
Apr
28, 2015
U-229
Apr
28, 2015
U-229
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA N020591 001 5721244 Feb 24, 2015 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA N020591 002 5721244 Feb 24, 2015 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA N020591 003 5721244 Feb 24, 2015 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE - TARKA N020591 004 5721244 Feb 24, 2015 TRANEXAMIC ACID - LYSTEDA N022430 001 7947739 8022106 TRAVOPROST - TRAVATAN N021257 001 5510383 5631287 5849792 5889052 6011062 TRAVOPROST - TRAVATAN Z N021994 001 5510383 5889052 6503497 6849253
Mar Mar
DP U-1182
NDF
Nov
13, 2012
DP DP DP DP
DP DP DP DP
U-383 U-383
DP DP
NDF U-796
Feb
02, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP
EXCLUSIVITY CODE(S)
NDF
TRAZODONE HYDROCHLORIDE - OLEPTRO N022411 002 6607748 Jun 7829120 Mar TREPROSTINIL SODIUM - REMODULIN N021272 001 5153222 Oct 6765117 Oct 7999007 Mar TREPROSTINIL SODIUM - REMODULIN N021272 002 5153222 Oct 6765117 Oct 7999007 Mar TREPROSTINIL SODIUM - REMODULIN N021272 003 5153222 Oct 6765117 Oct 7999007 Mar TREPROSTINIL SODIUM - REMODULIN N021272 004 5153222 Oct 6765117 Oct 7999007 Mar TREPROSTINIL SODIUM - TYVASO N022387 001 5153222 6521212 6756033 6765117 TRETINOIN - ATRALIN N022070 001 5670547 TRETINOIN - RENOVA N021108 001 6531141 TRETINOIN - RETIN-A MICRO N020475 001 5955109 TRETINOIN - RETIN-A MICRO N020475 002 5955109
Feb
02, 2013
U-796
U-455 DS DP U-1174
U-455 DS DP U-1174
U-455 DS DP U-1174
U-455 DS DP U-1174
NDF ODE
Jul Jul
Sep
23, 2014
DP
Mar
07, 2020
Sep
21, 2016
DP
U-134
Sep
21, 2016
U-134
TRIAMCINOLONE ACETONIDE - NASACORT AQ N020468 001 5976573 Jul 03, 5976573 Jul 03, 6143329 Jul 03, 7977045 Jul 03,
DP DP DP DP
NPP
Sep
19, 2011
TRIAMCINOLONE ACETONIDE - TRIESENCE N022048 001 6395294 Jan 13, 2020 TRIMETHOPRIM HYDROCHLORIDE - PRIMSOL Aug 07, 2016 A074973 001 5763449 Aug 07, 2016 5962461 TRIMETREXATE GLUCURONATE - NEUTREXIN May 18, 2018 N020326 001 6017922 TRIMETREXATE GLUCURONATE - NEUTREXIN May 18, 2018 N020326 002 6017922 TRIPTORELIN PAMOATE - TRELSTAR N020715 001 5776885 Jul TRIPTORELIN PAMOATE - TRELSTAR N021288 001 5776885 Jul TRIPTORELIN PAMOATE - TRELSTAR N022437 001 5776885 Jul
DP
U-846
07, 2015
07, 2015
DP
07, 2015
DP
NP
Mar
10, 2013
APPL/PROD NO
PATENT NO
PATENT CODES
U-173 U-251 U-301 U-317
EXCLUSIVITY CODE(S)
TROGLITAZONE - PRELAY N020719 001 5602133 5859037 6011049 6046202 TROGLITAZONE - PRELAY N020719 002 5602133 5859037 6011049 6046202 TROGLITAZONE - PRELAY N020719 003 5602133 5859037 6011049 6046202 TROGLITAZONE - REZULIN N020720 001 5602133 5859037 6011049 6046202 TROGLITAZONE - REZULIN N020720 002 5602133 5859037 6011049 6046202 TROGLITAZONE - REZULIN N020720 003 5602133 5859037 6011049 6046202
TROSPIUM CHLORIDE - SANCTURA XR N022103 001 7410978 Feb 7759359 Nov 7763635 Nov 7781448 Nov 7781449 Nov TROVAFLOXACIN MESYLATE - TROVAN N020759 001 5164402 Dec 5763454 Jun 6187341 Jan TROVAFLOXACIN MESYLATE - TROVAN N020759 002 5164402 Dec 5763454 Jun 6187341 Jan TRYPAN BLUE - MEMBRANEBLUE N022278 001 ULIPRISTAL ACETATE - ELLA N022474 001 UNOPROSTONE ISOPROPYL - RESCULA N021214 001 5221763 Jul 6458836 Jul UROFOLLITROPIN - FERTINEX N019415 004 5767067 UROFOLLITROPIN - FERTINEX N019415 005 5767067
U-282 U-282
U-282 U-282
ODE
Dec
16, 2011
Aug
13, 2015
Jun
16, 2015
Jun
16, 2015
APPL/PROD NO
PATENT NO
PATENT CODES
DP DP DS DS U-530 U-894 U-894 U-530
EXCLUSIVITY CODE(S)
I-570 NPP PED PED
VALACYCLOVIR HYDROCHLORIDE - VALTREX N020487 001 5879706 Jan 19, 2016 5879706 Jan 19, 2016 5879706*PED Jul 19, 2016 6107302 Jan 19, 2016 6107302 Jan 19, 2016 6107302*PED Jul 19, 2016 VALACYCLOVIR HYDROCHLORIDE - VALTREX N020487 002 5879706 Jan 19, 2016 5879706 Jan 19, 2016 5879706*PED Jul 19, 2016 6107302 Jan 19, 2016 6107302 Jan 19, 2016 6107302*PED Jul 19, 2016 VALDECOXIB - BEXTRA N021341 002 5633272 VALDECOXIB - BEXTRA N021341 003 5633272
DP DP DS DS
Feb
13, 2015
U-462
Feb
13, 2015
U-462
VALGANCICLOVIR HYDROCHLORIDE - VALCYTE Mar 29, 2015 N021304 001 6083953 Mar 29, 2015 6083953 Sep 29, 2015 6083953*PED VALGANCICLOVIR HYDROCHLORIDE - VALCYTE N022257 001 6083953 Mar 29, 2015 6083953 Mar 29, 2015
DS DS
DP DP
U-384 U-854
DS DS
DP DP
U-384 U-854
VALSARTAN - DIOVAN N020665 001 5399578 5399578*PED VALSARTAN - DIOVAN N020665 002 5399578 5399578*PED VALSARTAN - DIOVAN N021283 001 5399578 5399578*PED 5972990 5972990*PED 6294197 6294197*PED VALSARTAN - DIOVAN N021283 002 5399578 5399578*PED 5972990 5972990*PED 6294197 6294197*PED VALSARTAN - DIOVAN N021283 003 5399578 5399578*PED 5972990 5972990*PED 6294197 6294197*PED
Mar Sep
U-3
Mar Sep
U-3
U-692 U-3
U-692 U-3
U-692 U-3
APPL/PROD NO
PATENT NO
PATENT CODES
EXCLUSIVITY CODE(S)
VALSARTAN - DIOVAN N021283 004 5399578 5399578*PED 5972990 5972990*PED 6294197 6294197*PED VANDETANIB - VANDETANIB N022405 001 7173038 8067427 RE42353 VANDETANIB - VANDETANIB N022405 002 7173038 8067427 RE42353
U-692 U-3
DS DS
DP DP DP
NCE ODE
Apr Apr
DS DS
DP DP DP
NCE ODE
Apr Apr
VARDENAFIL HYDROCHLORIDE - LEVITRA N021400 001 6362178 Oct 7696206 Oct VARDENAFIL HYDROCHLORIDE - LEVITRA N021400 002 6362178 Oct 7696206 Oct VARDENAFIL HYDROCHLORIDE - LEVITRA N021400 003 6362178 Oct 7696206 Oct VARDENAFIL HYDROCHLORIDE - LEVITRA N021400 004 6362178 Oct 7696206 Oct VARDENAFIL HYDROCHLORIDE - STAXYN N200179 001 6362178 Oct 7696206 Oct VARENICLINE TARTRATE - CHANTIX May N021928 001 6410550 May 6890927 Aug 7265119 VARENICLINE TARTRATE - CHANTIX N021928 002 6410550 May 6890927 May Aug 7265119 VELAGLUCERASE ALFA - VPRIV N022575 001 VELAGLUCERASE ALFA - VPRIV N022575 002 VEMURAFENIB - ZELBORAF N202429 001 7504509 7863288
DS DS
DP DP
U-533 U-533
DS DS
DP DP
U-533 U-533
DS DS
DP DP
U-533 U-533
DS DS
DP DP
U-533 U-533
U-155 U-155
NDF
Jun
17, 2013
DS DS DS
DP DP DP
M-105
Jul
22, 2014
DS DS DS
DP DP DP
M-105
Jul
22, 2014
NCE
Feb
26, 2015
Feb
26, 2015
NCE ODE
Aug Aug
APPL/PROD NO
PATENT NO
PATENT CODES
U-398 U-398
EXCLUSIVITY CODE(S)
VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR N020699 001 5916923 Jun 28, 2013 5916923*PED Dec 28, 2013 6274171 Mar 20, 2017 6274171*PED Sep 20, 2017 6310101 Jun 28, 2013 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6403120*PED Sep 20, 2017 6403120*PED Sep 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 6419958*PED Sep 20, 2017 6419958*PED Sep 20, 2017 6444708 Jun 28, 2013 6444708*PED Dec 28, 2013 VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR N020699 002 5916923 Jun 28, 2013 5916923*PED Dec 28, 2013 6274171 Mar 20, 2017 6274171*PED Sep 20, 2017 6310101 Jun 28, 2013 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6403120*PED Sep 20, 2017 6403120*PED Sep 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 6419958*PED Sep 20, 2017 6419958*PED Sep 20, 2017 6444708 Jun 28, 2013 6444708*PED Dec 28, 2013 VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR N020699 003 5916923 Jun 28, 2013 5916923*PED Dec 28, 2013 6274171 Mar 20, 2017 6274171*PED Sep 20, 2017 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6403120*PED Sep 20, 2017 6403120*PED Sep 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 6419958*PED Sep 20, 2017 6419958*PED Sep 20, 2017 6444708 Jun 28, 2013 6444708*PED Dec 28, 2013 VENLAFAXINE HYDROCHLORIDE - EFFEXOR XR N020699 004 5916923 Jun 28, 2013 5916923*PED Dec 28, 2013 6274171 Mar 20, 2017 6274171*PED Sep 20, 2017 6310101 Jun 28, 2013 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6403120*PED Sep 20, 2017 6403120*PED Sep 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 6419958*PED Sep 20, 2017 6419958*PED Sep 20, 2017 6444708 Jun 28, 2013 6444708*PED Dec 28, 2013
U-46 U-451 U-535 U-535 U-451 U-459 U-535 U-535 U-459 U-398 U-398
U-398 U-398
U-46 U-451 U-535 U-451 U-535 U-535 U-459 U-535 U-459 U-398 U-398
U-398 U-398
U-535 U-451 U-535 U-451 U-535 U-459 U-459 U-535 U-398 U-398
U-398 U-398
U-46 U-535 U-451 U-535 U-451 U-535 U-459 U-535 U-459 U-398 U-398
APPL/PROD NO
PATENT NO
PATENT CODES
U-839 U-535 U-839 U-535
EXCLUSIVITY CODE(S)
VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE N022104 001 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE N022104 002 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE N022104 003 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 VENLAFAXINE HYDROCHLORIDE - VENLAFAXINE HYDROCHLORIDE N022104 004 6403120 Mar 20, 2017 6403120 Mar 20, 2017 6419958 Mar 20, 2017 6419958 Mar 20, 2017 VERAPAMIL HYDROCHLORIDE - COVERA-HS Apr 04, 2017 N020552 001 6096339 VERAPAMIL HYDROCHLORIDE - COVERA-HS Apr 04, 2017 N020552 002 6096339 VERTEPORFIN - VISUDYNE N021119 001 5095030 5707608 5756541 5770619 5798349 6074666 VIGABATRIN - SABRIL N020427 001 VIGABATRIN - SABRIL N022006 001 VILAZODONE HYDROCHLORIDE - VIIBRYD Sep N022567 001 5532241 Jun 7834020 VILAZODONE HYDROCHLORIDE - VIIBRYD Sep N022567 002 5532241 Jun 7834020 VILAZODONE HYDROCHLORIDE - VIIBRYD Sep N022567 003 5532241 Jun 7834020 VORICONAZOLE - VFEND N021266 001 5364938 5567817 VORICONAZOLE - VFEND N021266 002 5364938 5567817 VORICONAZOLE - VFEND N021267 001 5364938 5567817 6632803
U-365
U-365
NCE
Aug
21, 2014
Aug Aug
NCE U-839
Jan
21, 2016
DS DS
DP DP
NCE U-839
Jan
21, 2016
DS DS
DP DP
NCE U-839
Jan
21, 2016
Nov May
DS DS
DP
U-540
Nov May
DS DS
DP
U-540
DS DS
DP DP
U-540
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS
EXCLUSIVITY CODE(S)
VORICONAZOLE - VFEND N021630 001 5364938 5567817 VORINOSTAT - ZOLINZA N021991 001 6087367 7399787 7456219 7652069 7732490 7851509 8067472 RE38506 ZAFIRLUKAST - ACCOLATE N020547 001 5294636 5319097 5482963 5612367 6143775 ZAFIRLUKAST - ACCOLATE N020547 003 5294636 5319097 5482963 5612367 6143775 ZANAMIVIR - RELENZA N021036 001 5360817 5648379 5648379 5648379 6294572 ZICONOTIDE - PRIALT N021060 003 5364842 5364842 5795864 5859186 5859186 ZICONOTIDE ACETATE - PRIALT N021060 001 5364842 5364842 5795864 5859186 5859186 ZICONOTIDE ACETATE - PRIALT N021060 002 5364842 5364842 5795864 5859186 5859186 ZICONOTIDE ACETATE - PRIALT N021060 004 5364842 5364842 5795864 5859186 5859186 ZILEUTON - ZYFLO CR N022052 001 5422123 6183778
Nov May
DP
U-540
NCE ODE
Oct Oct
U-189
U-189
DS
DS
DP
Jun Sep
DP DP
APPL/PROD NO
PATENT NO
PATENT CODES
DS DS DP DP DP U-720
EXCLUSIVITY CODE(S)
I-615
ZIPRASIDONE HYDROCHLORIDE - GEODON N020825 001 4831031 Mar 5312925 Sep May 6150366 Dec 6245766 ZIPRASIDONE HYDROCHLORIDE - GEODON N020825 002 4831031 Mar 5312925 Sep May 6150366 Dec 6245766 ZIPRASIDONE HYDROCHLORIDE - GEODON N020825 003 4831031 Mar 5312925 Sep May 6150366 Dec 6245766 ZIPRASIDONE HYDROCHLORIDE - GEODON N020825 004 4831031 Mar 5312925 Sep May 6150366 Dec 6245766 ZIPRASIDONE HYDROCHLORIDE - GEODON Mar N021483 001 4831031 Sep 5312925 May 6150366 Dec 6245766 May 7175855 ZIPRASIDONE MESYLATE - GEODON N020919 001 4831031 6110918 6232304 6399777 ZOLEDRONIC ACID - RECLAST N021817 001 4939130 4939130*PED 7932241 7932241*PED 8052987 ZOLEDRONIC ACID - ZOMETA N021223 001 4939130 4939130*PED ZOLEDRONIC ACID - ZOMETA N021223 002 4939130 4939130*PED ZOLEDRONIC ACID - ZOMETA N021223 003 4939130 4939130*PED 7932241 ZOLMITRIPTAN - ZOMIG N020768 001 5466699 5466699*PED 5863935 5863935*PED ZOLMITRIPTAN - ZOMIG N020768 002 5466699 5466699*PED 5863935 5863935*PED
Nov
20, 2012
U-601
DS DS
DP DP DP
U-720
I-615
Nov
20, 2012
U-601
DS DS
DP DP DP
U-720
I-615
Nov
20, 2012
U-601
DS DS
DP DP DP
U-720
I-615
Nov
20, 2012
U-601
DS DS
DP DP DP DP
DS
DP
U-720
DS
DP DP
U-662
U-1199
Sep Mar
DS
DP
U-53
Sep Mar
DS
DP
U-53
PED
Sep
20, 2011
DS
DP DP
U-53
APPL/PROD NO
PATENT NO
PATENT CODES
U-436 DP DP
EXCLUSIVITY CODE(S)
ZOLMITRIPTAN - ZOMIG N021450 004 5466699 5466699*PED 6750237 6750237*PED 7220767 7220767*PED ZOLMITRIPTAN - ZOMIG-ZMT N021231 001 5466699 5466699*PED ZOLMITRIPTAN - ZOMIG-ZMT N021231 002 5466699 5466699*PED ZOLPIDEM TARTRATE - AMBIEN CR N021774 001 6514531 6514531*PED ZOLPIDEM TARTRATE - AMBIEN CR N021774 002 6514531 6514531*PED ZOLPIDEM TARTRATE - EDLUAR N021997 001 6761910 ZOLPIDEM TARTRATE - EDLUAR N021997 002 6761910
Nov May
Nov May
Dec Jun
DP
Dec Jun
DP
Sep
24, 2019
DP
U-674
Sep
24, 2019
DP
U-674
ZOLPIDEM TARTRATE - INTERMEZZO Apr N022328 001 7658945 Feb 7682628 ZOLPIDEM TARTRATE - INTERMEZZO Apr N022328 002 7658945 Feb 7682628 ZOLPIDEM TARTRATE - ZOLPIMIST N022196 001 7632517
DP
U-1194 U-1194
NP
Nov
23, 2014
DP
U-1194 U-1194
NP
Nov
23, 2014
Oct
01, 2017
U-70
Footnote: 1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5). 2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. They may not be flagged with respect to other claims which may apply.
ADB 1 of 51
NEW DOSING SCHEDULE (SEE INDIVIDUAL REFERENCES) NEW INDICATION (SEE INDIVIDUAL REFERENCES) MISCELLANEOUS EXCLUSIVITY CODES (SEE INDIVIDUAL REFERENCES) NEW COMBINATION NEW CHEMICAL ENTITY NEW DOSAGE FORM NEW ESTER OR SALT OF AN ACTIVE INGREDIENT NEW PRODUCT NEW PRODUCT (MINT FLAVORED) NEW PATIENT POPULATION NEW ROUTE NEW STRENGTH ORPHAN DRUG EXCLUSIVITY PATENT CHALLENGE PEDIATRIC EXCLUSIVITY RX TO OTC SWITCH OR OTC USE PATENT USE CODE (SEE INDIVIDUAL REFERENCES) EXCLUSIVITY ON THIS APPLICATION EXPIRING ON THIS DATE HAS BEEN WAIVED BY SPONSOR - SEE SECTION 1.8 OF ORANGE BOOK PREFACE WAIVED EXCLUSIVITY
ADB 2 of 51
D-45 D-46 D-47 D-48 D-49 D-50 D-51 D-52 D-53 D-54 D-55 D-56 D-57 D-58 D-59 D-60 D-61 D-62 D-63 D-64 D-65 D-66 D-67 D-68 D-69 D-70 D-71 D-72 D-73 D-74 D-75 D-76 D-77 D-78 D-79
DOSING REGIMEN FOR ADMINISTRATION EITHER ONCE DAILY (QD) OR TWICE DAILY (BID) CONTINUOUS INFUSION AS AN ALTERNATE METHOD OF ADMINISTRATION CHANGE IN TIME TO TAKE THE DRUG PRIOR TO A MEAL TO PREVENT MEAL-INDUCED HEARTBURN SYMPTOMS FROM "..1/2 TO 1 HOUR BEFORE EATING" TO ".. RIGHT BEFORE EATING OR UP TO 60MIN BEFORE CONSUMING..." ONCE-A-DAY DOSING REGIMEN DRUG MAY BE DOSED RIGHT BEFORE A MEAL OR ANY TIME UP TO 30MIN BEFORE EATING OR DRINKING FOOD AND BEVERAGES THAT WOULD BE EXPECTED TO CAUSE SYMPTOMS TEN DAY DOSING REGIMEN FOR TRIPLE THERAPY, PREVACID IN COMBINATION WITH CLARITHROMYCIN AND AMOXICILLIN, FOR THE ERADICATION OF H.PYLORI IN PATIENTS WITH DUODENAL ULCER DISEASE INITIATION OF TREATMENT WITH 900MG/DAY BY DELETION OF THE REQUIREMENT TO TITRATE TO 900MG/DAY OVER A 3-DAY PERIOD IN A CLINICAL TRIAL, FEWER DISCONTINUATIONS DUE TO ADVERSE EVENTS, ESPECIALLY DIZZINESS AND VERTIGO, WERE OBSERVED WHEN TITRATING THE DOSE IN INCREMENTS OF 50MG/DAY EVERY 3 DAYS UNTIL AN EFFECTIVE DOSE (NOT EXCEEDING 400MG/DAY) WAS REACHED ONCE DAILY DOSING FOR MAINTENANCE ONLY NEW DOSING REGIMEN OF 80MG DAILY PREVENTION OF HEARTBURN SYMPTOMS WHEN ADMINISTERED FROM 15 MINUTES UP TO, BUT NOT INCLUDING, 1 HOUR PRIOR TO A PROVOCATIVE MEAL ADIMISTRATION OF CISATRICURIUM A NEUROMUSCULAR BLOCKING AGENT AT DOSES OF 3 AND 4X THE ED95 OF CISATRICURIUM FOLLOWING INDUCTION WITH THIOPENTAL PEDIATRIC DOSING GUIDELINES INFORMATION FOR USE OF CORVERT IN POST-CARDIAC SURGERY PATIENTS OPTIONAL STARTING DOSE OF 40MG/DAY ALTERNATE DOSING REGIMEN OF 1250MG TWICE DAILY USE IN PEDIATRIC PATIENTS FROM 1 MONTH TO 16 YEARS OF AGE USE OF ZYBAN FOR MAINTENANCE THERAPY. TREATMENT UP TO 6 MONTHS WAS SHOWN EFFICACIOUS ADDITION OF A HIGHER DOSE OF NUTROPIN FOR PUBERTAL PATIENTS (PUBERTAL DOSE LESS THAN OR EQUAL TO 0.7MG/KG/WEEK) ADDITION OF POSTPRANDIAL DOSING 3-HOUR INFUSION OF TAXOL GIVEN EVERY THREE WEEKS AT A DOSE OF 175MG/M2 FOLLOWED BY CISPLATIN AT A DOSE OF 75MG/M2 FOR THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN CANCER CHANGE IN DOSING INTERVAL TO ONCE-DAILY ADMINISTRATION REDUCTION OF ELEVATED LDL-C IN A NEW, HIGHER STRENGTH TABLET, 0.8MG, AND FOR EXTENSION OF THE DOSAGE RANGE TO 0.8MG DAILY ADDITION OF A POST-OPERATIVE DOSING REGIMEN ONCE WEEKLY DOSING FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS ONCE WEEKLY DOSING FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS TO ALLOW A TITRATION DOSING REGIMEN USING A 25MG DOSE INCREASING DOSAGE FOR NERVE BLOCK ANESTHESIA USING NAROPIN 7.5MG/ML AND FOR EXTENDING THE DURATION OF TREATMENT FOR POSTOPERATIVE ANALGESIA USING NAROPIN 2MG/ML CHANGE DOSING AND ADMINISTRATION TO INDICATE MAINTENANCE OF WEIGHT LOSS OVER AN 18 MONTH PERIOD THUS EXTENDING THE USE OF THIS DRUG FROM ONE TO TWO YEARS DOSING RECOMMENDATIONS FOR PATIENTS UNDERGOING PCI SHORTER TREATMENT COURSE OF THREE DAYS IN THE TREATMENT OF RECURRENT EPISODES OF GENITAL HERPES CHANGE OF ADMIN RATE FOR INFUSION OF AREDIA FOR TREATMENT OF MODERATE AND SEVERE HYPERCALCEMIA OF MALIGNANCY FROM 24 HOURS TO 2 HOURS UP TO BUT NOT INCLUDING 24 HOURS SHORTENED DOSING REGIMEN TO 5 DAYS FOR THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC BRONCHITIS 80MG ONCE DAILY DOSING REGIMEN EIGHT WEEK DOSING REGIMEN INFORMATION REGARDING INCREASED RATE OF INFUSION FOR DEPACON ONCE A WEEK DOSING FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS ONCE A WEEK DOSING FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS INTERMITTENT DOSING REGIMEN, STARTING DAILY DOSE 14 DAYS PRIOR TO THE ANTICIPATED ONSET OF MENSTRUATION THROUGH THE FIRST FULL DAY OF MENSES AND REPEATING WITH EACH NEW CYCLE FOR USE ON AN "AS NEEDED" OR PRN BASIS FOR THE MANAGEMENT OF NASAL SYMPTOMS IN PATIENTS FOR WHOM THE DRUG IS INDICATED ADDITION OF 20MG AND 40MG DAILY AS OPTIONAL STARTING DOSES WITH 40MG INTENDED FOR PATIENTS WHO REQUIRE A LARGE REDUCTION IN LDL-C (MORE THAN 45%) USE OF FLEXERIL 5MG FOR THE RELIEF OF MUSCLE SPASM ASSOCIATED WITH ACUTE, PAINFUL, MUSCULOSKELETAL CONDITIONS NEW LOWER STARTING DOSE FOR TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS AND/OR MODERATE TO SEVERE SYMPTOMS OF VULVAR AND VAGINAL ATROPHY ASSOCIATED W/ THE MENOPAUSE
ADB 3 of 51
D-85 D-86 D-87 D-88 D-89 D-90 D-91 D-92 D-93 D-94 D-95 D-96 D-97
D-107
D-108 D-109
CHANGE OF DOSING SCHEDULE FOR LANTUS FROM ONCE DAILY AT BEDTIME TO FLEXIBLE DAILY DOSING NEW LOWER STARTING DOSE FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPORSIS USE OF PREMARIN 0.3 MG AND 0.45 MG FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS 750 MG, ONCE DAILY FOR 5 DAYS FOR COMMUNITY ACQUIRED PNEUMONIA (CAP) ONCE-A-DAY DOSING OF FLOXACIN OTIC FOR THE TREATMENT OF ADULTS AND PEDIATRIC PATIENTS(AGES 6 MO & OLDER) W/ OTITIS EXTERNA CAUSED BY SUSCEPTIBLE STRAINS OF E.COLI, P.AERUGINOSA AND S.AUREUS LOWER RECOMMENDED STARTING DOSE GUIDELINES FOR TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH THE MENOPAUSE FOR USE IN SELECT EXTERNAL INSULIN PUMPS ADDITION OF ONCE-WEEKLY DOSING FOR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS NEW DOSING RANGE OF 200-400MG PER DAY IN TWO DIVIDED DOSES FOR ADULTS WITH PARTIAL SEIZURES USE OF REYATAZ 300 MG/RITONAVIR 100 MG ONCE DAILY FOR TREATMENT IN HIV-INFECTED ANTIRETROVIRAL-EXPERIENCED PATIENTS ADDITION OF DAYTIME ADMINISTRATION TO TREAT VULVOVAGINAL CANDIDIASIS ALTERNATE INTERMITTENT DOSING REGIMEN ALTERNATIVE DOSAGE OF 1000MG ONCE DAILY AT BEDTIME ALTERNATE TWO OR THREE TIMES DAILY DOSING REGIMENS NEW MAXIMUM DOSAGE OF 72 MG/DAY IN ADOLESCENTS 13-17 YEARS OF AGE WITH ATTENTION DEFECIT HYPERACTIVITY DISORDER (ADHD) BROADENED INITIAL STARTING DOSE FOR HYPERTENSION FROM 50 MG TO 100 MG TO 25 MG TO 100 MG DOSE RANGE ONCE-MONTHLY TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH BONIVA (IBANDRONATE SODIUM) 150 MG TABLETS PED CANCER PT POPULATION EXPANDED TO INCLUDE PTS 6 MOS UP TO BUT NOT INCLUDING 4 YRS AND DOSING INSTRUCTIONS TO ADMIN 30 MIN BEFPRE CHEMO WITH SECOND AND THIRD DOSES 4 & 8 HOURS AFTER FIRST DOSE DOSING FOR PED SURGICAL PTS EXPANDED TO INCLUDE PTS 1 MONTH UP TO BUT NOT INCLUDING 2 YEARS OF AGE ONCE DAILY ADMINISTRATION FOR THE TREATMENT OF HIV INFECTION IN THERAPY NAIVE ADULT PATIENTS 750 MG ONCE DAILY FOR FIVE DAYS FOR THE TREATMENT OF ACUTE BACTERIAL SINUSITIS ONCE DAILY IN CHRONIC IDIOPATHIC UTICARIA FOR ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER NEW DOSING REGIMEN OF ONE SPRAY TWICE DAILY FOR SEASONAL ALLERIC RHINITIS IN PATIENTS 12 YRS OF AGE AND OLDER NEW DOSING RECOMMENDATION FOR THE TREATMENT OF RECURRENT GENITAL HERPES IN IMMUNOCOMPETENT PATIENTS, SPECIFICALLY A REDUCTION IN COURSE OF THERAPY FROM FAMCICLOVIR 125 MG TWICE-A-DAY FOR 5 DAYS TO 1000 MG TWICE-A-DAY FOR 1 DAY. 0.5MG/0.1MG FOR THE TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE IN WOMEN WHO HAVE A UTERUS USE OF ACTONEL 75MG TWO CONSECUTIVE DAYS PER MONTH FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS FIVE DAY TREATMENT OF SELECTED SUSCEPTIBLE STRAINS OF STREPTOCOCCUS PNEUMONIAE, HAEMOPHILUS INFLUENZA, MYCOPLASMA PNEUMONIAE, AND CHLAMYDIA PNEUMONIAE FOR COMMUNITYACQUIRED PNEUMONIA PROVIDES FOR THE COMBINATION TABLET OF 70MG ALENDRONATE AND 5600 IU OF VITAMIN D3 FOR THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AND TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS TREATMENT OF COMPLICATED URINARY TRACT INFECTION AND ACUTE PYELONEPHRITIS WITH LEVAQUIN 750MG ONCE DAILY FOR FIVE DAYS PROVIDE FOR THE USE OF A LOWER DOSE FOR THE TREATMENT OF ADULTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB MESYLATE TREATMENT OF SCHIZOPHRENIA IN ADOLESCENTS AGED 13-17 PROVIDES FOR ONCE DAILY USE OF CIALIS, 2.5 MG AND 5 MG, FOR THE TREAMTENT OF ERECTILE DYSFUNCTION PROVIDES FOR PEDIATRIC PUMP USE ONCE DAILY DOSING REGIMEN FOR PATIENTS WHO BECOME CONSTIPATED ON TWICE DAILY REGIMEN NEW DOSING RECOMMENDATIONS FOR USE OF SIROLIMUS IN COMBINATION WITH CYCLOSPORINE FOR THE PROPHYLAXIS OF REJECTION IN HIGH-RISK RENAL TRANSPLANT RECIPIENTS STARTING DOSE OF 15MG/DAY FOR MONOTHERAPY IN ACUTE TREATMENT OF BIPOLAR DISORDER, MANIC OR MIXED ALTERNATIVE DOSING REGIMEN ATAZANAVIR SULATE CO-ADMINISTERED WITH RITONAVIR FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT NAIVE PATIENTS
ADB 4 of 51
D-129 D-130
50 MG TABLET FOR INITIATION OF DOSE TITRATION FOR BIPOLAR DISORDER TWO 400MG TABLETS ONCE DAILY, CO-ADMINISTERED WITH 100MG RITONAVIR DOSING RECOMMENDATIONS FOR HIV INFECTED PEDIATRIC PATIENTS 6 TO LESS THAN 18 YEARS OF AGE DOSING REGIMEN ADJUSTMENTS CHANGE TO REMOVE 20 MG MAXIMUM DOSAGE RESTRICTION USE OF VAGIFEM 10 MCG FOR THE TREATMENT OF ATROPHIC VAGINITIS DUE TO MENOPAUSE ALTERNATIVE DOSING REGIMEN DOSE OF 20 MG/METER SQUARE BY CONTINUOUS INTRAVENOUS INFUSION OVER 1 HOUR REPEATED DAILY FOR 5 DAYS ONCE DAILY DOSING REGIMEN IN ADULT PATIENTS WITH LESS THAN THREE LOPINAVIR RESISTANCEASSOCIATED SUBSTITUTIONS EXTEND CURRENT DOSING REGIMEN TO 900MG (2-450MG TABLETS) ONCE A DAY WITHIN 10 DAYS OF TRANSPLANTATION UNTIL 200 DAYS POST-TRANSPLANTATION FOR THE PREVENTION OF CYTOMEGALOVIRUS (CMV) DISEASE IN ADULT KIDNEY TRANSPLANT PATIENTS AT HIGH RISK. CHANGE DOSAGE REGIMEN FROM 250MG TO 500MG DOSING REGIMEN FOR ADULT PATIENTS WITH CHRONIC HEPATITIS B (CHB) AND DECOMPENSATED LIVER DESEASE SINGLE IV DOSE OF FOSAPREPITANT 150MG, DOSED CONCOMITANTLY WITH 5HT3 RECEPTOR ANTAGONIST & CORTICOSTEROID, FOR PREVENTION OF ACUTE & DELAYED NAUSEA & VOMITING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF HIGHLY EMETOGENIC CANCER CHEMO 800/100 MG DARUNAVIR/RITONAVIR, ONCE DAILY, IN TREATMENT -EXPERIENCED HIV-1 INFECTED PATIENTS WITH NO DARUNIVIR RESISTANCE ASSOCIATED SUBSITUTIONS DOSING RECOMMENDATIONS FOR TREATMENT OF HIV-1 INFECTION DURING PREGNANCY BASED ON DATA FROM STUDY AI424-182, A STUDY OF ATAZANAVIR/RITONAVIR IN COMBINATION WITH ZIDOVUDINE/LAMIVUDINE IN HIV INFECTED PREGNANT WOMEN EVERY 6 TO 8 WEEKS FOR THE 120MG STRENGTH FOR PATIENTS WHO ARE CONTROLLED ON SOMATULINE DEPOT 60MG OR 90MG 45MG FOR 6 MONTH ADMINISTRATION NEW EFFICACY DATA AND DOSING REGIMEN FOR PREGNANCY IN NORMAL OVULATORY WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION AS PART OF AN IVF OR INTRACYTOPLASMIC SPERM INJECTION (ICSI) CYCLE
EXCLUSIVITY INDICATION
I-1 I-2 I-3 I-4 I-5 I-6 I-7 I-8 I-9 I-10 I-11 I-12 I-13 I-14 I-15 I-16 I-17 I-18 I-19 I-20 I-21 DYSMENORRHEA CHOLANGIOPANCREATOGRAPHY INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY PERIPHERAL VENOGRAPHY (PHLEBOGRAPHY) HYSTEROSALPINGOGRAPHY TREATMENT OF JUVENILE ARTHRITIS BIOPSY PROVEN MINIMAL CHANGE NEPHROTIC SYNDROME IN CHILDREN ADULT INTRAVENOUS CONTRAST-ENHANCED COMPUTED TOMOGRAPHY OF THE HEAD AND BODY PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING PREVENTION OF POSTOPERATIVE DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN TOTAL HIP REPLACEMENT SURGERY RELIEF OF MILD TO MODERATE PAIN TREATMENT OF CUTANEOUS CANDIDIASIS URINARY TRACT INFECTION (UTI) PREVENTION FOR PERIODS UP TO FIVE MONTHS IN WOMEN WITH A HISTORY OF RECURRENT UTI SEBORRHEIC DERMATITIS PHOTOPHERESIS IN THE PALLIATIVE TREATMENT OF SKIN MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PERSONS NOT RESPONSIVE TO OTHER TREATMENT STIMULATE THE DEVELOPMENT OF MULTIPLE FOLLICLES/OOCYTES IN OVULATORY PATIENTS PARTICIPATING IN AN IN VITRO FERTILIZATION PROGRAM MANAGEMENT OF CONGESTIVE HEART FAILURE ENDOSCOPIC RETROGRADE PANCREATOGRAPHY HERNIOGRAPHY KNEE ARTHROGRAPHY HIGH DOSE METHOTREXATE WITH LEUCOVORIN RESCUE IN COMBINATION WITH OTHER CHEMOTHERAPEUTIC AGENTS TO DELAY RECURRENCE IN PATIENTS WITH NONMETASTATIC OSTEOSARCOMA WHO HAVE UNDERGONE SURGICAL RESECTION OR AMPUTATION FOR THE PRIMARY TUMOR RESCUE AFTER HIGH-DOSE METHOTREXATE THERAPY IN OSTEOSARCOMA SHORT-TERM TREATMENT OF ACTIVE BENIGN GASTRIC ULCER TREATMENT OF RHEUMATOID ARTHRITIS ADULT INTRA-ARTERIAL DIGITAL SUBTRACTION ANGIOGRAPHY OF THE HEAD, NECK, ABDOMINAL, RENAL AND PERIPHERAL VESSELS
ADB 5 of 51
TREATMENT OF LIVER FLUKES ADJUNCTIVE THERAPY TO DIET TO REDUCE THE RISK OF CORONARY ARTERY DISEASE SELECTIVE ADULT VISCERAL ARTERIOGRAPHY METASTATIC BREAST CANCER IN PREMENOPAUSAL WOMEN AS AN ALTERNATIVE TO OOPHORECTOMY OR OVARIAN IRRADIATION TREATMENT OF TINEA PEDIS CONTRAST ENHANCEMENT AGENT TO FACILITATE VISUALIZATION OF LESIONS IN THE SPINE AND ASSOCIATED TISSUES PEDIATRIC MYELOGRAPHY ORAL USE OF DILUTED OMNIPAQUE INJECTION IN ADULTS FOR CONTRAST ENHANCED COMPUTED TOMOGRAPHY OF THE ABDOMEN ORAL USE IN ADULTS FOR PASS-THROUGH EXAMINATION OF THE GASTROINTESTINAL TRACT PEDIATRIC CONTRAST ENHANCEMENT OF COMPUTED TOMOGRAPHIC HEAD IMAGING ARTHROGRAPHY OF THE SHOULDER JOINTS IN ADULTS RADIOGRAPHY OF THE TEMPOROMANDIBULAR JOINT IN ADULTS CONTRAST ENHANCEMENT AGENT TO FACILITATE VISUALIZATION OF LESIONS OF THE CENTRAL NERVOUS SYSTEM IN CHILDREN (2 YEARS OF AGE AND OLDER) TREATMENT OF ACUTE MYOCARDIAL INFARCTION PRIMARY NOCTURNAL ENURESIS MIGRAINE HEADACHE PROPHYLAXIS HERPES ZOSTER HERPES SIMPLEX ENCEPHALITIS MAINTENANCE THERAPY IN HEALED DUODENAL ULCER PATIENTS AT DOSE OF 1 GRAM TWICE DAILY ACUTE TREATMENT OF VARICELLA ZOSTER VIRUS USE IN PEDIATRIC COMPUTED TOMOGRAPHIC HEAD AND BODY IMAGING TREATMENT OF PEDIATRIC PATIENTS WITH SYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE PEDIATRIC ANGIOCARDIOGRAPHY TREATMENT OF TRAVELERS' DIARRHEA DUE TO SUSCEPTIBLE STRAINS OF ENTEROTOXIGENIC ESCHERICHIA COLI FOR USE IN WOMEN WITH AXILLARY NODE-NEGATIVE BREAST CANCER TREATMENT OF PRIMARY DYSMENORRHEA AND FOR THE TREATMENT OF IDIOPATHIC HEAVY MENSTRUAL BLOOD LOSS PEDIATRIC EXCRETORY UROGRAPHY TREATMENT OF PANIC DISORDER, WITH OR WITHOUT AGORAPHOBIA RENAL CONCENTRATION CAPACITY TEST HYPERTENSION EROSIVE GASTROESOPHAGEAL REFLUX DISEASE SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER INITIAL TREATMENT OF ADVANCED OVARIAN CARCINOMA IN COMBINATION WITH OTHER APPROVED CHEMOTHERAPEUTIC AGENTS ENDOSCOPICALLY DIAGNOSED ESOPHAGITIS, INCLUDING EROSIVE AND ULCERATIVE ESOPHAGITIS, AND ASSOCIATED HEARTBURN DUE TO GASTROESOPHAGEAL REFLUX DISEASE SINGLE APPLICATION TREATMENT OF HEAD LICE IN CHILDREN TWO MONTHS TO TWO YEARS IN AGE FEMALE ANDROGENETIC ALOPECIA PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS ONCE DAILY TREATMENT AS INITIAL THERAPY IN THE TREATMENT OF HYPERTENSION PREVENTION OF SUPRAVENTRICULAR TACHYCARDIAS PREVENTION OF UPPER GASTROINTESTINAL BLEEDING IN CRITICALLY ILL PATIENTS UNCOMPLICATED GONORRHEA TREATMENT OF ACUTE ASTHMATIC ATTACKS IN CHILDREN SIX YEARS OF AGE AND OLDER CENTRAL PRECOCIOUS PUBERTY SHORT TERM TREATMENT OF PATIENTS WITH SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE (GERD), AND FOR THE SHORT TERM TREATMENT OF ESOPHAGITIS DUE TO GERD INCLUDING ULCERATIVE DISEASE DIAGNOSED BY ENDOSCOPY USE IN COMBINATION WITH 5-FLUOROURACIL TO PROLONG SURVIVAL IN THE PALLIATIVE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL CANCER VARICELLA INFECTIONS (CHICKENPOX) PREVENTION OF CMV DISEASE IN TRANSPLANT PATIENTS AT RISK FOR CMV DISEASE INITIATE AND MAINTAIN MONITORED ANESTHESIA CARE (MAC) SEDATION DURING DIAGNOSTIC PROCEDURES INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY TREATMENT OF ENDOSCOPICALLY DIAGNOSED EROSIVE ESOPHAGITIS PREVENTION OF OSTEOPOROSIS
ADB 6 of 51
I-104 I-105 I-106 I-107 I-108 I-109 I-110 I-111 I-112 I-113 I-114 I-115 I-116 I-117 I-118 I-119 I-120 I-121 I-122 I-123 I-124
DERMAL INFECTIONS-TINEA PEDIS, TINEA CORPORIS, TINEA CRURIS DUE TO EPIDERMOPHYTON FLOCCOSUM CONTRAST ENHANCED COMPUTED TOMOGRAPHIC IMAGING OF THE HEAD AND BODY AND INTRAVENOUS EXCRETORY UROGRAPHY MANAGEMENT OF CHRONIC STABLE ANGINA AND ANGINA DUE TO CORONARY ARTERY SPASM DIAGNOSIS AND LOCALIZATION OF ISCHEMIA AND CORONARY HEART DISEASE PROPHYLAXIS IN DESIGNATED IMMUNOCOMPROMISED CONDITIONS TO REDUCE THE INCIDENCE OF OROPHARYNGEAL CANDIDIASIS TREATMENT OF TRAVELERS' DIARRHEA ANGIOCARDIOGRAPHY, CONTRAST ENHANCED COMPUTED TOMOGRAPHIC IMAGING OF THE HEAD AND BODY, AND INTRAVENOUS EXCRETORY UROGRAPHY IN CHILDREN INTRAOPERATIVE AND POSTOPERATIVE TACHYCARDIA AND/OR HYPERTENSION TREATMENT OF ANOREXIA ASSOCIATED WITH WEIGHT LOSS IN PATIENTS WITH AIDS TREATMENT OF SECONDARY CARNITINE DEFICIENCY RENAL IMAGING AGENT FOR USE IN CHILDREN MANAGEMENT OF ENDOMETRIOSIS EPIDURAL USE IN LABOR AND DELIVERY AS AN ANALGESIC ADJUNCT TO BUPIVACAINE INTENSIVE CARE UNIT SEDATION MONOTHERAPY USE FOR HYPERTENSION ADJUNCTIVE THERAPY IN THE MANAGEMENT OF HEART FAILURE PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN CHILDREN AGES 4-11 YEARS USE WITH MRI IN ADULTS TO PROVIDE CONTRAST ENHANCEMENT AND FACILITATE VISUALIZATION OF LESIONS IN THE BODY [EXCLUDING THE HEART] TREATMENT OF LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA ORAL OR RECTAL USE IN CHILDREN FOR THE EXAMINATION OF THE GASTROINTESTINAL TRACT TREATMENT OF CHILDREN WHO HAVE GROWTH FAILURE ASSOCIATED WITH CHRONIC RENAL INSUFFICIENCY PEDIATRIC ANESTHESIA IN CHILDREN 3 YEARS AND OLDER TO DECREASE THE INCIDENCE OF CANDIDIASIS IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION WHO RECEIVE CYTOTOXIC CHEMOTHERAPY AND/OR RADIATION THERAPY TREATMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I INSULIN-DEPENDENT DIABETES MELLITUS AND RETINOPATHY TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER PROPHYLAXIS AGAINST PNEUMOCYSTIS CARINII PNEUMONIA IN INDIVIDUALS WHO ARE IMMUNOCOMPROMISED AND CONSIDERED TO BE AT RISK OF DEVELOPING PNEUMOCYSTIS CARINII PNEUMONIA TREATMENT OF PULMONARY AND EXTRAPULMONARY ASPERGILLOSIS IN PATENTS WHO ARE INTOLERANT OF OR WHO ARE REFRACTORY TO AMPHOTERICIN B THERAPY TREATMENT OF METASTATIC CARCINOMA OF THE BREAST AFTER FAILURE OF FIRST-LINE OR SUBSEQUENT CHEMOTHERAPY TREATMENT OF ACROMEGALY VAGINAL CANDIDIASIS EXPANDED USE-FOR ICU PATIENTS UNDERGOING LONG-TERM INFUSION DURING MECHANICAL VENTILATION TYPHOID FEVER PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH RADIOTHERAPY TREATMENT OF PAGET'S DISEASE OF BONE MANAGEMENT OF MODERATE TO SEVERE PAIN TREATMENT OF PROSTATITIS USE IN CHILDREN TO VISUALIZE LESIONS WITH ABNORMAL VASCULARITY IN THE BRAIN (INTRACRANIAL LESIONS), SPINE, AND ASSOCIATED TISSUE USE IN MRI IN ADULTS TO VISUALIZE LESIONS IN THE HEAD AND NECK MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS TO SLOW THE PROGRESSION FO CORONANY ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE PREVENTION OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM FOLLOWING KNEE REPLACEMENT SURGERY TREATMENT OF ANEMIA CAUSED BY UTERINE LEIOMYOMATA IN WOMEN WHO FAIL IRON THERAPY MAINTENANCE THERAPY FOR GASTRIC ULCER PATIENTS AT REDUCED DOSAGE AFTER HEALING ACUTE ULCERS EXPANDED PATIENT POPULATION -- USE IN ICU PATIENTS PSORIASIS OF THE SCALP RELIEF OF MILD TO MODERATE PAIN IN PATIENTS AGED 6 MONTHS AND OLDER LEUCOCYTE LABELED SCINTIGRAPHY AS AN ADJUNCT IN THE LOCALIZATION OF INTRA-ABDOMINAL INFECTION AND INFLAMMATORY BOWEL DISEASE
ADB 7 of 51
I-129 I-130 I-131 I-132 I-133 I-134 I-135 I-136 I-137 I-138 I-139 I-140 I-141 I-142 I-143 I-144 I-145 I-146 I-147 I-148 I-149 I-150 I-151 I-152 I-153 I-154 I-155 I-156 I-157 I-158 I-159
EXPANSION OF CONSCIOUS SEDATION INDICATION TO INCLUDE SHORT THERAPEUTIC PROCEDURES ADJUNCT TO THALLIUM- 201 MYOCARDIAL PERFUSION IN PATIENTS UNABLE TO EXERCISE ADEQUATELY TREATMENT OF ACYCLOVIR-RESISTANT HERPES IN IMMUNOCOMPROMISED PATIENTS IN PT W/ CH DISEASE AND HYPERCHOLESTEROLEMIA: REDUCE RISK TOTAL MORTALITY BY REDUCING CORONARY DEATH; REDUCE RISK NON-FATAL MI; REDUCE RISK UNDERGOING MYOCARDIAL REVASCULARIZATION PROCEDURES; REDUCTION ELEVATED TOTAL AND LDL CHOL LEVELS... TREATMENT OF ALCOHOL DEPENDENCE MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS PERIPHERAL ARTERIOGRAPHY TREATMENT OF MANIC PHASE OF BIPOLAR DISORDER MANAGEMENT OF CHRONIC STABLE ANGINA HEART FAILURE POST MYOCARDIAL INFARCTION BONE METASTASES ASSOCIATED WITH MULTIPLE MYELOMA IDIOPATHIC CHRONIC URTICARIA PREVENTION OF METAL-INDUCED HEART BURN, ACID INDIGESTION, AND SOUR STOMACH WHEN TAKEN 30 MINUTES PRIOR TO CONSUMING FOOD OR BEVERAGES TREATMENT OF ACUTE RECURRENT GENITAL HERPES PALLIATIVE TREATMENT OF ADVANCED BREAST CANCER IN PRE- AND PERIMENOPAUSAL WOMEN PREVENTION OF CYTOMEGALOVIRUS (CMV) DISEASE IN INDIVIDUALS WITH HIV INFECTION AT RISK FOR DEVELOPING CMV DISEASE TREATMENT OF HEMODYNAMICALLY STABLE PATIENTS WITHIN 24 HOURS OF ACUTE MYOCARDIAL INFARCTION TO IMPROVE SURVIVAL LOCALIZE MYOCARDIAL ISCHEMIA(REVERSIBLE DEFECT) AND INFARCTION (NON-REVERSIBLE DEFECTS) IN EVALUATING MYOCARDIAL FUNCTION EPISODIC TREATMENT OF RECURRENT GENITAL HERPES IN IMMUNOCOMPETENT ADULTS ENHANCEMENT OF MRI OF THE ADULT BODY INTERNAL ORGANS 0.1MMOL/KG AS A SINGLE INTRAVEOUS BOLUS FOR MRI OF THE CNS IN CHILDREN CONTRAST ENHANCEMENT AND FACILITATION OF VISUALIZATION OF EXTRACRANIAL HEAD AND NECK LESIONS PREVENTION OF GALLSTONE FORMATION IN OBESE PATIENTS EXPERIENCING RAPID WEIGHT LOSS TREATMENT OF ACUTE PNEUMOCYSTIC CARINI PNEUMONIA (PCP) IN HIV-INFECTED PATIENTS WHOSE ALVEOLAR-ARTERIAL OXYGEN DIFFERENCE (AaDO2) IS LESS THAN OR EQUAL TO 55 TORR TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER TREATMENT OF OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER PREVENTION OF AND PREVENTION OF FURTHER POSTOPERATIVE NAUSEA AND VOMITING IN PEDIATRIC PATIENTS RECEIVING GENERAL ANESTHESIA SLOWING THE PROGRESSION OF CORONARY ATHEROSCLEROSIS AND REDUCING THE RISK OF ACUTE CORONARY EVENTS MANAGEMENT OF SEVERE SPASTICITY [ENCOMPASES SPINAL AND CEREBRAL ORIGIN] PATIENT POPULATION ALTERED TO INCLUDE PEDIATRIC USE TREATMENT OF ONCHOMYCOSIS DUE TO DERMATOPHYTES (TINEA UNGUIUM) OF THE TOENAIL WITH OR WITHOUT FINGERNAIL INVOLVEMENT ADDITIONAL DATA REGARDING THE SAFE USE OF NORVASC IN PATIENTS WITH HEART FAILURE TREATMENT OF ACUTE UNCOMPLICATED CYSTITIS IN FEMALES TREATMENT OF OSTEOLYTIC BONE METASTASES OF BREAST CANCER FOR HYPERCHOLESTEROLEMIC PATIENTS WITHOUT CLINICALLY EVIDENT HEART DISEASE REDUCE THE RISK OF MYOCARDIAL INFARCTION, REVASCULARIZATION, AND DEATH DUE TO CARDIOVASCULAR CAUSES WITH NO INCREASE IN DEATH FROM NON-CARDIOVASCULAR CAUSES TREATMENT OF BACTERIAL CORNEAL ULCERS TREATMENT OF ADULT-ONSET OR CHILDHOOD-ONSET ADULT GROWTH HORMONE DEFICIENCY FOR USE IN PATIENTS 6-11 YEARS OF AGE TREATMENT OF PHOTOPHOBIA CHRONIC BACTERIAL PROSTATITIS MANAGEMENT OF ADULTS WITH ACTIVE, CLASSIC AND DEFINITIVE RHEUMATOID ARTHRITIS WHO HAVE HAD INSUFFICIENT THERAPEUTIC RESPONSE TO OR ARE INTOLERANT OF AN ADEQUATE TRIAL OF FULL DOSES OF ONE OR MORE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS TREATMENT OF BULIMIA COMPLICATED INTRA-ABDOMINAL INFECTIONS (USED IN COMBINATION WITH METRONIDAZOLE) CAUSED BY MIXED AEROBIC/ANAEROBIC PATHOGENS MANAGEMENT OF LOCALLY CONFINED STAGE B2-C METASTATIC CARCINOMA OF THE PROSTATE (IN COMBINATION WITH LHRH AGONISTS) USE IN COMBINATION WITH CORTICOSTEROIDS AS INITIAL CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH PAIN RELATED TO ADVANCED HORMONE-REFRACTORY PROSTATE CANCER PROPHYLACTIC USE DURING HEAD LICE EPIDEMICS RELIEF OF SYMPTOMS OF THE COMMON COLD
ADB 8 of 51
I-178 I-179 I-180 I-181 I-182 I-183 I-184 I-185 I-186 I-187 I-188 I-189 I-190
I-191 I-192
I-199 I-200 I-201 I-202 I-203 I-204 I-205 I-206 I-207 I-208 I-209 I-210
TREATMENT OF INITIAL EPISODE OF GENITAL HERPES PREOPERATIVELY FOR THE PREVENTION OF INFECTION IN TRANSRECTAL PROSTATE BIOPSY PELVIC INFLAMMATORY DISEASE TREATMENT OF TINEA CORPORIS AND TINEA CRURIS TREATMENT OF POSTOPERATIVE INFLAMMATION IN PATIENTS WHO HAVE UNDERGONE CATARACT EXTRACTION TX OF MODERATE ACNE VULGARIS IN FEMALES,GREATER OR EQUAL TO 15YRS OF AGE,WHO HAVE NO KNOWN CONTRAINDICATIONS TO ORAL CONTRACEPTIVE THERAPY,DESIRE CONTRACEPTION,HAVE ACHIEVED MENARCHE AND ARE UNRESPONSIVE TO TOPICAL ANTI-ACNE MEDICATIONS TREATMENT OF ONCHOMYCOSIS OF THE FINGERNAIL WITHOUT CONCOMITANT ONCHOMYCOSIS OF THE TOENAIL WITH A PULSE DOSING REGIMEN NOSOCOMIAL PNEUMONIA-MILD TO MODERATE AND SEVERE CAUSED BY HAEMOPHILUS INFLUENZAE OR KLEBSIELLA PNEUMONIAE TREATMENT OF PLANTAR TINEA PEDIS (MOCCASIN TYPE) TREATMENT OF PATIENTS WITH COMPLEX PARTIAL SEIZURES WITH AND WITHOUT SECONDARY GENERALIZATION TREATMENT OF GROWTH FAILURE ASSOCIATED WITH TURNER SYNDROME MAINTENANCE THERAPY IN THE MANAGEMENT OF MILD TO MODERATE ASTHMA IN PEDIATRIC PATIENTS AGES 6-11 TREATMENT OF PANIC DISORDER AT A RECOMMENDED DOSE RANGE OF 1 TO 2MG/DAY (MAXIMUM OF 4MG) PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR CAUSED BY OR PRESUMED TO BE CAUSED BY PITYROSPORUM ORBICULARE (ALSO KNOWN AS MALASSEZIA FURFUR OR M. ORBICULARE) PREVENTION OF FRACTURES IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS TREATMENT OF ACUTE SINUSITIS AND ACUTE EXACERBATION OF CHRONIC SINUSITIS TREATMENT OF ACUTE OTITIS MEDIA IN PEDIATRIC PATIENTS PLANAR IMAGING AS A SECOND LINE DIAGNOSTIC DRUG AFTER MAMMOGRAPHY TO ASSIST IN THE EVALUATION OF BREAST LESIONS IN PATIENTS WITH AN ABNORMAL MAMMOGRAM OR A PALPABLE BREAST MASS ENDOMETRIAL THINNING AGENT PRIOR TO ENDOMETRIAL ABLATION FOR DYSFUNCTIONAL UTERINE BLEEDING THE PREVENTION OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM, IN PATIENTS UNDERGOING ABDOMINAL SURGERY WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLICATIONS AND A NEW DOSAGE REGIMEN, 40MG ONCE DAILY, FOR THIS INDICATION TREATMENT OF PANIC DISORDER IN A RECOMMENDED DOSE RANGE OF 50 TO 200MG/DAY CONGESTIVE HEART FAILURE FOR USE OF LANSOPRAZOLE IN COMBINATION WITH CLARITHROMYCIN AND AMOXICILLIN FOR THE ERADICATION OF HELICOBACTER PYLORI IN PATIENTS WITH ACTIVE DUODENAL ULCER DISEASE OR A ONE-YEAR HISTORY OF DUODENAL ULCER ACUTE TREATMENT OF ACTIVE BENIGN GASTRIC ULCER MAINTENANCE OF HEALING OF DUODENAL ULCER FOR THE USE OF LANSOPRAZOLE IN COMBINATION WITH AMOXICILLIN FOR THE ERADICATION OF HELICOBACTER PYLORI IN PATIENTS WITH ACTIVE DUODENAL ULCER DISEASE OR A ONE-YEAR HISTORY OF A DUODENAL ULCER MONOTHERAPY AND COMBINATION THERAPY WITH SULFONYL UREAS IN THE TREATMENT OF TYPE II DIABETES TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC PATIENTS SECOND-LINE TREAMENT OF AIDS-RELATED KAPOSI'S SARCOMA MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS USE IN PEDIATRIC PATIENTS BETWEEN THE AGES OF 6 AND 11 FOR THE TREATMENT OF THE NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS INITIAL ANTICONVULSANT TREATMENT OF STATUS EPILEPTICUS TREATMENT OF EDEMA ASSOCIATED WITH CHRONIC RENAL FAILURE FOR THE SUPPRESSION OF RECURRENT EPISODES OF GENITAL HERPES IN IMMUNOCOMPETENT ADULTS TREATMENT OF OBSESSIVE COMPULSIVE DISORDER IN THE PEDIATRIC POPULATION PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) TO SLOW THE PROGRESSION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE AS PART OF A TREATMENT STRATEGY TO LOWER TOTAL AND LDL CHOLESTEROL TO TARGET LEVELS FOR USE IN PEDIATRIC POPULATION TREATMENT OF SYMPTOMS OF DRY MOUTH IN PATIENTS WITH SJOGREN'S SYNDROME TEMPORARY RELIEF OF PAIN AND PHOTOPHOBIA IN PATIENTS UNDERGOING CORNEAL REFRACTIVE SURGERY TREATMENT OF OSTEOPOROSIS
ADB 9 of 51
I-234
I-241
PRE-PROCEDURAL APPLICATION TO ADULT MALE GENITAL SKIN PRIOR TO SITE-SPECIFIC SUBCUTANEOUS INFILTRATION WITH LIDOCAINE FOR THE REMOVAL OF GENITAL WARTS FOR THE LONG-TERM TWICE-DAILY (MORNING AND EVENING) ADMINISTRATION IN THE MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD, INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA PREVENTION (DURING AND FOLLOWING HOSPITALIZATION) OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM, IN PATIENTS UNDERGOING HIP REPLACEMENT SURGERY USE OF LIPITOR AS AN ADJUNCTIVE THERAPY TO DIET FOR THE TREATMENT OF PATIENTS WITH ELEVATED SERUM TRIGLYCERIDE LEVELS (FREDERICKSON TYPE IV) USE OF LIPITOR BY PATIENTS WITH PRIMARY DYSBETALIPOPROTEINEMIA (FREDERICKSON TYPE III) WHO DO NOT RESPOND ADEQUATELY TO DIET TREATMENT OF EPISODIC- HEARTBURN, ACID INDIGESTION AND SOUR STOMACH TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) IN MEN WITH AN ENLARGED PROSTATE TO IMPROVE SYMPTOMS, REDUCE THE RISK OF ACUTE URINARY RETENTION AND REDUCE THE RISK OF THE NEED OF SURGERY PREVENTION OF ISCHEMIC COMPLICATIONS OF UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL INFARCTION, WHEN CONCURRENTLY ADMINISTERED WITH ASPIRIN USE IN THE SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH ALLERGIC AND NONALLERGICPERENNIAL RHINITIS IN CHILDREN AGE 6-11 YEARS FOR THE USE IN PEDIATRIC PATIENTS 4 TO 11 YEARS OF AGE FOR THE MANAGEMENT OF THE NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS USE IN PATIENTS WITH PREVIOUS MI AND NORMAL CHOLESTEROL LEVELS, TO REDUCE RISK OF RECURRENT MI, MYOCARDIAL REVASCULARIZATION, AND CEREBROVASCULAR DISEASE EVENTS FIRST-LINE THERAPY FOR THE TREATMENT OF ADVANCED CARCINOMA OF THE OVARY IN COMBINATION WITH CISPLATIN SHORT-TERM TREATMENT OF SYMPTOMATIC GASTROESPHAGEAL REFLUX DISEASE (GERD) PREVENTION OF MEAL INDUCED HEARTBURN AT A DOSE OF 75MG TAKEN 30-60MIN PRIOR TO A MEAL PRILOSEC (OMEPRAZOLE), AMOXICILLIN, AND CLARITHROMYCIN FOR THE ERADICATION OF H. PYLORI IN PATIENTS WITH DUODENAL ULCER DISEASE IN COMBINATION WITH CIS-PLATIN, FOR THE FIRST LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN PATIENTS WHO ARE NOT CANDIDATES FOR POTENTIALLY CURATIVE SURGERY AND/OR RADIATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER FAILURE OF PRIOR CHEMOTHERAPY TREATMENT OF RECURRENT MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS IN HIV-AFFECTED PATIENTS AT A DOSE OF 500MG TWICE DAILY PROPHYLACTIC USE TO REDUCE PERIOPERATIVE BLOOD LOSS AND THE NEED FOR BLOOD TRANSUFSION IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS IN THE COURSE OF CORONARY ARTERY BYPASS GRAFT SURGERY FOR USE IN COMBINATION WITH CISPLATIN FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH INOPERABLE LOCALLY ADVANCED (STAGE IIIA OR IIIB) OR METASTATIC (STAGE IV) NON-SMALL CELL LUNG CANCER PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN PATIENTS 12 YEARS OF AGE AND OLDER PREVENTION OF EXERCISE-INDUCED BRONCHOSPASM IN PATIENTS 4 YEARS OF AGE AND OLDER MAINTENANCE TREATMENT OF ASTHMA AND PREVENTION OF BRONCHOSPASM IN PATIENTS 4 YEARS OF AGE AND OLDER ADJUNCTIVE TREATMENT OF LENNOX-GASTAUT SYNDROME IN PEDIATRIC AND ADULT PATIENTS TREATMENT OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM AND RESULTANT METABOLIC BONE DISEASE IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENAL FAILURE (CCR 15 TO 55ML/MIN) NOT YET ON DIALYSIS USE IN PHOTODYNAMIC THERAPY (PDT) FOR REDUCTION OF OBSTRUCTION AND PALLIATION OF SYMPTOMS IN PATIENTS WITH COMPLETELY OR PARTIALLY OBSTRUCTING ENDOBRONCHIAL NONSMALL CELL LUNG CANCER TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH THE MENOPAUSE AND IN THE TREATMENT OF VULVAR AND VAGINAL ATROPHY IN WOMEN WITH AN INTACT UTERUS USE IN THE SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH THE COMMON COLD IN CHILDREN AGE 5 TO 11 YEARS REDUCE THE INCIDENCE OF BREAST CANCER IN WOMEN AT HIGH RISK FOR BREAST CANCER TREATMENT OF ACUTE SINUSITIS TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS USE IN CONVERSION TO MONOTHERAPY IN ADULTS WITH PARTIAL SEIZURES WHO ARE RECEIVING TREATMENT WITH A SINGLE ENZYME-INDUCING ANTIEPILEPTIC DRUG INPATIENT TREATMENT OF ACUTE DEEP VEIN THROMBOSIS WITH/WITHOUT PULMONARY EMBOLISM WHEN ADMIN WITH WARFARIN SODIM AND OUTPATIENT TREATMENT OF ACUTE DEEP VEIN THROMBOSIS WITHOUT PULMONARY EMBOLISM WHEN ADMIN WITH WARFARIN SODIUM
ADB 10 of 51
I-251 I-252 I-253 I-254 I-255 I-256 I-257 I-258 I-259 I-260 I-261 I-262 I-263 I-264 I-265 I-266 I-267 I-268 I-269 I-270 I-271 I-272
I-273
I-274 I-275 I-276 I-277 I-278 I-279 I-280 I-281 I-282 I-283
TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH COMPENSATED LIVER DISEASE PREVIOUSLY UNTREATED WITH ALPHA INTERFERON THERAPY PRIMARY PREVENTION OF CORONARY HEART DISEASE IN PATIENTS WITHOUT SYMPATOMATIC CARDIOVASCULAR DISEASE WHO HAVE AVERAGE TO MODERATELY ELEVATED TOTAL-C AND LDL-C AND BELOW AVERAGE HDL-C TREATMENT OF GENERALIZED ANXIETY DISORDER NEW COMBINATION USE OF PRECOSE FOR PATIENTS WITH TYPE 2 DIABETES TREATED WITH DIET PLUS METFORMIN COMBINATION USE OF PRECOSE FOR PATIENTS WITH TYPE 2 DIABETES TREATED WITH DIET PLUS INSULIN PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS (LOSS OF BONE MASS) PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA (PCP) USE IN TREATMENT OF SMALL CELL LUNG CANCER SENSITIVE DISEASE AFTER FAILURE OF FIRST-LINE CHEMOTHERAPY TREATMENT OF CHRONIC HEPATITIS B ASSOCIATED WITH EVIDENCE OF HEPATITIS B VIRAL REPLICATION AND ACTIVE LIVER INFLAMATION FOR PERENNIAL NONALLERGIC RHINITIS FOR AGES 4 AND ABOVE PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT), WHICH MAY LEAD TO PULMONARY EMBOLISM, IN PATIENTS UNDERGOING HIP REPLACEMENT SURGERY EXPANDED PEDIATRIC USE IN CHILDREN YOUNGER THAN ONE MONTH OF AGE TO BIRTH (WITH A GESTATIONAL AGE OF 37 WEEKS OR GREATER) TREATMENT OF SOCIAL ANXIETY DISORDER TREATMENT OR PREVENTION OF BRONCHOSPASM WITH REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE AND FOR THE PREVENTION OF EXERCISE INDUCED BRONCHOSPASM IN CHILDREN AGES 4-12 TREATMENT OF UNSTABLE ANGINA AND NON-Q-WAVE MYOCARDIAL INFARCTION FOR THE PREVENTION OF ISCHEMIC COMPLICATIONS IN PATIENTS ON CONCURRENT ASPIRIN THERAPY PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH RADIATION, INCLUDING TOTAL BODY IRRADIATION (TBI) AND FRACTIONATED ABDOMINAL RADIATION TREATMENT OF ATOPIC DERMATITIS IN PEDIATRIC PATIENTS 6 YEARS AND OLDER USE OF TOPAMAX AS ADJUNCTIVE THERAPY IN PEDIATRIC PATIENTS AGES 2-16 YEARS WITH PARTIAL ONSET SEIZURES USE IN PEDIATRIC PATIENTS 3 MONTHS OLD AND OLDER - FOR CORTICOSTEROID-RESPONSIVE DERMATOSES PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA IN PATIENTS 7-11 YEARS OF AGE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH HIGHLY EMETOGENIC CANCER CHEMOTHERAPY, INCLUDING CISPLATIN ADJUVANT TREATMENT OF NODE-POSITIVE BREAST CANCER ADMINISTRERED SEQUENTIALLY TO STANDARD DOXORUBICIN-CONTAINING COMBINATION CHEMOTHERAPY TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN MEN AND WOMEN RECEIVING GLUCOCORTICOIDS IN A DAILY DOSE EQUIVALENT TO 7.5MG OR GREATER OF PREDNISONE AND WHO HAVE LOW BONE MINERAL DENSITY ADJUNCT TO DIET TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA (HETEROZYGOUS FAMILIAL AND NON FAMILIAL) AND MIXED DYSLIPIDEMIA (FREDERICKSON TYPES IIA AND IIB) USE OF TOPAMAX AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED TONICCLONIC SEIZURES USE IN COMBINATION WITH METFORMIN AND SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES USE OF REZULIN IN COMBINATION WITH METFORMIN AND SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES TREATMENT OF TYPE III HYPERLIPOPROTEINEMIA TREATMENT OF PATIENTS WITH ISOLATED HYPERTRIGLYCERIDEMIA (FREDERICKSON TYPE IV) TREATMENT OF POST-TRAUMATIC STRESS DISORDER USE OF CARNITOR INJECTION FOR THE PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY IN PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS INCREASING HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA (HETEROZYGOUS FAMILIAL AND NONFAMILIAL) AND MIXED DYSLIPIDEMIA (FREDERICKSON TYPES IIA AND IIB) TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER AFTER FAILURE OF PRIOR PLATINUM-BASED CHEMOTHERAPY TO REDUCE THE INCIDENCE OF MODERATE TO SEVERE XEROSTOMIA IN PATIENTS UNDERGOING POSTOPERATIVE RADIATION TREATMENT FOR HEAD AND NECK CANCER, WHERE THE RADIATION PORT INCLUDES A SUBSTANTIAL PORTION OF THE PAROTID GLANDS TO REDUCE THE NUMBER OF ADENOMATOUS COLORECTAL POLYPS IN FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS AS AN ADJUNCT TO USUAL CARE TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL RHINITIS IN ADULTS AND CHILDREN 3 YEARS OF AGE AND OLDER TREATMENT OF PATIENTS WITH FREDERICKSON TYPE III
ADB 11 of 51
I-289
I-297 I-298 I-299 I-300 I-301 I-302 I-303 I-304 I-305 I-306 I-307 I-308 I-309 I-310 I-311 I-312 I-313 I-314 I-315
I-316
USE OF PRAVASTATIN IN PATIENTS WITH EVIDENT CORONARY HEART DISEASE TO REDUCE THE RISK OF TOTAL MORTALITY BY REDUCING CORONARY DEATH CHANGES IN SEVERAL SECTIONS OF THE INSERT TO INCORPORATE STATEMENTS CONCERNING THE USE OF HIGH DOSES OF LISINOPRIL TO REDUCE THE RISK OF THE COMBINED OUTCOMES OF MORTALITY AND HOSPITALIZATION IN PATIENTS WITH CONGESTIVE HEART FAILURE USE OF AVANDIA IN COMBINATION WITH A SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLLITUS WHEN DIET AND EXERCISE WITH EITHER SINGLE AGENT DOES NOT ACHIEVE ADEQUATE GLYCEMIC CONTROL PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS TREATMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS TREATMENT OF UNCOMPLICATED ACUTE ILLNESS DUE TO INFLUENZA A AND B IN PEDIATRIC PATIENTS 7 YEARS AND OLDER WHO HAVE BEEN SYMPTOMATIC FOR NO MORE THAN 2 DAYS PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS FOR WOMEN WITH AN INTACT UTERUS LONG-TERM INTRAVENOUS TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH THE SCLERODERMA SPECTRUM OF DISEASE IN NYHA CLASS III AND CLASS IV PATIENTS WHO DO NOT RESPOND TO CONVENTIONAL THERAPY SHORT-TERM TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDER TREATMENT OF PATIENTS WITH FREDERICKSON TYPE IIA AND IIB HYPERLIPOPROTEINEMIA USE OF CAMPTOSAR AS A COMPONENT OF FIRST-LINE THERAPY IN COMBINATION WITH 5-FLUROURACIL AND LEUCOVARIN FOR PATIENTS WITH METASTATIC CARCINOMA OF THE COLON OR RECTUM PROPHYLAXIS FOR ASTHMA IN CHILDREN 2-5 YEARS OF AGE TREATMENT OF SIGNS AND SYMPTOMS OF ALLERGIC CONJUNCTIVITIS TREATMENT OF PEDIATRIC PATIENTS WITH PRADER-WILLI SYNDROME INCREASING HDL-CHOLESTEROL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIAS TREATMENT OF PATIENTS WITH FREDERICKSON TYPE IV TREATMENT OF LEVOFLOXACIN SUSCEPTIBLE STRAINS OF PENICILLIN-RESISTANT STREPTOCOCCUS PNEUMONIAE IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA INDUCTION OF SPERMATOGENESIS IN MEN WITH PRIMARY AND SECONDARY HYPOGONADOTROPIC HYPOGONADISM IN WHOM THE CAUSE OF INFERTILITY IS NOT DUE TO PRIMARY TESTICULAR FAILURE NEW COMBINATION USE OF METFORMIN AND INSULIN IN TYPE 2 DIABETES TREATMENT OF PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE RHEUMOTOID ARTHRITIS WHO RESPONDED INADEQUATELY TO SALICYLATES OR OTHER NSAIDS USE OF ACTONEL 35MG ONCE A WEEK TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS REDUCTION IN RISK OF MYOCARDIAL INFARCTION, STROKE, AND DEATH FROM CARDIOVASCULAR CAUSES ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIAL SEIZURES IN PEDIATRIC PATIENTS AGE 3 TO 12 YEARS FIRST LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER EXTENSION OF INDICATION TO PROVIDE FOR MAINTENANCE OF RESPONSE TOPICAL ANESTHETIC FOR SUPERFICIAL MINOR SURGERY OF GENITAL MUCOUS MEMBRANES AND AS AN ADJUNCT FOR LOCAL INFILTRATION ANESTHESIA IN GENITAL MUCOUS MEMBRANES THROMBOPROPHYLAXIS OF DEEP VEIN THROMBOSIS, WHICH MAY LEAD TO PULMONARY EMBOLISM,IN MEDICAL PATIENTS WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLICATIONS DUE TO SEVERELY RESTRICTED MOBILITY DURING ACUTE ILLNESS TREATMENT OF NSAID-ASSOCIATED GASTRIC ULCER PATIENTS WHO CONTINUE NSAID USE AND REDUCING RISK OF NSAID-ASSOCIATED GASTRIC ULCERS IN PATIENTS WITH HISTORY OF DOCUMENTED GASTRIC ULCER WHO REQUIRE USE OF AN NSAID PROPHYLAXIS OF INFLUENZA IN ADULTS AND ADOLESCENTS 13 YEARS AND OLDER FIRSTLINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER USE FOR SUSPECTED OR CONFIRMED METHANOL POISONING, EITHER ALONE OR IN COMBINATION WITH HEMODIALYSIS TREATMENT OF TYPE 2 DIABETES IN PEDIATRIC PATIENTS (AGES 10-16 YEARS) JUVENILE RHEUMATOID ARTHRITIS USE OF DIPRIVAN IN PATIENTS 3 MONTHS TO 16 YEARS COLORECTAL CANCER REDUCING NEUROLOGIC DISABILITY AND/OR FREQUENCY OF CLINICAL RELAPSES IN PATIENTS WITH SECONDARY (CHRONIC) PROGRESSIVE, PROGRESSIVE RELAPSING, OR WORSENING RELAPSING-REMITTING MULTIPLE SCLEROSIS PREVENTION OF RELAPSE AND RECURRENCE OF DEPRESSION GENERALIZED ANXIETY DISORDER SYMPTOMATIC RELIEF OF RHINORRHEA ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN PATIENTS 5 YEARS AND OLDER
ADB 12 of 51
I-351 I-352 I-353 I-354 I-355 I-356 I-357 I-358 I-359 I-360 I-361
PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA IN PATIENTS 5-6 YEARS OF AGE UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND CONTROL OF DAYTIME AND NIGHTTIME HEARTBURN SYSTOMS IN PATIENTS WITH GERD TREATMENT OF MODERATE ACNE VULGARIS EMPIRIC THERAPY IN FEBRILE NEUTROPENIC PATIENTS WITH SUSPECTED FUNGAL INFECTIONS (EFTN) TOPICAL TREATMENT OF TINEA (PITYRIASIS) VERSICOLOR DUE TO MALASSEZIA FURFUR (FORMERLY PITYROSPORUM ORBICULARE) LONG-TERM TREATMENT OF GROWTH FAILURE IN CHILDREN BORN SMALL FOR GESTATIONAL AGE WHO FAIL TO MANIFEST CATCH-UP GROWTH BY TWO YEARS OF AGE ADJUNCTIVE THERAPY IN PATIENTS TWO YEARS AND OLDER WITH SEIZURES ASSOCIATED WITH LENNOXGASTAUT SYNDROME EXPANSION OF INDICATION TO INCLUDE THE TREATMENT OF PATIENTS WITH PREDOMINATELY CLASSIC SUBFOVEAL CHOROIDAL NEOVASCULARIZATION DUE TO PATHOLOGIC MYOPIA OR PRESUMED OCULAR HISTOPLASMOSIS PATHOLOGICAL HYPERSECRETION ASSOCIATED WITH ZOLLINGER-ELLISON SNYDROME MANAGEMENT OF ACUTE PAIN IN ADULTS AND TREATMENT OF PRIMARY DYSMENORRHEA TREATMENT OF HEPATITIS B IN PEDIATRIC PATIENTS AGES 2-17 YEARS ATOPIC DERMATITIS IN PEDIATRIC PATIENTS AGES 2-5 BREAST CANCER COMBINATION THERAPY USE OF FORADIL FOR LONG-TERM, TWICE DAILY (MORNING AND EVENING) ADMINISTRATION IN THE MAINTENANCE TREATMENT OF BRONCHO-CONSTRICTION IN PATIENTS WITH COPD INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA USE OF COREG FOR SEVERE HEART FAILURE ACNE VULGARIS TREATMENT OF POSTTRAUMATIC STRESS DISORDER TREATMENT OF SYMPTOMATIC GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT OR PREVENTION OF BRONCHOSPASM IN CHILDREN 6 YEARS OF AGE AND OLDER WITH OBSTRUCTIVE AIRWAY DISEASE LONG-TERM, TWICE-DAILY (MORNING AND EVENING) ADMINISTRATION IN THE MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD (INCLUDING EMPHYSEMA AND CHRONIC BRONCHITIS) ACUTE CORONARY SYNDROME TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN ADOLESCENT BOYS AND GIRLS AT LEAST ONE YEAR POSTMENARCHAL, AGES 10 TO 17 YEARS, WITH A RECOMMENDED DOSING RANGE OF 10 TO 40MG ONCE DAILY PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS FOR ALL STRENGTHS ANTICOAGULANT IN PATIENTS WITH OR AT RISK FOR HEPARIN-INDUCED THROMBOCYTOPENIA UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS (PCI) TREATMENT OF SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS MANAGEMENT OF POST HERPETIC NEURALGIA PREMENSTRUAL DYSPHORIC DISORDER TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS, INCLUDING ZOLLINGER-ELLISON SYNDROME TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS TREATMENT OF PANIC DISORDER TREATMENT OF VULVAR AND VAGINAL ATROPHY ASSOCIATED WITH THE MENOPAUSE TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL RHINITIS IN CHILDREN AGES TWO UP TO AGE THREE TREATMENT OF MULTIPLE MYELOMA AND DOCUMENTED BONE METASTASES FROM SOLID TUMORS, IN CONJUNCTION WITH STANDARD ANTINEOPLASTIC THERAPY. PROSTATE CANCER SHOULD HAVE PROGRESSED AFTER TREATMENT WITH AT LEAST ONE HORMONAL THERAPY TREATMENT OF PANIC DISORDER, WITH OR WITHOUT AGORAPHOBIA ADJUVANT TREATMENT OF POST MENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS TREATMENT OF HEART FAILURE (NYHA CLASS II-IV) IN PATIENTS WHO ARE INTOLERANT TO AN ACE INHIBITOR PREVENTION OF RELAPSE FOLLOWING LONG-TERM TREATMENT OF MAJOR DEPRESSIVE DISORDER COMBINATION THERAPY WITH THIAZOLIDINEDIONE TO LOWER BLOOD GLUCOSE IN PTS WHOSE HYPERGLYCEMIA CANNOT BE CONTROLLED BY DIET/EXERCISE PLUS MONOTHERAPY WITH ANY OF THE FOLLOWING AGENTS:METFORMIN,SULFONYLUREAS,REPAGLINIDE,OR THIAZOLIDINEDIONES USE OF GLUCOVANCE WITH A THIAZOLIDINEDIONE WHEN GLYCEMIC CONTROL IS NOT OBTAINED WITH GLUCOVANCE ALONE PREVENTION AND TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDREN, AGES 8-13 YEARS, WITH RECOMMENDED DOSE OF 20MG ONCE DAILY AND IN ADOLESCENTS, AGES 14-18 WITH A RECOMMENDED DOSE OF 40MG ONCE DAILY
ADB 13 of 51
I-378 I-379
I-391 I-392
I-393 I-394 I-395 I-396 I-397 I-398 I-399 I-400 I-401 I-402 I-403
I-404
I-405 I-406
HELICOBACTER PYLORI ERADICATION TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE NOSOCOMIAL PNEUMONIA TREATMENT OF TYPE 2 DIABETIC NEPHROPATHY SHORT TERM TOPICAL TREATMENT OF MILD TO MODERATE PLAQUE-TYPE PSORIASIS OF NON SCALP REGIONS FIRST LINE THERAPY FOR THE REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (CML) USE OF BRAVELLE FOR MULTIPLE FOLLICULAR DEVELOPMENT (CONTROLLED OVARIAN STIMULATION) DURING ASSISTED REPRODUCTIVE TECHNOLOGY CYCLES IN PATIENTS WHO HAVE PREVIOUSLY RECEIVED PITUITARY SUPPRESSION RELIEF OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER USE TAXOTERE IN COMBINATION WITH CISPLATIN FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHO HAVE NOT PREVIOUSLY RECEIVED CHEMOTHERAPY FOR THIS CONDITION TO TREAT PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER AT RISK FOR EMERGENT SUICIDAL BEHAVIOR TREATMENT OF COLD SORES (HERPES LABIALIS) IN ADULT AND ADOLESCENT PATIENTS 12 YEARS OF AGE AND OLDER FOR NEWLY-DIAGNOSED HIGH GRADE MALIGNANT GLIOMA PATIENTS AS AN ADJUNCT TO SURGERY AND RADIATION TREATMENT OF TYPE 2 DIABETIC NEPHROPATHY USE IN COMBINATION WITH INSULIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS MODIFICATION OF THE INDICATION FOR COMMUNITY ACQUIRED PNEUMONIA TO ADD"INCLUDING PENICILLIN-RESISTANT STRAINS, MIC PENICILLIN>=2MCG/ML TO STREPTOCOCCUS PNEUMONIAE RAPAMUNE (SIROLIMUS) WITHIN AN IMMUNOSUPPRESSIVE REGIMEN THAT WOULD ALLOW FOR THE WITHDRAWAL OF CYCLOSPORINE 2 TO 4 MONTHS AFTER RENAL TRANSPLANTATION IN PATIENTS CONSIDERED AT LOW TO MODERATE IMMUNOLOGIC RISK FOR RENAL TRANSPLANT REJECTION ADJUNCTIVE THERAPY OF PARTIAL SEIZURES IN PEDIATRIC PATIENTS GREATER THAT OR EQUAL TO 2 YEARS OF AGE TREATMENT OF PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION SUPRESSION OF RECURRENT GENITAL HERPES IN HIV-INFECTED INDIVIDUALS USE IN PTS AT HIGH RISK CORONARY EVENTS DUE TO EXISTING CORONARY HEART DISEASE,DIABETES,PERIPHERAL VESSEL DISEASE,STROKE HISTORY,OTHER CV DISEASE TO REDUCE RISK TOTAL MORTALITY BY REDUCING CORONARY DEATH,REDUCE NONFATAL MI & STROKE..... ABLATION OF HIGH-GRADE DYSPLASIA IN BARRETT'S ESOPHAGUS PATIENTS WHO DO NOT UNDERGO ESOPHAGECTOMY TX OF PED PATIENTS W/PH+ CHRONIC PHASE CML DISEASE RECUR AFTER STEM CELL TRNSPLT OR RESIST TO INTERFERON ALPHA THERAPY.NO CONTROLLED TRIALS DEMONSTRATING A CLINICAL BENEFIT SUCH AS IMPROVE IN DISEASE RELATED SX OR INCREASED SURVIVAL CHRONIC BACTERIAL PROSTATITIS USE IN PATIENTS WITH CORONARY HEART DISEASE TO REDUCE THE RISK OF UNDERGOING CORONARY REVASCULARIZATION PROCEDURES TO IMPROVE PHYSICAL FUNCTION EXPANDED INDICATION TO INCLUDE THE ASSESSMENT OF VENTRICULAR FUNCTION IN SUBJECTS BEING EVALUATED FOR HEART DISEASE AND/OR VENTRICULAR FUNCTION EXTENDED PROPHYLAXIS IN PATIENTS UNDERGOING HIP FRACTURE SURGERY IDIOPATHIC SHORT STATURE TREATMENT OF CANDIDEMIA AND THE FOLLOWING CANDIDA INFECTIONS: INTRA-ABDOMINAL ABSCESSES, PERITONITIS AND PLEURAL SPACE INFECTIONS USE OF OLANZAPINE IN COMBINATION WITH LITHIUM OR VALPROATE FOR THE TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR DISORDER LONGER-TERM EFFICACY OF ARIPIPRAZOLE IN THE TREATMENT OF SCHIZOPHRENIA DIABETIC FOOT INFECTIONS WITHOUT CONCOMITANT OSTEOMYELITIS USE OF VALTREX IN COMBINATION WITH SAFER SEX PRACTICES FOR THE REDUCTION OF THE RISK OF TRANSMISSION OF GENITAL HERPES DURING SUPPRESIVE THERAPY OF THE SOURCE PARTNER IN A HETEROSEXUAL COUPLE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER TO DELAY THE TIME TO OCCURRENCE OF MOOD EPISODES (DEPRESSION, MANIA, HYPOMANIA, MIXED EPISODES) IN PATIENTS TREATED FOR ACUTE MOOD EPISODES WITH STANDARD THERAPY TREATMENT OF PREMENSTRUAL DYSPHORIC DISORDER (PMDD) USING AN INTERMITTENT DOSING REGIMEN PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY, HEART, AND KIDNEY-PANCREAS TRANSPLANT PATIENTS AT HIGH RISK (DONOR CMV SEROPOSITIVE/RECIPIENT CMV SERONEGATIVE)
ADB 14 of 51
I-415 I-416 I-417 I-418 I-419 I-420 I-421 I-422 I-423 I-424 I-425 I-426 I-427 I-428
I-434
IMPROVE SURVIVAL OF STABLE PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (EJECTION FRACTION<=40%) AND CLINICAL EVIDENCE OF CONGESTIVE HEART FAILURE AFTER AN ACUTE MYOCARDIAL INFARCTION STIMULATION OF PANCREATIC SECRETIONS TO FACILITATE THE INDENTIFICATION OF THE AMPULLA OF VATER AND ACCESSORY PAPILLA DURING ENDOSCOPIC RETROGRADE CHOLANGIO-PANCREATOGRAPHY (ERCP) ESOPHAGEAL CANDIDIASIS USE OF ADVAIR DISKUS 250/50 FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ASSOCIATED WITH CHRONIC BRONCHITIS EXPANDED INDICATION FOR USE IN COMBINATION WITH ANTIDIABETIC DRUGS IN THE THIAZOLIDINEDIONE CLASS MONOTHERAPY FOR THE SHORT TERM TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER ADJUNCTIVE THERAPY FOR THE SHORT TERM TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT), WHICH MAY LEAD TO PULMONARY EMBOLISM (PE) IN MEDICAL PATIENTS WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLICATIONS DUE TO SEVERELY RESTRICTED MOBILITY DURING ACUTE ILLNESS SEVERE HYPERTENSION WHEN THE VALUE OF ACHIEVING PROMPT BLOOD PRESSURE CONTROL EXCEEDS THE RISK OF INITIATING COMBINATION THERAPY THE USE OF CIPRO XR FOR COMPLICATED URINARY TRACT INFECTIONS AND ACUTE UNCOMPLICATED PYELONEPHRITIS USE IN THE LONG TERM TREATMENT OF BIPOLAR I DISORDER ADJUNCTIVE THERAPY W/ MOOD STABILIZERS (LITHIUM OR DIVALPROEX) IN THE TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDERS MONOTHERAPY IN THE TREATMENT OF ACUTE MANIC EPISODES ASSOCIATED WITH BIPOLAR I DISORDER TOPICAL TREATMENT OF CLINICALLY TYPICAL, NONHYPERKERATOTIC, NONHYPERTROPHIC ACTINIC KERATOSES ON THE FACE OR SCALP IN IMMUNOCOMPETENT ADULTS TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS AND PYELONEPHRITIS DUE TO E.COLI FOR PED PATIENTS (1-17) NOT AS FIRST CHOICE INDICATED FOR THE IN-HOSPITAL SHORT-TERM (UP TO 4 HOURS) REDUCTION IN BLOOD PRESSURE IN PEDIATRIC PATIENTS ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH MODERATE TO SEVERE CHRONIC RENAL INSUFFICIENCY NOT YET ON DIALYSIS FLOXATIN IN COMBINATION WITH INFUSIONAL 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) FOR THE TREATMENT OF PATIENTS PREVIOUSLY UNTREATED FOR ADVANCED COLORECTAL CANCER TREATMENT OF ACUTE PULMONARY EMBOLISM WHEN ADMINISTERED IN CONJUNCTION WITH WARFARIN SODIUM TREATMENT OF ACUTE DEEP VEIN THROMBOSIS WITHOUT PULMONARY EMBOLISM WHEN ADMINISTERED IN CONJUNCTION WITH WARFARIN SODIUM FOR USE IN COMBINATION WITH PACLITAXEL FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER AFTER FAILURE OF PRIOR ANTHRACYCLINE CONTAINING ADJUVANT CHEMOTHERAPY UNLESS ANTHRACYCLINES WERE CLINICALLY CONTRAINDICATED FOR USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH ANDROGEN INDEPENDENT (HORMONE REFRACTORY) METASTATIC PROSTATE CANCER FOR USE IN THE RELIEF OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN ADULTS NOSOCOMIAL PNEUMONIA AND COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY STREPTOCOCCUS PNEUMONIAE INDICATION EXPANDED TO INCLUDE MULTI-DRUG RESISTANT STRAINS TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA CAUSED BY MULTI-DRUG RESISTANT STREPTOCOCCUS PNEUMONIAE TREATMENT OF BIOPSY-CONFIRMED, PRIMARY SUPERFICIAL BASAL CELL CARCINOMA IN IMMUNOCOMPETENT ADULTS, WITH A MAXIMUM TUMOR DIAMETER OF 2.0CM, LOCATED ON THE TRUNK (EXCLUDING ANOGENITAL SKIN), NECK, OR EXTREMITIES (EXCLUDING HANDS AND FEET) PREVENTION OF CARDIOVASCULAR DISEASE IN ADULT PATIENTS WITHOUT CLINICALLY EVIDENT HEART DISEASE, BUT WITH MULTIPLE RISK FACTORS FOR CORONARY HEART DISEASE TO REDUCE RISK OF MI AND RISK FOR REVASCULARIZATION PROCEDURES AND ANGINA CHRONIC IDIOPATHIC CONSTIPATION FOR USE IN COMBINATION WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE FOR THE ADJUVANT TREATMENT OF PATIENTS WITH OPERABLE NODE-POSITIVE BREAST CANCER TREATMENT OF ACUTE MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR DISORDER EMPIRICAL THERAPY FOR PRESUMED FUNGAL INFECTIONS IN FEBRILE, NEUTROPENIC PATIENTS USED TO TREAT ADULTS WITH GROWTH HORMONE DEFICIENCY FOR THE REPLACEMENT OF ENDOGENOUS GROWTH HORMONE IN ADULTS WITH GROWTH HORMONE DEFICIENCY USE COMBINATION WITH INFUSIONAL 5-FU/LV FOR ADJUVANT TREATMENT STAGE III COLON CANCER PTS WHO HAVE UNDERGONE COMPLETE RESECTION PRIMARY TUMOR-BASED ON IMPROVEMENT IN DISEASE FREE SURVIVAL, NO DEMONSTRATED BENEFIT OVERALL SURVIVAL AFTER 4YRS
ADB 15 of 51
I-446
I-456
I-457 I-458
I-462 I-463 I-464 I-465 I-466 I-467 I-468 I-469 I-470 I-471
USED FOR CANDIDEMIA IN NONNEUTROPENIC PATIENTS AND THE FOLLOWING CANDIDA INFECTIONS: DISSEMINATED INFECTIONS IN SKIN & INFECTIONS IN ABDOMEN, KIDNEY, BLADDER WALL, AND WOUNDS TREATMENT OF NASAL POLYPS IN PATIENTS 18 YEARS OF AGE AND OLDER USE OF PROTONIX IV FOR INJECTION AS STAND ALONE THERAPY FOR THE SHORT-TERM TREATMENT OF PATIENTS HAVING GASTROESOPHAGEAL REFLUX (GERD) WITH A HISTORY OF EROSIVE ESOPHAGITIS TO IMPROVE (COMPARED TO 4.25% DEXTROSE) LONG-DWELL ULTRAFILTRATION AND CLEARANCE OF CREATININE AND UREA NITROGEN IN PATIENTS WITH HIGH AVERAGE OR GREATER TRANSPORT CHARACTERISTICS, AS DEFINED USING THE PERITONEAL EQUILIBRATION TEST (PET) EXTENDED ADJUVANT TREATMENT OF EARLY BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE RECEIVED 5 YRS ADJUVANT TAMOXIFEN THERAPY-EFFECTIVENESS BASED ON AN ANALYSIS OF DISEASE FREE SURVIVAL IN PATIENTS TREATED FOR A MEDIAN 24 MONTHS USE OF COPEGUS (RIBAVIRIN) FOR TREATMENT OF CHRONIC HEPATITIS C IN ADULT PATIENTS COINFECTED WITH HIV IN COMBINATION WITH PEGASYS (PEGINTERFERON ALFA-2A) TREATMENT OF HEART FAILURE (NYHA CLASS II-IV AND EJECTION FRACTION <=40%) TO REDUCE THE RISK OF DEATH FROM CARDIOVASCULAR CAUSES AND TO REDUCE HOSPITALIZATIONS FOR HEART FAILURE TO IMPROVE WAKEFULNESS IN TWO NEW PATIENT POPULATIONS WITH EXCESSIVE SLEEPINESS: THOSE WITH OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME AND THOSE WITH SHIFT WORK SLEEP DISORDER TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED HIGH GRADE GLIOMAS CONCOMITANTLY WITH RADIOTHERAPY AND THEN AS ADJUVANT TREATMENT MANAGEMENT OF ENDOMETRIOSIS ASSOCIATED PAIN EXPANDED INDICATION TO INCLUDE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEAST 1 PRIOR THERAPY USE IN COMBINATION WITH A SULFONYLUREA PLUS METFORMIN WHEN DIET, EXERCISE AND BOTH AGENTS DO NOT RESULT IN ADEQUATE GLYCEMIC CONTROL (TRIPLE THERAPY) MAINTENANCE OF CLINICAL REMISSION OF MILD TO MODERATE CHRON'S DISEASE INVOLVING THE ILEUM AND/OR THE ASCENDING COLON FOR UP TO 3 MONTHS MODIFIED HEART FAILURE INDICATION TO INCLUDE TREATMENT OF HEART FAILURE IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (NYHA CLASS II-IV; EJECTION FRACTION LESS THAN OR EQUAL TO 40% TO REDUCE CARDIOVASCULAR DEATH AND TO REDUCE HEART FAILURE HOSPITALIZATIONS. INCLUDES ADDITIONAL INFORMATION ON THE ADDED EFFECT ON THESE OUTCOMES WHEN USED WITH AN ACE INHIBITOR TREATMENT OF PATIENTS UNDERGOING ABDOMINAL SUREGERY WHO ARE AT RISK FOR THROMBOEMBOLIC COMPLIATIONS USE OF BIVALIRUDIN FOR INJECTION WITH PROVISIONAL USE OF GLYCOPROTEIN IIB/IIA INHIBITOR (GPI) AS LISTED IN THE CLINICAL TRIALS REPLACE-2 SECTION FOR USE AS AN ANTICOAGULANT IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD) PATIENTS RECEIVING OR NOT RECEIVING AN ERYTHROPOIETIN TREATMENT OF DIARRHEA CAUSED BY CRYPTOSPORIDIUM PARVUM IN NON-HIV INFECTED PATIENTS 12 YEARS OF AGE AND OLDER USE AS A SINGLE AGENT FOR ADJUVANT TREATMENT IN PATIENTS WITH DUKES' C COLON CANCER WHO HAVE UNDERGONE COMPLETE RESECTION OF THE PRIMARY TUMOR WHEN TREATMENT WITH FLUOROPYRIMIDINE THERAPY ALONE IS PREFERRED LONG TERM TREATMENT OF IDIOPATHIC SHORT STATURE TREATMENT OF PATIENTS POST MYOCARDIAL INFARCTION TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEGS SYNDROME PERENNIAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 6 MONTHS OF AGE AND OLDER FOR RELIEF OF THE SIGNS AND SYMPTOMS OF ANKYLOSING SPONDYLITIS USE OF TOPIRAMATE AS INITIAL MONOTHERAPY IN PATIENTS 10 YEARS OF AGE AND OLDER WITH PARTIAL ONSET OR PRIMARY GENERALIZED TONIC CLONIC SEIZURES USE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE TO REDUSE THE RISK OF CARDIOVASCULAR MORTALITY OR NON-FATAL MYOCARDIAL INFECTION RELIEF OF THE SIGNS AND SYMPTOMS OF PAUCIARTICULAR OR POLYARTICULAR COURSE JUVENILE RHEUMATOID ARTHRITIS IN PATIENTS 2 YEARS OF AGE AND OLDER DIABETIC PERIPHERAL NEUROPATHIC PAIN INDICATED TO REDUCE THE RISK OF MYOCARDIAL INFARCTION AND STROKE IN PATIENTS WITH TYPE 2 DIABETES AND WITHOUT CLINICALLY EVIDENT CORONARY HEART DISEASE BUT WITH MULTIPLE RISK FACTORS FOR CORONARY HEART DISEASE USE IN PATIENTS WITH ANGIOGRAPHICALLY DOCUMENTED CORONARY ARTERY DISEASE USE IN COMBINATION WITH GEMCITABINE FOR THE FIRST LINE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PANCREATIC CANCER TREATMENT OF IRON DEFICIENCY ANEMIA IN PERITONEAL DIALYSIS DEPENDANT CHRONIC KIDNEY DISEASE IN PATIENTS RECIEVING AN ERYTHROPOIETIN PREVENTION OF NAUSEA AND VOMITTING ASSOCIATED WITH INITIAL AND REPEAT COURSES OF MODERATELY EMETOGENIC CANCER CHEMOTHERAPY TREATMENT OF DIABETIC FOOT INFECTIONS WITHOUT OSTEOMYELITIS
ADB 16 of 51
I-478 I-479
I-480 I-481 I-482 I-483 I-484 I-485 I-486 I-487 I-488 I-489 I-490
I-494
I-495
I-506 I-507
TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS CAUSED BY METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS, ESCHERICHIA COLI, KLEBSIELLA PNEUMONIAE, OR ENTEROBACTER CLOACAE FOR USE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIAL SEIZURES IN CHILDREN WITH EPILEPSY AGED 2-4 YEARS TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS CAUSED BY E.COLI, B. FRAGILIS, S.ANGINOSUS, S.CONSTELLATUS, E. FAECALIS, P. MIRABILIS, C. PERFRINGENS, B. THETAIOTAOMICRON OR PEPTOSTREPTOCOCCUS SPECIES PROPHYLAXIS OF INFLUENZA FOR PATIENTS BETWEEN 1-12 YEARS OF AGE INDICATED FOR THE ADJUVANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER WITH OR WITHOUT PSYCHOTIC FEATURES PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS FOR THE RISK REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCERS TREATMENT OF POSTOPERATIVE INFLAMMATION AND REDUCTION OF OCULAR PAIN IN PATIENTS WHO HAVE UNDERGONE CATARACT EXTRACTION ANGIOMAX IS INDICATED FOR PATIENTS WITH, OR AT RISK OF, HIT/HITTS UNDERGOING PCI INDICATED FOR THE RELIEF OF THE INFAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS 12 YRS OF AGE OR OLDER MAINTENANCE THERAPY IN BIPOLAR I DISORDER FOR USE IN PEDIATRIC PATIENTS WITH TYPE I DIABETES FOR USE IN COMBINATION WITH CISPLATIN AND FLUOROURACIL FOR THE TREATMENT OF PATIENTS WITH ADVANCED GASTRIC ADENOCARCINOMA, INCLUDING ADENOCARCINOMA OF GASTROESOPHAGEAL JUNCTION, WHO HAVE NOT RECEIVED PRIOR CHEMOTHERAPY FOR ADVANCED DISEASE INFLUENZA PROPHYLAXIS MONOTHERAPY IN THE TREATMENT OF ACUTE MANIC OR MIXED EPISODES IN BIPOLAR I DISORDER, WITH OR WITHOUT PSYCHOTIC FEATURES ADMINISTERED IN COMBINATION WITH FENOFIBRATE, AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF ELEVATED TOTAL-C, LDL-C, APO B, AND NON-HDL-C IN PATIENTS WITH MIXED HYPERLIPIDEMIA CLINICAL DATA IN SUPPORT OF AVANDAMET AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT WITH DUAL ROSIGLITAZONE AND METFORMIN THERAPY IS APPROPRIATE ADJUVANT TX OF POSTMENOPAUSAL WOMEN WITH ESTROGEN-RECEPTOR POSITIVE EARLY BREAST CANCER WHO HAVE RECEIVED 2 TO 3 YRS OF TAMOXIFEN AND ARE SWITCHED TO AROMASIN FOR COMPLETION OF A TOTAL OF 5 CONSECUTIVE YRS OF ADJUVANT HORMONAL THERAPY LONG TERM TREATMENT OF GROWTH FAILURE ASSOCIATED WITH TURNER SYNDROME IN PATIENTS WHO HAVE OPEN EPIPHYSES PREVENTION OF SEASONAL MAJOR DEPRESSIVE EPISODES IN PATIENTS WITH SEASONAL AFFECTIVE DISORDER PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING USE OF GEMZAR IN COMBINATION WITH CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH ADVANCED OVARIAN CANCER THAT HAS RELAPSED AT LEAST 6 MONTHS AFTER COMPLETION OF PLATINUMBASED THERAPY FOR USE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN IMMUNOCOMPETANT PATIENTS WITH A SINGLE DOSE OF FAMCICLOVIR 1500 MG. FOR PTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION, PLAVIX TO REDUCE RATE OF DEATH FROM ANY CAUSE AND THE RATE OF A COMBINED ENDPOINT OF DEATH, REINFARCTION OR STROKE. NOT KNOWN TO PERTAIN TO PTS WHO RECEIVE PRIMARY ANGIOPLASTY TREATMENT OF MAJOR DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS INCLUDING ZOLLINGER-ELLISON SYNDROME TREATMENT OF STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BACTEREMIA), INCLUDING THOSE WITH RIGHT SIDED INFECTIVE ENDOCARDITIS, CAUSED BY METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT ISOLATES ADJUNCTIVE THERAPY OF MYOCLONIC SEIZURES IN ADULTS AND ADOLESCENTS AGE 12 AND OVER WITH JUVENILE MYOCLONIC EPILEPSY ADJUNCT TO DIET TO REDUCE TOTAL-C, LDL-C AND APO B LEVELS IN ADOLESCENT BOYS AND GIRLS WHO ARE AT LEAST ONE YEAR POST-MENARCHE, 10-16 YEARS OF AGE, WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PREMENSTRUAL DYSPHONIC DISORDER TREATMENT OF IRRATABILITY ASSOCIATED WITH AUTISTIC DISORDER ADULT DERMAFIBROSARCOMA PROTUBERANS (DFSP) ADULT MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE DISEASES (MDS/MDP) ADULT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) MONOTHERAPY
ADB 17 of 51
I-520
I-521 I-522
I-523
I-524 I-525 I-526 I-527 I-528 I-529 I-530 I-531 I-532 I-533 I-534 I-535 I-536 I-537 I-538 I-539 I-540 I-541 I-542 I-543 I-544 I-545 I-546 I-547 I-548 I-549 I-550 I-551 I-552
I-553 I-554
ADULT AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM) ADULT HYPEREOSINOPHILIC SYNDROME/CHRONIC EOSINOPHILIC LEUKEMIA (HES/CEL) PROPHYLAXIS OF SURGICAL SITE INFECTION FOLLOWING ELECTIVE COLORECTAL SURGERY PRIMARY GENERALIZED TONIC CLONIC SEIZURES IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEG SYNDROME (RLS) TREATMENT OF SHORT STATURE OR GROWTH FAILURE IN CHILDREN WITH SHOX (SHORT STATURE HOMEOBOX CONTAINING GENE) DEFICIENCY WHOSE EPIPHYSES ARE NOT CLOSED USE OF TAXOTERE (DOCETAXEL) INJECTION CONCENTRATE IN COMBINATION WITH CISPLATIN AND FLUOROURACIL FOR THE INDUCTION OF PATIENTS WITH INOPERABLE LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) USE OF EXENATIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO ARE USING A THIAZOLIDINEDIONE ALONE OR IN COMBINATION WITH METFORMIN BUT HAVE NOT ACHIEVED ADEQUATE GLYCEMIC CONTROL TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHO HAVE RECEIVED AT LEAST 1 YEAR PRIOR THERAPY TREATMENT OF MODERATE ACNE VULGARIS IN WOMEN AT LEAST 14 YRS OF AGE, WHO HAVE NO KNOWN CONTRAINDICATIONS TO ORAL CONTRACEPTIVE THERAPY, AND HAVE ACHIEVED MENARCHE, IF THE PATIENT DESIRES AN ORAL CONTRACEPTIVE FOR BIRTH CONTROL. USE IN ADULT PATIENTS WITH CLINICALLY EVIDENT CORONARY HEART DISEASE TO REDUCE THE RISK OF NONFATAL MYOCARDIAL INFARCTION, FATAL AND NONFATAL STROKE, ANGINA, REVASCULARIZATION PROCEDURES AND HOSPITALIZATION FOR CONGESTIVE HEART FAILURE GENERALIZED ANXIETY DISORDER (GAD) USE OF 0.5MG/0.1MG FOR PREVENTION OF POST-MENOPAUSAL OSTEOPOROSIS TREATMENT OF HYPONATREMIA IN HOSPITALIZED PATIENTS ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER WITH IDIOPATHIC GENERALIZED EPILEPSY TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE, SYMPTOMS OF VULVAR AND VAGINAL ATROPHY ASSOCIATED WITH MENOPAUSE TREATMENT OF DEMENTIA OF THE ALZHEIMER'S TYPE IN PATIENTS WITH SEVERE ALZHEIMER'S DISEASE PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION IN PATIENTS 15 YEARS OF AGE AND OLDER MAINTENANCE TREATMENT OF SCHIZOPHRENIA TREATMENT OF BACTERIAL VAGINOSIS IN NON-PREGNANT FEMALES ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) EXTENDED TREATMENT OF SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE) AND/OR PULMONARY EMBOLISM TO REDUCE THE RECCURENCE OF VTE IN PATIENTS WITH CANCER MANAGEMENT OF FIBROMYALGIA FOR THE TREATMENT OF SHORT STATURE IN CHILDREN WITH NOONAN SYNDROME LONG TERM TREATMENT OF PANIC DISORDER SHORT TERM TREATMENT OF PANIC DISORDER REDUCTION IN RISK OF INVASIVE BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS OR AT HIGH RISK FOR INVASIVE BREAST CANCER TREATMENT OF SCHIZOPHRENIA IN ADOLESCENTS AGES 13-17 TREATMENT OF BIPOLAR I DISORDER IN CHILDREN AGES 10-12 AND ADOLESCENTS AGES 13-17 EXPANSION OF PATIENT POPULATION FOR HEAD AND NECK CANCER FROM "INOPERABLE" PATIENTS TO ALL PATIENTS USE IN COMBINATION WITH CISPLATIN AND FLUOROURACIL FOR THE INDUCTION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) ADJUNCTIVE THERAPY OF MYOCLONIC SEIZURES IN ADULTS AND ADOLESCENTS AGE 16 AND OVER WITH JUVENILE MYOCLONIC EPILEPSY ADJUNCTIVE TREATMENT TO TREAT PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA ADJUNCTIVE THERAPY TO DIET TO SLOW THE PROGRESSION OF ARTHEROSCLEROSIS IN ADULT PATIENTS AS PART OF A TREATMENT STRATEGY TO LOWER TOTAL-C AND LDL-C TO TARGET LEVELS SEASONAL ALLERGIC RHINITIS IN PATIENTS 6 THROUGH LESS THAN 12 YEARS OF AGE USE OF AVALIDE TABLETS AS INITIAL THERAPY IN PATIENTS WHO ARE LIKELY TO NEED MULTIPLE DRUGS TO ACHIEVE THEIR BLOOD PRESSURE GOALS TREATMENT OF HYPERTENSION IN PEDIATRIC PATIENTS 6-16 YEARS OF AGE TREATMENT OF SHORT STATURE IN CHILDREN WITH TURNER'S SYNDROME ADJUNCTIVE TREATMENT FOR RADIOIODINE ABLATION OF THYROID TISSUE REMNANTS IN PATIENTS WHO HAVE UNDERGONE THYROIDECTOMY FOR WELL-DIFFERENTIATED THYROID CANCER AND WHO DO NOT HAVE EVIDENCE OF METASTATIC THYROID CANCER FOR USE AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS TREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA PERITONIS AND ABSCESSES
ADB 18 of 51
I-569 I-570 I-571 I-572 I-573 I-574 I-575 I-576 I-577 I-578 I-579 I-580 I-581 I-582 I-583 I-584 I-585 I-586 I-587 I-588 I-589 I-590 I-591 I-592 I-593 I-594 I-595 I-596 I-597
TREATMENT OF ACUTE MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER IN PEDIATRIC PATIENTS AGED 10-17 YEARS PREVENTION OF POST OPERATIVE NAUSEA AND VOMITING FOR UP TO 24 HOURS FOLLOWING SURGERY USE OF AMITIZA (LUBIPROSTONE) 8 MCG TWICE DAILY FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN WOMEN GREATER THAN OR EQUAL TO 18 YEARS OLD MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION AND REDUCING EXACERATIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA ADJUNCTIVE THERAPY ADDED TO LITHIUM OR VALPROATE IN SHORT TERM TREATMENT OF BIPOLAR DISORDER, MANIC OR MIXED MAINTENANCE TREATMENT FOR BIPOLAR I DISORDER, AS ADJUNCTIVE THERAPY TO LITHIUM OR DIVALPROEX LONG-TERM TREATMENT OF SOCIAL ANXIETY DISORDER MAINTENANCE TREATMENT OF ATTENTION-DEFICIT DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS ADJUNCTIVE THERAPY IN THE TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SIEZURES IN ADULTS AND CHILDREN 16 YEARS OF AGE AND OLDER WITH IDIOPATHIC GENERALIZED EPILEPSY TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA USE OF DUTASTERIDE IN COMBINATION WITH TAMSULOSIN FOR THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH) MANAGEMENT OF FIBROMYALGIA INITIAL THERAPY IN PATIENTS LIKELY TO NEED MULTIPLE DRUGS TO ACHIEVE THEIR BLOOD PRESSURE GOALS USE OF APTIVUS, CO-ADMINISTERED W/RITONAVIR, FOR COMBINATION ANTIRETROVIRAL TREATMENT OF HIV-1 INFECTED PED (AGE 2-18 YRS) PATIENTS WHO ARE TREATMENT-EXPERIENCED AND INFECTED W/HIV-1 STRAINS RESISTANT TO MORE THAN ONE PROTEASE INHIBITOR TREATMENT OF CHRONIC HEPATITIS B TREATMENT OF CHICKEN POX IN IMMUNOCOMPETENT PEDIATRIC PATIENTS 2 TO <18 YEARS OF AGE NON-SMALL CELL LUNG CANCER IN COMBINATION WITH CISPLATIN AND AS SINGLE AGENT FOR NONSQAUMOUS NON-SMALL CELL LUNG CANCER TREATMENT OF GROWTH FAILURE IN CHILDREN BORN SMALL FOR GESTATIONAL AGE (SGA) WITH NO CATCH-UP BY AGE 2-4 YRS. TO TREAT PATIENTS WITH PRIMARY DYSBETALIPOPROTEINEMIA (FREDICKSON TYPE III HYPERLIPOPROTEINEMIA) AS AN ADJUNCT TO DIET MONOTHERAPY IN THE TREATMENT OF BIPOLAR DEPRESSION MONOTHERAPY IN THE TREATMENT OF BIPOLAR MANIA ADJUNCTIVE THERAPY IN THE TREATMENT OF BIPOLAR MANIA SEDATION OF NON-INTUBATED PATIENTS PRIOR TO AND/OR DURING SURGICAL AND OTHER PROCUDURES EXPANSION OF INDICATION TO INCLUDE TREATMENT OF HIV IN TREATMENT NAIVE ADULTS TREATMENT OF MODERATE TO SEVERE DYSPAREUNIA, A SYMPTOM OF VULVAR AND VAGINAL ATROPHY, DUE TO MENOPAUSE AND NEW TWICE WEEKLY DOSING REGIMEN FOR THIS INDICATION INDOLENT B-CELL NON-HODGKINS LYMPHOMA (NHL) THAT HAS PROGRESSED DURING OR WITHIN SIX MONTHS OF TREATMENT WITH RITUXIMAB OR A RITUXIMAB CONTAINING REGIMEN TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ADJUVANT TREATMENT OF ADULT PATIENTS FOLLOWING COMPLETE GROSS RESECTION OF KIT (CD117) POSITIVE GASTOINTESTINAL STROMAL TUMORS (GIST) TREATMENT AND PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN PATIENTS EXPECTED TO BE ON GLUCOCORTICOIDS FOR AT LEAST 12 MONTHS TREATMENT OF SHORT STATURE IN PEDIATRIC PATIENTS SMALL FOR GESTATIONAL AGE WHO DO NOT MANIFEST CATCH UP GROWTH BY AGE 2 TO 4 YEARS COMMUNITY ACQUIRED BACTERIAL PNEUMONIA ADDITIONAL PATHOGENS TO COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS INDICATION ADDITIONAL PATHOGENS TO COMPLICATED INTRA-ABDOMINAL INFECTIONS INDICATION TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) IN COMBINATION WITH OLANZAPINE ACUTE TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER (IN COMBINATION WITH OLANZAPINE) TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) IN COMBINATION WITH FLUOXETINE ACUTE TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDER (IN COMBINATION WITH FLUOXETINE) TREATMENT OF TREATMENT RESISTANT DEPRESSION (TRD) INDICATION EXPANDED TO INCLUDE PATIENTS WHO HAVE EXPERIENCED A FIRST CLINICAL EPISODE AND HAVE MRI FEATURES CONSISTENT WITH MULTIPLE SCLEROSIS PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN USE AS ADJUNCTIVE THERAPY WITH LITHIUM OR VALPROATE FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER MONOTHERAPY FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER
ADB 19 of 51
I-610 I-611
I-612
I-621
TREATMENT OF PULMONARY ARTERIAL HYPERTENSION INDICATION EXPANDED TO INCLUDE DELAY IN CLINICAL WORSENING PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 5 IN PATIENTS ON HEMODIALYSIS OR PERITONEAL DIALYSIS FOR USE AS INITIAL THERAPY IN PATIENTS WHO ARE LIKELY TO NEED MULTIPLE DRUGS TO ACHIEVE THEIR BLOOD PRESSURE GOALS MAINTENANCE TREATMENT IN PATIENTS WITH ADVANCED OR METASTATIC NONSQUAMOUS NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES OF PLATINUM-BASED FIRST LINE CHEMOTHERAPY TREATMENT OF MEN AND WOMEN WITH OSTEOPOROSIS ASSOCIATED WITH SUSTAINED SYSTEMIC GLUCOCORTICOID THERAPY AT HIGH RISK FOR FRACTURE GOUT FLARES PREVENTION OF CMV DISEASE IN KIDNEY AND HEART TRANSPLANT PATIENTS 4 MONTHS TO 16 YEARS AT HIGH RISK ADJUNCT TO MOOD STABILIZERS AND/OR ANTIDEPRESSANTS FOR SCHIZOAFFECTIVE DISORDER TREATMENT OF SCHIZOAFFECTIVE DISORDER AS MONOTHERAPY INDICATION EXPANDED TO INCLUDE TREATMENT OF PULMONARY ARTENAL HYPERTENSION (WHO GROUP I) IN PATIENTS WITH CLASS II SYMPTOMS REDUCE LDL-C LEVELS IN BOYS AND POSTMENARCHAL GIRLS, 10 TO 17 YEARS OF AGE, WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AS MONOTHERAPY OR IN COMBINATION WITH A STATIN AFTER FAILING AN ADEQUATE TRIAL OF DIET THERAPY TREATMENT OF HEAVY MENSTRUAL BLEEDING FOR WOMEN WHO CHOOSE TO USE INTRAUTERINE CONTRACEPTION AS THEIR METHOD OF CONTRACEPTION TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN ADOLESCENT BOYS AND POSTMENARCHAL GIRLS, AGES 10 TO 17 YEARS, WITH A RECOMMENDATION DOSING RANGE OF 5 TO 20 MG ONCE DAILY MICARDIS 80 MG FOR REDUCTION OF THE RISK OF MYOCARDIAL INFARCTION, STROKE, OR DEATH FROM CARDIOVASCULAR CAUSES IN PATIENTS 55 YEARS OF AGE OR OLDER AT HIGH RISK OF DEVELOPING MAJOR CARDIOVASCULAR EVENTS WHO ARE UNABLE TO TAKE ACE INHIBITORS MILD TO MODERATE ATOPIC DERMATITIS IN PATIENTS 3 MONTHS OF AGE TO LESS THAN 18 YEARS OF AGE SHORT TERM TREATMENT OF EROSIVE ESOPHAGITIS ASSOCIATED WITH GERD IN PEDIATRIC PATIENTS AGES FIVE YEARS AND OLDER MAINTENANCE TREATMENT OF BIPOLAR DISORDER AS AN ADJUNCT TO LITHIUM OR VALPROATE TREATMENT OF IRRITABILITY ASSOCIATED WITH AUTISTIC DISORDER IN PEDIATRIC PATIENTS AGES 617 YEARS OF AGE MAINTENANCE OF GENERALIZED ANXIETY DISORDER (GAD) ADJUNCTIVE THERAPY IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) INTRAVENOUS CONTRAST ENHANCED COMPUTER TOMOGRAPHY OF THE HEAD AND BODY FOR USE IN COMBINATION WITH LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER THAT OVEREXPRESSES THE HER2 RECEPTOR FOR WHOM HORMONAL THERAPY IS INDICATED PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE, BASED ON THE RESULTS OF JUSTIFICATION FOR THE USE OF STATINS IN PRIMARY PREVENTION; AN INTERVENTION TRIAL EVALUATING ROSUVASTATIN (JUPITER) ADJUNCTIVE THERAPY FOR PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN PATIENTS THIRTEEN YEARS OF AGE AND OLDER TREATMENT OF SIGNS AND SYMPTOMS OF ADVANCED IDIOPATHIC PARKINSON'S DISEASE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WHOSE DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES OF PLATINUM-BASED FIRSTLINE CHEMOTHERAPY PANCREATIC INSUFFICIENCY DUE TO CHRONIC PANCREATITIS AND PANCREATECTOMY RELIEF OF NASAL CONGESTION ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATENTS 2 YEARS OF AGE AND OLDER TREATMENT OF NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKEMIA (PH & CML) IN CHRONIC PHASE. MAINTENANCE TREATMENT OF SCHIZOPHRENIA IN ADULTS ADJUNCTIVE THERAPY WITH EITHER LITHIUM OR VALPROATE FOR THE ACUTE TREATMENT OF MANIC OR MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER TREATMENT OF PATIENTS WITH SUBEPENDYMAL GIANT CELL ASTROCYTOMA (SEGA) ASSOCIATED WITH TUBEROUS SCLEROSIS (TS) WHO REQUIRE THERAPEUTIC INTERVENTION BUT ARE NOT CANDIDATES FOR CURATIVE SURGICAL RESECTION. PREVENTION OF RELAPSE TO OPIOID DEPENDENCE FOLLOWING OPIOID DETOXIFICATION MANAGEMENT OF CHRONIC MUSCULOSKELETAL PAIN MAINTENANCE TREATMENT OF BIPOLAR I DISORDER AS AN ADJUNCT TO LITHIUM OR VALPROATE TREATMENT OF SEVERE HYPERCALCEMIA IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM WHO ARE UNABLE TO UNDERGO PARATHYROIDECTOMY
ADB 20 of 51
ADJUNCTIVE TREATMENT WITH LONG-ACTING ORAL PSYCHOSTIMULANTS FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) TREATMENT OF EXTERNAL GENITAL AND PERIANAL WARTS/CONDYLOMA ACUMINATA IN PATIENTS 12 YEARS OR OLDER USE IN COMBINATION CHEMOTHERAPY WITH 5-FLUOROURACIL IN THE PALLIATIVE TREATMENT OF PATIENTS WITH ADVANCED METASTATIC COLORECTAL CANCER FOR PATIENTS WITH PROGRESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED, OR METASTATIC. TREATMENT OF PROGRESSIVE, WELL-DIFFERENTIATED PANCREATIC NEUROENDOCRINE TUMORS IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED, OR METASTATIC DISEASE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS TREATMENT OF THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT OF ERECTILE DYSFUNCTION (ED) AND THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH) REDUCE THE RISK OF STROKE AND SYSTEMIC EMBOLISM IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION. MONOTHERAPY IN PATIENTS 13 YEARS OF AGE AND OLDER WITH PARTIAL SEIZURES WHO ARE RECEIVING THERAPY WITH A SINGLE ANTIEPILEPTIC DRUG (AED)
EXCLUSIVITY MISCELLANEOUS
M-1 M-2 INFORMATION REGARDING SUPERIORITY CLAIM OVER RANITIDINE FOR DAY AND NIGHT HEARTBURN ADDED TO CLINICAL STUDIES SECTION APPROVAL FOR ADDTION TO CLINICAL PHARMACOLOGY SECTION OF THE LABEL REGARDING (1) IMPROVEMENT IN BONE MINERAL DENSITY IN CHILDHOOD-ONSET ADULT GROWTH HORMONE DEFICIENT PATIENTS AND (2) INCREASES IN SERUM ALKALINE PHOSPHATASE ADDITION OF EFFICACY AND SAFETY INFORMATION IN WHICH FOSAMAX WAS USED CONCOMITANTLY WITH ESTROGEN ALONE OR WITH ESTROGEN PLUS PROGESTIN CHANGES TO PEDIATRIC USE SECTION TO PROVIDE INFORMATION REGARDING SAFETY AND EFFICACY IN PEDIATRIC PATIENTS AS YOUNG AS 2 YEARS OLD INFORMATION REGARDING EFFECTS IN PATIENTS WITH ASTHMA ON CONCOMITANT INHALED CORTICOSTEROIDS IN CLINICAL PHARMACOLOGY SECTION ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES DONE WITH GLUCOPHAGE/GLYBURIDE COMBINATION ADDED TO CLINICAL PHARMACOLOGY AND DOSING AND ADMINISTRATION CLINICAL PHARMACOLOGY IN PEDIATRIC PATIENTS; DOSAGE AND ADMINISTRATION INFORMATION ADDITIONAL INFORMATION FOR THE USE OF SONATA CAPSULES FOR UP TO 5 WEEKS (35 NIGHTS) OF TREATMENT IN A CONTROLLED TRIAL SETTING ADDITION TO THE CLINICAL STUDIES SECTION OF THE LABELING OF TEXT AND TWO TABLES CONTAINING INFORMATION FOR THE PRESCRIBING PHYSICIAN ON BLOOD PRESSURE, HEART RATE, AND HEART RATE VARIABILITY INFORMATION REGARDING MAINTENANCE OF AN ANTIDEPRESSANT EFFECT UP TO 1 YEAR OF DOSING USE FOR LONG-TERM TREATMENT OF POSTTRAUMATIC STRESS DISORDER NEW LANGUAGE FOR PEDIATRIC USE INFORMATION FROM PEDIATRIC STUDIES ADDED TO CLINICAL PHARMACOLOGY, PRECAUTIONS, AND DOSAGE AND ADMINISTRATION ADDITIONAL CLINICAL TRIAL INFORMATION ADDED TO PEDIATRIC USE SUBSECTION LONGER TERM EFFICACY INFORMATION FOR RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA CHANGE IN WORDING OF THE PEDIATRIC SECTION OF THE PACKAGE INSERT INFORMATION REGARDING USE OF ULTANE IN PEDIATRIC PATIENTS WITH CONGENITAL HEART DISEASE INFORMATION DENOTING THE EFFICACY OF REMERON IN MAINTAINING A RESPONSE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD) INFORMATION REGARDING USE IN PEDIATRIC PATIENTS TWO YEARS OF AGE AND OLDER LABELING REVISIONS RELATED TO MCCUNE ALBRIGHT SYNDROME COMPARISON DATA ON THE ANTIHYPERTENSIVE EFFECTS OF ATACAND AND COZAAR CHANGE IN TIME TO ONSET OF ACTION INFORMATION REGARDING ELIMINATION ADDED TO CLINICAL PHARMACOLOGY, STUDY RESULTS IN PATIENTS WITH HEPATIC AND RENAL IMPAIRMENT INFORMATION ON RESULTS OF A LONG TERM LONGITUDINAL GROWTH STUDY AND PEDIATRIC SAFETY INFORMATION ADDITIONAL SAFETY & PK INFORMATION IN CHILDREN 6 MONTHS TO LESS THAN 6 YEARS OF AGE ADDED TO PKG INSERT INCORPORATION OF INFORMATION CONTAINED IN THE PEG-INTRON PACKAGE INSERT INTO THE REBETOL PACKAGE INSERT AND MEDGUIDE-PEG-INTRON WAS APPROVED FOR USE IN COMBINATION WITH REBETOL FOR TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION ON 8/7/01 INFORMATION DESCRIBING ASPIRIN ENDOSCOPY STUDY AND THE MAXIMUM RECOMMENDED DOSE FOR PATIENTS WITH MODERATE HEPATIC INSUFFICIENCY
M-10 M-11 M-12 M-13 M-14 M-15 M-16 M-17 M-18 M-19 M-20 M-21 M-22 M-23 M-24 M-25 M-26
M-27
ADB 21 of 51
M-42 M-43
M-51 M-52
M-59
M-60
M-61
INFORMATION FROM A STUDY IN PEDIATRIC PATIENTS IN ASSOCIATION WITH A NEUROLOGICAL CONDITION LABELING CHANGES TO PROVIDE INFORMATION IN THE MANAGEMENT OF OBESITY IN ADOLESCENTS AGED 12 TO 16 YEARS CHANGES TO CLINICAL PHARMACOLOGY, PRECAUTIONS, AND DOSAGE AND ADMINISTRATION SECTIONS OF LABELING CONCERNING USE OF LOTENSIN IN PEDIATRIC PATIENTS WITH HYPERTENSION INFORMATION FOR USE IN PEDIATRIC PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5 (END-STAGE RENAL DISEASE) ADDITIONAL LANGUAGE TO CLINICAL PHARMACOLOGY AND CLINICAL STUDIES INFORMATION FOR USE OF ADVAIR DISKUS 100/50 IN CHILDREN 4 TO 11 YEARS OF AGE WITH ASTHMA EXPANDED INFORMATION TO PEDIATRIC USE SUBSECTION OF LABELING IN RESPONSE TO PEDIATRIC WRITTEN REQUEST ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES DONE WITH ACTOS IN COMBINATION WITH METFORMIN, A SULFONYLUREA, OR INSULIN ADDED TO CLINICAL PHARMACOLOGY ADDITION OF INFORMATION TO CLINICAL STUDIES REGARDING PREVENTION OF CARDIOVASCULAR DISEASE INFORMATION ADDED TO THE LABELING THAT DETAILS INFORMATION RELATIVE TO STUDIES DONE IN PEDIATRIC POPULATIONS IN THE CLINICAL PHARMACOLOGY AND PEDIATRIC USE SUBSECTIONS SAFETY AND IOP-LOWERING EFFECTS OF TRUSOPT HAVE BEEN DEMONSTRATED IN PEDIATRIC PATIENTS IN A 3 MONTH, MULTI-CENTER DOUBLE MASKED ACTIVE-TREATMENT-CONTROLLED TRIAL FOR LABELING CHANGES BASED ON RESULTS OF THE SPD422-202 CLINICAL STUDY REPORT (CSR) SUBMITTED IN RESPONSE TO THE WRITTEN REQUEST ADDITIONAL INFORMATION REGARDING CLINICAL STUDIES PERFORMED IN PEDIATRIC PATIENTS WITH LEUKEMIA ADDED TO PRECAUTIONS REVISION TO THE PEDIATRIC USE PRECAUTIONS OF THE PRESCRIBING INFORMATION TO INCORPORATE THE RESULTS FROM THE CAPPS-169 STUDY ENTITLED "THE EFFECT OF ORTHO TRICYCLEN ON BONE MINERAL DENISTY IN PEDIATRIC SUBJECTS WITH ANOREXIA NERVOSA" ADDITION OF A GERIATRIC USE SUBSECTION TO THE PRECAUTIONS SECTION OF THE PACKAGE INSERT AND GERIATRIC DOSING INFORMATION INCLUSION OF RESULTS OF STUDY-"PLACEBO-CONTROLLED STUDY TO EVALUATE SAFETY AND PILOT EFFICACY OF ILOPROST AS ADD ON THERAPY WITH BOSENTAN IN SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION CLINICAL INFORMATION ADDED TO THE PEDIATRIC USE SUBSECTION OF PRECAUTIONS REGARDING THE USE OF NOVOLOG IN ADOLESCENTS WITH TYPE I DIABETES AGE 6 TO 18 INFORMATION ADDED TO CLINICAL TRIALS SECTION OF LABELING - EFFECTS OF HUMATROPE TREATMENT IN ADULTS WITH GROWTH HORMONE DEFICIENCY PROVISION OF RESULTS OF STUDY AND PROPOSED REVISIONS TO PACKAGE INSERT SEE SECTION ON CARDIAC ELECTROPHYSIOLOGY PROVIDES FOR USE OF ANTARA WITHOUT REGARD TO MEALS CHANGES TO THE LABELING DESCRIBING THE RESULTS OF A STUDY OF THE USE OF NOVOLOG MIX 70/30 WITH ORAL ANTIDIABETIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES CLINICAL DATA ADDED TO THE CLINICAL PHARMACOLOGY SECTION REGARDING EFFECT OF SINGULAIR ON GROWTH RATES IN PREPUBERTAL CHILDREN NEW INFO TO THE CLINICAL STUDIES, ADULT GROWTH HORMONE DEFICIENCY (GHD) SUBSECTION OF THE NUTROPIN AQ PACKAGE INSERT DESCRIBING THE EFFECTS OF SOMATROPIN ON VISCERAL ADIPOSE TISSUE IN THE ADULT GROWTH HORMONE DEFICIENT PATIENT POPULATION INFORMATION ADDED TO LABELING REGARDING OSTEOGENESIS IMPERFECTA STUDY INFORMATION ADDED TO THE CLINICAL PHARMACOLOGY/CLINICAL STUDIES SECTION REGARDING THE USE OF RISEDRONATE ADMINISTERED ONCE A WEEK IN THE PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN FOR LABELING CHANGES TO THE QUALITY OF LIFE (QOL) STATEMENT IN THE APPROVED PACKAGE INSERT INFORMATION FROM PEDIATRIC STUDIES ADDED TO LABEL INFORMATION ON RESULTS OF A STUDY OF THE USE OF SANDOSTATIN LAR DEPOT IN PEDIATRIC PATIENTS WITH HYPOTHALAMIC OBESITY. INFORMATION ADDED TO CLINICAL TRIAL SECTION WITH INFORMATION ON "GEMINI" TRIAL CLINICAL DATA ADDED TO THE CLINICAL PHARMACOLOGY SECTION REGARDING THE PHARMACOKINETICS OF EZETIMIBE IN ASIAN SUBJECTS CHANGES TO THE CLINICAL STUDIES, PRIMARY HYPERCHOLESTEROLEMIA, VYTORIN SUBSECTION OF THE PACKAGE INSERT TO ADD EFFICACY DATA FOR THE EZETIMIBE/SIMVASTATIN COMBINATION PRODUCT AND FOR AN ATORVASTATIN PRODUCT ON LDL-C AND OTHER LIPID PRMTRS RESULTS OF THE T20-310 STUDY WHICH EVALUATED THE PHARMACOKINETICS, SAFETY, AND ANTIVIRAL ACTIVITY OF FUZEON IN TREATMENT EXPERIENCED PEDIATRIC SUBJECTS AND ADOLSCENTS WAS ADDED TO THE PEDIATRIC SUBSECTION OF PRECAUTIONS CHANGES TO CLINICAL STUDIES, PRIMARY HYPERCHOLESTEROLEMIA, TO ADD EFFICACY DATA FOR THE EZETIMIBE/SIMVASTATIN COMBINATION PRODUCT AND FOR A ROSUVASTATIN PRODUCT ON LDL-C AND OTHER LIPID PARAMETERS IN PATIENTS WTH HYPERCHOLESTEROLEMIA REVISIONS TO LABELING BASED ON DATA SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST
ADB 22 of 51
M-63 M-64 M-65 M-66 M-67 M-68 M-69 M-70 M-71 M-72 M-73 M-74 M-75 M-76
M-77
M-92
M-93
M-94 M-95
CLINICAL INFORMATION FROM ONE CLINICAL STUDY INVESTIGATING THE USE OF AVANDAMET PLUS INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE NOT ACHIEVED ADEQUATE GLYCEMIC CONTROL WITH PREVIOUS ANTI-DIABETIC THERAPIES DETAILED INFORMATION ON AN INCONCLUSIVE PEDIATRIC STUDY CHANGES TO CLINICAL PHARMACOLOGY DETAILING STUDY RESULTS ADDITION OF INFORMATION TO LABEL TO INCLUDE INFORMATION REGARDING USE IN PATIENTS WITH HIV-ASSOCIATED ADIPOSE REDISTRIBUTION SYNDROME (HARS) USE IN SPECIFIC POPULATIONS - PATIENTS WITH CONCOMITANT ILLNESS SUBSECTION OF THE LABELING REGARDING USE OF STRATTERA IN PATIENTS WITH ADHD WHO HAVE COMORBID TIC DISORDER INDICATION EXPANDED TO INCLUDE PATIENTS ON PERITONEAL DIALYSIS DESCRIPTION OF RESULTS OF STUDY OF INITIAL THERAPY IN COMBINATION WITH METFORMIN WHEN DIET AND EXERCISE DO NOT PROVIDE GLYCEMIC CONTROL RESULTS OF STUDY OF COMBINATION THERAPY AND NON-INFERIORITY STUDY PROVISION OF INFORMATION OF THE RESULTS OF A PHASE 2 RANDOMIZED TRIAL OF SPRYCEL 70MG TWICE DAILY OR IMATINIB 800MG DAILY REVISIONS TO PROVIDE FOR RESULTS OF MAINTENANCE DATA IN ADULT PATIENTS WITH MAJOR DEPRESSIVE DISORDER INFORMATION ABOUT USE OF INSPRA (EPLERENONE) FOR HYPERTENSION IN PEDIATRIC PATIENTS NEW INFORMATION ADDED REGARDING THE TUMOR SHRINKING POTENTIAL OF SANDOSTATIN LAR DEPOT INJECTION ON GH - SECRETING PITUITARY ADENOMAS REVISIONS TO CLINICAL STUDIES - CHILDREN AND ADOLSCENTS BASED ON CLINICAL TRIAL DATA TO SUPPORT A DURATION OF ACTION CLAIM UP TO 12 HOURS PROVISION FOR USE OF ARGAGATROBAN IN CERTAIN PEDIATRIC PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) OR HEPARIN-INDUCED THROMBOCYTOPENIA WITH THROMBOSIS (HITTS) REMOVAL OF SCREEN REQUIREMENT IN PTS WITH G6PD DEFICIENCY PRIOR TO INITIATING ACZONE TREATMENT; REMOVAL OF BLOOD COUNT & RETICULOCYTE MONITORING DURING TREATMENT IN G6PD DEFICIENT PTS AND IN PATIENTS WITH HISTORY OF ANEMIA USE IN COMBINATION WITH THE NEW AKTILITE CL128 LAMP FOR THE TREATMENT OF THIN AND MODERATELY THICK, NON-HYPERKERATOTIC, NON-PIGMENTED ACTINIC KERATOSES OF THE FACE AND SCALP IN IMMUNOCOMPETENT PATIENTS CLINICAL TRIAL INFO ON USE OF STRATTERA IN PATIENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AND COMORBID ANXIETY DISORDER WITHOUT CAUSING WORSENING OF ANXIETY LABELING REVISIONS RELATED TO SMOKING AND ERLOTIMB EXPOSURE ADDITIONAL TIME POINT OF 30 MINUTES (0.5 HOUR) IN CHILDREN AGED 6-12 YEARS WITH A DIAGNOSIS OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) ADDITIONAL INFO FOR PEDIATRIC USE FOR CASODEX (STUDIED IN COMBINATION WITH ARIMIDEX) IN THE PEDIATRIC POPULATION, SPECIFICALLY BOYS WITH FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY (TESTOXICOSIS) LABELING REVISIONS RELATED TO CLINICAL STUDIES ADDITIONAL INFORMATION ADDED TO LABELING REGARDING ESTABLISHMENT OF EFFICACY IN ADDITIONAL CLINICAL TRIALS AND ONE MAINTENANCE TRIAL STUDY INFORMATION ADDED TO LABEL REGARDING BONE MINERAL DENSITY INFORMATION ADDED TO LABELING REGARDING USE OF PREVACID IN PATIENTS LESS THAN 1 YEAR WITH SYMPTOMATIC GERD LABELING CHANGES SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST FOR INFANTS AGES BIRTH TO 11 MONTH INCLUSIVE REFLECTING LACK OF EFFICACY FOR GERD INDICATION FOR THIS PATIENT POPULATION INCLUSION OF RESULTS FROM TWO DRUG INTERACTION STUDIES WITH LIPITOR AND CRESTOR IN CLINICAL PHARMACOLOGY SECTION ADDITION OF INFORMATION REGARDING ABUSE POTENTIAL OF CONCERTA VERSUS IMMEDIATE-RELEASE METHYLPHENIDATE PROVIDES FOR REVISIONS TO MULTIPLE SECTIONS OF THE PACKAGE INSERT TO REFLECT RESULTS OF CLINICAL TRIALS 205.235 (UPLIFT) AND 205.266 (VA STUDY) IN SUPPORT OF EXACERBATION CLAIM LABELING CHANGES BASED ON DATA FROM CLINICAL STUDIES NV20235 AND NV20236 STUDIES OF SEASONAL PROPHYLAXIS OF INFLUENZA IN IMMUNOCOMPROMISED PATIENTS AND CHILDREN AGES 1-12 UPDATED LABELING BASED UPON STUDY: A SINGLE-DOSE, SINGLE-BLIND, PLACEBO-AND MOXIFLOXACIN-CONTROLLED 2-PERIOD, RANDOMIZED, CROSSOVER, 3RD PERIOD SEQUENTIAL STUDY OF SIDE EFFECTS OF TEMSIROLIMUS ON CARDIAC REPOLARIZATION IN HEALTHY SUBJECTS UPDATES TO THE PACKAGE INSERT BASED UPON THE TRIAL ENTITLED "A PHASE I PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF TEMSIROLIMUS IN PATIENTS WITH ADVANCED MALIGNANCIES AND NORMAL AND IMPAIRED LIVER FUNCTION EXPANSION OF LABELING TO INCLUDE INFORMATION ON SAFETY AND EFFICACY OF CREON IN PATIENTS AGES 7 YEARS THROUGH 11 YEARS WITH PANCREATIC EXOCRINE INSUFFICIENCY DUE TO CYSTIC FIBROSIS INFO ADDED TO LABEL RELATED TO NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE (PH+) CHRONIC MYELOID LEUKEMIA IC CHRONIC PHASE INFORMATION FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN ADULT PATIENTS WITH DECOMPENSATED LIVER DISEASE BASED ON DATA FROM CLINICAL TRIAL GS-US-174-0108
ADB 23 of 51
M-103
M-104 M-105
M-106 M-107
M-108
UPDATED INFORMATION IN THE CLINICAL STUDIES SECTION RELATED TO THE LOSS AND RECOVERY OF BONE MINERAL DENSITY IN ADOLESCENT GIRLS DURING AND FOLLOWING THE USE OF DEPO-PROVERA CONTRACEPTIVE INJECTION LABELING CHANGES IN RESPONSE TO PEDIATRIC STUDIES - NOT INDICATED FOR USE IN PEDIATRIC POPULATION NEW INFORMATION FROM A STUDY WHICH EVALUATED THE SAFETY AND EFFICACY OF FAMVIR IN TREATING RECURRENT GENITAL HERPES IN IMMUNOCOMPETENT BLACK/AFRICAN AMERICAN SUBJECTS. ADDITION OF FINDINGS FROM A SINGLE PEDIATRIC CLINICAL TRIAL (P04292) OF NASONEX NASAL SPRAY IN THE TREATMENT OF NASAL POLYPS IN PATENTS 6 TO <18 YEARS OF AGE TO THE PACKAGE INSERT. INFORMATION ADDED TO LABEL BASED UPON COMPLETED CLINICAL TRIAL REPORTS INCLUSION OF DATA FROM AN ADDITIONAL 19 SUBJECTS WITH HYPERCALCEMIA FROM PARATHYROID CARCINOMA TO THE INFORMATION CURRENTLY PRESENTED IN THE LABEL INFORMATION FROM PEDIATRIC STUDY REPORT ML16633, "INTRAVENOUS GRANISETRON (KYTRIL) IN THE PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING (PONV) IN PEDIATRIC SUBJECTS UNDERGOING TONSILLECTOMY OR ADENOTONSILLECTOMY." SAFETY, EFFICACY AND PHARMACOKINETIC INFO FOR FASLODEX IN THE PEDIATRIC POPULATION, SPECIFICALLY FOR GIRLS WITH PROGRESSIVE PRECOCIOUS PUBERTY ASSOCIATED WITH MCCUNEALBRIGHT SYNDROME ADDED TO THE PEDIATRIC USE SECTION OF THE LABELING INFORMATION ADDED TO DOSING AND ADMINISTRATION REGARDING A 26 WEEK STUDY NEW LANGUAGE ADDED TO CLINICAL STUDIES REGARDING USE IN SMOKERS WITH CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND USE ACCORDING TO AN ALTERNATIVE SET OF DIRECTIONS FOR SETTING A QUIT DATE ADDITION OF THE T1-WEIGHTED GD-ENHANCED LESION EFFICACY VARIABLE IN THE CLINICAL STUDIES SECTION 14 OF THE PACKAGE INSERT INFORMATION TO THE CLINICAL STUDIES SECTION OF THE LUPRON DEPOT-PED,1-MONTH,BASED UPON THE PHASE 3/4 COMPLETED CLINICAL STUDY REPORT FOR STUDY M90-516, ENTITLED "STUDY OF LUPRON DEPOT IN THE TREATMENT OF CENTRAL PRECOCIOUS PUBERTY". CHANGES ARE BASED ON RESULTS FROM STUDY CV181057
PATENT USE
U-1 U-2 U-3 U-4 U-5 U-6 U-7 U-8 U-9 U-10 U-11 U-12 U-13 U-14 U-15 U-16 U-17 U-18 U-19 U-20 U-21 U-22 PREVENTION OF PREGNANCY TREATMENT OR PROPHYLAXIS OF ANGINA PECTORIS AND ARRHYTHMIA TREATMENT OF HYPERTENSION PROVIDING PREVENTION AND TREATMENT OF EMESIS AND NAUSEA IN MAMMALS METHOD OF PRODUCING BRONCHODILATION METHOD OF PRODUCING SYMPATHOMIMETIC EFFECTS INCREASING CARDIAC CONTRACTILITY ACUTE MYOCARDIAL INFARCTION CONTROL OF EMESIS ASSOCIATED WITH ANY CANCER CHEMOTHERAPY AGENT DIAGNOSTIC METHOD FOR DISTINGUISHING BETWEEN HYPOTHALMIC MALFUNCTIONS OR LESIONS IN HUMANS TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERS METHOD OF TREATING [A] HUMAN SUFFERING FROM DEPRESSION A METHOD FOR TREATING ANXIETY IN A HUMAN SUBJECT IN NEED OF SUCH TREATMENT ADJUNCTIVE THERAPY FOR THE PREVENTION AND TREATMENT OF HYPERAMMONEMIA IN THE CHRONIC MANAGEMENT OF PATIENTS WITH UREA CYCLE ENZYMOPATHIES METHOD OF LOWERING INTRAOCULAR PRESSURE USE IN LUNG SCANNING PROCEDURES TREATMENT OF VENTRICULAR AND SUPRAVENTRICULAR ARRHYTHMIAS METHOD FOR INHIBITING GASTRIC SECRETION IN MAMMALS TREATMENT OF INFLAMMATION A PROCESS FOR TREATING A PATIENT SUFFERING FROM PARKINSON'S SYNDROME AND IN NEED OF TREATMENT TREATMENT OF HUMANS SUFFERING UNDESIRED UROTOXIC SIDE EFFECTS CAUSED BY CYTOSTATICALLY ACTIVE ALKYLATING AGENTS METHOD OF COMBATTING PATHOLOGICALLY REDUCED CEREBRAL FUNCTIONS AND PERFORMANCE WEAKNESSES, CEREBRAL INSUFFICIENCY AND DISORDERS IN CEREBRAL CIRCULATION AND METABOLISM IN WARM-BLOODED ANIMALS METHOD FOR TREATING PROSTATIC CARCINOMA COMPRISING ADMINISTERING FLUTAMIDE METHOD FOR TREATING PROSTATE ADENOCARCINOMA COMPRISING ADMINISTERING AN ANTIANDROGEN INCLUDING FLUTAMIDE AND AN LHRH AGONIST REDUCING CHOLESTEROL IN CHOLELITHIASIS PATIENTS REDUCING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THEREOF DISSOLVING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THEREOF
ADB 24 of 51
CEREBRAL, CORONARY, PERIPHERAL, VISCERAL AND RENAL ARTERIOGRAPHY, AORTOGRAPHY AND LEFT VENTRICULOGRAPHY CT IMAGING OF THE HEAD AND BODY, AND INTRAVENOUS EXCRETORY UROGRAPHY CEREBRAL ANGIOGRAPHY, AND VENOGRAPHY INTRA-ARTERIAL DIGITAL SUBTRACTION ANGIOGRAPHY PALLIATIVE TREATMENT OF PATIENTS WITH OVARIAN CARCINOMA RECURRENT AFTER PRIOR CHEMOTHERAPY, INCLUDING PATIENTS WHO HAVE BEEN PREVIOUSLY TREATED WITH CISPLATIN TREATING VIRAL INFECTIONS IN A MAMMAL TREATING VIRAL INFECTIONS IN A WARM-BLOODED ANIMAL TREATING CYTOMEGALOVIRUS IN A HUMAN WITH AN INJECTABLE COMPOSITION METHODS OF TREATING BACTERIAL ILLNESSES METHOD OF TREATING GASTROINTESTINAL DISEASE TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ANGINA PECTORIS METHOD OF TREATMENT OF BURNS METHOD OF TREATING CARDIAC ARRHYTHMIAS ADJUVANT TREATMENT IN COMBINATION WITH FLUOROURACIL AFTER SURGICAL RESECTION IN PATIENTS WITH DUKES' STAGE C COLON CANCER MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA RELIEF OF NAUSEA AND VOMITING TREATMENT OF INFLAMMATION AND ANALGESIA TREATMENT OF PANIC DISORDER STIMULATION OF THE RELEASE OF GROWTH HORMONE ANALGESIA SYMPTOMATIC CANCER-RELATED HYPERCALCEMIA USE IN TREATING INFLAMMATORY DERMATOSES BLOOD POOL IMAGING, INCLUDING CARDIAC FIRST PASS AND GATED EQUILIBRIUM IMAGING AND FOR DETECTION OF SITES OF GASTROINTESTINAL BLEEDING TREATMENT OF ADULT AND PEDIATRIC PATIENTS(OVER SIX MONTHS OF AGE) WITH ADVANCED HIV INFECTION HYPERCALCEMIA OF MALIGNANCY REVERSAL AGENT OR ANTAGONIST OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS TREATMENT OF PAIN AID TO SMOKING CESSATION OPHTHALMIC USE OF NORFLOXACIN METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES METHOD OF TREATING HYPERCHOLESTEROLEMIA NASAL ADMINISTRATION OF BUTORPHANOL CEREBRAL AND PERIPHERAL ARTERIOGRAPHY AND CT IMAGING OF THE HEAD CORONARY ARTERIOGRAPHY, LEFT VENTRICULOGRAPHY, CT IMAGING OF THE BODY, INTRAVENOUS EXCRETORY UROGRAPHY, INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY AND VENOGRAPHY ISOPRENALINE ANTAGONISM ON THE HEART RATE OR BLOOD PRESSURE TREATMENT OF VIRAL INFECTIONS METHOD OF TREATMENT OF A PATIENT INFECTED WITH HIV TRIPHASIC REGIMEN METHOD OF INDUCING ANESTHESIA IN A WARM BLOODED ANIMAL TREATMENT OF ACTINIC KERATOSIS TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS TREATMENT OF TRANSIENT INSOMNIA METHOD OF TREATMENT OF HEART FAILURE TREATMENT OF MIGRAINE METHOD OF TREATING DISEASES OR INFECTIONS CAUSED BY MYCETES METHOD OF PROVIDING HYPNOTIC EFFECT RELIEF OF OCULAR ITCHING DUE TO SEASONAL ALLERGIC CONJUNCTIVITIS USE TO IMAGE A SUBJECT WITH A MAGNETIC RESONANCE IMAGING SYSTEM TREATMENT OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS ULCERATIVE COLITIS SYMPTOMATIC TREATMENT OF PATIENTS WITH NOCTURNAL HEARTBURNDUE TO GERD METHOD OF TREATING OCULAR BACTERIAL INFECTIONS RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS TREATMENT FOR DEMENTIA IN PATIENTS WITH ALZHEIMER'S DISEASE TREATMENT OF SEIZURES
ADB 25 of 51
U-95 U-96 U-97 U-98 U-99 U-100 U-101 U-102 U-103 U-104 U-105 U-106 U-107 U-108
U-109
U-110 U-111 U-112 U-113 U-114 U-115 U-116 U-117 U-118 U-119 U-120 U-121 U-122 U-123 U-124 U-125 U-126 U-127 U-128 U-129 U-130 U-131 U-132
A METHOD OF BLOCKING THE UPTAKE OF MONOAMINES BY BRAIN NEURONS IN ANIMALS NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS METHOD OF TREATING CERTAIN FORMS OF EPILEPSY METHOD FOR NONINVASIVE ADMINISTRATION OF SEDATIVES, ANALGESICS, AND ANESTHETICS TREATMENT OF MODERATE PLAQUE PSORIASIS TREATMENT OR PROPHYLAXIS OF EMESIS TREATMENT OF PYSCHOTIC DISORDERS ALTERNATIVE THERAPY TO TRIMETHOPRIM-SULFAMETHOXAZOLE FOR TREATMENT OF MODERATE-TO-SEVERE PNEUMOCYSTIS CARINII PNEUMONIA IN IMMUNOCOMPROMISED AND AIDS PATIENTS TREATMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I INSULIN DEPENDENT DIABETES MELLITUS AND RETINOPATY USE AS AN ANTIHISTAMINE/DECONGESTANT TREATMENT-ADULTS W/ ADVANCED HIV,INTOLERANT OF APPROVED THERAPIES,INTOLERANT OF APPROVED THERAPIES W/PROVEN BENEFIT OR HAVE EXPERIENCED CLINICAL/IMMUNOLOGICAL DETERIORATION WHILE RECEIVING..OR FOR WHOM SUCH THERAPIES-CONTRAINDICATED SHORT TERM MANAGEMENT OF MODERATE PRURITIS IN ADULTS WITH ATOPIC DERMATITIS AND LICHEN SIMPLEX CHRONICUS METHOD OF TREATING VARICELLA ZOSTER (SHINGLES) INFECTIONS A METHOD OF TREATING A PATIENT IN NEED OF MEMORY ENHANCEMENT A METHOD OF INDUCING REGRESSION OF LEUKEMIA CELL GROWTH IN A MAMMAL METHOD OF PROVIDING POTASSIUM TO A SUBJECT IN NEED OF POTASSIUM METHOD OF TREATING OCULAR INFLAMMATION ADJUNCT TO CONVENTIONAL CT OR MRI IMAGING IN THE LOCALIZATION OF STROKE IN PATIENTS IN WHOM STROKE HAS ALREADY BEEN DIAGNOSED METHOD OF HORMONALLY TREATING MENOPAUSAL OR POST-MENOPAUSAL DISORDERS IN WOMEN TREATMENT OF OCULAR HYPERTENSION TREATMENT OF AQUEOUS HUMOR FORMATION AND INTRAOCULAR PRESSURE EMESIS TREATMENT OF EPILEPSY TREATMENT OF HYPERTENSION AND ANGINA PECTORIS SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER, GASTROESOPHAGEAL REFLUX DISEASE (GERD), SEVERE EROSIVE ESOPHAGITIS, POORLY RESPONSIVE SYMPTOMATIC GERD AND PATHOLOGIAL HYPERSECRETORY CONDITIONS AND MAINTENANCE HEALING OF EROSIVE ESOPHAGITIS ADJUNCT DIET IN THE TX OF ELEVATED TOTAL CHOLESTEROL AND LDL-C LEVELS IN PTS W/PRIMARY HYPERCHOLESTEROLEMIA WHOSE RESPONSE TO DIETARY RESTRICTION OF SAT FAT AND CHOLESTEROL AND OTHER NONPHARMACOLOGICAL MEASURES HAS NOT BEEN ADEQUATE USE AS A RETRIEVABLE PERSSARY DIABETES CONTRACEPTION METHOD OF CONDUCTING RADIOLOGICAL EXAMINATION OF A PATIENT BY ADMINISTERING TO SAID PATIENT A RADIOPAQUE AMOUNT OF IOPROMIDE USE FOR INHIBITING BONE RESORPTION USE OF VASODILATORS TO EFFECT AND ENHANCE AN ERECTION (AND THUS TREAT ERECTILE DYSFUNCTION), BY INJECTION INTO THE PENIS METHOD OF MYOCARDIAL IMAGING TREATMENT OF OCULAR ALLERGIC RESPONSE IN HUMAN EYES METHOD OF LOWERING BLOOD SUGAR LEVEL TREATMENT OF NASAL HYPERSECRETION CONTROLLING OR PREVENTING POST-OPERATIVE INTRAOCULAR PRESSURE RISES ASSOCIATED WITH OPHTHALMIC LASER SURGICAL PROCEDURES METHOD OF TREATING CONDITIONS MEDIATED THROUGH HISTAMINE H2-RECEPTORS A THERAPEUTIC METHOD FOR CONTROLLING THROMBOSIS METHOD FOR CONTROLLING THROMBOSIS AND DECREASING BLOOD HYPERCOAGULATION AND HEMORRHAGING RISKS TREATMENT OF ACNE TREATMENT NEUROGENERATIVE DISEASES TREATMENT OF GASTRITIS METHOD OF PRODUCING NEUROMUSCULAR BLOCKADE METHOD FOR TREATMENT OF TUMORS METHOD TO DESTROY OR IMPAIR TARGET CELLS MANAGEMENT OF PATIENTS WITH MASTOCYTOSIS PHOTODAMAGED SKIN INHIBITING HIV PROTEASE
ADB 26 of 51
MANAGEMENT OF OBESITY INCLUDING WEIGHT LOSS AND MAINTENANCE IN PATIENTS ON A REDUCEDCALORIE DIET TREATMENT OF ACNE VULGARIS ANTITUMOR AGENT PROCESS FOR WASTE NITROGEN REMOVAL METHOD OF TREATING BACTERIAL VAGINOSIS TREATMENT OF ALLERGIC RHINITIS TREATMENT OF ALLERGIC REACTIONS USE OF NORVIR TO INHIBIT HIV PROTEASE OR TO INHIBIT AN HIV INFECTION TREATMENT OF ULCERATIVE COLITIS METHOD OF TREATING ALLERGIC REACTIONS IN A MAMMAL BY USING THIS ACTIVE METABOLITE BIODEGRADABLE SUPERPARAMAGNETIC METAL OXIDES AS CONTRAST AGENTS FOR MR IMAGING BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC MATERIALS FOR USE IN CLINICAL APPLICATIONS BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC PARTICLES FOR USE AS NUCLEAR MAGNETIC RESONANCE IMAGING AGENTS METHOD OF TREATING SUSCEPTIBLE NEOPLASMS IN MAMMALS DETECTION OF GASTROINTESTINAL DISORDERS AND THE SUBSEQUENT BREATH COLLECTION AND MEASUREMENT OF 13CO2 DEVICE FOR COLLECTING A BREATH SAMPLE METHOD OF TREATING AN ANIMAL, INCLUDING A HUMAN SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS, ACUTE MANIA OR MILD ANXIETY STATES METHOD OF USE FOR CONTROLLING HYPERGLYCEMIA BY ADMINISTRATION OF THIS SUSTAINED RELEASE DOSAGE FORM OF GLIPIZIDE RELIEF OF SYMPTOMS OF THE COMMON COLD METHOD OF TREATING ANXIETY RELATED DISORDERS INCLUDING OBSESSIVE COMPULSIVE DISORDER TREATMENT OF INITIAL EPISODE GENITAL HERPES METHOD OF TREATING ANIMALS SUFFERING FROM AN APPETITE DISORDER TREATMENT OF ERECTILE DYSFUNCTION METHOD OF PROVIDING ANESTHESIA TREATMENT OF A HUMAN SUFFERING FROM VITAMIN B12 DEFICIENCY ANGINA TREATMENT OF INTERSTITIAL CYSTITIS TREATMENT OF BACTERIAL INFECTIOUS DISEASE METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS IN A PATIENT METHOD OF USE TO INHIBIT CHOLESTEROL SYNTHESIS IN A HUMAN SUFFERING FROM HYPERCHOLESTEROLEMIA METHOD OF USING TROGLITAZONE TO TREAT IMPAIRED GLUCOSE TOLERANCE TO PREVENT OR DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUS METHOD OF USING TROGLITAZONE TO PREVENT OR DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUS IN A DEFINED POPULATION OF PATIENTS TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA TREATMENT OF H.PYLORI-ASSOCIATED DUODENAL ULCER METHOD FOR TREATING HIV-1 INFECTION METHOD OF INHIBITING LIPOXYGENASE ACTIVITY IN A MAMMAL WHICH IS THE MODE OF ACTION IN THE TREATMENT OF ASTHMA METHODS OF USING THE COMPOUND/DRUG PRODUCT AS A CONTRAST AGENT IN MAGNETIC RESONANCE IMAGING METHOD OF OBTAINING AN MR IMAGE USING THE COMPOSITION/DRUG PRODUCT AS A CONTRAST AGENT METHODS OF USING THE COMPOUND/DRUG PRODUCT AS AN ORAL CONTRAST AGENT IN MAGNETIC RESONANCE IMAGING OF THE GASTROINTESTINAL TRACT TREATMENT OF GENITAL WARTS ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES USE AS AN ANTIHISTAMINE AGENT METHOD OF TREATING MALIGNANT TUMORS METHOD OF TREATING A PATIENT SUFFERING FROM LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOSES FUNGICIDE FACILITATED ADHERENCE OF AGENTS TO SKIN ENHANCED CUTANEOUS PENETRATION OF A DERMALLY-APPLIED PHARMACOLOGICALLY ACTIVE AGENT TREATMENT OF ADULT AND PEDIATRIC PATIENTS (OVER 6 MONTHS OF AGE) WITH ADVANCED HIV INFECTION PRODUCING ALPHA ADRENERGIC ANTAGONISTIC ACTION IN A HOST USE OF SALMETEROL IN PATIENTS WITH REVERSIBLE AIRWAY OBSTRUCTION TREATMENT OF CONDITIONS CAUSED BY DISTURBANCE OF NEURONAL 5HT FUNCTION
ADB 27 of 51
U-199 U-200 U-201 U-202 U-203 U-204 U-205 U-206 U-207 U-208 U-209 U-210 U-211 U-212 U-213 U-214 U-215 U-216 U-217 U-218 U-219 U-220 U-221 U-222 U-223 U-224 U-225 U-226 U-227 U-228 U-229 U-230 U-231
TREATING ALLERGIC EYE DISEASES IN HUMANS METHOD OF TREATING HYPERTENSION METHOD FOR TREATING GI DISORDERS CAUSED BY H.RYLORI WHICH COMPRISES ADMINISTRATION OF RANITIDINE BISMUTH CITRATE AND CLARITHROMYCIN FOR A GREATER THAN ADDITIVE EFFECT THERAPEUTIC TREATMENT OF CALCIFIC TUMORS TREATMENT OF H.PYLORI ASSOCIATED DUODENAL ULCER ENHANCEMENT OF THE BIOAVAILABILITY OF THE DRUG SUBSTANCE USE OF RITONAVIR IN COMBINATION WITH ANY REVERSE TRANSCRIPTASE INHIBITOR METHOD OF TREATMENT FOR CONTROLLING AND LOWERING INTRAOCULAR PRESSURE IN A HUMAN USE IN TREATING ALLERGIC REACTIONS PSORIASIS TREATING ANGINA PECTORIS AND HIGH BLOOD PRESSURE METHOD FOR THE DIAGNOSIS OF GASTROINTESTINAL DISORDERS BY UREA ISOTOAC OR NITROGEN LABELED CARBON TREATMENT OF METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR POSITIVE TUMORS USE IN COMBINATION WITH CERTAIN LHRH ANALOGUES FOR THE TREATMENT OF ADVANCED PROSTATE CANCER TREATMENT METASTATIC CARCINOMA OF OVARY AFTER 1ST LINE FAILURE OR SUBSQUENT CHEMOTHERAPY, TREATMENT OF BREAST CANCER AFTER FAILURE OF COMBINATION CHEMOTHERAPY FOR METASTATIC DISEASE AND 2ND LINE TREATMENT OF AIDS RELATED KAPOSI'S SARCOMA METHOD OF TREATING INFECTIOUS UPPER GI TRACT DISORDERS CAUSED BY CAMPYLOBACTER PYLORIDIS INFECTION COMPRISING ADMINISTRATION OF A BISMUTH AGENT AND AN ANTIMICROBIAL AGENT METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF A BISMUTH-CONTAINING AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENT METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF CAMPYLOBACTER-INHIBITING ANTIMICROBIAL AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENT METHOD OF TREATING PEPTIC ULCER DISEASE CAUSED BY CAMPYLOBACTER PYLORIDIS COMPRISING ORAL ADMINISTRATION OF 50 TO 5,000MG BISMUTH DAILY FOR 3-56 DAYS TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOWING ANTIESTROGEN THERAPY USE OF TAXOL IN COMBINATION WITH G-CSF FOR TREATMENT OF PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA METHOD FOR TREATING HEARTBURN METHOD OF USING FSH ALONE, WITHOUT THE PRESENCE OF EXOGENEOUS LH, IN IN VITRO FERTILIZATION USE AS NASAL SPRAY VAGINAL ADMINISTRATION USING SPECIFIED FORMULATION VAGINAL ADMINISTRATION OF PROGESTERONE USING SPECIFIED FORMULATION METHOD OF TREATING CONGESTIVE HEART FAILURE USE IN PATIENTS WITH REVERSIBLE AIRWAY OBSTRUCTION METHOD OF TREATMENT OF PARKINSON'S DISEASE METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS AND TREATING HYPERCHOLESTEROLEMIA AND METHOD FOR TREATING HYPERLIPIDEMIA USE AS A BLOOD GLUCOSE-LOWERING AGENT TREATMENT OF EPILEPSY TWICE DAILY. TREATING A PATIENT BY ADMINISTERING CARBAMAZEPINE IN A DOSAGE FORM CAPABLE OF MAINTAINING BLOOD CONCENTRATION FROM 4-12MCG/ML OVER 12 HOURS TREATMENT OF ADENOCARCINOMA, INCLUDING STAGE B2-C BY ADMINISTERING AN AGONIST OF LH-RH AND FLUTAMIDE METHOD OF PRODUCING ANESTHESIA METHOD FOR LIMITING THE POTENTIAL FOR MICROBIAL GROWTH IN THE DRUG PRODUCT TREATMENT OF PARKINSON'S DISEASE METHOD OF DIAGNOSIS SELECTIVE VASODILATION BY CONTINUOUS ADENOSINE INFUSION METHOD OF TREATING PAGET'S DISEASE USING ACTONEL TREATMENT OF BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF MICROORGANISMS CONTROLLING INTRAOCULAR PRESSURE MEHTOD FOR DELIVERY METHOD OF ENHANCING THE DISSOLUTION PROFILE OF A PHARMACEUTICAL FROM A SOLID DOSAGE FORM CONTAINING THE PHARMACEUTICAL AND SIMETHICONE NASAL ADMINISTRATION ASTHMA CARDIAC INSUFFICIENCY (CONGESTIVE HEART FAILURE) PREVENTION OF ACUTE CARDIAC ISCHEMIC EVENTS USE IN PARKINSON'S DISEASE
ADB 28 of 51
U-239
U-240 U-241
U-242 U-243 U-244 U-245 U-246 U-247 U-248 U-249 U-250 U-251 U-252 U-253 U-254 U-255 U-256 U-257 U-258 U-259 U-260
U-264
U-265 U-266
U-267
METHOD OF TREATING MIGRAINE DECREASING MORTALITY CAUSED BY CONGESTIVE HEART FAILURE METHOD OF USING RIBAVIRIN TO TREAT VIRAL INFECTIONS IN MAMMALS METHOD OF MODULATING TH1 AND TH2 RESPONSE IN ACTIVATED T CELLS OF A HUMAN COMPRISING ADMINISTERING RIBAVIRIN TO THE T CELLS IN A DOSAGE WHICH PROMOTES THE TH1 RESPONSE AND SUPPRESSES THE TH2 RESPONSE TREATING MALE PATTERN BALDNESS WITH 0.05 TO 3.0MG/DAY METHOD OF PERFORMING NMR IMAGING WITH A PATIENT COMPRISING ADMINISTERING TO THE PATIENT AN EFFECTIVE AMOUNT OF CONTRAST AGENT DISCLOSED IN THE CLAIMS IMAGING A BODY TISSUE AND SUBJECTING TO NMR TOMOGRAPHY, ADMINISTERING AN AMOUNT OF PHARMACEUTICAL AGENT FOR AFFECTING THE RELAXATION TIMES OF ATOMS IN BODY TISSUES UNDERGOING NMR DIAGNOSIS, WHEREBY THE IMAGE CONTRAST IN ENHANCED.... TREATING OR CONTROLLING OCULAR INFLAMATION WHICH COMPRISES TOPICALLY ADMINISTERING TO AFFECTED EYE A COMPOSITION COMPRISING AN NSAID, A POLYMERIC QUATERNARY AMMONIUM COMPOUND AND BORIC ACID TREATMENT OF ACUTE MIGRAINE ATTACKS FOR SHORT-TERM TREATMENT ACTIVE DUODENAL ULCER, MAINTENANCE THERAPY FOR DUODENAL ULCER PATIENTS AT REDUCED DOSAGE AFTER HEALING OF ACTIVE ULCER, SHORT-TERM TREATMENT ACTIVE BENIGN GASTRIC ULCER & GERD, PATHOLOGICAL HYPERSECRETORY CONDITIONS USE OF FOLLITROPIN ALPHA ALONE IN IN-VITRO FERTILIZATION TOPICAL ADMINISTRATION PLATELET AGGREGATION INHIBITORS TREATMENT OF SEBORRHEA DERMATITIS IN HUMANS PHOSPHATE BINDING TREATMENT OF RHEUMATOID ARTHRITIS TREATMENT OF HIV METHOD OF TREATING ALLERGIC OR NON-ALLERGIC RHINITIS IN PATIENTS BY ADMINISTERING AEROSOLIZED PARTICLES OF MOMETASONE FUROATE TREATMENT OF HEPATITIS B INFECTION USE OF TROGLITAZONE IN COMBINATION WITH SULFONYLUREAS IN THE TREATMENT OF TYPE II DIABETES METHOD OF TREATING A HUMAN SUBJECT HAVING GAUCHER'S DISEASE ORAL TRANSMUCOSAL USE USE OF AGGRASTAT IN COMBINATION WITH HEPARIN IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY TREATMENT OF HIV INFECTION IN COMBINATION WITH ONE OR MORE ADDITIONAL HIV ANTIVIRAL AGENTS TREATMENT OF HIV INFECTION TREATMENT OF NEURODEGENERATIVE DISEASES TREATMENT OF ANDROGENIC ALOPECIA BY ORAL ADMINISTRATION DRUG SUBSTANCE REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION WHO ARE INTOLERANT OF OTHER IOP LOWERING MEDICATIONS OR INSUFFICIENTLY RESPONSIVE TO ANOTHER IOP LOWERING MEDICATION TREATING BENIGN PROSTATIC HYPERPLASIA WITH A GENUS OF COMPOUNDS, INCLUDING FINASTERIDE TREATING BENIGN PROSTATIC HYPERTROPHY WITH FINASTERIDE METHOD OF TREATING A MALIGNANT CONDITION THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING LEUKEMIA OR LYMPHOMA IN A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVENOUS ADMINISTRATION OF BUSULFAN METHOD OF TREATING A MALIGNANT DISEASE THROUGH PARENTERAL ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN USE AS LAXATIVE RELIEF OF THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS; RELIEF OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN ADULTS; MANAGEMENT OF ACUTE PAIN IN ADULTS; TREATMENT OF PRIMARY DYSMENNORRHEA; ACUTE TREATMENT OF MIGRAINE ATTACKS IN ADULTS PREVENTING HEARTBURN EPISODES FOLLOWING INGESTION OF HEARTBURN-INDUCING FOOD/BEVERAGE, COMPRISING ADMIN TO PT, 30 MIN PRIOR TO CONSUMPTION BY THE PT THE FOOD/BEVERAGE, A COMPOSITION COMPRISING 10MG FAMOTIDINE ACROMEGALY EXCESS GH-SECRETION OR GASTRO-INTESTINAL DISORDERS METHOD OF IMPROVING THE TIME FOR ADMINISTRATION OR THE TIME BETWEEN CHANGES OF GIVING SETS FOR THE DRUG PRODUCT METHOD OF TREATING TUMORS METHOD OF TREATING CARCINOMA CUTANEOUS T-CELL LYMPHOMA
ADB 29 of 51
U-297 U-298 U-299 U-300 U-301 U-302 U-303 U-304 U-305 U-306 U-307 U-308
U-309 U-310 U-311 U-312 U-313 U-314 U-315 U-316 U-317 U-318 U-319 U-320 U-321
ZANAMIVIR FOR INHALATION METHOD OF USE OF THE DRUG SUBSTANCE METHOD OF USE OF LEVOBUPIVACAINE NEUROLOGICAL AND OTHER DISORDERS (TREATMENT OF EPILEPSY, BID ORAL DOSING) METHOD OF USE OF THE INDICATION OF THE DRUG PRODUCT METHOD OF USE OF THE APPROVED PRODUCT TREATING PRECIPITATED ACUTE URINARY RETENTION WITH FINASTERIDE ANTIMYCOTIC USES, SPECIFICALLY TREATMENT OF ONYCHOMYCOSIS METHOD OF TREATING BACTERIAL INFECTIONS METHOD FOR TREATING MENOPAUSAL SYMPTOMS IN A POSTMENOPAUSAL FEMALE MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE, AND VULVAR AND VAGINAL ATROPHY) AND OSTEOPOROSIS DEPRESSION AND SOCIAL ANXIETY DISORDER/SOCIAL PHOBIA DEPRESSION TREATMENT OR PREVENTION OF OSTEOPOROSIS THERAPY OF INFLUENZA TREATMENT OF NON-HYPERKERATOTIC ACTINIC KERATOSES OF FACE AND SCALP INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH CYCLOSPORIN INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH AZATHIOPRINE INHIBITING TRANSPLANT REJECTION USING RAPAMYCIN (SIROLIMUS) IN COMBINATION WITH A CORTICOSTEROID TREATMENT OF HYPERPIGMENTARY DISORDERS TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS TREATING MIGRAINE PAIN AND ONE OR MORE OF A CLUSTER OF SYMPTOMS CHARACTERISTIC OF A MIGRAINE ATTACK SYMPTOMS BEING SELECTED FROM PHOTOPHOBIA, PHONOPHOBIA NAUSEA AND FUNCTIONAL DISABILITY PREVENTION OR TREATMENT OF REVERSIBLE VASOCONSTRICTION BY THE INHALATION OF NITRIC OXIDE WITH AN OXYGEN CONTAINING GAS METHOD OF COMBATING BACTERIA IN A PATIENT TREATMENT OF ADENOMATOUS POLYPS INDICATED FOR THE REDUCTION OF ELEVATED TOTAL AND LDL CHOLESTEROL LEVELS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA USE OF TROGLITAZONE IN COMBINATION WITH SULFONYLUREAS AND BIGUANIDES IN THE TREATMENT OF TYPE II DIABETES TO REDUCE THE RISK OF STROKE IN PATIENTS WHO HAVE HAD TRANSIENT ISCHEMIA OF THE BRAIN OR COMPLETED ISCHEMIC STROKE DUE TO THROMBOSIS METHOD OF USE PATENT-PRODUCT APPROVED FOR TREATMENT OF OSTEOPOROSIS, PAGET'S DISEASE, PREVENTION AND TREATMENT OF GLUCOCORTICOID INDUCED OSTEOPOROSIS A METHOD OF TREATMENT OF A CONDITION INVOLVING AN ANTIBODY ANTIGEN REACTION METHODS FOR USING THE DRUG PRODUCT TREATMENT OF POST-MENOPAUSAL UROGENITAL SYMPTOMS ASSOCIATED WITH ESTROGEN DEFICIENCY CLAIMS AN OLANZAPINE POLYMORPH USEFUL FOR TREATING ANY NUMBER OF LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOSES,EMPLOYING OLANZAPINE AS PER THE INDICATION OF THIS NDA CLAIMS A SOLID ORAL FORMULATION INCLUDING TABLETS AND GRANULES OF OLANZAPINE USEFUL FOR TREATING ANY NUMBER OF LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOLES, EMPLOYING OLANZAPINE AS PER THE INDICATIONS OF THIS NDA TREATING SJOEGREN SYNDROME TREATMENT OF XEROSTOMIA HORMONE REPLACEMENT PANIC DISORDER, OBSESSIVE-COMPULSIVE DISORDER, POSTTRAUMATIC STRESS DISORDER TREATMENT OF CONGESTIVE HEART FAILURE METHOD FOR TREATING HYPERPARATHYROIDISM WHICH COMPRISES SUPPRESSING PARATHYROID ACTIVITY METHOD FOR ADMINISTERING DRUG TO GASTROINTESTINAL TRACT METHOD OF TREATING A SUBJECT SUFFERING FROM PROSTATE CANCER METHOD OF USING TROGLITAZONE TO TREAT PATIENTS HAVING INSULIN RESISTANCE TREATMENT OF PATIENTS WITH AN OVERACTIVE BLADDER WITH SYMPTOMS OF URINARY FREQUENCY, URGENCY, OR URGE INCONTINENCE TREATMENT OF MICROBIAL INFECTIONS INHIBITING OR ELIMINATING ACUTE MYELOID LEUKEMIA REDUCTION OF ELEVATED IPTH LEVELS IN THE MGT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS UNDERGONG CHRONIC RENAL DIALYSIS
ADB 30 of 51
TREATMENT OF ALZHEIMER'S DEMENTIA USE AS A BILE ACID SEQUESTRANT METHOD OF TREATING AN ANIMAL, INCLUDING A HUMAN, SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS OR ACUTE MANIA EMPLOYING OLANZAPINE METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED CONDITIONS, INCLUDING "BIPOLAR DISORDER NOS" EMPLOYING OLANZAPINE METHOD OF TREATING SCHIZOPHRENIA AND BIPOLAR DISORDER METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED PSYCHOTIC CONDITONS EMPLOYING OLANZAPINE METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF LISTED CONDITIONS INCLUDING "A PSYCHOTIC CONDITION" EMPLOYING AN OLANZAPINE POLYMORPH USE OF AVANDIA AS MONOTHERAPY, IN COMBINATION WITH METFORMIN, AND IN COMBINATION WITH SULFONYLUREAS TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATMENT OF NAUSEA AND VOMITING METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT TREATMENT OR PREVENTION OF BRONCHOSPASM METHOD OF TREATING OCULAR HYPERTENSION TREATMENT OF EXCESSIVE FEMALE FACIAL HAIR USE OF PRAVASTATIN SODIUM FOR SECONDARY PREVENTION OF CORONARY EVENTS IN MEN AND WOMEN WHO HAVE HAD A MYOCARDIAL INFARCTION AND HAVE NORMAL CHOLESTEROL LEVELS DIAGNOSTIC RADIOIMAGING USE OF CARDIOLITE/MIRALUMA KIT FOR THE PREPARATION OF TC99M SESTAMIBI METHODS FOR TREATING DISTURBANCES OF MOOD, DISTURBANCES OF APPETITE, DEPRESSED MOOD, OR CARBOHYDRATE CRAVING ALL ASSOCIATED WITH PREMENSTRUAL SYNDROME PREVENTION OF CARDIO-TOXICITY CAUSED BY THE ADMINISTRATION OF DOXORUBICIN THE LONG TERM TREATMENT OF GROWTH FAILURE DUE TO LACK OF ADEQUATE ENDOGENOUS GROWTH HORMONE SECRETION IN CHILDREN METHOD FOR ENHANCING THE TREATMENT OF ... LATE LUTEAL PHASE DYSPHORIC DISORDER METHOD FOR TREATMENT OF LATE LUTEAL PHASE DYSPHORIC DISORDER REDUCTION OF INTESTINAL GAS, CRAMPING AND ANORECTAL IRRITATION METHOD FOR INHIBITING HIV INFECTION BY ADMINISTERING RITONAVIR IN COMBINATION WITH ANOTHER HIV PROTEASE INHIBITOR RITONAVIR AND ANOTHER HIV PROTEASE INHIBITOR FOR CONCOMITANT ADMINISTRATION FOR THE TREATMENT OF AN HIV INFECTION METHOD FOR INHIBITING CYTOCHROME P450 MONOOXYGENASE WITH RITONAVIR AND A METHOD FOR IMPROVING THE PHARMCOKINETICS OF A DRUG THAT IS MTABOLIZED BY CYTOCHROME P450 MONOOXYGENASE BY ADMIN THE DRUG AND RITONAVIR METHOD OF USE IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS METHOD OF USE FOR INHIBITING HIV INFECTION METHOD OF USE WHICH IS SUBJECT OF THE APPLICATION PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR CONCOMITANT ADMIN WITH A REVERSE TRANSCRIPTASE INHIBITOR INHIBITING PROTEASE WITH LOPINAVIR AND INHIBITING AN HIV INFECTION WITH LOPINAVIIR INHIBITING HIV INFECTION BY ADMINISTERING RITONAVIR IN COMBINATION WITH A REVERSE TRANSCRIPTASE INHIBITOR PREVENTION AND TREATMENT OF OSTEOPOROSIS METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID WITHOUT CAUSING TREATMENT-LIMITING ELEVATIONS IN URIC ACID OR GLUCOSE LEVELS OR CAUSING LIVER DAMAGE, BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT METHOD OF ASSISTING PERSON TO QUIT SMOKING...TRANSDERMALLY ADMIN NICOTINE VIA..PATCH ADHERED TO SKIN AT DOSING RATE APPROX SAME AS ABSORBED FROM SMOKING DELIVERING A MEDICINAL AEROSOL FORMULATION USING CFC-FREE PROPELLANT 134A. USE OF THE DRUG PRODUCT IN PHOTODYNAMIC THERAPEUTIC PROTOCOLS FOR THE TREATMENT OF AGERELATED MACULAR DEGENERATION AND RELATED CONDITIONS INVOLVING UNWANTED NEOVASCULATURE IN THE EYE DEPRESSION, OBSESSIVE COMPULSIVE DISORDER, PANIC DISORDER AND SOCIAL ANXIETY DISORDER METHOD OF USE OF VISICOL METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF PATHOLOGICAL PSYCHOLOGICAL CONDITIONS INCLUDING MENTAL DISORDERS EMPLOYING OLANZAPINE AS PER THE INDICATION WHICH IS THE SUBJECT MATTER OF THIS SNDA-011 MANAGEMENT OF ANXIETY DISORDERS AND THE SHORT-TERM RELIEF OF THE SYMPTOMS OF ANXIETY USE OF APPROVED FORMULATIONS TO TREAT ALL APPROVED DISEASE INDICATIONS METHOD OF TREATING A PATIENT SUFFERING FROM ANY OF A NUMBER OF PATHOLOGICAL PSYCHOLOGICAL CONDITIONS THAT RELATE TO THE USE OF A PSYCHOACTIVE SUBSTANCE EMPLOYING OLANZAPINE AS PER THE INDICATION THE SUBJECT MATTER OF SUPPLEMENT 011
ADB 31 of 51
U-374
U-378 U-379 U-380 U-381 U-382 U-383 U-384 U-385 U-386 U-387 U-388 U-389 U-390 U-391 U-392 U-393 U-394 U-395 U-396 U-397 U-398 U-399 U-400
TREATING A PATIENT SUFFERING FROM OR SUSCEPTIBLE TO ANY NUMBER OF LISTED CONDITIONS INCLUDING PSYCHOSIS, EMPLOYING OLANZAPINE AS PER THE INDICATION WHICH IS THE SUBJECT MATTER OF THIS SNDA-011 METHOD FOR THE TREATMENT OF CARDIOVASCULAR DISEASE THROUGH THE ADMINISTRATION OF A CALCIUM BLOCKING VASODILATOR IN OUR EXTENDED, CONTROLLED RELEASE FORMULATION METHOD FOR THE TREATMENT OF CARDIOVASCULAR DISEASE THROUGH THE ADMINISTRATION OF A CALCIUM BLOCKING VASODILATOR IN A DELAYED RELEASE FORMULATION TREATMENT OF CARDIOVASCULAR DISORDERS HEARTBURN METHOD OF CONTROLLING AND LOWERING INTRAOCULAR PRESSURE INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH BUFFERED METRONIDAZOLE COMPOSITIONS APPROVAL FOR MARKETING ONLY UNDER A SPECIAL RESTRICTION PROGRAM APPROVED BY FDA CALLED "SYSTEM FOR THALIDOMIDE EDUCATION AND PRESCRIBING SAFETY" (S.T.E.P.S.) METHOD FOR ADMINISTERING A BENEFICIAL DRUG TO THE GI TRACT OF AN ANIMAL, WHICH METHOD COMPRISES ADMITTING AN OSMOTIC DEVICE ORALLY INTO THE ANIMAL... GENERAL USE CLAIM SUBMITTED FOR 12 NEXIUM PATIENTS STATING "PERTINENT TO THE CAPSULE FORMULATION FOR NEXIUM AND ITS INDICATIONS FOR THE TREATMENT OF GERD AND ERADICATION OF H.PYLORI TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE KIT ADAPTED AND DESIGNED TO PROVIDE BOTH DATA ON THE CURRENT REPRODUCTIVE STATUS OF A PATIENT AND CONTRACEPTION FOR THOSE WHO ARE NOT PREGNANT, BUT RECENTLY ENGAGED IN UNPROTECTED SEX METHOD OF USING RIBAVIRIN FOR TREATING A DISEASE RESPONSIVE TO RIBAVIRIN, E.G. HEPATITIS C TREATMENT OF INFLUENZA METHOD OF TREATING PT WITH CHRONIC HEPATITIS C HAVING HCV GENOTYPE 1 AND VIRAL LOAD GREATER THAN 2 MILLION COPIES/ML TO ERADICATE DETECTABLE HCV-RNA BY ADMIN COMBINATION OF RIBAVIRIN AND INTERFERON ALFA-2B FOR A LEAST 24 WEEKS METHOD FOR TREATING INCONTINENCE METHOD OF TREATING ONYCHROMYCOSIS COMBINATIONS OF TAXOL (PACLITAXEL) AND CISPLATIN WHICH ARE SUITABLE FOR THE TREATMENT OF OVARIAN AND NON-SMALL CELL LUNG CARCINOMAS TREATMENT OF HYPERPHOSPHATEMIA METHOD OF STABLIZING PROSTAGLANDIN METHOD FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION TREATMENT OF CMV RETINITIS TREATMENT OF PEPTIC ULCERS TREATMENT OF PATIENTS SUFFERING FROM A LATE ASTHMATIC REACTION OR LATE PHASE ASTHMA TREATMENT OF PATIENTS WITH RESPIRATORY DISORDERS SMOKING CESSATION AID APPLIED TO THE SKIN SMOKING CESSATION AID APPLIED TO THE SKIN ON WAKING AND REMOVED PRIOR TO SLEEP AFTER ABOUT 16 HOURS METHOD OF USING THE DRUG TO TREAT NEUROIMMUNOLOGIC DISEASES (INCLUDING MULTIPLE SCLEROSIS) USE OF CASODEX IN COMBINATION WITH LHRH AGONISTS FOR THE TREATMENT OF PROSTATE CANCER TREATMENT OF PATIENTS FOR INFLAMMATION MANAGEMENT OF INCONTINENCE, MGT OF HORMONE REPLACEMENT THERAPY, TREATMENT OF INVOLUNTARY INCONTINENCE, MGT OVERACTIVE BLADDER AND INCREASING COMPLIANCE IN SUCH PT METHOD OF USE OF ALPHAGAN METHOD OF USE OF ALPHAGAN P METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION METHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION WITHOUT AN INCREASE IN NAUSEA TREATMENT OF GENERALIZED ANXIETY DISORDER IN-THE-EYE USE OF CHLORINE DIOXIDE CONTAINING COMPOSITIONS USE OF RIBAVIRIN TO INCREASE TYPE 1 CYTOKINE RESPONSE AND SUPPRESS TYPE 2 CYTOKINE RESP0NSE TO LYMPHOCYTES, INCLUDING METHODS THAT TAKE ADVANTAGE OF SUCH MODULATION TO TREAT INFECTIONS AND INFESTATIONS USE OF LOPINAVIR IN COMBINATION WITH REVERSE TRANSCRIPTASE INHIBITORS FOR TREATING HIV INFECTION AND IN COMBO WITH OTHER HIV PROTEASE INHIBITORS TREATMENT OF ACTINIC KERATOSES ANTI-ALLERGIC FOR VARIOUS ALLERGIC DISEASES TREATMENT OF ALLERGIC CONJUNCTIVITIS FOR WOMEN WITH SEVERE DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS) METHOD OF USE OF ATOVAQUONE AND PROGUANIL METHOD OF TREATING OTOPATHY
ADB 32 of 51
U-411
U-416
U-417 U-418
U-431 U-432
U-433 U-434 U-435 U-436 U-437 U-438 U-439 U-440 U-441 U-442 U-443 U-444 U-445 U-446
FOR INDUCING OVULATION IN CONJUNCTION WITH A GONADOTROPIN RELEASING FACTOR ANTAGONIST AND RECRUITING OOCYTES FOR IN-VITRO FERTILIZATION METHOD OF TREATING INFLAMMATION USING DRUG SUBSTANCE METHOD OF REDUCING AMOUNT OF RESPECTIVE ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC PATIENT BY ADMINISTERING A CHEMICAL COMPOUND HAVING A PARTICULAR FORMULA (INCLUDING PIOGLITAZONE) IN COMBINATION WITH AN INSULIN SECRETION ENHANCER METHOD OF REDUCING THE SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC PATIENT BY ADMINISTERING A CHEMICAL COMPOUND HAVING A PARTICULAR FORMULA (WHICH INCLUDES PIOGLITAZONE) IN COMBINATION WITH AN INSULIN PREPARATION TREATMENT OF TYPE 2 DIABETES USE OF THE ACTIVE INGREDIENT FOR INHIBITING THE BIOSYNTHESIS OF CHOLESTEROL AND TREATMENT OF ATHEROSCLEROSIS A METHOD OF TREATING GLYCOMETABOLISM DISORDERS BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE A METHOD FOR REDUCING THE AMOUNT OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC PATIENT BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE AS SAID ACTIVE COMPONENTS A METHOD FOR REDUCING SIDE EFFECTS OF ACTIVE COMPONENTS ADMINISTERED TO A DIABETIC PATIENT BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE AS SAID ACTIVE COMPONENTS COMBINATION USE OF AD-4833 WITH A BIGUANIDE A METHOD OF TREATING LIPID METABOLISM DISORDERS BY ADMINISTERING A CHEMICAL COMPOUND HAVING A PARTICULAR FORMULA (WHICH INCLUDES PIOGLITAZONE) IN COMBINATION WITH AN INSULIN SECRETION ENHANCER A METHOD OF TREATING LIPID METABOLISM DISORDERS BY ADMINISTERING AN INSULIN SENSITIVITY ENHANCER (INCLUDING PIOGLITAZONE) IN COMBINATION WITH A BIGUANIDE METHOD OF TREATMENT OF TYPE II DIABETES USE FOR SEDATION METHOD OF TREATING AT LEAST ONE OF ATTENTION DEFICIT DISORDER AND ATTENTION DEFICIT HYPERACTIVITY DISORDER METHOD OF TREATING AT LEAST ONE OF ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, OR AIDS RELATED DEMENTIA FOR ONCE DAILY, BOLUS ADMINISTRATION TO A PATIENT IN ORDER TO ENGENDER TREATMENT FOR A NERVOUS DISORDER FOR SUBSTANTIALLY AN ENTIRE DAY ON A CHRONIC BASIS METHOD OF REDUCING SIDE EFFECTS OF ACTIVE COMPONENTS ADMIN TO A DIABETIC BY ADMIN A CHEMICAL COMPOUND HAVING FORMULA (INCL PIOGLITAZONE) IN COMBINATION WITH AN INSULIN SECRETION ENHANCER PREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION METHOD OF TREATING ALLERGIC REACTIONS IN MAMMALS METHOD OF TREATING ALLERGY IN A MAMMAL USING THIS ACTIVE METABOLITE METHOD OF USING DESLORATADINE TO TREAT ALLERGIC RHINITIS METHOD OF TREATING A DIABETIC BY ADMINISTERING AN INSULIN SENSITIZER IN COMBINATION WITH AN INSULIN SECRETION ENHANCER, AND A DRUG PRODUCT C0MPRISING AN INSULIN SENSITIZER AND AN INSULIN SECRETION ENHANCER POSTTRAUMATIC STRESS DISORDER REDUCTION OF ATHEROSCLEROTIC EVENTS (MYOCARDIAL INFARCTION, STROKE, AND VASCULAR DEATH) IN PATIENTS WITH ATHEROSCLEROSIS DOCUMENTED BY RECENT STROKE, RECENT MYOCARDIAL INFARCTION OR ESTABLISHED PERIPHERAL ARTERIAL DISEASE USE OF LEVOCARITINE IN PREVENTION AND TREATMENT OF CARNITINE DEFICIENCY IN PATIENTS WITH END STAGE RENAL DISEASE WHO ARE UNDERGOING DIALYSIS CONTROLLED SYMPTOMS OF DIARRHEA, BLOATING PRESSURE AND CRAMPS, COMMONLY REFERRED TO AS GAS A TITRATION DOSING REGIMEN FOR THE TREATMENT OF PAIN USING AN INITIAL DOSE OF ABOUT 25MG ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS METHOD OF USE EQUAL TO PROCESS OF PREPARATION TREATMENT/PREVENTION OF NEURODEGENERATIVE DISEASE TREATMENT OF OBESITY METHOD FOR TRANSDERMAL ADMINISTRATION OF A DRUG THROUGH NON-SCROTAL SKIN USING A TRANSDERMAL DRUG DELIVERY DEVICE CONTAINING THE DRUG AND HAVING AN ADHESIVE SURFACE METHOD OF TREATING MS BY ADMINISTERING COPAXONE METHOD FOR DELIVERING A DRUG TO A PATIENT IN NEED OF THE DRUG, WHILE AVOIDING THE OCCURENCE OF AN ADVERSE SIDE EFFECT KNOWN OR SUSPECTED OF BEING CAUSED BY SAID DRUG MANAGEMENT OF MODERATE TO SEVERE PAIN WHEN A CONTINUOUS, AROUND-THE-CLOCK ANALGESIC IS NEEDED FOR AN EXTENDED PERIOD OF TIME TREATMENT OF MIGRAINE USE AS AN ANTIMYCOTIC AGENT TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA
ADB 33 of 51
U-449 U-450
U-455 U-456 U-457 U-458 U-459 U-460 U-461 U-462 U-463 U-464 U-465 U-466 U-467 U-468 U-469 U-470 U-471 U-472 U-473 U-474
U-475 U-476
U-477
U-478
METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT METHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID WITHOUT CAUSING TREATMENT-LIMITING ELEVATIONS IN URIC ACID OR GLUCOSE LEVELS OR CAUSING LIVER DAMAGE, BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT USE IN COMBINATION WITH 5-FLUOROURACIL AND LEUCOVORIN FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER WHERE THE DOSE OF LEUCOVORIN IS AT LEAST 200MG PER SQUARE METER INTERMEDIATE REL NICOTINIC ACID FORMULATIONS HAVING UNIQUE URINARY METAB PROFILES RESULTING FROM ABSORPTION PROFILES OF NICOTINIC ACID FROM THE INTERMEDIATE NICOTINIC ACID FORMULATIONS,SUITABLE FOR TX HYPERLIPIDEMIA FOLLOWING QD DOSING TREATMENT OF DEPRESSION AND GENERALIZED ANXIETY DISORDER USE OF LANSOPRAZOLE FOR COMBATTING DISEASES CAUSED BY THE GENUS CAMPYLOBACTER (C.PYLORI=H.PYLORI) TREATMENT OF PLATELET ASSOCIATED ISCHEMIC DISORDERS METHOD OF TX A PT SUSPECTED OF HAVING HEPATITIS C BY ADMIN, IN COMBINATION, A CONJUGATE COMPRISING PEG 12000 & INTERFERON ALFA-2B IN AN AMT OF FROM 0.5MCG/KG TO 2MCG/KG, ONCE WEEKLY, AND RIBAVIRIN TREATMENT OF PULMONARY HYPERTENSION WITH UT-15 METHOD OF DECREASING THE PRODUCTION OF A-BETA USING A COMPOSITION WHICH DECREASES BLOOD CHOLESTEROL IN PATIENTS AT RISK OF OR EXHIBITING SYMPTOMS OF ALZHEIMER'S DISEASE METHOD OF TREATING A VAGINAL FUNGAL INFECTION IN A FEMALE HUMAN METHOD OF USE OF IMAGENT TREATMENT OF DEPRESSION AND GENERALIZED ANXIETY DISORDER METHOD OF TREATING PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PREMENSTRUAL DISORDERS USING SERTRALINE METHOD OF TREATMENT OF LATE LUTEAL PHASE DYSPHORIC DISORDER (PMDD) USING SERTRALINE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS AND ADULT RHEUMATOID ARTHRITIS AND TREATMENT OF PRIMARY DYSMENORRHEA VENOGRAPHY PERIPHERAL ARTERIOGRAPHY CT IMAGING OF THE HEAD TREATMENT OF IRRITABLE BOWEL SYNDROME USE OF EPLERENONE IN COMBINATION WITH AN ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR FOR TREATING HYPERTENSION METHOD OF USING FEXOFENADINE HCL IN TREATING ALLERGIC RHINITIS TREATMENT OF GASTROESOPHAGEAL REFLEX DISEASE (GERD) AND ERADICATION OF H.PYLORI TO REDUCE RISK OF DUODENAL ULCER RECURRENCE THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTION METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER USING METHYLPHENIDATE BI-MODAL RELEASE PROFILE EXTENDED-RELEASE CAPSULES TO REDUCE PLASMA CHOLESTEROL LEVELS IN A MAMMAL TO REDUCE PLASMA CHOLESTEROL LEVELS BY ADMIN EZETIMIBE IN COMBO WITH CHOLESTEROL BIOSYNTHESIS INHIB SELECTED FROM GROUP CONSISTING OF HMG COA REDUCTASE INHIBITORS INCL SIMVASTATIN TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY METHOD OF TREATING ANDROGEN RESPONSIVE/MEDIATED CONDITION IN MAMMAL BY ADMIN A SAFE, EFFECTIVE AMOUNT OF DUTASTERIDE OR PHARMACEUTICALLY ACCEPTABLE DERIVATIVE THEREOF..CONDITIONS INCLUDE BENIGN PROSTATIC HYPERTROPHY METHOD OF INHIBITING 5 ALPHA TESTOSTERONE REDUCTASE ENZYME WITH DUTASTERIDE OR ITS DERIVATIVE AND TREATING ANDROGEN RESPONSIVE/MEDIATED DISEASE INCLUDING BENIGN PROSTATIC HYPERPLASIA METHOD OF TREATING HEPATITIS C VIRAL INFECTION BY CONTINUOUS PARENTERAL ADMIN INTERFERON ALPHA 2-10 MILLION IU WEEKLY, SUBCUTANEOUSLY, INJECTION OF POLYMER-INTERFERON ALPHA CONJUGATE-POLYMER IS PEG-INTERFERON IS ALPHA 2B METHOD OF USING PEG-INTRON/REBETOL COMBINATION THERAPY AND INTRON/REBETOL COMBINATION THERAPY CONTRAST AGENT FOR MRI DISUBSTITUTED ACETYLENES BEARING HETEROAROMATIC AND HETEROBICYCLIC GROUPS HAVING RETINOID-LIKE ACTIVITY METHOD OF IN VITRO FERTILIZATION THERAPY INCLUDING MEANS FOR INDUCING OVULATION.... METHOD FOR THE ADMINISTRATION OF DRUGS USING THAT COMPOUND METHOD OF TREATING A SKIN DISEASE WITH A CORTICOSTEROID-CONTAINING PHARMACEUTICAL COMPOSITION METHOD AND COMPOSITION FOR REDUCING NERVE INJURY PAIN ASSOCIATED WITH SHINGLES (HERPES ZOSTER AND POST-HERPETIC NEURALGIA)
ADB 34 of 51
U-511 U-512 U-513 U-514 U-515 U-516 U-517 U-518 U-519 U-520 U-521 U-522 U-523 U-524 U-525 U-526 U-527 U-528 U-529 U-530
EXTERNAL PREPARATION FOR APPLICATION TO THE SKIN CONTAINING LIDOCAINE-DRUG RETAINING LAYER PLACED ON SUPPORT AND COMPRISES ADHESIVE GEL BASE 1-10% BY WEIGHT OF LIDOCAINE METHOD AND COMPOSITION FOR REDUCING NERVE INJURY PAIN ASSOCIATED WITH SHINGLES (HERPES ZOSTER AND POST-HERPETIC NEURALGIA) METHOD FOR REDUCING THE PAIN ASSOCIATED WITH HERPES-ZOSTER AND POST-HERPETIC NEURALGIA EXPECTORANT TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE METHOD OF DELIVERING A DRUG TO THE LUNG METHOD FOR THE TREATMENT OF SKIN, SUFFERING FROM A CONDITION SELECTED FROM A GROUP CONSISTING OF NONACNE INFLAMMATORY DERMATOSES... COMPRISING APPLYING TO AFFECTED AREA. A THERAPEUTICALLY EFFECTIVE AMT AZELAIC ACID TREATMENT OF TYPE 2 DIABETES MELLITUS TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER PERITONEAL DIALYSIS SOLUTION METHOD FOR TREATING CHRONIC RENAL FAILURE RELIEF OF THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS INTRA-ARTERIAL AND INTRAVENOUS USES OF ULTRAVIST METHOD OF USING REBETOL CAPSULES IN COMBINATION WITH A CONJUGATE COMPRISING POLYETHYLENE GLYCOL(PEG) AND AN ALPHA INTERFERON, INCLUDING, FOR EXAMPLE, PEG-INTRON POWDER FOR INJECTION USE AS AN ANTIHYPERTENSIVE AGENT TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN ADULTS PITYRIASIS VERSICOLOR GENERATOR MUST BE USED WITH INFUSION SYSTEM SPECIFICALLY LABELED FOR USE WITH GENERATOR TINEA PEDIS, TINEA CRURIS, TINEA CORPORIS ULTRASOUND CONTRAST AGENT PHARM PRODUCT CONTAINER 1ST CHAMBER IS DISPOSED AQUEOUS DILUENT SOL 2ND CHAMBER PHARM ACTIVE AGENT COMPRISING ACETYLCHOLINE,BUFFER IN 1ST CHAM IS SUFFICIENT TO BUFFER PH OF MIXED SOL RESULTING MIXTURE OF AQUEOUS DILUENT SOL & PHARM ACTIVE.. ACROMEGALY IN PATIENTS W/INADEQUATE RESPONSE TO SURGERY AND/OR RADIATION THERAPY AND/OR MEDICAL THERAPIES, OR FOR WHOM THESE THERAPIES ARE NOT APPROPRIATE METHOD OF RELEASING 17-BETA OESTRADIOL PRECURSOR IN A SUBSTANTIALLY ZERO ORDER PATTERN FOR AT LEAST THREE WEEKS TREATMENT OF CUTANEOUS MANIFESTATIONS OF CUTANEOUS T-CELL LYMPHOMA IN PATIENTS WHO ARE REFRACTORY TO AT LEAST ONE PRIOR SYSTEMIC THERAPY TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (STAGE IA AND IB) WHO HAVE REFRACTORY OR PERSISTENT DISEASE AFTER OTHER THERAPIES OR WHO HAVE NOT TOLERATED OTHER THERAPIES USE OF QUINOLONE COMPOUNDS AGAINST ANAEROBIC PATHOGENIC BACTERIA USE OF QUINOLONE COMPOUNDS AGAINST ATYPICAL UPPER RESPIRATORY PATHOGENIC BACTERIA METHODS OF USE OF ANTIMICROBIAL COMPOUNDS AGAINST PATHOGENIC AMYCOPLASMA BACTERIA PREVENTION OF OVULATION IN A WOMAN TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEAST TWO PRIOR THERAPIES AND HAVE DEMONSTRATED DISEASE PROGRESSION ON THE LAST THERAPY METHOD OF TREATING A PSYCHOTIC DISEASE STABLE GEL FORMULATION FOR TOPICAL TREATMENT OF SKIN CONDITIONS OBSESSIVE COMPULSIVE DISORDER POST OPERATIVE NAUSEA AND VOMITING PREMENOPAUSAL OSTEOPOROSIS METHOD OF USING RIBAVIRIN IN COMBINATION WITH INTRON A (INTERFERON ALPHA-2 B RECOMBINANT) INJECTION TO TREAT PATIENTS WITH CHRONIC HEPATITIS C TREATMENT OF CMV RETINITIS BY INTRAVITREAL ADMIN OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE CAPABLE OF HYBRIDIZING WITH CMV MRNA METHOD OF TREATING INFECTION BY CRYPTOSPORIDIUM PARVUM IN AN IMMUNOCOMPROMISED MAMMAL METHOD OF TREATING DIARRHEA METHOD OF TREATING PARASITIC INFECTIONS METHOD OF PROVIDING CONTROLLED RELEASE OF A TREATING AGENT USING A CONTROLLED RELEASE COMPOSITION METHOD OF DELIVERING AN ACTIVE INGREDIENT USING A PROGRESSIVE HYDRATION BIOADHESIVE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING ONCE DAILY TREATMENT OF ASTHMA WITH NEBULIZED BUDESONIDE TREATMENT OF HERPES ZOSTER, TREATMENT OF GENITAL HERPES, TREATMENT OF COLD SORES, SUPPRESSION OF GENITAL HERPES IN IMMUNOCOPETENT AND HIV-INFECTED INDIVIDUALS, REDUCTION OF RISK OF HETEROSEXUAL TRANSMISSION OF GENITAL HERPES
ADB 35 of 51
U-560 U-561
U-562 U-563 U-564 U-565 U-566 U-567 U-568 U-569 U-570 U-571 U-572 U-573
TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION. MAY BE USED ALONE OR GIVEN WITH OTHER CLASSES OF ANTIHYPERTENSIVES, ESPECIALLY THIAZIDE DERIVATIVES TREATMENT OF BRONCHOSPASM ASSOCIATED WITH COPD IN PATIENTS REQUIRING MORE THAN ONE BRONCHO DILATOR ERECTILE DYSFUNCTION HUMALOG IS AN INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS FOR THE CONTROL OF HYPERGLYCEMIA TREATMENT OF SOCIAL ANXIETY DISORDER CONTRAST AGENT FOR MAGNETIC RESONACE IMAGING TREATMENT OF CONDITIONS RELATED TO HYPERALDOSTERONISM SUCH AS HYPERTENSION AND CARDIAC INSUFFICIENCY, WITH EPLERENONE FIRST LINE TREATMENT OF SEVERE HYPERTENSION, IN PATIENTS WITH HYPERTENSION SEVERE ENOUGH THAT THE VALUE OF ACHIEVING PROMPT BLOOD PRESSURE CONTROL EXCEEDS THE RISK OF INITIATING COMBINATION THERAPY IN THESE PATIENTS TREATMENT OF MODERATE TO SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE TREATMENT OF FUNGAL INFECTIONS METHOD OF TREATMENT OF ADULTS INFECTED WITH HIV-1 METHOD OF TREATING PATIENT WITH TYPE 2 DIABETES BY ONCE DAILY ADMINISTRATION TREATMENT OF SCHIZOPHRENIA TREATMENT OF OVERACTIVE BLADDER. TREATMENT OF URINARY INCONTINENCE. METHOD FOR THE PREVENTION AND/OR TREATMENT OF THROMBOTIC EPISODES, SUCH AS MYOCARDIAL INFARCTION, IN A HUMAN PATIENT AND METHOD FOR THE PREVENTION OF VENOUS THROMBOSIS IN A POSTOPERATIVE HUMAN PATIENT USE OF REPAGLINIDE IN COMBINATION WITH METFORMIN TO LOWER BLOOD GLUCOSE MAINTENANCE MONOTHERAPY FOR BIPOLAR DISORDER A METHOD OF REDUCING FLUSH IN AN INDIVIDUAL BEING TREATED FOR A LIPIDEMIC DISORDER AND EFFECTIVELY TREATING THE LIPIDEMIC DISORDER USE IN THE TREATMENT OF MEN WITH ADVANCED SYMPTOMATIC PROSTATE CANCER TREATMENT OF BIPOLAR DISORDER AND SCHIZOPHRENIA METHOD FOR REDUCING TOXICITY OF ALIMTA TREATED PATIENTS BY ADMINISTERING FOLIC ACID TREATMENT OF HYPERTENSION AND HYPERLIPIDEMIA WITH A SINGLE COMPOSITION MANAGEMENT OF PAIN AND DISCOMFORT ASSOCIATED WITH PERIDONTAL SCALING AND ROOT PLANNING PROCEDURES BY APPLICATION OF AN EUTECTIC MIXTURE OF LOCAL ANESTHETICS TO PERIDONTAL POCKETS TREATING HIV INFECTION WITH INDINAVIR SULFATE IN COMBINATION WITH ANTIRETROVIRAL AGENTS TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS AND ACUTE UNCOMPLICATED PYELONEPHRITIS USE AS ADJUNCT DIAGNOSTIC FOR SERUM THYROGLOBULIN (TG) TESTING NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS INDICATED FOR THE RELIEF OF BRONCHOSPASM IN PATIENTS 2-12 YEARS OF AGE WITH ASTHMA (REVERSIBLE OBSTRUCTIVE AIRWAY DISEASE) METHOD OF DECREASING OR REDUCING PARATHYROID HORMONE LEVEL; METHOD OF MODULATING PARATHYROID HORMONE SECRETION;METHOD OF TREATING HYPERPARATHYROIDISM; METHOD OF REDUCING SERUM IONIZED CALCIUM LEVEL METHOD OF DECREASING PARATHYROID HORMONE LEVEL;METHOD OF TREATING HYPERPARATHYROIDISM COSOPT IS INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION WHO ARE INSUFFICIENTLY RESPONSIVE TO BETA BLOCKERS TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA MARINOL IS INDICATED FOR, INTER ALIA, ANOREXIA ASSOCIATED WITH WEIGHT LOSS IN PATIENTS WITH AIDS TREATMENT OF HIV IN CONCOMITANT THERAPY TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS, AND CHRONIC URTICARIA FOR THE LONG-TERM, ONCE-DAILY, MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA METHOD OF TREATING INFERTILITY METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION AND WHEREIN THEREAFTER AN OVULATORY INDUCING AMOUNT OF HCG IS ADMINISTERED METHOD OF USING FSH ALONE (WITHOUT EXOGENOUS LH) IN IN VITRO FERTILIZATION AND WHEREIN THE DAILY AMOUNT OF FSH IS ABOUT 5-10 IU/KG TREATMENT OF AGITATION ASSOCIATED WITH SCHIZOPHRENIA AND BIPOLAR I MANIA INTENSIVE CARE UNIT SEDATION TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL)
ADB 36 of 51
U-583
U-587 U-588
U-589
U-590
U-591 U-592 U-593 U-594 U-595 U-596 U-597 U-598 U-599 U-600 U-601 U-602
U-606
PROPHYLAXIS AND TREATMENT OF THE NASAL SYMPTOMS OF SEASONAL ALLERGIC RHINITIS AND TREATMENT OF THE NASAL SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER LOTEMAX OPTHALMIC SUSPENSION IS INDICATED FOR THE TREATMENT OF STEROID RESPONSIVE CONDITIONS OF THE PALPEBRAL BULBAR CONJUNCTIVA, CORNEA AND ANTERIOR SEGMENT OF THE GLOBE. ALREX OPTHALMIC SUSPENSION IS INDICATED FOR THE TEMPORARY RELIEF OF THE SIGNS AND SYMPTOMS OF SEASONAL ALLERGIC CONJUNCTIVITIS. TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH FINASTERIDE IN COMBINATION WITH DOXAZOSIN TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER. TREATMENT OF EPILEPSY AND/OR MIGRAINE. TREATMENT OF DISORDERS OF THE SEROTONERGIC SYSTEM SUCH AS DEPRESSION AND ANXIETY-RELATED DISORDERS METHOD OF TREATING A CONDITION CAPABLE OF TREATMENT BY INHALATION, E.G. ASTHMA, COMPRISING ADMINISTRATION OF A FORMULATION CLAIMED IN US PATENT NO. 6743413 METHOD FOR THE TREATMENT OF A RESPIRATORY DISORDER, E.G. ASTHMA, COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF AN AEROSOL COMPOSITION TO A PATIENT FROM A METERED DOSE INHALER SYSTEM AS CLAIMED IN US PATENT NO. 6253762 METHOD FOR THE TREATMENT OF A RESPIRATORY DISORDER, E.G. ASTHMA, COMPRISING ADMINISTERING TO A PATIENT BY INHALATION, A METERED AEROSOL DOSE OF A DRUG FORMULATION FROM THE METERED DOSE INHALER SYSTEM CLAIMED IN US 6546928 SINGLE-DOSE ADMINISTRATION BY THE EPIDURAL ROUTE, AT THE LUMBAR LEVEL, FOR THE TREATMENT OF PAIN FOLLOWING MAJOR SURGERY TO PROMOTE WEIGHT GAIN AFTER WEIGHT LOSS IN CERTAIN TYPES OF PATIENTS AN INTERMEDIATE RELEASE NICOTINIC ACID FORMULATION SUITABLE FOR ORAL ADMINISTRATION ONCEA-DAY AS A SINGLE DOSE FOR TREATING HYPERLIPIDEMIA WITHOUT CAUSING DRUG-INDUCED HEPATOTOXICITY OR ELEVATIONS IN URIC ACID OR GLUCOSE OR BOTH USE OF EPLERENONE IN COMBINATION WITH AN ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR (AND OPTIONALLY A DIURETIC) FOR TREATING CONGESTIVE HEART FAILURE AND HYPERTENSION SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER; TREATMENT OF HEARTBURN AND OTHER SYMPTOMS ASSOCIATED WITH GERD; SHORT-TERM TREATMENT OF EROSIVE ESOPHAGITIS; MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS METHOD FOR TREATMENT OF A RESPIRATORY DISORDER, E.G., BRONCHOSPASM, COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF AN AEROSOL COMPOSITION TO A PATIENT FROM A METERED DOSE INHALER SYSTEM AS CLAIMED IN U.S. PATENT NO. 6131966 METHOD FOR TREATMENT OF A RESPIRATORY DISORDER,E.G.,BRONCHOSPASM,COMPRISING ADMINISTERING TO A PATIENT BY ORAL OR NASAL INHALATION A DRUG FORMULATION BY USING THE METERED DOSE INHALER SYSTEM AS CLAIMED IN US PATENT NO.6532955 TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER USING A DOSAGE FORM WHICH PROVIDES ONCE-DAILY ORAL ADMINISTRATION OF A PHENIDATE DRUG TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA, MIXED HYPERLIPIDEMIA AND/OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA, MIXED HYPERLIPIDEMIA AND/OR HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS 35 MG ORALLY ONCE A WEEK FOR PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN; 35 MG ORALLY ONCE A WEEK FOR TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOWING ANTIESTROGEN THERAPY FORTEO IS INDICATED FOR THE TREATMENT OF POST MENOPAUSAL WOMEN WITH OSTEOPOROSIS WHO ARE AT HIGH RISK FOR FRACTURE PROPHYLACTIC TREATMENT OF MIGRAINE METHOD FOR TREATING ALLERGIC CONJUNCTIVITIS A METHOD OF TREATING A PATIENT IN NEED OF OPHTHALMIC ANTIMICROBIAL THERAPY WITH LEVOFLOXACIN TREATMENT OF BIPOLAR DISORDER SIGNS AND SYMPTOMS OF OSTEOARTHRITIS, RHEUMATOID ARTHRITIS IN ADULTS, AND/OR PAUCIARTICULAR OR POLYARTICULAR COURSE JUVENILE RHEUMATOID ARTHRITIS, ACUTE PAIN IN ADULTS; PRIMARY DYSMENORRHEA; AND/OR ACUTE MIGRAINE ATTACKS IN ADULTS METHOD OF TREATING INFECTIONS COMPRISING ORALLY ADMINISTERING AN EFFECTIVE AMOUNT OF THE FDA APPROVED ORAL SUSPENSION METHOD OF LOWERING BLOOD GLUCOSE BY ONCE DAILY ADMINISTRATION TREATMENT OF MAJOR DEPRESSIVE DISORDER(MDD);ALTHOUGH THE MEHCHANISM OF THE ANTIDEPRESSANT ACTION OF DULOXETINE IN HUMANS IS UNKNOWN, IT IS BELIEVED TO BE RELATED TO ITS POTENTIATION OF SERATONERGIC AND NORADRENERGIC ACTIVITY IN THE CNS USE OF IRINOTECAN IN COMBINATION WITH 5-FLUOROURACIL AND LEUCOVORIN FOR THE TREATMENT OF METASTATIC COLRECTAL CANCER
ADB 37 of 51
U-616
U-617 U-618
U-619 U-620 U-621 U-622 U-623 U-624 U-625 U-626 U-627 U-628 U-629 U-630 U-631 U-632 U-633
U-634
CANCIDAS IS INDICATED FOR EMPIRICAL THERAPY FOR PRESUMED FUNGAL INFECTIONS IN FEBRILE, NEUTROPENIC PATIENTS. USE OF QUINOLONE COMPOUNDS AGAINST PNEUMOCOCCAL PATHOGENIC BACTERIA USE OF QUINOLONE COMPOUNDS AGAINST QUINOLONE-RESISTANT PNEUMOCOCCAL PATHOGENIC BACTERIA ATROVENT HFA (IPRATROPIUM BROMIDE HFA) INHALATION AEROSOL IS INDICATED AS A BRONCHODILATOR FOR MAINTENANCE TREATMENT OF BRONCHOSPASM ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA. METHOD OF USING DESLORATADINE TO TREAT SEASONAL AND PERENNIAL ALLERGIC RHINITIS, PRURITIS, AND CHRONIC IDIOPATHIC URTICARIA IN PATIENTS 2 YEARS OF AGE AND OLDER TREATMENT OF SEASONAL ALLERGY SYMPTOMS WITH NASAL CONGESTION IN ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER REDUCTION OF SERUM PHOSPHATE TREATMENT OF SEXUAL DYSFUNCTION ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V) MANAGEMENT OF PERSISTENT, MODERATE TO SEVERE PAIN IN PATIENTS REQUIRING CONTINUOUS, AROUND-THE-CLOCK ANALGESIA WITH A HIGH POTENCY OPIOID FOR AN EXTENDED PERIOD OF TIME GENERALLY WEEKS TO MONTHS OR LONGER TREATMENT OF ACUTE PROMYELOGENOUS LEUKEMIA (APL) USE OF ROSUVASTATIN CALCIUM TO REDUCE ELEVATED TOTAL-C, LDL-C, APOB, NONHDL-C OR TG LEVELS; TO INCREASE HDL-C IN ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA; AND TO SLOW THE PROGRESSION OF ATHEROSCLEROSIS. TREATMENT OF MALIGNANT NEOPLASM TREATMENT OF INSOMNIA METHOD OF TREATING CANCER TREATMENT OF VEGF MEDIATED OCULAR DISEASE. SHORT TERM TREATMENT OF ACTIVE BENIGN GASTRIC ULCER REDUCTION OF RISK OF UPPER GASTROINTESTINAL BLEEDING IN CRITICALLY ILL PATIENTS ALLERGIC RHINITIS OR NASAL POLYPS CLOLAR IS INDICATED FOR THE TREATMENT OF PEDIATRIC PATIENTS 1 TO 21 YEARS OLD WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA AFTER AT LEAST TWO PRIOR REGIMENS TREATMENT OF PATIENTS USING EXTENDED-RELEASE CARBAMAZEPINE USE OF AVANDIA IN COMBINATION WITH A SULFONYLUREA, AND IN COMBINATION WITH METFORMIN AND A SULFONYLUREA TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS METHOD OF INDUCING A HYPNOTIC OR SEDATIVE EFFECT IN A HUMAN BY ADMINISTERING ESZOPICLONE TREATING URINARY INCONTINENCE BY ADMINISTERING AN EXTENDED-RELEASE FORM OF DARIFENACIN TREATING A DISEASE OF ALTERED MOTILITY OR TONE OF SMOOTH MUSCLE BY ADMINISTERING A MUSCARINIC RECEPTOR ANTAGONIZING AMOUNT OF DARIFENACIN METHOD OF TREATMENT OF CANCER BY ADMINISTERING PARTICLES OF PACLITAXEL THAT HAVE A PROTEIN COATING METHOD FOR TREATMENT OF TUMORS BY ADMINISTERING PACLITAXEL AT A DOSE IN THE RANGE OF ABOUT 30MG/METER SQUARE TO ABOUT 100MG/METER SQUARE IN A PHARMACEUTICALLY ACCEPTABLE FORMULATION THAT DOES NOT CONTAIN CREMOPHOR METHOD FOR DELIVERY OF A BIOLOGIC (INCLUDING ANTINEOPLASTIC AGENTS) BY ADMINISTERING TO A PATIENT AN EFFECTIVE AMOUNT OF A BIOLOGIC AS A SOLID OR LIQUID WITH A POLYMERIC BIOCOMPATIBLE MATERIAL TREATMENT OF GERD, MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND RISK REDUCTION OF NSAID ASSOCIATED GASTRIC ULCERS TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS TREATMENT OF DIABETES WITH AN AMYLIN AGONIST TREATMENT OF DIABETES WITH AN AMYLIN AGONIST, INCLUDING WITH INSULIN TREATMENT OF A MAMMAL HAVING A NEED OF OR REDUCED ABILITY TO PRODUCE INSULIN WITH AN INSULIN AND AN AMYLIN SUCH AS PRAMLINTIDE USE OF AN AMYLIN AGONIST TO REDUCE GASTRIC MOTILITY AND TREAT POST PRANDIAL HYPERGYLCEMIA USE OF AN AMYLIN AGONIST HAVING SPECIFIED BINDING ACTIVITY TO REDUCE GASTRIC MOTILITY, INCLUDING USE THROUGH PARENTERAL ADMINISTRATION TREATMENT AND PREVENTION OF OSTEOPOROSIS THE SHORT TERM TREATMENT (UP TO 10 DAYS) IN PTS HAVING GASTROESOPHAGEAL REFLUX DISEASE (GERD) AS AN ALTERNATIVE TO ORAL THERAPY IN PTS WHEN THERAPY WITH NEXIUM CAPSULES IS NOT POSSIBLE OR APPROPRIATE TREATMENT OF SEASONAL ALLERGIC RHINITIS TREATMENT OF ASTHMA METHOD OF TREATING OTITIS TREATMENT OF OSTEOPOROSIS IN POST MENOPAUSAL WOMEN AND/OR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS
ADB 38 of 51
U-656 U-657 U-658 U-659 U-660 U-661 U-662 U-663 U-664 U-665 U-666 U-667 U-668 U-669 U-670 U-671 U-672 U-673 U-674 U-675 U-676 U-677 U-678 U-679 U-680
U-681 U-682 U-683 U-684 U-685 U-686 U-687 U-688 U-689 U-690
THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AND/OR THE TREATMENT TO INCREASE BONE MASS IN MEN A METHOD FOR TREATING A TUMOR DISEASE TREATMENT OF ESOPHAGEAL CANDIDIASIS AND PROPHYLAXIS OF CANDIDA INFECTIONS IN HSCT PATIENTS TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATMENT OF CARDIAC ARRHYTHMIA STIMULATING INSULIN RELEASE BY ADMINISTERING EXENATIDE LOWERING PLASMA GLUCAGON IN A SUBJECT IN NEED THEREOF, INCLUDING ONE WITH TYPE 2 DIABETES, BY ADMINISTERING AN EXEDIN OR ANALOG, SUCH AS EXENDIN-4 TREATMENT OF MILD TO MODERATE ACTIVE CHROHN'S DISEASE INVOLVING THE ILEUM AND/OR THE ASCENDING COLON AND THE MAINTENANCE OF CLINICAL REMISSION OF MILD TO MODERATE CROHN'S DISEASE INVOLVING THE ILEUM AND/OR ASCENDING COLON FOR UP TO 3 MONTHS REDUCING GASTRIC MOTILITY OR DELAYING GASTRIC EMPTYING BY ADMINISTERING AN EXENDIN, SUCH AS EXENDIN-4 PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF ADVANCED HORMONE-DEPENDENT BREAST CANCER TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON SMALL-CELL LUNG CANCER (NSCLC) AFTER FAILURE OF AT LEAST ONE PRIOR CHEMOTHERAPY REGIMEN TREATMENT OF HYPERTENSION AND TREATMENT OF HEART FAILURE TREATMENT OF SEIZURE DISORDER TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN THE TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTIONS TREATMENT OF CONDITIONS FOR WHICH AN ALDOSTERONE RECEPTOR BLOCKER IS INDICATED, SUCH AS HYPERTENSION, HEART FAILURE, AND POST-MYOCARDIAL INFARCTION METHOD OF USING THE DRUG SUBSTANCE/DRUG PRODUCT FOR ULTRASOUND IMAGING METHOD OF TREATING ADHD MANAGEMENT OF INCONTINENCE; METHOD FOR TREATING INCONTINENCE LEVEMIR IS A LONG-ACTING BASAL INSULIN ANALOG THAT IS INDICATED IN THE TREATMENT OF PATIENTS WITH DIABETES MELLITUS INDICATION OF TYPE II DIABETES TREATMENT OF HIV-1 INFECTION BY THE CO-ADMINISTRATION OF TIPRANAVIR AND RITONAVIR. PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 3 AND 4 TREATMENT OF INFLAMMATION OR AN INFLAMMATION-ASSOCIATED DISORDER METHOD OF TREATMENT WITH ONCE-DAILY DOSES OF 625MG/5ML METHOD OF TREATING INSOMNIA CHARACHTERIZED BY DIFFICULTY WITH SLEEP ONSET PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA; RELIEF OF SYMPTOMS OF ALLERGIC RHINITIS METHOD OF TREATING ATTENTION DEFICIT DISORDER USING ORAL ADMINISTRATION OF A BI-MODAL OR PULSATILE RELEASE COMPOSITION A METHOD OF TREATING DISEASE AMENABLE TO TREATMENT WITH A PHENIDATE DRUG BY ONCE DAILY ORAL ADMINISTRATION OF AN EXTENDED RELEASE DOSAGE FORM METHOD OF TREATING ATTENTION DEFICIT DISORDER AND/OR ATTENTION DEFICIT HYPERACTIVITY DISORDER ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES WHO ARE ALREADY TREATED WITH A PIOGLITAZONE AND METFORMIN A METHOD OF TREATING DYSLIPIDEMIA AND DYSLIPOPROTEINEMIA USING A DOSAGE FORM THAT CAN PROVIDE AN EFFECTIVE AMOUNT OF FENOFIBRATE TO A PATIENT IN A FASTED STATE WHICH IS AT LEAST 90% OF THE AUC AMOUNT PROVIDED BY THE DOSAGE FORM TREATMENT OF PRIMARY IGF-1 DEFICIENCY NON-BENZODIAZEPINE HYPNOTIC AGENT INDICATED FOR TREATMENT OF INSOMNIA, CHARACTERIZED BY DIFFICULTIES WITH SLEEP ONSET AND/OR SLEEP MAINTENANCE PREVENTION OR TREATMENT OF ISCHEMIC HEART DISEASE TREATMENT OF UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER EXPECTORANT AND COUGH SUPPRESSANT EXPECTORANT AND NASAL DECONGESTANT REDUCING FOOD INTAKE IN A SUBJECT WITH TYPE 2 DIABETES BY ADMINISTERING AN EXENDIN, SUCH AS EXENDIN-4 TREATMENT OF HIV-INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS TREATMENT OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WHOSE DISEASE HAS NOT RESPONDED TO OR HAS RELAPSED FOLLOWING TREATMENT WITH AT LEAST TWO CHEMOTHERAPY REGIMENS TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
ADB 39 of 51
U-692 U-693
U-694
U-695
U-696 U-697 U-698 U-699 U-700 U-701 U-702 U-703 U-704 U-705 U-706 U-707 U-708 U-709 U-710
U-717 U-718 U-719 U-720 U-721 U-722 U-723 U-724 U-725 U-726 U-727 U-728 U-729 U-730 U-731 U-732
USE AS A MONOTHERAPY, IN COMBINATION WITH A SULFONYLUREA, METFORMIN OR INSULIN OR IN COMBINATION WITH A SULFONYLUREA PLUS METFORMIN TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS USE OF VALSARTAN TO REDUCE CARDIOVASCULAR MORTALITY IN CLINICALLY STABLE PATIENTS WITH LEFT VENTRICULAR FAILURE OR LEFT VENTRICULAR DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION THE RECOMMENDED INITIAL DOSE OF EQUETRO IS 400MG/DAY GIVEN IN DIVIDED DOSES, TWICE DAILY. THE DOSE SHOULD BE ADJUSTED IN 200MG DAILY INCREMENTS TO ACHIEVE OPTIMAL CLINICAL RESPONSE. LENALIDOMIDE IS AN ANALOGUE OF THALIDOMIDE. THALIDOMIDE IS A KNOWN HUMAN TERATOGEN THAT CAUSES SEVERE LIFE-THREATENING HUMAN BIRTH DEFECTS. IF LENALIDOMIDE IS TAKEN DURING PREGNANCY, IT MAY CAUSE BIRTH DEFECTS OR DEATH TO AN UNBORN BABY. TREATMENT OF PATIENTS WITH T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND T-CELL LYMPHOBLASTIC LYMPHOMA WHOSE DISEASE HAS NOT RESPONDED TO OR HAS RELAPSED FOLLOWING TREATMENT WITH AT LEAST TWO CHEMOTHERAPY REGIMENS TREATMENT OF PATIENTS WITH T-CELL LYMPHOBLASTIC LYMPHOMA WHOSE DISEASE HAS NOT RESPONDED TO OR HAS RELAPSED FOLLOWING TREATMENT WITH AT LEAST TWO CHEMOTHERAPY REGIMENS A METHOD OF USING RINFABATE RECOMBINANT (RHIGFBP-3) WITH MECASERMIN RECOMBINANT (RHIGF1) TO PROMOTE LINEAR GROWTH IN THE TRATMENT OF PRIMARY IGF-1 DEFICIENCY METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR INTRAVENOUS TREATMENT OF PATEINTS WITH EUVOLEMIC HYPONATREMIA NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN TREATMENT OF HYPERCHOLESTEROLEMIA AND/OR HYPERTRIGLYCERIDEMIA TOPICAL AEROSOL HAIR REGROWTH TREATMENT TREATMENT OF PROTEIN KINASE RELATED DISORDERS, SUCH AS GASTROINTESTINAL STROMAL TUMOR AND RENAL CELL CARCINOMA WITH SUNITINIB METHOD OF ADMINISTERING INSULIN VIA INHALATION TREATING CHRONIC ANGINA BY ADMINISTERING AN EXTENDED RELEASE FORM OF RANOLAZINE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA ALLERGIC RHINITIS TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE EYE METHOD OF COMBATING BACTERIA IN A PATIENT A METHOD OF TREATING RESPIRATORY DISORDERS, E.G., ASTHMA, WHICH COMPRISES ADMINISTRATION BY INHALATION OF AN EFFECTIVE AMOUNT OF A PHARMACEUTICAL FORMULATION AS CLAIMED IN US PATENT NO. 5658549 ACUTE AND LONGER-TERM TREATMENT OF MAJOR DEPRESSIVE DISORDER A METHOD OF USING A NICOTINIC ACID FORMULATION TO REDUCE ELEVATED TC, LDL-C AND TG LEVELS, AND RAISE HDL-C LEVELS IN PATIENTS WITH HYPERLIPIDEMIA TREATMENT OF MILD TO MODERATE DEMENTIA OF THE ALZHEIMER'S TYPE TOPICAL TREATMENT OF INTERDIGITAL TINEA PEDIS AND TINEA CORPORIS DUE TO TRICHOPHYTON RUBRUM, TRICHOPHYTON MENTAGROPHYTES OR EPIDERMOPHYTON FLOCCOSUM FOR CLEANSING THE BOWEL IN PREPARATION FOR COLONOSCOPY, IN ADULTS 18 YEARS OF AGE OR OLDER THE TREATMENT OR PREVENTION OF BRONCHOSPASM IN ADULTS AND CHILDREN 4 YEARS OF AGE AND OLDER WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE AND THE PREVENTION OF EXERCISEDINDUCED BRONCHOSPASM IN PATIENTS 4 YEARS OF AGE AND OLDER METHOD OF RELIEVING OR PREVENTING CONSTIPATION IN A HUMAN CONSTIPATED PATIENT TREATMENT OF FUNGAL INFECTIONS TREATENT OF PSYCHOSIS TREATMENT OF NEUROLEPTIC DISEASES TREATMENT OF INFLUENZA PROPHYLAXIS OF INFLUENZA PROPHYLACTIC TREATMENT OF MIGRAINE METHOD OF TREATING SEIZURES ALLERGIC RHINITIS AND URTICARIA ALLERGIC RHINITIS FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) METHOD FOR TREATING BACTERIAL INFECTION TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD), RISK-REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER, H. PYLORI ERADICATION TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE USE AS A NASAL SPRAY FOR TREATMENT OF THE SYMPTOMS OF SEASONAL ALLERGIC RHINITIS AND VASOMOTOR RHINITIS USE IN COMBINATION WITH DEXAMETHASONE IS INDICATED FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA ACUTE TREATMENT OF THE CUTANEOUS MANIFESTATIONS OF MODERATE TO SEVERE ERYTHEMA NODOSUM LEPROSUM (ENL)
ADB 40 of 51
MAINTENANCE THERAPY FOR PREVENTION AND SUPRESSION OF THE CUTANEOUS MANIFESTATIONS OF ENL RECURRENCE FIRST LINE THERAPY FOR TYPE 2 DIABETES MELLITUS METHOD OF TREATING CHRONIC IRON OVERLOAD METHOD FOR IONTOPHORETIC TRANSDERMAL DELIVERY OF FENTANYL HYDROCHLORIDE DISINFECTION OF PATIENT SKIN PRIOR TO AN INVASIVE PROCEDURE INDICATED FOR THE LONG-TERM, TWICE-DAILY MAINTENANCE TREATMENT OF ASTHMA IN PATIENTS 12 YEARS OF AGE OR OLDER METHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMALIAN SUBJECT FOR THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS COMBINATION THERAPY WITH CISPLATIN FOR THE TREATMENT OF LATE STAGE CERVICAL CANCER TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS. ONCE A DAY TOPICAL TREATMENT OF THE INFLAMMATORY LESIONS OF ROSACEA TREATMENT OF HIV INFECTION IN ANTIRETROVIRAL TREATMENT-EXPERIENCED ADULT PATIENTS TREATMENT OR PREVENTION OF EMESIS PREVENTION OR TREATMENT OF NAUSEA OR EMESIS INDUCED BY A CANCER CHEMOTHERAPEUTIC AGENT PREVENTION OR TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING A METHOD FOR THE TREATMENT OF A PROTEIN TYROSINE KINASE-ASSOCIATED DISORDER METHOD OF CONTRACEPTION TREATMENT OF HIV-1 INFECTION IN ADULTS ONCE DAILY DOSING OF BUDESONIDE VIA NEBULIZER FOR THE TREATMENT OF ASTHMA SUNSCREEN AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES USE FOR THE LONG-TERM MAINTENANCE TREATMENT OF ASTHMA TREATMENT OF ANOREXIA, CACHEXIA, OR AN UNEXPLAINED, SIGNIFICANT WEIGHT LOSS IN PATIENTS WITH A DIAGNOSIS OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) ADDITION OF ONCE-WEEKLY DOSING FOR THE TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS USE AS A BILE ACID SEQUESTRANT FOR LOWERING CHOLESTEROL TREATMENT OF SYMPTOMS OF PREMENSTRUAL DYSPHORIC DISORDER METHOD OF USE OF ADMINISTERING LEVOTHYROXINE PROPHYLAXIS OF INVASIVE ASPERGILLUS AND CANDIDA INFECTIONS AND TREATMENT OF OROPHARYNGEAL CANDIDAIASIS TREATMENT OF SCHIZOPHRENIA INCLUDING MAINTAINING STABILITY IN PATIENTS WITH SCHIZOPHRENIA TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ADMINISTRATION OF ARIPIPRAZOLE BY INJECTION TREATMENT OF SCHIZOPHRENIA METHOD OF TREATING ALLERGIC CONJUNCTIVITIS TREATMENT OF SEIZURES MANAGEMENT OF BREAKTHROUGH PAIN IN PATIENTS WITH CANCER A METHOD OF REDUCING THE CAPACITY OF EXTENDED RELEASE NICOTINIC ACID TO PROVOKE A FLUSHING REACTION BY PRETREATING AN INDIVIDUAL WITH A FLUSH INHIBITING AGENT PRIOR TO THE ADMINISTRATION OF THE EXTENDED RELEASE NICOTINIC ACID REVLIMID (LENALIDOMIDE) IN COMBINATION WITH DEXAMETHASONE IS INDICATED FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEASET ONE PRIOR THERAPY LONG-TERM TREATMENT OF PATHOLOGICAL HYPERSECRETORY CONDITIONS METHOD FOR THE TREATMENT OF DIABETES MELLITUS, SUCH AS TYPE 1 DIABETES MELLITUS OR TYPE 2 DIABETES MELITUS, IN A HUMAN PATIENT RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS IN CHILDREN 2 TO 11 YEARS AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN CHILDREN 6 MONTHS TO 11 YEARS PATHOLOGICAL HYPERSECRETORY CONDITIONS METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASTE-IV INHIBITOR METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN AND/OR A SULFONYLUREA TREATMENT OF CUTANEOUS MANIFESTATION IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL) WHO HAVE PROGRESSIVE, PERSISTENT OR RECURRENT DISEASE ON OR FOLLOWING TWO SYSTEMIC THERAPIES. DECREASING MORTALITY CAUSED BY CONGESTIVE HEART FAILURE REDUCTION OF ELEVATED INTRAOCULAR PRESSUE IN PATEINTS WITH OPEN ANGLE GLAUCOME OR OCULAR HYPERTENSION A METHOD FOR TREATMENT OF A CANCER, WHEREIN THE CANCER IS CHRONIC MYELOGENOUS LEUKEMIA A METHOD FOR THE TREATMENT OF CANCER
ADB 41 of 51
U-794
U-801 U-802 U-803 U-804 U-805 U-806 U-807 U-808 U-809 U-810 U-811 U-812 U-813 U-814 U-815 U-816 U-817 U-818 U-819 U-820
FOR TREATMENT OF ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO ARE NAIVE TO PHARMACOLOGIC THERAPY TREATMENT OF CHRONIC HEPATITIS B IN ADULT PATIENTS WITH EVIDENCE OF VIRAL REPLICATION AND EITHER EVIDENCE OF PERSISTANT ELEVATIONS IN SERUM AMINOTRANSFERASES (ALT OR AST) OR HISTOLOGICALLY ACTIVE DISEASE DESONATE GEL IS INDICATED FOR THE TREATMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN PATIENTS 3 MONTHS OF AGE AND OLDER TREATMENT OF MODERATE TO SEVERE PRIMARY RESTLESS LEGS SYNDROME (RLS) USE AS REPLACEMENT SOLUTION, HEMOFILTRATION SOLUTION OR HEMODIAFILTRATION SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY PRODUCT IS APPROVED FOR THE TOPICAL TREATMENT OF TINEA PEDIS MAINTENANCE TREATMENT OF ASTHMA AS PROPHYLACTIC THERAPY IN ADULT AND PEDIATRIC PATIENTS SIX YEARS OF AGE OR OLDER, INCLUDING PATIENTS REQUIRING ORAL CORTICOSTEROID THERAPY FOR ASTHMA METHOD OF TREATING PSYCHIATRIC SYMPTOMS ASSOCIATED WITH PREMENSTRUAL DISORDERS USING PAROXETINE TREATMENT OF KNOWN OR SUSPECTED CYANIDE POISONING FORTEO IS INDICATED FOR THE TREATMENT OF POST MENOPAUSAL WOMEN WITH OSTEOPOROSIS WHO ARE AT RISK FOR FRACTURE. FORTEO CAN BE USED BY PEOPLE WHO HAVE HAD A FRACTURE RELATED TO OSTEOPOROSIS GLEEVEC IS ALSO INDICATED FOR THE TREATMENT OF PATIENTS WITH KIT (CD117) POSITIVE UNRESECTABLE AND/OR METASTATIC MALIGNANT GASTROINTESTINAL STROMAL TUMORS (GIST) TREATMENT OF SEBORRHEA DERMATITIS IN HUMANS FOR THE LONG TERM TREATMENT, TWICE DAILY (MORNING AND EVENING) MAINTENANCE TREATMENT OF BRONCHOCONSTRICTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA CLOSURE OF A CLNICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS IN PREMATURE INFANTS WEIGHING BETWEEN 500 AND 1500G, WHO ARE NO MORE THAN 32 WEEKS GESTATIONAL AGE WHEN USUAL MEDICAL MANAGEMENT IS INEFFECTIVE METHOD FOR INHIBITING NOREPINEPHRINE UPTAKE METHOD OF TREATING DEPRESSION METHOD OF TREATING ANXIETY TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN BY ONCE-MONTHLY ORAL ADMINISTRATION OF IBANDRONATE SODIUM MONOHYDRATE EQUIVALENT TO 150MG OF IBANDRONIC ACID METHOD FOR INHIBITING SEROTONIN UPTAKE TREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC BREAST CANCER WHOSE TUMORS OVEREXPRESS HER2 AND WHO HAVE RECEIVED PRIOR THERAPY INCLUDING ANTHRACYCLINE, A TAXANE AND TRASTUZUMAB METHOD OF TREATING CANCER METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH METFORMIN TREATMENT OF ACTINIC KERATOSES BY PHOTODYNAMIC THERAPY TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES INTRATHECAL TREATMENT OF LYMPHOMATOUS MENINGITIS PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION THE TREATMENT OF THE SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN PATIENTS 2 YEARS OF AGE AND OLDER TREATMENT OF CHRONIC IDIOPATHIC URTICARIA METHOD OF TREATMENT TO ALLEVIATE INFLAMMATION OF THE EYE RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS AND TREATMENT OF THE UNCOMPLICATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS MAINTENANCE TREATMENT OF BRONCHOCONSTRICTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT OF SCHIZOPHRENIA TREATS COLD SORES/FEVER BLISTERS ON THE FACE OR LIPS. SHORTENS HEALING TIME AND DURATION OF SYMPTOMS: TINGLING, PAIN, BURNING AND/OR ITCHING DEPRESSION, PANIC DISORDER, PREMENSTRUAL DISORDERS AND SOCIAL ANXIETY DISORDER NASAL ADMINISTRATION OF CYANOCOBALAMIN TOPICAL TREATMENT OF ACNE VULGARIS MANAGEMENT OF FIBROMYALGIA IMPROVED WAKEFULNESS IN PATIENTS WITH EXCESSIVE SLEEPINESS ASSOCIATED WITH NARCOLEPSY, OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME, AND SHIFT WORK SLEEP DISORDER
ADB 42 of 51
U-824 U-825 U-826 U-827 U-828 U-829 U-830 U-831 U-832 U-833 U-834 U-835 U-836 U-837 U-838 U-839 U-840 U-841 U-842 U-843 U-844
U-848 U-849
U-860 U-861
METHOD OF INHIBITING ENTHOTHELIN RECEPTORS BY ADMINISTERING AMBRISENTAN TO A PATIENT TO TREAT PULMONARY ARTERIAL HYPERTENSION. USE IN LIPID MANAGEMENT RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS AND FOR THE TREATMENT OF UNCOMPLCATED SKIN MANIFESTATIONS OF CHRONIC IDIOPATHIC URTICARIA IN CHILDREN 6 TO 11 YEARS OF AGE METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 USE FOR PREVENTION OF BREAST CANCER RELIEF OF MODERATE TO SEVERE PAIN USE FOR TREATMENT OF DIABETES, PARTICULARLY TYPE 2 DIABETES PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD OF CONTRACEPTION TREATMENT OF EXTRAVASATION RESULTING FROM IV ANTHRACYCLINE CHEMOTHERAPY TREATMENT OF RELAPSED SMALL CELL LUNG CANCER METHOD OF ADMINISTERING LANREOTIDE ACETATE ZINGO IS INDICATED FOR THE USE ON INTACT SKIN TO PROVIDE LOCAL ANALGESIA PRIOR TO VENIPUNCTURE OR INTRAVENOUS CANNULATION. METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.25% BY WEIGHT OF ROPIVACAINE INVIRASE IN COMBINATION WITH RITONAVIR AND OTHER ANTIRETROVIRAL AGENTS IS INDICATED FOR THE TREATMENT OF HIV INFECTION RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF ATOPIC DERMATITIS IN PATIENTS ONE YEAR OF AGE OR OLDER A METHOD FOR THE TREATMENT OF LEUKEMIAS GASTROINTESTINAL LAVAGE INDICATED FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN ADULTS METHOD OF TREATING PAIN USING A PHARMACEUTICALLY ACCEPTABLE SALT OF ROPIVACAINE AND ADMINISTERING A COMPOSITION CONTAINING LESS THAN 0.5% BY WEIGHT OF ROPIVACAINE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) TREATMENT FOR TYPE 2 DIABETES MELLITUS INDICATED FOR THE LONG-TERM, MAINTENANCE TREATMENT OF ASTHMA IN PATIENTS 12 YEARS OF AGE AND OLDER INDICATED FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) METHOD FOR ADMINISTRATION OF TESTOSTERONE PREFEST IS INDICATED IN WOMEN WHO HAVE A UTERUS FOR THE TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE; TREATMENT OF VULVAR AND VAGINAL ATROPHY; PREVENTION OF OSTEOPOROSIS TREATMENT OF PATIENTS WITH CANDIDEMIA, ACUTE DISSEMINATED CANDIDIASIS, CANDIDA PERITONITIS AND ABCESSES USE FOR DELINEATION (VISUALIZATION) DURING A VITRECTOMY SURGICAL PROCEDURE ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V) ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY CONTROLLED IOP. DOSE IS ONE DROP OF COMBIGAN IN THE AFFECTED EYE TWICE DAILY PREVENTION OR TREATMENT OF NAUSEA OR EMESIS INDUCED BY A CANCER CHEMOTHERAPEUTIC AGENT TREATMENT OF TYPE 2 DIABETES MELLITUS RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL AND PERENNIAL ALLERGIC RHINITIS TREATMENT OR PREVENTION OF EMESIS PREVENTION OF CMV DISEASE IN KIDNEY, HEART, AND KIDNEY-PANCREAS TRANSPLANT PATIENTS AT HIGH RISK (DONOR CMV SEROPOSITIVE/RECIPIENT CMV SERONEGATIVE) METHOD TO INDUCE NATRIURESIS, DIURESIS AND/OR VASODILATION SUPPORT EMBRYO IMPLANTATION AND EARLY PREGNANCY BY SUPPLEMENTATION OF CORPUS LUTEAL FUNCTION AS PART OF AN ASSISTED REPORDUCTIVE TECHNOLOGY (ART) TREATMENT PROGRAM FOR INFERTILE WOMEN INHIBITION OF TRANSPLANT REJECTION PEDIATRIC USE AGED 1-11 YEARS, GERD AND EROSIVE ESOPHAGITIS EROSIVE ESOPHAGITIS, HYPERSECRETORY CONDITIONS INCLUDING ZOLLINGER-ELLISON SYNDROME, MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS AND REDUCTION OF SYMPTOMS IN PATIENTS WITH GERD FOR THE APPROVED USES AND CONDITIONS OF USE, INCLUDING DEPRESSION RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS 12 YEARS OF AGE OR OLDER
ADB 43 of 51
U-863 U-864 U-865 U-866 U-867 U-868 U-869 U-870 U-871 U-872
U-881 U-882 U-883 U-884 U-885 U-886 U-887 U-888 U-889 U-890 U-891 U-892 U-893 U-894 U-895 U-896 U-897 U-898 U-899 U-900 U-901 U-902 U-903 U-904 U-905
ADJUNCT TO DIET TO REDUCE ELEVATED TOTAL-C, LDL-C, NON-HDL-C, APO B, TG, AND LP(A) LEVELS AND TO INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA, AND HYPERTRIGLYCERIDEMIA TAKING ASPIRIN OR NON-STEROIDAL ANTI-INFLAMMATORY MEDICATIONS APPROXIMATELY 30 MINUTES BEFORE DOSING CAN MINIMIZE FLUSHING, A COMMON SIDE EFFECT OF NIACIN THERAPY PEDIATRIC USE AGES 1-2 YEARS, GERD AND EROSIVE ESOPHAGITIS TREATMENT OF A WOMAN WITH OSTEOPOROSIS AND A HIGH RISK FOR BONE FRACTURE BY REDUCING THE RISK OF VERTEBRAL AND NONVERTEBRAL BONE FRACTURE THE LABEL REFERENCES THE EFFECTS OF THE ACTIVE INGREDIENT OF REVLIMID UPON CYTOKINES TREATMENT OF MIGRAINE METHOD OF USING ANTAGONIST OF ARGININE VASOPRESSIN (AVA) V1A AND V2 RECEPTORS FOR INTRAVENOUS TREATMENT OF PATIENTS WITH HYPERVOLEMIC HYPONATREMIA METHOD FOR STIMULATING CORONOARY VASODILATION FOR PURPOSES OF IMAGING THE HEART METHOD OF PRODUCING CORONARY VASODILATION WITHOUT PERIPHERAL VASODILATION METHOD OF REDUCING RISK OF MYOCARDIAL INFARCTION, STROKE AND DEATH TWICE DAILY MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA. TO REDUCE EXACERBATIONS OF COPD IN PATIENTS WITH A HISTORY OF EXACERBATIONS METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME BY OPENING CHLORIDE CHANNELS (CIC) METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME FIRST-LINE TREATMENT OF LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PANCREATIC CANCER, IN COMBINATION WITH GEMCITABINE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA FOR USE AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PEPTIC ULCER A METHOD FOR BINDING A PERIPHERAL OPIOID RECEPTOR A METHOD OF TREATING OR PREVENTING ILEUS ENDOMETRIN IS A PROGESTERONE INDICATED TO SUPPORT EMBRYO IMPLANTATION AND EARLY PREGNANCY BY SUPPLEMENTATION OF CORPUS LUTEAL FUNCTION AS PART OF AN ASSISTED REPRODUCTIVE TECHNOLOGY (ART) TREATMENT PROGRAM FOR INFERTILE WOMEN TREATMENT OF NON-SMALL CELL LUNG CANCER MANAGEMENT OF FIBROMYALGIA (FM) TREATMENT OF GASTROINTESTINAL STROMAL TUMOR WITH SUNITINIB TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA TREATMENT OF PATIENTS WITH MANTLE CELL LYMPHOMA WHO HAVE RECEIVED AT LEAST 1 PRIOR THERAPY ADMINISTERING DESLORATADINE TO TREAT THE SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS, SEASONAL ALLERGIC RHINITIS, OR CHRONIC IDIOPATHIC URTICARIA TREATMENT AND PREVENTION OF OSTEOPOROSIS FEMALE HORMONE REPLACEMENT THERAPY FOR POSTMENOPAUSAL WOMEN MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCCIATED WITH MENOPAUSE) REDUCTION OF SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE USE AS AN INTRAOCULAR IRRIGATING SOLUTION DURING SURGICAL PROCEDURES INVOLVING PERFUSION OF THE EYE TREATMENT OF CUTANEOUS MANIFESTATIONS IN PATIENTS WTIH CUTANEOUS T-CELL LYMPHOMA (CTCL) CLEVIPREX IS A DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER INDICATED FOR THE REDUCTION OF BLOOD PRESSURE WHEN ORAL THERAPY IS NOT FEASIBLE OR NOT DESIRABLE TREATMENT OF COLD SORES IN PEDIATRIC PATIENTS TWELVE YEARS OF AGE AND OLDER TREATMENT OF HIV INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS TREATMENT OF NASAL SYMPTOMS OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS IN ADULTS AND CHILDREN TWO YEARS OF AGE AND OLDER METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT USE OF GLUTAMINE TOGETHER WITH GROWTH HORMONE FOR THE TREATMENT OF PATIENTS WITH SHORT BOWEL SYNDROME USE OF THALIDOMIDE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA INTEGRASE INHIBITION FOR THE TREATMENT OF HIV INFECTION PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING USE IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN ADULT PATIENTS TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE TREATMENT OF MODERATE TO SEVERE VAGINAL DRYNESS AND PAIN WITH INTERCOURSE, SYMPTOMS OF VULVAR AND VAGINAL ATROPHY, ASSOCIATED WITH MENOPAUSE
ADB 44 of 51
U-907 U-908 U-909 U-910 U-911 U-912 U-913 U-914 U-915 U-916 U-917 U-918 U-919 U-920
U-933
U-934
U-935
U-936
U-937 U-938 U-939 U-940 U-941 U-942 U-943 U-944 U-945 U-946
PROPHYLAXIS OF ORGAN REJECTION IN KIDNEY, LIVER AND HEART ALLOGENIC TRANSPLANTS; TREATMENT OF PATIENTS WITH SEVERE ACTIVE, RHEUMATOID ARTHRITIS; TREATMENT OF ADULT, NONIMMUNOCOMPROMISED PATIENTS WITH SEVERE, RECALCITRANT, PLAQUE PSORIASIS FOR THE MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS IN SUBJECTS 18 YEARS OF AGE AND OLDER PROPHYLAXIS OF ORGAN REJECTION IN PATIENTS RECEIVING ALLOGENEIC RENAL TRANSPLANTS TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA TREATMENT OF METASTATIC CARCINOMA OF THE OVARY AFTER FAILURE OF INITIAL OR SUBSEQUENT CHEMOTHERAPY METHOD OF TREATING, AS ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS AND OLDER WHEN ORAL TREATMENT IS TEMPORARILY NOT FEASIBLE SEDATION OF NON-INTUBATED PATIENTS PRIOR TO AND/OR DURING SURGICAL AND OTHER PROCEDURES TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE, URGENCY, AND FREQUENCY METHOD OF TREATING, AS ADJUNCTIVE THERAPY, PARTIAL-ONSET SEIZURES IN A PATIENT WITH EPILEPSY AGED 17 YEARS AND OLDER TREATMENT OF MUSCULOSKELETAL CONDITIONS TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OR OLDER TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET FOR THE TREATMENT OF DERMATITIS STEROID-RESPONSIVE INFLAMMATORY OCULAR CONDITIONS FOR WHICH A CORTICOSTEROID IS INDICATED AND WHERE SUPERFICIAL BACTERIAL OCULAR INFECTION OR A RISK OF BACTERIAL OCULAR INFECTION EXISTS TREATMENT OF ACNE VULGARIS FOR THE TREATMENT OF FUNGAL INFECTIONS METHOD OF TREATING OPHTHALMIC INFLAMMATION AND INFECTION TREATMENT OF MILD TO MODERATE INFECTION CAUSED ABY SUSCEPTIBLE STRAINS TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTILES) OF ROSACEA MGT SPECIFIC BACTERIAL INFECTIONS. TREATMENT PTS W/ COMMUNITY ACQUIRED PNEUMONIA OR BACTERIAL SINUSITIS DUE TO CONFIRMED, OR SUSPECTED B-LACTAMASE PRODUCING PATHOGENS & S. PNEUMONIAE WITH REDUCED SUSCEPTIBILITY TO PENICILLIN (MIC=2MC/ML) METHOD FOR INCREASING TEAR PRODUCTION TREATMENT OF BACTERIAL INFECTIOUS DISEASE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER TREATABLE WITH AN SSRI TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) RELIEF OF MODERATE TO SEVERE ACUTE PAIN PYLERA CAPSULES, IN COMBINATION WITH OMEPRAZOLE ARE INDICATED FOR THE TREATMENT OF PATIENTS WITH HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE TO ERADICATE H. PYLORI FOR THE TREATMENT OF PATIENTS WITH HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE TO ERADICATE H. PYLORI. THE ERADICATION OF HELICOBACTER PYLORI HAS BEEN SHOWN TO REDUCE THE RISK OF DUODENAL ULCER RECURRENCE IN COMBINATION WITH GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) TO MOBILIZE HEMATOPOIETIC STEM CELL TO THE PERIPHERAL BLOOD FOR COLLECTION AND SUBSEQUENT AUTOLOGOUS TRANSPLANTATION WITH NON-HODGKINS LYMPHOMA AND MULTIPLE MYELOMA TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN ADULT PATIENTS, AND TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN PEDIATRIC PATIENTS 6 YEARS OF AGE AND OLDER USE IN COMBINATION WITH GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) TO MOBILIZE HEMATOPOIETIC STEM CELLS TO PERIPHERAL BLOOD FOR COLLECTION & SUBSEQUENT AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA & MULTIPLE MYELOMA TREATMENT OF PROSTATE CANCER TREATMENT OF HAIR LOSS AND HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS TREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING AND STIMULATING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS METHOD TO TREAT AIDS-RELATED KAPOSI'S SARCOMA METHOD TO TREAT OVARIAN CANCER METHOD TO TREAT MULTIPLE MYELOMA GNRH ANTAGONIST INDICATED FOR TREATMENT OF PATIENTS WITH ADVANCED PROSTATE CANCER TREATMENT OF PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) SEDATIVE-HYPNOTIC AGENT INDICATED FOR MONITORED ANESTHESIA CARE (MAC) SEDATION TREATMENT OF BREAST CANCER
ADB 45 of 51
U-948 U-949 U-950 U-951 U-952 U-953 U-954 U-955 U-956 U-957 U-958
U-959
WHEN PATIENTS ARE UNABLE TO TAKE THE ORAL FORMULATIONS, PREVACID IV, FOR INJECTION IS INDICATED AS AN ALTERNATIVE FOR THE SHORT-TERM TREATMENT (UP TO 7 DAYS) OF ALL GRADES OF EROSIVE ESOPHAGITIS TREATMENT OF DIABETES MELLITUS HEALING OF ALL GRADES OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 8 WEEKS MAINTAIN HEALING OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 6 MONTHS TREATMENT OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (GERD) FOR 4 WEEKS USE AS AN ANALGESIC METHOD OF TREATING OPHTHALMIC INFLAMMATION AND INFECTION CHRONIC MANAGEMENT OF HYPERURICEMIA IN PATIENTS WITH GOUT. NOT RECOMMENDED FOR THE TREATMENT OF ASYMPTOMATIC HYPERURICEMIA PROPHYLACTIC TREATMENT OF MIGRAINE TREATMENT OF PATIENTS WITH H. PYLORI INFECTION AND DUODENAL ULCER DISEASE A METHOD OF TREATING CANCER IN A PATIENT COMPRISING ADMINISTERING IXABEPILONE OR PHARMACEUTICAL COMPOSITIONS COMPRISING IXABEPILONE METHOD OF TREATING PATIENT COMPRISING MIXING FIRST AND SECOND VIALS OF PRODUCT COMPRISING LYOPHILIZED IXABEPILONE TO PROVIDE AN EPOTHILONE ANALOG SOLUTION, DILUTING SOLUTION WITH A SUITABLE DILUENT TO PREPARE INTRAVENOUS FORMULATION FOR PT METHOD OF TREATING CANCER, IV ADMIN, LYOPHYLIZED IXABEPILONE DILUTED, EVERY WEEK OR 3 WEEKS; LYOPHILIZED IXABEPILONE WITH SOLVENT(DEHYDRATED ETHANOL) DILUTED TO CONCENTRATION OF 0.1MG/ML TO 0.9MG/ML METHOD OF TREATING CANCER IN A PATIENT COMPRISING INTRAVENOUSLY ADMINISTERING TO THE PATIENT IXABEPILONE DILUTED IN A PARENTERAL DILUENT METHOD OF TREATING BREAST CANCER BY ADMINISTERING IXABEPILONE; A METHOD OF TREATING A CANCER RESPONSIBLE TO MICROTUBULE STABILIZATION BY ADMINISTERING IXABEPILONE SYMBYAX IS INDICATED FOR THE ACUTE TREATMENT OF TREATMENT RESISTANT DEPRESSION IN ADULTS PROZAC AND OLANZAPINE IN COMBINATION FOR THE ACUTE TREATMENT OF TREATMENT RESISTANT DEPRESSION IN ADULTS ZYPREXA ZYDIS AND FLUOXETINE IN COMBINATION FOR THE ACUTE TREATMENT OF TREATMENT RESISTANT DEPRESSION IN ADULTS USE OF IXABEPILONE IN COMBINATION WITH CAPECITABINE IN TREATMENT OF METASTASIS BREAST CANCER TREATMENT OF ASTHMA (MAINTENANCE AND PROPHYLACTIC THERAPY) A METHOD OF REVERSING SOFT-TISSUE ANESTHESIA I.E. ANESTHESIA OF THE LIP AND TONGUE, AND THE ASSOCIATED FUNCTIONAL DEFICITS RESULTING FROM AN INTRAORAL SUBMUCOSAL INJECTION OF A LOCAL ANESTHETIC A METHOD FOR IMPROVING GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS TREATMENT OF MIGRAINE TOPICAL TREATMENT OF LICE INFESTATIONS INDICATED FOR THE ACUTE TREATMENT OF ADULTS WITH SCHIZOPHRENIA MONOTHERAPY OR AS ADJUNCTIVE THERAPY TO LITHIUM OR VALPROATE FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHO ARE ALREADY TREATED WITH PIOGLITAZONE AND METFORMIN OR WHO HAVE INADEQUATE GLYCEMIC CONTROL ON PIOGLITAZONE OR METFORMIN ALONE ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES WHO ARE ALREADY TREATED WITH A PIOGLITAZONE AND METFORMIN TREATMENT OF PULMONARY HYPERTENSION IMPROVEMENT OF GLYCEMIC CONTROL IN INDIVIDUALS WITH TYPE 2 DIABETES TREATMENT OF ACUTE, UNCOMPLICATED MALARIA INFECTION DUE TO PLASMODIUM FALCIPARUM IN PATIENTS OF 5KG BODYWEIGHT AND ABOVE METHOD OF TREATING HYPONATREMIA RELIEF OF MUSCLE SPASM NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN MANAGEMENT OF MILD TO MODERATE PAIN, MANAGEMENT OF MODERATE TO SEVERE PAIN AS AN ADJUNCT TO OPIOID ANALGESICS, REDUCTION IN FEVER THROUGH ANTI-INFLAMMATORY, ANALGESIC, AND ANTIPYRETIC ACTIVITY A METHOD OF TREATING OSTEOPOROSIS METHOD OF TREATING OSTEOPOROSIS IN A POST-MENOPAUSAL WOMAN AT RISK FOR FRACTURE METHOD FOR THE TREATMENT OF A WOMAN WITH OSTEOPOROSIS AND AT RISK FOR BONE FRACTURE TREATMENT OF MACULAR EDEMA FOLLOWING BRANCH RETINAL VEIN OCCLUSION (BRVO) OR CENTRAL RETINAL VEIN OCCLUSION (CRVO) TREATMENT OF PATIENTS INFECTED WITH PEDICULUS HUMANUS CAPITIS (HEAD LICE AND THEIR OVA) OF THE SCALP HAIR
ADB 46 of 51
U-997 U-998
TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS TREATMENT OF RHINITIS COMPRISING THE NASAL APPLICATION OF A PHARMACEUTICAL FORMULATION AS CLAIMED IN US PATENT 7541350 FOR REDUCING BLOOD PHENYLALANINE LEVELS IN A HUMAN SUFFERING FROM HYPERPHENYLALANINEMIA TREATMENT OF PROTOZOAL INFECTION TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISMS REDUCTION OF THE RISK OF CARDIOVASCULAR HOSPITALIZATION METHOD OF TREATING INFERTILITY METHOD OF TREATMENT OF OSTEOPOROSIS WHEREIN THE OSTEOPOROSIS IS STEROID-INDUCED METHOD FOR TREATING TYPE II DIABETES BY ADMINISTERING SAXAGLIPTIN AN ADJUNCTIVE THERAPY TO DIET TO REDUCT ELEVATED TOTAL CHLORESTEROL (TC), LOW-DENSITY LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN B, TRIGLYCERIDES, AND TO INCREASE HDL-C IN ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIX DYSLIPIDEMIA TREATMENT OF MAJOR DEPRESSIVE DISORDER BY DOSING AT INTERVALS OF 24 HOURS ADJUNCITVE THERAPY TO DIET TO REDUCE ELEVATED TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, APOLIPOPRTEIN B, TRIGLYCERIDES AND TO INCREASE HDL-C IN ADULT PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA TREATMENT OF CHRONIC HEPATITIS B IN ADULT PATIENTS ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH HYPERLIPIDEMIAS METHOD FOR DELIVERING DRUG TO LUNG OF MAMMAL, COMPRISING ADMINISTERING DRUG PRODUCT BY INHALATION. TREATING A MAMMAL HAVING A CONDITION CAPABLE OF TREATMENT BY INHALATION, COMPRISING ADMINISTERING TO THE LUNG THE DRUG PRODUCT BY INHALATION METHOD OF TREATING INFLAMMATORY CONDITIONS A METHOD OF MYOCARDIAL PERFUSION IMAGING AND INCREASING CORONARY BLOOD FLOW TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA METHOD OF TREATING A STAPHYLOCOCCAL INFECTION NEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER) METHOD OF TREATING GOUT FLARES APPLICATION OF ANTISEPTIC WITH MOISTURIZERS FOR SURGICAL AND HEALTHCARE PERSONNEL SKIN DISINFECTION METHOD FOR ADMINISTRATION OF TESTOSTERONE TO REDUCE BLOOD PHENYLALANINE LEVELS IN PATIENTS WITH HYPERPHENYLALANINEMIA DUE TO TETRA HYDROBIOPTERIN RESPONSIVE PHENYLKETONURIA. KUVAN SHOULD BE TAKEN ORALLY WITH FOOD TO INCREASE ABSORPTION USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING METHOD FOR TREATING INSOMNIA WHILE REDUCING THE RISK OF AN ADVERSE DRUG INTERACTION METHOD OF USING RIBAVIRIN IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2B TO TREAT PATIENTS WITH CHRONIC HEPATITIS C METHOD OF USING RIBAVIRIN IN COMBINATION WITH INTERFERON ALPHA-2B(PEGYLATED AND NONPEGYLATED) TO TREAT PATIENTS WITH CHRONIC HEPATITIS C TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-EXPERIENCED ADULT PATIENTS, WHO HAVE EVIDENCE OF VIRAL REPLICATION AND HIV-1 STRAINS RESISTANT TO AN NNRTI AND OTHER ANTIRETROVIRAL AGENTS A METHOD OF TREATING NASAL AND NON-NASAL SYMPTOMS OF SEASONAL ALLERGIC RHINITIS TREATMENT OF PULMONARY HYPERTENSION BY INHALATION TREATMENT OF PULMONARY HYPERTENSION METHOD OF USING COLCHICINE FOR THE PROPHYLAXIS OF GOUT FLARES SHORT-TERM TREATMENT (4-8 WEEKS) OF ACTIVE BENIGN GASTRIC ULCER FOR THE PREPARATION OF SKIN PRIOR TO SURGERY; HELPS REDUCE BACTERIA THAT CAN POTENTIALLY CAUSE SKIN INFECTION TREATMENT OF ATROPHIC VAGINITIS DUE TO MENOPAUSE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY CONTROLLED IOP TREATING FREQUENT HEARTBURN A METHOD OF TREATING HUMAN SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS. REDUCTION OF ELEVATED PLASMA STEROL AND/OR STANOL LEVELS IN A MAMMAL A METHOD OF DISTRIBUTING SODIUM OXYBATE UNDER CONTROL OF A CENTRAL PHARMACY METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF IMPROVEMENT OF WALKING IN PATIENTS WITH MULTIPLE SCLEROSIS (MS)
ADB 47 of 51
U-1031 IMPROVE RESPIRATORY SYMPTOMS IN CYSTIC FIBROSIS IN PATIENTS WITH PSEUDOMONAS AERUGINOSA U-1032 USE OF ROSUVASTATIN CALCIUM FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN INDIVIDUALS WITHOUT CLINICALLY EVIDENT CORONARY HEART DISEASE BUT WITH INCREASED RISK FACTORS U-1033 TOPICAL TREATMENT OF ACNE VULGARIS U-1034 TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS U-1035 NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN U-1036 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH INSULIN U-1037 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR IN COMBINATION WITH A PPAR-GAMMA AGONIST U-1038 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN AND A PPAR-GAMMA AGONIST U-1039 METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN COMBINATION WITH METFORMIN U-1040 INHIBITION OF THROMBIN IN A PATIENT U-1041 TREATMENT OF DISORDERS RESPONSIVE TO GROWTH HORMONE U-1042 METHOD FOR STIMULATING CORONARY VASODILATION FOR PURPOSES OF IMAGING THE HEART U-1043 MANAGEMENT OF MODERATE TO SEVERE PAIN U-1044 TOPICAL TREATMENT OF SCALP PSORIASIS U-1045 MAINTENANCE TREATMENT IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NSCLC WHO HAVE NOT PROGRESSED ON 1ST-LINE TREATMENT WTH PLATINUM-BASED CHEMOTHERAPY U-1046 MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NSCLC WHOSE DISEASE HAS NOT PROGRESSED AFTER FOUR CYCLES PLATINUM-BASED CHEMOTHERAPY U-1047 TREATMENT OF BIOPSY-CONFIRMED, PRIMARY SUPERFICIAL BASAL CELL CARCINOMA (SBCC) U-1048 WORKS THROUGH THE INDUCTION OF INTERFERON AND OTHER CYTOKINES U-1049 PROPHYLAXIS OF ORGAN REJECTION IN ADULT PATIENTS AT LOW-MODERATE IMMUNOLOGIC RISK RECEIVING A RENAL TRANSPLANT U-1050 USE OF METAXALONE FOR TREATMENT OF MUSCULSKELETAL CONDITIONS U-1051 TREATMENT OF OROPHARYNGEAL CANDIDIASIS U-1052 RELIEF OF SIGNS AND SYMPTOMS OF ARTHRITIS AND RISK-REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER U-1053 RISK-REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER U-1054 ONYCHOMYCOSIS OF THE TOENAIL CAUSED BY TRICOPHYTON RUBRUM OR TRICHOPHYTON MENTAGROPHYTES, ONCE DAILY USE FOR 12 CONSECUTIVE WEEKS U-1055 AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHO ARE ALREADY TREATED WITH A THIAZOLIDINEDIONE (TZD) AND METFORMIN OR WHO HAVE INADEQUATE GLYCEMIC CONTROL ON A TZD OR METFORMIN ALONE U-1056 TREATMENT OF PAIN USING A NASAL SPRAY OF KETOROLAC TROMETHAMINE U-1057 TREATMENT OF INFLAMMATION AND PAIN USING A NASAL SPRAY OF KETOROLAC TROMETHAMINE U-1058 USE OF THALIDOMIDE IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA U-1059 ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA U-1060 ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH ELEVATED CHOLESTEROL AND/OR LIPID LEVELS U-1061 ADJUNCTIVE THERAPY TO DIET IN PATIENTS WITH MIXED DYSLIPIDEMIA U-1062 ADMINISTRATION OF APPROVED PRODUCT FOR TREATMENT OF ALZHEIMER'S DISEASE U-1063 TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA U-1064 TREATMENT OF BIPOLAR DISORDER AND SCHIZOPHRENIA U-1065 METHOD OF TREATING ANDROGEN RESPONSIVE OR MEDICATED CONDITION IN A MAMMAL BY ADMINISTERING A SAFE & EFFECTIVE AMOUNT OF DUTASTERIDE OR A PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF.. CONDITIONS INCLUDE BENIGN PROSTATIC HYPERTROPHY U-1066 METHOD OF TREATING AN ANDROGEN RESPONSE OR MEDIATED DISEASE IN A MAMMAL BY ADMININSTERING AN EFFECTIVE ANDROGEN RESPONSIVE OR MEDICATED DISEASE AMOUNT OF DUTASTERIDE..CONDITIONS INCLUDE BENIGN PROSTATIC HYPERPLASIA U-1067 TREATMENT OF CANCER U-1068 TREATMENT OF ASTHMA U-1069 A METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING AN EXCLUSIVE COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION U-1070 A METHOD TO CONTROL ABUSE OF A SENSITIVE DRUG BY CONTROLLING WITH A COMPUTER PROCESSOR THE DISTRIBUTION OF THE SENSITIVE DRUG VIA AN EXCLUSIVITY CENTRAL PHARMACY THAT MAINTAINS A CENTRAL DATABASE U-1071 METHOD OF TREATING BLADDER DSYFUNCTION WITH ONCE A DAY TROSPIUM SALT FORMULATION U-1072 THE MANAGEMENT OF MODERATE TO SEVERE CHRONIC PAIN IN PATIENTS REQUIRING A CONTINUOUS, AROUND-THE-CLOCK OPIOID ANALGESIC FOR AN EXTENDED PERIOD OF TIME U-1073 USE FOR THE TREATMENT OF ASTHMA AND COPD
ADB 48 of 51
U-1074 USE OF EXENATIDE MAY RESULT IN REDUCTION IN BODY WEIGHT U-1075 USE FOR THE TREATMENT OF ASTHA U-1076 REDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA) IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING U-1077 PRETREATMENT OF PATIENTS WITH VITAMIN B12 AND FOLIC ACID PRIOR TO PEMETREXED DISODIUM ADMINISTRAION U-1078 TREATMENT OF ACNE U-1079 REVLIMID (LENALIDOMIDE) IS INDICATED FOR THE TREATMENT OF PATIENTS WITH TRANSFUSIONDEPENDENT ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS) U-1080 METHOD TO TREAT PULMONARY HYPERTENSION BY ADMINISTERING AMBRISENTAN TO A PATIENT U-1081 LUMIGAN IS A PROSTAGLANDIN ANALOG INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION U-1082 USE OF A COMBINATION OF TOBRAMYCIN AND DEXAMETHASONE TO TREAT OCULAR INFLAMMATION WHERE AN INFECTION OR RISK OF INFECTION EXISTS U-1083 ACUTE TREATMENT OF MIGRAINE ATTACKS, WITH OR WITHOUT AURA, AND THE TREATMENT OF CLUSTER HEADACHE EPISODES U-1084 RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS 12 YEARS OF AGE OR OLDER U-1085 METHOD FOR TREATING IRRITABLE BOWEL SYNDROME AND METHOD FOR TREATING ABDOMINAL DISCOMFORT ASSOCIATED WITH IRRITABLE BOWEL SYNDROME U-1086 TREATMENT OF AUTOIMMUNE DISEASE U-1087 DETECTION OF NON-MUSCLE INVASIVE PAPILLARY CANCER OF THE BLADDER BY PHOTODYNAMIC CYSTOSCOPY U-1088 RELIEF OF MUSCLE SPASM U-1089 INHIBITION OF THROMBIN U-1090 LO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOF OF CONTRACEPTION U-1091 ASSESSMENT OF BRONCHIAL HYPERRESPONSIVENESS IN PATIENTS 6 YEARS OF AGE OR OLDER WHO DO NOT HAVE CLINICALLY APPARENT ASTHMA U-1092 TREATMENT OF BREAST CANCER U-1093 TREATMENT OF PSEUDOBULBAR AFFECT U-1094 MANAGEMENT OF CHRONIC MUSCULOSKELETAL PAIN U-1095 METHOD OF TREATING OCULAR INFLAMMATION U-1096 TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER U-1097 ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS WHEN TREATMENT WITH BOTH SAXAGLIPTIN AND METFORMIN IS APPROPRIATE U-1098 METHOD OF TREATING HYPERPARATHYROIDISM; METHOD OF TREATING HYPERCALCEMIA U-1099 TREATMENT OF PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY, POSTHERPETIC NEURALGIA, AND FIBROMYALGIA U-1100 REDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY U-1101 METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH NARCOLEPSY U-1102 METHOD OF TREATING CATAPLEXY IN PATIENTS WITH NARCOLEPSY U-1103 TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE U-1104 USE OF TRAMADOL FOR THE MANAGEMENT OF MODERATE TO MODERATELY SEVERE CHRONIC PAIN U-1105 TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER U-1106 TREATING HYPERTRIGLYCERIDEMIAS WITH REDUCTION OF FOOD EFFECT U-1107 TREATING HYPERCHOLESTEROLEMIAS WITH REDUCTION OF FOOD EFFECT U-1108 TREATING TYPE 2 DIABETES MELLITUS WITH EXENATIDE BY STIMULATING INSULIN RELEASE U-1109 TREATMENT OF CUTANEOUS MANIFESTATIONS OF ERYTHEMA NODOSUM LEPROSUM (ENL) IN CONNECTION WITH A SPECIAL PROGRAM APPROVED BY FDA CALLED "SYSTEM FOR THALIDOMIDE EDUCATION AND PRESCRIBING SAFETY" (S.T.E.P.S.) U-1110 METHOD OF TREATING A PATIENT WITH A PRESCRIPTION DRUG USING A COMPUTER DATABASE IN A COMPUTER SYSTEM FOR DISTRIBUTION U-1111 NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN U-1112 METHOD OF MR IMAGING OF A MAMMAL U-1113 TREATMENT AND PROPHYLAXIS OF INFLUENZA U-1114 TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA U-1115 TREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS U-1116 METHOD OF ADMINISTERING COLCHICINE TO FAMILIAL MEDITERRANEAN FEVER PATIENTS U-1117 TREATMENT OF BREAST CANCER U-1118 USE FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND EMPHYSEMA
ADB 49 of 51
U-1119 CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING U-1120 TO REDUCE GASTROINTESTINAL SIDE EFFECTS ADMINISTER WITH A MEAL; AS STARTING DOSE ADMINISTER ONCE DAILY WITH EVENING MEAL U-1121 METHOD OF TREATING TRAVELERS' DIARRHEA U-1122 TREATMENT OF SECONDARILY INFECTED TRAUMATIC SKIN LESIONS DUE TO S. AUREUS AND S. PYOGENES U-1123 TREATMENT OF ALCOHOL DEPENDENCE U-1124 PREVENTION OF RELAPSE TO OPIOID DEPENDENCE, FOLLOWING OPIOID DETOXIFICATION U-1125 METHOD FOR THE DETECTION OF NEUROENDOCRINE TUMORS U-1126 USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO HAVE RECEIVED PRIOR CHEMOTHERAPY CONTAINING DOCETAXEL U-1127 TREATMENT OF PATENT DUCTUS ARTERIOSUS U-1128 TREATMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 INFECTION IN COMBINATION WITH PEGINTERFERON ALFA AND RIBAVIRIN IN ADULT PATIENTS (>=18 YEARS OF AGE) WITH COMPENSATED LIVER DISEASE U-1129 TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN U-1130 SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE EVENING OR A NIGHT WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN U-1131 TREATMENT OF HYPERTRIGLYDERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN U-1132 TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1133 SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1134 TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1135 TREATMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A) AND INCREASE OF HDL-C U-1136 SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C U-1137 TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C U-1138 TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1139 REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1140 REDUCTION IN ELEVATED TC AND LDL-C BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1141 REDUCTION IN TG BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1142 TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN U-1143 REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER DAY IN THE EVENING OR A T NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN U-1144 REDUCTION IN ELEVATED TC AND LDL-C BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITIN AGENT SUCH AS ASPIRIN U-1145 REDUCTION IN TG BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN U-1146 REDUCTION IN TG WITH REDUCED FLUSHING BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT U-1147 TREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C U-1148 REDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTINO OF LDL-C, TC, TG, LP(A), AND INCREASE OF HDL-C U-1149 TREATMENT OF HYPERTRIGLYCERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, WITH PRETREATMENT WITH A FLUSH INHIBITING AGENT SUCH AS ASPIRIN U-1150 TRETMENT OF HYPERCHOLESTEROLEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION IN TOTAL-C, LDL-C, TG, LP(A), AND INCREASE OF HDL-C U-1151 TREATMENT OF HYPERTRIGLYCDERIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT, THROUGH REDUCTION IN TOTAL-C, LDL-C, LP(A), AND INCREASE OF HDL-C U-1152 CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION U-1153 IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS, IS INDICATED FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN ANTIRETROVIRAL TREATMENT-NAIVE ADULT PATIENTS, AS SET FORTH IN THE LABELING, INCLUDING I&U SECTION U-1154 TREATMENT OF PROTEIN KINASE RELATED DISORDERS, SUCH AS GASTROINTESTINAL STROMAL TUMORS, RENAL CELL CARCINOMA AND ADVANCED PANCREATIC NEUROENDOCRINE TUMORS, WITH SUNITINIB U-1155 USE OF THALIDOMIDE IN TREATMENT OF CUTANEOUS MANIFESTATIONS OF ERYTHEMA NODOSUM LEPROSUM (ENL) U-1156 TO REDUCE BLOOD PHENYLALANINE (PHE) LEVELS IN PATINETS WITH HYPERPHENYLALANINEMIA (HPA)
ADB 50 of 51
U-1157 RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES IN ADULTS AND CHILDREN 2 YEARS OF AGE AND OLDER AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH HIVES (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER U-1158 RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH HIVES (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER U-1159 RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES, SWELLING OF THE NASAL PASSAGES AND SINUS CONGESTION AND PRESSURE IN ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER U-1160 RELIEF OF SYMPTOMS ASSOCIATED WITH RESPIRATORY ALLERGIES AND FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH HIVES (URTICARIA) IN ADULTS AND CHILDREN 6 YEARS OF AGE AND OLDER AND 12 YEARS OF AGE AND OLDER U-1161 FOR THE TREATMENT AND PROPHYLAXIS OF GOUT FLARES & THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER U-1162 TREATMENT OF SEBORRHEIC DERMATITIS OF THE SCALP U-1163 METHOD OF TREATING THROMBOSIS U-1164 METHOD OF TREATING AN ARGATROBAN TREATABLE CONDITION U-1165 USE FOR THE TREATMENT OF MULTIPLE MYELOMA U-1166 A METHOD FOR TREATMENT OF GOUT FLARES DURING PROPHYLAXIS U-1167 PROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT) U-1168 THE LONG TERM, ONCE-DAILY MAINTENANCE BROCHODILATOR TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA U-1169 MANAGEMENT OF BREAKTHROUGH PAIN IN CANCER PATIENTS 18 YEARS OF AGE AND OLDER WHO ARE RECEIVING AND TOLERANT TO OPIOID THERAPY FOR THEIR UNDERLYING PERSISTENT CANCER PAIN U-1170 TREATMENT OF HIV-1 INFECTION IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER U-1171 REDUCTION OF THE RATE OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME U-1172 TO REDUCE ELEVATED TOTAL-C, APO B, AND NON-HDL-C IN PATIENTS WIHT PRIMARY HYPERLIPIDEMIA BY ADMINISTRATION OF EZETIMIBE IN COMBINATION WITH A STATIN U-1173 TO REDUCE ELEVATED TOTAL-C, LDL-C, APO B AND NON-HDL-C IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA BY ADMINISTRATION OF EZETIMIBE ALONE OR IN COMBINATION WITH A STATIN OR WITH FENOFIBRATE U-1174 ADMINISTRATION OF REMODULIN DILUTED FOR INTRAVENOUS INFUSION WITH STERILE WATER FOR INJECTION, 0.9% SODIUM CHLORIDE INJECTION, OR FLOLAN STERIILE DILUENT FOR INJECTION PRIOR TO ADMINISTRATION U-1175 REDUCTION OF CARDIAC TISSUE DAMAGE ASSOCIATED WITH MYOCARDIAL INFARCTION U-1176 TREATMENT OR PREVENTION OF STROKE U-1177 REDUCTION OF CARDIAC TISSUE DAMAGE ASSOCIATED WITH MYOCARDIAL INFARCTION U-1178 RELIEF OF MODERATE TO SEVERE CHRONIC PAIN U-1179 TREATMENT OF A CANCER MEDIATED BY AN ANAPLASTIC LYMPHOMA KINASE (ALK) U-1180 TREATMENT OF THE FOLLOWING INFECTIONS: COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS AND STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BACTEREMIA) INCLUDING THOSE WITH RIGHTSIDED INFECTIVE ENDOCARDITIS U-1181 A METHOD OF TREATING OR PREVENTING OCULAR PAIN IN A PATIENT U-1182 TREATMENT OF CYCLIC HEAVY MENSTRUAL BLEEDING U-1183 A METHOD FOR ADMINISTERING FOLLICLE STIMULATING HORMONE (FSH) FOR OVARIAN FOLLICLE OR TESTICULAR STIMULATION IN THE HUMAN U-1184 TREATMENT OF ERECTILE DYSFUNCTION AND THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA U-1185 TREATMENT OF OPIOID-INDUCED CONSTIPATION U-1186 ADMINISTRATION OF AN INHALABLE POWDER COMPRISING TIOTROPIUM VIA DEVICE U-1187 TREATMENT OF PATHOLOGICAL STATE BY ANTAGONIZING BRADYKININ RECEPTOR INCLUDING TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) U-1188 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE U-1189 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH METFORMIN U-1190 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH INSULIN U-1191 METHOD OF TX TYPE 2 DM IN PTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBO WITH AN AGENT ACTING ON AN ATP-DEPENDENT CHANNEL IN BETA CELLS SUCH AS A SULFYONYLUREA(INCL GLIPIZIDE, GLIMEPIRIIDE & GLYBURIDE) U-1192 METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH A SULFONYLUREA (SUCH AS GLIPIZIDE, GLIMEPIRIDE AND GLYBURIDE) U-1193 METHOD OF TREATING TYPE 2 DIABETES MELITUS IN PATIENTS FOR WHOM TREATMENT WITH BOTH SITAGLIPTIN AND SIMVASTATIN IS APPROPRIATE, IN COMBINATION WITH A PPAR-GAMMA AGONIST (SUCH AS PIOGLITAZONE AND ROSIGLITAZONE) U-1194 METHOD FOR TREATING INSOMNIA
ADB 51 of 51
U-1195 PREVENTION AND TREATMENT OF SECONDARY HYPERPARATHYROIDISM ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) STAGE 5, WHICH MAY RESULT IN RENAL OSTEODYSTROPHY, WHILE AVOIDING HYPERPHOSPHATEMIA U-1196 RELIEF OF SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS AND TO DECREASE RISK OF DEVELOPING UPPER GASTROINTESTINAL ULCERS IN PATIENTS WHO ARE TAKING IBUPROFEN FOR THOSE INDICATIONS U-1197 METHOD OF TREATMENT OF CHILDREN WITH CENTRAL PRECOCIOUS PUBERTY U-1198 RECTIV IS A NITRATE VASODILATOR INDICATED FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH CHRONIC ANAL FISSURE U-1199 TREATMENT AND PREVENTION OF POSTMENOPAUSAL OR GLUCOCORTICOID-INDUCED OSTEOPOROSIS AND TREATMENT TO INCREASE BONE MASS IN MEN WITH OSTEOPOROSIS U-1200 REDUCING THE RISK OF STROKE AND SYSTEMIC EMBOLISM U-1201 FOR THE TREATMENT OF INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS U-1202 METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME U-1203 METHOD FOR RELIEVING OR TREATING CONSTIPATION IN A HUMAN CONSTIPATED PATIENT U-1204 TREATMENT OF UVEITIS U-1205 TREATMENT OF MACULAR EDEMA U-1206 DELIVERING AN OCULAR IMPLANT AS DESCRIBED IN THE DOSAGE AND ADMINISTRATION SECTION OF THE APPROVED LABELING OF OZURDEX U-1207 INFANT USE AGED 1 MONTH TO LESS THAN ONE YEAR, GERD AND EROSIVE ESOPHAGITIS U-1208 TREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS